<SEC-DOCUMENT>0001493152-19-015539.txt : 20191015
<SEC-HEADER>0001493152-19-015539.hdr.sgml : 20191015
<ACCEPTANCE-DATETIME>20191015173230
ACCESSION NUMBER:		0001493152-19-015539
CONFORMED SUBMISSION TYPE:	S-1
PUBLIC DOCUMENT COUNT:		95
FILED AS OF DATE:		20191015
DATE AS OF CHANGE:		20191015

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			TRXADE GROUP, INC.
		CENTRAL INDEX KEY:			0001382574
		STANDARD INDUSTRIAL CLASSIFICATION:	WHOLESALE-DRUGS PROPRIETARIES & DRUGGISTS' SUNDRIES [5122]
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		S-1
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-234221
		FILM NUMBER:		191151675

	BUSINESS ADDRESS:	
		STREET 1:		3840 LAND O' LAKES BOULEVARD
		CITY:			LAND O' LAKES
		STATE:			FL
		ZIP:			34639
		BUSINESS PHONE:		(800) 261 0281

	MAIL ADDRESS:	
		STREET 1:		3840 LAND O' LAKES BOULEVARD
		CITY:			LAND O' LAKES
		STATE:			FL
		ZIP:			34639

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	XCELLINK INTERNATIONAL INC.
		DATE OF NAME CHANGE:	20081230

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Bluebird Exploration Co.
		DATE OF NAME CHANGE:	20061204
</SEC-HEADER>
<DOCUMENT>
<TYPE>S-1
<SEQUENCE>1
<FILENAME>forms-1.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin-top: 0; text-align: center; margin-bottom: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">As
filed with the Securities and Exchange Commission on October 15, 2019</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">Registration
No. 333-</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Rule-Page --><DIV STYLE="width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 4pt solid; border-bottom: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 18pt"><B>UNITED
STATES</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 18pt"><B>SECURITIES
AND EXCHANGE COMMISSION</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 12pt"><B>WASHINGTON,
D.C. 20549</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-left: auto; margin-right: auto; width: 25%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B></B></FONT></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 18pt"><B>FORM
S-1</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>REGISTRATION
STATEMENT</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>UNDER
THE SECURITIES ACT OF 1933</B></FONT></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-left: auto; margin-right: auto; width: 25%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 18pt"><B><U>TRXADE
GROUP, INC.</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Exact
name of registrant as specified in its charter)</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-left: auto; margin-right: auto; width: 25%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top; background-color: white; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 32%; font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Delaware</B></FONT></TD>
    <TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 32%; font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>5122</B></FONT></TD>
    <TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 32%; font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>46-3673928</B></FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: white; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>(State
        or other jurisdiction of</I></FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>incorporation
        or organization)</I></FONT></P></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>(Primary
        Standard Industrial</I></FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Classification
        Code Number)</I></FONT></P></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>(I.R.S.
        Employer</I></FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Identification
        Number)</I></FONT></P></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>3840
Land O&rsquo; Lakes Boulevard</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Land
O&rsquo; Lakes, Florida 34639</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(800)
261-0281</B><BR>
<I>(Address, including zip code, and telephone number,</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>including
area code, of registrant&rsquo;s principal executive offices)</I></FONT></P>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-left: auto; margin-right: auto; width: 25%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Suren
Ajjarapu<BR>
Chief Executive Officer<BR>
Trxade Group, Inc.<BR>
3840 Land O&rsquo; Lakes Boulevard</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Land
O&rsquo; Lakes, Florida 34639</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(800)
261-0281</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>(Name,
address, including zip code, and telephone number,</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>including
area code, of agent for service of process)</I></FONT></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<!-- Field: Rule-Page --><DIV STYLE="margin-left: auto; margin-right: auto; width: 25%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Copies
To:</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>David
M. Loev, Esq.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>John
S. Gillies, Esq.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>The
Loev Law Firm, PC</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>6300
West Loop South, Suite 280</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Bellaire,
Texas 77401</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Telephone:
(713) 524-4110</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Facsimile:
(713) 524-4122</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Email:
<U>dloev@loevlaw.com</U>; <U>john@loevlaw.com</U></B></FONT></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-left: auto; margin-right: auto; width: 25%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Approximate
date of commencement of proposed sale to the public: <B>From time to time after this Registration Statement becomes effective.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
any of the securities being registered on this Form are to be offered on a delayed or continuous basis pursuant to Rule 415 under
the Securities Act of 1933 check the following box:&nbsp;[X]</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
this Form is filed to register additional securities for an offering pursuant to Rule 462(b) under the Securities Act, please
check the following box and list the Securities Act registration statement number of the earlier effective registration statement
for the same offering.&nbsp;[&nbsp;&nbsp;]</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
this Form is a post-effective amendment filed pursuant to Rule 462(c) under the Securities Act, check the following box and list
the Securities Act registration statement number of the earlier effective registration statement for the same offering.&nbsp;[&nbsp;&nbsp;]</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
this Form is a post-effective amendment filed pursuant to Rule 462(d) under the Securities Act, check the following box and list
the Securities Act registration statement number of the earlier effective registration statement for the same offering.&nbsp;[&nbsp;&nbsp;]</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Indicate
by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting
company or an emerging growth company. See the definitions of &ldquo;<U>large accelerated filer,</U>&rdquo; &ldquo;<U>accelerated
filer,</U>&rdquo; &ldquo;<U>smaller reporting company</U>&rdquo; and &ldquo;<U>emerging growth company</U>&rdquo; in Rule 12b-2
of the Exchange Act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 60%; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Large
    accelerated filer [&nbsp;&nbsp;]</FONT></TD>
    <TD STYLE="width: 40%; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accelerated
    filer [&nbsp;&nbsp;]</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Non-accelerated
    filer [X]</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Smaller
    reporting company [X]</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Emerging
    growth company [X]</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for
complying with any new or revised financial accounting standards provided to Section 7(a)(2)(B) of the Securities Act.&nbsp;[&nbsp;&nbsp;]</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>CALCULATION
OF REGISTRATION FEE</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Title
    of Each Class of<BR>
    Securities to be Registered</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></TD>
    <TD STYLE="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Amount
    to be<BR>
    Registered<SUP>(1)</SUP></B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Proposed Maximum<BR> Offering Price<BR> Per Share<SUP>(2)</SUP></B></FONT></TD>
    <TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: center">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Proposed Maximum<BR> Aggregate<BR> Offering Price</B></FONT></TD>
    <TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: center">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Amount of<BR> Registration Fee</B></FONT></TD>
    <TD STYLE="padding-bottom: 1.5pt; font: 10pt Times New Roman, Times, Serif; text-align: center">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: white; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 22%; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 2%; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 16%; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 2%; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 16%; text-align: right; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 2%; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 16%; text-align: right; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 2%; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 16%; text-align: right; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: #CCEEFF; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Common
    Stock, $0.00001 par value per share</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4,910,000
    </FONT><FONT STYLE="font: 10pt Times New Roman, Times, Serif">shares</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD>
    <TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif">1.03</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD>
    <TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif">5,057,300.00</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD>
    <TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif">656.44</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 0.25in; text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
    to Rule 416 under the Securities Act of 1933, as amended (the &ldquo;<U>Securities Act</U>&rdquo;), this Registration Statement
    shall also cover any additional shares of the Registrant&rsquo;s common stock that become issuable by reason of any stock
    split, stock dividends, recapitalization, or other similar transactions.</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Estimated
    solely for the purpose of calculating the registration fee pursuant to Rule 457(c) under the Securities Act based upon the
    last sale reported of the Registrant&rsquo;s common stock as reported on the OTCQB Market on October 11, 2019.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>The
registrant hereby amends this Registration Statement on such date or dates as may be necessary to delay its effective date until
the registrant shall file a further amendment which specifically states that this Registration Statement shall thereafter become
effective in accordance with Section 8(a) of the Securities Act or until the Registration Statement shall become effective on
such date as the Securities and Exchange Commission acting pursuant to said Section 8(a), may determine.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Rule-Page --><DIV STYLE="width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid; border-bottom: Black 4pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Red"><B>SUBJECT
TO COMPLETION, DATED OCTOBER 15, 2019</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><IMG SRC="image_001.jpg" ALT="">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>TRXADE
GROUP, INC.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>4,910,000
</B></FONT><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>Shares of Common Stock</B></FONT></P>






<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-left: auto; margin-right: auto; width: 25%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
prospectus relates to the resale by the selling stockholders named herein of 4,910,000 shares of common stock, par value
$0.00001 per share, which we refer to as common stock, of Trxade Group, Inc., which we refer to as us, we, the Company, the Registrant
or Trxade, representing 4,910,000 outstanding shares of common stock, held by the selling stockholders named herein. The
shares of common stock being offered by the selling stockholders (which term includes their respective donees, pledgees, transferees,
or other successors-in-interest) have been issued pursuant to private offering transactions which closed on July 30, 2019 (2,000,000
shares) and September 30, 2019 (2,910,000 shares), which are described in greater detail under &ldquo;<U>Private
Placement of Common Stock</U>&rdquo;, beginning on page 28. The selling stockholders are described in greater detail under
&ldquo;<U>Selling Stockholders</U>&rdquo;, beginning on page 33.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
shares of common stock described in this prospectus may be offered for sale from time to time by the selling stockholders named
herein. The selling stockholders may offer and sell the shares in a variety of transactions as described under the heading &ldquo;<U>Plan
of Distribution</U>&rdquo; beginning on page 31, including transactions on any stock exchange, market or facility on which
our common stock may be traded, in privately negotiated transactions or otherwise at market prices prevailing at the time of sale,
at prices related to such market prices or at negotiated prices. We have no basis for estimating either the number of shares of
our common stock that will ultimately be sold by the selling stockholders or the prices at which such shares will be sold.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
are not selling any securities covered by this prospectus and will not receive any of the proceeds from the sale of such shares
by the selling stockholders. We are bearing all of the expenses in connection with the registration of the shares of common stock,
but all selling and other expenses incurred by the selling stockholders, including commissions and discounts, if any, attributable
to the sale or disposition of the shares will be borne by them.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
selling stockholders and intermediaries through whom such securities are sold may be deemed &ldquo;<U>underwriters</U>&rdquo;
within the meaning of the Securities Act of 1933, as amended (the &ldquo;<U>Securities Act</U>&rdquo;), with respect to the securities
offered hereby, and any profits realized or commissions received may be deemed underwriting compensation.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
current prospectus must be in effect at the time of the sale of the shares of common stock discussed above. The selling stockholders
will be responsible for any commissions or discounts due to brokers or dealers. We will pay all of the other offering expenses.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Each
selling stockholder or dealer selling the common stock is required to deliver a current prospectus upon the sale. In addition,
for the purposes of the Securities Act of 1933, as amended, the selling stockholders may be deemed to be underwriters.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
common stock will be considered a &ldquo;<U>penny stock</U>&rdquo;, and subject to the requirements of Rule 15g-9, promulgated
under the Exchange Act of 1934, as amended. &ldquo;<U>Penny stock</U>&rdquo; is generally defined as any equity security not traded
on an exchange or quoted on NASDAQ that has a market price of less than $5.00 per share. Under such rule, broker-dealers who recommend
low-priced securities to persons other than established customers and accredited investors must satisfy special sales practice
requirements, including a requirement that they make an individualized written suitability determination for the purchaser and
receive the purchaser&rsquo;s consent prior to the transaction. The Securities Enforcement Remedies and Penny Stock Reform Act
of 1990, also requires additional disclosure in connection with any trades involving a stock defined as a penny stock.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
required penny stock disclosures include the required delivery, prior to any transaction, of a disclosure schedule explaining
the penny stock market and the risks associated with it. Such requirements could severely limit the market liquidity of the securities
and the ability of purchasers to sell their securities in the secondary market. In addition, various state securities laws impose
restrictions on transferring &ldquo;<U>penny stocks</U>&rdquo; and as a result, investors in the common stock may have their ability
to sell their shares of the common stock impaired.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
are an &ldquo;<U>emerging growth company</U>&rdquo; as that term is used in the Jumpstart Our Business Startups Act of 2012 (the
&ldquo;<U>JOBS Act</U>&rdquo;) and, as such, have elected to comply with certain reduced public company reporting requirements
for future filings.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
common stock is quoted on the OTCQB Market under the symbol &ldquo;<U>TRXD</U>&rdquo;. The closing price for our common stock
on October 11, 2019, was $1.10 per share.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Investing
in our securities involves risks. You should carefully consider the risk factors beginning on page 8 of this prospectus
and set forth in the documents incorporated by reference herein before making any decision to invest in our securities.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>We
are an &ldquo;<U>emerging growth company</U>&rdquo; under applicable federal securities laws and are subject to reduced public
company reporting requirements. See <I>&ldquo;</I>Risk Factors<I>&rdquo; </I>starting on page 8. Prices of our common stock
as reported on the OTCQB may not be indicative of the prices of our common stock if our common stock were traded on some other
exchange. Accordingly, an investment in our common stock is considered an illiquid investment and subject to many risks.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Neither
the Securities and Exchange Commission nor any state securities commission has approved or disapproved of these securities or
passed upon the adequacy or accuracy of this prospectus. Any representation to the contrary is a criminal offense.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>The
date of this prospectus is &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;, 2019.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>TABLE
OF CONTENTS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top; background-color: White; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 0.5in; border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Page</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif"><A HREF="#b_001"><FONT STYLE="font-size: 10pt">About
    This Prospectus</FONT></A></FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif"><A HREF="#b_002"><FONT STYLE="font-size: 10pt">Cautionary
    Statement Regarding Forward-Looking Statements</FONT></A></FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif"><A HREF="#b_003"><FONT STYLE="font-size: 10pt">Prospectus
    Summary</FONT></A></FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif"><A HREF="#b_004"><FONT STYLE="font-size: 10pt">This
    Offering</FONT></A></FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif"><A HREF="#b_005"><FONT STYLE="font-size: 10pt">Risk
    Factors</FONT></A></FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif">8</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="#k_001">Private
    Placement Of Common Stock</A></FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">28</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif"><A HREF="#k_002"><FONT STYLE="font-size: 10pt">Use
    Of Proceeds</FONT></A></FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">29</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif"><A HREF="#k_003"><FONT STYLE="font-size: 10pt">Determination
    Of Offering Price</FONT></A></FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">29</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif"><A HREF="#k_004"><FONT STYLE="font-size: 10pt">Description
    Of Capital Stock</FONT></A></FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">29</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif"><A HREF="#k_005"><FONT STYLE="font-size: 10pt">Plan
    Of Distribution</FONT></A></FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">31</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif"><A HREF="#k_006"><FONT STYLE="font-size: 10pt">Selling
    Stockholders</FONT></A></FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">33</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif"><A HREF="#k_007"><FONT STYLE="font-size: 10pt">Certain
    Beneficial Owners And Management</FONT></A></FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">35</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif"><A HREF="#k_008"><FONT STYLE="font-size: 10pt">Dividend
    Policy</FONT></A></FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">36</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif"><A HREF="#k_009"><FONT STYLE="font-size: 10pt">United
    States Federal Income Tax Considerations</FONT></A></FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">36</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif"><A HREF="#k_010"><FONT STYLE="font-size: 10pt">Legal
    Matters</FONT></A></FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">38</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif"><A HREF="#k_011"><FONT STYLE="font-size: 10pt">Experts</FONT></A></FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">38</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif"><A HREF="#k_012"><FONT STYLE="font-size: 10pt">Changes
    In And Disagreements With Accountants On Accounting And Financial Disclosure</FONT></A></FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">38</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif"><A HREF="#k_013"><FONT STYLE="font-size: 10pt">Description
    Of Business</FONT></A></FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">38</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif"><A HREF="#p_001"><FONT STYLE="font-size: 10pt">Description
    Of Property</FONT></A></FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">48</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif"><A HREF="#p_002"><FONT STYLE="font-size: 10pt">Legal
    Proceedings</FONT></A></FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">48</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif"><A HREF="#p_003"><FONT STYLE="font-size: 10pt">Market
    For Common Equity And Related Stockholder Matters </FONT></A></FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">48</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif"><A HREF="#p_004"><FONT STYLE="font-size: 10pt">Equity
    Compensation Plan Information</FONT></A></FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">50</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif"><A HREF="#p_005"><FONT STYLE="font-size: 10pt">Management&rsquo;s
    Discussion And Analysis Of Financial Condition And Results Of Operations</FONT></A></FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">50</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif"><A HREF="#p_006"><FONT STYLE="font-size: 10pt">Quantitative
    And Qualitative Disclosures About Market Risk</FONT></A></FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">57</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif"><A HREF="#p_007"><FONT STYLE="font-size: 10pt">Controls
    And Procedures</FONT></A></FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">57</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif"><A HREF="#s_001"><FONT STYLE="font-size: 10pt">Directors,
    Executive Officers And Corporate Governance</FONT></A></FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">58</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif"><A HREF="#s_003"><FONT STYLE="font-size: 10pt">Executive
    And Director Compensation</FONT></A></FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">64</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif"><A HREF="#s_004"><FONT STYLE="font-size: 10pt">Certain
    Relationships And Related Transactions, And Director Independence</FONT></A></FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">72</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif"><A HREF="#s_005"><FONT STYLE="font-size: 10pt">Where
    You Can Find Additional Information</FONT></A></FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">75</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif"><A HREF="#s_006"><FONT STYLE="font-size: 10pt">Indemnification
    Of Directors And Officers</FONT></A></FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">75</FONT></TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255); font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif"><A HREF="#s_007"><FONT STYLE="font-size: 10pt">Index
    To Financial Statements</FONT></A></FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">77</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>


<!-- Field: Page; Sequence: 4 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A NAME="b_001"></A>ABOUT
THIS PROSPECTUS</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
prospectus is part of a registration statement that we filed with the Securities and Exchange Commission (the &ldquo;<U>SEC</U>&rdquo;
or the &ldquo;<U>Commission</U>&rdquo;). This prospectus relates to the resale by the selling stockholders listed in this prospectus
of up to 4,910,000 shares of our common stock. We will not receive any proceeds from the resale of any of the shares by
the selling stockholders. We have agreed to pay for the expenses related to the registration of the shares being offered by the
selling stockholders.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">You
should read this prospectus, together with additional information described under &ldquo;<U>Where You Can Find More Information</U>&rdquo;,
beginning on page 75, before making an investment decision.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
prospectus does not contain all the information provided in the registration statement we filed with the SEC. For further information
about us or our securities offered hereby, you should refer to that registration statement, which you can obtain from the SEC
as described below under &ldquo;<U>Where You Can Find More Information</U>&rdquo;, beginning on page 75.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">You
should rely only on the information contained in this prospectus. We have not authorized any other person to provide you with
different information. If anyone provides you with different or inconsistent information<B>, </B>you should not rely on it. This
prospectus is not an offer to sell or the solicitation of an offer to buy any securities other than the securities to which it
relates and is not an offer to sell or the solicitation of an offer to buy securities in any jurisdiction to any person to whom
it is unlawful to make an offer or solicitation in that jurisdiction.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
will disclose any material changes in our affairs in a post-effective amendment to the registration statement of which this prospectus
is a part, or a prospectus supplement. We do not imply or represent by delivering this prospectus that Trxade Group, Inc., or
its business, financial condition or results of operations, are unchanged after the date on the front of this prospectus is correct
at any time after such date, provided that we will amend or supplement this prospectus to disclose any material events which occur
after the date of such prospectus to the extent required by applicable law.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Persons
outside the United States who come into possession of this prospectus must inform themselves about, and observe any restrictions
relating to, the offering of the securities and the distribution of this prospectus outside of the United States.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
logo and some of our trademarks and tradenames are used in this prospectus. This prospectus also includes trademarks, tradenames
and service marks that are the property of others. Solely for convenience, trademarks, tradenames and service marks referred to
in this prospectus may appear without the &reg;, &trade; and SM symbols. References to our trademarks, tradenames and service
marks are not intended to indicate in any way that we will not assert to the fullest extent under applicable law our rights or
the rights of the applicable licensors if any, nor that respective owners to other intellectual property rights will not assert,
to the fullest extent under applicable law, their rights thereto. We do not intend the use or display of other companies&rsquo;
trademarks and trade names to imply a relationship with, or endorsement or sponsorship of us by, any other companies.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
market data and certain other statistical information used throughout this prospectus are based on independent industry publications,
reports by market research firms or other independent sources that we believe to be reliable sources. Industry publications and
third-party research, surveys and studies generally indicate that their information has been obtained from sources believed to
be reliable, although they do not guarantee the accuracy or completeness of such information. We are responsible for all of the
disclosure contained in this prospectus, and we believe these industry publications and third-party research, surveys and studies
are reliable. While we are not aware of any misstatements regarding any third-party information presented in this prospectus,
their estimates, in particular, as they relate to projections, involve numerous assumptions, are subject to risks and uncertainties,
and are subject to change based on various factors, including those discussed under the section entitled &ldquo;<U>Risk Factors</U>&rdquo;
beginning on page 8 of this prospectus. These and other factors could cause our future performance to differ materially
from our assumptions and estimates. Some market and other data included herein, as well as the data of competitors as they relate
to Trxade Group, Inc., is also based on our good faith estimates.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 5; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Unless
the context otherwise requires, references in this prospectus to &ldquo;<U>we,</U>&rdquo; &ldquo;<U>us,</U>&rdquo; &ldquo;<U>our,</U>&rdquo;
the &ldquo;<U>Registrant</U>&rdquo;, the &ldquo;<U>Company,</U>&rdquo; &ldquo;<U>Trxade</U>&rdquo; and &ldquo;<U>Trxade Group</U>&rdquo;
refer to Trxade Group, Inc. and its subsidiaries. In addition, unless the context otherwise requires, &ldquo;<U>Exchange Act</U>&rdquo;
refers to the Securities Exchange Act of 1934, as amended; &ldquo;<U>SEC</U>&rdquo; or the &ldquo;<U>Commission</U>&rdquo; refers
to the United States Securities and Exchange Commission; and &ldquo;<U>Securities Act</U>&rdquo; refers to the Securities Act
of 1933, as amended. All dollar amounts in this prospectus are in U.S. dollars unless otherwise stated. You should read the entire
prospectus before making an investment decision to purchase our securities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><A NAME="b_002"></A><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">CAUTIONARY
STATEMENT REGARDING FORWARD-LOOKING STATEMENTS</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
prospectus, each prospectus supplement and the information incorporated by reference in this prospectus and each prospectus supplement
contain certain statements that constitute &ldquo;forward-looking statements&rdquo; within the meaning of Section 27A of the Securities
Act and Section 21E of the Securities Exchange Act. The words &ldquo;believe,&rdquo; &ldquo;may,&rdquo; &ldquo;will,&rdquo; &ldquo;potentially,&rdquo;
&ldquo;estimate,&rdquo; &ldquo;continue,&rdquo; &ldquo;anticipate,&rdquo; &ldquo;intend,&rdquo; &ldquo;could,&rdquo; &ldquo;would,&rdquo;
&ldquo;project,&rdquo; &ldquo;plan,&rdquo; &ldquo;expect&rdquo; and the negative and plural forms of these words and similar expressions
are intended to identify forward-looking statements, but are not the exclusive means of identifying such statements. Those statements
appear in this prospectus, any accompanying prospectus supplement and the documents incorporated herein and therein by reference,
particularly in the sections titled &ldquo;Prospectus Summary&rdquo; and &ldquo;Risk Factors,&rdquo; and include statements regarding
the intent, belief or current expectations of the Company and management that are subject to known and unknown risks, uncertainties
and assumptions.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
prospectus, any prospectus supplement and the information incorporated by reference in this prospectus and any prospectus supplement
also contain statements that are based on the current expectations of our Company and management. You are cautioned that any such
forward-looking statements are not guarantees of future performance and involve risks and uncertainties, and that actual results
may differ materially from those projected in the forward-looking statements as a result of various factors.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Because
forward-looking statements are inherently subject to risks and uncertainties, some of which cannot be predicted or quantified,
you should not rely upon forward-looking statements as predictions of future events. The events and circumstances reflected in
the forward-looking statements may not be achieved or occur and actual results could differ materially from those projected in
the forward-looking statements. Except as required by applicable law, including the securities laws of the United States and the
rules and regulations of the SEC, we do not plan to publicly update or revise any forward-looking statements contained herein
after we distribute this prospectus, whether as a result of any new information, future events or otherwise.</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">You
should also consider carefully the statements under &ldquo;Risk Factors&rdquo; and other sections of this prospectus, which address
additional facts that could cause our actual results to differ from those set forth in the forward-looking statements. We caution
investors not to place significant reliance on the forward-looking statements contained in this prospectus.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 6; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<DIV STYLE="padding-right: 0.1in; padding-left: 0.1in; border: Black 1.5pt solid; text-align: center">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><A NAME="b_003"></A><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">PROSPECTUS
SUMMARY</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following summary highlights material information found in more detail elsewhere in the prospectus. It does not contain all of
the information you should consider. As such, before you decide to buy our common stock, in addition to the following summary,
we urge you to carefully read the entire prospectus, especially the risks of investing in our common stock as discussed under
&ldquo;<U>Risk Factors</U>.&rdquo;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>About
Trxade Group, Inc.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have designed and developed, and now own and operate, a business-to-business, web-based marketplace focused on the United States
pharmaceutical industry. Our core service brings the nation&rsquo;s independent pharmacies and accredited national suppliers of
pharmaceuticals together to provide efficient and transparent buying and selling opportunities. Our executive offices are located
at 3840 Land O&rsquo; Lakes Boulevard, Land O&rsquo; Lakes, Florida 34639, and our telephone number is (800) 261-0281.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">We began operations as
Trxade Group, Inc., a Nevada corporation (&ldquo;<U>Trxade Nevada</U>&rdquo;) in August of 2010 and initially spent two years
creating and enhancing our web-based services. Our services provide enhanced pricing transparency, purchasing capabilities and
other value-added services on a single platform focusing on serving the nation&rsquo;s approximately 22,000 independent pharmacies
with an annual purchasing power of $76 billion (according to the National Community of Pharmacists Association&rsquo;s 2018 Digest).
Our national supplier partners are able to fulfill orders on our platform immediately and provide pharmacies with cost saving
payment terms and next day delivery capabilities in compliance with all state boards of pharmacy and federal regulations.
We have expanded rapidly since 2015 and now have over 10,000 registered pharmacy members purchasing products on our sales platform.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
December 2013, we launched a second service to help pharmaceutical distributors&rsquo; better source their pharmaceutical needs
within a highly structured single platform. This solution is designed to help purchasers overcome pharmaceutical supply issues
as a means to control costs on drugs with volatile pricing, as well as to help our buyers make better purchasing choices based
on their needs. Additionally, we built and, in February 2014, launched a new desktop application, named &ldquo;<U>RxGuru</U>&rdquo;,
to bring product information on a just-in-time basis to our member base. Our pharmacy members benefit from this application by
gaining advanced data analytics at point of purchase and patient care. RxGuru has been upgraded to continue the benefit to the
pharmacies.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
2015 and 2016, through Westminster Pharmaceuticals, LLC, our former wholly-owned subsidiary and distribution division (&ldquo;<U>Westminster</U>&rdquo;),
we launched a private label pharmaceutical product program and entered into various supply contracts with pharmaceutical manufacturers
to supply Westminster with generic pharmaceutical products on a private label basis to sell to our customers. In connection with
this expansion, Westminster received significant funding in late 2015 and early 2016. Westminster was not profitable and in December
2016 we sold this division and exited the private label distribution business.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
October 2018, we acquired 100 percent of Community Specialty Pharmacy, LLC (&ldquo;<U>CSP</U>&rdquo;) an accredited independent
retail pharmacy with a focus on specialty medications. CSP operates with an innovative pharmacy model which offers home delivery
services to any patient thereby providing convenience. We have continued CSP&rsquo;s pharmacy model.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">In late 2018, we launched
<I>Delivmeds.com</I>, a consumer-based app to provide delivery of pharmaceutical products operating as part of Alliance Pharma
Solutions, LLC (&ldquo;<U>Alliance</U>&rdquo;). In early 2019, as part of the SyncHealth MSO, LLC joint venture, technology was
being developed to assist independent retail pharmacies to better compete with large national pharmacies on exposure,
pricing, distribution and logistics. To date, we have not realized any income from the technology and presently
we are in discussions to dissolve this relationship.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

</DIV>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 7; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<DIV STYLE="padding-right: 0.1in; padding-left: 0.1in; border: Black 1.5pt solid">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Our
Principal Products and Services and their Markets.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Trxade.com
</I>is a web-based pharmaceutical marketplace engaged in promoting and enabling commerce among independent pharmacies and large
pharmaceutical suppliers nationally. Our marketplace has hundreds of suppliers providing over 20,000 branded and generic drugs
available for purchase by pharmacists. We already serve over 10,000 independent pharmacies with access to our proprietary pharmaceutical
database, data analytics regarding medication pricing, and manufacturer return policies. We generate revenues from these services
by charging a transaction fee to the seller of the products for sales conducted via our Trxade platform. The buyers do not bear
the cost of transaction fees for the purchases which they make, nor do they pay a fee to join or register with our platform. Substantially
all of our revenues since 2017, were from platform revenue generated on <I>www.Trxade.com. </I>For additional information, please
visit us at <I>http://www.trxadegroup.com, http://www.trxade.com, and http://www.delivmeds.com,  </I>information
on our website is not incorporated by reference into this prospectus.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Status
of new products or services.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have a number of products and services still in development, which are described below.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>InventoryRx.com</U>.
InventoryRx, launched in the first quarter of 2014, is a web-based pharmaceutical exchange platform where wholesalers can buy
and sell pharmaceuticals or over-the-counter medications with each other in a systematized online sales platform. The site offers
these trading partners&rsquo; greater product availability and pricing transparency. The site may also substantially improve our
customers buying efficiency and lower their cost of goods on a continuous basis. This product is built into the <I>Trxade.com
</I>platform and, accordingly, we have not generated any independent revenue from this product.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Pharmabayonline</U>.
We formed Pharmabayonline to provide proprietary pharmaceutical data analytics and governmental reimbursement benchmarks analysis
to United States-based independent pharmacies and pharmaceutical databases.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>RxGuru</U>.
Our RxGuru application was launched in the first quarter of 2014 and underscores our commitment to deliver timely information
to our customers at the moment before purchase. Our industry leading price prediction model, &ldquo;RxGuru&rdquo;, integrates
product insight into pharmacy acquisition cost benchmarks (&ldquo;<U>PAC</U>&rdquo;) to ascertain trends and pricing variances
which result in significant purchasing opportunities. &ldquo;<U>RX Guru</U>&rdquo; helps to predict prices and affords our members
an opportunity to continuously benefit from real price purchasing opportunities that are often concealed from the rest of the
industry. This product is built into the <I>Trxade.com</I> platform and, accordingly, this application works in conjunction with
the Trxade platform but, to date, has not generated any independent revenue.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Integra
Pharma Solutions, LLC</U>. Integra is intended to serve as our logistics company for pharmaceutical distribution.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Community
Specialty Pharmacy, LLC</U>. We acquired CSP on October 15, 2018. CSP is an accredited pharmacy located in St. Petersburg, Florida
and focuses upon specialty medications. The company operates with an innovative pharmacy model which offers home delivery services
to any patient thereby providing convenience.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Delivmeds.com</U>.
<I>Delivmeds.com</I> was launched in late 2018 as a consumer-based app to provide delivery of pharmaceutical products associated
with Alliance Pharma Solutions, LLC. To date, we have not generated any revenue from this product.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><U>Trxademso Technology</U>. Early
2019 as part of the SyncHealth MSO, LLC joint venture technology development began that would
assist independent retail pharmacies to compete better with large national pharmacies on exposure, pricing,
distribution and logistics. To date, we have not realized any income from this product and currently we are
in discussions to dissolve this relationship.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

</DIV>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 8; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<DIV STYLE="padding-right: 0.1in; padding-left: 0.1in; border: Black 1.5pt solid">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">All
our product offerings are focused on the United States markets. Some products are restricted just to certain states, depending
upon the various applicable state regulations and guidelines pertaining to pharmaceuticals, particularly, and drug businesses,
generally. Our services are distributed through our online platform.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>The
Pharmaceutical Industry</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">According
to the <I>2013-14 Economic Report on Retail, Mail, and Specialty Pharmacies</I> by Adam J. Fein, Ph.D. (the &ldquo;<U>Fein Report</U>&rdquo;),
United States pharmaceutical companies comprise a burgeoning $330 billion industry consisting of over 65,000 pharmacy facilities
and 700 Drug Enforcement Administration (DEA)-registered (and 1,500 State-licensed) suppliers. Management believes that few platforms
currently in place to bring these participants together to share market knowledge, product pricing transparency and product availability.
According to this, the pharmaceutical market is comprised primarily of three wholesalers that control an estimated approximately
92% of the market. Our management believes that this concentration has, over the years, led to a lack of price and cost transparency,
thereby resulting in severe limitations on the purchasing choices of industry participants. These market dynamics have enabled
these large wholesalers (McKesson, Cardinal Health and AmerisourceBergen), known as ADR distributors, to dominate the industry
with respect to both generic and brand pharmaceuticals. The increasing concentration of generic medications (ANDA, or &ldquo;<U>Abbreviated
New Drug Application</U>&rdquo;), however, with many more expected to go to market in the near future (approximately $80 billion
in branded medications lost their patent protection from 2008 to 2018, according to an article in Drug Topics from August 2004,
called &ldquo;Big Pharma uses effective strategies to battle generic competitors&rdquo;, by Martin Sipkoff), have enabled smaller
suppliers&rsquo; access to an increasing number of medications at highly discounted prices. The market is slowly changing towards
one where medications will become commoditized and influenced by price rather than the business relationships imposed by the dominant
participants of the past.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
fuel this change, insurance companies (Pharmacy Benefits Management (&ldquo;<U>PBM</U>&rdquo;) and private health payers) and
the federal government have recently initiated lower medication reimbursement payments to healthcare providers. We believe that
pharmacies in due course will face increasing pressure to source medications as inexpensively as possible and improve operational
efficiency. Trxade seeks to be in the forefront of solving these transparency and pricing concerns by providing independent, retail
pharmacies with real-time, pharmacy acquisition cost (&ldquo;<U>PAC</U>&rdquo;) benchmarks to the National Drug Code (the &ldquo;<U>NDC</U>&rdquo;)
standard. The NDC mark is a unique product identifier used in the United States for drugs intended for human use.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Penny
Stock Rules</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
common stock will be considered a &ldquo;<U>penny stock</U>&rdquo;, and subject to the requirements of Rule 15g-9, promulgated
under the Exchange Act. &ldquo;<U>Penny stock</U>&rdquo; is generally defined as any equity security not traded on an exchange
or quoted on NASDAQ that has a market price of less than $5.00 per share. Under such rule, broker-dealers who recommend low-priced
securities to persons other than established customers and accredited investors must satisfy special sales practice requirements,
including a requirement that they make an individualized written suitability determination for the purchaser and receive the purchaser&rsquo;s
consent prior to the transaction. The Securities Enforcement Remedies and Penny Stock Reform Act of 1990, also requires additional
disclosure in connection with any trades involving a stock defined as a penny stock.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
required penny stock disclosures include the required delivery, prior to any transaction, of a disclosure schedule explaining
the penny stock market and the risks associated with it. Such requirements could severely limit the market liquidity of the securities
and the ability of purchasers to sell their securities in the secondary market. In addition, various state securities laws impose
restrictions on transferring &ldquo;<U>penny stocks</U>&rdquo; and as a result, investors in the common stock may have their ability
to sell their shares of the common stock impaired.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

</DIV>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 9; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<DIV STYLE="padding-right: 0.1in; padding-left: 0.1in; border: Black 1.5pt solid">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 10pt; text-align: justify; text-indent: -10pt; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Implications
of Being an Emerging Growth Company</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 10pt; text-align: justify; text-indent: -10pt; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
a company with less than $1.0 billion in revenue during our last completed fiscal year, we qualify as an &ldquo;<U>emerging growth
company</U>&rdquo; as defined in the Jumpstart Our Business Startups Act of 2012, or the JOBS Act. An emerging growth company
may take advantage of certain reduced reporting requirements that are otherwise applicable generally to public companies. These
reduced reporting requirements include:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 0.25in; text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">an
    exemption from compliance with the auditor attestation requirement on the effectiveness of our internal control over financial
    reporting;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">an
    exemption from compliance with any requirement that the Public Company Accounting Oversight Board, or PCAOB, may adopt regarding
    mandatory audit firm rotation or a supplement to the auditor&rsquo;s report providing additional information about the audit
    and the financial statements;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">reduced
    disclosure about our executive compensation arrangements;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">an
    exemption from the requirements to obtain a non-binding advisory vote on executive compensation or stockholder approval of
    any golden parachute arrangements;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">extended
    transition periods for complying with new or revised accounting standards; and</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    ability to present more limited financial data, including presenting only three years of selected financial data in the registration
    statement, of which this prospectus is a part.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: -0.25in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
will remain an emerging growth company until the earliest to occur of: (i) the end of the first fiscal year in which our annual
gross revenue is $1.0 billion or more; (ii) the end of the fiscal year in which the market value of our common stock that is held
by non-affiliates is at least $700 million as of the last business day of our most recently completed second fiscal quarter; (iii)
the date on which we have, during the previous three-year period, issued more than $1.0 billion in non-convertible debt securities;
and (iv) the last day of the end of our 2024 fiscal year (5 years from our first public offering). We may choose to take advantage
of some, but not all, of the available benefits under the JOBS Act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
are choosing to irrevocably &ldquo;<U>opt out</U>&rdquo; of the extended transition periods available under Section 107 of the
JOBS Act for complying with new or revised accounting standards, but we currently intend to take advantage of the other exemptions
discussed above. Accordingly, the information contained herein may be different than the information you receive from other public
companies in which you invest.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

</DIV>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 10; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<DIV STYLE="padding-right: 0.1in; padding-left: 0.1in; border: Black 1.5pt solid">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A NAME="b_004"></A>THIS
OFFERING</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">The
selling stockholders named in this prospectus may offer and sell up to </FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4,910,000
</FONT><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="background-color: white">shares of our common stock,
par value $0.00001 per share. Our common stock is currently quoted </FONT>on the OTC Markets Group Inc.&rsquo;s OTCQB&reg; tier
Venture Market (the &ldquo;<U>OTCQB</U>&rdquo;) under the trading symbol, &ldquo;TRXD.&rdquo; <FONT STYLE="background-color: white">We
will not receive any of the proceeds of sales by our selling stockholders of any of the common stock covered by this prospectus.</FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 30%; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Shares
    of Common Stock Offered by the Selling Stockholders:</B></FONT></TD>
    <TD STYLE="width: 70%; text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4,910,000
    </FONT><FONT STYLE="font: 10pt Times New Roman, Times, Serif">shares of common stock.</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><B>Shares of Common Stock Outstanding Prior to, and after, this Offering:</B></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif">39,986,459 shares of common stock.</TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Use
    of Proceeds:</B></FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
    will not receive any of the proceeds from the sale or other disposition by the selling stockholders or their transferees of
    the shares of common stock covered hereby.</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Risk
    factors:</B></FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    purchase of our common stock involves a high degree of risk. The common stock offered in this prospectus is for investment
    purposes only and currently only a limited market exists for our common stock. Please refer to the section entitled &ldquo;<U>Risk
    Factors</U>&rdquo; before making an investment in our common stock.</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Trading
    symbol:</B></FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
    common stock is quoted on the OTCQB under the trading symbol &ldquo;TRXD&rdquo;.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
this prospectus, unless otherwise indicated, the number of shares of our common stock and other capital stock, and the other information
based thereon, is as of October 11, 2019 and excludes:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">shares
    issuable upon the exercise of outstanding warrants, options and convertible notes.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Additionally,
unless otherwise stated, all information in this prospectus:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 0.25in; text-align: left; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">reflects
    all currency in United States dollars.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

</DIV>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 11; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><A NAME="b_005"></A><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">RISK
FACTORS</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>You
should be aware that there are substantial risks for an investment in our common stock. You should carefully consider these risk
factors, along with the other information included in this prospectus, before you decide to invest in our common stock.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>If
any of the following risks were to occur, such as our business, financial condition, results of operations or other prospects,
any of these could materially affect our likelihood of success. If that happens, the market price of our common stock, if any,
could decline, and prospective investors would lose all or part of their investment in our common stock.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Risks
Related to the Business</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
business, financial condition and results of operations are subject to various risks and uncertainties, including those described
below and elsewhere in this prospectus. This section discusses factors that, individually or in the aggregate, we think could
cause our actual results to differ materially from expected and historical results. Our business, financial condition or results
of operations could be materially adversely affected by any of these risks. It is not possible to predict or identify all such
factors. Consequently, the following description of Risk Factors is not a complete discussion of all potential risks or uncertainties
applicable to our business.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>The
costs of being a public company could result in us being unable to continue as a going concern.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
a public company, we will be required to comply with numerous financial reporting and legal requirements, including those pertaining
to annual audits, quarterly review and reporting and internal controls. The costs of this compliance could be quite significant.
If revenues are insufficient, or we cannot satisfy many of these costs through the issuance of shares, we may be unable to satisfy
these costs through the normal course of business which would result in being unable to continue as a going concern.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>We
were recently unprofitable and we may incur losses in the future.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
2017, we became profitable for the first time; in prior years, we were unprofitable and generated a net accumulated deficit of
($8,120,113). Our current business model has been in constant and improved development since 2010 with results that culminated
in our first profit for the year ended December 31, 2017. Revenues generated from our consolidated operations for the years ended
December 31, 2018 and 2017 were $3,831,778 and $2,931,280, respectively. Revenues generated from our consolidated operations for
the six-month periods ended June 30, 2019 and 2018 were $3,428,935 and $1,690,611, respectively.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
incurred positive net income for the years ended December 31, 2018 and 2017 of $9,038 and $288,983, respectively and $183,210
and $102,782 for the six months ended June 30, 2019 and 2018, respectively. We may incur other losses in the foreseeable future
due to the significant costs associated with our business development, including costs associated with maintaining compliance
under SEC reporting standards. We cannot assure you that our operations will annually generate sufficient revenues to fund our
continuing operations or to fully implement our business plan, and thereafter sustain profitability in any future period.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
likelihood of our success must be considered in light of the problems, expenses, difficulties, complications and delays frequently
encountered in connection with the start and growth of a business, the implementation and execution of our business plan, and
the regulatory environment affecting the distribution of pharmaceuticals in which we operate.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 12; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>We
may be subject to claims that we violated intellectual property rights of others, which are extremely costly to defend and could
require us to pay significant damages and limit our ability to operate.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Companies
in the Internet and technology industries, and other patent and trademark holders seeking to profit from royalties in connection
with grants of licenses, own large numbers of patents, copyrights, trademarks and trade secrets and frequently enter into litigation
based on allegations of infringement or other violations of intellectual property rights. There may be intellectual property rights
held by others, including issued or pending patents and trademarks, that cover significant aspects of our technologies, content,
branding or business methods. Any intellectual property claims against us, regardless of merit, could be time-consuming and expensive
to settle or litigate and could divert our management&rsquo;s attention and other resources. These claims also could subject us
to significant liability for damages and could result in our having to stop using technology, content, branding or business methods
found to be in violation of another party&rsquo;s rights. We might be required or may opt to seek a license for rights to intellectual
property held by others, which may not be available on commercially reasonable terms, or at all. If we cannot license or develop
technology, content, branding or business methods for any allegedly infringing aspect of our business, we may be unable to compete
effectively. Even if a license is available, we could be required to pay significant royalties, which could increase our operating
expenses. We may also be required to develop alternative non-infringing technology, content, branding or business methods, which
could require significant effort and expense and be inferior. Any of these results could harm our operating results.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"><B><I>Our
websites may encounter technical problems and service interruptions.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">Our
websites may in the future experience slower response times or interruptions as a result of increased traffic or other reasons.
These delays and interruptions resulting from failure to maintain Internet service connections to our site could frustrate visitors
and reduce our future web site traffic, which could have a material adverse effect on our business.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>If
we do not successfully implement any acquisition strategies, our operating results and prospects could be harmed.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
face competition within our industry for acquisitions of businesses, technologies and assets, and, in the future, such competition
may become more intense. As such, even if we are able to identify an acquisition that we would like to consummate, we may not
be able to complete the acquisition on commercially reasonable terms or at all because of such competition. Furthermore, if we
enter into negotiations that are not ultimately consummated, those negotiations could result in diversion of management time and
significant out-of-pocket costs. Even if we are able to complete such acquisitions, we may additionally expend significant amounts
of cash or incur substantial debt to finance them, which indebtedness could result in restrictions on our business and use of
available cash. In addition, we may finance or otherwise complete acquisitions by issuing equity or convertible debt securities,
which could result in dilution of our existing stockholders. If we fail to evaluate and execute acquisitions successfully, we
may not be able to realize their benefits. If we are unable to successfully address any of these risks, our business, financial
condition or operating results could be harmed.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>If
we do not obtain additional financing, our business, prospects, financial condition and results of operations will be adversely
affected.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Management
anticipates that we will require additional working capital to pursue continued development of products, services, and marketing
operations. We cannot accurately predict the timing and amount of such capital requirements. Additional financing may not be available
to us when needed or, if available, it may not be obtained on commercially reasonable terms. If we are not able to obtain the
necessary additional financing on a timely or commercially reasonable basis, we will be forced to delay or scale down some or
all of its development activities (or perhaps even cease the operation of our business).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 13; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have no commitments for any additional financing, and such commitments may not be obtained on favorable terms, if at all. Any
additional equity financing will be dilutive to our stockholders, and debt financing, if available, may involve restrictive covenants
with respect to dividends, raising future capital, and other financial and operational matters. If we are unable to obtain additional
financing as needed, we may be required to reduce the scope of our operations or our anticipated expansion, which could have a
material adverse effect on us.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>We
have identified a material weakness in our internal control over financial reporting which could, if not remediated, adversely
affect our ability to report our financial condition, cash flows and results of operations in a timely and accurate manner and/or
increase the risk of future misstatements, which could have a material adverse effect on our business, financial condition, cash
flows and results of operations and could cause the market value of our shares of common stock and/or debt securities to decline.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
management is responsible for establishing and maintaining adequate internal control over our financial reporting, as defined
in Rule 13a-15(f) under the Exchange Act. Based on reviews conducted by management, we have concluded that a material weakness
in the Company&rsquo;s internal controls over financial reporting. A material weakness is a deficiency, or a combination of deficiencies,
in internal controls over financial reporting such that there is a reasonable possibility that a material misstatement of our
annual or interim financial statements will not be prevented or detected on a timely basis.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company has identified certain remediation actions and is in the process of implementing them, but such efforts are not complete
and remain ongoing. If we do not complete our remediation in a timely manner or if our remedial measures are insufficient to address
the material weaknesses, or if additional material weaknesses in our internal controls are discovered or occur in the future,
it may materially adversely affect our ability to report our financial condition and results of operations in a timely and accurate
manner and there will continue to be an increased risk of future misstatements. Although we regularly review and evaluate internal
controls systems to allow management to report on the effectiveness of our internal controls over financial reporting, we may
discover additional weaknesses in our internal controls over financial reporting or disclosure controls and procedures. The next
time we evaluate our internal controls over financial reporting and disclosure controls and procedures, if we identify one or
more new material weaknesses or have been unable to timely remediate our existing material weaknesses, we would be unable to conclude
that our internal controls over financial reporting or disclosure controls and procedures are effective. If we are unable to conclude
that our internal controls over financial reporting or our disclosure controls and procedures are effective, or if our independent
registered public accounting firm expresses an opinion that our internal controls over financial reporting is ineffective, we
may not be able to report our financial condition and results of operations in a timely and accurate manner, which could have
a material adverse effect on our business, financial condition, cash flows and results of operations and could cause the market
value of our shares of common stock to decline. In addition, any potential future restatements could subject us to additional
adverse consequences, including sanctions by the SEC, stockholder litigation and other adverse actions. Moreover, we may be the
subject of further negative publicity focusing on such financial statement adjustments and resulting restatement and negative
reactions from our stockholders, creditors or others with whom we do business. The occurrence of any of the foregoing could have
a material adverse effect on our business, financial condition, cash flows and results of operations and could cause the market
value of our shares of common stock to decline.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Failure
to adequately manage our growth may seriously harm our business.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
plan to grow our business as rapidly as possible. If we do not effectively manage our growth, the quality of our services may
suffer, which could negatively affect our reputation and demand for our services. Our growth may place a significant strain on
our managerial, administrative, operational, and financial resources and our infrastructure. Our future success will depend, in
part, upon the ability of our senior management to manage growth effectively. This will require us to, among other things:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">implement
    additional management information systems;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 14; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">further
    develop our operating, administrative, legal, financial, and accounting systems and controls;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">hire
    additional personnel;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">develop
    additional levels of management within our company;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">locate
    additional office space;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">maintain
    close coordination among our engineering, operations, legal, finance, sales and marketing, and client service and support
    organizations; and</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">manage
    our expanding international operations.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
a result, we may lack the resources to deploy our services on a timely and cost-effective basis. Failure to accomplish any of
these requirements could impair our ability to deliver services in a timely fashion or attract and retain new customers.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>The
public health crisis involving the abuse of prescription opioid pain medication could have a material negative effect on our business.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
Pharmaceutical segment distributes prescription opioid pain medications. In recent years, the abuse of prescription opioid pain
medication has become a public health crisis.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
significant number of counties, municipalities and other plaintiffs, including a number of state attorneys general, have filed
lawsuits against pharmaceutical manufacturers, pharmaceutical wholesale distributors, retail chains and others relating to the
manufacturing, marketing or distribution of prescription opioid pain medications. The defense and resolution of future lawsuits
and events relating to these lawsuits could have a material adverse effect on our results of operations, financial condition,
cash flows or liquidity or have adverse reputational or operational effects on our business.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other
legislative, regulatory or industry measures related to the public health crisis involving the abuse of prescription opioid pain
medication and the distribution of these medications could affect our business in ways that we may not be able to predict. For
example, several states have now adopted taxes or other fees on the sale of opioids, and several other states have proposed similar
legislative initiatives. These laws and proposals vary in the tax amounts imposed and the means of calculation. Liabilities for
taxes or assessments under any such laws could have an adverse impact on our results of operations unless we are able to mitigate
them through operational changes or commercial arrangements where permitted.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Our
business is subject to rigorous regulatory and licensing requirements.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
described in greater detail in the &ldquo;<U>Description of Business</U>&rdquo; section, our business is highly regulated in the
United States, at both the federal and state level, and in foreign countries. If we fail to comply with regulatory requirements,
or if allegations are made that we fail to comply, our results of operations and financial condition could be adversely affected.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
lawfully operate our businesses, we are required to obtain and hold permits, product registrations, licenses and other regulatory
approvals from, and to comply with operating and security standards of, numerous governmental bodies. For example, as a wholesale
distributor of controlled substances, we must hold valid DEA registrations and state-level licenses, meet various security and
operating standards, and comply with the Controlled Substances Act (CSA). Failure to maintain or renew necessary permits, product
registrations, licenses or approvals, or to comply with required standards, could have an adverse effect on our results of operations
and financial condition.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Products
that we source and distribute must comply with regulatory requirements. Noncompliance or concerns over noncompliance may result
in suspension of our ability to distribute or import products, product bans, recalls or seizures, or criminal or civil sanctions,
which, in turn, could result in product liability claims and lawsuits, including class actions.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 15; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Changes
to the U.S. healthcare environment may not be favorable to us.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Over
a number of years, the U.S. healthcare industry has undergone significant changes designed to increase access to medical care,
improve safety and patient outcomes, contain costs and increase efficiencies. These changes include adoption of the Patient Protection
and Affordable Care Act, a general decline in Medicare and Medicaid reimbursement levels, efforts by healthcare insurance companies
to limit or reduce payments to pharmacies and providers, the basis for payments beginning to transition from a fee-for-service
model to value-based payments and risk-sharing models, and the industry shifting away from traditional healthcare venues like
hospitals and into clinics, physician offices and patients&rsquo; homes.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
expect the U.S. healthcare industry to continue to change significantly in the future. Possible changes include repeal and replacement
of major parts of the Patient Protection and Affordable Care Act, further reduction or limitations on governmental funding at
the state or federal level, efforts by healthcare insurance companies to further limit payments for products and services or changes
in legislation or regulations governing prescription pharmaceutical pricing, healthcare services or mandated benefits. These possible
changes, and the uncertainty surrounding these possible changes, may cause healthcare industry participants to reduce the number
of products and services they purchase from us or the price they are willing to pay for our products and services, which could
adversely affect us.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Our
business and operations depend on the proper functioning of information systems, critical facilities and distribution networks.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
rely on our and third-party service providers&rsquo; information systems for a wide variety of critical operations, including
to obtain, rapidly process, analyze and manage data to:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 0.35in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">facilitate
    the purchase and distribution of inventory items from distribution centers;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">receive,
    process and ship orders on a timely basis;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">manage
    accurate billing and collections for thousands of customers;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">process
    payments to suppliers; and</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">generate
    financial information.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
business also depends on the proper functioning of our critical facilities and our distribution networks. Our results of operations
could be adversely affected if our or a service provider&rsquo;s information systems, critical facilities or distribution networks
are disrupted (including disruption of access), are damaged or fail, whether due to physical disruptions, such as fire, natural
disaster, pandemic or power outage, or due to cyber-security incidents, ransomware or other actions of third parties, including
labor strikes, political unrest and terrorist attacks. Manufacturing disruptions also can occur due to regulatory action, production
quality deviations, safety issues or raw material shortages or defects, or because a key product or component is manufactured
at a single manufacturing facility with limited alternate facilities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Consolidation
in the U.S. healthcare industry may negatively impact our results of operations.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
recent years, U.S. healthcare industry participants, including distributors, manufacturers, suppliers, healthcare providers, insurers
and pharmacy chains, have consolidated or formed strategic alliances. Consolidations create larger enterprises with greater negotiating
power, and also could result in the possible loss of a customer where the combined enterprise selects one distributor from two
incumbents. If this consolidation trend continues, it could adversely affect our results of operations.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 16; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Many
of our competitors are better established and have resources significantly greater than we have, which may make it difficult to
fend off competition.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
expect to compete with the three largest ADR distributors (McKesson, Cardinal Health and AmerisourceBergen), in addition to other
pharmaceutical distributors, buying groups, software products, and various start-up drug companies. Many of these operations have
substantially greater financial and manufacturer-backed resources, longer operating histories, greater name recognition and more
established relationships in the industry than us. In addition, a number of these competitors may combine or form strategic partnerships.
As a result, our competitors may establish a more favorable footing in the pharmaceutical industry with respect to pricing or
other factors. Our failure to compete successfully with any of these companies would have a material adverse effect on our business
and the trading price of our common stock.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
three distributors listed above have a strong control over our industry, as they have contracts with the 24,000 independent, retail
pharmacies that limit the participants&rsquo; ability to purchase pharmaceuticals outside of those primary distributors. Additional
restrictive elements exist within the pharmaceutical channels of distribution. For example, a number of the inventory management
systems, either developed by the distributors or third-party vendors, have been developed to require compliance to these restrictive
purchasing agreements. Management anticipates that other existing and prospective competitors will adopt technologies or business
plans similar to ours, or seek other means to develop operations competitive with ours, particularly if our development of large-scale
production progresses as scheduled.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>We
will need to expand our member base or our profit margins to attain profitability.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Currently,
we are paid an administrative fee of up to 6 percent of the buying price on the generic pharmaceuticals sold to pharmacies and
up to 1 percent on brand pharmaceuticals that pass through our pharmaceutical exchanges. Our management is aware that the competitiveness
of the group of suppliers that participate in our system and price products on our exchange is a key factor in determining how
many purchasing pharmacies and wholesalers will purchase products through our platforms. However, price is not the only factor
that influences where retail pharmacies will obtain their product. Quality fulfillment services are also important, and retail
pharmacies have historically received quality fulfillment services from the three major ADR distributors. In order to be more
competitive, we must improve our customer service and wholesaler fulfillment efforts, because the independent, retail pharmacy
has for years considered this element of the fulfillment process as important as price. Other factors influencing the pharmacies
purchasing behavior in the future will be changes brought upon by the Affordable Care Act, which regulates some aspects of pharmaceutical
spending and pricing. Management believes that we should benefit substantially from our pricing and product knowledge that is
offered by our platform.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Profitability
may be further increased as a result of lower cost of goods should the Company build stronger relationships with manufacturers
and other larger buying groups that serve wholesalers and distributors. On a larger scale, those margins are expected to drop
depending upon the breadth of products provided in the market and the sale turn rates required. We are currently undertaking a
significant effort to increase our membership base through attendance at annual conferences and other strategies. Trxade has an
expanded e-mail marketing strategy based on our competitive price advantages and price trend analysis tools.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>There
are inherent risks associated with our operations within the Pharmaceutical Distribution Markets.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">There
are inherent risks involved with doing business within the pharmaceutical distribution market, including:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 0.5in; text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Improperly
    manufactured products may prove dangerous to the end consumer.</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Products
    may become adulterated by improper warehousing methods or modes of shipment.</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Counterfeit
    products or products with fake pedigree papers.</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Unlicensed
    or unlawful participants in the distribution channel.</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Risk
    with default and the assumption of credit loss.</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Risk
    related to the loss of supply, or the loss of a number of suppliers.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 17; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Although
all of our end-user agreements require our customers to indemnify us and for any and all liabilities resulting from our participation
in the pharmaceutical distribution industry, we cannot assure you that the parties required to provide such indemnification will
have the financial resources to do so. Additionally, although we have evaluated appropriate state statutes and federal laws pertaining
to pharmaceutical distribution in an effort to diminish our risks, the Board of Pharmacy for each state is responsible for interpreting
their state laws, and their interpretations may not comport with our analysis. It is also possible that any third-party logistics
arrangements may disrupt service, create a loss of income, or other unforeseen disruptions should the service provider experience
any legal, financial or other difficulties of their own.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Regulatory
changes that affect our distribution channels could also harm our business.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Certain
states, including California, Florida, Nevada, New Mexico and Indiana, have enacted laws that prohibit lateral movement of pharmaceuticals
within the distribution channel. These laws prohibit wholesalers from selling pharmaceuticals directly from or to other wholesalers
where they maintain inventory. Other states may in the future enact similar laws that place restrictions in pharmaceutical trading
within the Trxade platforms. At the federal level, the implementation of the track and trace legislation by 2017 requiring the
use of pharmaceutical pedigree may, in the future, restrict and disrupt the movement of pharmaceuticals along the supply chain
should the cost of complying with this new legislation be too burdensome for smaller suppliers. Changes in the United States healthcare
industry and regulatory environment could have a material adverse impact on our results of operations.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Many
of our products and services are intended to function within the structure of the healthcare financing and reimbursement system
currently being used in the United States. In recent years, the healthcare industry in the United States has changed significantly
in an effort to enhance efficiencies, reduce costs and improve patient outcomes. These changes have included cuts in Medicare
and Medicaid reimbursement levels, changes in the basis for payments, shifting away from fee-for-service and towards value-based
payments and risk-sharing models, increases in the use of managed care, and consolidation in the healthcare industry generally.
We expect that the healthcare industry in the United States shall continue to change and evolve in the near future. Changes in
the healthcare industry&rsquo;s (or our pharmaceutical suppliers&rsquo;) pricing, selling, inventory, distribution or supply policies
or practices could significantly reduce our revenues and net income. Additionally, if we experience disruptions in our supply
of generic drugs, our margins could be adversely affected.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
distribute generic pharmaceuticals, which can be subject to both price deflation and price inflation. Continued volatility in
the availability, pricing trends or reimbursement of these generic drugs, or significant fluctuations in the nature, frequency
and magnitude of generic pharmaceutical launches, could have a material adverse impact on our results of operations. Additionally,
any future changes in branded and generics drug pricing could be significantly different than our projections. Generic drug manufacturers
are increasingly challenging the validity or enforceability of patents on branded pharmaceutical products. During the pendency
of these legal challenges, a generics manufacturer may begin manufacturing and selling a generic version of the branded product
prior to the final resolution of its legal challenge over the branded product&rsquo;s patent. To the extent we source, contract
manufacture, and distribute such generic products, the brand-name company could assert infringement claims against us. While we
generally obtain indemnification against such claims from generic manufacturers as a condition of distributing their products,
these rights may not be adequate or sufficient to protect us.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
healthcare industry is highly regulated, and further regulation of our distribution businesses and technology products and services
could impose increased costs, negatively impact our profit margins and the profit margins of our customers, delay the introduction
or implementation of our new products, or otherwise negatively impact our business and expose us to litigation and regulatory
investigations.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 18; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Healthcare
fraud laws are often vague and uncertain, exposing us to potential liability.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
are subject to extensive, and frequently changing, local, state and federal laws and regulations relating to healthcare fraud,
waste and abuse. Local, state and federal governments continue to strengthen their position and scrutiny over practices involving
fraud, waste and abuse affecting Medicare, Medicaid and other government healthcare programs. Many of the regulations applicable
to us, including those relating to marketing incentives, are vague or indefinite and have not been interpreted by the courts.
The regulations may be interpreted or applied by a prosecutorial, regulatory, or judicial authority in a manner that could require
us to make changes in our operations. If we fail to comply with applicable laws and regulations, we could become liable for damages
and suffer civil and criminal penalties, including the loss of licenses or our ability to participate in Medicare, Medicaid and
other federal and state healthcare programs.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Laws
reducing reimbursements for pharmaceuticals could ruin our industry.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Both
our profit margins and the profit margins of our customers may be adversely affected by laws and regulations reducing reimbursement
rates for pharmaceuticals, medical treatments and related services, or changing the methodology by which reimbursement levels
are determined. The federal government may adopt measures that could reduce Medicare or Medicaid spending, or impose additional
requirements on healthcare entities. We cannot predict what alternative or additional deficit reduction initiatives or Medicare
payment reductions, if any, will ultimately be enacted into law, or the timing or affect any such initiatives or reductions would
have on us. Any of the changes discussed above may have a material adverse impact on our results of operations</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Operating,
security and licensure standards of federal agencies challenge our ability to comply with applicable laws and regulations.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
are subject to the operating and security standards of the Drug Enforcement Administration (the &ldquo;<U>DEA</U>&rdquo;), the
U.S. Food and Drug Administration (the &ldquo;<U>FDA</U>&rdquo;), various state boards of pharmacy, state health departments,
the U.S. Department of Health and Human Services (&ldquo;<U>HHS</U>&rdquo;), the Centers for Medicare &amp; Medicaid Services
(CMS), and other comparable agencies. Although we have enhanced our procedures to ensure compliance, a regulatory agency or tribunal
may conclude that our operations are not compliant with applicable laws and regulations. In addition, we may be unable to maintain
or renew existing permits, licenses or any other regulatory approvals or obtain without significant delay future permits, licenses
or other approvals needed for the operation of our businesses. Any noncompliance by us with applicable laws and regulations or
the failure to maintain, renew or obtain necessary permits and licenses could lead to litigation and have a material adverse impact
on our results of operations.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Pedigree
tracking laws and regulations could increase our regulatory burdens.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Congress
and state and federal agencies, including state boards of pharmacy and departments of health and the FDA, have made increased
efforts in the past year to regulate the pharmaceutical distribution system in order to prevent the introduction of counterfeit,
adulterated or mislabeled drugs into the pharmaceutical distribution system (otherwise known as &ldquo;pedigree tracking&rdquo;).
In November 2013, Congress passed (and President Barack Obama signed into law) the Drug Quality and Security Act (the &ldquo;<U>DQSA</U>&rdquo;).
The DQSA establishes federal standards requiring supply-chain stakeholders to participate in an electronic, interoperable, lot-level
prescription drug track-and-trace system. The law also preempts state drug pedigree requirements and establishes new requirements
for drug wholesale distributors and third-party logistics providers, including licensing requirements in states that had not previously
licensed such entities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition, the Food and Drug Administration Amendments Act of 2007 requires the FDA to establish standards and identify and validate
effective technologies for the purpose of securing the pharmaceutical supply chain against counterfeit drugs. These standards
may include track-and-trace or authentication technologies, such as radio frequency identification devices, 2D data matrix barcodes,
and other similar technologies. On March 26, 2010, the FDA released the Serialized Numerical Identifier (the &ldquo;<U>SNI</U>&rdquo;)
guidance for manufacturers who serialize pharmaceutical packaging. We expect to be able to accommodate these SNI regulations in
our distribution operations. The DQSA and other pedigree tracking laws and regulations could increase the overall regulatory burden
and costs associated with our pharmaceutical distribution business and could have a material adverse impact on our results of
operations.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 19; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>We
are uncertain how new privacy laws shall be interpreted.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">There
are numerous federal and state laws and regulations related to the privacy and security of personal information. In particular,
regulations promulgated pursuant to the Health Insurance Portability and Accountability Act of 1996 (&ldquo;<U>HIPAA</U>&rdquo;)
establish privacy and security standards that limit the use and disclosure of individually identifiable health information (known
as &ldquo;protected health information&rdquo;) and require the implementation of administrative, physical and technological safeguards
to protect the privacy of protected health information and ensure the confidentiality, integrity and availability of electronic
protected health information. We are directly subject to certain provisions of the regulations as a &ldquo;Business Associate&rdquo;
through our relationships with customers. We are also directly subject to the HIPAA privacy and security regulations as a &ldquo;Covered
Entity&rdquo; with respect to our operations as a healthcare clearinghouse, specialty pharmacy and medical surgical supply business.
If we are unable to properly protect the privacy and security of protected health information entrusted to us, we could be found
to have breached our contracts with our customers. Further, if we fail to comply with applicable HIPAA privacy and security standards,
we could face civil and criminal penalties. Although we have implemented and continue to maintain policies and processes to assist
us in complying with these regulations and our contractual obligations, we cannot provide assurances regarding how these regulations
will be interpreted, enforced or applied by the government and regulators to our operations. In addition to the risks associated
with enforcement activities and potential contractual liabilities, our ongoing efforts to comply with evolving laws and regulations
at the federal and state level might also require us to make costly system purchases /or modifications from time to time.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>There
are continued uncertainties associated with efforts to change or repeal healthcare reforms, and we cannot predict their full effect
on us at this time.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Affordable Care Act (the &ldquo;<U>ACA</U>&rdquo;) significantly expanded health insurance coverage to uninsured Americans and
changed the way healthcare is financed by both governmental and private payers. While certain provisions of the ACA took effect
immediately, others have delayed effective dates or require further rulemaking action or regulatory guidance by governmental agencies
to implement or finalize (e.g. nondiscrimination in health programs and activities, or excise taxes on high-cost employer-sponsored
health coverage). Further, as a result of the November 2016 U.S. presidential election, there are continued uncertainties associated
with efforts to change or repeal certain provisions of the ACA or other healthcare reforms, and we cannot predict their full effect
on thus at this time. A top legislative priority of the Trump presidential administration and Congress may be significant reform
of the ACA, as discussed above. While there is currently a substantial lack of clarity around the likelihood, timing and details
of any such policies and reforms, such policies and reforms may have a material adverse impact on our results of operations.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Medical
billing and coding laws may subject us to fines and investigations.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Medical
billing, coding and collection activities are governed by numerous federal and state civil and criminal laws. In connection with
these laws, we may be subjected to federal or state government investigations and possible penalties may be imposed upon us, false
claims actions may have to be defended, private payers may file claims against us and we may be excluded from Medicare, Medicaid
or other government-funded healthcare programs. Any such proceeding or investigation could have a material adverse impact on our
results of operations.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>System
errors or failures of our platform or services to conform to specifications could cause unforeseen liabilities or injury, harm
our reputation and have a material adverse impact on our results of operations.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
software and technology services that we operate are complex. As with complex systems offered by others, our software and technology
services may contain errors, especially when first introduced. Failure of a customer&rsquo;s system to perform in accordance with
our documentation could constitute a breach of warranty and could require us to incur additional expense in order to make the
system comply with the documentation. If such failure is not remedied in a timely manner, it could constitute a material breach
under a contract, allowing the client to cancel the contract, obtain refunds of amounts previously paid, or assert claims for
significant damages.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 20; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>We
may apply working capital and future funding to uses that ultimately do not improve our operating results or increase the value
of your investment.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
general, we have complete discretion over the use of our working capital and any new investment capital we may obtain in the future.
Because of the number and variety of factors that could determine our use of funds, our ultimate expenditure of funds (and their
uses) may vary substantially from our current intended operating plan for such funds.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
intend to use existing working capital and future funding to support the development of our products and services, product purchases
in our wholesale distribution division, the expansion of our marketing, or the support of operations to educate our customers.
We will also use capital for market and network expansion, acquisitions, and general working capital purposes. However, we do
not have more specific plans for the use and expenditure of our capital. Our management has broad discretion to use any or all
of our available capital reserves. Our capital could be applied in ways that do not improve our operating results or otherwise
increase the value of a stockholder&rsquo;s investment.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>We
do not have a traditional credit facility with a financial institution, which may adversely impact our operations.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
do not have a traditional credit facility with a financial institution, such as a working line of credit. The absence of such
a facility could adversely impact our operations, as it may constrain our ability to have available the working capital for equipment
purchases or other operational requirements. If adequate funds are not otherwise available, we may be required to delay, scale
back or eliminate portions of our business development efforts. Without credit facilities, we could be forced to cease operations
and investors in our securities could lose their entire investment.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>We
are dependent upon our current management, who may have conflicts of interest.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
are dependent upon the efforts of our current management. All of our officers and directors have duties and affiliations with
other companies. Even though these companies are not competitors or involved in pharmaceutical distribution, involvement of our
officers and directors in other businesses may still present a conflict of interest regarding decisions they make for Trxade or
with respect to the amount of time available for Trxade. The loss of any of our officers or directors and, in particular, Mr.
Patel or Mr. Ajjarapu, could have a materially adverse effect upon our business and future prospects.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
do not have key-man life insurance upon the life of any of our officers or directors. While our management team has considerable
information technology and entrepreneurial experience, none of our management was involved in pharmaceutical distribution prior
to joining the Company and, as such, did not have any technical experience in pharmaceutical distribution prior to joining us.
Upon obtaining adequate funding, management intends to hire qualified and experienced personnel, including additional officers
and directors, and specialists, professionals and consulting firms to advise management, as needed; however, management may not
be successful in raising the necessary funds in respect of recruiting, hiring and retaining such qualified individuals and firms.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>A
significant disruption in our computer systems could adversely affect our operations.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
rely extensively on our computer systems to manage our ordering, pricing, point-of-sale, pharmacy fulfillment, inventory replenishment,
customer program, finance and other processes. Our systems are subject to damage or interruption from power outages, computer
and telecommunications failures, computer viruses, security breaches, vandalism, natural disasters, catastrophic events and human
error, and our disaster recovery planning cannot account for all eventualities. If any of our systems are damaged, fail to function
properly or otherwise become unavailable, we may incur substantial costs to repair or replace them, and may experience loss or
corruption of critical data and interruptions or delays in our ability to perform critical functions, which could adversely affect
our business and results of operations. In addition, we are currently making, and expect to continue to make, substantial investments
in our information technology systems and infrastructure, some of which are significant. Upgrades involve replacing existing systems
with successor systems, making changes to existing systems, or cost-effectively acquiring new systems with new functionality.
Implementing new systems carries significant potential risks, including failure to operate as designed, potential loss or corruption
of data or information, cost overruns, implementation delays, disruption of operations, and the potential inability to meet business
and reporting requirements. While we are aware of inherent risks associated with replacing these systems and believe we are taking
reasonable action to mitigate known risks, these technology initiatives may not be deployed as planned or may not be timely implemented
without disruption to our operations.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 21; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>We
plan to implement an aggressive growth strategy, which could increase the risk of failure.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
the foreseeable future, we intend to pursue an aggressive growth strategy for the expansion of our operations through increased
product development and marketing. Our ability to rapidly expand our operations will depend upon many factors, including our ability
to work in a regulated environment, market value-added products effectively to independent pharmacies, establish and maintain
strategic relationships with suppliers, and obtain adequate capital resources on acceptable terms. Any restrictions on our ability
to expand may have a materially adverse effect on our business, results of operations, and financial condition. Accordingly, we
may be unable to achieve our targets for sales growth, and our operations may not be successful or achieve anticipated operating
results.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>We
rely on third party contracts.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
depend on others to provide products and services to us. We do not manufacture pharmaceuticals and we do not sell pharmaceuticals
to the end consumer. We do not control these wholesalers, suppliers and purchasers and, although our arrangements with them will
be terminable or of limited length, a change may be difficult to implement. At this time, we have a working relationship with
over 25 wholesalers and the nation&rsquo;s largest buying group. Although we believe that those entities are satisfied with their
business relationship with Trxade, if our buying group and two or three of the wholesalers decided no longer to do business with
us, that supplier void would materially and adversely affect our competitiveness in the marketplace.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>It
may be difficult and costly for us to comply with the extensive government regulations to which our business is subject.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
operations are subject to extensive regulation by the U.S. federal and state governments. In addition, as we expand our operations,
we may also become subject to the regulations of foreign jurisdictions, as well as additional regulations relating to environmental
matters, transportation of pharmaceutical products, shipping restrictions, and import and export restrictions.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Further,
the enactment of new rules and regulations could adversely affect our business. For example, the Affordable Care Act has the primary
goal of reducing the cost of healthcare and providing medical coverage to some of the nation&rsquo;s 25 million uninsured. Depending
on future enforcement or additional rules and regulations created around it, pharmaceutical pricing controls could be established
resulting in substantially reduced margins and limited reimbursement for pharmacies and all other healthcare provider bases. In
turn, this may adversely affect our cash flow, profitability, and growth.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>We
will continue to incur increased costs as a result of being a reporting company, and given our limited capital resources, such
additional costs may have an adverse impact on our profitability.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
are an SEC-reporting company. The rules and regulations under the Exchange Act require reporting companies to provide periodic
reports with interactive data files, which require that we engage legal, accounting and auditing professionals, and eXtensible
Business Reporting Language (XBRL) and EDGAR (Electronic Data Gathering, Analysis, and Retrieval) service providers. The engagement
of such services can be costly, and we may continue to incur additional losses, which may adversely affect our ability to continue
as a going concern. In addition, the Sarbanes-Oxley Act of 2002, as well as a variety of related rules implemented by the SEC,
have required changes in corporate governance practices and generally increased the disclosure requirements of public companies.
For example, as a result of being a reporting company, we are required to file periodic and current reports and other information
with the SEC and we have adopted policies regarding disclosure controls and procedures and regularly evaluate those controls and
procedures.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 22; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
additional costs we continue to incur in connection with becoming a reporting company (expected to be several hundred thousand
dollars per year) will continue to further stretch our limited capital resources. Due to our limited resources, we have to allocate
resources away from other productive uses in order to continue to comply with our obligations as an SEC reporting company. Further,
there is no guarantee that we will have sufficient resources to continue to meet our reporting and filing obligations with the
SEC as they come due.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"><B><I>If
we make any acquisitions, they may disrupt or have a negative impact on our business.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">If
we make acquisitions in the future, funding permitting, which may not be available on favorable terms, if at all, we could have
difficulty integrating the acquired company&rsquo;s assets, personnel and operations with our own. We do not anticipate that any
acquisitions or mergers we may enter into in the future would result in a change of control of the Company. In addition, the key
personnel of the acquired business may not be willing to work for us. We cannot predict the effect expansion may have on our core
business. Regardless of whether we are successful in making an acquisition, the negotiations could disrupt our ongoing business,
distract our management and employees and increase our expenses. In addition to the risks described above, acquisitions are accompanied
by a number of inherent risks, including, without limitation, the following:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; background-color: white">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 0.35in; text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    difficulty of integrating acquired products, services or operations;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    potential disruption of the ongoing businesses and distraction of our management and the management of acquired companies;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">difficulties
    in maintaining uniform standards, controls, procedures and policies;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    potential impairment of relationships with employees and customers as a result of any integration of new management personnel;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    potential inability or failure to achieve additional sales and enhance our customer base through cross-marketing of the products
    to new and existing customers;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    effect of any government regulations which relate to the business acquired;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">potential
    unknown liabilities associated with acquired businesses or product lines, or the need to spend significant amounts to retool,
    reposition or modify the marketing and sales of acquired products or operations, or the defense of any litigation, whether
    or not successful, resulting from actions of the acquired company prior to our acquisition; and</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">potential
    expenses under the labor, environmental and other laws of various jurisdictions.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">Our
business could be severely impaired if and to the extent that we are unable to succeed in addressing any of these risks or other
problems encountered in connection with an acquisition, many of which cannot be presently identified. These risks and problems
could disrupt our ongoing business, distract our management and employees, increase our expenses and adversely affect our results
of operations.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 23; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>
<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Risks
Related to Our Common Stock</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>We
are subject to the &ldquo;<U>penny stock</U>&rdquo; rules which will adversely affect the liquidity of our common stock.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
stock is defined as a &ldquo;<U>penny stock</U>&rdquo; under Rule 3a51-1 of the Exchange Act. In general, a &ldquo;<U>penny stock</U>&rdquo;
includes securities of companies which are not listed on the principal stock exchanges or NASDAQ and have a bid price in the market
of less than $5.00 per share; and companies with net tangible assets of less than $2,000,000 ($5,000,000 if the issuer has been
in continuous operation for less than three years), or which has recorded revenues of less than $6,000,000 in the last three years.
&ldquo;<U>Penny stocks</U>&rdquo; are subject to rule 15g-9, which imposes additional sales practice requirements on broker-dealers
that sell such securities to persons other than established customers and &ldquo;<U>accredited investors</U>&rdquo; (generally,
individuals with net worth in excess of $1,000,000 or annual incomes exceeding $200,000, or $300,000 together with their spouses,
for the last two years with expectation of earning the same or higher income in the current year, or individuals who are officers
or directors of the issuer of the securities). For transactions covered by Rule 15g-9, a broker-dealer must make a special suitability
determination for the purchaser and have received the purchaser&rsquo;s written consent to the transaction prior to sale. Consequently,
this rule may adversely affect the ability of broker-dealers to sell our stock, and therefore, may adversely affect the ability
of our stockholders to sell stock in the public market.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>The
sale of shares by our directors and officers may adversely affect the market price for our shares.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Sales
of significant amounts of shares held by our officers and directors, or the prospect of these sales, could adversely affect the
market price of our common stock. Management&rsquo;s stock ownership may discourage a potential acquirer from making a tender
offer or otherwise attempting to obtain control of us, which in turn could reduce our stock price or prevent our stockholders
from realizing a premium over our stock price.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>If
the selling stockholders sell a large number of shares all at once or in blocks, the market price of our shares would most likely
decline.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Up
to 4,910,000 shares of common stock may be resold by the selling stockholders through this prospectus. Should the selling
stockholders decide to sell their shares at a price below the market price as quoted on OTCQB, or any exchange on which our common
stock might be listed in the future, the price may continue to decline. A steep decline in the price of our common stock upon
being quoted on OTCQB, or any exchange on which our common stock might be listed in the future, would adversely affect our ability
to raise additional equity capital, and even if we were successful in raising such capital, the terms of such raise may be substantially
dilutive to current stockholders.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Stockholders
may be diluted significantly through our efforts to obtain financing and satisfy obligations through the issuance of additional
shares of our common stock.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Wherever
possible, our Board of Directors will attempt to use non-cash consideration to satisfy obligations. In many instances, we believe
that the non-cash consideration will consist of restricted shares of our common stock or where shares are to be issued to our
officers, directors and applicable consultants. Our Board of Directors has authority, without action or vote of the stockholders,
to issue all or part of the authorized but unissued shares of common stock. In addition, we may attempt to raise capital by selling
shares of our common stock, possibly at a discount to market. These actions will result in dilution of the ownership interests
of existing stockholders, which may further dilute common stock book value, and that dilution may be material. Such issuances
may also serve to enhance existing management&rsquo;s ability to maintain control of the Company because the shares may be issued
to parties or entities committed to supporting existing management.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>A
significant number of our shares are eligible for sale and their sale or potential sale may depress the market price of our common
stock.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Sales
of a significant number of shares of our common stock in the public market could harm the market price of our common stock. Most
of our common stock is available for resale in the public market, and if sold would increase the supply of our common stock, thereby
causing a decrease in its price. Some or all of our shares of common stock may be offered from time to time in the open market
pursuant to compliance with Rule 144, which sales could have a depressive effect on the market for our shares of common stock.
Subject to certain restrictions, a person who has held restricted shares for a period of six months may generally sell common
stock into the market.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"></P>

<!-- Field: Page; Sequence: 24; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
limitation of monetary liability against our directors, officers and employees under Delaware law and the existence of indemnification
rights to them may result in substantial expenditures by us and may discourage lawsuits against our directors, officers and employees.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
certificate of incorporation contains a specific provision that limits the liability of our directors for monetary damages to
the Company and the Company&rsquo;s stockholders. We also have contractual indemnification obligations under our employment and
engagement agreements with our executive officers and directors. The foregoing indemnification obligations could result in us
incurring substantial expenditures to cover the cost of settlement or damage awards against our directors and officers, which
the Company may be unable to recoup. These provisions and resultant costs may also discourage us from bringing a lawsuit against
our directors and officers for breaches of their fiduciary duties and may similarly discourage the filing of derivative litigation
by our stockholders against our directors and officers, even though such actions, if successful, might otherwise benefit us and
our stockholders.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>There
may not be sufficient liquidity in the market for our securities in order for investors to sell their Shares. The market price
of our comment stock may be volatile</I></B>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">While
our common stock is quoted on the OTCQB Tier of the OTC Markets, our common stock is thinly traded and should be considered an
illiquid investment. The market price of our common stock will likely be highly volatile, as is the stock market in general, and
the market for over the counter quoted stocks in particular. Some of the factors that may materially affect the market price of
our common stock are beyond our control, such as conditions or trends in the industry in which we operate or sales of our common
stock. This situation is attributable to a number of factors, including the fact that we are a small company which is relatively
unknown to stock analysts, stock brokers, institutional investors and others in the investment community that generate or influence
sales volume, and that even if we came to the attention of such persons, they tend to be risk-averse and would be reluctant to
follow an unproven company such as ours or purchase or recommend the purchase of our shares until such time as we became more
seasoned and viable.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
a consequence, there may be periods of several days or more when trading activity in our shares is minimal or non-existent, as
compared to a mature issuer which has a large and steady volume of trading activity that will generally support continuous sales
without an adverse effect on share price. It is possible that a broader or more active public trading market for our common stock
will not develop or be sustained, or that trading levels will not continue. These factors may materially adversely affect the
market price of our common stock, regardless of our performance. In addition, the public stock markets have experienced extreme
price and trading volume volatility. This volatility has significantly affected the market prices of securities of many companies
for reasons frequently unrelated to the operating performance of the specific companies. These broad market fluctuations may adversely
affect the market price of our common stock.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>The
exercise of outstanding warrants, options and shares issued in connection with a joint venture will be dilutive to our existing
stockholders.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of October 11, 2019, we had 38,986,459 shares of our common stock issued and outstanding and the following securities,
which are exercisable into shares of our common stock, were outstanding:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;
2,863,475 shares of our common stock issuable upon the exercise of warrants with exercise prices ranging from $0.01 to $1.50 per
share;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;
2,081,846 shares of our common stock issuable upon the exercise of options with exercise prices ranging from $0.50 per share to
$1.61 per share; and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;
a maximum of 14,776,638 shares of our common stock which may be issued to PanOptic, subject to PanOptic and
SyncHealth meeting all of the revenue covenants, in connection with our Joint Venture. We are currently in discussions to
dissolve this relationship.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"></P>

<!-- Field: Page; Sequence: 25; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Shares
issued to PanOptic  will cause significant dilution to existing stockholders.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
January 17, 2019, we entered into a transaction, effective as of January 1, 2019, with PanOptic Health, LLC (&ldquo;<U>PanOptic</U>&rdquo;)
to: create a new entity, SyncHealth MSO, LLC (&ldquo;<U>SyncHealth</U>&rdquo;), owned by our wholly-owned subsidiary, Alliance
Pharma Solutions, LLC (&ldquo;<U>Alliance</U>&rdquo;) and PanOptic. Pursuant to the terms of the agreement, PanOptic is due up
to 14,776,638 shares of our common stock in the event certain quotas are met as of January 1, 2020 and January 31, 2020. Specifically,
PanOptic is due 2,273,329 shares if gross revenue recognized by the Company from SyncHealth is at least $5 million from January
1, 2019, through April 30, 2019; 2,273,329 shares if Gross Revenue is at least $8 million from May 1, 2019 to July 31, 2019; 2,652,217
shares if Gross Revenue is at least $12 million from August 1, 2019 through October 31, 2019; and the remaining balance of up
to 14,776,638 shares of our common stock if (i) Gross Revenue is at least $50 million from January 1, 2019 to December 31, 2019;
or (ii) SyncHealth generates at least $12.5 million in EBIDTA during the same period. The issuance of the shares of common stock
to PanOptic, if earned, will cause significant dilution to existing stockholders. As of September 30, 2019, none of the quotas
have been achieved and none of the shares are due. To date, we have not realized any income from the technology and presently
we are in discussions to dissolve this relationship.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>FINRA
sales practice requirements may also limit a stockholder&rsquo;s ability to buy or sell our stock</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition to the penny stock rules promulgated by the SEC, which are discussed earlier in this section, the rules of the Financial
Industry Regulatory Authority, Inc. (FINRA) require that in recommending an investment to a customer, a broker-dealer must have
reasonable grounds for believing that the investment is suitable for that customer. Prior to recommending speculative, low-priced
securities to their non-institutional customers, broker-dealers must have reasonable efforts to obtain information about the customer&rsquo;s
financial status, tax status, investment objectives and other information. Under interpretations of these rules, FINRA believes
that there is a high probability that speculative low-priced securities will not be suitable for at least some customers. FINRA
requirements make it more difficult for broker-dealers to recommend that their customers buy our common stock, which may limit
the ability to buy and sell our stock and have an adverse effect on the market value for our shares.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>We
have never paid or declared any dividends on our common stock.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have never paid or declared any dividends on our common stock or preferred stock. Likewise, we do not anticipate paying, in the
near future, dividends or distributions on our common stock. Any future dividends on common stock will be declared at the discretion
of our board of directors and will depend, among other things, on our earnings, our financial requirements for future operations
and growth, and other facts as we may then deem appropriate. Since we do not anticipate paying cash dividends on our common stock,
return on your investment, if any, will depend solely on an increase, if any, in the market value of our common stock.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Our
directors have the right to authorize the issuance of shares of preferred stock and additional shares of our common stock.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
directors, within the limitations and restrictions contained in our certificate of incorporation and without further action by
our stockholders, have the authority to issue shares of preferred stock from time to time in one or more series and to fix the
number of shares and the relative rights, conversion rights, voting rights, and terms of redemption, liquidation preferences and
any other preferences, special rights and qualifications of any such series. Any issuance of shares of preferred stock could adversely
affect the rights of holders of our common stock. Should we issue additional shares of our common stock at a later time, each
investor&rsquo;s ownership interest in our stock would be proportionally reduced.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>If
we fail to remain current in our reporting requirements on the OTCQB, where we are publicly quoted, we could be removed from the
OTCQB, which would limit the ability of broker-dealers to sell our securities and the ability of stockholders to sell their securities
in the secondary market.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Companies
whose shares are quoted for sale on the OTCQB must be reporting issuers under Section 12 of the Exchange Act, must be current
in their reports under Section 13 of the Exchange Act and must meet certain other requirements, in order to maintain price quotation
privileges on the OTCQB. If we fail to remain current in our reporting requirements, we could be removed from the OTCQB. As a
result, the market liquidity for our securities could be adversely affected by limiting the ability of broker-dealers to sell
our securities and the ability of stockholders to sell their securities in the secondary market.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"></P>

<!-- Field: Page; Sequence: 26; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>The
market price for our common stock is particularly volatile, given our status as a relatively unknown company with a small and
thinly quoted public float, and lack of profitability, which could lead to wide fluctuations in our share price.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
market for our common stock on the OTCQB will most likely continue to be characterized by significant price volatility when compared
to seasoned issuers, and we expect that our share price will be more volatile than a seasoned issuer for the indefinite future.
The volatility in our share price would be attributable to a number of factors. First, as noted above, the shares of our common
stock will likely be sporadically and/or thinly quoted. As a consequence of this lack of liquidity, the trading of relatively
small quantities of shares by our stockholders may disproportionately influence the price of those shares in either direction.
The price for our shares could, for example, decline precipitously in the event that a large number of shares of our common stock
are sold on the market without commensurate demand, as compared to a seasoned issuer which could better absorb those sales without
adverse impact on its share price.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>There
is not presently an active market for shares of our common stock, and therefore, you may be unable to sell any shares of our common
stock in the event that you need a source of liquidity.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
common stock is traded on the OTCQB quotation system, which is a FINRA-sponsored entity and operated inter-dealer automated quotation
system for equity securities not included in a national exchange. Quotation of our securities on the OTCQB limits the liquidity
and price of our common stock more than if our common stock were quoted or listed on the NYSE or the NASDAQ, which are national
securities exchanges. Although our common stock is quoted on the OTCQB, our common stock trades infrequently and in low volumes
on the OTCQB. A public trading market in our common stock having the desired characteristics of depth, liquidity and orderliness
depends on the presence in the market of willing buyers and sellers of our common stock at any time. This presence depends on
the individual decisions of investors and general economic and market conditions over which we have no control. In the event an
active market does not develop, you may be unable to sell your shares of common stock at or above the price you paid for them
or at any price.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Anti-takeover
provisions may impede the acquisition of Trxade.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Certain
provisions of the Delaware General Corporation Law (DGCL) have anti-takeover effects and may inhibit a non-negotiated merger or
other business combination. These provisions are intended to encourage any person interested in acquiring Trxade to negotiate
with, and to obtain the approval of, our directors, in connection with such a transaction. As a result, certain of these provisions
may discourage a future acquisition of Trxade, including an acquisition in which the stockholders might otherwise receive a premium
for their shares. In addition, we can also authorize &ldquo;<U>blank check</U>&rdquo; preferred stock, which could be issued by
our board of directors without stockholder approval and may contain voting, liquidation, dividend and other rights superior to
our common stock.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Our
Chief Executive Officer and President are our two largest stockholders and, as a result, they can exert control over us and have
actual or potential interests that may diverge from yours.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Suren
Ajjarapu, our CEO, and Prashant Patel, our President, beneficially own, in the aggregate, over 66% of our common stock. As a result,
these stockholders, acting together, will be able to influence many matters requiring stockholder approval, including the election
of directors and approval of mergers and other significant corporate transactions. This concentration of ownership may have the
effect of delaying, preventing or deterring a change in control, and could deprive our stockholders of an opportunity to receive
a premium for their shares of common stock as part of a sale of our company and may affect the market price of our stock.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"></P>

<!-- Field: Page; Sequence: 27; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Further,
Mr. Ajjarapu and Mr. Patel may have interests that diverge from those of other holders of our common stock. As a result, Mr. Ajjarapu
and Mr. Patel may vote the shares they own or control or otherwise cause us to take actions that may conflict with your best interests
as a stockholder, which could adversely affect our results of operations and the trading price of our common stock.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Through
this control, Mr. Ajjarapu and Mr. Patel can control our management, affairs and all matters requiring stockholder approval, including
the approval of significant corporate transactions, a sale of our company, decisions about our capital structure and the composition
of our Board of Directors.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Our
stock price could remain volatile.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
price of our common stock may be highly volatile and could be subject to fluctuations in price in response to various factors,
some of which are beyond our control. These factors include:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">quarterly
    variations in our results of operations or those of our competitors;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">announcements
    by us or our competitors of acquisitions, new products, significant contracts, commercial relationships or capital commitments;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">disruption
    to our operations or those of other sources critical to our operations;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    emergence of new competitors;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
    ability to develop and market new and enhanced products on a timely basis;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">seasonal
    or other variations;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">commencement
    of, or our involvement in, litigation;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">dilutive
    issuances of our stock or the stock of our subsidiaries, or the incurrence of additional debt;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">changes
    in our board or management;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">adoption
    of new or different accounting standards;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">changes
    in governmental regulations or in the status of our regulatory approvals;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">changes
    in earnings estimates or recommendations by securities analysts; and</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">general
    economic conditions and slow or negative growth of related markets.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; background-color: white; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Stockholders
who hold unregistered shares of our common stock will be subject to resale restrictions pursuant to Rule 144, due to the fact
that we are deemed to be a former &ldquo;<U>shell company.</U>&rdquo;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to Rule 144 of the Securities Act (&ldquo;<U>Rule 144</U>&rdquo;), a &ldquo;<U>shell company</U>&rdquo; is defined as a company
that has no or nominal operations; and, either no or nominal assets; assets consisting solely of cash and cash equivalents; or
assets consisting of any amount of cash and cash equivalents and nominal other assets. While we do not believe that we are currently
a &ldquo;<U>shell company</U>&rdquo;, we were previously a &ldquo;<U>shell company</U>&rdquo; and are deemed to be a former &ldquo;<U>shell
company</U>&rdquo; pursuant to Rule 144, and as such, sales of our securities pursuant to Rule 144 may not be able to be made
unless we continue to be subject to Section 13 or 15(d) of the Exchange Act, and have filed all of our required periodic reports
for at least the previous one year period prior to any sale pursuant to Rule 144. As a result, it may be harder for us to fund
our operations and pay our consultants with our securities instead of cash. Our status as a former &ldquo;<U>shell company</U>&rdquo;
could prevent us from raising additional funds, engaging consultants, and using our securities to pay for any acquisitions (although
none are currently planned).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>The
interests of stockholders may be hurt because we can issue shares of our common stock to individuals or entities that support
existing management with such issuances serving to enhance management&rsquo;s ability to maintain control of our company.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
board of directors has authority, without action or vote of the stockholders, to issue all or part of the authorized but unissued
common shares. Such issuances may be issued to parties or entities committed to supporting existing management and the interests
of existing management which may not be the same as the interests of other stockholders. Our ability to issue shares without stockholder
approval serves to enhance existing management&rsquo;s ability to maintain control of our company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 28; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->24<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Our
certificate of incorporation provides for indemnification of officers and directors at our expense and limits their liability,
which may result in a major cost to us and hurt the interests of our stockholders because corporate resources may be expended
for the benefit of officers or directors.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
Certificate of Incorporation provides for indemnification as follows: &ldquo;To the fullest extent permitted by applicable law,
the Corporation is authorized to provide indemnification of, and advancement of expenses to, such agents of the Corporation (and
any other persons to which Delaware law permits the Corporation to provide indemnification) through Bylaw provisions, agreements
with such agents or other persons, vote of stockholders or disinterested directors or otherwise, in excess of the indemnification
and advancement otherwise permitted by Section 145 of the Delaware General Corporation Law, subject only to limits created by
applicable Delaware law (statutory or non-statutory), with respect to actions for breach of duty to the Corporation, its stockholders
and others.&rdquo;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have been advised that, in the opinion of the SEC, indemnification for liabilities arising under federal securities laws is against
public policy as expressed in the Securities Act and is, therefore, unenforceable. In the event that a claim for indemnification
for liabilities arising under federal securities laws, other than the payment by us of expenses incurred or paid by a director,
officer or controlling person in the successful defense of any action, suit or proceeding, is asserted by a director, officer
or controlling person in connection with our activities, we will (unless in the opinion of our counsel, the matter has been settled
by controlling precedent) submit to a court of appropriate jurisdiction, the question whether indemnification by us is against
public policy as expressed in the Securities Act and will be governed by the final adjudication of such issue. The legal process
relating to this matter if it were to occur is likely to be very costly and may result in us receiving negative publicity, either
of which factors is likely to materially reduce the market and price for our shares, if such a market ever develops.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Currently,
we are followed by few analysts.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
the foreseeable future, our common stock is unlikely to be followed by any market analysts, and there may be few institutions
acting as market makers for our common stock. Either of these factors could adversely affect the liquidity and trading price of
our common stock. Until our common stock is fully distributed and an orderly market develops in our common stock, if ever, the
price at which it trades is likely to fluctuate significantly. Prices for our common stock are determined in the marketplace and
may be influenced by many factors, including the depth and liquidity of the market for shares of our common stock, developments
affecting our business, including the impact of the factors referred to elsewhere in these Risk Factors, investor perception of
us and general economic and market conditions. No assurances can be given that an orderly or liquid market will ever develop for
the shares of our common stock.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Because
of the anticipated low price of the securities being registered, many brokerage firms may not be willing to effect transactions
in these securities. Purchasers of our securities should be aware that any market that develops in our stock will be subject to
the penny stock restrictions.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>The
market for penny stocks has experienced numerous frauds and abuses that could adversely impact investors in our stock.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Company
management believes that the market for penny stocks has suffered from patterns of fraud and abuse. Such patterns include:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 0.25in; text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Control
    of the market for the security by one or a few broker-dealers that are often related to the promoter or issuer;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Manipulation
    of prices through prearranged matching of purchases and sales and false and misleading press releases;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;Boiler
    room&rdquo; practices involving high pressure sales tactics and unrealistic price projections by sales persons;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Excessive
    and undisclosed bid-ask differentials and markups by selling broker-dealers; and</FONT></TD></TR>
</TABLE>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0"></P>

<!-- Field: Page; Sequence: 29; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->25<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Wholesale
    dumping of the same securities by promoters and broker-dealers after prices have been manipulated to a desired level, along
    with the inevitable collapse of those prices with consequent investor losses.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Because
we are not subject to compliance rules requiring the adoption of certain corporate governance measures, our stockholders have
limited protection against interested director transactions, conflicts of interest and similar matters.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Sarbanes-Oxley Act of 2002, as well as rule changes proposed and enacted by the SEC, the New York Stock Exchange and the NASDAQ
Stock Market, as a result of Sarbanes-Oxley, require the implementation of various measures relating to corporate governance.
These measures are designed to enhance the integrity of corporate management and the securities markets and apply to securities
that are listed on those exchanges or the NASDAQ Stock Market. Because we are not presently required to comply with many of the
corporate governance provisions and because we chose to avoid incurring the substantial additional costs associated with such
compliance any sooner than legally required, we have not yet adopted these measures.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Three
out of five of our directors are independent directors, and certain of those independent directors serve on the independent audit
or compensation committees. We intend to comply with all additional corporate governance measures relating to director independence
as and when required. However, we may find it very difficult or be unable to attract and retain qualified officers, directors
or members of board committees required to provide for our effective management as a result of Sarbanes-Oxley Act of 2002. The
enactment of the Sarbanes-Oxley Act of 2002 has resulted in a series of rules and regulations by the SEC that increase responsibilities
and liabilities of directors and executive officers. The perceived increased personal risk associated with these recent changes
may make it more costly or deter qualified individuals from accepting these roles.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>We
plan to apply for listing of our common stock on the Nasdaq Capital Market. We may be unable to list our common stock, and if
listed, our common stock may not continue to meet Nasdaq Capital Market listing requirements. If we fail to comply with the continuing
listing standards of the Nasdaq Capital Market, our securities could be delisted.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
plan to apply for our common stock to be eligible to be listed on the Nasdaq Capital Market. However, our application may not
be approved, and an active trading market for our common stock may not develop or continue. If, after listing, we fail to satisfy
the continued listing requirements of the Nasdaq Capital Market, such as the corporate governance requirements or the minimum
closing bid price requirement, the Nasdaq Capital Market may take steps to delist our common stock. Such a delisting would likely
have a negative effect on the price of our common stock and would impair your ability to sell or purchase our common stock when
you wish to do so. In the event of a delisting, actions taken by us to restore compliance with listing requirements may not be
successful to allow our common stock to become listed again, stabilize the market price or improve the liquidity of our common
stock, prevent our common stock from dropping below the Nasdaq Capital Market minimum bid price requirement or prevent future
non-compliance with the Nasdaq Capital Market&rsquo;s listing requirements.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>We
will incur significant costs to ensure compliance with U.S. and Nasdaq Capital Market reporting and corporate governance requirements.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
will incur significant costs associated with our public company reporting requirements and with applicable U.S. and Nasdaq Capital
Market corporate governance requirements (assuming our common stock is approved for listing on the Nasdaq Capital Market), including
requirements under the Sarbanes-Oxley Act of 2002 and other rules implemented by the SEC and the Nasdaq Capital Market. We expect
all of these applicable rules and regulations to significantly increase our legal and financial compliance costs and to make some
activities more time consuming and costly. We also expect that these applicable rules and regulations may make it more difficult
and more expensive for us to obtain director and officer liability insurance and we may be required to accept reduced policy limits
and coverage or incur substantially higher costs to obtain the same or similar coverage. As a result, it may be more difficult
for us to attract and retain qualified individuals to serve on our Board of Directors or as executive officers.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 30; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->26<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Risks
Relating To The JOBS Act:</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>The
JOBS Act allows us to postpone the date by which we must comply with certain laws and regulations and to reduce the amount of
information provided in reports filed with the SEC. We cannot be certain if the reduced disclosure requirements applicable to
&ldquo;<U>emerging growth companies</U>&rdquo; will make our common stock less attractive to investors.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
are and we will remain an &ldquo;<U>emerging growth company</U>&rdquo; until the earliest to occur of (i) the last day of the
fiscal year during which our total annual revenues equal or exceed $1 billion (subject to adjustment for inflation), (ii) the
last day of the end of our 2024 fiscal year (5 years from our first public offering), (iii) the date on which we have, during
the previous three-year period, issued more than $1 billion in non-convertible debt securities, or (iv) the date on which we are
deemed a &ldquo;<U>large accelerated filer</U>&rdquo; (with at least $700 million in public float) under the Exchange Act. For
so long as we remain an &ldquo;<U>emerging growth company</U>&rdquo; as defined in the JOBS Act, we may take advantage of certain
exemptions from various reporting requirements that are applicable to other public companies that are not &ldquo;<U>emerging growth
companies</U>&rdquo; as described in further detail in the risk factors below. We cannot predict if investors will find our common
stock less attractive because we will rely on some or all of these exemptions. If some investors find our common stock less attractive
as a result, there may be a less active trading market for our common stock and our stock price may be more volatile. If we avail
ourselves of certain exemptions from various reporting requirements, as is currently our plan, our reduced disclosure may make
it more difficult for investors and securities analysts to evaluate us and may result in less investor confidence.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Our
election not to opt out of JOBS Act extended accounting transition period may not make our financial statements easily comparable
to other companies.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to the JOBS Act, as an &ldquo;<U>emerging growth company</U>&rdquo;, we can elect to opt out of the extended transition period
for any new or revised accounting standards that may be issued by the Public Company Accounting Oversight Board (PCAOB) or the
SEC. We have elected not to opt out of such extended transition period which means that when a standard is issued or revised and
it has different application dates for public or private companies, we, as an &ldquo;<U>emerging growth company</U>&rdquo;, can
adopt the standard for the private company. This may make a comparison of our financial statements with any other public company
which is not either an &ldquo;<U>emerging growth company</U>&rdquo; nor an &ldquo;<U>emerging growth company</U>&rdquo; which
has opted out of using the extended transition period difficult or impossible as possible different or revised standards may be
used.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>The
JOBS Act also allows us to postpone the date by which we must comply with certain laws and regulations intended to protect investors
and to reduce the amount of information provided in reports filed with the SEC.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
JOBS Act is intended to reduce the regulatory burden on &ldquo;<U>emerging growth companies</U>&rdquo;. The Company meets the
definition of an &ldquo;<U>emerging growth company</U>&rdquo; and so long as it qualifies as an &ldquo;<U>emerging growth company,</U>&rdquo;
it will, among other things:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 0.5in; text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">be
    exempt from the provisions of Section 404(b) of the Sarbanes-Oxley Act requiring that its independent registered public accounting
    firm provide an attestation report on the effectiveness of its internal control over financial reporting;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 0.5in; text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">be
    exempt from the &ldquo;<U>say on pay</U>&rdquo; provisions (requiring a non-binding stockholder vote to approve compensation
    of certain executive officers) and the &ldquo;<U>say on golden parachute</U>&rdquo; provisions (requiring a non-binding stockholder
    vote to approve golden parachute arrangements for certain executive officers in connection with mergers and certain other
    business combinations) of The Dodd&ndash;Frank Wall Street Reform and Consumer Protection Act (Dodd-Frank Act) and certain
    disclosure requirements of the Dodd-Frank Act relating to compensation of Chief Executive Officers;</FONT></TD></TR>
</TABLE>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0"></P>

<!-- Field: Page; Sequence: 31; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->27<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">be
    permitted to omit the detailed compensation discussion and analysis from proxy statements and reports filed under the Securities
    Exchange Act of 1934, as amended and instead provide a reduced level of disclosure concerning executive compensation; and</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">be
    exempt from any rules that may be adopted by the PCAOB requiring mandatory audit firm rotation or a supplement to the auditor&rsquo;s
    report on the financial statements.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company currently intends to take advantage of all of the reduced regulatory and reporting requirements that will be available
to it so long as it qualifies as an &ldquo;<U>emerging growth company</U>&rdquo;. The Company has elected not to opt out of the
extension of time to comply with new or revised financial accounting standards available under Section 102(b)(1) of the JOBS Act.
Among other things, this means that the Company&rsquo;s independent registered public accounting firm will not be required to
provide an attestation report on the effectiveness of the Company&rsquo;s internal control over financial reporting so long as
it qualifies as an &ldquo;<U>emerging growth company</U>&rdquo;, which may increase the risk that weaknesses or deficiencies in
the internal control over financial reporting go undetected. Likewise, so long as it qualifies as an &ldquo;<U>emerging growth
company</U>&rdquo;, the Company may elect not to provide certain information, including certain financial information and certain
information regarding compensation of executive officers, which it would otherwise have been required to provide in filings with
the SEC, which may make it more difficult for investors and securities analysts to evaluate the Company. As a result, investor
confidence in the Company and the market price of its common stock may be adversely affected.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Notwithstanding
the above, we are also currently a &ldquo;<U>smaller reporting company</U>&rdquo;, meaning that we are not an investment company,
an asset-backed issuer, or a majority-owned subsidiary of a parent company that is not a smaller reporting company and have a
public float of less than $75 million and annual revenues of less than $50 million during the most recently completed fiscal year.
In the event that we are still considered a &ldquo;<U>smaller reporting company</U>&rdquo;, at such time are we cease being an
&ldquo;<U>emerging growth company</U>&rdquo;, the disclosure we will be required to provide in our SEC filings will increase,
but will still be less than it would be if we were not considered either an &ldquo;<U>emerging growth company</U>&rdquo; or a
&ldquo;<U>smaller reporting company</U>&rdquo;. Specifically, similar to &ldquo;<U>emerging growth companies</U>&rdquo;, &ldquo;<U>smaller
reporting companies</U>&rdquo; are able to provide simplified executive compensation disclosures in their filings; are exempt
from the provisions of Section 404(b) of the Sarbanes-Oxley Act requiring that independent registered public accounting firms
provide an attestation report on the effectiveness of internal control over financial reporting; and have certain other decreased
disclosure obligations in their SEC filings, including, among other things, only being required to provide two years of audited
financial statements in annual reports. Decreased disclosures in our SEC filings due to our status as an &ldquo;<U>emerging growth
company</U>&rdquo; or &ldquo;<U>smaller reporting company</U>&rdquo; may make it harder for investors to analyze the Company&rsquo;s
results of operations and financial prospects.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>For
all of the foregoing reasons and others set forth herein, an investment in our securities in involves a high degree of risk.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><A NAME="k_001"></A><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">PRIVATE
PLACEMENT OF COMMON STOCK</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
July 10, 2019 we entered into a securities Purchase Agreement with R.S.N., LLC with respect to the private placement of 2,000,000
share of our common stock at a purchase price of $0.50 per share, for gross proceeds of $1,000,000. This transaction closed on
July 30, 2019.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
September 30, 2019, we closed the sale of securities pursuant to Securities Purchase Agreements entered into with certain accredited
investors with respect to the private placement of 2,910,000 shares of our common stock at a purchase price of $0.50 per share,
for gross proceeds of $1,455,000. Subscribers included Bedford Falls Capital, which is controlled by Gary Augusta, our director
(1,000,000 shares); Nitesh Patel, who is the cousin of Prashant Patel, our director and President (40,000 shares); Shilpa
Patel, who is the spouse of Nitesh Patel, the brother of Prashant Patel our director and President (20,000 shares); and
Nitil Patel, the brother of Prashant Patel, our director and President (200,000 shares).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></P>

<!-- Field: Page; Sequence: 32; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->28<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A NAME="k_002"></A>USE
OF PROCEEDS</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
are registering the shares of common stock for the benefit of the selling stockholders. We are not selling any securities under
this prospectus and we will not receive any of the proceeds from the sale or other disposition by the selling stockholders or
their transferees of the shares of common stock covered hereby. We have agreed to pay all costs, expenses and fees relating to
registering the shares of our common stock referenced in this prospectus. The selling stockholders will pay any brokerage commissions
or similar charges incurred in connection with the sale or other disposition by them of the shares covered hereby.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">See
&ldquo;<U>Selling Stockholders</U>&rdquo; and &ldquo;<U>Plan of Distribution</U>&rdquo; described below.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A NAME="k_003"></A>DETERMINATION
OF OFFERING PRICE</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
selling stockholders will offer the shares at the prevailing market prices or privately negotiated price. The offering price of
our common stock does not necessarily bear any relationship to our book value, assets, past operating results, financial condition
or any other established criteria of value. Our common stock may not trade at market prices in excess of the offering price as
prices for common stock in any public market will be determined in the marketplace and may be influenced by many factors, including
the depth and liquidity.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><A NAME="k_004"></A><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">DESCRIPTION
OF CAPITAL STOCK</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following information describes our common stock and preferred stock, as well as certain provisions of our certificate of incorporation
and bylaws. This description is only a summary. You should also refer to our certificate of incorporation and bylaws, which have
been filed with the SEC as exhibits to our registration statement, of which this prospectus forms a part.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>General</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
authorized capital stock consists of 100,000,000 shares of common stock with a $0.00001 par value per share, and 10,000,000 shares
of undesignated preferred stock with a $0.00001 par value per share. Our board of directors may establish the rights and preferences
of the preferred stock from time to time. As of October 11, 2019, there were 38,986,459 shares of common stock issued and
outstanding. The following is a summary of the material provisions of the common stock and preferred stock provided for in our
certificate of incorporation and bylaws. For additional detail about our capital stock, please refer to our certificate of incorporation
and bylaws.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Common
stock</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
are authorized to issue 100,000,000 shares of common stock, $0.00001 par value per share. Holders of shares of common stock are
entitled to one vote per share on each matter submitted to a vote of stockholders. In the event of liquidation, holders of common
stock are entitled to share <I>pro rata</I> in the distribution of assets remaining after payment of liabilities, if any. Holders
of common stock have no cumulative voting rights, and, accordingly, the holders of a majority of the outstanding shares have the
ability to elect all of the directors of the Company. Holders of common stock have no preemptive or other rights to subscribe
for shares. Holders of common stock are entitled to such dividends as may be declared by the Board out of funds legally available
therefore. The outstanding shares of common stock are validly issued, fully paid and non-assessable.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Preferred
Stock</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
are authorized to issue 10,000,000 shares of preferred stock, $0.00001 par value per share, all of which are undesignated and
unissued. We had no preferred shares outstanding at December 31, 2018 or as of the date of this prospectus.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 33; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->29<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under
the terms of our certificate of incorporation, our board of directors is authorized to issue shares of preferred stock in one
or more series without stockholder approval. Our board of directors may designate the powers, designations, preferences, and relative
participation, optional or other rights, if any, and the qualifications, limitations or restrictions thereof, including dividend
rights, conversion rights, voting rights, redemption rights, liquidation preference, sinking fund terms and the number of shares
constituting any series or the designation or any series. There are currently no shares of preferred stock outstanding.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Anti-Takeover
Effects Under Section 203 of Delaware General Corporation Law</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
are subject to Section 203 of Delaware General Corporation Law, which prohibits a Delaware corporation from engaging in any business
combination with any interested stockholder for a period of three years after the date that such stockholder became an interested
stockholder, with the following exceptions:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 0.25in; text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 0.25in; text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">before
    such date, the board of directors of the corporation approved either the business combination or the transaction that resulted
    in the stockholder becoming an interested stockholder;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">upon
    completion of the transaction that resulted in the stockholder becoming an interested stockholder, the interested stockholder
    owned at least 85 percent of the voting stock of the corporation outstanding at the time the transaction began, excluding
    for purposes of determining the voting stock outstanding (but not the outstanding voting stock owned by the interested stockholder)
    those shares owned (i) by persons who are directors and also officers and (ii) employee stock plans in which employee participants
    do not have the right to determine confidentially whether shares held subject to the plan will be tendered in a tender or
    an exchange offer; or</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 0.25in; text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 0.25in; text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">on
    or after such date, the business combination is approved by our board of directors and authorized at an annual or a special
    meeting of the stockholders, and not by written consent, by the affirmative vote of at least 66 2/3 percent of the outstanding
    voting stock that is not owned by the interested stockholder.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
general, Section 203 defines &ldquo;business combination&rdquo; to include the following:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 0.25in; text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 0.25in; text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">any
    merger or consolidation involving the corporation or any direct or indirect majority owned subsidiary of the corporation and
    the interested stockholder or any other corporation, partnership, unincorporated association, or other entity if the merger
    or consolidation is caused by the interested stockholder and as a result of such merger or consolidation the transaction is
    not excepted as described above;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">any
    sale, transfer, pledge, or other disposition (in one transaction or a series) of 10% or more of the assets of the corporation
    involving the interested stockholder;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">subject
    to certain exceptions, any transaction that results in the issuance or transfer by the corporation of any stock of the corporation
    to the interested stockholder;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">any
    transaction involving the corporation that has the effect of increasing the proportionate share of the stock or any class
    or series of the corporation beneficially owned by the interested stockholder; or</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    receipt by the interested stockholder of the benefit of any loss, advances, guarantees, pledges, or other financial benefits
    by or through the corporation.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
general, Section 203 defines an &ldquo;interested stockholder&rdquo; as an entity or a person who, together with the person&rsquo;s
affiliates and associates, beneficially owns, or within three years prior to the time of determination of interested stockholder
status did own, 15 percent or more of the outstanding voting stock of the corporation.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 34; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->30<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
Delaware corporation may &ldquo;opt out&rdquo; of these provisions with an express provision in its original certificate of incorporation
or an express provision in its certificate of incorporation or bylaws resulting from a stockholders&rsquo; amendment approved
by at least a majority of the outstanding voting shares. We have not opted out of these provisions. As a result, mergers or other
takeover or change in control attempts of us may be discouraged or prevented.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Listing</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
common stock is traded on the OTCQB Market under the symbol &ldquo;<U>TRXD</U>&rdquo;.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Transfer
Agent and Registrar</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
transfer agent and registrar for our common stock is Action Stock Transfer Corporation, 2469 E. Fort Union Boulevard, Suite 214,
Salt Lake City, Utah 84121. Its telephone number is (801) 274-1088.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><A NAME="k_005"></A><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">PLAN
OF DISTRIBUTION</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
are registering the shares of common stock covered by the registration statement of which this prospectus is a part, which are
held by the selling stockholders, to permit the resale of these shares of common stock by the selling stockholders from time to
time from after the date of this prospectus.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Each
selling stockholder may, from time to time, sell any or all of their shares of common stock covered hereby on the over-the-counter
market, any national securities exchange or quotation service on which the shares of our common stock may be listed or quoted
at the time of sale, in the over-the counter market, in privately negotiated transactions, through the writing of options, whether
such options are listed on an options exchange or otherwise, short sales or in a combination of such transactions. These sales
may be at fixed prices, at prevailing market prices at the time of the sale, at varying prices determined at the time of sale,
or privately negotiated prices. A Selling Stockholder may use any one or more of the following methods when selling shares:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ordinary
    brokerage transactions and transactions in which the broker-dealer solicits purchasers&#894;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top; width: 0.25in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">block
    trades in which the broker-dealer will attempt to sell the shares as agent but may position and resell a portion of the block
    as principal to facilitate the transaction&#894;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">purchases
    by a broker-dealer as principal and resale by the broker-dealer for its account&#894;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">an
    exchange distribution in accordance with the rules of the applicable exchange&#894;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">privately
    negotiated transactions&#894;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">settlement
    of short sales, to the extent permitted by law&#894;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">in
    transactions through broker-dealers that agree with the selling stockholders to sell a specified number of such shares at
    a stipulated price per share&#894;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">through
    the writing or settlement of options or other hedging transactions, whether through an options exchange or otherwise&#894;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a
    combination of any such methods of sale&#894; or</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">any
    other method permitted pursuant to applicable law.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
selling stockholders may pledge or grant a security interest in some or all of the shares of common stock owned by them and, if
they default in the performance of their secured obligations, the pledgees or secured parties may offer and sell the shares of
common stock from time to time pursuant to this prospectus.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 35; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->31<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
selling stockholders also may transfer and donate the shares of common stock in other circumstances in which case the transferees,
donees, pledgees or other successors in interest will be the selling beneficial owners for purposes of this prospectus.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
selling stockholders may also sell the shares of common stock under Rule 144 under the Securities Act, if available, rather than
under this prospectus.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Broker-dealers
engaged by the selling stockholders may arrange for other brokers-dealers to participate in sales. Broker-dealers may receive
commissions or discounts from the selling stockholders (or, if any broker-dealer acts as agent for the purchaser of shares, from
the purchaser) in amounts to be negotiated, but, except as set forth in a supplement to this prospectus, in the case of an agency
transaction not in excess of a customary brokerage commission in compliance with FINRA Rule 2440&#894; and in the case of a principal
transaction a markup or markdown in compliance with FINRA IM-2440-1.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
aggregate proceeds to the selling stockholders from the sale of the common stock offered by them will be the purchase price of
the common stock less discounts or commissions, if any. Each of the selling stockholders reserve the right to accept and, together
with their agents from time to time, to reject, in whole or in part, any proposed purchase of common stock to be made directly
or through agents. We will not receive any of the proceeds from the sale by the selling stockholders of the shares of common stock.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
connection with the sale of the shares of common stock or interests therein, the selling stockholders may enter into hedging transactions
with broker-dealers or other financial institutions, which may in turn engage in short sales of the shares of common stock in
the course of hedging the positions they assume. The selling stockholders may also sell the shares of common stock short and deliver
these securities to close out their short positions or to return borrowed shares in connection with such short sales, or loan
or pledge the shares of common stock to broker-dealers that in turn may sell these securities. The selling stockholders may also
enter into option or other transactions with broker-dealers or other financial institutions or create one or more derivative securities
which require the delivery to such broker-dealer or other financial institution of shares of common stock offered by this prospectus,
which shares such broker-dealer or other financial institution may resell pursuant to this prospectus (as supplemented or amended
to reflect such transaction).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
selling stockholders and any broker-dealers or agents that are involved in selling the shares of common stock may be deemed to
be &ldquo;underwriters&rdquo; within the meaning of the Securities Act in connection with such sales. In such event, any commissions
received by such selling stockholders, broker-dealers or agents and any profit on the resale of the shares purchased by them may
be deemed to be underwriting commissions or discounts under the Securities Act. Selling stockholders who are &ldquo;underwriters&rdquo;
within the meaning of Section 2(11) of the Securities Act will be subject to the prospectus delivery requirements of the Securities
Act and may be subject to certain statutory liabilities of, including but not limited to, Sections 11, 12 and 17 of the Securities
Act and Rule 10b-5 under the Exchange Act. Each selling stockholder has informed us that it is not a registered broker-dealer
or an affiliate of a registered broker-dealer.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under
the securities laws of some states, the shares of common stock may be sold in such states only through registered or licensed
brokers or dealers. In addition, in some states the shares of common stock may not be sold unless such shares have been registered
or qualified for sale in such state or an exemption from registration or qualification is available and is complied with. There
can be no assurance that any selling stockholder will sell any or all of the shares of common stock registered pursuant to the
registration statement, of which this prospectus forms a part.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
are required to pay certain fees and expenses incurred by us incident to the registration of the shares. We have agreed to indemnify
the selling stockholders against certain losses, claims, damages and liabilities, including liabilities under the Securities Act,
and the selling stockholders may be entitled to contribution. We may be indemnified by the selling stockholders against certain
losses, claims, damages and liabilities, including liabilities under the Securities Act that may arise from any written information
furnished to us by the selling stockholders specifically for use in this prospectus, or we may be entitled to contribution.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 36; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->32<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
selling stockholders will be subject to the prospectus delivery requirements of the Securities Act including Rule 172 thereunder
unless an exemption therefrom is available.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under
applicable rules and regulations under the Exchange Act, any person engaged in the distribution of the shares of common stock
may not simultaneously engage in market making activities with respect to the shares of common stock for the applicable restricted
period, as defined in Regulation M, prior to the commencement of the distribution. In addition, the selling stockholders will
be subject to applicable provisions of the Exchange Act and the rules and regulations thereunder, including Regulation M, which
may limit the timing of purchases and sales of shares of common stock by the selling stockholders or any other person. We will
make copies of this prospectus available to the selling stockholders and have informed them of the need to deliver a copy of this
prospectus at or prior to the time of the sale (including by compliance with Rule 172 under the Securities Act).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
the extent required, the shares of our common stock to be sold, the names of the selling stockholders, the respective purchase
prices and public offering prices, the names of any agents, dealer or underwriter, any applicable commissions or discounts with
respect to a particular offer will be set forth in an accompanying prospectus supplement or, if appropriate, a post-effective
amendment to the registration statement that includes this prospectus.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
selling stockholders may not sell any or all of the shares of common stock we registered on behalf of the selling stockholders
pursuant to the registration statement of which this prospectus forms a part.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Once
sold under the registration statement of which this prospectus forms a part, the shares of common stock registered herein will
be freely tradable in the hands of persons other than our affiliates.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A NAME="k_006"></A>SELLING
STOCKHOLDERS</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">This
prospectus covers the resale from time to time by the selling stockholders identified in the table below of up to 4,910,000 shares
of common stock through this prospectus, which were sold pursuant to private offering transactions which closed on July
30, 2019 (2,000,000 shares) and September 30, 2019 (2,910,000 shares), for an aggregate of $1,455,000 in cash ($0.50 per
share), which are described in greater detail under &ldquo;<U>Private Placement of Common Stock&rdquo;, beginning on
page <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">28.</FONT></U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
are registering the shares to permit the selling stockholders and any of their pledgees, donees, transferees, assignees and successors-in-interest
to, from time to time, sell any or all of the shares through public or private transactions at prevailing market prices, at prices
related to prevailing market prices or at privately negotiated prices of common stock on any stock exchange, market or trading
facility on which the shares are traded or in private transactions when and as they deem appropriate in the manner described in
&ldquo;<U>Plan of Distribution</U>&rdquo;. As of the date of this prospectus, there are 38,986,459 shares of our common
stock issued and outstanding.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table sets forth, as of the date of this prospectus, the name of each selling stockholder, the number and percentage
of shares of our common stock beneficially owned by each selling stockholder prior to the offering for resale of the shares under
this prospectus, the number of shares of our common stock beneficially owned by each selling stockholder that may be offered from
time to time under this prospectus, and the number and percentage of shares of our common stock beneficially owned by the selling
stockholder after the offering of the shares (assuming all of the offered shares are sold by the selling stockholder).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">There
are no agreements between the Company and any selling stockholder pursuant to which the shares subject to this registration statement
were issued. None of the selling stockholders has ever been an executive officer or director of the Company or has had a material
relationship with us at any time within the past three years unless disclosed in the footnotes below.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 37; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->33<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Beneficial
ownership is determined in accordance with the rules of the SEC, and includes any shares of common stock as to which a person
has sole or shared voting power or investment power and any shares of common stock which the person has the right to acquire within
sixty (60) days through the exercise of any option, warrant or right, through conversion of any security or pursuant to the automatic
termination of a power of attorney or revocation of a trust, discretionary account or similar arrangement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="font-weight: bold; text-align: center">&nbsp;</TD>
    <TD COLSPAN="6" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Number of Shares of Common
    Stock Beneficially Owned Prior to this <BR>
    Offering (1)</TD><TD STYLE="font-weight: bold; text-align: center">&nbsp;</TD><TD STYLE="font-weight: bold; text-align: center">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center">Number of Shares of Common Stock Being</TD><TD STYLE="font-weight: bold; text-align: center">&nbsp;</TD><TD STYLE="font-weight: bold; text-align: center">&nbsp;</TD>
    <TD COLSPAN="6" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Beneficial Ownership of Common
    Stock After Registration Assuming All Shares Are Sold (#)</TD><TD STYLE="font-weight: bold; text-align: center">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Name of Selling Stockholder</TD><TD STYLE="font-weight: bold; text-align: center; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="font-weight: bold; text-align: center; padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="font-weight: bold; text-align: center; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Number</TD><TD STYLE="font-weight: bold; text-align: center; padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="font-weight: bold; text-align: center; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Percentage</TD><TD STYLE="font-weight: bold; text-align: center; padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="text-align: center; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid"><B>Offered</B></TD><TD STYLE="text-align: center; padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="font-weight: bold; text-align: center; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Number</TD><TD STYLE="font-weight: bold; text-align: center; padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="font-weight: bold; text-align: center; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Percentage</TD><TD STYLE="font-weight: bold; text-align: center; padding-bottom: 1.5pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 40%; text-align: left">R.S.N., LLC</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: center">&nbsp;</TD><TD STYLE="width: 7%; text-align: center">(2)</TD><TD STYLE="width: 1%; text-align: left"></TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 7%; text-align: right">3,000,000</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 7%; text-align: right">7.69</TD><TD STYLE="width: 1%; text-align: left">%</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 7%; text-align: right">3,000,000</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 7%; text-align: right">-</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 7%; text-align: right">-</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Bedford Falls Capital</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center">(3)</TD><TD STYLE="text-align: left"></TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,034,422</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2.65</TD><TD STYLE="text-align: left">%</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,000,000</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">34,422</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</FONT></TD><TD STYLE="text-align: left">%</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Phil Hayden</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">400,000</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1.03</TD><TD STYLE="text-align: left">%</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">400,000</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Nitesh Patel</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center">(4)</TD><TD STYLE="text-align: left"></TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">60,000</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</FONT></TD><TD STYLE="text-align: left">%</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">40,000</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Shilpa Patel</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center">(5)</TD><TD STYLE="text-align: left"></TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">60,000</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</FONT></TD><TD STYLE="text-align: left">%</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">20,000</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Punil &amp; Awani Patel</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">200,000</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</FONT></TD><TD STYLE="text-align: left">%</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">200,000</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt">Dr. Fadi Saba</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="text-align: center; padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="text-align: center; padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="text-align: left; padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="text-align: left; border-bottom: Black 1.5pt solid">&nbsp;</TD><TD STYLE="text-align: right; border-bottom: Black 1.5pt solid">250,000</TD><TD STYLE="text-align: left; padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="text-align: left; border-bottom: Black 1.5pt solid">&nbsp;</TD><TD STYLE="text-align: right; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</FONT></TD><TD STYLE="text-align: left; padding-bottom: 1.5pt">%</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="text-align: left; border-bottom: Black 1.5pt solid">&nbsp;</TD><TD STYLE="text-align: right; border-bottom: Black 1.5pt solid">250,000</TD><TD STYLE="text-align: left; padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="text-align: left; border-bottom: Black 1.5pt solid">&nbsp;</TD><TD STYLE="text-align: right; border-bottom: Black 1.5pt solid">-</TD><TD STYLE="text-align: left; padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="text-align: left; border-bottom: Black 1.5pt solid">&nbsp;</TD><TD STYLE="text-align: right; border-bottom: Black 1.5pt solid">-</TD><TD STYLE="text-align: left; padding-bottom: 1.5pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; text-align: right">4,910,000</TD><TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">*
Less than one percent (1%).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">#
Assumes the sale of all shares offered herein.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)
&ldquo;<U>Beneficial ownership</U>&rdquo; means that a person, directly or indirectly, has or shares voting or investment power
with respect to a security or has the right to acquire such power within 60 days. The percentage is based upon 38,986,459
shares of our common stock outstanding as of October 11, 2019.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)
Darshan Ram and Savitri Ram are husband and wife and joint owners of R.S.N., LLC, a Delaware limited liability company (&ldquo;<U>RSN</U>&rdquo;),
and as such, Darshan Ram and Savitri Ram indirectly share voting and dispositive power over the securities directly held by RSN.
As a result, each of Darshan Ram and Savitri Ram may be deemed to have beneficial ownership of such securities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3)
Gary Augusta, a member of the Board of Directors of the Company controls and serves as President of Bedford Falls Capital LLC,
which shares he is deemed to beneficially own. Beneficial ownership totals do not include warrants to purchase 300,000 shares
of the Company&rsquo;s common stock at an exercise price of $0.01 per share, of which warrants to purchase 150,000 shares vest
on April 1, 2020 and warrants to purchase 150,000 shares vest on April 1, 2021, held by Flacane Advisors Inc., which
entity is controlled by Gary Augusta, the vesting of which is subject to Flacane Advisors Inc.&rsquo;s continued service to the
Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(4)
Nitesh Patel is a cousin of Prashant Patel, our director and President.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(5)
Shipla Patel is spouse of Nitesh Patel, who is a cousin of Prashant Patel, our director and President.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"></P>

<!-- Field: Page; Sequence: 38; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->34<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><A NAME="k_007"></A><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">CERTAIN
BENEFICIAL OWNERS AND MANAGEMENT</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; text-indent: -0.2in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table sets forth certain information regarding the beneficial ownership of our common stock as of October 11, 2019 (the
&ldquo;<U>Date of Determination</U>&rdquo;) by (i) each Named Executive Officer, as such term is defined below under &ldquo;<U>Executive
and Director Compensation</U>&rdquo;, (ii) each member of our Board of Directors, (iii) each person deemed to be the beneficial
owner of more than five percent (5%) of our common stock, and (iv) all of our executive officers and directors as a group. Unless
otherwise indicated, each person named in the following table is assumed to have sole voting power and investment power with respect
to all shares of our common stock listed as owned by such person. The address of each person is deemed to be the address of the
Company unless otherwise noted.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Beneficial
ownership is determined in accordance with the rules of the SEC and includes voting and/or investing power with respect to securities.
These rules generally provide that shares of common stock subject to options, warrants or other convertible securities that are
currently exercisable or convertible, or exercisable or convertible within 60 days of the Date of Determination, are deemed to
be outstanding and to be beneficially owned by the person or group holding such options, warrants or other convertible securities
for the purpose of computing the percentage ownership of such person or group, but are not treated as outstanding for the purpose
of computing the percentage ownership of any other person or group. The percentages are based upon 38,986,459 shares of our
common stock outstanding as of October 11, 2019.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
our knowledge, except as indicated in the footnotes to this table and pursuant to applicable community property laws, as of the
Date of Determination, (a) the persons named in the table have sole voting and investment power with respect to all shares of
common stock shown as beneficially owned by them, subject to applicable community property laws; and (b) no person owns more than
5% of our common stock. Unless otherwise indicated, the address for each of the officers or directors listed in the table below
is 3840 Land O&rsquo; Lakes Blvd, Land O Lakes, FL 34639.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-weight: bold; border-bottom: Black 1.5pt solid; text-align: left">Name and Address of Beneficial Owner</TD><TD STYLE="font-weight: bold; text-align: center">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Number of Shares Beneficially Owned</TD><TD STYLE="font-weight: bold; text-align: center">&nbsp;</TD><TD STYLE="font-weight: bold; text-align: center">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Percentage Beneficially Owned</TD><TD STYLE="font-weight: bold; text-align: center">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-style: italic; text-align: justify">Directors and Named Executive Officers:</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="width: 60%; text-align: justify">Suren Ajjarapu, Chairman, CEO (1)</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 16%; text-align: right">13,843,750</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 16%; text-align: right">35.4</TD><TD STYLE="width: 1%; text-align: left">%</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify">Prashant Patel, Director, COO, and President (2)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">12,350,000</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">31.6</TD><TD STYLE="text-align: left">%</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify">Donald G. Fell, Director (3)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">218,173</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify">Howard Doss, CFO (4)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">326,313</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify">Michael L Peterson, Director (5)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">183,173</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify">Gary Augusta, Director (6)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,034,422</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2.7</TD><TD STYLE="text-align: left">%</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold; font-style: italic; text-align: left">All executive officers and directors as a Group (six persons)</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; text-align: right">27,955,831</TD><TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; text-align: right">71.3</TD><TD STYLE="font-weight: bold; text-align: left">%</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-style: italic; text-align: justify">Greater than 5% Stockholders</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-style: italic; text-align: justify">Gajan Mahendiran (7)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2,760,002</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">6.8</TD><TD STYLE="text-align: left">%</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-style: italic; text-align: justify">R.S.N., LLC (8)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">3,000,000</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">7.7</TD><TD STYLE="text-align: left">%</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">*
Less than one 1%</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><SUP>(1)
</SUP>Includes (i) 7,143,750 shares owned directly by Mr. Ajjarapu, (ii) 4,050,000 shares owned by Mr. Ajjarapu&rsquo;s wife,
which Mr. Ajjarapu claims beneficial ownership of, (iii) 1,275,000 shares owned by the Surendra Ajjarapu Revocable Trust of 2007,
which Mr. Ajjarapu claims beneficial ownership of, as Trustee, and (iv) 1,275,000 shares owned by the Sandhya Ajjarapu Revocable
Trust of 2007 and options to purchase 100,000 shares of common stock granted in 2019, that are exercisable within 60 days of the
Date of Determination, which Mr. Ajjarapu claims beneficial ownership of, as Trustee.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><SUP>(2)
</SUP>Includes (i) 7,350,000 shares owned directly by Mr. Patel, (ii) 2,500,000 shares owned by Rina Patel, Mr. Patel&rsquo;s
wife, which Mr. Patel claims beneficial ownership of, (iii) 2,400,000 shares owned by the Patel Trust; and (iv) options to purchase
100,000 shares of common stock granted in 2019, that are exercisable within 60 days of the Date of Determination, which Mr. Patel
claims beneficial ownership of, as Trustee.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 39; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->35<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><SUP>(3)
</SUP>Includes 218,173 shares of common stock issuable upon the exercise of stock options that are exercisable within 60 days
of the Date of Determination.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><SUP>(4)
</SUP>Includes 326,313 shares of common stock issuable upon the exercise of stock options that are exercisable within 60 days
of the Date of Determination.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><SUP>(5)
</SUP>Includes 183,173 shares of common stock issuable upon the exercise of stock options that are exercisable within 60 days
of the Date of Determination.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><SUP>(6)
</SUP>Does not include warrants to purchase 300,000 shares of the Company&rsquo;s common stock at an exercise price of $0.01 per
share, of which warrants to purchase 150,000 shares April 1, 2020 and warrants to purchase 150,000 shares vest on April
1, 2021, held by Flacane Advisors Inc., which entity is controlled by Gary Augusta, the vesting of which is subject to Flacane
Advisors Inc.&rsquo;s continued service to the Company. Includes 1,000,000 shares of common stock held by Bedford Falls Capital LLC,
an entity which Mr. Augusta controls and serves as President of, and which shares he is deemed to beneficially own.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><SUP>(7)
</SUP>Includes 833,334 shares of common stock of the Company and warrants to purchase 1,926,668 shares of common stock at an exercise
price of $0.01 per share that are exercisable within 60 days of the Date of Determination, and which are held jointly with Mr.
Mahendiran&rsquo; s wife, as tenants by entirety. Address: 4427 Corral Road, Warrenton, Virginia 20187.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><SUP>(8)
</SUP>The securities held by R.S.N., LLC are beneficially owned by Darshan Ran and Savitri Ran, its Members. Address: 744 Broadway
Avenue, Orillia, Ontario, Canada.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Change
of Control</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company is not aware of any arrangements which may at a subsequent date result in a change of control of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A NAME="k_008"></A>DIVIDEND
POLICY</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have never paid or declared any cash dividends on our common stock and do not anticipate paying cash dividends in the foreseeable
future. We anticipate that we will retain all of our future earnings for use in the operation of our business and for general
corporate purposes. Any determination to pay dividends in the future will be at the discretion of our board of directors. Accordingly,
investors must rely on sales of their common stock after price appreciation, which may never occur, as the only way to realize
any future gains on their investments.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 20pt; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A NAME="k_009"></A>UNITED
STATES FEDERAL INCOME TAX CONSIDERATIONS</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following is a summary of the material U.S. federal income tax considerations relating to the purchase, ownership and disposition
of the shares of the common stock purchased by an investor pursuant to this Offering. We have based this summary upon the Internal
Revenue Code of 1986, as amended (the &ldquo;<U>Code</U>&rdquo;), Treasury regulations promulgated under the Code, as amended
(the &ldquo;<U>Treasury Regulations</U>&rdquo;), administrative rulings and pronouncements and judicial decisions, in each case
as of the date hereof. These authorities are subject to differing interpretations and are subject to change, perhaps retroactively,
resulting in U.S. federal income tax consequences different from those discussed below. We have not sought any ruling from the
Internal Revenue Service (the &ldquo;<U>IRS</U>&rdquo;) with respect to the statements made and the conclusions reached in the
following summary, and the IRS may not agree with such statements and conclusions or a court may not sustain any challenge by
the IRS in the event of litigation.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 40; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->36<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
summary assumes that a beneficial owner will hold the shares of the common stock, as the case may be, as capital assets within
the meaning of section 1221 of the Code. This summary does not address the tax consequences arising under the laws of any state
or local jurisdiction or non-U.S. jurisdiction or any other U.S. federal tax consequences, such as estate and gift tax consequences.
In addition, this summary does not address all tax considerations that might be applicable to your particular circumstances (such
as the alternative minimum tax provisions of the Code), or to certain types of holders subject to special tax rules, including,
without limitation, partnerships, banks, financial institutions or other &ldquo;financial services&rdquo; entities, broker-dealers,
insurance companies, tax-exempt organizations, regulated investment companies, real estate investment trusts, retirement plans,
individual retirement accounts or other tax-deferred accounts, persons who use or are required to use mark-to-market accounting
for federal income tax purposes, persons that hold shares of the common stock as part of a &ldquo;straddle&rdquo;, a &ldquo;hedge&rdquo;,
a &ldquo;conversion transaction&rdquo; or other arrangement involving more than one position, U.S. holders (as defined below)
that have a functional currency other than the U.S. dollar and certain former citizens or permanent residents of the United States.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
a partnership holds the shares of the common stock, the tax treatment of a partner in the partnership will generally depend upon
the status of the partner and the activities of the partnership. If you are a partner of a partnership holding the shares of the
common stock, you should consult your tax advisor.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
you are considering the purchase of the shares of the common stock, you should consult your own tax advisor concerning the U.S.
federal income tax consequences to you in light of your particular facts and circumstances and any consequences arising under
the laws of any state, local, foreign or other taxing jurisdiction.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
used in this discussion, a &ldquo;U.S. Holder&rdquo; is a beneficial owner of the shares of the common stock that is not a partnership
or entity treated as a partnership for U.S. federal income tax purposes and is:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 0.25in; text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 0.25in; text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">an
    individual who is a citizen or resident of the United States;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a
    corporation (or other entity treated as a corporation for U.S. federal income tax purposes) created or organized in or under
    the laws of the United States, any state thereof or the District of Columbia;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">an
    estate, the income of which is subject to U.S. federal income taxation regardless of its source; or</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a
    trust (i) if a court within the United States is able to exercise primary supervision over its administration and one or more
    U.S. persons have authority to control all substantial decisions of the trust or (ii) that has a valid election in effect
    under applicable Treasury Regulations to be treated as a U.S. person.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
used in this discussion, a &ldquo;Non-U.S. Holder&rdquo; is a beneficial owner of shares of the common stock that is neither a
U.S. Holder nor a partnership or other entity treated as a partnership for U.S. federal income tax purposes. Special rules may
apply to Non-U.S. Holders that are subject to special treatment under the Code, including controlled foreign corporations, passive
foreign investment companies, U.S. expatriates, and foreign persons eligible for benefits under an applicable income tax treaty
with the United States. Such Non-U.S. Holders should consult their tax advisors to determine U.S. federal, state, local and other
tax consequences that may be relevant to them.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">THIS
DISCUSSION IS ONLY A SUMMARY OF CERTAIN MATERIAL U.S. FEDERAL INCOME TAX OF THE ACQUISITION, OWNERSHIP AND DISPOSITION OF THE
COMMON STOCK. IT IS NOT TAX ADVICE. EACH PROSPECTIVE INVESTOR IS URGED TO CONSULT ITS TAX ADVISOR WITH RESPECT TO THE PARTICULAR
TAX CONSEQUENCES TO SUCH INVESTOR, INCLUDING THE APPLICABILITY AND EFFECT OF ANY LOCAL, AND NON-U.S. TAX LAWS, AS WELL AS U.S.
FEDERAL TAX LAWS, AND ANY APPLICABLE TAX TREATIES.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Distributions
made to U.S. Holders out of our current or accumulated earnings and profits, as determined for U.S. federal income tax purposes,
will be included in the income of a U.S. Holder as dividend income and will be subject to tax as ordinary income. Distributions
in excess of our current and accumulated earnings and profits will not be taxable to a U.S. Holder to the extent that the distributions
do not exceed the U.S. Holder&rsquo;s adjusted tax basis in the stock to which such distribution relates, but rather will reduce
the adjusted tax basis of such shares. To the extent that distributions in excess of our current and accumulated earnings and
profits exceed the U.S. Holder&rsquo;s adjusted tax basis in the shares of stock to which the distribution relates, such distributions
will generally be treated as the sale or exchange of such stock, resulting in capital gain. In addition, a corporate U.S. Holder
will not be entitled to the dividends-received deduction on this portion of a distribution.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 41; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->37<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any
distribution not constituting a dividend will be treated for U.S. federal income tax purposes as a tax-free return of capital
to the extent of the Non-U.S. Holder&rsquo;s adjusted tax basis in its shares of our common stock (with a corresponding reduction
to such basis), and, to the extent such distribution exceeds the Non-U.S. Holder&rsquo;s adjusted tax basis, as gain from the
sale or other disposition of the common stock. Generally, any distribution to a Non-U.S. Holder that is a dividend for U.S. federal
income tax purposes and that is not effectively connected with the Non-U.S. Holder&rsquo;s conduct of a trade or business within
the United States, as described below, will be subject to U.S. federal withholding tax at a rate of 30% percent of the gross amount
of the dividend, unless such Non-U.S. Holder is eligible for a reduced rate of withholding tax under an applicable income tax
treaty and provides proper certification of its eligibility for such reduced rate.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
will notify all of our U.S. and non-U.S. holders of our shares after the close of each taxable year as to the portions of the
distributions attributable to that year that constitute ordinary income, qualified dividend income and non-dividend distributions,
if any. Each investor should consult the investor&rsquo;s individual or corporate tax advisor.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A NAME="k_010"></A>LEGAL
MATTERS</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
Form S-1 registration statement was prepared by The Loev Law Firm, PC, Bellaire, Texas. The financial statements attached hereto
for the years ended December 31, 2018 and 2017, were audited by MaloneBailey, LLP. The Loev Law Firm, PC, and MaloneBailey, LLP
do not have any interest contingent or otherwise in the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A NAME="k_011"></A>EXPERTS</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
audited financial statements of Trxade Group, Inc. and its subsidiaries as of December 31, 2018 and, 2017, and
for the years then ended, included in this prospectus have been audited by MaloneBailey LLP, Houston, Texas, independent registered
public accounting firm, as stated in their report date dated March 22, 2019 which is incorporated herein, and has been so incorporated
in reliance upon the report of such firm given upon their authority as experts in accounting and auditing.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">No
expert or counsel named in this prospectus as having prepared or certified any part of this prospectus or having given an opinion
upon the validity of the securities being registered or upon other legal matters in connection with the registration or offering
of the common stock was employed on a contingency basis, or had, or is to receive, any interest, directly or indirectly, in our
Company or any of our parents or subsidiaries, nor was any such person connected with us or any of our parents or subsidiaries,
if any, as a promoter, managing or principal underwriter, voting trustee, director, officer, or employee.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><A NAME="k_012"></A><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">CHANGES
IN AND DISAGREEMENTS WITH ACCOUNTANTS ON ACCOUNTING AND FINANCIAL DISCLOSURE</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">None.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><A NAME="k_013"></A><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">DESCRIPTION
OF BUSINESS</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following discussion should be read in conjunction with our financial statements and the related notes and other financial information
appearing elsewhere in this prospectus.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Overview</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have designed and developed, and now own and operate, a business-to-business, web-based marketplace focused on the pharmaceutical
industry in the United States. Our core service is designed to bring the nation&rsquo;s independent pharmacies and accredited
national suppliers of pharmaceuticals together to provide efficient and transparent buying and selling opportunities on a web-based
platform.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 42; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->38<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>CORPORATE
HISTORY</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Background
of XCEL</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
Company was incorporated in Delaware on July 15, 2005, as &ldquo;Bluebird Exploration Company&rdquo; (&ldquo;<U>Bluebird</U>&rdquo;).
Bluebird was originally formed to engage in the exploitation of mineral properties. In December 2008, Bluebird changed its name
to &ldquo;Xcellink International, Inc.&rdquo; (&ldquo;<U>XCEL</U>&rdquo;), and subsequently announced that its business plan was
being expanded to include the development and marketing of platform-independent customer-centric payment systems and methodologies.
XCEL was unable to raise the funds necessary to implement its business strategy, never generated any revenue and was a reporting
as a &ldquo;<U>shell</U>&rdquo; corporation. On January 9, 2014, Trxade Group, Inc., a privately held Nevada corporation, merged
with and into XCEL, and XCEL changed its name to &ldquo;Trxade Group, Inc.&rdquo;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Background
of Trxade</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">PharmaCycle
LLC, a Nevada limited liability company (&ldquo;<U>PharmaCycle</U>&rdquo;), was formed in August 2010 by Prashant Patel, our President,
to serve as a web-based market platform designed to enable trading among healthcare buyers and sellers of pharmaceuticals, accessories
and services. In January 2013, PharmaCycle converted into a Florida corporation and changed its name to Trxade, Inc. (&ldquo;<U>Trxade
Florida</U>&rdquo;). In May 2013, Trxade Florida created a new wholly-owned subsidiary, Trxade Group, Inc., a Nevada corporation
(&ldquo;<U>Trxade Nevada</U>&rdquo;). Trxade Nevada acquired Trxade Florida pursuant to a reverse triangular merger, resulting
in Trxade Florida becoming a wholly-owned subsidiary of Trxade Nevada (the &ldquo;<U>Nevada-Florida Merger</U>&rdquo;). The sole
purpose of the Nevada-Florida Merger was to provide for a holding company to own Trxade Florida, the operating company. At all
times, up to the Nevada-Florida Merger, Trxade Florida was capitalized exclusively by cash capital contributions from Messrs.
Suren Ajjarapu and Patel, our Chief Executive Officer and President, respectively. Immediately following the Nevada-Florida Merger,
Messrs. Ajjarapu and Patel collectively owned 99% of Trxade Nevada. After the Nevada-Florida Merger (but prior to the merger with
XCEL), Trxade Nevada raised $670,000 through the sale of its preferred stock in private placements made to third party investors.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Reverse
Merger with Trxade</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
September 26, 2008, Mark Fingarson, the former President, sole Director and controlling shareholder of XCEL, sold 80,000,000 shares
of XCEL (prior to the reverse split discussed below) to XCEL&rsquo;s then attorney, Ron McIntyre. On November 22, 2013, Trxade
Nevada acquired Mr. McIntyre&rsquo;s controlling interest of 80,000,000 shares in XCEL pursuant to a Purchase and Sale Agreement
dated November 7, 2013. At the time of the sale, XCEL had 104,160,000 shares of common stock issued and outstanding, including
the 80,000,000 shares of stock acquired by Trxade Nevada (prior to the reverse split discussed below).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
December 16, 2013, Trxade Nevada and XCEL entered into a definitive merger agreement (the &ldquo;<U>Merger Agreement</U>&rdquo;)
providing for the merger (the &ldquo;<U>Merger</U>&rdquo;) of Trxade Nevada with and into XCEL, with XCEL continuing as the surviving
corporation. The Merger closed on January 8, 2014. Under the terms of the Merger Agreement, we amended our certificate of incorporation
changed our name to &ldquo;Trxade Group, Inc.,&rdquo; and changed our trading symbol to XCEL.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Recapitalization
of Common Stock by a Reverse Split and Increase of Authorized Shares of Stock</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
also reversed our issued and outstanding stock at the ratio of one for one thousand (1:1,000) shares effective upon the closing
of the Merger (the &ldquo;<U>Reverse Split</U>&rdquo;). In connection with the Reverse Split, 104,160,000 outstanding shares of
our common stock, including the 80,000,000 shares held by Trxade Nevada, were exchanged for 104,160 post-Reverse Split shares
of common stock. As a result of the Merger, Trxade Nevada shareholders holding 28,800,000 shares of common stock and 670,000 shares
of Series A Preferred Stock converted their shares on a one-to-one basis into 28,800,000 shares of our common stock and 670,000
shares of our Series A Preferred Stock, for an aggregate total of 29,470,000 shares. Further, 600,000 shares of our common stock
(on a post-Reverse Split basis) were issued following the Merger in connection with the conversion of our promissory notes. The
80,000,000 pre-Merger shares held by Trxade Nevada, which amounted to 80,000 shares after the Reverse Split, reverted to treasury
stock of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"></P>

<!-- Field: Page; Sequence: 43; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->39<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
June 11, 2015, pursuant to our Second Amended and Restated Certification of Incorporation, we decreased the authorized shares
of our common stock from 500,000,000 to 100,000,000 and decreased the authorized shares of our Preferred Stock from 100,000,000
to 10,000,000. The Company is currently authorized to issue 100,000,000 shares of common stock with $0.00001 par value per share
and 10,000,000 shares of preferred stock, $0.00001 par value per share.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Subsidiaries</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
own 100% of Trxade Florida. This subsidiary is included in our attached consolidated financial statements and is engaged in the
same line of business as Trxade. Trxade Florida is a web-based market platform that enables commerce among healthcare buyers and
sellers of pharmaceuticals, accessories and services.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
own 100% of Integra Pharma Solutions, LLC (formerly Pinnacle Tek, Inc., a Florida corporation) founded by Mr. Suren Ajjarapu,
our CEO, in 2011 (&ldquo;<U>INTEGRA</U>&rdquo;). Until the end of 2016, INTEGRA served as our technology consultant provider,
but we discontinued that line of business in 2016. We now intend that INTEGRA serve as our logistics company for pharmaceutical
distribution.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
own 100% of Community Specialty Pharmacy, LLC, an independent retail specialty pharmacy with a focus on specialty medications.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
own 100% of Alliance Pharma Solutions, LLC, a Florida limited liability company, which was founded in January 2018 (&ldquo;<U>Alliance</U>&rdquo;).
Alliance currently owns 30% (with the option to acquire more) of SyncHealth MSO, LLC as part of a joint venture enabling independent
retail pharmacies to better compete with large national pharmacies on pricing, distribution and logistics. Under our joint venture
arrangement, we have the option to acquire 100% of SyncHealth MSO, LLC. To date, we have not realized any income from
the technology and presently we are in discussions to dissolve this relationship.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Sale
of Westminster</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
also owned 100 percent of Westminster Pharmaceuticals LLC, a Delaware limited liability company (&ldquo;<U>Westminster</U>&rdquo;),
from 2015 through December 31, 2016. Trxade Florida formed Westminster in January 2013 as its wholly-owned subsidiary. This licensed
subsidiary provided state-licensed pharmacies and buying groups in the United States with pharmaceuticals approved by the United
States Food and Drug Administration (the &ldquo;<U>FDA</U>&rdquo;). In late 2015 and early 2016, Westminster entered into multiple
supply contracts with wholesale manufacturers of generic pharmaceuticals to begin selling Westminster private label generic pharmaceuticals
to our customers.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
December 2016, based on our management&rsquo;s strategic review of our portfolio of businesses, we committed to a plan to sell
our private label generic pharmaceutical businesses. On December 31, 2016, we entered into and consummated the sale of 100% of
our equity interests in Westminster, and, in connection with the sale, we exited the private label generic pharmaceuticals business
line. We sold Westminster in exchange for (a) the buyer&rsquo;s cancellation of $1,500,000 of indebtedness owed by us under a
senior secured note, (b) our issuance of warrants to purchase 1,500,000 shares of our common stock (the &ldquo;<U>Warrants</U>&rdquo;),
and (c) the buyer&rsquo;s assumption of various contracts and obligations of Westminster. We issued the Warrants to the buyer
at a strike price of $0.01 per share. The Warrants have an expiration date of five years from date of grant under the terms and
conditions of our warrant agreement with the buyer.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Acquisition
of Community Specialty Pharmacy, LLC</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
October 15, 2018, the Company entered into and consummated the purchase of 100% of the equity interests of Community Specialty
Pharmacy, LLC, a Florida limited liability company, (&ldquo;<U>CSP</U>&rdquo;), pursuant to the terms and conditions of the Membership
Interest Purchase Agreement, entered into by and among the Company as the buyer, and CSP, and Nikul Panchal, the equity owner
of CSP, a non-executive officer of the Company (collectively, the &ldquo;<U>Seller</U>&rdquo;). The purchase price for the 100%
equity interest in CSP was $300,000 in cash, a promissory note issued by the Company in the amount of $300,000, and warrants to
purchase 405,507 shares of common stock of the Company which vested at the acquisition date, are exercisable for eight (8) years
from the issuance date at a strike price of $0.01 per share, and subject to exercise restrictions which lapse over a period of
three (3) years.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 44; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->40<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SyncHealth
MSO, LLC Joint Venture</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
January 17, 2019, the Company and Alliance Pharma Solutions, LLC, a Delaware limited liability company and wholly-owned subsidiary
of the Company (hereafter &ldquo;<U>Alliance</U>,&rdquo; with Alliance and Trxade referred to collectively herein as the &ldquo;<U>Trxade
Parties</U>&rdquo;), entered into a transaction effective as of January 17, 2019 with PanOptic Health, LLC, a Delaware limited
liability company (&ldquo;<U>PanOptic</U>&rdquo;), to create a new entity, SyncHealth MSO, LLC (&ldquo;<U>SyncHealth</U>&rdquo;)
to enable independent retail pharmacies to better compete with large national pharmacies on pricing, distribution and logistics.
To date, we have not realized any income from the technology and presently we are in discussions to dissolve this relationship.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>BUSINESS
OF TRXADE</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Our
Principal Products and Services and their Markets.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Trxade.com
</I>is a web-based pharmaceutical marketplace engaged in promoting and enabling commerce among independent pharmacies and large
pharmaceutical suppliers nationally. Our marketplace has hundreds of suppliers providing over 20,000 branded and generic drugs
available for purchase by pharmacists. We already serve over 10,000 independent pharmacies. Access to Trxade&rsquo;s proprietary
pharmaceutical database, data analytics regarding medication pricing, and manufacturer return policies. We generate revenue from
these services by charging a transaction fee to the seller of the products for sales conducted via the Trxade platform. The buyers
do not bear the cost of transaction fees for the purchases that they make, nor do they pay a fee to join or register with our
platform. Substantially all of our revenues during the years ended December 31, 2018, and 2017, were from platform revenue generated
on <I>www.Trxade.com.</I> For additional information, please visit us at http://www.trxadegroup.com, http://www.trxade.com, and
http://www.delivmeds.com. Information on our website is not incorporated by reference into
this prospectus.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Status
of any publicly announced new products or services.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have a number of products and services still in development, which are described below.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>InventoryRx.com</B>.
InventoryRx, launched in the first quarter of 2014, is a web-based pharmaceutical exchange platform where wholesalers can buy
and sell pharmaceuticals or over-the-counter medications with each other in a systematized online sales platform. The site offers
these trading partners greater product availability and pricing transparency. The site may also substantially improve our customers
buying efficiency and lower their cost of goods on a continuous basis. This product is built into the <I>Trxade.com</I> platform
and, accordingly, we have not generated any independent revenue from this product.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Pharmabayonline</B>.
We formed Pharmabayonline to provide proprietary pharmaceutical data analytics and governmental reimbursement benchmarks analysis
to United States-based independent pharmacies and pharmaceutical databases.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>RxGuru</B>.
Our RxGuru application was launched in the first quarter of 2014 and underscores our commitment to deliver timely information
to our customers at the moment before purchase. Our industry leading price prediction model &ldquo;RxGuru&rdquo; integrates product
insight into pharmacy acquisition benchmarks (&ldquo;<U>PAC</U>&rdquo;) to ascertain trends and pricing variances which result
in significant purchasing opportunities. &ldquo;RX Guru&rdquo; helps to predict prices and affords our members an opportunity
continuously to benefit from real price purchasing opportunities that are often concealed from the rest of the industry. This
product is built into the <I>Trxade.com</I> platform and, accordingly, this application works in conjunction with the Trxade platform
but, to date, has not generated any independent revenue.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Integra
Pharma Solutions, LLC</B>. INTEGRA is intended to serve as our logistics company for pharmaceutical distribution and has limited
operations and revenue at this time.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 45; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->41<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Community
Specialty Pharmacy, LLC</B>. We acquired Community Specialty Pharmacy, LLC, a Florida limited liability company (&ldquo;<U>CSP</U>&rdquo;),
on October 15, 2018. CSP is an accredited pharmacy located in St. Petersburg, Florida. CSP has a focus on specialty medications.
The company operates with an innovative pharmacy model which offers home delivery services to any patient thereby providing convenience.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Delivmeds.com</B>.
<I>Delivmeds.com</I> was launched in late 2018 as a consumer-based app to provide delivery of pharmaceutical products associated
with Alliance Pharma Solutions, LLC. To date, we have not generated any revenue from this product.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Trxademso</B>.
Trxademso technology was developed early 2019 as part of the SyncHealth MSO, LLC joint venture to develop technology
that would assist independent retail pharmacies to compete better with large national pharmacies on pricing, distribution
and logistics. To date, we have not generated any income from this product and currently we are in discussions to dissolve
this relationship.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">All
of our product offerings are focused on the United States markets. Some products are restricted just to certain states, depending
upon the various applicable state regulations and guidelines pertaining to pharmaceuticals, particularly, and drug businesses,
generally. Our services are distributed through our online platform.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Discontinued
Operations:</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Westminster
Pharmaceuticals</B>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Westminster
bought FDA-approved prescription medications from licensed pharmaceutical wholesalers and manufacturers from 2015 until 2016.
Westminster stored these products at a licensed logistics location in Olive Brach, Mississippi until they were ready for delivery
to Westminster&rsquo;s customers once sold. In late 2015 and early 2016, Westminster entered into multiple supply contracts with
wholesale manufacturers of generic pharmaceuticals to begin selling Westminster private label generic pharmaceuticals to its customers.
Westminster generated very limited revenue from the sale of its private label products. This business line was not profitable
for the Company, and we sold Westminster in December 2016, thus concluding the Company&rsquo;s exit from the private label generic
pharmaceuticals business.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>The
Pharmaceutical Industry</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">According
to the <I>2013-14 Economic Report on Retail, Mail, and Specialty Pharmacies</I> by Adam J. Fein, Ph.D. (the &ldquo;<U>Fein Report</U>&rdquo;),
United States pharmaceutical companies comprise a burgeoning $330 billion industry consisting of over 65,000 pharmacy facilities
and 700 DEA-registered (and 1,500 State-licensed) suppliers. Management believes that few platforms currently in place to bring
these participants together to share market knowledge, product pricing transparency and product availability. According to this,
the pharmaceutical market is comprised primarily of three wholesalers that control an estimated approximately 92% of the market.
Our management believes that this concentration has, over the years, led to a lack of price and cost transparency, thereby resulting
in severe limitations on the purchasing choices of industry participants. These market dynamics have enabled these large wholesalers
(McKesson, Cardinal Health and AmerisourceBergen), known as ADR distributors, to dominate the industry with respect to both generic
and brand pharmaceuticals. The increasing concentration of generic medications (ANDA or Abbreviated New Drug Application), however,
with many more expected to go to market in the near future (approximately $80 billion in branded medications lost their patent
protection from 2008 to 2018, according to an article in Drug Topics from August 2004, called &ldquo;Big Pharma uses effective
strategies to battle generic competitors&rdquo;, by Martin Sipkoff), have enabled smaller suppliers&rsquo; access to an increasing
number of medications at highly discounted prices. The market is slowly changing towards one where medications will become a commoditized
and influenced by price rather than the business relationships imposed by the dominant participants of the past.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
fuel this change, insurance companies (Pharmacy Benefits Management (&ldquo;<U>PBM</U>&rdquo;) and private health payers) and
the federal government have recently initiated lower medication reimbursement payments to healthcare providers. We believe that
pharmacies in due course will face increasing pressure to source medications as inexpensively as possible and improve operational
efficiency. Trxade seeks to be in the forefront of solving these transparency and pricing concerns by providing independent, retail
pharmacies with real-time, pharmacy acquisition cost (&ldquo;<U>PAC</U>&rdquo;) benchmarks to the National Drug Code (the &ldquo;<U>NDC</U>&rdquo;)
standard. The NDC mark is a unique product identifier used in the United States for drugs intended for human use.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 46; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->42<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Competitive
Business Conditions, Our competitive position in our Industry, and our Methods of Competition.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
expect to face competition from the three large ADR distributors (McKesson, Cardinal Health and AmerisourceBergen), other pharmaceutical
distributors, buying groups, software products, and other start-up companies. Most of our competitors&rsquo; operations have substantially
greater financial- and manufacturer-backed resources, longer operating histories, greater name recognition, and more established
relationships in the industry.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Other
Start-up Companies.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have identified start-ups that provide for supplier-pharmacy trading such as PharmaBid, RxCherrypick, PharmSaver, MatchRx and
GenericBid, and provide web-based services similar to ours, allowing pharmacies to buy from several suppliers. Trxade differentiates
itself from these exchanges by providing our pharmacies with both brand and generic pharmaceutical products. Additional companies
target &ldquo;direct-to-consumer&rdquo; pharmacy deliveries, including <I>Amazon.com</I>&rsquo;s <I>PillPack</I>, <I>Capsule</I>
and <I>GetRoman.com</I>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Buying
Groups.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Buying
Groups provide discounted prices to their members by negotiating better pricing with one primary wholesaler, while charging administrative
fees generally ranging from 3 to 5 percent. Some Buying Groups are structured like co-operatives (such as Independent Pharmacy
Cooperative (IPC) and American Pharmacy Cooperative, Inc. (APCI) and offer their members monthly or quarterly rebates. Although
they can function well to bring pricing competition to the industry, they often offer rebates only after the purchase. Management
does not believe Buying Groups will provide long-term savings to customers with this model given the increased transparency and
competition in the industry.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Pharmaceutical
Software.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Some
pharmaceutical software companies compete with us to varying degrees at different levels. SureCost, for example, provides inventory
management software enabling pharmacies to comply with primary supplier contracts. This software is fee-based and requires training.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pharmacies
may be reluctant to buy pharmaceuticals on the internet due to the historical negativity and uncertainty with respect to the origin
and purity of drugs purchased off the web. Trxade management believes that as we continue to develop our brand, our customer base,
and our vast product offerings, we will gain the trust of the market and overcome the negativity associated with purchasing via
a pharmaceutical online marketplace.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">One
advantage that we believe we have over our competition is our ability to be flexible and fast moving in adjusting our business
model to address the needs of our customer base. Trxade started by offering pharmacies a reverse auction model to enhance savings
on the purchase of their pharmaceuticals. Customer feedback suggested that pharmacies prefer a more &ldquo;buy now&rdquo; format,
which we implemented. This resulted in a &ldquo;one-stop-one-search&rdquo; platform to buy quality pharmaceuticals for less and
a data-rich platform to help pharmacies overcome the complexities related to supply chain purchasing.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Sources
and Availability of Raw Materials; Principal Suppliers.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Trxade
is a web-based technology platform. Because we are not a manufacturing company, we do not need any raw materials. Our module on
the platform is drug supplier-to-retailer. We bring buyers and sellers together on this platform. Our suppliers include National
Apothecary Solutions, Integral RX, and South Pointe Wholesale, Inc.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 47; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->43<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Dependence
on One or More Major Customers.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of the date of this prospectus, we have over 10,000 independent pharmacies and over 30 pharmaceutical suppliers as customers,
with a market potential of approximately 24,000 independent pharmacies and 1,500 regional and local suppliers. We have a working
relationship with over 25 wholesalers and the nation&rsquo;s largest buying group. Although we believe those entities are satisfied
with their business relationship with Trxade, if our buying group and two or three of the largest wholesalers decided no longer
to do business with Trxade, the resulting supplier void would materially and adversely affect our competitiveness in the marketplace.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Intellectual
Property.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Although
we believe that our name and brand are protected by applicable state common law trademark laws, we do not currently have any registered
trademarks, patents, concessions, licenses, royalty agreements, or franchises other than &ldquo;Trxade&rdquo; (Serial Number 86021305),
&ldquo;RxGuru&rdquo; (Serial Number 86024745) and our pharmaceutical pricing benchmarks, PAC. Our business operates under a proprietary
software system which includes trade secrets within our database, business practices and pricing model.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Need
for Government Approval of Products and Services.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
are required to hold business licenses and to follow applicable state and federal government regulations detailed herein. In October
2018, we acquired Community Specialty Pharmacy, LLC, an accredited independent retail pharmacy with a focus on specialty medications,
which requires state approval, which we have obtained.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Effect
of Existing or Probable Government Regulations on the Business<I>.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Federal
Drug Administration Guidelines</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
April 12, 1988, President Ronald Reagan signed into law the Prescription Drug Marketing Act of 1987 (PDMA), setting the baseline
for wholesale distribution regulations. The final regulations were published in 1999, establishing the minimum wholesale distribution
requirements for state licensure. With the intent to prevent the introduction and retail sale of substandard, ineffective, or
counterfeit drugs into the distribution system, state licensing systems moved to update their standards to match those provided
federally as guided under FDA&rsquo;s Guidelines for State Licensing of Wholesale Prescription Drug Distributors (21 CFR 205).
PDMA established minimum federal pedigree requirements to trace the ownership of prescription drugs through the supply chain.
The principal goal of the PDMA was to further secure the nation&rsquo;s drug supply from counterfeit and substandard prescription
drugs. The law establishes two types of distributors: &ldquo;Authorized distributor[s] of record&rdquo; or ADRs; and &ldquo;Unauthorized
distributor[s],&rdquo; such as wholesalers. The pedigree requirement was to require each person engaged in the wholesale distribution
of a prescription drug in interstate commerce, who is not the manufacturer or an authorized distributor of record for that drug,
to provide a pedigree to the recipient. After meeting resistance from various stakeholders, the FDA delayed the effective date
of the regulations several times, until final implementation in December 2006.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">At
the federal level the implementation of the track and trace legislation which went into effect in 2018, requires the use of pharmaceutical
pedigree to track the movement of pharmaceuticals along the supply chain. The costs of complying with this new legislation may
be too burdensome for many of the smaller suppliers.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"></P>

<!-- Field: Page; Sequence: 48; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->44<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>State
Drug Administration Guidelines</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">There
are a number of national and state-wide regulations that have an effect on our business. All drug wholesalers must be licensed
under state licensing systems, which must in turn meet the FDA guidelines under State Licensing of Wholesale Prescription Drug
Distributors (21 CFR Part 205). The regulations set forth minimum requirements for prescription drug storage and security as well
as for the treatment of returned, damaged, and outdated prescription drugs. Further, wholesale drug distributors must establish
and maintain inventories and records of all transactions regarding the receipt and distribution of prescription drugs and make
these available for inspection and copying by authorized federal, state, or local law enforcement officials. In most states, wholesale
distributor licenses are issued by the State Boards of Pharmacy and require periodic renewal. Approximately 40 states also require
out-of-state wholesalers that distribute drugs within their borders to be licensed as well.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">California,
Florida, Nevada, New Mexico and Indiana define the normal distribution channel to not include the lateral sales of pharmaceuticals
between wholesalers. The new Supply Chain Act, part of the Quality Drug Act, which was signed into federal law in December 2013,
precludes all states from restricting, investigating or inspecting the distribution channel and transactional history. Until the
federal government provides guidelines for the new federal law, no state regulation or guideline exists.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
warehousing of pharmaceuticals is also restricted and requires additional state licenses. Some licenses require bonds and written
exams and may take some time to approve. Currently, Westminster Pharmaceuticals, our wholesale distributor, asks for formal pedigrees
from the ADR wholesalers and provides pedigrees to those entities they sell to in the marketplace. This requirement limits liability
and provides assurance if a recall is warranted that Trxade and its participants will receive value for the commodity.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Jumpstart
Our Business Startups Act</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
April 2012, the Jumpstart Our Business Startups Act (&ldquo;<U>JOBS Act</U>&rdquo;) was enacted into law. The JOBS Act provides,
among other things:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exemptions
    for &ldquo;<U>emerging growth companies</U>&rdquo; from certain financial disclosure and governance requirements for up to
    five years and provides a new form of financing to small companies;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Amendments
    to certain provisions of the federal securities laws to simplify the sale of securities and increase the threshold number
    of record holders required to trigger the reporting requirements of the Securities Exchange Act of 1934, as amended;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Relaxation
    of the general solicitation and general advertising prohibition for Rule 506 offerings;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Adoption
    of a new exemption for public offerings of securities in amounts not exceeding $50 million; and</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exemption
    from registration by a non-reporting company of offers and sales of securities of up to $1,000,000 that comply with rules
    to be adopted by the SEC pursuant to Section 4(6) of the Securities Act and exemption of such sales from state law registration,
    documentation or offering requirements.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
general, under the JOBS Act a company is an &ldquo;<U>emerging growth company</U>&rdquo; if its initial public offering (&ldquo;<U>IPO</U>&rdquo;)
of common equity securities was affected after December 8, 2011 and the company had less than $1 billion of total annual gross
revenues during its last completed fiscal year. A company will no longer qualify as an &ldquo;<U>emerging growth company</U>&rdquo;
after the earliest of</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 0.75in; font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    completion of the fiscal year in which the company has total annual gross revenues of $1 billion or more,</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    completion of the fiscal year of the fifth anniversary of the company&rsquo;s IPO;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    company&rsquo;s issuance of more than $1 billion in nonconvertible debt in the prior three-year period, or </FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iv)</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    company becoming a &ldquo;<U>larger accelerated filer</U>&rdquo; as defined under the Securities Exchange Act of 1934, as
    amended.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 49; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->45<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
JOBS Act provides additional new guidelines and exemptions for non-reporting companies and for non-public offerings. Those exemptions
that impact the Company are discussed below.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Financial
Disclosure.</I> The financial disclosure in a registration statement filed by an &ldquo;<U>emerging growth company</U>&rdquo;
pursuant to the Securities Act, will differ from registration statements filed by other companies as follows:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 0.75in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 0.25in; text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">audited
    financial statements required for only two fiscal years (provided that &ldquo;<U>smaller reporting companies</U>&rdquo; such
    as the Company are only required to provide two years of financial statements);</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 0.75in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 0.25in; text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">selected
    financial data required for only the fiscal years that were audited (provided that &ldquo;<U>smaller reporting companies</U>&rdquo;
    such as the Company are not required to provide selected financial data as required by Item 301 of Regulation S-K); and</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 0.75in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 0.25in; text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">executive
    compensation only needs to be presented in the limited format now required for &ldquo;<U>smaller reporting companies</U>&rdquo;.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">However,
the requirements for financial disclosure provided by Regulation S-K promulgated by the Rules and Regulations of the SEC already
provide certain of these exemptions for smaller reporting companies. The Company is a smaller reporting company. Currently a smaller
reporting company is not required to file as part of its registration statement selected financial data and only needs to include
audited financial statements for its two most current fiscal years with no required tabular disclosure of contractual obligations.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
JOBS Act also exempts the Company&rsquo;s independent registered public accounting firm from having to comply with any rules adopted
by the Public Company Accounting Oversight Board (&ldquo;<U>PCAOB</U>&rdquo;) after the date of the JOBS Act&rsquo;s enactment,
except as otherwise required by SEC rule.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
JOBS Act further exempts an &ldquo;<U>emerging growth company</U>&rdquo; from any requirement adopted by the PCAOB for mandatory
rotation of the Company&rsquo;s accounting firm or for a supplemental auditor report about the audit.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Internal
Control Attestation.</I> The JOBS Act also provides an exemption from the requirement of the Company&rsquo;s independent registered
public accounting firm to file a report on the Company&rsquo;s internal control over financial reporting, although management
of the Company is still required to file its report on the adequacy of the Company&rsquo;s internal control over financial reporting.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
102(a) of the JOBS Act exempts &ldquo;<U>emerging growth companies</U>&rdquo; from the requirements in &sect;14A(e) of the Securities
Exchange Act of 1934 for companies with a class of securities registered under the Securities Exchange Act of 1934, as amended,
to hold stockholder votes for executive compensation and golden parachutes.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Other
Items of the JOBS Act.</I> The JOBS Act also provides that an &ldquo;<U>emerging growth company</U>&rdquo; can communicate with
potential investors that are qualified institutional buyers or institutions that are accredited to determine interest in a contemplated
offering either prior to or after the date of filing the respective registration statement. The JOBS Act also permits research
reports by a broker or dealer about an &ldquo;<U>emerging growth company</U>&rdquo; regardless of whether such report provides
sufficient information for an investment decision. In addition, the JOBS Act precludes the SEC and FINRA from adopting certain
restrictive rules or regulations regarding brokers, dealers and potential investors, communications with management and distribution
of research reports on the &ldquo;<U>emerging growth company&rsquo;s</U>&rdquo; initial public offerings (IPOs).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 50; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->46<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
106 of the JOBS Act permits &ldquo;<U>emerging growth companies</U>&rdquo; to submit registration statements under the Securities
Act of 1933, as amended, on a confidential basis provided that the registration statement and all amendments thereto are publicly
filed at least 21 days before the issuer conducts any road show. This is intended to allow &ldquo;<U>emerging growth companies</U>&rdquo;
to explore the IPO option without disclosing to the market the fact that it is seeking to go public or disclosing the information
contained in its registration statement until the company is ready to conduct a roadshow.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Election
to Opt Out of Transition Period.</I> Section 102(b)(1) of the JOBS Act exempts &ldquo;<U>emerging growth companies</U>&rdquo;
from being required to comply with new or revised financial accounting standards until private companies (that is, those that
have not had a Securities Act registration statement declared effective or do not have a class of securities registered under
the Exchange Act) are required to comply with the new or revised financial accounting standard.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that
apply to non-emerging growth companies but any such election to opt out is irrevocable. The Company has elected not to opt out
of the transition period.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Research
and Development.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
the last two fiscal years, <I>Trxade.com</I>, <I>InventoryRx.com</I>, <I>Pharmabayonline,</I> and <I>RxGuru</I> have been developed
as proprietary software. For the years ended December 31, 2018 and 2017, $949,948 and $863,324, respectively, was spent by the
Company in technology activities, these were included in General and Administrative expenses. None of these expenses were borne
directly by customers.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Cost
of Compliance with Environmental Laws.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
operations are subject to regulations under various federal, state, local and foreign laws concerning the environment, including
laws addressing the discharge of pollutants into the air and water, the management and disposal of hazardous substances and wastes,
and the cleanup of contaminated sites. We could incur substantial costs, including cleanup costs, fines and civil or criminal
sanctions and third-party damage or personal injury claims, if in the future we were to violate or become liable under environmental
laws. We are not aware of any costs or effects of our compliance with environmental laws.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Employees</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Currently,
we have 28 full-time employees. We also utilize numerous outside consultants. Our future success will depend partially on our
ability to attract, retain and motivate qualified personnel. We are not a party to any collective bargaining agreements and have
not experienced any strikes or work stoppages. We consider our relations with our employees to be satisfactory.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Seasonality</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
business is not directly affected by seasonal fluctuations but is affected indirectly by the fall and winter flu season, to the
extent it leads to in increased demand for certain generic pharmaceuticals.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Available
Information</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
are subject to the information and reporting requirements of the Exchange Act, under which we file periodic reports, proxy and
information statements and other information with the Commission. Copies of the reports, proxy statements and other information
may be examined without charge at the Public Reference Room of the SEC, 100 F Street, N.E., Room 1580, Washington, D.C. 20549,
or on the Internet at <I>http://www.sec.gov</I>. Copies of all or a portion of such materials can be obtained from the Public
Reference Room of the SEC upon payment of prescribed fees. Please call the SEC at 1-800-SEC-0330 for further information about
the Public Reference Room.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 51; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->47<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Financial
and other information about Trxade Group, Inc. is available on our website (<U>www. https://www.trxadegroup.com</U>). Information
on our website is not incorporated by reference into this prospectus. We make available on our website, free of charge, copies
of our annual report on Form 10-K, quarterly reports on Form 10-Q, current reports on Form 8-K, and amendments to those reports
filed or furnished pursuant to Section 13(a) or 15(d) of the Exchange Act as soon as reasonably practicable after filing such
material electronically or otherwise furnishing it to the SEC.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A NAME="p_001"></A>DESCRIPTION
OF PROPERTY</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Description
of Property</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
do not own any real property. We entered into a new lease for our office space at 3840 Land O&rsquo; Lakes Blvd, Land O&rsquo;Lakes,
Florida 34639 for approximately $100,000 per year under a three-year lease agreement, beginning January 1, 2018. Our office space
occupies approximately 6,300 square feet. We entered into a lease for Integra Pharma Solutions, LLC at 6308 Benjamin Road, Tampa,
Florida 33634 for approximately $42,000 per year under a five-year lease agreement, effective October 17, 2018, occupying approximately
6,300 square feet. We believe our current and future facilities are adequate for our current and near-term needs. Additional space
may be required as we expand our activities. We do not currently foresee any significant difficulties in obtaining any required
additional facilities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A NAME="p_002"></A>LEGAL
PROCEEDINGS</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
the ordinary course of business, we may become a party to lawsuits involving various matters. The impact and outcome of litigation,
if any, is subject to inherent uncertainties, and an adverse result in these or other matters may arise from time to time that
may harm our business. We believe the ultimate resolution of any such current proceeding will not have a material adverse effect
on our continued financial position, results of operations or cash flows</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A NAME="p_003"></A>MARKET
FOR COMMON EQUITY AND RELATED STOCKHOLDER MATTERS</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">There
is no actively traded public market for our common stock. Although our common shares are quoted for sale on the OTCQB, our common
stock is mostly held by just a few stockholders. Therefore, the current and potential market for our common stock is limited and
the liquidity of our shares may be severely limited. We cannot provide any assurance that a meaningful trading market will ever
develop.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
trading price of our common stock could be subject to wide fluctuations in response to various events or factors, many of which
are beyond our control.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Holders</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">According
to the records of our transfer agent, as of September 30, 2019 were approximately 64 record holders of our common stock, not including
any persons who hold their stock in &ldquo;street name.&rdquo;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Market
Information</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Since
June 2014, our common stock has been quoted on the OTCQB tier of the marketplace maintained by OTC Markets Group, Inc. under the
symbol &ldquo;TRXD&rdquo;. Our common stock trades on a limited and sporadic basis and should not be deemed to constitute an established
public trading market. There may not be liquidity in the common stock.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 52; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->48<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table sets forth the high and low sale prices for each quarter within the fiscal years ended December 31, 2018 and 2017
and the first, second and third quarters of fiscal 2019, and the portion of the fourth quarter of 2019 from October 1, 2019 to
October 14, 2019. The information reflects prices between dealers, and does not include retail markup, markdown, or commission,
and may not represent actual transactions.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Fiscal Year</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Period</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">High Sales Price</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Low Sales Price</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 15%; text-align: left">2017</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 45%; text-align: left">First Quarter</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 15%; text-align: right">1.00</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 15%; text-align: right">0.25</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: right">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">Second Quarter</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">0.80</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">0.30</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: right">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">Third Quarter</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">0.52</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">0.41</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: right">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">Fourth Quarter</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">0.70</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">0.22</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">2018</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">First Quarter</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">0.75</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">0.22</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: right">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">Second Quarter</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">1.00</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">0.35</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: right">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">Third Quarter</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">0.75</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">0.43</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: right">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">Fourth Quarter</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">0.60</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">0.23</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">2019</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">First Quarter</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">0.59</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">0.35</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">Second Quarter</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">0.74</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">0.35</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">Third Quarter</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">1.60</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">0.54</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD>Fourth Quarter (through October 14, 2019)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">1.48</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">1.00</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Dividends</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have never paid any cash dividends on our common stock. We currently anticipate that we will retain all future earnings for use
in our business. Consequently, we do not anticipate paying any cash dividends in the foreseeable future. The payment of dividends
in the future will depend upon our results of operations, as well as our short-term and long-term cash availability, working capital,
working capital needs, and other factors as determined by our Board of Directors. Currently, except as may be provided by applicable
laws, there are no contractual or other restrictions on our ability to pay dividends if we were to decide to declare and pay them.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Common
Stock</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
are authorized to issue 100,000,000 shares of common stock with $0.00001 par value per share. Holders of shares of common stock
are entitled to one vote per share on each matter submitted to a vote of stockholders. In the event of liquidation, holders of
common stock are entitled to share <I>pro rata</I> in the distribution of assets remaining after payment of liabilities, if any.
Holders of common stock have no cumulative voting rights, and, accordingly, the holders of a majority of the outstanding shares
have the ability to elect all of the directors of the Company. Holders of common stock have no preemptive or other rights to subscribe
for shares. Holders of common stock are entitled to such dividends as may be declared by the Board out of funds legally available
therefore. The outstanding shares of common stock are validly issued, fully paid and non-assessable.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Preferred
Stock</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company is authorized to issue 10,000,000 shares of preferred stock, $0.00001 par value per share, all of which the 10,000,000
are undesignated and unissued. The Company had no preferred shares outstanding at December 31, 2018 or as of the date of this
prospectus.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Securities
Authorized for Issuance Under Equity Compensation Plans</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table sets forth information, as of December 31, 2018, with respect to our compensation plans under which common stock
is authorized for issuance.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 53; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->49<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A NAME="p_004"></A>EQUITY
COMPENSATION PLAN INFORMATION</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table provides information as of December 31, 2018 with respect to securities that may be issued under our equity compensation
plans.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Plan Category</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Number of<BR> securities to be<BR> issued upon<BR> exercise of<BR> outstanding options,<BR> warrants and rights</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Weighted-average exercise<BR> price of outstanding options,<BR> warrants and rights</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Number of securities<BR> remaining available</B></FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>for<BR> future issuance under<BR> equity compensation<BR> plans (excluding<BR> securities reflected in<BR> column (a))</B></FONT></P></TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center">(a)</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center">(b)</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center">(c)</TD><TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 43%; text-align: left">Equity compensation plans approved by security holders</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 15%; text-align: right">4,612,987</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 15%; text-align: right">0.47</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 15%; text-align: right">267,154</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt">Equity compensation plans not approved by security holders</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">-</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">-</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">-</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify; padding-bottom: 2.5pt">Total</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">4,612,987</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">1.10</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">267,154</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
equity compensation plans approved by the Company&rsquo;s security holders are the 2014 Equity Incentive Plan (&ldquo;<U>2014
Stock Plan</U>&rdquo;) of the Company, and the 2013 Equity Incentive Plan of Trxade Group, Inc., a Nevada corporation and predecessor
in interest to the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Stock
Transfer Agent</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
transfer agent is Action Stock Transfer Corp., 2469 E. Fort Union Boulevard, Suite 214, Salt Lake City, Utah 84121.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A NAME="p_005"></A>MANAGEMENT&rsquo;S
DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Forward-Looking
Statements</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
Management&rsquo;s Discussion and Analysis of Financial Condition and Results of Operations (the &ldquo;<U>MD&amp;A</U>&rdquo;)
is provided in addition to the accompanying consolidated financial statements and notes to assist readers in understanding our
results of operations, financial condition, and cash flows. MD&amp;A is organized as follows:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Overview</B>.
    Discussion of our business and overall analysis of financial and other highlights affecting us, to provide context for the
    remainder of MD&amp;A.</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Liquidity
    and Capital Resources</B>. An analysis of changes in our balance sheets and cash flows and discussion of our financial condition.</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Results
    of Operations</B>. An analysis of our financial results comparing the twelve months ended December 31, 2018 and 2017 and six-month
    periods ended June 30, 2019 and 2018.</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Critical
    Accounting Policies</B>. Accounting estimates that we believe are important to understanding the assumptions and judgments
    incorporated in our reported financial results and forecasts.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 54; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->50<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following discussion should be read in conjunction with our consolidated financial statements and accompanying notes included
elsewhere in this prospectus. The following discussion contains forward-looking statements regarding future events and the future
results of the Company that are based on current expectations, estimates, forecasts, and projections about the industry in which
the Company operates and the beliefs and assumptions of the management of the Company. Words such as &ldquo;expects,&rdquo; &ldquo;anticipates,&rdquo;
&ldquo;targets,&rdquo; &ldquo;goals,&rdquo; &ldquo;projects,&rdquo; &ldquo;intends,&rdquo; &ldquo;plans,&rdquo; &ldquo;believes,&rdquo;
&ldquo;seeks,&rdquo; &ldquo;estimates,&rdquo; variations of such words, and similar expressions are intended to identify such
forward-looking statements. These forward-looking statements are only predictions and are subject to risks, uncertainties and
assumptions that are difficult to predict. Therefore, actual results may differ materially and adversely from those expressed
in any forward-looking statements. Factors that might cause or contribute to such differences include, but are not limited to,
those discussed elsewhere in this prospectus, particularly under &ldquo;Risk Factors,&rdquo; and in other reports we file with
the SEC. All references to years relate to the calendar year ended December 31 of the particular year. The Company undertakes
no obligation to revise or update publicly any forward-looking statements for any reason. Factors that could cause or contribute
to these differences include those discussed below and elsewhere in this prospectus.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following discussion is based upon our Consolidated Financial Statements included elsewhere in this prospectus, which have been
prepared in accordance with U.S. generally accepted accounting principles. The preparation of these financial statements requires
us to make estimates and judgments that affect the reported amounts of assets, liabilities, revenues and expenses, and related
disclosure of contingencies. In the course of operating our business, we routinely make decisions as to the timing of the payment
of invoices, the collection of receivables, the shipment of products, the fulfillment of orders, the purchase of supplies, and
the building of inventory, among other matters. Each of these decisions has some impact on the financial results for any given
period. In making these decisions, we consider various factors including contractual obligations, customer satisfaction, competition,
internal and external financial targets and expectations, and financial planning objectives. On an on-going basis, we evaluate
our estimates, including those related to sales returns, pricing credits, warranty costs, allowance for doubtful accounts, impairment
of long-term assets, especially goodwill and intangible assets, contract manufacturer exposures for carrying and obsolete material
charges, assumptions used in the valuation of stock-based compensation, and litigation. We base our estimates on historical experience
and on various other assumptions that we believe to be reasonable under the circumstances, the results of which form the basis
for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. Actual
results may differ from these estimates under different assumptions or conditions.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Liquidity
and Capital Resources as of and for the Year Ended December 31, 2018</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Results
of Operations</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following selected consolidated financial data should be read in conjunction with the consolidated financial statements and the
notes to these statements included in this prospectus. For all periods presented, the consolidated statements of income and consolidated
balance sheet data set forth in this prospectus have been adjusted for the reclassification of discontinued operations information,
unless otherwise noted.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Six-Month
Period Ended June 30, 2019 Compared to Six-Month Period Ended June 30, 2018</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="6" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Six-Months Ended</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">June 30, 2019</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">June 30, 2018</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 64%">Revenues</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 14%; text-align: right">3,428,935</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 14%; text-align: right">1,690,611</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>Cost of Sales</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,118,977</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Gross Profit</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2,309,958</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,690,611</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Operating Expenses:</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">General and Administrative</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,905,504</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,472,365</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Warrants and Options Expense</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">99,990</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">88,072</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Total Operating Expense</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2,005,494</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,560,437</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Share in Equity Losses in Investment</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(87,822</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Interest Expense</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(33,432</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(27,392</TD><TD STYLE="text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Income from Operations</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">183,210</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">102,782</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>


<!-- Field: Page; Sequence: 55; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->51<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Substantially
all of our revenues during the six-months ended June 30, 2018 was from Trxade platform revenue. Revenues increased in the six-months
ended June 30, 2019 by $1,738,324 with the addition of Community Specialty Pharmacy, LLC, our partially-owned accredited independent
retail pharmacy.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">General
and administrative expenses increased for the six-months ended June 30, 2019 to $1,905,504 compared to $1,472,365 for the comparable
period in 2018. There was an increase in rent and employee cash compensation directly as a result of the acquisition of Community
Specialty Pharmacy, LLC.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Warrant
and options expense in the 2019 and 2018 periods represent compensation costs related to the issuance of employee stock options.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Three
Month Period Ended June 30, 2019 Compared to Three Month Period Ended June 30, 2018</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="6" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Three Months Ended</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">June 30, 2019</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">June 30, 2018</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 64%">Revenues</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 14%; text-align: right">1,916,414</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 14%; text-align: right">837,688</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>Cost of Sales</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">753,138</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Gross Profit</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,163,276</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">837,688</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Operating Expenses:</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">General and Administrative</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">966,560</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">755,626</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Warrants and Options Expense</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">64,011</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">50,616</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Total Operating Expense</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,030,571</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">806,242</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Share in Equity Losses in Investment</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(58,850</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Interest Expense</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(15,874</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(10,933</TD><TD STYLE="text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Income from Operations</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">57,981</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">20,513</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Substantially
all of our revenues during the three months ended June 30, 2018 were from Trxade platform revenue. Revenues increased by $1,078,726
in the three months ended June 30, 2019 with the addition of Community Specialty Pharmacy, LLC.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">General
and administrative expenses increased for the three months ended June 30, 2019 to $966,560 compared to $755,164 for the comparable
period in 2018. There was an increase in rent and employee cash compensation directly as a result of the acquisition of Community
Specialty Pharmacy, LLC.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Warrant
and options expense in the 2019 and 2018 periods represent compensation costs related to the issuance of employee stock options.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Fiscal
Year Ended December 31, 2018 Compared to Fiscal Year Ended December 31, 2017</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="6" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Fiscal Year Ended</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">December 31, 2018</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">December 31, 2017</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 60%">Revenues</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 16%; text-align: right">3,831,778</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 16%; text-align: right">2,931,280</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>Cost of Sales</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">449,049</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Gross Profit</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">3,382,729</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2,931,280</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Operating Expenses:</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>Technology</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">949,948</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">863,324</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">General and Administrative</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2,350,569</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,405,026</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Warrants and Options Expense</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">169,828</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">267,835</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Total Operating Expense</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">3,470,345</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2,536,185</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Other Income</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">161,639</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">67,500</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Loss on Extinguishment of Debt</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(7,444</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(16,556</TD><TD STYLE="text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Interest Expense</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(57,541</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(157,056</TD><TD STYLE="text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Net Income</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">9,038</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">288,983</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>


<!-- Field: Page; Sequence: 56; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->52<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Substantially
all of our revenues during the years ended December 31, 2018, and 2017 were from platform revenue. Revenues increased for the
Fiscal Year ended December 31, 2018 to $3,831,778 compared to $2,931,280 for the comparable period in 2017. This increase
was attributable to the mix of pharmaceuticals sold on the platform, brands vs. generics, the fee for generics are higher than
brands. Our sales department has continued to add customers in 2018 through direct marketing and customer training. In 2018, with
the acquisition of Community Specialty Pharmacy, LLC in the fourth quarter, $395,418 of revenue was added.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Technology
expenditures increased to $949,948 for the year ended December 31, 2018 from $863,324 for the year ended December 31, 2017 as
the Company developed apps for customers.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">General
and administrative expenses increased for the fiscal year ended December 31, 2018 to $2,350,569 compared to $1,405,026 for the
comparable period in 2017. There was an increase in legal fees, rent and employee cash compensation directly as a result of the
acquisition. In addition, Trxade Conference, increased employee benefits and computer software were additional expenditures.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Warrant
and options expense in the 2018 and 2017 periods represent compensation costs related to the issuance of employee stock options.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Interest
expense in 2018 was as a result of approximately $800,000 in debt borrowings. Interest expense in 2017 was as a result of approximately
$700,000 in debt borrowings.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Liquidity
and Capital Resources</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Cash
and Cash Equivalents</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cash
and cash equivalents were $540,034 at June 30, 2019. We expect that our future available capital resources will consist primarily
of cash generated from operations, remaining cash balances, borrowings, and any additional funds raised through sales of debt
and/or equity.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Liquidity</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Cash
and cash equivalents, current a</I>ssets, <I>current liabilities, short term debt and working capital</I> at the end of each of
the periods below were as follows:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">June 30, 2019</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">December 31, 2018</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 60%">Cash</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 16%; text-align: right">540,034</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 16%; text-align: right">869,557</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Current assets (excluding cash)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,412,236</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">596,520</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Current liabilities (excluding short term debt)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">945,163</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">538,867</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Short term debt</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">140,000</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">321,500</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Working Capital</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">867,107</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">605,710</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
principal sources of liquidity have been cash provided by operations, equity capital and borrowings under various debt arrangements.
Our principal uses of cash have been for operating expenses and acquisition. We anticipate these uses will continue to be our
principal uses of cash in the future.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
decrease in cash was primarily due to an investment in SyncHealth, LLC of $250,000. Cash decreased by $329,523.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 57; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->53<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Liquidity
Outlook cash explanation.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Cash
Requirements</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
primary objectives for 2019 are to continue the development of the Trxade Platform and increase our client base and operational
revenue. Additional funds will be needed to continue to expand our platform and customer base and cover general and administrative
expense. We expect to pursue raising capital to fund our operations and provide personnel to expand operations and required working
capital. Through these efforts, management believes the Company will be able to obtain the liquidity necessary to fund Company
operations for the foreseeable future, however there is no assurance that our operations will generate significant positive cash
flow, or that additional funds will be available to us, through borrowings or otherwise, on favorable terms when required, or
at all.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
estimate our operating expenses and working capital requirements for the next 12 months to be approximately as follows:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-weight: bold; border-bottom: Black 1.5pt solid">Projected Expenses for 2019</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Amount</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 78%; text-align: left">General and administrative (1)</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 18%; text-align: right">3,500,000</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>Total</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">3,500,000</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)
Includes wages and payroll, legal and accounting, marketing, rent and web development.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Since
inception, we have funded our operations primarily through debt and equity capital raises and operational revenue. In 2018, common
stock was issued for $800,000 and we acquired new unsecured long-term debt of approximately $300,000.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
July 10, 2019 we entered into a securities Purchase Agreement with R.S.N., LLC, with respect to the private placement of 2,000,000
share of our common stock at a purchase price of $0.50 per share, for gross proceeds of $1,000,000. This transaction closed on
July 30, 2019.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
September 30, 2019, we closed the sale of securities pursuant to Securities Purchase Agreements entered into with certain accredited
investors with respect to the private placement of 2,910,000 shares of our common stock at a purchase price of $0.50 per share,
for gross proceeds of $1,455,000. Subscribers included Bedford Falls Capital, which is controlled by Gary Augusta, our director
(1,000,000 shares); Nitesh Patel, who is the cousin of Prashant Patel, our director and President (40,000 shares); Shilpa Patel,
who is the spouse of Nitesh Patel, the brother of Prashant Patel our director and President (20,000 shares); and Nitil
Patel, the brother of Prashant Patel, our director and President, (200,000 shares).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Further,
on September 30, 2019, the Company converted $175,000 of principal under various outstanding promissory notes, including
$100,000 owed to Mr. Nitil Patel, the brother of Mr. Prashant Patel, our director and President, and $75,000 owed to Nikul
Panchal, a non-executive officer of the Company and noteholder, into 350,000 shares common stock of the Company at $0.50 per share
under the terms of the Securities Purchase Agreement referenced above.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
combined total of the transactions detailed above was $2,630,000 of investment and conversion of principal under various
Promissory Notes into an aggregate total of 5,260,000 shares of common stock.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
expect to continue to seek additional outside funding in the future although no assurance can be given that we will be able to
obtain financing on reasonable terms or revenues will continue. If we obtain additional financing by issuing equity securities,
our existing stockholders&rsquo; ownership will be diluted. Obtaining commercial loans, assuming those loans would be available,
will increase our liabilities and future cash commitments. We may be unable to maintain operations at a level sufficient for investors
to obtain a return on their investment in our common stock.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
will need significantly more cash to implement our plan to operate a business-to-business web-based marketplace focused on the
U.S. pharmaceutical industry. Our core service is designed to bring the nation&rsquo;s independent pharmacies and accredited national
suppliers of pharmaceuticals together to provide efficient and transparent buying and selling opportunities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 58; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->54<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Cash
Flows</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table summarizes our Consolidated Statements of Cash Flows for the six-months ended June 30, 2019 and 2018:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="6" STYLE="text-align: center; border-bottom: Black 1.5pt solid">Six-Months Ended</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid">June 30, 2019</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid">June 30, 2018</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 64%; text-align: left">Net Income</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 14%; text-align: right">183,210</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 14%; text-align: right">102,782</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Net Cash Provided by (used in) operations:</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Operating Activities</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(79,689</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">146,456</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Investing Activities</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(250,000</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Financing Activities</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">166</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(122,464</TD><TD STYLE="text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Net increase (decrease) in cash and cash equivalents</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">(329,523</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">23,992</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cash
used in operations for the six-months ended June 30, 2019 was $79,689. This compared to $146,456 provided in operating activities
for the six-months ended June 30, 2018. This decrease was due to inventory purchases and an increase in Accounts Receivables.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Investing
activities in 2019 include the $250,000 investment in SyncHealth MSO, LLC.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Financing
activities in 2018 included $122,464 payment of Notes.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Financing
activities in 2019 included $166 proceeds from warrant exercise.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Off-Balance
Sheet Arrangements</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
had no outstanding off-balance sheet arrangements as of June 30, 2019.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Critical
Accounting Policies</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
discussion and analysis of our financial condition and results of operations are based upon our consolidated financial statements,
which have been prepared in accordance with accounting principles generally accepted in the United States of America. The preparation
of these financial statements requires us to make estimates and judgments that affect the reported amounts of assets and liabilities
and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amount of net sales
and expenses for each period. The following represents a summary of our critical accounting policies, defined as those policies
that we believe are the most important to the portrayal of our financial condition and results of operations and that require
management&rsquo;s most difficult, subjective or complex judgments, often as a result of the need to make estimates about the
effects of matters that are inherently uncertain.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Revenue
Recognition</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
general, the Company accounts for revenue recognition in accordance with ASC 606, &ldquo;Revenue from Contracts with Customers.&rdquo;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 59; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->55<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company provides an online website service, a buying and selling marketplace for licensed Pharmaceutical Wholesalers to sell products
and services to licensed Pharmacies. The Company charges Suppliers a transaction fee, a percentage of the purchase price of the
Prescription Drugs and other products sold through its website service. The fulfillment of confirmed orders, including delivery
and shipment of Prescription Drugs and other products, is the responsibility of the Supplier and not of the Company. The Company
holds no inventory and assumes no responsibility for the shipment or delivery of any products or services from our website. The
Company considers itself an agent for this revenue stream and as such, reports revenue as net. Step One: Identify the contract
with the customer &ndash; the Company&rsquo;s Terms and Use Agreement is acknowledged between the Wholesaler and the Company which
outlines the terms and conditions. The collection is probable based on the credit evaluation of the Wholesaler. Step Two: Identify
the performance obligations in the contract &ndash; The Company provides to the Supplier access to the online website, uploading
of catalogs of products and Dashboard access to review status of inventory posted and processed orders. The Agreement requires
the supplier to provide a catalog of pharmaceuticals for posting on the platform, deliver the pharmaceuticals and upon shipment
remit the stated platform fee. Step Three: Determine the transaction price &ndash; The Fee Agreement outlines the fee based on
the type of product, generic, brand or non-drug. There are no discounts for volume of transactions or early payment of invoices.
Step Four: Allocate the transaction price &ndash; The Fee Agreement outlines the fee. There is no difference between contract
price and &ldquo;stand-alone selling price&rdquo;. Step Five: Recognize revenue when or as the entity satisfies a performance
obligation &ndash; Revenue is recognized the day the order has been processed by the Supplier.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Integra
Pharma Solutions, LLC is a licensed wholesaler and sells to licensed pharmacies brand, generic and non-drug products. The Company
takes orders for product and creates invoices for each order and recognizes revenue at the time the Customer receives the product.
Customer returns are not material. Step One: Identify the contract with the customer &ndash; The Company requires that an application
and a credit card for payment is completed by the Customer prior to the first order. Each transaction is evidenced by an order
form sent by the customer and an invoice for the product is sent by the Company. The collection is probable based on the application
and credit card information provided prior to the first order. Step Two: Identify the performance obligations in the contract
&ndash; Each order is distinct and evidenced by the shipping order and invoice. Step Three: Determine the transaction price &ndash;
The consideration is variable if product is returned. The variability is determined based on the return policy of the product
manufacturer. There are no sales or volume discounts. The transaction price is determined at the time of the order evidenced by
the invoice. Step Four: Allocate the transaction price &ndash; There is no difference between contract price and &ldquo;stand-alone
selling price&rdquo;. Step Five: Recognize revenue when or as the entity satisfies a performance obligation - The Revenue is recognized
when the Customer receives the product.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Community
Specialty Pharmacy, LLC is in the retail pharmacy business. The Company fills prescriptions for drugs written by a doctor and
recognizes revenue at the time the patient confirms delivery of the prescription. Customer returns are not material. Step One:
Identify the contract with the customer &ndash; The prescription is written by a doctor for a Customer and delivered to the Company.
The prescription identifies the performance obligations in the contract. The Company fills the prescription and delivers to the
Customer the prescription, fulfilling the contract. The collection is probable because there is confirmation that the customer
has insurance for the reimbursement to the Company prior to filling of the prescription. Step Two: Identify the performance obligations
in the contract &ndash; Each prescription is distinct to the Customer. Step Three: Determine the transaction price &ndash; The
consideration is not variable. The transaction price is determined to be the price of prescription at the time of delivery which
considers the expected reimbursements from third party payors (e.g., pharmacy benefit managers, insurance companies and government
agencies). Step Four: Allocate the transaction price &ndash; The price of the prescription invoiced represents the expected amount
of reimbursement from third party payors. There is no difference between contract price and &ldquo;stand-alone selling price&rdquo;.
Step Five: Recognize revenue when or as the entity satisfies a performance obligation &ndash; Revenue is recognized upon the delivery
of the prescription.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Stock-Based
Compensation</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company accounts for stock-based compensation to non-employees in accordance with the provision of ASC 505, &ldquo;Equity Based
Payments to Non-Employees&rdquo; (&ldquo;ASC 505&rdquo;), Share Based Payments to Non-Employees, and ASC 505 which requires that
such equity instruments are recorded at their fair value on the measurement date. The measurement of stock-based compensation
is subject to periodic adjustment as the underlying instruments vest. Effective January 1, 2019, the company adopted
ASU 2018-07 for the accounting  of share-based payments granted to non-employees for goods and services.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company accounts for stock-based compensation to employees in accordance with ASC 718, &ldquo;Compensation-Stock Compensation&rdquo;.
ASC 718 requires companies to measure the cost of employee services received in exchange for an award of equity instruments, including
stock options, based on the grant date fair value of the award and to recognize it as compensation expense over the period the
employee is required to provide service in exchange for the award, usually the vesting period. Stock option forfeitures are recognized
at the date of employee termination.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 60; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->56<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A NAME="p_006"></A>QUANTITATIVE
AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Not
applicable to a &ldquo;smaller reporting company&rdquo; as defined in Item 10(f)(1) of SEC Regulation S-K</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A NAME="p_007"></A>CONTROLS
AND PROCEDURES</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Disclosure
Controls and Procedures</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under
the supervision and with the participation of our management, including our Chief Executive Officer and our Chief Financial Officer,
Mr. Ajjarapu and Mr. Doss, respectively, conducted an evaluation of the effectiveness of the design and operation of our disclosure
controls and procedures, as defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act as of June 30, 2019. Based on this
evaluation, our Chief Executive Officer and our Chief Financial Officer concluded that as of June 30, 2019, our disclosure controls
and procedures were not effective.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
a result of the formative stage of our development, the Company has not fully implemented the necessary internal controls required
to maintain effective disclosure controls. The matters involving internal controls and procedures that the Company&rsquo;s management
considered to be material weaknesses under the standards of the Committee of Sponsoring Organizations of the Treadway Commission
(COSO) were: (1) insufficient written policies and procedures for accounting and financial reporting with respect to the requirements
and application of accounting principles generally accepted in the United States of America (&ldquo;<U>GAAP</U>&rdquo;) and SEC
disclosure requirements; and (2) ineffective controls over period end financial disclosure and reporting processes.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Management
believes that the material weaknesses set forth above did not have an effect on the Company&rsquo;s financial results reported
herein. We are committed to improving our financial organization. As part of this commitment, we have recently increased our personnel
resources and technical accounting expertise as we develop the internal and financial resources of the Company. In addition, the
Company plans to prepare and implement sufficient written policies and checklists which will set forth procedures for accounting
and financial reporting with respect to the requirements and application of GAAP and SEC disclosure requirements.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Management
believes that preparing and implementing sufficient written policies and checklists will remedy the following material weaknesses
(i) insufficient written policies and procedures for accounting and financial reporting with respect to the requirements and application
of GAAP and SEC disclosure requirements; and (ii) ineffective controls over period end financial close and reporting processes.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 27pt; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have improved our financial organization as we have increased our personnel resources and technical accounting expertise. We will
continue to monitor and evaluate the effectiveness of our internal controls and procedures and our internal controls over financial
reporting on an ongoing basis.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Management&rsquo;s
Report on Internal Control Over Financial Reporting</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Management
of the Company is responsible for establishing and maintaining adequate internal control over financial reporting as defined in
Rules 13a-15(f) and 15d-15(f) under the Exchange Act. The Company&rsquo;s internal control over financial reporting is designed
to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for
external purposes in accordance with GAAP, but because of its inherent limitations, internal control over financial reporting
may not prevent or detect misstatements. The Company&rsquo;s internal control over financial reporting includes those policies
and procedures that are designed to:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 0.25in; text-align: left; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">pertain
    to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions
    of the assets of the Company;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 61; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->57<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">provide
    reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance
    with GAAP, and that receipts and expenditures of the Company are being made only in accordance with authorizations of management
    and directors of the Company; and</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">provide
    reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use or disposition of the Company&rsquo;s
    assets that could have a material effect on the financial statements.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Management
assessed the effectiveness of the Company&rsquo;s internal control over financial reporting as of December 31, 2018. In making
this assessment, management used the criteria set forth by the Committee of Sponsoring Organizations of the Treadway Commission
in Internal Control &mdash; Integrated Framework. Based on our assessment, management believes that the Company&rsquo;s internal
controls over financial reporting were not effective as of December 31, 2018. Specifically, management&rsquo;s evaluation was
based on the following material weaknesses which existed as of December 31, 2018:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 27pt; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 0.2in; text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 0.2in; text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Financial
    Reporting Systems</I>: The Company did not maintain a fully integrated financial consolidation and reporting system throughout
    the period and as a result, extensive manual analysis, reconciliation and adjustments were required in order to produce financial
    statements for external reporting purposes.</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Segregation
    of Duties</I>: The Company does not currently have a sufficient complement of technical accounting and external reporting
    personal commensurate to support standalone external financial reporting under public company or SEC requirements. Specifically,
    the Company did not effectively segregate certain accounting duties due to the small size of its accounting staff and maintain
    a sufficient number of adequately trained personnel necessary to anticipate and identify risks critical to financial reporting
    and the closing process. In addition, there were inadequate reviews and approvals by the Company&rsquo;s personnel of certain
    reconciliations and other processes in day-to-day operations due to the lack of a full complement of accounting staff.</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Insufficient
    written policies and procedures for accounting and financial reporting with respect to the requirements and application of
    accounting principles generally accepted in the United States of America (&ldquo;GAAP&rdquo;) and SEC disclosure requirements.</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ineffective
    controls over period end financial disclosure and reporting processes.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company has engaged additional accounting support to provide more resources and expand the technical accounting knowledge to assist
Mr. Doss and Mr. Ajjarapu in their responsibilities with respect to financing reporting.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Changes
in Internal Control over Financial Reporting</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">There
has not been any change in our internal control over financial reporting that occurred during the three-months ended June 30,
2019 that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A NAME="s_001"></A>DIRECTORS,
EXECUTIVE OFFICERS AND CORPORATE GOVERNANCE</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Set
forth below is certain information regarding our directors and executive officers as of October 11, 2019:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-weight: bold; text-align: left; border-bottom: Black 1.5pt solid">Name</TD><TD STYLE="font-weight: bold; text-align: center; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Position</TD><TD STYLE="font-weight: bold; text-align: center; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Age</TD><TD STYLE="font-weight: bold; text-align: center; padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="font-weight: bold; text-align: center; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Director/Officer Since</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="width: 22%; text-align: center; vertical-align: top">Suren Ajjarapu </TD><TD STYLE="width: 2%; text-align: center">&nbsp;</TD>
    <TD STYLE="width: 33%; text-align: center">Chairman, Chief Executive Officer and Secretary </TD><TD STYLE="width: 2%; text-align: center">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: center">&nbsp;</TD><TD STYLE="width: 7%; text-align: center">49</TD><TD STYLE="width: 1%; text-align: center">&nbsp;</TD><TD STYLE="width: 2%; text-align: center">&nbsp;</TD>
    <TD STYLE="width: 30%; text-align: center">January 2014</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: center; vertical-align: top">Prashant Patel </TD><TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">Director, President and Chief Operating Officer </TD><TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center">45</TD><TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">January 2014</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: center; vertical-align: top">Donald G. Fell </TD><TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">Director </TD><TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center">73</TD><TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">January 2014</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: center; vertical-align: top">Howard A. Doss </TD><TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">Chief Financial Officer </TD><TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center">66</TD><TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">January 2014</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: center; vertical-align: top">Michael L. Peterson </TD><TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">Director </TD><TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center">57</TD><TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">August 2016</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: center">Gary Augusta</TD><TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">Director</TD><TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center">52</TD><TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">October 2019</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 62; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->58<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Business
Experience</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following is a brief description of the education and business experience of our current directors and executive officers.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Suren
Ajjarapu, Chairman of the Board, Chief Executive Officer and Secretary.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mr.
Ajjarapu has served as Chairman of the Board, Chief Executive Officer and Secretary since our acquisition of Trxade Group, Inc.,
a Nevada corporation (&ldquo;<U>Trxade Nevada</U>&rdquo;) (our predecessor company) on January 8, 2014, and as the Chairman of
the Board, Chief Executive Officer and Secretary of Trxade Nevada since its inception. Mr. Ajjarapu has also served as Chairman
of the Board for Feeder Creek Group, Inc., since March 2018. Feeder Creek Group, Inc. is a company involved in developing renewable
natural gas sites in Iowa. Mr. Ajjarapu was a Founder, CEO and Chairman of Sansur Renewable Energy, Inc., a company involved in
developing wind power sites in the Midwest, United States, from 2009 to 2012. Mr. Ajjarapu was a Founder, President and Director
of Aemetis, Inc., a biofuels company (AMTX.OB) and a Founder, Chairman and Chief Executive Officer of International Biofuels,
a subsidiary of Aemetis, Inc., from 2006 to 2009. Mr. Ajjarapu was Co-Founder, COO, and Director Global Information Technology,
Inc., an IT outsourcing and systems design company, headquartered in Tampa, Florida with major operations in India from 1995 to
2006. Mr. Ajjarapu holds an MS in Environmental engineering from South Dakota State University, Brookings, South Dakota, and an
MBA from the University of South Florida, specializing in International Finance and Management. Mr. Ajjarapu is also a graduate
of the Venture Capital and Private Equity program at Harvard University.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Prashant
Patel, Director, President and Chief Operating Officer</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mr.
Patel has served as our full-time President and COO, and as a director, since our acquisition of Trxade Nevada on January 8, 2014,
and as the COO and President and as a director of Trxade Nevada since its inception. Mr. Patel is a registered pharmacist and
pharmaceutical consultant with over ten years of experience in retail pharmacy and pharmaceutical logistics and the founder of
several pharmacies in the Tampa Bay, Florida area. Mr. Patel has been a President and Member of the Board of Trxade Nevada since
August 2010. Since October 2008, Mr. Patel has been Managing Member of APAA LLC, a pharmacy. Since April 2007, Mr. Patel has been
a Vice President of Holiday Pharmacy, Inc., a pharmacy. Mr. Patel graduated from Nottingham University School of Pharmacy and
practiced in the United Kingdom before obtaining his masters in Transport, Trade and Finance from Cass Business School, City University,
United Kingdom.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Howard
A. Doss, Chief Financial Officer</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mr.
Doss has served as our CFO since January 2014. Mr. Doss has served in a variety of capacities with accounting and investment firms.
He joined the staff of Seidman &amp; Seidman (BDO Seidman, Dallas) in 1977 and, in 1980, he joined the investment firm Van Kampen
Investments, opening the firm&rsquo;s southeast office in Tampa, Florida in 1982. He remained with the firm until 1996 when he
joined Franklin Templeton to develop corporate retirement plan distribution. After working for the Principal Financial Group office
in Tampa, Florida, Mr. Doss was City Executive for U.S. Trust in Sarasota, Florida, responsible for high net worth individuals.
He retired from that position in 2009. He served as CFO and Director for Sansur Renewable Energy an alternative energy development
company, from 2010 to 2012. Mr. Doss has also served as President of STARadio Corp. since 2005. Mr. Doss is a member of the America
Institute of CPA&rsquo;s. He is a graduate of Illinois Wesleyan University.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 63; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->59<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Donald
G. Fell, Director</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mr.
Fell has served as an Independent Director of our company since January 2014, as well as a director of Trxade Nevada since December.
He is presently Professor and Institute Director for the Davis, California-based Foundation for Teaching Economics and adjunct
professor of economics for the University of Colorado, Colorado Springs. From 1995 &ndash; 2012, Mr. Fell held positions with
the University of South Florida as a member of the Executive MBA faculty, Director of Executive and Professional Education and
Senior Fellow of the Public Policy Institute. He has also served as visiting professor of economics at the University of LaRochelle,
France, and as adjunct professor of economics at both Illinois State University and The Ohio State University. Mr. Fell holds
undergraduate and graduate degrees in economics from Indiana State University and is all but dissertation (ABD) in economics from
Illinois State University. Through his work with the Foundation for Teaching Economics and the University of Colorado, Colorado
Springs he has conducted graduate institutes on economic policy and environmental economics in 44 states, throughout Canada, the
Islands and Eastern Europe.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Michael
L. Peterson</I></B><I>, <B>Director</B></I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mr.
Peterson has served as an independent Director of our company since August 2016. Since June 2018, Mr. Peterson has served as the
president of the Taipei Taiwan Mission of The Church of Jesus Christ of Latter-day Saints, in Taipei, Taiwan. Mr. Peterson served
as the CEO of Pedevco Corp. (NYSE American:PED), a public company engaged primarily in the acquisition, exploration, development
and production of oil and natural gas shale plays in the US from May 2016 to May 2018. Mr. Peterson served as CFO of Pedevco between
July 2012 and May 2016, and as Executive Vice President of Pacific Energy Development (Pedevco&rsquo;s predecessor) from July
2012 to October 2014, and as Pedevco&rsquo;s President from October 2014 to May 2018. Mr. Peterson joined Pacific Energy Development
as its Executive Vice President in September 2011, assumed the additional office of Chief Financial Officer in June 2012, and
served as a member of its board of directors from July 2012 to September 2013. Mr. Peterson formerly served as Interim President
and CEO (from June 2009 to December 2011) and as director (from May 2008 to December 2011) of Pacific Energy Development, as a
director (from May 2006 to July 2012) of Aemetis, Inc. (formerly AE Biofuels Inc.), a Cupertino, California-based global advanced
biofuels and renewable commodity chemicals company (AMTX.OB), and as Chairman and Chief Executive Officer of Nevo Energy, Inc.
(NEVE) (formerly Solargen Energy, Inc.), a Cupertino, California-based developer of utility-scale solar farms which he helped
form in December 2008 (from December 2008 to July 2012). From 2005 to 2006, Mr. Peterson served as a managing partner of American
Institutional Partners, a venture investment fund based in Salt Lake City. From 2000 to 2004, he served as a First Vice President
at Merrill Lynch, where he helped establish a new private client services division to work exclusively with high net worth investors.
From September 1989 to January 2000, Mr. Peterson was employed by Goldman Sachs &amp; Co. in a variety of positions and roles,
including as a Vice President with the responsibility for a team of professionals that advised and managed over $7 billion in
assets. Mr. Peterson received his MBA at the Marriott School of Management and a BS in statistics/computer science from Brigham
Young University.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Gary
Augusta<I>, Director</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mr.
Augusta has over 25 years of experience in finance, healthcare, engineering, technology and other innovative sectors including
leadership roles in mergers and acquisitions, capital markets and investments, corporate development including strategic planning
and partnership development, and as a member of public company boards of directors. Mr. Augusta is currently on the Board of Directors
of First Choice Healthcare Solutions Inc. (OTC: FCHS) and was a Board Director, including Executive Chairman for over four years,
of Apollo Medical Holdings, Inc. (NASDAQ: AMEH) from 2012 to November 2018. Under Mr. Augusta&rsquo;s leadership, Apollo grew
from less than $10M in annual revenue and under a $3M market capitalization to a NASDAQ listed company with a market capitalization
of over $1 Billion. In addition to Board governance positions, Mr. Augusta was also President and lead growth and
capital initiatives during his tenure. Mr. Augusta has served as President of Bedford Falls Capital LLC since September 2018,
which invests in emerging growth companies, both public and private. Mr. Augusta also serves as President of Flacane Advisors
focusing on healthcare and technology capital investments, board roles and advisory services, a position he has held since January
2014. From January 2010 to December 2014, Mr. Augusta was President of SpaGus Ventures and SpaGus Capital Partners focusing on
healthcare and technology investments and advisory services. From March 2004 to December 2009, Mr. Augusta was President and CEO
of OCTANe, an innovation development company. From March 2001 to January 2004, Mr. Augusta was a Corporate Officer at Fluor, Inc.,
a Fortune 500 company, focusing on Corporate Development and M&amp;A. From June 1994 to March 2000, Mr. Augusta was a Consultant
and Principal with AT Kearney, a leading global consulting firm. Mr. Augusta earned a BS in Mechanical Engineering from the University
of Rhode Island and a Master of Science and Management (MSM) from Georgia Institute of Technology (Georgia Tech).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 64; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->60<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A NAME="s_002"></A>CORPORATE
GOVERNANCE</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Family
Relationships amongst Directors and Officers</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">There
are no family relationships among our directors or executive officers.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Arrangements
between Officers and Directors</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
our knowledge, there is no arrangement or understanding between any of our officers and any other person, including directors,
pursuant to which the officer was selected to serve as an officer.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Involvement
in Certain Legal Proceedings</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">None
of our executive officers or directors has been involved in any of the following events during the past ten years: (1) any bankruptcy
petition filed by or against any business of which such person was a general partner or executive officer either at the time of
the bankruptcy or within two years prior to that time; (2) any conviction in a criminal proceeding or being a named subject to
a pending criminal proceeding (excluding traffic violations and minor offenses); (3) being subject to any order, judgment, or
decree, not subsequently reversed, suspended or vacated, of any court of competent jurisdiction, permanently or temporarily enjoining,
barring, suspending or otherwise limiting his involvement in any type of business, securities or banking activities; (4) being
found by a court of competent jurisdiction (in a civil action), the SEC or the Commodities Futures Trading Commission to have
violated a federal or state securities or commodities law; (5) being the subject of, or a party to, any Federal or State judicial
or administrative order, judgment, decree, or finding, not subsequently reversed, suspended or vacated, relating to an alleged
violation of (i) any Federal or State securities or commodities law or regulation; (ii) any law or regulation respecting financial
institutions or insurance companies, including, but not limited to, a temporary or permanent injunction, order of disgorgement
or restitution, civil money penalty or temporary or permanent cease-and-desist order, or removal or prohibition order, or (iii)
any law or regulation prohibiting mail or wire fraud or fraud in connection with any business entity; or (6) being the subject
of, or a party to, any sanction or order, not subsequently reversed, suspended or vacated, of any self-regulatory organization
(as defined in Section 3(a)(26) of the Exchange Act), any registered entity (as defined in Section (1a)(40) of the Commodity Exchange
Act), or any equivalent exchange, association, entity, or organization that has disciplinary authority over its members or persons
associated with a member.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Committees
of the Board of Directors</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
Board of Directors has the authority to appoint committees to perform certain management and administration functions. Our Board
of Directors currently has two committees: the audit committee and the compensation committee.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Board
Committee Membership</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify; padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Independent</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Audit<BR> Committee</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Compensation Committee</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Suren Ajjarapu<SUP>(1)</SUP></FONT></TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify">Prashant Patel</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 40%; text-align: justify">Donald G. Fell</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 18%; text-align: center">X</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 18%; text-align: center">M</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 18%; text-align: center">C</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify">Michael L. Peterson</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">X</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">C</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">M</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify">Gary Augusta</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">X</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>(1)
Chairman of Board of Directors.</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>C
- Chairman of Committee.</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>M
- Member.</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 65; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->61<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Audit
Committee</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
primary purpose of the audit committee is to assist the Board of Directors&rsquo; oversight of:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 0.25in; text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    integrity of our financial statements; our systems of control over financial reporting and disclosure controls and procedures;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 0.25in; text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
    compliance with legal and regulatory requirements;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
    independent auditors&rsquo; qualifications and independence;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    performance of our independent auditors and our internal audit function;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">all
    related-person transactions for potential conflict of interest situations on an ongoing basis; and</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    preparation of the report required to be prepared by the committee pursuant to SEC rules.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mr.
Fell and Mr. Peterson serve on the audit committee, where Mr. Peterson serves as chairman of the audit committee. Mr. Fell and
Mr. Peterson each qualify as an &ldquo;audit committee financial expert&rdquo; as such term has been defined by the SEC in Item
407(d)(5) of Regulation S-K. Our Board of Directors has affirmatively determined that Mr. Fell and Mr. Peterson meet the definition
of &ldquo;independent directors&rdquo; for the purposes of serving on the audit committee under applicable SEC rules.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Compensation
Committee</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
primary purpose of our compensation committee is to recommend to our Board of Directors for consideration, the compensation and
benefits of our executive officers and key employees; monitor and review our compensation and benefit plans; administer our stock
and other incentive compensation plans and programs and prepare recommendations and periodic reports to the Board of Directors
concerning such matters; prepare the compensation committee report required by SEC rules to be included in our annual report;
prepare recommendations and periodic reports to the Board of Directors as appropriate; and, handle such other matters that are
specifically delegated to the compensation committee by our Board of Directors from time to time.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mr.
Fell and Mr. Peterson serve on the compensation committee, and Mr. Fell serves as the chairman.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Additional
Committees of the Board of Directors and Exchange Compliance Charters</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
the event that our Board of Directors determines that the uplisting of our common stock to the Nasdaq Capital Market or the NYSE
American is imminent, the Board anticipates adopting new charters of the Audit Committee and Compensation Committee, and adopting
a formal charter for a Nominating and Corporate Governance Committee, which committee charters, and which committee members, will
comply with all applicable requirements of the Nasdaq Capital Market or the NYSE American. The Company plans to file a Current
Report on Form 8-K relating to the adoption of such new charters, when and if, such new charters are adopted by the Board.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Compensation
Committee Interlocks and Insider Participation</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">None
of our executive officers serve on the compensation committee or Board of Directors of any other company of which any of the members
of our compensation committee or any of our directors is an executive officer.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 66; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->62<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Code
of Ethics</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
Board of Directors has adopted a Code of Ethics that applies to all of our directors, officers and employees. The Code of Ethics
will be available for review in print, without charge, to any stockholder who requests a copy by writing to us at Trxade Group,
Inc., 3840 Land O&rsquo; Lakes Blvd, Land O&rsquo; Lakes, Florida, 34639, Attention: Investor Relations. Each of our directors,
employees and officers are required to comply with the Code of Ethics.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Director
Nominations</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
do not currently have a standing nominating committee though we intend to form a corporate governance and nominating committee
as and when required to do so by law or the Nasdaq Capital Market or NYSE American rules. Our Board of Directors believes that
our independent directors can satisfactorily carry out the responsibility of properly selecting or approving director nominees
without the formation of a standing nominating committee at the current time. The independent directors will participate in the
consideration and recommendation of director nominees. As there is no standing nominating committee, we do not have a nominating
committee charter in place.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Board of Directors will also consider director candidates recommended for nomination by our stockholders during such times as
they are seeking proposed nominees to stand for election at the next annual meeting of stockholders (or, if applicable, a special
meeting of stockholders).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have not formally established any specific minimum qualifications that must be met or skills that are necessary for directors
to possess. In general, in identifying and evaluating nominees for director, our Board of Directors considers educational background,
diversity of professional experience, knowledge of our business, integrity, professional reputation, independence, wisdom and
the ability to represent the best interests of our stockholders.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Board
Leadership Structure</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
Board of Directors has the responsibility for selecting the appropriate leadership structure for the Company. In making leadership
structure determinations, the Board of Directors considers many factors, including the specific needs of the business and what
is in the best interests of the Company&rsquo;s stockholders. Our current leadership structure is comprised of a combined Chairman
of the Board and Chief Executive Officer (&ldquo;<U>CEO</U>&rdquo;), Mr. Ajjarapu. The Board of Directors believes that this leadership
structure is the most effective and efficient for the Company at this time. Mr. Ajjarapu possesses detailed and in-depth knowledge
of the issues, opportunities, and challenges facing the Company, and is thus best positioned to develop agendas that ensure that
the Board of Directors&rsquo; time and attention are focused on the most critical matters. Combining the Chairman of the Board
and CEO roles promotes decisive leadership, fosters clear accountability and enhances the Company&rsquo;s ability to communicate
its message and strategy clearly and consistently to our stockholders, particularly during periods of turbulent economic and industry
conditions. The Board believes that its programs for overseeing risk, as described below, would be effective under a variety of
leadership frameworks and therefore do not materially affect its choice of structure.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Risk
Oversight</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Effective
risk oversight is an important priority of the Board of Directors. Because risks are considered in virtually every business decision,
the Board of Directors discusses risk throughout the year generally or in connection with specific proposed actions. The Board
of Directors&rsquo; approach to risk oversight includes understanding the critical risks in the Company&rsquo;s business and strategy,
evaluating the Company&rsquo;s risk management processes, allocating responsibilities for risk oversight, and fostering an appropriate
culture of integrity and compliance with legal responsibilities. The directors exercise direct oversight of strategic risks to
the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Board
of Directors Meetings</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
the fiscal year that ended on December 31, 2018, the Board held six meetings, the Audit Committee held four meetings, and the
Compensation Committee held one meeting. All directors attended at least 75% of the Board of Directors meetings and committee
meetings of the committees on which they served, during the fiscal year ended December 31, 2018.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 67; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->63<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Stockholder
Communications with the Board</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
connection with all other matters other than the nomination of members of our Board of Directors (as described above), our stockholders
and other interested parties may communicate with members of the Board of Directors by submitting such communications in writing
to our Secretary, 3840 Land O&rsquo; Lakes Blvd, Land O Lakes, Florida 34639, who, upon receipt of any communication other than
one that is clearly marked &ldquo;<U>Confidential,</U>&rdquo; will note the date the communication was received, open the communication,
make a copy of it for our files and promptly forward the communication to the director(s) to whom it is addressed. Upon receipt
of any communication that is clearly marked &ldquo;<U>Confidential,</U>&rdquo; our Secretary will not open the communication,
but will note the date the communication was received and promptly forward the communication to the director(s) to whom it is
addressed. If the correspondence is not addressed to any particular member of the Board of Directors, the communication will be
forwarded to a Board member to bring to the attention of the Board.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Compliance
with Section 16(a) of the Exchange Act</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
16(a) of the Exchange Act requires our directors and officers, and persons who beneficially own more than 10% of a registered
class of the Registrant&rsquo;s equity securities, to file reports of beneficial ownership and changes in beneficial ownership
of our securities with the SEC on Forms 3, 4 and 5. Officers, directors and greater than 10% stockholders are required by SEC
regulation to furnish us with copies of all Section 16(a) forms they file.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Based
solely upon our review of the Section 16(a) filings that have been furnished to us and representations by our directors and executive
officers (where applicable), we believe that all filings required to be made under Section 16(a) during the fiscal year ended
December 31, 2018 were timely made.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A NAME="s_003"></A>EXECUTIVE
AND DIRECTOR COMPENSATION</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table sets forth certain information concerning compensation earned by or paid to certain persons who we refer to as
our &ldquo;<U>Named Executive Officers</U>&rdquo; for services provided for the fiscal years ended December 31, 2018 and 2017.
Our Named Executive Officers include persons who (i) served as our principal executive officer or acted in a similar capacity
during the years ended December 31, 2018 and 2017, (ii) were serving at fiscal year-end as our two most highly compensated executive
officers, other than the principal executive officer, whose total compensation exceeded $100,000, and (iii) if applicable, up
to two additional individuals for whom disclosure would have been provided as a most highly compensated executive officer, but
for the fact that the individual was not serving as an executive officer at fiscal year-end.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Summary
Executive Compensation Table</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; text-align: center; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P><P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; text-align: center; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Name and Principal<BR> Position</B></FONT></P></TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Year</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Salary<BR>
($)</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold"><SUP>&nbsp;</SUP></TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Bonus<BR>
($)</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Stock Awards<BR>
($)</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Option Awards<BR>
($)</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">All Other Compensation<BR>
($)</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Total<BR>
($)</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 37%; text-align: left">Suren Ajjarapu</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: center">&nbsp;</TD><TD STYLE="width: 5%; text-align: center">2018</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 5%; text-align: right">200,000</TD><TD STYLE="width: 1%; text-align: left"><SUP>(1)</SUP></TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 5%; text-align: right">&nbsp;&nbsp;&nbsp;-</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 5%; text-align: right">&nbsp;&nbsp;&nbsp;-</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 5%; text-align: right">-</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 5%; text-align: right">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;-</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 5%; text-align: right">200,000</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Chairman of the Board,</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center">2017</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">148,750</TD><TD STYLE="text-align: left"><SUP>(1)</SUP></TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">148,750</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Chief Executive Officer,<BR> and Director</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left"><SUP>&nbsp;</SUP></TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left"><SUP>&nbsp;</SUP></TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Prashant Patel</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center">2018</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">150,000</TD><TD STYLE="text-align: left"><SUP>(2)</SUP></TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">150,000</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Chief Operating Officer,</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center">2017</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">62,500</TD><TD STYLE="text-align: left"><SUP>(2)</SUP></TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">62,500</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">President and Director</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left"><SUP>&nbsp;</SUP></TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left"><SUP>&nbsp;</SUP></TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Howard A. Doss</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center">2018</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">62,500</TD><TD STYLE="text-align: left"><SUP>(3)</SUP></TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">17,250</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">79,750</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Chief Financial Officer</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center">2017</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">60,000</TD><TD STYLE="text-align: left"><SUP>(3)</SUP></TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">60,000</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 68; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->64<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 0.25in; text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 0.2in; text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    amount shown reflects compensation under an at will employment agreement with the Company.</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    amount shown reflects compensation under an at will employment agreement with the Company.</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3)</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    amount shown reflects compensation under a consulting agreement with the Company.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">No
Named Executive Officer received any Non-Equity Incentive Plan Compensation or Nonqualified Deferred Compensation Earnings for
the periods presented.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Employment
and Consulting Agreements</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">All
of our named executives are at-will employees or consultants. In 2016, the Company entered into an at-will employment agreement
with Mr. Ajjarapu, with an annual salary of $165,000 and a possible $50,000 performance bonus, and an at-will employment agreement
with Mr. Patel with an annual salary of $125,000 and a possible $50,000 performance bonus. In January 2017, each of Messrs. Ajjarapu
and Patel suspended their executive salaries through June 30, 2017, a period of six months. Mr. Ajjarapu entered into an amendment
in June 2017 to resume payment of the annual salary. Mr. Patel resumed his salary on July 1, 2017. In January 2018, Mr. Ajjarapu&rsquo;s
and Mr. Patel&rsquo;s salaries were amended to $200,000 and $150,000 per annum, respectively. The Company has an hourly rate consulting
arrangement with Mr. Doss. The Company has also entered into indemnification agreements with its officers and directors. The annual
bonus payable to each of Mr. Ajjarapu and Mr. Patel is based upon each executive&rsquo;s performance and the Company&rsquo;s attainment
of objectives established by the Board of Directors or Compensation Committee of the Board. With respect to any subjective milestones,
the determination of whether executive has attained the mutually agreed upon milestones for the bonus shall be reasonably determined
by the Board or the Compensation Committee.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">On August 28, 2019, the
Company entered into a Consulting and Representation Agreement with Flacane Advisors Inc. (&ldquo;<U>Flacane</U>&rdquo;), which
entity is controlled by Gary Augusta, who was appointed to the Board of Directors of the Company on October 9, 2019. The
agreement provides for Flacane to provide business consulting and advisory services to the Company. The agreement remains in effect
until March 31, 2020 and automatically renews for an additional year, to March 31, 2021, unless otherwise renegotiated by the
parties on such date. The agreement may be terminated by either party with 90 days prior notice during the term. As consideration
under the agreement, the Company granted Flacane warrants to purchase 300,000 shares of the Company&rsquo;s common stock at an
exercise price of $0.01 per share, of which warrants to purchase 150,000 shares vest on April 1, 2020 and warrants to purchase
150,000 shares vest on April 1, 2021, subject to Flacane&rsquo;s continued service to the Company. Flacane is also eligible
to receive bonuses under the agreement from time to time in the discretion of the Chief Executive Officer of the Company and the
Board of Directors.</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Compensation
of the Board of Directors</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table provides information regarding all compensation awarded to, earned by or paid to each person who served as a non-executive
director of the Company for some portion or all of 2018 and 2017. Other than as set forth in the table and described more fully
below, the Company did not pay any fees, make any equity or non-equity awards, or pay any other compensation, to its non-employee
directors. All compensation paid to its employee directors is set forth in the tables summarizing executive officer compensation
above.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 69; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->65<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Name</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Fees<BR>
 Earned</B></FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>or</B></FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>paid in <BR>
Cash</B></FONT></P></TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Stock</B></FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Awards</B></FONT></P></TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Option<BR> Awards <SUP>(1)</SUP></B></FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">All Other Compensation</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Total</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold; text-align: center">2017</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="width: 30%; text-align: center">Donald Fell</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 10%; text-align: right">15,000</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 10%; text-align: right">&nbsp;&nbsp;&nbsp;-</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 10%; text-align: right">50,000</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 10%; text-align: right">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;-</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 10%; text-align: right">65,000</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: center">Michael Peterson</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">15,000</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">113,883</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">128,883</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold; text-align: center">2018</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: center">Donald Fell</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">20,000</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">25,000</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">45,000</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: center">Michael Peterson</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">20,000</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">25,000</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">45,000</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 0.25in; text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><SUP>(1)</SUP></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
    April 2017, the Company granted Mr. Fell options to purchase 76,923 shares of common stock, vesting over one year and exercisable
    at $0.65 per share.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
April 2017, the Company granted Mr. Peterson options to purchase 76,923 shares of common stock, vesting over one year and exercisable
at $.65 per share.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
April 2017, the Company granted Mr. Peterson options to purchase 100,000 shares of common stock, vesting over four years and exercisable
at $0.65 per share.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
April 2018, the Company granted Mr. Fell options to purchase 50,000 shares of common stock, vesting over four years and exercisable
at $0.50 per share.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
April 2018, the Company granted Mr. Peterson options to purchase 50,000 shares of common stock, vesting over four years and exercisable
at $0.50 per share.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Non-employee
directors are paid $5,000 per quarter for Board responsibilities. The Company has also entered into an indemnification agreement
with Messrs. Fell and Peterson.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Outstanding
Option Equity Awards at 2018 Fiscal Year End</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table sets forth information as of December 31, 2018 concerning unexercised options, unvested stock and equity incentive
plan awards for each of the executive officers named in the Summary Compensation Table.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="19" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Option Awards</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Name</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Grant Date</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Number of Securities Underlying Unexercised Options<BR> (#) Exercisable</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Number of Securities Underlying Unexercised Options<BR> (#) Unexercisable</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Equity<BR> Incentive Plan Awards: Number of Securities Underlying Unexercised Unearned Options<BR> (#)</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Option Exercise Price<BR> ($)</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Option Expiration Date</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 20%; text-align: left">Howard A. Doss,<BR> Chief Financial Officer</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 10%; text-align: center">1/20/2014</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 10%; text-align: right">300,000</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 10%; text-align: right">&mdash;</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 10%; text-align: right">&mdash;</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 10%; text-align: right">1.00</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 10%; text-align: center">1/1/2024</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">4/1/2016</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">8,250</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">6,750</TD><TD STYLE="text-align: left"><SUP>(1)</SUP></TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&mdash;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1.02</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">4/1/2026</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">4/1/2018</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">7,031</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">30,469</TD><TD STYLE="text-align: left"><SUP>(2)</SUP></TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&mdash;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">0.50</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">4/1/2028</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 0.25in; text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Vesting
    is 6.25% of the total number of shares each quarter of the vesting commencement date of July 1, 2016.</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Vesting
    is 6.25% of the total number of shares each quarter of the vesting commencement date of July 1, 2018.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">There
were no stock awards outstanding at year end.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 70; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->66<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Equity
Compensation Plan Information</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table provides information as of December 31, 2018 with respect to securities that may be issued under our equity compensation
plans.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center; border-bottom: Black 1.5pt solid">Plan Category</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid">Number of<BR> securities to be<BR> issued upon<BR> exercise of<BR> outstanding options,<BR> warrants and rights</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid">Weighted-average exercise<BR> price of outstanding options,<BR> warrants and rights</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid">Number of securities<BR> remaining available <BR>for<BR> future issuance under<BR> equity compensation<BR> plans (excluding<BR> securities reflected in<BR> column (a))</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: justify">&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center">(a)</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center">(b)</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center">(c)</TD><TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 46%; text-align: left">Equity compensation plans approved by security holders</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 14%; text-align: right">4,612,987</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 14%; text-align: right">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;0.47</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 14%; text-align: right">267,154</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt">Equity compensation plans not approved by security holders</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">-</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">-</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">-</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify; padding-bottom: 2.5pt">Total</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">4,612,987</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">1.10</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">267,154</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
equity compensation plans approved by the Company&rsquo;s security holders are the 2014 Equity Incentive Plan (&ldquo;2014 Stock
Plan&rdquo;) of Trxade Group, Inc., Delaware corporation, and the 2013 Equity Incentive Plan of Trxade Group, Inc., a Nevada corporation
and predecessor in interest to Trxade Group, Inc., a Delaware corporation. The above listed equity compensation plans were adopted
as of December 31, 2018 with the approval of security holders.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>2014
Equity Incentive Plan</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following discussion summarizes the material terms of the 2014 Stock Plan. A description of the 2014 Stock Plan, which is intended
merely as a summary of its principal features and is qualified in its entirety by reference to the full text of the 2014 Stock
Plan, as filed and incorporated by reference to Exhibit 10.3 to the Registration Statement on Form 10 of Trxade Group, Inc., File
No. 000-55218, filed on June 6, 2014, is below.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Administration.
</B>The 2014 Stock Plan is administered by the Company&rsquo;s Board of Directors and the Compensation Committee of the Board.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Term.
</B>The 2014 Stock Plan shall continue in effect for a period of 10 years. In general, the term of each option granted shall be
no more than ten 10 years from the date of grant, though in certain instances such term may be shorter.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Eligibility.
</B>Employees and service providers of the Company and its subsidiaries and non-employee directors of the Company are eligible
to receive awards under the 2014 Stock Plan. Awards under the 2014 Stock Plan may include grants of options, stock appreciation
rights, restricted stock, restricted stock units, performance units and performance shares, and awards intended to qualify as
performance-based compensation under Section 162(m) of the Internal Revenue Code. Eligibility for any particular award is determined
by the Administrator (as defined in the 2014 Stock Plan) and, in the case of certain awards such as incentive stock options, eligibility
for receipt of such awards may be limited by the Internal Revenue Code.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Plan
Limit. </B>The Company has reserved 2,000,000 Common Shares for issuance under the 2014 Stock Plan. The 2014 Stock Plan had 802,154
remaining shares reserved for issuance as of March 2, 2018.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
above limit is subject to adjustment for certain changes in the Company&rsquo;s capitalization such as stock dividends, stock
splits, combinations or similar events. If an award expires, terminates, is forfeited or is settled in cash rather than in Common
Shares, the Common Shares not issued under that award will again become available for grant under the 2014 Stock Plan. If Common
Shares are surrendered to the Company or withheld to pay any exercise price or tax withholding requirements, only the number of
Common Shares issued net of the shares withheld or surrendered will be counted against the number of Common Shares available under
the 2014 Stock Plan. The exercise price for a stock option or stock appreciation right may not be less than 100% of the fair market
value of the shares on the date of grant or may not be less than 110% of the fair market value of the shares on the date of grant
for employees representing more than 10% of the voting power of all of the classes of stock of the Company. The Board may amend,
alter, suspend or terminate the plan. The Company must obtain stockholder approval of any amendment of the 2014 Stock Plan to
the extent necessary and desirable to comply with applicable law.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 71; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->67<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"><B><U>Company&rsquo;s
2019 Equity Incentive Plan</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
October 9, 2019, the Board of Directors adopted the Company&rsquo;s 2019 Equity Incentive Plan (the &ldquo;<U>Plan</U>&rdquo;).
The grant of incentive stock options under the Plan is subject to stockholder approval of the Plan within 12 months of the date
adopted by the Board of Directors.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 33.75pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Plan is intended to secure for the Company the benefits arising from ownership of the Company&rsquo;s common stock by the employees,
officers, directors and consultants of the Company, all of whom are and will be responsible for the Company&rsquo;s future growth.
The Plan is designed to help attract and retain for the Company, qualified personnel for positions of exceptional responsibility,
to reward employees, officers, directors and consultants for their services to the Company and to motivate such individuals through
added incentives to further contribute to the success of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following is a summary of the material features of the Plan:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Eligibility</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 33.75pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Plan will provide an opportunity for any employee, officer, director or consultant of the Company, subject to any limitations
provided by federal or state securities laws, to receive (i) incentive stock options (to eligible employees only); (ii) nonqualified
stock options; (iii) restricted stock; (iv) stock awards; (v) shares in performance of services; or (vi) any combination of the
foregoing. In making such determinations, the Board of Directors (or the Compensation Committee) may take into account the nature
of the services rendered by such person, his or her present and potential future contribution to the Company&rsquo;s success,
and such other factors as the Board of Directors (or the Compensation Committee) in its discretion shall deem relevant. Incentive
stock options granted under the Plan are intended to qualify as &ldquo;<U>incentive stock options</U>&rdquo; within the meaning
of Section 422 of the Internal Revenue Code of 1986, as amended (the &ldquo;<U>Code</U>&rdquo;). Nonqualified (non-statutory stock
options) granted under the Plan are not intended to qualify as incentive stock options under the Code. See &ldquo;<U>Federal Income
Tax Consequences</U>&rdquo; below for a discussion of the principal federal income tax consequences of awards under the Plan.
No awards can be issued to any person in consideration for services rendered where such services are in connection with the offer
or sale of securities in a capital-raising transaction, or they directly or indirectly promote or maintain a market for the Company&rsquo;s
securities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 33.75pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 33.75pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">No
incentive stock option may be granted under the Plan to any person who, at the time of the grant, owns (or is deemed to own) stock
possessing more than 10% of the total combined voting power of our Company or any affiliate of our Company, unless the exercise
price is at least 110% of the fair market value of the stock subject to the option on the date of grant and the term of the option
does not exceed five years from the date of grant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Administration
of Plan</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 33.75pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Plan shall be administered by the Board of Directors of the Company and/or the Company&rsquo;s Compensation Committee (if one
is formed). The Board of Directors (or the Compensation Committee) shall have the exclusive right to interpret and construe the
Plan, to select the eligible persons who shall receive an award, and to act in all matters pertaining to the grant of an award
and the determination and interpretation of the provisions of the related award agreement, including, without limitation, the
determination of the number of shares subject to stock options and the option period(s) and option price(s) thereof, the number
of shares of restricted stock or shares subject to stock awards or performance shares subject to an award, the vesting periods
(if any) and the form, terms, conditions and duration of each award, and any amendment thereof consistent with the provisions
of the Plan.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 72; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->68<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Stock
Subject to the Plan</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 33.75pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subject
to adjustment in connection with the payment of a stock dividend, a stock split or subdivision or combination of the shares of
common stock, or a reorganization or reclassification of the Company&rsquo;s common stock, the maximum aggregate number of shares
of common stock which may be issued pursuant to awards under the Plan is six million 6,000,000 shares. Such shares of common stock
shall be made available from the authorized and unissued shares of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 33.75pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 33.75pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
shares of common stock subject to an option or performance award granted under the Plan expire or otherwise terminate without
being exercised (or exercised in full), such shares shall become available again for grants under the Plan. If shares of restricted
stock awarded under the Plan are forfeited to us or repurchased by us, the number of shares forfeited or repurchased shall not
again be available under the Plan. Similarly, any shares cancelled in cashless exercises are not available for reissuance under
the Plan.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Term
of Awards</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 33.75pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Board of Directors, in its sole discretion, shall determine the exercise price of any Options granted under the Plan which exercise
price shall be set forth in the agreement evidencing the Option, provided however that at no time shall the exercise price be
less than $0.00001 par value per share of the Company&rsquo;s common stock. Also, the exercise price of incentive stock options
may not be less than the fair market value of the common stock subject to the option on the date of the grant and, in some cases
(see &ldquo;<U>Who is eligible to participate in the Plan?</U>&rdquo; above), may not be less than 110% of such fair market value.
The exercise price of non-statutory options also may not be less than the fair market value of the common stock on the date of
grant. The exercise price of options granted under the Plan must be paid either in cash at the time the option is exercised or,
at the discretion of our Board of Directors, (i) by delivery of already-owned shares of our common stock, (ii) pursuant to a deferred
payment arrangement, (iii) pursuant to a net exercise arrangement, or (iv) pursuant to a cashless exercise as permitted under
applicable rules and regulations of the Securities and Exchange Commission.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 33.75pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 33.75pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Options
and other awards granted under the Plan may be exercisable in cumulative increments, or &ldquo;<U>vest,</U>&rdquo; as determined
by our Board of Directors or the Compensation Committee. Our Board of Directors and the Compensation Committee has the power to
accelerate the time as of which an option may vest or be exercised. Shares of restricted stock acquired under a restricted stock
purchase or grant agreement may, but need not, be subject to forfeiture to us or other restrictions that will lapse in accordance
with a vesting schedule to be determined by the Board of Directors or the Compensation Committee. In the event a recipient&rsquo;s
employment or service with our Company terminates, any or all of the shares of common stock held by such recipient that have not
vested as of the date of termination under the terms of the restricted stock agreement may be forfeited to our Company in accordance
with such restricted stock agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 33.75pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 33.75pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
expiration date of Options and other awards granted under the Plan will be determined by our Board of Directors or the Compensation
Committee. The maximum term of options and performance shares under the Plan is ten years, except that in certain cases the maximum
term is five years.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Equitable
Adjustments to Awards</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 33.75pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Upon
the occurrence of:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    adoption of a plan of merger or consolidation of the Company with any other corporation or association as a result of which
    the holders of the voting capital stock of the Company as a group would receive less than 50% of the voting capital stock
    of the surviving or resulting corporation;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    approval by the Board of Directors of an agreement providing for the sale or transfer (other than as security for obligations
    of the Company) of substantially all of the assets of the Company; or</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">in
    the absence of a prior expression of approval by the Board of Directors, the acquisition of more than 20% of the Company&rsquo;s
    voting capital stock by any person within the meaning of Rule 13d-3 under the Exchange Act (other than the Company or a person
    that directly or indirectly controls, is controlled by, or is under common control with, the Company);</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 73; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->69<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">and
unless otherwise provided in the award agreement with respect to a particular award, all outstanding stock options shall become
immediately exercisable in full, subject to any appropriate adjustments, and shall remain exercisable for the remaining option
period, regardless of any provision in the related award agreement limiting the ability to exercise such stock option or any portion
thereof for any length of time. All outstanding performance shares with respect to which the applicable performance period has
not been completed shall be paid out as soon as practicable; and all outstanding shares of restricted stock with respect to which
the restrictions have not lapsed shall be deemed vested and all such restrictions shall be deemed lapsed and the restriction period
ended.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 33.75pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Additionally,
after the merger of one or more corporations into the Company, any merger of the Company into another corporation, any consolidation
of the Company and one or more corporations, or any other corporate reorganization of any form involving the Company as a party
thereto and involving any exchange, conversion, adjustment or other modification of the outstanding shares of the common stock,
each participant shall, at no additional cost, be entitled, upon any exercise of such participant&rsquo;s stock option, to receive,
in lieu of the number of shares as to which such stock option shall then be so exercised, the number and class of shares of stock
or other securities or such other property to which such participant would have been entitled to pursuant to the terms of the
agreement of merger or consolidation or reorganization, if at the time of such merger or consolidation or reorganization, such
participant had been a holder of record of a number of shares of common stock equal to the number of shares as to which such stock
option shall then be so exercised.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Termination
of Employment</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 33.75pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
incentive stock options shall lapse and cease to be exercisable upon the termination of service of an employee or director as
defined in the Plan, or within such period following a termination of service as shall have been determined by the Board of Directors
and set forth in the related award agreement; provided, further, that such period shall not exceed the period of time ending on
the date three (3) months following a termination of service. Non-incentive stock options are governed by the related award agreements.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Adjustments
for Withholding</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 33.75pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
the extent provided by the terms of an option or other award, a participant may satisfy any federal, state or local tax withholding
obligation relating to the exercise of such option, or award by a cash payment upon exercise, or in the discretion of our Board
of Directors or Compensation Committee, by authorizing our Company to withhold a portion of the stock otherwise issuable to the
participant, by delivering already-owned shares of our common stock or by a combination of these means.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Income
Tax Consequences</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 33.75pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following is a summary of the principal United States federal income tax consequences to the recipient and our Company with respect
to participation in the Plan. This summary is not intended to be exhaustive, and does not discuss the income tax laws of any city,
state or foreign jurisdiction in which a participant may reside.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Incentive
Stock Options</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 33.75pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">There
will be no federal income tax consequences to either us or the recipient upon the grant of an incentive stock option. Upon exercise
of the option, the excess of the fair market value of the stock over the exercise price, or the &ldquo;<U>spread,</U>&rdquo; will
be added to the alternative minimum tax base of the recipient unless a disqualifying disposition is made in the year of exercise.
A disqualifying disposition is the sale of the stock prior to the expiration of two years from the date of grant and one year
from the date of exercise. If the shares of common stock are disposed of in a disqualifying disposition, the recipient will realize
taxable ordinary income in an amount equal to the spread at the time of exercise, and we will be entitled (subject to the requirement
of reasonableness, the provisions of Section 162(m) of the Code and the satisfaction of a tax reporting obligation) to a federal
income tax deduction equal to such amount. If the recipient sells the shares of common stock after the specified periods, the
gain or loss on the sale of the shares will be long-term capital gain or loss and we will not be entitled to a federal income
tax deduction.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 74; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->70<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Non-statutory
Stock Options and Restricted Stock Awards</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 33.75pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Non-statutory
stock options and restricted stock awards granted under the Plan generally have the following federal income tax consequences.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 33.75pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 33.75pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">There
are no tax consequences to the participant or us by reason of the grant. Upon acquisition of the stock, the recipient will recognize
taxable ordinary income equal to the excess, if any, of the stock&rsquo;s fair market value on the acquisition date over the purchase
price. However, to the extent the stock is subject to &ldquo;<U>a substantial risk of forfeiture</U>&rdquo; (as defined in Section
83 of the Code), the taxable event will be delayed until the forfeiture provision lapses unless the recipient elects to be taxed
on receipt of the stock by making a Section 83(b) election within 30 days of receipt of the stock. If such election is not made,
the recipient generally will recognize income as and when the forfeiture provision lapses, and the income recognized will be based
on the fair market value of the stock on such future date. On that date, the recipient&rsquo;s holding period for purposes of
determining the long-term or short-term nature of any capital gain or loss recognized on a subsequent disposition of the stock
will begin. If a recipient makes a Section 83(b) election, the recipient will recognize ordinary income equal to the difference
between the stock&rsquo;s fair market value and the purchase price, if any, as of the date of receipt and the holding period for
purposes of characterizing as long-term or short-term any subsequent gain or loss will begin at the date of receipt.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 33.75pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 33.75pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">With
respect to employees, we are generally required to withhold from regular wages or supplemental wage payments an amount based on
the ordinary income recognized. Subject to the requirement of reasonableness, the provisions of Section 162(m) of the Code and
the satisfaction of a tax reporting obligation, we will generally be entitled to a business expense deduction equal to the taxable
ordinary income realized by the participant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 33.75pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 33.75pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Upon
disposition of the stock, the recipient will recognize a capital gain or loss equal to the difference between the selling price
and the sum of the amount paid for such stock plus any amount recognized as ordinary income with respect to the stock. Such gain
or loss will be long-term or short-term depending on whether the stock has been held for more than one year.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Potential
Limitation on Company Deductions</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 33.75pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
162(m) of the Code denies a deduction to any publicly held corporation for compensation paid to certain senior executives of our
company (a &ldquo;<U>covered employee</U>&rdquo;) in a taxable year to the extent that compensation to such employees exceeds
$1,000,000. It is possible that compensation attributable to awards, when combined with all other types of compensation received
by a covered employee from our company, may cause this limitation to be exceeded in any particular year.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Modification
of Awards After Grant</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 33.75pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Yes.
The Board of Directors (or Compensation Committee) may reprice any Stock Option without the approval of the stockholders of the
Company. For this purpose, &ldquo;<U>reprice</U>&rdquo; means (i) any of the following or any other action that has the same effect:
(A) lowering the exercise price of a Stock Option after it is granted, (B) any other action that is treated as a repricing under
U.S. generally accepted accounting principles (&ldquo;<U>GAAP</U>&rdquo;), or (C) cancelling a Stock Option at a time when its
exercise price exceeds the fair market value of the underlying common stock, in exchange for another Stock Option, restricted
stock or other equity, unless the cancellation and exchange occurs in connection with a merger, acquisition, spin-off or other
similar corporate transaction; and (ii) any other action that is considered to be a repricing under formal or informal guidance
issued by exchange or market on which the Company&rsquo;s common stock then trades or is quoted. In addition to, and without limiting
the above, the Board of Directors (or Compensation Committee) may permit the voluntary surrender of all or a portion of any Stock
Option granted under the Plan to be conditioned upon the granting to the participant of a new Stock Option for the same or a different
number of shares of common stock as the Stock Option surrendered, or may require such voluntary surrender as a condition precedent
to a grant of a new Stock Option to such participant. Subject to the provisions of the Plan, such new Stock Option shall be exercisable
at such Option Price, during such option period and on such other terms and conditions as are specified by the Board of Directors
(or Compensation Committee) at the time the new Stock Option is granted. Upon surrender, the Stock Options surrendered shall be
cancelled and the shares of common stock previously subject to them shall be available for the grant of other Stock Options.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 75; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->71<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Modification
of Plan</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 33.75pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Board of Directors may adopt, establish, amend and rescind such rules, regulations and procedures as it may deem appropriate for
the proper administration of the Plan, make all other determinations which are, in the Board of Directors&rsquo; judgment, necessary
or desirable for the proper administration of the Plan, amend the Plan or a stock award as provided in Article XI of the Plan,
and/or terminate or suspend the Plan as provided in Article XI thereof. Our Board of Directors may also amend the Plan at any
time, and from time to time. However, except as relates to adjustments upon changes in common stock, no amendment will be effective
unless approved by our stockholders to the extent stockholder approval is necessary to preserve incentive stock option treatment
for federal income tax purposes. Our Board of Directors may submit any other amendment to the Plan for stockholder approval if
it concludes that stockholder approval is otherwise advisable.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A NAME="s_004"></A>CERTAIN
RELATIONSHIPS AND RELATED TRANSACTIONS, AND DIRECTOR INDEPENDENCE</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Except
as discussed below or otherwise disclosed above under &ldquo;<U>Executive and Director Compensation</U>&rdquo;, which information
is incorporated by reference where applicable in this &ldquo;<U>Certain Relationships and Related Transactions, and Director Independence</U>&rdquo;
section, the following sets forth a summary of all transactions since the beginning of the fiscal year of 2017, or any currently
proposed transaction, in which the Company was to be a participant and the amount involved exceeded or exceeds the lesser of $120,000
or one percent of the average of the Company&rsquo;s total assets at the fiscal year-end for 2017 and 2018, and in which any related
person had or will have a direct or indirect material interest (other than compensation described above under &ldquo;<U>Executive
and Director Compensation</U>&rdquo;). We believe the terms obtained or consideration that we paid or received, as applicable,
in connection with the transactions described below were comparable to terms available or the amounts that would be paid or received,
as applicable, in arm&rsquo;s-length transactions.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Transactions
with Related Persons.</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">All
of our executives are at-will employees or consultants. Each of Messrs. Ajjarapu and Patel are parties to an at-will executive
employment agreement. In January 2017, each of Messrs. Ajjarapu and Patel suspended their executive salaries for a period of six
months. The Company has also entered into indemnification agreements with its officers and directors. In January 2018, Mr. Ajjarapu&rsquo;s
and Mr. Patel&rsquo;s executive salary agreements were amended to provide salary from $165,000 and $125,000, to $200,000 and $150,000,
per year, respectively.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company&rsquo;s founders, Mr. Ajjarapu (through Sansur Associates, a company that he controls) and Mr. Patel, have periodically
loaned funds on a short-term interest free basis to cover the Company&rsquo;s operating expenses. In November 2016, Mr. Patel
loaned the Company $10,000. In June 2017, the Company borrowed $100,000 and $80,000 from Sansur Associates, LLC, a limited liability
company controlled by Mr. Ajjarapu, and Mr. Patel, respectively. The note due to Mr. Patel is $122,552, which includes $17,280
due from a previously existing promissory note and $25,272 assumption of credit card obligation related to business expenses of
the Company. As of December 31, 2018, $222,552 was outstanding on these loans. The notes are due July 1, 2020 and each bear an
interest rate of 6% per annum, payable annually. The $222,552 of outstanding loans were paid in full on October 8, 2019.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 76; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->72<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">Further, the Company owed
$150,000 under a related party note that was renewed for a six-month extension at the same interest rate of 10% in September 2017,
which was due February 2018. Both of these notes were entered into with Nitil Patel, the brother of Prashant Patel, the
Director and President of the Company. In February 2018, $50,000 of the $150,000 of principal was paid. The remaining $100,000
was extended to July 2018 as the same interest rate of 10%. On September 30, 2019 the note was converted to 200,000 shares
of common stock at $0.50.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
October 2018 in connection with the acquisition of Community Specialty Pharmacy, LLC a $300,000 promissory note was issued to
Nikul Panchal, a non-executive officer of the Company and noteholder, accruing interest at simple interest of 10%, interest payable
annually, and principal payable at maturity on October 15, 2021. The $75,000 note was converted into 150,000 shares of common
stock at $0.50 on September 30, 2019.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of June 30, 2019, $40,000 in convertible promissory notes were due to Mr. Shilpa Patel, a relative of Mr. Prashant Patel. Simple
interest of 10% is payable at the maturity date of the note, which is August 8, 2019. Prior to maturity the note may be converted
for common stock at a conversion price of $1.50.</FONT> The note was paid in August 2019.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of June 30, 2019, $100,000 in convertible promissory notes were due to Mr. Nitil Patel, the brother of Mr. Prashant Patel,
our director and President. Simple interest of 10% is payable at the maturity date of the notes, which is July 7, 2019. Prior
to maturity, the notes may be converted for common stock at a conversion price of $0.62. In July 2019, the note was extended to
October 15, 2019. On September 27, 2019, this note was amended and converted into 200,000 shares of common stock at $0.50.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
the year ended December 31, 2018 and for the six months ended June 30, 2019, there have been no other related party transactions,
or currently proposed transactions, in which we were or are to be a participant and the amount involved exceeds the lesser of
$120,000 or one percent of the average of our total assets at year-end for the last completed fiscal years and in which any related
person had or will have a direct or indirect material interest.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
January 17, 2019, the Company, through its wholly-owned subsidiary, Alliance Pharma Solutions, LLC, a Delaware limited liability
company entered into a joint venture with PanOptic Health, LLC, a Delaware limited liability company (&ldquo;<U>PanOptic</U>&rdquo;),
to create a new entity, SyncHealth MSO, LLC (the &ldquo;<U>Joint Venture</U>&rdquo;). Under the terms of the Shareholders&rsquo;
Agreement included in the Joint Venture, PanOptic has agreed to vote all of its shares of stock of the Company for Suren Ajjarapu
and Prashant Patel (current directors) and the two or three independent designee directors, as determined by the founder Directors
(Mr. Ajjarapu and Mr. Patel). By January 2020, a maximum total of 14,776,638 shares of common stock of the Company may be issued
to PanOptic, subject to PanOptic and SyncHealth meeting all of the revenue covenants, in connection with the Joint Venture, and
these shares would be subject to the Shareholders Agreement. For further information on the Shareholders Agreement, please review
Exhibit 10.4 to the Current Report on Form 8-K filed January 22, 2019, and other documents referenced therein. To date, we
have not realized any income from the technology and presently we are in discussions to dissolve this relationship.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
February 6, 2019, the Company entered into an Indemnification Agreement with Board Members Suren Ajjarapu and Prashant Patel in
connection with a personal guarantee they had both given for a Credit Agreement of approximately $1,000,000 with the Company and
an outside lender.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 77; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->73<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
August 28, 2019, the Company entered into a Consulting and Representation Agreement with Flacane Advisors Inc. (&ldquo;<U>Flacane</U>&rdquo;),
which entity is controlled by Gary Augusta, who was appointed to the Board of Directors of the Company on October 9, 2019.
The agreement provides for Flacane to provide business consulting and advisory services to the Company. The agreement remains
in effect until March 31, 2020 and automatically renews for an additional year, to March 31, 2021, unless otherwise renegotiated
by the parties on such date. The agreement may be terminated by either party with 90 days prior notice during the term. As consideration
under the agreement, the Company granted Flacane warrants to purchase 300,000 shares of the Company&rsquo;s common stock at an
exercise price of $0.01 per share, of which warrants to purchase 150,000 shares vest on April 1, 2020 and warrants to purchase
150,000 shares vest on April 1, 2021, subject to Flacane&rsquo;s continued service to the Company. Flacane is also eligible
to receive bonuses under the agreement from time to time in the discretion of the Chief Executive Officer of the Company and the
Board of Directors.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
August 2019, Mr. Augusta, through Bedford Falls Capital LLC, an entity which he controls, purchased 500,000 shares of common stock
of the Company in the Company&rsquo;s private placement offering, for $250,000, or $0.50 per share.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
September 2019, Mr. Augusta, through Bedford Falls Capital LLC, an entity which he controls, purchased 500,000 shares of common
stock of the Company in the Company&rsquo;s private placement offering, for $250,000, or $0.50 per share.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
September 30, 2019, the Company converted $175,000 of principal under various outstanding promissory notes, including $100,000
owed to Mr. Nitil Patel, the brother of Mr. Prashant Patel, our director and President, $75,000 owed to Nikul Panchal,
a non-executive officer of the Company and noteholder, into 350,000 shares of common stock of the Company at $0.50
per share under the terms of the Securities Purchase Agreement referenced above.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
October 8, 2019, $122,552 and $100,000 in promissory notes due to Mr. Prashant Patel and Mr. Suren Ajjarapu, respectively, were
paid in full. The notes were due July 1, 2020.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Review
and Approval of Related Party Transactions</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have not adopted formal policies and procedures for the review, approval or ratification of transactions, such as those described
above, with our executive officer(s), director(s) and significant stockholders, provided that it is our policy that any and all
such transactions are presented and approved by the board and future material transactions between us and members of management
or their affiliates shall be on terms no less favorable than those available from unaffiliated third parties.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition, our Code of Ethics (described above under &ldquo;<U>Directors, Executive Officers And Corporate Governance</U>&rdquo;
- &ldquo;<U>Code of Ethics</U>&rdquo;), which is applicable to all of our employees, officers and directors, requires that all
employees, officers and directors avoid any conflict, or the appearance of a conflict, between an individual&rsquo;s personal
interests and our interests.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Director
Independence</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
common stock is traded on the OTCQB under the symbol &ldquo;<U>TRXD</U>&rdquo;. The OTCQB electronic trading platform does not
maintain any standards regarding the &ldquo;<U>independence</U>&rdquo; of the directors on our company&rsquo;s Board of Directors,
and we are not otherwise subject to the requirements of any national securities exchange or an inter-dealer quotation system with
respect to the need to have a majority of our directors be independent.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
the absence of such requirements, we have elected to use the definition for &ldquo;<U>director independence</U>&rdquo; under the
NASDAQ stock market&rsquo;s listing standards, which defines an &ldquo;<U>independent director</U>&rdquo; as &ldquo;a person other
than an officer or employee of the Company or the Company&rsquo;s subsidiaries or any other individual having a relationship,
which in the opinion of our Board of Directors, would interfere with the exercise of independent judgment in carrying out the
responsibilities of a director.&rdquo; The definition further provides that, among others, employment of a director by us (or
any parent or subsidiary of ours) at any time during the past three years is considered a bar to independence regardless of the
determination of our Board of Directors. We have determined that three of our five directors, Mr. Fell, Mr. Augusta, and Mr. Peterson,
are deemed &ldquo;<U>independent</U>&rdquo;.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 78; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->74<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A NAME="s_005"></A>WHERE
YOU CAN FIND ADDITIONAL INFORMATION</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
will provide without charge to each person, including any beneficial owner, to whom this prospectus is delivered, upon his or
her written or oral request, a copy of any or all of the reports or documents referred to above that have been incorporated by
reference into this prospectus, excluding exhibits to those documents unless they are specifically incorporated by reference into
those documents. You may request a copy of these filings, at no cost, by contacting us at our address at 3840 Land O&rsquo; Lakes
Boulevard, Land O&rsquo;Lakes, Florida, 34639 or by email at <I>info@trxade.com</I>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
do not incorporate information on our website into this prospectus or any supplement to this prospectus and you should not consider
any information on, or that can be accessed through, our website as part of this prospectus or any supplement to this prospectus
(other than those filings with the SEC that we specifically incorporate by reference into this prospectus or any supplement to
this prospectus).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><A NAME="s_006"></A><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">INDEMNIFICATION
OF DIRECTORS AND OFFICERS</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
145 of the Delaware General Corporation Law (&ldquo;<U>DGCL</U>&rdquo;) authorizes a corporation&rsquo;s board of directors to
grant, and authorizes a court to award, indemnity to officers, directors, and other corporate agents.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to the Company&rsquo;s Certificate of Incorporation:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 0.75in; text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 0.25in; text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
    director of the Company shall, to the fullest extent permitted by the DGCL as it now exists or as it may hereafter be amended,
    not be personally liable to the Company or its stockholders for monetary damages for breach of fiduciary duty as a director,
    except to the extent such exception from liability is not permitted under the DGCL as the same exists or may hereafter be
    amended; and</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
    the fullest extent permitted by applicable law, the Company is authorized to provide indemnification of, and advancement of
    expenses to, such agents of the Company (and any other persons to which Delaware law permits the Company to provide indemnification)
    through Bylaw provisions, agreements with such agents or other persons, vote of stockholders or disinterested directors or
    otherwise, in excess of the indemnification and advancement otherwise permitted by Section 145 of the DGCL, subject only to
    limits created by applicable Delaware law (statutory or non-statutory), with respect to actions for breach of duty to the
    Company, its stockholders and others.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
145 of the DGCL, provides, among other things, that a Delaware corporation may indemnify any person who was, is or is threatened
to be made, party to any threatened, pending or completed action, suit or proceeding, whether civil, criminal, administrative
or investigative (other than an action by or in the right of such corporation), by reason of the fact that such person is or was
an officer, director, employee or agent of such corporation or is or was serving at the request of such corporation as a director,
officer, employee or agent of another corporation or enterprise. The indemnity may include expenses (including attorneys&rsquo;
fees), judgments, fines and amounts paid in settlement actually and reasonably incurred by such person in connection with such
action, suit or proceeding, provided such person acted in good faith and in a manner he or she reasonably believed to be in or
not opposed to the corporation&rsquo;s best interests and, with respect to any criminal action or proceeding, had no reasonable
cause to believe that his or her conduct was unlawful. A Delaware corporation may indemnify any persons who were or are a party
to any threatened, pending or completed action or suit by or in the right of the corporation by reason of the fact that such person
is or was a director, officer, employee or agent of another corporation or enterprise. The indemnity may include expenses (including
attorneys&rsquo; fees) actually and reasonably incurred by such person in connection with the defense or settlement of such action
or suit, provided such person acted in good faith and in a manner he or she reasonably believed to be in or not opposed to the
corporation&rsquo;s best interests, provided further that no indemnification is permitted without judicial approval if the officer,
director, employee or agent is adjudged to be liable to the corporation. Where an officer or director is successful on the merits
or otherwise in the defense of any action referred to above, the corporation must indemnify him or her against the expenses (including
attorneys&rsquo; fees) which such officer or director has actually and reasonably incurred.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 79; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->75<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
145 further authorizes a corporation to purchase and maintain insurance on behalf of any person who is or was a director, officer,
employee or agent of the corporation or is or was serving at the request of the corporation as a director, officer, employee or
agent of another corporation or enterprise, against any liability asserted against such person and incurred by such person in
any such capacity, or arising out of his or her status as such, whether or not the corporation would otherwise have the power
to indemnify such person under Section 145.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
indemnification rights set forth above shall not be exclusive of any other right which an indemnified person may have or hereafter
acquire under any statute, any provision of our amended and certificate of incorporation, our amended and restated bylaws, agreement,
vote of stockholders or disinterested directors or otherwise. Notwithstanding the foregoing, we shall not be obligated to indemnify
a director or officer in respect of a proceeding (or part thereof) instituted by such director or officer, unless such proceeding
(or part thereof) has been authorized by the board of directors pursuant to the applicable procedure outlined in the amended and
restated bylaws.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
174 of the DGCL provides, among other things, that a director, who willfully or negligently approves of an unlawful payment of
dividends or an unlawful stock purchase or redemption, may be held jointly and severally liable for such actions. A director who
was either absent when the unlawful actions were approved or dissented at the time may avoid liability by causing his or her dissent
to such actions to be entered in the books containing the minutes of the meetings of the board of directors at the time such action
occurred or immediately after such absent director receives notice of the unlawful acts.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company&rsquo;s policy is to enter into separate indemnification agreements with each of its directors and officers that provide
the maximum indemnity allowed to directors and executive officers by Section 145 of the DGCL and also to provide for certain additional
procedural protections. The Company also maintains directors and officers&rsquo; insurance to insure such persons against certain
liabilities. These indemnification provisions and the indemnification agreements may be sufficiently broad to permit indemnification
of our officers and directors for liabilities, including reimbursement of expenses incurred, arising under the Securities Act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 80; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->76<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><A NAME="s_007"></A><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">INDEX
TO FINANCIAL STATEMENTS</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Unaudited
Financial Statements for the Three and Six Months Ended June 30, 2019 and 2018</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="vertical-align: top; border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Contents</B></FONT></TD>
    <TD STYLE="vertical-align: top; width: 0.1in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; width: 0.5in; border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Page(s)</B></FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif"><A HREF="#f_01"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Consolidated Balance Sheets as of June 30, 2019 and December 31, 2018 (unaudited)</FONT></A></TD>
    <TD STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">F-1</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif"><A HREF="#f_02"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Consolidated Statements of Operations for the Three and Six Months Ended June 30, 2019 and 2018 (unaudited)</FONT></A></TD>
    <TD STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">F-2</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif"><A HREF="#f_03"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Consolidated Statements of Changes in Shareholders&rsquo; Equity for the Three and Six Months Ended June 30, 2019 and 2018 (unaudited)</FONT></A></TD>
    <TD STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">F-3</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif"><A HREF="#f_04"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Consolidated Statements of Cash Flows for the Six Months Ended June 30, 2019 and 2018 (unaudited)</FONT></A></TD>
    <TD STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">F-4</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif"><A HREF="#f_05"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Notes to Unaudited Consolidated Financial Statements</FONT></A></TD>
    <TD STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">F-5</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Audited
Financial Statements for the Years Ended December 31, 2018 and 2017</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="vertical-align: top; border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Contents</B></FONT></TD>
    <TD STYLE="vertical-align: top; width: 0.1in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; width: 0.5in; border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Page(s)</B></FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif"><A HREF="#f_06"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Report of Independent Registered Public Accounting Firm</FONT></A></TD>
    <TD STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">F-11</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif"><A HREF="#f_07"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Consolidated Balance Sheets at December 31, 2018 and 2017</FONT></A></TD>
    <TD STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">F-12</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif"><A HREF="#f_08"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Consolidated Statements of Operations for the Years Ended December 31, 2018 and 2017</FONT></A></TD>
    <TD STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">F-13</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif"><A HREF="#f_09"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Consolidated Statements of Stockholders&rsquo; Equity (Deficit) for the Years Ended December 31, 2018 and 2017</FONT></A></TD>
    <TD STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">F-14</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif"><A HREF="#f_10"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Consolidated Statements of Cash Flows for the Years Ended December 31, 2018 and 2017</FONT></A></TD>
    <TD STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">F-15</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif"><A HREF="#f_11"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Notes to Consolidated Financial Statements</FONT></A></TD>
    <TD STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">F-16</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 81; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->77<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><A NAME="f_01"></A>Trxade
Group, Inc.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Consolidated
Balance Sheets</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>June
30, 2019 and December 31, 2018</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(unaudited)</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">June 30, 2019</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">December 31, 2018</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold; text-align: center">Assets</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; text-align: left">Current Assets</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 60%; padding-left: 10pt">Cash</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 16%; text-align: right">540,034</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 16%; text-align: right">869,557</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-left: 10pt">Accounts Receivable, net</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">713,479</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">433,627</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 10pt">Inventory</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">546,816</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">79,966</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt; padding-left: 10pt">Prepaid Assets</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">151,941</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">82,927</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-left: 10pt">Total Current Assets</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,952,270</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,466,077</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold; text-align: left">Property Plant and Equipment, Net</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">12,506</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">15,006</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold; text-align: left">Other Assets</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt">Deposits</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">21,636</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">20,531</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-left: 10pt">Equity method investment</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">162,178</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-left: 10pt">Right of use leased assets</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">803,502</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-bottom: 1.5pt; padding-left: 10pt">Goodwill</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">725,973</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">725,973</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold; text-align: left; padding-bottom: 2.5pt">Total Assets</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">3,678,065</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">2,227,587</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold; text-align: center">Liabilities and Shareholders&rsquo; Equity</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold; text-align: left">Current Liabilities</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-left: 10pt">Accounts Payable</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">763,143</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">400,544</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-left: 10pt">Accrued Liabilities</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">101,188</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">138,323</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-left: 10pt">Current Portion Lease Liabilities</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">80,832</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-left: 10pt">Short Term Convertible Notes Payable</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">181,500</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt; padding-left: 10pt">Short Term Convertible Notes Payable &ndash;
    Related Parties</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">140,000</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">140,000</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-left: 10pt">Total Current Liabilities</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,085,163</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">860,367</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold; text-align: left">Long Term Liabilities</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-left: 10pt">Notes Payable &ndash; Related Parties</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">522,552</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">522,552</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt; padding-left: 10pt">Other Long-term Liabilities &ndash; Leases</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">730,333</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">-</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; text-align: left">Total Liabilities</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2,338,048</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,382,919</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; text-align: left">Shareholders&rsquo; Equity</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-left: 10pt">Series A Preferred Stock, $0.00001 par value; 10,000,000 shares authorized; none issued and outstanding as of June 30, 2019 and December 31, 2018, respectfully</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt">Common Stock, $0.00001 par value; 100,000,000 shares authorized; 33,726,489 and 33,285,827 shares issued and outstanding, as of June 30, 2019 and December 31, 2018, respectively</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">337</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">332</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-left: 10pt">Additional Paid-in Capital</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">9,267,545</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">8,955,411</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt; padding-left: 10pt">Retained Deficit</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(7,927,865</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(8,111,075</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt; padding-left: 10pt">Total Shareholders&rsquo; Equity</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">1,340,017</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">844,668</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold; text-align: left; padding-bottom: 2.5pt">Total Liabilities and Shareholders&rsquo; Equity</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">3,678,065</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">2,227,587</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
accompanying notes are an integral part of the unaudited consolidated financial statements.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 82; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><A NAME="f_02"></A>Trxade
Group, Inc.<BR>
Consolidated Statements of Operations<BR>
Three and Six Months Ended June 30, 2019 and 2018</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(unaudited)</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="6" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Three months ended</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="6" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Six months ended</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2019</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2018</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2019</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2018</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 36%; font-weight: bold; text-align: left">Revenues</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 12%; text-align: right">1,916,414</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 12%; text-align: right">837,688</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 12%; text-align: right">3,428,935</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 12%; text-align: right">1,690,611</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold">Cost of Sales</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">753,138</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">-</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">1,118,977</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">-</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; text-align: left">Gross Profit</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; text-align: right">1,163,276</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; text-align: right">837,688</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; text-align: right">2,309,958</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; text-align: right">1,690,611</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: right">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; text-align: left">Operating Expenses</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-left: 10pt">General and Administrative</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">1,030,571</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">806,242</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">2,005,494</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">1,560,437</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold; text-align: left">Operating Income</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">132,705</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">31,446</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">304,464</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">130,174</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-left: 10pt">Share in Equity Losses in Investment</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(58,850</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(87,822</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-left: 10pt">Interest Expense</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(15,874</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(10,933</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(33,432</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(27,392</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold; text-align: left">Net Income</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">57,981</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">20,513</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">183,210</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">102,782</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify">Net Income per Common Share <BR>&ndash; Basic:</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">0.00</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">0.00</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">0.01</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">0.00</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify">Net Income per Common Share <BR>&ndash; Diluted:</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">0.00</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">0.00</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">0.01</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">0.00</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD>Weighted average Common Shares Outstanding Basic</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">33,726,489</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">31,985,827</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">33,546,329</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">31,985,827</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD>Weighted average Common Shares Outstanding Diluted</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">36,353,751</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">34,479,406</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">36,353,751</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">34,472,811</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
accompanying notes are an integral part of the unaudited consolidated financial statements.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 83; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><A NAME="f_03"></A>Trxade
Group, Inc.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Consolidated
Statements of Changes in Shareholders&rsquo; Equity</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Three
and Six Months Ended June 30, 2019 and 2018</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(unaudited)</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="6" STYLE="text-align: center; border-bottom: Black 1.5pt solid">Preferred Stock</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="6" STYLE="text-align: center; border-bottom: Black 1.5pt solid">Common Stock</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; padding-bottom: 1.5pt">Additional <BR>Paid-in-</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; padding-bottom: 1.5pt">Accumulated</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; padding-bottom: 1.5pt">Total <BR>Shareholders&rsquo;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid">Shares</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid">Amount</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid">Shares</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid">Amount</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid">Capital</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid">Deficit</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid">Equity</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 30%">Balance at December 31, 2018</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 7%; text-align: right">&nbsp;&nbsp;&nbsp;-</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 7%; text-align: right">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;-</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 7%; text-align: right">33,285,827</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 7%; text-align: right">332</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 7%; text-align: right">8,955,411</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 7%; text-align: right">(8,111,075</TD><TD STYLE="width: 1%; text-align: left">)</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 7%; text-align: right">844,668</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Common Stock issued for convertible debt and accrued interest</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">423,996</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">4</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">211,979</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">211,983</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify">Warrants exercised</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">16,666</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">165</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">166</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify">Options Expense</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">35,979</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">35,979</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify">Net Income</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">125,229</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">125,229</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify">Balance at March 31, 2019</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">33,726,489</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">337</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">9,203,534</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(7,985,846</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,218,025</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify">Options Expense</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">64,011</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">64,011</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify; padding-bottom: 1.5pt">Net Income</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">-</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">-</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">-</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">-</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">-</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">57,981</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">57,981</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify; padding-bottom: 2.5pt">Balance at June 30, 2019</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">-</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">-</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">&nbsp;33,726,489</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">337</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">&nbsp;9,267,545</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">(7,927,865</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">1,340,017</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center; padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="6" STYLE="text-align: center; border-bottom: Black 1.5pt solid">Preferred Stock</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="6" STYLE="text-align: center; border-bottom: Black 1.5pt solid">Common Stock</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; padding-bottom: 1.5pt">Additional <BR>Paid-in-</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; padding-bottom: 1.5pt">Accumulated</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; padding-bottom: 1.5pt">Total <BR>Shareholders&rsquo;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center; padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid">Shares</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid">Amount</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid">Shares</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid">Amount</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid">Capital</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid">Deficit</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid">Equity</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 30%">Balance at December 31, 2017</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 7%; text-align: right">&nbsp;&nbsp;&nbsp;-</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 7%; text-align: right">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;-</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 7%; text-align: right">&nbsp;31,985,827</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 7%; text-align: right">320</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 7%; text-align: right">7,807,860</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 7%; text-align: right">(8,120,113</TD><TD STYLE="width: 1%; text-align: left">)</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 7%; text-align: right">(311,933</TD><TD STYLE="width: 1%; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify">Options Expense</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">37,456</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">37,456</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify">Net Income</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">82,269</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">82,269</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify">Balance at March 31, 2018</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">31,985,827</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">320</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">7,845,316</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(8,037,844</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(192,208</TD><TD STYLE="text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify">Options Expense</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">50,616</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">50,616</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify; padding-bottom: 1.5pt">Net Income</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">-</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">-</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">-</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">-</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">-</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">20,513</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">20,513</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify; padding-bottom: 2.5pt">Balance at June 30, 2018</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">-</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">-</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">31,985,827</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">320</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">&nbsp;7,895,932</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">(8,017,331</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">(121,079</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">)</TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
accompanying notes are an integral part of the unaudited consolidated financial statements.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 84; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><A NAME="f_04"></A><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Trxade
Group, Inc.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Consolidated
Statements of Cash Flows</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Six-months
ended June 30, 2019 and 2018</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(unaudited)</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2019</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2018</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold; text-align: left">Operating Activities:</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="width: 60%; text-align: left; padding-left: 10pt">Net Income</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 16%; text-align: right">183,210</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 16%; text-align: right">102,782</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-left: 10pt">Adjustments to reconcile net income to net cash provided by (used in) operating activities:</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-left: 20pt">Depreciation Expense</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2,500</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-left: 20pt">Options expense</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">99,990</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">88,072</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-left: 20pt">Share in Equity Losses in Investment</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">87,822</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-left: 20pt">Amortization of right to use asset</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">43,939</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-left: 20pt">Amortization of Debt Discount</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">152</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-left: 10pt">Changes in operating assets and liabilities:</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-left: 20pt">Accounts Receivable</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(279,852</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(5,875</TD><TD STYLE="text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-left: 20pt">Prepaid Assets and other Current Assets</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(70,119</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(64,831</TD><TD STYLE="text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 20pt">Inventory</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(466,850</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-left: 20pt">Lease Liability</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(36,276</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-left: 20pt">Accounts Payable</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">362,599</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">22,671</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt; padding-left: 20pt">Accrued Liabilities and Other Liabilities</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(6,652</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">3,485</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-left: 10pt">Net Cash provided by (used in) operating activities</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(79,689</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">146,456</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold; text-align: left">Investing Activities:</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 2.5pt; padding-left: 20pt">Purchase of equity method investment</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">(250,000</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">-</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold; text-align: left">Net cash Used in Investing activities</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(250,000</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold; text-align: left">Financing Activities:</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-left: 10pt">Repayments of Short-Term Convertible Debt &ndash; Related Parties</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(111,725</TD><TD STYLE="text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-left: 10pt">Repayments of Short-Term Promissory Notes</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(10,739</TD><TD STYLE="text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-bottom: 1.5pt; padding-left: 10pt">Proceeds from exercise of Warrants</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">166</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">-</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt; padding-left: 10pt">Net Cash provided by (used in) financing activities</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">166</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(122,464</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Net increase (decrease) in Cash</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(329,523</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">23,992</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt">Cash at Beginning of the Year</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">869,557</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">183,914</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-bottom: 2.5pt">Cash at June 30, 2019 and 2018</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">540,034</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">207,906</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold; text-align: left">Supplemental Cash Flow Information</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Cash Paid for Interest</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">2,997</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">27,392</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Cash Paid for Income Taxes</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold; text-align: left">Non-Cash Transactions</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Common Stock Issued for Conversion of Note and Accrued Interest</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">211,983</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">ROU assets and operating lease obligations recognized</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">847,441</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
accompanying notes are an integral part of the unaudited consolidated financial statements.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 85; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A NAME="f_05"></A><B>Trxade
Group, Inc.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Notes To Unaudited Consolidated Financial Statements<BR>
For the six-months ended June 30, 2019 and 2018</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>NOTE
1 &ndash; ORGANIZATION AND BASIS OF PRESENTATION</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Trxade
Group, Inc. (&ldquo;we&rdquo;, &ldquo;our&rdquo;, &ldquo;Trxade&rdquo;, and the &ldquo;Company&rdquo;) owns 100% of
Trxade, Inc., Integra Pharma Solutions, LLC, Community Specialty Pharmacy, LLC and Alliance Pharma Solutions, LLC. The merger
of Trxade, Inc. and Trxade Group, Inc. occurred in May 2013. Community Specialty Pharmacy was acquired in October
2018.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Trxade,
Inc. operates a web-based market platform that enables commerce among healthcare buyers and sellers of pharmaceuticals, accessories
and services.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Integra
Pharma Solutions, LLC is a licensed pharmaceutical wholesaler and sells brand, generic and non-drug products.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Community
Specialty Pharmacy, LLC is an accredited independent retail pharmacy with a focus on specialty medications. The company operates
with innovative pharmacy model which offers home delivery services to any patient thereby providing convenience.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Alliance
Pharma Solutions, LLC has developed same day Pharma delivery software &ndash; Delivmeds.com and invested in SyncHealth MSO, LLC
a managed services organization during January 2019.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Basis
of Presentation</I> - The accompanying unaudited interim consolidated financial statements of Trxade Group, Inc. have been prepared
in accordance with accounting principles generally accepted in the United States of America and the rules of the Securities and
Exchange Commission and should be read in conjunction with the audited financial statements and notes thereto contained in the
Company&rsquo;s Form 10K.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
the opinion of management, all adjustments, consisting of normal recurring adjustments, necessary for a fair presentation of financial
position and the results of operations for the interim periods presented have been reflected herein. The results of operations
for the interim periods are not necessarily indicative of the results to be expected for the full year. Notes to the financial
statements that would substantially duplicate the disclosures contained in the audited financial statements for the year ended
December 31, 2018 as reported in the Company&rsquo;s Annual Report on Form 10K have been omitted.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Equity
Investments</I> &ndash; If the investments are less than 50% owned and more than 20% owned the entities use the equity method
of accounting in accordance with ASC 323-10 &ndash; Investments &ndash; Equity Method and Joint Ventures.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">The share of income (loss) of such entities is recorded as a single amount as share in equity income (loss)
of investments. Dividends, if any, are recorded as a reduction of the investment.&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Income
Per Common Share</I> &ndash; Basic net income per common share is computed by dividing net income available to common stockholders
by the weighted average number of common shares outstanding. Diluted net income per common share is computed similar to basic
net income per common share except that the denominator is increased to include the number of additional common shares that would
have been outstanding if the potential common shares had been issued and if the additional common shares were dilutive. The dilutive
effect of the Company&rsquo;s options and warrants is computed using the treasury stock method while the dilutive effect of our
convertible notes is computed using the if-converted method.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 86; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table sets forth the computation of basic and diluted Income per Share:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; text-align: center">&nbsp;</TD>
    <TD COLSPAN="6" STYLE="text-align: center; border-bottom: Black 1.5pt solid">For three months ended June 30,</TD><TD STYLE="padding-bottom: 1.5pt; text-align: center">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; text-align: center">&nbsp;</TD>
    <TD COLSPAN="6" STYLE="text-align: center; border-bottom: Black 1.5pt solid">For six months ended June 30,</TD><TD STYLE="padding-bottom: 1.5pt; text-align: center">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; text-align: center">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid">2019</TD><TD STYLE="padding-bottom: 1.5pt; text-align: center">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; text-align: center">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid">2018</TD><TD STYLE="padding-bottom: 1.5pt; text-align: center">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; text-align: center">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid">2019</TD><TD STYLE="padding-bottom: 1.5pt; text-align: center">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; text-align: center">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid">2018</TD><TD STYLE="padding-bottom: 1.5pt; text-align: center">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify">Numerator:</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="width: 40%; text-align: justify">Net Income</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 11%; text-align: right">57,981</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 11%; text-align: right">20,513</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 11%; text-align: right">183,210</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 11%; text-align: right">102,782</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Numerator for basic and diluted EPS - income available to common Shareholders</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">57,981</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">20,513</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">183,210</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">102,782</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify">Denominator:</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Denominator for basic EPS &ndash; Weighted average shares</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">33,726,489</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">31,985,827</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">33,546,329</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">31,985,827</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Dilutive Effect of Warrants, Options and Convertible Debt</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2,627,262</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2,493,579</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2,807,422</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2,486,984</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Denominator for diluted EPS &ndash; adjusted Weighted average shares and assumed Conversions</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">36,353,751</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">34,479,406</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">36,353,751</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">34,472,811</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Basic and Diluted income per common share</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">0.00</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">0.00</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">0.01</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">0.00</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
</TABLE>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Recent
Accounting Pronouncements </I>&ndash; The Company has implemented all new relevant accounting pronouncements that are in effect
through the date of these financial statements. The pronouncements did not have any material impact on the financial statements
unless otherwise disclosed, and the Company does not believe that there are any other new accounting pronouncements that have
been issued that might have a material impact on its consolidated financial position or results of operations.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Effective
January 1, 2019, the Company adopted ASU No. 2016-02, <I>Leases (Topic 842</I>) (&ldquo;ASU 2016-02&rdquo;) using the required
modified retrospective approach. The most significant changes under the new guidance include clarification of the definition of
a lease, and the requirements for lessees to recognize a Right of Use (&ldquo;ROU&rdquo;) asset and a lease liability for all
qualifying leases with terms longer than twelve months in the consolidated balance sheet. In addition, under Topic 842, additional
disclosures are required to meet the objective of enabling users of financial statements to assess the amount, timing and uncertainty
of cash flows arising from leases. See Footnote #7 below for more detail on the Company&rsquo;s accounting with respect to leases.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Effective
January 1, 2019, the Company adopted ASU No. 2018-07, Compensation &ndash; Stock Based Compensation (Topic 718): Improvements
to Nonemployee Share-Based Payment Accounting (&ldquo;ASU 2018-7&rdquo;), which aligns accounting for share-based payments issued
to nonemployees to that of employees under the existing guidance of Topic 718, with certain exceptions. This update supersedes
previous guidance for equity-based payments to nonemployees under Subtopic 505-50, Equity &ndash; Equity-Based Payments to Non-Employees.
The adoption of ASU 2018-07 did not have a material impact on the Company&rsquo;s consolidated financial statements.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>NOTE
2 &ndash; SHORT-TERM DEBT AND RELATED PARTIES DEBT</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Convertible
Promissory Note</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
February 2019, convertible promissory notes issued in 2015 for $181,500 were amended to a conversion price of $0.50 and the principal
and accrued interest total of $211,983 were then converted to 423,966 common shares.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of June 30, 2019 and December 31, 2018, short-tern convertible notes payable has a balance of $0 and $181,500 respectively, net
of $0 unamortized debt discount.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Related
Party Convertible Promissory Notes</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of June 30, 2019, $40,000 in convertible promissory notes were due to Mr. Shilpa Patel, a relative of Mr. Prashant Patel. Simple
interest of 10% is payable at the maturity date of the note, which is August 8, 2019. Prior to maturity the note may be converted
for common stock at a conversion price of $1.50.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 87; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of June 30, 2019, $100,000 in convertible promissory notes were due to Mr. Nitil Patel, the brother of Mr. Prashant Patel.
Simple interest of 10% is payable at the maturity date of the notes, which is July 7, 2019. Prior to maturity the notes may be
converted for common stock at a conversion price of $0.62. In July 2019, the note was extended to October 15, 2019.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>NOTE
3 &ndash; LONG TERM DEBT &ndash; RELATED PARTIES</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
October 2018 in connection with the acquisition of Community Specialty Pharmacy, LLC a $300,000 promissory note was issued to
Nikul Panchal, accruing interest at simple interest of 10%, interest payable annually, and principal payable at maturity in October
2021.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of June 30, 2019, $122,552 and $100,000 in promissory notes was due to Mr. Prashant Patel and Mr. Suren Ajjarapu, respectively.
The notes are due July 1, 2020 and each bear an interest rate of 6%.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>NOTE
4 &ndash; SHAREHOLDERS&rsquo; EQUITY</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
February 2019, convertible promissory notes issued in 2015 for $181,500 were amended to a conversion price of $0.50 and the principal
and accrued interest total of $211,983 were then converted to 423,966 common shares.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
February 2019, 16,666 of warrants issued in 2014 at $0.01 per share were exercised for 16,666 of common shares. $166 was received
in cash.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
April and May 2019, 505,000 options were granted with exercise prices ranging from $0.41 to $0.44 and a term of 10 years from
the grant date. The options vest over a period ranging from four to five years.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>NOTE
5 - WARRANTS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
the six-month period ended June 30, 2019, 16,666 warrants were exercised, See NOTE 4 &ndash; SHAREHOLDERS&rsquo; EQUITY, none
were granted or forfeited.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company&rsquo;s outstanding and exercisable warrants as of June 30, 2019 are presented below:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: justify">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Number</B></FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Outstanding</B></FONT></P></TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Weighted</B></FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Average</B></FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exercise Price</B></FONT></P></TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Contractual Life</B></FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>in Years</B></FONT></P></TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Intrinsic Value</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 44%; text-align: justify">Warrants Outstanding as of December 31, 2018</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 10%; text-align: right">2,880,141</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 10%; text-align: right">0.08</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 10%; text-align: right">3.74</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 10%; text-align: right">782,385</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify">Warrants granted</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify">Warrants forfeited</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify">Warrants exercised</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(16,666</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">0.01</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify">Warrants Outstanding as of June 30, 2019</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2,863,475</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">0.08</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">3.08</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">1,448,356</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>NOTE
6 &ndash; OPTIONS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company maintains a stock option plan under which certain employees are awarded option grants based on a combination of performance
and tenure. The stock option plan provides for the grant of up to 2,000,000 shares. All options may be exercised for a period
up to four 1/2 years following the grant date, after which they expire. Options are vested up to 5 years from the grant date.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
the six-month period ended June 30, 2019, 505,000 options were issued, none were forfeited or expired due to employee resignation.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 88; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company uses the Black-Sholes option pricing model to estimate the fair value of stock-based awards on the date of the grant.
The following table summarizes the assumptions used to estimate the fair value of the stock options granted during the quarter
ended June 30, 2019.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" ALIGN="CENTER" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: justify">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid">2019</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 78%; text-align: justify">Expected dividend yield</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: center">&nbsp;</TD><TD STYLE="width: 18%; text-align: center">0%</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify">Weighted-average expected volatility</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">209-250%</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify">Weighted-average risk-free interest rate</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.08-2.55%</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify">Expected life of options</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5-7 years</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total
compensation cost related to stock options was $99,990 and $88,072 for the six-months ended June 30, 2019 and 2018 respectively.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table represents stock option activity for the six-month period ended June 30, 2019:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Number</B></FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Outstanding</B></FONT></P></TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Weighted</B></FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Average</B></FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exercise Price</B></FONT></P></TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Contractual Life</B></FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>in Years</B></FONT></P></TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Intrinsic</B></FONT></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Value</B></FONT></P></TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 44%">Options Outstanding as of December 31, 2018</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 10%; text-align: right">1,732,846</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 10%; text-align: right">1.19</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 10%; text-align: right">6.98</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 10%; text-align: right">-</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>Options Exercisable as of December 31, 2018</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,107,259</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">0.96</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">5.91</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Options granted</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">505,000</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">0.43</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">9.86</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Options forfeited</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Options expired</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD>Options Outstanding as of June 30, 2019</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2,237,846</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">0.73</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">7.27</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">88,350</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>Options Exercisable as of June 30, 2019</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,239,384</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">0.91</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">5.77</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">8,809</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>NOTE
7 &ndash; LEASES</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company elected the practical expedient under ASU 2018-11 &ldquo;Leases: Targeted Improvements&rdquo; which allows the Company
to apply the transition provision for Topic 842 at the Company&rsquo;s adoption date instead of at the earliest comparative
period presented in the financial statements. Therefore, the Company recognized and measured leases existing at January 1, 2019
but without retrospective application. In addition, the Company elected the optional practical expedient permitted under the transition
guidance which allows the Company to carry forward the historical accounting treatment for existing leases upon adoption. No impact
was recorded to the beginning retained earnings for Topic 842. The Company has two operating leases for corporate offices. The
following table outlines the details:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid">Lease 1</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid">Lease 2</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Initial Lease Term</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 2017 to December 2021</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">November 2018 to November 2023</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Renewal Term</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">January 2021 to December 2024</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">November 2023 to November 2028</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 36%; text-align: left">Initial Recognition of Right to use assets at January 1, 2019</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 28%; text-align: right">534,140</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 28%; text-align: right">313,301</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Incremental Borrowing Rate</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">10</TD><TD STYLE="text-align: left">%</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">10</TD><TD STYLE="text-align: left">%</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 89; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
table below reconciles the fixed component of the undiscounted cash flows for each of the first five years and the total remaining
years to the operating lease liabilities recorded in the Consolidated Balance Sheet as of June 30, 2019</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" ALIGN="CENTER" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-weight: bold; text-align: justify; border-bottom: Black 1.5pt solid">Amounts due within twelve months of June 30</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: right">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 78%; text-align: justify">2019</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 18%; text-align: right">158,366</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify">2020</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">163,102</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify">2021</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">167,984</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify">2022</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">173,038</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify">2023</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">178,237</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify; padding-bottom: 1.5pt">Thereafter</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">305,012</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify">Total minimum lease payments</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,145,739</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify; padding-bottom: 1.5pt">Less: effect of discounting</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(334,574</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify">Present value of future minimum lease payments</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">811,165</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify; padding-bottom: 1.5pt">Less: current obligations under leases</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">80,832</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify; padding-bottom: 2.5pt">Long-term lease obligations</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">730,333</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
the three-months and six-months ended June 30, 2019 amortization of assets were $22,195 and $43,939, respectively.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
the three-months and six-months ended June 30, 2019, amortization of liabilities were $18,363 and 36,276, respectively.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>NOTE
8 &ndash; SEGMENT REPORTING</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company classifies its business interests into reportable segments which are Trxade, Community and Other.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" ALIGN="CENTER" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Six Months Ended June 30, 2019</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Trxade, Inc.</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Community Specialty Pharmacy, LLC</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Other</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Total</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 36%">Revenue</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 12%; text-align: right">2,182,668</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 12%; text-align: right">892,357</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 12%; text-align: right">353,910</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 12%; text-align: right">3,428,935</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Segment Assets</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">1,401,724</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">224,863</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">2,051,478</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">3,678,065</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Segment Profit/Loss</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">1,166,543</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">(61,628</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">(921,705</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">183,210</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company had no reportable segments for the six months ended June 30, 2018. See NOTE 9 &ndash; BUSINESS COMBINATION</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>NOTE
9 &ndash; BUSINESS COMBINATION</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
October 15, 2018, Trxade Group, Inc. (&ldquo;Company&rdquo;) entered into and consummated the purchase of 100% of the equity
interests of Community Specialty Pharmacy, LLC, a Florida limited liability company, (&ldquo;CSP&rdquo;), pursuant to the terms
and conditions of the Membership Interest Purchase Agreement, entered into by and among the Company as the buyer, and CSP, and
Nikul Panchal, the equity owner of CSP (collectively, the &ldquo;Seller&rdquo;). The purchase price for the 100% equity interest
in CSP was $300,000 in cash, a promissory note from the Company of $300,000 (see Note 3), and warrants to purchase 405,507 shares
of the Common Stock of the Company which vested at the acquisition date, are exercisable for eight (8) years from the issuance
date at a strike price of $0.01 per share, and subject to exercise restrictions which lapse over three (3) years.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company recorded the acquisition under ASC 805 &ldquo;Business Combination. All of the assets acquired and liabilities
assumed are recorded at their corresponding fair values. The excess of the purchase price over the net assets acquired
resulted in goodwill of $725,973. The following table is a summary of the allocation of the purchase price of $770,291
consisting of $300,000 in cash, a promissory note from the Company of $300,000, and the fair value of the warrants issued
calculated under the Black-Scholes calculation at $170,291.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" ALIGN="CENTER" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Purchase Price Allocation</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 78%">Purchase Price</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 18%; text-align: right">770,291</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>Cash</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(49,728</TD><TD STYLE="text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Accounts Receivable</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(114,899</TD><TD STYLE="text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>Inventory</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(76,156</TD><TD STYLE="text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD>Prepaid</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(3,000</TD><TD STYLE="text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Accounts Payable</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">199,312</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt">Accrued Expenses</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">153</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-bottom: 2.5pt">Goodwill</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">725,973</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 90; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
accompanying unaudited pro forma statements of operations presents the accounts of Trxade and CSP for the six- months ended June
30, 2018, assuming the acquisition occurred on January 1, 2018.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" ALIGN="CENTER" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-weight: bold; border-bottom: Black 1.5pt solid">2018 Summary Statement of Operations</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Trxade</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">CSP</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Combined</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: right">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: right">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: right">&nbsp;</TD><TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 55%; font-weight: bold">Revenue</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 11%; text-align: right">1,690,611</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 11%; text-align: right">1,323,117</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 11%; text-align: right">3,013,723</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold; text-align: left">Net Income</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">102,782</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">64,800</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">167,582</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold; text-align: left">Net Income per common share &ndash; basic</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">0.00</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">0.01</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold; text-align: left">Net Income per common share - diluted</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">0.00</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">0.00</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold">Weighted average common shares - basic</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">31,985,827</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">31,985,827</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold">Weighted average common shares - diluted</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">34,472,811</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">34,472,811</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
accompanying unaudited pro forma statements of operations presents the accounts of Trxade and CSP for the three- months ended
June 30, 2018, assuming the acquisition occurred on January 1, 2018.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" ALIGN="CENTER" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="font-weight: bold; border-bottom: Black 1.5pt solid">2018 Summary Statement of Operations</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Trxade</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">CSP</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Combined</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: right">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: right">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: right">&nbsp;</TD><TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 55%; font-weight: bold">Revenue</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 11%; text-align: right">837,688</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 11%; text-align: right">677,900</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 11%; text-align: right">1,515,588</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold; text-align: left">Net Income (Loss)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">20,513</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">(12,185</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">8,328</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold; text-align: left">Net Income per common share &ndash; basic</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">0.00</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">0.00</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold; text-align: left">Net Income per common share - diluted</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">0.00</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">0.00</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold">Weighted average common shares - basic</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">31,985,827</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">31,985,827</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold">Weighted average common shares - diluted</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">34,479,406</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">34,479,406</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>NOTE
10 &ndash; EQUITY METHOD INVESTMENT</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
January 2019, Trxade Group, Inc. through its wholly-owned subsidiary Alliance Pharma Solution, LLC (Alliance) entered into a transaction
to form SyncHealth MSO, LLC (&ldquo;SyncHealth&rdquo;). SyncHealth is owned by PanOptic Health, LLC (PanOptic) and Alliance. Alliance
contributed $250,000 for the acquisition of a 49% equity interest in SyncHealth and the option to acquire the remaining ownership
from PanOptic shareholders. Prior to March 31, 2019, $210,000 was paid with the remaining $40,000 paid in April 2019. Pursuant
to the operating agreement, PanOptic owns 70% of SyncHealth and Alliance owns 30%; however, pursuant to the Letter Agreement,
PanOptic will transfer to Alliance an additional 6% of SyncHealth&rsquo;s membership units on May 1, 2019, an additional 6% on
August 1, 2019 and an additional 7% on November 1, 2019 and at Alliance&rsquo;s option, the 51% balance on January 31, 2020, upon
transfer of Trxade Group, Inc. stock between 2,273,329 and 14,776,638 based on 2019 Gross Revenue Quotas.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
the three-months and six-months ended June 30, 2019, the Company recorded its equity share in the losses of SyncHealth amounting
to $58,850 and $87,822, respectively.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>NOTE
11 &ndash; SUBSEQUENT EVENTS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
July 10, 2019, the Company entered into a Securities Purchase Agreement with a certain accredited investor with respect
to the private placement of 2,000,000 share of its common stock at a purchase price of $0.50 per share, for gross proceeds of
$1,000,000.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT>&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On August 28, 2019, the Company entered
into a Consulting Agreement which included the grant of warrants to purchase 300,000 shares of Company stock at an exercise price
of $0.01 per share. 150,000 of the warrants are exercisable on April 1, 2020 and 150,000 are exercisable on April 1, 2021. The
warrants have a term of 5 years.</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
September 30, 2019, the Company entered into a Securities Purchase Agreement with certain accredited investors with respect
to the private placement of 2,910,000 shares of its common stock at a purchase price of $0.50 per share, for gross proceeds of
$1,455,000.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
September 30, 2019, the Company converted $175,000 of principal under various outstanding promissory notes (&ldquo;Promissory
Notes&rdquo;) into 350,000 shares common stock of the Company at $0.50 per share under the terms of the Securities Purchase Agreement
referenced above.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin: 0; text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
October 8, 2019, $122,552 and $100,000 in promissory notes due to Mr. Prashant Patel and Mr. Suren Ajjarapu, respectively, were
paid in full. The notes were due July 1, 2020.</FONT></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 91; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; text-align: center; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B><A NAME="f_06"></A>REPORT
OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM</B></FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
the Shareholders and Board of Directors of</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Trxade
Group, Inc.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">3840 Land O&rsquo; Lakes Boulevard</P>

<P STYLE="margin: 0">Land O&rsquo; Lakes, Florida 95662</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Opinion
on the Financial Statements</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have audited the accompanying consolidated balance sheets of Trxade Group, Inc., and its subsidiaries (collectively, the &ldquo;Company&rdquo;)
as of December 31, 2018 and 2017, and the related consolidated statements of operations, changes in shareholders&rsquo; equity
(deficit), and cash flows for the years then ended, and the related notes (collectively referred to as the &ldquo;financial statements&rdquo;).
In our opinion, the financial statements present fairly, in all material respects, the financial position of the Company as of
December 31, 2018 and 2017, and the results of their operations and their cash flows for the years then ended, in conformity with
accounting principles generally accepted in the United States of America.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Basis
for Opinion</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>&nbsp;</I></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">These
financial statements are the responsibility of the Company&rsquo;s management. Our responsibility is to express an opinion on
the Company&rsquo;s financial statements based on our audits. We are a public accounting firm registered with the Public Company
Accounting Oversight Board (United States) (&ldquo;PCAOB&rdquo;) and are required to be independent with respect to the Company
in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission
and the PCAOB.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit
to obtain reasonable assurance about whether the financial statements are free of material misstatement, whether due to error
or fraud. The Company is not required to have, nor were we engaged to perform, an audit of its internal control over financial
reporting. As part of our audits we are required to obtain an understanding of internal control over financial reporting but not
for the purpose of expressing an opinion on the effectiveness of the entity&rsquo;s internal control over financial reporting.
Accordingly, we express no such opinion.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
audits included performing procedures to assess the risks of material misstatement of the financial statements, whether due to
error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence
regarding the amounts and disclosures in the financial statements. Our audits also included evaluating the accounting principles
used and significant estimates made by management, as well as evaluating the overall presentation of the financial statements.
We believe that our audits provide a reasonable basis for our opinion.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>/s/
MaloneBailey, LLP</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>www.malonebailey.com</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have served as the Company&rsquo;s auditor since 2013.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Houston,
Texas</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">March
22, 2019</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>


<!-- Field: Page; Sequence: 92; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><A NAME="f_07"></A><FONT STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>Trxade
Group, Inc.</B></FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Consolidated
Balance Sheets</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>December
31, 2018 and 2017</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom; font-family: Times New Roman, Times, Serif">
    <TD STYLE="padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">December
    31, 2018</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">December
    31, 2017</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-weight: bold; text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Assets</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-weight: bold; text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Current
    Assets</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 60%; text-align: left; padding-left: 10pt; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cash</FONT></TD><TD STYLE="width: 2%; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="width: 16%; text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">869,557</FONT></TD><TD STYLE="width: 1%; text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="width: 2%; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="width: 16%; text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">183,914</FONT></TD><TD STYLE="width: 1%; text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; padding-left: 10pt; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accounts
    Receivable, net</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">433,627</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">319,467</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; padding-left: 10pt; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Inventory</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">79,966</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; padding-left: 10pt; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Prepaid
    Assets</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">82,927</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">102,095</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt; padding-left: 10pt; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other
    Assets</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,000</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; padding-left: 10pt; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total
    Current Assets</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,466,077</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">607,476</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-weight: bold; text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Property
    Plant and Equipment, Net</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">15,006</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-weight: bold; text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other
    Assets</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; padding-left: 10pt; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Deposits</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">20,531</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10,000</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt; padding-left: 10pt; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Goodwill</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">725,973</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-weight: bold; text-align: left; padding-bottom: 2.5pt; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total
    Assets</FONT></TD><TD STYLE="padding-bottom: 2.5pt; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,227,587</FONT></TD><TD STYLE="padding-bottom: 2.5pt; text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 2.5pt; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">617,476</FONT></TD><TD STYLE="padding-bottom: 2.5pt; text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-weight: bold; text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Liabilities
    and Shareholders&rsquo; Equity (Deficit)</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-weight: bold; text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Current
    Liabilities</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; padding-left: 10pt; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accounts
    Payable</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">400,544</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">106,084</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; padding-left: 10pt; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accrued
    Liabilities</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">138,323</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">156,961</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; padding-left: 10pt; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Short
    Term Notes Payable net of $0 and $152 discount</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10,587</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; padding-left: 10pt; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Short
    Term Convertible Notes Payable</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">181,500</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt; padding-left: 10pt; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Short
    term Convertible Notes Payable &ndash; Related Parties</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">140,000</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">251,725</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; padding-left: 10pt; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total
    Current Liabilities</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">860,367</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">525,357</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-weight: bold; text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Long
    Term Liabilities</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; padding-left: 10pt; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Convertible
    Notes Payable</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">181,500</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt; padding-left: 10pt; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Notes
    Payable &ndash; Related Parties</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">522,552</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">222,552</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-weight: bold; text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total
    Liabilities</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,382,919</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">929,409</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-weight: bold; text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Shareholders&rsquo;
    Equity (Deficit)</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; padding-left: 10pt; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Series
    A Preferred Stock, $0.00001 par value; 10,000,000 shares authorized; none issued and outstanding as of December 31, 2018 and
    December 31, 2017, respectively</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; padding-left: 10pt; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Common
    Stock, $0.00001 par value; 100,000,000 shares authorized; 33,285,827 and 31,985,827 shares issued and outstanding as of December
    31, 2018 and 2017, respectively</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">332</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">320</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; padding-left: 10pt; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Additional
    Paid-in Capital</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8,955,411</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7,807,860</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt; padding-left: 10pt; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Retained
    Deficit</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(8,111,075</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(8,120,113</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt; padding-left: 10pt; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total
    Shareholders&rsquo; Equity (Deficit)</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">844,668</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(311,933</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-weight: bold; text-align: left; padding-bottom: 2.5pt; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total
    Liabilities and Shareholders&rsquo; Equity (Deficit)</FONT></TD><TD STYLE="padding-bottom: 2.5pt; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,227,587</FONT></TD><TD STYLE="padding-bottom: 2.5pt; text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 2.5pt; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">617,476</FONT></TD><TD STYLE="padding-bottom: 2.5pt; text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-underline-style: double">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
accompanying notes are an integral part of the consolidated financial statements.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 93; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><A NAME="f_08"></A><FONT STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>Trxade
Group, Inc.</B></FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Consolidated
Statements of Operations</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Years
Ended December 31, 2018 and 2017</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2018</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2017</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 60%; font-weight: bold; text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Revenues,
    net</FONT></TD><TD STYLE="width: 2%; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="width: 16%; text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3,831,778</FONT></TD><TD STYLE="width: 1%; text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="width: 2%; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="width: 16%; text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,931,280</FONT></TD><TD STYLE="width: 1%; text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-weight: bold; text-align: justify; padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cost
    of Sales</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">449,049</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-weight: bold; text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Gross
    Profit</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3,382,729</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,931,280</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-weight: bold; text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Operating
    Expenses</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; padding-bottom: 1.5pt; padding-left: 10pt; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">General
    and Administrative</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3,470,345</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,536,185</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-weight: bold; text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Operating
    Income (Loss)</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(87,616</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">395,095</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; padding-left: 10pt; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other
    Income</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">161,639</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">67,500</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; padding-left: 10pt; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Loss
    on Extinguishment of Debt</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(7,444</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(16,556</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; padding-bottom: 1.5pt; padding-left: 10pt; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Interest
    Expense</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(57,541</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(157,056</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-weight: bold; text-align: justify; padding-bottom: 2.5pt; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net
    Income</FONT></TD><TD STYLE="padding-bottom: 2.5pt; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">9,038</FONT></TD><TD STYLE="padding-bottom: 2.5pt; text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 2.5pt; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">288,983</FONT></TD><TD STYLE="padding-bottom: 2.5pt; text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; padding-bottom: 2.5pt; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net
    Income per Common Share &ndash; Basic:</FONT></TD><TD STYLE="padding-bottom: 2.5pt; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.00</FONT></TD><TD STYLE="padding-bottom: 2.5pt; text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 2.5pt; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.01</FONT></TD><TD STYLE="padding-bottom: 2.5pt; text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; padding-bottom: 2.5pt; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net
    Income per Common Share &ndash; Diluted:</FONT></TD><TD STYLE="padding-bottom: 2.5pt; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.00</FONT></TD><TD STYLE="padding-bottom: 2.5pt; text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 2.5pt; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.01</FONT></TD><TD STYLE="padding-bottom: 2.5pt; text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Weighted
    average Common Shares Outstanding Basic</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">32,260,622</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">31,955,416</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Weighted
    average Common Shares Outstanding Diluted</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">34,958,502</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">34,086,251</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
accompanying notes are an integral part of the consolidated financial statements.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 94; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><A NAME="f_09"></A><FONT STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B>Trxade
Group, Inc.</B></FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Consolidated
Statements of Changes in Shareholders&rsquo; Equity (Deficit)</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Years
Ended December 31, 2018 and 2017</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: center; padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: center; padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="6" STYLE="text-align: center; border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Preferred
    Stock</FONT></TD><TD STYLE="text-align: center; padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: center; padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="6" STYLE="text-align: center; border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Common
    Stock</FONT></TD><TD STYLE="text-align: center; padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: center; padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: center; padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif"><P STYLE="margin-top: 0pt; margin-bottom: 0pt; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Additional</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif"><BR></FONT></P>
                                                                      <P STYLE="margin-top: 0pt; margin-bottom: 0pt; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Paid-in-</FONT></P></TD><TD STYLE="text-align: center; padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: center; padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: center; padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accumulated</FONT></TD><TD STYLE="text-align: center; padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: center; padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: center; padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif"><BR>
    <FONT STYLE="font-size: 10pt">Shareholders&rsquo;</FONT><BR>
    <FONT STYLE="font-size: 10pt">Equity</FONT></FONT></TD><TD STYLE="text-align: center; padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: center; padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif"></TD><TD STYLE="text-align: center; padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Shares</FONT></TD><TD STYLE="text-align: center; padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: center; padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Amount</FONT></TD><TD STYLE="text-align: center; padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: center; padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Shares</FONT></TD><TD STYLE="text-align: center; padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: center; padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Amount</FONT></TD><TD STYLE="text-align: center; padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: center; padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Capital</FONT></TD><TD STYLE="text-align: center; padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: center; padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Deficit</FONT></TD><TD STYLE="text-align: center; padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: center; padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Deficit)</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 44%; text-align: left; padding-bottom: 2.5pt; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Balance
    at December 31, 2016</FONT></TD><TD STYLE="width: 1%; padding-bottom: 2.5pt; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left; border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="width: 5%; text-align: right; border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD><TD STYLE="width: 1%; text-align: left; padding-bottom: 2.5pt; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="width: 1%; padding-bottom: 2.5pt; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left; border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="width: 5%; text-align: right; border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD><TD STYLE="width: 1%; text-align: left; padding-bottom: 2.5pt; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="width: 1%; padding-bottom: 2.5pt; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left; border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="width: 5%; text-align: right; border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">31,660,827</FONT></TD><TD STYLE="width: 1%; text-align: left; padding-bottom: 2.5pt; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="width: 1%; padding-bottom: 2.5pt; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left; border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="width: 5%; text-align: right; border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">316</FONT></TD><TD STYLE="width: 1%; text-align: left; padding-bottom: 2.5pt; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="width: 1%; padding-bottom: 2.5pt; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left; border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="width: 5%; text-align: right; border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7,260,723</FONT></TD><TD STYLE="width: 1%; text-align: left; padding-bottom: 2.5pt; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="width: 1%; padding-bottom: 2.5pt; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left; border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="width: 5%; text-align: right; border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(8,409,096</FONT></TD><TD STYLE="width: 1%; text-align: left; padding-bottom: 2.5pt; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</FONT></TD><TD STYLE="width: 1%; padding-bottom: 2.5pt; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left; border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="width: 5%; text-align: right; border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1,148,057</FONT></TD><TD STYLE="width: 1%; text-align: left; padding-bottom: 2.5pt; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Common
    Stock Issued for Cash</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">250,000</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">249,997</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">250,000</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Common
    Stock Issued for Services</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">50,000</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">12,499</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">12,500</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Warrants
    Issued for debt Amendment</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">16,556</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">16,556</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Warrants
    Exercised</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">25,000</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">250</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">250</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Options
    Expense</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">267,835</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">267,835</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net
    Income</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD><TD STYLE="text-align: left; padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD><TD STYLE="text-align: left; padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD><TD STYLE="text-align: left; padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD><TD STYLE="text-align: left; padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD><TD STYLE="text-align: left; padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">288,983</FONT></TD><TD STYLE="text-align: left; padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">288,983</FONT></TD><TD STYLE="text-align: left; padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; padding-bottom: 2.5pt; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">December
    31, 2017</FONT></TD><TD STYLE="padding-bottom: 2.5pt; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD><TD STYLE="text-align: left; padding-bottom: 2.5pt; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 2.5pt; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="text-align: right; border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD><TD STYLE="text-align: left; padding-bottom: 2.5pt; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 2.5pt; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">31,985,827</FONT></TD><TD STYLE="text-align: left; padding-bottom: 2.5pt; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 2.5pt; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="text-align: right; border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">320</FONT></TD><TD STYLE="text-align: left; padding-bottom: 2.5pt; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 2.5pt; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="text-align: right; border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7,807,860</FONT></TD><TD STYLE="text-align: left; padding-bottom: 2.5pt; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 2.5pt; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="text-align: right; border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(8,120,113</FONT></TD><TD STYLE="text-align: left; padding-bottom: 2.5pt; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</FONT></TD><TD STYLE="padding-bottom: 2.5pt; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="text-align: right; border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(311,933</FONT></TD><TD STYLE="text-align: left; padding-bottom: 2.5pt; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Common
    Stock Issued for Cash</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,300,000</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">12</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">799,988</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">800,000</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Warrants
    Issued for debt Amendment</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7,444</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7,444</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Warrants
    for Acquisition of Community Specialty Pharmacy, LLC</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">170,291</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">170,291</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Options
    Expense</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">169,828</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">169,828</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net
    Income</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD><TD STYLE="text-align: left; padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD><TD STYLE="text-align: left; padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD><TD STYLE="text-align: left; padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD><TD STYLE="text-align: left; padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD><TD STYLE="text-align: left; padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">9,038</FONT></TD><TD STYLE="text-align: left; padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">9,038</FONT></TD><TD STYLE="text-align: left; padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; padding-bottom: 2.5pt; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">December
    31, 2018</FONT></TD><TD STYLE="padding-bottom: 2.5pt; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD><TD STYLE="text-align: left; padding-bottom: 2.5pt; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 2.5pt; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="text-align: right; border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD><TD STYLE="text-align: left; padding-bottom: 2.5pt; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 2.5pt; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;33,285,827</FONT></TD><TD STYLE="text-align: left; padding-bottom: 2.5pt; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 2.5pt; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="text-align: right; border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">332</FONT></TD><TD STYLE="text-align: left; padding-bottom: 2.5pt; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 2.5pt; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="text-align: right; border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8,955,411</FONT></TD><TD STYLE="text-align: left; padding-bottom: 2.5pt; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 2.5pt; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="text-align: right; border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(8,111,075</FONT></TD><TD STYLE="text-align: left; padding-bottom: 2.5pt; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</FONT></TD><TD STYLE="padding-bottom: 2.5pt; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="text-align: right; border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">844,668</FONT></TD><TD STYLE="text-align: left; padding-bottom: 2.5pt; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
</TABLE>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
accompanying notes are an integral part of the consolidated financial statements.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 95; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B><A NAME="f_10"></A>Trxade
Group, Inc.</B></FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Consolidated
Statements of Cash Flows</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Years
ended December 31, 2018 and 2017</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2018</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2017</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-weight: bold; text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Operating
    Activities:</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 60%; text-align: left; padding-left: 10pt; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net
    Income</FONT></TD><TD STYLE="width: 2%; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="width: 16%; text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">9,038</FONT></TD><TD STYLE="width: 1%; text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="width: 2%; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="width: 16%; text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">288,983</FONT></TD><TD STYLE="width: 1%; text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; padding-left: 10pt; font-family: Times New Roman, Times, Serif"><P STYLE="margin: 0; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">Adjustments
                                         to reconcile net income to net cash provided by operating activities:</FONT></P>


</TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; padding-left: 20pt; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Stock
    Issued for Services</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">12,500</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; padding-left: 20pt; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Options
    expense</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">169,828</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">267,835</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; padding-left: 20pt; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Bad
    Debt Expense</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,271</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; padding-left: 20pt; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Loss
    on debt extinguishment</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7,444</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">16,556</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; padding-left: 20pt; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Amortization
    of Debt Discount</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">152</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">88,647</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; padding-left: 10pt; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Changes
    in operating assets and liabilities:</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; padding-left: 20pt; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accounts
    Receivable</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1,532</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(20,354</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; padding-left: 20pt; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Prepaid
    Assets and Other Assets</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">13,637</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(90,763</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; padding-left: 20pt; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Inventory</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3,810</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; padding-left: 20pt; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accounts
    Payable</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">95,149</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(98,213</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt; padding-left: 20pt; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accrued
    Liabilities and Other Liabilities</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(18,791</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(293,521</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; padding-left: 10pt; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net
    Cash provided by operating activities</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">273,386</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">171,670</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-weight: bold; text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Investing
    Activities:</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; padding-left: 10pt; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Purchase
    of Fixed Assets</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(15,006</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt; padding-left: 10pt; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cash
    paid for acquisition of Community Specialty Pharmacy, LLC, net of cash received</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(250,273</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net
    Cash Used in Investing Activities</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(265,279</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-weight: bold; text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Financing
    Activities:</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; padding-left: 10pt; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Repayments
    of Promissory Note &ndash; Third Parties</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(10,739</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(432,685</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; padding-left: 10pt; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Repayments
    of Short-Term Debt &ndash; Related Parties</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(111,725</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; padding-left: 10pt; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Proceeds
    from Convertible Note &ndash; Related Parties</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">180,000</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; padding-left: 10pt; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Proceeds
    from exercise of Warrants</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">250</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt; padding-left: 10pt; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Proceeds
    from Issuance of Common Stock</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">800,000</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">250,000</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt; padding-left: 10pt; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net
    Cash provided by financing activities</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">6</FONT></FONT><FONT STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">77,536</FONT></FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2,435</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net
    increase in Cash</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">685,643</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">169,235</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cash
    at Beginning of the Year</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">183,914</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">14,679</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; padding-bottom: 2.5pt; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cash
    at End of the Year</FONT></TD><TD STYLE="padding-bottom: 2.5pt; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">869,557</FONT></TD><TD STYLE="padding-bottom: 2.5pt; text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 2.5pt; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">183,914</FONT></TD><TD STYLE="padding-bottom: 2.5pt; text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-weight: bold; text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Supplemental
    Cash Flow Information</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cash
    Paid for Interest</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">36,970</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">71,210</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cash
    Paid for Income Taxes</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-weight: bold; text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Non-Cash
    Transactions</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><P STYLE="margin: 0; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">Related
                                         party note payable and warrants issued for acquisition of Community Specialty
                                         Pharmacy, LLC</FONT></P>


</TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">470,921</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Reclass
    from accrued interest to short term convertible notes</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">16,500</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Arrangement
    to move related party Accounts Payable to Notes Payable</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">32,552</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
</TABLE>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
accompanying notes are an integral part of the consolidated financial statements.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>


<!-- Field: Page; Sequence: 96; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt"><B><A NAME="f_11"></A>Trxade
Group, Inc.</B></FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Notes
to Consolidated Financial Statements</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>For
the years ended December 31, 2018 and 2017</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>NOTE
1 &ndash; ORGANIZATION</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Trxade
Group, Inc. (&ldquo;we&rdquo;, &ldquo;our&rdquo;, &ldquo;Trxade&rdquo;, and the &ldquo;Company&rdquo;) owns 100% of
Trxade, Inc., Integra Pharma Solutions, LLC, Community Specialty Pharmacy, LLC and Alliance Pharma Solutions, LLC. The merger
of Trxade, Inc. and Trxade Group, Inc. occurred in May 2013. Community Specialty Pharmacy was acquired October
2018.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Trxade,
Inc. operates a web-based market platform that enables commerce among healthcare buyers and sellers of pharmaceuticals, accessories
and services.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Integra
Pharma Solutions, LLC is a licensed pharmaceutical wholesaler and sells brand, generic and non-drug products.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Community
Specialty Pharmacy, LLC is an accredited independent retail pharmacy with a focus on specialty medications. The company operates
with innovative pharmacy model which offers home delivery services to any patient thereby providing convenience.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif">Alliance
Pharma Solutions, LLC has developed same day Pharma delivery software &ndash; Delivmeds.com and invested in SyncHealth MSO, LLC
a managed services organization in January 2019. (See Note 13).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>NOTE
2 &ndash; SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The accompanying financial statements
have been prepared in accordance with accounting principles generally accepted in the United States of America (&ldquo;GAAP&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
summary of significant accounting policies presented below is designed to assist in understanding the Company&rsquo;s financial
statements. Such financial statements and accompanying notes are the representations of the Company&rsquo;s management, who are
responsible for their integrity and objectivity. These accounting policies conform to accounting principles generally accepted
in the United States of America (&ldquo;GAAP&rdquo;) in all material respects, and have been consistently applied in preparing
the accompanying financial statements.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Basis
of Presentation &ndash; Historically, operations have been funded primarily through the sale of equity or debt securities and
operating activities. In 2018, the Company renewed outstanding debt (See Note 3 and 4), raised capital (See Note 5) and
had positive operating cash flow from operations. The Company has the ability to maintain the current level of spending or reduce
expenditures to maintain operations if funding is not available.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Use
of Estimates &ndash; In preparing these financial statements, management is required to make estimates and assumptions that effect
the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities as of the date of the financial
statements and the reported amount of revenues and expenses during the reporting periods. Actual results could differ from those
estimates.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Reclassification
&ndash; Certain prior year amounts have been reclassified to conform to the current year presentation.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Principle
of Consolidation &ndash; The Company&rsquo;s consolidated financial statements include the accounts of Trxade Group, Inc., Trxade,
Inc., Integra Pharma Solutions, Inc., Alliance Pharma Solutions, LLC and Community Specialty Pharmacy, LLC. All significant intercompany
accounts and transactions have been eliminated.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cash
and Cash Equivalents &ndash; Cash in bank accounts are at risk to the extent that they exceed U.S. Federal Deposit Insurance Corporation
insured amounts. All investments purchased with a maturity of three months or less are cash equivalents. Cash and cash equivalents
are available on demand and are generally within of FDIC insurance limits for 2018.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 97; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accounts
Receivable &ndash; The Company&rsquo;s receivables are from customers and are collected within 90 days. The Company determines
the allowance based on known troubled accounts, historical experience, and other currently available evidence. During the years
ended December 31, 2018 and 2017, $2,271 of bad debt expense and $0 of recovery of bad debt was recognized, respectively.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Inventory
&ndash; Inventories are stated at the lower of cost or net realizable value. Cost is determined on a weighted average basis. On
a quarterly basis, we analyze our inventory levels and no reserve is maintained as obsolete or expired inventories are written
off. There is no reserve for inventory obsolescence during the periods presented. </FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Beneficial
Conversion Features &ndash; The intrinsic value of a beneficial conversion feature inherent to a convertible note payable, which
is not bifurcated and accounted for separately from the convertible note payable and may not be settled in cash upon conversion,
is treated as a discount to the convertible note payable. This discount is amortized over the period from the date of issuance
to the date the note is due using the effective interest method. If the note payable is retired prior to the end of its contractual
term, the unamortized discount is expensed in the period of retirement to interest expense. In general, the beneficial conversion
feature is measured by comparing the effective conversion price, after considering the relative value of detachable instruments
included in the financing transaction, if any, to the fair value of the common shares at the commitment date to be received upon
conversion.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Derivative
financial instruments &ndash; The Company evaluates its financial instruments to determine if such instruments are derivatives
or contain features that qualify as embedded derivatives. For derivative financial instruments that are accounted for as liabilities,
the derivative instrument is initially recorded at its fair value and is then re-valued at each reporting date, with changes in
the fair value reported in the statements of operations. For stock-based derivative financial instruments, the Company uses a
Black-Scholes option pricing model, assuming maximum value, in accordance with ASC 815-15 &ldquo;Derivative and Hedging&rdquo;
to value the derivative instruments at inception and on subsequent valuation dates. The classification of derivative instruments,
including whether such instruments should be recorded as liabilities or as equity, is evaluated at the end of each reporting period.
Derivative instrument liabilities are classified in the balance sheet as current or non-current based on whether or not net-cash
settlement of the derivative instrument could be required within 12 months of the balance sheet date.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fair
Value of Financial Instruments &ndash; The Company measures its financial assets and liabilities in accordance with the requirements
of FASB ASC 820, &ldquo;Fair Value Measurements and Disclosures&rdquo;. ASC 820 clarifies the definition of fair value, prescribes
methods for measuring fair value, and establishes a fair value hierarchy to classify the inputs used in measuring fair value as
follows:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level
1 &ndash; Quoted prices are available in active markets for identical assets or liabilities as of the reporting date. Active markets
are those in which transactions for the asset or liability occur in sufficient frequency and volume to provide pricing information
on an ongoing basis. Level 1 primarily consists of financial instruments such as exchange-traded derivatives, marketable securities
and listed equities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level
2 &ndash; Pricing inputs are other than quoted prices in active markets included in level 1, which are either directly or indirectly
observable as of the reported date and includes those financial instruments that are valued using models or other valuation methodologies.
These models are primarily industry-standard models that consider various assumptions, including quoted forward prices for commodities,
time value, volatility factors, and current market and contractual prices for the underlying instruments, as well as other relevant
economic measures. Substantially all of these assumptions are observable in the marketplace throughout the full term of the instrument,
can be derived from observable data or are supported by observable levels at which transactions are executed in the marketplace.
Instruments in this category generally include non-exchange-traded derivatives such as commodity swaps, interest rate swaps, options
and collars.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 98; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level
3 &ndash; Pricing inputs include significant inputs that are generally less observable from objective sources. These inputs may
be used with internally developed methodologies that result in management&rsquo;s best estimate of fair value.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company does not have any assets or liabilities that are required to be measured and recorded at fair value on a recurring basis.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
carrying amounts of cash, accounts receivable, accounts payable, accrued liabilities and short-term debt approximate fair value
because of the short-term nature of these instruments. The carrying amount of long-term debt approximates fair value because the
debt is based on current rates at which the Company could borrow funds with similar maturities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Goodwill
&ndash; The Company accounts for goodwill and intangible assets in accordance with ASC 350 &ldquo;Intangibles Goodwill and Other&rdquo;.
ASC 350 requires that goodwill and other intangibles with indefinite lives be tested for impairment annually or on an interim
basis if events or circumstances indicate that the fair value of an asset has decreased below its carrying value. The Company
performed impairment analysis using the qualitative analysis under ASC 350-20 and noted no impairment issues for 2018.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Revenue
Recognition &ndash; In May 2014, the Financial Accounting Standards Board (FASB) issued Accounting Standards Update No. 2014-09
(Topic 606) &ldquo;Revenue from Contracts with Customers.&rdquo; Topic 606 supersedes the revenue recognition requirements in
Accounting Standards Codification Topic 605, &ldquo;Revenue Recognition&rdquo;, and requires entities to recognize revenue when
they transfer control of promised goods or services to customers in an amount that reflects the consideration to which the entity
expects to be entitled to in exchange for those goods or services. The Company adopted ASU 2014-09 using the modified retrospective
approach effective January 1, 2018, under which prior periods were not retrospectively adjusted. The adoption of Topic 606 does
not have a material impact to our consolidated financial statements, including the presentation of revenues in our Consolidated
Statements of Operations.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Trxade,
Inc. provides an online website service, a buying and selling marketplace for licensed Pharmaceutical Wholesalers to sell products
and services to licensed Pharmacies. The Company charges Suppliers a transaction fee, a percentage of the purchase price of the
Prescription Drugs and other products sold through its website service. The fulfillment of confirmed orders, including delivery
and shipment of Prescription Drugs and other products, is the responsibility of the Supplier and not of the Company. The Company
holds no inventory and assumes no responsibility for the shipment or delivery of any products or services from our website. The
Company considers itself an agent for this revenue stream and as such, reports revenue as net. Step One: Identify the contract
with the customer &ndash; Trxade, Inc.&rsquo;s Terms and Use Agreement is acknowledged between the Wholesaler and Trxade, Inc.
which outlines the terms and conditions. The collection is probable based on the credit evaluation of the Wholesaler. Step Two:
Identify the performance obligations in the contract &ndash; The Company provides to the Supplier access to the online website,
uploading of catalogs of products and Dashboard access to review status of inventory posted and processed orders. The Agreement
requires the supplier to provide a catalog of pharmaceuticals for posting on the platform, deliver the pharmaceuticals and upon
shipment remit the stated platform fee. Step Three: Determine the transaction price &ndash; The Fee Agreement outlines the fee
based on the type of product, generic, brand or non-drug. There are no discounts for volume of transactions or early payment of
invoices. Step Four: Allocate the transaction price &ndash; The Fee Agreement outlines the fee. There is no difference between
contract price and &ldquo;stand-alone selling price&rdquo;. Step Five: Recognize revenue when or as the entity satisfies a performance
obligation &ndash; Revenue is recognized the day the order has been processed by the Supplier.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Integra
Pharma Solutions, LLC is a licensed wholesaler and sells to licensed pharmacies brand, generic and non-drug products. The Company
takes orders for product and creates invoices for each order and recognizes revenue at the time the Customer receives the product.
Customer returns are not material. Step One: Identify the contract with the customer &ndash; The Company requires that an application
and a credit card for payment is completed by the Customer prior to the first order. Each transaction is evidenced by an order
form sent by the customer and an invoice for the product is sent by the Company. The collection is probable based on the application
and credit card information provided prior to the first order. Step Two: Identify the performance obligations in the contract
&ndash; Each order is distinct and evidenced by the shipping order and invoice. Step Three: Determine the transaction price &ndash;
The consideration is variable if product is returned. The variability is determined based on the return policy of the product
manufacturer. There are no sales or volume discounts. The transaction price is determined at the time of the order evidenced by
the invoice. Step Four: Allocate the transaction price &ndash; There is no difference between contract price and &ldquo;stand-alone
selling price&rdquo;. Step Five: Recognize revenue when or as the entity satisfies a performance obligation - The Revenue is recognized
when the Customer receives the product.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 99; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Community
Specialty Pharmacy, LLC is in the retail pharmacy business. The Company fills prescriptions for drugs written by a doctor and
recognizes revenue at the time the patient confirms delivery of the prescription. Customer returns are not material. Step One:
Identify the contract with the customer &ndash; The prescription is written by a doctor for a Customer and delivered to the Company.
The prescription identifies the performance obligations in the contract. The Company fills the prescription and delivers to the
Customer the prescription, fulfilling the contract. The collection is probable because there is confirmation that the customer
has insurance for the reimbursement to the Company prior to filling of the prescription. Step Two: Identify the performance obligations
in the contract &ndash; Each prescription is distinct to the Customer. Step Three: Determine the transaction price &ndash; The
consideration is not variable. The transaction price is determined to be the price of the prescription at the time of delivery
which considers the expected reimbursements from third party payors (e.g., pharmacy benefit managers, insurance companies and
government agencies). Step Four: Allocate the transaction price &ndash; The price of the prescription invoiced represents the
expected amount of reimbursement from third party payors. There is no difference between contract price and &ldquo;stand-alone
selling price&rdquo;. Step Five: Recognize revenue when or as the entity satisfies a performance obligation &ndash; Revenue is
recognized upon the delivery of the prescription.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="margin: 0; text-align: justify">Cost of Goods Sold &ndash; The company recognized cost of goods sold in 2018 from activities in Integra
Pharma Solutions, LLC and Community Specialty Pharmacy, LLC, which were not active in 2017.</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Stock-Based
Compensation &ndash; The Company accounts for stock-based compensation to non-employees in accordance with the provision of ASC
505, &ldquo;Equity Based Payments to Non-Employees&rdquo; (&ldquo;ASC 505&rdquo;), which requires that such equity instruments
are recorded at their fair value on the measurement date. The measurement of stock-based compensation is subject to periodic adjustment
as the underlying instruments vest.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company accounts for stock-based compensation to employees in accordance with ASC 718, &ldquo;Compensation-Stock Compensation&rdquo;.
ASC 718 requires companies to measure the cost of employee services received in exchange for an award of equity instruments, including
stock options, based on the grant date fair value of the award and to recognize it as compensation expense over the period the
employee is required to provide service in exchange for the award, usually the vesting period. Stock option forfeitures are recognized
at the date of employee termination.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Income
Taxes &ndash; The Company accounts for income taxes utilizing ASC 740, &ldquo;Income Taxes&rdquo; (SFAS No. 109). ASC 740 requires
the measurement of deferred tax assets for deductible temporary differences and operating loss carry forwards, and of deferred
tax liabilities for taxable temporary differences. Measurement of current and deferred tax liabilities and assets is based on
provisions of enacted tax law. The effects of future changes in tax rates are not included in the measurement. The Company recognizes
the amount of taxes payable or refundable for the current year and recognizes deferred tax liabilities and assets for the expected
future tax consequences of events and transactions that have been recognized in the Company&rsquo;s financial statements or tax
returns. The Company currently has substantial net operating loss carry forwards. The Company has recorded a 100% valuation allowance
against net deferred tax assets due to uncertainty of their ultimate realization. Valuation allowances are established when necessary
to reduce deferred tax assets to the amount expected to be realized. Tax years from 2015 forward are open to examination
by the Internal Revenue Service.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Income
(loss) Per Share &ndash; Basic net income (loss) per common share is computed by dividing net loss available to Common Stockholders
by the weighted average number of common shares outstanding. Diluted net loss per common share is computed similar to basic net
loss per common share except that the denominator is increased to include the number of additional common shares that would have
been outstanding if the potential common shares had been issued and if the additional common shares were dilutive. The treasury
stock method and as if converted methods are used to determine the dilutive shares for our options and warrants and convertible
notes, respectively.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 100; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">The
following table sets forth the computation of basic and diluted income per common share for the years ended December 31, 2018
and 2017:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom; font-family: Times New Roman, Times, Serif">
    <TD STYLE="padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: black 1.5pt solid; text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">December
    31, 2018</FONT></TD>
    <TD STYLE="padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: black 1.5pt solid; text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">December
    31, 2017</FONT></TD>
    <TD STYLE="padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Numerator:</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 60%; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net
    Income</FONT></TD>
    <TD STYLE="width: 2%; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD>
    <TD STYLE="width: 16%; text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">9,038</FONT></TD>
    <TD STYLE="width: 1%; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 2%; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD>
    <TD STYLE="width: 16%; text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">288,983</FONT></TD>
    <TD STYLE="width: 1%; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Numerator
    for basic and diluted income available to common shareholders</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD>
    <TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">9,038</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD>
    <TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">288,983</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Denominator:</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Denominator
    for basic income per common share &ndash; Weighted average common shares outstanding</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">32,260,622</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">31,955,416</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dilutive
    effect of Common Stock Equivalents</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,697,880</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,130,835</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Denominator
    for diluted income per common share &ndash; adjusted weighted average common shares outstanding</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">34,958,502</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">34,086,251</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Basic
    and Diluted income per common share</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD>
    <TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.00</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD>
    <TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.01</FONT></TD>
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Concentration
of Credit Risks and Major Customers - Financial instruments that potentially subject the company to credit risk consist principally
of cash and cash equivalents and receivables. The Company places its cash and cash equivalents with financial institutions. Deposits
are insured to Federal Deposit Insurance Corp limits. During the years ended December 31, 2018 and 2017, sales to
two customers each represent greater than 10% of revenue.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Recent
Accounting Pronouncements &ndash; The Company has implemented all new relevant accounting pronouncements that are in effect through
the date of these financial statements. The pronouncements did not have any material impact on the financial statements unless
otherwise disclosed, and the Company does not believe that there are any other new accounting pronouncements that have been issued
that might have a material impact on its consolidated financial position or results of operations.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
February 2016, the FASB issued ASU 2016-02, Leases, which will amend current lease accounting to require lessees to recognize
(i) a lease liability, which is a lessee&rsquo;s obligation to make lease payments arising from a lease, measured on a discounted
basis, and (ii) a right-of-use asset, which is an asset that represents the lessee&rsquo;s right to use, or control the use of,
a specified asset for the lease term. ASU 2016-02 does not significantly change lease accounting requirements applicable to lessors;
however, certain changes were made to align, where necessary, lessor accounting with the lessee accounting model. This standard
will be effective for fiscal years beginning after December 15, 2018, including interim periods within those fiscal years. The
Company adopted the provisions of this ASU at January 1, 2019.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>NOTE
3 &ndash; SHORT-TERM DEBT AND RELATED PARTIES DEBT</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Convertible
Promissory Note</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Convertible
promissory notes were issued in the aggregate amount of $200,000 in April and May 2015. The term of the notes was one year. Simple
interest of 10% was payable at the maturity date of the note. Prior to maturity the notes may be converted for Common Stock at
a conversion price of $1.50. The holders of the notes were granted warrants at one share of Common Stock for every $4.00 of the
note principal amount, which totaled a warrant to purchase 50,000 shares of Common Stock. These warrants were issued at a strike
price of $1.50 and an expiration date of five years from date of issuance. The Company used the Black-Scholes pricing model to
estimate the fair value of the warrants issued along with convertible notes on the date of grant. The Company accounted for the
relative fair value of the warrants issued and a total debt discount $53,546 was recorded.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 101; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence --></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
April and May 2016, $50,000 of the $200,000 in convertible promissory notes (plus $5,000 in interest) was repaid. A one-year extension
was executed on the remaining notes and the interest owed, totaling $15,000 became part of the adjusted principal of notes and
the balance of $165,000 is due May 2017. In connection with the one-year extension of the maturity date of the outstanding notes,
the holders of the notes were granted warrants at one Common Stock for $4.00 of the note amount and warrants to purchase 41,250
shares of Common Stock were issued at a strike price of $1.50 and an expiration date of five years from date of issuance. The
amendment of the note was considered a debt extinguishment and a loss on extinguishment of debt was booked in the amount of $37,579.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
April 2017, $165,000 in convertible promissory notes (plus $5,500 in interest) was amended. A two-year extension was executed
on the remaining notes and the interest owed, totaling $16,500 became part of the adjusted principal of the notes and the balance
of $181,500 is due May 2019. The conversion price was adjusted to $0.85 per share. In connection with the two-year extension of
the maturity date of the outstanding notes, the holders of the notes were granted warrants to purchase 18,150 shares of Common
Stock that was issued at a strike price of $0.65 and an expiration date of five years from date of issuance. The amendment of
the note was considered a debt extinguishment and a loss on extinguishment of debt was booked in the amount of $11,512.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company evaluated the embedded conversion feature within the above convertible notes under ASC 815-15 and ASC 815-40 and determined
that the embedded conversion feature does not meet the definition of a derivative liability. Then the Company evaluated the conversion
feature for a beneficial conversion feature at inception. The Company accounted for the intrinsic value of a Beneficial Conversion
Feature inherent to the convertible note payable the conversion was not beneficial and a total debt discount from the issued warrants
of $53,546 was recorded in 2015 and $0 as of the date of the debt modification.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin: 0; text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
2017, debt discount of $0 was amortized. As of December 31, 2018 and 2017, short-tern convertible note has a balance of $181,500
and $0 respectively, net of $0 unamortized debt discount.</FONT></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Promissory
Note</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
May 2016, a promissory note that was issued in May 2015 was renewed in the face amount of $250,000 and the term was extended an
additional year. The note has an original issuance discount of $45,000 and this amount was paid in cash at the renewal. During
2016, a debt discount of $45,000 was amortized. As of December 31, 2016, the promissory note has a balance of $250,000 with an
unamortized debt discount of $15,000.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
2017 the debt discount of $15,000 was fully amortized and the balance of $250,000 was paid.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
October 2016, a promissory note was issued in the face amount of $47,000. The term of the note was one year. Payments are made
daily and $3,917 of principal was paid in 2016. At December 31, 2016 the balance was $43,083.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
2017 $43,083 of principal was paid and at December 31, 2017 the balance was $0.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
September 2016, a promissory note was issued for $189,000. The term of the note is 494 days. The debt discount was $39,000 thus
the initial net proceeds were $150,000. At December 31, 2016, $139,602 was classified as short term with a discount of $25,306
and $10,739 was classified as long term with a discount of $152. Payments are made each weekday in the amount of $537. In 2017,
$139,602 was paid off by cash and debt discount of $25,306 was amortized.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of December 31, 2017, short term promissory notes have a balance of $10,739, net of $152 unamortized debt discount.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">In
2018, $10,739 was paid off by cash and the debt discount of $152 was amortized.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 102; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence --></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of December 31, 2018, short term promissory notes have a balance of $0, net of $0 unamortized debt discount.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Related
Party Convertible Promissory Notes</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
August 2016, $40,000 in promissory notes were issued to Mr. Shilpa Patel, a relative of Mr. Prashant Patel. The term of the note
was one year. Simple interest of 10% is payable at the maturity date of the note. Prior to maturity the note may be converted
for Common Stock at a conversion price of $1.50.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
August 2017, $40,000 in convertible promissory notes was amended. A one-year extension was executed to August 2018. In connection
with the one-year extension of the maturity date of the outstanding notes, the holder of the notes was granted warrants to purchase
10,000 shares of Common Stock that was issued at a strike price of $0.80 and an expiration date of five years from date of issuance.
The amendment of the note was considered a debt extinguishment and a loss on extinguishment of debt was booked in the amount of
$5,044.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
August 2018, $40,000 in convertible promissory notes was amended. A one-year extension was executed to August 2019. In connection
with the one-year extension of the maturity date of the outstanding notes, the holder of the notes was granted warrants to purchase
10,000 shares of Common Stock that was issued at a strike price of $0.50 and an expiration date of five years from date of issuance.
The amendment of the note was considered a debt extinguishment and a loss on extinguishment of debt was booked in the amount of
$7,444.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">The
Company evaluated the embedded conversion feature within the above convertible notes under ASC 815-15 and ASC 815-40 and determined
that the embedded conversion feature does not meet the definition of a derivative liability. Then the Company evaluated the conversion
feature for a beneficial conversion feature at inception. The Company accounted for the intrinsic value of a Beneficial Conversion
Feature inherent to the convertible note payable and $0 was recorded as of the grant date.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
September and October 2016, convertible promissory notes were issued in the aggregate amount of $211,725 to a related party, Mr.
Nitil Patel, the brother of Mr. Prashant Patel. The term of the notes was one year. Simple interest of 10% is payable at
the maturity date of the notes. Prior to maturity the notes may be converted for Common Stock at a conversion price of $0.62.
In connection with the notes, the holders of the notes were granted warrants to purchase 52,861 shares of Common Stock. These
warrants were issued at a strike price of $0.62 and an expiration date of five years from date of issuance.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company evaluated the embedded conversion feature within the above convertible notes under ASC 815-15 and ASC 815-40 and determined
that the embedded conversion feature does not meet the definition of a derivative liability. Then the Company evaluated the conversion
feature for a beneficial conversion feature at inception. The Company accounted for the intrinsic value of a Beneficial Conversion
Feature inherent to the convertible note payable and the beneficial feature was not beneficial and a total debt discount of $65,390
due to the warrants was recorded as of the grant date.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
April 2017, a $61,725 related party note was renewed for a one-year extension at the same interest rate of 10%, due April 2018.
In April 2018, $61,725 was paid in cash for full payment.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
September 2017, a $150,000 related party note was renewed for a six-month extension at the same interest rate of 10%, due in February
2018. In February 2018, $100,000 of the related party note was extended to July 2018 and then renewed for a year extension at
the same interest rate of 10%, due July 2019. The remaining $50,000 was paid in cash in February 2018.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
2017, the remaining debt discount of $48,341 was fully amortized. As of December 31, 2017, the short-term related party convertible
notes had a principal balance of $251,725, net of an unamortized debt discount of $0.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of December 31, 2018, the short-term related party convertible notes had a principal balance of $140,000, net of an unamortized
debt discount of $0.</FONT></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 103; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence --></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Related
Party Promissory Note</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
November 2016, Mr. Prashant Patel loaned the Company $10,000. The term of the loan is 90 days and is at zero percent interest.
The balance at December 31, 2016 was $10,000.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">In
February 2017, $7,280 of accounts payable to Mr. Patel was added to the loan. The term of the loan was extended for 90 days and
is at zero interest rate. An additional $25,272 of accounts payable was added to the loan in the second quarter and the balance
of $42,552 was converted to long-term debt in July 2017 and will mature in July 2020. (See Note 4).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>NOTE
4 &ndash; LONG TERM DEBT</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">In
2017, there are $181,500 in convertible promissory notes due in May 2019 as described in Note 3.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Related
Party Promissory Notes</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
June 2017, the Company satisfied an outstanding promissory note, dated May 8, 2016, as amended, in the principal amount of $250,000
(the &ldquo;NPR Note&rdquo;), made by between the Company and NPR INVESTMENT GROUP, LLC (the &ldquo;Lender&rdquo;). The NPR Note
included a personal guarantee from Suren Ajjarapu and Prashant Patel, who both serve on the Board of Directors of the Company
and are controlling stockholders of the Company. Further, Mr. Ajjarapu is the CEO and President of the Company and Mr. Patel is
Vice Chairman and Executive Director of Strategy.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
connection with the foregoing satisfaction of the NPR Note above, the Company received funds in June 2017 and entered into a promissory
note agreement on July 1, 2017, whereby the Company borrowed $100,000 and $80,000 from Sansur Associates, LLC, a limited liability
company controlled by Mr. Ajjarapu, and Mr. Patel, respectively (the &ldquo;Promissory Notes&rdquo;). The term of each of these
N<FONT STYLE="background-color: white">otes is three years and they each bear interest at 6%, which is payable annually.</FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">The
note due to Mr. Patel is $</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">122,552. It comprises
$80,000 for the NPR note, $17,280 for an existing promissory note and $25,272 assumption of credit card obligation related to
business expenses of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
October 2018 in connection with the acquisition of Community Specialty Pharmacy, LLC a $300,000 promissory note was issued to
Nikul Panchal, accruing interest a simple interest of 10%, interest payable annually, and principal payable at maturity on October
15, 2021.&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">At
December 31, 2018 and 2017, total related party long term debt was $522,552 and $222,552, respectively.</FONT></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif"></FONT></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Future
maturities of long-term debt in the next five years are as follows:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" ALIGN="CENTER" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; width: 72%; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Due
    in 2020</FONT></TD><TD STYLE="width: 2%; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; width: 1%; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="text-align: right; width: 24%; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">222,552</FONT></TD><TD STYLE="text-align: left; width: 1%; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Due
    in 2021</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">300,000</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Due
    in 2022</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Due
    in 2023</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; padding-bottom: 2.5pt; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total
    Debt</FONT></TD><TD STYLE="padding-bottom: 2.5pt; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">522</FONT></FONT><FONT STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">,052</FONT></FONT></TD><TD STYLE="padding-bottom: 2.5pt; text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><B>NOTE 5 &ndash; STOCKHOLDERS&rsquo; EQUITY</B></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>2017</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
January 2017, under a Private Offer Memorandum, 250,000 shares of Common Stock were issued for $250,000 cash. The Common Stock
was sold at $1.00 per share. In connection with this Common Stock offering, warrants to purchase 87,500 shares of Common Stock
were issued with a strike price of $0.01 and an expiration date of five years.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 104; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence --></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">In
February 2017, 25,000 shares were issued when warrants were exercised at $0.01 grant price for $250.</FONT></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
March 2017, 50,000 shares were issued for services performed for the Company and valued at fair value of $12,500.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>2018</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
July 2018, under a Private Offer Memorandum, 300,000 shares of Common Stock were issued for $300,000 cash. The Common Stock was
sold at $1.00 per share. In connection with this Common Stock offering, warrants to purchase 161,538 shares of Common Stock were
issued with a strike price of $0.01 and an expiration date of five years.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin: 0; text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
November 2018, under a Private Offer Memorandum, 1,000,000 shares of Common Stock were issued for $500,000 cash. The Common Stock
was sold at $0.50 per share.</FONT></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>NOTE
6 - WARRANTS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">In
2017, 87,500 warrants were issued related to common shares sold for cash (See Note 5). Likewise, 28,150 were issued
for renewal of convertible debt (see Note 3) and 25,000 warrants were exercised. No warrants were forfeited in 2017.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">In
2018, 161,538 warrants were issued related to common shares sold for cash (see Note 5), 10,000 were issued for renewal
of convertible debt (see Note 3), 405,507 were issued related to the acquisition of Community Specialty Pharmacy, LLC,
none were exercised and 435,000 were forfeited.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table summarizes the assumptions used to estimate the fair value of warrants granted during the years ended December
31, 2018 and 2017:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" ALIGN="CENTER" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2018</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2017</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 60%; text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Expected
    dividend yield</FONT></TD><TD STYLE="width: 2%; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="width: 16%; text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">0</FONT></TD><TD STYLE="width: 1%; text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</FONT></TD><TD STYLE="width: 2%; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="width: 16%; text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">0</FONT></TD><TD STYLE="width: 1%; text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Weighted-average
    expected volatility</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">231-632</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">200</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Weighted-average
    risk-free interest rate</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.55-2.75</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.81-1.84</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Expected
    life of warrants</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5-8
                                         years</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5
                                         years</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company&rsquo;s outstanding and exercisable warrants as of December 31, 2018 and 2017 are presented below:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: center; padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-weight: bold; text-align: center; padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Number
    Outstanding</FONT></TD><TD STYLE="font-weight: bold; text-align: center; padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-weight: bold; text-align: center; padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Weighted
    Average Exercise Price</FONT></TD><TD STYLE="font-weight: bold; text-align: center; padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-weight: bold; text-align: center; padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Contractual
    Life in Years</FONT></TD><TD STYLE="font-weight: bold; text-align: center; padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-weight: bold; text-align: center; padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Intrinsic
    Value</FONT></TD><TD STYLE="font-weight: bold; text-align: center; padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 40%; text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Warrants
    Outstanding as of December 31, 2016</FONT></TD><TD STYLE="width: 2%; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="width: 11%; text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,647,446</FONT></TD><TD STYLE="width: 1%; text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="width: 2%; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="width: 11%; text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.24</FONT></TD><TD STYLE="width: 1%; text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="width: 2%; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="width: 11%; text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.24</FONT></TD><TD STYLE="width: 1%; text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="width: 2%; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="width: 11%; text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">930,751</FONT></TD><TD STYLE="width: 1%; text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Warrants
    granted</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">115,650</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.18</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.0</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Warrants
    forfeited</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Warrants
    exercised</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(25,000</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.01</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Warrants
    Outstanding as of December 31, 2017</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,738,096</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.24</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.28</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">937,567</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Warrants
    granted</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">577,045</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.02</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7.11</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Warrants
    forfeited</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(435,000</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Warrants
    exercised</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Warrants
    Outstanding as of December 31, 2018</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,880,141</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.08</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.74</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">782,385</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
</TABLE>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 105; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->24<!-- Field: /Sequence --></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>NOTE
7 - OPTIONS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company maintains a stock option plan under which certain employees and management are awarded option grants based on a combination
of performance and tenure. All options may be exercised for a period up to four &frac12; years following the grant date, after
which they expire. Options are vested up to 5 years from the grant date. The Board has authorized the use of 2,000,000 shares
for option grants.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Stock
options were granted during 2018 and 2017 to employees totaling, 560,400 and 263,846 respectively. These options vest over a period
of 4 to 5 years, are granted with an exercise price of between $0.41 and $1.02 per share and have a term of 10 years. The
last options expire April 2028.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under
the Black-Scholes option price model, fair value of the options granted in 2018 and 2017 were $278,358 and $169,100, respectfully.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
April 2017, 253,846 options were granted with an exercise price of $0.65 and a term of 10 years from the grant date. The options
vest over a period of one and four years.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
April 2017, four option grants, totaling 650,000 options, were amended to extend the exercise terms to 10 years from the date
of grant. Incremental option expense recognized as a result of the amendment amounted to $69,611.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
April 2018, 560,400 options were granted with an exercise price of $0.50 and a term of 10 years from the grant date. The options
vest over a period of four to five years.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company uses the Black-Scholes option pricing model to estimate the fair value of stock-based awards on the date of grant. The
following table summarizes the assumptions used to estimate the fair value of stock options granted during the years ended December
31, 2018 and 2017:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" ALIGN="CENTER" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2018</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2017</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 56%; text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Expected
    dividend yield</FONT></TD><TD STYLE="width: 2%; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="width: 18%; text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">0</FONT></TD><TD STYLE="width: 1%; text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</FONT></TD><TD STYLE="width: 2%; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="width: 18%; text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">0</FONT></TD><TD STYLE="width: 1%; text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Weighted-average
    expected volatility</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">192-265</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">200</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Weighted-average
    risk-free interest rate</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.08-2.73</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.92</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Expected
    life of warrants</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4-5
                                         years</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.74
                                         -7.50 years</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total
compensation cost related to stock options was $169,828 and $267,835 for the years ended December 31, 2018 and 2017, respectively.
As of December 31, 2018, there was $192,007 of unrecognized compensation costs related to stock options, which is expected to
be recognized over a weighted average period of 6.98 years. The following table represents stock option activity for the two years
ended December 31, 2018:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: center; padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-weight: bold; text-align: center; padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Number
    Outstanding</FONT></TD><TD STYLE="font-weight: bold; text-align: center; padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-weight: bold; text-align: center; padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Weighted
    Average Exercise Price</FONT></TD><TD STYLE="font-weight: bold; text-align: center; padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-weight: bold; text-align: center; padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Contractual
    Life in Years</FONT></TD><TD STYLE="font-weight: bold; text-align: center; padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-weight: bold; text-align: center; padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Intrinsic
    Value</FONT></TD><TD STYLE="font-weight: bold; text-align: center; padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 42%; text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Options
    Outstanding as of December 31, 2016</FONT></TD><TD STYLE="width: 2%; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="width: 11%; text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,044,500</FONT></TD><TD STYLE="width: 1%; text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="width: 2%; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="width: 11%; text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.92</FONT></TD><TD STYLE="width: 1%; text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="width: 2%; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="width: 10%; text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.38</FONT></TD><TD STYLE="width: 1%; text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="width: 2%; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="width: 10%; text-align: right; font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD><TD STYLE="width: 1%; text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Options
    Exercisable as of December 31, 2016</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">584,000</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.05</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.02</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Options
    granted</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">263,846</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.64</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">9.05</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Options
    forfeited</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(35,000</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.02</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8.25</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Options
    expired</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(75,000</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.13</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.54</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Options
    Outstanding as of December 31, 2017</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,197,846</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.97</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.96</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Options
    Exercisable as of December 31, 2017</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">781,300</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.02</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.30</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Options
    granted</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">560,400</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.50</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">9.26</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Options
    forfeited</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(25,400</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.46</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">9.06</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Options
    expired</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Options
    Outstanding as of December 31, 2018</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,732,846</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.19</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.98</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Options
    Exercisable as of December 31, 2018</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,107,259</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.96</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.91</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
</TABLE>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 106; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->25<!-- Field: /Sequence --></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>NOTE
8 &ndash; INCOME TAXES</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
December 22, 2017 H.R. 1, originally known as the Tax Cuts and Jobs Act, (the &ldquo;Tax Act&rdquo;) was enacted. Among the significant
changes to the U.S. Internal Revenue Code, the Tax Act lowers the U.S. federal corporate income tax rate (&ldquo;Federal Tax Rate&rdquo;)
from 35% to 21% effective January 1, 2018.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
statutory tax rate is the percentage imposed by law; the effective tax rate is the percentage of income actually paid by a company
after taking into account tax deductions, exemptions, credits and operating loss carry forwards.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">At
December 31, 2018 and 2017 deferred tax assets consist of the following:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" ALIGN="CENTER" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">December
    31, 2018</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">December
    31, 2017</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 48%; text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Federal
    loss carry forwards</FONT></TD><TD STYLE="width: 2%; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="width: 22%; text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">922,850</FONT></TD><TD STYLE="width: 1%; text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="width: 2%; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="width: 22%; text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">963,833</FONT></TD><TD STYLE="width: 1%; text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Less:
    valuation allowance</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(922,850</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(963,833</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: justify; padding-bottom: 2.5pt; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 2.5pt; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD><TD STYLE="padding-bottom: 2.5pt; text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 2.5pt; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</FONT></TD><TD STYLE="padding-bottom: 2.5pt; text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company has established a valuation allowance equal to the full amount of the deferred tax asset primarily due to uncertainty
in the utilization of the net operating loss carry forwards.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
estimated net operating loss carry forwards of approximately $4,400,000 will be available based on the new carryover rules in
section 172(a) passed with the Tax Cuts and Jobs Acts.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>NOTE
9 &ndash; RELATED PARTIES</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">In
January 2017 Mr. Ajjarapu and Mr. Patel suspended their executive salaries of $165,000 and $125,000, for a period of five and
six months, respectively. In January 2018, Mr. Ajjarapu and Mr. Patel&rsquo;s executive salaries were amended to $200,000 and
$150,000, respectively. All of our executives are at-will employees or consultants. Each of Messrs. Ajjarapu and Patel are
parties to an at-will executive employment agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company owed management wages to Mr. Prashant Patel at December 31, 2018 of $0 and December 31, 2017 of $62,500, respectively.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">In
October 2018 in connection with the acquisition of Community Specialty Pharmacy, LLC a $300,000 promissory note was issued to
Nikul Panchal, accruing interest a simple interest of 10%, interest payable annually, and principal payable at maturity on October
15, 2021.</FONT></FONT><FONT STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>NOTE
10 &ndash; COMMITMENTS AND CONTINGENCIES</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company leases two premises in Land O&rsquo; Lakes, Florida under an operating lease that expires in 2021 and in Tampa, Florida
under an operating lease that expires in 2023. Future minimum rental payments under these non-cancelable operating leases as of
December 31, 2018 are:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" ALIGN="CENTER" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 60%; text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2019</FONT></TD><TD STYLE="width: 2%; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="width: 36%; text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">156,024</FONT></TD><TD STYLE="width: 1%; text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2020</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">160,709</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2021</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">165,506</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2022</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">49,080</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font-family: Times New Roman, Times, Serif">
    <TD STYLE="padding-bottom: 1.5pt; text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2023</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">41,934</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font-family: Times New Roman, Times, Serif">
    <TD STYLE="padding-bottom: 2.5pt; text-align: center; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total</FONT></TD><TD STYLE="padding-bottom: 2.5pt; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">573,253</FONT></TD><TD STYLE="padding-bottom: 2.5pt; text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 107; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->26<!-- Field: /Sequence --></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>NOTE
11 &ndash; SEGMENT REPORTING</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company classifies its business interests into reportable segments which are Trxade, Inc., Community Specialty Pharmacy, LLC,
and Other. Operating segments are defined as the components of an enterprise about which separate financial information is available
that is evaluated regularly by the chief operating decision maker in deciding how to allocate resources and in assessi</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif">ng
performance. Our chief operating decision makers direct the allocation of resources to operating segments based on the profitability,
cash flows, and growth opportunities of each respective segment.</FONT></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" ALIGN="CENTER" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Year
    Ended December 31, 2018</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Trxade,
    Inc.</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Community
    Specialty Pharmacy,&nbsp;LLC</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 43%; text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Revenue</FONT></TD><TD STYLE="width: 2%; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="width: 14%; text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3,407,822</FONT></TD><TD STYLE="width: 1%; text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="width: 2%; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="width: 16%; text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">395,418</FONT></TD><TD STYLE="width: 1%; text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="width: 2%; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="width: 15%; text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">28,538</FONT></TD><TD STYLE="width: 1%; text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">Gross
    Profit</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><P STYLE="margin: 0; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">3,407,822</FONT></P>


</TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><P STYLE="margin: 0; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">(34,971</FONT></P>


</TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><P STYLE="margin: 0; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">9,878</FONT></P>


</TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Segment
    Assets</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">822,412</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">112,123</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,293,052</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Segment
    Profit/Loss</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,371,615</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(116,588</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1,245,989</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</FONT></TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">The
Company had no reportable segments in 2017. See Note 12.</FONT></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>NOTE
12 &ndash; BUSINESS COMBINATION</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">On
October 15, 2018, the Company entered into and consummated the purchase of 100% of the equity interests of Community Specialty
Pharmacy, LLC, a Florida limited liability company, (&ldquo;CSP&rdquo;), pursuant to the terms and conditions of the Membership
Interest Purchase Agreement, entered into by and among the Company as the buyer, and CSP, and Nikul Panchal, the equity owner
of CSP (collectively, the &ldquo;Seller&rdquo;). The purchase price for the 100% equity interest in CSP was
$300,000 in cash, a promissory note issued by the Company of $300,000 (see Note 4), and warrants to purchase 405,507
shares of the Common Stock of the Company which vested at the acquisition date, are exercisable for eight (8) years
from the issuance date at a strike price of $0.01 per share, and subject to exercise restrictions which lapse over a period
of three (3) years.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">The
Company recorded the acquisition under the guidance of ASC 805 &ldquo;Business Combinations&rdquo;. All the assets
acquired and liabilities assumed are recorded at their corresponding fair values. The excess of the purchase
price over the net assets acquired resulted in goodwill of $725,973. The following table is a summary of the allocation of
the purchase price of $770,291 consisting of $300,000 in cash, a promissory note from the Company of $300,000, and <FONT STYLE="background-color: white">the
fair value for the warrants issued calculated under the Black-Scholes calculation at $170,291.</FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" ALIGN="CENTER" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Purchase
    Price Allocation</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 64%; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Purchase
    Price</FONT></TD><TD STYLE="width: 2%; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="width: 32%; text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">770,291</FONT></TD><TD STYLE="width: 1%; text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cash</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(49,728</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accounts
    Receivable</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(114,899</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Inventory</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(76,156</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Prepaid</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3,000</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accounts
    Payable</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">199,312</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font-family: Times New Roman, Times, Serif">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accrued
    Expenses</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">153</FONT></TD><TD STYLE="padding-bottom: 1.5pt; text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font-family: Times New Roman, Times, Serif">
    <TD STYLE="padding-bottom: 2.5pt; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Goodwill</FONT></TD><TD STYLE="padding-bottom: 2.5pt; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">725,973</FONT></TD><TD STYLE="padding-bottom: 2.5pt; text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<!-- Field: Page; Sequence: 108; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->27<!-- Field: /Sequence --></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">The
accompanying unaudited pro forma combined statements of operations presents the accounts of Trxade and CSP for the years
ended December 31, 2018 and 2017, respectively, assuming the acquisition occurred on January 1, 2017.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" ALIGN="CENTER" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-weight: bold; border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">2018
    Summary Statement of Operations</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">Trxade</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">CSP</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">Combined</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 49%; font-weight: bold; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">Revenue</FONT></TD><TD STYLE="width: 2%; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="width: 13%; text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">3,436,360</FONT></TD><TD STYLE="width: 1%; text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="width: 2%; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="width: 13%; text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">2,387,636</FONT></TD><TD STYLE="width: 1%; text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="width: 2%; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="width: 13%; text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">5,823,996</FONT></TD><TD STYLE="width: 1%; text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-weight: bold; text-align: left; padding-bottom: 2.5pt; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">Net
    Income (Loss)</FONT></TD><TD STYLE="padding-bottom: 2.5pt; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="text-align: right; border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">125,626</FONT></TD><TD STYLE="text-align: left; padding-bottom: 2.5pt; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 2.5pt; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="text-align: right; border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">(6,723</FONT></TD><TD STYLE="text-align: left; padding-bottom: 2.5pt; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">)</FONT></TD><TD STYLE="padding-bottom: 2.5pt; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="text-align: right; border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">118,903</FONT></TD><TD STYLE="text-align: left; padding-bottom: 2.5pt; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-weight: bold; text-align: left; padding-bottom: 2.5pt; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">Net
    Income per common share &ndash; basic</FONT></TD><TD STYLE="padding-bottom: 2.5pt; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="text-align: right; border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">0.00</FONT></TD><TD STYLE="text-align: left; padding-bottom: 2.5pt; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 2.5pt; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; padding-bottom: 2.5pt; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right; padding-bottom: 2.5pt; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left; padding-bottom: 2.5pt; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 2.5pt; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="text-align: right; border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">0.00</FONT></TD><TD STYLE="text-align: left; padding-bottom: 2.5pt; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-weight: bold; text-align: left; padding-bottom: 2.5pt; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">Net
    Income per common share - diluted</FONT></TD><TD STYLE="padding-bottom: 2.5pt; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="text-align: right; border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">0.00</FONT></TD><TD STYLE="text-align: left; padding-bottom: 2.5pt; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 2.5pt; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; padding-bottom: 2.5pt; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right; padding-bottom: 2.5pt; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left; padding-bottom: 2.5pt; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 2.5pt; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">$</FONT></TD><TD STYLE="text-align: right; border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">0.00</FONT></TD><TD STYLE="text-align: left; padding-bottom: 2.5pt; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-weight: bold; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">Weighted
    average common shares - basic</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">32,260,622</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">32,260,622</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-weight: bold; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">Weighted
    average common shares - diluted</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">34,958,502</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">34,958,502</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" ALIGN="CENTER" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-weight: bold; border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2017
    Summary Statement of Operations</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Trxade</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">CSP</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Combined</FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font-family: Times New Roman, Times, Serif">
    <TD STYLE="width: 49%; font-weight: bold; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Revenue</FONT></TD><TD STYLE="width: 2%; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="width: 13%; text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,931,280</FONT></TD><TD STYLE="width: 1%; text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="width: 2%; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="width: 13%; text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,633,914</FONT></TD><TD STYLE="width: 1%; text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="width: 2%; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="width: 13%; text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5,565,194</FONT></TD><TD STYLE="width: 1%; text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-weight: bold; text-align: left; padding-bottom: 2.5pt; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net
    Income (Loss)</FONT></TD><TD STYLE="padding-bottom: 2.5pt; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">288,983</FONT></TD><TD STYLE="padding-bottom: 2.5pt; text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 2.5pt; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(63,132</FONT></TD><TD STYLE="padding-bottom: 2.5pt; text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</FONT></TD><TD STYLE="padding-bottom: 2.5pt; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">225,851</FONT></TD><TD STYLE="padding-bottom: 2.5pt; text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-weight: bold; text-align: left; padding-bottom: 2.5pt; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net
    Income per common share &ndash; basic</FONT></TD><TD STYLE="padding-bottom: 2.5pt; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.01</FONT></TD><TD STYLE="padding-bottom: 2.5pt; text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 2.5pt; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 2.5pt; text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 2.5pt; text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 2.5pt; text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 2.5pt; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.01</FONT></TD><TD STYLE="padding-bottom: 2.5pt; text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-weight: bold; text-align: left; padding-bottom: 2.5pt; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net
    Income per common share - diluted</FONT></TD><TD STYLE="padding-bottom: 2.5pt; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.01</FONT></TD><TD STYLE="padding-bottom: 2.5pt; text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 2.5pt; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 2.5pt; text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 2.5pt; text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 2.5pt; text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="padding-bottom: 2.5pt; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</FONT></TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.01</FONT></TD><TD STYLE="padding-bottom: 2.5pt; text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-weight: bold; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Weighted
    average common shares - basic</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">31,955,416</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">31,955,416</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White; font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255); font-family: Times New Roman, Times, Serif">
    <TD STYLE="font-weight: bold; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Weighted
    average common shares - diluted</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">34,086,251</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">34,086,251</FONT></TD><TD STYLE="text-align: left; font-family: Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>NOTE
13 &ndash; SUBSEQUENT EVENTS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">In
January 2019, Trxade Group, Inc. through its wholly owned subsidiary Alliance Pharma Solution, LLC (&ldquo;Alliance&rdquo;)
entered into a transaction to form SyncHealth MSO, LLC (&ldquo;SyncHealth&rdquo;). It will be owned by PanOptic Health,
LLC (&ldquo;PanOptic&rdquo;) and Alliance. Alliance will transfer $250,000 for the acquisition of the remaining
49% and the option to acquire the remaining ownership from PanOptic shareholders. Pursuant to the operating agreement PanOptic
initially owns 70% of SyncHealth and Alliance owns 30%; however, pursuant to the Letter Agreement, PanOptic will transfer
to Alliance an additional 6% of the SyncHealth units on May 1, 2019, an additional 6% on August 1, 2019, an additional
7% on November 1, 2019 and at Alliance&rsquo;s option, the balance of 51% on January 31, 2020. The Company has transferred
$250,000 and has a 30% equity interest.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">In
February 2019, convertible promissory notes issued in 2015 for $150,000 were amended to reduce the conversion price from
$0.85 to $0.50 and the remaining principal and accrued interest total of $211,983 were converted to 423,966 common
shares.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
February 2019, 16,666 of warrants issued in 2014 at $0.01 were converted for $166 to 16,666 of common shares.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"></P>

<!-- Field: Page; Sequence: 109; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->28<!-- Field: /Sequence --></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="margin-top: 0; text-align: center; margin-bottom: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><IMG SRC="cover_001.jpg" ALT=""></FONT></P>

<P STYLE="margin-top: 0; text-align: center; margin-bottom: 0; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>TRXADE
GROUP INC.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>4,910,000
</B></FONT><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>SHARES OF COMMON STOCK</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>PROSPECTUS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>October
15,</B></FONT><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B> 2019</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Neither
we nor the selling stockholders have authorized any dealer, salesperson or other person to give any information or to make any
representations not contained in this prospectus or any prospectus supplement. You must not rely on any unauthorized information.
This prospectus is not an offer to sell these securities in any jurisdiction where an offer or sale is not permitted. The information
in this prospectus is current as of the date of this prospectus. You should not assume that this prospectus is accurate as of
any other date.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-right: 0; margin-bottom: 0; text-align: left"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 110 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; text-align: center; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>PART
II</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>INFORMATION
NOT REQUIRED IN PROSPECTUS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>ITEM
13. OTHER EXPENSES OF ISSUANCE AND DISTRIBUTION</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table sets forth an estimate of the registrant&rsquo;s expenses, other than any sales commissions or discounts, in connection
with the issuance and distribution of the securities being registered hereby. All amounts are estimates except the SEC registration
fee.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 81%; text-align: left">Securities and Exchange Commission registration fee</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 15%; text-align: right">689.86</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Accounting fees and expenses</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">5,000.00</TD><TD STYLE="text-align: left">*</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Legal fees and expenses</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">37,500.00</TD><TD STYLE="text-align: left">*</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-bottom: 1.5pt">Miscellaneous</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="text-align: left; border-bottom: Black 1.5pt solid">&nbsp;</TD><TD STYLE="text-align: right; border-bottom: Black 1.5pt solid">10,000.00</TD><TD STYLE="text-align: left; padding-bottom: 1.5pt">*</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold">Total</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD STYLE="font-weight: bold; text-align: left">$</TD><TD STYLE="font-weight: bold; text-align: right">53,189.86</TD><TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD></TR>
</TABLE>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 0.35in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Indicates
    expenses that have been estimated for filing purposes only.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>ITEM
14. INDEMNIFICATION OF DIRECTORS AND OFFICERS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
145 of the Delaware General Corporation Law (&ldquo;<U>DGCL</U>&rdquo;) authorizes a corporation&rsquo;s board of directors to
grant, and authorizes a court to award, indemnity to officers, directors, and other corporate agents.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to the Company&rsquo;s Certificate of Incorporation:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="width: 0.75in; font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="width: 0.25in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
                                         director of the Company shall, to the fullest extent permitted by the DGCL as it now
                                         exists or as it may hereafter be amended, not be personally liable to the Company or
                                         its stockholders for monetary damages for breach of fiduciary duty as a director, except
                                         to the extent such exception from liability is not permitted under the DGCL as the same
                                         exists or may hereafter be amended; and</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
<TD STYLE="font: 10pt Times New Roman, Times, Serif"></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD><TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
                                         the fullest extent permitted by applicable law, the Company is authorized to provide
                                         indemnification of, and advancement of expenses to, such agents of the Company (and any
                                         other persons to which Delaware law permits the Company to provide indemnification) through
                                         Bylaw provisions, agreements with such agents or other persons, vote of stockholders
                                         or disinterested directors or otherwise, in excess of the indemnification and advancement
                                         otherwise permitted by Section 145 of the DGCL, subject only to limits created by applicable
                                         Delaware law (statutory or non-statutory), with respect to actions for breach of duty
                                         to the Company, its stockholders and others.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
145 of the DGCL, provides, among other things, that a Delaware corporation may indemnify any person who was, is or is threatened
to be made, party to any threatened, pending or completed action, suit or proceeding, whether civil, criminal, administrative
or investigative (other than an action by or in the right of such corporation), by reason of the fact that such person is or was
an officer, director, employee or agent of such corporation or is or was serving at the request of such corporation as a director,
officer, employee or agent of another corporation or enterprise. The indemnity may include expenses (including attorneys&rsquo;
fees), judgments, fines and amounts paid in settlement actually and reasonably incurred by such person in connection with such
action, suit or proceeding, provided such person acted in good faith and in a manner he or she reasonably believed to be in or
not opposed to the corporation&rsquo;s best interests and, with respect to any criminal action or proceeding, had no reasonable
cause to believe that his or her conduct was unlawful. A Delaware corporation may indemnify any persons who were or are a party
to any threatened, pending or completed action or suit by or in the right of the corporation by reason of the fact that such person
is or was a director, officer, employee or agent of another corporation or enterprise. The indemnity may include expenses (including
attorneys&rsquo; fees) actually and reasonably incurred by such person in connection with the defense or settlement of such action
or suit, provided such person acted in good faith and in a manner he or she reasonably believed to be in or not opposed to the
corporation&rsquo;s best interests, provided further that no indemnification is permitted without judicial approval if the officer,
director, employee or agent is adjudged to be liable to the corporation. Where an officer or director is successful on the merits
or otherwise in the defense of any action referred to above, the corporation must indemnify him or her against the expenses (including
attorneys&rsquo; fees) which such officer or director has actually and reasonably incurred.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-right: 0; margin-bottom: 0; text-align: left"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 111; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">II-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
145 further authorizes a corporation to purchase and maintain insurance on behalf of any person who is or was a director, officer,
employee or agent of the corporation or is or was serving at the request of the corporation as a director, officer, employee or
agent of another corporation or enterprise, against any liability asserted against such person and incurred by such person in
any such capacity, or arising out of his or her status as such, whether or not the corporation would otherwise have the power
to indemnify such person under Section 145.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
indemnification rights set forth above shall not be exclusive of any other right which an indemnified person may have or hereafter
acquire under any statute, any provision of our amended and certificate of incorporation, our amended and restated bylaws, agreement,
vote of stockholders or disinterested directors or otherwise. Notwithstanding the foregoing, we shall not be obligated to indemnify
a director or officer in respect of a proceeding (or part thereof) instituted by such director or officer, unless such proceeding
(or part thereof) has been authorized by the board of directors pursuant to the applicable procedure outlined in the amended and
restated bylaws.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
174 of the DGCL provides, among other things, that a director, who willfully or negligently approves of an unlawful payment of
dividends or an unlawful stock purchase or redemption, may be held jointly and severally liable for such actions. A director who
was either absent when the unlawful actions were approved or dissented at the time may avoid liability by causing his or her dissent
to such actions to be entered in the books containing the minutes of the meetings of the board of directors at the time such action
occurred or immediately after such absent director receives notice of the unlawful acts.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company&rsquo;s policy is to enter into separate indemnification agreements with each of its directors and officers that provide
the maximum indemnity allowed to directors and executive officers by Section 145 of the DGCL and also to provide for certain additional
procedural protections. The Company also maintains directors and officers&rsquo; insurance to insure such persons against certain
liabilities. These indemnification provisions and the indemnification agreements may be sufficiently broad to permit indemnification
of our officers and directors for liabilities, including reimbursement of expenses incurred, arising under the Securities Act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>ITEM
15. RECENT SALES OF UNREGISTERED SECURITIES</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>During
the year ended 2016</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under
a Private Offer Memorandum, 200,000 shares of common stock were sold for $300,000 cash, which included 100,000 shares in June
2016 and 100,000 shares in August 2016. The common stock was sold at $1.50 per share. In connection with this common stock offering
warrants to purchase 50,000 shares of common stock were issued at a strike price of $0.01 and an expiration date of five years.
Warrants were exercised for 25,000 shares of common stock at $.01 for $240.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
September and October 2016, convertible promissory notes were issued in the aggregate amount of $211,725 to a related party, Nitil
Patel, the brother of Prashant Patel, our President and major stockholder. The term of the notes was one year. Simple interest
of 10% is payable at the maturity date of the notes. Prior to maturity the notes may be converted for common stock at a conversion
price of $0.62. In connection with the notes, the holders of the notes were granted warrants to purchase 52,861 shares of common
stock. These warrants were issued at a strike price of $0.62 and an expiration date of five years from date of issuance.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 112; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">II-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
October 2016 and December 2016 additional secured convertible promissory notes totaling $300,000 were issued in connection with
similarly issued notes, first issued in October 2015. The term of the notes was three years, and these notes, together with other
similarly issued notes, were cancelled in connection with the sale of Westminster Pharmaceuticals, LLC, a Delaware limited liability
company (&ldquo;<U>Westminster</U>&rdquo;) in December 2016. The holder of the note was granted a warrant to purchase a total
of 183,335 shares of common stock at a strike price of $0.01 and an expiration date of five years from date of issuance.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
December 31, 2016, the Company entered into and consummated the sale of 100% of its equity interests in its wholly owned
subsidiary, Westminster. The purchase price for Westminster included the cancellation of $1,500,000 of indebtedness with the buyer
under the secured promissory note and the issuance of a warrant to purchase 1,500,000 shares of the Company&rsquo;s common stock.
The warrants were issued at a strike price of $0.01 per share and have an expiration date of five years from date of grant under
the term and conditions of a warrant agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Stock
Options to purchase 740,000 shares of common stock were granted during 2016 to employees. These options vest in up to 5 years
and are granted with an exercise price of between $0.75 - $1.60 per share and an expiration date up to five years after the last
vesting period. The last options expire December 2026.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>During
the year ended 2017</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
January 2017, pursuant to a Private Offering Memorandum, 250,000 shares of common stock were sold for $250,000 cash. The common
stock was sold at $1.00 per share. In connection with this common stock offering, warrants to purchase 87,500 shares of common
stock were issued with a strike price of $0.01 and an expiration date of five years.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
February 2017, the Company issued 25,000 shares of common stock when warrants were exercised at a $0.01 strike price for a total
of $250. In March 2017, the Company issued 50,000 shares of common stock for services performed for the Company and valued at
fair value of $12,500.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Stock
options to purchase 263,846 shares of common stock were granted during 2017 to employees. These options vest over a period of
5 years, are granted with an exercise price of between $0.41 - $1.02 per share and have a term of 10 years. The last options expire
October 2027.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>During
the year end 2018</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
July 2018, under a Private Offer Memorandum, 300,000 shares of common stock were sold for $300,000 cash. The common stock was
sold at $1.00 per share. In connection with this common stock offering, warrants to purchase 161,538 shares of common stock were
issued with a strike price of $0.01 and an expiration date of five years.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
November 2018, under a Private Offer Memorandum, 1,000,000 shares of common stock were sold for $500,000 cash. The common stock
was sold at $0.50 per share.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
2018, 161,538 warrants were issued related to common shares sold for cash, 10,000 were issued for renewal of convertible debt,
405,507 were issued related to the acquisition of Community Specialty Pharmacy, LLC.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Stock
options to purchase 560,400 shares of common stock were granted during 2018 to employees. These options vest over a period of
4 to 5 years, are granted with an exercise price of between $0.41 - $1.02 per share and have a term of 10 years. The last options
expire April 2028.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>


<!-- Field: Page; Sequence: 113; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">II-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>During
the Past Year</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
February 2019, convertible promissory notes issued in 2015 for $150,000 were amended to a conversion price of $0.50 and principal
and accrued interest totaling $211,983 were then converted to 423,966 common shares. In addition, 16,666 of warrants that were
issued in 2014 with an exercise price of $0.01 were converted to 16,666 of common shares.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
April and May 2019, options to purchase 505,000 shares of common stock were approved by the Compensation Committee of the Board
of Directors and issued to employees, contractors and board members under our 2014 Equity Incentive Plan. The options were granted
with an exercise price ranging from $0.41 to $0.44 and a term of 10 years from the grant date. The options vest over a period
ranging from four to five years.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
July 10, 2019, we entered into a securities Purchase Agreement with R.S.N., LLC with respect to the private placement of 2,000,000
shares of our common stock at a purchase price of $0.50 per share, for gross proceeds of $1,000,000. This transaction closed on
July 30, 2019.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">On September 30, 2019,
we closed the sale of securities pursuant to Securities Purchase Agreements entered into with certain accredited investors with
respect to the private placement of 2,910,000 shares of our common stock at a purchase price of $0.50 per share, for gross proceeds
of $1,455,000. Subscribers included Bedford Falls Capital, which is controlled by Gary Augusta, our director (1,000,000 shares);
Nitesh Patel, who is the cousin of Prashant Patel, our director and President (40,000 shares); Shilpa Patel, who is
the spouse of Nitesh Patel, the brother of Prashant Patel our director and President (20,000 shares); and Nitil
Patel, the brother of Prashant Patel, our director and President, (200,000 shares).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">Further, on September
30, 2019, the Company converted $175,000 of principal under various outstanding promissory notes (&ldquo;<U>Promissory Notes</U>&rdquo;)
into 350,000 shares common stock of the Company at $0.50 per share under the terms of the Securities Purchase Agreement referenced
above.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">The combined total of
the transactions detailed above was $2,630,000 of investment and conversion of principal under various Promissory Notes
into an aggregate total 5,260,000 shares of common stock.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">*
* * * * * *</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
use of proceeds associated with the above listed sales of unregistered securities was for general working capital purposes.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
issuances and grants described above were exempt from registration pursuant to Rule 701 promulgated under Section 3(b) of the
Securities Act as transactions by an issuer not involving any public offering pursuant to benefit plans and contracts relating
to compensation as provided under Rule 701, or were exempt offerings under Section 4(a)(2), Rule 506 of Regulation D and/or
Regulation S of the Securities Act, since the foregoing issuances and grants did not involve a public offering, the recipients
took the securities for investment and not resale, we took take appropriate measures to restrict transfer, and the recipients
were (a) &ldquo;accredited investors&rdquo;; (b) had access to similar documentation and information as would be required in a
Registration Statement under the Act; (c) were non U.S. persons; and/or (d) were officers or directors of the Company. The securities
are subject to transfer restrictions, and the certificates evidencing the securities contain an appropriate legend stating that
such securities have not been registered under the Securities Act and may not be offered or sold absent registration or pursuant
to an exemption therefrom. The securities were not registered under the Securities Act and such securities may not be offered
or sold in the United States absent registration or an exemption from registration under the Securities Act and any applicable
state securities laws.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>ITEM
16. EXHIBITS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
Exhibits Pursuant to Item 601 of Regulation S-K:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
list of exhibits filed with this registration statement on Form S-1/A is set forth on the Exhibit Index and is incorporated herein
by reference.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 114; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">II-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>ITEM
17. UNDERTAKINGS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
undersigned registrant hereby undertakes:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1) To
file, during any period in which offers or sales are being made, a post-effective amendment to this registration statement to:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.4in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i) Include
any prospectus required by Section 10(a)(3) of the Securities Act;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.4in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii) Reflect
in the prospectus any facts or events arising after the effective date of the registration statement (or the most recent post-effective
amendment thereof) which, individually or in the aggregate, represent a fundamental change in the information set forth in the
registration statement. Notwithstanding the foregoing, any increase or decrease in volume of securities offered (if the total
dollar value of securities offered would not exceed that which was registered) and any deviation from the low or high end of the
estimated maximum offering range may be reflected in the form of prospectus filed with the Commission pursuant to Rule 424(b)
if, in the aggregate, the changes in volume and price represent no more than a 20% change in the maximum aggregate offering price
set forth in the &ldquo;<U>Calculation of Registration Fee</U>&rdquo; table in the effective registration statement; and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.4in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii) Include
any material information with respect to the plan of distribution not previously disclosed in the registration statement or any
material change to such information in the registration statement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2) That,
for the purpose of determining any liability under the Securities Act of 1933, each such post-effective amendment shall be deemed
to be a new registration statement relating to the securities offered therein, and the offering of such securities at that time
shall be deemed to be the initial bona fide offering thereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3) To
remove from registration by means of a post-effective amendment any of the securities being registered which remain unsold at
the termination of the offering.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(4) That,
for the purpose of determining liability under the Securities Act of 1933 to any purchaser each prospectus filed by the registrant
pursuant to Rule 424(b)(3) shall be deemed to be part of the registration statement as of the date the filed prospectus was deemed
part of and included in the registration statement; and each prospectus required to be filed pursuant to Rule 424(b)(2), (b)(5),
or (b)(7) as part of a registration statement in reliance on Rule 430B relating to an offering made pursuant to Rule 415(a)(1)(i),
(vii), or (x) for the purpose of providing the information required by section 10(a) of the Securities Act of 1933 shall be deemed
to be part of and included in the registration statement as of the earlier of the date such form of prospectus is first used after
effectiveness or the date of the first contract of sale of securities in the offering described in the prospectus. As provided
in Rule 430B, for liability purposes of the issuer and any person that is at that date an underwriter, such date shall be deemed
to be a new effective date of the registration statement relating to the securities in the registration statement to which that
prospectus relates, and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof.
Provided, however, that no statement made in a registration statement or prospectus that is part of the registration statement
or made in a document incorporated or deemed incorporated by reference into the registration statement or prospectus that is part
of the registration statement will, as to a purchaser with a time of contract of sale prior to such effective date, supersede
or modify any statement that was made in the registration statement or prospectus that was part of the registration statement
or made in any such document immediately prior to such effective date.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(5) Insofar
as indemnification for liabilities arising under the Securities Act of 1933 may be permitted to directors, officers and controlling
persons of the registrant pursuant to the foregoing provisions, or otherwise, the registrant has been advised that in the opinion
of the Securities and Exchange Commission such indemnification is against public policy as expressed in the Act and is, therefore,
unenforceable. In the event that a claim for indemnification against such liabilities (other than the payment by the registrant
of expenses incurred or paid by a director, officer or controlling person of the registrant in the successful defense of any action,
suit or proceeding) is asserted by such director, officer or controlling person in connection with the securities being registered,
the registrant will, unless in the opinion of its counsel the matter has been settled by controlling precedent, submit to a court
of appropriate jurisdiction the question whether such indemnification by it is against public policy as expressed in the Act and
will be governed by the final adjudication of such issue.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 115; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">II-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><A NAME="poa_001"></A>SIGNATURES</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to the requirements of the Securities Act of 1933, the registrant has duly caused this registration statement to be signed on
its behalf by the undersigned, thereunto duly authorized, in the city of Land O&rsquo; Lakes, State of Florida on the 15th
day of October 2019.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>TRXADE
    GROUP, INC.</B></FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 50%; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 3%; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 47%; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>/s/
    Suren Ajjarapu</I></FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Suren
    Ajjarapu, Chief Executive Officer (Principal Executive Officer)</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">KNOW
ALL MEN BY THESE PRESENTS, that each person whose signature appears below constitutes and appoints Mr. Suren Ajjarapu and Mr.
Howard A. Doss, as his true and lawful attorneys-in-fact and agents, with full power of substitution and re-substitution for him
and in his name, place and stead, in any and all capacities, to sign any and all amendments (including post-effective amendments)
to this Registration Statement, and to file the same, with all exhibits thereto, and other documents in connection therewith,
with the Securities and Exchange Commission, granting unto said attorneys-in-fact and agents, and each of them, full power and
authority to do and perform each and every act and thing requisite and necessary to be done in and about the premises, as fully
to all intents and purposes as he might or could do in person, hereby ratifying and confirming all that each of said attorney-in-fact
or his substitute or substitutes, may lawfully do or cause to be done by virtue hereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to the requirements of the Securities Act of 1933, this Registration Statement has been signed by the following persons in the
capacities and on the dates indicated.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 30%; font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Signature</B></FONT></TD>
    <TD STYLE="width: 2%; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 46%; font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Title</B></FONT></TD>
    <TD STYLE="width: 2%; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 20%; font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Date</B></FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>/s/
    Suren Ajjarapu</I></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chairman
    of the Board, Chief Executive Officer and Secretary</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">October
    15, 2019</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Suren
    Ajjarapu</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Principal
    Executive Officer)</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>/s/
    Howard A. Doss</I></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief
    Financial Officer</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">October
    15, 2019</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Howard
    A. Doss</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Principal
    Financial and Accounting Officer) </FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>/s/
    Prashant Patel</I></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director,
    President and Chief Operating Officer</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">October
    15, 2019</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Prashant
    Patel</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>/s/
    Donald G. Fell</I></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">October
    15, 2019</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Donald
    G. Fell</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">October
    15, 2019</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Michael
    L. Peterson</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>/s/
    Gary Augusta</I></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">October
    15, 2019</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Gary
    Augusta</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 116; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">II-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>EXHIBIT
INDEX</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; text-align: center; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="vertical-align: top; text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="7" STYLE="vertical-align: bottom; text-align: center; font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Incorporated
    by Reference</B></FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: center; font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Filed
    Herewith</B></FONT></TD></TR>
<TR STYLE="vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 8%; border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit</B><BR>
    <B>No.</B></FONT></TD>
    <TD STYLE="width: 1%; text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 36%; border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Description</B></FONT></TD>
    <TD STYLE="width: 1%; text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 10%; border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Form</B></FONT></TD>
    <TD STYLE="width: 1%; text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 10%; border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>File
    No.</B></FONT></TD>
    <TD STYLE="width: 1%; text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 8%; border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit</B></FONT></TD>
    <TD STYLE="width: 1%; text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 14%; border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Filing
    Date</B></FONT></TD>
    <TD STYLE="width: 1%; text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 8%; text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.1</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><A HREF="http://www.sec.gov/Archives/edgar/data/1382574/000107878218001180/f8k101618_ex2z1.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Membership Interest Purchase Agreement</FONT></A></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8-K</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">000-55218</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.01</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Oct
    16, 2018</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.2</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><A HREF="http://www.sec.gov/Archives/edgar/data/1382574/000107878217000020/f8k010417_ex2z1.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Purchase and Sale Agreement</FONT></A></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8-K</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">000-55218</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.01</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Jan
    5, 2017</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.1</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><A HREF="ex3-1.htm"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Second Amended and Restated Certificate of Incorporation of Trxade Group, Inc.</FONT></A></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">X</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.2</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><A HREF="http://www.sec.gov/Archives/edgar/data/1382574/000107878214001329/form10_ex3z1.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Amended and Restated Bylaws of Trxade Group, Inc.</FONT></A></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10-12G/A</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">000-55218</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.1</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">July
    24, 2014</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.1</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><A HREF="ex5-1.htm"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Form of Opinion and consent of The Loev Law Firm, PC re: the legality of the securities being registered</FONT></A></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">X</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.1</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><A HREF="http://www.sec.gov/Archives/edgar/data/1382574/000107878218001180/f8k101618_ex2z2.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Promissory Note</FONT></A></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8-K</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">000-55218</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.02</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Oct
    16, 2018</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.2</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><A HREF="http://www.sec.gov/Archives/edgar/data/1382574/000107878218001180/f8k101618_ex2z3.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Revocable Warrant</FONT></A></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8-K</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">000-55218</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.03</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Oct
    16, 2018</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.3</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><A HREF="http://www.sec.gov/Archives/edgar/data/1382574/000107878217000020/f8k010417_ex2z2.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Warrant Agreement</FONT></A></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8-K</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">000-55218</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.02</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Jan
    5, 2017</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.4</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><A HREF="http://www.sec.gov/Archives/edgar/data/1382574/000149315219003756/ex10-01.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Indemnification Agreement</FONT></A></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10-K</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">000-55218</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.1</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">March
    22, 2019</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.5</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><A HREF="http://www.sec.gov/Archives/edgar/data/1382574/000149315219000788/ex10-1.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Contribution Agreement</FONT></A></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8-K</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">000-55218</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.1</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Jan
    22, 2019</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.6</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><A HREF="http://www.sec.gov/Archives/edgar/data/1382574/000149315219000788/ex10-2.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Technology Integration Agreement</FONT></A></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8-K</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">000-55218</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.2</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Jan
    22, 2019</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.7</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><A HREF="http://www.sec.gov/Archives/edgar/data/1382574/000149315219000788/ex10-3.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Operating Agreement</FONT></A></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8-K</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">000-55218</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.3</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Jan
    22, 2019</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.8</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><A HREF="http://www.sec.gov/Archives/edgar/data/1382574/000149315219000788/ex10-4.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Shareholder Agreement</FONT></A></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8-K</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">000-55218</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.4</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Jan
    22, 2019</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.9</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><A HREF="http://www.sec.gov/Archives/edgar/data/1382574/000149315219000788/ex10-5.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subscription Agreement</FONT></A></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8-K</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">000-55218</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.5</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Jan
    22, 2019</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.10</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><A HREF="http://www.sec.gov/Archives/edgar/data/1382574/000149315219000788/ex10-6.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Letter Agreement</FONT></A></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8-K</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">000-55218</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.6</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Jan
    22, 2019</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.11</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><A HREF="http://www.sec.gov/Archives/edgar/data/1382574/000107878218001310/f8k111318_ex10z1.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Form of Securities Purchase Agreement</FONT></A></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8-K</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">000-55218</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.1</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Nov
    14, 2018</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.12</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><A HREF="http://www.sec.gov/Archives/edgar/data/1382574/000107878218000694/f8k071118_ex10z1.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Form of Securities Purchase Agreement</FONT></A></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8-K</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">000-55218</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.1</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">July
    13, 2018</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.13</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><A HREF="http://www.sec.gov/Archives/edgar/data/1382574/000107878218000694/f8k071118_ex10z2.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Form of Investment Warrant Agreement</FONT></A></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8-K</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">000-55218</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.2</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">July
    13, 2018</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.14</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><A HREF="http://www.sec.gov/Archives/edgar/data/1382574/000107878217000952/f8k070517_ex10z1.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Promissory Note with Sansur Associates LLC</FONT></A></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8-K</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">000-55218</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.1</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">July
    5, 2017</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.15</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><A HREF="http://www.sec.gov/Archives/edgar/data/1382574/000107878217000952/f8k070517_ex10z2.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Promissory Note with Prashant Patel</FONT></A></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8-K</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">000-55218</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.2</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">July
    5, 2017</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.16</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><A HREF="http://www.sec.gov/Archives/edgar/data/1382574/000107878216003345/f8k082516_ex10z1.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Form of Indemnification Agreement</FONT></A></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8-K</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">000-55218</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.1</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Aug
    25, 2016</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.17</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><A HREF="http://www.sec.gov/Archives/edgar/data/1382574/000107878216002937/f8k060216_ex10z1.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Amendment to Convertible Note Agreement and Note</FONT></A></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8-K</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">000-55218</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.1</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">June
    3, 2016</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.18</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><A HREF="http://www.sec.gov/Archives/edgar/data/1382574/000107878216002504/f10k123115_ex10z14.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Amendment to Ajjarapu Executive Employment Agreement</FONT></A></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10-K</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">000-55218</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.14</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">March
    28, 2016</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 117; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">II-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 8%; text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.19</FONT></TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 36%; font: 10pt Times New Roman, Times, Serif"><A HREF="http://www.sec.gov/Archives/edgar/data/1382574/000107878215001680/f8k102615_ex10z1.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Note Purchase Agreement</FONT></A></TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 10%; text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8-K</FONT></TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 10%; text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">000-55218</FONT></TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 8%; text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.1</FONT></TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 14%; text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Oct
    27, 2015</FONT></TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 8%; text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.20</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><A HREF="http://www.sec.gov/Archives/edgar/data/1382574/000107878215001680/f8k102615_ex10z2.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Form of Note</FONT></A></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8-K</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">000-55218</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.2</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Oct
    27, 2015</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.21</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><A HREF="http://www.sec.gov/Archives/edgar/data/1382574/000107878215001680/f8k102615_ex10z3.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Form of Warrant</FONT></A></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8-K</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">000-55218</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.3</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Oct
    27, 2015</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.22</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><A HREF="http://www.sec.gov/Archives/edgar/data/1382574/000107878215000391/f8k031715_ex10z1.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Indemnification Agreement</FONT></A></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8-K</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">000-55218</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.1</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mar
    18, 2015</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.23</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><A HREF="http://www.sec.gov/Archives/edgar/data/1382574/000107878214002341/f8k122314_ex10z1.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Indemnification Agreement</FONT></A></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8-K</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">000-55218</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.1</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dec
    23, 2014</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.24</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><A HREF="http://www.sec.gov/Archives/edgar/data/1382574/000107878214001742/f8k092514_ex10z1.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subscription Agreement</FONT></A></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8-K</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">000-55218</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.1</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Sep
    26, 2014</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.25</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><A HREF="http://www.sec.gov/Archives/edgar/data/1382574/000107878214001742/f8k092514_ex10z2.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Warrant Agreement</FONT></A></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8-K</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">000-55218</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.2</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Sep
    26, 2014</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.26</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><A HREF="http://www.sec.gov/Archives/edgar/data/1382574/000107878214001742/f8k092514_ex10z3.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Registration Rights Agreement</FONT></A></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8-K</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">000-55218</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.3</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Sep
    26, 2014</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.27</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><A HREF="http://www.sec.gov/Archives/edgar/data/1382574/000107878214001641/f1012ga090214_ex10z9.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">RxTPL Logistics Services Agreement</FONT></A></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10-12G/A</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">000-55218</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.9</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Sept
    5, 2016</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.28</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><A HREF="http://www.sec.gov/Archives/edgar/data/1382574/000107878214001329/form10_ex10z5.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Employment Agreement - Suren Ajjarapu</FONT></A></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10-12G/A</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">000-55218</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.5</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">July
    24, 2014</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.29</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><A HREF="http://www.sec.gov/Archives/edgar/data/1382574/000107878214001329/form10_ex10z6.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Employment Agreement - Prashant Patel</FONT></A></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10-12G/A</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">000-55218</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.6</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">July
    24, 2014</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.30</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><A HREF="http://www.sec.gov/Archives/edgar/data/1382574/000107878214001329/form10_ex10z7.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Related Parties - Promissory Note Patel</FONT></A></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10-12G/A</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">000-55218</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.7</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">July
    24, 2014</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.31</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><A HREF="http://www.sec.gov/Archives/edgar/data/1382574/000107878214001329/form10_ex10z8.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Related Parties - Promissory Note Sansur</FONT></A></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10-12G/A</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">000-55218</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.8</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">July
    24, 2014</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.32</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><A HREF="http://www.sec.gov/Archives/edgar/data/1382574/000107878214001079/form10_ex3z1.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Bylaws of Trxade Group, Inc.</FONT></A></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10-12G</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">000-55218</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.1</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">June
    11, 2014</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.33</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><A HREF="http://www.sec.gov/Archives/edgar/data/1382574/000107878214001079/form10_ex10z3.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2014 Equity Incentive Plan</FONT></A></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10-12G</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">000-55218</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.3</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">June
    11, 2014</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.34</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><A HREF="http://www.sec.gov/Archives/edgar/data/1382574/000107878214001079/form10_ex10z1.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Merger and Reorganization Agreement of XCELLINK INTERNATIONAL, INC., a Delaware corporation (predecessor to Trxade Group, Inc. a Delaware corporation) and Trxade Group, Inc., a Nevada corporation</FONT></A></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10-12G</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">000-55218</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.1</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">June
    11, 2014</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.35</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><A HREF="http://www.sec.gov/Archives/edgar/data/1382574/000107878214001079/form10_ex10z4.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Form of Indemnification Agreement entered into between Trxade Group, Inc. and its directors and certain officers</FONT></A></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10-12G</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">000-55218</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.4</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">June
    11, 2014</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.36</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><A HREF="http://www.sec.gov/Archives/edgar/data/1382574/000107878214001079/form10_ex10z2.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Series A Preferred Stock Purchase Agreement</FONT></A></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10-12G</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">000-55218</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.2</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">June
    11, 2014</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.37</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><A HREF="http://www.sec.gov/Archives/edgar/data/1382574/000149315219010501/ex10-1.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Form of Securities Purchase Agreement (July 30, 2019 Offering)</FONT></A></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8-K</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.1</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">July
    11, 2019</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.38</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><A HREF="http://www.sec.gov/Archives/edgar/data/1382574/000149315219014871/ex10-1.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Form of Securities Purchase Agreement (September 30, 2019 Offering)</FONT></A></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8-K</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">000-55218</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.1</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">October
    2, 2019</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.39</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><A HREF="http://www.sec.gov/Archives/edgar/data/1382574/000149315219015507/ex10-1.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Trxade Group, Inc. 2019 Equity Incentive Plan</FONT></A></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8-K</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif">000-55218</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif">10.1</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif">October 15, 2019</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">14.1</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><A HREF="http://www.sec.gov/Archives/edgar/data/1382574/000107878215000415/f10k123114_ex14z1.htm" STYLE="-sec-extract: exhibit"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Code of Ethics</FONT></A></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10-K</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">000-55218</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">14.1</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mar
    23, 2015</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">23.1</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><A HREF="ex23-1.htm"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Consent of Independent Registered Public Accounting Firm</FONT></A></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">X</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">23.2</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><A HREF="ex5-1.htm"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Consent of The Loev Law Firm, PC (included in Exhibit 5.1)</FONT></A></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">X</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">24.1</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><A HREF="#poa_001"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Power of Attorney (included on signature page of Original Form S-1 Registration Statement)</FONT></A></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">X</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">101.INS</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">XBRL
    Instance Document</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">X</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">101.SCH</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">XBRL
    Taxonomy Extension Schema Document</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">X</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">101.CAL</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">XBRL
    Taxonomy Extension Calculation Linkbase Document</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">X</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">101.DEF</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">XBRL
    Taxonomy Extension Definition Linkbase Document</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">X</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">101.LAB</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">XBRL
    Taxonomy Extension Label Linkbase Document</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">X</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">101.PRE
    </FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">XBRL
    Taxonomy Extension Presentation Linkbase Document</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">X</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 118; Value: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">II-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>
</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-3.1
<SEQUENCE>2
<FILENAME>ex3-1.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin-top: 0; text-align: center; margin-bottom: 0">&nbsp;</P>

<P STYLE="margin-top: 0; text-align: center; margin-bottom: 0"><IMG SRC="ex3-1_001.jpg" ALT="" STYLE="height: 868; width: 670">&nbsp;</P>

<P STYLE="margin-top: 0; text-align: center; margin-bottom: 0"></P>

<P STYLE="margin-top: 0; text-align: center; margin-bottom: 0"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid; text-align: center"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%; text-align: center">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">&nbsp;</TD><TD STYLE="width: 33%; text-align: center">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; text-align: center"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="margin-top: 0; text-align: center; margin-bottom: 0">&nbsp;</P>

<P STYLE="margin-top: 0; text-align: center; margin-bottom: 0"><IMG SRC="ex3-1_002.jpg" ALT="" STYLE="height: 868; width: 670">&nbsp;</P>

<P STYLE="margin-top: 0; text-align: center; margin-bottom: 0"></P>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid; text-align: center"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%; text-align: center">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">&nbsp;</TD><TD STYLE="width: 33%; text-align: center">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; text-align: center"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="margin-top: 0; text-align: center; margin-bottom: 0">&nbsp;</P>

<P STYLE="margin-top: 0; text-align: center; margin-bottom: 0"><IMG SRC="ex3-1_003.jpg" ALT="" STYLE="height: 868; width: 670">&nbsp;</P>

<P STYLE="margin-top: 0; text-align: center; margin-bottom: 0"></P>

<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid; text-align: center"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%; text-align: center">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">&nbsp;</TD><TD STYLE="width: 33%; text-align: center">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; text-align: center"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="margin-top: 0; text-align: center; margin-bottom: 0">&nbsp;</P>

<P STYLE="margin-top: 0; text-align: center; margin-bottom: 0"><IMG SRC="ex3-1_004.jpg" ALT="" STYLE="height: 868; width: 670">&nbsp;</P>

<P STYLE="margin-top: 0; text-align: center; margin-bottom: 0"></P>

<!-- Field: Page; Sequence: 4 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid; text-align: center"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%; text-align: center">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">&nbsp;</TD><TD STYLE="width: 33%; text-align: center">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; text-align: center"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="margin-top: 0; text-align: center; margin-bottom: 0">&nbsp;</P>

<P STYLE="margin-top: 0; text-align: center; margin-bottom: 0"><IMG SRC="ex3-1_005.jpg" ALT="" STYLE="height: 868; width: 670">&nbsp;</P>

<P STYLE="margin-top: 0; text-align: center; margin-bottom: 0"></P>

<!-- Field: Page; Sequence: 5 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid; text-align: center"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%; text-align: center">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">&nbsp;</TD><TD STYLE="width: 33%; text-align: center">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; text-align: center"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="margin-top: 0; text-align: center; margin-bottom: 0">&nbsp;</P>

<P STYLE="margin-top: 0; text-align: center; margin-bottom: 0"><IMG SRC="ex3-1_006.jpg" ALT="" STYLE="height: 868; width: 670">&nbsp;</P>

<P STYLE="margin-top: 0; text-align: center; margin-bottom: 0"></P>

<!-- Field: Page; Sequence: 6 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid; text-align: center"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%; text-align: center">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">&nbsp;</TD><TD STYLE="width: 33%; text-align: center">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; text-align: center"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="margin-top: 0; text-align: center; margin-bottom: 0">&nbsp;</P>

<P STYLE="margin-top: 0; text-align: center; margin-bottom: 0"><IMG SRC="ex3-1_007.jpg" ALT="" STYLE="height: 868; width: 670">&nbsp;</P>

<P STYLE="margin-top: 0; text-align: center; margin-bottom: 0"></P>

<!-- Field: Page; Sequence: 7 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid; text-align: center"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%; text-align: center">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">&nbsp;</TD><TD STYLE="width: 33%; text-align: center">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; text-align: center"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="margin-top: 0; text-align: center; margin-bottom: 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>ex3-1_001.jpg
<TEXT>
begin 644 ex3-1_001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 2X Z0# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 >.:_-=W/C_2HG^T2VJ:E"+BY@C5[>)Q.A12&P8270\ACDL.6R0WL=>0:_
M#)=_$/038VKO+IUS$KW"NF8;<S1C(7*@ Y\HJ%##Y^"%R_K] !1110 4444
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MQ+J=Q#\3= MS$UC&^J01B"WVN9P9!AR23M7C!& ?D(QCD>X4 %%%% !1110
M4444 %8?BV]U"Q\/ROIFCMJUS(ZQ?90P7<C'#$G_ '<U>UJ]FTS0M0O[>V:Z
MGMK:2:.!<YE95)"C )Y(QT[UYOX?\>7,U[#J.H>,M#N-(2TDN-2A6W^SO9O\
MFR,!G+MEF(Z?P8ZL!0!%X3\,ZG%XBF>VL-:C\+I8S0C2_$,L4@WMTBB&7*Q;
M<#)ZXP=W-5O#]KJ/AKP= -#^&LC>)K"T"O>W=O;1AY#P^'63?(,;NF"0 .]=
M%I/Q<TF\U.6TU.PN]'3[/)<P37;(1*D8W.,(20P7YMO/0^V9+#XD7EYK5C82
M^#-;M4OTE>UDGV*9 D9D P3A6( &&8#)Z\&@#D/AUX9OM'\?>?<Z%J:V-YIT
MMO)-<:;:VT8=F5SN2)B%0^60!S]X=!S4FD^'[ZT\*3:7I7@22P\3QK<;=7>&
MU00LS.P\N;=O;@A%( P,'@"NBT[XLKJ&)#X7U:&U@G,&H7;A?)LR&VDL^<-M
M^\V/NC'TJ?2?BK9ZIK<-B='OK>"Z#?8[B1D_?L%+!=H.5+ ' ;'.!UH X3P/
MX%\1+XGT6[F_M&SCL91+<3S:-:6KO\IRC3)*TLH;E22#UR<'%>X:HEY)I%ZF
MGNB7K0.+=G^ZLFT[2?;.*X+PE\0?$&O:S=07/A'4$LS?M;I,IC M0@"L)"6&
M2'#$XYYP,G JSI/Q3L]5\;IX9&F30RR2R1)*US"Q!1&<[D5BR@A#^GK0!S>E
M^&F%MHRVG@N_TS5-,NHKW4M5N3$\T[)EI4217+S&0[EQPN&[# J_X7TZRO/&
M^K7VI_#Z[MY-0O1<6US=V$!2V"1+\Q;<2KLZLQV@\L#G))J[;?%::ZO[JP@\
M&:[->6<XBNHH%23R5..68';N.>%SV;) %2K\4MWA2'6O^$=OC-/JG]EPV(E0
MRM)@^_'*L,=>,].: ._FD,4,D@1Y"BEMB#+-@=![UY392>(=0T7Q+H]OX2U.
MTN]=N[ES=W12*&&*51&KL=Y8NJ!<JH/(.*]9K@;OXI6<-U)/;:/J%YH$,HBG
MUN$ VR\@,R]W12<%AZ-C..0#R^'X?>+;F[^R3PWD5W]I#&Y&D6DBQ@2##)>/
M*)B%4#'&<#;BO1I]:O[SXA:=J;^$O$1LK.TFMHB;>(;9973,G^LSMV)WYYZ5
MG>*O'/BJX\8W'AGP]I&HPFR3S)KBV2&223<1L($@VJF-W)R2<=,<^HV,-Q;V
M,,-U=M=SH@5[AD5#(?[Q5>!^'% '@OBCP]XBUOQ'<:Q=>&]2_M!;U#Y=MI]J
M8EMT<!2)B_F2/L .?EY..%6K_BWP1XGN_%>L1Z!IT-GI=_?)#*T405;B.>U5
M9)),<,D3J6 QG?(Q'/-=#XM\;:M:^)-7TJUUO3=$ELHD-A#>VNXZD[1[^)79
M40;L)GG!R3V%6=3\=^)-+\9Q:'%X;NM4^S:<LUVUJ%'G2/M =,GA 5D7GG/T
MS0!YWXJ\!ZU="[LK7PU=J+!?LED+6PM3&]NORK(968R/(V=Q  ()/H378ZU9
M1>(_B3I^H:CX"U>>PMX'@8O:P 33%U"-(=_SQ!03ACP<<=:U_%/Q9MO"EU;P
M7VB70=[9+B17N8$:/(R5"E\LPZ''?IFG^)O'FM:5XYM=#TOPS?7\26[W%P8P
MH,RX4 QG/ 5F )/?C'>@#@_$G@37T\5:C#:6$AT^1P-.BMM"LKNWBB.3M#3.
MOD_.SD@#'.[)KV;PIIMQH_A+2=.NY9);BVM(XY&DQNR%'!P2..G4].IKEM6^
M*<.F^5!'H-[<WXA66\M4EB!M"PR$8[N7[X'(!&<9 KM=)U.UUK2+34[*3?:W
M42S1MWP1GGT/8CL: +E%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 >1:_#IR>.=!:Y6&ZF6^0QR$22,[?:$$9^0J$91))EF
M#H=JX(9SCUVO&M5,5O\ $GP_<Q?8H&N=2:$,;D"8X.06((^\KRH,[MV\  EA
M)7LM !1110 4R6:.")I9I$CC499W8  >Y-/KCOBE=00?#O58)I(T:[1;6/>1
M]Z1U3."1TW9]L9H ZFUO[.]W_9+N"XV8W>5('VYZ9QTZ&EMKVUO#,+6YAG,$
MIAF\J0-Y<@QE&QT89'!YYKRR/1_#.E>.K6+P==6>E-'IEPFH7EM*LB0[C%Y(
M;<2N\D%@#U )Y%.\+W^J:E\'=2U;2-5CM];E>YU#?'9VZ2,P=MHE0*%+.J#+
MD \YR<<@'?>*=%N]?T;[%8ZM+I<XE29;F*,.04.Y>"1D;@I([@8[UQ@^'5GX
MGBU2/Q'XJ&OZNB"T^T0PQ0_8E!#JIC3(W;N3NZC P.I@\*ZMXC\3_P#$X7Q7
M+:>'H+..(SS6MN#<710%W!*8"*S 8S]Y2O8TSP+XEM=+\$:_K>I:EIPN'U*?
M%P]M'!ORXCC:40KELODE\'[Q["@"UIOP:L$M;M-8U".[GN(9+<26.EVMB(T8
M#D!$)+C!Y)Q@XQ5FP\/^)+AK^U_X6BUWJMHB1QB&Q@ M"Q!)FA!.\LJD+O(Q
MEB,GIB^#O$_B>?QG-IOB375B LY+E88EM9X"N0H?S8\-'@GA7'./O9QF'0?%
M4WAWPSXY\0S/!JM]:Z@\,92UA@ENHXV6,3.8E&]-SM\W. #S0!T^@?#J[L?#
M6I>'=<\1R:MI=VCJD*6:6QA+NSNP8$EB6;(R<#T(Z0>$OA:OA[6(=2O]2L[Z
M:V_X]A;:+;6>TE2I+,BEFX(Q\PQ@YSGC$O?%VNZ/>:6?^$LLM7&HVL\UU##;
MQQI9(D6_S4?JH!X'FYW>F>*T/#>K>)8-:\(Q:IXHCU)]9M))[FS-K#&(@L6[
M*,@R2'(7DX/S$#C@ TK#X=ZA9Q7VGOXRU1M&G,YCM8XHEE4R[]Y>=E9Y#EV(
M)P<X/:LBP^$NL:?<Z=>6_C*..\L$EC@>/18$1 T>Q2$4CYAEB22=V0.,$GTC
M5K_^RM&OM1\B2?[+;R3^3']Z3:I;:/<XQ7FUKXFUM3X;U0^+;*^?5[J%9-'A
MMXQ''#(I9RK?ZP>6GS98]1@CD"@!+"T_X5(=0U3Q'XY6\L[V>2[DL%L(H9)[
MB1E#2+\Q8X[JN .O0'-KP#X?M]1\4:SXOGL=0M@U[*--MK^)HS"KJAEE5"HQ
MYA)Y';(/.:Q]$T&U\:^.]:U"_P#$5IJT%C>)9Q17&GVLAFCC&]T >,E5#R.N
MY,;@,Y. :]=F9;*PD:& LL$1*0Q+R0HX50/I@"@".]NM/1&MKZXMXUE1@8Y9
M NY<<]3TQFN,LOAFUM;_ -CW'B34+GPO&08-(:.-<#.XI),!OD3).%XXP#G%
M<I;Z+X \3>"H-<\0SQWFM:NL37$\$I-R;AV"B*-,G&#B, #&%YXR:(/&6JS^
M"[;Q-IOB'3K#>Z1:?X9@MXBC 2"-("2!)N(!Y7: .0,#- '3Z'X"\3Z5XNGU
M^Z\<?;&NS&+R'^RHT\Y$!"H#N.P#)^Z!GJ<FO0J\HMM8\1Z]\1?$>BZ=XVM[
M/3;00&!C:P2R%I%+A8N &4="6W'@#OD9FH^+]=CLO%NJKXYBM!I6J3VUEIS6
M$3R2LC +$PQN()(4,O(!+,>"% .F/PXUJZ:6PU/QI<WGAZXG::?36L8PTF7\
MPKYQ)8+OYP!TX&.M:VL>#]2OO%#:OIOBB[TJ.XMTMKR&*WCD>1$+E?+=P?*^
M^W0'GGK7%/XVUW4?"VH^)V\2V^BS632)'H;6B,[R1G:(Y0_SAG<8PI^4,.20
M:UKK6=?U/X@+I%CXLM=-MI-,BGFB\J"8Q3L^S9$3U;*'.XL/FX!XP 5M4^#=
MUJ#:JB>+95MKZ3S\3Z;!++YA(+&27 9UQN 7Y0,KUVX/2ZUX3U.]U[3M2LO%
MDVF72VHM+O9:Q2&YC#!CY8?(B8G.2 ?X>/EY\]\5^./%5A!<R:3KJ-%IC-93
M2SM:0O=7*$JQ6$HS-R#P"N<''K71>*([F^^*5F/^$O32K>RTQKV F*$B%I&$
M>09 0VY5DYZJ.!@$Y *^O?"W3H-574;CQ/9VEI=/$ET=5TZTN)KB7&T[)I5^
M1F ' 4C=DXYQ7I^FZ?!I6EVNGVPQ!;1+$G '"C X  _("O.?$EPE[K7@VS;Q
M18WUE).LET9[6UGCD$<;2&7)'R%QA 5P!NR,]Y-0\5WVK>(M?L8?%-IX:LM%
M"99K=9)Y]R;_ ##Y@*>7C. N6.,G (! /3**\AT?Q%XL\2SQ277B&/0$@T.*
M_OH8(()]C.\FU@&!9<Q(CD'.-X& <55O/&_B_4/#VCRZ3J>EB[&GQ3ZDB7$$
M,X>0!E8>>ICQLR2!CG/3 ! /:**Q/!][/J7@[2+ZYNY+N:YM4F:>6W$#/N&<
ME!P.O;CN,BMN@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MJ&LV]I#&(9G90%W'#N067=@<9'7-=S#H>DV^I2:E#I=E'?RG,ETEN@E<].7
MR?SKRQOAS?>(?%)O)M*O-#L)+];Z\AEU-98YY5.=T<,? 9NA=CP"<+GFO7YF
M=(9'CC,CJI*H" 6..!D\#- 'DNI:]X:T==8N-#\#&PN]*G>U;6%TBW,-M(,
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M@;2"3CM6CX9UN7Q!HZZC)9+:+(Y$86ZBN%=1_$'C)7KD=>U8VLW>L7,EBS^
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M9!]H61A&-DD6&4Y'SA1(I#%ADLH&4!KW6O*O%(F'C3PY*UO,;/[="EK*\6]
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M36:6?P7\==0UK6%F32M>LECMKA8GEV3*(_W;[0<$"-SW&,'/!QB+:76K>/\
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M&/\ :<:L@N(T!+-%B1 Y+,!C;\N22I&5SM;VB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *0JI() )4Y&1
MT-+10 FU0Q; W$8)QSC_ "32"-%=G5%#-C<P')QTS3J* (T@ACFDF2*-99<>
M8ZJ SXX&3WQ4$FEZ?-%%%+86KQQ B-&A4A >N!CBK=% %5=,L%DBD6RM@\(V
MQL(ER@] <<=3T]:F:"%YXYVBC::,,J2%064'&0#VS@9^@J2B@"A;Z'I-I+YM
MMI=E#)NW[X[=%.[UR!UJ>ZL+.^""\M(+@(=R":,/M.,9&>G%6** ,NW\-:#:
M79N[;1--AN6(8S1VJ*Y(Y!W 9I@\*^'56%1H&EA8#F("SCQ&?]GCC\*UZ* $
M5510J@!0,  < 50@T'1[6XN[BWTJQAGO,_:9([=%:?)R=Y RV223GUK0HH P
MD\%>%(TD2/PQHJK*NR0+81 .N0<'Y>1D _4"M1=/LDT\:>EK"EF$\M8$0*BK
MZ #@#Z59HH RKWPQH&IS--?Z'IEW*PP7GM(Y&(Z]2/85=LK"STZW%O8VD%K
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MN <$$CH33?#O@O1/"NG75AH\-S;VUR273[7*V,Y^[EOD.#C*X)P,DD UT%%
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M?O=6N[IK>4/8W;HHDM ,95,8R#@\$D<Y !&:TO#/P\N= \3R:[<>*=3U.>2
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** /)O%,>G)XJ\._NW:_N-5A'FAS%$722(G<A7+,4#8
MW,<%1@L<UZS7BWB^^:?XH^%(;N6:-;>Z@>T@%KM4^;*  Y&[Y@H<8.TC&<<F
MO:: "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HK \4^,-*\(06LNIFX)NI3%#';PF1F8#)X%<]I?QD\*:MJ-O96QU 23W"6
MRL]HP02.=JJQ[9)Q0!Z!17GUQ\9?"EO-<PD:F\EHS+<*EBY\K!/+'H!P3^%:
M^N_$/P[X?T.RUJXN9)].O#B&>UC\U3]2.GI]>* .JHKA;GXM>&;33=)U";^T
M!;:KN^RN+1CN*OL(P.^>W7!'K79W=[:V$'GWES#;0[@GF32!%W$X R>Y) %
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M*IGB^(?A_37,LER^LVURX8HF%#?<4+G< OENQ?)!3AOF6O;* "BBB@ HHHH
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M->+:VEQ%XX\,RR7@EN)M50M-!Y:QW"!P%;=C*N4;E5/S#*X/S-7M- !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MPVEU!=)X?TM;BW"""06<>Z+:<KL./EP>F*V:* ,BU\*^'K&TN;2TT+3(+:Z
M%Q%':(JS $D!P!A@,G /3-1R^#O#,^FC3I/#VEFS#,ZP"T0*K,,%E '#8QR.
M>*VZ* *]C8VFF645E8VT5M:Q#;'#"@55'L!6)<> ?"5U:?99_#NG/%YK3<P#
M=O8@LV[KDX&>>P'85T=% '/)X$\*I87%B- L&M;B7SI(GA#*9,$;QGHV&(R,
M$9IT?@CPM#97EG%X?TZ.VO&5KB*.W55DVD,H('8$ @=/S-;]% %:+3[.&_GO
MX[:-;NX54EF"_,ZKG:"?09/YU9HHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#R+Q/>+:>.?#EOJ,
M5Q=)//"L;6TA"0NUVCQM)CAE("#:6QN!;#G##UVO%_%ZP3^-O"#2R>;&-5MX
MX6MCB.-T974?<(9=K%0%(P-K,0<BO:* "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH ***@O;.WU&PN+&[C$MM<Q-#+&20&1
MA@CCU!- #K>Y@NXO-MIXYH\XWQN&&?J*EKR_X _\DO@_Z^YOYBO4* "BBB@
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MQG.:L^+/&47A<P0QZ9>:G>SQ33I;VH7*QQ -([$G@ 'CJ22 !DT =-17$_\
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M]R!;,<,Q;Y@.I4;"2V,<KC.17:03PW5O%<6\L<T$J!XY(V#*ZD9!!'!!'.:
M)**X*T\<Z7I'A=]4DN]6UA9]5ELX$6V#3O*68B)%& 0 IQTZ5TWAOQ)IWBO1
MUU32WD:W9VC(EC*,K*<$$&@#7HKSKQ%#XITNXT<KXONTEU361:.D5K;F**%E
ME=0BM&6W *HR6/OGK5K4?&^F_#YO[/\ %.OW5_=3%[BV?^S]K^3V5C&H1F!#
M<@+QC('4@'=T5QE[\4_"ME#+(UW<2"*ZBM)%CM9-ZR2*S)\I 8@A"00"#QC-
M6;WXB>&[#6H-+FO)#-+Y0>1(6:. R'$:RL!^[+>C8]3@<T =517EGQ:^)47A
MK3;O3='U62V\00B&13' DJ#<W^K<L"%8H&< X. /6M^3XE>'-)N-.TS5=47[
M=+;PR7$JQDQP%P-IE8#$>XD=<8!!. 0: .THJO?WUOIFG7-_>2>7:VL3S3/M
M)VHH)8X')P >E<-ILGBK7M&B\33^)H]$M;I?/MK'[+"\:0M_JO,D;+%F!4G!
M R< "@#T&BN-3X@Z5I'AG2[_ ,47<5C=7-MYLB1*TRY5E1B-@./F=>#SSCL<
M2R?$[P9#J%E8RZ_;I<7L,<\*LK@;)%W(6;&$)!!PQ!P1QR* .MHKF[KQ[X9L
MTUI[C4MBZ*\::@?(D/DF1MJ#A?FR?[N<=ZCU3XC>#M&W"]\16*LL23;8Y/-8
MH^-I 3).0P;C/RG=TYH ZBBHK:Y@O+:.YM9XY[>50\<L3AE=3T((X(KE_B5K
M.J>'O E_K&CRA+JS*/@PB4.I8*01V W9SVVT =;17+Z=XKTNPT2W&N^(]-.H
MI:+<W0:1(G 8!L^7G(&& 'KQZU:U7QIX=T30;;6]0U2*+3KG;Y$RJS^9N&1M
M"@D\<].* -ZBH;2[MK^UCNK.XBN+>4;HY87#HX]01P:FH **XOQM)XML;75-
M7TG5[&STZPTY[@0R6GGR32H'9@22H0$!0#\W?BL34-9\=:=X2.OIJFCW-I-I
MD=UYGD;?(F)0X0[@KH0S8+$8P"?< ]/HK/L];TF\^U):ZM9W367%UY=PC&$\
M_?P?E^ZW7'0^E.T[6M*UCS?[,U.SO?)(67[-.LFPGH&VDXZ'KZ4 7J*K7^HV
M6EVC7>H7EO9VRD!IKB58T!)P,L2!UKF]!\8V$VDWE_JNO:3]GCOY;>&[69(H
M748*@$L03@^IH ZVBN4UCXB^&='ETI)-6LI1J4H6-X[E"B1_-F5FS@)E2N?7
MCL<;_P#:VF_VI_9?]H6G]H;-_P!D\Y?-V^NS.<>^* +E%%9,?B?0KC3;K4;7
M5[&ZM+49FEM[A)%3CH2#P3V% &M17 _#[Q/KWBU5UF:;2CI=TCDV,,FZ>Q(;
M"!F&=^X DY"X_2D\2>,=4;QC'X7\-76DQWJ6+7CR7Y+QR/Y@C6 ;6!5B<D]3
MTXH [^BO,_$?C+Q;X7\-:5?WH\/SW5YK"V3BS$LD0B8-@ABRG>"C \$?E7:V
M-UJ2ZGJZZI-IBV4#(UKY#,)%C*DDS9.!R.",< T :]%117,$\CQQ3QR/& 75
M'!*@C(R.V1TJ"VU;3;R5HK74+2>1)#$R13*Q5P,E2 >H'./2@"Y16;K4^H06
M]L=-:S65[F-'-V2%\LGYMN"/F[#W[&JUCXHT^^UW6-+26-6TH)YTAE&,E=S<
M=@H*Y/3)QV- &W14%I>VNH6XN+*YAN8"2!)#('4D=>1Q4] !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110!XMXUNIX_B+X5MK*8);+
MJ5O',&4-\WFJ3&C*,D?*3DC@ALE22#[37D&KW-@_C30'$!1X;Z(6_F6$BNCO
M(N]'([ 22$$_)N;"@X<)Z_0 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !115#4=<TG2&B74]4LK)I3B,7-PD9<^VXC- %^BJ-SK6E69(NM3LX"
M$#D2SJORD@ \GIDCGW%5-.U&Y^UZV=0O-,-I:3XB:"7YH8_+5B)LG"L,D_0Y
MXH V:*P;GQ-I]UHUW/H6L:-<W2Q/Y#/=JT/F8PN\J>F2,XJW;:M%!IMNVK7E
MA;WGDQM<JDX$:NP'W23G:6R!GK0!IU7OTNI-.N4L98XKQHG$$DB[E23!VDCN
M <<5!>ZYI.FPP37^J65K%<$"%Y[A$60XS\I)Y_"LF\UW4[3X@:5HS6]G_9E_
M:SR)*'8S>9%L)R,!0OSCU)]L8(!B>!_ NM>$O ^I>'VUF S3"3['<P1$&!W4
MC<<]<-@_A7=6D<L-E!%/)YLR1JLDG]Y@.3^)J/4M0@TG2KS4KHL+>T@>>4J,
MD(BEC@=^!7#7WC#QC9^$9/%0\/Z<]@L/VH61NI!<K 0"&8[-H8 [F7L ><T
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M!>VTMW!_KH$E5GCZ?>4'(ZCKZBK5 'G7P1FM9/AEI\43QM=0%DN=L95@2Q=
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MAN5Y.!NSVJKI?CS1H=#LX'^UG4XX%B;34M'%P9E4 QA,  YXZA1USMYKM**
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MC3M:LM8M=-9=0LHO)MYFN97*)M*XPS$'Y6(Y!H ;\0[7[9X*O8_M$\&'B;=
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M&5=W W88A\-GYE'; &QX+\+)X-\,P:'%?2W<,#NT;RHJE0S%BO'N2><GGZ4
M9OQ#M8KBV\/L\4;NNNV6&9-Q \U=P''?'^-<UX@\4^*](T3QG)%JEK+=:#=6
MYBD^P\2121JQ0J"<$>8/F_V>< G'3S> (+GQXWB>;5]29=\<JZ>)<0+*B!%;
M'?C/XL>>U4/%'PLMO$][J\KZ[J=I;ZJ(7N;6%E\MI8@%1CD9(V@97H2 >JC
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MUEAPC+NZD<C@4 3GXG:_!HNE:C>> [N/^U+AH+:".]5Y&/E[T)!4$;B" #R
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M##R\LK8VJ< ]&QSV\BG6-"9&CEM#>6Q!291OBWKT8 XR,\@'MUKSKP9K.H>
M_"%OX=UKPSK<U[IYE57TRP-Q%.A=F5E9/E!.<8;!R,G&: .GM/&MEIOAW29_
M%]Y::/JES$OFVT\@1MXX8A3R%R.O09'-:LOBKP[;[O.U_2X]L0F;?>1C$9(
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M'S)M*G0>=%))(ZD-&#N",IZ<Y ') (!T&C^(QI_@V/6/%&OZ+/&SD?;;!O\
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MW$G(!SN"^U=[7$?"22%OAKI,$<;QRVZ>5<(\+1D2#DY! SP1STKMZ "BBB@
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M*T+2(" '7&1R!Z@^X(-</\0O$VE:K*GA*'Q/8Z<DDA&LSM<QH8[8 AX5+?\
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MI=^*+:W\0ZG!:3Z%#=^?%<_:)OM$DSH)$WG R"@.W;\N""I 89;ZC#I/P_\
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M[NUWE/-CSM)'4#/UK0KPOPS>:_8_!+P9)X?U6.QGFU,VCB2W659!+=.@SGD
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M<<X;+CCC!I:Q<Z_'XA\2W5W?036</A<W2Z1<POY(WF3*/APK$>407."0V
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M0LP!ZD#KTKDX-3U+POKOB&UO]>?5K*UTHZJGVF-1- 07W*3&H!4A<C ]@!W
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M:U:&ZTZY2X@#M&77/#*<$'/<5=H **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** /$_$ MH?%WAJ5II##<:I9^6C&1AY_GRL2CE<XV2
MKA,JFU\A1Q7ME>,>);%SXU\%RRQN;F&^@$:LJK%(K$,YB;Y20BLN05!PL8 .
M'(]GH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ K@O$_PQCU_Q
M#)JUGXBU;1VNU2/48K&78MTB*57.,?, <9;<,<8KO:Y[QKXD'A;PQ=W\7DR7
MY7R[*WD/,\QX5%4<L<\[1R0#TZT 8%W\*K2:YU!+36]2LM+U,1"_L(BI$^P8
MX<@LF0 #M//(Z<"S?_#^2XN=?-EK L;/5["/3S:16:;(8T0H-O/HSX QC=["
MMVW\2Z</"-MXAO;ZVALGMXYI+C=B-2V!_P"A'&.N>*JK\0/"#QW4B^)=,,=K
MCS7%RNT9SC!S\V<'IF@# TWX9W5A>BY?Q&\K1Z(NB0@6:KLA!SD_,<G./_KU
M77X2RQV>GBU\5:C87UI:"R:YT]! )H0.%90>2"6;=G.6]0".PU/QAX=T:PL[
M[4=9M+>VO5WVTCR#$RX!W+CJ,$<].1ZBFWGC3PQIX!NM?TZ/, N1_I"G,1V[
M7X/0[EQZYXS0!RW_  J.UM-L>C>(]9TV":T^R7ZQRJ[7:[R^\LP^5R6?Y@/X
MN !D-<UGX=S:A=2O8:[)86\NA_V,\'V5) Z?.%8G(/ <\+CD#G&0=W6/%VAZ
M/I%O?W6L65M%>)NLYI7RDN5R" .2N"#D>H]161X9\;0GX<:5XD\4WMI8M=@[
MG;$:%BS;0HW'/RC/7. 20.0 "I:_#W5;"VT:2S\4F/5-+M#81W+6(,<EO\N$
M:/>,D;1@[OKD\U-8^ ;[2F\.6]AXB<:;HTK3M!/:"22YF?S1(YDW#&1,X P<
M=>:V=9\8Z#I.D17LNN:?!'>(WV.XD?S(I& ZC:?F .,X/XU5^'&OWWBCP%IV
ML:D8C>7!F\SR1A/EE=1CD]E'>@"7P;X:O_#-KJ$5]K":DUY>R7FY;00!&D.Y
MQC<V03S[5%JW@/3M:\:6?B.]EED-M;K#]C8_N7*L[*S#N07;@Y%:Y\1:.-?&
MA?VC;_VJ4\P6@?Y]N,]/ISCTYJ)/%?AZ2:UBCUO3WDNY3#;A+A6\UQU5<'G'
M ^I ZG% '*)\+(;#X=WGA+2-0CLQ?3/)=7<ELTI=2>BJ9!M( 1<Y(PI.,G-/
M?X=ZHNJIJ-GXG^QS2:<EC=B*P4B?8K!"-SDH.5R <G:<,N<A_P 2/B#%X2T*
MZ?2[_2Y-9MPDGV*Y)<O&7"'"JRD$%L]>@/'IV.JG4!I5T=*\C[>(R8!<(61G
M'0$!EZ],Y&,Y]J .1T[P'?Z:/"<,.KVQ@\/!N7M&+7)=61^D@"?(W'WN>3P,
M'5\4^'M3UF\TJ[TK58=/GLGEW&:T%PKJZ%3\I(Y_$<$_0\EIGC[Q2-.\+:UJ
M=KHTFEZ[=P68CMO,CGA>3(#?,2K#()QP0,#GDCT6]UC3--F@AO\ 4;.UEN&"
M0I/.J-(V<84$\GZ4 9/@OPW>>%=%?3+K5!J$:SRR0MY B**[LY#8)W'+$YX'
M. .*R)/"&O:+XGU+5O">I:;;VNI[7N=/O;5FB250!YB>6RX+?Q>IY.>,=5=:
M]H]C>I97FJV-O=N-R037"([#U"DY-4=.\:^&=6%^UCK=G-'8<W,HDPB#&2VX
M\%?]H$CWH YN_P#AYJMS9V%_'XDD;Q197LE['J$T9,0\Q0CPK'NPL954'<\'
M^\:@;P-XN>XTR>Y\36]])!J::G.;B)P%95*^5"H8A(]KMVR3@\=*[*[\4Z#9
M:,-8FU>S_LYF")<1RB178]%7;G<?89-7?[3L,PC[;;9G_P!4/-7]YSCY>>>?
M2@#EM0\*:U)XGUK4M/U2SBM-4L%MY8)K=F8R(DBI\P887,FX]SC''6LJ/P+X
MACT7PG9B\TH2^'Y%D4JDBI,5#J,@?[)0D]=V[UKJ/&7B,^&O#5_J%O\ 9);V
MW@,T=M<3B/S O+8[G R0!U(QWJYHNL+J?A73];G1;=;JRCNY%W9$89 Y&>^,
MT <'>_#75=<NO%5QJEU8P2ZT]K- ]L6D^S26WRQY5E <,OWLXQT /4.U7X?>
M*O$6E77]M>);:>^\N.*VBB@9+4JKJ[^:H/S;RJ@\<!>.N!*OQ \3ZZ)M1\'^
M$QJ6B02F-;BYN1 ]X5;#&$'^'CAC],9!6NST77H-5\-Z?K$P6S%W$C-%*^/+
MD/6/) R0V1T&<4 <+'\/O% NM?O3JNC176J#3IHQ!:2+'#/:NK  %C\@"8[E
MB?X ,&_)X;\=6FKW>HZ3JNA12ZJD8U#S;64B*1$V"2$;CD[0ORL<?+]:[R2Y
M@BE$4D\:2$ A6< D$A1Q]2!]2*P=5\27!\/:K>>&K(:M?V4ODK;!PHD8,H;!
M] "WU*D"@"QKN@2:YX/NM#EOY/.GMA";LJ Q8 ?.0H !)&> !Z5@Z;X>\4SZ
M_8:MXCDT>ZFTBREAL6MRZM/-(%#2R$KB/(3&$4XWMU  JSXK\6ZGI6M6FBZ'
MI4>H:C/;2W?ERS",,B$#8I_O$G\,=^VMX6U;4]:T5;S5]&DTB[,C*;5Y-Y"@
M\'.!U'M0!2\ Z+JWA_PP--U@V1GCN9I$:SD=U*2.9.2RJ<AG8=.@%8.K^!-4
M\2:CXLAU(V5MIFMVT$,4L%P\DT30,S1NR&-002P)7=QC )SFO0XY$EC62-U=
M' 964Y!!Z$&H;B^M;2:VAN)XXY+J0Q0*QP9'"EL#\%)_"@#SD>"?$FFZ/H%G
M81Z9=S:?J U6[N+B]DC:YN")!(H41,%!\SAL]ONU9T;PIXWT:>XTBUUZPA\/
M->O<07"1;KV&)V9VC"LAC)+-]YLXY..@'HM% 'EVI6VJ>%_ASXX.LVMJ;:\:
M[N(&M9GE8?:68;778N I<$L">,^G/"^"+$7^HWVA)J5OJU[JMB\!U.*^>[>S
M6(!HRRO&H$18*,<G) XKZ"U&XM+/3+NYOV1;.&%Y)RZ[E$8!+9'<8SQ7#?#W
M7/[0OG@MO '_  CVFS6@O+2]B5!'<1LPV@[% 5B#NVY)'/L2 07/A_QQ<^%=
M4M;U-$DN[C39+,I9'9]LFE"JT\KM&NPJ S;5&&+8)&!7<:!'=P^']/AOH$@N
MHH$CDC23S I48X; ST]*QO#7BV_UW7-1TRZ\.W.FOIX43R2W,4@5V565/D)S
ME6W9''&#S754 >=:CHGB:_F\=XTNU1-7L5L[(F]SOVB2/>PV_+E9-V/;&3U%
M/1?"7B6+4?AY+?65G$GAZVN8+IH[@'(>/RT(&WDX4$_6O4:* /+-&\%^(XM&
M'AF]TW0H;*&"6U.K0#$\\90JA"!?D?D%F+9].>32B\)^.WE\%)=:=I A\-2B
M(M%>G-Q&%5 _,>5P%R1G)+?=&./8** .;\4:3?W>H:#JVEQQ376EWAD,$TFQ
M9(I(VC?!P?F 8$=N#7.ZWX?\2ZWH>N/_ &=:0WVH7MHT5L;O(2*!T;<SA>K;
M3P!QQR:]&HH YO1])O[;QOXDU:YCB2UO8[2*VV2;F81*^XL,#;R^,<]#4&K6
M6OZOKD=L]I:Q:5:7UM=6]T+AO,D"#+AE'3G@<X/?(-=+-=P6\MO%-*J/<R&*
M%3_&X5GP/^ HQ_"J>C:LVKPW4C6%W9B"[EME%RFWS0C8$B]]I[9 /7ZD \LE
M\%>*HO$]QK*:%:7MY%KQOHKRXU(+)+;!75(E41D1J 5).<D@9! &V[?:#XKG
M\/\ B&R'A]3/JNN17\>R]C*QQJ\).XG'/[GL#][VY]8HH \L\1>$_%,NH^/3
MIEE874'B*"UC@:YN,"/9'Y;G;C[_ "2IR -H/.,'G];^'_BG5;JXGN-%$]U&
M;-K*6/5%2&!8PNX"(CYI!M9-S':0X(^[S[G6=KVKQZ!H5[JLMM<7,=K$9&BM
MTW.P'H/U)[#)H R-);4+/6]<U/6+*+3[*6..3SVND9$$:D,6/&!CG)[#G%<M
M\/="L[GQ9K6M6=\+O1[&[E@T<P\1()?WEP$ X*!W"@CCY#BNXA^P>,_!]N]Y
M:EK#5K*.5[=V(.R10VTD8.1GJ*OZ;IMGI&G0:?I]O';VEN@2**,8"C_/.>I/
M- '-_$/1=0UW1+*TLK-;Z!-0AFO;)IA%]I@7)*9/'WMC8.,[>M<]9R7OPX\.
M^)-;30H[31VOUNHM,FO(XW@C9560J4WIDN!MC#8P< @X!]/JO=V%G?B(7EI!
M<"&02Q":,/L< @,,]#@GD>IH HZQ?ZI%X:FO=%TMKS4C$K6]G,ZQ$LV.&+$
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MX$KQ$GRV;&=HP.G S76444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M_P!% 'SI>364'A?Q=I>OZ9=3>(+C7A,S&PDF,\(FB)V.@4!=BOA?,7V(SQ]
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M&B$J$94="02"!WQ75#X6>$5TU]/%A<_9GO%OBIOYS^_4$!P=^0<,02.3QG)
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MM\UQ)]K>![TZ@UDUPQMS.>2Y3_>^;'3/:NHH \_\,8N/BQ\189E62/9IJ;&
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MM"]  >JT5S7@+2;W1O"-K::@MQ'<;G<P7%PL[P L2$,B@!\#OCO72T %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% 'B?BJ>*/XC>%
M+*\N[E;A]01HH(K:*2-0EP0 7RC+D$DXW8 ^[ARH]LKQKQ+J-I=?$KPPTTFI
MK=+?QQQ*]KM\P*[J!L8JRJ [,9 ISE1P #7LM !1110 4444 %%%% !1110
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH \-\3-8V/Q,\#S0I+,]Q=K&H^:./(E*LS!2=S+O.,'&2=
MW&0?<J\4\:3V]O\ $GPJCZ5(M^VKP+]N:&)$\O?\D?W=QPKE00P!*Y^8J /:
MZ "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@#P;6)[^\^(/ALVRP_85U*/;+)+;LTB>>OF#'3?YB;CM.YN6 ;
M:2GO->'^*IY_^%E>%=/>UBMDM]0@C@AQ,3&@DRKH,A>8XPG =02YRIYKW"@
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M;H,X;TZ<_P"*-*L=<^)6L0W%]/ ;;PTCJ;>\,!BD$LI#L0P^[D'#';SDCH0
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M<_N\8.>O- 'LM%%>*^%?$VNK\1M%MIM<OM1L-;-YYBSVZK /*#LA@;JR]B0
M#QUXP >U5G:GKNFZ--9Q:A="&2]F6"W!1FWNS*H' ..6'7^AKR'P1XI\4W9\
M-ZWJ6OF_LK[49=):S,*1$_*S+,2F0Q&W!_#D\FKS1:UXCL;'Q;)XBNH[&77[
M3;I&%,8A%Y%&B-T*R @,>O(QUH ]AKE3\2O!JS^3)XALXY X1A*Q3:3T!) Q
M^-=57C7B/7-4T76O'_V328;JSN9[:WN;J68A;17M$!D= I+( >Q_^N >R*RN
MH92"I&00>"*6O+O$O]LZ%HWA+P?X/GD8SPDM>0R1&8PP"/)C65U5BV\'&[@
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MS ,H*$[<G)D/S84"MF]U+5-3UCQ]I5E_95A+IT=L[W0LVDDN(G@=BDAWKEL
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M>8Q160!AC'W6(Z56_P"$ ,5YXBNK;7K^*77+:*WF9DC<H(T"*P)7);;N!/\
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MLZ!>Z;>^))99-3E634;AK1,R!<;$C7.(U4J#_$>O/3';V45Q#901W=P+FY5
M)9A&$$C8Y(49VC/;)QZGK5.Z\1Z'965O>W>LZ=;VER,P3RW2)'*,9^5B<-QZ
M59FU.PMHDEGO;:*.1"Z.\JJ&4#)()/(QSF@#"U;PUJFH>+]*UJWUR.VM]/)
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MC\RX\31ZA"#I4@+P83ID9# 1<]/O#GD@>OOX(\..JK_9JJJ] DKH!SGLP_\
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MH:ZRHK:V@L[:.VM8(X+>)0D<42!511T  X J6@ HHHH **** "BBB@ HHHH
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M-N?$-Q!>:/XI?3A<I#"/M7$OEN4V8W*%/R_=(&<9P1WEK\,=!M'TIHYM3/\
M9=RUU;JUXQ'F,VYBP[Y.<^H)'>F0?"SP_;P7:1RZD);F[6]:Y^UMYRS#=\ZO
MU4G<<D=: ..7Q)X_N[GQ!J&FWT;Z=H-Z]FPN_(6.7R%7S7EP@<9&7RA RV
M!RE_\0]<E\07FEV6JQPZRFMBVM-+^S(T<]DP39-O(SDC<_#CANF,5V;_  J\
M*R7RW+VUTR[8Q+;F[D\FX,:[5:1<X<X SGKWSDY\YO/"WC2'6/$L&G:7KL=U
M>:K-=V-];:R(;55D;AGCSR0@]R>F!@9 .SM=:\377Q%\4VO]M6T6DZ (Y?LS
MV8/FK+;LRAG'S (P!XY//3I7,:+XN\5:GJ%[I5YJMU/'>>'IK^.X-A'"D1W8
M66'@.T9&0/,4-T.*]&T_P+8V<^IW,]]?W=QJUMY&HM+-\LYVA=^T#"'&0 N
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M("DJ;&C8/^[R=R-L.".!QAOFH YOPIXM^(6OWH>?0[>VL;^T:XM9Y8?W-N2
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MC;C@-G(4AO:J\<\0RB^^(GAUD%[*D-^A+RW$ODV[+*4;!P%)R$3&<DS*K#.
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M@="3GG->/3VME>2_$#P_:>'A=:CJ.K"VL);:S8Q(01NS*HPGEDAFSC!;N"<
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M1533-3L]9TRVU+3YA/:7*"2*0 C<I]B 1]#5N@ HHHH **** "BBB@ HHHH
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M)TL?+$DTF\@G=D;0@7(4\DGD;2* .ZTK5++6]+M]2TZ;SK.X3?%)M*[AZX8
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ML9 .#*V.BDG !(/!X(%9WAWXLZ=XCN]/M[:QD$FH_:A:()XV9FA4,0Z@YCW
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M=Z\.\71$?$;P;;RSW9F755<D#".PG8]78G;MZ8)_B'WB:]QH **** "BBB@
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M<#W. .,GF@#R;Q3X,\2ZKXRU?0M,\RV\-WP76)IE4#_2PA4*C\?,SI&Q!/&
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M;QRH4966-0000".0:WZ** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M$O/7Y\9YR>] ' >"=(TNW^+?C>>VN"987@6./[8[L=T2M*7!)+#?P-Q.TY
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MQG6V-JAB$A!&[;C&<$C.*PM<\%/K/B[0I);'1)?#.FV<T#64UON<,X &Q<;
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M_4*RAL=SC/2J=C\-M-TW1?$NG6EW<H-=,HDE)#-#&X;$:YR-H+R'U^<\YYH
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MRH!E>0,X!'(R.>#0!H4444 %%%% !1110 4444 %)M4L&P-P& <<X_R!2T4
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !7/:UX/LM=\1:1K-U>7Z2Z4_F0013!86;U9<$D]N"..*Z&B@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MOF%OFV!5#*2=V.1DCG#F^*&AQ^'%UJ6VU.*/[<MA-;-;9N+>4]I$!)7'Y]
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M/&'AS7OM(TO6K*Z-L7\X)*,H%."V#_!_M?=/8FN7L?B19:]\3++0]!U.WO+
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MX;33+*70-21V\<)JY<P (EL-BEFP3M^\./0'&=IQ[]10!XO#I>NI\6(;S3]
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M%% !1110 4444 %%%% #9'6*-I'.%4%B?0"O!)[*/Q?8>+KWP_>7EW>PZO\
MV@FG"246VHVH$8PT1^1P3')@@9)7'(QCWVLJ;Q+HEOK4.CRZI:IJ,S%$MS(-
MY;:&VX['!!P><$>HH \B\47.CZ_XT\/^(M6;4U\)M9-:Q1QVK'R+K<2\4T15
MBH=/ER@RV!@X&ZL+Q-::/H_AZQC@CN(+FUL)88[#Q-9&5KVV-P^T(44-%)N/
M&-A 9,D8#5]'T4 >">*[BQL[3XAVUQI<R7]Q#97$<?ERDK&8X5=VF53E0^[=
MDY;:P]:P]1DL_LWC2U:\&HV\^C6U];,-)-M'NXVR(@3" *P 8G."!DX-?2]%
M 'SOJ@\(:IXEU6YU275;+0=4MH8=#:RTY3'<QC!>*)7@9HV\[+#&W);/0@F?
M5;FPM&\=V7BV&;^T[C3$&D)>6[3%8DA8KY;A=HQ(021M^8$GG./>Y[NVM6A6
MXN(H3/((HA(X7S'()"KGJ< G ]#4U &)X/OK;4?!^D7-G"D-NUI$$CC1U1 %
M VIO )4= <<@5P'@+Q)I/P]\.GPKXHNFTV\L+BY$4EQ;O&EU$'+"6-MN&!W8
M R6XZ=*]:HH \1^(FIVFO:CH.K7UY>:=X4:*9/M5UI9FC,QQL;R9$;[R_=<K
MTS@CFN>T_P -^#9_%OA/1YI[B?3[S3;F,/<EH'NAY\@A; /W202G3("$^E?0
M-MJ6E:K/<VMK>V=Y+:2!;B**59&A<$X#@$[2"IZ]U]JNLJL,, 1D'D=QTH ^
M?/$A\+VFD?$FSNHK.+6&O9)(%^S;9!&1 1\X'0N<A2>2"0#R:TK^Z\*3_$GP
M:-2_L.XMY]$5)S=QB4,S "+! *[LC@OP%W=RM>W/!#)YF^*-O,38^Y0=R\\'
MU')X]S0\$,KJ\D4;LA#*S*"01G!'YG\S0!X7<ZMX3@\(?9;.2.?PW;>*/^)A
M!:EG$=JP;:S 9;RO,V<]&Q@9SBJ_BK6/"+^#8H/"[*VF77B&*</?0R1:?&X3
M<\>W9N\KY1E0!@N2#@8KWPP0M')&8HRDF?,4J,/GKD=\TGV: Q1Q&"/RXBIC
M38,(5Z8';':@#YUTZW\,7'A&P;4VM+JQT[Q3);RSM"\:):OO887)V*S*IP?I
MSW=<)::]\0[O5_%/BJ;1=5ANX4L;&PM9)IG@*H8&@;Y\;MQ)55)W,VX#.!]%
MI&D>[8BKN.XX&,GUIC6T#7"W#01F=1A9"@W <]#U[G\SZT 4/$LUY;^%=7GT
MX,;Z.RF>W"C)\P(2N!WYQ7E&BVG@RZUSPH=#O!=7.HVEQ'K:17!E$\!MB7-U
MDDJ?,*8W8R2?08]KJ&.TMH9Y)XK>))I/OR*@#-]3WH \^^$]IX;2+7[C0HK)
M'&ISPG[+-OS"KGRCU/RD D=N3CBE^(EW;1>-? <4EQ$D@U-G*,X!"[",X],\
M9KOK6PL[+?\ 9+2"WWXW>5&$W8Z9QUZFFSZ987-W#=SV5M+<P_ZJ:2)6=._R
ML1D?A0!\^>)Y-+@TOQYK&EZC>P3Z;JMO;Z83J$HV393SMBE\,25D/.>%R, 5
MLR:OX3U/6]<E\2^)9;;7+.]B?3+Z(-NB@"1LI@0!E.X[\C!R&&<\5["?#FAM
M;S6YT;3C!/-]HEC-JFV27^^PQ@M[GFK"Z7IZ2PRI86JR0HL<3B%08T7.U5..
M ,G '3- 'C?B/#S>.=0\1:I)9:WI+)+HI2X:)4B5"8&0;L.SMD-P1N) QT%G
MPE;)XF\375OKFL:A#>OI^FW;6MOJDL?F2['9^A!&#M)5<!2>.@->JWN@:/J5
M[#>W^E65U=0KMCFG@5V09S@$CC_ZY]:9+H.FI>3:I:Z5IJZP062[>W4.7VE0
M6<#=T..O0D4 >(VZ_P!F>#=.UO3_ !/J$WB=-3>WM+":\:42K]K9#&8A\Q!7
M+$D,?_'<5M1UBYC\%/XNBUB:U\=QZR\-U:"X<@,'9/LR0$E2H38>03\I^8GB
MO5O ?@B3PU8H-7CTN\U*%Y##J$%MMEVR,SL"Q[Y=A\N!C QQ73?V)I7]L'5_
M[-L_[3*[?M?DKYN,8QOQGIQ]* /'[-GN/$OQ(EE\1:VD&@H9;1(]2E<19AF\
MS"L2#@@8XX(&#ZX%K?Q2Z=XRTB[U"VBM+G0#>6=JNKO<-+(H:0.Q,A/FD*"R
MK@;=N5(Z^]6WAK0;.2YDM=$TV![I&2=HK5%,JMU#$#Y@>X--M/"_A^PV?8]#
MTV I&T2F.U12$;[RY Z'OZT >3>'K^VTO5/A;%INKW!M[O3I_M]I'?O(CRBV
M4J&0L0&WL0%[$  # J&TOV/A[0/%VA:Y>:IXGO[Z%+RQ;4 BW+-_K+?RR=L8
M4=#CA<'I7KD?A'PU#-;31>'M)26U(-NZV48:$ABPV';\OS$GCN<U-#X<T2WU
M9]6@T>PCU%R2UTEN@E).<G=C.3DY/>@#R.6;4CX<\3:Z_B+5EETSQ0\%JB7[
MB)8#<0KM<9^9=K' )( (QU->M^)(5G\,ZG&SRH/LTC;H96C8$*2,,I!'(]:@
M7P=X86S>S'AS2?LKRB9H/L4?EEP-H;;C&<$C/N?6MF.-(HUCC141 %55&  .
M@ H \(\ SQ3:3X&T!]5O-.L+NVNYY5MKTQ-<W"RKMBR'+QC:2^%*[MW09./2
M?AY>74^G:Q97&H2:A'INJS6=M=2MODDB4(PWMGYF!<J3WV^M:4_@GPM<::VG
M/X=TP6;2>:88[5$7?C&X;0,''&?3CI6M8V-IIEE%96-M%;6L0VQPPH%51[ 4
M <;K^C1>(/'IL#K.I:?(-($F=.N_(E \XC.0,X^O'%>3MXH\;^+IM.TN+Q'!
MI<?]ER3K>WDTEBMUMF9!*&0 EBH4A>5P&)KWS6/#&A>()()-7TBSOG@.8VGA
M#%?;)[>W0^E&H^%] U>""#4=%T^ZCMTV0K+;(WE+QPN1\HX' ]* #P]=/)X1
MTJ[O+Z*Y=K"&6:[4X24^6"T@R!@'D\@=>@KR[3O$M]:>(;P7>MS"UOS>_P!F
MZ@)VNK?4$#':(]IV6\D6W&0A5LMP?E)]ECC2*-8XT5$0!551@ #H *YZW\ ^
M$[.>YFMO#]A ]S"\$OE1!0T;C#+@< $<<8H \^C\17]YX:^'Z:KJ>IK:ZK%<
M&]FT\O\ :I953,8'E?O,9W$[0>0N>#4=@?&T5CX0LK[7M5BO=4U&[29T6(R>
M0(SM8K(-HP$+X!/#$@,V!70^)?APD@TR+0=$T"?3[19E:PU 2(H:5HR9%=<D
M$>6!C'0GKQ5GPW\,M-M-.C_MS3]-EN1/]H2WLQ(+:V?"@F,.Q.3M!)XSCH.X
M!S&K:YXALO#E]IEGK;^<?%0TE;Z]EVO' 85DP9%7Y26.W=M. WKS3;#6?$QU
MRV\-:CXBM7$VMR0R/9W!,EM&(FD$'FL@W'[HS@DGY<@@@>CR^!_#-Q)?O-HU
MM(;\EKK>"1*2P;)!.,Y .>U22^#?#<VAIHCZ+9_V8CB1;98@J!A_%QW]^IH
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MW4D89ACFHKGX5Z+-I6GV<.H:Q:7%@K10:A;W>VZ$!+?N#(0<QC=@+C@ >IR
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M'('0YZ5N53TK3+71M+M].LH]EO;IM0=SW)/N3DGW-7* "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@#Q/7KEY/B1X?)NU%JEQ$@"7
M30+,ZW$,1C53CSB&"2DXP0  Q$>&]LKPO7H;EOB%X3:*\ENII=5198)(U4I'
M&[,=W WX(9MQY4KP/NU[I0 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% #9 YC81LJN0=I9<@'MD9&?S%>,175_;R>)-9U^+0+N:TUI8[4FTD4K?
MB*!$*G<<1A>QYW#.1P*]H8$J0&*DCJ.HKAK/X:6YTO6;#6M6N=534=0:_21X
MHXI+>0A0KJRCB0!<;A@8X"CG(!D:AXZ\6Z/=:_H][9Z/+JNGZ2=7MYXUE2"6
M%3AP5+%MP/0 X.#DBBZ\:^-K6ZLK"ZTS3+6ZN[5KXNEM<W0M8E5<I(D8W;]Q
M89!QT')-:<WPPCNM+U/[5X@U*XUO4=/%A-JD@3(C &46,  (Q&2,EB,_/DYJ
MWXB\!-K']CW%CK=YINJ::ODI?Q*@=X2,,I10J<X&,  =<=J ,&T\?^*]7U+0
M-%M]%M]'U._L)+NX;4X)2J,CNFQ4!5AG8&Y)P''7J8O#_P 1?$OBC2]!%C;Z
M-;ZCJYN7!F$KQPQP84Y4$$LS-Q@X '<\#"^('@6TG\0:997D7BNYTRVTY_+N
M+*V:]WW#NYD>3KL<G:QPOS9XV[16UH/A?Q/K'A.V=[Z32M8TB9HM%U"2R2"1
MK;:J[)H,$!2,@#.>%)&1R $OB&]U^3PZ-8T/3'OK#Q,VFW+LT@6*X1=ZRP#J
M4*;B-YZ[3@XR);SXA^*K"'6+^?2](?3M%U5;.[$4[F:2-O+4",$ ;LR9)8@8
MX X)JW>_#35YK72DLO%9M;FVO6U2\N7LEF:ZO2 /,QN4*@7<H0<!< YZB.3X
M<^)GM-<A3Q;"C:EJ\.HJ?[/5ECV,&Z$\G*Q<=/W0!^\< #/&_P 2-:\-SZU<
M6%EI\MAH\MO;S)<%_-E>5 X92"   P&,$\$UW&OR:E'X5O9;5X([Y+9F));:
M"%^;:1@CO@_2O#/%^@ZI?_$;6;V&+4Q=O+^[@D\/I?#8@'E,DC#8%9AU.-HX
M8G!%>W7]EK&L^"FLQ<QZ9J]U:*DLAC$ZPN0-XQD _P 0!_'GI0!YUX>9O#>A
M>%=7:R\.V-Q=Z8L1U*9WA00-''(?.;A3(TF.O4DD'DBK^C?%74/$-IH5OIND
MVO\ :VI65S>21R3-LC2*1T4* ,L7*'J1CWITOPMUJ>V\+_\ %41P7FBVS6OV
MB.P5CY95 H0,2%<!2/,Z\@X&,56M?@]J>DVNBG1/%DEC?Z8]RBW+VBRY@D?<
MJ!20..20<Y9VY    +L7BKQ7?^.?"D M(]/M;^QDGN;*Y1T=0-F\-D<NI#;>
M%X;GK@:_@[QM>^*]29?L%M%9K!(9MDY::UG678(94(&"5^8'I\K 9QFIG\%7
M47B+P]JEIK<[-ID$MM<O>HL\MU&Q#8W$#:<@_,!G!QTZYW@KP%JWA_Q(^KZQ
MJUKJ,XL39I-%;"*64%U8M*>KM\H&XDD\DY)H =XT\?WNA:_'H>DV-O-?&RDO
M/]-9XUN"I 6&#:"9)3S\O Z#.3@,DUWQ1IOBSQ9<&SCU+2["VADBLK>1O.^Z
MQ&S<H4D]6 )("C 8D M\;^ =>\4ZE<&WU^V32KRW6WELKNT\Y8,'_61<\/R3
MD;>@Y/&#Q;X!\0>(]1UH6?B?^S-,U&VCC>"*#<SNO!W-D$*5R, \[CD<<@&2
M_P 3=;N/"WC"1;32AJ.B00.)K6[:6$^:#D=,[TVD$9^]QQC)K:]\5?$/@R73
M]+UC3-+>_%@+V<F\=1(F=H124_UIVOD8(Z8S4Z?"OQ,\.LPW7B>Q,&JZ>MM+
M#!IRQ('3/E@!>BC<QR,$[N0<"K=[X$\=M-IVL67C*-/$20-:7UQ);)Y,L/F%
MTVQA,97<>HYSU'< LS>/+OQ1;P67AW0H[^&YTO[9?&Z>1$B1E/[C*H<NW(&#
MV)QWK3^&EO%>?"31+:=2T,UCY;@,5)4Y!Y'(X[BLB[^'?B2VO$N="\4-%)<:
M>+/4&OU-P)FSGS O +<D GL<=SGJ?"^B:GX=\#V&C?:+.6^LXO*$HC81$!CC
MC.<[<9YZ\T >6?"OX@W>D>'_  SI.IZ1=_V?J%S+;0ZF\@/F7#S,0 O4KEL%
MNQS^&]8?&N/4?&HT.VT99K::XDM[6XCO$+RLO )C/* [6P3ZBJ8^%OBVV\,>
M&M+M-3T8OX?O6O8/-27;,_F&1=Y'0<D' _&M+3/AOXGT5XK#3O$MM%H5I<M<
M6EO]FQ-@.TD<3R#DJ&8YZY!88P<4 00_&PIX<?7=0\,S6UF%94=;M7$DXE"&
M$':/FVDR?13C.#52/XI6GC#X=>(+F_T2Y T\Q"[AL;P;A&[$K(LG'0KR!D\5
M:M?A5J]U\-KKPUK&H6/V\7_]H6E[;AG"RG!;<I"]RZY'9@<<8-^;P/XLD\':
MY82:OID^IZ@D,$ 6$V]M B,6+;54_.VYLG'9>PQ0!:UCXBZGI>MZGHMEX*U:
M_N;&V6YCVRIB>+=MWC!8X)'  9C@Y48..IM?$EC=>$4\2*6:R-F;QO+!8A0N
MX@# )(P1TKF7T/QN?%.IZY'+H,4LVC165JH:5MDZD.2V5Y7<\N#UP$R.M7]#
M\,:GI_PL3PS+=0P:DMA+:K<6\C,B.P8*X.%;C(/08/YT 86C?%QM2-TMSX<E
MMW&G-J5FD-[%.US$"."!C8^&R5.2 #Z<T[OXV"V\/0ZK_P (O>1K=2PQV8N[
MA(8[@.'W,),%0%*8.?[RDX!K*TOX7>-+&56+>%X4CTFXTV)+4S1D>8F!(7V9
M+[_F)]SC&>-=_ASXE3P3X7AL=1T^T\4>'I'^SW*.[0-$^0RG*YY7;G*GH1P#
MP =EX/\ &-MXQT";5+.VD1H)Y+>2 2(YWI@X5@=IR"I!SCGKCFN&T_XO:K!I
M7B#5]:\,72V6FZFMHXMY$/V<95&4DD;V!YXXRZC('([SP?IVOZ?I=P?$MY97
M.I7%RTS&RCV1HNU5 ' +'Y<DD=6QVK@YO GC6#2_%&E6#Z*8-5UO^TK2:65R
M\)\U9=T@9&##]U&NW!R68DD#D W+#XG3WNLKI,OA+5K*\EM9[BVBNRD;3F//
MRJ">IQU/'/IS5"Z^-%A!X3T;6$TW=<ZJD[Q6<EY'%L$3%26=L#!(X[GL#BK?
MB3P]XPO?$GA_Q'HW]F17T%C):W45R[;8GD7EEP#N"MV[X'8DCFK#X>^/+#3-
M#G0^'9+_ $V(V:VTQD:%[9B&/F<?,X;GY2!A>,F@#U/PQXBLO%?AVTUJP#BW
MN5)"/C<A!(*G!/((-<OIGQ1AU"^B230[VVL[FUGO+6X=T+3PQ#)81@[AD$8S
MC/;.#73^&-/U/3="A@UBZ@N+\N\DQMHPD2%F+;$& =HSC)Y/4^E>;^'? _BK
M2-;T[59=&T$R6UO<17!%T_GWDCHFZ6:8HV_?(K$#'RASUH WO"7Q7L_%6JV%
ME_8NI:?'J$4C6=S<I^ZN'CSO1&&0< ,<DC[N.I&<#Q)XTO-8\5^&X]'MM:MM
M/.NP0+?K*8[2]C5F$J\$9Y'R@Y#A6XXP6Z-X$\7:?H7@W2Y8[<0::=06\1+K
M(S.'2-\8P2HE<X&>,^M6+3PAXXM=-\,Z/Y&CO9Z!JJ3+/Y\BO<PJ' 8@ ["
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M,?NX&1C#-R,XKZ"H \H\4_$$ZCXJF\,:/XDL-%M[16.H:A+\TN5W;XX5((W
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M*Y8*HRPQASU(/7/R@'H]%%% !1110 445AZOXR\-Z XCU37+&UD)QY;S#?\
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MTW+S]W#>UUXOKVJ2#XC>&6(RGVQ;:;,BM(LDD[85WQM&#"X !R0I4#(ROM%
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M[[AM7;D-D]L8.?3%8\_C3PK:W$MO<>)=&AGB<I)')?Q*R,#@@@MD$'C%9?\
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M  3HUKJ$[3W<=H@DD9B23C.,GGC./PH WJ*** "BBB@ HHHH **** "BBB@
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M<+QTWL,^N./K3KGP=XLU$A+_ .(5ZEN2?,CT^QBMFQP/E?+,O&[J3R0>,8H
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M'/<OPHVNDD:L<].)3^=>V4 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% 'B_B&SBM_B9X6NV7S/-O%_>2$HT3
M>:?D78=K;O-5_G+-MW'D$8]HKQ'5H8Y?BOHX2WGNX(+R%_.A2&?R0V,/*Q5M
MI=P'^4J0LJ$X8J*]NH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MZ&@#"_:!TV2[^'"WL1*MIU[%.6!Y"G,?KZNOKTKTZRN#=V%O<E AFB63:&W
M9&<9[_6O'OB+\1O"'C#X?ZQHFBZUY]_+$)8X_L=P-PB996Y\OCY4;DX ZD@9
M(ZBQ^*/@[3-(M;:ZU619+:RADE*6<\BJA"J&W*A4KN(7(.,D#K0!Z!17G_\
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M HHHH **** "BBB@ HHHH \(\0I;6'Q2\).+>.;[9=1+&;>8QH4\TR;MH W
M,ZG+,W*N"!E<^[UXCKMI=GXH^'+9Y6@,.II-Y:2,3,6:60@X5AE4(&692P9L
M#J1[=0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M5" !5.,@>QP./:G""$*5$48!W9 4<[CEOS/)]:DHH CB@A@1$BBCC5!M544
M*/0>E2444 %%%% !1110 4444 %%%% !1110 4444 %%%% 'DNJ/;K\1/"MG
M:W&FF&VN?+*^6V7;;(WR$KLR,DG#Y!( 7GYO6J\IUF[$'Q'T%FMXI+.2X\B.
M47+G<S,K*$3)(9,QD@C8%+XQD[?5J "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %8'C:>Z@\%ZLUFT:3O 8E>0G";R%+8 .2 Q
M(&.2 .];]47TJ!]974VEN?-$'D^5Y[>20&W!C'G:6!SAL9YH ;H6G6VD:#8Z
M?9QK';P0*B!8O+[<DJ>02<DYYR3FM"BB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#RCQ%)I<?Q-\,6RA([I
M+]W(6%W\QI%)8LHRRG=&"KY 4'D,C$CU>O*[\M'\0?#MLL+0HY$\QM9LQR2.
M[,=P5<E=ZR-@[5WG=DXVGU2@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH \?U6ZTR;XD^$&5+F%VGCC";F(!
M1+@8,FT[B"Z C=C!P0>J^P5XW=W<$/QETZ %8!-<-$;(6 &]D.=ROM!''E2;
M\MNPR\!<-[)0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 >.ZA;O/\4?#E_=O;1[KAF2&0^;NDW2 '?LZ[<A
M!\H_<Y#$A0?8J\5U2=YOB)X$FCD^T7%Q)G,,8VR0;<^:N2>,=U( 4'LV![50
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 >(32S2_%GPY]H;4UNC=R/_ *SY903, VP'A#&%^8A?D &TY8CV
M^O'I[Z2'XIZ'9NL),]\ZB82L7E@2-RBXV@!48X##!; W!OOO[#0 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %)\VX\C;C@8YS_G%+10 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% 'CDJVLWQ1T)Q+(WV:8+"K0A ?W0  !VK(%61<$#S%Y)W!
M2(_8Z\4U#SH_BOX:B@O9KR6+49DN+@LH7#AG*!>2%#)(!D@9C8!25+5[70 4
M444 %%%% !1110 4444 %%%% !1110 4444 ,CB6(,%+G<Q8[G+<GTR>![=!
M3Z** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** &A KLP+
M9;&<L2/P';\*=110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 QXHY'C9U!:-MR$_PG!&?R)'XT^BB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@!DT4<\,D,JAXY%*LIZ$$8(I]%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !3!%&)FF"@2,H5F[D D@?\
MCQ_.GT4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M 'CT]Q9K\6-%D)$TEW?7$<GV=FB:V>/?M62($CDCEL@2 ;P#CCV&O&))-.F^
M,6F7,JV\3M,R6R6ZMYDD@)4-)C:&^3>Q8LQ7?@CG%>ST %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% 'C=RE]
M>?%KP]?3PQ?94GD9H8[0KY.?/C#,Q4@'?MSR?G< '@&O9*\)>.-?BQX>N8+2
M58;B[,+$(5Q)$&0IC@A/EWX)8_(H;:00ONU !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!Y7+>.?B_HEU'?Q
M SP/!/';R QRNRY"],[0L>X$]6''& ?5*\GE-U)\4="O3)<Q32SRQ/!'<LS+
M$58XDC^9@FZ,' .P%ASE37K% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH \=U-K>X^)7AJ6
MW2[MU:Y)<R.P\]Q)*9$*9)&UW1@,8P7R5VBO8J\@UY1#\1_#9"VH8ZJ8/-%N
MDK-&!NQO"*L;@I@@'> PR6'%>OT %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% 'DGB>WCM?B'X?7[5:V\YU(>
M2TL(DDG.^-GC#L6(Q'(>H3!;@YSN];KQ'Q.MQ_PM7PS>0I+LFO+=IK9 "D(<
MYW$*"3D[3N) #(QP<@U[=0 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 >0^);[[3X_\ #>B;VNUL[R&64I/Y
MT<+B4$,P+,P?/R#)SC>< #%>O5XS>RW=M\6O"L3&*56N)61VC:/AHB&*!6X&
MU1@-P2YP" 37LU !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110!Y1/#)?_ !6T616MS'9RW,B./*"EB5$A7;CY
MF5XA\V\X7C#!BOJ]>/7]P&^+/AX3L]HS3NRS*,B=G#,%X&0VPHN.@5S\QRRM
M[#0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 >)O%#J/Q:TJ]2W:<6?D@3."'5"WR.W 9LF4@,0H.227*@#V
MROGFRDC'QFT<QP6B/=7.)-RHTG[M3B0M]P%MK!=C<C=\H.,_0U !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M!XW<;3\9M MTEN81;1NT;X\W[4K ??+8*9)9BVW:6P!\WS5[)7CMK'$?B;H)
MEDMC*TEQ<^3=11^?N)9=@4*TB$9,F2Q&U "1C<?8J "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** &3.T<,DB1/*RJ2(T(#.0.@R0,GW('O67X;UT>(M+:^%G-9E9Y8&MYR
MOF(4<J=X!(4\9QD\$>M:]<=\.KRUN]-UL6TL<ACUV_WE&!Y,[,#QZJ10!V-%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 5%'Y_GS>8(Q#D>5M)W$8YW?CZ5+10 4444 %%%% !11
M10!XC?W=S<?%GP=:Q17**DLMQ,DD1'DL5(? ( "G<%QEL *,ALBO;J\2G@:7
MXY>'@R3%99I':>>-@SF*!V (;!4Y=F Z .H& @%>VT %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %5[2PL[!&2SM(+96.YEAC" GU.*L44 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 >(WT+CXQ>&-6MYM0F26YF %\K)Y892DJ*,*JA&P..&
M:3!SU?VZO&M2E^T_%GPT^H+):F*ZD$"*S?+(P8DL,' ?!&"<X6/HIKV6@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M@P!QD_,..N))-3EC,:MI=\6>-WPH1MNTCY20V,G.1Z_7B@#0HK%?7YU@=_\
MA']7:1;CR!"$BW-]WYP?,V[/FZDC[K<<4V+Q!=2W*0_\(UK*!QD2.L 48&2#
M^]XZCZ]LX- &Y16%=^(Y[<71B\.ZU=?9W*?N8HAY@'\2;Y%W#]?:K5UJ\EKL
M']DZC,S.BD0HC;0Q8;B=V, )DX)/S+P2<4 :=%8%YXEN;*:WC/AC7)O-#%F@
M2%UB 8CYB)>X&X 9.".^0(5\6W#,ZCPIXA^5(WR8(@#NVY S)U7=S_NG&0*
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MPN"F%&TMO.6SC(V\ G)Z8YH FHHK*U76+C3#'Y6AZG?AV9<V8B.W"@@G=(I
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110!Y5XMN9(?BMX>61;J6$W,:JT6'C5B<#S WRJ1O.&!#8?@')W>J
MUY3XKN!'\4/#-NMW':.[QAXI(T<R[92RJ3G*Y5I#NW'+*!MYKU:@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHIJ%RI\Q54Y/"MGC/'8=L?3WZT .HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@#R;Q9>*?B'X=FOFA>U>>WCLC)#&PE<S#<R;
MCNXW1D-'T ^8D'#>LUY#K\4TOQ)T"ZN4@\R6Y@MKKRI %+ILE3"!P7PP8'=G
M;MC8 [=M>O4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% '+:SID=Y<6TMO:V0M;2>.62Z8*7C\J0RLJEN -R
M!<]MS8Q@D=3110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
510 4444 %%%% !1110 4444 ?__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>ex3-1_002.jpg
<TEXT>
begin 644 ex3-1_002.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 2X Z0# 2(  A$! Q$!_\0
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110!Y*9-_QD\+W<L,:K=171MO)(>%@
MT3,SCH0Y((\S&'4+C=R5]:KS2S+P?&*V\F6XN+:6REC:2:01CS22SD*J@,1Y
M:JRMTW*01C!]+H **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** /,Y+??\ %G0IKF&021>>MN7=85V&)P&\L#+R
M$*RYR,)'DJ"5KTRO)HUN$^+^@&X:UG\UKEHYU4!VC\AF3+$%6.'.?+(^\>"H
M->LT %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% 'D,LANOCKH<)FV/8I<?\?(>+S\I(-L:D')&]FSD97!.206
M]>KR2?>?C+X2>:..$S+=2G;"J2RN(I5Q+\Y/R@/C&0-W1<UZW0 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M>0Z9;W,/Q<TJ&&2Y>%#<RS+M(A4&-N4*C]Y@LH+MA06 QDKCUZO+YK-[CXPZ
M-+<6,&H&".2.2]*^8]N41RN=I 3)<D[MW,B !?E(]0H **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** /,(K6*+
MXPV1NR9[AC<20E"R>2V)<;E.=R^6Q&[(7)X /!]/KRJ346/Q@\.VLS/#-()Y
M!;AF0^6R7)5B&7+ [2<9&"1P. /5: "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#R=TBF^-&@RQ/)+*KWKN'
MF+*J;'4,B@A5QE!R"6\S/( ->L5Y@S&7XL>'[R.UMY;65KN..Y=VW$F(N2F/
MD8J1L!'9I!AL;QZ?0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 >;ZG,(_B[X5A$[%F28R0/,AFB=H)6.[JV
MPA1A4.S<F>"!N](KSF:)Y/BGX?5]T,UJEP6*/N2X0HZ]2VX?-\VWD*1U)/'H
MU !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110!Y->W"M\</#4%S)>F[5KK:2ZM ZBW8# &"#RQ[X)(YY->LUY:
MT*R?%7P[*#=FZ,]U+,&EB>,Q+%*J,64 [OW@ !S@$@'"FO4J "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#R
MV\TW/QJ\.W'F^2(?M<HMY'2,-NB,8,2$@GB,%BNX\J< 9">I5YCJ%U%)\9/#
M'F0_Z0OVF!'G@VN5,#R,RGK@':HR> 6&.<GTZ@ HHHH **** "BBB@ HHHH
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** /*(YVM/C'HMH\$*37*
MW#EDE;;(BK-AL*P3>A^0H?,X)/RD UZO7E$D,,?QB\+>?);_ &EH;DJ2667<
MD3#RRJJ4 Q([<$#(<YS@-ZO0 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %>1V&ESZT/B']F\7W.D0KJ
MDROY#PB.,K$FZ1R5WJ.""5=?N'T->LS*[PR)'(8W92%< $J<<'!X.*\TD^$
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MKGZ+&!0!+XUEN-8UG2?"=@\3/,?[0U&)Y0@:SC8#8?E9AO=E&0,X1AD<U@^
MC+X2^(FO^$]1^S6XU4_VQI\4<^]?F)$B D*21MX&W.$)YZULGP'K9U,:F?&4
MAU!4\L71T>S\T)_=W^7G'MFEA\ :A_;]MK-WXF^U7D+J3,^CV8E91U42"/<N
M1D<'O0!W5%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 >3&S^T_&?1-3G2:.6%[B -),)<,8
MIW$7$A"_(P;[H VXSTSZS7EML]SH_P 6])ME1;>VU:*9W";QY[(CD,Q$CJ[;
M5!RV#SUX KU*@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH \JQ<3?%KPW>NP@MKDW316TLBLX80MN(!;IDYW
M ,1]WY1NSZK7E[Z@8?C1H]A/+(LXMY(5C,2;64I*VY?[H(C3)3YN$#''RCU"
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MT_WO,((Z' XZYR+#X=G0A);>'?$FJZ3ILLK2R64:PRJI('$;21LR=/4UVU%
M',:WX$TG7M)TZQNI;U9=.=9;2^CN#]ICD'\>]LY8D9).<GFH&^']E>^(-/US
M6]1OM7O=/_X]/M'EI'$=VX-LC106Z<GC(!P. .NHH XU/AOIB^/;KQ@]]?27
MUR"DD#>486C\L)L*[,XP!WS^N:6G?";2]'T_6=.TW6M:M=/U962XM5DA9%#9
M!";HB5^4E<YSC'< COZ* ,+PCX7M_!WA^'1;.\NKBTA9S%]HV%D#,6(RJC/+
M'K_]:LU_AWID'B>X\1:/>7NCZE=*RW+69C9)MQ!+,DB,-V1G(QSR<Y.>OHH
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M 0&4QD$?*6R&*_.=H6O4: "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBN5D\>6$FJW^
MG:5IVI:Q-IV1>M81H5@8?P$NZ[FX/RIN/!'7B@#JJ*YD>/-"D\(2^*()I9]-
M@XF,<9WQ'@$,IP01D9']*SX?BAHMQI-KJ\=CJ[:9<RB%+P69\L$L4&XYX&X;
M<^I% ';4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!Y!8QQ'XP:,+F[F
MG<-=W%NPDC(#,)4VOT9OE5@#\Y"I& <9)]?KRL721?%?P^MNFUI9[ZTN"'GS
M\B2/R'/ 9L-CE6V[@20"OJE !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MW[Q&11G!D1B5^7&1C&15KX9Z'J'A'5?$/@34M,D!O49[?6(+4LDD>U@/,8<
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M@:YCBABF#,\GE3%]R@+TR?FYY;'.21Z_0 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% 'DP*VWQD\/V5O"BQQK.V"D9.R2%W+A-H:%AB%"<#
M(P/[P/K->21:E*GQ9\.V4J6YDFFN]_F0D3$+"Y5\EC@9:1 ""1M<ECO%>MT
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% $5S<PV=K-=7#B."%&DD<]%4#)/Y"OFO5I];T#QUHOQ)O-"O
M;6VN+DM=3W$B2J8WRHPJ$LF(6"C=W4?2OH_4=-L=7LGLM1LX+NUDQNAGC#J<
M=.#5*]\+:!J.F6^FWFCV4]E; ""&2%2L0&,;?3ICCJ.* . ^)OG2_$7X<_8Y
MHDF:XNO*DD0R(#MBP2H9=P]@1]:P?AU+_:GQ<U^7QH^SQ2L;6\%F$Q;M#C#[
M.N[  QD\AB?F.2/6+CP9X7N_L_VCP[I4HMTV0J]G&51?0#&,>U6YM T:XU"'
M4)](L);V *(KE[9&DC"]-K$9&.V* . \3_\ )P'@;_KTN_\ T5)67\=TBBA\
M)@!8X_[5W-M^7&<$G(Z<DG->ES>$O#MSK*ZQ-HEA)J(.?M+0*7)[$G')X&">
M14^I^'M$UJ2.35='T^_>,;4:ZMDE*CT!8'% 'C^HA]/_ &I]/N=0#"WN8-EG
M(PV*I,!3 ./FRVX?5QZ8KV65M.DU>VAE>$ZC'$\T,9;]XJ<*S >G(&?>F7NA
M:1J5A'87VEV=S9Q@+'!+ K(@ P-H(P,#ICI46G>&=!TFUEM=/T:PM8)D\N5(
MK=5$JXQA^/FX]<T <!\$YX8/#/B>2:6.-(M=NGD9V "+LCY)/0<'GVJCX^OA
MK7B_X67]C<_9A>O--!*R!MH=82O!Z]1Q7H"> ?!T:!5\*Z(0/[UA$Q_,K4]U
MX.\,WSP-=>'M+G,"".(26B,$0  * 1C    [8XH P_ H_L58_#^I$7'B%EN[
MF[NEC4%XQ=R&-GP<KO\ .9U7_?Z=^<^+LC#QM\-HO,4*VLJQ3G)(DAY].,GK
MSR,=Z](TSP]HNB22R:5I-C8-* LAM;=(MX&<9V@9ZFDU+PYH>LS)-JFC:=?2
MHNQ7NK5)65<YP"P.!S0!IT4V.-(HUCC141 %55&  .@ IU !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 >5SPVZ?&W1;@7T7GS^>CQP;G4ND4FY"1PF5:-BIR2R<\!2?5*\K5KN
M7XP^'KMC^ZEM[E KQ,I"%7?.  H8CRLD]>1QA=WJE !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MP*,8YX'7BN32SEB^'G@T@ZGI^L6^FW)M94L7G1F.P&"6/8<B08QG&=O&<@$
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M/EQ"5SE<\\@8X]: .E\1^+9[/Q-IGA71X8Y-9OU\XR7 )AMK<$[I& (+'Y2
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MMOHL^BPRN\J6-Q,\DL89CRY8D@G[V.V<=<UT-S;QW=K-;2Y,<R-&V#@X(P:
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M.\>0F*U+NA58)CM:3 !^8!MG^[V48]6H **** "BBB@ HHHH **** "BBB@
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M% ' ?"/PWKOA+PG)H^MV]K&8YVDA>&?S"X;D[AC P>G)SSP,<]_110 4444
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M+&LD;JZ. RLIR"#T(- #J*J6.IV.I_:#8W4=P+:8P3&,Y"2  E3[X8?G5N@
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MT::^<AFW"20QRD#J2K;6)YP#EB"<C/L- !1110 4444 %%%% !1110 4444
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M C$$K&I^51P.@SP,DUI76@VMYXAL-;EDG^TV,<D<**^$ D&&R,<YPO\ WR*
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MF%<S8!(!QD=<>O&A=>*]6O\ QSJGAO19M)MI]-@BD\O4E<O>.Z[L1[7!5%7
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M=KJ/!?B>/3_">G:+J.GZE!K6G6D5M)8BSD9G*#8I1@-C X!W;L#.20* )_\
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M:B[L/&>IK-I6J%;[PQ%%"Z64C+OCB)93@<'HN.NX@8R13/ ]A]@F^'3KI%U
MZZ=>+=2+82* SF/:78+CG#<DXY]Z .W^(?B'5?#&AVM]I1LR\EY%;.MU"T@P
M[;<C:ZXQU[Y]JS=?\8:[X$O+*Y\2_P!FWF@74HMWO;*"2&2U<@D%HR\F]3@_
M=(/'T!/BZLLOA>Q@M[6[N96U.W<);6TDIPK9).P'''Y]JSO'*W7Q'2R\+Z;I
MNJ0:?)<I-?:C=V$ENL4:@D!!+M+,3QT(% '?R^(=$@M9[J;6-/CM[><VTTKW
M*!(I1UC8DX##^Z>:Y74M>\5-\1Y_"^EW&C)'_9!U*&2ZLI7.?,\ORV*RCOSN
M X'&T]:XKQG_ &E%X?\ 'OAN#P]JUW=ZCJ:7<$L-FSP&)A!@[^[9C88&3NQZ
M'&[JFBVOB?XTK_:.FZF=-/A_[/YOE7$">=YV\IYB[0?D8Y^;;SCKQ0!M^$OB
M3I^M>!H/$6L/;Z7OEDA\MI=WF.N>(Q]YV(Z* 2>@S71/XIT"/3;347UBR2SO
M"!;S-,H64_[/KCOZ8.<8-<%K>AIX-\;^#]1TO1)7\.V$%Q:RK96[W#VI=3^\
M*C+<]VY) ;/)&:!T.X2"QDFT2Z>RO?&KZDEL+220QVQC9!)(A7]V"V'VL!@-
M[' !U^L?%#PUI_@ZX\1V=]%J$$;M#''"^"\PSA#D97) YQT(/((ST=[J(/AZ
MXU/39[>91;-/!*#YD;@*2#\I&0?8UXOX\T*^U'3?'UOI.B7Y,NIVES$D>GRH
M)\(J2LGR .?,+$D9SRW(YKV&_NFO_"-W<I:7<;3V;E()(3YWS*< H,D'D<=1
MW - '.Z=XJUNZ^$<WBR1M/%^-/DO4C6W<1#8&;:1YF3D+C.1USCM46A>*M7U
MG3?!]_-JNA6;ZD'DN[.3*23KC"B %B20>OU'I@\UI?A.R/P0G$VB:@NM)I<L
M7DM;W"RF<JP4"/'/)'08[]*@TVPOETCX61/I&IK-873"Z#6$P-N/NY<[?E&2
M.3QCGH,T >G77C3PS8ZA+8WFNV%M/$/G\Z8(JG^Z7/R[^Y7.X @D8(K$A\>V
MFF^)]>T[Q%J=C:1VU[;VUD.59A)&KC/)/5N6X4=\"N#AU%$N;W^U3J46AV/B
MBXU,3V^B22I^[G<Y-RIV[-P).$) !7/I+X[TB[U#3/B/';Z'J,]U=7=B;,BP
ME<RA!$',;;3D#:_0\#ZB@#UV3Q#HD,]W!+K&GI-9ION8VN4#0+QRXS\HY')]
M14B:UI4D5O*FIV;1W*,\#B=2)5498J<_, .21TK@O%OAF_N_%VF:SH4=P(];
M@.F:L"A14MRI;S64C*N%#*-PZ[!P>#SNG:#XLTOP;XDM-1T<ZF^C6LNF:/#,
M3*;F&1U=VQCYP%6':!TV%< @@ 'J=CXN\.ZE!=3VFLV;Q6FXSN90HC4?QG./
MDP00_P!T@@@D&M!-2L)(+6>.]MGBNR%MI%E4K,2"P"'/S< GCL":\=\$:=>W
M/Q4N+J^TG66T^\\/BUDDU&S,2AMR H1A0%^1@!C)'/3FM/P!'JVG7NO6NI2W
M&HZ5X3EE@TQ8 )GD!0$(,?>DCC 4#J/.9<\   ]9KS[P]KOC'Q(-?>UN]"A.
MEZM<:='%+83'S1'MPQ<3?+G=_=.,=ZZOPUX@M?%.A0:O9PW,,,Q=?+N8]DBE
M6*L",D=5/0FN$\#:L=!'BH7FCZ[YM[XAN[NUC32+@^;$^W8P8H%7.#]XC'?%
M '0^#O'MKXDT"_U'48HM)ETVY>UO4FN%*1,N/FW'&%.>X'((YQFM:T\7>';W
M13K$.LV8T\$*\\LHB6-LXVOOP5.>QP:\@M/"?BC1=,7Q/>^'Q>:C<^)#J=YI
M0"S[8"D@#8'_ "T4R.5VYY*G&1BNTLO#47B;Q!XOOI8+J#2-5M(K-8;FU: 3
M2!3NF:)U5]R_(%;C^+T! !W;:E8(\:->VRM)$TZ*95!:,8RXYY49&3TY%4;3
MQ7H%\M\]OJUHR6'-RS2!5C7&0Y)P"A'1Q\IP>>#7EFG^'?&&L?"WQ!'J\=PN
MNQ6ITJT0Q[3+!$^\E0<?ZS.S.!N$:'D\T_2K$W_@S6;B+POKEMJX\.7.GW$E
M]+<RL\F,)%"CLVY2P=OE VY _B- 'J.B^*-$\1R74>CZE#>-:B,S>5DA0Z[E
MYZ'(].X(/((K7K@O#-U8^$O"7A9'T"\ANM1AM+.[EM[#8T<VQ8P;@G! W';D
MYZUWM !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MK')>:A+=74$]O:^4T$LVYN TA!PQ&.1TY]:W=,UO2]9-R--O[>[^S2F&;R9
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M1TU^]2[TR[DN=+OT0*]J&.=F ?F&?F)!!)QR ,5N1>!)TBT,2Z]=74MAJ/\
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M?;R21-MN+E[0Q.J M#, Z[@,?*%7H<[>O=O9Z "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH IZM;27FC7UK"<2S6\D:'T)4@=?K7FGPK\3Z-X;\
M!6V@:]?PZ5JVFO,EQ:7KB*0EI7<%%/+@AA]W//X5ZO10!Y5JFH03?$^UN_%<
M<,/A6YTAUL/[3C40"=F4MNW?*LAC#?>P=IQU)%<UI&DZ!-)X0TK73++:M?ZA
M!IKZ@[0RRVHXA5N%;#9 "D '.,<[3[U10!\_:OX<\!V6H^/M*NUM;:ZM8+=-
M*MVDS*#]E7;Y*LV7<OC/))XSUS71V4MC!K\=G\1C;+YWA^TA@DU65 GF!?\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M?H<A!GH<-7.>+_#<7A3Q_P"!-%M[Z_GBNYH$OGENI#]I)F56)7<0H()&!_\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M"V4+A%S@)G'4# &XX.>0#U_6M?LM!%E]L$Y-[=Q6D(BB+#S)'"C<>BCG/)'
M.,GBM2O)?$L#KHR:)!XAGNIT\26303DM+)9QRRCRU,CY$C*0QY)."N>H)W/
MEQ?6GC'QAX;N-3O-0L]+DM)+:6^D\R8>=$7=2^!D C@=A0!WU%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% 'EUS++/\9M'MY)$5X)I
MY?*>0;A'Y,RC&XG).\, I^ZY^4>6V/4:\HBU*2?XJ:+;3N]PZ74P)9&80,(K
ML8#Y&TD*/EVD<G:Q"J3ZO0 4444 %%%% !1110 4444 %%%% !1110 4444
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M;PPV3,UI;27+O%;E@RDHI/H[ 9S@$XQ4C>,O#ZZ3::FNHI+:WA(MS#&\KRD
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M)-(TGSY!#D$XW#'!QQGUQA=2^)V@6^A:Q?64EQ<7.G6RS-:R6<\3G>"8R0R
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MX4T:;Q$^OR6\KZE)!]F:1KJ4J8O^>?E[MFW/.W&"<GJ<U#=>--$LK=)KA[Y
MT33F/^S;DR1QJ2"[H(]R+E3RP ..*UK34K.^TN'4[>XC>RFB$R39PI0C.[GI
MQZT 8ND> O#>A7D-UIMA)"\#N\*&ZF>.)G&&*1LY1202,@#CBM'0_#^F>'+.
M6TTJ!X()9FG96F>3+MC<<N21G'0<=?4U6T_Q?HNIWUM96]Q.L]U$TUL+BTF@
M$Z+C)C:1 'P&!X)X.>G-<KHNJZEXN\0:M]FUK5-.?3]3,<47]G,('MD2/<C^
M8@ D8N>K;@,$ "@#NK_2K'5&M#?6T<YL[A;J#?SY<J@A7'N-QQ^=-_L>Q$NH
M3)"T4NH "YDBD9'?"[ 0RD%2%X!&#P.>*O44 <_;>"M!LTT=+>UGC71RQL0+
MR;$6[.[^/YL@D8;/!QTXJK<_#CPK=Z5?:9/IC26M]=F]G5[F5B;@]9 2Q*L>
M^,9'!XKJJ* .9M?A_P"&;+1[32K;3FAL[6Y6\C2*XD0F=<8D8JP+$8'7/0>@
MK4L=!TW3=6U+5+6W9+W4C&;N5I7?S-@(3AB0, D8&*TJ* "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#QJQO;V'XRZ)9.XMX7:Z&
M+>7*W/[IF.Y,YCP0"5Z;E& 1M8>RUY"QM%^.NC_9;6031^=!<3,)%)WQ32J"
M"<= I&?O$N2 0#7KU !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M 4]6:==&OFM;6.ZN!;R&*WD^[*^TX0^Q/'XUY!\.;/6].\7:/->Z#KL<1TB3
M3W,T*1P6KK*APHW<1X3.XDLY;//./:)IH[>&2::1(XHU+N[L JJ!DDD] *Q8
MO&OA2>58H?$^BR2,<*B7\1)/L U '+^*DU31/B7IGB6+1KW6=,FTU]-F@LHQ
M));L9-X?:2!AN%)R  #D] 45M1T#Q1I.K2>&)8=,ETQK%K33[=97T]_-W@8B
MSE6&W.. 4S7HJLKJ&4@J1D$'@BJEWJVGV%Y9VEW>P07-ZY2VBD<!I2!DA1WQ
MQ^8]10!X^WA;68/%7@N\73+L6HUO4;UXQ%D64,SJT:OMR%X4DC/!./2K?B&&
MU_X2_P :V7_".7NJ/<Z1:6D,=E$,1AA)QD@B/E5(8J0"GMS[#659:!:V.NZC
MK"37#W=^J)-O<%=J9V * ,8W'\^<T >;>&M+UGP1-/:ZUI>J:M;:EH]G;1_8
MX_-$#Q1NLD#E3E1ER0W3!P#Q5W0?#=_INH^ =,O]/>3^S]*O$NY!$9(8VD$8
M"%\;<G##'?W%>HT4 >#>)K+Q)<>,TN?^$<UIH++Q3#>)%8PI]FEA 5?-Z@O*
MVP99CM09&1N-:]O8ZM;>&OB9HLWAW4GDOK^_NK240*\4PE"",)\V2W\60,#!
MYR,5[%10!YM:K?\ AKQL=6N])U&]L]0TJUM8I;2%YY(9$SN21>"H.[.XC''4
M'(K \)>&=4\.>(_!BW6CW8BL]+O#*T:>:L#RRNZQEQQN 8+[_3./:** .0^&
M-O/:> [.VN;*XLI8YKC_ $>XB,;1JTSL@QZ;67IQV[5PNJZ+J,FAQH_AR\NM
MOC9M2FM_L^YGMC([;P,[6RI"X/J?J/::* /&M<L=9BU3XIRV7AR:\-_!9&T2
M:T+Q3[$V2%>S,N2P R20.*T_ NG75UXE\4C5-(\0'3]8LK=O.UL)ND'[P/&P
M0X3/F'"*!M Y"Y /J59?B#0++Q+I$FF7YG6"0@DP2F-N#ZC\L4 <G\,=&O+*
MUN7U&=;DZ>\FC6$V.MO!*XW=3M+-A6 X_<IUP*LZZ+C3?B5IFM-I%[?68TR:
MT$EI )3%*TB,"1G*C:&&??ZUUNFZ=::1IT&GV$"P6L"!(XU).![D\DGJ2>22
M2>:M4 ?/[_#_ %;1TT/5[[P_=ZE8H]T]YI]A.T=S LLA9=OEL-Q"X^4-UX]Z
M]<\(:)%H_A?[+9:8NB^<\DJP ^9)&6/#2.6;>^,$Y) X7HM=)10!XQ:^'==G
M^%MKX N]#NK74HKJ-%OX%0P1H)A*9@^1@[=PX^8M]:N6&F'3?!_Q,;6-.DME
MN;[4+N&>550RPRQLJ%&;H?O#GIO]Z];JIJ>F6>LZ9<Z;J$(GM+E#'+&21N4^
MX((^HH \L\-7VIKK^G2:OIFJQZE)H[Z98+<:8MO;.ZKYI5V\YR6(B&,[!A6X
M].<TC0]?M?$6GW\WAK709M(N[>962+R892I.R*-&Q%%S\H."Q)P"<U[!H_@S
M2]%NH[F.6_NY801;F_O)+@6X(P1&')"<<9'..,X-=#0!XGX-\-ZWIQ^&(NM*
MNXSI1U07V8_]1YQ;RR3[Y'3-:=S<^*-*TGQ4-'\/7[7^J:O,UM/Y8!@B>*)?
M-QG)^XV!ZA<UZS10!XCJ'A*;_A$M(TW2?"^JS6>@7,4TD4LHM9-1+J_FLNUM
MRE3M.<_Q$#@5<&@7FBW>C>)?#?A'4H;2UU"5[O2Y[G?=7 >'RA.=[OC;N<!
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MIZH^Z-F+;)$+!@V2>Q'.,G&:YR[\!Z_;:+_:EMH227$?BF;5_P"R6E0%K9N
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MP22V,#-O0]+\1Z?X4\?QPZ04U"]U:]NK**Z$;I,DBKCC<0> >#QGCGFO3Z*
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M8"M)"% &YAW'Y8KJ?B+87VI>![VWTVT>[NQ+;S) C ,XCGC=@,D#.U374T4
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% 'DD%O';_&71I'2-+B99U+0MM5RL3ETP9"3M)7'W@,GY5()'K=>2VL4(
M^+&B1-:[;BVEN5\Z3,>X^3)NP@ !9B<J>1Y8)&. /6J "BBB@ HHHH ****
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% 'E&^W3XUZ-
M([6Y.VZD5Q.F^W9Q,<XX?<0"I0@J!SDD?+ZO7E-O+=WOQ8T+S(V6.W25HWDB
M9!)&T,A.T$D+@R( .H ;G#!1ZM0 4444 %%%% !1110 4444 %%%% !1110
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M:B15; E+! IXX.XA>>Y [T :M%8J>+M EU$6":I TYE\@$$[&E_YYA\;2_\
ML@[N#QQ6U0 45S>H:_/)XLM_#^EF-IH8/MU^Q&YEA!PD:Y(&]V[D\*I/=37*
MWWB'Q[H>O:'=ZK%I8TK6-32Q^P1H6FM!(3LRX.&8*I+$$KG.!C& #TZBN9TC
MQ%,WB[4O"^H[3>V\0O;:5$*B:V9BHR/[RG"DC@GH!R!TU !16#!XQ\/WNJG2
M8-5C^VL[Q(NUE#NF0X1F&URN.0"<=ZYSP-XSGE\(2ZCXGOQ+<?VG-9Q-#;DM
M*5)VHD<:DDX#<#<<#.30!Z#17/\ _";^'#IUK?+J2R17<C101QQ.\TCK]Y!$
M%+[AW&W([TZ;QGH,-E97C7DC07J/) T=M*Y*)C>Y"J2JKD99@ ,C)H WJ*YZ
M^\<>'-.MXKBXU(>1)#'<>9%#)(J12?<=RJD(K=BV :63QOX=CU5=-&H>;<L8
M%)AADEC4S?ZH-(JE%W\8R1G(]: .@HHK(U?Q/H^A/Y>H7920)YK1QQ/*R)DC
M>RH"57(/S' X/H: ->BN&\9>,$LKCP_IUA?7EN=6FWF[L[%KEOLXC9CY?R.&
M<D(,;6P&)('!KI/#T&J6^E!-7U$:A<%V9+CR!"S1D_+N0  -CKP.: -6BL/6
M/%^A:#</;ZC>M')'$)Y0D$DOE1DD!G**0@)!&6Q4=IXPTR[\0:MI \^*32T5
MKF::"1(TR"QRY4*!C!!)^8$D9 S0!T%%8>G>,-!U6]-E:Z@HNA'YPAFC>%GC
M_OH' W)_M+D'UK)U?Q[I4FA:TVC:BKZC:Z7-?V^Z%@DJHI(=&90LB[A@E2?P
MH [*BN&\%^.(+[P_X<M]7O9)]=U*T%QMCM78L-Q4NWEKM1<\9.!7<T %%0W=
MW;V%I-=W<T<%O"A>261L*BCJ2:X'1/'0U#X@^(H9-1DCT*PT^&X"7=L;?R&(
MRQ.]%?!&#SQSQ0!Z)16!:^-?#UT+LC41!]DA%Q,+N)[<K$>!(!(J[D/]X9'3
MGFLGQ!XOL[SP;K-WI.O/HT]B(O,O+S3Y 8"S*1F*1 6W*<# /W@10!VM%8%_
MXKT?P^+>UU74B]R;83R/%;O)B,84RN(U(C0G^)L+UYX-59?B/X2AV;]9C!DM
MC=1@12'S(P<$IA?F/? R< G& 30!U-%8-QXST"VTFPU1KYGM-03?:M#!)*TH
M"ER0B*6X4$G(XP<XQ6=)\2-!:^T&WLY+B\CUI7DMYH+65U*H#G&U"2P88*\%
M1DMMXR =?16#+XST&#45L9;R1)&N/LHE:VE$'G?\\_.V^7NXQC=G/'6N5^(G
MCW^R[2T@T'5&CO1JD%M.Z6AEB8-RT7FE3&K[2&QG=@=.<T >D4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 >46=F(OBUH^I/8PM;S
MQ36EK<2%%:-D64%4502V%B(!+$!6Y^9P!ZO7F$%_9#XJ:;9K%'%(9[HB.6RD
M5S)Y3'S [$$,4&.0X(R05W 5Z?0 4444 %%%% !1110 4444 %%%% !1110
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MIKN@^.6T:XEDN?#T*KJ\<[0 (;IE:-XPWNS-)C^'8G3)SZ2-5L#K!T@7<1U
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M"XGTF]CNXK><V\CQ@[1( &(!(YX8<CB@#0C8O&K,C(2 2C8ROL<$C\C3J**
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** /*H3''\8]+B:
MYM]Z+.)8H9"'$\B2/B0 C<-JNP9D'!&.-N?5:\G:RL+?XU:+<1SWR7KFYBE2
M5E1)E$4FU@%R7^Z_)QT'(*A3ZQ0 4444 %%%% !1110 4444 %%%% !1110
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MT>6NU<$#/ )Z8Z\YHO?"GVSQUIWB<:E-$UE;-;BU6-2KALY)8C(ZKT_N^YH
MXO1?B5XG\1:^B:9X=,NE1:DMA=2>22$4 "23S?,X*E@=GEG*_P 0-5I;Z^T_
M4/B+J6K#3=2L+*6%Y[&33W_?E8%,04O(0@#;"25;."5QD5U>G_#>RTGQ'/J.
MG:MJEKI\\XNY=*BGQ TX(.[UP2 2N><8^[\M6!X#MI9O$WVW4KR[MM?51/"X
M0>60FS*L%SD #'88Z'K0!R<OCSQY9:%K=_?^'X;9+&R6XAGN;1H5:3<H:,H)
MG)X)(8$?=Y S3+;QWX_:;PK ^F^'99O$<4LUJ$>9%1%@20%R<XP7R0 <A2!U
M#5O+\,0_ARZTF\\3ZS>&>T^QB2X=&6*/(.$3'?:H)))^7J*M_P#"OD$OA.6/
M6KV*3PW \$#I'%F1614.<J0/E7'0\=\\T <O=?$;QC_;=]H^FZ#;ZC>Z2D"W
MWV.%I(I97&YU5FD4Q*,, 2LA)'(%1>._$VI>(_"GC6VL&L8-/TF*.WN5EC:6
M664@&10RN%38?EZ/D@]!BNIUCX:66J>*+K7K?6-4TZ>^B6&_BM9@$N8PH7'(
MRIP ,@]N,$DU5UOX3:=JM[J4UGJM_I4&I0)%>6MIM\N8H"$8A@>@/(&,^Q)-
M '8Z#_R+VF?]>D7_ * *\.D:[\)^%%\(^+K=+[P3>L3:^(-/_>F))',BL>#D
MDG(.._&_ KW72=/&E:/9:<)Y;@6L"0B68@NX4 98CJ>*Y'_A6<,FBP^'KWQ%
MJ][X>B2-?L$YARP1MRJ950/LX' ((P,$#B@#"C\6:KIOC/Q]JEU?6MUI6C6M
MHR6\=N098VCDDC5'WX4[G^9R&W=@H  NW/CG7O##Z5=>(QIEQINIV;S(]G&\
M3V\RQF78VYF#)M& P /<@8YV;GX=V%SXEU756U"_CM]6MEM[W3XI D,P6(Q#
M.!NP%/ !'/MQ3[/X>Z="+)+^_P!0U6"QMFM;6&]="L:,I4GY%7+;25R>V.XS
M0!DZ9KOB;Q%X;;6;B#35T/4=+N)1%$&$UJXSL!8DB3*YR0J\]O7'^#WB2^US
M0M+TS29;%-/TFV2+4?M$;M.TK%BHC 8 +@'YCGD' /6NBT3X7:=H<<EM'JVJ
MSV*)*ME:33 QV9E4J[(,8+89P"<X#-UR28M"^%5AH&IZ1J-GK&HQW>GP&WD>
M/RU%W'D$)*-I!4 8QU^Z005!H ZS5=%@U:ZTV>;8&L;D7$;>6"^X C 8_=!S
MSZCBDT;0[;1&U%K98U^W7C7;K'&$4,55> /9 2>Y)/>DT'1YM%M+B";5;W4F
MEN9)Q+>/N9 QX0=@H[  #V%:M %;4-/M=4L9;*]B$UM* 'C)(# '/;Z5P[*K
M_M!E6 *GPI@@C@C[57H-8'_"*P?\)PWBK[?>?:S9"Q$'[ORA%OWD?=W<MSG.
M>O;  !Y:]QKWAGQS\1)?"T&EQ6.EV-C+*MXKL D-KE(T"L.JA^3Z#IG-=/JW
MCKQ'=ZZ=,\,Z4LLL&F1WTH>))MS2 E4^:>+"CCYAN)/\/'.U<_#VTN;_ ,37
MO]K:E'+XAMQ;72J8]BH$"#:"G7;E<G/#'OS5>Z^&-C->65[;:[KEC?6UH+.2
MZM+E$DN(@,*)/DVDCCD ?G@@ Z?3+C4KWP_;3WEJFGZG+ #)"_[Q89".^"-P
MSVR..XKRSP9XPUZ+P1X<>2XLY[WQ%J,Z0/):MBW)FE:5I,2#?D_=50@'3/>O
M6M-T^WTK3H+"T5E@@0(@9BQ^I)Y)/4DUQ=G\)]*LM&BTR/5M75+6Y^TV$B3*
M'LCO9L1':>N[#;LY]J .=\8:YXJ?PCXQT>XO;:"^T6."1KZUB*"\MY5;@+N)
MC?*G)R1Q@#!S5[QUXY\1>$9A;Q7&FW$UIIRWLH%E([73&0QL-J.?(C PV]C@
MM@ ]17377@*SO-'UVSN=1OKBZUJ-8[F^F*>9A!A %550!>> HSDY.3FLW6OA
M58ZU)/+-KVN"2XL%LK@FY#"8+DJS KQ@G)5=JD]N6R 69% ^-]LVQ 3X<E&X
M+\QQ<Q\$]P,\#MD^M2_$'Q#JWAZUT+^QQ:&?4=8M[!OM*L5Q)N/4'C[N"<'@
MG'-7K7PF+7Q'8ZT=7U">:UL&L2D_EMYRLRMN8A <Y4$XQT&,#(,WB7PO;>*(
M].6YN[NV.GWL=] ]L4!\U,[2=ZL"!D\8H \VU?XC^+_#FD>*EO(])NM4T.]M
M59HK>7R?(G4LO\0((X')]N<@UI>*OB+K>B>)O%.E6T5DT>GZ,NH6KO$Q(;>B
MLK_-\V=Y((QC X/.=_4?AII6KMXB-_?ZE.->\K[0I>,"+RCF/R\(-NWISG(Z
MY/-5V^%>G36^H)=:[KUS-J-HEK=S2W8)E522#M*[<@' ..![EB0#)M_$/CN3
MQ)9:*UWH@;5].^V03>0_^BA0,_+N'F$YZ9 '7H,'F?\ A*M6\9:/\.]5"VBZ
MN=7FB8NC+"74$!L D_=P3TYST%>IQ>#88=9TW5$U;4Q<6%@;! &BVR1GNX\O
MELA3Q@90<=<XUE\)M(TW1]-TZSU75XO[-O6OK6X$D)D1V !',>TKQG!!Z]<<
M4 <^/B)XKMEO/#MU86TWB*UU2WT]KBV4%'2:.219$1V0%ML9X9E'S ^QEU7Q
M;\0]$TO3%N]-L([J[UJ'3H7N553<)(,J2(Y76,Y5E/+<," ,<]/=?#30[S2[
MBUFEO#>7%XM^^J)(L=WYZYVN'50!M!8 ;<#<< &J]Y\,+*[TZQMWU[7&N;2]
MCOEO9KE9IGD3A-Q92/E!., #))(.3D Z739=2L/#WG>(9;66]@61YY+-&$94
M,Q4@'G.S;D>N:\TC^)7B"W\(Z=X]OFL6T&YN6@ETV"V83QQ^8Z!UD+X9_E&0
M0%QZ&O7I(TEC:.1%='!5E89!!Z@BN,L/ACH^G116<5[J,FDPW8O8]+E>-[=9
M1TQE-^W/.W=MR2<4 8/A33[Z;XR>/Q<WT,UH&L_/MVM1B96A8Q+DDXV#@\?,
M>>.E;GQ*\3:GX6TRPO+1C;6$ESY5]?K:_:3:J0=C&/*Y4M@$YXZ#)(%:^D^$
MX-(\4:QK\>HWTUQJVS[1#-Y7EC8,1[=J!AM7*CDY!YR>:=X@\+Q^(+FUG;5-
M0L7MXIH"+4QE98Y0H=9%D1PP^08X_I0!Y+?7NM:WX_\ AU=V>HZ>VJW.G7++
M>>2[0'*298(=K?=S@''.,CJ*Z >._$MYX!\.7L8BM]7U"2YAF$5HT[L\/F*%
M2('DDH"QZ*-QXK?TWX6:/I.I:'>V>H:G&VBPO#:1[HBF'W;RW[O)+%V)YZGC
M%,M?A3I5G::3;PZSKBC2S,(76Z569)FW2(V$&03GD8;GKP, '-:/\0O%OBC1
M_"TNEC2[:ZU66ZM)_/C<JLD<9<2*03Q@9VD=>,X.1;_X2;XB7;7D>EZ9%?76
MEW$5G.D:PK!/(L<;3$R/*KC)<[<)@#&222!K:-\(](T&;2)+'6=<4:7</<01
MM<1E&9\!@PV=",J<8.&/-7=1^&FDZAXBN=8&H:Q9_;"IO;.SO#%;W>T8_>*!
MDY'!P1GGN22 8C>--<_X6D?#]W<1:9;_ &E5M8)[)MM]!MRS)-DY?<1Q@+@=
M<UT_COQ4WA/0([F"..2]N[J*RM%FSY?FN>"^"/E #'J,XQD9S3)_ EG>:Y#J
M-YJ>J744%^-0AL9I$:"*8*0"OR;U )W;0V,\D&MK7-%L?$.C7.E:C&TEK< !
MPK%2""&4@CH00"/I0!PUSXHU_2_$>I>$[[4+62\.DOJ5CJ,5MM/!(*-'DKGY
M7(.<8QWXJS\&K!K7X9Z-(\RRJT3M"/)VF(,Y9ESU.6YS].V*U[;P-:0RW]U/
MJFIWFHWEE]@-]<M$98H/[B80+UY)*DD\G-:'A?PY#X4T*'1[:]O+JV@)\DW9
M0LB_W055<C.3SD\]<8  .&\/%K_]H/Q7+>+ODL+"""UW'/E1LJ,=OIDDGU^8
MCUKH?%EY%X5G_M;3H81K&NW5GI49F4F(ON?:[A<$X5WSSR%4<5;U?P-IFJ:X
MNNP3WFF:P(Q$U[82!'=!_"P8,K=N2N> ,X I+WP+IFIZ)=Z=J%S?W4ET(]][
M+/\ OU:,ED9"!M0J22 J@<GCDT <SK7B_P 1>&=0U?1+R:UNIET2;4]/U 6Y
M3YXE.Z-XP<'H2"#QQD-FA=8\=#6-!L'U31\Z]92S*PL'(LC&J,2/G_>$A^^T
M9[?PG??X?64]E?176K:K<W=[9?V?)?SR1M.ML?O1K\FP;NYV[CG.<X(F/@BU
M;5?#^HOJFI/+H5N\%HK&+:VY-C._[O)8KCN!\HP.N0#SBR^*'BC4O"_@VZAD
ML(+O5=7.GW,CVQD5AO4*P4,,##<C.3C@K6A)XK\>VF@:[J5Q=Z.8_#M^T%QM
MMVWWJJ48\9Q'\CC&,DG@XQD[EC\']&L+72+6+5M8:#2;[[?;1N\.!+E3R1%D
MC*],]S[8T;SX<V5[IFO:=)K.KK::W=F[N41X@5<D9"-Y>0I"J,$GA?<Y *FH
MZ[XBU?Q'XDTGP]<6MI-H,5N0DT!E^U/*OF<\C: HV@#DDDD@8K L/'?BKQ1X
MET?3=)>QL8=2T(:B[R6K3?9WWLI_C&1N3 )QC?T)'/:7G@BVN=6NM3MM6U33
M[N]MUM[Y[1XP+I5&%9PR, P&0&7:0#QBD@\!:79>(+?5]/GO+)[?3?[,BMX&
M01+#DL."I;<&.[.>H&<\T -^&_B6^\7>!-/UK488XKJ<R!_*7"-MD900,DC@
M<Y[YXQBN'U677O _B#Q%KEIIMKXB\+ZE,[ZC#$<2VQ5<.&!R"H4'.1@CKMKT
M?PEX7M/!WA^+1;&ZN[BUA=FC-TRLR[CD@%548R2>G<U0NO L5Q-J!BU_6[6W
MU!V>YM8)XQ&Y8_-@E"R9  .UAQ[DD@''-JL\7C_PQ?66H3MI$GAZ2ZAMI8EW
M"((C;3Z,VU26'(Z=*>GQ%UJUT'P]XNNVLY]+UJ_^R-IT"?-;*Q8(5ES\SJ(S
MN! !)(&W&:[*Y\!Z/<:KHU\C75N-)MOLD%O#+B)X< !'!!++P.,C/0Y'%4]/
M^&6AZ<;.%)[^;3+&Z-W9Z;/,'M[>7GYERN\X)) 9B 23W- %/1]=\2>(8[?6
M["\TZ+3_ .U7M)["9,%8%D,>?,SGS#P0O0[@*\^^%>OWT^IZIX1TB\BL+Q]7
MNM0N+J>,2!H0$3RXT[N6&221M"YPV2!Z79?#'1]/U\ZG;7^L);FZ^V?V8+PB
MS$V0=_E@9)W 'D]1Z<507X.Z)':"&+5=9BE34&U&*YBEB6:&5EVN$81\*V$R
M/]A>G.0#T-00H!8L0.IZFEID*-'#'&\KRLJ@&1P SD#J< #)]@![4^@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#Q^6YDN?CIHI>^@D,
M,LEN\,.T*'6TF9B ?G&"YXR1SDXW 5[!7AEBMO\ \+V\.M!;O' HO$1"A5H7
MVS9#.1^\)PV?F.#@9&"#[G0 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !4<<\,SS)%+&[POLE56!*-M#8;T.UE.#V(/>J6OW"VGAS5+EHYI5BM
M)9#' <2, A.%_P!H]O>O _!>J:+_ &A%"M]9R/?^&IX'@CB;+7'F*RI(Q'[V
M;!<EL#J<<8) /HN21(HVDD=41 69F.  .I)KBM4^(EJMEX>O]$6'4+'5M9CT
MMI_,*^66<J2%QD_=8CIV/(->:>%]1TC6]5^%5F7MKIX;._L[V-T!&#;X$;Y&
M#P3QSU]ZPM*?0KGX=?#^S L1,?$2#4F52DV#*^-T@Q@;&').<;<=. #Z=21)
M%+1NK $KE3GD'!'X$$4ZO#'FT_1/#7B"RM0&T33_ !<JWUG#*S!+,J@=2,\)
MOW9!^4X9?HWQDF@PZ=XR30)K)=%.C6\CQ6>Q;9;II#L*%3MWL@&0!R-O)SB@
M#UW6;[6+.^TI=/L+:XLIK@1WTTMP(V@0X"LH/WLDXQUSC@YR-BO%KS2M#\//
M\-'T\0P17=^MS)*9<^:[P(I?)/\ %A.G!.#U-5](_P"$,U_XG"6.WT73;'0K
MH16@1U6YU&\9P [='95;&,@Y)SDC( ![;Y\/VC[/YL?G[-_E[ANVYQG'7&>,
MUS_B?Q2-!N=,M;=+:XN+N_MK:6)IPLD,4LFP2[,$D9! Z#/T(KQOP8MC-K5D
MVNWNMCQU::R(KBUMQ"'D^=0SO(L>]H G##>1A3C (-26NI:#=>'?";ZA+;+X
MNM_$\3ZD9U5;I'^T'S#(0H(3&T<X4!5&<KB@#W'Q!K^G>&-%N-6U2<16T"Y/
M]YSV51W8] *NW%W;6:QM<W$4 DD6)#*X7<['"J,]23P!WKS;X^6QF^%]Q*(@
MY@N86+8Y0%MN?S('XUF1S^#SXSUA=?.F)H=QI5N=!\R$+"MMM<S^5E=H;?@X
M')&,4 >P2%Q&QC56< [0S8!/;)P<?D:P?"'B3_A(]#@N[A8(+R1YPUO')N(6
M.9XMPSS@[.N.IJ+X?+J"_#_1!JGVC[;]E4R_:23)GMNSSG&.M>-V.FZ-/;^'
MFT60KXT7Q#*)OLSEI88A<2;VF3^&,)CL <]\F@#Z!^WV?]H_V=]K@^W>5Y_V
M;S!YGEYV[]O7;GC/3-9_B:^U?3=%>[T6P@OKJ-U+0SSB%?+S\S;SP,#FO&O"
MCZ;>ZY!;:_J6K)XPL]>\PV,,,:-,Q?\ UF\Q>881$3N4R'Y$]-M=7^T!L_X5
MA)NVY^V0[<^O/3\,T >E/?V<=]'8O=P+>2H7CMVD D=1U(7J0/6FC4K Z@VG
MB]MC>J QMO-7S ""0=N<\@'\C7D7B>:#3?B#>:K92Z7J[3:EI\-SI=R@%U%(
M$C:*2W=3N(P5.,$</P>:H^%1H\'Q*TR"RNM,UV+4YKQY9)[95O[!UB8-'(<Y
M:,\J,C'H<=0#W$3PG;B6,[G*+AARPSD#W&T\>Q]*C^WV?]H_V=]K@^W>5Y_V
M;S!YGEYV[]O7;GC/3->#:%X@TB30_AS8M YU/3=3$-U/]F_X]0!*OE,_."YP
MP4=0A)Q@4_P@NF:GJ5O%+J6I1^-]-U.5S:FWBC$DA8[Y'D6'S#$4SN#OGC;_
M '"0#T[Q=XV'A[5]"TZU6SN9K_4X+*YC:X E@64_*VP<\X;DX''?/&YXCOK[
M3/#U[?:=!;3W4$?F*EU.(8L _,6<\* N3SZ=1UKYWMM3T5K7P';SI)%XHMO$
M:/JOVJ,FY+&4;FD8_-SA>",\=L<^S?%S[-_PJW7?M/E8\@;/-Q]_<-N,]\]*
M .KN-3LK.:""]O;6WN)U=HXI)E4N$&Y]H."P4<D@<#DXJ'7M;L?#>AW>L:E(
M8[2U3>Y R3S@ #U)( ]S7DOQ(U"RLO$-WJMI<:7JUR4LHI=$OUS+,F_,<EFZ
MG=NRYR!G^(G/ /;_ !7T&\\1_#C5+#3Q*]T DT<,9YEV,&*D=^ <#U H CO_
M !?XBT7P_P#\)'J_AZ"'340/<6D-T7NX$) W<J$8C/*Y&/4XQ72#Q'HPTN'4
MI=3M+>TEMTN5DGF6,")\!6.XC )8#ZG%<1XN\>:+K'PYU"VTR:'4-7U&T:VB
MTF!]]R)'&U@8L;\IEF.5'W>U</H_A72]/U37=*\06]I<2V7A2*5Q,@/EL$.Y
MUSR"N0-PP1[9H ]YU#4K#2;4W6I7MM9VX(4RW,JQH">@RQ JU7S]?W.GRIX)
MD\0ZK<0^'KCPPEL)8;=+A5N@%WCYXY!O(7;P-P*]1R#Z_P"!;.#3_!FG6EH+
MS[)$'6V-Z^Z5XM[>6QX&,KM(7 *@A<<4 0^%?$6J^(+?6I9]/M+=K&]FL8(U
MG9A(\1()+E!A2< $*3P>.U0^!O&J>*?#>EZE?BSL+K4S*+6T%SN>41$JY4$
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M;D9CGY0PY!/4<BO'M0U7PM?ZAXPG\.BW^Q7/A!CF"V:-&D7S1DC: " $&3W
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MI%OXI\2^'O$UAJGVR2[,VB6UO(VVXA&1!$K*&$8 V $D*H.#C;74W3QVGQ-
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MV <8),HSU;AF )&+7Q4TV]M[;3/&6C1>9JN@3^8(U0EIX'(62/CV/X#=C!-
M'4W?C#P[8V5U>76LVD5M:W1LYI&D&%G R8_=@.2!Z'T-9VJ>,8X-3\)C3[BQ
MFT[6[AXC<228!'EEDV-G&XM@ $').."<CD_&%N/#]MX0M+T3DK+<2W6I6MH;
MEEG=#Y@6(@KF9Y7 +*P4XX[CEO"U]+I?A?X;*;>]CN;#6;NVNXS:.#$&=T?=
MN'0"4 D=/F'52* /;5\2:&UK)=+K%BUO'<"U>47"E%F./DSG&[YAQ[TW4?$^
MA:1J5MIVHZO9VEY<C=%#-,%9AG //3)! SU(('->1:KKABT+Q9X<FL[QM3_X
M2/[4L4%H[C[*;J-UERB;<'!&,EB<U6U^WM)/%OBC3?$^G>(-4&H3P76G&S@,
M:7 *JL<."/D,>XKO)&0KYP>& /?**BMD:*UAC?.]456RY<Y _O$ GZD<U+0
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M2^<&7$@SG:,CD J ?3)[5TWC7Q7XA\,,C6ECI]W]KNX[73[7,AGG)4%B0.
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M->=WVKQZ1\4]9*Z#!/>Q>&WOX[B!W,\Z(X AQC RP/0'HOT%2S^)M]/X*O\
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M.[!7V)Q7ME !1110 4444 %%%% !1110 4444 %%%% !1110 4444 9^O?\
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M</NCE5)C?!/7 X -:WB7Q';^&M.AN)H9+B>ZN8[.TMHB T\\APB L0H[DDD
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M]Q5./Q2C^/IO"C6,\<R:?]O6Y9EV2)O"?* 2>I(YQ]T\8P3T% '):+X=U_\
MM2QOO$FK6=Z^G0O%:_9;=HR[, K2R$L<N0,84 #<U2^"=!U?0+34H]6N[.Y>
M\OY;U3:QL@0R'<R_,3QGI_,UU%% '+>(= UC5/%?AS5+&]LX;72IGDEBEB9G
MD#KL8 @X'R%L>YSS5?XB>#[WQEIFFVME?6]HUG?QWA::)G#%0P X(_O=._J*
M[&B@#@_$G@;6;OQ='XD\,>(FTB]F@^S7GF0K,CQC&TJAXW#GKUXZ<YFO_!FJ
M'QIH6LZ5J=M#;:99&S,=W"\\CJ>I+;P22 O).<@D[LXKMJY[5?%!TOQCX?\
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MKUR> *^J?"J;4-<\0ZM'>6D%U=O:RZ5+%$R/8R0)L4Y!Z8X*X(/!P,"O3J*
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MN:MXLOXO$%UHF@Z1#JE]:6@NIXYKPVW#'"HA,;!F.#U*@<<^G4QEFC5G78Q
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MNL(XG50@ 3/^K"#8%R?4YZ'I/#6D:CI-@XUC69=7U&9]\UR\:Q*,# 5$7A5
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MPP.I;)QP!TLE]>Q:VT$FGHFDK:&9M1:Y4!90V/+,>,XV_-OSCC%9TWB&]O\
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MQRT.^-T[W#I,VR<J9HR(YU:(GY<A?E QO8  G&[<WLM !1110 4444 %%%%
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M' "<%\>JUY$D:6_QJT.V6\O)747/FM<! LF(I%CP,J/E4%0RIOX?)96!'KM
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M1;FQMWG>" 1!CE"R@R9R/0<GD  @'J]S<P6=M)<W4\<%O$I>265PJHHZDD\
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MSQRB!89(D5=\K,TJN),G(51L ."6(S0![#1110 4444 %%%% !1110 4444
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MLQP1L+*JG'(W#K74>$_$UOXC\/:7>M-;I>W5JDTMLD@)5BH+8&2<9Z9YQC-
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M'/3Z"LGP_INA::WPNNM)MK"VU"XMI3+/LPTDCVC_ .L;J<R9 !/8A>E>VT4
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MK$?.<KG&T#N )="U2PL_%5EJ6IPS#0KO0H;>QFELI/*CD4E9(\%/E+9)SC#
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M3@UE^-Y+"+XC>#)-1LY+JW6#420ELT^P[(OF*J"<=1G!QD?6NX73K1=2?41
MIO&C\KSF)9E3(.U<_=!(!(&,D GFJ-[X=AOO$^EZ[)>7:S:='+'# A01,)!A
MBWR[CT7^(#Y1[Y /'%\,S1?\(VL>@:H=*;Q3->QVDEBY-K;,55=ZC[JY4MAN
M0#R#WT]5TK3;#QUKVG:EX,UNYT_44MX[!]*>:."5%@5?(=8W6, ,C$9Z98G
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MW!=1^\FC?:5"_+'OQS@ 9(R?3H9X;A"\$L<J@E2R,&&1U'%0W^G6FJ6ZV]]
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M353(8DDF\I$1%W,S,%8] <  Y([=:;X&\'0^"M(N[**9)#=7LEXZQQ[(XR^
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MV*)3YDF[<VV0\HK=" .1P21@  ]$HHHH **** "BBB@ HHHH **** "BBB@
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MA /?J2.G3O6%\1K">_U#1#;+HM[+;+<W#:5K _=74:JFYE)!42+D %N!O)Z
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M)0\8?))5>F1T[Y';)\N&IZ?9^%K)A):2^%+;QA<I<A,2Q1P;W:(!1D>7EE;
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M>X$+>4IA<O"X\LL6#!E50<;2>O!'SUZ[0 4444 %%%% !1110 4444 %%%%
M!1110 44@922 02IP<'H:6@ HHHH 9-#'<0R0S1I)%(I1T=0592,$$'J#6:O
MAC0$%D%T/3%%BQ>T M(Q]G8MN)CX^4[N>,<\U?N[N"PLI[RZE6*W@C:661NB
M(HR2?H!7D&O>*;O7/B!\/+FVM-1L-+NYY7A>:556\3"8;RU8D8R2-P&0X]P
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M6)G3?Y43;")'"\_PKR.1FNATK5X-<T&UU;3OGANH!-")#MZC(#8SCG@]<>]
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M--&LZ!J6ELY1;VUEMRXZJ'4KG]:\QB^'7BN]O?",.L2Z*^G>'0]ON@EE$EQ
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M)).%')VC.!DDX R2:\]N_!?BN70?$.D0MHODWNK'4+1WFE#8-R)L283 X4#
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MNHR7F'@8W,"R/O>.-L[ "2W)4_>)X)KN:YZ?Q;;0>.[3PF;68W5Q:-=B;*[
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M,_@]=">SCMO#XGRMP'9I3,NUR#R5R69L9QD@< "N]HH **** "BBB@ HHHH
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MT!BS@ABRIR >#D^E4[S0;?Q!\0_"NER:W?W%H-"FC6]MYA'-.J.RAS(I.Y6
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M-A(^X$!"%).S@CEC7NHT'1U^W;=*L1]O_P"/S%NG^D]?]9Q\_4]<]343>&-
M:PAL&T/3#9P/YD5N;2/RXW_O*N, \GD>M '(^ ='MO#'C/Q7H5E<7#V:):74
M<=Q+O8/()/,.3R<E5SGO3/&\Z:A\1/"WAG56D&AWT=Q*\(8HMS,J_*CL,$J
M<[0<$L,@\"NZM])TVTOKB^MM/M(;RX_U]Q'"JR2_[S 9;\:=J&FV&K6IM=2L
MK:\MR0QBN8ED0D=#A@10!X;)?W=A!86(U.2;2],\=6]E:W4DP+B'#.\3OG+*
MI(^]].P I>,'M=3\)_$N1K@3_9-6MY;7;,2%#.BD@ X*G<W'3.#U (]ZDT/2
M9M*72I=+LGTY0 MHUNAA !R,)C'!YZ4Q/#VB16]S;QZ/IZ0705;B-;9 LP P
M XQAL#@9H \@\6VJ:1JU_KEJ;76- TZVMK<P07C&[TW;L/F1DYSG>K$[OF#,
M&.,FIM8F\/\ AK6/B5J-Q/<6=TQBAA:TD/F@S0(S%5)V@ES]_&1DX(S7J;>$
M_#;7,-RWA_2C/ $6*4V4>Z,( $"G&1M  &.F!BK$^@Z/=3W,]QI5C+-=1B*X
MDDMT9ID&,*Y(^8<#@^@H ^>YKB>S;X@Z7'J$D%O:Z=!/;6UIJ<LD:2;8RQ5L
MC>>?F..3G(KH-9>\^'GBCQ#'X<N[NY>3PN-0:6\N#.S3"YV><2V02J,QQC!Q
M[FO6#X,\+L7+>'=*(>-(F4V<94HIRHQC'']!Z"KRZ+I273W2Z99K</!]F:40
M*':+C]V3C)7@?+TXH \2TF#0H?BS\/;O1YHY/M>G2R7,PF+M)*8'&Y\G[Y[Y
MP<]>E8NEQ37?@S3[*6_O]C>/DL2ZW3A_*,:C&<]1@$'L>E?0%GX8T#3KM;NQ
MT/3+6Y4L5F@M(T<%A@X8#/(ZU%'X/\,11K''X<TA$202JJV,8 <=& V]?>@#
MR&Z-SHO@?XGV&FZG/:PV-ZB6QFN7;RD8J616.3E@2H]2PR>]=/X)TJRT7Q5X
ME\1-<6NF:*R(EI927R,+9/E,CD)(T<:%Q\HSP./E'!ZOQ)X,M-:TR\M[(VVF
MW%Y/%-<SI91R"Z,;;@LRD R+GMD'MG!(.5X?^&UG87LE]JD&CS2RVQMWMK'3
M%MK<HQ4D.N3YG*_Q>W' P =S'(DL:R1NKHX#*RG((/0@U1U[_D7M3_Z])?\
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M(R-86[2N[R&)2S/'L9CCDE?X3[=JGHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH \PLTNXOB_ITT5O-&9[6Y6_:1?-;G&T,5)$>3$C
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M90' )0,?E. >*XR3X3:IX8O-$N]*TK2_$L4-D+&\LM1"[0S.\C3)OX4!B ,
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MG]<CBU^&/B>[/BF\O;K2(-1U2[M;ZT\EWEB26!F.V0/&,J=V._T/0@'2Z?\
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M_P 1[^A&" :QI+OQ=JLNM_V=XGMK6ZT"]2"2:\D2.$P+"I>26,1$?,?,;.X
M8P, 4 >M45Y-)KFKI\24TK5KS4[>VO-1==/O+)E:SEB52/(88RL@((9LDAQT
M"]*.B>(-=DT+PS*VK7EQ=2>*GL)2\BYFMAOW!AP#@(#GKUQUH ]GHKQ6XU#Q
M,=&\3:POBK4HYM)\2&QMXMD)C:)I84^==O.!)QR![<FK&J^)/$/@E?'D<FLR
MZQ)9VEI<V+3H-T!F8HY8*@7@D-M'& /]K ![%3)IH[>&2::1(XHU+N[L JJ!
MDDD] *X[PC;ZY!K$DMUK]GJ6D75FDMNB7)FDW@\NIVC,9!'<\X_%/BW )_A=
MKH,DB;(-_P"[;;NPPX/J/44 =$==M!XH7P^5F^V-9&]#;/W?EAPA&[^]DCCT
M_"M.O-M3T*>Y^)%AIEOKFIVC+H-P3=QNC3L/M,1P693QDCH,X&,USUMXH\2:
MS9>!M)36%M)=4T^2>:[D<1O/(ORJH8#KWP.2<9]P#VJHYX(;JWEM[B*.:"5"
MDD<BAE=2,$$'@@CC%8G@]=7AT$6NNZK:ZGJ-M-)%+<VZX! .5## &X*0#@?F
M<D\Q\2;_ ,0:7?65Y9QZG-H*02?;QI4J+/;GJ)<,"6P <#[ORG..#0!WMLME
M9B/3K46\ BB!CMH@J[(QP,*.B]NF*LUX3I-\1\0/&FICQ)=M!::'#-:WLKDK
MMD@#J=C8^7=(65,CD^M2:!K.OZK//I=]J.J0VMWX4758I3=D7!D27 E#)CR@
M_)V M\I&3DD  ]N@GANK>*XMY8YH)4#QR1L&5U(R""."".<U)7EOAZ>;2+'X
M7Q)J%R(-0M@DZ2S$HP^R%D3!X&&QCOT%<YHGBGQ5?^$I;N"2\U@6GB.9)K:V
MGV7,MFD:D+&P^9@&8$@98Y R!F@#W6HWGACFCA>6-99<^6C, SXY.!WQ6'X)
MU:#6O"=G>07-S.#O5C=X\Y&#$%),?Q#H?7K@9KF-;MC+\<_#F;FZ5!IUQ+Y:
MS-M# @' [ X7('7 H [3P_KEKXCT:+5+..:."1Y$59E"N"DC1G(!..5/X>E:
M=>"Z=?:SH-IX)O++6+P6VH^()[*:S(3R!&UW(#QMSN.6.2?ITK7.NZ^_CB%X
MIKV73Y?$;Z:]V]SY410+(#;I;C(^79GSOE8MQZ$ 'KT5S!/)/'%*CO XCE53
MDHQ56P?0[64_0BG2S1P1-+-(D<:C+.[  #W)KS_X66@@G\8M]JO9ROB&XAS=
M29)VK'\V.Y.<9[@+TJY\6;87/@*7]]-%Y=[:,/*?;NS<1K@^H^;/U /:@#H8
M/$5E<>*+OP_&)?MMK;I<2DJ-FUC@ '/)_"M:O%/$=K>6WC;QC/I^M7]G/IWA
MJ.<21E=\KQ@L-S$$D';SC&<^U5=.\5>*?%U]H6AMJR:8USH2W27!E\DW5P'V
M[E*C)88)*?=.&)&.* /=:*\OU;5]2\*)X8\17NKRZE8,AM-2-NY\B:0H1',J
M]LL,''RG.>._<>%S>2^'[:[U!9X[N\W7<D,[$M;^82XAY QL4A.@^[G&2:
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M=L\7D%,D%#P><=>!V S0!])T444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 >56-B?\ A;.A;(-.^S6MC*T9@*1O&2&S\O/7>/D4 J/X
MB!\_JM>0V.DB/XO>'U$MG&;6*\N/+01B:5<-$'<@*S9#!@64D_,02-QKUZ@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** &R1I+&T<B*Z."K*PR"
M#U!%<K8_#3PAIU]9WEKHZI-92M-;9GE98G;J54L5'(R!C /(Q7522)%&TDCJ
MB("S,QP !U)-<UIWQ \-ZIK)TRWOBLK*SV\LL;1Q72J<,89"-L@!!^Z><$C(
M!- ":;\.O"6D:])K=CHT46HOOS*9'8#?PV%9BHR"1P.A([FG:-\/O"OAZZNK
MK2-(CL[BZC,4DL4KA@IZA#NRG_ <=!Z"N;O_ (L>&]5T74TTG7;FPNK>S-R;
MH6!E, $JQ\QL.269>#V;)([=)K7C+3?"ODVFIO>75TMM]HG:ULWDV1+PTSA0
M0BYS0!8;P9X?D\*IX9DTY9='082WEE=]O)/#DEA@DX.>.@XJ@GPR\&Q:1%I<
M6B1QVT4WGH8Y9%D#\C/FAMYX./O?RK/;QWIM_P"*_#@T[Q"ZV-[:W%P;(Z=)
MFZ15?:X=E!0*8W.!R>."&!%G1_BIX4U[5+/3["]E>2\=TA=H&5&9<G;N(X)
MR <'D<<C(!93X;>$XCNM]+>V<7+70>UNYH664KM+ HX(XXP..3QS4FH?#SPI
MJNDZ?I=]H\<UGIY)M4,C@QYZ_,&W'/4Y)R>3DTD/Q T"?Q/_ & LTZW1GDMH
MY6@8023( 7C63&"PSR/7CJ1GA=;\:^)-,\,_$.YBU/=<:1J$,%C(T$?[I'=
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M=H')VF9QQ'D GYL<<]*YSQ[XH=M>TOP_"VOQV-Y!---<Z+;N9I<!#'Y,B@Y
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M7+"0JN.%ZJ&R">/4:* /'/#?@75M,UE]$N?"6CS6$-\T\/B2ZCAGN'@WEPK
MC<TI^[O. O7!P,Z^A^&M<L_A/XET>?3)$U&]-\+>W\Z(E_-!"'<&VC[W.3V-
M>F44 >.ZGX6UV/5-%UE/ UCKJG2(K*\TV_G@/V5X\X\IF)4#)[ Y]B:=JOA'
M6YK=)+?PPVG:Y;62"PU#P_=101Q2$NS0R(TBYC!*]%;(+?C[!10!BZ=>:[)X
MBU*SO]-BCTV".(VM\D@_TABOSC9DE<-D<GTZYS6U110 4444 %%%% !1110
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M52,J23ZM7EUO900_%[3;R:6%WN$E^RQ--N95,;G>"Q+$Y$HQA?E;KE6#>HT
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% 'DO]G64/QC\/R1[H)(O- 1I#*9,VT@4[N2^X*S[V.<@YR6./6J\
MDT_3YI?C/8OJ-O"D\,-U/$(62<[ Q4%VQN7[_4G/"@8RRKZW0 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 >
M50M)>?&K3IIK0S7$,,JW!16$=FXB.TG ^\P<KEC@JRGJ8POJM>5PZ:M_\8M+
MU2%HXVB269XS#("\0CDCC8'8 .)$&#@_*>2/+SZI0 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %(K*ZAE(*D9!!X(I:* "BBB@ HHHH **** "BBB@ HHHH **** /)XB7^-F
MFC^S_,F5)FFN!"&,(\IL$G *;MZ@D]\< .N/6*\NLVM(_BKIT&GW5T%B,]O-
M$=V#M1QM.UN5 6+&\,.!]UCSZC0 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 >9&]M&^,NE_9K*X:X>"2WN+
MM&GCB?\ =NY;9G85#(H&2<ER>2JM7IM>3V0CTKXT6,0O9+@:A;'RV>'S2Z;9
MY ?,9B0,APK$DX3: 5(*^L4 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %0W<LEO93S0P
M-/+'&SI"IP9"!D*">F>E35#=W*V=I-<NDKK$A<K#&TCMCLJJ"2?84 <'HOBG
MQA:>-;'0?%^FZ9%'JEO+)93:878*\8#.DFYNRGJ!C)&,Y./0J\Z\-ZU_;/C&
M'5+_ $/Q-;W\\4EK;QW6GR1VMC#RY)9L#>Y1<MSSL4<#)]%H **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@#S!;0:I\9M+GD$D$FD03M&/)R)D9 @#8"[,!P
M02/]G)R,>GUY9:SV,/Q@TN%K%_.EANE@GB988R078L5',@QN5>HX)^8KN7U.
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH \KATZ.'XN:/-=WD;3"-O(BB8DDB*927WA3R/,<J"[*['. VX^
MJ5YO>2%_BUH,URL:.[S1PQNB&0C[.[[C@Y7 &,_[14@XROI% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH \YUJXOE^
M+>BVZ>?(DL?F?Z/;@[(T+AO-)(/E[F4\<;@C<G:*]&KR[Q!,J_$'0%>\DLYV
MNTRMN8RTD>XX+@_.N_Y%8 *IW?>+82O4: "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#$U'2YKO4["\@C2*X
MAFR\TC,VV(,,JH# 99>.A R>^,[=%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
A%% !1110 4444 %%%% !1110 4444 %%%% !1110!__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>5
<FILENAME>ex3-1_003.jpg
<TEXT>
begin 644 ex3-1_003.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 2Y Z4# 2(  A$! Q$!_\0
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 >0/9)_PMNWN[>62*\MS&UY 8!M\MY&0'L 2\
MA]=V?,QG&WU^O*=8:S/C_13)=>1(UW'&+:5=KEA(2OREL*&,<D@<@EMVWACD
M>K4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M0 4444 %-=-Z@;F7D'*G'0YQ3J* "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@#RWQ0]C:_$_P[<SV\7G27 B@F@E\K9*7VG>W&2R.%V#=O(.<!>?4J\?
MU>!KKXJ:(T'S01W<33R/&^^-U1@J*NP;5X<%CA#NX 96)]@H **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MKS!UYP/4JBM[:"S@6"V@C@A4DB.) J@DY/ ]22?QJ6@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* /*[ID3XFZ0MY#$8)"6CS>+)]EG#<M@J&R^Y%&[D;B !DE?5*\A\4_VG'\1
M/#TT5RS6S:K'#<2631XDX0%)O0!HT(4YY9L'(45Z]0 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M'=ZY'';GDUS_ /PG]QJ?CK4?#&AVUD9]-BW2B^G,;7+]TB"@\ =6/<_=P,D
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M/X)\3P2B;3W^RV-TL#>7(L9*%-V,<8&TGJ,Y[9]@HHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH \L\2
MJ%^)^A+=6R1(+I7AE=MT32%OE9^0VXJSHAP0K[5''->IUY;XAU"63XG>&;(7
M\#.9UG*K%N8':V4P20H\L[@P).=_4,%KU*@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MJ(\*?F^9LD?G0L?AWXG31-+L;F;2R;#Q0NL+ME8?N 22F1'EG+,Q!/8@9&
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M F0NU?.56WJ1G*LS%N.PK<;4[S1_BF)M7N+V32+[4A;V%[;7C&)9C#Y8M)H
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M,9).&X;;NXZ]&%<YK4ZZ7^T=H]UJ%QY=M=:08+9W3:@?<_[O=T)SSS_? ]*
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M3_MK2B<S&$$^9G.X>ASSQ5EO"?A]M?\ [=;1[,ZKD'[48QOR!@'ZX[]:\_\
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M;B%SA=V,\XP<9GQ \=A+"XM=(CUA6M-1@MYM4M546L;[U$D<C[LCY6(/& Q
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MUK:H)=QZG?C.3D\YJ$^#_#!LULSX<T@VJR&40?88]@<@ MMVXR0 ,^PK:HH
MS/\ A'-#\^:?^QM.\Z>59I9/LJ;I)%.5=CC)8$Y!/(-(WAK062]1M$TTI?N'
MO%-JF+A@Q8&3CYR&).3GDYK4HH AM+2VL+6.UL[>*WMXAMCBA0(B#T ' JC_
M ,(UH/\ :G]J?V)IO]H;]_VO[*GF[O7?C.??-:E% %"XT/2;O4(=0N=+LIKV
M$@Q7,ENC21D=-K$9'X5=DC26-HY$5T<%65AD$'J"*=10!F6'AS0]*6==.T;3
MK-9UV3"WM4C$B\\-M R.3U]:2T\-:#82QRV>B:;;R1QF)'AM40JA))4$#@$D
MDCW-:E% '/7&@#2+6:?PAI&A66I2,N]I;;RDE3.2&:,;L^AYP>QIF@>%DLM!
MO-/UA;34#?WD]Y<QF',):20OM"MG(!QU]*Z2B@#/?0='DTE=)?2K%M-7I9FW
M0PCG/W,;>O/3K39/#VB2Z=!ITFCZ>]C;OOAMFMD,4;<\JN, \GD>IK2HH *R
MQX:T%=.ETX:)IHL9I/-EMA:IY3OQ\S+C!/ Y/H*U** *]E86>FVJVMA:06MN
MGW8H(PB+] .*L444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 >*>);V&Z^*V@C[)&C1WUO);NI8. S8D+8)SG?'U  VJNXD%*]KKQ?QE
M>6EU\2/"$<#_ &HQ:HGF2K(9%CVR, &+';U= "#D'(P6XKVB@ HHHH ****
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M<Y;@8&3OZUX3UK7=0\8Q"WBMK76].MH8)Y9@2DD8.595S_ST/()^[WS7HU%
M'E=SX>\8:SX-U:SN="T33KJ:R:S2*!D+W#ETS*SA0J+A6(49))[$"M/Q1H.O
MZA)X;UK3=&TM[S3TDBN-+O)=T020)D(P &1LP#@=>AQBO0:* /-W\,>(X?$.
MB>*;>QTU;JW2:&YTJ&7;''"Y^7RWV@%Q@%B1R2<< 53\1^!]=U;P7XIBCM+1
M-6\0WD$WV>*<>5;I'Y>-S$#<Q\L[B!R6X]:]4HH RX+G6)=:1)=/BATMK/>T
MC2@RK<;\;,#C;MYSZUJ444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MD#E%B<\,#(F.K<*5X5*]SH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MB/EK@!4&9R2!SR>3F@"_>>.?$%MX?N_%D=MI\VA6]_)"+9(W\][=)3$9C(6
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M%YA&"VU0,X[9Q7&WGPRMI_[=M[;6+VTTW79C/?6J*CDR$Y<H[ E=W&>OMCC
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M5/ #:L?$OGZQ*/[=BB@?; O[E(V8J!Z\,1D_6DD^'<$VO6NKR:I<&>#1O[)
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M@;<$[GA>_P##&I:7IXBLKVV\2Z1I-Y;ZE&(3&L3;")'N&*C+,RD@9R"YSR.
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MO(/$\EO/\1?#5J7DDO[>_25)5MV>#8[(6').P\R8)W?ZQ,$ AH_7Z "BBB@
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MG!/3%-TCP/XFM=4\-2ZCXBLKFST /%!%'8E6F0Q&,,[%S\^TXXX& >37H=%
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M+9R?E[+BNV\Z/]W^\3]X<)\P^8X)X]> 3^%$DT<1022(A=MB;F W-Z#U/!H
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MI;RPJT8_X"1CO3;C1=*N[&*QN=,LYK.$AH[>2!6C0CH0I&!B@#YOT"73=/\
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M64=XUXEG;K=.,-.L2AV'NV,TTZ7IYG,YL+4S&43&3R5W&0 @/G'W@"0#UYH
MK^(X8Y_#.JQ31I)&UI*&1U!!&P]0:\7\/7WA>'0/AXLKVI\/JUPFIM)'BW74
M#"A7S_,ZL-TF">.A&% Q[W5--)TV.S-FFGVBVI<OY*PJ$W$Y)VXQDDDYH XS
MX71QPQ^(X].DC?05U5QIIBF\Q FQ=P0Y/R9Z <9S7?U'!!#:P)!;Q1PPQC:D
M<:A54>@ Z5)0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M!X[XF,7_  GWAN$7T$0CU&+R4V,1(=ZAD!7)5\$D[R,;2O*M@^Q5Y!XX:2V^
M*?@N:*\F#'4V1[42;,A@J^9G(SQN7!Y(&T9&,^OT %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 5SVI^,++2?%ND^';FUO!/JJL;>Y"H(,J"64L
M6!W# X /WE]:Z&N0\?>#9_%=GI\VG7HL-7TZY$UK=]T!X=<X.,C!Z=5% $[>
M-(Y;73FL=)OKFZU+SFM;;,:EDC^](S%]JIRN#G/S+QS7,^(_B9,L?AY='LKR
M*:]UN.PNX9EC66(JZ[X2K$C<RL,'(&&!W5T&I>&+^SU;0M4\-O K:9;/8O8W
M4[QPRV[!< %58(P**<A/FP 3A17(^(OASKDKZ?K&FQV<VL_\)"FJ7$#2D0HO
MR@+O(!95V GY<G<V!T% &WJ'Q@\.:;JL]I<,5AM;O[%<RF:+?')@;B(MV]D4
MG:6 QD'&0,UZ#7 :7X:\9:)JVK6]EJ>EG1]1OWO1<.C_ &FV,AW2*B8*'G@9
M/'4@]*[^@"CK&K6NAZ5-J-XS"&+:,*,EF9@JJ/<L0!G YY(KGIO'T-@^I6^I
MZ-J-I?6%@VI-;9BD,MLK%6=&#[<K@95BIYX#5;\<>%4\7^'6L1(L5Y!*MU93
M-G;'.F=I('4$$J>O#$]0*PM;\)Z_XA_M&_NX-)AU"71IM*MH4NI)(P9B-\ID
M,0*D#.%"G/(+#/ !J>&O']GXGU.*RATK5+(SV(O[>2]B5%FBW*"5PQ_OK]<_
MGUM</X<\*ZQI.L^'[FY^PF#3O#XTJ8Q3N6,@9#N4% "N(QU(/S'CCGN* ,7Q
M!X@;0Q9QQ:?/>W%W(R(J,J(@52S/([$!5"@GN3T KG!\5](>Q\/7,.F:I<-K
MQF6TB@2)FWQ-M93EP.O0YQWR*N^./#FK>(+C2/L2:7=65K*\EU8:D7$4Y( 1
MCM!SM.[Y2,'//05REA\-/$5I<>#"\NCF+0+Z[FD$3R(&BFD#@(NP\CYN,@=!
MGO0!T$7Q4TH^&&UV;3=3C@@O_P"SKU-B$VDW )<[P-F6 W ]QQ74V.LPZAJM
M[96\4C):I$QN0RF-RZ[@JX.>%VGICYA7GAT?2_"OA'Q38>/+^PM[#7M3N+J-
MH97D<"0 @ ,F=ZE P.&YQ^/6_#[2)-(\&6"W$D\EW<1K/.]Q_K22BJH?W5%1
M>_W>IZT =17)^*O'">&)YHSI5S=+;VGVR>59(XD6/)&%+L-[X5CM'.!ZD"NL
MKS?QSX$USQ/K5W-#)HUS93:<UI;IJ4;,;*1C\TD0 QN.!\^01@<$#% %Z\^)
M]G#J+V5GHFJW[_V8FJQ20+$$EMFQ\XW.#QG'(SD'CH3-HOQ(L=:US3=/72M4
MLXM4MVGL+F\A$:W.U0S!1DGA2#GH>W&"<'2_ ?B>QU*&ZF;2)1!X670D"7$B
MY<$$.<QGC/'ZX[5/IO@SQ+;:G\/Y+O\ LZ1/#EK<0W,D=PWSAT$2A!Y8SA I
MYQGD'H"P!9M?B_H-[K]EIULC30WL[6UO<17$3LT@8@;H@V]%8CAF SD'@'-2
MZ;\4K+47T]VT;4;6SO-1;3!=3F,*ESD[$P&).0O4 J"<9/.(?"?AKQSX:\G1
M?[3T5_#MK*Q@D$<ANS%NW+&<_( >A/S$ G'."*47@/Q(_AKP]IMPVE++I7B,
M:J3'<2%6A\QY"N3&/GS(PZ 8 YYH H_%KQ/<7W@+7?[*L;S[-8W*6LNHQW0B
M$<JRJ' 0-N< X7..K=.":W-4^*L.E:OKEC-X<U5TT5XOM<\?ELB1.,B0_-W!
M!"]2.H7!QAWWPP\1Q^$==\'Z3<Z0FA7MV+BT,[R^=;KYB.8S\IR!MX)))SS[
M7]6\!^(M0NO'DBOI:IXBAMHH,SR QF)=FYOW?&1S@9QTR>M '0Z1X]M]2U^;
M2KG2[S3F&G#5(9+EHR)+<MM+$(S;>>QYQU Z5CV/QDT*]U*WM5M;DI=P23VD
MD;QN9%C#%@R[LQD[>,\$\$C!Q:@\%:D?%\6J7$MHMF?#0T:01R,9!)OW%@"H
M!7MU!]JJ:+X6\=66B)H%]JVCR:59VS06SP)*L\X\ME192<JJC*YV@G"_F 3^
M&_BC'XAFT@#P]J5M!JR3_8YV>-EDDAW%D&&R.%."V,G(Z FM#X>>)M1\4Z5J
M%[?VOD!+^:*$!U8!%;&W@#.,=2.<USOACX>:]H:>!4G?3)!X?>^-RR3/EQ/N
MQLS'V#<@XS@5T_@3PUJ'A73]0L+R>UF@>^EN+9X0VXH[;OGSP#[#/3J<\ '5
MUQJ>,;BW\8^)+34K:.TT72+2WF:[>5>-XD8N0.><!0O7Y,_Q8KLJX36? EQK
MVO\ B!+V2U.A:U96\4H!?[0DL)8H5QA0 S!LDG[N"N#F@"[9>.A+J6E6VH:/
M=Z=!K$>_3YYG1O,;&X1NJDF-]IS@\=1G-==7 :=X0U^ZNO#8\0SZ=Y'A\9AD
MM))&DNG"E%9PR@)QM) +9(/0'COZ .-^('B?4_#D>AQZ;9^:^HZK;69D,BKC
M<^2@!!^\JLN>,9SG-<8OBRY\'^./B%>'2K^_M(#832QI<@K:AXBSGYV[LW11
MT!Z 5WGCGPW>^(['23ITMO'=Z9JMOJ,8N"PC<QDY4E02.&/;M7-:GX!\0W\G
MCQS-I9;Q%%:Q6[>;(@3RD*$N-AQGK@$_6@#1:[T:X^+D-UNU/[9%X=^U(R2D
M6S6YEP"8U^9GRQX;C@<9 (U?"?C$^*U6>#39(K*6W6>*Z$Z2H23S&VW.V0<9
M4\BLJR\(Z]:^,M/UT3Z<@B\.KI4RAG8B4-OW*-H!7=CKS@=.>*W@?X?W_AWQ
M;?:[<II5@MS;"!['2=_DN^X'S,./DZ8VKP/4YH ]&KS'XG7M_IFO:+J%]:ZE
M<^#X0XU%+*3 $ASL:0*0S(N >RY [\'TZN?U>V\3+KD%]HMU8O9B QW%A>%E
M$C;LAE=02AQD9P0<\@X& #E-&\5:)X8\*3:C9Z_<>(++4-5,>GH\SO)!N1<0
M$R$LH0*S?-@X(X)/.EI_Q-L+ZPN'&GW2WL=_'IT=H,$S32#<F&X 7;EB3C 4
MGGC/-6OPAU'3=+N+G3=0L;77%U7^T[)8XC]F@X(\G!R2N#C.,C P.M;NM^$_
M%OB3PW;G4M4TN+7K&_AU"R6UB<6L<D6<!BV78'<<GV''7(!H)X](18+G0-3M
M=4DOFL;>TG3:+AP"2Z2'AH\ G=_];,%W\2;?3].U:6\T:^6]TFYAM[VSB:.1
MHQ-CRI 0V&5L@8&6R>5[U%>^%/%6HQZ=J]WK%D=?L+D7$-O%&R6:C84:,'_6
M88')8Y.2>,8 KZMX'U[5-,U>=[S3AJ^K3633)AQ!!';,&"(V-S$L"=Q ^]C'
M H NI\3;"!->&L:7J&ESZ/'',]O,$=YDDXCV;&(+$D+C. 6 SUQ3TR_U&Z^,
MRK?:9<Z<Q\/NWEO<B6.3]_'@C:=H(RP/?GT(J'Q!\.]5\1:SXFN9;VVLXM3L
MK>"U>%V:2*2%UD!;Y1QN7J#G%:^CZ%XH?QA:^(->N-'5H]-DLY(+!)2-S2*V
M0SGI\@/3CIS]Z@#LZHZSJ]IH.CW>JW[LEK:QF20JI8X'H!5ZN>\3Z)=>('TZ
MS9;-](2Y6>^AGR3.JG*IMP5*YPQSUV@>] ')_"[Q-=WNL>(-&U>5#J#S+JL*
M+/Y@2&95)B7C_EDV%/NU6-0^+$>G-K,LOAS439Z-=K;7UP)8L1AF"JP&[+9+
M#@9]\5+J?@*XL/%^C:YX,MM(TD6Z20ZA$J>4MU$Q4A=J(1P5//!Y'/ K-UGX
M<:WJ>C>,;%+G3T/B"\BN$+2/^X".IP?E^;(0>F,GK0!TUEXW!O\ 5[36-'N]
M(;3;/[>WVB2.3?;Y<%_W;,!C8>,FL6U^+=K<+>F30=2C$&GO?QN K(ZHA8HS
M#A6P.G(]^F=6^\*7VK^)-8N[V2UBL-1T(:7LB9GD5B7+-R ,#S"!W.!TK,3P
MQXXN/"NH:'J>KZ1/#_9\UE:&&)XFF+IL5YFP0-H+?*B\G'- %_2/B/::AJ-K
M;WNFW6E07FFG4K:YO)8MCP@ L3L=M@ .<MC@'.*XO7/$E]KOQ ^'-\-/NM/T
M^[GFDMFDN ?M,1";69%/RG!S@YX<<]0-_P#X5S?W,F@PWL]L+2S\/R:-=^3*
MWF-O01[X\IC[N3ST/'/6J-E\.O%O]J^$&U+5=(EL_#,C) T44BRRPE5 W#[N
MX!%4 >Y)8\4 ;-C\5=.O=6L[9-/NOL=W.T$5XGSJ.2%=@OW48C@YX!!..<<_
MXO\ %,OB&?P=>:=:S+HTGB>VBAOUN@%N=LC*P\L'.TLA()[+VSSM^'_!7B?1
MXCX?FUVTF\*(3Y06)EO%CR2(=WW=O3).202!CC&4GPS\26EEH>AVFIZ6VB:+
MK2:C:M-%)]H*!W?:Y&%)!<C@#.<Y7&" >LUG:]JO]AZ'=ZD+.ZO3;IN%O:QE
MY)#G   ^O)[#)[5HUS/C[P[J/BKPA=Z1I>I?8+B? ,AR Z?Q(Q'.".#U],<T
M 8H^*=HFAZY?2:>TMSHUQ!!<VUE<I<;O-954HXP&Y)!'4%2*L0?$9;:?6$\1
M:)=Z(-.M$O0994E,L+$J#A"<-N!&W)^HK!N/AQXEO=-UZQN+OP^MOJILF\BV
MM98XX_($0*J-QVH%BV@8.<Y^3[M;'BGP#=^*]5U9KJXMH+'4-*CL1LW-)%)'
M+YJOC@,-Q/&1P!ZD4 5-#U:\UGXM6=Y=:5)IZ2^'))( \PD+QM/$02!PK>HY
M[<FO2:X#PUX3\667B+3]5UG5M)E6STYM-\NVM9,R1;E(8L6 #G8">,#D <Y'
M?T <!\8[2WD^'US>RM<1S6DT!CFMI&61 \T:/C!YRK'@Y&<<9 K'\%SW%Q\2
M]6N/#]W>OX.@@,$T=Y)((H;I=I98E?E2,Y.?[S>U=EXWT34_$6@_V9ITEG$)
M)HI)7N"W CE20 !1WV]ZQ_\ A ;JP\877B#1;JWMXM53;J^F3*6AF8CED(P0
MV2QR1SN;IDB@"KI7Q?T_6-=MK2STJ\DTZZN?LL5ZGS'S,XW,@'RQDXPV[//(
M%6[7XB7.HIJ,EAH330VIN565;I25:'(Q,F,Q%B&(!Z@ ]\57\(^"?%/A IHU
MIXAM)/#<5QY\?F6Q-T%+;C"#G8%)SEL9Y)&TGBM;_#*\D\7_ -OW,^F6DYMK
MB"X>PA93>-(FT/(A.U6!)8[>IQ^ !+I/Q!U.V\%:!J6L:9ON=2W%KEIXX;=$
M"[][R'Y8\CA5/4CK4+_$G4M3U/P9_8VF*UIK1NV>-KA-[F!75H\X*@!MK;@>
M=N.G6&P^'WBVVTSPI:R:EH;C0KB1EBDMI9(F4KA)"NX;Y4.XC[H&[.<CDL?A
MWXIT]?#$\6JZ0]]HE[?.'D@D,;07).25# LXR3C*CD#)QE@#7_X6E8'6H[./
M3KJ:T>^-D+J(A\,&*F0J/^6>Y2,YZ8.*YSXB>*VUS0H)=(@DDTJ/6(;8ZE#>
M*$E(8;@$4_.AR1D^G P<UT>A^%O%V@ZE-I]MK>G-X9:Z:XC5K9OM42/(TC1*
M00,$L1O))Y) 7 KG;CX6>([72'\-Z/J.DKH":BE];-<QRFXCPX)0X.U@.QX)
MZ<9R #U^N>\<^(V\)>"M4UR.))9;6(>4CYVEV8(N<<XW,,]..XKH:S?$&AV7
MB70;S1M11FM;N/8^T@,O<,,Y&00".#R!0!QV@>"SJW@>"ZU34[^37]0M1<'4
M1=OOMY'0%?+V, %7C"C@X/8U)KOQ+@\,W+:9+:R:G?6-M')J)MV V%ER HQ\
MS'!;'  (Y[5;T+1/&&@Z7::'%J.D3V-I%Y,5[+#)YP0<*#&#M.%XSN'0<57U
M'PAXBM/&ESK_ (7UBSMQJD44.I17T#2<QC:LR;2,L%X"G ZY)S@ "R?$KSM4
MDT[2/#.K:C.ME#> )Y<7RR$8R'8$8SZ9X/&!FL:;Q+-XB^'LNH^(=$N4LQJ(
M2.2UNT!R+LQIQZ+\JG(.[&<<Y'2:/X3OM)\=7>LF[6ZM9["&TWSRDSDQ@Y=O
MEVDD^F!S^%8C>!_% \(:CX;6]T<VGVX7%@Q242%/M/V@^:W3.>,*OXT 1^*'
MO->^* \+W>EO=Z2-&:X6(7 0%VF0>=Z;DQ@ Y(R3T/+_  =XBTK0/!5I:V-O
MJ4UQ-JDUA;V][<*UQ-/O)8LW"@  DG'&.Y//0OX?U,_$F/Q,OV+[,-,&GM$7
M;S"#()&;.W'!& ._/(S7+'X8:LN@6HM[^QM]<T_5Y=2LKH(S)B1B6C88& ?E
MS@'[HH Z2X\<3V>DBZO?#]Y97'VUK1XKN6.*-0L9D,OG$[/+VC&[NW KF-1^
M+%]=6WABXT#2DDAU34_L4WFR@L"K@%4(XP1SO/ ';/(TM>\&>*?$%GIT^H7^
MB7E];W?GR6%S:NU@5V%!\F2S,NYFR3R3@X %9,/PR\3V5A8"UU?26O-.UJ34
M+<R6\@C='^]O&XD'K\H^F[O0!MW/Q7T^/7IM.MM+OKN*VO\ ^SYYXE'R2@X8
MA.I53@$\>P(YKT"O/[#P9XDT+Q+J;Z1K=H-"U>]>^NXYH3]H@D<@L(B/E.<8
MRPX&."1FO0* *.L:K;Z)I-QJ-T)&A@ )6,99B2  !QDDD#\:R++Q5</KBZ-J
M6C3:??36K7-JK2K(DX4X= Z\!ERN1Z,#5SQ7H(\3>&+W2//-N\ZJ8Y@,^7(K
M!T;&1G#*#BLZRT/6KK7['6==FL3/I]M-!;Q6F_:[2,NYV+#CY47Y0#@D\G H
M YGX::6=<B3Q/J<,\>J0ZA=$7(NPWVA2TJ&-T P$3=\H/((R,*<'U"N:\"Z%
M?^&_#@TW47MY)A/--O@D=E/F2,^,,!C&[''UZDUTM !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% 'D?B.73KKQUX>:]@NPJWL$D*R2)&T=
MR920K94J0/,/R@Y/EG:20V?7*\E\2BZMOB%X9C%I'-:?VBMLD09FD1B%E>4R
M,<EA@'_KF2O\;J/6J "BBB@ HHHH **** "BBB@ HHHH **1=Q4;@ V.0#D9
MI: "BBB@ HHHH *PM9\66&AZUI6DW<=P;G5&9+3RU!5V7&X$Y&,;@>?7C/-;
MM>7_ !&_Y*A\-?\ K[NOY14 >H45XI!;W\+6^K'7M4=[;QJUE#"\P,8A:X\I
MU;C+Y7CYB<=L<YM:G=)KFN^)M1NO%]UHM[X<NP+=(')C2V15<DP[AYA<[@<]
M< 8(P* /8:*\9UFYN+_0/%?C"'5+R'6M U6XM[;RY6$,:1,%$9B/R,&5LL<$
MDGJ ,5HVFD:KXD^*%[<7&OZU8Q:?:V5U]D@GV1AY Y*,F,$#:1R#GG.<\@'J
MM%?.GALZWIV@> _%]OX@U2\O]3U4Z?<6-S<EHI8VEF!/KQ@DEMV"P/& *Z73
M;F:]\*6GC^TU/4I=?&HQP7-H;EFC4/<B)K5H>B@+("!@'(5N] 'LU(S*BEF(
M"@9))X KQ6PMKJ'Q!XYU^Z\6ZU NA37 A5YA-$"\!PWE-A6*D@JO )"CBN8L
MHM13_A*=&N[ZY^PS>#VU,6XU)YSYJB,B1SGY7?!9D!(P^,E<4 >\S^)+9)-&
M^S6E[?6^K']S=6D.^*-2H8-(V1M4@\'GH:V:\B\+V*Z5#\+8[2]O#%<Q2RSP
MM.60N]D7Y7V/W0>@/'6L^2?4)_!L7Q!DO[R+Q+%J9AEM/M9\E5^U>2+;RP0H
M 7!Z9)))SG( /9Y[2VNFA:XMXIC!()8C(@;RW (#+GH<$C(]34U?/7B)M6LH
M/'NOV_B/6$N=#U>%[*,7),89V16+*1AAM;:%^Z!QC!(KVKQE<S6?@?Q!=6[F
M.>'3;B2-QU5A&Q!_,4 ,'BNUEM9+NTLKZ\LUN([=+BVC5TF9GV$I\V2J'[S8
MQCH6P<;U>8:S;16WP6\.RZ??75O%:#3)8Y+9C$90SQ*=P&,@ARV#CY@#VK*\
M7^'I+_4/'MT=>U>%=-LH=0MH8+X@+,(I6Y4Y(7Y0 !COW' ![)6*/$MJ?&I\
M+>1.+P:?_:'FD+Y9C\P1X'.<YSV[5YE<747C/Q+KFF:_XC?2/L5C92:;Y=X;
M==\D)DDEV;AYA4D#T X[TGB]Q/XVUJ=+B23_ (M]--'.N8V8B8LK\8QR <4
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M\MO)'XYTM-\*CQGXNU22_P#$.N*J:=IEQNMIC:^9*\;9D,?(0XC^Z.F]N_-
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M*MC?E@2=Q'4 =">*KQ>&_$[Z ]\FEM;ZE9^)9M7M].GGB(N(W8G!=6(5MLC
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MDBLT#S1P+O=03P<=N_)QTH YW7M$U^3QK=:CIUK:3V-YH3V,ADN#&Z2*SLH
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M'OAVZM-,E-O_ &K:V=S=*@C9F!#1C:N-R(&4!MN.HR2%(]@H **** "BBB@
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MJY!\+O!=LL(AT.-/(+^6PFDW+OZC.[.,\@=%/(P>: /-M(USQ2OPWT_Q=?\
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M>S98VMV3:5FF<DY7&0L87).<G!&.Z\+:A/JWA'1=2NBIN+NP@GE*C +O&K'
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MD,<%O"@2.*-<*BCH * /)8O$&N_\(/X<\90ZQ<W5]?W\44]FH4V\BR2%#&J
M94KP 0<Y'.237/\ B'3S9_"[XF$W5]*5UT18NI@^<26QW<=SGKZ8&!BO9+3P
M?H%CJ3ZA;:;''</*9VP[%/-)YD"$[0_/W@,]LU7O_ /A?4Y-1DN])C=]2='N
MR)'7S2F",X88&54D# )4$Y(H \ZU'Q-X@\(^(O%^G_V[<:D;30A?0M>*F5F+
M*I955 H4%_N_0<]M:#_A)M/L-6U&7Q=;W-K/HD]S:I#.LCB:+!,B,Z!0@W!3
MT +#IQCN!X1T(:M<:I]@#7EQ:_8Y9'E=@\/]PJ3C'3MV%4=,^''A+1[._M-/
MT:."*_0Q7.V60M(AZIN+;@I[J" : &_#ZWU0>%K/4=6UFZU&XU&VANB)T5?(
M+1@E%"@<9-=75>QL;?3+"WL;./R[:WC6**/<3M11@#)YX%6* "BBB@ HHHH
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MP.>#W&:R/".A:GI]]#HFI>"99I].U#[3%K5Q(7C:(.[[\ @&;@*N.[[FQC#
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M;:3RK=G^X)7QA"<XYZ=\57^(,.H>1X?O=/TRXU$V&LQ7,\%OM\SRA'(K$ D
MD;AQ_+K7.366MVFB^--!ET"^N9-;GN)K&>,1LO\ I";0LC;L+Y9')).% QG
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M2N<<] #D\ D8?C+PEJ_BW5_$<4=C<6EM=:%%:V]R\L6V2>.<S!<!RP4[@I)
MZ-[9R-'T/6I/".OQ2^ +'1;Y=$GTX/:"/S;V5E R,8PO&>K9/0G% '<^'OB1
MX<\3ZH^G:?/<"=;;[4OVBW:)7BR!N4L!D<C]?2L./XC6^N^._"UEH=S?C3[U
MKGS?.LC'#=(D+L&1G7<<.H^Z1[UBZAX+UW5_%]D?[+DL[-_"<FDO/(\96&8H
MXP0CG@;U''7G' )IWA*Q\6I<^!['4_"TUI%H+SQ7%R)H2K PNBD*IY'S+D]S
MG&3F@#N8/'^B7&OQ:0OVQ7GGDMX+F2U=+>:6/(=$D(VL058<=2.,\5@:Q\0H
M;WQ)H>G:%-?F-]9%G=3K:8MIE56WJLK#DA@OW3R >HKFO!_@[6-*EA\-WO@?
M3 ;623_BIPT:N8R6PR@#>7P<#+<<9'%5_#VE>-M)TOPIX:N?!\K1:)K'VJ2]
MCO(BCQGS3D GTD8]1]U1U;@ ]TKCM.^)OA[4KJ.&(:C&D\,L]K--82HETD8W
M.8OERY"\X S[9XKK+D3FUF%LR+<%&\HO]T-CC/MFO"]!TCQC'XC\):M/X+O$
M;27F@NWDU)&:;S(MI9$.$B1?F*JN%).,C.: /0M&^*_A77=3TW3[*XN/.U$/
MY!DA*+N7=E2QXW?+T_VE]:H^*O'875M*T[2'U.)O[=MK*XN5L_\ 1I090LD7
MFLI&1R/E(.5(KE=#\*^(K7PS\-[.71[U)M+U*6XNPCQ@QH9'89RW0@C(ZXR!
MSBF6FE^--+T+3O""^%9[F/1]8BNX]22[0+<1BX,N0&'!^8=??.",$ ]RKQ.;
MQ7XGL/#/B[Q!+XKDSHNMS:?:VL]G 8YU1E 5MJ*Q8[QRI&-I)&.GME>)V_PY
MO-:TKQ5+/H<FFZ\^N7&J:3J$HBWCY@8XRRL3@G=P<KSN&2* /2;CQ9%I6@Z3
M=ZK;7!O[^)"+&QA:>4OLW.%11N*KSD]N,]15)/B5H$]M826@OKN:]$QCM;:U
M9YU\HX?>@Y7!XP>O;-<?XGM/%&NV'ACQ#?\ @F*^O=*DG@OM&N7BD682 +YB
M')&,H#T)&X8R!NI+GPM>75C:R77@@Z6Z133V4V@SH)]-G9@54C>@DSU/\(Z<
M#)4 ZB/XFV,WB6RTV/3-3-G<Z:-0%\;5]@1@C*> ?E"N=S= V%ZFK&E_$S0-
M::[73TU&8P64E\@^QNOVF%&VEHMP&[G@#UX]:YZZTOQC:W^ASV^D07MXWAJ7
M3KF5Y(TA@N"$8%EY##<@&  #GL.*Q_AQH7BBQ\1Z7=:CX8EM(&TN>QN+BYO1
M)C#(RMY6 $7*A%C7'&3VR0#M-)^).GWO@ZUU^[L[Z W,_D0VJVKM+.YY'E*.
M7&.<C(X;TJ>/XE>'9] BU:%[R5);LV*6L5J[W!G )*>6!G.T9^F.Y KSP^&_
M%P\!>'1<^$;.[D\/W!7^SKB=)OML3*RLY4KM7&5*C+'J<# SH)HOB/1I_#GB
M+2_!%I;);7-V;C1+2=/,B29(D#;_ +K-F,L<8PI5>,$@ [7X?:_+XCTC4;R6
M[FN!'J=Q#&)X5BDA12-L;*HX(!'7GG)]*ZVN/^'D&K0:?K!UC29--FGU>YN8
MXGD1\QR-O!RA(XR1[XSWKL* "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** /%_&IM_^%F>&%O+2*V+ZI \,2R^69'64CS.$.[);/.,@ 9SD
M5[17BWCF<+\5O!R-:PFY%W"OVF)]C8\UUPV<F0%0>#]TJ<'#G=[30 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !6?K.N:7X>L?MNKW\%E;;P@D
MF?:"QZ >IX)P.P)[5H5YI=!=0_:$MK35(HY+>RT(W.G)*P8"4S &11V? 8>N
M$![9H Z[1/&7AWQ'=26FDZK#<W,:>9)  5D1<@'*L 1@D @C@GFMVN*\>7-C
MX/TK5/&UO:H=8AL?LJ,#@2!Y$52X_B"L5/K@D=ZQY-4\=:=IWBB[NS-!:6NG
M->6,M_%:F7S(U+.FV!R-AQP6R0#U)YH ]-K*TOQ)I&M:AJ5AIUZEQ=:9*(;Q
M%5AY3G/&2,'E6'&>AKR35+GQB/%7@1-7\1*RZK=O/'%90K''$!#%@$$9;#22
M#YB<C!X)P-_6[F_DTSXH0_V@+=[.(-%/!!'&Y4VPD",V,MP=F[[P'0@T ='9
M_$[P??ZQ;:3;:LSWMT0((S:3*),YP58H%(.#@YP?6NNKQ:SO[[2#\);6.:&9
M=2M5$LLMK$95C6*(K&K[<A1O[<\<FNC\,:_K^O6EAXG&M6?]F3W\]O<V$L2Q
M)!"'9(R'/S^;N5."<'S -HQD@'HU%>3>$_%WB35]=TRVO-3$D>KVEVY>"T5;
M>!XR IMG8;I,!ANW[AGH3VR_"/B36K/X9^%_)OKV]U'7M1G1B3 9(T$DS2&)
MI-JER5&/,+<L<=A0![;4<4$,&_R8HX_,<N^Q0-S'J3CJ?>N6\ W7BR?3+N'Q
M?;QQWL,^V%P\1>2(@8+K&2JMG/3'TXR<V\U?7M6/BN[TG5!9#0I3!;6ODQNM
MPZ1+(_G;@6VDMM4HRX R<]* .JUWQ)I/AJU2XU:Z,$;EMH6)Y6.U2[$*@)P%
M4DG& !DTZ+Q#I<_AU=?CNPVEM#Y_V@(V!'W8C&0!WR.,'/2N)EDEUGQ]X!UG
M[5=1)>:;<W*VK)'B+,<)*\J6YW8/)Z<$<YZ;QM#'!\-_$<4,:1QKI-T%1%
M'E-T H V=.U&TU?3X;^PG6>UF&Z.50<,,XR,_2K5>16VI^(((/ACHFDZNEA;
MZOHQ64FU24H8K9'W+N[\X'8$ D$9!C\%>/\ 6?$6@^&K/4-5CM;_ %2>[C>]
M6&,.RPA<*H/R"0F1<?*1A3Q0![#17G1UW7DU_1/!\^KP_P!H7#7;WE_%''YR
MQ1G,.U2"@D92C,"N #P.E8.I>+O&-C%'H<FJ6\>K0^)K;26OA9HPEMYDWQR,
MF<;\=0,#!P,'F@#V.BO))9?B&?'J>%(_%]J)!I#W[W/]FQ@']^44!><'&WU
MRW#8%2^&_'&L^*6T+19YY=+O91=K>7L<* W#6Y50;?S%9"&+-N^7@HP&,9H
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M@+W)K5UR'Q#;^%]?:_\ $-OJ6F7/ABXE"2*BS"X"'<T82-<P[67[Q+ E?7D
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MC\EII+A#+%%_%&AV856R<C!SGUP1U,_B+1[;3;?4)=1MQ:7(!MY ^[SLC(V
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MK.E0:YHE]I5T\J07D#P2-"^UPK#!P?Q[Y'J".*BMM=T^;5WT3[;&^K0PB6:
M(R';P-X!_AR1W/7K56?QGX=MK&&]FU6%+>9&D1B#DHI(+8QD+D'D\4 5(? >
MEP7OAFZ6XOC)X=MVM[0&;*NK1A"7&.3@?P[??(  R[SX2>'+OP\NC>=J44,=
M^]_#,ESF:&1CR%9@>/KD\9R3S7<PS1W$,<T,B212*'1T8%64C(((Z@U0OM?T
MK3=2LM.O+V.&\O3MMH6!W2G.#C ]Z ,J;P%HCZ-8Z?$MQ;R6#&2TOHI3]IA=
MOO,)#DDMW!R#W' Q4OOAKI%[HUGIXO=4@DMK]=2^VQW ,\MRJ[?,=G5@3T/
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MC,MNT*-,94 !+*J D@ @D@< \U6O_B#X2TRUL;J[UZSC@OD:2V<,6$BJ"2>
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MX^8@9. 3GC)H \L\8?#.."PT"Q\-:$]SI%E?M>75E'J)BF9B% \N20G:."2
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MC@DU?4;:Q2>3RHVGD"AF^I_GT% &?;>!O#UG<VMS;V<L<]M=RWL<@NYMQGD
M#NQW_.2!@[L\9'0FJ5[\-/#5_ \4L%TH;4O[4#I=R!DG)4L5;.0&QSCU)&"
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M)0Q[02XP!DXP.*]AHH \U^(&@:]J>N>']8\,2265S=1R:9?7 1A+%;2KN#D
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M&I2FSBVMYFXQEMI 8;OFR,\FNO@GANK>*XMY8YH)4#QR1L&5U(R""."".<T
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M\)(C$P/ED[<[02V.<$8)(Q@GW&J6K:OI^A:9/J6J7<=K9P+NDED/ ]@.I)Z
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M7C_CBVLC\2?##7FJP65T-3MWCM50>9,OFOY9^4$X)+*2< <?WB1[!0 4444
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MX5%#+H<MG>>)M8N[_P ^&:VU&>7?+:^625$9).WJW(([>E &:OQ!\0OX.O\
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MD?<((HDV1(2"07QDL1QEL#@9H X'4H=<G_:"U1- O+>TN_["!:6>#S1M#(<
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M]3G& /7 / ZAH1L/A1X5^P>'KF'4?,LEO)[?3#+>VI169I50C=N#[@">@D)
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MF&VMHQEYIY B*,XY8\#DUXQX4T>[LO _P\@FT34(KZUUQWN@;&0-"A,PW/\
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M=SY!MY%!"N'[8W'K7$?\+)\0)XW6PELM..G#5TTN2VM]\TR!QM\YI5.Q1O\
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M*KQK 3@1X1, LQ&.IK9'@:X.O^'=8FUN2YNM(>YDEDGMUW733J$))4J%VJ
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M%B QYR,CIT'2IM9U?4XIM$DT2/3;JQNKU8;R>:Z"E(SGF,=';(/<G(QM.25
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M,Q3/(C8JY&, @9'!%>YT4 >3_"W[':_$7XAZ=8^1#:Q7<'DVT&%1,>8K[5'
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MCH"1[O10!Y/K?BC0_%_B;PLGAGQ'J4MU)>I]JM]/N9XT-JJLS&1!A5^;8"2
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M)*UZY0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 >,^)X-0B\=:!<?N$MIM?6)=L,C,P$H8A2&9.<!F)"G*8
MQ\K[O9J\9\616UO\0_#BRF*6634;<222QB2665904Q(A&W9E^-H 4J".>/9J
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M*I:P\T6BWTEO,89T@=HY!M^5@I(/S C\ZNU4U0SKI-V;6"2>X\E_+BB<(SM@
MX 8D '/?(Q0!Y-X8\77VL^!='O[OQ_\ 9O$%[<>0EHT-LR22&<JB,BQ%U#*
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MF7D*&[1XM;BAP6FBA*NF[;RK;@J$G!P0,\ 'T61BD;,J,Y )"+C+>PR0/S-
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MK<1OR/F'(&<<XH 2?XC:#::%=ZQ="_@MK.[^Q7*O9R;H9?EX8 ' ^=>2<'(
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MNO%CIOB?P#:1W<6H6]KJ'BGQ3$DMLH-Q;VB3%SA5.W+=F(QD*H!&,G3?4_B
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M,-,G74KVZ:=P',Z"5U\J(,.O!)9N0$/RGJ/:Z (;J[@LK9[BYE6.),99O4G
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MT:R &-BC -AP1M.,-GC-4A\4_!+6-Q>)K\$D-O)Y<GEQR,P.TMD*%W,, G<
M1P>>#0 ZZ^&WAR>[AN((KNP,=N+5DL+I[=981_ ^P@D?C70:-I-KH6CVFE67
MF_9K6,1Q>;*TC!1T&YB3]!T P!@ "N>G^)&@QZCH=K!)<70UB%I[=X+660E
M"0=JH6)X/&. "3CO)H'B2WDL?$6I7WB"SO+"RU*9!.D9C2VC5$/E$D?,02?F
M!.=W![  GNO!5A<7FH745]JMI)J)W70M[UU$AVA <$G;\H XQT'H,-E\ ^'W
MU+2;^.UDMYM*@%M;B&5E4Q Y"./XE!SP>N3G-)%\0_"DNG7]]_;$<4&GRB&[
M$\;Q20N20%9&4,#D$8QV/H:ETCQWX7UZYO+?2]:MKF6SB$\ZIGY8R,[@2/F
MXSC."0#@F@"+3O 6B:9-:F'[9);6<WGVEI<7+RPV\F"H9%8G& S8'09R!G!J
M*T^''ARRUR358+>=6>X^U?9?M#_9UGX/F"+.W=D9&>AZ8P,=!I6J66MZ7;ZE
MITWG6=PF^*3:5W#UPP!'XBLW7_&>@>&+B&WU:^:&::-Y4C2"25BB L[8120
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M#MGD2YN;-AN94+GY'4!3QC#<\YV^NS+XWT70M(L#K6H,MR]@EU*L<,DSK'@
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M0RQ[=GS1CAOD^7GC':I(/&F@W":BWVJ:%M.A^T7<=S:30211X)W['0,5P#R
M:JZ%\1O"?B;51IFCZPEU>&+S1&(9%RN >K*!GD<9SU]#0!8TOP7I&DW,%Q%]
MLGDM8GAM#=74DOV6-\;ECW'Y> !GK@8SBEMO!VF6GA@^'X)+Q++S?.1A<MYJ
M/YGF@A^OW^:W9I8X(9)I6"1QJ69CT  R37,1^.-'UK3-2&B:CF^AL&NXTFMY
M(GV%<I($D52Z=.1D<CGD4 :VBZ!9:$MT;8SRSW<OG7%Q<RF665L!1ECV"@
M8  X%5=2\(:9J6L+JQ>\M;[RQ#)+97<D!FCY^5]A&>IP>H[$8%<)X8\4^(]1
M\&> -4GU4/+J.IR6E]NAC!G3,VWG&%P(@.!DYZ^OK- &!=^#=%NWT8F"2%-'
M8-9QP2LBI@8' //%;<\$=S;RV\R[HI4*.N<9!&".*P[?QMX?N=2@L(KV3S;B
M5X(':VE6&:1"0RI*5".05(X8\BN)\5_$V:Y\!^*-1\-M<V5UH]Y';+//9/\
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M$?D$BO9:\&\013CXBZ"B7<-LKZS;B5$=$-Q&LBLH;:0K$%4; '+/D<J0/>:
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MM+^N5Z9.*]@HH \9\36M]XBM?%^LV?A?4K%;K2H[*-9;4BXOI Y.XQ*"PVJ
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M0=H0LQSA<[0,@@>WUAZ=XQ\/:MK$FDV.JP3WT89C$N?F"DJQ4D8;!!'!/0T
M<]#;W<WQO35#87D=DWAH6YF>!@BR^>'V%ON[MI]?7TKIO%5C/JG@_6]/M@#<
M75A/!$#T+-&RC]35C5M:T[0[>*?4[I+:*:98$9@2"[?=''K5^@#QH^';KQK;
MZ-%:>'+K0VT[2+RTFGO[<0 R2VY@6-0#EER2^[;@ #'+8J3X6:?=I>Z=%>^!
MIM(N]+M6AFU*X9P)N  (P3@EC\QZ@8/0D5[#6?J^N:7H%JMSJM_!9Q.X1#*^
M-['H%'4GV% &9X^TJ[UOP%K>FV*"2ZGM6$2$XWL.<?4XP*\PN;*ZUKPEX@N+
M;X?7VD7LFEFU+RF22:9]ZMY<:'G9PQSCGBO8=+U[2=::9=-U"WNG@"F9(G!:
M+=G 8=5)VG@^E:- 'CNAZ+JJ>(],#Z9>(/\ A X]-+O RHMR&!,;,1A3CU(J
MI8V6OWO@3P'I]QH&HV]QI.OVC3++&Q;R8@Q:4C'RJ-P !Y.#@5[;10!Y%-9Z
MS9I\4K1M!O9(]0BEDM9XHR_GEXMBJ@'WL9R<<CFL74] U33O%L6HW?@_4=?L
M-8TBW@^SI(4-I*L:JT;E3A1QDDX&6."<&O=Z* /)X8=<\&>,;*ZB\-7FI6MS
MH=O8I#I[%ULY(A_JRSG 3/\ $6]>IZ]3\+X+VU^'&C6NH6%Q8W,$/EM#<+M;
M@G!QU&1V.#[5U]4K;5["\U2^TVWN4DO+$1FYB&<Q>8"4SVY )H Y#Q':ZJ?B
M-8265G>&&^T>YT_[?;@8LW:2-O,8G@8"D@'[QP!WQR=EIFNZAHOASPA<^%M0
MBO-$U&">;5I7588XTD),D3[OG=ER-N#C=SR :]HHH *\ZT_PC>6WQ0U(O&&\
M.RNFLQQE,I]N(*'VR,%^_)0]0,>BT4 >/ZC8ZQ_8GBOP2V@ZA<W.I:A-<6M_
M#"#;-%,XD#O(Q4!E)(90.PP#R:@\0^$?$5WJWCG1[.UNIEUG3;&2WU#(56:W
M7!C9B1EY"I'7@-D\5[/10!Y9\.-*EN-3MM3N?!CZ'<V%I]DENKN61I)VX!$2
M$X"<$ECGJ N<DCJOB)I5_K/@B^MM,1);N-HKA(' *S^5(LGEG@]=N .,G&3C
M-=310!Y1JMM>^+=:E\36^EZW86UIH5S;-;7%J8I;N216 A,>[<P&=WIN"X/<
M6-!T^Y@U'X;R#2;Q#:Z++;WLAM63R',<059"0,?,KC'OGH<UZ?10!G:^+L^'
M-4%A EQ>?9)?(A<?+))L.U3R."<#J*\1\(:5KT/BZXOIO#6NP6][X:EM!)=J
MN$=<8 5541K^["K&!GD'&#D>_P!% 'C/@^QUFQ\$_#FPDT:^2:WU>:6[$ENZ
MFW7]^ 7!' (E!!/'UKV:BB@#Q2PTG6KWPMI'@.?0[^VN](U-&?4UM\6IBCD+
M"5'8C)8-T&3G.<9J/Q=8Z[)X4^(FB)H&HS/=ZK'=VTT,#.LX9H"%0+DMA8V+
M'H, =3@>WT4 >)Z[X:U77/'WB?[#IMW:VUWX9^R6\LENR1>9NC;RMP&.BD<9
M%3^%XI9K75-4_P"%?7^BW4&C36,A=II))V)4I'"C'E3AB6(X.T;L9->RT4 <
MYX#L/[/\#:)#)8&RNEL84N(WC"/YBH%);'?(/7FNCHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH \8\0&\U#QUX4@1KJZMHKV*Y$T\B
M D1RA,LI5<GY\A=I8>8Q!"CGV>O(_%T=]<>-/#P62)9+76%.U6<2- ]Q$?DP
M=I7 ?>>>0 1P"/7* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M*\]\3^*?$MKXWNM!T8Z6D<.A-JGF7<+L01+L(^5AG@<=.O.<5Z%7,WW@V&_\
M73^('O[F-YM*;2VAC5,>6S%MP)!YR<_4>G% ',>'/''BG4]2\)2W]II*:5X@
M2; MQ)YL#1Q%QEF;!W%2<!>!QD]35T?XB^(-0\;V.B7$6G1_;GNH2D,3S1VC
M1QF2,^>&"S%A]Y5VX&!\IR*Z.Q^'RZ=)X3^SZS=^3X>$@6)XT(GWHRDDX&W[
MV._''!^:LW1_A);:-=Z?)%XBU<V^FWLEQ96RR )%&ZX:+OG)+988.&(&"=U
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 >/>,I)D^)OAC[1*$6:]A02K-L#@2*_ELA?<>3"=@  )5
MFW8Y]AKQSQ1+=6OQ,\.W$-[#.&OTCN6_>)R\WE[0JJ5&U55?F?#'MD U['0
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M_)&>OI7*>$$U/1/!7@'5]"U#4)M0O]1DM)-*-P6@F@\R;>PBZ#:!DMT&XDT
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M)5BR9//RUUM !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MR(&1EZ8*G@CVKF=4^(&FZ5J5S:O8ZA/#9W$%M=WD"(T5O),1M#9<.?O+DJI
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M:(;5B1A(<[MIR3G@DG=]:;XG\(ZG#\19M=M?"MAXIT_4K6.*:WOYH5^QRH0
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MYEA8,K..#R.,Y&#COFL[5?AWX4UO2].T[4=)6>UTZ,16BF>0-&@ &W<&#$8
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M 4444 %%%% !1110!XUXMG#_ ! \)R.7N&.JA[>6&ZPL09XPRL&^^0-PP!D
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MK&6XAE,88J40M]UACG&.1WK*\"^.](\2Z3IMI_;5M=:Y]@AENXEPK&0Q@O@
M '!SD+T]JVO%EC<:GX-URPLX_,NKK3[B&%-P&YVC8*,G@9)'6O,8/".M>(8O
M"4,>F2Z1_8VAW-C=7-SB-VEEMO) 0+DG#9;/3D]^" >FV'BO0]4U!;&SOTEN
M'0R1#8RK,@ZM&Q 611GJI(JUJNM:?HD"3:A<B)9&V1J%9WD;!.U44%F. 3@
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M-W[O>%._8PP.,@B@#U*Z\>^%K+3+#4KG6;>*ROU=K69@VV0("6[<'C&#@DX
MY(%9'B?XA:1'X+O[_1]6D-T=/:YM9+:U>8QDJ?+,@V,(PS#'[P =:YGP[HNK
M:?;>!8+OP]>(FG:I?-*IVR^6DAD\N0G/0&1>3S\A/IFUK&G:]IL_CK3;?0+[
M4+76[,_8+BU:+9%_H_E^6RLR[0IZ 9)'09H [SPMJ,M]X)T74]0G5II].@N+
MB9@%!9HU9F., <DGTJKIGCWPUK%X;33]1:>;RWE15MI<3(K%&:,E<2 ,"/DS
MT/I3O#UE>V7PYTNPFLU^W6^E10-;38(,BQ!=K<X()&.M>:^ _#^NV?B7PWJ-
MYH6LQM!;7%M>R7$D2Q1,VTKY408!(QS]T<GMD9(!Z5X)\5Q>,_#<>LPP2P1R
MRRJB21E3L61E4YZ$E0"=I(!R,\4L_CCPY;:XNC2ZD!>F=+;:L,C(LS@E(S(%
MV*YP<*2#Q63\*-,U+0O =KHFJ6$EK<6$LT99V4K+F5VW)@GY<,.3C//&,$\3
MJ.B^)+KQ5?7<WAW4YVM_$5M>6WV5XH;=K:.0?-MW())F!Y9P< ?>4#D ]$OO
MB/X1TV]GL[O6X8Y[>803J$=A$Y./G(!"C)QN)P#P36A#XJT:?Q%=:!'=.=3M
M4$D\)@D 1" =Q<KMQ@CG/>O-]4\/:U)H7Q-A&C74CZE=HUD@529Q\HW+ST&,
M_3WXK7\;Z?\ VEXET"]TBZMH-:N ^G7=K,W[QK26,L^X*<@Q\L.@R>IX! .[
MTW6;+5](BU6R::2SE3S(W:WD1G7J"$90Q!'(XYXQFN,M_'</B/P+;:[!JTGA
MY)=0\E)9[(R&11*RK& >&+*!DH6"G<,\&N^@@BM;>*W@C6.&) D:*,!5 P /
MPKQA?#>NVWP@TWPY_85ZUY8:NN "A\Q!</(9!@_<VD#)QR?3D@'H>H?$7PEI
M5[=6E[K,44]HZ)<)Y;MY98D#)"D#D<GH,C.,C-[1_%N@^(+ZZLM)U**[GM@&
MD$8.W:>C*V,,/=217EE_X;UT2?%1$T>\D&KB V+(H(FVE@<<_P"V#] :WFTC
M4-1U62T_LV]M3?>%!IBWDD2[()2'.&(.X?>'X\<&@#L-.\:^'M5U=-*L]1#W
MLD/VB*-XGC$T?/SQLRA9%X/*D]#Z&KNK:]I^B&W6]DE$ERY2"*"WDGDD(!8A
M4C5F. "3QP!7GWP_TB:&718[[P"=.U+2H3!/JD\R'@1>6#&5)+EB#D8VJ"Q!
M)/.UX_M=3NM4\.BUL=3N;%)Y&NVTITCN5X78HD8J41CD,593CC- &O+X[\,0
MZ?IU^^L0"UU(LMI( Q$I4X(&!U!XP>_'6EC\<^&9= ;6X]7A;3UE$)D"MN\W
M /E[,;M_(^7&?:O.-$\->(+32O -E/HEY&^DZQ<M=,\D;[8V=R'W!N1\_7 )
MVDXP1EMAHGB#2IKC5HM!NYX[7QA<ZC]@V*#+;31^6)4!8 LF20/?J!F@#N/!
M?B2;Q!KOBE!>2W%C9WD<5JLUL8'B!C!="K*K</N'S#/%0>-O%%UIWB?PYX=M
M9[RT_M5IVEO+6U,TD:QH2H13&ZMEB-W!VJ,G (8/\&?VE-XI\4:A>Z'?:=!J
M$MO- ;HQY(6!$P0KMSQG';H3GBF^*=/U"?XF>!]1M[">>SL3>BYFC (B\R)4
M4GGUH =X>\>^'_*@TB^\7V>I:M$DIGN#!]F#",;V9E^ZFU>O.#M8]B!KP>-?
M#UQ+<1#41%+;PFX>.XB>%C$/^6BJZ@LGHRY![&N'G\*ZIXA\(^/+(Z;)8ZA?
M:G+/9-.J9=-D8 #9( ;RV7.> U:&J0:EXGU2SUA?#M[8_8=,NQ(\S*LDLDD6
MW[.$&2X!PV[@9'!ZB@#;@^)O@NX953Q%9C=%YRER4##., L "V?X!\WM6[H^
MM:=X@TV/4-+NDN;60D!U!!!'!!!P5(]" :\@\(>'->TH?# W>BWB#2WU);P[
M0?)\XD(3@\#Y@?I7H/@&TNK*QUF.YL9K02:S=SQ+*H7=&\A92!GI@B@!Y\9V
M=SXBUS0(S<VT^G6R.UR;1V5&978GIC"A5()P&)P,U!I?C/1M,T/1EUCQ3#?7
M-^CM!>O;&#[5@DY" 87@  =S@#E@"R!=1TKXDZ[=G2+NXL+ZPMW6YAVE5,(E
MRA!()8E@ !GK7':%HFL6UU\+FN=$O5328KN.])C!\EI%"(3STR,^P&: /0+/
MX@>%+]].2UUJWD?43BU4!@7.2,'(^4Y!&&P>*GU3QGX?T:_^QZAJ*PRAUC=O
M*=HXW8957< JC$<@,02,'O7FMAI&L0Z7??\ $BU!3-XV758HO) /V;S$;=UP
M,!2,9]*GO_#-U'XNUZUN_ HUV+4[L7=K?-<B.%04 VR\\!2I/0GDX!XR >D^
M*?$$/A;PU?:S/%+*EK'NV1(6)/0=.@R1DG@"H(_%NG)HUC?79N(WNX/.6!+2
M9Y2 %+$1A2Y4;UR<8&14/CW2;K5_A_K.F:=")+F:U*0Q A=Q&" .W:N4TU-:
ML_%>B^)9]"U3[!_89TJ2U 5IK>59 _F,@;[K[< C)X&<9% 'HVG:C::OI\-_
M83K/:S#,<B@C/.#P>1R",&K5<OX$TF[TG1;P7=JMHUWJ-S>1VX()BCDD+*IQ
MP#C' Z5U% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% 'B
MVMO%8>.O#$,-C#=M=WRS&:,F(QDSJ?-?  #;6<%2=SEOF)R5;VFO%?&UQ$?&
M?@N1RW]H-K%O$9]Q(<;U,F"GRCDA<,22K] ,&O:J "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH ***X"5?$,WQDN(+?7DBT^/28IUM'M-Z8:1E(
M^^/FW)G<.Q"XXS0!VFF:G9:QI\=_I]PEQ:R%@DB="58J?R((_"K=>3V/B/Q)
M#X*\*/I:Z-;SW^J7.G31BU*1*V^<(RA3P!Y9)&,L<<CG-&X\:>.M+LWN[RXT
MR>+3-<73+M88B'N]Q0_+D83Y7QWY)]!0![-17D^K^-?&5YJ^K7'A33VN]/TJ
M_P#L#0M;Q[)9$"^:6D,JNF"Q (0K@ YY..O^(7BJ;P=X0N-5MH8Y;K>D,"S<
M1[V. 7.X87KWH ZFBO,[[Q'XJ\/R>(])U&^M+RZMM$DU?3[^*S\M2(^)(W3>
M1G.W&.Q))Z 7-1U_7FOXK>TOH(5N/#4E^I^SAVBN$:/YR"1E2'P!ZB@#T"JN
MI:?;ZMIT]A>*SVUPACE16*[T/521S@C@^Q-<K\*9-2N/AUI=UJFHM?37"&5)
M'0AU4_PLQ)+G.X[CC.>G%<U=^.?$">%?^%@VM_9R>'!>[3IC69$IMA/Y&X2;
M_P#6'[V" !GJ<8(!W>M:SX9\.2V$NKWEG9.O[FU\QL; Q520!]U?N@MT4'D@
M&MU65U#*05(R"#P17EVG6FJWOQNUZUU#4X+O3UTY5DM9+,%7MY"^V+EB."W+
M8.[I@9J_\0O%&L:%J.FZ;H\]O:K+;33,RVOVJ9B@&U%B# JG7+\@8[8.0#T.
MBO)W\6^-M<_X16#0KC1K:;6-':[E:YC+!94VEB"K'@Y VX)4%LY(&&7/C?Q1
M;^&?"_B6::UCTLW?V7772WW",+.8C(.<A3M/0<9'TH ];KCOB&_A"ZT>'2?%
MNHI;6UU/'L42%6W9.UB0#M3/5CA1W(K3\.WM]J=SJE])=QRZ6]QY>GHL8!"(
M,.^\'YPS9QQP%')S7G]S:7DWQ8\8_:KJ"XM4T17-M+:*ZLF&*(0Q(^5N>G/I
M0!Z>=%TUM#317LXWTU(5@%LXW+Y:@ *<]1@#K5^O-K?Q7KAU+X>01S6OE>(=
M*DDN(V@^5)4MQ(&4@@@%F QZ#WKG_!GC_P 9ZA/X4U#6Y-.;2=;N9[18X(2)
M24#;7)S@?.,?1>A)S0!ZWJNLZ=H=JMSJ=Y%:Q/(L2&1L;W/15'4D\\#T/I5Z
MO%/%VI>(/%'A1M;AO[5=#36HH#8"V'FJB7 0.TF\_,7"G:!T([5NGQGK2?$R
M;1-1O(M*MENXXK&":R*I?Q-G)69CCS,X  P#C !)X /3J;)(D4;22.J(@+,S
M'  '4DUROC;Q%>:.^C:9IS10WNL7@M(KJ9=Z6_<L4XWG' &1R>O8^?>)?$6N
M7'A#QQX3U74(9M5T:&-WOH;;8MW;2*IP5SA'^;G''. #U(!ZMHOBC1/$4EU'
MI&I0W3VK[)E3((XR& .-R$'AQE6[$UDZ9HOA/X>SW$L$B6<VMWJ+B64L\TK-
MA$0=2 7/3H"23@9%OPQIUU%X3LFGNXI=3DLE07J6RH57!*#;DY"YZ$\G)XSB
MO+;*7Q)=?"#PYJ%SJ<5_J%WKEK-:?:$)".;DD"1@V6!;'3;@?*.E 'NE%>.2
M>//%NBQ>(-!O)K74=?MM1L;.SN(K8*C&Z!8#;E1\H# %B!G&2:[7P1=>*I9=
M5MO$UO(J0RH;*>984EDC8'(98G91@CKWS[$  Z'4M8TS1H4FU34;.QB=MBO=
M3K$K-UP"Q&3Q3[#4K#5;?[1IU[;7D&=OF6\JR+G .,J2.A!_&O,? TC:U\9?
M&U]JJM]MTUX[6PBE;=Y4)+@L@/W=P53Q_P ]#US6UXVOO^$+MVO/#]O;1ZOX
M@U&VLB\Q_=)(X8"9E_W5(ZXR ><'(!WU%>0ZWXP\6>%9/%&B7>HVU[>6NEC5
MM-U VJJWE>:$9)$!VY!.%(],G.<!TFI_$Z&]T*#^V-!=M<DD\D-:.%A00>9D
MX.<C#8'/(&3@X !ZY17E%EXX\2#2Y-#O)K(>(DUV/1SJ"QYA =3)YFSC<VU6
M7;P,[>>M8GB#XD>+/#-AXCTBYOK&XU?0Y;8I>BTVBZAE ^\N["O\RG@8X(]Z
M /<J*\@US7_'FBSVVE:CK>G)=RP7=UYNEVQFF*JH,2B)D(50^<LV 5R-P89,
M>EZ]KVL_%'P;'=:H1:W/AZ/5'@CA4+YCH0XSUY*YR>@) QG- 'JNFZQI^KM>
MBPN5G-E<M:7&T$;)5 ++R.<;ATX[=C5ZO&]/\7ZY!IVI6-O)IL>L7OC"728K
ME;=((8U4(7E*D_.QP<*SEV+@ L0!3O%7CSQ)X7LO%NF&]BGU#3$@N[.\-H/F
MMY953;)C""0;Q@XP0"<>@![%5&YUG3K/4[+3)[R)+Z]+"WM]V7DVJS$X'( "
MGD\=!G) /*^&M1\40^.]5T/Q#?6=Y']BBOK=K:W\H1AF*%!R20&5OO$D\'CI
M5;Q:JCXP?#ML#<1J0)QSCR!_B: /0:*\I\+>)O'.L7NCZTT#3:'J#OYL3):Q
M1Q1G.SRW$S2,X/!#*,XQ@$$U0L_'?B/6M6T--/U1(;C4=1N8;W2I+17DTZ*)
M\+N488-M^\6.,D8 P<@'LM<ZOCOPN^CWVK#6K86%E</:S3ME5\U!N*)D?.<'
MC;G=VS7"Z5XXU^;QII$5S=RSV=WJ%S93Q6]D/L@VAO+,4Q4%F!0[\,PQZ8Q7
M-ZU_R2'XI?\ 8US_ /I1!0![]'(DL:R1NKHX#*RG((/0@U#?V-OJ>G7-A>1^
M9:W43PS)N(W(P(89'(R">E<'JOBN\\'^,M.35V6T\(W=D5BD\KBUN$3/EN^.
MZJVT#DD^@KL=$EO5\.6=QK3".\, ENM^U1$Q&XJ2./ESC/?&: (_#?AG2?"6
MD)I>C6HM[8,7;YBS.YQEF)Y).!^0 P *UZ\H\'>*O%6MZ]_9]U>HZWFA-?13
M"U$<27 E"8B)7+1A67+'=DY*G:16AX-\<7?B2#1+-[I%U2W:X_MU&15,0A&T
MC&, EY(B"."H?N"  >CU@R>-/#L6F-J3ZI$+1;PV(DVM\TX;;L48RW.>1D8!
M.< FN!\+>.O$%UXN\/V6HWL%Y'K'VQ)EM[?;;0/""Z^1+C,H*XR<L.1@YS3M
M4O+J\^&'B#[6\3R0>(Q!NBA6(,$OXQG [GJ2<DD\DT >M5FZ=K^DZMJ&HV&G
MWT5Q<Z;((KN.,Y\IR#@$]#T(XZ$$'D$5YGX\^(FJ^&=9O[NQOX[JUTZXMHWT
M^&$/&4<-Y@EFV_NY"1A0"<!<E3NXJ:C;^,8/B#\0-6\+WUG;);"RDFCN(@YN
M3';!O+!/W>"03Q]X<C&0 >MG6-/&NKHGVE?[2-L;L08.?*#!-V<8'S''7/7T
M-7J\KU#Q0;77K3Q2UNVX>#)KWR=A^\9(6"D9XY///'K5GP+KWC/4;W2+O58)
M)]'U.Q$C3R"UB6*<@NOE*DA=D*C!##=G)^4950#TNJ.E:SIVN6KW6EWD5W;K
M(T7FPMN0L.N#T/U'%<-XM_M0?&#P/ FL7$6G7(NV^RQH@"R1PL2Q)!W;@X7!
M'RX)!!;CE4UGQ3X;6_U>RO;(:/\ \)=<V\UD8,R2J]P0Q,AS@YX  'KD]* /
M<:*\L?Q1XRU?5=2N- M)FM]/UI[%XW:U-J8(PJR%R7699-VYQCC:0,'K6;:^
M,?&\/_"2Z]<7UA<:)X>U*ZM9;06XCDN1&, !AG;R5.?<_>P!0![+6!9>-?#N
MH:^VB6VI(^H R!8S&ZK(4.'".0%<KW"DD8/H<<IX1O?'>KNQO9Y(-/O]'6XM
M[Z=+5S#=G;_JEB?YX<-N&\;L  D'DY'@V2[M/ _@BT34R+W5W:.*XDMXC]CC
M EED,65_UC *F7+ G!QU! /8:PK/P=H%AXFN_$=OIZ+JUV,2W!=B<$ ' )PN
M<=0,]:\\\4^+O%OAW0O%<,>IQ/=Z#/;2QW<MHA:YM[@A44A2%5U.[)VX.T8
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M&-28*(K5I69BTN!P!YF1W.,+D\5Z110!4TO3;;1])M--LU*VUI"D,0)R=J@
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M@;?F. <@9&\ BO1** .4F\ :7<:++I\US>M,^H_VH+[>@N$N=V1(I"[00/E
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M$X0;]J@@9=F7:V,C:SYQN /8:EI\&K:5>:;=!C;W<#P2A3@E'4J<'MP:M44
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MY:!TC4#Y,?,"RCGCBK-CX>\8W'A+6M-U+2O#]K<RZ7-8PO9DAKEW7:'9SG:
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MFA$B&5%#L@8;@I) )'H=K8^A]*?7A']I:EX5\1_%76X;N]N[G3EMEMX979D
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M [6]#Z'D5SSWOAO2?&GV1;&./7=0MGN7FBLR7DC3 .7 RWW1\H)/ XY&?!]
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M R>#QC>O]2\5>!O"'B/4KK6(;U9;&&6QC;4&NIH9'=8S,&:),(3(&"XQE<#
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M,$HZAAD=N#7EWC*[O?$=U\0]/.H7EG:>'](3RH;>3:LSR0O*[/QE@5'E[22
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M:TV%/E [3]_'0^APS4?&_A_3+>*>6]>:.2V^UAK2WDN (.\K>6K;4']XX'%
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M),BOMV-Y>-V"649QQD9QD5)%\2/#-S&K6=W/=R2SO!!#!:R-).ZQB1MB[<L
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MT*:ZN%8K/817,:NRFY+[E<.%R%(8 L 2N#UKH? -CXATZQOK?6[B^FMEN/\
MB7_VE)')="+:"1(T;,K?,2 =Q.!VX ZZL/6?&/A_P_=);:KJ<5K(^W[X8JF[
M.W>P&$SM;&XC.#B@#FKG1=6T?XE:MK]OI%QK6G:K81PO%'/"K0NG&S;*R@H0
M 3SU8\&LRT\(:OX=\,^"]*CL9;^:RUDWUU]FD3RX%*S$J-[+P/,'08)!Z$@'
MU2J.F:QI^L"Z.G74=P+6X:UF*9PDJ@%ESWQD=* );U7ETRX5;<2N\+ 0.0 Y
M*GY2<XYZ=:\:;P3XE@\.:UI.F:;K(TV?2S%;V.J7EK*T5PTJ?+"ZO\L04$D,
M1G .":]NHH \ZU>SUVZ\<3:MI_AZ97D\,S6BR7+PE%G9]\<<@WD$ H0=NX9<
M9XYKD_#_ (=\66FNB_E\,WH2?PM)I^);Z)L39W !<A8E)VJL:@  YP"& ]2D
M\;^%XKB2&37K!3$0)',P\N,]@S_=4^Q-;L<B2QK)&ZNC@,K*<@@]"#0!Y+XB
M\)ZU>?#GPACP_%?7NAQQI=Z/=R+^^58O+;:R.1G@,O/<<9&TV+KPLD_@6&"/
MP7=Z='_:/VZ.UTJ[5;NT(A(6<$LJM(& &S/ 8=2*]4HH YOP+%XCA\+0IXH=
MGU)9)!ERA?RPQ";RF5+8P>">O)SFN;N='U^R7QKI2:-+J%IKSR2VMQ!-"B1M
M+"(V$N]U88VKRH;CISQ7I%% '!0^']4TOQ#X'@BLI+NQT;3)+.XO4>-5#,D:
M [&<-C]T2< _>'7FK_Q/T.]\1_#C6=+TY%>[DC1XT)/S[)%D*CW(4@>Y'3K7
M752U;5[#0M+GU+4[E+:S@ ,DKYPN2 .G/4@?C0!P5I_;TOB7P5=7'AF^@AL]
M,N8YF$D3;'=4 5OF&WB(=>[@=C7(6_P_\2)X-\'0WGA6'49=$FO(KS2[FZB7
MSXYG#AT<.5&.G)!SV(YKW:&6.>&.:)@\<BAE8="",@T^@# \':8=*T!8/[&M
M]'5I7=;&"3?Y0)XW,"06.,G''..<9._110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110!XGXHV:=XU\,W/E2F6_P!;ABC:1S%Y$?FJY5(D
M('.Y%8G.2K;E+!2/;*\/\4SV<GQ)\,>;8+YL^KI*E[,)2\A615 B0D@+PI)S
M@ 9X.%7W"@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "O.=.VZ
MO\=-<.H1[CHVGP1Z<CQY4"0!Y)5SP&S\F1R1D9XKT:N=UOP;8ZUJT.KK=ZAI
MVJPQ"!;RPN/+<Q!MVQ@059<\X*F@"EXA2S\(OJ/B:RB']I:D;6QV2R%8#(9"
MB.^.F/,R23T7 P2<Y&M>+M?\+WNHZ;>SZ?>7 T>XU.SG6U>-=\62T;IO/RXZ
M'=GUSWZ.?P5IE_I5Y8ZI+>:BUXH6:YN9?WN P9=I4*$ 8 @* ,@<5"_@:TN+
M.^BO=4U.\N+RQ;3VO)VB\U(&^\JX0*,\9)4DX!SF@#B--\8^/M0UO1]*6?0U
M;6]&34H9VMW_ -&)7[NT/\W8\\9;C(7!=I/Q/U_6M \(W5K;:?'=ZI?RV5R)
MD<H2BY#+ALKGKCG_ !Z^P^'>FZ=KVDZQ!J&HFXTO35TR!6:(HT*A@-PV9+?-
MG((Y [9!JZ3\+-&T:UT:VMK_ %-H])O7O8/,>,EG8 $-A!E>#TP>3STP <VW
MC+QO'IM[J+7&B26^C:V-,O52%]URID1=R_,0A'FJ-O8ALGC!V;WQGK5W<>+F
MTM+2WA\,@,8Y4,KWK*C.Z\$>6"!@8!.><\%:TY_AU8S:9JU@NK:I%!JFI_VI
M/L:$D2[@VU2T9PF50XY/R 9P2#-J'@#3+Z^U"ZCN[VR.IP?9]2CM6C5+Q<$9
M<%#AL,1E2IY- '++XW\2>(W:31);'3K9_#Z:L!<0&:2.0NZF/.X!@3&1NP,
M_=)Z>@>&M2FUGPKI&J7"QK/>V4-Q(L8(4,Z!B!DDXR?4UGIX*TV&^GN;::YM
MTDTQ=+6WB\L1Q0KNQM!7.06)R2:U-#TB+0=#LM)@GGGALXEACDG*ERB\*"5
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M@DT;1L5Z@$8./SKG;SP'I5_X-L?#-S->/;V C^RW0E"W$+1C".K  !@.,XH
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MR[6W@* V5P#["@#D?#_C_7K[QCH5A,PELM6>^C,K6GEPAH5WKY#;M\BCA2S
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MN(+B2.T="%"F7:X10@^7<!NQQD'KZQXY5Y/ /B&***26633;B-(XD+LS-&P
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M(I1/)*K@L1USG.37HF@6D^D>#=.M-3=[B>TL8X[@A#(S%4 88&2QXQQDG\:
M.;M_B+I^D67A>UUW5+6ZOM84YN[1&$' .&&1G!;:@X&2<\ 5T=OXMT&ZUQM&
M@U*)[]9'B\L X:1%#.BMC:S*""R@DKD9 KSG1H-2TKP[\,[J31-5F-A+-%=0
M16C>;"7BDC!96QM7)R6.!CGTS?T6TOK7XD(VF6^J1Z;<7U]+J5I?6DGDV[Y<
M+/!,R 8D.#M5FX?IQE0#O]9U_2] @CFU.[6!97V1J%9W<^BJH+''4X' Y/%9
M+_$#P^GB72]#^U,UQJ=HMW:R"-MDBL0$ ..=PW'T&TYQQ5'XAV0NUTIT?5;6
M[MY9);;4=-MI+AK9]F,/&B,2K D'C^M<OI7_  E5O>>$[S4=&N[>^O=&GTIW
ML+8,-/8S1F.613E% 0!MI[@C:,8H ] M?&GAV^UI=(M=4BEOG++&BJVV0J"6
M"/C:VW:<X)QWIS>,- 771HIU*/[>9/*\L(Q'F8!V;\;=V#G;G/MQ7GVFV-W>
M>$_#OA:\T74QK&FZO%))<26\J11B*8N]P)MNQMR;@!DG=)WQFD\+7&JV>H_\
M(GJ/@J[G:UUN2ZM]6D@/V<J97<SES_&%8A<$YR <8P0#J?#OC/=::G+X@N(X
M/+U^XTJS98B/.VMA%4#)+'##WQ5/3_B18V?BC7M(\0ZM80M!J*6]@B(5=E9
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M,%RN&&0<A5 ;U6O'/&E[J*_%_P +1K<O"EO=*Y1BWENLCK%E?0E)-O+!24<
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M_$7Q9''X5O=0M-$-EK&IG3)H[<R"57$K1F1=S<+E<XPW3DC<,>MT 96H^)]
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MAE,GE.0&'RO@L/F(Z#@#OD<CIGQ3\97'AK2?%%Q9:+)IESJ(L)[>&.5)5).
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M>4[=C LQPIYSD$@'N0* /6**X7P;X@\6ZEXBO[36]%GM],$7FVMW-:BW?=D
MQLHD<=S@YSA>:TO$.OZAH?BGPW"S6:Z+J=P]G.\D;>:DQ1FB"L&Q\S#;@KVZ
M\\ '452U75].T.Q-[JEY#:6H95,LS;5R3@"N%3Q[J6H7^A:3;"U@NM?GNI+:
M<QEQ!9Q[BCD;L-(ZKD8.T9Y![\MXM\6:CK7P^\=:)K4%M'?:'>6D37"QE8IX
MVN%V.4RQ&0F2 3P1B@#W"BN$UCQ?K%GJ?C.U@@M?(T;2%OK>4QL3YA1VVO\
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M2T9C<2,7SPK;E7G& .10!Z=1110 4444 %%%% !1110 4444 %%%% !1110
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M5W;0DB2:WN$D1"!DY() XYYH R_#'@ZW\,!MFK:QJ3[/*C;4KLS>4G!VH
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M^#_#&F1)9G4HK'6=5=;.>X@D(N9&6/=(N5&U"QVC(&2"0,9QZ4)$,C1AU+J
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M#!"PS&ZM/#.L:?I]S<ZMHZZ!+'9SO820W5CYDL:BU9L896';DG:>BC)^A**
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ME7(X4C@')!'.,G;O%_XDOCSP[J>D7KZW?WT]S8!+9I6N5?!MV60 CY" #SA
MI]#CV>B@#Q^:9_#WB;4K#Q=I5]K5OK&EV=M#/#:>:TC(FR6/*^KG?U&"P]C6
M7K]KKT/B#4[^.TE$5E;:7-J&DPV[2072(DGF1A\?,$SP,X;N#CCW2HQ/"UP]
MNLL9G1%=XPPW*K$A21U )5@#WVGTH P[#Q?I%[JEAI=N+E);RS^UV^^V=$*
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M9)%9'9EE)W 'ER2, 'MB@#"N?BI<M<>'X+:WT^V_M;2EODGOIF6)IB<?9T8
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M0AP I!  4$'D$D[LXXH K>!/%.NZ59^"]*U30K.TT;5+%(;.YAGW.)%BW R
M# ,@&X <C=R<@BK4?CW6]5\(>(=4L9-+BN+2TN9TAPQFLFB/,<R$G+[02#PI
M(Z8'.SX=\$:CIDFA#5M<BU&'08GBL!%9>0QW((P9#O8-M3<H  ZY))K.@^&-
MW<S7EQK6N1W5Y+I,NE)=V]JT,DJN@7S)_P!X?-8= #QP#UQ@ SKCQUX@T+P/
MX6F8:>T]YI0N9;Z^9W61EC5A&%4[VD8,"3SSDX(!Q<M/'GBC7Y-&@T'2M*\W
M4]&-^7O9Y%6"19 C9"@EEY& ,$[NHQS6_P"%3ZVUEHJ_\)G)'=V%C)822K81
MD>0RA1&@XP  !N;+').1P!J>$/A[JGAB_P!)NI=?CNULM*DT]H6LPH&Z3S 4
M8,#@80?-G.T]-WR@&$WCWQ#K]IX#U+3A:6-OK%V\4\+%F)=&=2"1CY#MSCKR
M.>*O7/BB31M?^(=U8:%9G4K Z<'D:Z*"Y$BX5I&;"H$4Y[#KD]Z=;_"O4+3P
MKX<TFV\1+#=:'?O<07D=F.8W+$@HS,"V6X/3M@]:M:W\-+O4[WQ+?P:Y'#=:
MM/9W$ -F&2%[;[@8%B) >^0.><$<$ Q/$/BB7Q3\,/&]K>QV4KZ:JH+BUW^5
M-D*ZLJN,C''.3DC(.,5M:O"(_CCHTELL<5S/I%P&EV9W$,,;P,%@!VR*K)\,
MM>GL_$D&H^,/M3:Y!$DKM8)@2*$!?"E?X5*J 0 #D@D5T5]H%W%XJM?%MQ?^
M:-.T^6%[.ULF+SY&YMOSDYW#(7![#D\T 9>C^/[S4].L(GM8(];FUF32I[95
M+)&8LM*<Y!XC&[..I P =PV_&>OWV@6%E)91VJ?:+I8);R\/[BU4@G>X# G)
M   (R3US@'%\#Z=:ZMXHUCQY#IUY8?VG%';Q0WD021E51OD(R=H8A5QGGRRW
M.X8UO&?A.[\3?V5-8:P^EW>FW0N(I1 LHSC:?E;C."<9S0!YEX[U^7Q/X$T"
M_NX;875MXI6S,L"L$DV>8"RAOF4-@':2>@KT7PLD<?CKQPL<:(/M=J3M&,DV
MR$D^Y)KG7^$=_/H TRY\5/.5UO\ M=99;,,=V&RIPXR6+$D^O0#OV>C^'KK3
M/%.O:O)J,<T&K/$XMA;[#"8T" []QW94#/ Y'&* *NI>(-3G\3S^'M!6Q^VV
MMFEY-)>[RAW,56/Y2"I.,[N< CY37!^)?%VH^*_"GA&\M8(+6.\\0VUG>6<^
M6_?)(QV-QAH\HK'OT]Z[_4O"]Z_BM/$6C:E;V-XUK]EN4GLS/'.@;<I($B$,
M">#GIQTK&N/AK(OAWP_I5AJL43:3J<>IO/-:EVN9E9F);#C&2YX]@,@4 3>,
M[=_!WPQUR3PRD%A*J/.Q0, K.?G9!GY3SQC@&N;U.3Q'9?%YI;&/2KC6AX1+
MRM)YD4&X7!)(4;F/( P6''.1C!]&\5:%_P )-X7U'1?M/V;[9$8_.V;]G/7;
MD9_.N=TSP-K5CXBAUNY\3K>WR:,^EM/+8@,Q,ID23 ?'!(&#U"\G)S0!FK\2
M[R_T;0EL88(]7U'3GOY5^R7%XD*J0@_=P@OAW)&XG"A3]XX![#PCKEYXA\.V
M]_J&D7>E7C96:UN8RC!AU(!YVGMFN-/PFNX+#P\^F>)VT_6M%B:V34(;($30
MDDA'C9R#@D]R.3QR,=]HFEC1M(M[+SY+B5!NFN)"2TTA.7<Y)QEB3CH.@X H
M X72OB+J=SX[TO0;RUL574)+N-H8BYELS!O(WMRKE@H.!@KGGM4.B_$Z_P!2
MT.^U:.'3[Z6VLY;B72;;?%=6TBNJB-@2Q<8+$N% &!QS3-&^%.L:5JN@7;>+
MI)XM$NI3:Q-:(-MO(#YB$]2[="QZ Y&"!5UOAKJL]]'J=QXGC75H-.^PPWUK
M8&.5C\O[V4F5C(V ?[HY/TH @3XI?9?!;:[<W&F7YG>""S_L\2<W$@),4D?S
M,A0#/^T!P 2%K+U'QQXV;1-:22Q2T>TNK06^I?V=<VL=Q%)(J,JK-\P<,RYZ
MC&['0$[L_P +5U*Q\0?VIJ<$VI:N8'6ZM[ 0"VEA4A)54.3O)9BS;AG<1P.*
M8OPYUVX\):IINJ>,)K_4KLV_D7<ML"ML(9!(H"YRQ8CDD\\<''(!:USQI?Z9
MXMBT!+C28)Q;1S*+]7B%^6=E*PONVHRX& V2Q;' !:NC\5:W+H&@R7EM!'<W
MCRQ6]M \FP22R2*BC/)X+9..< URWB#X=:OXFTB32]4\41W5O.D'G/-IBF1)
M(SEGA*N!%O  (VL,?4YZ?Q)X7M/$GA>;0Y7DA1D7R9D)+PNA!1P2<Y! [Y/(
MSS0!B6WB'Q)%XCN/"VHC21J<M@U[87L4<@@?#[3&\9?=N'!^5CQ]*QO@WI<.
MI>"M(\1:C;6TVJ>9=-'>[3Y[;YI-Y=OXB3N_"NGL/#6L0ZM<:S?ZW:WFJ&R%
MG:NNG^7%"N0S%D$A9RS!2?F4<<8J;P+X7D\&^$K709+Y+U;9I#',L!B)5G+X
M(W-SECSD<8X]0#R+Q=JNN:KX'^)<6L7EM<1V&H6\,"1(<1_OHQ\N3QQUZG)/
M/KWB^/\ 5]'OM9B\4Z;9VPM=(35H(+25I'5"Q0Q2,1M+[QC<N%Y[]J6K?":_
MU*3Q5;Q>)$M],U^5)WMS8AS'*)%<MG>"?N =<?,>. :WK_P++K'B&YU/4]1M
MYH;O1?[)N+5+,J&^8L9%8R$J=Q) YP,<DC- %#P?XS\2:UXH>QU'1I/[*ELU
MN(-0CTZXMD1R 3&QE^_U(#+C.,XP>(O$4$7B7XO:=X:U0B71[723J9LW)\N>
M;SMB[P"-P&,X.1UXYK2\&^"=7\-7GF:GXNO=:MX8#!:VTT6Q(@2#N/S-N8 ;
M03C +#H>+7BWP;+XAO+#5-,UB;1M9L"PAO(HQ*"C?>1D) 8''?\ 6@"KK&B:
M'X.N)O&EK +)-.TZ6*6TM(PD=PORE1M P&RBC..@7/"C$:^+M9L-7T*'5+>P
M>UUY&%J;?>IMY@F]4D))WAA@;@HVG.0>M7/^$+DU2*]'BG57U9KBV-JB11&V
MBA0@!BJ!FR[$ EF)P1\NT<5#HO@O4K2^TB;6O$":K%H\3I9H+%86#,-H=VW-
MN(3Y1@+ZG)Y(!S$/Q \<_P#"(:GXEGT31!86T4IB=;B3+21SF-LKU(P#Z9*Y
MR,X%R^^)&M^%;K58O%6DV8\C2QJ=K]@E<@YE6(0.S#EM[KEE& "#BF:[X;O?
M"_P0U70)+N35YRL@ADM[)P[F23?AE5GYW,WS<#&![G8N_AZ/$2WLWB;4A?SW
M6FC3T:WMVMEC3>)-^PN_[S>$.>!\@&WK0 LOBK7M*\86'AS4K6QN)M6@FDL9
M[=7BCC>-&9DD+%MW1>5 (STK"TOQ]XSO?#D6N7>D:/:6%ZD'V:Y:X.V$M(4D
M:4%@2 !O"C'! W%L@=%9^#-5%U::AJOB"/4-4TZRFMM/N38[!$\@ ,SKYAWO
M@ <%01GN<U6D^'MZ/ FA^'[7Q!]FO='N$N(+]+(,"5WA<Q,Q!X?UZ@'VH XS
M4/B3XCU;PO=26<]G:W-AK\>GW%S;Q.JW$1<[616)*9P,@DY!/(Z5T&I>(+?P
MO\2=8N]1TRS>X@\,B]:^MRXDF59 OE["2J@OTZ\!<L>T!^#=T--U>V7Q;.TF
MHW\5_P";+9(VR9269B 1N))]@/0UMR?#J6_\27&IZOK(U"VN-%&CR0/:!'9.
M&:3>&QO+@M]WC.!T!H EM_$^NV^O:'::A!8S6VNV\KVOV='C-O*D?F!)&9FW
M KGY@H.1]VL71_B)XAN9O#,]]8Z5]AUJ\GL_]&ED+HT;NNX$C!'R]/QXS@=!
MIOA#5+5M.DO];MKZ;2;:2'3G-BT>QW4())0)?WA"@K@;,AF[D$9EC\-K^UMO
M#$,GB"&;^Q+Z6\9S8%6N#(Y9AQ)A?O-S@]N.,$ Z7Q1XA.A1:=#!''+?:E>Q
M6=O&Y.,L?F<@<D*H)/T R,UR'B7XBZSX4L?$,%Y8V=SJ&EP6]S#.BO%#/%+(
M(\["200Q/ 8@XZC&*Z_Q9X9C\4:5% MQ]DOK6XCN[*\$8D-O,C JVT\-W!!X
M(-<YK_PWN_$NEZW%J.N0G4-56"%KF.R8)!#$X<1I&93C+ L26/+'VP =5X>N
M-=N;*:77[.SM)VF)@BM9&D B*J0&+ '>"6!X XX%</X>^)>I:EXLT?2+ZWTY
M6U)[R*2VMW+2V+P#</,<,5<L ?E &W(.3TKT>""8:=%;WD_GS^4$FFC4Q;VQ
MAF !RN3D\'CUKS?0?A)>Z'?:!,OBZ>:WT.XF>S@^PQJ%BESYD9;))+9Y8YP.
M@7J #K?%/B*72+C1],L!;MJFKW7D0"?)6-%4M)*5!!8* /ERN2PY%8T?B[Q
MLUCHM[IMI::W?:C<6=O-(6\B2&&/>URL>=Q!' 3=U/+BMCQIX23Q=I=O#'>R
M:??VEPES9WL:;F@D7OC(R"">,CMZ5D'X=W7V'3ICXEO+C7[&]2\35+N(29PF
MQH=@*D0L,_(&ZL3DY.0#,U/Q[XGTO0]>633=-?6M&N;:*1076*XCG95C= 3D
M9+$<MQM/T"_\+(U:PN_%VFZKIUF;W0XH[A9;1G:+RI I&Y6PQV!MS$8W8. .
M,ZNK^!-0U;0=3M&UZ./4=3NX;BXO/L99$$6THD41DPH!13R6SELYR"&S> ;\
M>+/$'B&P\0_8[K54MUC"VF[R#"8\9._YPPC((P,AC0!%%XWO[C3]/CTNXT?6
M;S4M16TMKBT8QQ+'Y7FR2/&78J47.4+ACQP,@5D>,==OM0\#^.]"U>W@^VZ5
M;Q-]HMU*Q7$<GS(RJQ)4@J01DX(X)JW>_"&"_COKIM42SUFXOXM0BN]/LQ#%
M!+&A5<1%F/))=OF!9L'/%:E]X"N]3T+Q%;7FM1OJ6N!$FNULML<4:<*B1[\X
M W=7/+9]00"F=1M]+\0^%)[ZTLEMO["GD^WN6$L C2-I >VS!7U/7IWYO4-7
MU#Q+XA^'FOSP64-C>W[-;1(K&>-=IP'<\-D<X &#Q\W6NZN/!;WM_H4E[>V\
M]IIVG36,]L;4C[2)8U1SN\SY1\B\8/<9.01S=M\)-1M;K2%3QE=?V;I%[]IL
MK3[&A,2DY*"0DD^F3D8[4 2-\1-63QBFE31Z9;Q/K+:8MLP=Y]FTLDY<-M4-
M\N$(R<Y!K N?$.L2^ OB#?ZZFFZS;V.LM:+:3(\4?[MHDR 7.%^ZP0'.[=\Q
M)K;7X2:A!K,UW:>,+B&U.KG5X;4V:N$F)Y+.S9?Y"5YQUR<U<U'X7S7>G>*]
M.@U\P66O70NQ ]FLBV\C,K2-RV7+%%QR O.!GF@!]OXNU?4=3D\/>'K338[F
MPTN"[D>X+.K,Z@K"J C;P1\Q8XR.#UK-M?B9KNO3>%H=%TRQ@EUC[5'<)?&0
MFVE@P7!V@<8((]2<';UK9;X>W=KX@L=?TC718ZG'8+8WI:T\R&Z55 #;-X*,
M" 1\Q'RKUYW&F_#C^Q]2\,S66K%K?0Q=$K=6PEFN&N"3(QD##:>F"%SZD@T
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% 'C'BV+ROB7X6,>F.CC5D9;V 1GS8^(W!"+_"P4,6!*[@ 5SS
M[/7B?BG^T$^(OAQI)H)H9-5@CW3@QE2DH#*-SG<.%9 2QW,Y 7&:]LH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** /&_$!-[X^\-PI:P2WUCJ$4\S21)YT<;. [LIW$(2Z[>N&8$&/9S[)7D
M'BE-WQ*\.LS/.$OU:&.1F80_OBLC*F <$NGS_, >.0NY?7Z "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#QS
MQG=H/B1X4F%W:@O<PQS0A ))&-RH R3N^7=D@'"E"#G/'L=>0>(K%+?QOHTT
M<%O'9VFKPI'(L*(YDDD VJ50,% 9@2S;2$ QN*UZ_0 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 >3>*Y);3
MQAX<AB80PG58!/;AG+LSR(R[6&%PO/RXY7S.2!QZS7CGBN7'Q.TN6WGDMWDO
M;2"46H+BY N02)77.P* H"'&3GE1P?8Z "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#R_P <R6]MXY\(W-R)
M&D&HQVL,;!XHTDD8$RJ0&#Y&01D<NF3\IKU"O(_%LT*_$/0!;SVT2#4X8/*G
MC=?,+2EV=) ,,0XD4*QV@DX ;##UR@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
MX3QMKWC;06N-0TC3-)GTBT$9=;AY#<7)9@"L07@')QSU)& >A[NO-_B,--\4
MVNH^&TT_69M=LHTGL3;0RH@E<$QOYO$87*D$N0/E8#YAQZ) )5MXEG97F" 2
M,HP"V.2!]: )**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#S?QC=V%GXH\/O
M=P7,<LES& LB-+C;-& P*/A,X7+-NR%48R<CTBO)O'5H]UKVCF1KB:2VG266
M&T=8V9A*521EE5GV?/*BJNY2TBC*\;O6: "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MTJE1FW=<;6&Z0[9"1\Q;:V 3ZQ0 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 <)X_:V>&U,BS)+:@W*30,AF
M@8O&I7+-\NX2;05YR005QSW=>=_$&>:WA-TR2*!^Z4!3MGC^8NLY4;A#@'A-
MQY1NFX'T2@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH X/QK*B"PU&W@CNIWD>&WG>-9!$/*D?S%5_E;: 6#
M+R0".1DUWE><_$1 +(W,TL211 O;&(JTLA<$;8_ES$Y!8B0-RP49P2M>BJP9
M0PS@C/(P?RH 6BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@#(UJTN[M5BM)A"9 RN71F5LKG&5(*#*C)R 1E1\
MS!EOV$,EOIUM#-Y9ECB1'\L87( !P !@?@*L44 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
G!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% '__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>6
<FILENAME>ex3-1_004.jpg
<TEXT>
begin 644 ex3-1_004.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 2Y Z4# 2(  A$! Q$!_\0
M'P   04! 0$! 0$           $" P0%!@<("0H+_\0 M1   @$# P($ P4%
M! 0   %] 0(#  01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$  P$! 0$!
M 0$! 0        $" P0%!@<("0H+_\0 M1$  @$"! 0#! <%! 0  0)W  $"
M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#H(X8O^%S>
M%[@Z=#&]Q#=W+3?(DGFNL@;<1_K,+&H4#) ))Y&3Z_7BNFF23XSZ/,]RLQ,M
MUN=H=ZE&CG>-4DV'8VTDD%UW#'RJ  ?:J "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#R^RO+:[^*&FRS"-F
MDDN!'YD<T#&Y6$1LZJ1\Y\N-D.\*,8(.0 WJ%>:P2"/XOV[QI&T4J36VT0AF
MC*J3O\S#;0=A0)^[SLZMMPWI5 !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110!YKONF^,VD^99[@-/D5KE3(ZLH#<[?^6>",$L2
M,N5RS$%?2J\RD;S?BOX;^U:F)-D4_P!A2X@(E9?+D61<$##$C)?"\1A3S@R>
MFT %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% 'F-O_:*_$K0 ^I1B.1+B26(SG+@"8>6"2?-QF%L?[&X *%5/
M3J\TEL8C\8]&DN+TK<1PW$R022LGF-L*97=_K2 S?*JJ ,L&P"A]+H ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** /,@5A^+NC)=@2RSQ7$L+^2L9B?:PV[68M@@2,".<, 1CD>FUYA:P-#\8
MM.E>2XAB>UNH;??.G^D!"%8,69FDQL0XSNXW-M VUZ?0 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4GS;AR-N.1CG/\ G-+10 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110!YE;_;K?XL:6MVED([V&6=0D;-);O&A00^9'A2 KY_>*1\O!W;:
M]-KS>VW+\5[6S662:VC26XB4W48\HLK[LXW-)G>K*F5P&W'<0-OI% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110!Y3/$UK\9O#D45NTD-Q]IN"Z9:*%5BDC3:P4#[NU=N2%.>/F5CZM7DT=O
M=M\9M%9Y$#1"Z+(B;0(@CJB[NKG'E @G :)CG#+7K- !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!Y)II@M?
MBAH]K;64T-N[.PGC/RMNBN70-GEE?,\F\?>;@_ZL >MUY2+G44^*?A9'N(YH
M9S<B:01%26\B1MJGH5RN[. =S-@!3M'JU !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%8/B77+K2W
MTZQTVW@N-4U*=H;9+B1HXAMC:1F9@I. %Z 9)(]ZO:'=:A>Z-;3ZK8?8+]@1
M/;[PX1@2,AAU!QD>Q% &A17/ZUXLM-.T[7I;/R[Z]T6T^U7-J)"F%(9@"^"
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M.J@IQ\V2<!<D#)X)('4T :M%%9^JZYI>AQI)J=_!:J^=OFOC('4X]!W/0=Z
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M3;/M8/YKAF<@#@",<$CG &""/5* "BBB@ HHHH **** "BBB@ HHHH ****
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M12K*>A!&"*XOP_X5\2^%=/71=,UNRN-(B+?9I+ZU9KBW4L3MRKA9 .W"]?0
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M9+?S/,C8Y.#N&#P!^).>,4 >:?!OQ+J&C>%-#L9-'5]+U#49+5;X7(W+,P+
M>7C.,(><_P#U^Q'Q,N[K6 FE^'[K4-,6^-C+-!!<,ZX8*901$8R@YXWYZ'BF
M:)\+KO0_#^B:5!K\3_V7JAU$2/8'$IVE0I DX^\W.>XXXYTM*\#ZIHFJ70T[
MQ*T&AW%Z;QM/6S7>I8AF19MV0I(_NYP2!@\T =M7(:AXNU%M:UG3="TF._ET
M6*&2[1Y]DDC2*6$<:[2"=HSN)'/ !Y(Z^N*U#P1J7_"6:CKNA>)'TIM4ACBO
MHC9K/O,8VJZ$L-C!>!P1WP: "[\<WCMKITC1Q=)H2AKQ9I_+>1MA=HXPJMEE
M'<\$X SG(J7OC[6;O4K:R\+^'%U(W.D0ZM&\]TL.(Y&("L",!L*0.3R>P!S+
M)\/;JTU76KS0]<%FFM0+#>QW-J;DE@I42(Q=2'PS'G<,MTXK3TWP@VD>*8-3
ML[V--/@TJ+2X[(P$L(XR2K>87Z\D?=Z>_- ',7GQ1UJTL+_57\(@:1I>HO97
MUP+\,V%?RRR)L!."0?S'N+U_\1;P'Q!>:3I,=YI?AZ9H;YGF9)I67_6>6NPC
M"<DDGG'88)QO#6C7'B_2O%.F'6+8:+/X@O!<0Q6K>>R>=OPLWF;=K#'.P\%A
MG/3<G^'$\=QXD32];6TT_P 1%VO;>2T\UU9P0YC?>-N[<W4,!GC% "_\)YK%
M_KMO9:)X<COK:YTZVU..9[X1.()20=RE<!Q@\ D8&<\XJ#3?B'?W?BRSTB6S
MTW_3I;J***&Z9Y8#$I9?.8*44L%/R@[@&4\\BM_2O"2Z1XE34;:Z06,.DPZ7
M#:>42R)$Q*L9"QS]XC&WTYX.<'1_AOJFE3Z$6\4F>'1KJ2:WC.GHI=) XD5V
MW99R'/S^Y)!)R #E8_&5UJ/P@UCQ)XAT*PU>U74R1:/=$HB[U48)5AA6(Q@X
M()Z=#VM[XWOY]8\16.A:?:70\/11R79N+AD,S,K-Y<>%(! 0C<3C)Z=ZS9?A
M3+_PA&L^$[;7EBT^_O!<0A[$$VR;PY0;77=\RKR> ,C'IIS> KN+6M8U'2=:
MCLCKD"Q:E$]EYH9PI7S(OG&QL,W#;QD\@T ,F\:ZQJ&HV%KX>T>TN%U#1AJM
MNUY=&)@,H-K*JL,_.O0]>X%=%X5US_A)?"VFZSY'D&\@$ABW;MI[C/?FLNS\
M&S:9K^GW]AJ4:6MAHXTF"VFMB[;0RG>7#C)^11C'K5_P;X=/A/PE8:$;E+K[
M(K+YR0^4'RY;.W)P>>>>3SWH K>.?%$WA+0H=1CMXY$>[B@FFEW>7;(QP97V
M@D@' X[L*YU/B+?KJGA>V:/2KJ#7+N>%;BSG9UV)MPZGU^;!5L$$=Z[+Q!IN
MH:G9PQ:;J<=A*DN]S+;">.9-K*8W3<N0=P/7JHKB_P#A4D=K:Z>VEZQ]@O[3
M59-4,D=H#!ND #(D.["J JA<EBH!]: +=QX]U2#0'O8=)M[J[77SHX@$YC#8
ME,88$@\D@=< 9SGC!=;>,?$&G>(M'T[Q7IVF:;!J2RJD\=R642KC:F3@98$8
M'?MZ40_#JZ@T86(\122R#6DU<3SVJL=PD\PJ0I7)+=3T]%%:GCOP/8^/-&@T
MZ\E,/DW*3I,J98 <,HY'WE)'L<'!Q0!S-UXK:XU3X?OJOA^PFO-7FEEMK@YW
M6B8&"H()W,KH3SP1C!(!JQ#X_P!9=]4TB:STZ+Q-;:E#9P632G9+'( RRE@2
M0-F]R "0%P1D\;_B'P<NMZSX<U&"[CLSHD[2QQ?9@ZR*0!MZ@K]T=./8X&'2
M^"=/E^(<'C%G;[9#9FV$6T;<D\29Z@[2R_0C\0# NO%$FCZI\0+FVT*R^VZ1
M:VL[SB38;T&)B"YQQM"D!>3VSR*DLO'FM6][<1Z[HMK% -"?6H38W+2L50KN
MB(95^?YATX]SVN:CX$NKZZ\7S+K9B7Q%:Q6Q7[.6^S!%*<'?R"&;(P.3G-1Z
MOX:U+38FUVQU"2:\T_P]/81VUO;?/,^ RLF2V&W(O&&H R_#OQ+U;6-=\/6<
MFD69MM>@DN8GAG?=:QIG(<[2&.5QQM&2!Q7IM?/WPLL=1T[5;>+PY=WDL3,A
MODOO#D=J%AWKNW7'F%BVW=M4%\GL!EA] T ><GX@ZG)X\?PZ+6QLW2]2%;:^
M9XYKBWS\UQ$_W&S@X09)]>U68?&^IG3+>ZFMK,2#Q#_8LZ)N((\X1;U)/'<X
M(/;I4M[\/'U37+"^U+7)[J#3]3;4K2-X5\V)BY?RA*23Y6=HVXZ(,$8JM/\
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MQ^+==U'5H?#UE8V%IK<>FI?7K7,OFQ0.25\D!#DG<!\P.%!S\QP#CV/Q3O\
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M*ZG#*2.A!ZCM4]9^C:/IFB6/V;2;:.WM7<R[(R2I+=2,GO6A0 4444 %%%%
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M)!/H.E6[#X@:=>:II-E-87]BNL0M/IUQ=>4([E0%;Y=LC,"0P(# 'GUXKFO
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MO;":_A>Z$&Q&^ZJD@Y<@YP2H&1\PSP =396=OIUA;V-I&(K:VB6&*,$D*BC
M'/H *;_9UD+@W'V.W\\MO,GE+NW>N<9SR:\=\.ZCI=IIGPIM[W1WN[V=)EL[
ML731BU/R[SM'W\Y7@\?K73)\2;S4-#UW4M)T_3)DTRTGG(;4&,D;1D86:/R@
M4+*'88)!*$9') !W;Z982&8O96S&;'FEHE/F8.1NXYY]:0Z7IYMA;&PM3;JV
M\1&%=H;UQC&:\T\-?$'6K?PYX0M;S2)-5U36XIV@DBO%!<1)NW.7"A22<$<X
M R"Q^6J'B#5;&]UKQA:7/A@V.N'PA-/<73WGFD+L7]UL&5X8CY@>=O2@#UZ2
MRM9K9;:6VA>W4 +$T8*@#I@=.*5K2V>!('MXFA3&R,H"JXZ8';%>=>!O%FH6
M^E>$M#OM >UCOM)1=/NS<JZSO%"K8<*#Y891N!))QQC(("V/Q7?4+?P?+%H:
MJ?$CW$:A[S'D-$^WD[/F!/?C'I0!Z(]I;2RF62WB>0IL+L@)*YSC/IGG%/\
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M+W)/8 GGI63+XHUW3TFMM1T2!;QKV&RL9H[H""[:0;BPR-ZA%SN&#G:<9YP
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MV3R+$!"(BP^XQZQ[0<<\G X%6_$_@S6_$FI^()<Z?;P7VB+I]NWGN[>8LC2
MN/+ 527(R"2, X.<#T*B@#R_Q-X)\5^*K@RZ@/#\B2Z9):>2[S%+69B^)4&W
M#M@IAFQMQP.Y7PCX,\2Z?XF\.:UJ4&EQQ67AZ/29XA,SS1E26#+\NW=]U3AL
M<M@GBO3ZR?$OB*Q\*:!<ZSJ7F_9+?;O\I-S?,P4<?4CK0!Q$EIH7C#XGVMYI
M>H)=PVT&_5H8G.QI(9!]G#_[0?><>B<\'#=]:?VM_:VH_;#9?V;F/["(0_G8
MV_O/-SQ][[NWMUJK93:;8Z_/HUCI3VTCPF]EGAM1'"[,V""XQND)Y/MWK9H
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M110 4444 %%%% !1110 4444 >87$L8^+GA^TGE!:V>9+9(T53M^SR[0V."
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M1?SLZ1,TQV>2 0QF+ *"6PJJORM@@>XS:/IEQ:QVLVG6<EO$V^.)X%*(V<Y
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M KY9!QA=K'DE22.@!R/2?!,&M)IDT^NZ/IFD74S@BTL "   -SL"06)XP,X
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M3GC X(]*I?$SP?K/B74A)I6D6K7"6T2VNK+?&VGM9 \FX'"DNA5EXXQENYX
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M&1;W?G$M('4$LG)&""< 8(/4 %FT^)(O8OL<6C2KKXU,Z6VGR3 (L@4NTGF
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M XH G:1$9%9U4N=J@G&XX)P/7@$_A65X?\2:?XEAO9=.,VVSNWLYA-$T;"1
M"PVMS_$.H%<;XWMKBY^*W@.W35+^V@N#>,T<$H50T4)(8 @C<0[*2<_*<#&3
MGE] GU33-1U?4;/59HH'\?26<ED$0QRK+(J.6.-Q.&&.< KG!SP >XT5Y7J5
M_P"*=>U+Q+-HNLVVG'1+P11K/>!8D1$1F,L0A8LK@R?-N&-H '#$^I1[_+7S
M-N_ W;>F>^* ,C5O%.E:+J%M87C7ANKE&DABM[&><NJ_>QY:-TR,CMD>HIVA
M>)]&\2"Z&E7HFDM)3#<PO&\4L+\C#HX#+R".1V/H:YSQ9'?R?$;PBNFW-M;W
M'V;4,27-NTR8Q#GY5=#^M>8RZSJG@WXE_$'4+I8[S64TI9H9[:/RX0"85!,1
M)Z;E.2W&QOO;J /HBBO/YKC4_#'B;1D7Q!+J.E:G;7!N)+[:X@:*+S!.I0#Y
M#C!&0/F&.HQPFA>+?%=QXD%A/J>HQ6U[H$E\D\PB+3,-Y6>-=I\I6Q@(1TYQ
MTP >]UEZ9KUIJVI:I86Z3K-ILJPS^;&4&XC<-N>2,8.>A!&,UYII\_B6#1_"
M4U[XJO)3XF>U6:1T14MD\DR;$8#(D? 7/<[CUP1T?@2U:R\7>-K=KR6\*7MO
M^^F;<Y!MT(!/? .W\* .\HJCK5^^E:%J&HQP-.]K;23K"O60JI8*/KC%>76/
MB/7H/#_@GQ,-8DN7US4X;.^M9PIAVRLPS&!@H4VX&#_O9P: .XU/QUINF:U_
M9C6FHW!CFB@N;BVM]\5M)+M\M7.<Y;<N-H/WA73UQ'@[1%M?%/BR\&I7MPXU
M,1E9)0RL/LT##/&25WE1SP ..M=O0!QT7Q)TB6SN;UK#6H[.TE>*YN&T^0K
MR??W!02 N#DXXP:U9_%NDQ:3IFJ12R7-IJ5S!;6TD*9W-*VU2<XP,]<^G<X%
M9/@#9_9OB'S-NS^W]1W;NF/.;.:\P\$75]86%_=:-,]GH5UXSMXK-(@,20M+
MM=.^4*&,<=U/)Y% 'T#17ENJ2^(I?$'C.^M-?O$@T!XKFVTY(U*3D6RRF-CC
M=M8\8&#R>I(QD:?JOB[3/"D?C$^);?4+:32&E-@<REI_*+[N!\NT\LHP %-
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M+D@"3 &#GITZF@#VJBL?PHV_PIIC?:+FY7[.NR>Y0+)(N/E9@..1@_SYK8H
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M=WMHV9F.225&237):?X]N8XO$=UK>GB&WT_4_L-LMO('DF<B,)& <9=B^<\
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M.)YDN) ZJP& $.-P ' !)   & *Q==^%WASQ!XH7Q!=K=I=% EQ'#-LCNE
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH \IUJ*VB^
M+?A>*>\@58IW6*)%97_U+[ PX 7._;MR.>F&KU:O*]7TV[?XJ>%IX(_/^SRR
M&^DD497*2",+R#CF1B5P"7R1@!5]4H **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MPQE6KT>O-9%M]0^*NEWDEY);W4<<ICL3$RLX( 9MZ;@PV>5D$[3G@Y4[?2J
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M"\NS;NRX; #J20I S0!U%%<IIWCRSU?7KG3M/TZ_NK>%Y(1?Q(I@>9 2Z9+
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MB&UMHFEFD()VJHR3@<GCL.:R?#OBF/Q#/=PKIM_9/;A'7[5$ )8W&4=2"1R
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MAAX=O/LP4W]K%!8+IOE6MV\2R6X).Q]I^8'<<YZYKL8XTBC6.-%1$ 5548
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M["X<K"I(,C*$)5,@_,0!QUKS?_A6OBO^SM+UA;S_ (J:R?\ LJ)G(,<5CB2
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M&)(W4]015JL_0[22QT2SMIK>TMI$C&Z"S39#$3SL0>@SC/&<9P,UH4 %%%%
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M[_2+W39KUH9KJ)7,B1-+MMU4 XPN"IR0,D]#0!ZG=:WI]EK%CI5Q.R7M_O\
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M<I(SM.",CTX)'XUX'X8\2^+8[;P!KEYK\]]#J]_)8S64@ 4IYCIO+=V&2?\
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M=6C!SC&X''4B@#!F\%27VL6EYJ.MW=W;V6H-J%I R(K1.=V$\P ,8QN/RGJ
M <@8J3Q;X+A\4WNCWZZC<Z??:3.TMO<0*K$;L;AM8$'.U>H/3IS70VM[:WT;
MR6ES#<(CM&S0R!PKJ<,I(Z$'J.U1/JVFQ7*VTFH6B3M((EB:90Q<@D*!G.<
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M))8;ZW<FZ3.9'#C[N,JH7&3R<CI7?:GK&G:-%'+J%W' LK[(]V27;!. !R>
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M,]]AP#6;X2T"[FU"PTC6O"FKSZCHU_YJZK=WTZV6%DW"6-#)M+$ #:H(R1G
MSCVJB@#P:UAUE/#OA'PL?".M"Z\/:_;S7-S':[;614FD!>-R07!#!B< <DD@
M=?>:** /&_"6FWU[H_@G1AX>U"PNM O#<7L]Y;&&)5 D#!&/$A9F4_+GU.*W
M-(\+G3/B7?Z=9;5T$>5KA@!.8[IQ)"%Y))5MCR<=&11P.#Z+-$D\,D,@)212
MK $@X(P>1R*QO"_A'1?!VG/8Z+:>1%)(9'+,69R?5CSP.!_^N@"YKUDVH^'M
M3L47<]S:2PJ,*<ED(_BX[]^/6O,=*EOIH/A@+KPSK,,>GDVTXFLB3&RV_DB1
M@,^6GF,""^TX4M@  GUZB@#P.[TK7]7L+G5['P]J833_ !+<:E]CE$UG<3VT
MBJ28N00W#\(0<D<$DY]2\ V"6>A3SIH4^C"^N6O#;W-T\\[EU7+RER2KD@Y7
M/&!G!) ZJB@#R[XC117'Q!\(R7OAW4=6TRQBNY+M8=,:[B/F(%0$ $$ADSCM
M\I[USEKX$UC6(_%S^'].N?#V@:M8".UT^^ C>2X5U);RN?+4A'7)P<."!CI[
MI10!Y5<0:GXPN]%N[7PM-9RZ)97L<D6L0>5!)))!Y2PJFX^9&QP2V<;5QG)Q
M6!\/HO$&B^)M-O=2\.Z]Y9TRXL<-"OEPLKI*0J# 1#M8*3RYP!GJ/=** /)+
M/3=9TKX/^$I[32+PWFCW45Y<Z8D16:907#KMZ[OGWX(SD=,UK^ QJ-WX[\7Z
M[<Z)J6FV>JI9-;?;HUC?]W$48%0Q(.>?YX/%>B44 <-\1XKYFT">UTFZOH(;
MXM<-8QAKF(%&4%">5!)&6'( SD8KR_2-%N].\,:5:7_AWQ7I]Y9W=_)97^E0
MM++;,=@ 9,9:-P<9.W=M(Z$D?1-% &'X.CU&+P=I2ZM#'#J'V=3<1I&L8#GD
M_*H !YY '7-;E%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% 'F^KW@'Q#T>&]CN=D5YY4,XE2,2.4+?, H+8!08].=N/GKTBO.]5FV?$
M?21)JN#<RF-88[+&V6, E26ZAT+\D_+@%1\Q->B4 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 5X]8>(M0\%R>+[RWT076C1>(Y9KZZ-SAXQ(L
M6[8@4EMI8,>@QQ[CV&O/]1\"ZQ=^'O%^E1:C8K_;FH-<Q.T#_)&R1J5;YOO#
M9@$9'&?XL* 5]5^)]]9:]>6MGX7O+ZQL+U+.XFA29Y&9MNXH%B,?R[A\K."V
M1P,U)_PL75O^$@UN >&U;1M#DF^WZ@MXN41(RX*QD EC@\#CD<]33F\!^(;;
MQ;J%YIGBF2VT;5W,NHV@CQ(C[5&86S\A8;AN&"H"_>(!&CI_@=H;CQ>E]?)-
M9>(G;,<4122)6CV'YBQ!.">W;/?  ,/3OB%J/B&QOH[KP==&PN-,:[@F/G)!
M(ICR87D>)0&(S\R;E.1@G&38TOQ'/I6F^"](\.^&+40:MIOVF*+[9Y26^$1V
M!.QB>9 2W+$YX))-6M$\%>(+#29]-U#Q4]W!!;-9Z<!;A4$;(!NF4$%V7E0-
MV, 'J>$T3P3K6EW'A![G6+2[70[2>UE)M2C.CA0H7#8^4(JY(Y R<D\ %;_A
M8VJ?V!:7+: D5X;NXLK^26X(M+!H20TCRA3\I.,#C/(!Z$XWB;QCJ'B/P+X/
MO["PLQ%K&N6]M/#<3$J72<E5R$.49X<ENH 'RG)Q9N/ACXAFDT^X77K);BWU
MV[U)T-L6AV3'((0D[G7&1GIYC ,=N6MVWPSU9-$T;3+CQ)!(FE:S_:L3'3^7
M(=G"G$@ZEV)X[@#ID@%70+^^\*>)?&WFZ18VVE6=HFJW,%E=.^V1HW8[ R*"
M6$>#PH&U>I)J>T^)FN-;:E<7/A.86UOISZC#<@7$4+!5#&%GDA'S[=Q# %6X
MZ9R->_\ !6H:AXOUN[?5%AT/6-,6SNK:*,><[!9$&&8$* )"P(ZG@C YH6W@
M/Q4/#%]H^H>,Q?QR:=)86L;V(C2,,"@=RK;G;9QR2 3GYB,D Z/PGK.N:W:/
M=:OHD>F0O'%):[;D2F567)W  %2..#Z]3BN-NOB?XBCBUS4H/#%M)H^AZC-9
MWDOVW]XPC*@E 0.>2W/8@=037H'AS2[C1/#MAI=S=173V<"0++%!Y(95 5?E
MW-@X S@XST Z5Y7X/T>X\76/CK3H-:LX]'O/$=UY\:6WFRNA93N202 *& P,
MJW0D'T -BV^*>IWNMZTEMX=B?2-%*27MW]L^=;<J[>8$*@EMJ@[!GD$9Y!%R
M+XC7T4F@3ZAI44&G^(W$>G2+*6DB9_\ 5"5<<[@5)*GY<]^M6='^'"Z;JGBJ
M2?48Y]-\11>3+:1VQC:% &50LF\YPCL#\O)P1C&#!I_PQ>$^'[;4-96\TW0+
M@W%C MIY4A(.4\R0.0VTX/"KGOQQ0 W1OB!J>HVMQ9W%G9P^(;?6(].DL49V
M 5N2X/?")*^>F(SWJ"Z\=6'ASQ!XWEET0"[LI;&+=;2%GOY)8SY0.0 N  ">
M>,]<#._#X$LX/B-<>+UG;=-;JAM-F%$P!7SLYZ^667!'\3<\XK+UCX8_VY>>
M)9KO6I(X]9DMYHA;P;'M98%VHP8L=W'48'L10!R\FL7_ (;^+FKZWXBL;%)K
M?PJ9V7379A,!.H!)8 [LC;DCHHK4L/BOJ<-GJ>I:_P"&;NSTRVL%NX;E;>9%
M=V94$.9$ ))<88<8!/KB\WPPO=3U>XU#Q'XE;4VN-(;2Y5CLA;Y4OO##:V.#
MSC'7VX#8_A=J%YHEYH_B'QA>:K826AMK6(6R0^1\Z.&)!)D(,:8ST&X=Z .=
M%QJFH?'#P3?:O:V-J]QI\\T*VKLY8-#)\KD@<@'KTKMO&=\9_$WA/PNX_P!%
MU>YEEN3@$/';H)?+(/9FVY]0".AK-TKX:ZM;>*-!UO4_%?\ :#Z+ UO!&-/6
M+<A4KR=YYP3S]/?.KXQTR9?$7A?Q/#!-<+H]S,MQ%$,E89XRC28ZML(4X )(
MS0!E>+/B/>>&M?:TDM=/CMTG@C6&>X/VJZCD8!I(44'@9(^;'*'Z5U/BW2-1
MUK15M]+O(;6[CGCF1IX_,C;8V<,O<=_J!7):W\,)M>DUV6U\4-#9ZT\,YC-E
M'.,HR, 68Y:/Y<A1MY(R6&0?1X4:.&.-Y7E95 ,C@!G('4X &3[ #VH X'Q9
MX>N(O#GC^\OY[6[L;ZP:Y@MVMQN@FCMMI;)SWC5AZ'ISR>8L-!O;OQOX/UCP
MWX?GTU+/3RFH7,R""&=-@"H ,Y/)YV]U/\/'??$0S2>#KNQ@-XIOP;1WL].>
M]=4=6W?NU((XR-W;(]167I/C9=/T2TL9M%\3SSV\"Q&=?#\Z*Y48!V\XZ=,T
M 8=A\5M=N?#>GZ]<>'K:.SU2<65B([@R/)<M,4&5 X4*KGU)3' 8&K.L>(_%
M6J^ _&,5SH8L);.UD FF22-)X&A8L8\\[UQ].@K L;*RM_AW%X1N+7QD_P!E
MN?M-E?6^@30RVS!]ZD=<D$MSG^+C&!5TZA?W/@_5M'U*X\8WU_J,/V=KY_#,
MB+''@C:L:XZ@MDELG- $PUJZ\/WNG0:1X9M[KQ!-H27%U<6L,A5H@=L*':.I
M"8W'IMP,U?'Q!\6ZCK5GI6E^%8(+V?2!J4EMJ-PT<D7[XQ%3\OL",X.#DX/%
M8&I232WFD:GI@\9Z=K5C9"P>\A\-.Z30@]&C?C/.>I&1G&<5=T:]MM)\7PZV
M=-\97+Q:5]@<S:#,3,6F,KR%NNXODXQC# #V -"/XD>(/LOB+4Y=#L1I.A7E
MU:3R)=,9'>,?(%4J/XBN22.&X''*S?$3Q+X?TO6-2\1>&R;.TMEGAE@1H%+M
M*L8A;>6)/S@[QC@'Y<USUI?P6^A^)M)O/#'C6\MM?O9;Y_)T%HFA,V"4R9#N
MV[1SQ^/;.$EU?>'-2T7Q%8_$;5HI81!;/_80B\E1(KCC>=[;D7EN< @8R<@'
M7:&-8_X7U(VN+8+=/X9+*+(,%"?:1@-N/+#D9'! '3I6A\1+'78=:T;Q)I>D
M1Z[;:9%.D^F-@.1(H!=#@Y; QC!.,X')KB-!U&^TCQ79>(+[3/B!JD\&G'3R
MDOAR-"8]Y*C<&SQUSRQ/5L96M[7O&=W>:K;ZCI7A[QY87<$$D&Y="$T,JMM(
MW(SCHR@Y&#U&<&@"I_;JGX;ZSK7@E8].6[U=%O[6[MR&MY9!!$Z( 0.20Q/^
MT<8.,=5=^,->EU77=,TNRL/M'A^TAGO9+AFV3R21^8$C P5& ?F;//;O7"S7
M4<OA/6=,D\.>.VU+6+E;RYOXO#ZIMF4HRE8PP 4%!QDD_-\W(-2SWSG5)]4L
M]'^($-]JEHEGJC?V"C"XVQJHD 8A8VZCC*\'Y1U(!UVC_$#4?&*62>'+.VMI
M9M+.H2-? R*&\UXO) 4J>7C?Y^PP=IS@<YJ?B:?1?C#I]U?:>EMK.I^&8K2&
MS\P,@NY+G"JSCC:".6'8<9. <IXX[&XT:7PUX>^(&BSV&GO9M*FCQRF> DR$
M-N?:'WEFZ9)/ SC#KZRL-5O99)/"?CPHVC_V>JRZ8A91YGF"7>9 3()/GQ^F
M* /<K(7BVD8OY('N<#>8$*IGO@$DUPG@[0]'U2X\;+>:5:RB77KB)_-@7<RF
M*+//7!+,?^!$]Z32/&>IZ5806%]X8\9:C,@"K<OI\(9A@ ;R)2">"2>.M<M:
M:GK5E)J2P67CV%=3NFN[@PZ';AE8A5;8Q<[?E50,Y(QGKDT 5O!_C'6?#HU'
MPE:1RZA]DUN73=->2/S3%"@D9LJ"K/M"@@9'!QD "NCU/XD>(=$T#3[K7-'A
MTF2XU-K&2]GC=XD3;N6;R@P?#?-\N[C8>>U8W]D:7;^&['3]+\&^-["XM+E;
MR#4([>!KCS^A=\R8;(X(( ]A5YK_ %IX$B6P\=//F0WKW&G6DD5V) @VF,R;
M  $  3&,MGECD Z1-=N+K5? TEQ:Z-=OJ+W6Z\A'F>3B%F!@;)QN"X8YZ<8Y
MXY_4OBEK<,*7ME8Z>\4^N-HL6GRA_M*.O&]B#SGN@4;=R\MFH;+?ID?A>*T\
M+^,%70Y)74-8VY$S2JP?.)0$&&? ' R!V KC]%&O6FIWUW!HOB6R\137%Q<_
MN_#UK,D9D9R ;F3#LIP1G(!Y ]P#MM9^)/B?3++Q/?1V.D-;^'[^*"96,A>=
M'95PO("GYL[CG_=XYF^('Q)UWPAJU_'#9:>+6T@AFACE#RRW:.P5Y,HP$"*Q
MVY<?,V,9SQA7&EW&HZ#XAL+[P_XQ\W7IXKFY>*RMML;H0V%S+R/E'7T^M0:]
MHO\ ;VL:S*^A^.H5UBWA^W0K86Y1WCP$8.9.,%<[,_I@4 =KIFI:_=?$7QQ;
M-<VL]MIUK:I!:^0QW;XY)$'W\ Y8AL@[OEQM %1^'O%E[J&C^%--T>UTG3KK
M4[*6[<>4?)M8HR  D(92Q8L!@,, ,><8K+LYKRQ\07>L6^A^.%N+RTBAN?\
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M5A>5F1D&8@NUU(Y7  R21GMOAU:_9?AYH'^D3S>;I]O+^^?=LS$GRKZ*.PH
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MPT >_45@>";Z'4_!>DWT#7C13P!P;R;S91DGAG_BQTSW %;] !1110 4444
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M'YM;A[F!TOM1$L<C$999/,W#. V,XR,]37H%K\1=.U#Q#I6F6%EJ%RFH6C7
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MZB66WGC:*6-NCHPP0?J#6%:^ _#5G<VD\.F#_0VWVT3S2/# W]Y(F8HK<?>
MS[U4L_B+I&H%$M;35'GFM&O+2%K0H]W$#UCW8SG((SC(.>E)H7CVWU;PQ8ZQ
M-IM[ ]Z_EV]LL1=I6(9L)_>PB,2>/NF@">]^'/A#4=5FU.[T*VDNYW221\L
MS*VX,5!QG/4XR02#D$BIK[P)X9U&]>[N=*C,LJ)',(Y'C295QM61%(60#:N
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M ?E. >*YW5/%=[:>(_!NJ36VK@ZCI]V9-(MB',KH(V4A%<J3AF8$MG&.AXH
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MTDE6>2&.)X944L=OE@ QD*>""1D?,:L^+X+BX\>^"XX]6N;2-I[IO*A$?+K
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MR2 *S9O%WARWTL:I)KVF"P9BBW ND*.P&2JD'YFXZ#FLGXAV=O>Z3IR7#:G
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MVE"Y=O\ 5,V6Y&XC '(!Z167=>(M*LO$%CH5Q=;-2OT=[:#RV.\*"6.X#:,
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M!H-QXC\2:LNF6YO+?69#:7(AQMB,2*-AQ@KGS.GU]*U_BB^WP)<+MD9FN[3
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M_93V=U$LMO/&T4L;='1A@@_4&G000VMO%;V\4<,$2!(XXU"JB@8  '  '&*
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MNJ66B:7<:EJ,WDV=NF^63:6VCUPH)/X"I+"^M]3TZVO[.3S+6ZB2:%]I&Y&
M*G!Y&01UH \MUW3-6OM/TG7!X1V6UKJDUQ+H\"JEP89(]A<A" TA;<YP<_,
M<X)J*\\-1RV%B8?"6K:#)YUS=65SI,^;FT<I$O[T D?O,-D G 0#J3CU^B@#
M$\'IJD?A#2UUN,1ZF(%^TJ H^?O]WC/<XK;HHH **** "BBB@ HHHH ****
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MC1HM*N?*L5S(L2;48,6)4'^)0?F!(R.".DL/"5U8^(=)U0ZL)A8Z8VG2QO;
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M96:=PYZ* &0CJ>.V3QZ0?!;VWBFPUG2M5DL8K33%TTV:PJZ2QH2T>[)X )[
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MLMEAT)^49^]CG73Q=XEU+_A'=#%G#HFOZE;2W%V]S"94@6,E3L0,"2QPPR<
M<<GD27OPHL&@TJ72-3O-+U;3)7EAU"(!F=G8L^]. P))&/3@Y'%3:I\.&N++
M1I-,UZZT_6]*:1H]4:,3-*926EWJ2 P9B3C.!D@#'% &1KNM:I%XJ^'$.M:+
MIB:C=3W"SL1YIA=0JDQ-GY0VX-SD\*.QR[1/&VO7/CNQL+Z>S>UU"YN[?[';
MV[$6@B#E";@$I(Y$9W*#D;N@Z#<G^'=O+?\ AF[_ +2N6?0I99U:4;VN9)6#
M2,YSQD@GC@9],"J>F?#*;2[O0Y4\4ZE+%HUR\MK#+'&5$;JP>,G&3G=C<Q)
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M<K&N7$A'S;9%XXP0!U&:O1_"*S*:R;O7]5O;C5K9(9Y[ED=@RMN#C*\88+M
MQ@#'O0!GZ!XLUG5KGQ+H^HWL=];P:1]JAN3ISV;MO4Y&QSG;Z$@9Z]*31M1N
MK34?A-9B.RDM;W1G7<]L&GB9+5&)60GY0WR@@ ?=.2<@#=TOX96VG:K=:G+X
M@UN]N[NR>TN7N+@-YF[/S8Q@8SA5Y ]#5B#X?QP7?A*X&LWC-X;@>"$&./\
M>JR!"#\O'R@+ZX'7/S$ \\LK'4H8_BE=37.F7XM7:5X;W35D262-!('(W8X4
M, ,8W$-VP>FT?Q+KOB)-,T;0[BSTVY@T"WOYY'M0T<DDL:^7&B@_(@.23@\<
M #&:W%^'L:VWBF(:W?\ _%0E_/)2+$89=OR_)Z97KT/8_-5+4OA397L>A-;Z
M[J^GW>DVBV*WEG*L<LL _@+*!CV/N<@YH R/%?C#Q;I@DC2YTZVN;71!>RPV
MD!NF>X7_ %H89_=1+M(#-P2>"QRHT=)U/5]?^(.AZ@NH2VVF7?AQ;\V"(&6-
MG>,[68CDG^]@'"$#&2:74_@YHE_?RW,&IZQ8)/8K93PVUT0DRI&(T+Y!+851
MD$X) )[YT+/X;6-A=^'Y[?6=:7^Q83;Q@W7,\6_>$D( )0$ ;>F% Q@4 86D
M^+-2B\'^&+9/LEOJ>L:I<6CSPVH$2;9I=[A 0-QVY[\DD^]7Q%XW\6^&]&\5
M*\MC->Z#<VDR7#P?)=6LYVJA4,-K!@<G/(!P!P:ZT_#S3CX:AT47]_BVNVO;
M2[W1B:WE+E\J0@&-S,>0>I&<5'JGPWT[6-&U2PO-2U&275987OKW]T)IEBQL
M3B,(JC QM4<\G.3D RK37_&=K9^,+"\%IJ6M:79Q7%H+*(JI:59"%"GEMI3.
M.K=*T/A]XF?Q)<:LR:]'JEK!Y02.2S^S7-JY+[HY5Z,<!/F7 )#X Q5^X\$0
MW%[J]VVM:LDNJ00PS&)XD,9B.4>,B,%7!W'.<?,>.!C$UWX8RW=CJ<NG:_J:
MZWJ-S;3RZA)<+"P\E2B\0QJ" K$[0!D@?,.M 'HE>,C5+[2/A'H]S9_9"IUR
M6.5+BW$NX->R?=R<*1ZX)],'FO9JXIOAIIS^&(= ?5]6:TBOOMP<O$7+[M^/
M]7@+N);  Y)YH X3QAXS\=:7?>,GM-9T^.V\//8ML2P ,HGQA1N9L?>Y.23C
MC;FND\)^(?%TOCZ?1-;O]/N8;S1%U:U,%L4%N2ZH$QG)&2V<DDX&".16MJ?P
MRTO5QXD^UZEJ;?\ "0/ UWM:(;1"<QJG[O@ 8'.20.3GFK]KX)MK/Q#;ZY%J
MFH_;(-,72UR8BK1#D$CR_O;OFR,#/;'% 'F^F7VL:IH'A.3[=#8$>*9+6XBL
M+5(XIL!VW[<=<HQ]"6R02HJ_K7CCQ'IOCB"T2_62R.NVVF/%%:AXQ%( 3NDQ
MGSN#\JD@ G('&>F_X5;I?_"/6^CC5M7$<&J?VHDZS(DHEP00&1%P#N8\8()X
M.!BJVH_!W0=1N[FY?4=:CDGNH[L".\PL<J@ NHQ]]@.6.3Z$4 <=9:SJ]MHW
MQ3U/^T&N+FQU!X8OM<22IL1]HRN .%& /N\YP:ZK0=;UCQ&NE:1:ZLVGRIX;
MM;Z::"VC#//*!MP&1D" *<A0/O  \$#2F^%FBS2Z\XOM5C76X_+N8EN047E2
M64,I^8[1EFW'D],U:7X?6,/]E26>J:I9W>FV']G)=P/$));<8PCYC(.,9! !
M!YSF@#D(?%WC'Q!#X7CT_4+#3KB_N;FQNRUD9%\R%7+RH2W*X7Y5P/F!R<<"
MGI/C_P 57O@Z*[NEO9EL=6GL-3O=(M(Y+CRTC#+(L; H!N8!CM( '&":]!_X
M0335FT!HKJ^BBT1VDMX5D4K([9W-(Q4LQ.3GYAUJAIGPSLM%C TS7=:M91>R
MWOFH\)8O*@1P0T14KA0<$<$9["@#>\*:B-6\,65^NI1ZDLRLRW<:[1(-Q XP
M,$8P1@8((K9JAHND6^A:1!IMJ7:*$'YGQN=F)9F.T 9+$DX Y-7Z "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** /)O%4XE\<Z )F0S1ZK"
M((Y2HC5?.D#XVC<9"/+8=!][)(#@^LUY)XCMH]'\:^&UEN@T]Q?Q*#-=*DA5
MI0RH$QEHT^X,<Y<9<@,I];H **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHKQ?5+6#6-+^(=]J<,:^(]*U!S82A-UQ!$(T^S!,<A7.XCMEB3DY
MH ]HHKQKPSX=M-=^+OB2?6'F^VZ<-+NXHA,R8F\D,SE0<'#9&,$#S#TS71?$
M+0K37_%G@ZPNWN$@N;FYCF\B9HS)&+=V*$C^%AE3CDJS#(S0!Z'17S5<Z;I4
M%]K>BZIXG&BZEI5]%%ITK:>9[WR(XT6#RY5*G#+R54#YL'(!(/7W,=JGQ1.J
MF6TUJUFUN&T^T(56\TVZ52HAQMPT.,Y"\\$DDJ20#URQU*SU))GLKB.=(96A
M=HSD!U^\N>^.GUJ"YOKV+7;"RBTYY;.>*5I[L-@0LNW8N.^[+>G2OGOQ%9Z)
M!X8N+"PCM8;A?&C6US%;$(X@WS^6C[<':-AVYZ8XKT77M)M_#'BKPU:^'+6.
M&Y73-6%E$TA;?+A)%7+$D_.S'\3V% 'I[,J*68@*!DDG@"L.[U^:73]+OM!L
MAJUM>WL<,DL<NU8H"Q#S#CY@N.@ZYSG%>6?"ZX\'ZXFB.TDD_B*6VNK?4H'
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M7=M&3Q"8E5<G"L1CDB@#K] \5)_PC6G77BC4]$L]1N@Y*P7:>2V'8#82YW8
M&<$\YK;_ +:TK^R?[6_M.S_LW&[[9YZ^3C.,[\[>O'7K7SOX=AMKNP^#L,\"
M2J;K4 ZR1Y5AYX(ZC!P?RJ&PU2'1?A__ &EM4"R\>?:$CDC(1@L.=I.TE> >
M0I(...X /HE?$>AO8R7R:UIS6D:AWG%TAC52< ELX SQ6G7C'A;Q'X/G\*^,
MM:U":'45O)OMNHZ;;0O((D;"HJAT0N<]7X /.1C->RQ[?+78NU<# QC ^G:@
M!U%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M' QQCI3)- T:;3%TR72+!]/4@K:M;(8@1TPF,<?2M&B@"J=,L#-!,;*V,MN
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M+2."]DBN=2B4O#;@I%MG4MN=>&3=&"1G*ERQ^Z$KTN@ HHHH **** "BBB@
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MV^LUY3XMAL7\5^&8Q.MK_P 3.WG:)MBM*5D78JG<%*DL9"$);+*=C?,R>K4
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M !/4@5ZS110!YQ96/C;0_$>KZ79Z9:W>C:G?/>0:I)<J&L3(=SAHSS)M(RH
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MH<E_.48+[S&0.F PYSD]#X T34_#_AQK#4[F:8BYD:W$\_G21PG&U7?H3U/
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MLO4=1AVXH \RT7Q+=^)%\/\ AVR\4WDT=\+J[FU:"%8K@QHYVPD.I"L-PR0
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M2>3]33J "BBB@ I%)(Y4CD\&EHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@#SC7O+D\3Z&UB\V];Y&DD\Q93(/. ?YEW-&OXA>40KEE*>CUY3
MXI'_ !7>@Q6MG$SC5(V>6-=OE%I0Q9SLW9*1R 9.#YP(..&]6H **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M@%CC [XJG\-5TJZUCPW&=6U&'Q-82W$=U8)8JDO.?-^T2./F3@#D[AG"@$<
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M]]>6F@W6AM:1W=I;0SK'.)7\U6WQN5R @^49ROL<6];@L-#BTL6VI)<75MH
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MO*/$M_#=>*= NVOD\B74H[>V#R>87?[1"WRX7"'8N-I/*\GYRI/J] !1110
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MWEO;"UN9+=B\#S0JYB;U4D<'@=*MT4 8P\(^&EM4M1X=TD6R2F98191[%D(
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MW)&#^&<=* -"BBB@ HHHH **** "BJFHZG9Z5IMUJ%[,(K6T0R3N 6V*!D\
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M_MH;*>*ZE>)[=W),80')$@!R'^7CY3DG=G [2L'7/#(UG6-(U./4;FRGTXR
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MBK@D;\'@YQD=,<%_A/Q%XRUC4='O;W2MFBZE9B661A#&L+E Z&/$SNZGD'<
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M%. !GKP*SM.^('B;5-(LH6>"VU./5[G2KB.&W\VXNI(XPRF*)MJJ 3\Y=@%
MR6&<5H7/A2>Q\;>'M.L[CQ!#8V6B/:1:E:[25/F(%21BI0C:#P5[*0,C(Z&?
MX;Z%)%I"V[7ME)I;S/#-:7!CD<S#$NYNI+=R,$=B* //M-\0ZYXMU/X7ZA/J
M7V:6_P#[1:18H4**\*NF\ CJ5)&"<#J!72:AXIUZR\+>+[ZTDLS?V.OK9VS/
M!A#&S0*H?!R2!)C=UP*OQ_"30(=-TJR@O=8@72[J6YM98KTK(GF??C# 95#@
M<+@]3G)).A>?#W2[VVUNW>]U-(M8N4NKE8[@ +(C*RF/Y?D.57)')P,G@4 9
MUIK'BO3/$>NZ9?SVFL30Z0-2M(;:V-O\Y9U$(^9B02G4DGD5@>#_ !EX@UOQ
MAH=@FLQZC87.D1ZC?O';QM]GF;=F L@&P @##?-ZDUU_B#PDT\6MZK:37=UJ
MUUHTFGI!)*JQR_*Q4<!=I+$G((QN/2N+\-^'-=_XED>GV_B[3K2&V>*\CU75
MHVAP(E4111X8G)Z/M0+R<'[H /8JH:YJ8T70-2U5HC*ME:RW)C!P7"*6QGMG
M%0^&M+GT3PWI^F75V]W/;0B-YW))8CW/)QT_#M6A<VT%Y:S6MS$DMO,C1RQN
M,JZD8(([@@T <$=?\0:.?"EW=WL>HVNO2QV\ZI;*!;RR1ED,>T@E,@YW;C@$
M[AP*Y*]\:^-]"T&?Q/>:M:7-KI^KRZ=/IQL%C,RJY0N7#G:W!P 2/4MTKTO3
M/!&DZ7-82*]Y<#3@5L8[FX:1+8;=OR _[/ SG KF?"'A"/5[6_N]?LM4@5]=
MN-1AT^[DV("S[XV9%.#C(XR5R#P: *]I/JEAX=^)>HP:I(]U:ZA=R1F>%)$^
M2WB8 C S\H"#G&,'!K;AUK5M7\066APWXLO^))%J4MPD:/)+([[0-K J$&TY
MP,G<,%<9K1F\"Z3+-K4GG:@B:PCK=P)>.(B74*[!,[0Q"@9QG'3%.D\%:<\M
MC<I<WT-[96WV..\AGV2M!D$1N0,, 0",CKSU)H X'3O'7BG6]0\'V$-[:6D]
M_<:A:WS_ &8.CFW7[Z@G(R#G&<;@.HR"N@>./$NK>#1YVH1G4HM?.EF2VMT%
MQ=1*@8^6C9C$A)SEL(J@DXQFN[C\":+!=Z)<VXN87T7S/L@68D R?ZPMG.XM
MDY)YYK.A^%?AZVLDMH)M3AV7QOUFBO&2592NUB'&" R\''Z4 <;=ZOK>L_#K
M2UUZW%UJ$'BF&RN9Q;)OA\N?&_*L$C;(";@<?-M_BW5[37%#X7: FF'3HY]4
MCM?MWV]4%\YV2]L$Y. >><G)R2>,=K0!S'B?6[JUUSP]H%E,;:?6)I@UUY0?
MRHXHF<[0>-Q.T#((QNXKD];\2>+-'TGQ-:1WB27NDW=F+2^N+=-MS#<,$"N%
M &Y2QR0HZ#CFN[\1>&M/\3V4-O?B56MYUN+>>"0I+!*O1U;L:I3^!M'N-'N]
M.?[5MO)TN;FX\\F::1"I4LY]-JX'08H OZ!9ZU96MS'K>K1:G,UPSPRQ6P@"
M1D#";03T.[DDDC&33?%>LOX=\)ZKK$</G26=L\J)C(+ <9Y'&<9]LUK1IY<:
MIN9MH W,<D^YJ.[M(+^RGL[J)9;>>-HI8VZ.C#!!^H- 'G?B#4M>T"33X&U^
M?4(-9MKB,RI!$&MI5A:19(2B#Y./X]Q P<]:XSP<FL7GA[X=7-OJSM?WE_J+
MB6]02K$2L_F,,89F(W-\['YCZ<5ZSIG@?2-,,(#7ES';0&WMHKJZ>1+>,C:5
M12<#Y?ER<G' .,U1LOAEX?TW^SA92:E!'IUR]S:HE[)B,MU0<YV?>XSSO;.<
MF@#FV\7^(=.\.7%C<:C'<ZJOB,Z*E^T4<9=2@D#;3A%;:=HR&&<9!JCK>N?$
M30/#4XO]3M(;W^U+>.WF"0RS?9I6<#S4 "CE0 P'/S# QD=Q<_#O0KVRU6SN
M?MDL&I7(NY5:Y;Y)1C#(>Q^51WX ]ZCE^&N@RZ$NDN^H-%]K6\>9KQVFDD7.
MW<YSD#.0O3//7)(!O:%9ZI8Z8L&L:LNJ78=B;E;98,@G(&Q21QTS6E2*H50H
MS@#')R?SI: "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** /
M-/$FIM9^-=)TM;1S_:5] Q=P4/[N9GR2L@4C"L5!7)P,Y)S7I=>4^+II(?B!
MX<\ZQ@9[W4$B@6%G\S"3 O,<'8<+#$&R,A6 !XX]6H **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHKQ76OL5G\5+6:2#3];@U+6$AWJP6^TZ<
M1A"AP0S0XRV,%0.>"02 >U45\_Z)I>B6MGX5U6PNI?\ A)F\0_9"L5V[N+87
M,H>,QY(6/R\L>!UR3SRWP8=/U+5M.N?$.IZK'XYM=8/VBUMH%6:168 JY5 ?
M) ^9AN("!\8R!0!]!5F:+>:K>0W3ZMI2:=(ER\<,:W(F\R( ;9,@#&3GCJ.*
M\E^'UQX=U"?2GUMKA?B!9W]PMUL4K<3,S,"),<-&J%>O"A"!QP<BVNM*BT;5
M=/F:V2RN/'5P$EN&!LHU505\\9 =" <+D E0<_+0!ZUXZ\8/X,T_3;I;!;L7
MNH161!F\O9O#'=]TYX4\<=:ZJOF"ZOH/^$':P6]AFCL_'?[HQ((XQ"4<@HHX
M5"=QP.!GZ5Z_\;./A%KC#J/(P?3,\8/Z$C\: .OU"XU6&^T^/3["&YMY92MW
M++/Y?D)C[P&"6/H,<]R!S6C7E]_I/AKPIXQ\$?V<8+2">]NI2\ETS[S);,H.
MYV.=Q"@<\D^I.>!GO-%O_%VK:/J,FFVUP/%$EU)K5S=)'(L"-@P_-EN &0#A
M,<_4 ]QT77I]3UW7M,GM(X#I4\<2M',9/-5T$BL<JNT[67(YP<\GK5^WU>RN
MM8O=*@F5[NQCBDN$4@^7YF[:#Z'"$X]"I[UXIXQT[PQJ]S\3=2O+FW-[8-!]
MEF6X),<JVZ*%"JV-QD4IR.#D'IBM0R>'6\5^*;G5!9V=_>:%;W=M<V\*F9"8
M9O.E@;U (.X'L,GB@#V6HYVE2WE:"-99E0F.-GVAFQP"<'&3WP:\@\#^(=&\
M*3:X]_=: ]E:V-HSZKH<;&-T\QXXUFC3.)<MSCL1GI7IVN2P3^$]2F#(]O)8
MRMN/W2I0G/TQ0!E:EXJO-$\.:+<:GIT<.KZG=V]@MH)MR1SRG!RX!X #'C.<
M8SSFMK2)M4FMY1J]G!;W$<I13!+YB2I@$.,@%<Y(VGICJ>*\2NX=,N/A=\+#
M>QV<H.LVL;><JM^Y+/YJG/\  <+N'3@9KT#XKWMIH'PLOXELI#:,D=HL%I+]
MG"(2% RH.$P,%<8(.WH: .[CD26-9(W5T<!E93D$'H0:;'/#,\R12QN\+[)5
M5@2C;0V&]#M93@]B#WKYWO+O1&T#X@Z/_:%HT,D^GSI<6UKY-N0WE!GC0;@O
M.>>^0=QZCN-.\,>&8_B!XA\+644"Z;J&A0275K')N)?S)!OY)(8*R-GL6![B
M@#U2BO*?!&G7UO,^FZR8_P"R/!TLJ0DQ',LNW='*3CG;#(W ZEP<< UZ1H^L
M:?K^DV^J:7<K<V5P"8I5!&[!(/! (P01@^E $R7]G)?26*7<#7D2!Y+=9 9$
M4]"5Z@'UJ19X78*DL;,=V &!)VG#?D>#Z&OF[P]J.G77B;P?J22&&X.JW,-U
M:-%)-<1F0$ 3SMS(S<\<#!^Z2&SL:#;^&M.\/^"-<MELK>[E\2S1O=*P5O*+
M3@+[)CRN.@R#_$<@'J'C?QK'X4MK=;?['<W\L\*M:R7 6187?890@R2,\=AD
M]>,'>UK6;'P_HUUJVI3"&TM4WR.?R 'J22 !W)%?/.I:GI\_ABY76E(\40>)
M5DE:YC8SB(. "&(SY87Y0.!\O KV3XG0B_\ A=KGDPF<FT,B )N/&#D#V'-
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MY%<KI%AI-KX:\,ZK;6EI#<GQJF^Z6-5<6XD8$%NHC&4&.@)'K0!] ?V[H_\
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M0GIGH1F>]AF\0?$.\U6X\-ZG%;MX3>%%O+(G9-YI<)\H92Y4@@!B1D@_-D
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M+ 30,,'<%,8YP&V'(&:NZEX U[4O%^EW<UYI,FFZ;/:W$%R\+_;4\H('B!!
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% 'DVKW<7_"8Z1NEN+>ZG
MOHHA!'& @"W.097WHS,\:X"L'Y5B-VW</6:\I\7[7\7^$(XDEO;N#4UEN-[M
MNC@,B+ND084?.\+ [,\)RH&3ZM0 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 457NKZUL?(^U
M3QQ&>58(@QYDD;HJCN>"?H">@-5=5U_2]$EL8M1NU@DO[A;:V4JS&21B %&
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M!89SUP0< &M6@ HHHH ***Q?$WB:S\*Z?!>WL-S+%-<QVP%NH8JSG )R1@4
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M"HV\$8'3!YK%3X3>'_\ A%GT&>XU&YC^UM>PW4LRBX@E;&2C*H Y&<$'D_3
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M.-P4\E2"5]"<]0I6C9?#_0;5?#[V[7A.AL[V+_:F^ZZD,IP<%3D?7: <@D$
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M !1110 4444 %%%% !1110 4444 %%%% !1137?8H.UFY PHSU.,T .HHHH
M**** /-]92^EUK29[![:'3KBXMGN+18(U"_Z6LGFN2<DEVP,8;>6)!Y*^D5X
MKXI7SO&?A7_3[2X>SU&$,SX0%!,HV!2Y)ER=R!1DH6.<<5[50 4444 %%%%
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M^6PT1VN"6 !WC'0T >EZ1\0/#NMIJ#6=U-_H,/VB5)+61':'!/F(A7<Z\$<
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M7V_5C>"[FLX/.9/L[8'EINVL6RI)SC&[ Z8[[P?>:[?>'XY?$5FMKJ"R/&0
M%\Q5. ^T$[=V,XS^E &]17AP^)7C:S\/:KXHO1I)TJUGGLX(A&WF2SAPJ$@'
MA!D_Q _(?49Z'6/&'B_PHNO7&HV$4]C#9K-8W$_E1'SGD2((RK(<H&?<3D8
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M<+,54JPD,WFJ=N58#=G&%[]-XR\27.DZCX>T>QD$-UK-Z8#,8M_E1*I+,N>
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M96:QW\FGW]A=+>6=Y'&KF.50<95OO+SRN1G K<CO;6:V:YBN87MU!+2K("H
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MU#X8)/?6>I:=XCU73=4AM_L\]W"R[KH%BQ,@P 3N8G\N.!CO(Y$EC62-U='
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M]U<1V0_>.?/7]X4&5#?*%PS''0L1O?!_18+'P]<33Z$]A?+?7&PW-B8)1$[
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M]9HH \PATZ]B\?\ A743HMXMK8:$T,TH@_U;[,A..<]1@=SCO7/IX<UD>%_
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M@$XP!@8X'!.<VXO".LV+:E)IGB..VFO-7;4MSV.]0K1^686'F#<,!2"-IRM
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M03@CH,8&00#H*\&\!:WXK\.>!O#6I.^F'P[-?-:/9I _VA?,N'!8'ID,3QZ
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M2;XZWX@O&TK>+6*\O1)&B,@0H%VC"X&,+C/0Y&!4_A3X8:5X/U1KO3]1U1X
M6,-E-<;H8F889@N.6(XSUQ0!B^&M?\<ZI?:1JDMO(='U2'=*LZVJQ6S,"T;1
M%9?-=<%058!B03QG:,+1O%GQ"U/PYX7UM-5TPIK-W-I_DR6V-KDR[)20/X?+
M("CJ%7))8E>W\._##2O"]^MSI^JZT8HA+]FLY[H206S/G+1H5X8 D9.>ISFG
M:=\--.TS3M!L(-7U8VNB7;7=M&SQ89F).'_=\CYGQT/SMSTP 8]KXE\2P^!M
M<%_J=DNLZ=JPT[[?Y!9"I:([EB5<L^V0@(!R0.M<O-XHUWQ!\.?&%K?SI/=:
M9K-M:VTMQ (F;%U&!YJIP#D<X'K7HE_\.-,U&RU&VFU#4U-YJ8U59HI(TDMK
M@  &)@GRX  YR<=\Y-9]K\(-#M+#6K1=4UMUUAHY+B22[#.)$D$@D4[?O[AD
ML<F@#*N+[Q1'8>-/#7BB]M+UO[ DO+>YM8-FU'65"NT=>5X[\=\\9D/B7Q,^
MF>%_#'A=9(KB+PS;7SR1I SRL4"H@$[(!&",LR[CS@ $$UZ*O@RT:#5_M=_?
M7=YJMI]CGO93&LJQ88!4V(JKC>3]WDXSG%8^H?";0]0CT@F_U>WN]*M$LH;R
MUNA'*\"9VHQ"X[GD $]S0!TWAF^U#4?#=C=:M;1VVHM'MN8HY$D42*2K$%21
M@D9QDXS@\@UR/Q!U[6['6;:QTG5_L2"PGNG2VM5N+F1U!"?*RLJQ@\LQQT(!
MR17>6-E;Z;8P65I$L<$*!$51C %<SXD^'>D^)]?@UBZO-3MKB.V-I(MG=>4L
M\)8DH^!D@ECG!&: ./T[Q?XN\7V_A!M,U*STC^V[*\^T$V@G,4ENX4R)D@'<
M2,*>%!.2W%.TWQWX@U5?"&@?:XK?5-6DNQ>:A';J=L=O)("8U.5#L(B,LI S
MG':NFT#X9:;X;?2S8:MJY734N%@2:6-U'G8WG!3CD*0!@97."2VZO<_"71KK
M1M/T]M4UE'T^[EN[:\BG1)XWD.Y@&"84%N< #D4 4O@U#<06'BR&]G%S?1^(
M[I+BY$003. @+8' R<G Z9J;XTS:G;^!5DTS4IK M>PQSO$/O1L2I!(Y R5S
MCKT.<UT'A'P1IO@M=0&GW-_.;^?[1*;RX\PAO;@>O).2>,DX&+WB?P[:^*_#
MUUHM[-<0V]P4+26[!9%*.KC!(('*CM0!Y#K,'B"#XSZRNB:RD%[;^'-\M[=0
M)([JI0\* $W%@HSC !/'05T5YXTU[6;G0]+T>"]2[N_#RZQ,UBUMOW/M5%_?
MC;L#%MV,-RN#P0=^#X:Z;;:O<ZI%JNKBZN-..G2/)-'(6C(&6)="2Y(W9)//
M;'%4[[X0Z'?Z)H^FS:EK(?20Z6MZERHN!&W_ "S+;,%1P ,< 8'&: .F\)76
MJWGA:PEUQ(DU4(8[I8G5E$BL5/*$KGCD \'(XQBMJJNFZ=;:3IMMI]G'Y=M;
MQB.-<Y. .Y[GN2>2>:M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 >:^-].8^*-&O;B99!!/&P63."GF1KN1?+8&3YB,# "[F8@$;?2J
M\F\8ZB(/$OAR?4;:.(R:DL)GD$2O;$Y3/)=3E9!\N"< ,6X4KZS0 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !4;SPQLJO+&I9]@!8#+8SCZXY
MQ4E?/_C+P]X<N'^)VIO'$UYI\]M+;.)R##*\2Y(P>K.6&#U(QU% 'OL<T<I<
M1R(Y1MC[6!VMZ'T/(I(IX9]_DRQR>6Y1]C [6'4''0^U?/\ '%HWAGQMXSTS
M3'G&F3^%'GEC2XWS2R%5;=N8G#[79O0 DXQ6=I%_H5MI?B*+[=IA2X\'JD0C
MC:-3*H=0I+XWR9"98!<L< 9% 'TC'/#,S+%+&Y3&X*P.,C(S]1S2K-&[!5D0
ML5W@!ADKZ_2OGCPW::!IWC;PVLB6T>GZAX+634%,@"3G:YDW9.#Q'SZ;.V*D
M^&-AH]@OPWU2!XX=2O;C48;IO/.90$D"J5)[?N\ 8Y8'JV: /H(3PM.T"RQF
M90&:,,-P!Z$BE6:-GV+(A?!.T,,X!P?UXKY\\")I&I:II*ZKJ-X/$VGW-VVI
MV26(Y#2$R-<S8"E 0,[B<;@H'KV?P8\-^';?0QKVFD2WY>ZLY)%N3(L<0G++
M'MR0ORJC>IW9[T >G37,%NT:S3QQM*VR,.X!=O09ZFN<\6^*9M$GTW3=-6QE
MU74962%+RX,4:*J,Y9B 3SLVCIDMUXKD==N/#Q\3>,M.\:?9+>*XM(VT^XNH
ME!>#RL-Y+-G+K)DX'.<$#TJ_Z'%JWPNM/$?V$:T8&6ZCN<&4AK9D02;^<E]H
MYZN"!TH ]+T34+^XT*TN=>L8]*U"4[);7[0L@5]Q"@,.#N ! [9QSBK[W=M'
M"LSW$2Q,=H<N I/3&:\V^.$>G/X9TC[9-'%,-6@,+-+Y; 9(?#9! "G).1C
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ML5XYI$_@J+P3XYAU#R9_#$>N[VBLW8QB-_(V%/+/"^9SA3C@]N*]CH ****
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#R#Q@T<GCG0&:S
MN%^Q,PBGMV80(JJ#(HSD1L&BVA@,$$JV!AZ]?KR#Q]I[-XH\.PQ0@VLE[$WV
M;SAO9U9A^[)! ;D$G((VMSCFO7Z "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@#RGQ<]M)XHTUC8QED=8GE:+
M $HG0*T;E5PX>4L64YPV1QOKU:O'/B#;;=:MKA[81PPW:*FV%1\W*J[J6&Y,
M2R#< 2#$N V6"^QT %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% 'C/Q#MKV\UO3(;>".:Y$L0@LQ;LA2-I(PT
MC@,%*!F Y)*L^01\VWV:O*O&\=O-/9.-&2628JL,K95HI,@<#&%4?.0=S ES
MMX9Y$]5H **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** /'O'5K9OXETZYN;<*#*J27$J?O(0&C;?O 8;E?RHU8
M#&&E3<7<$>PUX[XZM OBW0)FW-/%>J%>9'E>(F5/E4A')!#*RGC!# LIPA]B
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** /(?&=O"OB?24EM8YW,\!\H.LA1=SJ $+AF(Z'82<1R< 'Y?7J
M\D\=73P/H(@@1K*SN3$S*HN" 61=X)1@L8)"D_+C)49Y0^MT %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% 'C
MWQ U6\74M)&XPVQNT@DV+(!(6?&)OE"*/GW9^8;T4 $$E?8:\<^(T@B\2>'/
M/N'CFGU:-(H+<^7)*/-<*Q 8, #M);!W83!'->QT %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% '%^,/&4VCZOHVE:7&LUQ<:C:Q7SX#+;022!1GGAWY"C!X5CQ@5
MVE>5>(_!/BY3$UEXACNXY]>@OC'_ &8NZ ^8N'9O,^94 7C R%[5ZG&&6-5=
MM[  %L8R?7% #J*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#S;QG:1?VGI*V
M;NTWVD_96$B9\_S07)9F!R!B,'#X\PK@5Z37CWC^7'BWP\7DCCL[2]4+<+(3
M\SG>2ZE6+CRV9<*ZL2Q;H/E]AH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** /'_BC,8+S1(;S2+F66YN3*+R
M*8QI',L93: JL=K!0>3RI(.,?+[!7EOC^T"W6D2-J4&Z2YB$0N(PS.4EW!0.
M'^7!+$%SGC8,K7J5 !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110!YYXZM+G4[B"*-) T86XN+=I$5'CC<*IW;
M@N0S^8@EX.QN,CY?0Z\Y\?W4-G?V[7Q\FPDBD$4L:EKCSP06906 P$'7(/R\
M _*4]&H **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** /*_B9>6%P;&:.\@-XJ2RVQ2X612BI(KN4(P<(TG(X4@
M$LH7GU2O/OB)IKZEI@@5DO%PZ^3,%4D@$LP8@ @*O*@H."2VX!6[NTE:>R@F
M;;NDC5CM! R1GC(!_, T 34444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 9FJ6TDWRPVB3M<HUM(SN56)"K$LW.
M6&0JX7GYNN,D6-+M'L-(LK.1S(]O D3.2"6*J 3P .WH/H*MT4 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
#'__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>7
<FILENAME>ex3-1_005.jpg
<TEXT>
begin 644 ex3-1_005.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 2Y Z4# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH \P^'EM91^-]>N+$V8CEBWE88$
MC?+2OUQ\QX"G. ,.. <@>GUYOX)>W?Q]J_D)(T:6:Q1SNZOYH6:0-AP@)VL=
MN&^8;>=P*D>D4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% 'G7@BZOH_&NL:=?!-YA-P-HQ@"9X^!R ,H1@'
M^$?0>BUP'A!EA\:ZG9V]Q<36RVV]?M)<,I\TC #'(Q@@\=AT^Z._H **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** . \*VS)\0-4N%@>SAGL59;=DD0LQGD);#\\<#@8Q@C .*[^N!\&@KXPU9
M-GE(L1*QC,9R9GRSQGC<RB-LKC&[!5>%'?4 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% 'G_ (4^R2^/M4N8
M(E\][9A<2(2REC,SKANA!5QCU !P,FO0*X+P7,+KQ1J=R?M332P[IA>1M%)$
M?-<*%5\.%=%5L$8& !@':.]H **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** .,\,+;+XOU6*TM[B%+>VCMV1R[
M(C*[]&8\[@01@<!>2> O9UP'A6VBA^(FM2Q0/:I):K$D"H%BQ%(4)3& 1]T9
MVYX(_ARW?T %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% '"^$KM9?&6KP7 N3>)&X4L0T:Q+<R[5W=2V&!.2>
MOI@GNJXKP\;W_A/M7:[TPVL<ELIB=HU0?*VTA2/OC:(R3D]%X7OVM !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110!P?A5/^*]U>1);N>/[''&TTJ[5\Q9'#* <$D<9) SG( ##/>5Q'ANYE'C
MK5;*6YNIU,'VB,2L0L69-I0!AN/W5&3CH<#!R>WH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** .1T&.XF\9Z
MG>W$WF VZQQ \&-=Y)4KN..S8(! 8 ]JZZN(\/W9E\>W\5O$\5J;9Y6Y;9,[
M.I#*.$&W+!L*3N+ L2#7;T %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% ' >&)+6Y^(FJ212.9HK0QM',B(Z#
MS<# 4<+\A!SCD9P0<GOZX/PY<W!^(>HVUP8I)/L9D:3&73,@Q'NQ\P&2>0F,
MA0I*L:[R@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HK,M-<M;_6;S3;2.:8V0"W%PJCR8Y#
M@B+<3R^#DA00!U() -C4K[^S;"6\-M<7"1#<Z6ZAG"]V"DC.!DX&6.. 3@4
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M0&7'>4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M<36D$D\>-DCQ@LN#D8)Y'/- 'C<=U'I'Q!B5I=(UI+W5X$DMYW"ZI8W&T(7
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ME/,F08P$.X$D<9'7YN?<W6.4E'".0,E2 < Y'^(_.FI;01Q1Q)!&L<9!1 @
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M3?\ VZ/ IBW%LL;D)(N23U.X#DU[O'(DL:R1NKHX#*RG((/0@US&C>"H]/\
M$ U_4-4NM5U5+4V<4]PB+LAWE\84#YLL1N].,=<@'E7@B'1M53S/#>H>(#XF
MM-(N+8P7*I''8G85'W8P&_>;=JY)[D BM;PI>^%=:\/(^G>'I5UBTT>:TU"4
MPNJ6V$)979OED8N 0.6PQ/&#7LRQHC.RHJESN8@8W' &3Z\ #\*$C2/=L15W
M'<<#&3ZT <?\+-0TO4?AWH[:7M(@MHH+DK"T>9UB0/U W<\;AD''7BO.]4DA
M6U\8V]I!'*FG^)8K[6+5+8DRZ<!&60-M(^\A8C(X1^W!]S9H[>$LQ2.*-<DD
M@*J@?H!2IL(WIM(?YMR_Q<=??C% 'G7A2;0=5^)5_JOA1X7T\::(;][>-DC>
MXWJ8^P4D('Y'3/-/\1ZGIF@_%_0;W5=T:W>F36=I(L+2%IS-'A0%!/1B/^!>
M]>B44 ?/&C/H5MX.T_5U73OM_P#PEZ8N5"^:R"<,1N +$;&S@9X;IS4<>CVE
MSXHU71O&UUXC_P"$AN=6^V6=G9JK+=1[?W<BR!&("A6!(90JC QM;'T73)&C
MB5II2B*BDEV( 5>IY[#C]* 'T4R*:.>)989$DC895T8$$>Q%/H **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH XKPY?M=>,KQ&<O&+4F X(
M14#(-B;L,<8!;@$,QR2"H7M:\Y\,W"W/Q/O"S7,DL>G21DSNQ\L"93C#J&&X
M,IP#CY02J[E%>C4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!%
M<W,-G:S75PXC@A1I)'/15 R3^0KE[/X@Z==3Z6DNGZG:1:NI.FSSQ+LNC@$
M;68H2#D;PH([UOZUIB:UH6H:5)(T:7MM);,ZC)4.I4D?3-<#9>#/$5Y%X5TK
M68=*2Q\-7$4R7D,KO+=>4N(@J;5\L=-V6.2HZCJ :5I\5-(NI;+=I>LP6MW>
M?85O)K91"D^YE",P<]2O4 CGD@@@)=_%OPS8^(1H\SS>8;LV1F5HF590VTAE
M#^8H!XW%,<<&N<\,:+K/B3P5I>F/;Z>NCKK,]U+<&5C*8HKMG\O9MX9GW#<&
M&%'J<5K^&O"'B;POJ4^C:<VDQ>&!>F\M9V#R7,*,?FB ;C.,J&). Q/S'@ %
MP_%/3DAU*XDT+7TM=.,ZSW+6B^4'B.UD#!_O$XQG /KP<4]=^*9L-!\0R6VD
M31:QI"(SVMS)$ZA7<JKDQR$$#C<H.03CWI[>%O$Y^'OBC3()K:QU;4K^ZN;=
MH9BX"22[BI8J,$KN7..,@\'@<^/A?KK_ /"0QP6F@Z9#JFD16L<-H7"+*#DY
M^7/;EL$G(]\ '3KJ%O?>-_#E_J$FMZ3=-IEQ.EI)(BVLJ@@,)-KL-P#!\>FS
M)!7;5Z#XA6$LNF22Z;J-MIVJSK;6.H2K'Y4\C;MHVARZAMORDJ ?8<UGOX>\
M6:AJOAR;4&TY8+;3KFTU)HKJ0R2><%!VY3!(\N-LMU.[I@$UM+\%:XNE:!X=
MU&+31I^AWL5Y%?Q3L\LPC=V11&4 1L;0S;B,$XZ_* 6?^%KV"W5O'+H&MP0R
M:D=+EN)88_+AN-VW:2KD,,YR5ST[GBN[GGBM;>6XGD6.&)"\CL<!5 R2?PKR
M_4/ OBJ^\+SZ:J:,EQ/K[ZLV;R4H$:0R! ?)SG)QG'09[X'I.J:=!J^D7NF7
M)<6]Y ]O*4.&VNI4X/K@T <W:_$&QGETA[C3K^RL=981Z?=W(C"S.<E055BR
M[A@J2.<]N^!I5O/XS\4Z[+?P:W8G3]46.UNH+N)4@$21GRMH9C\Y8LWRD$-C
M(QBIK/P1XBN=-\,Z-K-UIHLO#U[#=0W5JSF6Y$(*Q*R%0$^4C<=S9Q^-=!X4
MT?6-(U/Q ]_'8_9=0U![V!H+AW=<JB;6!10.$!R">N/>@"QXC\5P^'+O3+9]
M-U"^EU!Y$B2RC5VW(F_&"P/('T&"217+ZK\8])TD?Z1I\\<D(B-Y;S7$,4\&
M\9P(B^Z0@8)"CC(]]O1^(=&U._\ $WAG4K 69ATVYEDN1/*R,4>,Q_( I!(#
M,>2.0!WR,*;PMXPTGQ9J]]X8O]&BT_5Y%FN!?QR/+#(%"ED"X#>N"<4 1Q>+
M[W5O$GC;2;G3[S^RM.LHE0VDL:R@/'(Y<,6!#.I7;S\NT9VDFH-"\<0:)X0\
M+V=IH^MZK-J%B\EKM\MWD\O[P<[A@_,ISC&#P21BKS>$?$-MXQ\4ZE9W.F2:
M?KEI&C)/O$PDC@,:#*C:JECDMAN. O>H?#O@W7](?P:)QIC)HEK<VUR8[J0E
MQ*5PR Q#. G0XZ]>,D ;>?&30[.[\MX'5(YX[:X5[B)9X96 W#R=Q9@A.&(X
MR& SBC4/B]9Z;<ZDL_AW6%MM+NEM[ZYVQE( VT*Q(8YR3T'.,'OBI+/PKXQT
M+Q'JHT'4='CT+5;]K^9KJ.1[F%WQYFP#"G..-Q_#US_$/@3Q1KVD>,K5O['B
MFUZZM9(2+J4K%'%M'S?NOO8C7IQ\QZ8&0#?LOB1I\@UH:II]]I,FDP"ZDBND
M&]X&'RL "<$]-IY!(]\9\'Q;T^<ZHD>GR7$UAIAU,QVMU#+F)6VL&(;".N02
MIR<9QDX!K:G\.]8UWQ5KE_J$]A%9ZIHHT]O(9C(DH*L& 9/N94\;N1CN.+EO
MX>\<W/@_5-%UB_T1_,TV6PM$M4D4,74*))78$@J,_*JX.3D], %S0?B!)K]R
MMO'X?O;>6?2O[3LQ/)&/M*?*, @_+\S  MC(P>AK2\"Z_?>*/"%EK&H6<=K-
M<KN"Q-E67L1W'<8/I6+H?A37]*U[PO=%],-IIVB#2KW$LC.Y 4[HQM ^_&O4
M]">,XK7\ Z'JOAKPA9Z/J\]G--:YCC:T5@OE_P .2W5NI)P!SC'&2 /U'Q3)
M!JUYINF:5-JD]A D]XL,J*8P^[8H#'YG(1CCCMSS6)<_%.S:728M'T74M5?5
M+)KRW$ 1>%."AR>",'/;H 6)Q5V?PYK.F>,]3U_0)+!UU:"*.\@O7==LL8*I
M*I4'("D I\N?[PK*T7X>ZCH/B3PS=6T]C)8:7I\MM<<&-WDD9G9D0 J!N.<9
M'>@#O9KZ*VTR2_N%DBACA,TBE"SHH&2-JY)('89]LUPO_":Q>*O NN7KZ3>1
M:2VDS3?:(+F)F92K!D!&0D@ S@YQD=>E=SJ45W/I5Y#I]PMM>O ZV\[*&$<A
M4A6(/!P<''M7GMG\.M1M[7Q0432K.XUO3C9O':22B&65@P:=@1\GWSA%!'7G
MDT 6$\?PZ/IWAZPT_0]0OOM6B)?0C[1'N6)4!P[.PR0.I[]@:P-3\<Z7J/B7
MX<>+)+J33]*N(M2:<7$A"J4BV8(!P3NR!@9.1["MR'P#JRW6AR//9!=,T%]*
M.V1R9',84/\ =X&1T]/RK&L_@_=3:1X1TK6CI]U9:*+M;E$ED'GBX).5.T8*
M'!'KC^&@#H/%>M17'@JQOO$.AWUJDNIVNRVCN5652) R,Y'0$CE?O '^$]$U
MOXIQZ)J.O6[^'M1GM]#>W%[<12181)AE6"E@3U& /?.VHKWP3XDO_!%CX=N]
M1L;F2QNX)(KMBZL\4;9"N-IRV!C=GGOSR:WB+X;ZMKC^-PEU91)XB:Q$)+N3
M"MN1DL-O)8#H.GKWH UM5^)=K97]Q9V>G37DMKI!UBX!D$>R$8..<@MA@<#C
MWKJ]&U2+6]$L=5@BEBAO($GC28*'",,KG:2.A!ZUX;K]I&WQ"N-.O=;T/3IK
M?1(+"XCU!Y[:.YC(!<B2-X]X^Z-K-TW#!VYKV;PE?W>I^%-.O+VSBM+B2+YH
MH598\ D!E5@&56 #!2,@$#G&: /--4$GBCQWXWL=6T1[JTTJTA6"9;P(]D?+
M>19(L@XD<X.0.-H#9&17?6GC**[N?#<0LW4:]8->V_[P;DVHCE".F<2#!!['
MIBJ=GX2U"'Q?XJU.6:U-EK\443(I;S(1'$8U8<8.<DD<8]3CFAH/@OQ)I]]X
M;N+_ %;39X]#M);..*&V==\;(BJ2Q;[WR#)QC &!DF@"MHWQ?AU;^Q;AO#FH
MVNF:K=_8([Z1T*"X)(50H.2#_>XYSUP:J^/O$,FN^%3<6&EO)I<.K6\2:@9R
MC+*EPJEU3'S1Y#)NW9W$?+CD26/PUUFT\(>%]!-_8-_8>KKJ/FA7_>*KLX7'
MKF1N?8>]23?#OQ&ND7GAZTU^P71);X7D)N+1Y)T_?+*4R'5=H8$\#GVSP ;U
MOXZ6]\97GA^TTYY#93)#/(\HCD!9=Q=8F&YHQQ\_0Y!&00:U_%>JW6A>$]5U
M:RMH[FXL[9YUBD?:IVC))/L 3COC'&:Y2?X?ZEJ?B^WUO5+O3FDL]1^U6UU;
MVY2Y\@,2L#D85EP0,D9Q]:[+7],;6O#FJ:4LHB:]M);82$9"%T*YQWQF@#!L
MO%-\;70].&G"XUR]L/M<D37&V..-0H+-)M/)+*  O4\X'-:WAKQ';^)=.FN(
M89+>>UN9+.[MI2"T$\9PZ$J2I[$$$@@CZ5@1>$]?M;C0=5BU*Q?5=/LGL+E6
MA=8)XB001@E@P*IGL>>!TK8\(>&V\-Z;=K//'/?:A>S:A>21(4C,TIR0BDDA
M0  ,GG&>] 'F^I:GJ.C?'W6KS2M$GUBX&A(6MHIUC(7?%N8%NN .%4$DD<<D
MUU#?%;3+JPTZ?285N);VT-WY=Q(T/EH'*%20C9;>KJ.-IVD[L8)M7O@W5(_B
M%/XLTC4;2.6ZT_[#)%=0,XB^92'7:PW?=^Z<?7GC.'PXU+P^NE/X,U>&PFM+
M'[#/]KB,JSIO:3<1GAM[NW']['3 H [3P]K*>(= L]52UN+47*;O(N$*.A!(
M((/N#@]Q@]ZY.[^)R67B^/19]*,,3ZC'IRR37(2=W?I(D.,M%D@;PW<<5VFF
M07=MIL$5_="ZNU7]],$V!V/)PO8>@]*\XN/AKXB;7=0O+?7]/,5UK,.JA[BS
M>2;]VP,<3-O&40< #''=<\ %_4OB9>Z?)JTX\*W4VE:1?&UOKU+J,;% 4[U0
M\L<,"5XQD<]<1ZC\4KFWU#78-.\,7&H6VC0PW-S<I=)&!#(GF;MK#.=F"!WP
MV<8&<W3-)O?%2^.-$AO[!=/N=;DCNV"L9D&R(,4PV!G:5&>A!Z]*J6.F7&J_
M$'XCZ!I-W8P6ES;65G-YH:1UB^SF-BF&Y*@D<]R,D=P#IM,U>TU[XF:1JM@[
M/:W7AN>2,LI4X-Q#U!JAHGCG1M(\'P2Z?I!LVN=2N;:*TEN'=?,4N\CLX5V"
M\'[JMR0 ,<C>TGP3_87B'2+G3KI!ING:2^F^3,A>63+J^[<" #E03QZ@#D8P
MK?X;:Q8>'K6*QUJV@UJQU6;4+:Z$!,>V4%7C92>X8\^V/>@#1TKXB7&LV=G%
M;^'YH-8NIY84L[R4PQ@1!3))YFPDH-P PI))' Y(J?"$RFR\7&>".";_ (2>
M\WQ1OO6-L1Y4-@9 /&<#/H*LWW@_Q/<?V/JJ>([=_$-A-([22VI%L\<BHKQ!
M <A?D4YSG.3QGC5\$^&+SPQ;ZN+Z]@NY]2U.747,$)C5&D"Y4 LQQE>.?SH
MAU7Q!K5EX^LM+@M;$Z4UA+=W$LL[HZHCQJSC"$97<<+GYL\E<"LR/XH(^GZ9
MKG]D./#FI7?V2&]$Q,J-O*!GB"?*A*M@AB>F0,UN:[X;O=4\2:9J5MJ"06\4
M$UI>P21E_.@D*,53D;&)C +=<'VKG;#X;ZG::#:^%3K</_"-VEZ+E5%MFYFC
M$OFK$[YVKA^2RC)P.%Y! .Q\4:G<Z+X5U75;2&*:>RM)+A8YF*J=BECG )Z
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M\%&7ODQX(]>F/>M>#Q]JM[->V]CX8^T76EI#_:=L+]?,BDDY,<0"D2%1GDE
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M_B'/ $>2<6#M<2.A/D-OCQ'&VW C.3@!R/W>#DH=O<T %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 45!>^=]@N/L\J13^4WER/]U6P<$]> :\*
M&J:IHOA/Q5HFJ7WB.T\3VNEQW),^H/+$ZI)CSX)0<KN+ ,H('&.<,  >Y6&F
MV&E0-!IUE;6<+.7:.WB6-2QZG"@<GUINK:G;Z-I%WJ=WYGV:TB::4QH78*HR
M< 5XM?\ BK6]&\6Z[<6E_>S^1X1CNTMY9F>))R85\P(Q*Y .X\<_-UR<[[6%
MM:?#W7[NQ\7ZEK=IJ'AN>1%OIFF+%4?,JEC\F=X4I@<CGD< 'I6DZE#K.C6.
MJ6ZR+!>V\=Q&L@ 8*ZA@#@D9P?4U<KQ+X>7>IZ-XU\-:*NL7]WINI^&+>^DM
M[N0.L+[2 (A@;% 7&!U[D\8]9\1M>KX=OSIM];6-\8B(+FYQY<;G@%L@CK['
MZ&@!/$.OVOAO3%O[R&XD@,T<)\A Q4NP52<D8&2!GW%:M>#/<WTO@/Q/I-_-
MK5OJ]E/I<=S#J%U]K2*1KA<2PNV25< -M/ (XSFKQN]0T#_A96DMXGUAH+$V
M MKN=UFGB:X'SA.452Q; (VA<ANU 'M=%?/NJW6M^'/"/Q!L;?4+RR73_P"S
MI+../4GGDMA))M=?-X(+;=Q"\#<1DBM3Q#::U8>+=,\$7.O7D]EJ[RW_ -OO
M)Y(/.G*LIMU:/ " @.$'&YU'H" >W45XE?Q^(UT:P\[6AXLM=)BF^W)IFHFU
MN 4P5F5E(,K1C(P2<L.<MFO5_"TZ7/A'19XY[FX26P@=9KH_O9 8U(9^3\QZ
MGD\YYH K:[XKM]$O%LH]/O\ 4[XVSW9M;!$>585(4OM9ESRP  R3S@<&MN"8
M7%O%,J2()$#A9$*L,C."#R#[&O)==@72_C/J6J0I=W-S9^$YM1BB-U+\\JS-
MA,!ON$<; -O?&>:I:?JFJVFG^!_%L&J7$U]X@U&&RU.&64O%*CLV=L>=J;-I
MP5 QGG@D$ ]KHKS'X:Z%+/>7>N7'B#7KF2SO[RQBM[N\$L9B60J-_!W-POS;
MOX1V %2_'.^O=/\ AK/-8WEQ:RFYC1G@D*%E.05)'.#Z4 >DU$US MU':M*@
MN)$:1(R?F95*AB!Z NN?]X5X;XGTJYM_'%CX*D\47?V*2PGU!)M0O6C+SR2-
MPQCVA@H0LHQU+=CBK7A;3[75?'WA[5-5UJ34;Q-*N#]N25H%N)(;P11C:",C
M!QCHV 2#DY /7-'U==8@N)5L;VT$%S);[;N+RRY0X+KR<H>Q[XK1KP_Q!+?'
MX=ZA''JVI1.GBV6V$\=TXD,?GLFTMG) !Z'C('I1XDT2YC\2VW@B+Q7/%!;Z
M.U[:7&JWCJ_GO<$%B\93>RJIVALXRW!% 'N%%>-Z397GC/Q"MK=>*=0GL[KP
MY%---:GR%G<SR*&52N4'R D+M)Q@Y!(JOX3COK:;P%KZZEJ5[?ZM;7$-S#-<
M_NYECMW:-<8PO,:?-U)R3DDF@#VRBO / D^H:O?:'XIE\3HFI7&I2PWUBGGR
MS3;G/[HQ&38J*@W9"@(HR<[:@TZWN[3PY9^*AJFIW%_;>)?LL44ERSHT1FP4
M8')8G)^8\\CG@4 ?0$=W;S7,]O%-&\T&WS45LE-PR,^F1S]*FKS3PI9:#X?^
M(?C6X:X2U>*:WC4W%ZV LD43'(=L',A4 GD9"C .*]*5E=0RD%2,@@\$4 +1
M7S[XQU@-XRU;5[#5KGS;#6+.V!GN7B\C:=LD<46[:\>02S,!U. >6*^/K*7[
M)X_U>VUS5 -.O;*:S2*]?RP9DBW'KR,2?*,X4#C )H ]VU2_72M)N]0>&:=+
M6%YFB@4-(P4$D*"1D\=,TFDZE#K.C6.J6ZR+!>V\=Q&L@ 8*ZA@#@D9P?4UX
MQJE[!XM\2>)['Q#J4UL++0H)M/2.Z>",,T'F22%0X#,&?'0C:,'I7J'@_5K6
MX\+>'8)+BUCOI])M[@6JN VPQKEE3.=H/&: -B]M[8J;N6Q2ZGMU+Q@1JTF1
MR A/0Y''(YK-;Q,D&AZ5J%WIUY;W&HO%%%8OL699'&=I#, " "2"<X!XSQ6E
MJB"72+V,RR0AH'4R1,RNF5/*E?F!'8CGTKRG4-(L];\%_"Z34&FN9)9[2&24
M3LC,KVSLP)0CD%1@_>&#SRV0#U#1=2GU2Q::YTRZTZ=)6B>"X SE3C*D'#*>
MQ'6M&H;2UBL;*"TMPRPP1K%&&<L0JC R223P.I.:\GM(9M(^(5O>:E;Q:C::
MGK-U'::K;S.TB$B2/[+,K\;$VL  < ID#K0!Z]17SQI&M1OX#^'44^I%=8@\
M3)#<1O<$3>49G+AU)!*_ZO.<@<#VKH?#3Z1K5VNN:IK-S:^*;+Q ]JX$I\QD
M:4(MOY1/^J*E<X'&&.>&H ])\)^)X?%FD2:C!:S6J)<R6_ES%2P*'!SM)'Y$
M_6MVOGSPMI$-M8Z?XD2[NGO5\7"T6,SMY4<<DNQUV9QDAMV>N<=NOT'0 5%<
MW,%G;27-S*D4$2EGD<X"@=S7S_%I;VV@^/\ Q'#J^K?;-*U6]L+=/MKN(H&*
MJS$,268*Q()()*#G(!$VHZ3I<7A#Q)=Z3K>G:E:7^C"Z-I86+JD3QE569R\L
MC)(59P0<%BKD\JU 'M<NL-]NTB*VL+FYM=0#L;N-?W=NH3<I?/(W=!QUK4KR
M%;6PC\6?"R.PN)3;2VE[&5CNG9"5MSDCYN'#.X+#YNQ/R@#@=$L9--^#>H^-
M++4M0AU)I)+*66*X)189)T#,J-R6Y..0<L6SD @ ^G**^<]?T^SMO!WBB;1O
M$]M=6-S80SR6>F0M%:PR>=& 6<S2;9&5G!C.-^<XRH(T_%'@+2K'6?&%LEWJ
MDEL/#G]JM#+?.RR72F0"1^<N<Q[OF)Y9NV  #W:.&.(N8XT0NV]]J@;F]3ZG
M@4HC02-($4.P"EL<D#.!GVR?S->"7>I)J4O@?3]9U.RMM(N/#2>5)JEM)-#-
M>':C[U$B L% *LY*@G(Y((TV\-Z?KM[\/M*O-8N]3L9+._CDN!(\/VV.,IL!
M 8G;@GOD@?D >QSWEM;3VT$TR)+=.8X$)YD8*7('_ 58_A4]?._@IM/U/PW\
M/7\11V<]G!J%[:%[]59-GDN8T8OQ][:%'LN.@KZ%A:-X8VA*&(J"A0C:5QQC
M':@!]%?.D5U=77PZO?%&Z0^/;776@CD1#+-YK,H\A5.04"%L)RHQP,YKM_#_
M (.TV_\ BCXGU&6XO"VFZI%<6\*W1:(2/ K,Q4]\MCV  ' H ]4JGJMY-I^E
MW%W;V4M[-$FY+:$@/(?09K)\>1)/X%UB!]173A-;F(73;L(6(49V\X)(!QZU
MY3<(D'P\\?:5<:38Z?J%M:6TMR^E38M;G<"8Y8U4#9E4&5Z'KCYC0![K"SO#
M&\D9C=E!9"02IQR,C@XK+.O(/%Z>'C;2"1[%[T3DC:55U0KCKG+C\J\/U?P]
MINJ:SXMEO3<2O#X4BODC:ZDPTRQ95R-W.T@8!^49Z4LNKZ\=)\.7U@BW,W_"
M)R+>Y<+*;59HQ(8RP(,FU>X/<X)P" >YZIJ=Y87>G0VVD75]'=3^5--"Z!;5
M<??8,02/H.@/? ;3KRV\M_#ZZ3\-[[0(E@T_^U(8[8(^T;)(7+!P#AGW(N2<
MG<#SDG/F^O:#8'P?X\\0/>W:ZGIOB66WL5^UMMC'F1KPN>6*$C/7"#T- 'TS
MM4,6P-Q&"<<X_P DTM>"^.9K+4_&OBW2[B?3[B]FM[!=+NKFZBM_[-;!<[6D
M96YR')B#YW 'T'MNCV::=HMC9(X=8($C#@D[L*!G)Y.>N3UH R-<\47.G:FV
MF:9H\NJ7T=I]MEB298]L6XKQG)+'#8&,''45O6DSW%E!/+;R6\DD:NT,A!:,
MD9*G!(R.G!Q7 R:%H.H?&B^6\TK3;ESHD$[":W1SYGG2 N<C[VT(,]< >U>=
M>&=2TV]T3X4VK7-G)?07\Z20;T,D:%W RHY ;"]1SQU/- 'T36/XIUY?#'AN
M]UE[62Y2U0.\:,%)&0"<FOGN#1-+@\)1>+XY)%U:W\5!89VFRBJ)<X"_=Q_%
MR,\>G77\6/H6J>'/B)<>(!;CQ%::LT5HTPVSK"NQ8!&,9V$!NG!Y8^M 'T+1
M2*RNH92"I&00>"*\:UVUTK5K+XE2:TL;:SISO-923866WB2%&@,1ZJ"X/W>&
M)YSF@#V:BO$=(\.6_BSXF7*>)A.=1CT;3[N>)9V39<@*6)0''!XQC W$XR<U
M[=0!R]IXLN=3U66+3=(:ZT^WU&33KFZ$^UXG106;RRO*!B5SG.1G!!S745X&
MVE:)8> /&VHQ:=8Q367BAX_.BML200I=PG8#C(4+SA>,=LYJ]XEU/0-:UOX@
M"PU""XMY/#"RRM%,#'+/&7V%2.&QF-<C."2.O% 'MNY2Q7(W 9(SSC_(-8^J
M:\=-\0Z%I7V4RC599H_.\S B\N)I.F/FSMQVQ^E>(:)IT'A/4- U/PZDBZC?
M>#Y[IU#M+Y]PL0<#:2<_,!\HX^4<<5J>&9_""ZQ\,+G3I=-&K21S+?2Q,OFM
M*UJ0XE/4L9& &[DD_+UH ]R$B,[(KJ67&Y0>1GIFG5X1X%33;+QUX:\W[%K#
M7ZWDVFZQ&[)>Y*;W^V*?OM@LJDDXR<>WIOQ)N(+7X=:Y+<K<F'[/M;[,VU_F
M8 '.&P,GDX.!GB@#J$D212T;JP!*Y4YY!P1^!!%,:Y@2%IGGC6)!EG+@*!C/
M)_$?G7SS+%HDVA_$JP34= 8?V=97*C3W,=N9$#$^7EVWMN,:EA]YF (!8BI-
M9T72O"6H^#S)=S6WAW4X6GN9+D?:[=KEH54-)&V01@C&1QDD< X /H965U#*
M05(R"#P155M3LEU>/2C<)]OD@:Y6 <MY2LJECZ#+ #/7G&<'')_"NRT[3_"#
MVNCZC=:AI<=W*+6XFCV*R\;A'W*!]XR>K!NHP31UJ#0X_C1I<VI0Z8)Y=)?[
M,UV$!>Y$\0BVEADR#G;CGKB@#T+SHS,8?,3S0N\IN&[;G&<>G!I9"RQLR+O8
M D+G&3Z9KPG0TT^?PAX1U329+1?&(U5(KJ:64"YD=I&$RSDG>P*Y.#SC&.U>
M\4 <]X2\5P>*=(6\\D6DYGG@-L\H9LQN5)!XSQM)QTSCWK<-S +D6QGC%PR[
MQ$7&XKZXZXKYPLM!T.3PVNLVYD'BI?$?EVWD3N967S^5$8;@;=[9 SQ]:9 V
MF:IK6M0^*]9N+/7K;Q$)H8H[59+F7Y@D:1R'G8"3A<[0,$4 ?2]%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% 'GOANSU"S^(82[>V>
M(:5,D)0D,$6Y&T8?+M\I!8ECAGVGH"?0J\X\.+'+\6-0NK22..!M.=9;5?E*
MN)457*%04SLD."3USU+8]'H **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@!DT4<\,D,JAXY%*LIZ$$8(K!L? WAG3;>[@MM(A$=W";>8.S2$Q'/[
ML%B2J<_=& ...!6]-+'!#)-*P2.-2S,>@ &2:Y;3_B)H6H:@MH?M=KYUH;VT
MENH3&MY !DO%_$> 3M(#8YQCF@";2?A[X2T22233]"M(FEMC:2;@7#Q'JK!B
M<YSR3R1P20*=8^ /"VF6-_96.C06\%^ACN1&6#2(>JELY"^P.*Q=:^)T.G>%
M-8U6+2-0CN+"W@F6&[C10RSDK#)D.<H6&#@[AR" 0<7=7^(^FZ,[QS:;JTTL
M$"W-W'!;J[6D+$X>0;N!@$G&2!U H V+3PIH=C?6=[;6")=65L+2WEWL6CA
M("#)^Z,GBM#4-/M-5L)K&^@2>UG7;)$_1AZ&O.;GQ]:^'/''BA[V?5-0M?L%
MG>6MI:0M,(X@K^:Z@85%Y0EF(ZCG@ :<NOQZQXG\$ZKHVKSOI>I&ZC:%3B*8
M+"[<KC.Y67OTVF@#:'@3PP+&2R_L> P2R))(I+$LR9V9;.2%R<#.!G@"EN_
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M"WQ%\<7%Q9:G?VMO;6<S6JSJRVJF-2QRS< -(>$XY)Q@9 ![0JJBA5 "@8
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MP4?* 20#K(],L(KLW<=E;)<G.9EB4.<\GYL9Y[TXV%FUZMZUI ;M056<QC>
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M. <4 >;:1X)\:0>)?#>MWMEIDM_IUW>)>W<ET3)=I(&"RD@':F/E5!G:6SM
M+!7>'O OB?3/#W@:TN-.M1-H^KRRW.RZ&1"S/^\/&&//0'.-O')V^P0RI/#'
M-&24D4,I((.",C@\BGT >87?A3Q++X)UW34L+,WESKS7\*_;2%:(W"S==G7C
M&#]>H .1XD^&OB>]O/&%MIW]GO9^)#:S-/-*RF!XI,[, '/7.[T'3/%>S44
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M8I%NV1[W+;%W$G ! Y/.,\9Q6]0 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %1PSQW"%XFW*'9"<8Y5BI'Y@U)10 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110!PVA79D^(4]M:RF2QCL)/F X9A,J9+
M_.^Y9,[MQ&<@J'(/<UPFC&6T^(,_VQGE^UI(+1HB-B9;=('5AO4_(F "1UX'
M!/=T %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% 'F^C/]K^,=Y.EKY6S2U%Q%(>8Y"^X'*C!;:_1OF ?@A3@^
MD5YQX2NL^/9+.% +5;":1'5F8,3.G.XM\PYR-P9AEAE1P?1Z "BBB@ HHHH
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M7=9U[2O#UM#<ZO?0V4$TRP)),VU2[9P,]NA.3P #FO'_  #I$LNH>';._P#
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M'\*^/-#\4I_9VF:Q#=:O!:K).OE-@-@ MT 8!B,[3W[55\+>,53P5I]_XCU
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MN/HE>8Z&]CJ'QCN9Y5:XO+:SF\IB$*Q@R!&D!.#T4*-H)"O@L0:].H ****
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M5L44 <$G@K7[\B\US7+.ZU*TL9+*P>*T98U\Q0LDTJ[LM(P 'RE0,=#GC?\
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M^SQHQ= BY;G>6).>1@< 5VTUW;6Y GN(HB<8#N%ZG Z^].EGA@7=-+'&/5V
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M"0ZRNM*Q>(M]H P/^6>-OMBK'_"N-/37;O4(-4U2"UOY?/OM.BF"V]S)QDL
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MLOL-N%;*B+&%R#GE1N /7#'.>,9'@7Q5K7BV&WU43:')IMP',UI;RN;FP/\
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M&;D!> PW*5W  Y#!%.#@&H-&UC2I]'^'MKXHO8'T1["??]JD#0O=)L"+-N.
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MJOXD6ZT2QGMS<3M$)&6.7>ZKN4.RG&._)Q@$TKC6+:]^%44V?[;33=1")<2
M-YAM@(PQ.<9.T<YKVPPQE44QH50@J-HPI'3'I3MJE@V!N P#CG'^0* /"/AM
M;^';N_T#4)=<U5_%<1D%S:+;HKL['Y_/<1!F7 +9D<GT.>#[3HNM:?XATB#5
M=*N1<65P"8I0K+NP2IX8 CD$<CM5X*H)( !8Y.!U-4M(TJ#1=-2QMVD=%=Y&
M>3&YW=R[L<  99F.  !G  '% '#_ !'BT*+Q1X/O=?MK-[$7-Q%/)=0"12#
M^Q3D'/SX('KS7":UI_AV[T'XBZX6MWU&QU/_ $.3S"# 0L>PJ,X!+!AC&3LP
M<XP/H JI() )4Y&1T-+0!X/XO'AZ_P#B'XAB\6:IJ5I"\%G-H\EM''(9HP@)
M%N[1.RGS,_<9=V3G.*]OTY533+15$P40H )Q^\ VC[W^UZ^]6"JD@D E3D9'
M0TM 'SWXCL_"UQ\5?B GB1K9%%A"UHLDI1C,8$P44'+/GT!/)]34N@>%;'7_
M !QHFD>,+,SW!\(QO+%<.8Y?-%P=N2I#;Q'Q@\X&#WKU32?!TFF?$#7/%+ZB
MDW]JQ1Q_9EMROE! J@[]YSPO/ ZUU= '@FF0:#J?B74+#6M3UJ+Q/;Z_+.EG
M;11[Y&W_ +MXY6AWB/9M&"X&%S@ BH_$\._4_B[!HT:-?&'3A%':J#)Y>T"X
MV@<XP2'QZ\U[_10!\]I#X.O/ WB?4=(OM9N(I=&V7*/;Q0V<,ZE#$A"Q1JTH
M; # 'Y=W(R,W]<TC0/"<GA35(I)M/\,W<+27-_;0K<$W#1*(Y'202J-R[L%0
M3DMSSFO=:* /GX:!X5/B+X<V,'G7.AW,U_Y,E^ KW$9560%=BD1F5G"J1@Y)
MZ-4T5[8Z5X?TV129_">F^*[R.Y2$F:**$,QB+ 9)0$AQU&<'J17O=% '@_B*
M\T& >'M<TB74[3P<VJ7L]Y=1VV]//DB4(Z13(PV;C(H^3 ._')!/I7PWMM(M
MO"@&@W.H76FR7$DL,U]&(R^XY)0!%^3.<?*._:NNHH \V^*"6D.O>"[Z^A0V
MD6IE)Y7BW* 4.%/!ZGH.]8>J2:;+I/CS3]:@C7Q%+<SSZ;OW?:+E=@:U,.0'
M.TJHVKP"ISU->RT4 4])2[BT:QCU"3S+U;>-;A\ ;I HW'@D=<]Z\UU0Z,OC
MOQG:^+(X@MY86_\ 9;7(5S+"L3"1( W\0D+':#DE@<<9KU:B@#Q2QT6QU?6O
MA]I_B:SCN=2?2+K[:ER,R2 +&8Q(W\1 W$ DD'G@U[7110!X-JZ6MGI_Q8M6
MMQ#=N_F1#R2#Y153D''"DX/OQ6KKNG0V'B"_L? T$=K=3^%Y&06!$;O)YL91
MBW!,FPN02=QSGTKV2B@#R?X6CP]>:K!?Z7'J2ZG!I0L=0BEB,<5HZ-'^Z/[M
M5+YW<@YPIR,FNV\?;/\ A7GB,/M^;3+A5#=V,;!0/?.,>^*Z*FF1!(L9=0[
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M>7$5O;Q#=)+,X1$'J2>!4D<B2QK)&ZNC@,K*<@@]"#0 ZBBB@ HHHH ****
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MP3C)'.,FEXN\.Z]JWB30=0TR?3Y+.Q,IGM-0+^678 +*$08=E&[ 8C'8@DD
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M:,MAL_+7>UYUI=C;I\3H)W$RWRVUTLN+MC$N75E4 ##,06.&(SMWD;D&/1:
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M4KH0=O[IHSR.X&,5+?Z-HJ0_%2(QHD6DS02:>GGL%@E8LI91G&XE47/7MWH
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M.,JP(S7@OC4:3<S^,[O0'L)/#_\ 8,7VI[4H8&O_ #_W9!'RF0)Z>H[FO5O
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MA?N@Y)XQ3K[Q[;VNJ2V]MI.H7]G:W*VE[?6RJT=O,V,)C.YL;EW$#"Y'.>*
M.ACT?3(1"(M.LT$)S%M@4>6?]GCC\*D73K);O[6MG;BYR3YPB7?DC!^;&>E<
MOJGQ&T[1]/UV\O=,U-%T2>*"Z0+$6/F;2C+B3!4AU[@C/3KB+7OB*FBZCJUA
M%X?U6^FTRWCN)6@12FQMQ)+9^7 4D9Y/.!P30!U']BZ5B0?V99XE</(/(7YV
M P">.3@GGWJ233+"6XBN)+*V>>$!8I&B4L@!R IQD<\\5S.@?$&UU_7H-/CT
MK4K2WO+/[78WEW%Y:704C>%!YX#(0>X)Z#!:)?B7I@M-#N)K"_C76M1?3[8
M1ML=93%E_GX!(SQGH?;(!U;Z9827$EP]E;-/* LDAB4LX!! )QDX(!'THETR
MPGDEDELK:1Y0%D9XE)<#& 3CGH/R%>;Z'XC.@ZGX^O+K[9>+%JZ100AFD.64
M84$D[5&?HH'L!5+Q7\6-3M_ .H7^EV$=KJ]G?K977[]+B* $;ED1QQ(&&!C
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MDN$@C6>0 /($ 9@.F3U-5='TBUT/3Q9VBD)O>1V8 %W9BS,< #J>@  &
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M !1110 4444 %%%% !1110!#=JSV4Z)%',S1L!')]USCH?8UY#9_#368]/\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% 'F=HAM?BK81WEG;)=7$;N'%VZE=L;#"(2 XP>4_>; 5(P"=OIE>617=Q-\
M:;1KDF/*&&!HT53)&$N"RLQ8L5W_ #;.?F5> 8VKU.@ HHHH **** "BBB@
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MD22T\0B.-V90OEK$I<G..-WR+QC/8 '5?#R62*+Q#I+2%K?3-9GM[11&56*
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ML6)88^;DL.<\,PZ$U"?A;X<6XU"6V-_:&]N5NG6VNVC$<H.=T>/NG//'T&
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M>3?*20%'RH0-P('';@=3-K'BKP_87UIJ%Y]F\_4[&*RN+BXBN)K6">3:Y?Y
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M?0@C.:X[5K&WC?PC-K]OXABTB_\ "UOI"2:8&5S=9R8G3J=PQ@$$,0,!@"0
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M?NAB5! QPC=R" #TF-Q)&LBA@& (#*5//J#R/H:=110 4444 %%%% !1110
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MD":&.56>(D9&Y0<CCUJS7EMUXIN-&UKX@W&G^&;-K_2_L;230%G>=)%SODP
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MOPKHT6E:1;""UC);&2S.QZLQ/))_P P !6K110 4444 %%%% !1110 4444
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M^I7VGVCE+N].YW8G@MZXR/R&:P+9+W0_$_ABUM=?U.6+Q-;7'VH7<_G/'(D
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MMY+C$)_Y:'RP<)[UYMJU[/\ \)7\2-'M_"U]J\FHI;0K);QJ8PQM  LC$@J
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MD)<&$/LR-N3G=VQVSTK'T+XHZ!K^KVNG0Q:C:R7D!GM9+RU,4=PH!9MC'KM
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M$P.N3M&.1@=0*%IX&\3:7XK\)ZM;?V;+_9VAII5T&E;:I0-\RG:"=V?3CWH
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MEVS,S')),2Y)-<M<^"_$,VL^/KI7TQ;;Q'8K;6Z&=]R,L1B5G_=\##,2!GG
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M .WN;:&\M9K6X0203(T<B'HRD8(_(UE7=YHW@KPO+.4^S:7IL8!C@C9]@R,
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M4,<$2Q0QI'&HPJ(H  ]@*XSP3XLN/&EPM[;O)'86EG%'<*8UQ+>. SKGJ/+
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M#<78O9;-KEA;O.  '*#&<!1QT/<' I\_P_T*[U?7-2NXYKB76H!;W<<C_(4
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M)"ZL.A#HP8=3WK%A^'OA>WNK*ZCTU_M%E<R7<,K74S/YTA!=V)?+L=JY+9X
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MZ?LAM8#;1QP320KY1ZQL$8;U/=6R#DYK=AACMX8X88TCBC4(B(H"JH&  !T
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M$#')% #K[X<>$-3N#/>:';RRFT6RW%F'[I?NC@_>&  WWA@<\59N/ _AJZ,
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MP3F@#L**9#(988Y"CQEU#;'&&7(Z'WI] !1110 4444 %%%% !1110 4444
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M>W&DW;F2S$JIYD,J&.0KN(4NH((R0.O/-=-=WD%C;2W%PY6.)#(^U2Q"CJ<
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M3ACTBQTR#Z;5#3-$TO11<#3+"WM/M$IFF\F,+O<]2: +]%%% !1110 4444
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M6#X8!NCC+8QM/.WDX.36]H/A>/0-0U2[BU34+DZE.;B:*Y,>Q9" -RA44C@
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M[8DSKM0888CVJ,</C)R>!SFJFG?#'2-/V@ZAJUTG]G-IDB7-R&66W((5& 4
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M,L X.&(R"1U?9>/O$NE3>&;WQ'+ITVG:SI-Q>&.TA9&A$,"S[V))W,02-H
M[9[[]E\*-&L)X)X=5UPS16!T\.][NS#V4C;C QPH 7U!K1_X5_I1N/#TCW%Y
M)'H-M):VT$A1HY(WC\MA("F6RH Z@<4 >:ZAJ.N^(+SX;Z_?ZA"L5_JRR1VE
MO;A?(7/3>S9;*C!^IP#P#Z)\3YK^W\#SRZ?>FT?[3;QR,$#%XWE6-EYZ??\
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MCU1BIY&0#GJ,#!%-A\&:+;:MI&HVL$EO)I-NUM:QQ2$1B-@00P_BZYY[\]:
M$\376JZ5\/\ 4[V&[A75;/3GG,XARC2(FYB$)X!P<9)QGOCGE=+U+QE%XETO
M3]2UJUN+?7=.DNH7BL5C^QR($)51N)<8<<MZ\>E==XU@N;OP-KUK9VTES<W%
MA-#%#%C<S.A4=2!WSZ\<9/%9^D>";2+3[>6[EU$W_P!@%JLDEXS26@91O$3
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MK6MJ\GE+("DD@4Y!^HZ$=QWJUIW@/PUI.MMK%CI@@O6E>;<LTA0.X(9A&6V
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M"9057<CE=NW<P&<^IZ=76_Q=\)_V-IU[J%\UE/>VGVD6S02L5PN7 ;8 <$$
M\!L<5Q)\)ZFV@:MIVCV6M_9)=#E5;+5(P?LEP7B;R;>1OF*LJDD*2N57)+<+
MJ:5:ZI-J?PKN'T/5+>/2-/N(KWSK?!B)@6)20"<9920/O8(R!0!U^G?$_P (
MZMK%AI5GJHDN[^+S($,3J#QD*21@,0#Q[8ZD9GO_ (A>&=,\21Z#=W[)>O(D
M/$+M&LKXV1LX!"L0<\]!UQ7 1:-J+>#?!EG%H]['-9^*Q>7$9M74I )I7\P\
M<#:Z>_8=*;?Z'J1\1^(-(N/!#ZS+?WS76GZA=RD6:(_4S$'HAQA0-S#([ D
M[:3XJ^#8M4&FOK""[-\U@$\MO]8"H))QPF6QN. <-C(!--MOB5I-QXZU+PXR
MR0QV$!DDNYHW1 Z;C)DE<*BA?OL0"<XSP3S.IZ7J,OAGQE&FC7KW%SXAAO+<
M"W^:6%7@.Y?7B*3CKR/6I]>L=3A\>>)+J/PS/K%IJ.AHD*%0(792<HY)&#Z
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M*R'"%W7A=V.!U/'J*YG6K#6X]6\>6MOX8?4?[<2W%E([H(9,0"-][$_+L(+
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M@*2"#QTJM?\ A_QG9^';[PROA62],&MKJ=K>03+Y<L9?)7GD-DCMT+$XV_,
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M$XQP,#C.,DD]]10!7L+./3M.MK*%I&BMXDA0R-N8A0 ,D]3QUJQ110 4444
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M8&-P&<<9P: .%\-:S#K?V?6M0\2ZAIVM1:Q+#>:0MP9=J[VCCM1 !MP 8R9
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M"O7Y=#TF<W1ETNRD-V,7.^W0^<./O\?-]U>OH/2H[KPYH=Z]N]WHVG7#VPQ
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MFX#*MM;'?CD#BJGB+QSHGA>Y\C4I+D,L2SS&&V>18(F?8'<J.!N!'KQTKF/
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M:>2%D"@%F\PL&7!/"MT&#Z 'H%OXM2/1]$DOK6X?5=1LDN396<#2,ORJ7/\
MLJ"X&6/4@<FHIOB'H"6NF2V\ES>2:D\B6UO:V[/,S1C,@*8RI7N#R,UQ_ACP
M9XC\#WOAW4#;MK7D:5+IE[#;3HKQ;IFF5D\UE5@,JAY' ! [54O/!WBM;G2M
MVC1WNDRZE?7][IL-ZL+(9F)B5WR,JN1D+D'!!##% ':W?Q-\,6FEZ=J1N;F6
MTU&.22VDAM9'#; 2RD@<-\I&.N?;FN9^(GQ'A/P_OKCPW=7R7H@M+C[1#"<6
MZRLK*)&(^4LF<#W'J,U_!GA?Q/H]CX&LK[1&3^QKN[:YE6ZB8!)5E ; ;/\
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M% !1110 4444 %8WASPIH?A*RDL]"L$M()'\QP'9RS8QRS$G\,ULT4 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !6?J>AZ7K+VK:G8079M9/-A\Y-P1_4 UH44 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% 'F5T+<?%W0GA$,.^>Y4
MHJE][+#-N);HK'*D>H#KD%65O3:\KN9YKKXN>$Q#;SQ6T9NBT;Q$>7B*88/S
M$#!<@X ^\HRV :]4H **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHK#\1:#9:TD;ZI>W,6FV\<C301W3VZ.?E(=V1E.%"M
MQG'S9/04 ;E%<5\*_M)\$1O+<7MQ:M<S&PEOGW3/:[SY1;_@./3V&,5D>.;?
M2]!U31M4ENM7COY-8@=K_P Z401Q-(-T<FWY FP% N,]">KD@'IE%%% !112
M,JNI5@"I&""."* %HKQBSU#5? 'BG4=7GGFG\%S:B]E<1;FD_LXC 20 GA2S
M8./U.T5O3^)H?"TGB+5;6TCOH;C7K>URMQM 62VMSE3A@1ND=L<<L: /2:*X
M35OB,^ER^,(QHYF;PVMN[;;D*)UE0N#RORXQ@]:SM3^*&M:7?7MC-X*E^U6V
MF?VKL;48QBV&1(SG!VE2,;1N)]A0!Z664$ D L<#)ZFEKPSQ-XK_ +3\:_#;
MQ%I6C/-?75M.Z6QN%B9]Z[50N0<*"7.2.03WKIHOC#!)IZQ-HMQ#KXOGLI=+
M=G?RRB[G?=&CLR*O4JA.>V/FH ]-HKS)OBMJ M=*<>$+O[5?W\FGBVDF,3+*
MH&"-\8)0[NI"XPV1Q7H>FW,]YI5G=75HUI<30))+;,VXPN5!*$X&<$XSCM0!
M:IKR)$A>1U11U9C@"N&O_B+(MAJ^JZ-I":KI&CW)M[V=+HQR90*TK1H4(=4#
M=2RYP<9'-<OKE[+XK^+V@6#65AJ.A7&C&[MX+B<A724$-*1L.'P,*/0?>&2
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ML_#/C/PC-X=T2 S37]RPM(2D$8)M2C,.,*-JJS8'.SH35^W^(TL7AC[9J&G
MZHNKOH[6MKYDB&96;)!5&<KL4MPI/&,4 =_17,>"_$>J>(;*Z_M;1;C3;BUE
M\G?)#)''=<?ZR-9%5@IZX.2,X)S2>-?%J^$[2QD98HUN[CR3=7.X06_RELN5
M!/., >IY( H Z5IHUE2)I$$C@E$+#+ =<#OC(I]>/^*-5U-/'_A[6--L;-]2
M?P]/-Y<ESNAC. QS(H_>*N3C&-W8C.1JW'Q-OK[P;HFM:1I]G:MJJS9EU&?,
M=LT38*;5P\S.58*%P>Y& 10!Z717F5]\2=;NK/PG_8&AVLMYXBMKB:*.YN3B
M-HHBVWHH(W%3G(R 1@$@B*[^*.M2O/+H_AF>[73;DVE_9+!/++)*%&]8I8XS
M&OEL3G<?F XVY7< >I45Y];^/+^_\<R:)$-,LA#,D3V-^72\E0JK&6/D(1AB
M-G)^5FR>%KO9YX;6WEN+B6.&")"\DDC!510,DDG@ #G- $E037MK;S1PS7,,
M<LIQ&CR ,YSC@'K7GP^(>K6:Z'K6J:;:0^'==N$M[;;(WVBVW@F-Y.JN& +8
M4#:#C+8YQ_!-M=:_\3_&R^(([/418W%J(S(K'R"C2-&(@V=H!R2,C).>YH ]
M@HKGO&?BRW\':&NH30F>6:=+:W@#%?,D<\#(!P, D\'IT-<R/&OBJRTG7_[2
MT2W6YT]8FMM0*26]G.)&"EB)<,/+SEANYVD97@D ]'IDDT<(4RR(@9@B[F R
MQZ >YKS/3/B-K5SIM[:36-D^N#4UTVS=4EAMI&DC,D<K*^7";5+''48P>0:H
M_$)];N_!4:ZYIUDFJ6FMVT4%Q"2D,ZLRL&4MED'(4Y)Y4GV !Z[17$^!/%VJ
MZ_JWB/1];MK.*_T:Y1"UD6,3(X.T9;DD%6R<#.1P*UO%WB8>&;&R9+9KB[U&
M]BT^T3("":3.TN<\+P<XR?Y@ W99HX(S)-(D: @%G8 9)P.3[FGUY7XQG\3W
M7P^UF'Q#IEC#=VM_9_8KR YAGS<1@,$W,Z8Z')&0W'>G?$/XFZIX-UAX[>VT
M^2TMO(>6&7>T\Z.3N*E2!&!C&6!R2/I0!ZE17!7/C:^'Q&;P\+C2;&&*6)/(
MOA(+B\1U!\R%\A.I*[>3E#W.!6\+^/\ 4O$'C2ZTR<:;8PPSRP_V=,KK>[57
MB0%B%=20<A5RN1UQNH ]&HJAK>K6V@Z'>ZM=DBWM(6E?'4@#H/<]/QKD]/\
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MP:MIMS,L-OJ%I+*WW4CF5F/?@ U<KYJT?PW>^)/AWX@TO1_#HN[]_$<IBO\
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M/;LRD,?O*58_(AP H(Z8'J->4KJ[R?&71[&.UCV.;IFFB8,S(!*07.#E2QP
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MR,YW>@P;=U:R""'4[&V\31^*4U)]1:_;PW*(R74(\04#(CV@#!)/!]>/>:*
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M0#)'%=6]_9QW2VKW<"W#=(C( Y_#K3=1U*RTBQEO=0NHK6UB&7EE8*H_SZ4
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M#-)<R2Z)IKO=($N&:U0F91C <X^8#:O!]!Z4 >*>*M3T_4] LY-4NK675?\
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M1V(QVKK5L+-//V6D"_:,^=B,#S<YSN]>IZ^IJ2""&VA6&WBCBB7[J1J%4=^
M* /&O&VJ:/I/QD#>-E$F@7.B/;VGF1&5(G9AO("@LK$!EW 9^8<XZ;MQ>V6F
M^*? *".>W2+2KQ8;2X(^T[=D(C1E)SYA"XQUR".U>CSVT%TJK<01S*K!U$B!
M@&'0C/>AK:![B.X>"-IXP0DA0%E!ZX/44 >!?#[7-#@\1V%['<1V5G-H5S9P
M^5"1*)5EC<J\I7$LY!+G  &Y<*,Y+-)DTH:1J&@3ZEH]W8MHEQY.O6'_ !\P
M0M+'E;J,'GYF3IDX4^K&O?XK2V@(,-O%&1NP40#&X@GIZD#/T%1PZ986R.D%
ME;1+)C>J1*H;'3.!S0!PGPRO5NM1UN%X]'N;JUBM8I=7TAQY%\,2%<JORK(N
M6W8Z[AP %J?QA>VVG^//#DWB"*T'A]H+F)+BX?$<-VP4@R!AL'R*ZJ2<_,_3
M'/<6UI;6<9CM;>*!"=Q6) H)]<#Z4Z>"&YA:&XBCEB;[R2*&4]^0: /G>#3[
M>;4O#,.I00/HEWXHN6TB&[C(W63!=@4/UB/[O Q@Y'7(KZ#T_3[32K"&QL8$
M@M8%VQQ)T4>@J62"&9XWEBC=HSN1F4$J?4>E24 >":9?7]JVHZ-H,^F:U<WU
MAJ#6ES:PA+W3B,%HI@#P"^T*23EL<E0*SO UKX3N=%CU2TU759M0LM'EBU*.
M94AM+=3&P"2'RP'!DP47>22-QY4BOH6WLK6T:1K:VAA:0Y<QQA2Q]\=>I_.E
MCM+:+S?+MXD\XEI=J ;R>I;U_&@#Q&;3_"NG? S2-6@CL4N[O^SU:[=5#O,D
MRF0;L=5 E!]E.<XK-\76&CWGQ"\1V'BW5-9L[VZGMY-*BL[<2"ZCQM1$^0G=
MD%1RHW$YR<U]!""$0I"(H_*3;L3:-J[<%<#MC QZ8I## UR)3'&;A%P'*C<J
MGWZ@'% 'CDEY;:5\3&2TO-,U2*^UN))["Y&V_L9@ OF1L#EX\*&.> ,#&2V>
M\^)T#W'PR\1)'&KL+)W(8 \+\Q//H 3Z\<<UTYMH#<BY,$9N%78)2@W!?3/7
M%2T ?/\ :7OA?6;WX26<XLYK.*PN1>0W$.$WB!4W,K !AYL;#=R"4//%90N;
M >&?"\\VMWJ^'K35[]=0-D4D^PLY9;?:FT@)MW'HW^L;'4 ?2*00Q^7LBC7R
MTV)M4#:O' ]!P./84>1#Y!@\J/R6!4Q[1M(/48H ^?#HW@VTD\"6&GRS7^F7
MFM221?VH@+RQLJ+PI12(RX& 1R<GG-1^(-+T*U\8Z[X=UJ?6-/NKEH!I$5G#
M&\=Q"%1(8URA8$,I ^8*"#R"#GZ(:&-Y(Y'C1GC)*,5!*DC!P>W%*8T9U=D4
MLN=K$<C/7% 'B=Q)9:)=>-])\<R1W-WJ* Z:TT1D-S J$1)&VT9=3@<8._)&
M2<T_[;I^F_$;P':>([BW2^AT!8+K[4P<K.5& ['(W%@V"3U/OS[72,RHI9B
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M+9_\+.T")985N6GN)'$-R2'<M+M;"MMW;!)G>"0LI0'.TKZK0 4444 %%%%
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M>VV0*Q+$9+#&% ]:X_5]*D3X)C7UU;6#=S:#%+-YFIW$@>5Q$^_#2$*00W
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M%UB\LYM/T"_CO+>ZBD<S3",-Y4;(5"J%W 9#'(4# ZUCVWPQ\21^([#57ET
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MDUYS'J^L:A??"W6Y[!+[5YQ>[1#<!7F3RQRS,!M RQ(PV #@Y.#[1K&F#6=
MO]*FE*+>VLEL\B#E0ZE20#]:X?1OAQJNF3>#II=:M96\.M<($%H0)(I4"8!W
M\-@9YSRQZ@ $ M/\2UB\/VUS+H\PU>>_ETX:=&SS!9HF(DR\:,2H SE4)] >
MM;OA3Q%=^(;2ZDO=%N]+FMYS$%GCD595[.AD1&(/NH(KFKKX;7\^DL8M:CM]
M8@UJ?5[*ZCMSLC:1B?+="QW YY/;CK@[NM\/:?JUE:.^MZHM_?2D%FBC\N)
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M 1*H;CID=?4<4 8,WB+5--\;>&=/M;BTN-".C-<LT<K#S451F3A2#Q@JO?\
MO#/$R_$VZAAT?7;_ $J.#PSK$XM+5TEWW4<C,VQY5^Z%95)VJ6*XZDG:+]Q\
M.\ZCX;FM-3>*WTG3FTV9)(PS3P%57@\;6.#D\]>,54M/A:4T[2]$U#6FOM T
MJ\-W:6S6Y2?(W;%>8/AE7>>B+VZ 8H MV/BKQ+JVI6NH:;HUK-X9FNVLB?-/
MVL;7='N"#A1&&7&WECU[X'"?"?7[FV@U;P[H5O:7&JOKEQ=2QW,IBCAM%\I6
M;(!))/R* #@G)X&#VNE_#B]TN_N((O$TS>')[MKM]*:SC)+$[BOG')V[@#@
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M_4] T;6FC;5=(L+]H@1&;JV24H#UQN!QT%1Z[K-EX5\.76JW$,AL[*(,8K9
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MQ-X:G949R88"DL05E3H,#T%>6ZC8)8^'?$FB:O!=IK$6B)>>='J3W-K>JL@
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MGD!9I)6 '8 <D_A73VOQ6TW5K;2!H=A<7]_JB2O%9&1(641_?!9SMW<' !Y
M)H ZV+P]HD%E/9PZ/I\=K< +- EL@20 8 90,'   SZ4C>'-#>1I'T;3F=X/
MLS,;5"3#C'EDX^Y@#Y>G%<W;ZO8R^.+._NK;5+*]E\-&[ECF;$,47F(2K)][
MS5)(/ XXY[1V?Q,BO+[1(8] U%XM=61].D22',BQC+EPSC9@<]3GMSQ0 WQ%
M\,[?5+RPETJ72].MK2)XQ93:-#<VYW'<65#C8Q.,D'G KH_#'ARV\,:6]I;F
M-FEE,\IBA6%"Y 'RQH J#"@8'IDDDDGCM+^,5IJG]E7">'=4BTS4]1&G0WKF
M+:)6.%!4-GOD_0XW8K8;X@*NK0VO]C70MKC49=-MKEI8QYLT>X,0A.=FY&7=
M[=.: .K-A9M?K?M:0&]6,Q+<&,>8$)R5#=<9YQ3+;2]/LKB6XM;"U@GE.9)(
MH55G/'4@9/0?D*\_TKXH2PZ?XDU/Q%IYM;/3M6?3X?)=6)==J^7R0,YRQ<D+
M\W7BK^G_ !5T>^T_5)DADDNK"XAMOL]K(D_GR3'$0B=3M;<<CKQ@YH [B>"&
MYA:&XBCEB;[R2*&4]^0:KG2=-.G/IQT^T-BXVM;>2OE,/0KC!KA? EY?7?Q+
M\?+?0RVS(;#;;//YHBS$_0CCG@\>OM4WQ2UG4M/M-$TZSLFEMM5U6VLYY5N#
M$Q4ON,0((*[PNTMR-I8=Q0!VT6FV$ G$-E;1BX 6;9$H\P!=H#8'.%  SV&*
MB70])2P%BNEV0LP<BW%NGE@XQ]W&.G'TKBK'7K?PEI>IV^E:%J5SI^DDS7^+
MN-DLR461X8=S#=L4YVC '0')Q5N\^),1N[>WT30M1UG[38B_MY+;8JRQ;PA(
M#$,""PR" : .P33K*.[%VEG;K<A=@F$2A]N ,;L9Q@#\A3KRRM=0MGMKVVAN
M;=QAHIHPZL/<'@U6US5HM"T2\U2:*69+:,OY4*[G<]E4>I.!7*7GQ*73=/\
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MD<!B#M4Y;[@)X'X]>: .8T37O$UYKD_@75-5N?[>M]1%S<7\$*!38!%<;<*
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M=GJ4^GQO=V0 MI,D>2!T"@' 'L* /(/!^O>(?$267B6X\7P6$IU=;6ZL7=I
MZ22(L< @^ZI.& 8*&QN);J1-?0>((_"GBSQ(OC'6Q)IE[?VT%L)5\O8LFQ<\
M=1@G/;@#&#GU:+PAX=@UM]9BT2Q347)9KA85#%B<EO\ >)YW=?>A?"6@)I%Y
MI*Z7 MA>RF:Y@ .V5R02QY_V5_*@#S&_35M'O?#&GS^+[R6WUZ.2YE.H7CPA
M9(XHB%66,AT4EF.T$#.!]9+/5]17Q)X8\(:IXGGNK65[M)KJT9XVN)$'R0M-
MN5QM'\2DECM!ZY'INH^%]#U;2;?2]0TRWN;*V"B&&5<B/:,#!ZCCBH[SP?X;
MO]*M]+NM#L)+*W!$$)@4"+)R=F/NYQSCKWH P_A?"MOH>KP+/)<+'K=\@FE?
M>\@$I&YF[D]2:R-;T#7;;Q5JWB#P)J]M#=HZKJFEWA'V>X<1(X88^ZQ4KR=I
M/)W $Y] TK1M,T.U>UTJPMK*!Y&E:.WC"*7/4X'T ^@ Z 53U#PCX>U2\DN[
MW2+26YE&V679M:48 PY&-XP ,-GCB@#S>QM[+4_%G@7Q+9:=/;7%YHUP4LH[
MMT11"L?EQKR $^<\8VD')'6H--\1ZU?>!/#_ (OCU627Q!/JR6=Q9-<LD$X:
M=D$'E<I&VPJ=^W< ,Y.>?5[GP_I%W-ITL^FVSOIIS9'RP/L_0?)CI]T<>P]*
MBM_"V@VNI'4;?2+.*Z+F7S$B _>'@OCH'(R"V,\GGF@#@M+U1=4FO-4U'Q#<
MZ;K%EKK0FQCO&D4PK((UM_LX;:V\<!MN=S;A7%^&=4,7Q-UK1[R>\LM*O_$U
MUFZLY7C:2X5F\N!W4@JC;FZ9+$*. &->WMX3\/MK_P#;K:/9G5<@_:C&-^0,
M _7'?K5=O OA9[>YMVT*R,-U.+F:,Q_*\@SAB/\ @1]N30!6^)&N7GASX>ZO
MJNGG;=0QJJ/MW%-[JA<#N5#%AGC(YXKS3793X5\?:YJ.A:A=7CKX--Q#+=7;
MW>S,ZC*LS$[<#>!G&6)Z'%>V+I]F--_LXVT;69B,)@==RLA&"I!Z@CKGK65I
MO@KPQH\HET_0K&"01&'>L(SL))*Y/KDY]N.E 'G-M]O:QO+O3OB+8Q17VC 1
MK+>23".<.@:3=)*PC.9/+^4@ LORDBLK5-:U?3OAIXPA>YUO3=>TQ[,2K+J$
MLP4.ZIYD,K'=LDPYQG@UZQ;>!/"MG8WME;Z!8);7P N8A",2 '(S]#R/0\BG
MKX*\-+I%QI0T:T^PW+J\T6S_ %C*002>IQ@8YH X#XF:]>V'BV:QAN-:+R:)
MOTZ#2G?*WAE(5I$3[RG:H^;(P& &33XM)UN\\<:1X>U'Q+K-N1X;%U?K:WC#
M?.) C%6QQ\S$Y!/W0, =9?&OP]UO5O$ZW^FZ=X9U&R^R0VL4.KK,&M@A<X3R
MR,J=^222>V..>G\-> -)T?3=.-YI]C/J=K'(OVA(>$$A<M&F>?+'FLH!_AQ0
M!YQ>^(]5U'PAX.MH]4N%U";2+FXF9M0EM0^Q,+(TB?,[@J?E/#%LFG>%KR/7
MY?AQJ.LZE=-=/97\,LIOY8B6C>/9G#CYB"">[@KG(P!ZF/ WA406<'_"/::T
M5F6:!&MU8(6ZG!'.>.O< ]J6+P1X7BM[&W70; PV+O);(T(81LWWB,]S@?D/
M04 >8^%+K4M8&E:Y<>-3#>KJWE7NF;IW=V,I4P[//,>T!AAEB&% 8]#7/ZIJ
M[^)/ &FZ[J6J7DFLS>(XH;BS-RZ16P#-MB$ ^3A4#98!B<_,>A]TA\)>'H-<
MDUN+1K)=3D;>UUY(W[B,%@>Q/<CDY-5I/ 7A*6]FO)/#NFM<32++(YMURS Y
MS^)Y/J>N: .BHI%544*H 4#  ' %+0 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110!Y;J\@3XL^%83:,]S)<32,[2ERJ".Y ZD(1\S$$890
M@##[@/J5>5!E?XL:.T\D>[=,+?;;*3*NQ@=SJ_S$;<DY?YADJNT[/5: "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH 1F5%+,0% R23P!7G6F>-+
MOQ)K%_?Z3KVC0:+I.H-;WD-Q@F2V5 3<+(&XRY8*3A2%SG@@^BLP52QS@#/
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M.#C@#.-J2ROXO'<&H:!INLVLU]JD1U6ROK;?:2P#.;A)"-J2* .-P.>@(QN
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MRN[ X8-AL(HQR ,D8) H W8?&F@W%II%U#>2/%K$IBL2+67,K G/&W*C@G+
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M1M-O]334-/>_ ,4,MG(2WR@DJ0N'7+ !AU/:J.I:%J?C6[$\6E-I"P^'[JQ
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M,68Y.>%)! ."0#3T?Q@-"\-:K?:[=7E_*FO75A;1Q1[YIV$I6..-!@9(7@#
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M6R2"3G/%8OASPAK.@^+?!T4EE)-:Z=HTMO<WB.AC65CN*C+;B 3@<<Y&!@'
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MAPK%@=R!O5J\CN70_%KPQ=.C-=/<2KLWGS0OV>5"[K]P\KR4.%V$8!R*]<H
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M_G,TCN55=I(&T!23SDY XQ0!TNHZC:Z58O>7CLD*%5)5&=BS,%50J@EB6(
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MN\T">X\875W'HXDC2$V:*IA?&43DE"?F#-DDJ0!MQ7J--$B&1HPZEU 8KGD
MYP<>^#^1H \VT+X47FBWVA7'_"8:C<1Z//(\%NT*>6(F4KY8!S@D$@MSP3@*
M>:2+X1FRLH['3O$4]M9V^L1ZI:0&W#I;[&<B,9;+??Y9B<[5XXY](6>%Y/+6
M6,OS\H89XQGCVR,_45)0!Q5_\.X-6C\2IJ&HR2?VS<Q7,3Q1^6]HT:!8RI!^
M8C:.>,_K4.H?#Z]UG2M3CU?7DNM4O;!-/6]6R\M(H@VYB(P_WG."QR!D+@ #
M%=I->VMO*D4]S#%(XRJ/(%+#V!ZT\SPK.L#2QB9@66,L-Q ZD"@#C]0\ O?:
M!X7TH:Q)"N@2V\T<B6ZDRO"H5"02<<9]>3[8JCIWPWU+3M9UK4D\6W)DU>7=
M<?Z%%N* \)N.2,#<N1C@\ $ UW4UT@#Q0S0&Z.5CC=\9<+NP<<]"">^.:JZ;
M?S'0H+W6#:6LY0&?RY@T2-G& YZT <S#\-XH?%%SJ(UO4#I5U<F]GT?=B"2<
MG.XD8RN<$KW(&<CBLBX^#[RF_M8/%NJ6NCW%T+J'3H541P/Y@D(&<Y7(^48&
M#@G=W](N;VULE5KJYA@5CA3+(%!/MFIZ *6L:;'K.B7^ES.Z17MM);NZ8W*K
MJ5)&>_->:6GP6G@=6F\9:E-G2'TF0>2H!B.0%7D[4 Q\O)R,[NU>L57NK^SL
MMGVN[@M]^=OFR!-V.N,]>HH YF;P/]LOM$EOM2:YM=-T^:PDMF@4"Z61 CEC
MVR%7@=QV!Q6%8_"(6&K:/=1>*-4:UT>[::SLWVE8XCUB!Z\G )_NY&!G->B3
MWMK:Y^T7,,.%WGS) N%R!GGMD@?C3I;F""W-Q-/''  "9'<!<'IR>.] %#Q'
MH5KXF\.W^BWH_<7<1C+8R4/56'NK $>XKE(OADP;4YKKQ)J-[=ZCICZ;/+<
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MH>CC>!E/]H9'O0!Y-<_#?Q+>:SJDAL-0L;ZYU&:ZAU/3]8CAMP'8;2T6W?\
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MN<#)]>N21[9YT9F,/F)YH7>4W#=MSC./3@T2S1P1F2:1(T! +.P R3@<GW-
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MFPLC21G=Y@[X4YZGY^< -CZ*HH 122H)4J2.AZBEHHH **** "BBB@ HHHH
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MAVXZD<X!X(S4\_PVU>'7-*UO2_%4D6IPVC6=_/<6_F?:E9VD9@-PVG>QPN<
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M=P(*9)Y"*<#H*?Q.L=<MO$>C^(K73TU[2+1&2ZT9XO,*\G=.BY^9MK;<X^7
MZACC9\-^!]:TCQ,-<U7QA<ZK-]C%H\9LHXA(JLQ7)Y.!NSQ@D\EB.*MZSX1U
M*[\90>)M(U\Z=<QVBVDEO):^?#,@=G^8;E/5CT(/OUR >::QKMEI_@2&]\ S
MR:5:ZKXDCAN[9H#%):RE$+1C:PVC]T"5&00Y ('%=M?^+?$LK:ZFAQZ1<_\
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MCJ&Q7J]><ZPL"?$7PW<H8%F:62*Y:7 *EER$0+U)9,\MP%;ACG'HU !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% 'CNHP._Q8\/"U-R
MR6MW(9IX(\A3C#(Y &5S*<O@?-,0=Q)(]BKR77E1_BGX6N?M$:^;>NL<959'
ME"(PWA>RY,IW<89@0#RU>M4 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% 'E&OSL?BYX8CC4SF.7>CM*@$6Y9
M$EW*%P>0 "&'SY&":]7KR'7;9+;XU: SSQI-YI=%^T*'>-O-[$AC\TK#@8*H
M0<E1GUZ@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH \VO[F*S^*FB06EE&UG-#)-)(TB(RO(^=ZJ^"WS,H.T
MM_K#D HN/2:\DDL[FX^*FE2S/<7,5E.[-->/%+M1MP /EK\C"5@J=. 023D#
MUN@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH \BU^9I?BWX5#V]Q#^^9([HW<GE@@R$*1DY=D&-N,?O"">H'
MKM>0:B=6M_B?X=@O)A=1SOC#PR%X?+(+$'C",Y.&.<A$&!AF;U^@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH \;\1-"_P ;?#4T7F_9_M.'90_E+,8Y%*AE&W?E &&3T'3#Y]DKRSQ)>12_
M%#P[;^8F\71;<D[.WRD@ 1C@,"9%)+8"-(=NY?D]3H **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** /&/%<]Q;
M_%?P\7O3;*]U:BZM8W<)/*SL(R%88QS-\PX8KT!P3[/7C6N6MS:?$_P](BW%
MX]Q-$T5Q$H*QCS 9 RLVY28W!+@8ZJ Q8E/9: "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH \>\7RZM:?$_PV7:0B2Z
MMT=H51?-4RD$GYF9(P" !P"0P.3)D>PUY%XHUFZA\;>'--(FDMKZ_B4R.DC,
MQ2X68!DPFTC<,;MVU>0N"&KUV@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH \<UZ:PB^(GAF74O.NY)=3*Z?
M=)(2VUI)&X&<>6&>-.K?*"3LPJM['7F.HV-M)\0])::SD_M*V=)5<SL4M8RP
M0M][+F4@KN88.WD!F->G4 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% 'F_AOQWJW
MBCQS=V5A>>'?[&MIY4>%C*+\H@V[@I(4@OWQP.O.,^D5Y\P3Q;XI\.ZO9Z%J
MFF7FFW,CSW6H69A(A:%E>+!.'+,R $9  8@]<^@T %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110!YKJ9B;XF:1%>W<\=Q#LGC:WM-JS!\QA9"<8SCD#=]T'Y
M<8KTJO+/$-S<1_$;P_;Z=:EFDO\ $LC1.$2-0-[%@V&<@;?FX[[<@-7J= !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
C **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>8
<FILENAME>ex3-1_006.jpg
<TEXT>
begin 644 ex3-1_006.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 2Y Z4# 2(  A$! Q$!_\0
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M=.<*P==UJAPPZ$<=12GP]HC$DZ/IY)QR;9.QR.W8UI44 9_]@Z/_ - FQ_\
M =/\*:?#VB$.#H^GD/\ >'V9/FXQSQSQ6E10!G_V#H__ $";'_P'3_"C^P='
M_P"@38_^ Z?X5H44 9_]@Z/_ - FQ_\  =/\*/[!T?\ Z!-C_P" Z?X5H44
M9_\ 8.C_ /0)L?\ P'3_  J6WTO3[27S;:PM89,8WQPJIQ]0*MT4 5VL+-SE
M[2!C@+DQ@\ @@?FJ_D/2IRJD@D E3D9'0TM% !1110 4444 %%%% !1110 5
M3O-)TW40PO=/M+D,"K">%7R",$'(]*N44 0V]I;6B;+:WBA7^[$@4?I4U%%
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M XGP[9+'XZU.Z.U&>*0JC*@9]TQW,NSC:-JJ<_,6#$Y!!/;5PGA[RS\3=:8W
M8+FU'E6IC56C7S#OSA1_&<Y+-G=GY1C/=T %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% '$Z#<^9\0M21-NTV
M[B3"Y+2+*,EGX)P&"@8'RJ.6P0O;5QV@I:0>.M7A66,WAB$TRHTC#+;<X!^5
M,$$$#K\I/.0.QH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** //?#@N8?BEJ=M.D9C73QY17YM@$@!&[W^4]!
MEMPZ* /0J\Z\&0-'X_UV;?')YHE1Y#'A\QS8"@\\#<<\Y.03DDX]%H ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** .#\.QRP?$6\M[GR_/ATQ4XC8%E\W=G/("Y8X7)/4]257O*X?0I)KSXBW
M]YA6@-FT8D6 )N ==I8@G(/S%"2"5&<$8-=Q0 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MH>1CC(9F] H **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** /._#4R_\+*NT1=\=S9SW44BN/D4RQYCD49(?<6/
M))VD#"XVCT2N)L;H0_$?RDBMK@WEH\@DA<JUO'NR"R$$G>0%+9 R@7L .VH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M->J5D2^%?#L^H'4)M TN2]+B0W+V<9DWCHVXC.>.M:] !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 ><6\$9^*EC(+:.,H+G;&DBG:/F7S<2<[F.[=L ;E3N92Y/H]>5W0:X^-/
MARY:VU R1BXA$LT68A&(YMV&Z!M^WD 9!P&(&!ZI0 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M,I(/7.*HW'Q&\-6]C<WAN;IH[>V%V?\ 0IE,D)95\R/<H$B99?F4D8(.<<T
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M;PV'V:Y5(I1."04.Y@BXPQ)9@!@\T ;>D>&M$T"2>32=+M;)YPHD,,84L%&
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MQ8+I@]Q&+2,+,PS@N,88\GKZU+:Z#H]C!/!::58V\5P@2:.&W1%E4#: P Y
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M3U#0K#4=).E2PJE@Q'F6\2JJ2+G)4C'0GKC!]ZY>7Q_?GQ]<^%K+PS+=FU>
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M%+1)('>2-VEDL[B-5\N9_)F\P C.5"LN#DY*D[CQ7K= !1110 4444 %%%%
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M9^3!;<3G!P. "W+51NO!'B:70)98(='35[?7[C5K:*=C-%+'(7S$QVKC(?\
M' SM/W?4Z* ,#PIINI6-E/-JHLH;FZ<2?9+&%4BME"@; P&7.026/<X' YXB
MVT?5?$=IX]T2VCLTLKW6WC>XDN&62/,46XA A#<!<?,,Y/3 SZM56TTVPL)+
MB2RLK:V>YD,L[0Q*AE<]68@?,?<T >?OX'\1Z?!XFTC2[G3[C1=<BVJ;N5HY
M;1VB\J1@%C(DRH4X++RO;DFUK_PYFO!X771M1^QG2(OL$\C9+369CV.H[;B
M,=,;B000*] HH \[TKX70Z<OB6U%RJ66H6\]IIRQ@_Z'#.,RKMX!^<+U)X08
MV\Y-"\-^,]-TYH9T\+)/;61@MI+6*1&N),%0\KA04 &"0@R3G!45Z)10!@^"
MM&NO#W@W2M(O1!]IM(!$Y@D9T8@GD%E4\]<8XSCG&:XRZ^&VMW=]XVC.HV<-
MCKSPW%K+&6,T,T3AUW KC:2.<$G@8KU&B@#E+/1M<U#Q-INM:\-.MVTZVGAB
MAL)7E$CRE,LS.JX "8"@'GG=VJKXT\*:QXCU*U-O<V$NE_9I89K'4(V:-)&^
M[.JK]]QTPQP.HP>:[6B@#SFP\(^+=(_X1R\L;O2#>Z?IRZ5=PS&4PR0#:0Z$
M#.\%.X .>U5[+X>^(--M= O;;4K$ZQH]Q=L$ =(+F*=R[(QP2N,G!P>W4@&O
M3J* /$/&?A2XT!;+5Y+BUDUK6O%EE-T=8(2JR>6F<[B!ELO@$YZ# KL]9\$:
MAXAM?$EQ>S6=MJ&JZ?%8P)"6=(%3+'<Y"E]SL>=HP .#S7:W-E:WJJMU;0SJ
MIRHEC# 'VS4] '%:7=^,8O&-CIVIW.F7=G_9Q>\-I!(ICF!X8L?E&[@ 9R<,
M=H S3_%GA?6-;\1:3?65SI;6=JCK+:ZG;O/$')4B545E#.,'&2,=NO'944 >
M9>&?A_K^AZOX9N[B\TRXBTC3IK-UC$B,Q9LC!(.>V3Q].].T3P!KFE>&/#^E
MO=:<\FCZN]^-I<(\9\S"#CY3^\;L0..M>ET4 <%8^$?%&CZ]JB:;KMJN@ZE?
M-?2++"6N8&=MTBQ'[H!]2#CL,Y)H'X?^(/[%\1:=_:6GL-6UE=40LC_NOWBR
M%??_ %<8'MN]J],HH \ZU3P%KQN_$\>CZO80Z?XB1C<K=VS22Q.8RA"%6 P<
MCD@X]#CGJ;KPY'J?@D^'-1EWK+9+:RRPC;R% W*"3CD9 .??-;E% '!6W@;4
M[VY\.KXBO[*[M?#[B2V-O%)').Z*%C>3+D C 8@9!/MD';\$Z'?^'/#HTS4)
M[:9TN)I$>W5@-LCF3!SW#,P^F*Z*B@#E='\-ZCIWC[Q!KTUS:/9ZK'"JPQH1
M(AB7:N3T;(+9)R>@!Q69X8\'>(/#,J6/_"21GPU:RF2&V\@^<$SN"&4GA0<>
MN1D<9S7>T4 >-?"W0;_Q#\,?#,-Q>V<>DVEZ;ORD@+32-'<.P1F)PHW8)(&2
M...IZ?1_ 6K^'M4GM=(\0K:>&9;@W/V!+8>:A)&Z)9"<JA /(PPSQ@\UWJJJ
MC"@ 9)X'<]:6@#RVT^&&M6][I<S:[9R#3M4DO%F>S+7%PCECF:3<-[C=@< #
MWX%=9X0\,7/AF;7O.O8KF+4]4EU% D)1HS)C<I)8YZ #Z9[X'344 <+JW@G5
MKO5/%$ECJMM#8Z_9^7/%+ SNLH@,(P0P 7!#'@G*XZ4DOPZ:Y_X1>"YU*.2R
MT739M/FB^S$&Z22%8FYW_)\J@]^?KQW=% '#^$O!&L^&TM;"Y\42W>CV))M;
M6.W6%VSG"RN"2RC/08R<9X&VKOC3PMJ'B=M'^QZE:V:Z;J,.H*)K5I2TD>[&
M<.OR_-TZ^XKJZ* .,3PC<GQA!XN\0:M#>3:=:O':PVEDT"1;@=[D>8[.2I(Q
MG\,UD>!;73_$_BO4/'=I8:E8VLR+%;P7:JBR2XVRSA 3S@*F<_W^N<+Z510!
MY[J_PYU#5IM5N&U^*.>\U.UU",)9'RU\A=@213(?-4J%./E^9<].!=T;X?"Q
MB\20:GJAU"#7A^_C2W6$)E-C8P3^'3'OUKM:* .#M/A=IUK'X9S=223Z,[O/
M,R9:]+?,V_)/'F!6 .[ 7 ]:?XE^'T_BC78;N]U6W6T@NXKF!5L!]IA"* 8T
MGW\(S L05/)]J[FB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** /+/*.H?&;0[[S;]UCMII-MQ(J(&5983Y:X&]0<Y*Y/SJ
MP^5LUZG7DRQ1WWQGTB;38I#;VLUW)=/]FVJI,<B Y5>"7,H)8C.U1][[WK-
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ME_=@A=JGA>"<XZT :%%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!YGY(
M_P"%MZ&USJ<Z7:QW6VT:X?RVC1"B[0Q(D.&+-CYB1DXPP7TRO,$M=3N?BEX=
MO&MT9(%NUN(]C-]FC9&:)P[ '+;L'(!&XKS@D>GT %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% 'DTMG:S?&[PX;2.W%Q:PW%Q<F.Y)#*\;IE5)(X;:,*0P!!*X(V
M^LUYCA/^%MZ'%<_NKY(YI3&95ED<&$J&? X VNH;@XVY.78'TZ@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M:$(-4MB$N+Q#:QS1F11Y3L(RN RHJE&VY;#.?E')'JU !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %<9\5,GX?W:K((W>Z
MLU1CSS]IB[=_7\*[.J&JZ)I6NVZ6^K:=:WT,;B1$N(@X5AW&?R]QD=#0!D6-
MK>Z?XI5]4\1+>-<6WDVUIY0C.02SOM7V"C/T''&?)]&U&;_A / >G_VE'8:1
MJ-SJ/VB[NT8(S"20Q)(4ECP&RQP&^\J]@:]IT[PQH&D7)N=,T/3+*X*E/-MK
M2.-MIZC*@'' I?\ A&M!_LO^R_[$TW^S]^_[)]E3RMWKLQC/OB@#RBTUB+3K
MKPUH>K>,CJ_AZ=[F-]361H%GE0($A=U<DH-W7=M;.#G%+<V^BP^,_AL(=9EO
M].A?4XTU&:[/SJBY0"0$ A2=F1][;CD5ZS-H&C7.F1:9/I%A+I\1!CM7MD:)
M",XPA&!U/;O3IM#TFXALX9M+LI(K(J;5'MT*P%<!=@(^7&!C&,8H \:FUF_T
MVZ\16Z:I=C36\6VEK=W$MY)FVM6_UF)=P,8RJIG/ X]QM>([=M/7QQIMA?WD
M>EC0%U!3'=.?(N<R':KDDC>$4E<\@].:]'3PYH<<=[''HVG(E\<W:K:H!<')
M/[P8^;DGKGJ:6/P]HD.F2:9'H^GI82??M5MD$3<YY3&#SSTH \^\,65QHOQB
M_L\ZE?W*7/AE+RY6XO'F5I_.5-PR<= <>@)QP:V]>EMKWXCZ?HNKS2II\NG/
M-;1>?Y<4\_F!2& P2P4J5&3U/&>O4IH>DQZC'J*:79+?1H(TN1;H)%3&-H;&
M0,<8]*?J.DZ;K$ @U/3[2]A4[A'<PK(H/KA@: /';V--2\%6$FKRM=6-GXL%
MG8WCW#,TED+D)N+@\_=(W=<*#FNV^*5C;K\)-:MA'^Y@M%\M-QXV%=OUQ@=?
M2NKNM'TR^B@BN].L[B.W(,*30*XC(QC:".,8'3TJQ-;07%K):S01R6TB&-X7
M0%&0C!4@\$$<8H \4;3M$UCQQX#TZ*ZD;3Y='F&+*\9?,8#<REU;=C(8D ]O
M2JXUQI/#7@FQU#7Y;;2)KN_MKF\<[TW12%;=)GR.-IR,GLK'ID>SQ:!HT!B,
M.D6$9A4)%LMD&Q1G &!P.3T]3ZTO]@Z/]@-A_95C]B8EC;_9T\LDC!.W&.G%
M &/X M;2Q\+I:6.NRZW;0RNB7LCA]_.2%8$A@"2,Y[$=J\RATJU?P9H&KOJ.
MHI?W&O\ V"68:E,I$#W<L;1@;L#Y"3D#/?->Y10QP1+%#&D<:C"HB@ #V JJ
MFCZ9'$L2:=9K&KF0(L"@!SU;&.OO0!XUKUS/X=T/QUI^@7=W'8V6HV:N8YWF
MDMX7BC\XABQ8<@@\\<]*DOH-%3X?>,I]&\62ZDLL5M=%+:0PQ6KECC;@[59\
M?,O48&0.*]FAL+.W\WR+2"+S?]9LC"[^O7'7J?SJ--)TV.U:U33[1;=GWF(0
MJ$+>N,8S[T >/>*O#>CV^N^+(+9[CR8O#7]K1Q"]E*_:D\U4F/S<L J8SGKG
MKBL5TL]?U[X8#Q'<B6RNM&FCN)GG>$2?NF&UI,J<YV@\\D]P>??3IE@SR.;*
MV+2)L=C$N67C@\<C@<>PHDTRPF@C@ELK9X8_N1M$I5?H,<4 > 6D]XEEI]AJ
M^L&+P2NK7T%C>72"=)H@-L/F=FCSOP6X!QV QK0Z+H#7'@?3H?$-[=Z0]]?)
M!+]J:!6B\@DI&00Q0-\F<Y^9ES@BO;9K2VN(!!/;Q2PC&(W0,O'3@TUK"S?R
M-]I WV?'DYC!\K&,;?3H.GH* /$-4TZS\'_$.&:RELM5LX'T^R>RENF_M"PV
M;-OD@G)C(*L0.#EE( !-=]\4KRXLM"TF17DCTXZS:KJDB9 2TW$N6(Y"Y"@_
M7'>NP;3K)KO[6UG;FYR#YQB7?D# ^;&>E3R1I+&T<B*Z."K*PR"#U!% 'D31
MZ9%XD\4V&D_8V\'?V";BZA18S9Q7I.5V\;03& V!QT)Z#'8_#2TTJW\ Z+)I
MMO9Q/+86[736R*I>7REW%RO5N><\\UU$-I;6\!@@MXHH3G,:(%7GKP*DCC2*
M-8XT5$0!551@ #H * / YSX:LO!'C*RA.FVE]'XA,;K"JPRI +Z/:NX8(4 $
MC&, <=*IZY<7&C>(?B'H^@SM#I,/V.XGMX2)-B8C$[J&S\W)W>N.>@KZ%^S0
M;9%\B/;(V]QL&&;CD^IX'Y4J00QS23)%&LLN/,=5 9\<#)[XH \_^&MKX:CO
M=3NO"VK7>H6MS'$T_P#HT4-O&XSM 6.*,!]O4 >F[DK6)XEO-)3X]Q?VAX@.
ME11^'A&TT=XD&)/.9A&['U4[MO7[IKUJWMH+2+RK:".&/.=D:!1GZ"G>3&9A
M-Y:>:%V!]HW;<YQGTX% 'SG:SMI6G^+_ .R)K_5_"BZK:W-UJ,);[1/'O!N$
M\S*EN <N"!WW88UTFIS:9:>(=3O_  483H:^'+I]331Y%CA#A6\OE/E27K@X
M+  \8S7M=% 'S.UYI/\ 8OB*&UELY%N?#$/R6-HT,0E20DC)!\PH"H,A.2>.
M#P-9M.T?P[I/PXU06S)H5]'')KD@9I(7E$*",RYW 89I., =1Q@8^@!&B[=J
M*-HVK@=!Z#\A^5.H \[^%$VD,GBN#1A&EFNN2RQ1QQE$5&CCQM! P,JV .PX
MXQ7-W)TDW/CR+QV+--2:XD?37NY$$KVH4F!8,<\8SA#N+-R-Q.?:** /%XS!
M%\3O ,'B*:VDU4Z(4N/.4%FG*_*'W9.XX8 G&2..N*UOC_(B_#*1&=0S7<6U
M2>3@G.*]2HH \E^)6M6WCG2;;PGX7\O6);V\B%U<VJ>=%:1*0Q?S1\JMDJ._
M!8<$BL77CI[:A\9H66"1#:63K&& _>+$?FX!Y$A!/OU(ZU[I10!X?KUAX<\*
M0^"-:L8Y$\+,'>^O+>'>)': )!(\;AB>#(!D?+N/?JR\;1?#-OX,U%%U.[\&
M17]Y)=37]MD>9*F(I?*"K\H9I,'9QS@<KGW.B@#QB.W\+Z'K/A&XM](NK?0"
MVH06_P!IM)I7E9_+:,"-E+X)\S8",D#/4U6NH[:^\(ZWH=U;+%XW757DA/E_
MZ1+(UQNBG4@9\L*5&X?*%7MP*]PHH \6\*Z#HU_\0_B/)J%A&_V6>-[>1(QY
MD64E#F/CK@C(]=N>U:7PPB33/$<^DV)M=3TR+34>'54LS;SQ#?Q;3C RW)<9
MPV.3]X5ZO10!Y!XLTO2]0^,%]_:&GV]Q&/"LAC,\ 93<+(2",C!<)WZ@5S^G
MS)IVD^";G6!JD6CKI,]I-):*Q-O,7&[>@4D J"#QR/7I7O\ 10!X!=:99Z1K
MV@376E^(;3PF=&GM;=@&DDA=YY&.X ,5+QD<8!PP!^Z16OIYA\)^)M"FU;2M
M3M?#2Z-<6UI#<QO>-!*UPQRX0,49X=O&,@'9V->T44 <1\)=J?#VTMUM;BU$
M%S=)Y4\#Q%09W90 P&1M8<C(SD=00/+O#FG6=EH<MQ-IJPWD/C:"02/;_O4M
MPZD'=MSL $G/3[WK7T110!Y)JT42Z=\1-'U/3KB34M5FDEL-UJTGVI?(00!&
M .=CIT_A]JL>&TN]'^+4UOJ:74]Y=Z+:0M=+ Q2:5%_>.S@;1]T]3UP!DUZG
M10!Y_P".XM.3QKX1U#6;+S],MQ=HSO:M.D<KB+R]P"G'W6()X&,\8KS^7P_J
M6AQV.K)INJP^&(_$-]=O9VADCFB@D6-(9/* 5EVE78#&5##U-?0%% ''?#G3
M;73M'U%K#3+VPLKN_>Y@6^)\Z4-'&"[*3E<L& !YP >]>?:MX?MM4\/>*M$B
MT.1O%%UKD\UK*;%E94:Y#++Y^PA4V9.=PR,J#DU[E10!Y;XP\/7=AX]L[O17
MC7_A*0=+U.$D*P01EFGC.00ZHK>HR!W(KTB33;*32FTMK6(6#0&W-NJA4\HK
MMV #H,<8%8^C^#-.T77]0UJ*>\N+N]D=S]IFWK#N;<5C&/E&?\]*Z*@#PU/#
MWCK3M T_4XFE?4?#%RVG:=:L@"W5L7*&4XP2&4Q*%(Z0AN=U=-=^%;.'Q5X$
MTF?2FO+2TL[_ .T,;=I8!)(B;FD8C;\S>9U[L..17IE% 'E>I6VW4?B79V>G
M7*+-H$45N([-UC<I!,NQ&V[21O0  \]LX.%EO;F76/AYJ TC5HX1;75D6^QY
MDB=XXE5B#]P?*QRPZ*21CFO4Z* /#/!6CA8](T;7/!^NR>(M+ODG\V:[G^QQ
M R[S< ^88\XW'"@[V'H3B]9:8R>!O#3?V)?I?P>)Q<R?\2V9940W+,TC#9G:
M8BO)XP .HP/9:* .$^+>G76I^"ECM;":^\J^MY98(8C*[1AQNP@Y;@] .GM7
M%Z_HM]<ZAXJ\1:!X9D;3YM(BLQ83V<D3W4YE0F18&0$[$!Z@\J,;@37M]% '
MBJ+>);>/VBT?Q/-%JNC116CWEDYDD<)+%MV@97YG7Y0HP,M@+S2V>DZK_P )
M9\,+@:?J,,=IHC6UQ/\ 8WQ:RFW9 'RN%.['WN/PKVFB@#QW3M,U*]\'^%_"
MSZ->:?K.DZA"TTWV5A#$D3Y:5)\;&+*>@)))(/K73_#NSOM+U+QA97NGW4/G
M:]<WT4[QXBDCDV%-K'[QX.<9QCG!KNZ* "BBB@ HHHH **** "BBB@ HHHH
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MQC'?MCJ3IZSI7B"R\?Q>)M'M8-0@DTLV$]G)<>00RR&1'#$$'EBIXX&3STH
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MRMAS&H8 G<,GC'4UR/A?Q?JOAZ[FTV3P]<W&D2^)9].74FOPWE,\Q5%"MEV
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M?E[>8OY^O%.T"TOX_P!HKQ%JTFE:E'IUU8+!#=/:2+$SA8!]XC'\#?E7KE%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 ><Z]<C3OB1X-CBMVGL9C/$)<E_P!ZZN=Z$$;6&#N)
MX*R'@XX]&KS+Q'>)I?Q3\(PRS7K32-)%&JD>7M8,H#*-JXP3_M H,!AU]-H
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M8Z\$<C@Y&*\XET:/4?!?B>ZT?P9K^F7-QIHMV74))99IW##"QH[,Y  Z\=0
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MLHBFLF;DXY5T?#(PXX(&00: -RQTRSTT3_9(0C3RM-,Y)9Y'/=F))/H,G@
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M;/N;PH(4'C)7<#@@@'KE%<AX'G\4I)JFG>*9H;B>W=)+:<&)99(7!P7CC.%
M96 /\6&].>OH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH \M\726TWQ&\*W$A:X N43R3"DHBEW 8'F%3'UWDIECY
M8)4 *:]2KQ_QFTUI\2O#@DMU83WMM#&HB;+#SV9FR'&<*L9+'/(.1@X'L% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %<#HOA'6_!&HZA%X87
M3+G0[VX-T+*\F>![:0J P1U1]RG"]0, 8]37?44 >:R> -<_X16*&TO=/L]9
MM]<?6K=4#-;*S%\1$X#;<.1D+VZ4_5?"_C?7[;0Y=5O-$>ZL=:@U&2&W\R.%
M(XL@*C%69F;))+8 X ]_1Z* /.+WP/XCN=/\0I:ZA9V%[/K0U;3+B.1WVLJJ
MH64%  "$&1\P^8\''-;Q7X-\;^,_!-UINJWFAIJ,MQ$T:6QE2WCC3<2V6#,7
M8M@\ 84>^?4** ."\6^#]9U_Q&E[ -%FLSIDEGY6HQO+]FE8DM)$H&"6&U2<
M@X4=>AM6GAO6TU?PE>74EA+_ &18S6UT\;NI=I!&H*+M/ \ON1G/05V=5[^\
M33].N;V1)'2WB>5DC&68*"2 .YXH YKQ?X-DU_4=*UK2]0&G:WI3LUO.T9D1
MU((:-UR/E/3(Y )]:N6-KXDOU*>('TN&V*NLEO8>9)YP92N#(X4J!G. N2<<
M@ AH=/\ '.G:D/#K0VMZJ:^LC6K.BX38A<A\,<'"G&,UT] 'FMEX \0/H^F^
M&]8U2QNM#TVYBFBF5'%S-'&V4C89"H  !D%CCTQFDU#1M0\/?#+QZ-6N+7%Z
M^H7D A=F$:3 D1D[5).XGG_:]!7>:UJL>AZ+>:I-!--!:0O/*L.W=L52S$;B
M >!ZUFPZ^NIZI9Z8VAWLEG>Z<MZUV\.;=-QXB8G^/OCZ<>@!R<7@B\\::9IL
M_B&:P2UM]*EM[ 609V_?Q(OFN6P 5"\* >3G/:KMCX'U>X?P\FO7MG=0>'G+
MVAC5C)<,JA8VD)X7& > 22 <^O8ZI?V^@:#=Z@\+FUL+9YFB@49V(I)"@D#H
M.F147AS6X?$GAZRUFWBDBANX_,1),;@,GKB@#BK7X>ZQ9_"*W\)17]DU];2^
M8&=6-O./.,ICD'4H<D' Y%9FJ_"G7=8T?7+"XU32(5U"2TFB6TLWC2(Q((]@
M7<=J!5 '7/MTKT3PYX@B\1V-S<Q6L]KY%W+:/%/MWAXVVMG!(ZY[UL4 >?7_
M (!U'7O%$NIZS=V1M[G0CI-S%;1L"Q+;RZ[B=N'/')X ]:M:;X3U[=H9UO4[
M.]70P[VZ0Q&,7,A0HC29R%VJ3C:#R<]L'K[:^MKR6ZBMYED>UE\F<#^!]JOM
M_P"^74_C5B@#SN/P!JH\/>'-.>_L=^DZV=4=O)9ED!DD? Y&"/,/Y#D=]WX@
M>&KKQAX-O-"M+F&V>Z:/=)*I8!5</QCOE1^M;DVI6L-ZMB9D:^>%YX[8,/,=
M%(!(!([D#G'\Z@T#6(]?T*TU6*&2%+E-XCD(++R1@XX[4 9-QI_BS4I[:&ZU
M#3[.Q60/<-8^:)WV\J%8G &X#.0<CCH2#@>%_AWK.@S>'#-K5E)#HBW$*116
M94212D$DG=]\D YZ<="<D^CUFZ]KMCX<TB;4]1D988\ *B[GD<G"HB]V)X H
M Y&Z^%&D73^)T8XM=8C'D6Z91;20["[* <'<\4+GC^ #&.O7Z#I2:'H%CIB2
M/)]FA6-I'8LSMCYF)/<G)_&LEO&7V2]TV#5=#U/38]2G%O;SSF%D5R,JLFR1
MBK,00!SVY'('3T >76_POURTGQ!XGA%O'KK:Q&6LMTC.ZE6WL6Y(!(!]R3G@
M+K/X"N[WQS8>([Z_LUDT^YFDBDMK9DGFB?<%BD??@A 0,[>1D<<D]W10!SGB
M3PO)KVKZ#?QWR6QTFZ-SL: R>:2,8SN&WOZTGA[PW=Z%KFNW1U/S['4KLWD=
ML8@&CD95#9?N/D  XP/6NDHH XC5/ =UJ/B#Q'J"ZM#'!K6E'3C$;0LT(V[0
MV[> W5CC [#U)DMO!NJV6HZ?JMMKUN-3M]-_LV=I+%F@GC5BT;>6)05<$\G<
M<Y. ,UUE[>6VG64][>3)#;0(9)9'. J@9)-49=6N#J&D1V>G275A?J[2WJN%
M6V 3<A92,G=T]N] '/S?#JU;P*_AR"_FMIVN1>"_B!#I<>8)-ZC/R\C P>!W
MSS4^G?#K1-)\:)XDL8VAE2P6R6 ,Q4!0J*V2>R(JXZ=^O-=7YT8F$/F)YI7>
M$W#=MSC./3D4XLH(!(!8X&3U- ',^-/!L7C"SL@+Z;3[_3[E;JRNXE#^7(.A
M*GAAG!QQT'/4&!O"&I7NB0:;K'B*34U>Y$VHM-;!!=(  (E5& C3@$CG)SZF
MNNIJ2))NV.K;3M.#G!]* /.Y_A?/+X,U[PI'KD<6E:A<B>SC6S)^PKYHD,8S
M)\R_+_L\DGOBK6O_  _OO$6CC1;S6K1M*,=NOEOIN^6)XP SPR>9\A89'*MC
M)]3GN]REBN1N R1GG'^0:Q9O$(T^YUI]6MAI^EZ<D4B7\LRE9U926PHY&TC;
M@]3TH SIO">J1:YKVIZ7XB:Q.JQH0GV-)?)F1%0298_,-J_=XY).>U6?#/A=
MM!OM5OY[FWFN]3=))_LML;>(LH(+["[?.V26;/)K=^UVV(3]HBQ/_JCO'[SC
M/R^O'I4U '$7/P\QJ&O-INJFTT_Q K#4K-K<299E*LT39&PL"<Y#=3C'&-33
M/"<6D^)1J=K<!+.+2H=+M[(1G]W'&Q927+$L?F([>^35S4O%&BZ5I3:G<ZC;
M_9!*L.])%;+L0 HP>3SG'IS5Z34;*%86EO+=%G&8BTJ@2#C[O//4=/6@#'\5
M>&[CQ!_9<MGJKZ==:==BYCD\A9E/RLI!1OESACAN=O45B:%X U3PYHLNG:?X
MH:17NY9R+RP26-T<C*.H*EL\Y8,.O  XKMKF[MK.,275Q% A.T-*X4$^F3]*
MR7\0M%XU7P_):*L3:<]^+OSO[LBH5*XX^]G.?_K $GA;P];^%?#EIHMK(TD-
MOO(9AC)9V<\=N6-<VGP\O$\+:9I">(6BN--U%M0@O8K-=VYFE)!1F93_ *UO
MR'%:6H^-8+'Q9H.D1PP3V>K)<M]O6Z&V$PQ[V!&"#QCG(QGVKI6N8%MOM+3Q
MBWVA_-+C;M/0YZ8H R_$6B7&N>'I-*AU)[1Y"F^Y\E9'PK G X4$XZXQR>/3
M*U/P7-JNI:W>SZMC^T](.E>6ML-L*$L=P^;)/SMU]:O^)_$JZ#X2O/$%G##J
M$-LAD*K<; Z@X.&"MSG^M2>+-?7PYX;O]10VK7,%M)-##<3>6)2@R0."2<=@
M.3@9&<T <X/AH\:Z9]G\2ZA;R6>F'29'2*)O.MMP.W#JP5L #</0>E8^KZ5_
M9_AS3OA8NG:OJL=Y;HIU,0*L$"><-S%A@ H 6 .>?+!SNX[[2_$5G>^'M*U:
M[E@L?[0M([E8I9A\NY%8J"<9QN SBK\NHV4&?.O+>/""0[Y5'R$X#<GIDXS0
M ^TM(+"R@L[6)8K>"-8HHUZ(BC  ^@%<@WP_+Z0;%M9F#MK7]L&9(5!$F_?M
M [#=SGKVKKA>VINS:"YA-RHR81(-X&,_=Z]*Q/%_BJ#POI\#9@>]N[B.UMHI
M9@@+NVT,V>=HY)QZ=NM &./AE;0^);_4[/6]3M;+4IQ<7^G12 1SOG)Y W ,
M>H')!(S@X&IIW@VWM&\2I<W375MKTKR31-$J[ RE"H8<D;<#GI@GN:=HFOWB
M6JP>*SI>G:D\[16XBNU*7J  B6-2=P!R?E.2-N>];%YJVFZ<<7VH6EJ<!L3S
M*G&<9Y/K0!Q5M\+530;G1;[Q)JE_8M:&TM(IBH6U7& P 'S,!P,]!D=#QJ:5
MX+NM.UIM7F\2ZC>WC6 LF>>*'! 9F5N$[%L^YZDYKIKJ]M;&-)+NYAMT=UC5
MII @9V.%4$]23T'>J+>)] 6))6US3!&\QMT<W<>&E'5 <\L,CCK0!ST7P[6+
MPCHVA+K=X&TF[6ZMKM40.I7< N,8QM<CG)J&X^%NGRZ]J%[#JNJ6NGZGSJ&F
M03E8KECPQ8_>^;O@Y.3SS77:AK6E:1Y?]I:G9V7F':GVF=8]Q]!N(S3;W7M'
MTTJ+_5;&U+1^:!/<(F4R!NY/3)'/O0!6T3P^NB7VL7$=Y--'J=W]L,4BKB)R
MH5L$ $@A5Z^@]R:OB7PH=>U#2]3MM4N--U+3#+]FN(HXY !(H5P5=2#D#&>W
M-:DFN:3%IB:G)JEDFGN,I=-<((F'L^<'H>]4M2\8:!I,NF)>:I:1C4G*V\AF
M0(0%+;BQ.-O 7/JRCO0!@:K\*M%U+2K.V2[O[>]LKE[R#45FS,)W96>0\8)+
M*#P ,],5U.A:-%H6F+9QSSW+EVDEN+AMTDTC'+,Q_H. ,"EDU_1H=572I=7L
M$U%B MHUR@F)(R,)G/(YZ5#+XJ\.P&02Z_I<9B8I)OO(QL8=0>>",C\Z .)7
MX*:3#';0VNMZQ!;V=^M[9PK*A6W(.2%RN<D_Q')&!UYSL2?#:SN-%ETRZUC4
MY(Y=3?4V=?)5C*S[P/\ 5XP#S]2>V .DCU_1IK2VNXM7L'MKJ86]O,MRA2:4
MD@(C9PS9!X'/%6+_ %&RTNT:[U"\M[.V4@--<2K&@).!EB0.M ')7/POT2\/
MB87%UJ$B>(BC7:>8@",C;D,>$R-I]20>^:2'X9V(\.WVCW>LZQ>?:X1;&ZGG
M5I8H%;<(TRI4#L3C)]L "'P+X[.M:#K6K:]?Z7;V]GJTMG'<12[+<QJL>TAW
M/.XL3D]<]!TKISXI\/"VMKDZ[I?D73E+>7[7'MF8'!"'.&(/&!0!E2^ =-N]
M7U/4+Z\O;PZG8K8W4,IB$;H  "-J ALY;(/4G & !3T#X9V6@ZQIFI+K6L7D
MFFP/;6T=U,C(L3# 3A!P!^N/3%= GBKP[+%!+'K^EO'<2F&%UO(R)9!C**<\
MM\PX'/(]:EU'Q#HFCRB+4]8T^RD9-X2YN4C)7.,X8CC/&: .;T7X7Z-H@6".
M_P!7N=.C>1X=.N;O=;PEP0=J@ \;CC)."<]>:BT/X5:5H-UI<MMJ^N21:7-)
M-:6\UTIBC+@AA@(.#N/?N?4YZS4-<TG26"ZCJEE9L5W@7-PD9*^OS$<57E\5
M>'H+&WOI==TQ+2Y+""<W:;)=IPVULX.#UQT[T 1^&='O=&M;R*]U&ZO3-=O-
M$;FX,[1(0 $#%5XR"0,<;L<XR<&[^%FCWJ>)4EU#4]OB*6.2\ :+Y?+<LH3]
MWP!G'.3P.<\UT5YXJ\/:<MNU[KFG6Z7*[X6EN44.O]X$G&WMGID@=2*N:IJ5
MKH^E76I7L@CMK:)I9&) X SQGOZ4 8UWX-M[C5VU6'5-2L[^6W%M<SVSQJUQ
M&#D!LH0I_P!I-K#UJ/\ X0#0HM5T74;..>RETB#[- MM*5#Q#D)(3DL <GKD
MDG.<FL'PIXOU?58;;Q)J.JZ#'X?O48-:^84FLI"Q$:!N1*QQ@@[#D\#C!Z]O
M%7A]-*BU236K".PE;8EQ)<*J%LXVY)Z@]1U'.: (O$?A>V\1FPDDO;ZQNK"?
MS[:ZL90DB$@J1R"""#@@CD<=":S[_P"'6@ZIX;NM%ODGGCNKG[9-</(/.:?@
M>8&Q@': O  QQBM,Z_::AX8O=6T.]M;M(X93%*O[R/>@/4 @D9'3(R._.:P/
M GQ!TSQ!HNEP7VL6)UZ>V\Z:V5PK9P2<#_=YQUQD]* -[PWX:M_#5I+#%>ZA
M?S3/OFN]0N#--)C@ L>P'   K:K$MO&/AF\EDCMM?TR9HX7N',=TC!8TQN<D
M' 49Z^Q]#B6T\4:%?6]S<6^KV;Q6HW7#F8*(EQG<V>@QSD\$4 :U%95KXET2
M\L+B^M]4M7MK8XG?S /*/HX/*GV/6N6\9^/H[#PPFIZ!J-FYCU""WNC*N3$C
MGG()&PXP<D'C/U !WU%9FE>(M%UUYTTK5;.]>W;;*L$RN4.2.0.W!P>AQQ6G
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 >.^+)
MKNU\>>&9Y;63RKK5(@LLT #X,B*)&*'*<?( VW._E<APWL5>6^+M&M9/'/AZ
M\BN)$\N_AD6(*OE,YE4YW#@9$LI QN9ADY!S7J5 !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 (P)4@,5)'4=17@TG_  D'_"/^+/$<'B[6UN?#
MVOW$%K;//O@FCC,85'3 +9R!UQUXRQ)]ZKSKP;\/EM+_ %K4?$ND:=+>W.LR
MZA;,DIG5 ^".&51E26PQ&>2<#B@#G&U'6=<UG6]0@\5Q:7<:3JKQ?9)[I_DA
MC8J$-NI5'$F>IR2> W%:&E6FMZCK7C*['C#4(#I=Q<06L<\Z"W0M!\KR+C@*
MS;N@'R\9YKO9/!_AV;7UUV31K-M45@XN3&-VX# ;ZCUZ\"IHO#6C0IJB1Z="
MJZJ6-]P?W^X$'=^#'\Z /)5\2:GH7AS5M/N[G5-.U2TO=/M]1EN[UKQ8(Y>#
M-#(QX#!2Q4_=)Q]-+QQ/J7AE/$&GZ5JNIK:/H37RM+=R32VTRS(@V2NQ90RE
MN,_PDC'->B6/A/P_IMA<V-KH]FEK=!1/$T8=90HPH;=G( & #P*CA\&>'+?3
M+G38]'M1:7*A)HRN=ZC&U23S@8&!T% 'F?AC6;_2]23[=X@U2YMKCP0FL7#W
M4AF,4H(&^,<=%SQU. 22233]"N=9AUJXL[R]G>SO/"3WGD3ZD]V\CAP!.P;(
MB+!S\B$IQP3BO2T\'^'4ECE71K/?':"Q0F,'$']SZ?K4=IX'\+6&W[)X?TZ$
MK$\6Y+=02KC# GJ<@8R><9'>@#S[PE_R#/A+_P!O7_I-+0-0U71/&^I^ );S
M4+B36Y4N]-OGO9&>WM6;][&"S$H41)MC#DD#(YKT5/!_AQ(K"(:+9>7I[;[5
M3$"(F]1GOW^O-9WASP]KD>KR:UXHU."]OT22WM([5-L4$+.&)P0"7.U 3V"@
M<\D@%SQW_P D\\2_]@JZ_P#135YU=:[<Z7\0]+CDU.]@TJ/P@;N:&*5B@95D
MS((\[2P"CMVKUR_T^SU2RELK^VCN+:52KQR+D$$8JF/#.A+?0WJZ19"XAMOL
MD3B!1LAQC8.,!<<8]"1T- 'CL-Y?36VHV3:C<7/VSP3=3O;-JDEX9)OE"R%2
M2$=E8G:G Y )'--\*KJVB67PUN-+U;49QJKF&ZL)IRT'D@$LRICY=JY.1Z#-
M>O:=X/\ #>D3VT^G:'86TUL'\F2*!0R;P QSUR0 ,]<<=#5K3M T?2)I9M-T
MJRLY91AWMX%C+#K@D#IGG'J2: /)+V_DMM%DLGOUT^PU#QC?VMU=N7V %I2J
M,$='VLP&2'7 7G@D'OO D%S9Q:I:3^(&UM([D-'-M<K$&4-Y:N\DC-C/=B1D
M>M;"^%O#R64]DNA:6MI<.'F@%I&$D8="RXP2/4U>LK"STVU6UL+2"UMT^[%!
M&$1?H!Q0!XC!=G0?#WCN?3+V>&Z_X2>2*9VO'#0V[21!Y0I;&<L1YF,X/)(%
M=OH-A;^&_B4^B://(NDW>DOJ$EHTS2JDWG*HD4L25W!FXS@[<]J[$:+I0N;N
MY&F68GO$V7,H@7=.N,8<XRPQQ@TFF:'I.BK(NE:796"RD&06MND0<CIG:!GJ
M: ."UBTTNT^.^C7L[>1-<:7+F3S64.ZLH4'Y@!QGC!ST([C#T/2I-)L_ NLP
MZUJ%Q<SZK-8L6NB\36\AF8KL^[_RS3..X]EQZS>Z'I.I7,-S?Z7975Q",12S
MVZ.R#_9)&1^%5X?"OAVV6!8- TN);>;[1"$LXU$<O'SK@<-\J\CGY1Z4 >.:
M#<7^O:W'J>N>,K/1/$=IJ[6TNF1[C/(-Z#[,N9]IB8A<;5*YY))R:[?XK*UO
M'X7U:7#:?INMV]Q=J20%7) DX_NYSZ<UV@T/21J9U,:79#4&&#="W3S2/]_&
M?UJY+#'/$T4T:21L,,CJ""/<&@#+OM8T9H-/$LD-XE]<QI:)$HF\UPP8,H&>
M$*[RW\.W/&*\J\R._P#!6I^+X[V3_A,+'4984GDG(,;"X(2VVD@"-D(&P\$L
M3UYKUO3M T;2)I9M,TBPLI91B1[:V2-G'7DJ!FG'0]).IC4SI=D=048%T;=/
M- _W\9_6@#S+3/"UGKWQB\8->7NJA=+ELYK98=0E3:9H&W\AMP')P%(P.!@<
M5RGANRGTUOAUK.BZE>SZMJ]SY.I(USO$EN.7#)TPJ[R/0Y/)P:]X&DVMK)>W
M6FVEE:ZC=*=]R+8$N^#M,FTJ7 /;</J*QO OA)/"?ARTLIX[&2_BC,4EW;0;
M#*N3MW$\GC'6@#S.RC:?PEX>\6V2R_\ ":SZJEM>3R-B:1FE>.2.1,X"[5.%
M(&U5&,8XGEM=+T>#QOXQO+S6GGTO4[BS@-O>LS1^;##%D;R1N!=>3T\M>#M
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MI&\*"*X?PWX<\?+J.DQ:MIFFV]A;Z--HK/'=;FCC^3$I7G);8N /0YV\5M^
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MR 2F(R>24Y3> /O[L'.WBM'Q!H&JZAXK\.ZQIEY9VZZ<+F.X6YB:3>DJI]T
MCG*#J1C.><8.#_PK[4IM,O/"MS>V<OA2>Y%R"P?[7S,)FAX(4*6W?..1G[O<
M &I\4?$&J^%_ &H:OH_DBYA**9)>L8=@FY5P0S!F7@X&,GM@\CJVHZKHWQCG
MU*#18[S4/^$4\V>UBOL1KBXY(D=1QA0.%&2>@Y-=UX_\-S^+O ^IZ':RQQ7%
MTJ>6\I(4,LBN,D G'RXZ5@KX.\3W7BB37=1O]+:>;P\^ER+#&X'FLP?(S_"&
M+#/7"CC). ";5/B5]FM-$.G:-->WNK:=_:,5MF3(CV!MN8XY"7.<#Y0O!RPX
MST.@>)8];\&VGB.2TGLXYK;[0\$H^9  <XX&X'&5.!N!![UR4G@7Q19Z?X9N
MM&UNRMM;TK3ETVXWPEK>6'Y<XSELC:#GC<0/N]*[BTTR1-#.GW]Y)>R2(ZSS
ML-I<N26P.=J_,0HR<  9.* .3TKX@ZGK-W:1V?A:Z>VOK:2:UNF\](U(7<@F
M9X J!QG#(TG..Q!I/!_Q$O\ QA=K;0>'&M7MI)(]4$]RP^QNK85!^[_>,>3@
M8VX.>V4\+>$O%^B(=/N_$MO)I5A$T>DA(29#\K*GGCY0RH",(#R0#E=O+M,^
M'MWH/B*TU?2-7AAED@*ZP9;5G_M&4MN:0C>-C$LY&#\N0,$<4 9>B_$K4H_"
MEUK.M6=N\DVKG3["&WD=B[ERH0A8BV% SD!V;GY0< W%^).K+HYN9_!U[%=K
MJ,-@L,S/ MP9&VJ\+2QJ2"1T8+C(R?1D?PPNSHU]IYUM82FL#5=)F2W#-:2A
MRVYAP),[B-N ![UHS^$O$>JZ)9IJOB2WDU2&]M[XL+'=!&T1#"-%#(Q7=G+$
MY/HO0 &-K_Q UO\ X1CQ?%;Z5;6&LZ((Q.KWC2!(I8]RR(RH,OZ+P ><\8/>
MW6HW6F^&KG4KZT1[JUM7GEM[20R!F52VU"5!.<<9 ZURVK?#R;4)/&LR:I&K
M>)(((U0VY @,2;1D[OFSWX&*ZD6FJ2>&FLYM21-6>U,9O8H1M28KC>J'J >0
M#Z4 <.OQ4G_X5W?>,1I=E<VENL!6*WU DAW<*\3YCRKIN0GC#!ACWOW?Q(73
M=:N;:^L%2SB\/#7!+'-N<_/M,>" ,DD '/;WXJR?"BUOO[=;4+FS3^U;);4Q
M:99-:0JZN9!,R>:V^0-M.<C@$'.XT@^%D]WJ$ESJ_B)[Q)=$;1I(TLDB^3=N
M5E.3C!P<')R.N.* *GCK4/$=S\/_ !#;:[H=M;0OIGVA);>X\U8G\P 0OD#+
M@8.Y1C@^V3X>^+]3CG\,^%M1TF**WN= @NK.ZBG+$HJ!<."H&3C=@'Y05SG/
M%YOAUK=[X7N=%UCQC)J :T^RVTKV"IY()7+, ^9&PN,ENY)R:OZ;X#GT[7?#
M6H?VM')'HNE#33%]D(,XVXW[M_R]%XP>AYYX +'B[Q?/H5_9:9IUD]W?744L
MYQ!-,(HTP,E8E9OF9E4'&!SD] >>O/B3KVE:!HOB'5O#,MEI<[F+4UDC?SK-
MPQ ;:0/D;C!(ZD#N,])XI\(76MZIINL:3K<NCZM8!XTG6!9DDB?&Y'0D;N@(
MYXY.,X(AN? \FIPVMIK.J_VI91I*\\5U;_-<3O\ =D;:P7"#A4VX'7J%( ";
MQ5J4-MH=JUI9_P!LZW*XM83,?+2)4,C.Q&2<(!PO!+ 9'6LW5?'6O:1!IME=
MZ JZS>7<L.R!9;F+R8]NZ=1&A<K\XP,9IO\ PK?5F\+Z1IK>+)!J6C3B73]3
M6S^:, %2CH7(<;2!VZ#.1D&?5/A[J>I:?ILI\77D?B&QN3<+JPMDY+*JLOE#
M "$(HVYP<'=NR: ,B;XG^(XO^$>LF\*+!JNJW<]MY5W+) G[O;\Z[DW;6W@@
MD=B,'K4-YX^\27L!TT6UII>N6&OV=E>Q;G=)(I7!C96P,*^"#U.T=MPQ0\7Z
M'JFG>+_ (;5GO=1%W<S76I3VP\L.1"JEHU("IA H4$=#SGFNPOOAY)>:?>NN
MN21ZW=W\&H/J7V9"%DAP(E6+@;%"C@DD\Y)S0!%<ZY:^'_&&M7NJ:99QW%KH
M$-W/>V[,7E4.XV $?+\P('4GY<G@!;,/BK7K>^T6/4M.L/L^M1,+:6"=@L4_
ME^8D<C,O1@& 8 G*_=JS-X)74-1O;C5[_P"W17FCQZ5,A@",P4LS2D@X#$N3
M@* .,=*2W\&W23:0USKDETFC1.MD'MU!,C(45Y2#\Y53@ !?4Y- '):-\5M;
MO8/"NH7NBV,6G:]>&R4QW+&4/O9-V",!<XXR2<'U%=-\63<K\,-=-LT:_P"C
MD2;\\H>"!CO^G6LFQ^$[6NB>%=,?7?,7P_?F]C<6FWS3O+A2-YP,D>O?IV['
MQ7H)\3^&;[1?M1M5NT\MI1'O*C.>!D>E ')7=[K^F^,5LM,T#09M:N],:XFN
M1(\0,<3A50G!)^\ /?&< 5)=^.-:AT&;Q5#96,N@V]S+%+"&<3F*.7RFF5C@
M=5<["H.,<YKHHO#UU_PE=KK]QJ,<DL-D]DT26^P.K.')R6.#E4Z>A]>,N3X?
M[K>\TU-:N5T.[O&NI-/\E" &<.T2L1\L9;)P!_$1WH Y?6/BKKVFWOBR2'2=
M-ET_PW<01S!YW66997*#;A2 >A)/3'1L\=5X7\4ZSJ?B.YTS5["SMU>PBU&U
M-M*SE8I&90CD@98;3D@ =N>M9M_\*H=07Q='+J\BQ^))X)90D S"(FW*%.[G
M)SDD=.U;^E^%9=-\00ZL=2,S)IL6G/$T  9(R6# @\-ECGJ/;I@ P_B"JGQC
MX!; W#57 ..<>7_]852D\67>C?\ "<7=IH6EP3V.H1HTDLPMU<.@Q-*S?>X*
M_*N"<X&2<GK_ !!X877M5T.^:[>!M)NOM*JJ!O,.,;3GH,9_.N?U7X6VVJKK
M:MJUQ$NJ7T5_\L2GRI4X'7AE([$>E ''^)?%^H>)?AS>RRVT,DEIXA@M8I5M
MVMUN%#(ZD)(6>,G<,Y['ODBMO4_%.O1V?B?PYXJTO1KF\BT234T2SFE6":U!
M*.C$C<'X.",9R.G6M23X8R7&G:G9W7BG4YQ?W,=Z7:*$%+E=F9.$Y'R* GW0
M!TSS6G<^"3?6^L/>ZK)<:CJEC_9S730(ODV_S91% '7>Q))/..P H X:&:*Z
M^(OPGNH[>.W\[1I7$$1^2-3;$A5!.<#)'/H/>B#6=3DT*]33X-*TBZ3QK'IT
M[VELY68B:,EV^<%LL>>1E?EXZUVEOX!2#4?"=Y_:L['PY;-;0(8UVRJR>62?
M0[0!QZ543X:"/2]4LQKMT)+W5EUB.X$*!H+D.&+ ="#M'!&!B@"2Y\8WGAOQ
MG'I7BB[TZ+3;FP:XM+R*VDCWRQ@&56)=@,#+ >A SG&[<M[K5!X'^V:U!:_V
MF;%IKB!8B(E<H6,94LV0/NGYN<$\9P.3\0:.GB76]&\)W.BZC?VVESQW5WK&
MH*-C($+ *00)&=@$8;2 "W' (]!O[47VG7-F9&C$\3Q%U RNX$9&?K0!Y#IO
MQ(GTSX?^$[X6ND:'::F]VDMQ'ITKVELZ2,$01QL"I?DYW?PL<'G'IT&IW)\&
MQ:K(UI+='3Q<LUN2T#OY>XE#G)0GISTKG+#X<RZ5X7L- LO$%P+2V2>-TFMH
MY4F$KA^5(QE2"0>3\Q[<5TEGX=L].\*+X=LFDBM$M3;(Y.YP"I&[G@GG/I[4
M >?>#?B1XDUJ^\)?VK::4+/Q$EZ$^RK(LD36^>3N8C!QC'XY[5ICQOKRZ#8^
M+#:Z=-H%U<I&UM&'6XAB>41I*)"=KDD@[-BXR!G@FKNC?#.QT1O"QM]2O'_X
M1[[3Y(D"8D\\'?G"\<GCT''O4MK\.K.TB73X]3O?["CNQ>1:3B/RE</YFPG;
MN,>_YMN>O4F@#%^%^HZUJ?B?QL^J7\-P+?4VMMJ0,@S'\@*?.0J[5^[R<\EC
MSGTVN:\.^#;;PWKFMZE:WMTZZM<M<R6\FW8CL<L1@9/.<9/ _.NEH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#R+QC>/_
M ,)QX96&.X>5M7ABW,R@&/>#P&+%T"QJVX8P68Y&_;7KM>8^-/-D\5^&0L\@
MF@U&U,_EC>=IE*J67;PHRZ[P%P9T!R&S7IU !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%>&OJ?B_P#L3Q1XC3Q?=L/#FMW-NMK+;1%;F*+8
M K[0H&1CH,=2!DT >Y45XVFL^-->U36=7L]9T_2X]'O5273[J=L0PIG<)8Q&
M2=_)#[LG'RXQ5JVE\4:MX@\97,?B^^M(-&N)4@MX[>!E*^464'<A'!QU!. >
M<G- 'K54-5U:'1X()9H;J833I JVT#2L"QQDA>0HZDUY/I$_B6^UOPMITGB_
M5%@UW0DOKDJD.^-U13B,E/ESGD\D\D^R^&?%?B'5/AQX;U&\U2?[:?$-O93L
M$53-$9@I1_E]#U&"<<YYH ]A:Y@0RAIXU,*[Y<N!L7GEO0<'KZ4^.1)8UDC=
M71P&5E.00>A!KQ'Q1I;PVWQ4N(]4U)3&\3;!<85P\"$JPQRH#%0/[H K3N[O
M7KG5]"\&:/JIL _A[[:EU-.0\DQ8* #@EM@#'8"!@DG[HH ]:FD$,,DI5V"*
M6VHNYC@= .YJGHNL6FOZ-:ZK8ES:W2>9&77:<>XKSK1-0UWQ'XC?PYJ7B)DF
ML=(21[K2755GG9RID&5Y  48P!G)QR .C^%JAOA9X?4YP;0#@X/4]Z .JCLK
M6*[FNX[:%+F8 2S+& \@ P-S=3@>M3UX%H'B[Q%=^#O!%_/JUX]Q=^)DLKB0
MR#$L+,,HR]3TZCISZBK4^O>(H;/6-97Q'J):P\7R:;%:GRS"T.]!AALW'@X^
M]@=@.: /7/$_B.Q\)^'KK6M169K6V"[A"FYB68* !P.I'4@5HVEREY907488
M)-&LBANH!&1G\Z\(\=ZE=>)/!GQ"O+O4KI&TK4TL(--C<+"L*S1 2,N,L7.Y
MLDG&..*UO,U_7]5O]/L/$R:0-'L;.2!6N&C"H8$=I64#$BY)!W9 P.E 'L-S
M:6U[$(KJWBGC#JX25 P#*<J<'N" 0>Q%.DGBA>%))%5IGV1@G[S;2V!^"L?P
MKS72X=;USXBZC"_BR\%C81:?>>1:JJQ2NRDLIXR(V"M\N>=X)SMK0\<6,%WX
MZ\"F>ZN;=?MEPN8;EHLGR&(&01U("^I#$=Z .KT?7+76I-32VCF0Z=>O92^:
MH7<ZJK$KSRN'')Q6G7B]_P#;]/L_&&NV>M7EF;/Q1$!!$RK$VXVZN7XRV0XX
M)(^7IR<FO:EKNK^-O$R6_BS_ (1[^PC"T$5Q,%01&,,TAC7*RAB2?FR0"H(4
M\4 >M:QJD.B:1=:G<QRO;VL;2S>4H+*BC+-C(S@#-<_/\1='L8[2?4K75+"S
MNB EY<V;"$;ON[G&0N<CDX_('$_BZ1I?A=KLCN'=]%N&9PI4,3"W.#R/H:P_
M&=WI8^!TYOFCEAN=*C2V&X'S)F0&+;SR=VUN/3- 'H=8$OBZQA\<0>$W@NOM
M\]H;Q)0J^5LRPZ[LYRI[5Y-H8UN[MK?POJ.N-H4]EH$!MHY[J>WD5W#_ #G8
MZ[BA$:[6R #TR"#;O[YK?XKZ1?W>J).T?@PS2ZA HVR$"4F50,#!Y8#@4 >V
MT5XUX%N]7N/&$&GZEJ-Y;V^I>'#*MO)JSW$[2>8H%Q\Q(B=U8L%0D #U!QS9
M\5^([1]/1AK$DOA&]D37I&U!_+FMS(/+>09.]B-W SPIX(("@'T317CE]>ZI
M<W&@R7%_J-M/KU_>7*::;V:WA6WCCPC-*&#HBH!*57 =G(PH QF:9?:OKC?#
M[3&\4:I%]MDU:WO9K6[.]Q"6V98YR=N,,>>01S@T >[5!>7MKIUG+>7MQ';V
MT*[I)96"JH]237A=E<ZY?ZMXAL;KQQ)I,^A7<=O!]K:9II88\+YFP2JLA<+N
M.4<L7X(R*[;XWVFHWOPOOXM/BDFVRQ/.D:[B8E;).!S@$*3Z $].0 :P\?Q/
MI!UJ+P[KLFCA/-%Z((@K1]=XC,@E*XYSLZ<].:Z^N&U_Q"L?P?EU[09(1$M@
MDL"L!,FW !C8-UXRIS@Y'/<5Q_B&>XU_Q);Z7JGBQ-$5=%@OK6>>0H&D8N7E
M7RY8@'3  #!QA2<#DD ]IHKP1?[0USQCJ6DS>+=8N;&/PO\ :EFMIWMUN'&P
M"3820 P.>/O>X)S8U:1_%2^$]"U[6;>VLK[PU#=+)?AW2XNCMW$[)8SY@ !&
MXD'<W&: /<5C1&=E15+G<Q QN. ,GUX 'X4ZO!KS3[O4_&_@O0Y?&.L7UG?Z
M;=6\][:SO;_:%C$I5P,D'.U,M\PD"*W(.2R2]2/QS#JSZM%');>*/[.^T7E\
M6NWA!*O"(U&U( 2,;N<Y8D9H ]DTG7TU76-:TT6DL$FESI"YD93YFY X88)P
M,$=>?7!XJEJ'C2SMO$P\-V-I=:EK'E":2WM]H$,9(^=W=@ .1P,GD<<U4\,?
M\C[XY_Z^[3_TECK%\*ZA;:3\6?&&D:G-'%J.HRP75FTAP;F$1X"J3UV=-O\
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MWR0S.,,0=RGDDD]@#U^YU?3[/4;+3KB[C2\OF9;: G+R;5+L0/0!3DGCH.I
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M@ #@YZXZUAV?C:Y/CO79]0BU33M(TW0TNI;*^CC#*^XMO386!RG'WL[LCM@
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MF^T0IY"XCEY^=1CAN3R.>320:+I5M]J\C3+.+[6=UQY<"KYQ]7P/FZ]ZO44
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M!+.>W;5H+,MY2^;&0VXJ,KDA2!]T_*&).17H] !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %>./H7B&#P=XOLSX?O7N+_Q1]N@C1XB3"9HI-WW
M\=$P<9P2.P8K['10!XTWA;6[?QEJ=G-X&T?5-/U6^:YAUFZCADEM%D8-)O#
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MM:U%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% 'EGC2VD?QUX-NY9I&C^WQN5DM'
M4Q@?(/W@8<EG4%0N#G<WRC!]3KS'QLC2^-/#DKR03);7]OMA W-&6N-K2YWJ
M?EW1)SN ,WW22,>G4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 44@922 02IP<'H:6@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH \A\:QS2^-/#S7%K:7+27
M\,<5Q.X41-OCD!B90'XY&WT8$YP6KUZO)_%UU-;>.O#$-M;\'4X?MA;)FP[G
M8X(&U$R'4G(+?,JY4ON]8H **** "BBB@ HHHH **** "BBB@ HHHH ****
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MJ\>K^'-2L;_3;,7QM \<K30;MK.C*VW"G&[G@>O2JMO\6K.?1Q?OHFI6YN#
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M\;7/AR/PYJ,JVDJ"ZO$9&2&)P")B%)^3!!ZY Z@'Y:Y^UM-?\0R_$'P_I/\
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M\+>&AIUTT&\W$LPBMV9HH%9B5C1F^8A1@9(% '34444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 >5^,KB>_U[PW
M!*)!:0:C%'<1S*Z><&N(U *N!Y@#J,$%P<@X;'F+ZI7D_BRTW^,]"WF!?*U2
M&:7S(=SL&N<(JN<*A&$8# 8J7 8YVOZQ0 4444 %%%% !1110 4444 %%%%
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MU(@I8(7VMMD8HV!PK $GC'!Q@_%.2.TU+P9J5XC_ -F6>LH]S+CY(<\([GH
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M<C#AAS@XZ'CK6Q45M;Q6EM';P*5BB4*BEB< =!D\U+0 4444 %%%% !1110
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MO['@GH#D$Y!K+&MQ:-\1O$9OM;N#I5KI,-Y-#.Q9+=B[YV +TVA3CDDM@9Z
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M^#5M)N].N5#074+PN",\,"/ZU;JI%J=C-J<^FQW4;7MNBR2P _,JMG!QZ<4
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M+/6K6\BB"$R-OBG5F#-&!AN%;))'J#5U/P5X@O\ 7O'<'D6_V/Q#8VPBOA*
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M/XLYX8_EC/'>KND>#YM/FTLWNN7FH0Z4K"SCE55VL4,>YR.78(S*,_WCWQ@
MS?A%JNMZ[\/[35=;O8[N6YEF:-Q&5? E<'><XZ@@!0 % %8MU\1M7L_&\%M-
M]E-A+K2Z1]AC@=V1&)5)VN1\@<LI/E=0OODCL?!'A,^"_#Z:,FISWUM$[& 2
MQHOE!B6(&T9.6+'))Z]JYZX^%;SR@+XHU&*UBU?^U[>!886\J;>6)WLI9CAB
M!N)'<@]* .<O_B7XWM+76M=&G:(VB:'K,FGW<:M)YTB!T4;2>,C</FXY;[N
M:U=?\7^/+;4O$QTNTT)M.\.NLL_G&02S0F)9=J\XW!2<GCMCISF>$O"C>,+;
MQ=::C=ZA;:+=>))[F2Q:T,#3KN5U.]U#+DA<KU&W^$G-;%MH=WXD\7>/+;[=
M?6.EW<]O;S(;(IYZBW5'V.ZCK@C(R,$$<$$@#);F]OOC(;K2?L\=[-X,$ML+
ML,T8<W.5#[2#CL2/UZ5>\.^,]=\0#1+2)-.74Q<SIKT)B8&S2)L853)D%LH
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M3-&G#+')(RKO=0V"=H[<9S5?_A5_@TZ"-#;1@^G";SUA>YE8HY&"58ON7/<
M@'O70Z/H^GZ!I-OI>EVRVUE;@B*)23MR23R22<DDY/K0!>HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MO Z  8P ,0^$3_PB[^&=6U,3Q>$4N]0-C<7,)'DK)M\F208^7>H.UN?O'L:
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MSP3Y8)!/' %<K-:OJ'PU\2Z;I5Y9Z]:Z?I5N8=5@A>W?RDF$K12*QV[D5&(
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M:%FC#1OOVX&WY59L=0%YYKUWQG&=;^&>M^5'<QM/IDLD<;*8Y,["RJ5/(S@
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M&=W?Y@<<5O4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110!YE\0+I4U;3@MG'+*MRAE=Y<& E\PML7)<,8@,9P!U7YOE]-KR
M_P 7WEM<WNB2V_EW=GJ&IP6R7&X,@D%P9-H+$'=F%TP#\N2 %+UZA0 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !37C25"DB*ZGJK#(-.HH *:
M\:2*%D16 (;##/(.0?P(!IU% '-7/@^*X^(5GXN^VR)-;61LS;A 5=27.<]0
M<O\ I72T44 %)M4L&P-P& <<X_R!2T4 %%%% !1110 4444 %%%% !1110!Q
M=M\-K*U+PQZ[KW]G/*\K:=]K40'<Q9EX0. 6)/##K791QI%&L<:*B( JJHP
M!T %.HH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** (KFV@O+=[>Z@CG@<8>.5 RL/<'@U(JJBA5 "@8  X I
M:* "LO6= L=>-B;[SR+*Y2ZB6*9D!D0Y7< ><'!Y[BM2B@ HHHH *B6V@6Y>
MY6",7#J$>4(-S*.@)ZD#)J6B@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "J6KZ39:[I5QIFHPF:SN%VRQAV3<,YQE2".G8U=HH C@@CMK>*WA
M7;%$@1%SG  P!S4E%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110!Y3X\U&UM+W3[BYA\J[27RH8WE<R,.XP
M&P^%<MR>"F%))4MZM7DOQ+@M;C4-#O;^*66ZM[CBWA?8 S. @+-G'\(.%<-G
M&T!@P]:H **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BO+OC5XNU+P[H-K#H<TD=\)DN[AH_^6=NCA?G
M(.0&D:-?]H;ATS6QXTUC^TOA'>:_I%U<1,UDMY;S6TS1LIX/)4@\<Y!XX.10
M!W-%?.=QXKU#3M*\'77A'Q-J&M^(KU ;_3I[UKI7<KN96B)^3!)7C;\H!_VJ
M[/XKZ5JFE^&?$OBB+Q%K%O.DMO\ 8H+2_DBBBC)AC8% 0-Q8R'/N* /6:*\D
M@T6_M_A5<:^/$6MRO<>&OMC>;J4Q>.Y$0E#H=W )R"/3CG/'+Z5\1-1\+_!"
M'6);N\O=;U*[DMX)KJ>2;9M)^?\ >$C  Q@8SD>AH ^@Z*\X;P1K,O@ ^1XB
MUL>)Y;7S#</J,R*96&2GEEBJ#G&0H(ZC%8K-=M^T0VC_ -JZL-,:R:Z:T&HS
M^69"I)XW\#)X P!@8% 'L-%<?\46FA^'.L75K=W=I<VT7G136MP\+JP([J1D
M<G@\?I7$>![J/Q%J&@QZ7KNMOJ%A96UYJWVG5+AXI6=1N0QOD$\AAM('.#0!
M[/17(_$^6:W^'.M75M<W-M<6\'FQ2VT[Q.K CNI!_#I7%PZ'K>O_  .L;_2=
M:UQ?$!@^UK(FJ3EIVZ,ARQX*C@#&& ]3D ]BHKQ7X9:S-\1K?38KK4-4@_L*
MV*7HCU29'OI7.$9MI!*@*Q))SN('W0<^U4 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!Y)\1IK
MFYU?2;7,SVT4[7$2O*FQS&)(W4E7W$@,"!C<1OSPK%?6Z\I^(4<LGB#2T:1E
M,AVHUON39$[C/FIM8L,@D@$%F5#@;6(]6H **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M !L<@'(S2T4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MGYL= >_MG% 'G'A'QC-K$FB^*-2\1ZA91ZC>O9MI4E@[6KEVD2".*7RP"P*
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MX[9YX!P<9&EZ;XPM_ GAJVF\*2+=>']5A<6XO8RUU&%D1F'9<%QU."!G..:
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M.H6&LVLS1W7V>..6WFB7<V-O&S!&-P8\@9."2 =#!XPT&ZUQ='@U!9+UW>-
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M^U6TMLWFQA]NPX&1@[@,Y[_2@"WJOP]\*:W?7%YJ.BP3SW$:QRL690P52JG
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M%KJZM>&XMSCRS&RK/M/_ "S5GSD@<@$ C!KS_P")UC%_8/BVYTN!%TF>^L!
M(HBJ/<*K+(T8Z="@)7@GOG-?0M% 'C'B'1O!ND?%GP]!<:3ID>FOIUQ(T*V@
M>-F+$J2H!!'+8R,#MVJEX2MKGP[-H.HW<%\OA@:GJ!M(IK,AK1),>1(XZX(#
MX;'&_P!#7J-YX3%WX]T_Q3_:$R-9VKVPM BE'#;LDGJ#DKT_NCWK?2>&2:2%
M)8VEBQYB*P+)GD9';- 'A.M:5;SV=BKV&_3+OQPES;Q-;M@V94+*P4C(C+YX
MP >O((J/XH+:VK^(='@TB73H[;2K>.R^S6S2+>PB3S&RVQEBCC8DX&TD@9<
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MV?B/2+BXE.V.*&^C=W/H &R: ,7XLZ7>ZU\,-:L=.MY+BZ=(G2*-2S/LE1R
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MLK1>%K"22"=&CLXR\+1D2 A!E=O7/&,5Y?\ #&^UOPG\-18OX3UN;4_-E>*
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MC*!^&!R>N.*Y3P%JFN://\/-/;4A-I6MV%P#9&U5! 8HPX8/RS$Y[G')( R
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MD CYC@YXH ]KHKQ3P=;^'-!O_#$Z7KVMSJWA23[3,+G<SNODL-HR2&4"4#C
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M0R^5(&V2+]Y&QT8=P>14]>16'C:\L8M3L]-T_28=4OO%]QI<)\MHXC@*6GD
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M8BVX$A64[E))'/.<<=:VSJMBNLII!N%^WO;M=+!@Y\I6"EL]!RP'OSCH:N4
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MG<,,3TQZT <%+\++2XT_5;>75;D37>L'6;:XA01O9W!(R4.>>F.?;N,TZ_\
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M1X42[@9I@6B59 3(!U*^OX57M]>T>[@N9[;5;&:&U)6XDCN$982.H<@_+^-
M',Z]\,-$U70-,TK3GGT;^RY?-LI[%L/$W?D\G/7.<Y .>N9Y/ 4;Z1HED-:U
M$3:7>I?&[9EDEN91D%I&<$G(9A[# Y %=$VL:8MK/=-J-F+:W ,TQG79&" 1
MN.<#@@\^M3VEW;7]K'=6=Q%<6\HW1RPN'1QZ@C@T >=3?!G3))G\O7=:@MAJ
M8U*&VBN-J0R?Q;<#.?1OO+C@]2>J?P=IDGC6+Q0R!KN.Q:RVLN0P)SO)/5@-
MRY[AOI4&C^)+F36?$UIK$EC!;Z1<1)'.I,:['B5P7+-C/S =OQK67Q#HC:?%
MJ"ZQIYLII/*CN1<IY;OG&T-G!.0>!Z4 <S%\,=+MO TGAFSN9[0-=_;$O(/E
MECF$@=67T*@*H/H/7FJ%W\(K6[TG6;%_$6L-_:[PR7,DKI(7:/!.05[D*>,$
M;0 0N0>Y36M*DO)[--3LVNK>,2SPB=2\2$ AF7.0,$')XY%6+2[MK^UCNK.X
MBN+>4;HY87#HX]01P: .7\6> K?Q3-IUV-6U+3M2L04COK*7RY61OO D =?;
M'4]N*Z'2-,@T;2K?3[=Y)$A7!EE;=)*Q.6=SW=F)9CW))J[10 4444 %%%%
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MZ38:NCWCJ.(SN0JY."<#:W'?..N*]&N-0TLFR2:>WD-U*/LJ\.9''S90#.<
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MVULMSYDR.Z)OSS@(2!M'4$2 \BO9+C0='NK>TM[C2K&:"SQ]FCDMT98,# V
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MT59=R[3N3J5 YXP3SD '1:EX_L]/U^+1XM(UC4)Y;:*[5[&!94\EVV!S\X(
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M7+@X(XV 8[^HK$T[P1K%KH=KX:GU"QET.TO8IHV:$M,\$<HE6)APOWE4%N>
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MBBB@ HHIJNKLZJ<E#M;V. ?Y$4 .HHHH **** "BBB@ HHHH **** "BBB@
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MD,2<; V?O=\?_K.M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M\LIP"TC-DOPH'/;BFGX?:(=)O=/!O%2[U$ZH\R7++*MSE3O5AR.5% '4J"%
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M?8&57/(."=N.<G(Y.:Z+X7VDT^L:GK%J=;M]#:"*&VMM3N)7W38!FD57;GD
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M=&**6P0&!Y QUXSGGI7E/BB6.+QEXGT[6/#'B'4;'7UM6L'T_>@DV1*"K_,
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MQ#\*WUA)>V>JBYACN5M?W$$DCO*PR%1%4LYQD_*#P#Z&O,IX;C5_"WB/58O
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M C$>XJ>ZCRV.>G([G%;?C+1VOO$VAZGI6J?8-9O1_95Y"-HD:V=&D<X&2'0
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M'7;GD^U6],TCQWJW@O4=)UZ"QL&33)M.B2$K(]ZQB*)(S X103T')).0H !
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M@N)'C4N#F1W\M3_$W&T]N37H6C07-IHEC;7BQ+<0P)'((9"Z948X)52>GH*
M+U%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% 'E'QFA
ML]0T0VZW,G]I0N7M4CY$;;55BY*X1664#KDOY>WYB0?5Z\N^*MK%>7%@DUY"
MD<S+'';.0J7KB11Y+-CGJS $D;E7*\<^HT %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 445P&H>,M8DL/$VKZ,EA)8^'KF2WEMIXF,EP8D1Y2)
M X"8W,!\K9V^^* .ZN;F"SMI+FZGC@MXE+R2RN%5%'4DG@"DM+NVO[6.ZL[B
M*XMY1NCEA<.CCU!'!KQ_7-:US4]5\:P/J49TE?"[W,=F8#\BR0L0 0^-P."6
M(.1D +4GPT\4:MI6F^&=(U**Q_LFZTB:YAFA#^;&(CD[^QX/0 ?4T >Q45Y/
MX=^(/C;6M8TP-X7D72M3MW>.Y-DZ+;N5+(6D$C!X_N_,0A;.0.,'HOASXA\3
M^*M&M];UBVTNWL+J#,$=N)!-O#E26#9&T@9&">"* .VHKS/6?%OCB+4O%D>D
M6&C36V@&-_WRRF2=&B60JH#?>"D\]^ !52;XIZSJU]J$'A313?\ V*UM9L+"
M95E>4*Y4N'78 NX [6R0>F & /5Z*X*V\1>+]6\9W&GZ?;:3;Z;:+97%RE^D
MJW*Q3!BRC8Q7S%V$>F?6L33?BK>2Z%?:U=2Z4ZV>GS2SZ6JF"\M[E)%14=6D
M;,9W8W[0>G )VT >L45R+ZYKNF>*]+T74A8S1ZI;R""[@@>,1W$:%F4J78L"
M!D<KT(R37)^'OB/XHNM0\&'5[/2UL_$@G 2TCD\V(QCALER,'*G&,@9[T >M
M45QWCGQ;=>'[G1M,TZVFN+_5995000":18XTW.50LBEN5ZM@9)PV,'G-1\<>
M-]%\'VOB+4-#@C@M;WRM3AEA*S-;;E FC E(4G."IW8)S]T$T >DZGJ=CHVG
MR7^I74=K:1%0\TIPJ[F"C)^I _&K=>>ZGX@U"Y^%\6OWMKI<_P!IN;:6.UDA
M+QB%[A!&&Q(07 *MNSC(QCBG7WC6_M_B+)X<>ZT_3OWMK]E2_A<"^A?'FF*0
M$ 2 Y55(() '.3@ [?4-0M-*L)KZ^G2"U@7=)*_11ZFIXY$EC62-U=' 964Y
M!!Z$&O'HM=U@>"OB-J5[)8:A]CUFZ@$%W:;XV6,1(HV[L;=H'!!YY)))JSXE
M\;>+8-5N;32Y]+ACB\,?VZ3+;,67:V&0'<0<X.,C@'U&2 >M45Y9%\0]7U9?
M"%M#)8:5-K-C)>3W4R%XPT:G**I(P"1G))('OR>P\"ZOJ>O^#[#6-6-J+B]0
M3*EM T:HA' ^9V+'J<\<$<<9(!T=%>0V'Q'\0GQ?I.G7/V&>*^O9[.?[+"SV
M\!3A/+GR ['&\KS@$ [3P.K^%\NI7/@U;K4K\7DLUW=-N\K801<2!NAZ$C('
M;..F, '5WU]:Z98S7M[/';VL"%Y)9#A5 [FI898YX8YHF#QR*&5AT((R#7EF
MHMJCP_%-+W5&NH;73FACC,*K@-:>8,$=,;V&.^<U#:>,O$GAC4;:SU?[#=:<
M_AQ]3C%O"4:(Q(28P2Q+< 9) R6XQC% 'KE,FBCGADAE4/'(I5E/0@C!%>?^
M%O$/C*_U?29=1TPKH^IVOFR22B!/(DV;U$129F=".,,H;C/][&?XOEU*3XW^
M"[&+43%;M%<S1IY*L$81.&/OD#'/3/% '5^";+PII5A=:3X66 +8SM!=[ 3)
MYJD@^8QY8YS[8X'&*ZBO$8_'&M:=I_BUM/CTRVFM_% LU=+(*&#R%6=@I&YS
MM&6))/ZC3U#Q'XYBG\:6D.L:3O\ #<,=Z9?[/(,Z/"9/+ \P[ -K<G<3QT%
M'K=%>2WWC_Q9K%[ING>&=.B>YN-"AU28*8]Z22=%'FLH,8R,D9.2!D<UU\'B
M?4;'X<3^(]=T^&'4+6VFFFM+>8.A9"P50Z[@,X&3SMR<]#0!U=8K^+-$CUP:
M,U[_ *=Y@B*+$Y57*[@A<#:&(.<$YKE5\1>(M,G\)ZEJ&H6-[I>O2I;2PP0%
M3!+,A>(QL,[D&""6[8/?C(^$5K,?$7CP7-R)U36Y0ZM$H#R"0GS/8Y' ' H
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M25GB5C(@PKD@<CV-3T (JJBA5 "@8  X I:** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** /,?B;=^4+1_FN(;B4(
MR^3@)'@+]X@XSO=@VQ\E0 OWF'IU>5?$^%&ED\Z:P5I(F$4<T@DDS\I=D1L*
M&'E0'G=P7XP2P]5H **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M*RKDL0#@'#*-QKM- T.T\-Z':Z38F5H+<'#S2%W=F8LS,3U+,23VYX '%:5
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MI;"[B5$/G*Y39&ZX52=ZGY..1SZG:7<%_907EK*LMO/&LL4B]'1AD$?4&IJ
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M! &1ACR0,*><X4P>(?AOJVKZGXC^Q>((['3-<BA\Z 6V]E>*/RU49. A&"2
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M;_"62"RA@/B>[EDCUK^VS+);QDO<   G]<\X.>@H S[SQ]XUL8O$GF6NA/\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH \\^*EVI\,^1) )DF=HBGD!FB!)0REF=#&I7<FX9SY
MFT$[AGN["19=.MI$965XD8,JX!! Y P,?E7E_P 2Y[RVEBEFNFLHU<@M$7GR
MNYI!A6(RVV(, @(##:QQB1?3=+D$ND64@QAX$;CIRHH MT444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 >2?$V*
M[LM/>_AE=;28RQZA,9=\84Q,I2,LK>4Y?*JQP%;Y20& /I>@RS3^'M,FN2IG
MDM(FD*H%!8H"<*"0.>V37 _$>86VD+'9WDOVHSNWV>6X4*8U#[HU4 JV1@[7
M^4*F3@@ ^@:+$L.A:?$BQ*B6T:J(69D "@?*6Y(]"><=: +U%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% 'F?Q
M(=3$+ERTOD^7;7,=M)N!AD9E8.GEDD%@H(W<':3G&&[_ $>)8=$L(DC,2);1
MJJ$@E0%'&0 #CV%</XO^US2:<)DU&U5UD29H;E1(R[79UV MO'$9^488E5)4
M9 [VP.=.MCF0YB3F0Y8\#KR>?Q/UH L4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 >8?$K4K=5ETQM.CFN9D8
M0,;L(X=TD4$J&S)G^%, @ E2&"X]$TMS)I%DY():!#D=/NCW/\S7 _$:&WFT
MN6S:Z,,4,+1&*W4EI%(W^4%QY:+L3[S\ A<@97/?Z;";?2K. F,F.!$)C)*\
M*!P3U% %JBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110!PGQ!:>;3X4M;*.80W.
MR5[F9$\DOA0R;\Y;YP 55FRX0#YF%=1X<$(\+Z2+=2D LH?+4Q["%V# V_P\
M=NU87CVVN9+"$6^W9+($E+QM(!DKM[[$&>Y!.0N #AEW?#@V^%])7RTCQ90C
M8B!57Y!P . /84 :=%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% ',>-N-'6Z+F*&S=I9Y6<(@01MPP8@.I8K\I
MR"0,\BM3PZXD\-Z:<@E;9$;$OF\J #\Y)+<@\DY]>:H^, YT=D6YNK=)&59I
M89!&(X0<R,7(.T[0<>K;1P"U:.APO!HEG%)-Y[K&-TOE>7O/KMR<9]CCTXH
MT**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** (+O88?+>*202';MCSD\9Y/&!QW(].^*I^'X9K?0[6&99 T:[1Y
MOW\9XW<=??G/7)S6G10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
8% !1110 4444 %%%% !1110 4444 ?_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>9
<FILENAME>ex3-1_007.jpg
<TEXT>
begin 644 ex3-1_007.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 2X Z0# 2(  A$! Q$!_\0
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 <KX&2V6TU22VVXGU"6:
M1M@1I)#C<[  8)(P1C@J>3755S?@]T>VO JWF])0LLETBHTK[ =X &3E&0Y)
M)_A)^6NDH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** .4\$QI'_:ZLX^U+=E9HUE9E5L9.U6'R@NS\ L.."!
M\B]77*>#9+IKO75N#<>6MZ3 9G#%T(SOQ_"6)/& -NS Y-=70 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** .2\$2P.=5C5(TNXYU%V-I60O
MM^5G'0?)L '7"\\\#K:Y?P9)?-%J*7DLDBK<LT+-%Y8*,200I^;D8;+=V/)K
MJ* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@#F/"S7K:EJPU">WEG5D7$,2H5&7X;!Y/).<#@CKR3T]<SX61
M8=0UF% VQ)U"EH@@P 4(3DDIN1B 0 &+@< 8Z:@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH Y+P9<R7%YK6
M[R63SU97CG:0M]X'JQPN5.W'4$$X)('6UQG@>4/J>OJ)'=1.A3$F^/9\P&PY
M/&5;CCC'KD]G0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 <KX:GAF\3Z^()8YDV6SF:-54.Y#ALX4'(*X/W
M@,8SD,!U5<EX3>237-:^U7KW=Y$L,,KF,QKM#S,A53S@JX.1E22=IZJO6T %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** .(\,Q6R^-=3EMGM2DD)8JK*)58N&)*KUSN
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MR0!7.2^,O$.@^(+U-6U"^2]2"^NX+=H8I;#4(XH9'C$;J T6T*"PY)/7&<
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MQN8RL);!WCIG(&,^A/0:E'JWAV7X<:9+K%_+.]V8K]WNG?[2Q3<V\DY90V<
M\ 8]!0!W/B'Q!:^&M/6^O(;F2%I4B/D1[MI=@H)R0 ,D#KWK6KP_6(#XC\&Z
MGXJN-7U/[8NN1PM8+=.MO"B7:1)$T?W6^4J^< [CGU!)[K5?$FO^(=4;Q+%I
M4F@ZRR1Q&YF+1V\6%&+=3AQ(21T)8G:..* /5_%7B6T\(^';G7+^&XEM;8IY
MBVZJ7^9@HP&('5AWK0N;Q;?3)KZ.&:Y6.%IEB@7=)* ,A5!QECT XY->'?$A
MAXC\)>.=3O;BY2\T;48K&VM$NB(T@WQ89HU.#O+,V6!/R*!C;BO5Y4D?X;LL
M5Q-;R'2?EF@;;(A\KJI['W[4 ;=A=?;M.MKS[//;^?$DODW";)(]P!VNO9AG
M!'8U8KQ."QF\0:SX"TNZU74X[.\\+H]Q';W;('944[O8DGDCD@ $XXKM_A1=
M23_#VRAGNWNKBTFN+665P024F<+G_@.WU^N: -37/&>E:%9/=2&2Z2.^CL)1
M:[6,4K@$!LD=-RYQDC/2MF_N6LM.N;I+>6Y:")Y!!",O(5!.U1W)Q@?6OG3^
MQ-,7PKXTM[>2:&XMO%8@0K=.76'ST1<;B06!)^;EO7@5Z#INC_V5J/Q!T:+4
M]5EM5L+>XC:>]=Y(Y'28LROG()*J2>^.>* /2K"Y:]TZVNGMY;9IXDD,$PP\
M98 [6'8C.#]*==W<%A93WEU*L5O!&TLLC=$11DD_0"O$-;6_O/"VA7?GC4K6
MS\*0S7U@)C!<VRNH/VR&4\.X\H@J3T4C!\PU[)>SV=YX;N+B97DLIK1G=0/F
M:,H21@]\&@#)TSQFNI7&EJ=!UBTM]4!-K=7"0^6V(S(,A9&9<JI(W**Z>O'-
M&CUCX<:CH5KIFL0ZUX1UJ_6WM;:7=]IMQ*"0R'IL7 +=!R?E!.1A^"Y+;6=?
MTO5]2\2V5GXGAU69;NP2VE^TRL\A!A+F;!B"J" J[4]R3N /?Z*\-\)7>AZG
M%I>K7VHM%\0(;^\BEM('VR7$[,S".48R8555Q@A%Y&<Y%6M)B@/ASP5XAL_*
M3Q+<:Q'%?3QJ&GG$CL+B.3.6.%).#R@08VXX /:*R/%&NKX9\,W^M/;/<K9Q
M>88D8*6Y ZGIUKP[7= TRS@US7;=I8KNR\8""&1+AE2*-Q$74*#M'WL'C.%
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MS(;9) 6W*"67ZC!R.HP?0T 95Q\/K>]AFCO]?UN\%Q<1S3^=+%^^5,D0L%C
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MG!83ZFS65C'@W-XR1A%]R  !GUR?<UMPS1W$,<T,B212*'1T8%64C(((Z@T
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MN9 AA$GF8SY>=V>,8QWSVJ['X-U[3K+Q!H=A/IT^C:N\TD<MT[B6T\X-YB[
MI$HYX)=3R<YKK]5UVQTBPU&[FD\S^S[?[3<0PD-*D>&(.W/&=K8SUVGTJ;2=
M2AUG1K'5+=9%@O;>.XC60 ,%=0P!P2,X/J: . U?X:WFHZY<;+BU32I/#/\
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MCCJ.XHH \W/PZUFU\.^%X]*UZ*TUK0$DCCG\@O#,DF ZLI/H!SSR.W!$VJ^
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M)R/44 :]%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MGJ2: .02^\;>(M5U74=(U?3[6'2M8FMC%/>;8EAB;:RR1"$D[@"VXR C=QC
MK2T+4=1\1P#7QXDELWAUB2SN+ 1J8HXQ+Y:PD;<F0YC;>>[^F -Z?X=>$KGQ
M%_;\NC1-J7FK.91(X4R#HQ0-L)[Y(Z\]:6/X>>$XO$[>)$T6$:LTIF,Y=R/,
M/5]F=H;OG&<\]>: /-KZ^UKPYX$^).KVVLW@U"+7VC25RKX0F!1@$$ ['V\8
MP%7 &!75V=]JGBJ]U6P;7[C2YK&RMGMQ!Y:^8TD(<SN"I)4,VW (7Y3WZ=#?
M> O#.I+JJW>F^8-5='O )Y%\PJ00>&&WE5)VXSM&<X%2W?@KP_>R0236!\V"
M 6RRQSR1NT(&/+=E8%T]58D'OF@#SO2O$7B'Q?J_A&&XU'4=%75-&FFN8[4(
MK.R/@2+OC.T. &&!T88/<]C\*M8OM>^&FCZEJ5PUQ>2B422MU;;*Z@G\%%;C
M^&=(?5+;4OLFR[M;9K2!XI'C$41ZJJJ0!]<9'&#Q5C2-'T_0=/2PTNUCM;1"
M66*/.T$G)Q^- 'B-_P"*O$6CW?B#P]_:.H7>KZ3J?VZ-O,9B^G! Y5BHP?E*
MYX!R_7 KI]5\17NL?#+Q'XQTG4K^SMYPDNG ,H:-(PJL"IW;29?-!P>0JXZG
M/ICZ?9RW3W4EM&\[P^0[LN2T>2=I]1DGCWJE+X9T6;04T)M/B&E( HM$RL>!
MS@@$9YYY[\]: /+-4LEC\3?%EFU"ZD9=%62.$7#L@5K:7<KCIP3E5[!N/:]X
M)GU'2]:\$V0U6ZN+'4_#BRR6\\BE49$0KL0 ;  V,XRP')8C-=[>>"O#>H7[
M7UYH]M/=-;FV,L@);RR,%>OIQGK@D=":EM?">A65QIUQ;Z9#'-IR-'9N,DPJ
MV=P7)Z'<?SH YOQ]JK'7- \/6E[=)>7KRRM:P3M:B6-(V.7N%^:-5(W?*&)Q
MC'-<GX9U;6/$>@?#7[1KM_%/=RWL5U)!-M:9(UE"[_[QQ$/F.3G)Z\UZMJ_A
MW1M>:U;5M,M;UK5_,@,\88H>,X]C@9'0X&>E5K;P;X;LWMGMM%LX7MIVN(6C
MB"E9&ZMD=3T'/8#TH \[TVVUW7? _BBTLM9U1M1T+7;N#3I/MDHDECC*L(I&
M4[I,@L.>>1C&*ZKP%K<GC!KCQ,L5]:V+P16=K;W#N%<H"\DP4G:<LX3=R?W/
M7D@6=8\.ZO8VOE^!WTO29KN]-Q?RSPEBVX?,R@ @MG!P<#CJ._1:781Z7I5K
M8QD%8(E3<!C<0.6^I.2?K0!YUJM^NM^._$V@ZKX@O-!6QMK672YK>\:VR""T
MLG4+(-VU3NS@ XP<FLR+4;K7]8\:0:EK%Y:C2--@GTIH[HP%$,+.UP0I 8GY
M<DYP&*\ D5Z?J7AO0]9NH+K4]'L;R>#_ %<EQ;J[*.>,D=.2<=,\]:??:!HV
MIW,=S?Z187=Q$<QRW%LDC(?8D9'0?E0!YQ%;ZAXNUWPY#>:[K>GM>^%UO;G^
MSKQK?=-NB&=OW1]]N@';M7+/I;7-CXL\3KK.HC7-#\1W,&E^9?L44;HU6/#'
MHP^0\C( '05[L=+T\ZF-3-A:G4%3RQ=&%?-"?W=^,X]LURG@_P "0Z)J6M:G
MJ=CI<^H7FKW%];721AY88Y#PF]E!&.>G'S'\0#B]1NH]7M?'VJ:EJ,MMK_AV
M[G.F2K=;#:Q!!Y00 X'F$%6XRV0#G %7;+0I_%7BRSM]?O=6CDE\.:??7EJ+
MAHE:Z#MDM$?E7!7.P #=DXSS7I]UHNE7M]#?7>F6<]Y"-L5Q+ K21CGA6(R.
MIZ>M2KIUDFH2:@EG;K>R((WN1$HD9!T4MC)'M0!X-X:DTBY\;>&M0AU"SVZQ
M+?178:_+7EQ')&^Q;@ @ ;E4*N.#MY+"N:T74%TSX1:8+:Y6WMKG6U77)(?G
MD%N<A1(@.2C .,8PVW'L?I:/0-&AE$L6D6"2";[0'6V0$2\_/G'WOF//7D^M
M2_V3IIAN83I]IY5TY>X3R5VRL>27&/F/N: .4^&>G6&E:1J-GI.N#5]/2^=H
MGC4>3"657,<1#$%1N!XX!+=\UY=?ZYH=SXO_ +:%_;0SP^*X(O,U*4?;5C4J
M)  "!%;*"X&X-G!R0<5]!6EI;6%K':V=O%;V\0VQQ0H$1!Z #@5%+I>GSRRR
MS6%K))*%$CO"I+@=,DCG':@#QB#5?"NJ^(]3D\17=\/$EGXAQIK6^3/)!N)@
MCB !'DE<YZ [@2<N"<9;#PW9>#_BC8&UM8-5AO[KRH_*Q(EJLD9B ]$WXP!U
MX.#@5]!FPLS>B]-I ;L#:)_+&_'/&[KW/YFD;3K)Q,'L[=A.09LQ*?,(Z;N.
M<>] 'G&K/H&K_$ZZL_%9L9],DT=6TO[6R>206/G,C$X$G"\@AL+GH,URVD:?
MIVJWOPZ3Q&[S37FG7\3&=RCW%LK;K<2;3]WRR2,]>^37M\FF6$T$<$ME;/#'
M]R-HE*K]!CBI&M+9[I+IK>)KA!M64H"ZCG@'J.I_.@#RCX7^*-#\,^"K2PO]
M2$4<NKW%E9AMS@9<E02,A0<YR<#G/J:V_C)INGW/@9M1O;6*4Z?<P2B1XPS)
M&9D60#@G!7J!C.!Z8KK+WPUI.H16D,]G&(+2X6YBBC'EKYBG*DA<9P0#CH<<
M@UIRPQSQ-%-&DD;##(Z@@CW!H \1\:6_A?7=4UUE6UDM;+P>)K"-6,:Q.CS!
M"J<8QN0#CHPQPW/.MJ&F7T7AV;QQ?26^D7.@1P6EW!9Q7&)$)60,9(Y&5S@'
M*C/N.:^D1&@D:0(H=@%+8Y(&<#/MD_F:888$MUC,<:P1 %5*@*@7D<=!C QZ
M8H P]!L]/@\ 65G.LPTI; 1LFI[0XM]G27@ ?)P1VZ5X;X.TWPTFB?#J>^PL
MNIW5[8WFR>0-,K%U2)@I^X6:+(QCYN>&.?I&.1)8UDC=71P&5E.00>A!H21)
M-VQU;:=IP<X/I0!\\^=;V7@?65MVD_L?2O&TC2I9I'*T-H/N%5<,I ?:1D8.
M#5F[_L;3?!G_  D7AZ[\0WFBKXBBOKRY\J%6#"-]TD4;1*F!(T8Y7;N3 QMS
M7OS*KJ58 J1@@C@BF>?#]H^S^;'Y^S?Y>X;MN<9QUQGC- 'A\KZ#_P (K%XC
MTF/4AI">*[/4)IKJ$* 055WCC1!A?F R!DGC)QBK7C.32KGQ5XM=X($^T^"V
MEE250#YZNVS>.GFC$>,_,-HQTKVJB@#Y]\'I8:?XY^&4FF0QV)OM&E6]$1VF
MX81OS)C[V77(SW ]!BI\//$OA_4]0\%Z+J9LK=]%EE-GO@<M<R2Y\L$%-L;9
M*OD,P+ $$'&?HJ:))X9(9 2DBE6 )!P1@\CD5RND^ ;72OLL3ZUK5]96@C^S
MV-W<(88S&08SA44G:5&,DC@'J : ,;XI:RNAWOA:\>.>$"]D4:C#%YS6Y:)E
MV+%T9I 2 3D#!.#TKSO1(].N]'\.:9K&E7,EQ'XIE>3[=I[?ZEMP;<=N -YC
M# X&1R/E./H/[;:F_-C]IA^V"+SC;^8/,\O.-^WKMR",],U/0!\]V<O]FZ/J
MLMIH]Y)8Z3XX&IR6MO"8O]$.5C,:G ;#JI"#I@9P.1W_ ,/M535/&/B^ZM]+
MO[6SO);:Y@EN+1H5D_<A&ZCKN4GWSFO1:* /.?B#H6KR>)='U;0RJRWD;Z-?
M.5!*6\I#!Q_ND,>01DCCK45XEMX*\<Z>;RRO)?#SZ"FE6TZ6[W(B='YC944G
MYTV\XY*]\<>ET4 >'C2-9T/0?!-[<:9J%PEOK,UP+."+=+!#(&,4>PD;.,<'
M 4G!Q6*WAZ6RU[5- U_P_P"(M3O[O6&U#3Y[&YD6SD+D 228.$*Y)+@%@#C(
M R?HJB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M X;1-4V^-;323#=/OTZXNHYFQMVF9%9F)+%\LHVD.2$*Y!SNKN:XS2UBD^(9
MNIK@-J+:8Z/&<X\H/$%,9SM9=XE)(&1O4,%XSV= !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %-$B&1HPZEU 8KGD YP<>^#^1J.[\_P"Q3_9=
MOVCRV\K=TWXXS^-> 6SV4WA#0UFD=?B/!K>)5A51>M(9F+^;QN,?DGK]WA1G
M (H ]6E\5:K>>+-5T31-,M;C^R#;&\:XN3&SB8%L1@*1\JC.2>>F*ZF>[MK7
M9]HN(H=YVIYCA=Q]!GK7FG@ZVT;_ (77X[\N"P^U0BS>VVHF] 82)BG<?,P#
M8[D9ZU1^+4T5EK/VVWO=+ENTTTQW&CZJ $N[=C)S"V0?-R",(<G*^@! /3;7
M7],O=7N]+M[R*2[M-HFC5QE203MQG.0 ,^F15V&Y@N&D6&>.1HFV2!'!*-Z'
M'0UXQ?RQG4/B19:?9_9_$EW;07$%M;PYG*M;)YFP@9/S,V<<DGU-6K_['K=U
MIEY\,WBM[Y=+NXIQ:($V((OW44HX"/YI7;NQC#'D"@#U+4-32WT[4)K1X)[B
MSB9VB\W&" 2 V,D=#VJIHFOKJGAS2;^4V\%[J-E'<);/,%RS(&P.IQD]<$^U
M>7^#]3\/77AM)+'2WBUZRT:>RUF>2-XA!P2QD9E"O(\J@XSN^9SGY2#7^$&H
M76C)IL?B:-#;WEB7T;46<LD48*AX<=(SG:Q; W8Y9L+@ ]*\!^+E\7>$]-U2
MY%O;7EXLC_94DR0JR.F0#R1\M=#]OL_MGV/[7!]J_P">/F#?TS]WKTYKYL\)
MPKI>B?#Z^LK,6FIMXADMKVX5 )9(]X#JYQD*$)!!Z8)XKI9T%W\/=1\/RV4C
M>/(]3.'-L(YI)6N]Z3J^#A-I^]G&U6 .!F@#U72M=O;WQCKVC7%M"D&GQ6TD
M,D;$EA)O^]G'/R#@#CGDUG6'C-]1^)TOARUET^YTQ=*-ZMQ;R>8_F"81E"0=
MHQ\V1C/3GM7"?$&RUZ\UCQS'H/VS[0]A8EU@)7S(EWF10<\M@CY1R0Q ZX-/
M4FCUSQ?K$_@W3KJV%QX1>WB\NP>VS-YX)7E0-VP8STX !H ]JM=<TF]BN);3
M5+*XCMFV3O%<(XB;T8@_*?K4<WB/0[:"2>?6=.BAB8))(]TBJC$ @$DX!(93
M]"/6O'K6TT"Z\*:Y>V6GZS)J2^&IK.Y-[ RB%R!Y<00K\S%U)!7.T)R1Q5HZ
M!HFG^"/!UU:R7>A:R;9)H;VUL]\8NA"H8W"[3G))&2/6@#V1+NVDM3=1W$36
MX!;S5<%,#J<].,&J%KXGT"]95M-<TR=F1I%$5W&Y*+]YA@]!W/:LOP'/=3?#
MS3)M5TL6$Y@8RVB0D8 9N0G4;AAMO^UBO$M-T2(^#/AJC:/(T_\ ;I^WAK-B
M2OG_ ,?R\C85]L?0T ?0R:]H\FDMJR:K8MIJ];P7"&$<X^_G;UXZ]:K_ /"6
M>&_[._M'_A(-*^P^;Y'VG[;'Y?F8W;-V<;L<XZXKR6.T:T\'^*XI=*N1 ?&3
MR@K:.6MX"\9\Y$ YVJ"0""O3((.#?T#PO:>(T\?>'9[/5+6WO9H98KF_M]KF
M3RU(E., L7&_'!(/S8)(H ];%_9M>K9K=P&Z:+SU@$@WF/.-X7KMR0,]*Y:X
M\6_V1X^O-+UK5-,M-+&G17=N\Q$!#-(Z%69GPQ^3/ '7IQDU?AA;ZE<Z'_;.
MNA'U2519K*%7F"$E1@@9PS;VY]>@K/\ %%LB_$FZGO\ PY<:G97/AT6T4B64
MDZ&83.?*)53LW!A\Q*@8ZT =KJWB?0]#M8[G4M4MH(I0&CR^XR+_ 'E49) !
MR2!@#). ":THYX9;=;B.6-X'0.LBL"I4C((/3&.<UX#8^&-8\(/HL'B#1/$&
MM6%QI1M+E-)N)MUHWF2.8V6%@)%PZK@MCKCH ?5+C1+F7X57.C:=:MID\FF2
M0V]KYIE,.4.V,L<DG!"DC..<=!0!2D\>VUY\2-$T+1]3L[NTN(KG[6L2%R&1
M R%9!\I'WAQQE6!.>!=TCQ7:0Z/K&HZKX@L[VWL]1DMS-:6[JL7W=L0 R9&^
M8<KG);'.*X_3;W5-7\6_#V2/PQK=C%I=O=6]]]IM/+CC+0H@PQP"N5R#QD=.
M<@,L-)E'AWQ9'J.G:["LWBV>[MYK&WD%Q&I*F.>-=N77(YP#P2>U ':GXF>#
M5TJ'4I-=@BM9GD2,RHZ,QC4LX",H;C&.G)(49+ '0@\8^'KGPZNOPZK VF-P
MLW.6;^X%QN+]@F-Q/ %>46XU>UU[P9J'B>VN+E8=6U'R=FG8GN(C"#'/)"@W
M"0%2V-NX 9ZCF+6_!^N&*;Q#I^@RW-L/$$FH#27)AD> JJ$A1RK,0QZ9P 2.
MU 'J/_"P_"8TBVU5M:A2SN96BC=T=3N7<6!4C<N-C<L .GJ,M@^(OA:Y\,OX
MAAU,2:<L_P!FWK$^]I<@! F-Q8Y! QT.>F:XBWT=_-TF]T[P?>:782^(X;XQ
M2HS7&Q8'#RS+N;9\[X Z\$XR:?J6@R7L>N66J>']4NK.X\3?:XY;-2DL2&#:
ML\9R,X= #[-D9)% '=#QQH9\.'7/-N!;"7R/*:VD$YFZ>4(R-Q?/8#L3G )J
M+_A8/AZ3P]!K5M<RW<%Q/]FAAMX&:=Y<\QB+&[<,$XQTYZ$9\YO-%\9R>'M.
MO[O29];?2]9N&BMKN7R[JYLV3RT9RO._D^X^7@@5?CTO5=$U30?$.G>"3;6$
M%[>!]-M7$ET(IHHE69@6VB0F(Y&[@%5SG)H [/X?>(9O$^AWFHRSM/%_:-S'
M;,T80^2KX3(P.=N,YYJ!OB=H"Z7J^HE+\6^DW(M;O_1CNC?)'3K@$<D^HH^'
M,.K0:=K']K:1-ILEQJUS=Q)+(CEDE;>/NDX(R0?I^69KG@%]2^($DT<4B:#K
M%H/[;1)F43R1$>6.&!7((!QP0K="22 ;&M^+]/.@WBI<WEC)+HCZBET+8LUO
M&PVJQ7.=X+ [3CH>>#C*T_XCP7&OZ'X72+4[JYOM-CN&U,VHC#!XU9957!&#
M\V[C:IXYP15#1O">MZ?\+_$MEJ*->ZM)9W&FV>U%#FVCC:*!!TX^\X[G?SDU
M0TWPUXGTOQIX(U:/1#/;VWAZ#3+T&X1#;NH.\GKG / '4\9% %_X7?$NVUO1
M]%TK5;Z>ZU^\^T,\GD80L'D?86 "@B, X],>M=[K_B&Q\.6,5S>^8QGG2V@A
MA7=)-*YPJ*.Y//Y&O+-#\,>);#P+X&TQ="GBO]+U_P"T7C%X<+"'DWG._G*O
M@8Z[?]TGN?B+::Y>Z!:1:%IYOW%]$]U;+<K;O) H8L%E)!0[@G(.<9H A7XI
M^&CI-MJ,C7D,,]V]D4DMSYD4RC+(ZC)#8[<D] "<5/IWQ(\/ZCX:U+7@]S;V
MNG2F&XCN(MLH;C;A,D_-N4+ZDXX.:X'PYX7\6:<$BN?##11Q>+#JV(+V)\0M
M$R$#<PR%RF#G)R<@$<Z=]X2\42)XPNK&S2.]DUFVU+3%EDCV7/DE2 =K<9V_
MQ8R<9QR0 6?!/BC4_$'Q9\3P7)U*WLK:T@6"PO4$;0'@ME!QDDL0W)*E>2,5
MU?B#QG;:#>RV@TO4]1G@M/MLZ6,:,8H=Q4,0[J6R5;A<G@YQ7,^#-+\4M\2]
M<\2:YH$>EVVI64:(BW<<QC>/:NTE,;B0"V>PP/H[X@^'=3UC63<:9H=XU]%8
MJEAK%C?I;O#*7?*2@N"T8^1N%)^\!U. #9N_B-I=E_PDXDL-2+>'/*-VHC0%
MQ)G:T>7&1@9YQQTS5GQ!XXL?#]S<VYL-1U"2S@6YNUL(ED-O$S%0S L#V)P,
MD 9( YKS_P 3>$?&TE_XOBT_3+6_C\0V%H)+M[I(A'+#'M957JQ;G!.U1D9/
M!%;>K67CS3?&,NL:%I&FWL.KV5O#>V\]P MK*FX9W':70!VZ#)ST&!D PKSQ
MZV@_%S4M0E?6M2T9M!2Y2ULT,JQ@LC>84R%50I;+'IGKS7L5E>0:A86][;.'
MM[B)98G'1E89!_(UY7?>"O$EUXM\17KVL;QWOA9M*CG61%62X9%!(7.50$'J
M!VP#7=Z%IFHVGP^T[2?.^P:G!I<=J)MJR^1*L07=C.&PPSCH: ,_1/B-I.MW
MHMEL]0M"VF'54>YC3:]L'V;AL=CUYP0#BF)\1+:>VBDM]%U3==:9+J5EYR(B
M7")C*[@QVDAE/( PP]0#PWA_P)XO758UU+1=*MK2YTB;2;^X6Z+RR*^TM*W.
M23MX4$ 9/W>*Z7PKI7Q!&C'1/$+:7'9VUD]O%/"[/+<G9L0.2#A1R2PPQ(7_
M &L@% ^)FUWPUX$UK63J^GW%[JL2(VF/&L;RON"JX+D^4>>H)PK @;N>EU/X
MA6FFPW]Z=,O9=)TVZ^R7M^FS;&^0IVINW.%9@&(''.,D$#DK?P;XP_X0KPCI
M=Q9:?Y^AZS;W11+H_-#%DY)(QDECP.F!USQ?E\'^)K>#7_"UI;Z=-X=UB=Y8
M[Z:8^=:+*<R@H0?,8<[.1S@EO[H!?\1_%%/#VHZQ9MX<U.Y.EQ1SS2QF/9Y3
MG&_.[CDC Z]3@!2:[!]7@_X1\ZS;*US;FV^U1B,C+IMW#!)QT]ZX#7O"'B34
M1XVCM[.P2+5;*VM;(?:V)81,PRQ*#:=K9QSS@9/)KJK+2M4M/AO;Z.8;5]3A
MTQ;38)2L1<1[/O;>!W^[[>] &)#\3I;A]'CA\*ZF9-9M&GTY7F@7[0RJK.HR
M_P H"MNW-MSC@'BK$/Q)MI?#&GZM_9%\MS>ZB=,%BP"O#."^1(6QM "$D\X[
MC@XHV7A7Q);7/@"?RK'_ (D.GRVUXGVIUW%HD0 80YQL![C/T!K*U#P-XQNO
M#<L,7]DK/)KUSJ$NGS7$CVUQ#(Q8)(0JEL-SM( (P3@C% '11_$B&3P_:ZR-
M-*VTFI_V;<,UTFVW;S-@D+C*M'GJP/<=1S746FJ&[UK4=/6 A+(1AIBW#,Z[
MMH'L,9^HKS>VTM/"O@C6=$\<7%@MIJ][.MG#IMJY+LX+X4<@-D?(F!@J!EB1
MCL_ .B7N@^#K*VU6267591Y]])-,97:5NNY^^!M7C(^7J>I .$7Q'?\ A7XA
M_$*XL]$O=6LX7L)KA8KA0+:,PEI' 8Y8G.0JC'RG)4 5T7B#XJ:;I-G'+:QV
M\TLNE)JT4=[=K:B6%L[40D,6D.#\N/QIM]X1\20^+O$=_I%SI?V'Q#%;Q7+7
M7F"6V$:&-BBJ"KG:=PR5YXZ#)AU+P/XCTC6M-U7P3?Z9"UOIL6F3VNHH_ES1
MQYV,64%BW0=C@=>U '4VOB1=4\$#Q'IL&X26;7,4-PVSD*3M8@''(QQFN6T_
MXAZJ/!V@:C=:3:RW6I0O(9C=F*UC2.,,SS2F/$3,V5"X(S_%7;G3II- ?3KF
M\:>>2W:*2Y9 -S,I!;:.!R<X[=*\YA^'?BH:%X3MIM2T9[C19'B>!X'EM_)9
M=@DPW+S(!E<A5RV. #N ,J_\<:=JNO?#7QG>1#3K1H=6DF5WWE D6T@' W<@
MX&,G(XR:[+5OB!<^'O#VFWNMZ,EGJ&HRB.&S6X>4)\N[]XRQ%@1W"HWXUR>F
M?!_5QIOA+3=9O-+NK+2C?K=Q!'/[NX& L9P-S=3N.TJ2"-VWG8?P)XQE\)Z5
M%)XFM6\0Z-,TEC=^4V&4[EVRL2=V4."=OM\W)(!%)\8)T>RMQX:9KR?5SI3Q
M_;,1[\@*\<A3$BL#G.%_(YKLO"?B.X\16FH&]TS^SKRPO7LIX!.)EW*JMD.
M,@AQVKF;_P"'VNZV?#U[JWB**34]/U"._G(MR805"XCB7<,+E>2>6W$\8"UU
M/A[0)]#N];EEO8[B/4K]KU$6 QF(LJKM)W'=PB\X'.?7  .;U7XD7FDWGBFU
MN-!CBET2!+N$3WWEB]@8D;T)CP,<#&3ECMZBK,7B]/$?AU672()[:\T-[ZYA
MDN6  8%1#GR^<D."W'0D!JU=6\'V>K>+M(\022%);!'CDB5>+E<JT8<]PCKO
M4?WL'M571/ =GX=T;7;#39RAU66:17D4LL <$*H7<,JN3W!/KWH YO3?$FIV
M^M_#C2K*SM[70]3TKS4C,[,^4MP=A..0BE<9^\>I!%9FA^)K[P9:WBP:%;'P
M_P#\)1=6+R).(VB#S[5*1A<;5Y&.">,8'-=;!X#O(7\%S?VV@G\-1/!N2TPM
MU$R*FT@N=IV(.<GG) ' %.Y^&^H7GAZ;2YM>M=TVLMJSRIIS ;B^\H%,QP-Q
MZY/''O0!L?$;5=5T;P9<7>D&%;GSH82TK%=JR2*A(P#S\P^F2>H /#:[J'B#
M1OBQ<:C:V&GW>I0>$GFGC$CI&46Y9OEPI9F(55 XY/7 KTOQ5H)\3>&[O25N
MC:/,49)Q'O\ +='5U.W(SRHXS6&/ VH-XC?6Y_$)GNY-%;2G>2QCSEI#)YF
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MOX>FZTG5M/.NW:+J>J#49G$,992"A51QC@QIS[=.: .VHHHH **** "BBB@
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M[O#A3M'.#R0: /2Z*\IT_P 5>-3:Z3K=]=:0^G76N?V:;2"W8.T;3O#O+EB
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MEB&4@#G##UKQ2UG\.:!+H%WI]Q>WG@=]:N#?7%]"GDM<&!1&R1A% C5RW.W
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M^W1&M[%.^Z,K&FU0H[8ZYZ@]".,4M$^&OAW0]%?384NY_,"![J6Z<7!"/OC
MD0J4"D# 3:..YR3D^/=?\1:#J?A*WLM1MXO[5O8K&Z M@RAF*@NF3D=3P2>W
MOFQ/XA\0>%?%FDZ;KUS8:AI6KS&WMKJ*(P3Q3=55U+%64\#(P23TZ @&PW@7
M1Y+18Y'OVNP_G'4%O98[EI3&(RYD0@Y*@#;]WC[N.*V-)TFQT/3H[#3K<06T
M9)"[BQ))R26)))))))))K-'C/0SXC&A&Z=;MF,<;M$PADD7!:-9"-K. 1E0>
M,XZY R-%\8?9-!U6_P!?NVE-OK-SI\ B@S)*5E*1QHB#+,?09/4G@4 3:;\,
M?"VE6T<%M:7*K%>&]C(O)5*29;;C:PX4,5 ].N223HW?@O0+]=56ZLGF&JO'
M)>![B4[VC^X1\WR$8 ^7'0>E4K;XD>&;RRTR[ANY6BU*\%A"3;N"+@X_=L"/
ME//7I[U>_P"$PT?;K^)9=V@H7OT\E@4 4OD$C#952>#_ #% &>OPQ\'HDZ)I
M+*MQ+'/*%NYAND3[K</UR<GU/)R:WK71-/LM9O\ 5K>!DOM0$:W,GFN0XC&$
M^4G:, GH!U-8,WQ(\/P:VNDLUX9O-A@ED%JYB@EE^Y'(^,*QR..W(/0X)OB5
MX9M_$!T26[E2\6Y^RN'@9%1\9^9F  !'0]&Y(R!0!K:EX6T35]5MM4OM/CEO
MK:-HHYMS*P0\X."-V#R,YVGD8/-58/ OARU@TN"#3VCBTIV>R1;B4"%CG) W
M<DY/)SR2:CTCQWHNM:TNE6YNXKB6)I[9KFV:)+J,'[\3,,.,$$8ZCGUKG_BC
MXTO_  U<:!IU@MW&=2O8XY[BWMO,<1;@&6+((,A!X&"?04 =':^ O"UEXD?Q
M#;:-;QZJQ8F=2V 6ZL%SM#'GD#/)]:T]4T33M9:U:_M_-:TE\^!@[*8Y,$!@
M5(YY-<K:^,[+P[8O!JFH:AJ<=K/'%<Z@;,!;3S,E$G*]U  8XXW+NP6&9/$'
MQ3\.^&];GT>^74&O8?++)#:LX(?&&!Z$98#Z\#)H VY_"&@W,5_%-IZ/'J$H
MENT+MB=AT+#//TZ<#T%27?A?1;^]CO+K3XY;F.V:U21B<B)@5*]>A#'\ZRO&
MWC*3PBVB)'I4][_:>H1V9>/[L08C/'5G(SM7H<')&,'AK'XHGP_XW\9Q>(IM
M3N;"WNK=+=8;?S$LXR65BQ7 5<L@ZDD],F@#TJ/PAX?A32UCTN%1I3,UCC/[
M@L06V\]R!4,O@7PQ-%<Q2:/;F.ZN1=S(,@/,,_/@'K\Q_P BHO$7C:R\.272
M2:?J5]]CMTNKPV42N+>)F*AFRP_NL<#) 4D@ 9K1U/Q!9Z9X8G\0;)KJRAMO
MM7^CIN=X\;L@$CMSSCB@"*Y\(Z!>-J#3Z7 YU$*MWP1YP4Y&[!]>?S]:;=>#
M?#=]]@^U:'8S#3TV6JO""L2\< =,<=*P=*^*FCZO?FSATK7(I6LC?6XFL2OV
MJ( ',0R2_&<<8..">,Q:9\7="U6Q>[AT[6TC(B%N9+$XNGD8H(XV!*EMX*\D
M#(."0"0 =-!X2\/6KV30:-91M8JRVQ6$#RPP ;'N0 ">M-/@[PR8#"V@:8T9
MG-SM:U0_O2<E^1U_IQTXKGYOBKI%GI>N75]IVIVUQH;PI?6;+$TJ^80%92'V
MLN3U#?ATJQH7Q*TG6M1O;*2QU33)+6T-^#J%J8A+; X,J\D[<^O7MW  -'QW
MH=[XE\$ZIHVGO EU=QK&C3NRH/F!.2H)Z ]N>_%7]+T#2=)A86&C:=8-,H$R
M6D"(K'T)"C</J*Q;7Q[:M>6,&HZ9?Z:FHP27-C-.J,LR(@D8$(Q9'VDMM8#@
M=<\4:3X]M-3TNYU9]/O+;2H[22]BO'"LLL*$ACA22&&W.T\X([\4 ;-OX:T&
MTL;BQMM$TV&SN/\ 7V\=JBQR_P"\H&&_&GG0-&.D#23I%@=,4Y%F;9/)!SN^
MYC;UYZ=>:Y"'XN:&MY>VNIVUW82V]I]M7<%E$D. >L9.''0J>A'4U3CU[5KS
MXR:+:W$&H:=;2Z5+*;22?,4G)VL5!QO'((/(XH [V30])ETQ-,DTNR?3T&$M
M6MT,2CV3&!U/:E.BZ48[.,Z99E+$AK1?(7%N1T,8Q\N/;%9^N>)O[*U&RTNT
MTZYU+4[Q'DCMX"JA(TQN>1F("+R ">I(%4D\;?:[?1OL&C7L]YJL$EPEM(5B
M,$:;0QD)/R\LH'7)- &W_8.C_8I[+^RK'[)<'=-!]G39*?5EQ@]!UILWA[1+
MB>6>?1]/EFF14DD>V1F=5QM!)'(&!@'I@5Q=U\7;*#2-)O8M#U*:>_O6T]K/
M"I-#<*0#&03UR<#I[XJ(_%JY:2XMHO!6MF^M[+[;+;2[$*)AB2W/' X!&XDX
M"T 7-8\":C>>+KW5X&\/7EO>F',6L:7]H:U\M=O[HAESGDX)Z^G-=+I7A;2M
M,TC3[ V=M/\ 8DQ')) N0Q)+,HQA,DDX7 &<# XK(LO']OX@M-.?PQ9G4+F^
MMGNECN9#;I"B,$82-M;#;SM 4-D\YV_-63>?%F-!HT%AX?N[O4-2GGM#9O,D
M303PX#QL6XSEASTP<^U 'H]06]E:VC2-;6T,+2'+F.,*6/OCKU/YUYWJGQ;;
M2+62[N_#EU;P6B6C7J7,XBF4SJ&VPH1^]*=&!*$'MU(U1XQU2V\1^)X;[3K1
M=(T.!9Y9H[EC,8S$\@*QE/F)VX/S*!R 6(- '80VEM;R2R06\43RG=(R(%+G
MGDD=>I_.E>V@EE$LD$;R!2@=D!(4]1GTKC?#WQ$BUKQ-#H<ME''/<V(U""6U
MNA<1^43@!R%7:_J.1[G(JSXR\9S^%5E=-.MIH8+-[N2:ZO?LR':<")#L;=(W
M.%XZ=>E '4BV@7R<01CR!B+"#]V,8^7TXXXI4@ACFDF2*-99<>8ZJ SXX&3W
MQ7$/\1)[\Q0^'=!DU*[.E1:K+%-<" )'(NY(U.UBTA],;?\ :[4MOXJURZ^*
M=IH7V*"WTY]$_M!XY)2)06=5RPV'#*P9=@."&+%LX4 ';AHYXVP4D0DHV"",
M@X(_,$&G,JNI5@"I&""."*\Q\'^*K.T\.V=OHVAI#?:GK-S;Q6$NH9^92SRR
MERN=BJ.RGJHZG-6)?B??6]CXA^T>&PFIZ%>V]O<6@O?EE29@L<D<AC&<DYP0
M/EP<]J /0_(A^S_9_*C\C9L\O:-NW&,8Z8QQBI*YGPSXCU'5=6U;2M7TN*PO
M=/$,A6&Y\Y&24,5^;:O(V$'CTK9U>\GT[1KR]M[=+B:WA:587D\L/M&<;L''
M3TH NT5YYHGQ UO4-4T"&_\ #26=KKUH\MC*+L29D6+S?GP/D5EZ=6XY'4"A
M:_$_7QH_]M:AX8@@TU\V]NZ7H8RW7VCR0G3*KC><E3]P^H! /4JY[PYX:DT'
M4]=O9+\7)U6[^U;%A,8B.T+C[QST'/%8M]XN\1:??ZGHS:1:W.K0:4VJ6C6Y
MD,5PBN%>+&-WF>@&<[AG'>7PWXPU/Q+%H$MM;V*K>6<MU?(SONAVML54XP27
MR#G[NT]3@$ ["UN[:^MDN;2XBN('SMEA<.K8.#@C@\@BB"[MKIIEM[B*8P2&
M*41N&\MP 2K8Z'!!P?45YOX,\3D^ O"T/A[0H+2359[A(+<RNT%JB22,[,WW
MCG;^;?0'+TOQ/J'A33_$)32X[O5KWQ9+ MK9HT@YAC>24(HWL JECCG)YH ]
MBJO!?V=S<36]O=P2SP8\Z..0,T>20-P'(R58<^A]*X"P^(FM7.GM%<^'+BRU
M2748K&S-[!+;P3B3<0X++N^58W+#']T G-0_#RWGMOB;\0H[J.SCN2VGO*+-
M"L1=HG8L ><DDDYZDF@#TVBBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@#SZV25/B3I3W:P[C:W,2QHY7:X?_6(F2 FU2N.I.20.I]!
MKR][.0?%[P[):O*D"P3R-$TY(,>)P3GS&5R9'4]VY)X"G'J% !1110 4444
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M&81C>1C'WNO2@#S[1_AW?>#)=#NO#,EI--;6;V>I0W<KQ)=ACO#AE5RI$A)
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MR1C)-5;J_P!-U/Q!XJAUWQ3=Z3J>GW:"QAAOC#Y, B1E>./(5V?<X)(;@@<
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MM[B*.:"5"DD<BAE=2,$$'@@CC%244 0FTMC>K>&WB-TL9B$^P;PA()7=UP2
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH \ZU016OQ8T$W4"%Y7D2S=(P$
M0^5,S_-MRK$2<KN;>=K87 ->BUY3>^6_Q1T"X>:[%R;ATM[=@"#A9 S.=V_B
M,N.1PRC[RMNKU:@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **\O^,GC?5/"EAI\>B^9]H\T75V\>T^
M7;HZKAL@[0[NJ@XYPPK;\;ZT9_A5>Z_H]Y- WV1;NUGA?:PS@C..#P<$'/Z4
M =K17@MQXTU6"U\$MX5UZ77->O8HVU#36N5E1B44L'_YY$,2.HQ^!KI?B98Z
MSH/A+Q!XEA\2ZHMU%/&]E%#<%(HHWDB4J4'#'EN3G\,D4 >JT5YIJ6BZA9>
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110!P&N.B?$7PU:1W=U"SW,AD0ALNJPNP3(!#
MJS*K?/G&SY2I! [^O--5U**T\7^'8Y)$@@N)H885W("ZG)"E0"6"N NU/E1B
MK%@!L'I= !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !114<,\-PA>"6.502I9&##(
MZCB@"2BFM(B,BLZJ7.U03C<<$X'KP"?PIU !1110 4444 %%1SSPVT+37$L<
M42_>>1@JCMR34E !1145S<P6=N]Q=3QP0(,O)*X55'N3P* ):*KV5_9ZC;BX
ML;N"Z@;I)!('4\9ZCCH0?QI?MMK]M^Q?:8?M>PR>1Y@\S8" 6V]<98<^X]:
M)Z*@N+VUM)(([FYAA>X?RX5DD"F1\9VJ#U. >!Z5/0 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% 'F'BA9+KQQX<=]D/F:C
M$^R2,MM*JK?Q.%#$ @$#<!N^7[QKT^O+_%LDE[XYT.-;6*6.RU.%VG5HT"2$
MPJ25+;F)#,HX/W>!\I(]0H **** "BBB@ HHHH **** "BBB@ HHHH ****
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M+"-A"TZL&^T,C'A@53&W&/F/4YJQKG@7Q1XJ\*7VFZYK]G)>2P)! ;:W:.+
MECD=Y!D[G/E@#  49_O' !!XC\2HVM>&!XB\%W4$SZVMO822WZ9B)VA9<1,0
MQ^;E#D#'4UHI\2_.U:WBM]'DN-.GOVL?M$+N\B$2-'YC((]OEEE."')Z<#I5
MOQCX/U#Q->>&KJ*^M8Y-(OTO) T3 2E2I ')QT]^M5])\&^(M$U9[>Q\1QIX
M;-ZUVMH;<F9 S^88E?/W"V>>N"?6@"7PY\0/^$C\276F06-M'%;7$UO)OO?]
M)0Q\;F@*#"D@@$,<=\5K:YXF.F:UINB65E]LU344EDB1IA'%&D8!+2-AF4'.
M!A6R0:Q[7P=J]UXJTW7=:O[%KG3'F\F>RMS'+/&XVB.7/RD >@^F.2=#Q/X5
MGU;6=(U[2[V.TU?2C((C+%OBFCD&&20##?0@\9/![ '#?$#QK<ZO\*_%=O!;
MBPU33IX[+4H!<[O+1Y%&Z-@OSJX.W!"<%\],-UNCV3Z%X!FU73-+TVTU>73U
ME>-)&,$CHAV,V%4DXY.%!/3)P#6=K'PQEU'PIXDTY-3A_M'7KM+JXNFMBJ@(
MRLJ*H8X V]22>3^':P:9M\/II5Q-Y@%M]F>2-=F1MVY )../K0!Y;=ZSK3VW
MPQUNXTVVOM7EW")5N@OGB6TQN9V0!"2=Q4!AQ@$\5OR_%);'2?-U+1WM]3.K
MG2/L,4QG_>X5MP9$RRX93A5)YP 3Q5BW^'UZEIX2@N->2<^'I@ZM]BV^:BH$
M5  _RX4=3NR3GVJIJGPMDUC3M0AN-<\F]GU?^UK6\M+4QO:R[ @ _>$D?*IX
M*G(^F #H?!OB+4M?L+C^U='N-/NK67RB[P211W(Q_K(UD57"DY^4C(X&365:
M>.+Z^^(%YH$5O8PQVSO ;6[F,5U(1'O6X7JK1,?EV@%@"'/&5&]X<T6^TN.>
MXU?5I-4U.YVB6X\ORHU5<[42,'"@;F)/4ECGL!C?\(/?7.OV=_J>M0WD%CJ4
MU_: V.+B)7+D0><9#F,;AQM_A7D    Y[PMXSU[_ (0Y[BZ\B\UC4-;ET^R:
M1V$*R$M]Y<96-%0D $DXQP3FM8_$#4=+GN]'UK28O[=AEMHK86\I6WO1.^Q)
M%8@F,!@0P.XC'&ZFI\+O*T2?3TUR7='JHU7393;J?L<P8L"1G][]X@YP,8P
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MH!_"3R3BNCU3Q?KOA[QSJ.BZE*CVVH6N_09%A5-\Q8+Y18\%@S#@9.,$]<4
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MS+#:2+NEPX^89*C./[S>IH ]BT?Q0NK>+/$&A"RD@;1OLX:5W!\TRJS# '0
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M&,8Q0!/1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MTA1%89!)S@ @$C/I5;5?&&@Z/I5GJ=UJ=M]BO)XX()TE4HY=L9#9QM RQ.<
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M<;@ <XSQFM*@#RM/!Q\(>+?!JVU[KVIV$%S<(BRH\\5E&T+(H^1,*"SJ,MT
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M)ND27?#M+9^4XW8'(!(SGD]WZ-XQU'4?$-CI5WHD4 O=/_M&*>"^$RK#D##
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M39*EMY30QS*$D1QNP!E48?+G<0NT=..+L/[4U/6-0>'2?$=TMYX,GL$GNK4
M"4AF"@# 5,HR*.23CKG=7OFIZOIVC6\<^I7D-K%)*L,;2MC>[=%'J3SP/0GM
M5V@#S&VN)-6U7X<ZA%I&I1PVOG))+-8N"@:T"Y) .Q2[!?FQN*Y&5 8OA\*:
MK#\3;RWA C\,7-S'K<PVMB2Y&1L!QMSYB)*>_"]>WI=% 'A%CHUW'XRUW1M5
M\':W>K>^(7OK2[6XG2Q1'<,)'V.(R54;NA;/RGD8KUOQ?X9M?%_A>]T6[^59
MT_=R <QR Y5A]"!]1D=ZW** /);;0O$U]\)]1U"ZM93XJOQ;R2PN-DC);,@6
M,\\[UC=STYF88JWXCL+KQ5=ZCJ>FZ3>P.OAF\LI&G@>%[B64?NX K@$A2K-N
M'&7&":]/K(F\4:+!KL6BRZA&FH2L42(@\L%5MN[&T-M93MSD@CB@#QF[L->B
M@\"^()?!VJ7<&BV/V"XLXV:.Y1T556150[L$Y(Z\ YQD&O7/ ^G#2O!VGVBZ
M4-*51(ZV/FM(8%:1F"EF));##//7/3H.AHH \5M?#VJR_#NQ^']QH5VM_9ZH
MB?VA'"/)AB$_F&ZC=L DH77 .[).0-P!Z3PYIM_#\:O%VJRV5S'87<$$5O</
M$P21DC0-@D>H//0XXS7HU9S:[IJ^(5T%KH#5&MOM0@V-DQ;BN[.,=01C.: .
M9UJ/5;'XGZ5JUGHUQ?VDNFR6,LL<@58"94?<V3T 4]!D]!D\5R,.FZT?"_@J
MR?P[J(EM?$K7]R'C7$$(FD;<V"3G$P(P#]QO;/LBLK#*D$9(X/<=:S]0UW3M
M+OK"RO;@Q7%_+Y-LOEL1(^"<9 P.!WQ0!XYX#\#7OASQ%'I6H>!H+EK:_,MO
MK\LH*K$I)#;03\WRKM'4%LG&.?0_B1'?2Z%IXL=-NM2V:K:S3VUN 2\4;^8P
M8$@$?(!SW(KL:* /%M8\-^(=5\1^.+VWT6X1GN]/N[!9@A2[^RY4J"20-W49
M!XX([5T,=KJOB#7=5\32^'[S3MGA]].AMK@Q^=<R,Q<@8? "E0!NQG?GC%>D
M44 >(^'/#_BGP@_ASQ%:Z#=ZE<R:4=)N],>9(WMB)-ZN&)(VG'(.,9R3S@8F
MF^ ?%&B^$?#FHS^&(=5GT^YN1/HUT8Y1)#,%VO@Y"L&7G&6^[G@&O<=*\3Z7
MK6L:MI5C+(]UI3HET&C90K-NP 2.?NGD<5L4 >7OIFMM#X0AM_!T6G0IK*W]
MQ;V<L0BLDV.N&^[N;YBQ(7'11DX%4?$_ASQ--\2GU3P]I,NGW[RQI'K,=ROV
M>:V$<>];B(DEB&! P!G:O'R[J]>KG4\;Z)+KATF":>:9;DV;RQ6[M%'.%W&-
MG P&P#],'.,4 5/B#X>U#7M(T^;2C&U_I.HPZI!;R\+<M%NQ%NR-N=W4\?3.
M1S6IZ#XAU^?Q+XAN-!EL[RXT!]#LM.%W#))+O)9I6;<$4 L!C<3A6..@/H][
MJ5KI]M=3S2$BUA\^6.-2\@3G!VC).=K8XYP?2ETW4(-6TJSU*U+&WNX$GB+#
M!*.H89';@T <Y\-;+5=+\"Z?I>L::]A=62^1L:9)/, YW@H2 ,DC!YXKCM'\
M*>+8O%>DZ[J>CVD^H6FJSI=7QO1YEQ;.DBK(JX/EQH' 6/)8GJ%'->O51U;6
M-/T.R^UZC<K!"7$:\%F=ST55 )9CV !)H PO&>G:KJ-]X9.F6*7"6>JK=W#O
M.(Q&JQNO.>3DOV!/'2N;U3PSXDN/"GCO38=,A:75]3,EGFZ4%XW6)"YXPH 0
MG!.3@C'3=V=CXJLKW4(+"2VU"RN[A&>&.[M'C\Q5 +8.,<9'!(//2MR@#Q?X
MB>!?%OBC4]9#P6=]:&R633;F:81BR96#20(N>7?:N9& &T8R.@T?LG_"8?$J
M^/VBU>UO?!K6<US83B>*-I;AP KX&[@-S@9V]!TKU9E5U*L 5(P01P15+3-%
MTK18Y(]*TRSL$D.YUM8%B#'U(4#- '':9HOBG4?[#M=>LM.MK?0;GS5GANF=
MKUTA9(V"[<1H?,).23E<;0#FJ7ASP'KV@_"'4O";-ILVH7:7$2N+AUB"RKMW
M$^7G(R3C;SCJ,\>F44 <79Z3X@TCQ%:ZFTVEII2Z-;VFH(SNSK)"9&W1G: 5
M D89.,^G%9'@ZRTG4OB)K.O>'+YYM%=$FE$9/DO?OO$A&5Y(CVD\\&7WX]&N
M98(+:26Y9%@527+],>]9UO=6VG:K;^'[/2+F"W%L9HYH+8+:1 -CR]PX#=]N
M.E &/XU\)76OW6B:OI<\$6K:+<F>W%SN\J56P'1BN2N=J_, <8Z<Y%*^\)ZY
MJMKXGO+R73EU75M-_LVUAC=S#;0X?[S[07),A.=@Z"N[HH R?#&G7.C^%=)T
MN[\HSV5G#;.T3%E8HBJ2,@'J#VKB-'\ :_IGA+2/#[W6F2P:7JT5W"RF16:)
M)VE.XX(+-N V@ +@G<V>/3:* /-O$/P[U7Q!+XH!U&ULDU*ZM;NRDC#2/&\*
M!/G! &#M!XZ<]:ZWPW;^(XX9IO$MY8RW3;42*P1EA15S\WS_ #%VW<]OE7 Z
MD[;,J*68@*!DDG@"L.X\2!;[08['3;S4++5U9Q?6R;HH$"JRLY[!MW'T/6@#
M.\6^!H/%6N:'J$MQY4=A(PN8=@(NH3M;RVR.5W(H(/!5F'>I+OP]JUKXPN?$
M&BW5I_IMHEO<VUV'VEHR2CJ5/HS#!'X\FF>(OB#I6A^&;_7;=)-4M[&Z^R7(
MM"O[J3(!#%B. 64<9^\.,9(ZV@#S\_#V\L9O"$^E:C ;C0I;EII+J(E9A<9\
MU@BD8.22HW8&>2<<Y_B7X8:AKMAXFM8KVSB_MC4(;N-RK?N@BX(('4G _,UZ
M#K>J+HF@ZAJKPO,EE;27#1H0"P12Q S]*9X?UF#Q%X>L-8ME98KR!90C=5R.
M5/T.1^% '$^(='U'1;GQ9XNN)(I([G1!;+;VR%I%D5<9YP",EOP K ^'<R6O
MB'1UL+_0-6\ZU^QS26)NI;BUMD1W7)ED81Q^8JKMVKDLN!TKU^QOK;4K..[L
MYEFMY,[)%Z-@D<?B*ECACA#"*-$#,7;:H&6/4GW- 'FOC^:=?BI\/DL;BSCO
M ;\K]JR4PT2C! (/S88 ^O8XQ4MK\,;JPC_M.TU6)/$;:NVK/<>2WD%G4K)#
MLW$^60S#.=W/6O1FC1V1F16*'<I(SM.",CTX)'XTZ@#F;/PIYW]O3:U+'<7&
MN1+;W26X,<:0JA0(O.?XW);KENV!6!8?":QLM&\-V7VZ1IM*G,UQ-C'VL,!O
M1A_=^2-1SPJ <XKNSJ5FNJII9N(_MSP-<+!GYO+5@I;V&6 ]^<=#5J@#B-1\
M&ZU'XRO-=\.Z_'IJZI%&FHQS6@G+-&NV-TR1@X.,9QWYZ#3TCP[?:;XNU;5Y
M=1BGMKZWMX1$8")08@0&9]V#G>^?EYR.F#GI** .>\3^&Y-9DTW4;"YCM-8T
MJ9IK.>6,R)\RE7C< @[&'!P01@'M@Y]QX-U"[T37HIM5M?[5UV+R+NZ%D3&D
M7EE D<?F C 9B"6/))QSBNQHH R4TB9O"9T6XNU:4V9M6N88BG5-NX*6./SK
ME?#'P\U3PYJ.EW7_  D<=T+#3Y=/6,V"HIC8JR\!LY#+DG/. ..2?0** .$M
M?A_>VWA/1]#_ +;A=M.U-=0-PUDW[TB8S;=OF\?,QYR>.W>N[HHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** /-_'%E-?\ C'PH
M9'81VVIV\YW1#;%GS<+N8["6V#IR"O7+1J?2*\[\;(+SQ1X59+Z1=NKQYA.T
M* A;<OJ2QV,!TQ&Q/0"O1* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH *X;4OB#/:6^NZC::3#=Z1H=R;:[G^V[9BZA2XCCV%3MW@<NO(-=S7"
M7/@34%.O:=INJ6MKHFOS2W%ZKVS27$;R*BR"-M^W#@,<D'8<8#9^4 Y[6([C
MQE\6(=$U.QL;[07T(W=O!),R&-))%5IN$)\X8("Y  Y# DYZGQ!JFN:+XE\*
M:3H\=K-97;2PR+=W+^9)Y<+,,R%7/1<[N2Q&#U)J6'P?=6OQ$B\26^H0+9QZ
M6-,6S:W8LD8=7&'W\G(/)' XP>HM^)O#=[K5_H]_I^JIIUUIDTDJ.]KYX8/&
M4(QN7'#'GF@#S;PUXKO?"+:K%#I4<N@1^*[JRGG:X/F1%Y%"A$YR!D$DGG/X
MUM:]\9(--UV]LM,TM]3BT^?[-<K&LPE:09#;/W93"D8.YANSQP,FY<_#&[N-
M"U'3AKL"O>ZZ=9,OV D*20WE[?-&>0/F)Z9&.A%B?X;W4.NZI=Z)XGO-'L-7
MD,U_:V\2M(\AR6>.5B3&22>@.,\8P, &A\2];UCP[X&OM4T3R!=0;/FE0N0&
M<+\J@<GYN_%<1XBOM3\._%K4-8L=/TZ2_B\(M=W8+M&C!)_F;(4EVV(JC..W
M( KTWQ5H7_"3>%]1T7[3]F^V1&/SMF_9SUVY&?SKF+SX>ZGJ6K:AJ-_XBAFG
MO-!DT4E=/V;5<[C)Q)@G<6P,#C R2"2 4;OXL"33--DT^R"7MYIJZAY,L4\P
M&6*",&)#U=2-QQT''/#K?XCZ]K&LZ?I.D^&H8KJ]TC^TL:A=-#Y1WE"I'EY(
MRK8('S!E;Y1FG1?##5--MM&?0_%KZ;J6GV)L);I;!)5N(=Y=08V8@$$GG)_"
MM6+P)/!XWL?$J:SYDEKIAL#'/;;VE8LS&5F##!+/D@ #' P.@!K^#?$L?B_P
MCIVNQ0/ +I"6B8@[75BC 'N-RG![C' Z5RY^(>III.F^)9-,LU\/:A=K;QCS
MV^U(COL20@*5.<%BN> 0,DYKI?!7A@>#?"=GH*WC7:VV_$K1A,[F+'C)[L>]
M8EG\-EM=-AT+^V)F\-V]T+F'3Q$%<8D,@1I<Y9 ^". ?<\$ %3_A8.KMX:UW
M4X=,LY;C2=?.E& SF-9U\R.,$.W"$M(.3P *D7Q-XCM-8\<SW L[FQT.,/!;
M1(RNW[CS5&<XY##<<'D<#IB._P#A2+XZU;#Q!=PZ5JM^NH2V20H0)O,5G.6S
MN#!<!2"H.#@X K?7PG=0Z_K6J6FO75N-4@16A2&,[)EC\L2[B"20 I"C R#G
M.<  XN\\=>(M2\"W>J:=>:.Z!K)5N[4L"1-)Y<B&,L6C=24Y/8DCGI/XZ^(?
MB/P7EY[?2&$,<3^4!([W>YR'V[6S"J@8W."&8\=P-2;X5V=Q::]OU.6._P!8
M\@R7%O"D2QF)PZL(QP26 R3U[8Y)-6^%ZZU'J:7OB+4)/[3M(HKL&.("6:+_
M %<APHP >=BX!/)ZF@"/Q!XR\46.J^*;?3=/TI[;1+"*^\ZXDDSM*NS*5'WB
MP0XY 7');-6[_P 0:KK>H0:#I-II;O+I*W]\-15GA=),JL("G(SALD@@#'#9
MQ4TO@.>>77WF\074O]M6"65P7MX@0%0IN&T 9.]SC Y;T&*AD^'ER;[3M0@\
M4ZC:WUM8#39IX(H@9X Y8#!4A6&3\P'H>* .7\.R&W\'_#*=]/TZY1[E+=9I
MXV,T#,LC$QD$8SL&<Y[<<#%ZS^('BB>^FDDL]'&G6_B<:%)M,OG,I=4W#G (
M+ Y[Y(P,9.]9_#U;+1?#VEQZW>-#HETMS"7CC)<C>,'CIB0@>GOVB'PT@6SU
M&W76;P?;-;&M ^7$1'*&#8P5Y!P.O' XZ@@%3Q/XWUO37\2RZ:NG*F@F#=;7
M<+M)="0*Q*NL@V_>P/E;)':NJ\0ZEJ>C^#[S4;:S2\U.WMMXMXE9E>3 R !\
MQ'7WQ7D^KZ%>3_$K5M6GB\26]ZEVIL)K32%NH_+6-0I65P0OS!LKD#GW->MV
MUEJ.H>$K6TU2[GM-3DM(A=3VCJKI-M!<J<%?O9[$4 >3^*?%4OBSX<+>VVI:
M;J 75+(1&&VDMC&Y;E)49W(P<<@X(Z9KJH/&/BB"/QI::C;Z0-0T*WAGMY4\
MR.WD$D;/\V]LD+M(R",X/2KMW\,-.U&&]-WJ5Z+R]NH;JXNK=(8F=H0WEC;L
M*]6))QDGOC"BQJ?PYT[5Y]=DO-3U1EUJ*".YC$D85#"08VC^3*D$$]<'<<@\
M8 ./U'XIZY'X;\87UM;PJVD)8M:2W%A+ 95G;:S&-W)P#DJ>GJ#5M_%OCQ+_
M $O23;Z;/=ZE ]]OL4!:&WV)M55FEC5G#L0?F^Z,X/(&U=_"O3=0@UB"]UG6
M;A-6M[>&Y>2=6<F%]ZMDKC/ &,8'S8ZU>UOX>:9KEOHPDOM2M;S2$"6VH6<J
M1W! 7:0S;<<XR0 .^, D4 <SXC\<>*O#_A[0KC7;2#0Y;P31WUU'%]JCMI@3
MY0VJQ^5@-QQN/8<BNJU;Q4?#'PV'B/46BU"6&SA>1[)@T4\K[5#(>/D+,#G^
M[SCM3)_ %G+8P6<.KZQ;PI!)!,!.LINA(Q=VD,J/EBQ8[A@C/&.,;$/AS2HO
M#$?APVB2:6EL+;R7YW(!CD^O?/7//6@#DSXBU_3-5\,C4;VUN+;Q GDF."UV
M&UF,>\,I+'<F>,'GOD]*Q_@G;S7=AK]Y>SI<LFOW+KOA7*S%%#2ANH)5R..Q
M/J:[#2? MCI4]E(=0U&]33XC%I\5V\;)9C!'R80$D*=H+%CCBK/A3PA8^#[>
M^M["YNY8KR[:[=;AD.V1@ =NU1QP.N>E &')K?B/Q!JWB*W\.75I:OHTL=O'
M#>6^Y+B3&YM[ Y52.!CGOWXY3QI\3O$'A_5M:DLVM;FUTRYMXQ#%;EH_+D7=
M^]E)!WG/ 0$#'-=SJ_PZT;6/$CZX]QJ5M//&(KR*SNFACO$ P%E Y88XX(XK
M/U?X0>&M8GU:2675($U.03S0P7C+$)LY,H0Y!8Y/W@0,\ 4 9FM:_P",3?>,
MYM-U;3(+#P^B7$2-9&1YQY F*%M^ ".-W).>U56\7WVH>*8UC^RV+ZIX-&HP
MS10 SQ2'+!?,(.Y5^8@' Y]>NCIWA :CXK\6PWHUNWTR[\B%,W#B.ZB2!8G#
M,Q+,20PW$Y(YR:Z>;P1HL_B*/6VBD6XCLC8)$C[8E@((V!1T'S'IB@#@-#UW
M6;3P'X,@36+R6[U?SGD,$"37LAP6'E[U,>T,1O>3L<[AU%R'6=0U_P +?#_4
M-5V_;F\0^7,54+EHQ<QYP.!G;VXK?MOA9H-I9:?:PW>L(-/EEDM9$U"1)(A(
M%#HK*00AVC@>_J:NVWP^T6SL].M(7OE@TZ__ +0MD^U-A)<DG_@)W'CW/J<@
M#O'NH:WI?AU;O0[:[N)5N$%PEE&LEQY)R"8U96!;)7JIP,GM7 /J=WXHL?"6
MJVGBG4VADUYK0JUM#')'F-V'F+L*&1=OH5^;( ->K:QHT&LPVZ33W4#V\PGB
MEMIC&ZMM9>HZC#,,'CFLR?P-HUSIL%C,+MEAO?M_G"Y=97GP069P03D,5QZ<
M#&!0!R-UXKUZ3PGK/C&TU:(1Z;>S(ND^2A3RHY-A28X+K*1\_# #<O!!JY;Z
M[K?BYM<N-'UF70IM,> 1V%_9Q@ &-)6-SN#,,Y=,(R[=F>:Z!O /A]M4NKY;
M>>,WDHGNK>.YD6">4'(=XP=I.1GW/)S4>K?#OPWK7B(:Y>V<C79"B4),R)/M
M^[YB@_-C Z^@!R.* /,;77Y=.^,/BC1[6YDTTZ[>V*1ZI'&DJ0_NV=0 <J6E
M!VKG.-Q..,5Z]XGUE_#/A#4=6$4MY)96S2!0FXNP'!8*.!GEB!@#)Z"L^]^'
MGA_4;C6I[J&YD;63"UV#<N 3$04*\_+C'X#@8!Q71064$%BMD!)+ $V$7$C3
M,P[AF<DM^)- '"17GB33M3\*WIUJ34],UL"WNH)(8@T4K0F1982B#"CRVR&)
M 'KG(@^$EK-#)XR:34+F<+XDO(BDBQ@,PV9D.U =Q[@$+QPHKIM*\">']&U"
MVOK6VG:XM$>.T-Q=RS+;(PP5C5V*H,<<#IQ5S0_"^D>')+R32X)8FO93/<%[
MF67S)#U8[V/)[F@#AK6&^/CSXE-<:C=20Q6-MY43LC+L:&4A<;<J%8M@#&<D
MG<3DY>D:MKGA/0?#%P-5FU&WN?#$]V+&6*-8T,$$;Q*FU=W1]I)))QGT ])O
M?"&AZAJT^J7%I)]MGMS;2RQW$L>Z/!&,*P&<,1NZC/6B#PAH=O-I,L=I)NTB
M![>RWW$K"*-EVLN"Q#97 ^;/0>@H X?P'JWBW59/#^N7^K6+:=J@ECN('N=[
MRR;'=!%&(5$14(V1O;*@DY(R=+QZX7QY\/UO>=*.H3>8K$;?M/E_Z.?J&+8K
M<T/X>^%/#>J/J>D:+!;7C@KYH9FV@]=H8D+_ ,!Q6SJND:=KE@]CJEG#=VKD
M$Q3+N&1T/L?>@!UZ((_+NGMA/<PAS;HI42.VTY1"Q R0#U(''.,9KRJ#Q!KH
M\&^&?&D6L7-W=WU_%%=6"A3;RI)(4,:*!E67@ @DY!R"37I&E^%](T>=)[2"
M5ITC\J.6YN9;AXTX^16D9BJ\#@8'%0V7@OP]I]Z+NUTR-'64SQH79HH9#U:.
M,DI&3W*@4 >06&K>*[[P)XM\3MXOU..;3+VYMXH%2+8P 3!Y3C[QZ8QQC%:-
MOXB\5>')?!]\=6N=<&OZ/-<3V=TJ*(GC@64-&1M[$ Y/.&R<L"O<>)/!-N/
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M6W)&Y.U/E( R?NG/)R0!VF?$C1M0UGQ#8R)<6D.AJK3W5S$\<9!SG.0-I!&
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M@!]-:>^LF>U683W%P(RQD9]V!L (51U/). >/8]36[_L.]&FPQ?;FMY#;QS
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M>TGT:6VDTTQA;<VV/+"+\H50.!C&,=L8[5Q?@G7?$4FI1Z#JL5B@.AV]_;/
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M/87UOJ>G6U_9R>9:W4230OM(W(P!4X/(R".M23SI;6\L\N[RXD+MM4L< 9.
M,D_0<UY18ZIXDN-*\'>'/#MS#:2MX:AO9)9)%C+$(B*H+0R@@9)*A<]/F7C=
M9T77/%?B#6+/P]?ZY::/J-MI9N+W[&D<LLL_FO'@;E:/:H12^WHS;0>NT ]$
MT?5[37M(MM4L'9[2Y3?$S*5)&>N#TJ]7'?"UE3X6>'V8@*+0$DG@#)KAK?QQ
MXA'Q!T2"+5)+W2=6O;JU\\11BTD2-_E-M@;_ ) P#.Q*LV0"P7) /:JQ?%'B
MG2_!^CG5-7>5+;S%B!BB9R6.<=.G0\G [=2 ?-+;Q%XLM[;PIK]QXB>ZM]1U
MYM)EL6M(D4QM-*FXLH!+ 1C&,?SW8OQ3O+S7O _B'4Y=5F,%GK9TZ/3XP@BC
M$3;26X+%R?FSD8! QCJ >N^+M(\+W>ERZCXFTRVNK:SC+O,]L97B0<DC:"V.
MYQQW/2JNB^,?"6_3M+TQFLUO4W6,;:;-:Q3+MR/++1JIXZ8//:KGCO\ Y)YX
ME_[!5U_Z*:O*=,>YO]8^&FE^(T@M]+@T^WO=,N( W[^X5%"1.Q. 1@,0 <\#
MOP >[45Y3X@N_%GB#Q;XETO0]9@TX:,+<Q,][Y 3?%YC.Z^2_F*2<<LN-GN<
MT+GQ%XBA\>POJ^HW4>B7=[90V%YIC(UHK_*9(95SN^<DKEB".N".* /8DFCD
M>1(Y$9HFV2!6!*-@'!]#@@_0BB6:.")I9I$CC499W8  >Y->16ZSZ'X8^(-W
M:ZY?6MPFL-!'.R_:&W%8 ,)QF1MVP,2 ,@DC&:Q+W5->U#0_%^C:K?7D1TG4
MM-EA N=TJI<2 -#(Z@!PH/8?>'WF !H ][JO?WD>GZ?<7DRR-'!&TC"-=S$
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M!)W8F,2 XRS<8=AG&  >F7MY;:=93WMY,D-M ADED<X"J!DDU/7S[XR:YN?
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MUN+[0M0L[22..YGMI(H7D'RJ[*0I/MDBKU,EFC@0/+(D:EE0%V !9B H^I)
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MS,;$[=BR2,6.6"9& .H!R2"3U=[K-G8:KIFFSNPN=2>1+=0,Y*(7;/IP*T*
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MQ\M]A"Y&2, Y) QZ,LT;R21I(C/&0'4,"5)&1D=N*<64$ D L<#)ZF@#'O\
MPQINH>$_^$;F60:?Y"0+A\NJIC:0QS\PV@Y/<9JCH_A.ZM+F&]U;7KK5=0MH
M);:VN)(8X_)1V!)  .9,*H+'.=O09.=+2/$FDZXETVGWD<HM9I(9?F P4.&/
M^[GOT-7DO;62".=+F%H9&")() 59LXP#W.>* ,GPEX=?POH8TUM1DO0)I90[
MQJ@7?(SX '^]W)Y]!P,'4_AG!?R>)S%K-[;PZ]$/,@"JR1S $%^1E@1M^7(Z
M-SR-O1ZYXGTGP_H%UK5Y=QFTM@<^6ZL7<?P+S@L3P!G\JUHY$EC62-U=' 96
M4Y!!Z$&@#F[7P7!9Z];ZQ#JVI"YATY--VGR2KQ+G!(\O.[<=V00,]L<57MO
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M9UVHQ\QCM.&  /K0!W%YX!\+W[ZJUUI,<C:KM^V'S'!DP5(Z-\O**?EQD@5
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M=;H\LD^B6$TK%Y)+:-F8]22H)- $+>'=&>;4)7TRU:345V7;-&"9EP%PWJ,
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M9=S ,JA1DL1QD9-=+!X[LM=TZQ.B:?J.H2:C:-<B.W:.-X(@VQBSLX4/NW
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M(9T$&\2ABQ*LKD .N"-X&>@KK_"_A73/#>D1P6VEV5K<RQ+]K-NN5D?: W)
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M.H*UG;I&B^:Q0,W/*'!)7G/516YHWC;^VM4MU@TB[71[R"26RU(\B?RR P*
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M\XPSG"'^%<]3G0^(FNW%OJ5GI.F:A<K?FSN+HV5J1&[@#Y)&D/"(NV3CDL<
M#N,GPM\-Y;#6]-U*'P[:>&WM)0]P]KJTURUTH1EV;"-JJ6()))/'N37>ZYX0
M\/\ B6XM9]9TJWO9;4GRFE!XSU!Q]X>QR.] 'FOA[6_$'C&R\#?:/$%[8?VI
M8Z@EX;%8U,AA<(K@LK8<@Y)'0_="U.][XD;X3:9XAM=3OKB^TJ[D-VJ.2;RV
MBN'1@P[G8H.00< \UW^G>"?#>D26DFGZ3#;/:*ZP-&6!3>,,<YZD=2>>!Z#&
M3J?AW6=+T^WT7P7;:3;:5<M,+XWKS.T7F<[HP#ZEN,]2,8&30!?\(:U_PDPU
M'7+>25M+GG$-@'X5XXU :0#MF0R+[A :Y#4;K4-3L/'&LQ:]J-I?>'[F<6<5
MO-MB5(H5<;XB-KACN&6!Z<8YSZ;864.G:=;6-NNV"VB2&,8 PJ@ =..@K.U#
MPGH&J7IO+[2;6>X8H7=D_P!9L.5WCHV.V[- 'F5K;M<>--3U6_FN[:[N?"\5
MY+:F>5(UGD1U9-K-AP,<#H#VRM9_@FZU7P]'X$:VU*^O8]7TR^\RQED'DIY,
M8>,1H!USP3RQR><<5Z]JGA70=:ODOM2TJVN;M(C"LSK\ZH<_*#^)_,^M,M_"
M'A^U?37ATJW5M,#"RX)\C<23MSTY- 'E'A"]\3:O?:+K=QXHL88KR5H[RU75
M)I9)"['Y!;LI2)@< ;<8 Z]<]-\(K74KW1DUS4_$>IZC*#<V8@N)CY8439#-
M&>5DR&^\20K =  .PMO!OANRU2?4[;1;.*^GW>9.D0#G=G=@]LY.<8SFK>BZ
M#I?AVR:RTBRCL[9G,ACCSC<0 3^@H T:*** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** /*_BE=P"&PCOK!G2]D^RSQ@C[HD.S=G&8V8
M^H(7')!'JE>;_$JXMH+6RM9=/4EIT:(Q+M*A7)8%\8&]?N@X^8<YZ'TB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBO'M9E\4:GXO\ 'R6'
MBF\L8-!M;>:TMD6,(SO#YGS,5/R_*W'?<,GY>0#V&BO&]-U/Q5X@\:R8US4+
M*UBT>RU22QAC1FWML9XE4ISE1(.<'<5SD<5':^*?$,G@SP]XX35VGGOM36"]
MT]!^X,;2E!'&I&5("@9.XDDG)[@'M%9L.N6D_B*[T-!+]KM;>*XD)C(0JY8
M!NY&SGZC&<''GQUC5;?Q-K_@V6_O/M]Y?03:9.[D,EI(-TA0]UCV..G)X)/:
M35M7\0)XR\6Z;I>JB!K?2;>2R%RZ>7#*S8SEP1S_ +6>30!WVNZU:^'M%N-5
MO5F:VMPI<0QEWP6"\*.O7\JT:\<N->OX_AYXI\K4=<TW7M*BBDNK6ZD$CP2'
M)S'*=P:)R"1@\ <8! K2NM;U37O$'CVR-_<:8/#]K$=.$4ABPYC=S+(/XP2J
M\'Y=IZ9.2 >HT5Y%HUYK/C>]T<7'B"_T\ZCX:EGD2Q<1J)1*J"0#&0?FR>0>
MF,#(J!]:\2WO@KPKJ\\]Y>Z<VGR2ZC!ID_D7VY< 7"G</,"Y&4&!ELMN! 4
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M;2'& >"&+'KC YO7XYVU3XE/<WU_#>6-I97<,,>H3!8IFB#.0 W(#-@#.%!
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M'/<$'G/-GQ[J.@R>%O'5GJ(M_P#A*O[6S'YT>Z;R%F01%&.<+Y1(X(ZGCGD
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M&I19R*,:7*W^C<$,)MY^7H" ?]KGIC=MM?T:\TV;4;75[">Q@)$US%<HT49
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M-8T&!T QVH L4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110!Y5\40LT$+*]Q;,EMYN8YC&;B,, L4C,RE,EB<$$E@#_R
MS;'JM>2_&"U%UH\3,8DFCC,OE3QO*DDFX*(PQ9=N<OAL 8S_ 'N/6J "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH *\\@\"SZAX[\87^J"ZBTO5
M5MHXE@NM@G1(=CB15/()/&>V>Q(/H=<IJGQ)\)Z-JEWIM_JCPW=H5^T)]DF8
M1[@""2$(Q@CG..: +]IX1T>Q\3S>(8()%U"6W6VW>:VQ8ACY53. .%[<8&,5
M3MOA[X<L[N.:&SD6&*Y%Y!9B=_L\$XZ2)%G:I^@P.P%$_P 1/"MMJD>FRZKB
M[D$3(@MY2&60@(P8+@@EEYSCD4]O'WAQ-2BLFOG'G3?9XKDP2?9Y)LX\M9MN
MQFSV!XP1U!H TI?#VES>(X?$#V@.JPP&VCN-[ B,DG;C.#R3U&>:I7_@K0-3
MO]2O;RSDEFU*V6TNO](D"R1@@@;0P Z#D8/7U.71^,M"ET_5;X7<@@TJ=K>\
M+6\@:)U."-NW+=1T!ZU1;Q#I]EXIU22]UJYBCMM/BGFLYX2D5LA/W]V/F))P
M<$XQCM0!.? /AQM+N]->SN'MKP(+C??3L\BH,(A<ONV#)PN=O)XYJ?4_!NA:
MO>1WE[:RR7"6WV,R+=2H9("<F.3:P\Q2>H;(/>LC4_&>EZAX0UB\2ZU32XK:
MVCF-U]C<2".3[DD:D?,#@C/0<YQ@XU-5\7Z7H#_9[N2\N'AM1=7$L%LTHB@R
M1YKE!@#Y6/'/RD@8% %A/"NBQ:O'JL-F8+R.R%A&\$SQJEN.1&J*P4 'D8''
M&.E4)/AYX8EL=,LS8SK#I:2I9^7?3HT2R_? =7#$$<8)/''3BFW7Q#\/6UQ!
M DMW=M<V9O8#9V<DXFC!Q\I13D^OIWQ6[I&JVFN:1::I8N7M;J(2QL1@X/J.
MQH FALK6"PCL8K>-+2.(0K"%&P(!@+CIC'&*QM%\$>'/#UVMUIFEQPSHC1QN
M9'D,2,Q8JFXG8NXDX7 R3ZFJD7Q%\.3/;LES,;*XG-M%J!@86SR@D;1(1CJ"
M >A[&N=@U+4/%/Q)\2Z(]SJUC#I;V?V22T8QK'\KNYE&<,).@R#E0,8(S0!V
MVA>&-(\-+<KI%L]NEU,T\R>?(ZM(V,MAF(!.!T]*AU#P;X=U35)]3O=*AFO9
M[9K5YF)W&)@5*C!XR"1D8."1G!-9'B#5+RQ^*'@VQBN91::C'>I/!NPA,<8=
M6QW/)'/'3TJ:S^(VB7NLQZ5'%?+<7"2O9%X,+>>67#B,YXQY;??VYXQG- &I
M%X3T2&XTR=+-A)I<30V),\A^SHR;"%!; ^7 _ >E5X? GAFWLK6SATF)(+6X
M-U;JKL/)E./G4YRIX'3I52V^(FB7FE:-J=NET]IJ]Z+&V?8J_O2Q7#988Z,?
M4[> 20#O:?JL6HW6H010S+]AG^SO(X&R1MJL2A!.0-V#T((([4 3V-C:Z98P
MV5E!';VL"!(XHQA5 ["L"S^'7@_3]0BO[3P[8174+^9&XC^XPZ$#H"#R/3M7
M&:KXZU+5?!?BJ_,%WI1T?7(K-)(I 6*+-$CJ=A)+89B0./F !;!QU"?$O1DM
MM:FOK74M.;2$CDN(;RW"2-&YPKHH))!/'8CN!0!LWGA/0-0UR#6KO2;6;4H"
MICN73YE*G*GZ@]#2R^%- G\0)KTFDVC:JF,71C&_(& 2>Y XR>>!Z"N8U'XF
M1#PIXBU"QTJ]CU#1XD,EK=B-67S%RCG:[ KUR <_*1BNGT[69)/"4.LW]K/
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M1^8GG102Y8$D;E.<A3P#UW%0: /6J*\L/CGQ=>ZW='1]&>[M;369-.F@%O\
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M0LYDF#QD;>0 !@<,>NW&OX;\076M?#FSUZY>WM[J:Q,SN<B)& /S'KA>,]Z
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MN964@VY/*%B"1C@D9 &!@5-:2:QX1N;N:/Q#J.H!_"$^I+#>.&BBGCV;-B
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M<=& (Y!_E7GGQ+CTY].WZ@;6"ZA"217-Q<+'M.[.U-I$C942+_"-NXYZUZ#
M9#;Q&9=LI0;QNS@XYY &?R% $E%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 5P^J:WK^M^,KKPWX8NK2Q32XHY=2O;FW,Q#R#,<:)E<_*"Q/T&1W
M[BO-;ZXN_ ?Q#US7[G2[[4-&UV*W+3V$!E>TDA39AU'.T@D[O7 QWH U]$U3
MQ#I6H:^GC"[LSIUC%;O:W\5N8(Y0WF!LY)^?(0;03U'J*U4\9^'VLKN[>_\
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M7EE(.#@J.#TH XK1/&/A33="UKQ5IVMW=WHL,4"&QDED>2VE!?Y465N-V]
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MW!QS\HP ,52U+X8ZAJM^]]<^+KLW-UI;:9?R+9Q S1LQ;"=HUYQ@ D@=<Y)
M(+?7O$NM?$+PU/I]Q9V^E7VB+?O:31LY6-FB,GS+C,G*A2<*,'CGFKX?\?\
MB[4M3MM4FT82>%[P2R;TMF1[6)<E&+EB')&-V!C(X]]RQ^'=WIUSX<N;?Q3>
MK-I%H+*1OL\6+B#Y/W>,85?D[[FZ<Y&2:-\-AH__ !+UUZ]F\-H[20Z.ZJ%1
MF+'!E'SLH+9"D]1DY- & E[K^K^)/!/B#5_[/_LB_O7EL;:*$_:+=7MI#%E\
MG<",%^@!5?H-#XP7TZVGAW1C.UOIFL:K%::BZG:3"6&Y=_\ "",Y]ACID&_H
M_P .)M*.D1'Q1J<MAI%SY]G:>7$BJ-KJ59@NYAAR.3T)'<$=%XH\+Z7XPT*;
M2-6A+V\A#*Z8#Q..CH2#AAS^!(.02* &7GA#0KR"RB&FVUO]BN(;BV:WA1#$
MT3AU"\< X(('9CTZUP]WXS\9W'B:271--6[T:WU1K">#[-C$<;!99#,9  V<
MXXV@=<X.>TM/#^H*T"ZGXAN]0@@=76,PQQ%V4Y4NR@%L$ X& 2.<CBLI/AU%
M%XCO=1@US4X-/OKG[7<Z7"X2&64XW$X&<-@;AWZ'CB@#BK_7_B-KFA>+[J"_
MT:RTW2)[ZUD>."3SW$*DDIDD<X"@YR-S'J!6U:7FKZ?XH^'5CJ-S8ZB;^WNR
M;@V(26(+ K *Q9B,\ D8SCGVZ73O UM8:1XFTUKZXG@U^YN;B;<J@QF9=K;<
M#T_ET%16W@)8=3\-7\VM7UU/H23*AF"?O?,C$9!P!M "CI]22220#SZVMM5+
M_$^\O+ZPOX;)Y)7MKS3A*DSQP[HS\S8 4* !@] ?:NA@\3Z_JUKX?T#P])9V
M&J2^&XM8DEDM@T+9"HL*J"-@+$Y./E & >E=(G@.T2'Q-$-2OBOB .+D-Y?R
M;DV$KA/3/Y^O-5+SX:64\6@O::MJ-A?:-:K917UJR+++  !L?*X/&<<<$DX-
M '->*_%/C&RM5"ZG::??V.EF^N[>QLOM@EE5GRC9)\F/"#YV/)) Y&#%!XEU
MB;XCV^KS:H3I8\(_VS]A2#Y0C;=T8/)R64-NP3CY0.]=-?\ PLTN\N9)8M6U
MBT6XL6LKP0W(9KI3GEV<,2?F;/J2/?,UO\-=-M;W2+J+4=1#6&FC2W7S1BZM
MP<A'XR!D_P ..P["@#+\):QXWO-8T>YU&)Y=&U&U+S22K:QI'(5+H8/+E9V0
MJ /FR>K< X78\3>(;Q?&.A>$]/N#92ZDLL\UZ-C.D<:D[8U<$%R1U(. #P>S
M?"GPXL/"4T?V?5-4O+6V=WL[2[F#16K,,,R@*/F^9QGT<\9))U=>\)6&O7ME
MJ#S7-GJ=B^ZVOK1E66,<@K\P92I!((((- 'E?CG5M>NOAAXST;7;V.34=%N[
M57N;.'RX[J&5HV0-N!P?FR0N,$*.1G=ZWX8MOLWAK30TKSRFUBW32*H=OE&,
M[0!P.!QT%8VH_#K3M5\.ZEH]YJ.I2?VG<+<7UYNB\^<KMV@GR]H4;$ "J,;?
M<YZ?3[,:=IMM9+-),MO$L0DEV[F & 3M &?H!0!9HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#S/XF3-9V%QJ-Y?6W
MV:"6T\JT9>#+Y@W[B6W/B/>P 4 !6)_BSZ6K!E##.",\C!_*O//B*9K&WBDB
MAMOLR"+[0\NZ,&,/\S%XSE=H"C.TJ!(RD8?CT&'S!#'YQ0R[1O* A=V.<9[4
M /HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "LV;Q#HEOJBZ7-K&
MGQ:@Q55M'N464D] $)SSVXK2KSYMQ_:#.T@-_P (IP2,C/VJ@#T&BO,-%\;>
M+KD>']0U*WT,:9JFI2:<\5LLOG(Z^:-P9CMQF(\8Z8]>+N@>+/$GBT6NM:#'
MILFA/J#VTL$\;I.L"G'FA]^"<<[=HZXYZ@ Z;6?">EZ]K&E:K>B<W6ENSVQC
MF9 "V,Y _P!T5N5Y:?B+J\?A&#QX5M)/#TMYY4EDMLWGQ6XF:(2"3?@OD E=
MN.@&.2:<7CGQM?-XPO+0Z&ECX;N+M'26"4O,L2L4QA_]CGD=?PH ]>HKR&Q^
M(OBG2;WPW<>)(=,N-.\16#3VZ6 =9('6-7RV[@[@RY'8DX^[\VU#XOUNRLO"
MNL:C)9S67B26&W\B*%E:TDF3=%M.3O'!#YQS@C XH ]$HKQ72/B-XQO? -UX
MONKGP[;V@WPI',DJ;)=Z@,,%BP )^4<G%0>*O&FOW7@+QWIMPQAN-+%JGGR6
MRQR36]U@%'CRP1@K'D'."/E5@: /99-5L8=5@TN2YC6^GC:6* _>9%ZD?2KE
M<%>:_J.A^/=,TR]EM[RW;2;FXGG%J$F8HV[ (; & !CU!)/(Q6B\2^)H-/\
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MSGXCZDEO;B!ILIJ5M+"B,BK%*5#-@N02!C))Y!V@8.ZO0X7$D,;A@P90=P&
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M-15UMYC,NT>3M^<HA/4G&.,FJFF?%"XU+4K5X_#5\VA7)EQJ4<,Y$4:$[9)
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MKS1431-3L1=Q3QIM-LQY".Q<[P01A@J'/\.* .YHHHH **** "BBB@ HHHH
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MTCPY+KK?$3[3HDD%[>2N;"6]M"A5VA9 T;L #ALC*GWZ$9I>'EDU32[D:CX
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M%+<PI(S!%1I "6/0 >IK+\5^(D\,>'KS4_+AGFMX6F2VDN!"90O+ $@\@<\
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M 4444 %%%% !1110 4444 %>;>*_B9?Z3KNJZ9HVAS:@^DQ1/<[8)I-S2*7
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M;CE6'K@]C6=I?@ZYMM5FUW4]9;4-?>R-C%>"V6*.&/<6&V($Y.XY)).>@P*
M.9^".C6S?#W1-5FM[1KE!<+!*D.V5%:9PP9LG=G:,<# &/>LOQWK.J^(O"5O
MJJ-9Q:,==B@A@,+&=A',8_,,F_:,LK?+LX&.:]"\">%I/!?A.VT)]1^WK;NY
M27R?*P&8MC&3W)YSWKG;GX4F<7MHGB6^AT>;48]0M]/2&,K ^\-(-[ L03G:
M!M"DY(?G(!0O?$\OA_5/B7=Z=I&F17FE16<IEVO_ *2SHS9DP1G / &.<Y//
M#9?'_C*VU+1M(GTK3'U'6D:YMA9 R^5"(]VUEDDB#/PV?G48Z9/!W-1^&_\
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M)A_TB9I9/0L2.,\ MT(%:NN>*?$OA33O%L!!U:YTRUM[VPGD@&YH969',HC
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M2@A8$'*[2.<CK]?4UGK\-?!JW4MS_P (]9M++<B[<NI;,@SS@G ')^4?+[4
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MC@&O<Q;64JW"K!;NLK8G 12';_:]3]:DEMH+@@S01R$*R#>@/RM]X<]CW]:
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MH.:L:E\3KZ+6;R#1_#=WJUG87_V&Y:UBG>0L I=EVQ&,;"2-I?<?0#!.C?>
M[_4M'6"]\237&H-J,-]+=R6XV 1'*QQ1!@(UX'<DDL3G/#8_ NJ:?XDU&ZT?
MQ+)8:1JDYNKRR6V5G\TXWF.0GY=^#DXR.W8@ [FBBB@ HHHH **** "BBB@
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M7F+F&5Y9"R2-L 5@"28S@\8X&#G( ._GGAM;>6XN)8X8(D+R22,%5% R22>
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M?CKQ7DWA?Q+K5]XJ\,I)KMY=Z;K$NHP2WDL@B^VK&I\N2.#'[A00 ""&)#9
MXRW0KK5-)^!>D:G;ZM=0W\VJ@3M),6+@W;HR+G(YR6/<\G/04 >YT5P%PLWB
MCQ7XHTM];O\ 3)-*6W%F;2X:()OBW^:R@@2#<2"&R,)CC)SPZ:QKOB'Q!IB7
M^O:G8K<^$3J;06EQY(DFR0"-HXR%#]B.<'!((![O17+>!-=DU7P1X?NM3O(V
MU"^ML_,0K3,H.2!W.!DXKJ: "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MPT1F   #CH<8';-,U/P'H.LZ&=*U"":XC,PN#/).QF\W&-^\G.< #T
MKI:* .8D\!Z-+IME9R/>O]DOTU))Y+IWF>X48#L[9)XX_ 5=O?"VFW_B.TUV
M;SUO;:,1#RY2BR*&W*' ^\ WS '@'FMJB@#DI/ASH$OA2Y\-D7@TVYN3<RJ+
MAMS.6#=?3(!QZC-:LGAG3I?$5CKK"<WUE;M;0DS,5V-UR"?F/N:V** .1TKX
M9^%='%XEK82&*ZBD@:*6X=TCCD&'5 3\N<G)'//6DL?AGX8L+A;A;:ZGF^R/
M9.US>2R^9"RA2C!FQM"C ' &>F<$=?10!Q;_  K\*3>';?1+BTN9[:VD:6W>
M6[D,D3$ 95L\  #Y?N\ XSS74:7I5CHNGQV.GVZP6T><*"222<DDG)8D\DDD
MD]:N44 <Y9^!/#NGW[7=I8O#F<7/V=+B06XF_P">@AW>6&X'.WL,5<@\,Z7;
M>(;G788[A-0N@HG<7<NR0*NU=T>[8< G''&>*UZ* ,G5_#>EZ[=65SJ$4[RV
M,GFVYCNI8@C_ -[", 3VYSP2.YJE<>!?#UU%JT4UI<,FKRK+?+]MG'G,,XZ/
MP.<8&!@ 8P!CHZ* .9OOA[X3U/5K;5+[18+B]MPJI)(S'(4 +N&</@ ?>!JU
MJ?@_0=9OGO;[3UDN)(O(E99'3S8_[KA2 X]FST'H*W** ,B'PQHT&OQZW#9!
M-0CM19QR+(X5(0<A%3.T#Z"N-^'?P_?1[>^DU^S!NCJTE]:@7!:-0P7:Q0';
MO!#<D$C/!Y->DT4 8=YX.\/ZAJDFI76F12W4NWSF);;+MQMWKG:^ ,#<#@9'
M0FKJ:-81ZRVKK ?M[1>29S(Q/EYSLY.-N><=,\U?HH Y.U^&7@NQN[6[M?#]
MI%<6LXN(9%W JXY!Z\X/(!R!Z5</@;PN;:[MQH=FL5W.+BX"Q[?,D!)!)'/!
M)P.@R<=:Z"B@#(U'PMH>K7HO+_3+>XN-@C9W7[Z YVL.C+R>#D<FG7'AK1;K
M4CJ,^FV[W9MC:&4KR83D%/IR:U:* ,JV\-:+9_V;]FTVWB_LP.+(JO, <8?;
MZ9!YK5HHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH X3QW:E+:VFMI'C
MNQ=J[30%%2-0ZE?,0G?(-YBX0@EBIR!@5U^DQQ0Z-8Q0%3"EO&L948&T*,8&
M3CCW-<?\1H4O;#[!&DIOKJ,>7&F0S(DT89D=3E&7S!_O[PIR2,=AI+SR:-8O
M=1^5<-;QF6/9LVOM&1M[8/;M0!<HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **S+C7].M?$5EH4TX6_O
M89)H$/\ $$QD?7!) ]%;TK+\8^-K3P5#:3W^F:C<P74RV\<EHL3#S6!(0AG4
MY(4\@8XZT =/17,Z=XVL;WQ*?#EU8ZAIFK^5YZ6]Y&A\R/\ O*\;.A'4=>H(
M[5S8^-.CF72(_P"P->#ZP5%@#';CSLML'6;CYCC)Q0!Z517!7_Q6TW3-"O-7
MN]$UJ*"ROVT^Z0I!OBE4*>1YN"IW#!4GH>V";VH?$C0=)\,:9KFH?:H%U2(2
M65GY8>XGR 0 J$C)!7J0!N )!.* .OHKF8/%T_VZRL[_ ,-:O82WSR);&4P.
MCE4:3:620[6*H>&QSD9.":K>#_B'IWC6]O[73M.U&%K!@EP]R(@$8D@#Y9&)
M^ZW(&..M '7T5R?C?QY:> [>VO-3TV^GL9W\K[1:^6VV0@E5*LZGD*QST&!Z
MU8TWQ3=7GB=M$O?#VH:8S6C7<$MR\3+*JLBL/W;L 077C/3!XR* .DHKC?B#
MX_3X?V=G>7.DW-Y:W$AB,L4BJ$?&0ISSR QZ?PU/#XRDN]7T6PLM)>Y_M&Q2
M_DECN$*VL38Y;U'/!'WL''0T =717"Z%\1)M<\7ZAX;30)X;K3T9KF1KA"BD
M= ".N20/S/:G^!OB+'XXU/5+.#29K0::0L\DDJL-Y+   =?NMS[>] ';T444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% ' _$$Q7-OIL[:3)J=B]R+6X7<S*$<@,1& 09 5*C=CYCM^
M\176>'I%E\,Z5(EU]K5K.%A<[-GG H/GVY.,]<9.,UQWQ$ECM['^V9+H1Z=9
M6CW$81<Q2RM)%Y;,_EN%^8Y&S#-GKC-=7X3,9\&Z&8HUCC.GV^Q%8,%'EK@
MC@_44 ;%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MG'U H MT444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% 'G7Q%8#0;PRK;K" L,SO'M60DEAC*-M*C>2
M3\I61N<D8[703.WA[3&N55+@VD1E522 VP9 )YZ^O-<K\1&NUTA8K;4X]/D,
MZ33W1:,+Y*R#Y=LF1D#YL\?<8CJ5/4Z D\?AO2TNE=+A;2(2JX 8-L&00  #
MGT 'M0!HT444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MRH$@Z@9Z]^>GID<UK5X/(^MZ;K?CC6--UN6TBM-=M0UND2-YYD=(R&)'0*_
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M+4+BZ;5;MKN1950!68DGH!Z_3VJJOP_A&G1VAUF_.W5SJ[2;8MSR^9Y@'W,
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 <1XQM[F".*Y:2ZN%D:..:&*!)?LZ%LN\6
MY"V#T8$GY2  "5K?\*" >$]*^RC$'V9/+YSD8X/MGKCMTJAXK$L&G"]MW$YW
MQA(&FD (:1!N548%WRWR\C!*XQCF]X3+MX3TPO()#Y"X<.&W+V.1QTQQVZ4
M;-%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% '(>/KY[73$2 E[IB3%%&@=SP<L,\)C ^<@C!8':"77?T,*NBVJ
MH9&C5,1M(069 3M)P .1@X P,\<5SWBR\A^S_9+FS>]EN8C%!%$/,43&0%-S
M*H*(#'N+,RC$9^\16QX2$B^$M*$I!E^S)O(G689QSAUX(],<8H V:*** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M70>%K2>P\+:;:W,TD\T4"HTDJE6;'0D$ CC'! ([\T :]%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M444 %%%% !1110 44R%VDACD>)XF903&Y!9"1T."1D>Q(]Z?0 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 44@W9.0 ,\8/44M !1110!
MS'BE%2RE+W9$9+"6Q8JXO(V7!CVNXR,DG *D[=O0\V/!45U%X1L!>SF>X8/(
MTI<.SAG9@6( &X@C(QP<CGK47B1I[.**:WM(YF=S'MW9V,[*BL!@G!W;6"@'
MYSR,9IW@6"&V\'V<-O;M;0H\P2%B,H/-?CC'\A]!TH Z*BBB@ HHHH ****
M"BBB@ HHHH *15"J%&< 8Y.3^=+10 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4U(TC4K&BJ"2V%&.2<D_B233J* "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MX50!M'^R0".A&0: -NBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110!5N8U,T$SQ9,<F Z,VX*W'11R-V,@\8&X]*Q-">X@U
M_4;6YLTBFG/VF29)Q)YG"*F0#PX48/RJ" H4L%)'07$D<4#22*652,*%R2<\
M8'KG%<SH-U WB6YMX%D4"#'SJ$R@V,A(W$DGS6.XA>RX!5J .KHHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH K
MW3.J?NT\V1B B,ORY&3DD#Y>G4],# )X/.^'+.:PUZ_@CA:*R !V@%@)BL98
MO(9,NQ!7^  !3@]<].SJDD8:1%WDJJGJS8SQ^ )Q_A7.VUI>0^+XYC-&;(6S
MPH0^7D?=N8LI  /W!D%B=O.,4 =+1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 TKF16^7@$=.><=_P_E6?&ZO
M=V$RE298I#LB8%=K;6W<'G! &1Q\W;(!** -*BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
EHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-5.1
<SEQUENCE>10
<FILENAME>ex5-1.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin-top: 0; text-align: center; margin-bottom: 0">&nbsp;</P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit
5.1</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>
<IMG SRC="ex5-1_001.jpg" ALT=""></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">October
[&nbsp;&nbsp;], 2019</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Trxade
Group, Inc.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3840
Land O&rsquo; Lakes Boulevard</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Land
O&rsquo; Lakes, Florida 34639</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 0.5in; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Re:
    </B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>Form
    S-1 Resale Registration Statement</U></B></FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>File
    No. 333-_________</U></B></FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ladies
and Gentlemen:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have acted as counsel to Trxade Group, Inc., a Delaware corporation (the &ldquo;<U>Company</U>&rdquo;), in connection with the
filing, with the Securities and Exchange Commission (the &ldquo;<U>Commission</U>&rdquo;), by the Company, of a Registration Statement
on Form S-1 (the &ldquo;<U>Registration Statement</U>&rdquo;) (File No. 333-_________) under the Securities Act of 1933, as amended
(the &ldquo;<U>Securities Act</U>&rdquo;), relating to the resale from time to time by the selling stockholders identified in
the prospectus constituting a part of the Registration Statement of up to 4,910,000 shares of common stock, par value $0.00001
per share of the Company (the &ldquo;<U>Common Stock</U>&rdquo; and the &ldquo;<U>Shares</U>&rdquo;), as described in greater
detail in the Registration Statement to which this opinion has been filed as an exhibit. This opinion is being furnished in accordance
with the requirements of Item 16 of Form S-1 and Item 601(b)(5)(i) of Regulation S-K.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
reaching the opinions set forth herein, we have examined and are familiar with originals or copies, certified or otherwise identified
to our satisfaction, of such documents and records of the Company and such statutes, regulations and other instruments as we deemed
necessary or advisable for purposes of this opinion, including (i) the Company&rsquo;s Certificate of Incorporation, as amended
to date, (ii) the Company&rsquo;s Bylaws, as amended and restated to date, (iii) the Registration Statement and the exhibits thereto,
(iv) certain resolutions adopted by the Board of Directors of the Company, (v) the Subscription Agreements entered into between
the Company and certain of the selling stockholders; (iv) the asset purchase agreement entered into between the Company
and one of the selling stockholders and its affiliate; and (v) such other certificates, instruments, and documents as we
have considered necessary for purposes of this opinion letter. We have also reviewed such matters of law as we considered necessary
or appropriate as a basis for the opinion expressed below.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
to various questions of fact material to the opinions expressed below, we have, without independent third party verification of
their accuracy, relied in part, and to the extent we deemed reasonably necessary or appropriate, upon the representations and
warranties of the Company contained in such documents, records, certificates, instruments or representations furnished or made
available to us by the Company, including the Registration Statement and, to the extent that we deemed such reliance proper, upon
certificates of public officials and officers or other representatives of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 10 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Loev Law Firm PC</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">October [&nbsp;&nbsp;], 2019</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">Page 2 of 2</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">With
your permission, we have made and relied upon the following assumptions, without any independent investigation or inquiry by us,
and our opinion expressed below is subject to, and limited and qualified by the effect of, such assumptions: (1) all corporate
records furnished to us by the Company are accurate and complete; (2) the Registration Statement to be filed by the Company with
the Commission will be identical to the form of the document that we have reviewed; and (3) all statements as to factual matters
that are contained in the Registration Statement (including the exhibits to the Registration Statement) are accurate and complete.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have also assumed (i) the legal capacity of all natural persons, (ii) the genuineness of all signatures, (iii) the authority of
all persons signing all documents submitted to us on behalf of the parties to such documents, (iv) the authenticity of all documents
submitted to us as originals, (v) the conformity to authentic original documents of all documents submitted to us as copies, and
(vi) that all information contained in all documents reviewed by us is true, correct and complete.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Based
upon the foregoing, and subject to the qualifications, assumptions and limitations, and exceptions set forth stated herein, and
having due regard for the legal considerations we deem relevant, we are of the opinion that the Shares are validly issued, fully
paid and non-assessable.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
opinion is expressly limited in scope to the Shares enumerated herein which are to be expressly covered by the referenced Registration
Statement. Without limiting the generality of the foregoing, we neither express nor imply any opinion regarding the accuracy or
completeness of the information included in the Registration Statement or the compliance and conformity thereof with the rules
and regulations of the SEC or the requirements of Form S-1.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
express no opinion as to the laws of any state or jurisdiction other than the General Corporation Law of the State of Delaware
and the federal laws of the United States of America. No opinion is expressed herein with respect to the qualification of the
Shares under the securities or blue sky laws of any state or any foreign jurisdiction. We have made such examination of Delaware
law as we have deemed relevant for purposes of this opinion. We express no opinion as to any county, municipal, city, town or
village ordinance, rule, regulation or administrative decision. The references and limitations to the &ldquo;General Corporation
Law of the State of Delaware&rdquo; include all applicable Delaware statutory provisions of law and reported judicial decisions
interpreting these laws.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
opinion (i) is rendered in connection with the filing of the Registration Statement, (ii) is based upon the law in effect (and
published or otherwise generally available) on the date hereof, (iii) is rendered as of the date hereof, and we undertake no,
and hereby disclaim any kind of, obligation to advise you of any change or any new developments that might affect any matters
or opinions set forth herein, and (iv) is limited to the matters stated herein and no opinions may be inferred or implied beyond
the matters expressly stated herein.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
hereby consent to the filing of this opinion with the Securities and Exchange Commission as an exhibit to the Registration Statement
and further consent to statements made therein regarding our firm and use of our name under the heading &ldquo;<U>Legal Matters</U>&rdquo;
in the prospectus constituting a part of such Registration Statement. In providing this consent, we do not thereby admit that
we are within the category of persons whose consent is required under Section 7 of the Securities Act or the rules and regulations
of the Commission promulgated thereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 50%; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 50%; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Sincerely,</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    Loev Law Firm, PC</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 11 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>11
<FILENAME>ex5-1_001.jpg
<TEXT>
begin 644 ex5-1_001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" !_ A,# 2(  A$! Q$!_\0
M'P   04! 0$! 0$           $" P0%!@<("0H+_\0 M1   @$# P($ P4%
M! 0   %] 0(#  01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$  P$! 0$!
M 0$! 0        $" P0%!@<("0H+_\0 M1$  @$"! 0#! <%! 0  0)W  $"
M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#^_C(SC(SC
M..^/7'IR*3(]1^8JM<HT@V@CD'8CP"XBD<*_$R-L 4$JR$3VY:0 -)M^4_(_
MC3]F?XK^+O%.M^)-(_;E_:L^&VF:O>&ZLO O@K1OV4'\+>&H3''&--T1_&'[
M,WC'Q,UDC(TB'6?%&MWFZ1M]](-JJ ?8.1ZC\Q1D>H_,5\+?\,A_&G_I(Y^V
MI_X)/V*__H0:/^&0_C3_ -)'/VU/_!)^Q7_]"#0!]TY'J/S%&1ZC\Q7PM_PR
M'\:?^DCG[:G_ ()/V*__ *$&C_AD/XT_])'/VU/_  2?L5__ $(- 'W3D>H_
M,49'J/S%?"W_  R'\:?^DCG[:G_@D_8K_P#H0:/^&0_C3_TD<_;4_P#!)^Q7
M_P#0@T ?=.1ZC\Q1D>H_,5\+?\,A_&G_ *2.?MJ?^"3]BO\ ^A!H_P"&0_C3
M_P!)'/VU/_!)^Q7_ /0@T ?=.1ZC\Q1D>H_,5\+?\,A_&G_I(Y^VI_X)/V*_
M_H0:/^&0_C3_ -)'/VU/_!)^Q7_]"#0!]TY'J/S%&1ZC\Q7PM_PR'\:?^DCG
M[:G_ ()/V*__ *$&C_AD/XT_])'/VU/_  2?L5__ $(- 'W3D>H_,49'J/S%
M?"W_  R'\:?^DCG[:G_@D_8K_P#H0:/^&0_C3_TD<_;4_P#!)^Q7_P#0@T ?
M=.1ZC\Q1D>H_,5\+?\,A_&G_ *2.?MJ?^"3]BO\ ^A!H_P"&1/C1_P!)'/VU
M/_!)^Q7_ /0@T ?=.1ZC\Q1D>H_,5\*-^R-\9D(#?\%'_P!M)2Q(4-HO[%(+
M$*SD#/[(0R0B.Y _A1FZ*2#_ (9&^,Y*@?\ !1[]M(EE+*/[%_8JRRC:"RC_
M (9"R5!9<D<#<N3R,@'W7D>H_,49'J/S%?"H_9%^,Y.T?\%'OVTRVT-M&B_L
M59VDD!L?\,A9VD@@'H2#Z4+^R+\9W4,O_!1[]M-E8!E9=%_8J964@$$$?LA$
M$$$$$<$$$<4 ?=61ZC\Q1D>H_,5\+?\ #(?QI_Z2.?MJ?^"3]BO_ .A!I#^R
M)\:!C/\ P4=_;3&3@9T3]BH9/H/^,0>30!]U9'J/S%&1ZC\Q7PI_PR-\9]VW
M_AX]^VENQG;_ &+^Q5NQZX_X9"SCWQ3O^&0_C3_TD<_;4_\ !)^Q7_\ 0@T
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ML5__ $(- 'W3D>H_,49'J/S%?"O_  R)\:,X_P"'CO[:><9Q_8G[%6<>N/\
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MG[H5B< &O /#?A'X'_LG?!&TTCP[:>&_@C\"?@CX&MA$+N_@TOPC\/\ X?\
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M^*']BQ:A\-_ _A&Z\%_#O5=:^)FMZAJ/BO3;5]%\ W<6L0ZG+X8BU&\&B?\
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M'/.X$=J=5:U 2(+L6'=),XB"+$4,DCRE&17D3S$WD2/$[QS,&G0[91BP&4G
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M_:>\52ZK\,$^+,&@^(_#/BKX&>"-0N-)^+/P]U#X6:GIB:5X5\$:'X<T6_\
M#'PVU#4O OP\UNPTG2-9\*^'M8OX_P"V9=2EA>S /LFW_:1_9YN[_P *:5:_
M''X13:IX]T?0/$/@>RC^('A1[GQGH7BK7CX6\,:QX5MUU?S?$.F>(_$W_%.Z
M%?:0+RVU?7"NDZ?+<W[+;FGXA_:B_9L\)03W/BCX\_!_P[;VWC'6/A[<2:U\
M0_">E+%X^\/76FV/B#P8[7VKP!?%6AWNKZ38ZOX>.-7TV\U*PMKVUAGO((Y/
MAO4_V'?V+]3^-GPG^-5Y\0_/UCX+Z/\  WPC\-?"$GCWP+<_"WPCX(_9[TWX
M@1>#O!MIX)U"RU*VO].U'6_B#-XW&L:M=W?BK0_&GA'P3K^A>,?#]WH+:5K/
M4M^RK^RG-\/OA/\ #W7/BY?^*]'^$_[2VM?M8W6I^)/'O@#5]9^)GQ=U'X@>
M+_BQ=ZC\3I7T(-KGAQ?BAXF'CBR\*^$+#PK FM>%?A_INFO_ ,(IX>6SF /L
MA/VC?@!/8ZUJT/QJ^%,VE^'/#/@KQEXAU&/QUX8>RT7P?\27GB^'7B'4[Q=6
M-OI^C^/);>=?!FJ7;PV/B@HW]AS7VTD*_P"T5\!8;'P[J$GQD^&,6G^+M3U'
M1/#%PWCGPQ$FLZMHWBJW\"ZQI^F22:J!J%_I/C>\M?!VIVMIYUQ8>*;FV\/7
M,4>KSI9M\4?$W]D#]E3XJQ?&>'Q3\8M0BT_X[_$GX(_$7Q_I6E_$'X>6.GW6
ME_L\:'H.G?#/X16,&G:>+VS^#NEZQH@\8W7A=+Z?6=0UZ_UR)==M].U.;3+V
MMKW[*OP!U37/@%XATO\ : N-+UK]F'PQ;Z!\&IKO5OA.\UE)I>AZGH,UOXP\
M3^'+#POXU\6?#_QR\WA?6_B3\+9O%^D^%O'.J^$O".IW-EHNI^'[JXL #]&?
M&WC/PO\ #WPEXG\?>,]6MM(\(>!O#NN>+?%'B*ZW&ST'0O#%G-J.M:A>O &D
M$-E8VUW<71QLCBL[AI% C<5X9\-/VS/V7?BW%=R>!_C1X.U"6VUGX=:#);ZM
M=W7A?4QKOQB\/V7BOX3:5!HOBU-)UB:X^)WAW4;75_AREK9M!XXLC/+X4;5%
MM;GRO.OB-\//AO\ &;]E[Q-^S%\6_P!IJ\\40?$+X90_#+XG_%30_$/PU\"^
M._%FB7]A;V/CNX@L/#^A'P/X?G\:Z/+>:'>:9H/AY-*L['5K^+1M/L[ZTN+^
M7@O%?[*G[(EQH'PPT?X7^,?"WP#C^%GQ&L_BAHUQ\'_$'PTT2YU7Q;IGP_\
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M'/!W@SPW<>#M1N_#=S;:&_PJ\*>!]$T?X1PZII^O6_A/3VUFXU&+5]8U*V2
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MM90Z_L(_L;LK ,K+^S1\&"K*5W AAX)P05^8$'!7D<5^)VO>._VA/V4_B/\
MMB-^S'X'^('PALOVG?B=\+OB=\&?A5=_ +QWK/PR^&WAWQ%JWPR_91C^-6O>
M&SX8O/#GPQL_B)\7;WQM\=OC[\)-(TV+XI6?PW\.>%/B/XLG\ Z[XW\001?8
M'QO_ &E_VU_ACH/[<FLW^D:A;I\'?C]J_@;]EB.V^$&GZMHWQFMOB[\&OA3;
M?!;1=EK8ZGK]WH?@7XO?%+Q;XA^,_P 3;:RT_3HO#'@74?#EQ#'9SZIXAN #
M[.\7?L&_\$O_ (?Z#>>*?'G['7["G@GPQIQA&H>(_%WP#^ OAO0;$W$R6]N+
MS5]9\)66GVQGGDCAA$]PAEF=(TW.RJ=I_P#@G3_P3ACFCMY/V'/V+DN)MQA@
M?]F_X)K-*$2XD8QQ-X+#R;8[6Z=MJG"6UPQP(9"OY"G5_'/[06K_  3_ &!O
M%>A>++;X9^$/VU;+P#\1O 4G[-7B_1_AU8?LT?L"0S>-]+\?>.O']YX-M_#U
MA=_M<?&/PA\'O%G@32O!^N7_ ((L?A?\28?"]CJ^HZCH_B(GW/\ ;KN/B+XR
M_;1_8F^,_P $OAUXU^)>N_L7?M8^#/A1XET+P3H,]C/>Z+^U3\%_BOX5^+\^
MM>.IK>TL+#X7?#S2G^%^K^)-1GL+SP[!J=A?0WVIZ;KNDVMHX!^A)_X)S?\
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M_P Q%?:%LI2+!9G^8X9MOS ?*'^15!:3;YDAQAI7D9/W92K% 'Q/_P .VO\
M@G?_ -&'_L<_^(S?!G_YB*/^';7_  3O_P"C#_V.?_$9O@S_ /,17VQ10!\3
M_P##MK_@G?\ ]&'_ +'/_B,WP9_^8BC_ (=M?\$[_P#HP_\ 8Y_\1F^#/_S$
M5]L44 ?$_P#P[:_X)W_]&'_L<_\ B,WP9_\ F(H_X=M?\$[_ /HP_P#8Y_\
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MXGT;XE1>%_A9X+MOAF?VG;/X?^%M%^(?Q8^+?AX:R-;\2Z1?:3IP!^ZNJ?\
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M9G^#)ZC(_P"9([@@_0U^+O[(WP>\>_M177['5_X@^%/C/X??$#X9?MZ?'/\
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MP%X?N-;N[+3[*XUBXT;PAI>D:;/JESI^FZ79S:C/:O?3V=A86\L[P6MLD?\
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MM6]M_P )5X9\&P?#NR6#P%\ _P!FJTL/ _PST^*^TR6S^(T-QJDNC@O!K-X
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M4 %%%% !1110!7FC$IP1NV ,$95\MF^;&YVBD*D$=82)%R"1@C-26WDD5'5
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MU(((X(I2RCJ0/N]2!]X[5_[Z/"^IX'-?-UO^T_\ !N?QKXO\!77B2]\/^(?
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+ **** "BBB@#_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.1
<SEQUENCE>12
<FILENAME>ex23-1.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin-top: 0; text-align: center; margin-bottom: 0">&nbsp;</P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit
23.1</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><FONT STYLE="font: 10pt Times New Roman, Times, Serif"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><IMG SRC="ex23-1_001.jpg" ALT=""></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 36.2pt 0 0.5in; text-align: center"><B>CONSENT OF INDEPENDENT REGISTERED
PUBLIC ACCOUNTING FIRM</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
consent to the inclusion in this Registration Statement on Form S-1 of our report dated March 22, 2019 with respect to the audited
consolidated financial statements of Trxade Group, Inc. for the years ended December 31, 2018 and 2017.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
also consent to the references to us under the heading &ldquo;Experts&rdquo; in such Registration Statement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="width: 50%; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>/s/
    MaloneBailey, LLP</I></FONT></TD>
    <TD STYLE="width: 50%; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">www.malonebailey.com</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Houston,
    Texas</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top; font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">October
    15,</FONT><FONT STYLE="font: 10pt Times New Roman, Times, Serif"> 2019</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><IMG SRC="ex23-1_002.jpg" ALT="" STYLE="height: 104; width: 680">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 12 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: center">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>13
<FILENAME>ex23-1_001.jpg
<TEXT>
begin 644 ex23-1_001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" !  3L# 2(  A$! Q$!_\0
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MTI3?->#=TERN+^.Z6Q<,?A)49UW5@X0@Y2:DFE:ROHUW6[7SNK^PYP1AP^2
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ME_X(^_"PKM4GXO2J2JMRO_"2^-N,%SZ#GGIQCFOE>&<CR[$9AXAX6O2P[P^
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MWDC^\?VV_CI8^(?@#_P1=^.'Q+UVSTJW\&?\%&/@S=>/O%^HSI'%IMIX0O\
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MO:O(EEI^A:=9?$/6;VZO[J>0NL<=O97$C%\ L8MH7][A?&;;_@H%_P %$_\
M@I1X[\7Z5_P2U\&_#WX-?LU>"-8O_"5U^V#\>](N]5/C/7-,N([+6E^'G@N?
MP_);Z@(%O+74=,N);Q]/U.TMKQY;ZSDCAM[O\B/%WQGN?AW_ ,&_'@[X?+K<
M^@:/^T9^VO\ $;X4^-/$.FPW%U+:?#ZY^*&OWOC1;6.U,=Q)=7^AZ//81"*1
M6A$[RA9O*$4G[:? [_@MG_P23^ /PP\$_"#P%X^\5Z%X,^'WAK2_"?A^VL/A
M7XVAAFM=#L[?3KB>6>STV!;N_DEMHVN[UH&:>82.7(<5PYEE5>G7Q.9X+ 0S
M)5)UE0E7;BJ,:.+R^C&4Z?/",_:1K3A:4))2<-$TY%95FT,91RO!5JL\-A:N
M58G&8VK2NJBK0KJ,:T>57BX)I.,'&'OMN+=K/U+]@+_@M'X>M9O&_A3_ (*\
MZ=XA^(=O:&X71/%_[,O@>+X=:E?.Z.;'_1_$5Y'I%L[@6ZZB?"][=06SS!&4
MRM&\_P"S[_P4\_:0^"G[0/@W]B[_ (*L?"[PE\*?BA\49FTKX%?M _#FYOKW
MX'?&'46C$,UO<ZCJTL$'AG6YC+)<16D45E8,UK-;K9V[M'(GI4G_  <'_P#!
M,%FB"_%OQTS"08<_#+QR9HL*S*R2_P!F1GY9 A*RF:)URKQ-D,OYQ?\ !5;_
M (*@?\$P/VY?V-OBK\+-.^('BZ\^*.BZ?:^.O@YK_P#PJ7QE#J_A?XD^$IXM
M1T74-$U:VT?[=HZZC(DNFWQ2<6[QWPD=6:)8I%@\/F>:3IY?G61X6&'Q5Z"Q
M-&G"C5PRY*DH58RH5*3:A.G"4HRYH\CGH]GUXK$Y7@G'&9;G>,JUL+*-3V%3
MFG3K/FC3<)^UC))-56[Z:I>37Z@?\%H?BY^T7^S-\#OA1^V!\!/&^M:5X=^
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MC_/6#]@+]LZ62WT"'X7>(8=/@O8I+.23Q#9Z?X;L+N[W:7=:I9VMW<F-+R,
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MYT.]2.U9+'4;.\BN4O[*;RITFC5V 'RCY-_X)-_LN?$G]F#]AR#X%?M&>$-
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M2U&72)=8M+B":2RN;[2["[EL@[*\UA;W)C8VHQY7I/Q _:>\-_%#QA\2[?\
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&2MHA'__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>14
<FILENAME>ex23-1_002.jpg
<TEXT>
begin 644 ex23-1_002.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" !Z QX# 2(  A$! Q$!_\0
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MO%NW;&C!&?7'K22Z?8SJ4ELX'! 4AHP>!T'T%<1+JFJ)?7UJVHRA9KFSC#D
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MZ)XDNM3BMH+&U:X*0))<RSR!2N_) XZG HT_5M>UGP;->P6\$.HMN$ 5]RL
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M"GRRMN*Z.CUKPW%J9+PBVBF=LR220!RV!@8]",U9T_P_8:?8VMLD*O\ 9H#
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MJGUK!M_%^L+#]D_?/?730K D\ 21=P)=P!P4]"::C+HP;1V?_",Z,+H7*Z=
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MQSI6H2K#(7M96X EZ'\:Z8'(S7G?B;P7!;V+7^DABBC<\.=P*^JU9\"^*!<
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M'-2R_$?2H3(TEO<BV'G".? VRF(98+S[\57+4%>)TXTRS&H+?"W07*QF,.%
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M )XW'_?(H_X63I'_ #QN/^^11]:H_P R#GCW.RHKC?\ A9.D?\\;C_OD4?\
M"R=(_P">-Q_WR*/K5'^9!SQ[G945QO\ PLG2/^>-Q_WR*/\ A9.D?\\;C_OD
M4?6J/\R#GCW.RHKC?^%DZ1_SQN/^^11_PLG2/^>-Q_WR*/K5'^9!SQ[G945Q
MO_"R=(_YXW'_ 'R*/^%DZ1_SQN/^^11]:H_S(.>/<[*BN-_X63I'_/&X_P"^
M11_PLG2/^>-Q_P!\BCZU1_F0<\>YV5%<;_PLG2/^>-Q_WR*/^%DZ1_SQN/\
MOD4?6J/\R#GCW.RHKC?^%DZ1_P \;C_OD4?\+)TC_GC<?]\BCZU1_F0<\>YV
M5%<;_P +)TC_ )XW'_?(H_X63I'_ #QN/^^11]:H_P R#GCW.RHKC?\ A9.D
M?\\;C_OD4?\ "R=(_P">-Q_WR*/K5'^9!SQ[G945QO\ PLG2/^>-Q_WR*/\
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M]HWTYDM6NIA'=V4DRL[(SK@9! 7H".QJU!<265CHS+-]M<0/(-V"V1%D*,4
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M35F]\/ZGJ^F+8:I?6TL221ON2$@OM8$[N<<X[5H_V[9QQSRW,T<$,4@C$CR
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5110 4444 %%%% !1110 4444 ?_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>15
<FILENAME>image_001.jpg
<TEXT>
begin 644 image_001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" !> .\# 2(  A$! Q$!_\0
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MM6C.E+DJ*S"BBBM#,**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M[..Z@;='(,CV]0:L5Z=&$(4U&GL>57G.=1RJ;A1116ID%%%% !1110 4444
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JJO\ (VKI8FE]87Q+27Z/_,Z2BBBO0/."BBB@ HHHH **** "BBB@#__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>16
<FILENAME>cover_001.jpg
<TEXT>
begin 644 cover_001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" !> .\# 2(  A$! Q$!_\0
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6%>@< 4444 %%%% !1110 4444 ?_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.INS
<SEQUENCE>17
<FILENAME>trxd-20190630.xml
<DESCRIPTION>XBRL INSTANCE FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" ?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.1b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: http://www.novaworks.co -->
    <!-- Field: Doc-Info; Name: Source; Value: TRXD 20190630 S%2D1 DFN.xfr; Date: 2019%2D10%2D15T18:00:38Z -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<xbrli:xbrl xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:dei="http://xbrl.sec.gov/dei/2019-01-31" xmlns:ref="http://www.xbrl.org/2006/ref" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:us-gaap="http://fasb.org/us-gaap/2019-01-31" xmlns:us-roles="http://fasb.org/us-roles/2019-01-31" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:num="http://www.xbrl.org/dtr/type/numeric" xmlns:us-types="http://fasb.org/us-types/2019-01-31" xmlns:country="http://xbrl.sec.gov/country/2017-01-31" xmlns:srt="http://fasb.org/srt/2019-01-31" xmlns:TRXD="http://trxadegroup.com/20190630">
    <link:schemaRef xlink:href="trxd-20190630.xsd" xlink:type="simple" />
    <xbrli:context id="From2019-01-01to2019-06-30">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001382574</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2018-12-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001382574</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2018-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-06-30">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001382574</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2016-12-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001382574</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2016-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2016-09-30_custom_PromissoryNoteMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001382574</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">TRXD:PromissoryNoteMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2016-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2016-09-01to2016-09-30_custom_PromissoryNoteMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001382574</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">TRXD:PromissoryNoteMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2016-09-01</xbrli:startDate>
        <xbrli:endDate>2016-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2017-01-01to2017-12-31_custom_PromissoryNoteMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001382574</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">TRXD:PromissoryNoteMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2017-01-01</xbrli:startDate>
        <xbrli:endDate>2017-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2016-08-01to2016-08-31_custom_RelatedPartyConvertiblePromissoryNoteMember_custom_MrShilpaPatelMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001382574</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">TRXD:RelatedPartyConvertiblePromissoryNoteMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">TRXD:MrShilpaPatelMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2016-08-01</xbrli:startDate>
        <xbrli:endDate>2016-08-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-06-30_custom_RelatedPartyConvertiblePromissoryNoteMember_custom_MrShilpaPatelMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001382574</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">TRXD:RelatedPartyConvertiblePromissoryNoteMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">TRXD:MrShilpaPatelMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2017-08-31_custom_RelatedPartyConvertiblePromissoryNoteMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001382574</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">TRXD:RelatedPartyConvertiblePromissoryNoteMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2017-08-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2017-08-01to2017-08-31_custom_RelatedPartyConvertiblePromissoryNoteMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001382574</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">TRXD:RelatedPartyConvertiblePromissoryNoteMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2017-08-01</xbrli:startDate>
        <xbrli:endDate>2017-08-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2018-08-31_custom_RelatedPartyConvertiblePromissoryNoteMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001382574</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">TRXD:RelatedPartyConvertiblePromissoryNoteMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2018-08-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2018-08-01to2018-08-31_custom_RelatedPartyConvertiblePromissoryNoteMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001382574</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">TRXD:RelatedPartyConvertiblePromissoryNoteMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2018-08-01</xbrli:startDate>
        <xbrli:endDate>2018-08-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2018-01-01to2018-12-31_custom_RelatedPartyConvertiblePromissoryNoteMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001382574</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">TRXD:RelatedPartyConvertiblePromissoryNoteMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2018-01-01</xbrli:startDate>
        <xbrli:endDate>2018-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2016-10-31_custom_RelatedPartyConvertiblePromissoryNoteMember_custom_MrNitilPatelMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001382574</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">TRXD:RelatedPartyConvertiblePromissoryNoteMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">TRXD:MrNitilPatelMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2016-10-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2016-09-30_custom_RelatedPartyConvertiblePromissoryNoteMember_custom_MrNitilPatelMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001382574</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">TRXD:RelatedPartyConvertiblePromissoryNoteMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">TRXD:MrNitilPatelMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2016-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2016-09-01to2016-09-30_custom_RelatedPartyConvertiblePromissoryNoteMember_custom_MrNitilPatelMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001382574</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">TRXD:RelatedPartyConvertiblePromissoryNoteMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">TRXD:MrNitilPatelMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2016-09-01</xbrli:startDate>
        <xbrli:endDate>2016-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2016-10-01to2016-10-31_custom_RelatedPartyConvertiblePromissoryNoteMember_custom_MrNitilPatelMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001382574</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">TRXD:RelatedPartyConvertiblePromissoryNoteMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">TRXD:MrNitilPatelMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2016-10-01</xbrli:startDate>
        <xbrli:endDate>2016-10-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2017-04-30_custom_RelatedPartyConvertiblePromissoryNoteMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001382574</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">TRXD:RelatedPartyConvertiblePromissoryNoteMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2017-04-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2017-04-01to2017-04-30_custom_RelatedPartyConvertiblePromissoryNoteMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001382574</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">TRXD:RelatedPartyConvertiblePromissoryNoteMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2017-04-01</xbrli:startDate>
        <xbrli:endDate>2017-04-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2017-09-30_custom_RelatedPartyConvertiblePromissoryNoteMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001382574</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">TRXD:RelatedPartyConvertiblePromissoryNoteMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2017-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2018-12-31_custom_RelatedPartyConvertiblePromissoryNoteMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001382574</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">TRXD:RelatedPartyConvertiblePromissoryNoteMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2018-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2017-01-01to2017-12-31_custom_RelatedPartyConvertiblePromissoryNoteMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001382574</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">TRXD:RelatedPartyConvertiblePromissoryNoteMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2017-01-01</xbrli:startDate>
        <xbrli:endDate>2017-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2017-12-31_custom_RelatedPartyConvertiblePromissoryNoteMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001382574</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">TRXD:RelatedPartyConvertiblePromissoryNoteMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2017-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2018-02-01to2018-02-28_custom_RelatedPartyConvertiblePromissoryNoteMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001382574</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">TRXD:RelatedPartyConvertiblePromissoryNoteMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2018-02-01</xbrli:startDate>
        <xbrli:endDate>2018-02-28</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2018-02-28_custom_RelatedPartyConvertiblePromissoryNoteMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001382574</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">TRXD:RelatedPartyConvertiblePromissoryNoteMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2018-02-28</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2018-12-31_custom_ShortTermRelatedPartyConvertibleNotesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001382574</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">TRXD:ShortTermRelatedPartyConvertibleNotesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2018-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2018-10-15_custom_CommunitySpecialtyPharmacyLLCMember_us-gaap_SubsequentEventMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001382574</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">TRXD:CommunitySpecialtyPharmacyLLCMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2018-10-15</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2018-10-14to2018-10-15_us-gaap_SubsequentEventMember_custom_CommunitySpecialtyPharmacyLLCMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001382574</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">TRXD:CommunitySpecialtyPharmacyLLCMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2018-10-14</xbrli:startDate>
        <xbrli:endDate>2018-10-15</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2018-12-31_custom_MrPrashantPatelMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001382574</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">TRXD:MrPrashantPatelMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2018-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2017-12-31_custom_MrPrashantPatelMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001382574</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">TRXD:MrPrashantPatelMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2017-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2017-01-01to2017-01-31_custom_MrPrashantPatelMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001382574</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">TRXD:MrPrashantPatelMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2017-01-01</xbrli:startDate>
        <xbrli:endDate>2017-01-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2017-01-01to2017-01-31_custom_MrSurenAjjarapuMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001382574</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">TRXD:MrSurenAjjarapuMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2017-01-01</xbrli:startDate>
        <xbrli:endDate>2017-01-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2018-01-01to2018-01-31_custom_MrPrashantPatelMember_srt_MaximumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001382574</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">TRXD:MrPrashantPatelMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2018-01-01</xbrli:startDate>
        <xbrli:endDate>2018-01-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2018-01-01to2018-01-31_custom_MrSurenAjjarapuMember_srt_MaximumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001382574</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">TRXD:MrSurenAjjarapuMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2018-01-01</xbrli:startDate>
        <xbrli:endDate>2018-01-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2018-07-31_custom_PrivateOfferMemorandumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001382574</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">TRXD:PrivateOfferMemorandumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2018-07-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2018-07-01to2018-07-31_custom_PrivateOfferMemorandumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001382574</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">TRXD:PrivateOfferMemorandumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2018-07-01</xbrli:startDate>
        <xbrli:endDate>2018-07-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2017-04-30_custom_ConvertiblePromissoryNoteMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001382574</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">TRXD:ConvertiblePromissoryNoteMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2017-04-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2017-04-01to2017-04-30_custom_ConvertiblePromissoryNoteMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001382574</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">TRXD:ConvertiblePromissoryNoteMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2017-04-01</xbrli:startDate>
        <xbrli:endDate>2017-04-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2015-12-31_us-gaap_WarrantMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001382574</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2015-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2017-01-01to2017-12-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001382574</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2017-01-01</xbrli:startDate>
        <xbrli:endDate>2017-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-01to2019-06-30_custom_StockOptionPlanMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001382574</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">TRXD:StockOptionPlanMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2018-01-01to2018-12-31_custom_EmployeeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001382574</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">TRXD:EmployeeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2018-01-01</xbrli:startDate>
        <xbrli:endDate>2018-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2018-01-01to2018-12-31_srt_MinimumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001382574</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2018-01-01</xbrli:startDate>
        <xbrli:endDate>2018-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2018-01-01to2018-12-31_srt_MaximumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001382574</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2018-01-01</xbrli:startDate>
        <xbrli:endDate>2018-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2018-01-01to2018-12-31_us-gaap_WarrantMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001382574</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2018-01-01</xbrli:startDate>
        <xbrli:endDate>2018-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2018-12-31_us-gaap_WarrantMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001382574</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2018-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2017-12-31_us-gaap_WarrantMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001382574</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2017-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2018-06-30">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001382574</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2018-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2018-12-31_custom_ShortTermNotesPayableMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001382574</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">TRXD:ShortTermNotesPayableMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2018-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2017-12-31_custom_ShortTermNotesPayableMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001382574</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">TRXD:ShortTermNotesPayableMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2017-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2017-01-01to2017-12-31_us-gaap_PreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001382574</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2017-01-01</xbrli:startDate>
        <xbrli:endDate>2017-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2018-01-01to2018-12-31_us-gaap_PreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001382574</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2018-01-01</xbrli:startDate>
        <xbrli:endDate>2018-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2016-12-31_us-gaap_PreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001382574</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2016-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2017-12-31_us-gaap_PreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001382574</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2017-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2018-12-31_us-gaap_PreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001382574</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2018-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2017-01-01to2017-12-31_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001382574</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2017-01-01</xbrli:startDate>
        <xbrli:endDate>2017-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2018-01-01to2018-12-31_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001382574</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2018-01-01</xbrli:startDate>
        <xbrli:endDate>2018-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2016-12-31_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001382574</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2016-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2017-12-31_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001382574</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2017-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2018-12-31_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001382574</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2018-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2017-01-01to2017-12-31_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001382574</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2017-01-01</xbrli:startDate>
        <xbrli:endDate>2017-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2018-01-01to2018-12-31_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001382574</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2018-01-01</xbrli:startDate>
        <xbrli:endDate>2018-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2016-12-31_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001382574</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2016-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2017-12-31_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001382574</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2017-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2018-12-31_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001382574</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2018-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2017-01-01to2017-12-31_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001382574</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2017-01-01</xbrli:startDate>
        <xbrli:endDate>2017-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2018-01-01to2018-12-31_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001382574</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2018-01-01</xbrli:startDate>
        <xbrli:endDate>2018-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2016-12-31_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001382574</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2016-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2017-12-31_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001382574</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2017-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2018-12-31_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001382574</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2018-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-06-30_custom_ConvertiblePromissoryNoteMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001382574</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">TRXD:ConvertiblePromissoryNoteMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2017-06-30_custom_RelatedPartyPromissoryNoteMember_custom_NPRINVESTMENTGROUPLLCMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001382574</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">TRXD:RelatedPartyPromissoryNoteMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">TRXD:NPRINVESTMENTGROUPLLCMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2017-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2017-06-30_custom_RelatedPartyPromissoryNoteMember_custom_SansurAssociatesLLCMember_custom_MrSurenAjjarapuMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001382574</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">TRXD:RelatedPartyPromissoryNoteMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">TRXD:SansurAssociatesLLCMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">TRXD:MrSurenAjjarapuMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2017-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2017-06-30_custom_RelatedPartyPromissoryNoteMember_custom_SansurAssociatesLLCMember_custom_MrPrashantPatelMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001382574</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">TRXD:RelatedPartyPromissoryNoteMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">TRXD:SansurAssociatesLLCMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">TRXD:MrPrashantPatelMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2017-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2017-06-01to2017-06-30_custom_RelatedPartyPromissoryNoteMember_custom_SansurAssociatesLLCMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001382574</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">TRXD:RelatedPartyPromissoryNoteMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">TRXD:SansurAssociatesLLCMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2017-06-01</xbrli:startDate>
        <xbrli:endDate>2017-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2017-06-30_custom_RelatedPartyPromissoryNoteMember_custom_SansurAssociatesLLCMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001382574</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">TRXD:RelatedPartyPromissoryNoteMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">TRXD:SansurAssociatesLLCMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2017-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2018-12-31_custom_RelatedPartyPromissoryNoteMember_custom_MrPrashantPatelMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001382574</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">TRXD:RelatedPartyPromissoryNoteMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">TRXD:MrPrashantPatelMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2018-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2018-12-31_custom_RelatedPartyPromissoryNoteMember_custom_NPRINVESTMENTGROUPLLCMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001382574</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">TRXD:RelatedPartyPromissoryNoteMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">TRXD:NPRINVESTMENTGROUPLLCMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2018-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2018-12-31_custom_RelatedPartyPromissoryNoteMember_custom_PromissoryNoteMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001382574</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">TRXD:RelatedPartyPromissoryNoteMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">TRXD:PromissoryNoteMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2018-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2015-04-30_custom_ConvertiblePromissoryNoteMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001382574</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">TRXD:ConvertiblePromissoryNoteMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2015-04-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2015-05-31_custom_ConvertiblePromissoryNoteMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001382574</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">TRXD:ConvertiblePromissoryNoteMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2015-05-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2015-04-01to2015-04-30_custom_ConvertiblePromissoryNoteMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001382574</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">TRXD:ConvertiblePromissoryNoteMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2015-04-01</xbrli:startDate>
        <xbrli:endDate>2015-04-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2015-05-01to2015-05-31_custom_ConvertiblePromissoryNoteMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001382574</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">TRXD:ConvertiblePromissoryNoteMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2015-05-01</xbrli:startDate>
        <xbrli:endDate>2015-05-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2016-04-30_custom_ConvertiblePromissoryNoteMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001382574</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">TRXD:ConvertiblePromissoryNoteMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2016-04-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2016-05-31_custom_ConvertiblePromissoryNoteMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001382574</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">TRXD:ConvertiblePromissoryNoteMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2016-05-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2016-05-01to2016-05-31_custom_ConvertiblePromissoryNoteMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001382574</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">TRXD:ConvertiblePromissoryNoteMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2016-05-01</xbrli:startDate>
        <xbrli:endDate>2016-05-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2016-04-01to2016-04-30_custom_ConvertiblePromissoryNoteMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001382574</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">TRXD:ConvertiblePromissoryNoteMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2016-04-01</xbrli:startDate>
        <xbrli:endDate>2016-04-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2016-05-31_custom_PromissoryNoteMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001382574</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">TRXD:PromissoryNoteMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2016-05-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2016-01-01to2016-12-31_custom_PromissoryNoteMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001382574</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">TRXD:PromissoryNoteMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2016-01-01</xbrli:startDate>
        <xbrli:endDate>2016-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2016-12-31_custom_PromissoryNoteMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001382574</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">TRXD:PromissoryNoteMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2016-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2016-10-31_custom_PromissoryNoteMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001382574</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">TRXD:PromissoryNoteMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2016-10-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2016-01-01to2016-10-31_custom_PromissoryNoteMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001382574</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">TRXD:PromissoryNoteMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2016-01-01</xbrli:startDate>
        <xbrli:endDate>2016-10-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2016-12-31_custom_PromissoryNoteOneMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001382574</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">TRXD:PromissoryNoteOneMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2016-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2017-12-31_custom_PromissoryNoteOneMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001382574</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">TRXD:PromissoryNoteOneMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2017-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2017-01-01to2017-12-31_custom_PromissoryNoteOneMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001382574</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">TRXD:PromissoryNoteOneMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2017-01-01</xbrli:startDate>
        <xbrli:endDate>2017-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2016-01-01to2016-12-31_custom_PromissoryNoteTwoMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001382574</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">TRXD:PromissoryNoteTwoMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2016-01-01</xbrli:startDate>
        <xbrli:endDate>2016-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2016-12-31_custom_PromissoryNoteTwoMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001382574</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">TRXD:PromissoryNoteTwoMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2016-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2017-12-31_custom_ShortTermPromissoryNotesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001382574</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">TRXD:ShortTermPromissoryNotesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2017-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2017-09-01to2017-09-30_custom_RelatedPartyConvertiblePromissoryNoteMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001382574</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">TRXD:RelatedPartyConvertiblePromissoryNoteMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2017-09-01</xbrli:startDate>
        <xbrli:endDate>2017-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2016-11-01to2016-11-30_custom_RelatedPartyConvertiblePromissoryNoteMember_custom_MrPrashantPatelMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001382574</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">TRXD:RelatedPartyConvertiblePromissoryNoteMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">TRXD:MrPrashantPatelMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2016-11-01</xbrli:startDate>
        <xbrli:endDate>2016-11-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2016-11-30_custom_RelatedPartyConvertiblePromissoryNoteMember_custom_MrPrashantPatelMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001382574</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">TRXD:RelatedPartyConvertiblePromissoryNoteMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">TRXD:MrPrashantPatelMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2016-11-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2016-12-31_custom_RelatedPartyConvertiblePromissoryNoteMember_custom_MrPrashantPatelMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001382574</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">TRXD:RelatedPartyConvertiblePromissoryNoteMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">TRXD:MrPrashantPatelMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2016-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2017-02-28_custom_RelatedPartyConvertiblePromissoryNoteMember_custom_MrPrashantPatelMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001382574</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">TRXD:RelatedPartyConvertiblePromissoryNoteMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">TRXD:MrPrashantPatelMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2017-02-28</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2017-02-01to2017-02-28_custom_RelatedPartyConvertiblePromissoryNoteMember_custom_MrPrashantPatelMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001382574</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">TRXD:RelatedPartyConvertiblePromissoryNoteMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">TRXD:MrPrashantPatelMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2017-02-01</xbrli:startDate>
        <xbrli:endDate>2017-02-28</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2018-06-30_custom_RelatedPartyConvertiblePromissoryNoteMember_custom_MrPrashantPatelMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001382574</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">TRXD:RelatedPartyConvertiblePromissoryNoteMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">TRXD:MrPrashantPatelMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2018-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2017-07-01to2017-07-31_custom_RelatedPartyConvertiblePromissoryNoteMember_custom_MrPrashantPatelMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001382574</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">TRXD:RelatedPartyConvertiblePromissoryNoteMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">TRXD:MrPrashantPatelMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2017-07-01</xbrli:startDate>
        <xbrli:endDate>2017-07-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2017-01-01to2017-12-31_custom_ConvertiblePromissoryNoteMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001382574</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">TRXD:ConvertiblePromissoryNoteMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2017-01-01</xbrli:startDate>
        <xbrli:endDate>2017-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2018-01-01to2018-12-31_custom_PromissoryNotesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001382574</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">TRXD:PromissoryNotesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2018-01-01</xbrli:startDate>
        <xbrli:endDate>2018-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2018-12-31_custom_ShortTermPromissoryNotesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001382574</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">TRXD:ShortTermPromissoryNotesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2018-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2018-04-01to2018-04-30_custom_RelatedPartyConvertiblePromissoryNotesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001382574</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">TRXD:RelatedPartyConvertiblePromissoryNotesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2018-04-01</xbrli:startDate>
        <xbrli:endDate>2018-04-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2018-10-31_custom_CommunitySpecialtyPharmacyLLCMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001382574</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">TRXD:CommunitySpecialtyPharmacyLLCMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2018-10-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2017-01-01to2017-01-31_custom_PrivateOfferMemorandumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001382574</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">TRXD:PrivateOfferMemorandumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2017-01-01</xbrli:startDate>
        <xbrli:endDate>2017-01-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2017-01-31_custom_PrivateOfferMemorandumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001382574</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">TRXD:PrivateOfferMemorandumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2017-01-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2017-02-28">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001382574</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2017-02-28</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2018-11-01to2018-11-30_custom_PrivateOfferMemorandumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001382574</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">TRXD:PrivateOfferMemorandumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2018-11-01</xbrli:startDate>
        <xbrli:endDate>2018-11-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2018-11-30_custom_PrivateOfferMemorandumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001382574</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">TRXD:PrivateOfferMemorandumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2018-11-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2017-01-01to2017-12-31_us-gaap_WarrantMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001382574</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2017-01-01</xbrli:startDate>
        <xbrli:endDate>2017-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2016-12-31_us-gaap_WarrantMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001382574</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2016-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2017-01-01to2017-12-31_custom_EmployeeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001382574</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">TRXD:EmployeeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2017-01-01</xbrli:startDate>
        <xbrli:endDate>2017-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2018-01-01to2018-12-31_us-gaap_ValuationTechniqueOptionPricingModelMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001382574</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueOptionPricingModelMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2018-01-01</xbrli:startDate>
        <xbrli:endDate>2018-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2017-01-01to2017-12-31_us-gaap_ValuationTechniqueOptionPricingModelMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001382574</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueOptionPricingModelMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2017-01-01</xbrli:startDate>
        <xbrli:endDate>2017-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2017-04-01to2017-04-30">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001382574</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2017-04-01</xbrli:startDate>
        <xbrli:endDate>2017-04-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2017-04-01to2017-04-30_custom_FourOptionGrantedMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001382574</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:OptionIndexedToIssuersEquityTypeAxis">TRXD:FourOptionGrantedMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2017-04-01</xbrli:startDate>
        <xbrli:endDate>2017-04-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2017-01-01to2017-12-31_srt_MinimumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001382574</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2017-01-01</xbrli:startDate>
        <xbrli:endDate>2017-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2017-01-01to2017-12-31_srt_MaximumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001382574</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2017-01-01</xbrli:startDate>
        <xbrli:endDate>2017-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2018-01-01to2018-12-31_custom_CommunitySpecialtyPharmacyLLCMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001382574</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">TRXD:CommunitySpecialtyPharmacyLLCMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2018-01-01</xbrli:startDate>
        <xbrli:endDate>2018-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2018-12-31_custom_CommunitySpecialtyPharmacyLLCMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001382574</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">TRXD:CommunitySpecialtyPharmacyLLCMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2018-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-01to2019-06-30_custom_TrxadeIncMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001382574</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">TRXD:TrxadeIncMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-06-30_custom_TrxadeIncMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001382574</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">TRXD:TrxadeIncMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-01to2019-06-30_custom_CommunitySpecialtyPharmacyLLCMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001382574</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">TRXD:CommunitySpecialtyPharmacyLLCMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-06-30_custom_CommunitySpecialtyPharmacyLLCMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001382574</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">TRXD:CommunitySpecialtyPharmacyLLCMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-01to2019-06-30_custom_OtherMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001382574</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">TRXD:OtherMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-06-30_custom_OtherMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001382574</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">TRXD:OtherMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2018-01-01to2018-06-30_custom_TrxadeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001382574</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">TRXD:TrxadeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2018-01-01</xbrli:startDate>
        <xbrli:endDate>2018-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2017-01-01to2017-12-31_custom_TrxadeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001382574</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">TRXD:TrxadeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2017-01-01</xbrli:startDate>
        <xbrli:endDate>2017-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2017-01-01to2017-12-31_custom_CommunitySpecialtyPharmacyLLCMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001382574</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">TRXD:CommunitySpecialtyPharmacyLLCMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2017-01-01</xbrli:startDate>
        <xbrli:endDate>2017-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2018-12-31_custom_AlliancePharmaSolutionLLCMember_custom_SyncHealthMSOLLCMember_custom_JanuaryThortyOneTwoThousandTwentyMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001382574</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">TRXD:AlliancePharmaSolutionLLCMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:OwnershipAxis">TRXD:SyncHealthMSOLLCMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">TRXD:JanuaryThortyOneTwoThousandTwentyMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2018-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2017-01-01to2017-12-31_custom_ShortTermPromissoryNotesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001382574</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">TRXD:ShortTermPromissoryNotesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2017-01-01</xbrli:startDate>
        <xbrli:endDate>2017-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2017-02-01to2017-02-28">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001382574</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2017-02-01</xbrli:startDate>
        <xbrli:endDate>2017-02-28</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2018-12-31_us-gaap_WarrantMember_us-gaap_MeasurementInputExpectedDividendRateMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001382574</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedDividendRateMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2018-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2017-12-31_us-gaap_WarrantMember_us-gaap_MeasurementInputExpectedDividendRateMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001382574</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedDividendRateMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2017-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2018-12-31_us-gaap_MeasurementInputPriceVolatilityMember_srt_MinimumMember_us-gaap_WarrantMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001382574</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputPriceVolatilityMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2018-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2017-12-31_us-gaap_MeasurementInputPriceVolatilityMember_srt_MinimumMember_us-gaap_WarrantMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001382574</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputPriceVolatilityMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2017-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2018-12-31_us-gaap_MeasurementInputPriceVolatilityMember_srt_MaximumMember_us-gaap_WarrantMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001382574</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputPriceVolatilityMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2018-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2018-12-31_us-gaap_MeasurementInputRiskFreeInterestRateMember_srt_MinimumMember_us-gaap_WarrantMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001382574</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputRiskFreeInterestRateMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2018-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2017-12-31_us-gaap_MeasurementInputRiskFreeInterestRateMember_srt_MinimumMember_us-gaap_WarrantMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001382574</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputRiskFreeInterestRateMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2017-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2017-12-31_us-gaap_WarrantMember_us-gaap_MeasurementInputRiskFreeInterestRateMember_srt_MaximumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001382574</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputRiskFreeInterestRateMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2017-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2018-12-31_us-gaap_MeasurementInputRiskFreeInterestRateMember_srt_MaximumMember_us-gaap_WarrantMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001382574</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputRiskFreeInterestRateMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2018-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2018-01-01to2018-12-31_us-gaap_MeasurementInputExpectedTermMember_srt_MinimumMember_us-gaap_WarrantMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001382574</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedTermMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2018-01-01</xbrli:startDate>
        <xbrli:endDate>2018-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2017-01-01to2017-12-31_us-gaap_MeasurementInputExpectedTermMember_srt_MinimumMember_us-gaap_WarrantMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001382574</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedTermMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2017-01-01</xbrli:startDate>
        <xbrli:endDate>2017-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2018-01-01to2018-12-31_us-gaap_MeasurementInputExpectedTermMember_srt_MaximumMember_us-gaap_WarrantMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001382574</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedTermMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2018-01-01</xbrli:startDate>
        <xbrli:endDate>2018-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2018-04-01to2018-04-30">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001382574</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2018-04-01</xbrli:startDate>
        <xbrli:endDate>2018-04-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2018-01-01to2018-12-31_custom_EmployeeMember_srt_MinimumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001382574</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">TRXD:EmployeeMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2018-01-01</xbrli:startDate>
        <xbrli:endDate>2018-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2017-01-01to2017-12-31_custom_EmployeeMember_srt_MinimumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001382574</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">TRXD:EmployeeMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2017-01-01</xbrli:startDate>
        <xbrli:endDate>2017-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2017-01-01to2017-12-31_custom_EmployeeMember_srt_MaximumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001382574</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">TRXD:EmployeeMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2017-01-01</xbrli:startDate>
        <xbrli:endDate>2017-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2018-01-01to2018-12-31_custom_EmployeeMember_srt_MaximumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001382574</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">TRXD:EmployeeMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2018-01-01</xbrli:startDate>
        <xbrli:endDate>2018-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2018-10-01to2018-10-31_custom_CommunitySpecialtyPharmacyLLCMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001382574</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">TRXD:CommunitySpecialtyPharmacyLLCMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2018-10-01</xbrli:startDate>
        <xbrli:endDate>2018-10-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2018-01-01to2018-12-31_custom_TwoCustomersMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001382574</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">TRXD:TwoCustomersMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2018-01-01</xbrli:startDate>
        <xbrli:endDate>2018-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2017-01-01to2017-12-31_custom_TwoCustomersMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001382574</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">TRXD:TwoCustomersMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2017-01-01</xbrli:startDate>
        <xbrli:endDate>2017-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2018-10-01to2018-10-31_custom_RelatedPartyPromissoryNoteMember_custom_CommunitySpecialtyPharmacyLLCMember_custom_NikulPanchalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001382574</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">TRXD:RelatedPartyPromissoryNoteMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">TRXD:CommunitySpecialtyPharmacyLLCMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">TRXD:NikulPanchalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2018-10-01</xbrli:startDate>
        <xbrli:endDate>2018-10-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2018-10-30_custom_RelatedPartyPromissoryNoteMember_custom_SpecialtyPharmacyLLCMember_custom_NikulPanchalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001382574</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">TRXD:RelatedPartyPromissoryNoteMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">TRXD:SpecialtyPharmacyLLCMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">TRXD:NikulPanchalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2018-10-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2018-01-01to2018-06-30">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001382574</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2018-01-01</xbrli:startDate>
        <xbrli:endDate>2018-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2018-06-30_us-gaap_PreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001382574</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2018-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-06-30_us-gaap_PreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001382574</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2018-06-30_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001382574</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2018-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-06-30_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001382574</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2018-06-30_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001382574</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2018-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-06-30_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001382574</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2018-06-30_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001382574</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2018-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-06-30_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001382574</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2017-12-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001382574</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2017-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2018-03-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001382574</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2018-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-02-28_custom_ConvertiblePromissoryNoteMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001382574</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">TRXD:ConvertiblePromissoryNoteMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-02-28</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-02-01to2019-02-28_custom_ConvertiblePromissoryNoteMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001382574</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">TRXD:ConvertiblePromissoryNoteMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-02-01</xbrli:startDate>
        <xbrli:endDate>2019-02-28</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-01to2019-06-30_custom_RelatedPartyConvertiblePromissoryNoteMember_custom_MrShilpaPatelMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001382574</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">TRXD:RelatedPartyConvertiblePromissoryNoteMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">TRXD:MrShilpaPatelMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-06-30_custom_RelatedPartyConvertiblePromissoryNoteMember_custom_MrNitilPatelMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001382574</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">TRXD:RelatedPartyConvertiblePromissoryNoteMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">TRXD:MrNitilPatelMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-01to2019-06-30_custom_RelatedPartyConvertiblePromissoryNoteMember_custom_MrNitilPatelMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001382574</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">TRXD:RelatedPartyConvertiblePromissoryNoteMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">TRXD:MrNitilPatelMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-01to2019-06-30_us-gaap_WarrantMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001382574</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-06-30_us-gaap_WarrantMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001382574</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-02-28_us-gaap_WarrantMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001382574</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-02-28</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2018-01-01to2018-06-30_custom_CommunitySpecialtyPharmacyLLCMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001382574</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">TRXD:CommunitySpecialtyPharmacyLLCMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2018-01-01</xbrli:startDate>
        <xbrli:endDate>2018-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-01to2019-06-30_custom_LeaseOneMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001382574</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:LeaseArrangementTypeAxis">TRXD:LeaseOneMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-01to2019-06-30_custom_LeaseTwoMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001382574</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:LeaseArrangementTypeAxis">TRXD:LeaseTwoMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-06-30_custom_LeaseOneMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001382574</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:LeaseArrangementTypeAxis">TRXD:LeaseOneMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-06-30_custom_LeaseTwoMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001382574</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:LeaseArrangementTypeAxis">TRXD:LeaseTwoMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-01to2019-01-31_custom_AlliancePharmaSolutionLLCMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001382574</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">TRXD:AlliancePharmaSolutionLLCMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-01-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-01-31_custom_AlliancePharmaSolutionLLCMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001382574</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">TRXD:AlliancePharmaSolutionLLCMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-01-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-01-31_custom_PanOpticHealthLLCMember_custom_SyncHealthMSOLLCMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001382574</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">TRXD:PanOpticHealthLLCMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:OwnershipAxis">TRXD:SyncHealthMSOLLCMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-01-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-04-01to2019-04-30_custom_AlliancePharmaSolutionLLCMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001382574</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">TRXD:AlliancePharmaSolutionLLCMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-04-01</xbrli:startDate>
        <xbrli:endDate>2019-04-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-01-31_custom_SyncHealthMSOLLCMember_custom_AlliancePharmaSolutionLLCMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001382574</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:OwnershipAxis">TRXD:SyncHealthMSOLLCMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">TRXD:AlliancePharmaSolutionLLCMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-01-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-05-01_custom_SyncHealthMSOLLCMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001382574</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:OwnershipAxis">TRXD:SyncHealthMSOLLCMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-05-01</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-08-01_custom_SyncHealthMSOLLCMember_srt_ScenarioForecastMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001382574</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:OwnershipAxis">TRXD:SyncHealthMSOLLCMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">srt:ScenarioForecastMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-08-01</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-11-01_custom_SyncHealthMSOLLCMember_srt_ScenarioForecastMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001382574</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:OwnershipAxis">TRXD:SyncHealthMSOLLCMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">srt:ScenarioForecastMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-11-01</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-01-31_custom_SyncHealthMSOLLCMember_srt_ScenarioForecastMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001382574</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:OwnershipAxis">TRXD:SyncHealthMSOLLCMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">srt:ScenarioForecastMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-01-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2018-10-31_custom_RelatedPartyPromissoryNoteMember_custom_CommunitySpecialtyPharmacyLLCMember_custom_NikulPanchalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001382574</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">TRXD:RelatedPartyPromissoryNoteMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">TRXD:CommunitySpecialtyPharmacyLLCMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">TRXD:NikulPanchalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2018-10-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-06-30_custom_RelatedPartyPromissoryNoteMember_custom_MrPrashantPatelMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001382574</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">TRXD:RelatedPartyPromissoryNoteMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">TRXD:MrPrashantPatelMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-01to2019-06-30_custom_RelatedPartyPromissoryNoteMember_custom_MrPrashantPatelMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001382574</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">TRXD:RelatedPartyPromissoryNoteMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">TRXD:MrPrashantPatelMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-01to2019-06-30_custom_RelatedPartyPromissoryNoteMember_custom_MrSurenAjjarapuMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001382574</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">TRXD:RelatedPartyPromissoryNoteMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">TRXD:MrSurenAjjarapuMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-06-30_custom_RelatedPartyPromissoryNoteMember_custom_MrSurenAjjarapuMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001382574</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">TRXD:RelatedPartyPromissoryNoteMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">TRXD:MrSurenAjjarapuMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2018-12-31_custom_ConvertiblePromissoryNoteMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001382574</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">TRXD:ConvertiblePromissoryNoteMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2018-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-01to2019-06-30_srt_MinimumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001382574</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-01to2019-06-30_srt_MaximumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001382574</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-04-01to2019-06-30">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001382574</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-04-01</xbrli:startDate>
        <xbrli:endDate>2019-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2018-04-01to2018-06-30">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001382574</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2018-04-01</xbrli:startDate>
        <xbrli:endDate>2018-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-01to2019-03-31_us-gaap_PreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001382574</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2018-01-01to2018-03-31_us-gaap_PreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001382574</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2018-01-01</xbrli:startDate>
        <xbrli:endDate>2018-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-03-31_us-gaap_PreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001382574</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2018-03-31_us-gaap_PreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001382574</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2018-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-01to2019-03-31_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001382574</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2018-01-01to2018-03-31_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001382574</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2018-01-01</xbrli:startDate>
        <xbrli:endDate>2018-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-03-31_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001382574</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2018-03-31_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001382574</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2018-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-01to2019-03-31_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001382574</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2018-01-01to2018-03-31_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001382574</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2018-01-01</xbrli:startDate>
        <xbrli:endDate>2018-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-03-31_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001382574</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2018-03-31_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001382574</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2018-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-01to2019-03-31_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001382574</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2018-01-01to2018-03-31_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001382574</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2018-01-01</xbrli:startDate>
        <xbrli:endDate>2018-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-03-31_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001382574</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2018-03-31_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001382574</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2018-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-01to2019-03-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001382574</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2018-01-01to2018-03-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001382574</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2018-01-01</xbrli:startDate>
        <xbrli:endDate>2018-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-03-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001382574</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-04-01to2019-06-30_us-gaap_PreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001382574</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-04-01</xbrli:startDate>
        <xbrli:endDate>2019-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-04-01to2019-06-30_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001382574</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-04-01</xbrli:startDate>
        <xbrli:endDate>2019-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-04-01to2019-06-30_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001382574</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-04-01</xbrli:startDate>
        <xbrli:endDate>2019-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-04-01to2019-06-30_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001382574</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-04-01</xbrli:startDate>
        <xbrli:endDate>2019-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2018-04-01to2018-06-30_us-gaap_PreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001382574</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2018-04-01</xbrli:startDate>
        <xbrli:endDate>2018-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2018-04-01to2018-06-30_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001382574</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2018-04-01</xbrli:startDate>
        <xbrli:endDate>2018-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2018-04-01to2018-06-30_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001382574</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2018-04-01</xbrli:startDate>
        <xbrli:endDate>2018-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2018-04-01to2018-06-30_us-gaap_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001382574</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2018-04-01</xbrli:startDate>
        <xbrli:endDate>2018-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2018-04-01to2018-06-30_custom_TrxadeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001382574</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">TRXD:TrxadeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2018-04-01</xbrli:startDate>
        <xbrli:endDate>2018-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2018-04-01to2018-06-30_custom_CommunitySpecialtyPharmacyLLCMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001382574</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">TRXD:CommunitySpecialtyPharmacyLLCMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2018-04-01</xbrli:startDate>
        <xbrli:endDate>2018-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-07-09to2019-07-10_us-gaap_SubsequentEventMember_custom_SecuritiesPurchaseAgreementMember_custom_AccreditedInvestorMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001382574</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">TRXD:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">TRXD:AccreditedInvestorMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-07-09</xbrli:startDate>
        <xbrli:endDate>2019-07-10</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-07-10_us-gaap_SubsequentEventMember_custom_SecuritiesPurchaseAgreementMember_custom_AccreditedInvestorMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001382574</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">TRXD:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">TRXD:AccreditedInvestorMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-07-10</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-07-01to2019-07-31_custom_RelatedPartyConvertiblePromissoryNoteMember_custom_MrNitilPatelMember_us-gaap_SubsequentEventMember_us-gaap_ExtendedMaturityMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001382574</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">TRXD:RelatedPartyConvertiblePromissoryNoteMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">TRXD:MrNitilPatelMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:LoanRestructuringModificationAxis">us-gaap:ExtendedMaturityMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-07-01</xbrli:startDate>
        <xbrli:endDate>2019-07-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-02-01to2019-02-28">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001382574</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-02-01</xbrli:startDate>
        <xbrli:endDate>2019-02-28</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-04-01to2019-04-30">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001382574</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-04-01</xbrli:startDate>
        <xbrli:endDate>2019-04-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-04-01to2019-04-30_srt_MinimumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001382574</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-04-01</xbrli:startDate>
        <xbrli:endDate>2019-04-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-04-01to2019-04-30_srt_MaximumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001382574</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-04-01</xbrli:startDate>
        <xbrli:endDate>2019-04-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-05-02to2019-05-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001382574</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-05-02</xbrli:startDate>
        <xbrli:endDate>2019-05-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-05-02to2019-05-31_srt_MinimumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001382574</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-05-02</xbrli:startDate>
        <xbrli:endDate>2019-05-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-05-02to2019-05-31_srt_MaximumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001382574</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-05-02</xbrli:startDate>
        <xbrli:endDate>2019-05-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2018-01-01to2018-12-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001382574</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2018-01-01</xbrli:startDate>
        <xbrli:endDate>2018-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2017-12-31_custom_ConvertiblePromissoryNoteMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001382574</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">TRXD:ConvertiblePromissoryNoteMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2017-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2016-08-31_custom_RelatedPartyConvertiblePromissoryNoteMember_custom_MrShilpaPatelMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001382574</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">TRXD:RelatedPartyConvertiblePromissoryNoteMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">TRXD:MrShilpaPatelMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2016-08-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2018-10-01to2018-10-31_custom_RelatedPartyPromissoryNoteMember_custom_SpecialtyPharmacyLLCMember_custom_NikulPanchalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001382574</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">TRXD:RelatedPartyPromissoryNoteMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">TRXD:SpecialtyPharmacyLLCMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">TRXD:NikulPanchalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2018-10-01</xbrli:startDate>
        <xbrli:endDate>2018-10-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2017-03-01to2017-03-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001382574</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2017-03-01</xbrli:startDate>
        <xbrli:endDate>2017-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2018-01-01to2018-12-31_custom_StockOptionPlanMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001382574</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">TRXD:StockOptionPlanMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2018-01-01</xbrli:startDate>
        <xbrli:endDate>2018-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2018-01-01to2018-12-31_custom_TrxadeIncMember500701218">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001382574</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">TRXD:TrxadeIncMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2018-01-01</xbrli:startDate>
        <xbrli:endDate>2018-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2018-12-31_custom_TrxadeIncMember500716984">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001382574</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">TRXD:TrxadeIncMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2018-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2018-01-01to2018-12-31_custom_CommunitySpecialtyPharmacyLLCMember500738546">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001382574</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">TRXD:CommunitySpecialtyPharmacyLLCMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2018-01-01</xbrli:startDate>
        <xbrli:endDate>2018-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2018-12-31_custom_CommunitySpecialtyPharmacyLLCMember500745734">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001382574</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">TRXD:CommunitySpecialtyPharmacyLLCMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2018-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2018-01-01to2018-12-31_custom_OtherMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001382574</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">TRXD:OtherMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2018-01-01</xbrli:startDate>
        <xbrli:endDate>2018-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2018-12-31_custom_OtherMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001382574</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">TRXD:OtherMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2018-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2018-01-01to2018-12-31_custom_TrxadeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001382574</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">TRXD:TrxadeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2018-01-01</xbrli:startDate>
        <xbrli:endDate>2018-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-01to2019-01-31_custom_AlliancePharmaSolutionLLCMember_us-gaap_SubsequentEventMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001382574</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">TRXD:AlliancePharmaSolutionLLCMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-01-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-01-31_custom_AlliancePharmaSolutionLLCMember_us-gaap_SubsequentEventMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001382574</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">TRXD:AlliancePharmaSolutionLLCMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-01-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-01-31_custom_PanOpticHealthLLCMember_us-gaap_SubsequentEventMember_custom_SyncHealthMSOLLCMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001382574</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">TRXD:PanOpticHealthLLCMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:OwnershipAxis">TRXD:SyncHealthMSOLLCMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-01-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-01-31_custom_AlliancePharmaSolutionLLCMember_us-gaap_SubsequentEventMember_custom_SyncHealthMSOLLCMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001382574</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">TRXD:AlliancePharmaSolutionLLCMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:OwnershipAxis">TRXD:SyncHealthMSOLLCMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-01-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2018-12-31_custom_AlliancePharmaSolutionLLCMember_us-gaap_SubsequentEventMember_custom_SyncHealthMSOLLCMember_custom_MayOneTwoThousandNineteenMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001382574</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">TRXD:AlliancePharmaSolutionLLCMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:OwnershipAxis">TRXD:SyncHealthMSOLLCMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">TRXD:MayOneTwoThousandNineteenMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2018-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2018-12-31_custom_AlliancePharmaSolutionLLCMember_us-gaap_SubsequentEventMember_custom_SyncHealthMSOLLCMember_custom_AugustOneTwoThousandNineteenMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001382574</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">TRXD:AlliancePharmaSolutionLLCMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:OwnershipAxis">TRXD:SyncHealthMSOLLCMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">TRXD:AugustOneTwoThousandNineteenMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2018-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2018-12-31_custom_AlliancePharmaSolutionLLCMember_us-gaap_SubsequentEventMember_custom_SyncHealthMSOLLCMember_custom_NovemberOneTwoThousandNineteenMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001382574</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">TRXD:AlliancePharmaSolutionLLCMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:OwnershipAxis">TRXD:SyncHealthMSOLLCMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">TRXD:NovemberOneTwoThousandNineteenMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2018-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-01to2019-01-31_us-gaap_SubsequentEventMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001382574</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-01-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-01-31_us-gaap_SubsequentEventMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001382574</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-01-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-02-28_us-gaap_SubsequentEventMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001382574</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-02-28</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-02-28_us-gaap_SubsequentEventMember_srt_MaximumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001382574</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-02-28</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-02-28_us-gaap_SubsequentEventMember_srt_MinimumMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001382574</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-02-28</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-02-01to2019-02-28_us-gaap_SubsequentEventMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001382574</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-02-01</xbrli:startDate>
        <xbrli:endDate>2019-02-28</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-09-29to2019-09-30_us-gaap_SubsequentEventMember_custom_SecuritiesPurchaseAgreementMember_custom_AccreditedInvestorMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001382574</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">TRXD:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">TRXD:AccreditedInvestorMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-09-29</xbrli:startDate>
        <xbrli:endDate>2019-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-09-30_us-gaap_SubsequentEventMember_custom_SecuritiesPurchaseAgreementMember_custom_AccreditedInvestorMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001382574</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">TRXD:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">TRXD:AccreditedInvestorMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-09-29to2019-09-30_us-gaap_SubsequentEventMember_custom_SecuritiesPurchaseAgreementMember_custom_PromissoryNotesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001382574</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">TRXD:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">TRXD:PromissoryNotesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-09-29</xbrli:startDate>
        <xbrli:endDate>2019-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-09-30_us-gaap_SubsequentEventMember_custom_SecuritiesPurchaseAgreementMember_custom_PromissoryNotesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001382574</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">TRXD:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">TRXD:PromissoryNotesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-10-07to2019-10-08_us-gaap_SubsequentEventMember_custom_SecuritiesPurchaseAgreementMember_custom_MrPrashantPatelAndMrSurenAjjarapuMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001382574</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">TRXD:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">TRXD:MrPrashantPatelAndMrSurenAjjarapuMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-10-07</xbrli:startDate>
        <xbrli:endDate>2019-10-08</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-10-07to2019-10-08_us-gaap_SubsequentEventMember_custom_SecuritiesPurchaseAgreementMember_custom_MrPrashantPatelMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001382574</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">TRXD:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">TRXD:MrPrashantPatelMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-10-07</xbrli:startDate>
        <xbrli:endDate>2019-10-08</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-10-07to2019-10-08_us-gaap_SubsequentEventMember_custom_SecuritiesPurchaseAgreementMember_custom_MrSurenAjjarapuMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001382574</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">TRXD:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">TRXD:MrSurenAjjarapuMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-10-07</xbrli:startDate>
        <xbrli:endDate>2019-10-08</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-08-28_us-gaap_SubsequentEventMember_custom_ConsultingAgreementMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001382574</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">TRXD:ConsultingAgreementMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-08-28</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-04-01_srt_ScenarioForecastMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001382574</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">srt:ScenarioForecastMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-04-01</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-04-01_srt_ScenarioForecastMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001382574</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">srt:ScenarioForecastMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-04-01</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:unit id="USD">
      <xbrli:measure>iso4217:USD</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="Shares">
      <xbrli:measure>xbrli:shares</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="USDPShares">
      <xbrli:divide>
        <xbrli:unitNumerator>
          <xbrli:measure>iso4217:USD</xbrli:measure>
        </xbrli:unitNumerator>
        <xbrli:unitDenominator>
          <xbrli:measure>xbrli:shares</xbrli:measure>
        </xbrli:unitDenominator>
      </xbrli:divide>
    </xbrli:unit>
    <xbrli:unit id="Percentage">
      <xbrli:measure>xbrli:pure</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="Integer">
      <xbrli:measure>TRXD:Integer</xbrli:measure>
    </xbrli:unit>
    <dei:EntityRegistrantName contextRef="From2019-01-01to2019-06-30">TRXADE GROUP, INC.</dei:EntityRegistrantName>
    <dei:EntityCentralIndexKey contextRef="From2019-01-01to2019-06-30">0001382574</dei:EntityCentralIndexKey>
    <dei:DocumentType contextRef="From2019-01-01to2019-06-30">S-1</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="From2019-01-01to2019-06-30">2019-06-30</dei:DocumentPeriodEndDate>
    <dei:AmendmentFlag contextRef="From2019-01-01to2019-06-30">false</dei:AmendmentFlag>
    <dei:EntityFilerCategory contextRef="From2019-01-01to2019-06-30">Non-accelerated Filer</dei:EntityFilerCategory>
    <dei:EntitySmallBusiness contextRef="From2019-01-01to2019-06-30">true</dei:EntitySmallBusiness>
    <dei:EntityEmergingGrowthCompany contextRef="From2019-01-01to2019-06-30">true</dei:EntityEmergingGrowthCompany>
    <dei:EntityExTransitionPeriod contextRef="From2019-01-01to2019-06-30">false</dei:EntityExTransitionPeriod>
    <us-gaap:StockholdersEquity contextRef="AsOf2018-12-31" unitRef="USD" decimals="0">844668</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="AsOf2019-06-30" unitRef="USD" decimals="0">1340017</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="AsOf2016-12-31" unitRef="USD" decimals="0">-1148057</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="AsOf2018-06-30" unitRef="USD" decimals="0">-121079</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="AsOf2016-12-31_us-gaap_PreferredStockMember" unitRef="USD" xsi:nil="true" />
    <us-gaap:StockholdersEquity contextRef="AsOf2017-12-31_us-gaap_PreferredStockMember" unitRef="USD" xsi:nil="true" />
    <us-gaap:StockholdersEquity contextRef="AsOf2018-12-31_us-gaap_PreferredStockMember" unitRef="USD" xsi:nil="true" />
    <us-gaap:StockholdersEquity contextRef="AsOf2016-12-31_us-gaap_CommonStockMember" unitRef="USD" decimals="0">316</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="AsOf2017-12-31_us-gaap_CommonStockMember" unitRef="USD" decimals="0">320</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="AsOf2018-12-31_us-gaap_CommonStockMember" unitRef="USD" decimals="0">332</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="AsOf2016-12-31_us-gaap_AdditionalPaidInCapitalMember" unitRef="USD" decimals="0">7260723</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="AsOf2017-12-31_us-gaap_AdditionalPaidInCapitalMember" unitRef="USD" decimals="0">7807860</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="AsOf2018-12-31_us-gaap_AdditionalPaidInCapitalMember" unitRef="USD" decimals="0">8955411</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="AsOf2016-12-31_us-gaap_RetainedEarningsMember" unitRef="USD" decimals="0">-8409096</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="AsOf2017-12-31_us-gaap_RetainedEarningsMember" unitRef="USD" decimals="0">-8120113</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="AsOf2018-12-31_us-gaap_RetainedEarningsMember" unitRef="USD" decimals="0">-8111075</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="AsOf2018-06-30_us-gaap_PreferredStockMember" unitRef="USD" xsi:nil="true" />
    <us-gaap:StockholdersEquity contextRef="AsOf2019-06-30_us-gaap_PreferredStockMember" unitRef="USD" xsi:nil="true" />
    <us-gaap:StockholdersEquity contextRef="AsOf2018-06-30_us-gaap_CommonStockMember" unitRef="USD" decimals="0">320</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="AsOf2019-06-30_us-gaap_CommonStockMember" unitRef="USD" decimals="0">337</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="AsOf2018-06-30_us-gaap_AdditionalPaidInCapitalMember" unitRef="USD" decimals="0">7895932</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="AsOf2019-06-30_us-gaap_AdditionalPaidInCapitalMember" unitRef="USD" decimals="0">9267545</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="AsOf2018-06-30_us-gaap_RetainedEarningsMember" unitRef="USD" decimals="0">-8017331</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="AsOf2019-06-30_us-gaap_RetainedEarningsMember" unitRef="USD" decimals="0">-7927865</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="AsOf2017-12-31" unitRef="USD" decimals="0">-311933</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="AsOf2018-03-31" unitRef="USD" decimals="0">-192208</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="AsOf2019-03-31_us-gaap_PreferredStockMember" unitRef="USD" xsi:nil="true" />
    <us-gaap:StockholdersEquity contextRef="AsOf2018-03-31_us-gaap_PreferredStockMember" unitRef="USD" xsi:nil="true" />
    <us-gaap:StockholdersEquity contextRef="AsOf2019-03-31_us-gaap_CommonStockMember" unitRef="USD" decimals="0">337</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="AsOf2018-03-31_us-gaap_CommonStockMember" unitRef="USD" decimals="0">320</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="AsOf2019-03-31_us-gaap_AdditionalPaidInCapitalMember" unitRef="USD" decimals="0">9203534</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="AsOf2018-03-31_us-gaap_AdditionalPaidInCapitalMember" unitRef="USD" decimals="0">7845316</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="AsOf2019-03-31_us-gaap_RetainedEarningsMember" unitRef="USD" decimals="0">-7985846</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="AsOf2018-03-31_us-gaap_RetainedEarningsMember" unitRef="USD" decimals="0">-8037844</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="AsOf2019-03-31" unitRef="USD" decimals="0">1218025</us-gaap:StockholdersEquity>
    <us-gaap:PreferredStockParOrStatedValuePerShare contextRef="AsOf2018-12-31" unitRef="USDPShares" decimals="INF">0.00001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockParOrStatedValuePerShare contextRef="AsOf2019-06-30" unitRef="USDPShares" decimals="INF">0.00001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockParOrStatedValuePerShare contextRef="AsOf2017-12-31" unitRef="USDPShares" decimals="INF">0.00001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockSharesAuthorized contextRef="AsOf2018-12-31" unitRef="Shares" decimals="INF">10000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesAuthorized contextRef="AsOf2019-06-30" unitRef="Shares" decimals="INF">10000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesAuthorized contextRef="AsOf2017-12-31" unitRef="Shares" decimals="INF">10000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesIssued contextRef="AsOf2018-12-31" unitRef="Shares" xsi:nil="true" />
    <us-gaap:PreferredStockSharesIssued contextRef="AsOf2019-06-30" unitRef="Shares" xsi:nil="true" />
    <us-gaap:PreferredStockSharesIssued contextRef="AsOf2017-12-31" unitRef="Shares" xsi:nil="true" />
    <us-gaap:PreferredStockSharesOutstanding contextRef="AsOf2018-12-31" unitRef="Shares" xsi:nil="true" />
    <us-gaap:PreferredStockSharesOutstanding contextRef="AsOf2019-06-30" unitRef="Shares" xsi:nil="true" />
    <us-gaap:PreferredStockSharesOutstanding contextRef="AsOf2017-12-31" unitRef="Shares" xsi:nil="true" />
    <us-gaap:CommonStockSharesAuthorized contextRef="AsOf2018-12-31" unitRef="Shares" decimals="INF">100000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized contextRef="AsOf2019-06-30" unitRef="Shares" decimals="INF">100000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized contextRef="AsOf2017-12-31" unitRef="Shares" decimals="INF">100000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockParOrStatedValuePerShare contextRef="AsOf2018-12-31" unitRef="USDPShares" decimals="INF">0.00001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare contextRef="AsOf2019-06-30" unitRef="USDPShares" decimals="INF">0.00001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare contextRef="AsOf2017-12-31" unitRef="USDPShares" decimals="INF">0.00001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesIssued contextRef="AsOf2018-12-31" unitRef="Shares" decimals="INF">33285827</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesIssued contextRef="AsOf2019-06-30" unitRef="Shares" decimals="INF">33726489</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesIssued contextRef="AsOf2017-12-31" unitRef="Shares" decimals="INF">31985827</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding contextRef="AsOf2018-12-31" unitRef="Shares" decimals="INF">33285827</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesOutstanding contextRef="AsOf2019-06-30" unitRef="Shares" decimals="INF">33726489</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesOutstanding contextRef="AsOf2017-12-31" unitRef="Shares" decimals="INF">31985827</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:NetIncomeLoss contextRef="From2019-01-01to2019-06-30" unitRef="USD" decimals="0">183210</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="From2017-01-01to2017-12-31" unitRef="USD" decimals="0">288983</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="From2017-01-01to2017-12-31_us-gaap_RetainedEarningsMember" unitRef="USD" decimals="0">288983</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="From2018-01-01to2018-12-31_us-gaap_RetainedEarningsMember" unitRef="USD" decimals="0">9038</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="From2018-01-01to2018-06-30" unitRef="USD" decimals="0">102782</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="From2019-04-01to2019-06-30" unitRef="USD" decimals="0">57981</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="From2018-04-01to2018-06-30" unitRef="USD" decimals="0">20513</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="From2019-01-01to2019-03-31_us-gaap_PreferredStockMember" unitRef="USD" xsi:nil="true" />
    <us-gaap:NetIncomeLoss contextRef="From2018-01-01to2018-03-31_us-gaap_PreferredStockMember" unitRef="USD" xsi:nil="true" />
    <us-gaap:NetIncomeLoss contextRef="From2019-01-01to2019-03-31_us-gaap_CommonStockMember" unitRef="USD" xsi:nil="true" />
    <us-gaap:NetIncomeLoss contextRef="From2018-01-01to2018-03-31_us-gaap_CommonStockMember" unitRef="USD" xsi:nil="true" />
    <us-gaap:NetIncomeLoss contextRef="From2019-01-01to2019-03-31_us-gaap_AdditionalPaidInCapitalMember" unitRef="USD" xsi:nil="true" />
    <us-gaap:NetIncomeLoss contextRef="From2018-01-01to2018-03-31_us-gaap_AdditionalPaidInCapitalMember" unitRef="USD" xsi:nil="true" />
    <us-gaap:NetIncomeLoss contextRef="From2019-01-01to2019-03-31_us-gaap_RetainedEarningsMember" unitRef="USD" decimals="0">125229</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="From2018-01-01to2018-03-31_us-gaap_RetainedEarningsMember" unitRef="USD" decimals="0">82269</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="From2019-01-01to2019-03-31" unitRef="USD" decimals="0">125229</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="From2018-01-01to2018-03-31" unitRef="USD" decimals="0">82269</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="From2019-04-01to2019-06-30_us-gaap_PreferredStockMember" unitRef="USD" xsi:nil="true" />
    <us-gaap:NetIncomeLoss contextRef="From2019-04-01to2019-06-30_us-gaap_CommonStockMember" unitRef="USD" xsi:nil="true" />
    <us-gaap:NetIncomeLoss contextRef="From2019-04-01to2019-06-30_us-gaap_AdditionalPaidInCapitalMember" unitRef="USD" xsi:nil="true" />
    <us-gaap:NetIncomeLoss contextRef="From2019-04-01to2019-06-30_us-gaap_RetainedEarningsMember" unitRef="USD" decimals="0">57981</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="From2018-04-01to2018-06-30_us-gaap_PreferredStockMember" unitRef="USD" xsi:nil="true" />
    <us-gaap:NetIncomeLoss contextRef="From2018-04-01to2018-06-30_us-gaap_CommonStockMember" unitRef="USD" xsi:nil="true" />
    <us-gaap:NetIncomeLoss contextRef="From2018-04-01to2018-06-30_us-gaap_AdditionalPaidInCapitalMember" unitRef="USD" xsi:nil="true" />
    <us-gaap:NetIncomeLoss contextRef="From2018-04-01to2018-06-30_us-gaap_RetainedEarningsMember" unitRef="USD" decimals="0">20513</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="From2018-01-01to2018-12-31" unitRef="USD" decimals="0">9038</us-gaap:NetIncomeLoss>
    <us-gaap:StockOptionPlanExpense contextRef="From2019-01-01to2019-06-30" unitRef="USD" decimals="0">99990</us-gaap:StockOptionPlanExpense>
    <us-gaap:StockOptionPlanExpense contextRef="From2017-01-01to2017-12-31" unitRef="USD" decimals="0">267835</us-gaap:StockOptionPlanExpense>
    <us-gaap:StockOptionPlanExpense contextRef="From2017-04-01to2017-04-30_custom_FourOptionGrantedMember" unitRef="USD" decimals="0">69611</us-gaap:StockOptionPlanExpense>
    <us-gaap:StockOptionPlanExpense contextRef="From2018-01-01to2018-06-30" unitRef="USD" decimals="0">88072</us-gaap:StockOptionPlanExpense>
    <us-gaap:StockOptionPlanExpense contextRef="From2018-01-01to2018-12-31" unitRef="USD" decimals="0">169828</us-gaap:StockOptionPlanExpense>
    <us-gaap:AmortizationOfDebtDiscountPremium contextRef="From2019-01-01to2019-06-30" unitRef="USD" xsi:nil="true" />
    <us-gaap:AmortizationOfDebtDiscountPremium contextRef="From2017-01-01to2017-12-31_custom_PromissoryNoteMember" unitRef="USD" decimals="0">15000</us-gaap:AmortizationOfDebtDiscountPremium>
    <us-gaap:AmortizationOfDebtDiscountPremium contextRef="From2017-01-01to2017-12-31_custom_RelatedPartyConvertiblePromissoryNoteMember" unitRef="USD" decimals="0">48341</us-gaap:AmortizationOfDebtDiscountPremium>
    <us-gaap:AmortizationOfDebtDiscountPremium contextRef="From2017-01-01to2017-12-31" unitRef="USD" decimals="0">88647</us-gaap:AmortizationOfDebtDiscountPremium>
    <us-gaap:AmortizationOfDebtDiscountPremium contextRef="From2016-01-01to2016-12-31_custom_PromissoryNoteMember" unitRef="USD" decimals="0">45000</us-gaap:AmortizationOfDebtDiscountPremium>
    <us-gaap:AmortizationOfDebtDiscountPremium contextRef="From2017-01-01to2017-12-31_custom_ConvertiblePromissoryNoteMember" unitRef="USD" decimals="0">0</us-gaap:AmortizationOfDebtDiscountPremium>
    <us-gaap:AmortizationOfDebtDiscountPremium contextRef="From2018-01-01to2018-12-31_custom_PromissoryNotesMember" unitRef="USD" decimals="0">152</us-gaap:AmortizationOfDebtDiscountPremium>
    <us-gaap:AmortizationOfDebtDiscountPremium contextRef="From2017-01-01to2017-12-31_custom_ShortTermPromissoryNotesMember" unitRef="USD" decimals="0">25306</us-gaap:AmortizationOfDebtDiscountPremium>
    <us-gaap:AmortizationOfDebtDiscountPremium contextRef="From2018-01-01to2018-06-30" unitRef="USD" decimals="0">152</us-gaap:AmortizationOfDebtDiscountPremium>
    <us-gaap:AmortizationOfDebtDiscountPremium contextRef="From2018-01-01to2018-12-31" unitRef="USD" decimals="0">152</us-gaap:AmortizationOfDebtDiscountPremium>
    <us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock contextRef="From2019-01-01to2019-06-30">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;The&#13;following table represents stock option activity for the six-month period ended June 30, 2019:&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Number&lt;/b&gt;&lt;/font&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Outstanding&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Weighted&lt;/b&gt;&lt;/font&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Average&lt;/b&gt;&lt;/font&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Exercise Price&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Contractual Life&lt;/b&gt;&lt;/font&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;in Years&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Intrinsic&lt;/b&gt;&lt;/font&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Value&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="width: 44%"&gt;Options Outstanding as of December 31, 2018&lt;/td&gt;&lt;td style="width: 2%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 10%; text-align: right"&gt;1,732,846&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 10%; text-align: right"&gt;1.19&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 10%; text-align: right"&gt;6.98&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 10%; text-align: right"&gt;-&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td&gt;Options Exercisable as of December 31, 2018&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,107,259&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;0.96&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;5.91&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="text-align: left"&gt;Options granted&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;505,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;0.43&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;9.86&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="text-align: left"&gt;Options forfeited&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="text-align: left"&gt;Options expired&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td&gt;Options Outstanding as of June 30, 2019&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;2,237,846&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;0.73&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;7.27&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;88,350&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td&gt;Options Exercisable as of June 30, 2019&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,239,384&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;0.91&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;5.77&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;8,809&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock>
    <us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock contextRef="From2018-01-01to2018-12-31">&lt;p style="margin: 0pt"&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The following table represents stock option&#13;activity for the two years ended December 31, 2018:&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="padding-bottom: 1.5pt; text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt; text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Number Outstanding&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt; text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt; text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Weighted Average Exercise Price&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt; text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt; text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Contractual Life in Years&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt; text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt; text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Intrinsic Value&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt; text-align: center"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="width: 46%"&gt;&lt;font style="font-size: 10pt"&gt;Options Outstanding as of December 31, 2016&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 11%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;1,044,500&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 11%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;0.92&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 10%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;3.38&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 10%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Options Exercisable as of December 31, 2016&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;584,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;1.05&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;3.02&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Options granted&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;263,846&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;0.64&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;9.05&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Options forfeited&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;(35,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;1.02&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;8.25&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Options expired&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;(75,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;1.13&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;4.54&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Options Outstanding as of December 31, 2017&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;1,197,846&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;0.97&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;6.96&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Options Exercisable as of December 31, 2017&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;781,300&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;1.02&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;6.30&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Options granted&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;560,400&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;0.50&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;9.26&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Options forfeited&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;(25,400&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;0.46&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;9.06&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Options expired&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Options Outstanding as of December 31, 2018&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;1,732,846&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;1.19&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;6.98&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Options Exercisable as of December 31, 2018&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;1,107,259&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;0.96&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;5.91&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&#13;&#13;&lt;p style="margin: 0pt"&gt;&lt;/p&gt;</us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage contextRef="AsOf2018-12-31" unitRef="Percentage" decimals="INF">1.00</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage contextRef="AsOf2019-06-30" unitRef="Percentage" decimals="INF">1.00</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage contextRef="AsOf2018-10-15_custom_CommunitySpecialtyPharmacyLLCMember_us-gaap_SubsequentEventMember" unitRef="Percentage" decimals="INF">1.00</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage contextRef="AsOf2018-12-31_custom_AlliancePharmaSolutionLLCMember_custom_SyncHealthMSOLLCMember_custom_JanuaryThortyOneTwoThousandTwentyMember" unitRef="Percentage" decimals="INF">0.51</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage contextRef="AsOf2019-01-31_custom_AlliancePharmaSolutionLLCMember" unitRef="Percentage" decimals="INF">0.49</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage contextRef="AsOf2019-01-31_custom_PanOpticHealthLLCMember_custom_SyncHealthMSOLLCMember" unitRef="Percentage" decimals="INF">0.70</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage contextRef="AsOf2019-01-31_custom_SyncHealthMSOLLCMember_custom_AlliancePharmaSolutionLLCMember" unitRef="Percentage" decimals="INF">0.30</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage contextRef="AsOf2019-05-01_custom_SyncHealthMSOLLCMember" unitRef="Percentage" decimals="INF">0.06</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage contextRef="AsOf2019-08-01_custom_SyncHealthMSOLLCMember_srt_ScenarioForecastMember" unitRef="Percentage" decimals="INF">0.06</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage contextRef="AsOf2019-11-01_custom_SyncHealthMSOLLCMember_srt_ScenarioForecastMember" unitRef="Percentage" decimals="INF">0.07</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage contextRef="AsOf2020-01-31_custom_SyncHealthMSOLLCMember_srt_ScenarioForecastMember" unitRef="Percentage" decimals="INF">0.51</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage contextRef="AsOf2019-01-31_custom_AlliancePharmaSolutionLLCMember_us-gaap_SubsequentEventMember" unitRef="Percentage" decimals="INF">0.49</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage contextRef="AsOf2019-01-31_custom_PanOpticHealthLLCMember_us-gaap_SubsequentEventMember_custom_SyncHealthMSOLLCMember" unitRef="Percentage" decimals="INF">0.70</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage contextRef="AsOf2019-01-31_custom_AlliancePharmaSolutionLLCMember_us-gaap_SubsequentEventMember_custom_SyncHealthMSOLLCMember" unitRef="Percentage" decimals="INF">0.30</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage contextRef="AsOf2018-12-31_custom_AlliancePharmaSolutionLLCMember_us-gaap_SubsequentEventMember_custom_SyncHealthMSOLLCMember_custom_MayOneTwoThousandNineteenMember" unitRef="Percentage" decimals="INF">0.06</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage contextRef="AsOf2018-12-31_custom_AlliancePharmaSolutionLLCMember_us-gaap_SubsequentEventMember_custom_SyncHealthMSOLLCMember_custom_AugustOneTwoThousandNineteenMember" unitRef="Percentage" decimals="INF">0.06</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage contextRef="AsOf2018-12-31_custom_AlliancePharmaSolutionLLCMember_us-gaap_SubsequentEventMember_custom_SyncHealthMSOLLCMember_custom_NovemberOneTwoThousandNineteenMember" unitRef="Percentage" decimals="INF">0.07</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage contextRef="AsOf2019-01-31_us-gaap_SubsequentEventMember" unitRef="Percentage" decimals="INF">0.30</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights contextRef="AsOf2018-12-31" unitRef="Shares" decimals="INF">161538</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights contextRef="AsOf2017-08-31_custom_RelatedPartyConvertiblePromissoryNoteMember" unitRef="Shares" decimals="INF">10000</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights contextRef="AsOf2018-08-31_custom_RelatedPartyConvertiblePromissoryNoteMember" unitRef="Shares" decimals="INF">10000</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights contextRef="AsOf2016-10-31_custom_RelatedPartyConvertiblePromissoryNoteMember_custom_MrNitilPatelMember" unitRef="Shares" decimals="INF">52861</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights contextRef="AsOf2016-09-30_custom_RelatedPartyConvertiblePromissoryNoteMember_custom_MrNitilPatelMember" unitRef="Shares" decimals="INF">52861</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights contextRef="AsOf2018-10-15_custom_CommunitySpecialtyPharmacyLLCMember_us-gaap_SubsequentEventMember" unitRef="Shares" decimals="INF">405507</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights contextRef="AsOf2018-07-31_custom_PrivateOfferMemorandumMember" unitRef="Shares" decimals="INF">161538</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights contextRef="AsOf2017-04-30_custom_ConvertiblePromissoryNoteMember" unitRef="Shares" decimals="INF">18150</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights contextRef="AsOf2015-04-30_custom_ConvertiblePromissoryNoteMember" unitRef="Shares" decimals="INF">50000</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights contextRef="AsOf2015-05-31_custom_ConvertiblePromissoryNoteMember" unitRef="Shares" decimals="INF">50000</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights contextRef="AsOf2016-04-30_custom_ConvertiblePromissoryNoteMember" unitRef="Shares" decimals="INF">41250</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights contextRef="AsOf2016-05-31_custom_ConvertiblePromissoryNoteMember" unitRef="Shares" decimals="INF">41250</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights contextRef="AsOf2017-01-31_custom_PrivateOfferMemorandumMember" unitRef="Shares" decimals="INF">87500</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights contextRef="AsOf2018-12-31_custom_CommunitySpecialtyPharmacyLLCMember" unitRef="Shares" decimals="INF">405507</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights contextRef="AsOf2017-12-31" unitRef="Shares" decimals="INF">87500</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights contextRef="AsOf2019-08-28_us-gaap_SubsequentEventMember_custom_ConsultingAgreementMember" unitRef="Shares" decimals="INF">300000</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross contextRef="From2019-01-01to2019-06-30" unitRef="Shares" decimals="INF">505000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross contextRef="From2017-01-01to2017-12-31" unitRef="Shares" decimals="INF">263846</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross contextRef="From2019-01-01to2019-06-30_custom_StockOptionPlanMember" unitRef="Shares" decimals="INF">2000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross contextRef="From2018-01-01to2018-12-31_custom_EmployeeMember" unitRef="Shares" decimals="INF">560400</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross contextRef="From2017-01-01to2017-12-31_custom_EmployeeMember" unitRef="Shares" decimals="INF">263846</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross contextRef="From2017-04-01to2017-04-30" unitRef="Shares" decimals="INF">253846</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross contextRef="From2017-04-01to2017-04-30_custom_FourOptionGrantedMember" unitRef="Shares" decimals="INF">650000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross contextRef="From2018-04-01to2018-04-30" unitRef="Shares" decimals="INF">560400</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross contextRef="From2019-04-01to2019-04-30" unitRef="Shares" decimals="INF">505000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross contextRef="From2019-05-02to2019-05-31" unitRef="Shares" decimals="INF">505000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross contextRef="From2018-01-01to2018-12-31" unitRef="Shares" decimals="INF">560400</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross contextRef="From2018-01-01to2018-12-31_custom_StockOptionPlanMember" unitRef="Shares" decimals="INF">2000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardDescription contextRef="From2019-01-01to2019-06-30_custom_StockOptionPlanMember">All options may be exercised for a period up to four 1/2 years following the grant date, after which they expire. </us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardDescription>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardDescription contextRef="From2018-01-01to2018-12-31_custom_StockOptionPlanMember">All options may be exercised for a period up to four 1/2 years following the grant date, after which they expire. </us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardDescription>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1 contextRef="From2019-01-01to2019-06-30_custom_StockOptionPlanMember">P5Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1 contextRef="From2018-01-01to2018-12-31_custom_EmployeeMember_srt_MinimumMember">P4Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1 contextRef="From2017-01-01to2017-12-31_custom_EmployeeMember_srt_MinimumMember">P4Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1 contextRef="From2017-01-01to2017-12-31_custom_EmployeeMember_srt_MaximumMember">P5Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1 contextRef="From2018-01-01to2018-12-31_custom_EmployeeMember_srt_MaximumMember">P5Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1 contextRef="From2019-04-01to2019-04-30_srt_MinimumMember">P4Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1 contextRef="From2019-04-01to2019-04-30_srt_MaximumMember">P5Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1 contextRef="From2019-05-02to2019-05-31_srt_MinimumMember">P4Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1 contextRef="From2019-05-02to2019-05-31_srt_MaximumMember">P5Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1 contextRef="From2018-01-01to2018-12-31_custom_StockOptionPlanMember">P5Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice contextRef="From2019-01-01to2019-06-30" unitRef="USDPShares" decimals="INF">0.43</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice contextRef="From2017-01-01to2017-12-31" unitRef="USDPShares" decimals="INF">0.64</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice contextRef="From2019-04-01to2019-04-30_srt_MinimumMember" unitRef="USDPShares" decimals="INF">0.41</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice contextRef="From2019-04-01to2019-04-30_srt_MaximumMember" unitRef="USDPShares" decimals="INF">0.44</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice contextRef="From2019-05-02to2019-05-31_srt_MinimumMember" unitRef="USDPShares" decimals="INF">0.41</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice contextRef="From2019-05-02to2019-05-31_srt_MaximumMember" unitRef="USDPShares" decimals="INF">0.44</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice contextRef="From2018-01-01to2018-12-31" unitRef="USDPShares" decimals="INF">0.50</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice contextRef="From2019-01-01to2019-06-30" unitRef="USDPShares" xsi:nil="true" />
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice contextRef="From2017-01-01to2017-12-31" unitRef="USDPShares" decimals="INF">1.02</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice contextRef="From2018-01-01to2018-12-31" unitRef="USDPShares" decimals="INF">0.46</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2 contextRef="From2019-01-01to2019-06-30">P6Y11M23D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2 contextRef="From2017-01-01to2017-12-31">P3Y4M17D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2 contextRef="From2019-04-01to2019-04-30">P10Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2 contextRef="From2019-05-02to2019-05-31">P10Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2 contextRef="From2018-01-01to2018-12-31">P6Y11M15D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber contextRef="AsOf2018-12-31" unitRef="Shares" decimals="INF">1732846</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber contextRef="AsOf2019-06-30" unitRef="Shares" decimals="INF">2237846</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber contextRef="AsOf2016-12-31" unitRef="Shares" decimals="INF">1044500</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber contextRef="AsOf2017-12-31" unitRef="Shares" decimals="INF">1197846</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice contextRef="AsOf2018-12-31" unitRef="USDPShares" decimals="INF">1.19</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice contextRef="AsOf2019-06-30" unitRef="USDPShares" decimals="INF">0.73</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice contextRef="AsOf2016-12-31" unitRef="USDPShares" decimals="INF">0.92</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice contextRef="AsOf2017-12-31" unitRef="USDPShares" decimals="INF">0.97</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice contextRef="AsOf2018-12-31" unitRef="USDPShares" decimals="INF">0.96</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice contextRef="AsOf2019-06-30" unitRef="USDPShares" decimals="INF">0.91</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice contextRef="AsOf2016-12-31" unitRef="USDPShares" decimals="INF">1.05</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice contextRef="AsOf2017-12-31" unitRef="USDPShares" decimals="INF">1.02</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice contextRef="From2019-01-01to2019-06-30" unitRef="USDPShares" xsi:nil="true" />
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice contextRef="From2017-01-01to2017-12-31" unitRef="USDPShares" decimals="INF">1.13</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice contextRef="From2018-01-01to2018-12-31" unitRef="USDPShares" xsi:nil="true" />
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber contextRef="AsOf2018-12-31" unitRef="Shares" decimals="INF">1107259</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber contextRef="AsOf2019-06-30" unitRef="Shares" decimals="INF">1239384</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber contextRef="AsOf2016-12-31" unitRef="Shares" decimals="INF">584000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber contextRef="AsOf2017-12-31" unitRef="Shares" decimals="INF">781300</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber>
    <TRXD:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTermForfeitures contextRef="From2019-01-01to2019-06-30">P0Y</TRXD:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTermForfeitures>
    <TRXD:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTermForfeitures contextRef="From2017-01-01to2017-12-31">P8Y2M30D</TRXD:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTermForfeitures>
    <TRXD:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTermForfeitures contextRef="From2018-01-01to2018-12-31">P9Y22D</TRXD:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTermForfeitures>
    <TRXD:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTermExpired contextRef="From2019-01-01to2019-06-30">P0Y</TRXD:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTermExpired>
    <TRXD:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTermExpired contextRef="From2017-01-01to2017-12-31">P4Y6M14D</TRXD:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTermExpired>
    <TRXD:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTermExpired contextRef="From2018-01-01to2018-12-31">P0Y</TRXD:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTermExpired>
    <us-gaap:SharesOutstanding contextRef="AsOf2016-12-31_us-gaap_PreferredStockMember" unitRef="Shares" xsi:nil="true" />
    <us-gaap:SharesOutstanding contextRef="AsOf2017-12-31_us-gaap_PreferredStockMember" unitRef="Shares" xsi:nil="true" />
    <us-gaap:SharesOutstanding contextRef="AsOf2018-12-31_us-gaap_PreferredStockMember" unitRef="Shares" xsi:nil="true" />
    <us-gaap:SharesOutstanding contextRef="AsOf2016-12-31_us-gaap_CommonStockMember" unitRef="Shares" decimals="INF">31660827</us-gaap:SharesOutstanding>
    <us-gaap:SharesOutstanding contextRef="AsOf2017-12-31_us-gaap_CommonStockMember" unitRef="Shares" decimals="INF">31985827</us-gaap:SharesOutstanding>
    <us-gaap:SharesOutstanding contextRef="AsOf2018-12-31_us-gaap_CommonStockMember" unitRef="Shares" decimals="INF">33285827</us-gaap:SharesOutstanding>
    <us-gaap:SharesOutstanding contextRef="AsOf2018-06-30_us-gaap_PreferredStockMember" unitRef="Shares" xsi:nil="true" />
    <us-gaap:SharesOutstanding contextRef="AsOf2019-06-30_us-gaap_PreferredStockMember" unitRef="Shares" xsi:nil="true" />
    <us-gaap:SharesOutstanding contextRef="AsOf2018-06-30_us-gaap_CommonStockMember" unitRef="Shares" decimals="INF">31985827</us-gaap:SharesOutstanding>
    <us-gaap:SharesOutstanding contextRef="AsOf2019-06-30_us-gaap_CommonStockMember" unitRef="Shares" decimals="INF">33726489</us-gaap:SharesOutstanding>
    <us-gaap:SharesOutstanding contextRef="AsOf2019-03-31_us-gaap_PreferredStockMember" unitRef="Shares" xsi:nil="true" />
    <us-gaap:SharesOutstanding contextRef="AsOf2018-03-31_us-gaap_PreferredStockMember" unitRef="Shares" xsi:nil="true" />
    <us-gaap:SharesOutstanding contextRef="AsOf2019-03-31_us-gaap_CommonStockMember" unitRef="Shares" decimals="INF">33726489</us-gaap:SharesOutstanding>
    <us-gaap:SharesOutstanding contextRef="AsOf2018-03-31_us-gaap_CommonStockMember" unitRef="Shares" decimals="INF">31985827</us-gaap:SharesOutstanding>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition contextRef="From2017-01-01to2017-12-31" unitRef="USD" decimals="0">267835</us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition contextRef="From2017-01-01to2017-12-31_us-gaap_PreferredStockMember" unitRef="USD" xsi:nil="true" />
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition contextRef="From2018-01-01to2018-12-31_us-gaap_PreferredStockMember" unitRef="USD" xsi:nil="true" />
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition contextRef="From2017-01-01to2017-12-31_us-gaap_CommonStockMember" unitRef="USD" xsi:nil="true" />
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition contextRef="From2018-01-01to2018-12-31_us-gaap_CommonStockMember" unitRef="USD" xsi:nil="true" />
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition contextRef="From2017-01-01to2017-12-31_us-gaap_AdditionalPaidInCapitalMember" unitRef="USD" decimals="0">267835</us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition contextRef="From2018-01-01to2018-12-31_us-gaap_AdditionalPaidInCapitalMember" unitRef="USD" decimals="0">169828</us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition contextRef="From2017-01-01to2017-12-31_us-gaap_RetainedEarningsMember" unitRef="USD" xsi:nil="true" />
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition contextRef="From2018-01-01to2018-12-31_us-gaap_RetainedEarningsMember" unitRef="USD" xsi:nil="true" />
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition contextRef="From2019-04-01to2019-06-30" unitRef="USD" decimals="0">64011</us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition contextRef="From2018-04-01to2018-06-30" unitRef="USD" decimals="0">50616</us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition contextRef="From2019-01-01to2019-03-31_us-gaap_PreferredStockMember" unitRef="USD" xsi:nil="true" />
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition contextRef="From2018-01-01to2018-03-31_us-gaap_PreferredStockMember" unitRef="USD" xsi:nil="true" />
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition contextRef="From2019-01-01to2019-03-31_us-gaap_CommonStockMember" unitRef="USD" xsi:nil="true" />
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition contextRef="From2018-01-01to2018-03-31_us-gaap_CommonStockMember" unitRef="USD" xsi:nil="true" />
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition contextRef="From2019-01-01to2019-03-31_us-gaap_AdditionalPaidInCapitalMember" unitRef="USD" decimals="0">35979</us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition contextRef="From2018-01-01to2018-03-31_us-gaap_AdditionalPaidInCapitalMember" unitRef="USD" decimals="0">37456</us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition contextRef="From2019-01-01to2019-03-31_us-gaap_RetainedEarningsMember" unitRef="USD" xsi:nil="true" />
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition contextRef="From2018-01-01to2018-03-31_us-gaap_RetainedEarningsMember" unitRef="USD" xsi:nil="true" />
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition contextRef="From2019-01-01to2019-03-31" unitRef="USD" decimals="0">35979</us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition contextRef="From2018-01-01to2018-03-31" unitRef="USD" decimals="0">37456</us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition contextRef="From2019-04-01to2019-06-30_us-gaap_PreferredStockMember" unitRef="USD" xsi:nil="true" />
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition contextRef="From2019-04-01to2019-06-30_us-gaap_CommonStockMember" unitRef="USD" xsi:nil="true" />
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition contextRef="From2019-04-01to2019-06-30_us-gaap_AdditionalPaidInCapitalMember" unitRef="USD" decimals="0">64011</us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition contextRef="From2019-04-01to2019-06-30_us-gaap_RetainedEarningsMember" unitRef="USD" xsi:nil="true" />
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition contextRef="From2018-04-01to2018-06-30_us-gaap_PreferredStockMember" unitRef="USD" xsi:nil="true" />
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition contextRef="From2018-04-01to2018-06-30_us-gaap_CommonStockMember" unitRef="USD" xsi:nil="true" />
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition contextRef="From2018-04-01to2018-06-30_us-gaap_AdditionalPaidInCapitalMember" unitRef="USD" decimals="0">50616</us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition contextRef="From2018-04-01to2018-06-30_us-gaap_RetainedEarningsMember" unitRef="USD" xsi:nil="true" />
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition contextRef="From2018-01-01to2018-12-31" unitRef="USD" decimals="0">169828</us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition>
    <us-gaap:PropertyPlantAndEquipmentNet contextRef="AsOf2018-12-31" unitRef="USD" decimals="0">15006</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet contextRef="AsOf2019-06-30" unitRef="USD" decimals="0">12506</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet contextRef="AsOf2017-12-31" unitRef="USD" xsi:nil="true" />
    <us-gaap:AssetsCurrent contextRef="AsOf2018-12-31" unitRef="USD" decimals="0">1466077</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent contextRef="AsOf2019-06-30" unitRef="USD" decimals="0">1952270</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent contextRef="AsOf2017-12-31" unitRef="USD" decimals="0">607476</us-gaap:AssetsCurrent>
    <us-gaap:PrepaidExpenseCurrent contextRef="AsOf2018-12-31" unitRef="USD" decimals="0">82927</us-gaap:PrepaidExpenseCurrent>
    <us-gaap:PrepaidExpenseCurrent contextRef="AsOf2019-06-30" unitRef="USD" decimals="0">151941</us-gaap:PrepaidExpenseCurrent>
    <us-gaap:PrepaidExpenseCurrent contextRef="AsOf2017-12-31" unitRef="USD" decimals="0">102095</us-gaap:PrepaidExpenseCurrent>
    <us-gaap:InventoryNet contextRef="AsOf2018-12-31" unitRef="USD" decimals="0">79966</us-gaap:InventoryNet>
    <us-gaap:InventoryNet contextRef="AsOf2019-06-30" unitRef="USD" decimals="0">546816</us-gaap:InventoryNet>
    <us-gaap:InventoryNet contextRef="AsOf2017-12-31" unitRef="USD" xsi:nil="true" />
    <us-gaap:AccountsReceivableNetCurrent contextRef="AsOf2018-12-31" unitRef="USD" decimals="0">433627</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:AccountsReceivableNetCurrent contextRef="AsOf2019-06-30" unitRef="USD" decimals="0">713479</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:AccountsReceivableNetCurrent contextRef="AsOf2017-12-31" unitRef="USD" decimals="0">319467</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:Assets contextRef="AsOf2018-12-31" unitRef="USD" decimals="0">2227587</us-gaap:Assets>
    <us-gaap:Assets contextRef="AsOf2019-06-30" unitRef="USD" decimals="0">3678065</us-gaap:Assets>
    <us-gaap:Assets contextRef="AsOf2019-06-30_custom_TrxadeIncMember" unitRef="USD" decimals="0">1401724</us-gaap:Assets>
    <us-gaap:Assets contextRef="AsOf2019-06-30_custom_CommunitySpecialtyPharmacyLLCMember" unitRef="USD" decimals="0">224863</us-gaap:Assets>
    <us-gaap:Assets contextRef="AsOf2019-06-30_custom_OtherMember" unitRef="USD" decimals="0">2051478</us-gaap:Assets>
    <us-gaap:Assets contextRef="AsOf2017-12-31" unitRef="USD" decimals="0">617476</us-gaap:Assets>
    <us-gaap:Assets contextRef="AsOf2018-12-31_custom_TrxadeIncMember500716984" unitRef="USD" decimals="0">822412</us-gaap:Assets>
    <us-gaap:Assets contextRef="AsOf2018-12-31_custom_CommunitySpecialtyPharmacyLLCMember500745734" unitRef="USD" decimals="0">112123</us-gaap:Assets>
    <us-gaap:Assets contextRef="AsOf2018-12-31_custom_OtherMember" unitRef="USD" decimals="0">1293052</us-gaap:Assets>
    <us-gaap:Goodwill contextRef="AsOf2018-12-31" unitRef="USD" decimals="0">725973</us-gaap:Goodwill>
    <us-gaap:Goodwill contextRef="AsOf2019-06-30" unitRef="USD" decimals="0">725973</us-gaap:Goodwill>
    <us-gaap:Goodwill contextRef="AsOf2018-10-15_custom_CommunitySpecialtyPharmacyLLCMember_us-gaap_SubsequentEventMember" unitRef="USD" decimals="0">725973</us-gaap:Goodwill>
    <us-gaap:Goodwill contextRef="AsOf2017-12-31" unitRef="USD" xsi:nil="true" />
    <us-gaap:DepositsAssetsNoncurrent contextRef="AsOf2018-12-31" unitRef="USD" decimals="0">20531</us-gaap:DepositsAssetsNoncurrent>
    <us-gaap:DepositsAssetsNoncurrent contextRef="AsOf2019-06-30" unitRef="USD" decimals="0">21636</us-gaap:DepositsAssetsNoncurrent>
    <us-gaap:DepositsAssetsNoncurrent contextRef="AsOf2017-12-31" unitRef="USD" decimals="0">10000</us-gaap:DepositsAssetsNoncurrent>
    <us-gaap:LiabilitiesCurrent contextRef="AsOf2018-12-31" unitRef="USD" decimals="0">860367</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent contextRef="AsOf2019-06-30" unitRef="USD" decimals="0">1085163</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent contextRef="AsOf2017-12-31" unitRef="USD" decimals="0">525357</us-gaap:LiabilitiesCurrent>
    <us-gaap:ConvertibleNotesPayableCurrent contextRef="AsOf2018-12-31" unitRef="USD" decimals="0">181500</us-gaap:ConvertibleNotesPayableCurrent>
    <us-gaap:ConvertibleNotesPayableCurrent contextRef="AsOf2019-06-30" unitRef="USD" xsi:nil="true" />
    <us-gaap:ConvertibleNotesPayableCurrent contextRef="AsOf2017-12-31_custom_RelatedPartyConvertiblePromissoryNoteMember" unitRef="USD" decimals="0">251725</us-gaap:ConvertibleNotesPayableCurrent>
    <us-gaap:ConvertibleNotesPayableCurrent contextRef="AsOf2018-12-31_custom_ShortTermRelatedPartyConvertibleNotesMember" unitRef="USD" decimals="0">140000</us-gaap:ConvertibleNotesPayableCurrent>
    <us-gaap:ConvertibleNotesPayableCurrent contextRef="AsOf2019-06-30_custom_ConvertiblePromissoryNoteMember" unitRef="USD" decimals="0">0</us-gaap:ConvertibleNotesPayableCurrent>
    <us-gaap:ConvertibleNotesPayableCurrent contextRef="AsOf2016-12-31_custom_PromissoryNoteTwoMember" unitRef="USD" decimals="0">139602</us-gaap:ConvertibleNotesPayableCurrent>
    <us-gaap:ConvertibleNotesPayableCurrent contextRef="AsOf2017-12-31_custom_ShortTermPromissoryNotesMember" unitRef="USD" decimals="0">10739</us-gaap:ConvertibleNotesPayableCurrent>
    <us-gaap:ConvertibleNotesPayableCurrent contextRef="AsOf2018-12-31_custom_ShortTermPromissoryNotesMember" unitRef="USD" decimals="0">0</us-gaap:ConvertibleNotesPayableCurrent>
    <us-gaap:ConvertibleNotesPayableCurrent contextRef="AsOf2017-12-31" unitRef="USD" xsi:nil="true" />
    <us-gaap:ConvertibleNotesPayableCurrent contextRef="AsOf2018-12-31_custom_ConvertiblePromissoryNoteMember" unitRef="USD" decimals="0">181500</us-gaap:ConvertibleNotesPayableCurrent>
    <us-gaap:ConvertibleNotesPayableCurrent contextRef="AsOf2017-12-31_custom_ConvertiblePromissoryNoteMember" unitRef="USD" decimals="0">0</us-gaap:ConvertibleNotesPayableCurrent>
    <us-gaap:AccruedLiabilitiesCurrent contextRef="AsOf2018-12-31" unitRef="USD" decimals="0">138323</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent contextRef="AsOf2019-06-30" unitRef="USD" decimals="0">101188</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent contextRef="AsOf2017-12-31" unitRef="USD" decimals="0">156961</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:AccountsPayableCurrent contextRef="AsOf2018-12-31" unitRef="USD" decimals="0">400544</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccountsPayableCurrent contextRef="AsOf2019-06-30" unitRef="USD" decimals="0">763143</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccountsPayableCurrent contextRef="AsOf2017-12-31" unitRef="USD" decimals="0">106084</us-gaap:AccountsPayableCurrent>
    <us-gaap:Liabilities contextRef="AsOf2018-12-31" unitRef="USD" decimals="0">1382919</us-gaap:Liabilities>
    <us-gaap:Liabilities contextRef="AsOf2019-06-30" unitRef="USD" decimals="0">2338048</us-gaap:Liabilities>
    <us-gaap:Liabilities contextRef="AsOf2017-12-31" unitRef="USD" decimals="0">929409</us-gaap:Liabilities>
    <us-gaap:LiabilitiesAndStockholdersEquity contextRef="AsOf2018-12-31" unitRef="USD" decimals="0">2227587</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity contextRef="AsOf2019-06-30" unitRef="USD" decimals="0">3678065</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity contextRef="AsOf2017-12-31" unitRef="USD" decimals="0">617476</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:RetainedEarningsAccumulatedDeficit contextRef="AsOf2018-12-31" unitRef="USD" decimals="0">-8111075</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit contextRef="AsOf2019-06-30" unitRef="USD" decimals="0">-7927865</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit contextRef="AsOf2017-12-31" unitRef="USD" decimals="0">-8120113</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:AdditionalPaidInCapital contextRef="AsOf2018-12-31" unitRef="USD" decimals="0">8955411</us-gaap:AdditionalPaidInCapital>
    <us-gaap:AdditionalPaidInCapital contextRef="AsOf2019-06-30" unitRef="USD" decimals="0">9267545</us-gaap:AdditionalPaidInCapital>
    <us-gaap:AdditionalPaidInCapital contextRef="AsOf2017-12-31" unitRef="USD" decimals="0">7807860</us-gaap:AdditionalPaidInCapital>
    <us-gaap:CommonStockValue contextRef="AsOf2018-12-31" unitRef="USD" decimals="0">332</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue contextRef="AsOf2019-06-30" unitRef="USD" decimals="0">337</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue contextRef="AsOf2017-12-31" unitRef="USD" decimals="0">320</us-gaap:CommonStockValue>
    <us-gaap:PreferredStockValue contextRef="AsOf2018-12-31" unitRef="USD" xsi:nil="true" />
    <us-gaap:PreferredStockValue contextRef="AsOf2019-06-30" unitRef="USD" xsi:nil="true" />
    <us-gaap:PreferredStockValue contextRef="AsOf2017-12-31" unitRef="USD" xsi:nil="true" />
    <us-gaap:EarningsPerShareDiluted contextRef="From2019-01-01to2019-06-30" unitRef="USDPShares" decimals="INF">0.01</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted contextRef="From2017-01-01to2017-12-31" unitRef="USDPShares" decimals="INF">0.01</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted contextRef="From2018-01-01to2018-06-30" unitRef="USDPShares" decimals="INF">0.00</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted contextRef="From2019-04-01to2019-06-30" unitRef="USDPShares" decimals="INF">0.00</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted contextRef="From2018-04-01to2018-06-30" unitRef="USDPShares" decimals="INF">0.00</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted contextRef="From2018-01-01to2018-12-31" unitRef="USDPShares" decimals="INF">0.00</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic contextRef="From2019-01-01to2019-06-30" unitRef="USDPShares" decimals="INF">0.01</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic contextRef="From2017-01-01to2017-12-31" unitRef="USDPShares" decimals="INF">0.01</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic contextRef="From2018-01-01to2018-06-30" unitRef="USDPShares" decimals="INF">0.00</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic contextRef="From2019-04-01to2019-06-30" unitRef="USDPShares" decimals="INF">0.00</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic contextRef="From2018-04-01to2018-06-30" unitRef="USDPShares" decimals="INF">0.00</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic contextRef="From2018-01-01to2018-12-31" unitRef="USDPShares" decimals="INF">0.00</us-gaap:EarningsPerShareBasic>
    <us-gaap:InterestExpense contextRef="From2019-01-01to2019-06-30" unitRef="USD" decimals="0">33432</us-gaap:InterestExpense>
    <us-gaap:InterestExpense contextRef="From2017-01-01to2017-12-31" unitRef="USD" decimals="0">157056</us-gaap:InterestExpense>
    <us-gaap:InterestExpense contextRef="From2018-01-01to2018-06-30" unitRef="USD" decimals="0">27392</us-gaap:InterestExpense>
    <us-gaap:InterestExpense contextRef="From2019-04-01to2019-06-30" unitRef="USD" decimals="0">15874</us-gaap:InterestExpense>
    <us-gaap:InterestExpense contextRef="From2018-04-01to2018-06-30" unitRef="USD" decimals="0">10933</us-gaap:InterestExpense>
    <us-gaap:InterestExpense contextRef="From2018-01-01to2018-12-31" unitRef="USD" decimals="0">57541</us-gaap:InterestExpense>
    <us-gaap:OperatingIncomeLoss contextRef="From2019-01-01to2019-06-30" unitRef="USD" decimals="0">304464</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss contextRef="From2017-01-01to2017-12-31" unitRef="USD" decimals="0">395095</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss contextRef="From2018-01-01to2018-06-30" unitRef="USD" decimals="0">130174</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss contextRef="From2019-04-01to2019-06-30" unitRef="USD" decimals="0">132705</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss contextRef="From2018-04-01to2018-06-30" unitRef="USD" decimals="0">31446</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss contextRef="From2018-01-01to2018-12-31" unitRef="USD" decimals="0">-87616</us-gaap:OperatingIncomeLoss>
    <us-gaap:GeneralAndAdministrativeExpense contextRef="From2019-01-01to2019-06-30" unitRef="USD" decimals="0">2005494</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense contextRef="From2017-01-01to2017-12-31" unitRef="USD" decimals="0">2536185</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense contextRef="From2018-01-01to2018-06-30" unitRef="USD" decimals="0">1560437</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense contextRef="From2019-04-01to2019-06-30" unitRef="USD" decimals="0">1030571</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense contextRef="From2018-04-01to2018-06-30" unitRef="USD" decimals="0">806242</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense contextRef="From2018-01-01to2018-12-31" unitRef="USD" decimals="0">3470345</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GrossProfit contextRef="From2019-01-01to2019-06-30" unitRef="USD" decimals="0">2309958</us-gaap:GrossProfit>
    <us-gaap:GrossProfit contextRef="From2017-01-01to2017-12-31" unitRef="USD" decimals="0">2931280</us-gaap:GrossProfit>
    <us-gaap:GrossProfit contextRef="From2018-01-01to2018-06-30" unitRef="USD" decimals="0">1690611</us-gaap:GrossProfit>
    <us-gaap:GrossProfit contextRef="From2019-04-01to2019-06-30" unitRef="USD" decimals="0">1163276</us-gaap:GrossProfit>
    <us-gaap:GrossProfit contextRef="From2018-04-01to2018-06-30" unitRef="USD" decimals="0">837688</us-gaap:GrossProfit>
    <us-gaap:GrossProfit contextRef="From2018-01-01to2018-12-31" unitRef="USD" decimals="0">3382729</us-gaap:GrossProfit>
    <us-gaap:GrossProfit contextRef="From2018-01-01to2018-12-31_custom_TrxadeIncMember500701218" unitRef="USD" decimals="0">3407822</us-gaap:GrossProfit>
    <us-gaap:GrossProfit contextRef="From2018-01-01to2018-12-31_custom_CommunitySpecialtyPharmacyLLCMember500738546" unitRef="USD" decimals="0">-34971</us-gaap:GrossProfit>
    <us-gaap:GrossProfit contextRef="From2018-01-01to2018-12-31_custom_OtherMember" unitRef="USD" decimals="0">9878</us-gaap:GrossProfit>
    <us-gaap:CostOfGoodsAndServicesSold contextRef="From2019-01-01to2019-06-30" unitRef="USD" decimals="0">1118977</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold contextRef="From2017-01-01to2017-12-31" unitRef="USD" xsi:nil="true" />
    <us-gaap:CostOfGoodsAndServicesSold contextRef="From2018-01-01to2018-06-30" unitRef="USD" xsi:nil="true" />
    <us-gaap:CostOfGoodsAndServicesSold contextRef="From2019-04-01to2019-06-30" unitRef="USD" decimals="0">753138</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold contextRef="From2018-04-01to2018-06-30" unitRef="USD" xsi:nil="true" />
    <us-gaap:CostOfGoodsAndServicesSold contextRef="From2018-01-01to2018-12-31" unitRef="USD" decimals="0">449049</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities contextRef="From2019-01-01to2019-06-30" unitRef="USD" decimals="0">-79689</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities contextRef="From2017-01-01to2017-12-31" unitRef="USD" decimals="0">171670</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities contextRef="From2018-01-01to2018-06-30" unitRef="USD" decimals="0">146456</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities contextRef="From2018-01-01to2018-12-31" unitRef="USD" decimals="0">273386</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:IncreaseDecreaseInAccountsPayable contextRef="From2019-01-01to2019-06-30" unitRef="USD" decimals="0">362599</us-gaap:IncreaseDecreaseInAccountsPayable>
    <us-gaap:IncreaseDecreaseInAccountsPayable contextRef="From2017-01-01to2017-12-31" unitRef="USD" decimals="0">-98213</us-gaap:IncreaseDecreaseInAccountsPayable>
    <us-gaap:IncreaseDecreaseInAccountsPayable contextRef="From2018-01-01to2018-06-30" unitRef="USD" decimals="0">22671</us-gaap:IncreaseDecreaseInAccountsPayable>
    <us-gaap:IncreaseDecreaseInAccountsPayable contextRef="From2018-01-01to2018-12-31" unitRef="USD" decimals="0">95149</us-gaap:IncreaseDecreaseInAccountsPayable>
    <us-gaap:IncreaseDecreaseInInventories contextRef="From2019-01-01to2019-06-30" unitRef="USD" decimals="0">466850</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInInventories contextRef="From2017-01-01to2017-12-31" unitRef="USD" xsi:nil="true" />
    <us-gaap:IncreaseDecreaseInInventories contextRef="From2018-01-01to2018-06-30" unitRef="USD" xsi:nil="true" />
    <us-gaap:IncreaseDecreaseInInventories contextRef="From2018-01-01to2018-12-31" unitRef="USD" decimals="0">3810</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets contextRef="From2019-01-01to2019-06-30" unitRef="USD" decimals="0">70119</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets contextRef="From2017-01-01to2017-12-31" unitRef="USD" decimals="0">90763</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets contextRef="From2018-01-01to2018-06-30" unitRef="USD" decimals="0">64831</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets contextRef="From2018-01-01to2018-12-31" unitRef="USD" decimals="0">-13637</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
    <us-gaap:IncreaseDecreaseInAccountsReceivable contextRef="From2019-01-01to2019-06-30" unitRef="USD" decimals="0">279852</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInAccountsReceivable contextRef="From2017-01-01to2017-12-31" unitRef="USD" decimals="0">20354</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInAccountsReceivable contextRef="From2018-01-01to2018-06-30" unitRef="USD" decimals="0">5875</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInAccountsReceivable contextRef="From2018-01-01to2018-12-31" unitRef="USD" decimals="0">1532</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities contextRef="From2019-01-01to2019-06-30" unitRef="USD" decimals="0">-250000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities contextRef="From2017-01-01to2017-12-31" unitRef="USD" xsi:nil="true" />
    <us-gaap:NetCashProvidedByUsedInInvestingActivities contextRef="From2018-01-01to2018-06-30" unitRef="USD" xsi:nil="true" />
    <us-gaap:NetCashProvidedByUsedInInvestingActivities contextRef="From2018-01-01to2018-12-31" unitRef="USD" decimals="0">-265279</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:PaymentsForProceedsFromInvestments contextRef="From2017-01-01to2017-12-31" unitRef="USD" xsi:nil="true" />
    <us-gaap:PaymentsForProceedsFromInvestments contextRef="From2019-01-01to2019-01-31_custom_AlliancePharmaSolutionLLCMember" unitRef="USD" decimals="0">-210000</us-gaap:PaymentsForProceedsFromInvestments>
    <us-gaap:PaymentsForProceedsFromInvestments contextRef="From2019-04-01to2019-04-30_custom_AlliancePharmaSolutionLLCMember" unitRef="USD" decimals="0">-40000</us-gaap:PaymentsForProceedsFromInvestments>
    <us-gaap:PaymentsForProceedsFromInvestments contextRef="From2018-01-01to2018-12-31" unitRef="USD" decimals="0">250273</us-gaap:PaymentsForProceedsFromInvestments>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities contextRef="From2019-01-01to2019-06-30" unitRef="USD" decimals="0">166</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities contextRef="From2017-01-01to2017-12-31" unitRef="USD" decimals="0">-2435</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities contextRef="From2018-01-01to2018-06-30" unitRef="USD" decimals="0">-122464</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities contextRef="From2018-01-01to2018-12-31" unitRef="USD" decimals="0">677536</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:ProceedsFromWarrantExercises contextRef="From2019-01-01to2019-06-30" unitRef="USD" decimals="0">166</us-gaap:ProceedsFromWarrantExercises>
    <us-gaap:ProceedsFromWarrantExercises contextRef="From2017-01-01to2017-12-31" unitRef="USD" decimals="0">250</us-gaap:ProceedsFromWarrantExercises>
    <us-gaap:ProceedsFromWarrantExercises contextRef="From2018-01-01to2018-06-30" unitRef="USD" xsi:nil="true" />
    <us-gaap:ProceedsFromWarrantExercises contextRef="From2018-01-01to2018-12-31" unitRef="USD" xsi:nil="true" />
    <us-gaap:IncomeTaxesPaidNet contextRef="From2019-01-01to2019-06-30" unitRef="USD" xsi:nil="true" />
    <us-gaap:IncomeTaxesPaidNet contextRef="From2017-01-01to2017-12-31" unitRef="USD" xsi:nil="true" />
    <us-gaap:IncomeTaxesPaidNet contextRef="From2018-01-01to2018-06-30" unitRef="USD" xsi:nil="true" />
    <us-gaap:IncomeTaxesPaidNet contextRef="From2018-01-01to2018-12-31" unitRef="USD" xsi:nil="true" />
    <us-gaap:InterestPaidNet contextRef="From2019-01-01to2019-06-30" unitRef="USD" decimals="0">2997</us-gaap:InterestPaidNet>
    <us-gaap:InterestPaidNet contextRef="From2017-01-01to2017-12-31" unitRef="USD" decimals="0">71210</us-gaap:InterestPaidNet>
    <us-gaap:InterestPaidNet contextRef="From2018-01-01to2018-06-30" unitRef="USD" decimals="0">27392</us-gaap:InterestPaidNet>
    <us-gaap:InterestPaidNet contextRef="From2018-01-01to2018-12-31" unitRef="USD" decimals="0">36970</us-gaap:InterestPaidNet>
    <us-gaap:LongTermDebtTextBlock contextRef="From2019-01-01to2019-06-30">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;NOTE&#13;3 &amp;#8211; LONG TERM DEBT &amp;#8211; RELATED PARTIES&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&amp;#160;&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;In&#13;October 2018 in connection with the acquisition of Community Specialty Pharmacy, LLC a $300,000 promissory note was issued to&#13;Nikul Panchal, accruing interest at simple interest of 10%, interest payable annually, and principal payable at maturity in October&#13;2021.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&amp;#160;&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;As&#13;of June 30, 2019, $122,552 and $100,000 in promissory notes was due to Mr. Prashant Patel and Mr. Suren Ajjarapu, respectively.&#13;The notes are due July 1, 2020 and each bear an interest rate of 6%.&lt;/font&gt;&lt;/p&gt;</us-gaap:LongTermDebtTextBlock>
    <us-gaap:LongTermDebtTextBlock contextRef="From2018-01-01to2018-12-31">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;NOTE&#13;4 &amp;#8211; LONG TERM DEBT&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&amp;#160;&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;In&#13;2017, there are $181,500 in convertible promissory notes due in May 2019 as described in Note 3.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Related&#13;Party Promissory Notes&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&amp;#160;&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;In&#13;June 2017, the Company satisfied an outstanding promissory note, dated May 8, 2016, as amended, in the principal amount of $250,000&#13;(the &amp;#8220;NPR Note&amp;#8221;), made by between the Company and NPR INVESTMENT GROUP, LLC (the &amp;#8220;Lender&amp;#8221;). The NPR Note&#13;included a personal guarantee from Suren Ajjarapu and Prashant Patel, who both serve on the Board of Directors of the Company&#13;and are controlling stockholders of the Company. Further, Mr. Ajjarapu is the CEO and President of the Company and Mr. Patel is&#13;Vice Chairman and Executive Director of Strategy.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;In&#13;connection with the foregoing satisfaction of the NPR Note above, the Company received funds in June 2017 and entered into a promissory&#13;note agreement on July 1, 2017, whereby the Company borrowed $100,000 and $80,000 from Sansur Associates, LLC, a limited liability&#13;company controlled by Mr. Ajjarapu, and Mr. Patel, respectively (the &amp;#8220;Promissory Notes&amp;#8221;). The term of each of these&#13;N&lt;font style="background-color: white"&gt;otes is three years and they each bear interest at 6%, which is payable annually.&lt;/font&gt;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif; background-color: white"&gt;The&#13;note due to Mr. Patel is $&lt;/font&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;122,552. It comprises&#13;$80,000 for the NPR note, $17,280 for an existing promissory note and $25,272 assumption of credit card obligation related to&#13;business expenses of the Company.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;In&#13;October 2018 in connection with the acquisition of Community Specialty Pharmacy, LLC a $300,000 promissory note was issued to&#13;Nikul Panchal, accruing interest a simple interest of 10%, interest payable annually, and principal payable at maturity on October&#13;15, 2021.&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="margin: 0; font: 10pt Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;At&#13;December 31, 2018 and 2017, total related party long term debt was $522,552 and $222,552, respectively.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Future&#13;maturities of long-term debt in the next five years are as follows:&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;table cellpadding="0" cellspacing="0" align="center" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255); font-family: Times New Roman, Times, Serif"&gt;&#13;    &lt;td style="text-align: left; width: 72%; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Due&#13;    in 2020&lt;/font&gt;&lt;/td&gt;&lt;td style="width: 2%; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left; width: 1%; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right; width: 24%; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;222,552&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: left; width: 1%; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White; font-family: Times New Roman, Times, Serif"&gt;&#13;    &lt;td style="text-align: left; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Due&#13;    in 2021&lt;/font&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;300,000&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: left; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255); font-family: Times New Roman, Times, Serif"&gt;&#13;    &lt;td style="text-align: left; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Due&#13;    in 2022&lt;/font&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: left; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White; font-family: Times New Roman, Times, Serif"&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Due&#13;    in 2023&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255); font-family: Times New Roman, Times, Serif"&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 2.5pt; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Total&#13;    Debt&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; text-align: left; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font-size: 10pt"&gt;522&lt;/font&gt;&lt;/font&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font-size: 10pt"&gt;,052&lt;/font&gt;&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:LongTermDebtTextBlock>
    <us-gaap:StockholdersEquityNoteDisclosureTextBlock contextRef="From2019-01-01to2019-06-30">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;NOTE&#13;4 &amp;#8211; SHAREHOLDERS&amp;#8217; EQUITY&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;In&#13;February 2019, convertible promissory notes issued in 2015 for $181,500 were amended to a conversion price of $0.50 and the principal&#13;and accrued interest total of $211,983 were then converted to 423,966 common shares.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;In&#13;February 2019, 16,666 of warrants issued in 2014 at $0.01 per share were exercised for 16,666 of common shares. $166 was received&#13;in cash.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;In&#13;April and May 2019, 505,000 options were granted with exercise prices ranging from $0.41 to $0.44 and a term of 10 years from&#13;the grant date. The options vest over a period ranging from four to five years.&lt;/font&gt;&lt;/p&gt;</us-gaap:StockholdersEquityNoteDisclosureTextBlock>
    <us-gaap:StockholdersEquityNoteDisclosureTextBlock contextRef="From2018-01-01to2018-12-31">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;NOTE 5 &amp;#8211; STOCKHOLDERS&amp;#8217; EQUITY&lt;/b&gt;&lt;/p&gt;&#13;&#13;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;2017&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&amp;#160;&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;In&#13;January 2017, under a Private Offer Memorandum, 250,000 shares of Common Stock were issued for $250,000 cash. The Common Stock&#13;was sold at $1.00 per share. In connection with this Common Stock offering, warrants to purchase 87,500 shares of Common Stock&#13;were issued with a strike price of $0.01 and an expiration date of five years.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&amp;#160;&lt;font style="font: normal 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;In&#13;February 2017, 25,000 shares were issued when warrants were exercised at $0.01 grant price for $250.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;In&#13;March 2017, 50,000 shares were issued for services performed for the Company and valued at fair value of $12,500.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;2018&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&amp;#160;&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;In&#13;July 2018, under a Private Offer Memorandum, 300,000 shares of Common Stock were issued for $300,000 cash. The Common Stock was&#13;sold at $1.00 per share. In connection with this Common Stock offering, warrants to purchase 161,538 shares of Common Stock were&#13;issued with a strike price of $0.01 and an expiration date of five years.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="margin: 0; text-align: justify; font: 10pt Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;In&#13;November 2018, under a Private Offer Memorandum, 1,000,000 shares of Common Stock were issued for $500,000 cash. The Common Stock&#13;was sold at $0.50 per share.&lt;/font&gt;&lt;/p&gt;</us-gaap:StockholdersEquityNoteDisclosureTextBlock>
    <TRXD:WarrantsTextBlock contextRef="From2019-01-01to2019-06-30">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;NOTE&#13;5 - WARRANTS&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;For&#13;the six-month period ended June 30, 2019, 16,666 warrants were exercised, See NOTE 4 &amp;#8211; SHAREHOLDERS&amp;#8217; EQUITY, none&#13;were granted or forfeited.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;The&#13;Company&amp;#8217;s outstanding and exercisable warrants as of June 30, 2019 are presented below:&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="text-align: justify"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Number&lt;/b&gt;&lt;/font&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Outstanding&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Weighted&lt;/b&gt;&lt;/font&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Average&lt;/b&gt;&lt;/font&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Exercise Price&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Contractual Life&lt;/b&gt;&lt;/font&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;in Years&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;Intrinsic Value&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="width: 44%; text-align: justify"&gt;Warrants Outstanding as of December 31, 2018&lt;/td&gt;&lt;td style="width: 2%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 10%; text-align: right"&gt;2,880,141&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 10%; text-align: right"&gt;0.08&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 10%; text-align: right"&gt;3.74&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 10%; text-align: right"&gt;782,385&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="text-align: justify"&gt;Warrants granted&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="text-align: justify"&gt;Warrants forfeited&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="text-align: justify"&gt;Warrants exercised&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(16,666&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;0.01&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="text-align: justify"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="text-align: justify"&gt;Warrants Outstanding as of June 30, 2019&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;2,863,475&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;0.08&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;3.08&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;1,448,356&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</TRXD:WarrantsTextBlock>
    <TRXD:WarrantsTextBlock contextRef="From2018-01-01to2018-12-31">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;NOTE&#13;6 - WARRANTS&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;In&#13;2017, 87,500 warrants were issued related to common shares sold for cash (See Note 5). Likewise, 28,150 were issued&#13;for renewal of convertible debt (see Note 3) and 25,000 warrants were exercised. No warrants were forfeited in 2017.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;In&#13;2018, 161,538 warrants were issued related to common shares sold for cash (see Note 5), 10,000 were issued for renewal&#13;of convertible debt (see Note 3), 405,507 were issued related to the acquisition of Community Specialty Pharmacy, LLC,&#13;none were exercised and 435,000 were forfeited.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;The&#13;following table summarizes the assumptions used to estimate the fair value of warrants granted during the years ended December&#13;31, 2018 and 2017:&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;table cellpadding="0" cellspacing="0" align="center" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"&gt;&#13;&lt;tr style="vertical-align: bottom; font-family: Times New Roman, Times, Serif"&gt;&#13;    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;2018&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;2017&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255); font-family: Times New Roman, Times, Serif"&gt;&#13;    &lt;td style="width: 60%; text-align: left; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Expected&#13;    dividend yield&lt;/font&gt;&lt;/td&gt;&lt;td style="width: 2%; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%; text-align: left; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="width: 16%; text-align: right; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;0&lt;/font&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;%&lt;/font&gt;&lt;/td&gt;&lt;td style="width: 2%; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%; text-align: left; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="width: 16%; text-align: right; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;0&lt;/font&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;%&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White; font-family: Times New Roman, Times, Serif"&gt;&#13;    &lt;td style="text-align: left; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Weighted-average&#13;    expected volatility&lt;/font&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;231-632&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: left; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;%&lt;/font&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;200&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: left; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;%&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255); font-family: Times New Roman, Times, Serif"&gt;&#13;    &lt;td style="text-align: left; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Weighted-average&#13;    risk-free interest rate&lt;/font&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;2.55-2.75&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: left; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;%&lt;/font&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;1.81-1.84&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: left; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;%&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White; font-family: Times New Roman, Times, Serif"&gt;&#13;    &lt;td style="text-align: left; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Expected&#13;    life of warrants&lt;/font&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;5-8&#13;                                         years&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: left; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;5&#13;                                         years&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: left; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;The&#13;Company&amp;#8217;s outstanding and exercisable warrants as of December 31, 2018 and 2017 are presented below:&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"&gt;&#13;&lt;tr style="vertical-align: bottom; font-family: Times New Roman, Times, Serif"&gt;&#13;    &lt;td style="text-align: center; padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: center; padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Number&#13;    Outstanding&lt;/font&gt;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: center; padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: center; padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Weighted&#13;    Average Exercise Price&lt;/font&gt;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: center; padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: center; padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Contractual&#13;    Life in Years&lt;/font&gt;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: center; padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: center; padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Intrinsic&#13;    Value&lt;/font&gt;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: center; padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255); font-family: Times New Roman, Times, Serif"&gt;&#13;    &lt;td style="width: 40%; text-align: left; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Warrants&#13;    Outstanding as of December 31, 2016&lt;/font&gt;&lt;/td&gt;&lt;td style="width: 2%; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%; text-align: left; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="width: 11%; text-align: right; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;2,647,446&lt;/font&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="width: 2%; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%; text-align: left; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="width: 11%; text-align: right; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;0.24&lt;/font&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="width: 2%; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%; text-align: left; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="width: 11%; text-align: right; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;4.24&lt;/font&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="width: 2%; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%; text-align: left; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="width: 11%; text-align: right; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;930,751&lt;/font&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White; font-family: Times New Roman, Times, Serif"&gt;&#13;    &lt;td style="text-align: left; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Warrants&#13;    granted&lt;/font&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;115,650&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: left; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;0.18&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: left; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;5.0&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: left; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: left; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255); font-family: Times New Roman, Times, Serif"&gt;&#13;    &lt;td style="text-align: left; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Warrants&#13;    forfeited&lt;/font&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: left; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: left; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: left; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: left; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White; font-family: Times New Roman, Times, Serif"&gt;&#13;    &lt;td style="text-align: left; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Warrants&#13;    exercised&lt;/font&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(25,000&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: left; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;0.01&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: left; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: left; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: left; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255); font-family: Times New Roman, Times, Serif"&gt;&#13;    &lt;td style="text-align: left; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: left; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: left; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: left; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: left; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White; font-family: Times New Roman, Times, Serif"&gt;&#13;    &lt;td style="text-align: left; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Warrants&#13;    Outstanding as of December 31, 2017&lt;/font&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;2,738,096&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: left; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;0.24&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: left; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;3.28&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: left; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;937,567&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: left; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255); font-family: Times New Roman, Times, Serif"&gt;&#13;    &lt;td style="text-align: left; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Warrants&#13;    granted&lt;/font&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;577,045&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: left; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;0.02&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: left; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;7.11&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: left; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: left; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White; font-family: Times New Roman, Times, Serif"&gt;&#13;    &lt;td style="text-align: left; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Warrants&#13;    forfeited&lt;/font&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(435,000&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: left; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: left; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: left; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: left; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255); font-family: Times New Roman, Times, Serif"&gt;&#13;    &lt;td style="text-align: left; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Warrants&#13;    exercised&lt;/font&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: left; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: left; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: left; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: left; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White; font-family: Times New Roman, Times, Serif"&gt;&#13;    &lt;td style="text-align: left; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: left; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: left; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: left; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: left; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255); font-family: Times New Roman, Times, Serif"&gt;&#13;    &lt;td style="text-align: left; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Warrants&#13;    Outstanding as of December 31, 2018&lt;/font&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;2,880,141&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: left; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;0.08&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: left; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;3.74&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: left; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;782,385&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: left; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</TRXD:WarrantsTextBlock>
    <us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock contextRef="From2019-01-01to2019-06-30">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;NOTE&#13;6 &amp;#8211; OPTIONS&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;The&#13;Company maintains a stock option plan under which certain employees are awarded option grants based on a combination of performance&#13;and tenure. The stock option plan provides for the grant of up to 2,000,000 shares. All options may be exercised for a period&#13;up to four 1/2 years following the grant date, after which they expire. Options are vested up to 5 years from the grant date.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;For&#13;the six-month period ended June 30, 2019, 505,000 options were issued, none were forfeited or expired due to employee resignation.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;The&#13;Company uses the Black-Sholes option pricing model to estimate the fair value of stock-based awards on the date of the grant.&#13;The following table summarizes the assumptions used to estimate the fair value of the stock options granted during the quarter&#13;ended June 30, 2019.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;table cellpadding="0" cellspacing="0" align="center" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="text-align: justify"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid"&gt;2019&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="width: 78%; text-align: justify"&gt;Expected dividend yield&lt;/td&gt;&lt;td style="width: 2%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; text-align: center"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 18%; text-align: center"&gt;0%&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="text-align: justify"&gt;Weighted-average expected volatility&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;209-250%&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="text-align: justify"&gt;Weighted-average risk-free interest rate&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;2.08-2.55%&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="text-align: justify"&gt;Expected life of options&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;5-7 years&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Total&#13;compensation cost related to stock options was $99,990 and $88,072 for the six-months ended June 30, 2019 and 2018 respectively.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;The&#13;following table represents stock option activity for the six-month period ended June 30, 2019:&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Number&lt;/b&gt;&lt;/font&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Outstanding&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Weighted&lt;/b&gt;&lt;/font&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Average&lt;/b&gt;&lt;/font&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Exercise Price&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Contractual Life&lt;/b&gt;&lt;/font&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;in Years&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Intrinsic&lt;/b&gt;&lt;/font&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Value&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="width: 44%"&gt;Options Outstanding as of December 31, 2018&lt;/td&gt;&lt;td style="width: 2%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 10%; text-align: right"&gt;1,732,846&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 10%; text-align: right"&gt;1.19&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 10%; text-align: right"&gt;6.98&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 10%; text-align: right"&gt;-&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td&gt;Options Exercisable as of December 31, 2018&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,107,259&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;0.96&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;5.91&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="text-align: left"&gt;Options granted&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;505,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;0.43&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;9.86&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="text-align: left"&gt;Options forfeited&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="text-align: left"&gt;Options expired&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td&gt;Options Outstanding as of June 30, 2019&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;2,237,846&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;0.73&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;7.27&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;88,350&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td&gt;Options Exercisable as of June 30, 2019&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,239,384&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;0.91&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;5.77&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;8,809&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock>
    <us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock contextRef="From2018-01-01to2018-12-31">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;NOTE&#13;7 - OPTIONS&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;The&#13;Company maintains a stock option plan under which certain employees and management are awarded option grants based on a combination&#13;of performance and tenure. All options may be exercised for a period up to four &amp;#189; years following the grant date, after&#13;which they expire. Options are vested up to 5 years from the grant date. The Board has authorized the use of 2,000,000 shares&#13;for option grants.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;Stock&#13;options were granted during 2018 and 2017 to employees totaling, 560,400 and 263,846 respectively. These options vest over a period&#13;of 4 to 5 years, are granted with an exercise price of between $0.41 and $1.02 per share and have a term of 10 years. The&#13;last options expire April 2028.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Under&#13;the Black-Scholes option price model, fair value of the options granted in 2018 and 2017 were $278,358 and $169,100, respectfully.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;In&#13;April 2017, 253,846 options were granted with an exercise price of $0.65 and a term of 10 years from the grant date. The options&#13;vest over a period of one and four years.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;In&#13;April 2017, four option grants, totaling 650,000 options, were amended to extend the exercise terms to 10 years from the date&#13;of grant. Incremental option expense recognized as a result of the amendment amounted to $69,611.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;In&#13;April 2018, 560,400 options were granted with an exercise price of $0.50 and a term of 10 years from the grant date. The options&#13;vest over a period of four to five years.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;The&#13;Company uses the Black-Scholes option pricing model to estimate the fair value of stock-based awards on the date of grant. The&#13;following table summarizes the assumptions used to estimate the fair value of stock options granted during the years ended December&#13;31, 2018 and 2017:&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;table cellpadding="0" cellspacing="0" align="center" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"&gt;&#13;&lt;tr style="vertical-align: bottom; font-family: Times New Roman, Times, Serif"&gt;&#13;    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;2018&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;2017&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255); font-family: Times New Roman, Times, Serif"&gt;&#13;    &lt;td style="width: 56%; text-align: left; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Expected&#13;    dividend yield&lt;/font&gt;&lt;/td&gt;&lt;td style="width: 2%; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%; text-align: left; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="width: 18%; text-align: right; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;0&lt;/font&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;%&lt;/font&gt;&lt;/td&gt;&lt;td style="width: 2%; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%; text-align: left; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="width: 18%; text-align: right; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;0&lt;/font&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;%&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White; font-family: Times New Roman, Times, Serif"&gt;&#13;    &lt;td style="text-align: left; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Weighted-average&#13;    expected volatility&lt;/font&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;192-265&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: left; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;%&lt;/font&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;200&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: left; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;%&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255); font-family: Times New Roman, Times, Serif"&gt;&#13;    &lt;td style="text-align: left; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Weighted-average&#13;    risk-free interest rate&lt;/font&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;2.08-2.73&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: left; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;%&lt;/font&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;1.92&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: left; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;%&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White; font-family: Times New Roman, Times, Serif"&gt;&#13;    &lt;td style="text-align: left; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Expected&#13;    life of warrants&lt;/font&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;4-5&#13;                                         years&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: left; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;4.74&#13;                                         -7.50 years&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: left; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Total&#13;compensation cost related to stock options was $169,828 and $267,835 for the years ended December 31, 2018 and 2017, respectively.&#13;As of December 31, 2018, there was $192,007 of unrecognized compensation costs related to stock options, which is expected to&#13;be recognized over a weighted average period of 6.98 years. The following table represents stock option activity for the two years&#13;ended December 31, 2018:&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"&gt;&#13;&lt;tr style="vertical-align: bottom; font-family: Times New Roman, Times, Serif"&gt;&#13;    &lt;td style="text-align: center; padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: center; padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Number&#13;    Outstanding&lt;/font&gt;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: center; padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: center; padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Weighted&#13;    Average Exercise Price&lt;/font&gt;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: center; padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: center; padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Contractual&#13;    Life in Years&lt;/font&gt;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: center; padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: center; padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Intrinsic&#13;    Value&lt;/font&gt;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: center; padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255); font-family: Times New Roman, Times, Serif"&gt;&#13;    &lt;td style="width: 42%; text-align: left; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Options&#13;    Outstanding as of December 31, 2016&lt;/font&gt;&lt;/td&gt;&lt;td style="width: 2%; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%; text-align: left; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="width: 11%; text-align: right; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;1,044,500&lt;/font&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="width: 2%; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%; text-align: left; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="width: 11%; text-align: right; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;0.92&lt;/font&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="width: 2%; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%; text-align: left; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="width: 10%; text-align: right; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;3.38&lt;/font&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="width: 2%; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%; text-align: left; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="width: 10%; text-align: right; font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White; font-family: Times New Roman, Times, Serif"&gt;&#13;    &lt;td style="text-align: left; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Options&#13;    Exercisable as of December 31, 2016&lt;/font&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;584,000&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: left; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;1.05&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: left; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;3.02&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: left; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: left; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255); font-family: Times New Roman, Times, Serif"&gt;&#13;    &lt;td style="text-align: left; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Options&#13;    granted&lt;/font&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;263,846&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: left; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;0.64&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: left; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;9.05&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: left; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: left; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White; font-family: Times New Roman, Times, Serif"&gt;&#13;    &lt;td style="text-align: left; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Options&#13;    forfeited&lt;/font&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(35,000&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: left; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;1.02&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: left; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;8.25&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: left; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: left; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255); font-family: Times New Roman, Times, Serif"&gt;&#13;    &lt;td style="text-align: left; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Options&#13;    expired&lt;/font&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(75,000&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: left; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;1.13&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: left; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;4.54&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: left; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: left; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White; font-family: Times New Roman, Times, Serif"&gt;&#13;    &lt;td style="text-align: left; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: left; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: left; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: left; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: left; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255); font-family: Times New Roman, Times, Serif"&gt;&#13;    &lt;td style="text-align: left; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Options&#13;    Outstanding as of December 31, 2017&lt;/font&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;1,197,846&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: left; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;0.97&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: left; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;6.96&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: left; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: left; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White; font-family: Times New Roman, Times, Serif"&gt;&#13;    &lt;td style="text-align: left; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Options&#13;    Exercisable as of December 31, 2017&lt;/font&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;781,300&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: left; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;1.02&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: left; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;6.30&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: left; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: left; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255); font-family: Times New Roman, Times, Serif"&gt;&#13;    &lt;td style="text-align: left; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Options&#13;    granted&lt;/font&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;560,400&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: left; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;0.50&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: left; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;9.26&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: left; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: left; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White; font-family: Times New Roman, Times, Serif"&gt;&#13;    &lt;td style="text-align: left; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Options&#13;    forfeited&lt;/font&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(25,400&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: left; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;0.46&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: left; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;9.06&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: left; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: left; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255); font-family: Times New Roman, Times, Serif"&gt;&#13;    &lt;td style="text-align: left; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Options&#13;    expired&lt;/font&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: left; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: left; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: left; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: left; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White; font-family: Times New Roman, Times, Serif"&gt;&#13;    &lt;td style="text-align: left; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: left; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: left; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: left; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: left; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255); font-family: Times New Roman, Times, Serif"&gt;&#13;    &lt;td style="text-align: left; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Options&#13;    Outstanding as of December 31, 2018&lt;/font&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;1,732,846&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: left; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;1.19&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: left; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;6.98&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: left; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: left; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White; font-family: Times New Roman, Times, Serif"&gt;&#13;    &lt;td style="text-align: left; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Options&#13;    Exercisable as of December 31, 2018&lt;/font&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;1,107,259&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: left; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;0.96&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: left; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;5.91&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: left; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: left; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock>
    <us-gaap:SegmentReportingDisclosureTextBlock contextRef="From2019-01-01to2019-06-30">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;NOTE&#13;8 &amp;#8211; SEGMENT REPORTING&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&amp;#160;&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;The&#13;Company classifies its business interests into reportable segments which are Trxade, Community and Other.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;table cellpadding="0" cellspacing="0" align="center" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;Six Months Ended June 30, 2019&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;Trxade, Inc.&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;Community Specialty Pharmacy, LLC&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;Other&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;Total&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="width: 36%"&gt;Revenue&lt;/td&gt;&lt;td style="width: 2%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;2,182,668&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;892,357&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;353,910&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;3,428,935&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="text-align: left"&gt;Segment Assets&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;1,401,724&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;224,863&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;2,051,478&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;3,678,065&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="text-align: left"&gt;Segment Profit/Loss&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;1,166,543&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;(61,628&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;(921,705&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;183,210&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;The&#13;Company had no reportable segments for the six months ended June 30, 2018. See NOTE 9 &amp;#8211; BUSINESS COMBINATION&lt;/font&gt;&lt;/p&gt;</us-gaap:SegmentReportingDisclosureTextBlock>
    <us-gaap:SegmentReportingDisclosureTextBlock contextRef="From2018-01-01to2018-12-31">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;NOTE&#13;11 &amp;#8211; SEGMENT REPORTING&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&amp;#160;&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0"&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;The&#13;Company classifies its business interests into reportable segments which are Trxade, Inc., Community Specialty Pharmacy, LLC,&#13;and Other. Operating segments are defined as the components of an enterprise about which separate financial information is available&#13;that is evaluated regularly by the chief operating decision maker in deciding how to allocate resources and in assessi&lt;/font&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;ng&#13;performance. Our chief operating decision makers direct the allocation of resources to operating segments based on the profitability,&#13;cash flows, and growth opportunities of each respective segment.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0in"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;table cellpadding="0" cellspacing="0" align="center" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"&gt;&#13;&lt;tr style="vertical-align: bottom; font-family: Times New Roman, Times, Serif"&gt;&#13;    &lt;td style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Year&#13;    Ended December 31, 2018&lt;/font&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Trxade,&#13;    Inc.&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Community&#13;    Specialty Pharmacy,&amp;#160;LLC&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Other&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255); font-family: Times New Roman, Times, Serif"&gt;&#13;    &lt;td style="width: 43%; text-align: left; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Revenue&lt;/font&gt;&lt;/td&gt;&lt;td style="width: 2%; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%; text-align: left; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="width: 14%; text-align: right; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;3,407,822&lt;/font&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="width: 2%; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%; text-align: left; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="width: 16%; text-align: right; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;395,418&lt;/font&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="width: 2%; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%; text-align: left; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="width: 15%; text-align: right; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;28,538&lt;/font&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White; font-family: Times New Roman, Times, Serif"&gt;&#13;    &lt;td style="text-align: left; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;Gross&#13;    Profit&lt;/font&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right; font-family: Times New Roman, Times, Serif"&gt;&lt;p style="margin: 0; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;3,407,822&lt;/font&gt;&lt;/p&gt;&#13;&#13;&#13;&lt;/td&gt;&lt;td style="text-align: left; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right; font-family: Times New Roman, Times, Serif"&gt;&lt;p style="margin: 0; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;(34,971&lt;/font&gt;&lt;/p&gt;&#13;&#13;&#13;&lt;/td&gt;&lt;td style="text-align: left; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right; font-family: Times New Roman, Times, Serif"&gt;&lt;p style="margin: 0; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;9,878&lt;/font&gt;&lt;/p&gt;&#13;&#13;&#13;&lt;/td&gt;&lt;td style="text-align: left; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255); font-family: Times New Roman, Times, Serif"&gt;&#13;    &lt;td style="text-align: left; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Segment&#13;    Assets&lt;/font&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;822,412&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: left; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;112,123&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: left; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;1,293,052&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: left; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White; font-family: Times New Roman, Times, Serif"&gt;&#13;    &lt;td style="text-align: left; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Segment&#13;    Profit/Loss&lt;/font&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;1,371,615&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: left; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(116,588&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: left; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(1,245,989&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: left; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;The&#13;Company had no reportable segments in 2017. See Note 12.&lt;/font&gt;&lt;/p&gt;</us-gaap:SegmentReportingDisclosureTextBlock>
    <us-gaap:BusinessCombinationDisclosureTextBlock contextRef="From2019-01-01to2019-06-30">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;NOTE&#13;9 &amp;#8211; BUSINESS COMBINATION&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&amp;#160;&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;On&#13;October 15, 2018, Trxade Group, Inc. (&amp;#8220;Company&amp;#8221;) entered into and consummated the purchase of 100% of the equity&#13;interests of Community Specialty Pharmacy, LLC, a Florida limited liability company, (&amp;#8220;CSP&amp;#8221;), pursuant to the terms&#13;and conditions of the Membership Interest Purchase Agreement, entered into by and among the Company as the buyer, and CSP, and&#13;Nikul Panchal, the equity owner of CSP (collectively, the &amp;#8220;Seller&amp;#8221;). The purchase price for the 100% equity interest&#13;in CSP was $300,000 in cash, a promissory note from the Company of $300,000 (see Note 3), and warrants to purchase 405,507 shares&#13;of the Common Stock of the Company which vested at the acquisition date, are exercisable for eight (8) years from the issuance&#13;date at a strike price of $0.01 per share, and subject to exercise restrictions which lapse over three (3) years.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;The&#13;Company recorded the acquisition under ASC 805 &amp;#8220;Business Combination. All of the assets acquired and liabilities&#13;assumed are recorded at their corresponding fair values. The excess of the purchase price over the net assets acquired&#13;resulted in goodwill of $725,973. The following table is a summary of the allocation of the purchase price of $770,291&#13;consisting of $300,000 in cash, a promissory note from the Company of $300,000, and the fair value of the warrants issued&#13;calculated under the Black-Scholes calculation at $170,291.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;table cellpadding="0" cellspacing="0" align="center" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;Purchase Price Allocation&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="width: 78%"&gt;Purchase Price&lt;/td&gt;&lt;td style="width: 2%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 18%; text-align: right"&gt;770,291&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td&gt;Cash&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(49,728&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="text-align: left"&gt;Accounts Receivable&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(114,899&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td&gt;Inventory&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(76,156&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td&gt;Prepaid&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(3,000&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="text-align: left"&gt;Accounts Payable&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;199,312&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Accrued Expenses&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;153&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;Goodwill&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;725,973&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;The&#13;accompanying unaudited pro forma statements of operations presents the accounts of Trxade and CSP for the six- months ended June&#13;30, 2018, assuming the acquisition occurred on January 1, 2018.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;table cellpadding="0" cellspacing="0" align="center" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="font-weight: bold; border-bottom: Black 1.5pt solid"&gt;2018 Summary Statement of Operations&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;Trxade&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;CSP&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;Combined&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="width: 55%; font-weight: bold"&gt;Revenue&lt;/td&gt;&lt;td style="width: 2%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 11%; text-align: right"&gt;1,690,611&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 11%; text-align: right"&gt;1,323,117&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 11%; text-align: right"&gt;3,013,723&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="font-weight: bold; text-align: left"&gt;Net Income&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;102,782&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;64,800&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;167,582&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="font-weight: bold; text-align: left"&gt;Net Income per common share &amp;#8211; basic&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;0.00&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;0.01&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="font-weight: bold; text-align: left"&gt;Net Income per common share - diluted&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;0.00&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;0.00&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="font-weight: bold"&gt;Weighted average common shares - basic&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;31,985,827&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;31,985,827&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="font-weight: bold"&gt;Weighted average common shares - diluted&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;34,472,811&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;34,472,811&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;The&#13;accompanying unaudited pro forma statements of operations presents the accounts of Trxade and CSP for the three- months ended&#13;June 30, 2018, assuming the acquisition occurred on January 1, 2018.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;table cellpadding="0" cellspacing="0" align="center" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="font-weight: bold; border-bottom: Black 1.5pt solid"&gt;2018 Summary Statement of Operations&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;Trxade&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;CSP&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;Combined&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="width: 55%; font-weight: bold"&gt;Revenue&lt;/td&gt;&lt;td style="width: 2%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 11%; text-align: right"&gt;837,688&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 11%; text-align: right"&gt;677,900&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 11%; text-align: right"&gt;1,515,588&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="font-weight: bold; text-align: left"&gt;Net Income (Loss)&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;20,513&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;(12,185&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;8,328&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="font-weight: bold; text-align: left"&gt;Net Income per common share &amp;#8211; basic&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;0.00&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;0.00&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="font-weight: bold; text-align: left"&gt;Net Income per common share - diluted&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;0.00&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;0.00&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="font-weight: bold"&gt;Weighted average common shares - basic&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;31,985,827&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;31,985,827&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="font-weight: bold"&gt;Weighted average common shares - diluted&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;34,479,406&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;34,479,406&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:BusinessCombinationDisclosureTextBlock>
    <us-gaap:BusinessCombinationDisclosureTextBlock contextRef="From2018-01-01to2018-12-31">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;NOTE&#13;12 &amp;#8211; BUSINESS COMBINATION&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&amp;#160;&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;On&#13;October 15, 2018, the Company entered into and consummated the purchase of 100% of the equity interests of Community Specialty&#13;Pharmacy, LLC, a Florida limited liability company, (&amp;#8220;CSP&amp;#8221;), pursuant to the terms and conditions of the Membership&#13;Interest Purchase Agreement, entered into by and among the Company as the buyer, and CSP, and Nikul Panchal, the equity owner&#13;of CSP (collectively, the &amp;#8220;Seller&amp;#8221;). The purchase price for the 100% equity interest in CSP was&#13;$300,000 in cash, a promissory note issued by the Company of $300,000 (see Note 4), and warrants to purchase 405,507&#13;shares of the Common Stock of the Company which vested at the acquisition date, are exercisable for eight (8) years&#13;from the issuance date at a strike price of $0.01 per share, and subject to exercise restrictions which lapse over a period&#13;of three (3) years.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;The&#13;Company recorded the acquisition under the guidance of ASC 805 &amp;#8220;Business Combinations&amp;#8221;. All the assets&#13;acquired and liabilities assumed are recorded at their corresponding fair values. The excess of the purchase&#13;price over the net assets acquired resulted in goodwill of $725,973. The following table is a summary of the allocation of&#13;the purchase price of $770,291 consisting of $300,000 in cash, a promissory note from the Company of $300,000, and &lt;font style="background-color: white"&gt;the&#13;fair value for the warrants issued calculated under the Black-Scholes calculation at $170,291.&lt;/font&gt;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;table cellpadding="0" cellspacing="0" align="center" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"&gt;&#13;&lt;tr style="vertical-align: bottom; font-family: Times New Roman, Times, Serif"&gt;&#13;    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Purchase&#13;    Price Allocation&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255); font-family: Times New Roman, Times, Serif"&gt;&#13;    &lt;td style="width: 64%; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Purchase&#13;    Price&lt;/font&gt;&lt;/td&gt;&lt;td style="width: 2%; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%; text-align: left; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="width: 32%; text-align: right; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;770,291&lt;/font&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White; font-family: Times New Roman, Times, Serif"&gt;&#13;    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Cash&lt;/font&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(49,728&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: left; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255); font-family: Times New Roman, Times, Serif"&gt;&#13;    &lt;td style="text-align: left; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Accounts&#13;    Receivable&lt;/font&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(114,899&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: left; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White; font-family: Times New Roman, Times, Serif"&gt;&#13;    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Inventory&lt;/font&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(76,156&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: left; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255); font-family: Times New Roman, Times, Serif"&gt;&#13;    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Prepaid&lt;/font&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(3,000&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: left; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White; font-family: Times New Roman, Times, Serif"&gt;&#13;    &lt;td style="text-align: left; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Accounts&#13;    Payable&lt;/font&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;199,312&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: left; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255); font-family: Times New Roman, Times, Serif"&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Accrued&#13;    Expenses&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;153&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White; font-family: Times New Roman, Times, Serif"&gt;&#13;    &lt;td style="padding-bottom: 2.5pt; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Goodwill&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; text-align: left; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;725,973&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;The&#13;accompanying unaudited pro forma combined statements of operations presents the accounts of Trxade and CSP for the years&#13;ended December 31, 2018 and 2017, respectively, assuming the acquisition occurred on January 1, 2017.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;table cellpadding="0" cellspacing="0" align="center" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"&gt;&#13;&lt;tr style="vertical-align: bottom; font-family: Times New Roman, Times, Serif"&gt;&#13;    &lt;td style="font-weight: bold; border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;2018&#13;    Summary Statement of Operations&lt;/font&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;Trxade&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;CSP&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;Combined&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255); font-family: Times New Roman, Times, Serif"&gt;&#13;    &lt;td style="width: 49%; font-weight: bold; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;Revenue&lt;/font&gt;&lt;/td&gt;&lt;td style="width: 2%; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%; text-align: left; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="width: 13%; text-align: right; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;3,436,360&lt;/font&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="width: 2%; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%; text-align: left; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="width: 13%; text-align: right; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;2,387,636&lt;/font&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="width: 2%; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%; text-align: left; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="width: 13%; text-align: right; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;5,823,996&lt;/font&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White; font-family: Times New Roman, Times, Serif"&gt;&#13;    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: left; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: left; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: left; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255); font-family: Times New Roman, Times, Serif"&gt;&#13;    &lt;td style="font-weight: bold; text-align: left; padding-bottom: 2.5pt; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;Net&#13;    Income (Loss)&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left; border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right; border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;125,626&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 2.5pt; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left; border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right; border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;(6,723&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 2.5pt; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left; border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right; border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;118,903&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 2.5pt; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White; font-family: Times New Roman, Times, Serif"&gt;&#13;    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: left; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: left; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: left; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255); font-family: Times New Roman, Times, Serif"&gt;&#13;    &lt;td style="font-weight: bold; text-align: left; padding-bottom: 2.5pt; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;Net&#13;    Income per common share &amp;#8211; basic&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left; border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right; border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;0.00&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 2.5pt; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 2.5pt; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right; padding-bottom: 2.5pt; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 2.5pt; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left; border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right; border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;0.00&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 2.5pt; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White; font-family: Times New Roman, Times, Serif"&gt;&#13;    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: left; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: left; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: left; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255); font-family: Times New Roman, Times, Serif"&gt;&#13;    &lt;td style="font-weight: bold; text-align: left; padding-bottom: 2.5pt; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;Net&#13;    Income per common share - diluted&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left; border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right; border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;0.00&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 2.5pt; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 2.5pt; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right; padding-bottom: 2.5pt; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 2.5pt; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left; border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right; border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;0.00&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 2.5pt; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White; font-family: Times New Roman, Times, Serif"&gt;&#13;    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: left; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: left; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: left; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255); font-family: Times New Roman, Times, Serif"&gt;&#13;    &lt;td style="font-weight: bold; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;Weighted&#13;    average common shares - basic&lt;/font&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;32,260,622&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: left; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: left; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;32,260,622&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: left; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White; font-family: Times New Roman, Times, Serif"&gt;&#13;    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: left; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: left; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: left; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255); font-family: Times New Roman, Times, Serif"&gt;&#13;    &lt;td style="font-weight: bold; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;Weighted&#13;    average common shares - diluted&lt;/font&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;34,958,502&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: left; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: left; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;34,958,502&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: left; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;&#13;&#13;&lt;table cellpadding="0" cellspacing="0" align="center" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"&gt;&#13;&lt;tr style="vertical-align: bottom; font-family: Times New Roman, Times, Serif"&gt;&#13;    &lt;td style="font-weight: bold; border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;2017&#13;    Summary Statement of Operations&lt;/font&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Trxade&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;CSP&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Combined&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255); font-family: Times New Roman, Times, Serif"&gt;&#13;    &lt;td style="width: 49%; font-weight: bold; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Revenue&lt;/font&gt;&lt;/td&gt;&lt;td style="width: 2%; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%; text-align: left; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="width: 13%; text-align: right; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;2,931,280&lt;/font&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="width: 2%; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%; text-align: left; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="width: 13%; text-align: right; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;2,633,914&lt;/font&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="width: 2%; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%; text-align: left; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="width: 13%; text-align: right; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;5,565,194&lt;/font&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White; font-family: Times New Roman, Times, Serif"&gt;&#13;    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: left; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: left; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: left; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255); font-family: Times New Roman, Times, Serif"&gt;&#13;    &lt;td style="font-weight: bold; text-align: left; padding-bottom: 2.5pt; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Net&#13;    Income (Loss)&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; text-align: left; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;288,983&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; text-align: left; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(63,132&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; text-align: left; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;225,851&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White; font-family: Times New Roman, Times, Serif"&gt;&#13;    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: left; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: left; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: left; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255); font-family: Times New Roman, Times, Serif"&gt;&#13;    &lt;td style="font-weight: bold; text-align: left; padding-bottom: 2.5pt; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Net&#13;    Income per common share &amp;#8211; basic&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; text-align: left; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;0.01&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt; text-align: left; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: right; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; text-align: left; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;0.01&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White; font-family: Times New Roman, Times, Serif"&gt;&#13;    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: left; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: left; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: left; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255); font-family: Times New Roman, Times, Serif"&gt;&#13;    &lt;td style="font-weight: bold; text-align: left; padding-bottom: 2.5pt; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Net&#13;    Income per common share - diluted&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; text-align: left; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;0.01&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt; text-align: left; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: right; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; text-align: left; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;0.01&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White; font-family: Times New Roman, Times, Serif"&gt;&#13;    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: left; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: left; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: left; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255); font-family: Times New Roman, Times, Serif"&gt;&#13;    &lt;td style="font-weight: bold; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Weighted&#13;    average common shares - basic&lt;/font&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;31,955,416&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: left; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: left; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;31,955,416&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: left; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White; font-family: Times New Roman, Times, Serif"&gt;&#13;    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: left; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: left; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: left; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255); font-family: Times New Roman, Times, Serif"&gt;&#13;    &lt;td style="font-weight: bold; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Weighted&#13;    average common shares - diluted&lt;/font&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;34,086,251&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: left; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: left; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;34,086,251&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: left; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:BusinessCombinationDisclosureTextBlock>
    <us-gaap:SubsequentEventsTextBlock contextRef="From2019-01-01to2019-06-30">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;NOTE&#13;11 &amp;#8211; SUBSEQUENT EVENTS&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&amp;#160;&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;On&#13;July 10, 2019, the Company entered into a Securities Purchase Agreement with a certain accredited investor with respect to the&#13;private placement of 2,000,000 share of its common stock at a purchase price of $0.50 per share, for gross proceeds of $1,000,000.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;On August 28, 2019, the Company entered into&#13;a Consulting Agreement which included the grant of warrants to purchase 300,000 shares of Company stock at an exercise price of&#13;$0.01 per share. 150,000 of the warrants are exercisable on April 1, 2020 and 150,000 are exercisable on April 1, 2021. The warrants&#13;have a term of 5 years.&lt;/p&gt;&#13;&#13;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;On&#13;September 30, 2019, the Company entered into a Securities Purchase Agreement with certain accredited investors with respect to&#13;the private placement of 2,910,000 shares of its common stock at a purchase price of $0.50 per share, for gross proceeds of $1,455,000.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;On&#13;September 30, 2019, the Company converted $175,000 of principal under various outstanding promissory notes (&amp;#8220;Promissory&#13;Notes&amp;#8221;) into 350,000 shares common stock of the Company at $0.50 per share under the terms of the Securities Purchase Agreement&#13;referenced above.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="margin: 0; text-align: justify; font: 10pt Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;On&#13;October 8, 2019, $122,552 and $100,000 in promissory notes due to Mr. Prashant Patel and Mr. Suren Ajjarapu, respectively, were&#13;paid in full. The notes were due July 1, 2020.&lt;/font&gt;&lt;/p&gt;</us-gaap:SubsequentEventsTextBlock>
    <us-gaap:SubsequentEventsTextBlock contextRef="From2018-01-01to2018-12-31">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;NOTE&#13;13 &amp;#8211; SUBSEQUENT EVENTS&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&amp;#160;&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;In&#13;January 2019, Trxade Group, Inc. through its wholly owned subsidiary Alliance Pharma Solution, LLC (&amp;#8220;Alliance&amp;#8221;)&#13;entered into a transaction to form SyncHealth MSO, LLC (&amp;#8220;SyncHealth&amp;#8221;). It will be owned by PanOptic Health,&#13;LLC (&amp;#8220;PanOptic&amp;#8221;) and Alliance. Alliance will transfer $250,000 for the acquisition of the remaining&#13;49% and the option to acquire the remaining ownership from PanOptic shareholders. Pursuant to the operating agreement PanOptic&#13;initially owns 70% of SyncHealth and Alliance owns 30%; however, pursuant to the Letter Agreement, PanOptic will transfer&#13;to Alliance an additional 6% of the SyncHealth units on May 1, 2019, an additional 6% on August 1, 2019, an additional&#13;7% on November 1, 2019 and at Alliance&amp;#8217;s option, the balance of 51% on January 31, 2020. The Company has transferred&#13;$250,000 and has a 30% equity interest.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;In&#13;February 2019, convertible promissory notes issued in 2015 for $150,000 were amended to reduce the conversion price from&#13;$0.85 to $0.50 and the remaining principal and accrued interest total of $211,983 were converted to 423,966 common&#13;shares.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;In&#13;February 2019, 16,666 of warrants issued in 2014 at $0.01 were converted for $166 to 16,666 of common shares.&lt;/font&gt;&lt;/p&gt;</us-gaap:SubsequentEventsTextBlock>
    <us-gaap:BasisOfAccountingPolicyPolicyTextBlock contextRef="From2019-01-01to2019-06-30">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;i&gt;Basis&#13;of Presentation&lt;/i&gt; - The accompanying unaudited interim consolidated financial statements of Trxade Group, Inc. have been prepared&#13;in accordance with accounting principles generally accepted in the United States of America and the rules of the Securities and&#13;Exchange Commission and should be read in conjunction with the audited financial statements and notes thereto contained in the&#13;Company&amp;#8217;s Form 10K.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;In&#13;the opinion of management, all adjustments, consisting of normal recurring adjustments, necessary for a fair presentation of financial&#13;position and the results of operations for the interim periods presented have been reflected herein. The results of operations&#13;for the interim periods are not necessarily indicative of the results to be expected for the full year. Notes to the financial&#13;statements that would substantially duplicate the disclosures contained in the audited financial statements for the year ended&#13;December 31, 2018 as reported in the Company&amp;#8217;s Annual Report on Form 10K have been omitted.&lt;/font&gt;&lt;/p&gt;</us-gaap:BasisOfAccountingPolicyPolicyTextBlock>
    <us-gaap:BasisOfAccountingPolicyPolicyTextBlock contextRef="From2018-01-01to2018-12-31">&lt;p style="margin: 0pt"&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Basis of Presentation &amp;#8211; Historically,&#13;operations have been funded primarily through the sale of equity or debt securities and operating activities. In 2018, the Company&#13;renewed outstanding debt (See Note 3 and 4), raised capital (See Note 5) and had positive operating cash flow from operations.&#13;The Company has the ability to maintain the current level of spending or reduce expenditures to maintain operations if funding&#13;is not available.&lt;/p&gt;</us-gaap:BasisOfAccountingPolicyPolicyTextBlock>
    <us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock contextRef="From2019-01-01to2019-06-30">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;i&gt;Recent&#13;Accounting Pronouncements &lt;/i&gt;&amp;#8211; The Company has implemented all new relevant accounting pronouncements that are in effect&#13;through the date of these financial statements. The pronouncements did not have any material impact on the financial statements&#13;unless otherwise disclosed, and the Company does not believe that there are any other new accounting pronouncements that have&#13;been issued that might have a material impact on its consolidated financial position or results of operations.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Effective&#13;January 1, 2019, the Company adopted ASU No. 2016-02, &lt;i&gt;Leases (Topic 842&lt;/i&gt;) (&amp;#8220;ASU 2016-02&amp;#8221;) using the required&#13;modified retrospective approach. The most significant changes under the new guidance include clarification of the definition of&#13;a lease, and the requirements for lessees to recognize a Right of Use (&amp;#8220;ROU&amp;#8221;) asset and a lease liability for all&#13;qualifying leases with terms longer than twelve months in the consolidated balance sheet. In addition, under Topic 842, additional&#13;disclosures are required to meet the objective of enabling users of financial statements to assess the amount, timing and uncertainty&#13;of cash flows arising from leases. See Footnote #7 below for more detail on the Company&amp;#8217;s accounting with respect to leases.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Effective&#13;January 1, 2019, the Company adopted ASU No. 2018-07, Compensation &amp;#8211; Stock Based Compensation (Topic 718): Improvements&#13;to Nonemployee Share-Based Payment Accounting (&amp;#8220;ASU 2018-7&amp;#8221;), which aligns accounting for share-based payments issued&#13;to nonemployees to that of employees under the existing guidance of Topic 718, with certain exceptions. This update supersedes&#13;previous guidance for equity-based payments to nonemployees under Subtopic 505-50, Equity &amp;#8211; Equity-Based Payments to Non-Employees.&#13;The adoption of ASU 2018-07 did not have a material impact on the Company&amp;#8217;s consolidated financial statements.&lt;/font&gt;&lt;/p&gt;</us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock>
    <us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock contextRef="From2018-01-01to2018-12-31">&lt;p style="margin: 0pt"&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Recent Accounting Pronouncements &amp;#8211; The&#13;Company has implemented all new relevant accounting pronouncements that are in effect through the date of these financial statements.&#13;The pronouncements did not have any material impact on the financial statements unless otherwise disclosed, and the Company does&#13;not believe that there are any other new accounting pronouncements that have been issued that might have a material impact on its&#13;consolidated financial position or results of operations.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;In February 2016, the FASB issued ASU 2016-02,&#13;Leases, which will amend current lease accounting to require lessees to recognize (i) a lease liability, which is a lessee&amp;#8217;s&#13;obligation to make lease payments arising from a lease, measured on a discounted basis, and (ii) a right-of-use asset, which is&#13;an asset that represents the lessee&amp;#8217;s right to use, or control the use of, a specified asset for the lease term. ASU 2016-02&#13;does not significantly change lease accounting requirements applicable to lessors; however, certain changes were made to align,&#13;where necessary, lessor accounting with the lessee accounting model. This standard will be effective for fiscal years beginning&#13;after December 15, 2018, including interim periods within those fiscal years. The Company adopted the provisions of this ASU at&#13;January 1, 2019.&lt;/p&gt;</us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock>
    <us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock contextRef="From2019-01-01to2019-06-30">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;The&#13;following table sets forth the computation of basic and diluted Income per Share:&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="6" style="text-align: center; border-bottom: Black 1.5pt solid"&gt;For three months ended June 30,&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: center"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="6" style="text-align: center; border-bottom: Black 1.5pt solid"&gt;For six months ended June 30,&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: center"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid"&gt;2019&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: center"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid"&gt;2018&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: center"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid"&gt;2019&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: center"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid"&gt;2018&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: center"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="text-align: justify"&gt;Numerator:&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="width: 40%; text-align: justify"&gt;Net Income&lt;/td&gt;&lt;td style="width: 2%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 11%; text-align: right"&gt;57,981&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 11%; text-align: right"&gt;20,513&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 11%; text-align: right"&gt;183,210&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 11%; text-align: right"&gt;102,782&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="text-align: justify"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="text-align: left"&gt;Numerator for basic and diluted EPS - income available to common Shareholders&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;57,981&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;20,513&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;183,210&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;102,782&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="text-align: justify"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="text-align: justify"&gt;Denominator:&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="text-align: left"&gt;Denominator for basic EPS &amp;#8211; Weighted average shares&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;33,726,489&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;31,985,827&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;33,546,329&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;31,985,827&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="text-align: left"&gt;Dilutive Effect of Warrants, Options and Convertible Debt&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;2,627,262&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;2,493,579&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;2,807,422&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;2,486,984&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="text-align: left"&gt;Denominator for diluted EPS &amp;#8211; adjusted Weighted average shares and assumed Conversions&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;36,353,751&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;34,479,406&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;36,353,751&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;34,472,811&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="text-align: left"&gt;Basic and Diluted income per common share&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;0.00&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;0.00&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;0.01&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;0.00&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock>
    <us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock contextRef="From2018-01-01to2018-12-31">&lt;p style="margin: 0pt"&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The following table sets forth the computation&#13;of basic and diluted income per common share for the years ended December 31, 2018 and 2017:&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;December 31, 2018&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;December 31, 2017&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Numerator:&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td style="width: 62%"&gt;&lt;font style="font-size: 10pt"&gt;Net Income&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 16%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;9,038&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 16%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;288,983&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Numerator for basic and diluted income available to common shareholders&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;9,038&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;288,983&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Denominator:&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Denominator for basic income per common share &amp;#8211; Weighted average common shares outstanding&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;32,260,622&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;31,955,416&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Dilutive effect of Common Stock Equivalents&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;2,697,880&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;2,130,835&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Denominator for diluted income per common share &amp;#8211; adjusted weighted average common shares outstanding&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;34,958,502&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;34,086,251&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Basic and Diluted income per common share&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;0.00&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;0.01&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&#13;&#13;&lt;p style="margin: 0pt"&gt;&lt;/p&gt;</us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock>
    <us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock contextRef="From2019-01-01to2019-06-30">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;The&#13;Company&amp;#8217;s outstanding and exercisable warrants as of June 30, 2019 are presented below:&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="text-align: justify"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Number&lt;/b&gt;&lt;/font&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Outstanding&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Weighted&lt;/b&gt;&lt;/font&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Average&lt;/b&gt;&lt;/font&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Exercise Price&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Contractual Life&lt;/b&gt;&lt;/font&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;in Years&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;Intrinsic Value&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="width: 44%; text-align: justify"&gt;Warrants Outstanding as of December 31, 2018&lt;/td&gt;&lt;td style="width: 2%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 10%; text-align: right"&gt;2,880,141&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 10%; text-align: right"&gt;0.08&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 10%; text-align: right"&gt;3.74&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 10%; text-align: right"&gt;782,385&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="text-align: justify"&gt;Warrants granted&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="text-align: justify"&gt;Warrants forfeited&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="text-align: justify"&gt;Warrants exercised&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(16,666&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;0.01&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;-&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="text-align: justify"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="text-align: justify"&gt;Warrants Outstanding as of June 30, 2019&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;2,863,475&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;0.08&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;3.08&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;1,448,356&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock>
    <us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock contextRef="From2018-01-01to2018-12-31">&lt;p style="margin: 0pt"&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The Company&amp;#8217;s outstanding and exercisable&#13;warrants as of December 31, 2018 and 2017 are presented below:&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="padding-bottom: 1.5pt; text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt; text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Number Outstanding&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt; text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt; text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Weighted Average Exercise Price&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt; text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt; text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Contractual Life in Years&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt; text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt; text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Intrinsic Value&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt; text-align: center"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="width: 44%"&gt;&lt;font style="font-size: 10pt"&gt;Warrants Outstanding as of December 31, 2016&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 11%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;2,647,446&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 11%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;0.24&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 11%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;4.24&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 11%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;930,751&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Warrants granted&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;115,650&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;0.18&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;5.0&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Warrants forfeited&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Warrants exercised&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;(25,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;0.01&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Warrants Outstanding as of December 31, 2017&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;2,738,096&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;0.24&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;3.28&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;937,567&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Warrants granted&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;577,045&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;0.02&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;7.11&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Warrants forfeited&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;(435,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Warrants exercised&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Warrants Outstanding as of December 31, 2018&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;2,880,141&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;0.08&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;3.74&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;782,385&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&#13;&#13;&lt;p style="margin: 0pt"&gt;&lt;/p&gt;</us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="From2019-01-01to2019-06-30" unitRef="Shares" decimals="INF">33546329</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="From2017-01-01to2017-12-31" unitRef="Shares" decimals="INF">31955416</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="From2018-01-01to2018-06-30" unitRef="Shares" decimals="INF">31985827</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="From2019-04-01to2019-06-30" unitRef="Shares" decimals="INF">33726489</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="From2018-04-01to2018-06-30" unitRef="Shares" decimals="INF">31985827</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="From2018-01-01to2018-12-31" unitRef="Shares" decimals="INF">32260622</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding contextRef="From2019-01-01to2019-06-30" unitRef="Shares" decimals="INF">36353751</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding contextRef="From2017-01-01to2017-12-31" unitRef="Shares" decimals="INF">34086251</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding contextRef="From2018-01-01to2018-06-30" unitRef="Shares" decimals="INF">34472811</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding contextRef="From2019-04-01to2019-06-30" unitRef="Shares" decimals="INF">36353751</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding contextRef="From2018-04-01to2018-06-30" unitRef="Shares" decimals="INF">34479406</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding contextRef="From2018-01-01to2018-12-31" unitRef="Shares" decimals="INF">34958502</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1 contextRef="AsOf2017-08-31_custom_RelatedPartyConvertiblePromissoryNoteMember" unitRef="USDPShares" decimals="INF">0.80</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1 contextRef="AsOf2018-08-31_custom_RelatedPartyConvertiblePromissoryNoteMember" unitRef="USDPShares" decimals="INF">0.50</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1 contextRef="AsOf2016-10-31_custom_RelatedPartyConvertiblePromissoryNoteMember_custom_MrNitilPatelMember" unitRef="USDPShares" decimals="INF">0.62</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1 contextRef="AsOf2016-09-30_custom_RelatedPartyConvertiblePromissoryNoteMember_custom_MrNitilPatelMember" unitRef="USDPShares" decimals="INF">0.62</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1 contextRef="AsOf2018-10-15_custom_CommunitySpecialtyPharmacyLLCMember_us-gaap_SubsequentEventMember" unitRef="USDPShares" decimals="INF">0.01</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1 contextRef="AsOf2018-07-31_custom_PrivateOfferMemorandumMember" unitRef="USDPShares" decimals="INF">0.01</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1 contextRef="AsOf2017-04-30_custom_ConvertiblePromissoryNoteMember" unitRef="USDPShares" decimals="INF">0.65</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1 contextRef="AsOf2015-04-30_custom_ConvertiblePromissoryNoteMember" unitRef="USDPShares" decimals="INF">1.50</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1 contextRef="AsOf2015-05-31_custom_ConvertiblePromissoryNoteMember" unitRef="USDPShares" decimals="INF">1.50</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1 contextRef="AsOf2016-04-30_custom_ConvertiblePromissoryNoteMember" unitRef="USDPShares" decimals="INF">1.50</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1 contextRef="AsOf2016-05-31_custom_ConvertiblePromissoryNoteMember" unitRef="USDPShares" decimals="INF">1.50</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1 contextRef="AsOf2017-01-31_custom_PrivateOfferMemorandumMember" unitRef="USDPShares" decimals="INF">0.01</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1 contextRef="AsOf2017-02-28" unitRef="USDPShares" decimals="INF">0.01</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1 contextRef="AsOf2019-02-28_us-gaap_WarrantMember" unitRef="USDPShares" decimals="INF">0.01</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1 contextRef="AsOf2019-02-28_us-gaap_SubsequentEventMember" unitRef="USDPShares" decimals="INF">0.01</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1 contextRef="AsOf2019-08-28_us-gaap_SubsequentEventMember_custom_ConsultingAgreementMember" unitRef="USDPShares" decimals="INF">0.01</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:ProfitLoss contextRef="From2019-01-01to2019-06-30" unitRef="USD" decimals="0">183210</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss contextRef="From2019-01-01to2019-06-30_custom_TrxadeIncMember" unitRef="USD" decimals="0">1166543</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss contextRef="From2019-01-01to2019-06-30_custom_CommunitySpecialtyPharmacyLLCMember" unitRef="USD" decimals="0">-61628</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss contextRef="From2019-01-01to2019-06-30_custom_OtherMember" unitRef="USD" decimals="0">-921705</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss contextRef="From2018-01-01to2018-12-31_custom_TrxadeIncMember500701218" unitRef="USD" decimals="0">1371615</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss contextRef="From2018-01-01to2018-12-31_custom_CommunitySpecialtyPharmacyLLCMember500738546" unitRef="USD" decimals="0">-116588</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss contextRef="From2018-01-01to2018-12-31_custom_OtherMember" unitRef="USD" decimals="0">-1245989</us-gaap:ProfitLoss>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod contextRef="From2019-01-01to2019-06-30" unitRef="Shares" xsi:nil="true" />
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod contextRef="From2017-01-01to2017-12-31" unitRef="Shares" decimals="INF">35000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod contextRef="From2018-01-01to2018-12-31" unitRef="Shares" decimals="INF">25400</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod contextRef="From2019-01-01to2019-06-30" unitRef="Shares" xsi:nil="true" />
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod contextRef="From2017-01-01to2017-12-31" unitRef="Shares" decimals="INF">75000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod contextRef="From2018-01-01to2018-12-31" unitRef="Shares" xsi:nil="true" />
    <us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock contextRef="From2019-01-01to2019-06-30">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;table cellpadding="0" cellspacing="0" align="center" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;Purchase Price Allocation&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="width: 78%"&gt;Purchase Price&lt;/td&gt;&lt;td style="width: 2%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 18%; text-align: right"&gt;770,291&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td&gt;Cash&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(49,728&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="text-align: left"&gt;Accounts Receivable&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(114,899&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td&gt;Inventory&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(76,156&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td&gt;Prepaid&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(3,000&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="text-align: left"&gt;Accounts Payable&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;199,312&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="text-align: left; padding-bottom: 1.5pt"&gt;Accrued Expenses&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;153&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;Goodwill&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;725,973&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock>
    <us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock contextRef="From2018-01-01to2018-12-31">&lt;p style="margin: 0pt"&gt;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Purchase Price Allocation&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="width: 65%"&gt;&lt;font style="font-size: 10pt"&gt;Purchase Price&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 32%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;770,291&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Cash&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;(49,728&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Accounts Receivable&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;(114,899&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Inventory&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;(76,156&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Prepaid&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;(3,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Accounts Payable&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;199,312&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;font style="font-size: 10pt"&gt;Accrued Expenses&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;153&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&lt;font style="font-size: 10pt"&gt;Goodwill&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;725,973&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&#13;&#13;&lt;p style="margin: 0pt"&gt;&lt;/p&gt;</us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock>
    <us-gaap:BusinessAcquisitionProFormaInformationTextBlock contextRef="From2019-01-01to2019-06-30">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;The&#13;accompanying unaudited pro forma statements of operations presents the accounts of Trxade and CSP for the six- months ended June&#13;30, 2018, assuming the acquisition occurred on January 1, 2018.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;table cellpadding="0" cellspacing="0" align="center" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="font-weight: bold; border-bottom: Black 1.5pt solid"&gt;2018 Summary Statement of Operations&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;Trxade&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;CSP&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;Combined&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="width: 55%; font-weight: bold"&gt;Revenue&lt;/td&gt;&lt;td style="width: 2%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 11%; text-align: right"&gt;1,690,611&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 11%; text-align: right"&gt;1,323,117&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 11%; text-align: right"&gt;3,013,723&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="font-weight: bold; text-align: left"&gt;Net Income&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;102,782&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;64,800&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;167,582&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="font-weight: bold; text-align: left"&gt;Net Income per common share &amp;#8211; basic&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;0.00&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;0.01&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="font-weight: bold; text-align: left"&gt;Net Income per common share - diluted&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;0.00&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;0.00&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="font-weight: bold"&gt;Weighted average common shares - basic&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;31,985,827&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;31,985,827&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="font-weight: bold"&gt;Weighted average common shares - diluted&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;34,472,811&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;34,472,811&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;The&#13;accompanying unaudited pro forma statements of operations presents the accounts of Trxade and CSP for the three- months ended&#13;June 30, 2018, assuming the acquisition occurred on January 1, 2018.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;table cellpadding="0" cellspacing="0" align="center" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="font-weight: bold; border-bottom: Black 1.5pt solid"&gt;2018 Summary Statement of Operations&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;Trxade&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;CSP&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;Combined&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="width: 55%; font-weight: bold"&gt;Revenue&lt;/td&gt;&lt;td style="width: 2%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 11%; text-align: right"&gt;837,688&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 11%; text-align: right"&gt;677,900&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 11%; text-align: right"&gt;1,515,588&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="font-weight: bold; text-align: left"&gt;Net Income (Loss)&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;20,513&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;(12,185&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;8,328&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="font-weight: bold; text-align: left"&gt;Net Income per common share &amp;#8211; basic&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;0.00&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;0.00&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="font-weight: bold; text-align: left"&gt;Net Income per common share - diluted&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;0.00&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;0.00&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="font-weight: bold"&gt;Weighted average common shares - basic&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;31,985,827&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;31,985,827&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="font-weight: bold"&gt;Weighted average common shares - diluted&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;34,479,406&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;34,479,406&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:BusinessAcquisitionProFormaInformationTextBlock>
    <us-gaap:BusinessAcquisitionProFormaInformationTextBlock contextRef="From2018-01-01to2018-12-31">&lt;p style="margin: 0pt"&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The accompanying unaudited pro forma combined&#13;statements of operations presents the accounts of Trxade and CSP for the years ended December 31, 2018 and 2017, respectively,&#13;assuming the acquisition occurred on January 1, 2017.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;2018 Summary Statement of Operations&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Trxade&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;CSP&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Combined&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="width: 52%"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Revenue&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 13%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;3,436,360&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 13%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;2,387,636&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 13%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;5,823,996&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Net Income (Loss)&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;125,626&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;(6,723&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&lt;font style="font-size: 10pt"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;118,903&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Net Income per common share &amp;#8211; basic&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;0.00&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;0.00&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Net Income per common share - diluted&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;0.00&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;0.00&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Weighted average common shares - basic&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;32,260,622&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;32,260,622&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Weighted average common shares - diluted&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;34,958,502&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;34,958,502&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;b&gt;&amp;#160;&lt;/b&gt;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;2017 Summary Statement of Operations&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Trxade&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;CSP&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Combined&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="width: 52%"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Revenue&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 13%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;2,931,280&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 13%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;2,633,914&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 13%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;5,565,194&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Net Income (Loss)&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;288,983&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;(63,132&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&lt;font style="font-size: 10pt"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;225,851&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Net Income per common share &amp;#8211; basic&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;0.01&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;0.01&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Net Income per common share - diluted&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;0.01&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt; text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;0.01&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Weighted average common shares - basic&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;31,955,416&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;31,955,416&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Weighted average common shares - diluted&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;34,086,251&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;34,086,251&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&#13;&#13;&lt;p style="margin: 0pt"&gt;&lt;/p&gt;</us-gaap:BusinessAcquisitionProFormaInformationTextBlock>
    <us-gaap:PaymentsToAcquireBusinessesGross contextRef="From2018-10-14to2018-10-15_us-gaap_SubsequentEventMember_custom_CommunitySpecialtyPharmacyLLCMember" unitRef="USD" decimals="0">300000</us-gaap:PaymentsToAcquireBusinessesGross>
    <us-gaap:NotesPayable contextRef="AsOf2018-10-15_custom_CommunitySpecialtyPharmacyLLCMember_us-gaap_SubsequentEventMember" unitRef="USD" decimals="0">300000</us-gaap:NotesPayable>
    <us-gaap:NotesPayable contextRef="AsOf2019-02-28_us-gaap_SubsequentEventMember" unitRef="USD" decimals="0">211983</us-gaap:NotesPayable>
    <us-gaap:WarrantsAndRightsOutstandingTerm contextRef="AsOf2017-08-31_custom_RelatedPartyConvertiblePromissoryNoteMember">P5Y</us-gaap:WarrantsAndRightsOutstandingTerm>
    <us-gaap:WarrantsAndRightsOutstandingTerm contextRef="AsOf2018-08-31_custom_RelatedPartyConvertiblePromissoryNoteMember">P5Y</us-gaap:WarrantsAndRightsOutstandingTerm>
    <us-gaap:WarrantsAndRightsOutstandingTerm contextRef="AsOf2016-10-31_custom_RelatedPartyConvertiblePromissoryNoteMember_custom_MrNitilPatelMember">P5Y</us-gaap:WarrantsAndRightsOutstandingTerm>
    <us-gaap:WarrantsAndRightsOutstandingTerm contextRef="AsOf2016-09-30_custom_RelatedPartyConvertiblePromissoryNoteMember_custom_MrNitilPatelMember">P5Y</us-gaap:WarrantsAndRightsOutstandingTerm>
    <us-gaap:WarrantsAndRightsOutstandingTerm contextRef="AsOf2018-10-15_custom_CommunitySpecialtyPharmacyLLCMember_us-gaap_SubsequentEventMember">P8Y</us-gaap:WarrantsAndRightsOutstandingTerm>
    <us-gaap:WarrantsAndRightsOutstandingTerm contextRef="AsOf2018-07-31_custom_PrivateOfferMemorandumMember">P5Y</us-gaap:WarrantsAndRightsOutstandingTerm>
    <us-gaap:WarrantsAndRightsOutstandingTerm contextRef="AsOf2017-04-30_custom_ConvertiblePromissoryNoteMember">P5Y</us-gaap:WarrantsAndRightsOutstandingTerm>
    <us-gaap:WarrantsAndRightsOutstandingTerm contextRef="AsOf2015-04-30_custom_ConvertiblePromissoryNoteMember">P5Y</us-gaap:WarrantsAndRightsOutstandingTerm>
    <us-gaap:WarrantsAndRightsOutstandingTerm contextRef="AsOf2015-05-31_custom_ConvertiblePromissoryNoteMember">P5Y</us-gaap:WarrantsAndRightsOutstandingTerm>
    <us-gaap:WarrantsAndRightsOutstandingTerm contextRef="AsOf2016-04-30_custom_ConvertiblePromissoryNoteMember">P5Y</us-gaap:WarrantsAndRightsOutstandingTerm>
    <us-gaap:WarrantsAndRightsOutstandingTerm contextRef="AsOf2016-05-31_custom_ConvertiblePromissoryNoteMember">P5Y</us-gaap:WarrantsAndRightsOutstandingTerm>
    <us-gaap:WarrantsAndRightsOutstandingTerm contextRef="AsOf2017-01-31_custom_PrivateOfferMemorandumMember">P5Y</us-gaap:WarrantsAndRightsOutstandingTerm>
    <us-gaap:BusinessCombinationConsiderationTransferred1 contextRef="From2018-10-14to2018-10-15_us-gaap_SubsequentEventMember_custom_CommunitySpecialtyPharmacyLLCMember" unitRef="USD" decimals="0">770291</us-gaap:BusinessCombinationConsiderationTransferred1>
    <us-gaap:BusinessCombinationConsiderationTransferred1 contextRef="From2019-01-01to2019-01-31_us-gaap_SubsequentEventMember" unitRef="USD" decimals="0">250000</us-gaap:BusinessCombinationConsiderationTransferred1>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable contextRef="AsOf2018-10-15_custom_CommunitySpecialtyPharmacyLLCMember_us-gaap_SubsequentEventMember" unitRef="USD" decimals="0">199312</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther contextRef="AsOf2018-10-15_custom_CommunitySpecialtyPharmacyLLCMember_us-gaap_SubsequentEventMember" unitRef="USD" decimals="0">153</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther>
    <us-gaap:BusinessAcquisitionsProFormaRevenue contextRef="From2017-01-01to2017-12-31" unitRef="USD" decimals="0">5565194</us-gaap:BusinessAcquisitionsProFormaRevenue>
    <us-gaap:BusinessAcquisitionsProFormaRevenue contextRef="From2018-01-01to2018-12-31_custom_CommunitySpecialtyPharmacyLLCMember" unitRef="USD" decimals="0">2387636</us-gaap:BusinessAcquisitionsProFormaRevenue>
    <us-gaap:BusinessAcquisitionsProFormaRevenue contextRef="From2018-01-01to2018-06-30_custom_TrxadeMember" unitRef="USD" decimals="0">1690611</us-gaap:BusinessAcquisitionsProFormaRevenue>
    <us-gaap:BusinessAcquisitionsProFormaRevenue contextRef="From2017-01-01to2017-12-31_custom_TrxadeMember" unitRef="USD" decimals="0">2931280</us-gaap:BusinessAcquisitionsProFormaRevenue>
    <us-gaap:BusinessAcquisitionsProFormaRevenue contextRef="From2017-01-01to2017-12-31_custom_CommunitySpecialtyPharmacyLLCMember" unitRef="USD" decimals="0">2633914</us-gaap:BusinessAcquisitionsProFormaRevenue>
    <us-gaap:BusinessAcquisitionsProFormaRevenue contextRef="From2018-01-01to2018-06-30" unitRef="USD" decimals="0">3013723</us-gaap:BusinessAcquisitionsProFormaRevenue>
    <us-gaap:BusinessAcquisitionsProFormaRevenue contextRef="From2018-01-01to2018-06-30_custom_CommunitySpecialtyPharmacyLLCMember" unitRef="USD" decimals="0">1323117</us-gaap:BusinessAcquisitionsProFormaRevenue>
    <us-gaap:BusinessAcquisitionsProFormaRevenue contextRef="From2018-04-01to2018-06-30" unitRef="USD" decimals="0">1515588</us-gaap:BusinessAcquisitionsProFormaRevenue>
    <us-gaap:BusinessAcquisitionsProFormaRevenue contextRef="From2018-04-01to2018-06-30_custom_TrxadeMember" unitRef="USD" decimals="0">837688</us-gaap:BusinessAcquisitionsProFormaRevenue>
    <us-gaap:BusinessAcquisitionsProFormaRevenue contextRef="From2018-04-01to2018-06-30_custom_CommunitySpecialtyPharmacyLLCMember" unitRef="USD" decimals="0">677900</us-gaap:BusinessAcquisitionsProFormaRevenue>
    <us-gaap:BusinessAcquisitionsProFormaRevenue contextRef="From2018-01-01to2018-12-31" unitRef="USD" decimals="0">5823996</us-gaap:BusinessAcquisitionsProFormaRevenue>
    <us-gaap:BusinessAcquisitionsProFormaRevenue contextRef="From2018-01-01to2018-12-31_custom_TrxadeMember" unitRef="USD" decimals="0">3436360</us-gaap:BusinessAcquisitionsProFormaRevenue>
    <us-gaap:BusinessAcquisitionsProFormaNetIncomeLoss contextRef="From2017-01-01to2017-12-31" unitRef="USD" decimals="0">225851</us-gaap:BusinessAcquisitionsProFormaNetIncomeLoss>
    <us-gaap:BusinessAcquisitionsProFormaNetIncomeLoss contextRef="From2018-01-01to2018-12-31_custom_CommunitySpecialtyPharmacyLLCMember" unitRef="USD" decimals="0">-6723</us-gaap:BusinessAcquisitionsProFormaNetIncomeLoss>
    <us-gaap:BusinessAcquisitionsProFormaNetIncomeLoss contextRef="From2018-01-01to2018-06-30_custom_TrxadeMember" unitRef="USD" decimals="0">102782</us-gaap:BusinessAcquisitionsProFormaNetIncomeLoss>
    <us-gaap:BusinessAcquisitionsProFormaNetIncomeLoss contextRef="From2017-01-01to2017-12-31_custom_TrxadeMember" unitRef="USD" decimals="0">288983</us-gaap:BusinessAcquisitionsProFormaNetIncomeLoss>
    <us-gaap:BusinessAcquisitionsProFormaNetIncomeLoss contextRef="From2017-01-01to2017-12-31_custom_CommunitySpecialtyPharmacyLLCMember" unitRef="USD" decimals="0">-63132</us-gaap:BusinessAcquisitionsProFormaNetIncomeLoss>
    <us-gaap:BusinessAcquisitionsProFormaNetIncomeLoss contextRef="From2018-01-01to2018-06-30" unitRef="USD" decimals="0">167582</us-gaap:BusinessAcquisitionsProFormaNetIncomeLoss>
    <us-gaap:BusinessAcquisitionsProFormaNetIncomeLoss contextRef="From2018-01-01to2018-06-30_custom_CommunitySpecialtyPharmacyLLCMember" unitRef="USD" decimals="0">64800</us-gaap:BusinessAcquisitionsProFormaNetIncomeLoss>
    <us-gaap:BusinessAcquisitionsProFormaNetIncomeLoss contextRef="From2018-04-01to2018-06-30" unitRef="USD" decimals="0">8328</us-gaap:BusinessAcquisitionsProFormaNetIncomeLoss>
    <us-gaap:BusinessAcquisitionsProFormaNetIncomeLoss contextRef="From2018-04-01to2018-06-30_custom_TrxadeMember" unitRef="USD" decimals="0">20513</us-gaap:BusinessAcquisitionsProFormaNetIncomeLoss>
    <us-gaap:BusinessAcquisitionsProFormaNetIncomeLoss contextRef="From2018-04-01to2018-06-30_custom_CommunitySpecialtyPharmacyLLCMember" unitRef="USD" decimals="0">-12185</us-gaap:BusinessAcquisitionsProFormaNetIncomeLoss>
    <us-gaap:BusinessAcquisitionsProFormaNetIncomeLoss contextRef="From2018-01-01to2018-12-31" unitRef="USD" decimals="0">118903</us-gaap:BusinessAcquisitionsProFormaNetIncomeLoss>
    <us-gaap:BusinessAcquisitionsProFormaNetIncomeLoss contextRef="From2018-01-01to2018-12-31_custom_TrxadeMember" unitRef="USD" decimals="0">125626</us-gaap:BusinessAcquisitionsProFormaNetIncomeLoss>
    <us-gaap:BusinessAcquisitionProFormaEarningsPerShareBasic contextRef="From2017-01-01to2017-12-31" unitRef="USDPShares" decimals="INF">0.01</us-gaap:BusinessAcquisitionProFormaEarningsPerShareBasic>
    <us-gaap:BusinessAcquisitionProFormaEarningsPerShareBasic contextRef="From2018-01-01to2018-06-30_custom_TrxadeMember" unitRef="USDPShares" decimals="INF">0.00</us-gaap:BusinessAcquisitionProFormaEarningsPerShareBasic>
    <us-gaap:BusinessAcquisitionProFormaEarningsPerShareBasic contextRef="From2017-01-01to2017-12-31_custom_TrxadeMember" unitRef="USDPShares" decimals="INF">0.01</us-gaap:BusinessAcquisitionProFormaEarningsPerShareBasic>
    <us-gaap:BusinessAcquisitionProFormaEarningsPerShareBasic contextRef="From2018-01-01to2018-06-30" unitRef="USDPShares" decimals="INF">0.01</us-gaap:BusinessAcquisitionProFormaEarningsPerShareBasic>
    <us-gaap:BusinessAcquisitionProFormaEarningsPerShareBasic contextRef="From2018-04-01to2018-06-30" unitRef="USDPShares" decimals="INF">0.00</us-gaap:BusinessAcquisitionProFormaEarningsPerShareBasic>
    <us-gaap:BusinessAcquisitionProFormaEarningsPerShareBasic contextRef="From2018-04-01to2018-06-30_custom_TrxadeMember" unitRef="USDPShares" decimals="INF">0.00</us-gaap:BusinessAcquisitionProFormaEarningsPerShareBasic>
    <us-gaap:BusinessAcquisitionProFormaEarningsPerShareBasic contextRef="From2018-01-01to2018-12-31" unitRef="USDPShares" decimals="INF">0.00</us-gaap:BusinessAcquisitionProFormaEarningsPerShareBasic>
    <us-gaap:BusinessAcquisitionProFormaEarningsPerShareBasic contextRef="From2018-01-01to2018-12-31_custom_TrxadeMember" unitRef="USDPShares" decimals="INF">0.00</us-gaap:BusinessAcquisitionProFormaEarningsPerShareBasic>
    <us-gaap:BusinessAcquisitionProFormaEarningsPerShareDiluted contextRef="From2017-01-01to2017-12-31" unitRef="USDPShares" decimals="INF">0.01</us-gaap:BusinessAcquisitionProFormaEarningsPerShareDiluted>
    <us-gaap:BusinessAcquisitionProFormaEarningsPerShareDiluted contextRef="From2018-01-01to2018-06-30_custom_TrxadeMember" unitRef="USDPShares" decimals="INF">0.00</us-gaap:BusinessAcquisitionProFormaEarningsPerShareDiluted>
    <us-gaap:BusinessAcquisitionProFormaEarningsPerShareDiluted contextRef="From2017-01-01to2017-12-31_custom_TrxadeMember" unitRef="USDPShares" decimals="INF">0.01</us-gaap:BusinessAcquisitionProFormaEarningsPerShareDiluted>
    <us-gaap:BusinessAcquisitionProFormaEarningsPerShareDiluted contextRef="From2018-01-01to2018-06-30" unitRef="USDPShares" decimals="INF">0.00</us-gaap:BusinessAcquisitionProFormaEarningsPerShareDiluted>
    <us-gaap:BusinessAcquisitionProFormaEarningsPerShareDiluted contextRef="From2018-04-01to2018-06-30" unitRef="USDPShares" decimals="INF">0.00</us-gaap:BusinessAcquisitionProFormaEarningsPerShareDiluted>
    <us-gaap:BusinessAcquisitionProFormaEarningsPerShareDiluted contextRef="From2018-04-01to2018-06-30_custom_TrxadeMember" unitRef="USDPShares" decimals="INF">0.00</us-gaap:BusinessAcquisitionProFormaEarningsPerShareDiluted>
    <us-gaap:BusinessAcquisitionProFormaEarningsPerShareDiluted contextRef="From2018-01-01to2018-12-31" unitRef="USDPShares" decimals="INF">0.00</us-gaap:BusinessAcquisitionProFormaEarningsPerShareDiluted>
    <us-gaap:BusinessAcquisitionProFormaEarningsPerShareDiluted contextRef="From2018-01-01to2018-12-31_custom_TrxadeMember" unitRef="USDPShares" decimals="INF">0.00</us-gaap:BusinessAcquisitionProFormaEarningsPerShareDiluted>
    <us-gaap:WeightedAverageBasicSharesOutstandingProForma contextRef="From2017-01-01to2017-12-31" unitRef="Shares" decimals="INF">31955416</us-gaap:WeightedAverageBasicSharesOutstandingProForma>
    <us-gaap:WeightedAverageBasicSharesOutstandingProForma contextRef="From2018-01-01to2018-06-30_custom_TrxadeMember" unitRef="Shares" decimals="INF">31985827</us-gaap:WeightedAverageBasicSharesOutstandingProForma>
    <us-gaap:WeightedAverageBasicSharesOutstandingProForma contextRef="From2017-01-01to2017-12-31_custom_TrxadeMember" unitRef="Shares" decimals="INF">31955416</us-gaap:WeightedAverageBasicSharesOutstandingProForma>
    <us-gaap:WeightedAverageBasicSharesOutstandingProForma contextRef="From2018-01-01to2018-06-30" unitRef="Shares" decimals="INF">31985827</us-gaap:WeightedAverageBasicSharesOutstandingProForma>
    <us-gaap:WeightedAverageBasicSharesOutstandingProForma contextRef="From2018-04-01to2018-06-30" unitRef="Shares" decimals="INF">31985827</us-gaap:WeightedAverageBasicSharesOutstandingProForma>
    <us-gaap:WeightedAverageBasicSharesOutstandingProForma contextRef="From2018-04-01to2018-06-30_custom_TrxadeMember" unitRef="Shares" decimals="INF">31985827</us-gaap:WeightedAverageBasicSharesOutstandingProForma>
    <us-gaap:WeightedAverageBasicSharesOutstandingProForma contextRef="From2018-01-01to2018-12-31" unitRef="Shares" decimals="INF">32260622</us-gaap:WeightedAverageBasicSharesOutstandingProForma>
    <us-gaap:WeightedAverageBasicSharesOutstandingProForma contextRef="From2018-01-01to2018-12-31_custom_TrxadeMember" unitRef="Shares" decimals="INF">32260622</us-gaap:WeightedAverageBasicSharesOutstandingProForma>
    <us-gaap:ProFormaWeightedAverageSharesOutstandingDiluted contextRef="From2017-01-01to2017-12-31" unitRef="Shares" decimals="INF">34086251</us-gaap:ProFormaWeightedAverageSharesOutstandingDiluted>
    <us-gaap:ProFormaWeightedAverageSharesOutstandingDiluted contextRef="From2018-01-01to2018-06-30_custom_TrxadeMember" unitRef="Shares" decimals="INF">34472811</us-gaap:ProFormaWeightedAverageSharesOutstandingDiluted>
    <us-gaap:ProFormaWeightedAverageSharesOutstandingDiluted contextRef="From2017-01-01to2017-12-31_custom_TrxadeMember" unitRef="Shares" decimals="INF">34086251</us-gaap:ProFormaWeightedAverageSharesOutstandingDiluted>
    <us-gaap:ProFormaWeightedAverageSharesOutstandingDiluted contextRef="From2018-01-01to2018-06-30" unitRef="Shares" decimals="INF">34472811</us-gaap:ProFormaWeightedAverageSharesOutstandingDiluted>
    <us-gaap:ProFormaWeightedAverageSharesOutstandingDiluted contextRef="From2018-04-01to2018-06-30" unitRef="Shares" decimals="INF">34479406</us-gaap:ProFormaWeightedAverageSharesOutstandingDiluted>
    <us-gaap:ProFormaWeightedAverageSharesOutstandingDiluted contextRef="From2018-04-01to2018-06-30_custom_TrxadeMember" unitRef="Shares" decimals="INF">34479406</us-gaap:ProFormaWeightedAverageSharesOutstandingDiluted>
    <us-gaap:ProFormaWeightedAverageSharesOutstandingDiluted contextRef="From2018-01-01to2018-12-31" unitRef="Shares" decimals="INF">34958502</us-gaap:ProFormaWeightedAverageSharesOutstandingDiluted>
    <us-gaap:ProFormaWeightedAverageSharesOutstandingDiluted contextRef="From2018-01-01to2018-12-31_custom_TrxadeMember" unitRef="Shares" decimals="INF">34958502</us-gaap:ProFormaWeightedAverageSharesOutstandingDiluted>
    <TRXD:ExerciseRestrictionsLapsePeriod contextRef="From2018-10-14to2018-10-15_us-gaap_SubsequentEventMember_custom_CommunitySpecialtyPharmacyLLCMember">P3Y</TRXD:ExerciseRestrictionsLapsePeriod>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory contextRef="AsOf2018-10-15_custom_CommunitySpecialtyPharmacyLLCMember_us-gaap_SubsequentEventMember" unitRef="USD" decimals="0">76156</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables contextRef="AsOf2018-10-15_custom_CommunitySpecialtyPharmacyLLCMember_us-gaap_SubsequentEventMember" unitRef="USD" decimals="0">114899</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents contextRef="AsOf2018-10-15_custom_CommunitySpecialtyPharmacyLLCMember_us-gaap_SubsequentEventMember" unitRef="USD" decimals="0">49728</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets contextRef="AsOf2018-10-15_custom_CommunitySpecialtyPharmacyLLCMember_us-gaap_SubsequentEventMember" unitRef="USD" decimals="0">3000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets>
    <TRXD:ShortTermConvertibleNotesPayableRelatedParties contextRef="AsOf2018-12-31" unitRef="USD" decimals="0">140000</TRXD:ShortTermConvertibleNotesPayableRelatedParties>
    <TRXD:ShortTermConvertibleNotesPayableRelatedParties contextRef="AsOf2019-06-30" unitRef="USD" decimals="0">140000</TRXD:ShortTermConvertibleNotesPayableRelatedParties>
    <TRXD:ShortTermConvertibleNotesPayableRelatedParties contextRef="AsOf2019-06-30_custom_RelatedPartyConvertiblePromissoryNoteMember_custom_MrShilpaPatelMember" unitRef="USD" decimals="0">40000</TRXD:ShortTermConvertibleNotesPayableRelatedParties>
    <TRXD:ShortTermConvertibleNotesPayableRelatedParties contextRef="AsOf2017-12-31" unitRef="USD" decimals="0">251725</TRXD:ShortTermConvertibleNotesPayableRelatedParties>
    <TRXD:ShortTermConvertibleNotesPayableRelatedParties contextRef="AsOf2019-06-30_custom_RelatedPartyConvertiblePromissoryNoteMember_custom_MrNitilPatelMember" unitRef="USD" decimals="0">100000</TRXD:ShortTermConvertibleNotesPayableRelatedParties>
    <us-gaap:NotesPayableRelatedPartiesNoncurrent contextRef="AsOf2018-12-31" unitRef="USD" decimals="0">522552</us-gaap:NotesPayableRelatedPartiesNoncurrent>
    <us-gaap:NotesPayableRelatedPartiesNoncurrent contextRef="AsOf2019-06-30" unitRef="USD" decimals="0">522552</us-gaap:NotesPayableRelatedPartiesNoncurrent>
    <us-gaap:NotesPayableRelatedPartiesNoncurrent contextRef="AsOf2017-12-31" unitRef="USD" decimals="0">222552</us-gaap:NotesPayableRelatedPartiesNoncurrent>
    <us-gaap:NotesPayableRelatedPartiesNoncurrent contextRef="AsOf2019-06-30_custom_RelatedPartyPromissoryNoteMember_custom_MrPrashantPatelMember" unitRef="USD" decimals="0">122552</us-gaap:NotesPayableRelatedPartiesNoncurrent>
    <us-gaap:NotesPayableRelatedPartiesNoncurrent contextRef="AsOf2019-06-30_custom_RelatedPartyPromissoryNoteMember_custom_MrSurenAjjarapuMember" unitRef="USD" decimals="0">100000</us-gaap:NotesPayableRelatedPartiesNoncurrent>
    <us-gaap:ConversionOfStockAmountConverted1 contextRef="From2019-01-01to2019-06-30" unitRef="USD" decimals="0">211983</us-gaap:ConversionOfStockAmountConverted1>
    <us-gaap:ConversionOfStockAmountConverted1 contextRef="From2018-01-01to2018-06-30" unitRef="USD" xsi:nil="true" />
    <us-gaap:ConversionOfStockAmountConverted1 contextRef="From2019-02-01to2019-02-28_us-gaap_SubsequentEventMember" unitRef="USD" decimals="0">166</us-gaap:ConversionOfStockAmountConverted1>
    <us-gaap:OperatingLeaseRightOfUseAsset contextRef="AsOf2018-12-31" unitRef="USD" xsi:nil="true" />
    <us-gaap:OperatingLeaseRightOfUseAsset contextRef="AsOf2019-06-30" unitRef="USD" decimals="0">803502</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAsset contextRef="AsOf2019-06-30_custom_LeaseOneMember" unitRef="USD" decimals="0">534140</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAsset contextRef="AsOf2019-06-30_custom_LeaseTwoMember" unitRef="USD" decimals="0">313301</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseLiabilityCurrent contextRef="AsOf2018-12-31" unitRef="USD" xsi:nil="true" />
    <us-gaap:OperatingLeaseLiabilityCurrent contextRef="AsOf2019-06-30" unitRef="USD" decimals="0">80832</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent contextRef="AsOf2018-12-31" unitRef="USD" xsi:nil="true" />
    <us-gaap:OperatingLeaseLiabilityNoncurrent contextRef="AsOf2019-06-30" unitRef="USD" decimals="0">730333</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities contextRef="From2019-01-01to2019-03-31_us-gaap_PreferredStockMember" unitRef="USD" xsi:nil="true" />
    <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities contextRef="From2019-01-01to2019-03-31_us-gaap_CommonStockMember" unitRef="USD" decimals="0">4</us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities contextRef="From2019-01-01to2019-03-31_us-gaap_AdditionalPaidInCapitalMember" unitRef="USD" decimals="0">211979</us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities contextRef="From2019-01-01to2019-03-31_us-gaap_RetainedEarningsMember" unitRef="USD" xsi:nil="true" />
    <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities contextRef="From2019-01-01to2019-03-31" unitRef="USD" decimals="0">211983</us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities>
    <us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities contextRef="From2019-01-01to2019-03-31_us-gaap_PreferredStockMember" unitRef="Shares" xsi:nil="true" />
    <us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities contextRef="From2019-01-01to2019-03-31_us-gaap_CommonStockMember" unitRef="Shares" decimals="INF">423996</us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities>
    <us-gaap:Depreciation contextRef="From2019-01-01to2019-06-30" unitRef="USD" decimals="0">2500</us-gaap:Depreciation>
    <us-gaap:Depreciation contextRef="From2018-01-01to2018-06-30" unitRef="USD" xsi:nil="true" />
    <TRXD:AmortizationOfRightToUseAsset contextRef="From2019-01-01to2019-06-30" unitRef="USD" decimals="0">43939</TRXD:AmortizationOfRightToUseAsset>
    <TRXD:AmortizationOfRightToUseAsset contextRef="From2018-01-01to2018-06-30" unitRef="USD" xsi:nil="true" />
    <TRXD:RightUseOfAssetsAndOperatingLeaseObligationsRecognized contextRef="From2019-01-01to2019-06-30" unitRef="USD" decimals="0">847441</TRXD:RightUseOfAssetsAndOperatingLeaseObligationsRecognized>
    <TRXD:RightUseOfAssetsAndOperatingLeaseObligationsRecognized contextRef="From2018-01-01to2018-06-30" unitRef="USD" xsi:nil="true" />
    <us-gaap:OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock contextRef="From2019-01-01to2019-06-30">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;NOTE&#13;1 &amp;#8211; ORGANIZATION AND BASIS OF PRESENTATION&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Trxade&#13;Group, Inc. (&amp;#8220;we&amp;#8221;, &amp;#8220;our&amp;#8221;, &amp;#8220;Trxade&amp;#8221;, and the &amp;#8220;Company&amp;#8221;) owns 100% of&#13;Trxade, Inc., Integra Pharma Solutions, LLC, Community Specialty Pharmacy, LLC and Alliance Pharma Solutions, LLC. The merger&#13;of Trxade, Inc. and Trxade Group, Inc. occurred in May 2013. Community Specialty Pharmacy was acquired in October&#13;2018.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.5in"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Trxade,&#13;Inc. operates a web-based market platform that enables commerce among healthcare buyers and sellers of pharmaceuticals, accessories&#13;and services.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Integra&#13;Pharma Solutions, LLC is a licensed pharmaceutical wholesaler and sells brand, generic and non-drug products.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Community&#13;Specialty Pharmacy, LLC is an accredited independent retail pharmacy with a focus on specialty medications. The company operates&#13;with innovative pharmacy model which offers home delivery services to any patient thereby providing convenience.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Alliance&#13;Pharma Solutions, LLC has developed same day Pharma delivery software &amp;#8211; Delivmeds.com and invested in SyncHealth MSO, LLC&#13;a managed services organization during January 2019.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;i&gt;Basis&#13;of Presentation&lt;/i&gt; - The accompanying unaudited interim consolidated financial statements of Trxade Group, Inc. have been prepared&#13;in accordance with accounting principles generally accepted in the United States of America and the rules of the Securities and&#13;Exchange Commission and should be read in conjunction with the audited financial statements and notes thereto contained in the&#13;Company&amp;#8217;s Form 10K.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;In&#13;the opinion of management, all adjustments, consisting of normal recurring adjustments, necessary for a fair presentation of financial&#13;position and the results of operations for the interim periods presented have been reflected herein. The results of operations&#13;for the interim periods are not necessarily indicative of the results to be expected for the full year. Notes to the financial&#13;statements that would substantially duplicate the disclosures contained in the audited financial statements for the year ended&#13;December 31, 2018 as reported in the Company&amp;#8217;s Annual Report on Form 10K have been omitted.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;i&gt;Equity&#13;Investments&lt;/i&gt; &amp;#8211; If the investments are less than 50% owned and more than 20% owned the entities use the equity method&#13;of accounting in accordance with ASC 323-10 &amp;#8211; Investments &amp;#8211; Equity Method and Joint Ventures.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;The share of income (loss) of such entities is recorded as a single amount as share in equity income (loss)&#13;of investments. Dividends, if any, are recorded as a reduction of the investment.&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;i&gt;Income&#13;Per Common Share&lt;/i&gt; &amp;#8211; Basic net income per common share is computed by dividing net income available to common stockholders&#13;by the weighted average number of common shares outstanding. Diluted net income per common share is computed similar to basic&#13;net income per common share except that the denominator is increased to include the number of additional common shares that would&#13;have been outstanding if the potential common shares had been issued and if the additional common shares were dilutive. The dilutive&#13;effect of the Company&amp;#8217;s options and warrants is computed using the treasury stock method while the dilutive effect of our&#13;convertible notes is computed using the if-converted method.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;The&#13;following table sets forth the computation of basic and diluted Income per Share:&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="6" style="text-align: center; border-bottom: Black 1.5pt solid"&gt;For three months ended June 30,&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: center"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="6" style="text-align: center; border-bottom: Black 1.5pt solid"&gt;For six months ended June 30,&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: center"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid"&gt;2019&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: center"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid"&gt;2018&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: center"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid"&gt;2019&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: center"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid"&gt;2018&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: center"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="text-align: justify"&gt;Numerator:&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="width: 40%; text-align: justify"&gt;Net Income&lt;/td&gt;&lt;td style="width: 2%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 11%; text-align: right"&gt;57,981&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 11%; text-align: right"&gt;20,513&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 11%; text-align: right"&gt;183,210&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 11%; text-align: right"&gt;102,782&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="text-align: justify"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="text-align: left"&gt;Numerator for basic and diluted EPS - income available to common Shareholders&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;57,981&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;20,513&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;183,210&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;102,782&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="text-align: justify"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="text-align: justify"&gt;Denominator:&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="text-align: left"&gt;Denominator for basic EPS &amp;#8211; Weighted average shares&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;33,726,489&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;31,985,827&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;33,546,329&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;31,985,827&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="text-align: left"&gt;Dilutive Effect of Warrants, Options and Convertible Debt&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;2,627,262&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;2,493,579&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;2,807,422&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;2,486,984&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="text-align: left"&gt;Denominator for diluted EPS &amp;#8211; adjusted Weighted average shares and assumed Conversions&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;36,353,751&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;34,479,406&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;36,353,751&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;34,472,811&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="text-align: left"&gt;Basic and Diluted income per common share&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;0.00&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;0.00&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;0.01&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;0.00&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&#13;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;i&gt;&amp;#160;&lt;/i&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;i&gt;Recent&#13;Accounting Pronouncements &lt;/i&gt;&amp;#8211; The Company has implemented all new relevant accounting pronouncements that are in effect&#13;through the date of these financial statements. The pronouncements did not have any material impact on the financial statements&#13;unless otherwise disclosed, and the Company does not believe that there are any other new accounting pronouncements that have&#13;been issued that might have a material impact on its consolidated financial position or results of operations.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Effective&#13;January 1, 2019, the Company adopted ASU No. 2016-02, &lt;i&gt;Leases (Topic 842&lt;/i&gt;) (&amp;#8220;ASU 2016-02&amp;#8221;) using the required&#13;modified retrospective approach. The most significant changes under the new guidance include clarification of the definition of&#13;a lease, and the requirements for lessees to recognize a Right of Use (&amp;#8220;ROU&amp;#8221;) asset and a lease liability for all&#13;qualifying leases with terms longer than twelve months in the consolidated balance sheet. In addition, under Topic 842, additional&#13;disclosures are required to meet the objective of enabling users of financial statements to assess the amount, timing and uncertainty&#13;of cash flows arising from leases. See Footnote #7 below for more detail on the Company&amp;#8217;s accounting with respect to leases.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Effective&#13;January 1, 2019, the Company adopted ASU No. 2018-07, Compensation &amp;#8211; Stock Based Compensation (Topic 718): Improvements&#13;to Nonemployee Share-Based Payment Accounting (&amp;#8220;ASU 2018-7&amp;#8221;), which aligns accounting for share-based payments issued&#13;to nonemployees to that of employees under the existing guidance of Topic 718, with certain exceptions. This update supersedes&#13;previous guidance for equity-based payments to nonemployees under Subtopic 505-50, Equity &amp;#8211; Equity-Based Payments to Non-Employees.&#13;The adoption of ASU 2018-07 did not have a material impact on the Company&amp;#8217;s consolidated financial statements.&lt;/font&gt;&lt;/p&gt;</us-gaap:OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock>
    <us-gaap:OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock contextRef="From2018-01-01to2018-12-31">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;NOTE&#13;1 &amp;#8211; ORGANIZATION&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Trxade&#13;Group, Inc. (&amp;#8220;we&amp;#8221;, &amp;#8220;our&amp;#8221;, &amp;#8220;Trxade&amp;#8221;, and the &amp;#8220;Company&amp;#8221;) owns 100% of&#13;Trxade, Inc., Integra Pharma Solutions, LLC, Community Specialty Pharmacy, LLC and Alliance Pharma Solutions, LLC. The merger&#13;of Trxade, Inc. and Trxade Group, Inc. occurred in May 2013. Community Specialty Pharmacy was acquired October&#13;2018.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Trxade,&#13;Inc. operates a web-based market platform that enables commerce among healthcare buyers and sellers of pharmaceuticals, accessories&#13;and services.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Integra&#13;Pharma Solutions, LLC is a licensed pharmaceutical wholesaler and sells brand, generic and non-drug products.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Community&#13;Specialty Pharmacy, LLC is an accredited independent retail pharmacy with a focus on specialty medications. The company operates&#13;with innovative pharmacy model which offers home delivery services to any patient thereby providing convenience.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;Alliance&#13;Pharma Solutions, LLC has developed same day Pharma delivery software &amp;#8211; Delivmeds.com and invested in SyncHealth MSO, LLC&#13;a managed services organization in January 2019. (See Note 13).&lt;/font&gt;&lt;/p&gt;</us-gaap:OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock>
    <us-gaap:LesseeOperatingLeasesTextBlock contextRef="From2019-01-01to2019-06-30">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;NOTE&#13;7 &amp;#8211; LEASES&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;The&#13;Company elected the practical expedient under ASU 2018-11 &amp;#8220;Leases: Targeted Improvements&amp;#8221; which allows the Company&#13;to apply the transition provision for Topic 842 at the Company&amp;#8217;s adoption date instead of at the earliest comparative&#13;period presented in the financial statements. Therefore, the Company recognized and measured leases existing at January 1, 2019&#13;but without retrospective application. In addition, the Company elected the optional practical expedient permitted under the transition&#13;guidance which allows the Company to carry forward the historical accounting treatment for existing leases upon adoption. No impact&#13;was recorded to the beginning retained earnings for Topic 842. The Company has two operating leases for corporate offices. The&#13;following table outlines the details:&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid"&gt;Lease 1&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid"&gt;Lease 2&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="text-align: left"&gt;Initial Lease Term&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;December 2017 to December 2021&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;November 2018 to November 2023&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="text-align: left"&gt;Renewal Term&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;January 2021 to December 2024&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;November 2023 to November 2028&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="width: 36%; text-align: left"&gt;Initial Recognition of Right to use assets at January 1, 2019&lt;/td&gt;&lt;td style="width: 2%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 28%; text-align: right"&gt;534,140&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 28%; text-align: right"&gt;313,301&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="text-align: left"&gt;Incremental Borrowing Rate&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;10&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;10&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;The&#13;table below reconciles the fixed component of the undiscounted cash flows for each of the first five years and the total remaining&#13;years to the operating lease liabilities recorded in the Consolidated Balance Sheet as of June 30, 2019&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;table cellpadding="0" cellspacing="0" align="center" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="font-weight: bold; text-align: justify; border-bottom: Black 1.5pt solid"&gt;Amounts due within twelve months of June 30&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="width: 78%; text-align: justify"&gt;2019&lt;/td&gt;&lt;td style="width: 2%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 18%; text-align: right"&gt;158,366&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="text-align: justify"&gt;2020&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;163,102&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="text-align: justify"&gt;2021&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;167,984&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="text-align: justify"&gt;2022&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;173,038&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="text-align: justify"&gt;2023&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;178,237&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="text-align: justify; padding-bottom: 1.5pt"&gt;Thereafter&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;305,012&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="text-align: justify"&gt;Total minimum lease payments&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,145,739&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="text-align: justify; padding-bottom: 1.5pt"&gt;Less: effect of discounting&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(334,574&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="text-align: justify"&gt;Present value of future minimum lease payments&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;811,165&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="text-align: justify; padding-bottom: 1.5pt"&gt;Less: current obligations under leases&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;80,832&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="text-align: justify; padding-bottom: 2.5pt"&gt;Long-term lease obligations&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;730,333&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;For&#13;the three-months and six-months ended June 30, 2019 amortization of assets were $22,195 and $43,939, respectively.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;For&#13;the three-months and six-months ended June 30, 2019, amortization of liabilities were $18,363 and 36,276, respectively.&lt;/font&gt;&lt;/p&gt;</us-gaap:LesseeOperatingLeasesTextBlock>
    <us-gaap:LeaseCostTableTextBlock contextRef="From2019-01-01to2019-06-30">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;The&#13;following table outlines the details:&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid"&gt;Lease 1&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid"&gt;Lease 2&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="text-align: left"&gt;Initial Lease Term&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;December 2017 to December 2021&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;November 2018 to November 2023&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="text-align: left"&gt;Renewal Term&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;January 2021 to December 2024&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;November 2023 to November 2028&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="width: 36%; text-align: left"&gt;Initial Recognition of Right to use assets at January 1, 2019&lt;/td&gt;&lt;td style="width: 2%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 28%; text-align: right"&gt;534,140&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 28%; text-align: right"&gt;313,301&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="text-align: left"&gt;Incremental Borrowing Rate&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;10&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;10&lt;/td&gt;&lt;td style="text-align: left"&gt;%&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:LeaseCostTableTextBlock>
    <us-gaap:RepaymentsOfShortTermDebt contextRef="From2019-01-01to2019-06-30" unitRef="USD" xsi:nil="true" />
    <us-gaap:RepaymentsOfShortTermDebt contextRef="From2017-01-01to2017-12-31" unitRef="USD" decimals="0">432685</us-gaap:RepaymentsOfShortTermDebt>
    <us-gaap:RepaymentsOfShortTermDebt contextRef="From2018-01-01to2018-06-30" unitRef="USD" decimals="0">10739</us-gaap:RepaymentsOfShortTermDebt>
    <us-gaap:RepaymentsOfShortTermDebt contextRef="From2018-01-01to2018-12-31" unitRef="USD" decimals="0">10739</us-gaap:RepaymentsOfShortTermDebt>
    <TRXD:OperatingLeaseAmortizationOfLiabilities contextRef="From2019-01-01to2019-06-30" unitRef="USD" decimals="0">36276</TRXD:OperatingLeaseAmortizationOfLiabilities>
    <TRXD:OperatingLeaseAmortizationOfLiabilities contextRef="From2019-04-01to2019-06-30" unitRef="USD" decimals="0">18363</TRXD:OperatingLeaseAmortizationOfLiabilities>
    <TRXD:OperatingLeasesUnits contextRef="From2019-01-01to2019-06-30" unitRef="Integer" decimals="INF">2</TRXD:OperatingLeasesUnits>
    <TRXD:OperatingLeaseInitialLeaseTerm contextRef="From2019-01-01to2019-06-30_custom_LeaseOneMember">December 2017 to December 2021</TRXD:OperatingLeaseInitialLeaseTerm>
    <TRXD:OperatingLeaseInitialLeaseTerm contextRef="From2019-01-01to2019-06-30_custom_LeaseTwoMember">November 2018 to November 2023</TRXD:OperatingLeaseInitialLeaseTerm>
    <TRXD:OperatingLeaseRenewalTerm contextRef="From2019-01-01to2019-06-30_custom_LeaseOneMember">January 2021 to December 2024</TRXD:OperatingLeaseRenewalTerm>
    <TRXD:OperatingLeaseRenewalTerm contextRef="From2019-01-01to2019-06-30_custom_LeaseTwoMember">November 2023 to November 2028</TRXD:OperatingLeaseRenewalTerm>
    <us-gaap:LesseeOperatingLeaseDiscountRate contextRef="AsOf2019-06-30_custom_LeaseOneMember" unitRef="Percentage" decimals="INF">0.10</us-gaap:LesseeOperatingLeaseDiscountRate>
    <us-gaap:LesseeOperatingLeaseDiscountRate contextRef="AsOf2019-06-30_custom_LeaseTwoMember" unitRef="Percentage" decimals="INF">0.10</us-gaap:LesseeOperatingLeaseDiscountRate>
    <us-gaap:ShortTermDebtTextBlock contextRef="From2019-01-01to2019-06-30">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;NOTE&#13;2 &amp;#8211; SHORT-TERM DEBT AND RELATED PARTIES DEBT&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Convertible&#13;Promissory Note&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&amp;#160;&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;In&#13;February 2019, convertible promissory notes issued in 2015 for $181,500 were amended to a conversion price of $0.50 and the principal&#13;and accrued interest total of $211,983 were then converted to 423,966 common shares.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;As&#13;of June 30, 2019 and December 31, 2018, short-tern convertible notes payable has a balance of $0 and $181,500 respectively, net&#13;of $0 unamortized debt discount.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&amp;#160;&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Related&#13;Party Convertible Promissory Notes&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;As&#13;of June 30, 2019, $40,000 in convertible promissory notes were due to Mr. Shilpa Patel, a relative of Mr. Prashant Patel. Simple&#13;interest of 10% is payable at the maturity date of the note, which is August 8, 2019. Prior to maturity the note may be converted&#13;for common stock at a conversion price of $1.50.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;As&#13;of June 30, 2019, $100,000 in convertible promissory notes were due to Mr. Nitil Patel, the brother of Mr. Prashant Patel. Simple&#13;interest of 10% is payable at the maturity date of the notes, which is July 7, 2019. Prior to maturity the notes may be converted&#13;for common stock at a conversion price of $0.62. In July 2019, the note was extended to October 15, 2019.&lt;/font&gt;&lt;/p&gt;</us-gaap:ShortTermDebtTextBlock>
    <us-gaap:ShortTermDebtTextBlock contextRef="From2018-01-01to2018-12-31">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;NOTE&#13;3 &amp;#8211; SHORT-TERM DEBT AND RELATED PARTIES DEBT&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Convertible&#13;Promissory Note&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&amp;#160;&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Convertible&#13;promissory notes were issued in the aggregate amount of $200,000 in April and May 2015. The term of the notes was one year. Simple&#13;interest of 10% was payable at the maturity date of the note. Prior to maturity the notes may be converted for Common Stock at&#13;a conversion price of $1.50. The holders of the notes were granted warrants at one share of Common Stock for every $4.00 of the&#13;note principal amount, which totaled a warrant to purchase 50,000 shares of Common Stock. These warrants were issued at a strike&#13;price of $1.50 and an expiration date of five years from date of issuance. The Company used the Black-Scholes pricing model to&#13;estimate the fair value of the warrants issued along with convertible notes on the date of grant. The Company accounted for the&#13;relative fair value of the warrants issued and a total debt discount $53,546 was recorded.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;In&#13;April and May 2016, $50,000 of the $200,000 in convertible promissory notes (plus $5,000 in interest) was repaid. A one-year extension&#13;was executed on the remaining notes and the interest owed, totaling $15,000 became part of the adjusted principal of notes and&#13;the balance of $165,000 is due May 2017. In connection with the one-year extension of the maturity date of the outstanding notes,&#13;the holders of the notes were granted warrants at one Common Stock for $4.00 of the note amount and warrants to purchase 41,250&#13;shares of Common Stock were issued at a strike price of $1.50 and an expiration date of five years from date of issuance. The&#13;amendment of the note was considered a debt extinguishment and a loss on extinguishment of debt was booked in the amount of $37,579.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;In&#13;April 2017, $165,000 in convertible promissory notes (plus $5,500 in interest) was amended. A two-year extension was executed&#13;on the remaining notes and the interest owed, totaling $16,500 became part of the adjusted principal of the notes and the balance&#13;of $181,500 is due May 2019. The conversion price was adjusted to $0.85 per share. In connection with the two-year extension of&#13;the maturity date of the outstanding notes, the holders of the notes were granted warrants to purchase 18,150 shares of Common&#13;Stock that was issued at a strike price of $0.65 and an expiration date of five years from date of issuance. The amendment of&#13;the note was considered a debt extinguishment and a loss on extinguishment of debt was booked in the amount of $11,512.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;The&#13;Company evaluated the embedded conversion feature within the above convertible notes under ASC 815-15 and ASC 815-40 and determined&#13;that the embedded conversion feature does not meet the definition of a derivative liability. Then the Company evaluated the conversion&#13;feature for a beneficial conversion feature at inception. The Company accounted for the intrinsic value of a Beneficial Conversion&#13;Feature inherent to the convertible note payable the conversion was not beneficial and a total debt discount from the issued warrants&#13;of $53,546 was recorded in 2015 and $0 as of the date of the debt modification.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="margin: 0; text-align: justify; font: 10pt Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;During&#13;2017, debt discount of $0 was amortized. As of December 31, 2018 and 2017, short-tern convertible note has a balance of $181,500&#13;and $0 respectively, net of $0 unamortized debt discount.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Promissory&#13;Note&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&amp;#160;&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;In&#13;May 2016, a promissory note that was issued in May 2015 was renewed in the face amount of $250,000 and the term was extended an&#13;additional year. The note has an original issuance discount of $45,000 and this amount was paid in cash at the renewal. During&#13;2016, a debt discount of $45,000 was amortized. As of December 31, 2016, the promissory note has a balance of $250,000 with an&#13;unamortized debt discount of $15,000.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;During&#13;2017 the debt discount of $15,000 was fully amortized and the balance of $250,000 was paid.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;In&#13;October 2016, a promissory note was issued in the face amount of $47,000. The term of the note was one year. Payments are made&#13;daily and $3,917 of principal was paid in 2016. At December 31, 2016 the balance was $43,083.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;In&#13;2017 $43,083 of principal was paid and at December 31, 2017 the balance was $0.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;In&#13;September 2016, a promissory note was issued for $189,000. The term of the note is 494 days. The debt discount was $39,000 thus&#13;the initial net proceeds were $150,000. At December 31, 2016, $139,602 was classified as short term with a discount of $25,306&#13;and $10,739 was classified as long term with a discount of $152. Payments are made each weekday in the amount of $537. In 2017,&#13;$139,602 was paid off by cash and debt discount of $25,306 was amortized.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;As&#13;of December 31, 2017, short term promissory notes have a balance of $10,739, net of $152 unamortized debt discount.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;In&#13;2018, $10,739 was paid off by cash and the debt discount of $152 was amortized.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&amp;#160;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;As&#13;of December 31, 2018, short term promissory notes have a balance of $0, net of $0 unamortized debt discount.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Related&#13;Party Convertible Promissory Notes&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&amp;#160;&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;In&#13;August 2016, $40,000 in promissory notes were issued to Mr. Shilpa Patel, a relative of Mr. Prashant Patel. The term of the note&#13;was one year. Simple interest of 10% is payable at the maturity date of the note. Prior to maturity the note may be converted&#13;for Common Stock at a conversion price of $1.50.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;In&#13;August 2017, $40,000 in convertible promissory notes was amended. A one-year extension was executed to August 2018. In connection&#13;with the one-year extension of the maturity date of the outstanding notes, the holder of the notes was granted warrants to purchase&#13;10,000 shares of Common Stock that was issued at a strike price of $0.80 and an expiration date of five years from date of issuance.&#13;The amendment of the note was considered a debt extinguishment and a loss on extinguishment of debt was booked in the amount of&#13;$5,044.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;In&#13;August 2018, $40,000 in convertible promissory notes was amended. A one-year extension was executed to August 2019. In connection&#13;with the one-year extension of the maturity date of the outstanding notes, the holder of the notes was granted warrants to purchase&#13;10,000 shares of Common Stock that was issued at a strike price of $0.50 and an expiration date of five years from date of issuance.&#13;The amendment of the note was considered a debt extinguishment and a loss on extinguishment of debt was booked in the amount of&#13;$7,444.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;The&#13;Company evaluated the embedded conversion feature within the above convertible notes under ASC 815-15 and ASC 815-40 and determined&#13;that the embedded conversion feature does not meet the definition of a derivative liability. Then the Company evaluated the conversion&#13;feature for a beneficial conversion feature at inception. The Company accounted for the intrinsic value of a Beneficial Conversion&#13;Feature inherent to the convertible note payable and $0 was recorded as of the grant date.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;In&#13;September and October 2016, convertible promissory notes were issued in the aggregate amount of $211,725 to a related party, Mr.&#13;Nitil Patel, the brother of Mr. Prashant Patel. The term of the notes was one year. Simple interest of 10% is payable at the maturity&#13;date of the notes. Prior to maturity the notes may be converted for Common Stock at a conversion price of $0.62. In connection&#13;with the notes, the holders of the notes were granted warrants to purchase 52,861 shares of Common Stock. These warrants were&#13;issued at a strike price of $0.62 and an expiration date of five years from date of issuance.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;The&#13;Company evaluated the embedded conversion feature within the above convertible notes under ASC 815-15 and ASC 815-40 and determined&#13;that the embedded conversion feature does not meet the definition of a derivative liability. Then the Company evaluated the conversion&#13;feature for a beneficial conversion feature at inception. The Company accounted for the intrinsic value of a Beneficial Conversion&#13;Feature inherent to the convertible note payable and the beneficial feature was not beneficial and a total debt discount of $65,390&#13;due to the warrants was recorded as of the grant date.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;In&#13;April 2017, a $61,725 related party note was renewed for a one-year extension at the same interest rate of 10%, due April 2018.&#13;In April 2018, $61,725 was paid in cash for full payment.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;In&#13;September 2017, a $150,000 related party note was renewed for a six-month extension at the same interest rate of 10%, due in February&#13;2018. In February 2018, $100,000 of the related party note was extended to July 2018 and then renewed for a year extension at&#13;the same interest rate of 10%, due July 2019. The remaining $50,000 was paid in cash in February 2018.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;During&#13;2017, the remaining debt discount of $48,341 was fully amortized. As of December 31, 2017, the short-term related party convertible&#13;notes had a principal balance of $251,725, net of an unamortized debt discount of $0.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;As&#13;of December 31, 2018, the short-term related party convertible notes had a principal balance of $140,000, net of an unamortized&#13;debt discount of $0.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;Related&#13;Party Promissory Note&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&amp;#160;&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;In&#13;November 2016, Mr. Prashant Patel loaned the Company $10,000. The term of the loan is 90 days and is at zero percent interest.&#13;The balance at December 31, 2016 was $10,000.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;In&#13;February 2017, $7,280 of accounts payable to Mr. Patel was added to the loan. The term of the loan was extended for 90 days and&#13;is at zero interest rate. An additional $25,272 of accounts payable was added to the loan in the second quarter and the balance&#13;of $42,552 was converted to long-term debt in July 2017 and will mature in July 2020. (See Note 4).&lt;/font&gt;&lt;/p&gt;</us-gaap:ShortTermDebtTextBlock>
    <us-gaap:EarningsPerSharePolicyTextBlock contextRef="From2019-01-01to2019-06-30">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;i&gt;ncome&#13;Per Common Share&lt;/i&gt; &amp;#8211; Basic net income per common share is computed by dividing net income available to common stockholders&#13;by the weighted average number of common shares outstanding. Diluted net income per common share is computed similar to basic&#13;net income per common share except that the denominator is increased to include the number of additional common shares that would&#13;have been outstanding if the potential common shares had been issued and if the additional common shares were dilutive. The dilutive&#13;effect of the Company&amp;#8217;s options and warrants is computed using the treasury stock method while the dilutive effect of our&#13;convertible notes is computed using the if-converted method.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;The&#13;following table sets forth the computation of basic and diluted Income per Share:&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="6" style="text-align: center; border-bottom: Black 1.5pt solid"&gt;For three months ended June 30,&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: center"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="6" style="text-align: center; border-bottom: Black 1.5pt solid"&gt;For six months ended June 30,&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: center"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid"&gt;2019&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: center"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid"&gt;2018&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: center"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid"&gt;2019&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: center"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: center"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid"&gt;2018&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: center"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="text-align: justify"&gt;Numerator:&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="width: 40%; text-align: justify"&gt;Net Income&lt;/td&gt;&lt;td style="width: 2%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 11%; text-align: right"&gt;57,981&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 11%; text-align: right"&gt;20,513&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 11%; text-align: right"&gt;183,210&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 11%; text-align: right"&gt;102,782&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="text-align: justify"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="text-align: left"&gt;Numerator for basic and diluted EPS - income available to common Shareholders&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;57,981&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;20,513&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;183,210&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;102,782&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="text-align: justify"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="text-align: justify"&gt;Denominator:&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="text-align: left"&gt;Denominator for basic EPS &amp;#8211; Weighted average shares&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;33,726,489&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;31,985,827&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;33,546,329&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;31,985,827&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="text-align: left"&gt;Dilutive Effect of Warrants, Options and Convertible Debt&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;2,627,262&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;2,493,579&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;2,807,422&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;2,486,984&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="text-align: left"&gt;Denominator for diluted EPS &amp;#8211; adjusted Weighted average shares and assumed Conversions&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;36,353,751&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;34,479,406&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;36,353,751&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;34,472,811&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="text-align: left"&gt;Basic and Diluted income per common share&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;0.00&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;0.00&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;0.01&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;0.00&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:EarningsPerSharePolicyTextBlock>
    <us-gaap:EarningsPerSharePolicyTextBlock contextRef="From2018-01-01to2018-12-31">&lt;p style="margin: 0pt"&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Income (loss) Per Share &amp;#8211; Basic net income&#13;(loss) per common share is computed by dividing net loss available to common stockholders by the weighted average number of common&#13;shares outstanding. Diluted net loss per common share is computed similar to basic net loss per common share except that the denominator&#13;is increased to include the number of additional common shares that would have been outstanding if the potential common shares&#13;had been issued and if the additional common shares were dilutive. The treasury stock method and as if converted methods are used&#13;to determine the dilutive shares for our options and warrants and convertible notes, respectively.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The following table sets forth the computation&#13;of basic and diluted income per common share for the years ended December 31, 2018 and 2017:&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;December 31, 2018&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;December 31, 2017&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Numerator:&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td style="width: 62%"&gt;&lt;font style="font-size: 10pt"&gt;Net Income&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 16%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;9,038&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 16%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;288,983&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Numerator for basic and diluted income available to common shareholders&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;9,038&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;288,983&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Denominator:&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Denominator for basic income per common share &amp;#8211; Weighted average common shares outstanding&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;32,260,622&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;31,955,416&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Dilutive effect of Common Stock Equivalents&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;2,697,880&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;2,130,835&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Denominator for diluted income per common share &amp;#8211; adjusted weighted average common shares outstanding&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;34,958,502&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;34,086,251&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Basic and Diluted income per common share&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;0.00&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;0.01&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&#13;&#13;&lt;p style="margin: 0pt"&gt;&lt;/p&gt;</us-gaap:EarningsPerSharePolicyTextBlock>
    <us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock contextRef="From2019-01-01to2019-06-30">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;The&#13;Company classifies its business interests into reportable segments which are Trxade, Community and Other.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;table cellpadding="0" cellspacing="0" align="center" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;Six Months Ended June 30, 2019&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;Trxade, Inc.&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;Community Specialty Pharmacy, LLC&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;Other&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&amp;#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;Total&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="width: 36%"&gt;Revenue&lt;/td&gt;&lt;td style="width: 2%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;2,182,668&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;892,357&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;353,910&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;3,428,935&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="text-align: left"&gt;Segment Assets&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;1,401,724&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;224,863&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;2,051,478&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;3,678,065&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="text-align: left"&gt;Segment Profit/Loss&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;1,166,543&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;(61,628&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;(921,705&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;183,210&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock>
    <us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock contextRef="From2018-01-01to2018-12-31">&lt;p style="margin: 0pt"&gt;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Year Ended December 31, 2018&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Trxade, Inc.&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Community Specialty Pharmacy,&amp;#160;LLC&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;&lt;b&gt;Other&lt;/b&gt;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="width: 46%"&gt;&lt;font style="font-size: 10pt"&gt;Revenue&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 14%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;3,407,822&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 16%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;395,418&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 15%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;28,538&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Gross Profit&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;3,407,822&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;(34,971&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;9,878&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Segment Assets&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;822,412&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;112,123&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;1,293,052&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Segment Profit/Loss&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;1,371,615&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;(116,588&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;(1,245,989&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&#13;&#13;&lt;p style="margin: 0pt"&gt;&lt;/p&gt;</us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock>
    <TRXD:IncreaseDecreaseInLeaseLiability contextRef="From2019-01-01to2019-06-30" unitRef="USD" decimals="0">36276</TRXD:IncreaseDecreaseInLeaseLiability>
    <TRXD:IncreaseDecreaseInLeaseLiability contextRef="From2018-01-01to2018-06-30" unitRef="USD" xsi:nil="true" />
    <us-gaap:EquityMethodInvestments contextRef="AsOf2018-12-31" unitRef="USD" xsi:nil="true" />
    <us-gaap:EquityMethodInvestments contextRef="AsOf2019-06-30" unitRef="USD" decimals="0">162178</us-gaap:EquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments contextRef="From2019-01-01to2019-06-30" unitRef="USD" decimals="0">-87822</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments contextRef="From2018-01-01to2018-06-30" unitRef="USD" xsi:nil="true" />
    <us-gaap:IncomeLossFromEquityMethodInvestments contextRef="From2019-04-01to2019-06-30" unitRef="USD" decimals="0">-58850</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments contextRef="From2018-04-01to2018-06-30" unitRef="USD" xsi:nil="true" />
    <us-gaap:PaymentsToAcquireEquityMethodInvestments contextRef="From2019-01-01to2019-06-30" unitRef="USD" decimals="0">250000</us-gaap:PaymentsToAcquireEquityMethodInvestments>
    <us-gaap:PaymentsToAcquireEquityMethodInvestments contextRef="From2018-01-01to2018-06-30" unitRef="USD" xsi:nil="true" />
    <us-gaap:EquityMethodInvestmentsDisclosureTextBlock contextRef="From2019-01-01to2019-06-30">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;NOTE&#13;10 &amp;#8211; EQUITY METHOD INVESTMENT&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&amp;#160;&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;In&#13;January 2019, Trxade Group, Inc. through its wholly-owned subsidiary Alliance Pharma Solution, LLC (Alliance) entered into a transaction&#13;to form SyncHealth MSO, LLC (&amp;#8220;SyncHealth&amp;#8221;). SyncHealth is owned by PanOptic Health, LLC (PanOptic) and Alliance. Alliance&#13;contributed $250,000 for the acquisition of a 49% equity interest in SyncHealth and the option to acquire the remaining ownership&#13;from PanOptic shareholders. Prior to March 31, 2019, $210,000 was paid with the remaining $40,000 paid in April 2019. Pursuant&#13;to the operating agreement, PanOptic owns 70% of SyncHealth and Alliance owns 30%; however, pursuant to the Letter Agreement,&#13;PanOptic will transfer to Alliance an additional 6% of SyncHealth&amp;#8217;s membership units on May 1, 2019, an additional 6% on&#13;August 1, 2019 and an additional 7% on November 1, 2019 and at Alliance&amp;#8217;s option, the 51% balance on January 31, 2020, upon&#13;transfer of Trxade Group, Inc. stock between 2,273,329 and 14,776,638 based on 2019 Gross Revenue Quotas.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;For&#13;the three-months and six-months ended June 30, 2019, the Company recorded its equity share in the losses of SyncHealth amounting&#13;to $58,850 and $87,822, respectively.&lt;/font&gt;&lt;/p&gt;</us-gaap:EquityMethodInvestmentsDisclosureTextBlock>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues contextRef="From2018-07-01to2018-07-31_custom_PrivateOfferMemorandumMember" unitRef="Shares" decimals="INF">300000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues contextRef="From2017-01-01to2017-12-31_us-gaap_PreferredStockMember" unitRef="Shares" xsi:nil="true" />
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues contextRef="From2018-01-01to2018-12-31_us-gaap_PreferredStockMember" unitRef="Shares" xsi:nil="true" />
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues contextRef="From2017-01-01to2017-12-31_us-gaap_CommonStockMember" unitRef="Shares" decimals="INF">250000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues contextRef="From2018-01-01to2018-12-31_us-gaap_CommonStockMember" unitRef="Shares" decimals="INF">1300000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues contextRef="From2017-01-01to2017-01-31_custom_PrivateOfferMemorandumMember" unitRef="Shares" decimals="INF">250000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues contextRef="From2018-11-01to2018-11-30_custom_PrivateOfferMemorandumMember" unitRef="Shares" decimals="INF">1000000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues contextRef="From2019-01-01to2019-06-30_srt_MinimumMember" unitRef="Shares" decimals="INF">2273329</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues contextRef="From2019-01-01to2019-06-30_srt_MaximumMember" unitRef="Shares" decimals="INF">14776638</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues contextRef="From2019-07-09to2019-07-10_us-gaap_SubsequentEventMember_custom_SecuritiesPurchaseAgreementMember_custom_AccreditedInvestorMember" unitRef="Shares" decimals="INF">2000000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues contextRef="From2019-09-29to2019-09-30_us-gaap_SubsequentEventMember_custom_SecuritiesPurchaseAgreementMember_custom_AccreditedInvestorMember" unitRef="Shares" decimals="INF">2910000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock contextRef="From2019-01-01to2019-06-30">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;The&#13;table below reconciles the fixed component of the undiscounted cash flows for each of the first five years and the total remaining&#13;years to the operating lease liabilities recorded in the Consolidated Balance Sheet as of June 30, 2019&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;table cellpadding="0" cellspacing="0" align="center" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="font-weight: bold; text-align: justify; border-bottom: Black 1.5pt solid"&gt;Amounts due within twelve months of June 30&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: right"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="width: 78%; text-align: justify"&gt;2019&lt;/td&gt;&lt;td style="width: 2%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 18%; text-align: right"&gt;158,366&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="text-align: justify"&gt;2020&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;163,102&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="text-align: justify"&gt;2021&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;167,984&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="text-align: justify"&gt;2022&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;173,038&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="text-align: justify"&gt;2023&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;178,237&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="text-align: justify; padding-bottom: 1.5pt"&gt;Thereafter&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;305,012&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="text-align: justify"&gt;Total minimum lease payments&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;1,145,739&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="text-align: justify; padding-bottom: 1.5pt"&gt;Less: effect of discounting&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;(334,574&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="text-align: justify"&gt;Present value of future minimum lease payments&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;811,165&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="text-align: justify; padding-bottom: 1.5pt"&gt;Less: current obligations under leases&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;80,832&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="text-align: justify; padding-bottom: 2.5pt"&gt;Long-term lease obligations&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;730,333&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock>
    <us-gaap:OperatingLeaseLiability contextRef="AsOf2019-06-30" unitRef="USD" decimals="0">811165</us-gaap:OperatingLeaseLiability>
    <us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount contextRef="AsOf2019-06-30" unitRef="USD" decimals="0">334574</us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue contextRef="AsOf2019-06-30" unitRef="USD" decimals="0">1145739</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="AsOf2018-12-31" unitRef="USD" decimals="0">869557</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="AsOf2019-06-30" unitRef="USD" decimals="0">540034</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="AsOf2017-12-31" unitRef="USD" decimals="0">183914</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <TRXD:StockIssuedDuringPeriodValueStockWarrantExercised contextRef="From2017-01-01to2017-12-31" unitRef="USD" decimals="0">250</TRXD:StockIssuedDuringPeriodValueStockWarrantExercised>
    <TRXD:StockIssuedDuringPeriodValueStockWarrantExercised contextRef="From2017-01-01to2017-12-31_us-gaap_PreferredStockMember" unitRef="USD" xsi:nil="true" />
    <TRXD:StockIssuedDuringPeriodValueStockWarrantExercised contextRef="From2018-01-01to2018-12-31_us-gaap_PreferredStockMember" unitRef="USD" xsi:nil="true" />
    <TRXD:StockIssuedDuringPeriodValueStockWarrantExercised contextRef="From2017-01-01to2017-12-31_us-gaap_CommonStockMember" unitRef="USD" xsi:nil="true" />
    <TRXD:StockIssuedDuringPeriodValueStockWarrantExercised contextRef="From2018-01-01to2018-12-31_us-gaap_CommonStockMember" unitRef="USD" xsi:nil="true" />
    <TRXD:StockIssuedDuringPeriodValueStockWarrantExercised contextRef="From2017-01-01to2017-12-31_us-gaap_AdditionalPaidInCapitalMember" unitRef="USD" decimals="0">250</TRXD:StockIssuedDuringPeriodValueStockWarrantExercised>
    <TRXD:StockIssuedDuringPeriodValueStockWarrantExercised contextRef="From2017-01-01to2017-12-31_us-gaap_RetainedEarningsMember" unitRef="USD" xsi:nil="true" />
    <TRXD:StockIssuedDuringPeriodValueStockWarrantExercised contextRef="From2019-01-01to2019-03-31_us-gaap_PreferredStockMember" unitRef="USD" xsi:nil="true" />
    <TRXD:StockIssuedDuringPeriodValueStockWarrantExercised contextRef="From2019-01-01to2019-03-31_us-gaap_CommonStockMember" unitRef="USD" decimals="0">1</TRXD:StockIssuedDuringPeriodValueStockWarrantExercised>
    <TRXD:StockIssuedDuringPeriodValueStockWarrantExercised contextRef="From2019-01-01to2019-03-31_us-gaap_AdditionalPaidInCapitalMember" unitRef="USD" decimals="0">165</TRXD:StockIssuedDuringPeriodValueStockWarrantExercised>
    <TRXD:StockIssuedDuringPeriodValueStockWarrantExercised contextRef="From2019-01-01to2019-03-31_us-gaap_RetainedEarningsMember" unitRef="USD" xsi:nil="true" />
    <TRXD:StockIssuedDuringPeriodValueStockWarrantExercised contextRef="From2019-01-01to2019-03-31" unitRef="USD" decimals="0">166</TRXD:StockIssuedDuringPeriodValueStockWarrantExercised>
    <TRXD:StockIssuedDuringPeriodSharesStockWarrantExercised contextRef="From2019-01-01to2019-06-30" unitRef="Shares" decimals="INF">16666</TRXD:StockIssuedDuringPeriodSharesStockWarrantExercised>
    <TRXD:StockIssuedDuringPeriodSharesStockWarrantExercised contextRef="From2017-01-01to2017-12-31_us-gaap_PreferredStockMember" unitRef="Shares" xsi:nil="true" />
    <TRXD:StockIssuedDuringPeriodSharesStockWarrantExercised contextRef="From2017-01-01to2017-12-31_us-gaap_CommonStockMember" unitRef="Shares" decimals="INF">25000</TRXD:StockIssuedDuringPeriodSharesStockWarrantExercised>
    <TRXD:StockIssuedDuringPeriodSharesStockWarrantExercised contextRef="From2019-01-01to2019-03-31_us-gaap_PreferredStockMember" unitRef="Shares" xsi:nil="true" />
    <TRXD:StockIssuedDuringPeriodSharesStockWarrantExercised contextRef="From2019-01-01to2019-03-31_us-gaap_CommonStockMember" unitRef="Shares" decimals="INF">16666</TRXD:StockIssuedDuringPeriodSharesStockWarrantExercised>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect contextRef="From2019-01-01to2019-06-30" unitRef="USD" decimals="0">-329523</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect contextRef="From2017-01-01to2017-12-31" unitRef="USD" decimals="0">169235</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect contextRef="From2018-01-01to2018-06-30" unitRef="USD" decimals="0">23992</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect contextRef="From2018-01-01to2018-12-31" unitRef="USD" decimals="0">685643</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations contextRef="AsOf2018-12-31" unitRef="USD" decimals="0">869557</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations contextRef="AsOf2019-06-30" unitRef="USD" decimals="0">540034</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations contextRef="AsOf2016-12-31" unitRef="USD" decimals="0">14679</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations contextRef="AsOf2018-06-30" unitRef="USD" decimals="0">207906</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations contextRef="AsOf2017-12-31" unitRef="USD" decimals="0">183914</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations>
    <us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock contextRef="From2019-01-01to2019-06-30">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;The following table summarizes the assumptions used to estimate the fair value of the stock options granted during the quarter&#13;ended June 30, 2019.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;table cellpadding="0" cellspacing="0" align="center" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="text-align: justify"&gt;&amp;#160;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid"&gt;2019&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="width: 78%; text-align: justify"&gt;Expected dividend yield&lt;/td&gt;&lt;td style="width: 2%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%; text-align: center"&gt;&amp;#160;&lt;/td&gt;&lt;td style="width: 18%; text-align: center"&gt;0%&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="text-align: justify"&gt;Weighted-average expected volatility&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;209-250%&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&#13;    &lt;td style="text-align: justify"&gt;Weighted-average risk-free interest rate&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;2.08-2.55%&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&#13;    &lt;td style="text-align: justify"&gt;Expected life of options&lt;/td&gt;&lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: center"&gt;&amp;#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;5-7 years&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock>
    <us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock contextRef="From2018-01-01to2018-12-31">&lt;p style="margin: 0pt"&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The Company uses the Black-Scholes option pricing&#13;model to estimate the fair value of stock-based awards on the date of grant. The following table summarizes the assumptions used&#13;to estimate the fair value of stock options granted during the years ended December 31, 2018 and 2017:&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;2018&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;2017&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="width: 58%"&gt;&lt;font style="font-size: 10pt"&gt;Expected dividend yield&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 18%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;0&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&lt;font style="font-size: 10pt"&gt;%&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 18%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;0&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&lt;font style="font-size: 10pt"&gt;%&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Weighted-average expected volatility&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;192-265&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;%&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;200&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;%&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Weighted-average risk-free interest rate&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;2.08-2.73&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;%&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;1.92&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;%&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Expected life of warrants&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;4-5 years&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;4.74 -7.50 years&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&#13;&#13;&lt;p style="margin: 0pt"&gt;&lt;/p&gt;</us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1 contextRef="From2018-01-01to2018-12-31_srt_MinimumMember">P4Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1 contextRef="From2018-01-01to2018-12-31_srt_MaximumMember">P5Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1 contextRef="From2017-01-01to2017-12-31_srt_MinimumMember">P4Y8M26D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1 contextRef="From2017-01-01to2017-12-31_srt_MaximumMember">P7Y6M</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1 contextRef="From2019-01-01to2019-06-30_srt_MinimumMember">P5Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1 contextRef="From2019-01-01to2019-06-30_srt_MaximumMember">P7Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1 contextRef="From2018-01-01to2018-12-31">P6Y11M23D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate contextRef="From2019-01-01to2019-06-30" unitRef="Percentage" decimals="INF">0.00</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate contextRef="From2017-01-01to2017-12-31" unitRef="Percentage" decimals="INF">0.00</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate contextRef="From2018-01-01to2018-12-31" unitRef="Percentage" decimals="INF">0.00</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum contextRef="From2019-01-01to2019-06-30" unitRef="Percentage" decimals="INF">2.09</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum contextRef="From2018-01-01to2018-12-31" unitRef="Percentage" decimals="INF">1.92</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum contextRef="From2019-01-01to2019-06-30" unitRef="Percentage" decimals="INF">2.50</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum contextRef="From2017-01-01to2017-12-31" unitRef="Percentage" decimals="INF">2.00</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum contextRef="From2018-01-01to2018-12-31" unitRef="Percentage" decimals="INF">2.65</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum contextRef="From2019-01-01to2019-06-30" unitRef="Percentage" decimals="INF">0.0208</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum contextRef="From2018-01-01to2018-12-31" unitRef="Percentage" decimals="INF">0.0208</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum contextRef="From2019-01-01to2019-06-30" unitRef="Percentage" decimals="INF">0.0255</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum contextRef="From2017-01-01to2017-12-31" unitRef="Percentage" decimals="INF">0.0192</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum contextRef="From2018-01-01to2018-12-31" unitRef="Percentage" decimals="INF">0.0273</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1 contextRef="From2019-01-01to2019-06-30">P5Y10M28D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1 contextRef="From2017-01-01to2017-12-31">P3Y7D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1 contextRef="From2018-01-01to2018-12-31">P6Y3M19D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1>
    <TRXD:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTermGranted contextRef="From2019-01-01to2019-06-30">P9Y10M10D</TRXD:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTermGranted>
    <TRXD:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTermGranted contextRef="From2017-01-01to2017-12-31">P9Y18D</TRXD:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTermGranted>
    <TRXD:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTermGranted contextRef="From2018-01-01to2018-12-31">P9Y3M4D</TRXD:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTermGranted>
    <TRXD:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm contextRef="From2019-01-01to2019-06-30">P7Y3M8D</TRXD:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm>
    <TRXD:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm contextRef="From2017-01-01to2017-12-31">P6Y11M15D</TRXD:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm>
    <TRXD:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm contextRef="From2018-01-01to2018-12-31">P6Y11M23D</TRXD:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm>
    <TRXD:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm contextRef="From2019-01-01to2019-06-30">P5Y9M7D</TRXD:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm>
    <TRXD:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm contextRef="From2017-01-01to2017-12-31">P6Y3M19D</TRXD:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm>
    <TRXD:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm contextRef="From2018-01-01to2018-12-31">P5Y10M28D</TRXD:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths contextRef="AsOf2019-06-30" unitRef="USD" decimals="0">158366</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo contextRef="AsOf2019-06-30" unitRef="USD" decimals="0">163102</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree contextRef="AsOf2019-06-30" unitRef="USD" decimals="0">167984</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour contextRef="AsOf2019-06-30" unitRef="USD" decimals="0">173038</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFive contextRef="AsOf2019-06-30" unitRef="USD" decimals="0">178237</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFive>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive contextRef="AsOf2019-06-30" unitRef="USD" decimals="0">305012</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive>
    <us-gaap:ProceedsFromIssuanceOfPrivatePlacement contextRef="From2019-07-09to2019-07-10_us-gaap_SubsequentEventMember_custom_SecuritiesPurchaseAgreementMember_custom_AccreditedInvestorMember" unitRef="USD" decimals="0">1000000</us-gaap:ProceedsFromIssuanceOfPrivatePlacement>
    <us-gaap:ProceedsFromIssuanceOfPrivatePlacement contextRef="From2019-09-29to2019-09-30_us-gaap_SubsequentEventMember_custom_SecuritiesPurchaseAgreementMember_custom_AccreditedInvestorMember" unitRef="USD" decimals="0">1455000</us-gaap:ProceedsFromIssuanceOfPrivatePlacement>
    <us-gaap:SharesIssuedPricePerShare contextRef="AsOf2015-04-30_custom_ConvertiblePromissoryNoteMember" unitRef="USDPShares" decimals="INF">4.00</us-gaap:SharesIssuedPricePerShare>
    <us-gaap:SharesIssuedPricePerShare contextRef="AsOf2015-05-31_custom_ConvertiblePromissoryNoteMember" unitRef="USDPShares" decimals="INF">4.00</us-gaap:SharesIssuedPricePerShare>
    <us-gaap:SharesIssuedPricePerShare contextRef="AsOf2016-04-30_custom_ConvertiblePromissoryNoteMember" unitRef="USDPShares" decimals="INF">4.00</us-gaap:SharesIssuedPricePerShare>
    <us-gaap:SharesIssuedPricePerShare contextRef="AsOf2016-05-31_custom_ConvertiblePromissoryNoteMember" unitRef="USDPShares" decimals="INF">4.00</us-gaap:SharesIssuedPricePerShare>
    <us-gaap:SharesIssuedPricePerShare contextRef="AsOf2019-07-10_us-gaap_SubsequentEventMember_custom_SecuritiesPurchaseAgreementMember_custom_AccreditedInvestorMember" unitRef="USDPShares" decimals="INF">0.50</us-gaap:SharesIssuedPricePerShare>
    <us-gaap:SharesIssuedPricePerShare contextRef="AsOf2019-09-30_us-gaap_SubsequentEventMember_custom_SecuritiesPurchaseAgreementMember_custom_AccreditedInvestorMember" unitRef="USDPShares" decimals="INF">0.50</us-gaap:SharesIssuedPricePerShare>
    <TRXD:NumeratorForBasicAndDilutedEpsIncomeLossAvailableToCommonShareholders contextRef="From2019-01-01to2019-06-30" unitRef="USD" decimals="0">183210</TRXD:NumeratorForBasicAndDilutedEpsIncomeLossAvailableToCommonShareholders>
    <TRXD:NumeratorForBasicAndDilutedEpsIncomeLossAvailableToCommonShareholders contextRef="From2017-01-01to2017-12-31" unitRef="USD" decimals="0">288983</TRXD:NumeratorForBasicAndDilutedEpsIncomeLossAvailableToCommonShareholders>
    <TRXD:NumeratorForBasicAndDilutedEpsIncomeLossAvailableToCommonShareholders contextRef="From2018-01-01to2018-06-30" unitRef="USD" decimals="0">102782</TRXD:NumeratorForBasicAndDilutedEpsIncomeLossAvailableToCommonShareholders>
    <TRXD:NumeratorForBasicAndDilutedEpsIncomeLossAvailableToCommonShareholders contextRef="From2019-04-01to2019-06-30" unitRef="USD" decimals="0">57981</TRXD:NumeratorForBasicAndDilutedEpsIncomeLossAvailableToCommonShareholders>
    <TRXD:NumeratorForBasicAndDilutedEpsIncomeLossAvailableToCommonShareholders contextRef="From2018-04-01to2018-06-30" unitRef="USD" decimals="0">20513</TRXD:NumeratorForBasicAndDilutedEpsIncomeLossAvailableToCommonShareholders>
    <TRXD:NumeratorForBasicAndDilutedEpsIncomeLossAvailableToCommonShareholders contextRef="From2018-01-01to2018-12-31" unitRef="USD" decimals="0">9038</TRXD:NumeratorForBasicAndDilutedEpsIncomeLossAvailableToCommonShareholders>
    <us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment contextRef="From2019-01-01to2019-06-30" unitRef="Shares" decimals="INF">2807422</us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment>
    <us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment contextRef="From2017-01-01to2017-12-31" unitRef="Shares" decimals="INF">2130835</us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment>
    <us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment contextRef="From2018-01-01to2018-06-30" unitRef="Shares" decimals="INF">2486984</us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment>
    <us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment contextRef="From2019-04-01to2019-06-30" unitRef="Shares" decimals="INF">2627262</us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment>
    <us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment contextRef="From2018-04-01to2018-06-30" unitRef="Shares" decimals="INF">2493579</us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment>
    <us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment contextRef="From2018-01-01to2018-12-31" unitRef="Shares" decimals="INF">2697880</us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment>
    <us-gaap:EarningsPerShareBasicAndDiluted contextRef="From2019-01-01to2019-06-30" unitRef="USDPShares" decimals="INF">0.01</us-gaap:EarningsPerShareBasicAndDiluted>
    <us-gaap:EarningsPerShareBasicAndDiluted contextRef="From2017-01-01to2017-12-31" unitRef="USDPShares" decimals="INF">0.01</us-gaap:EarningsPerShareBasicAndDiluted>
    <us-gaap:EarningsPerShareBasicAndDiluted contextRef="From2018-01-01to2018-06-30" unitRef="USDPShares" decimals="INF">0.00</us-gaap:EarningsPerShareBasicAndDiluted>
    <us-gaap:EarningsPerShareBasicAndDiluted contextRef="From2019-04-01to2019-06-30" unitRef="USDPShares" decimals="INF">0.00</us-gaap:EarningsPerShareBasicAndDiluted>
    <us-gaap:EarningsPerShareBasicAndDiluted contextRef="From2018-04-01to2018-06-30" unitRef="USDPShares" decimals="INF">0.00</us-gaap:EarningsPerShareBasicAndDiluted>
    <us-gaap:EarningsPerShareBasicAndDiluted contextRef="From2018-01-01to2018-12-31" unitRef="USDPShares" decimals="INF">0.00</us-gaap:EarningsPerShareBasicAndDiluted>
    <us-gaap:ConvertibleNotesPayable contextRef="AsOf2017-04-30_custom_ConvertiblePromissoryNoteMember" unitRef="USD" decimals="0">165000</us-gaap:ConvertibleNotesPayable>
    <us-gaap:ConvertibleNotesPayable contextRef="AsOf2015-04-30_custom_ConvertiblePromissoryNoteMember" unitRef="USD" decimals="0">200000</us-gaap:ConvertibleNotesPayable>
    <us-gaap:ConvertibleNotesPayable contextRef="AsOf2015-05-31_custom_ConvertiblePromissoryNoteMember" unitRef="USD" decimals="0">200000</us-gaap:ConvertibleNotesPayable>
    <us-gaap:ConvertibleNotesPayable contextRef="AsOf2016-04-30_custom_ConvertiblePromissoryNoteMember" unitRef="USD" decimals="0">200000</us-gaap:ConvertibleNotesPayable>
    <us-gaap:ConvertibleNotesPayable contextRef="AsOf2016-05-31_custom_ConvertiblePromissoryNoteMember" unitRef="USD" decimals="0">200000</us-gaap:ConvertibleNotesPayable>
    <us-gaap:ConvertibleNotesPayable contextRef="AsOf2018-10-31_custom_CommunitySpecialtyPharmacyLLCMember" unitRef="USD" decimals="0">300000</us-gaap:ConvertibleNotesPayable>
    <us-gaap:ConvertibleNotesPayable contextRef="AsOf2017-12-31" unitRef="USD" decimals="0">181500</us-gaap:ConvertibleNotesPayable>
    <us-gaap:ConvertibleNotesPayable contextRef="AsOf2019-02-28_custom_ConvertiblePromissoryNoteMember" unitRef="USD" decimals="0">181500</us-gaap:ConvertibleNotesPayable>
    <us-gaap:DebtInstrumentConvertibleConversionPrice1 contextRef="AsOf2019-06-30_custom_RelatedPartyConvertiblePromissoryNoteMember_custom_MrShilpaPatelMember" unitRef="USDPShares" decimals="INF">1.50</us-gaap:DebtInstrumentConvertibleConversionPrice1>
    <us-gaap:DebtInstrumentConvertibleConversionPrice1 contextRef="AsOf2016-10-31_custom_RelatedPartyConvertiblePromissoryNoteMember_custom_MrNitilPatelMember" unitRef="USDPShares" decimals="INF">0.62</us-gaap:DebtInstrumentConvertibleConversionPrice1>
    <us-gaap:DebtInstrumentConvertibleConversionPrice1 contextRef="AsOf2016-09-30_custom_RelatedPartyConvertiblePromissoryNoteMember_custom_MrNitilPatelMember" unitRef="USDPShares" decimals="INF">0.62</us-gaap:DebtInstrumentConvertibleConversionPrice1>
    <us-gaap:DebtInstrumentConvertibleConversionPrice1 contextRef="AsOf2017-04-30_custom_ConvertiblePromissoryNoteMember" unitRef="USDPShares" decimals="INF">0.85</us-gaap:DebtInstrumentConvertibleConversionPrice1>
    <us-gaap:DebtInstrumentConvertibleConversionPrice1 contextRef="AsOf2015-04-30_custom_ConvertiblePromissoryNoteMember" unitRef="USDPShares" decimals="INF">1.50</us-gaap:DebtInstrumentConvertibleConversionPrice1>
    <us-gaap:DebtInstrumentConvertibleConversionPrice1 contextRef="AsOf2015-05-31_custom_ConvertiblePromissoryNoteMember" unitRef="USDPShares" decimals="INF">1.50</us-gaap:DebtInstrumentConvertibleConversionPrice1>
    <us-gaap:DebtInstrumentConvertibleConversionPrice1 contextRef="AsOf2019-02-28_custom_ConvertiblePromissoryNoteMember" unitRef="USDPShares" decimals="INF">0.50</us-gaap:DebtInstrumentConvertibleConversionPrice1>
    <us-gaap:DebtInstrumentConvertibleConversionPrice1 contextRef="AsOf2019-06-30_custom_RelatedPartyConvertiblePromissoryNoteMember_custom_MrNitilPatelMember" unitRef="USDPShares" decimals="INF">0.62</us-gaap:DebtInstrumentConvertibleConversionPrice1>
    <us-gaap:DebtInstrumentConvertibleConversionPrice1 contextRef="AsOf2016-08-31_custom_RelatedPartyConvertiblePromissoryNoteMember_custom_MrShilpaPatelMember" unitRef="USDPShares" decimals="INF">1.50</us-gaap:DebtInstrumentConvertibleConversionPrice1>
    <us-gaap:DebtInstrumentConvertibleConversionPrice1 contextRef="AsOf2019-02-28_us-gaap_SubsequentEventMember_srt_MaximumMember" unitRef="USDPShares" decimals="INF">0.85</us-gaap:DebtInstrumentConvertibleConversionPrice1>
    <us-gaap:DebtInstrumentConvertibleConversionPrice1 contextRef="AsOf2019-02-28_us-gaap_SubsequentEventMember_srt_MinimumMember" unitRef="USDPShares" decimals="INF">0.50</us-gaap:DebtInstrumentConvertibleConversionPrice1>
    <us-gaap:DebtInstrumentConvertibleConversionPrice1 contextRef="AsOf2019-09-30_us-gaap_SubsequentEventMember_custom_SecuritiesPurchaseAgreementMember_custom_PromissoryNotesMember" unitRef="USDPShares" decimals="INF">0.50</us-gaap:DebtInstrumentConvertibleConversionPrice1>
    <us-gaap:DebtInstrumentPeriodicPayment contextRef="From2019-02-01to2019-02-28_custom_ConvertiblePromissoryNoteMember" unitRef="USD" decimals="0">211983</us-gaap:DebtInstrumentPeriodicPayment>
    <us-gaap:DebtConversionConvertedInstrumentSharesIssued1 contextRef="From2019-02-01to2019-02-28_custom_ConvertiblePromissoryNoteMember" unitRef="Shares" decimals="INF">423966</us-gaap:DebtConversionConvertedInstrumentSharesIssued1>
    <us-gaap:DebtConversionConvertedInstrumentSharesIssued1 contextRef="From2019-02-01to2019-02-28_us-gaap_SubsequentEventMember" unitRef="Shares" decimals="INF">423966</us-gaap:DebtConversionConvertedInstrumentSharesIssued1>
    <us-gaap:DebtConversionConvertedInstrumentSharesIssued1 contextRef="From2019-09-29to2019-09-30_us-gaap_SubsequentEventMember_custom_SecuritiesPurchaseAgreementMember_custom_PromissoryNotesMember" unitRef="Shares" decimals="INF">350000</us-gaap:DebtConversionConvertedInstrumentSharesIssued1>
    <us-gaap:DebtInstrumentUnamortizedDiscount contextRef="AsOf2016-09-30_custom_PromissoryNoteMember" unitRef="USD" decimals="0">39000</us-gaap:DebtInstrumentUnamortizedDiscount>
    <us-gaap:DebtInstrumentUnamortizedDiscount contextRef="AsOf2018-12-31_custom_RelatedPartyConvertiblePromissoryNoteMember" unitRef="USD" decimals="0">65390</us-gaap:DebtInstrumentUnamortizedDiscount>
    <us-gaap:DebtInstrumentUnamortizedDiscount contextRef="AsOf2017-12-31_custom_RelatedPartyConvertiblePromissoryNoteMember" unitRef="USD" decimals="0">0</us-gaap:DebtInstrumentUnamortizedDiscount>
    <us-gaap:DebtInstrumentUnamortizedDiscount contextRef="AsOf2018-12-31_custom_ShortTermRelatedPartyConvertibleNotesMember" unitRef="USD" decimals="0">0</us-gaap:DebtInstrumentUnamortizedDiscount>
    <us-gaap:DebtInstrumentUnamortizedDiscount contextRef="AsOf2015-12-31_us-gaap_WarrantMember" unitRef="USD" decimals="0">53546</us-gaap:DebtInstrumentUnamortizedDiscount>
    <us-gaap:DebtInstrumentUnamortizedDiscount contextRef="AsOf2019-06-30_custom_ConvertiblePromissoryNoteMember" unitRef="USD" decimals="0">0</us-gaap:DebtInstrumentUnamortizedDiscount>
    <us-gaap:DebtInstrumentUnamortizedDiscount contextRef="AsOf2015-04-30_custom_ConvertiblePromissoryNoteMember" unitRef="USD" decimals="0">53546</us-gaap:DebtInstrumentUnamortizedDiscount>
    <us-gaap:DebtInstrumentUnamortizedDiscount contextRef="AsOf2015-05-31_custom_ConvertiblePromissoryNoteMember" unitRef="USD" decimals="0">53546</us-gaap:DebtInstrumentUnamortizedDiscount>
    <us-gaap:DebtInstrumentUnamortizedDiscount contextRef="AsOf2016-05-31_custom_PromissoryNoteMember" unitRef="USD" decimals="0">45000</us-gaap:DebtInstrumentUnamortizedDiscount>
    <us-gaap:DebtInstrumentUnamortizedDiscount contextRef="AsOf2016-12-31_custom_PromissoryNoteMember" unitRef="USD" decimals="0">15000</us-gaap:DebtInstrumentUnamortizedDiscount>
    <us-gaap:DebtInstrumentUnamortizedDiscount contextRef="AsOf2017-12-31_custom_ShortTermPromissoryNotesMember" unitRef="USD" decimals="0">152</us-gaap:DebtInstrumentUnamortizedDiscount>
    <us-gaap:DebtInstrumentUnamortizedDiscount contextRef="AsOf2018-12-31_custom_ShortTermPromissoryNotesMember" unitRef="USD" decimals="0">0</us-gaap:DebtInstrumentUnamortizedDiscount>
    <us-gaap:DebtInstrumentUnamortizedDiscount contextRef="AsOf2018-12-31_custom_ConvertiblePromissoryNoteMember" unitRef="USD" decimals="0">0</us-gaap:DebtInstrumentUnamortizedDiscount>
    <us-gaap:DebtInstrumentUnamortizedDiscount contextRef="AsOf2017-12-31_custom_ConvertiblePromissoryNoteMember" unitRef="USD" decimals="0">0</us-gaap:DebtInstrumentUnamortizedDiscount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage contextRef="AsOf2019-06-30_custom_RelatedPartyConvertiblePromissoryNoteMember_custom_MrShilpaPatelMember" unitRef="Percentage" decimals="INF">0.10</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage contextRef="AsOf2016-10-31_custom_RelatedPartyConvertiblePromissoryNoteMember_custom_MrNitilPatelMember" unitRef="Percentage" decimals="INF">0.10</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage contextRef="AsOf2016-09-30_custom_RelatedPartyConvertiblePromissoryNoteMember_custom_MrNitilPatelMember" unitRef="Percentage" decimals="INF">0.10</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage contextRef="AsOf2017-04-30_custom_RelatedPartyConvertiblePromissoryNoteMember" unitRef="Percentage" decimals="INF">0.10</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage contextRef="AsOf2017-09-30_custom_RelatedPartyConvertiblePromissoryNoteMember" unitRef="Percentage" decimals="INF">0.10</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage contextRef="AsOf2018-02-28_custom_RelatedPartyConvertiblePromissoryNoteMember" unitRef="Percentage" decimals="INF">0.10</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage contextRef="AsOf2017-06-30_custom_RelatedPartyPromissoryNoteMember_custom_SansurAssociatesLLCMember" unitRef="Percentage" decimals="INF">0.06</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage contextRef="AsOf2015-04-30_custom_ConvertiblePromissoryNoteMember" unitRef="Percentage" decimals="INF">0.10</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage contextRef="AsOf2015-05-31_custom_ConvertiblePromissoryNoteMember" unitRef="Percentage" decimals="INF">0.10</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage contextRef="AsOf2016-11-30_custom_RelatedPartyConvertiblePromissoryNoteMember_custom_MrPrashantPatelMember" unitRef="Percentage" decimals="INF">0.00</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage contextRef="AsOf2017-02-28_custom_RelatedPartyConvertiblePromissoryNoteMember_custom_MrPrashantPatelMember" unitRef="Percentage" decimals="INF">0.00</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage contextRef="AsOf2018-10-31_custom_CommunitySpecialtyPharmacyLLCMember" unitRef="Percentage" decimals="INF">0.10</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage contextRef="AsOf2018-10-30_custom_RelatedPartyPromissoryNoteMember_custom_SpecialtyPharmacyLLCMember_custom_NikulPanchalMember" unitRef="Percentage" decimals="INF">0.10</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage contextRef="AsOf2019-06-30_custom_RelatedPartyConvertiblePromissoryNoteMember_custom_MrNitilPatelMember" unitRef="Percentage" decimals="INF">0.10</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage contextRef="AsOf2018-10-31_custom_RelatedPartyPromissoryNoteMember_custom_CommunitySpecialtyPharmacyLLCMember_custom_NikulPanchalMember" unitRef="Percentage" decimals="INF">0.10</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage contextRef="AsOf2019-06-30_custom_RelatedPartyPromissoryNoteMember_custom_MrPrashantPatelMember" unitRef="Percentage" decimals="INF">0.06</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage contextRef="AsOf2019-06-30_custom_RelatedPartyPromissoryNoteMember_custom_MrSurenAjjarapuMember" unitRef="Percentage" decimals="INF">0.06</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage contextRef="AsOf2016-08-31_custom_RelatedPartyConvertiblePromissoryNoteMember_custom_MrShilpaPatelMember" unitRef="Percentage" decimals="INF">0.10</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentMaturityDate contextRef="From2017-04-01to2017-04-30_custom_RelatedPartyConvertiblePromissoryNoteMember">2018-04-30</us-gaap:DebtInstrumentMaturityDate>
    <us-gaap:DebtInstrumentMaturityDate contextRef="From2018-02-01to2018-02-28_custom_RelatedPartyConvertiblePromissoryNoteMember">2019-07-31</us-gaap:DebtInstrumentMaturityDate>
    <us-gaap:DebtInstrumentMaturityDate contextRef="From2017-04-01to2017-04-30_custom_ConvertiblePromissoryNoteMember">2019-05-31</us-gaap:DebtInstrumentMaturityDate>
    <us-gaap:DebtInstrumentMaturityDate contextRef="From2017-01-01to2017-12-31">2019-05-31</us-gaap:DebtInstrumentMaturityDate>
    <us-gaap:DebtInstrumentMaturityDate contextRef="From2016-05-01to2016-05-31_custom_ConvertiblePromissoryNoteMember">2017-05-31</us-gaap:DebtInstrumentMaturityDate>
    <us-gaap:DebtInstrumentMaturityDate contextRef="From2016-04-01to2016-04-30_custom_ConvertiblePromissoryNoteMember">2017-05-31</us-gaap:DebtInstrumentMaturityDate>
    <us-gaap:DebtInstrumentMaturityDate contextRef="From2017-09-01to2017-09-30_custom_RelatedPartyConvertiblePromissoryNoteMember">2018-02-28</us-gaap:DebtInstrumentMaturityDate>
    <us-gaap:DebtInstrumentMaturityDate contextRef="From2017-02-01to2017-02-28_custom_RelatedPartyConvertiblePromissoryNoteMember_custom_MrPrashantPatelMember">2020-07-31</us-gaap:DebtInstrumentMaturityDate>
    <us-gaap:DebtInstrumentMaturityDate contextRef="From2018-10-01to2018-10-31_custom_CommunitySpecialtyPharmacyLLCMember">2021-10-15</us-gaap:DebtInstrumentMaturityDate>
    <us-gaap:DebtInstrumentMaturityDate contextRef="From2018-10-01to2018-10-31_custom_RelatedPartyPromissoryNoteMember_custom_CommunitySpecialtyPharmacyLLCMember_custom_NikulPanchalMember">2021-10-31</us-gaap:DebtInstrumentMaturityDate>
    <us-gaap:DebtInstrumentMaturityDate contextRef="From2019-01-01to2019-06-30_custom_RelatedPartyConvertiblePromissoryNoteMember_custom_MrShilpaPatelMember">2019-08-08</us-gaap:DebtInstrumentMaturityDate>
    <us-gaap:DebtInstrumentMaturityDate contextRef="From2019-01-01to2019-06-30_custom_RelatedPartyConvertiblePromissoryNoteMember_custom_MrNitilPatelMember">2019-07-07</us-gaap:DebtInstrumentMaturityDate>
    <us-gaap:DebtInstrumentMaturityDate contextRef="From2019-01-01to2019-06-30_custom_RelatedPartyPromissoryNoteMember_custom_MrPrashantPatelMember">2020-07-01</us-gaap:DebtInstrumentMaturityDate>
    <us-gaap:DebtInstrumentMaturityDate contextRef="From2019-01-01to2019-06-30_custom_RelatedPartyPromissoryNoteMember_custom_MrSurenAjjarapuMember">2020-07-01</us-gaap:DebtInstrumentMaturityDate>
    <us-gaap:DebtInstrumentMaturityDate contextRef="From2019-07-01to2019-07-31_custom_RelatedPartyConvertiblePromissoryNoteMember_custom_MrNitilPatelMember_us-gaap_SubsequentEventMember_us-gaap_ExtendedMaturityMember">2019-10-15</us-gaap:DebtInstrumentMaturityDate>
    <us-gaap:DebtInstrumentMaturityDate contextRef="From2018-10-01to2018-10-31_custom_RelatedPartyPromissoryNoteMember_custom_SpecialtyPharmacyLLCMember_custom_NikulPanchalMember">2021-10-15</us-gaap:DebtInstrumentMaturityDate>
    <us-gaap:DebtInstrumentMaturityDate contextRef="From2019-10-07to2019-10-08_us-gaap_SubsequentEventMember_custom_SecuritiesPurchaseAgreementMember_custom_MrPrashantPatelAndMrSurenAjjarapuMember">2020-07-01</us-gaap:DebtInstrumentMaturityDate>
    <us-gaap:ProceedsFromIssuanceOfDebt contextRef="From2016-09-01to2016-09-30_custom_PromissoryNoteMember" unitRef="USD" decimals="0">150000</us-gaap:ProceedsFromIssuanceOfDebt>
    <us-gaap:ProceedsFromIssuanceOfDebt contextRef="From2018-10-01to2018-10-31_custom_RelatedPartyPromissoryNoteMember_custom_CommunitySpecialtyPharmacyLLCMember_custom_NikulPanchalMember" unitRef="USD" decimals="0">300000</us-gaap:ProceedsFromIssuanceOfDebt>
    <us-gaap:ProceedsFromIssuanceOfDebt contextRef="From2018-10-01to2018-10-31_custom_RelatedPartyPromissoryNoteMember_custom_SpecialtyPharmacyLLCMember_custom_NikulPanchalMember" unitRef="USD" decimals="0">300000</us-gaap:ProceedsFromIssuanceOfDebt>
    <TRXD:WarrantsIssued contextRef="AsOf2017-02-28" unitRef="Shares" decimals="INF">25000</TRXD:WarrantsIssued>
    <TRXD:WarrantsIssued contextRef="AsOf2019-02-28_us-gaap_WarrantMember" unitRef="Shares" decimals="INF">16666</TRXD:WarrantsIssued>
    <TRXD:WarrantsIssued contextRef="AsOf2019-02-28_us-gaap_SubsequentEventMember" unitRef="Shares" decimals="INF">16666</TRXD:WarrantsIssued>
    <TRXD:StockIssuedDuringPeriodSharesWarrantsExercised contextRef="From2019-02-01to2019-02-28" unitRef="Shares" decimals="INF">16666</TRXD:StockIssuedDuringPeriodSharesWarrantsExercised>
    <TRXD:StockIssuedDuringPeriodValueWarrantsExercised contextRef="From2019-02-01to2019-02-28" unitRef="USD" decimals="0">166</TRXD:StockIssuedDuringPeriodValueWarrantsExercised>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber contextRef="AsOf2018-12-31_us-gaap_WarrantMember" unitRef="Shares" decimals="INF">2880141</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber contextRef="AsOf2017-12-31_us-gaap_WarrantMember" unitRef="Shares" decimals="INF">2738096</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber contextRef="AsOf2016-12-31_us-gaap_WarrantMember" unitRef="Shares" decimals="INF">2647446</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber contextRef="AsOf2019-06-30_us-gaap_WarrantMember" unitRef="Shares" decimals="INF">2863475</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted contextRef="From2018-01-01to2018-12-31_us-gaap_WarrantMember" unitRef="Shares" decimals="INF">577045</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted contextRef="From2017-01-01to2017-12-31_us-gaap_WarrantMember" unitRef="Shares" decimals="INF">115650</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted contextRef="From2019-01-01to2019-06-30_us-gaap_WarrantMember" unitRef="Shares" xsi:nil="true" />
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures contextRef="From2017-01-01to2017-12-31" unitRef="Shares" xsi:nil="true" />
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures contextRef="From2018-01-01to2018-12-31_us-gaap_WarrantMember" unitRef="Shares" decimals="INF">-435000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures contextRef="From2017-01-01to2017-12-31_us-gaap_WarrantMember" unitRef="Shares" xsi:nil="true" />
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures contextRef="From2019-01-01to2019-06-30_us-gaap_WarrantMember" unitRef="Shares" xsi:nil="true" />
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures contextRef="From2018-01-01to2018-12-31" unitRef="Shares" decimals="INF">435000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised contextRef="From2018-01-01to2018-12-31_us-gaap_WarrantMember" unitRef="Shares" xsi:nil="true" />
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised contextRef="From2017-01-01to2017-12-31_us-gaap_WarrantMember" unitRef="Shares" decimals="INF">25000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised contextRef="From2019-01-01to2019-06-30_us-gaap_WarrantMember" unitRef="Shares" decimals="INF">16666</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised>
    <TRXD:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice contextRef="AsOf2018-12-31_us-gaap_WarrantMember" unitRef="USDPShares" decimals="INF">0.08</TRXD:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice>
    <TRXD:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice contextRef="AsOf2017-12-31_us-gaap_WarrantMember" unitRef="USDPShares" decimals="INF">0.24</TRXD:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice>
    <TRXD:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice contextRef="AsOf2016-12-31_us-gaap_WarrantMember" unitRef="USDPShares" decimals="INF">0.24</TRXD:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice>
    <TRXD:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice contextRef="AsOf2019-06-30_us-gaap_WarrantMember" unitRef="USDPShares" decimals="INF">0.08</TRXD:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice>
    <TRXD:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGrantsInPeriodWeightedAverageExercisePrice contextRef="From2018-01-01to2018-12-31_us-gaap_WarrantMember" unitRef="USDPShares" decimals="INF">0.02</TRXD:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGrantsInPeriodWeightedAverageExercisePrice>
    <TRXD:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGrantsInPeriodWeightedAverageExercisePrice contextRef="From2017-01-01to2017-12-31_us-gaap_WarrantMember" unitRef="USDPShares" decimals="INF">0.18</TRXD:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGrantsInPeriodWeightedAverageExercisePrice>
    <TRXD:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGrantsInPeriodWeightedAverageExercisePrice contextRef="From2019-01-01to2019-06-30_us-gaap_WarrantMember" unitRef="USDPShares" xsi:nil="true" />
    <TRXD:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitedInPeriodWeightedAverageExercisePrice contextRef="From2018-01-01to2018-12-31_us-gaap_WarrantMember" unitRef="USDPShares" xsi:nil="true" />
    <TRXD:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitedInPeriodWeightedAverageExercisePrice contextRef="From2017-01-01to2017-12-31_us-gaap_WarrantMember" unitRef="USDPShares" xsi:nil="true" />
    <TRXD:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitedInPeriodWeightedAverageExercisePrice contextRef="From2019-01-01to2019-06-30_us-gaap_WarrantMember" unitRef="USDPShares" xsi:nil="true" />
    <TRXD:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisesInPeriodWeightedAverageExercisePrice contextRef="From2018-01-01to2018-12-31_us-gaap_WarrantMember" unitRef="USDPShares" xsi:nil="true" />
    <TRXD:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisesInPeriodWeightedAverageExercisePrice contextRef="From2017-01-01to2017-12-31_us-gaap_WarrantMember" unitRef="USDPShares" decimals="INF">0.01</TRXD:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisesInPeriodWeightedAverageExercisePrice>
    <TRXD:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisesInPeriodWeightedAverageExercisePrice contextRef="From2019-01-01to2019-06-30_us-gaap_WarrantMember" unitRef="USDPShares" decimals="INF">0.01</TRXD:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisesInPeriodWeightedAverageExercisePrice>
    <TRXD:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageRemainingContractualTermBeginning contextRef="From2018-01-01to2018-12-31_us-gaap_WarrantMember">P3Y3M11D</TRXD:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageRemainingContractualTermBeginning>
    <TRXD:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageRemainingContractualTermBeginning contextRef="From2017-01-01to2017-12-31_us-gaap_WarrantMember">P4Y2M27D</TRXD:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageRemainingContractualTermBeginning>
    <TRXD:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageRemainingContractualTermBeginning contextRef="From2019-01-01to2019-06-30_us-gaap_WarrantMember">P3Y8M26D</TRXD:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageRemainingContractualTermBeginning>
    <TRXD:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageRemainingContractualTermEnding contextRef="From2018-01-01to2018-12-31_us-gaap_WarrantMember">P3Y8M26D</TRXD:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageRemainingContractualTermEnding>
    <TRXD:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageRemainingContractualTermEnding contextRef="From2017-01-01to2017-12-31_us-gaap_WarrantMember">P3Y3M11D</TRXD:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageRemainingContractualTermEnding>
    <TRXD:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageRemainingContractualTermEnding contextRef="From2019-01-01to2019-06-30_us-gaap_WarrantMember">P3Y29D</TRXD:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageRemainingContractualTermEnding>
    <us-gaap:RepaymentsOfRelatedPartyDebt contextRef="From2019-01-01to2019-06-30" unitRef="USD" xsi:nil="true" />
    <us-gaap:RepaymentsOfRelatedPartyDebt contextRef="From2017-01-01to2017-12-31" unitRef="USD" xsi:nil="true" />
    <us-gaap:RepaymentsOfRelatedPartyDebt contextRef="From2018-01-01to2018-06-30" unitRef="USD" decimals="0">111725</us-gaap:RepaymentsOfRelatedPartyDebt>
    <us-gaap:RepaymentsOfRelatedPartyDebt contextRef="From2018-01-01to2018-12-31" unitRef="USD" decimals="0">111725</us-gaap:RepaymentsOfRelatedPartyDebt>
    <us-gaap:RepaymentsOfRelatedPartyDebt contextRef="From2019-10-07to2019-10-08_us-gaap_SubsequentEventMember_custom_SecuritiesPurchaseAgreementMember_custom_MrPrashantPatelMember" unitRef="USD" decimals="0">122552</us-gaap:RepaymentsOfRelatedPartyDebt>
    <us-gaap:RepaymentsOfRelatedPartyDebt contextRef="From2019-10-07to2019-10-08_us-gaap_SubsequentEventMember_custom_SecuritiesPurchaseAgreementMember_custom_MrSurenAjjarapuMember" unitRef="USD" decimals="0">100000</us-gaap:RepaymentsOfRelatedPartyDebt>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod contextRef="From2019-01-01to2019-06-30" unitRef="Shares" xsi:nil="true" />
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1 contextRef="AsOf2018-12-31" unitRef="USD" xsi:nil="true" />
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1 contextRef="AsOf2019-06-30" unitRef="USD" decimals="0">8809</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1 contextRef="AsOf2016-12-31" unitRef="USD" xsi:nil="true" />
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1 contextRef="AsOf2017-12-31" unitRef="USD" xsi:nil="true" />
    <TRXD:OperatingLeaseAmortizationOfAssets contextRef="From2019-01-01to2019-06-30" unitRef="USD" decimals="0">43939</TRXD:OperatingLeaseAmortizationOfAssets>
    <TRXD:OperatingLeaseAmortizationOfAssets contextRef="From2019-04-01to2019-06-30" unitRef="USD" decimals="0">22195</TRXD:OperatingLeaseAmortizationOfAssets>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="From2019-01-01to2019-06-30" unitRef="USD" decimals="0">3428935</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="From2017-01-01to2017-12-31" unitRef="USD" decimals="0">2931280</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="From2019-01-01to2019-06-30_custom_TrxadeIncMember" unitRef="USD" decimals="0">2182668</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="From2019-01-01to2019-06-30_custom_CommunitySpecialtyPharmacyLLCMember" unitRef="USD" decimals="0">892357</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="From2019-01-01to2019-06-30_custom_OtherMember" unitRef="USD" decimals="0">353910</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="From2018-01-01to2018-06-30" unitRef="USD" decimals="0">1690611</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="From2019-04-01to2019-06-30" unitRef="USD" decimals="0">1916414</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="From2018-04-01to2018-06-30" unitRef="USD" decimals="0">837688</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="From2018-01-01to2018-12-31" unitRef="USD" decimals="0">3831778</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="From2018-01-01to2018-12-31_custom_TrxadeIncMember500701218" unitRef="USD" decimals="0">3407822</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="From2018-01-01to2018-12-31_custom_CommunitySpecialtyPharmacyLLCMember500738546" unitRef="USD" decimals="0">395418</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="From2018-01-01to2018-12-31_custom_OtherMember" unitRef="USD" decimals="0">28538</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:WarrantsNotSettleableInCashFairValueDisclosure contextRef="AsOf2018-10-15_custom_CommunitySpecialtyPharmacyLLCMember_us-gaap_SubsequentEventMember" unitRef="USD" decimals="0">170291</us-gaap:WarrantsNotSettleableInCashFairValueDisclosure>
    <us-gaap:PaymentsToAcquireBusinessesAndInterestInAffiliates contextRef="From2019-01-01to2019-01-31_custom_AlliancePharmaSolutionLLCMember" unitRef="USD" decimals="0">250000</us-gaap:PaymentsToAcquireBusinessesAndInterestInAffiliates>
    <TRXD:EquityMethodInvestmentDescription contextRef="From2019-01-01to2019-06-30">If the investments are less than 50% owned and more than 20% owned the entities use the equity method of accounting in accordance with ASC 323-10</TRXD:EquityMethodInvestmentDescription>
    <us-gaap:OtherAssetsCurrent contextRef="AsOf2018-12-31" unitRef="USD" xsi:nil="true" />
    <us-gaap:OtherAssetsCurrent contextRef="AsOf2017-12-31" unitRef="USD" decimals="0">2000</us-gaap:OtherAssetsCurrent>
    <us-gaap:NotesPayableCurrent contextRef="AsOf2018-12-31" unitRef="USD" xsi:nil="true" />
    <us-gaap:NotesPayableCurrent contextRef="AsOf2017-12-31" unitRef="USD" decimals="0">10587</us-gaap:NotesPayableCurrent>
    <us-gaap:OtherNonoperatingIncome contextRef="From2017-01-01to2017-12-31" unitRef="USD" decimals="0">67500</us-gaap:OtherNonoperatingIncome>
    <us-gaap:OtherNonoperatingIncome contextRef="From2018-01-01to2018-12-31" unitRef="USD" decimals="0">161639</us-gaap:OtherNonoperatingIncome>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt contextRef="From2017-08-01to2017-08-31_custom_RelatedPartyConvertiblePromissoryNoteMember" unitRef="USD" decimals="0">5044</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt contextRef="From2018-08-01to2018-08-31_custom_RelatedPartyConvertiblePromissoryNoteMember" unitRef="USD" decimals="0">7444</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt contextRef="From2017-04-01to2017-04-30_custom_ConvertiblePromissoryNoteMember" unitRef="USD" decimals="0">11512</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt contextRef="From2017-01-01to2017-12-31" unitRef="USD" decimals="0">-16556</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt contextRef="From2016-05-01to2016-05-31_custom_ConvertiblePromissoryNoteMember" unitRef="USD" decimals="0">37579</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt contextRef="From2016-04-01to2016-04-30_custom_ConvertiblePromissoryNoteMember" unitRef="USD" decimals="0">37579</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt contextRef="From2018-01-01to2018-12-31" unitRef="USD" decimals="0">-7444</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="From2018-07-01to2018-07-31_custom_PrivateOfferMemorandumMember" unitRef="USD" decimals="0">300000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="From2017-01-01to2017-12-31" unitRef="USD" decimals="0">250000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="From2017-01-01to2017-12-31_us-gaap_PreferredStockMember" unitRef="USD" xsi:nil="true" />
    <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="From2018-01-01to2018-12-31_us-gaap_PreferredStockMember" unitRef="USD" xsi:nil="true" />
    <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="From2017-01-01to2017-12-31_us-gaap_CommonStockMember" unitRef="USD" decimals="0">3</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="From2018-01-01to2018-12-31_us-gaap_CommonStockMember" unitRef="USD" decimals="0">12</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="From2017-01-01to2017-12-31_us-gaap_AdditionalPaidInCapitalMember" unitRef="USD" decimals="0">249997</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="From2018-01-01to2018-12-31_us-gaap_AdditionalPaidInCapitalMember" unitRef="USD" decimals="0">799988</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="From2017-01-01to2017-12-31_us-gaap_RetainedEarningsMember" unitRef="USD" xsi:nil="true" />
    <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="From2018-01-01to2018-12-31_us-gaap_RetainedEarningsMember" unitRef="USD" xsi:nil="true" />
    <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="From2017-01-01to2017-01-31_custom_PrivateOfferMemorandumMember" unitRef="USD" decimals="0">250000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="From2018-11-01to2018-11-30_custom_PrivateOfferMemorandumMember" unitRef="USD" decimals="0">500000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="From2018-01-01to2018-12-31" unitRef="USD" decimals="0">800000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodSharesIssuedForServices contextRef="From2017-01-01to2017-12-31_us-gaap_PreferredStockMember" unitRef="Shares" xsi:nil="true" />
    <us-gaap:StockIssuedDuringPeriodSharesIssuedForServices contextRef="From2017-01-01to2017-12-31_us-gaap_CommonStockMember" unitRef="Shares" decimals="INF">50000</us-gaap:StockIssuedDuringPeriodSharesIssuedForServices>
    <us-gaap:StockIssuedDuringPeriodSharesIssuedForServices contextRef="From2017-03-01to2017-03-31" unitRef="Shares" decimals="INF">50000</us-gaap:StockIssuedDuringPeriodSharesIssuedForServices>
    <us-gaap:StockIssuedDuringPeriodValueIssuedForServices contextRef="From2017-01-01to2017-12-31" unitRef="USD" decimals="0">12500</us-gaap:StockIssuedDuringPeriodValueIssuedForServices>
    <us-gaap:StockIssuedDuringPeriodValueIssuedForServices contextRef="From2017-01-01to2017-12-31_us-gaap_PreferredStockMember" unitRef="USD" xsi:nil="true" />
    <us-gaap:StockIssuedDuringPeriodValueIssuedForServices contextRef="From2017-01-01to2017-12-31_us-gaap_CommonStockMember" unitRef="USD" decimals="0">1</us-gaap:StockIssuedDuringPeriodValueIssuedForServices>
    <us-gaap:StockIssuedDuringPeriodValueIssuedForServices contextRef="From2017-01-01to2017-12-31_us-gaap_AdditionalPaidInCapitalMember" unitRef="USD" decimals="0">12499</us-gaap:StockIssuedDuringPeriodValueIssuedForServices>
    <us-gaap:StockIssuedDuringPeriodValueIssuedForServices contextRef="From2017-01-01to2017-12-31_us-gaap_RetainedEarningsMember" unitRef="USD" xsi:nil="true" />
    <us-gaap:StockIssuedDuringPeriodValueIssuedForServices contextRef="From2017-03-01to2017-03-31" unitRef="USD" decimals="0">12500</us-gaap:StockIssuedDuringPeriodValueIssuedForServices>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued contextRef="From2017-01-01to2017-12-31" unitRef="USD" decimals="0">16556</us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued contextRef="From2017-01-01to2017-12-31_us-gaap_PreferredStockMember" unitRef="USD" xsi:nil="true" />
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued contextRef="From2018-01-01to2018-12-31_us-gaap_PreferredStockMember" unitRef="USD" xsi:nil="true" />
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued contextRef="From2017-01-01to2017-12-31_us-gaap_CommonStockMember" unitRef="USD" xsi:nil="true" />
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued contextRef="From2018-01-01to2018-12-31_us-gaap_CommonStockMember" unitRef="USD" xsi:nil="true" />
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued contextRef="From2017-01-01to2017-12-31_us-gaap_AdditionalPaidInCapitalMember" unitRef="USD" decimals="0">16556</us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued contextRef="From2018-01-01to2018-12-31_us-gaap_AdditionalPaidInCapitalMember" unitRef="USD" decimals="0">7444</us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued contextRef="From2017-01-01to2017-12-31_us-gaap_RetainedEarningsMember" unitRef="USD" xsi:nil="true" />
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued contextRef="From2018-01-01to2018-12-31_us-gaap_RetainedEarningsMember" unitRef="USD" xsi:nil="true" />
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued contextRef="From2018-01-01to2018-12-31" unitRef="USD" decimals="0">7444</us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued>
    <TRXD:AdjustmentsToAdditionalPaidInCapitalWarrantsForAcquisition contextRef="From2018-01-01to2018-12-31_us-gaap_PreferredStockMember" unitRef="USD" xsi:nil="true" />
    <TRXD:AdjustmentsToAdditionalPaidInCapitalWarrantsForAcquisition contextRef="From2018-01-01to2018-12-31_us-gaap_CommonStockMember" unitRef="USD" xsi:nil="true" />
    <TRXD:AdjustmentsToAdditionalPaidInCapitalWarrantsForAcquisition contextRef="From2018-01-01to2018-12-31_us-gaap_AdditionalPaidInCapitalMember" unitRef="USD" decimals="0">170291</TRXD:AdjustmentsToAdditionalPaidInCapitalWarrantsForAcquisition>
    <TRXD:AdjustmentsToAdditionalPaidInCapitalWarrantsForAcquisition contextRef="From2018-01-01to2018-12-31_us-gaap_RetainedEarningsMember" unitRef="USD" xsi:nil="true" />
    <TRXD:AdjustmentsToAdditionalPaidInCapitalWarrantsForAcquisition contextRef="From2018-01-01to2018-12-31" unitRef="USD" decimals="0">170291</TRXD:AdjustmentsToAdditionalPaidInCapitalWarrantsForAcquisition>
    <us-gaap:IssuanceOfStockAndWarrantsForServicesOrClaims contextRef="From2017-01-01to2017-12-31" unitRef="USD" decimals="0">12500</us-gaap:IssuanceOfStockAndWarrantsForServicesOrClaims>
    <us-gaap:IssuanceOfStockAndWarrantsForServicesOrClaims contextRef="From2018-01-01to2018-12-31" unitRef="USD" xsi:nil="true" />
    <us-gaap:ProvisionForDoubtfulAccounts contextRef="From2017-01-01to2017-12-31" unitRef="USD" xsi:nil="true" />
    <us-gaap:ProvisionForDoubtfulAccounts contextRef="From2018-01-01to2018-12-31" unitRef="USD" decimals="0">2271</us-gaap:ProvisionForDoubtfulAccounts>
    <us-gaap:ProceedsFromIssuanceOfCommonStock contextRef="From2017-01-01to2017-12-31" unitRef="USD" decimals="0">250000</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <us-gaap:ProceedsFromIssuanceOfCommonStock contextRef="From2018-01-01to2018-12-31" unitRef="USD" decimals="0">800000</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <TRXD:RelatedPartyNotePayableAndWarrantsIssuedForAcquisition contextRef="From2017-01-01to2017-12-31" unitRef="USD" xsi:nil="true" />
    <TRXD:RelatedPartyNotePayableAndWarrantsIssuedForAcquisition contextRef="From2018-01-01to2018-12-31" unitRef="USD" decimals="0">470921</TRXD:RelatedPartyNotePayableAndWarrantsIssuedForAcquisition>
    <TRXD:ReclassFromAccruedInterestToShortTermConvertibleNotes contextRef="From2017-01-01to2017-12-31" unitRef="USD" decimals="0">16500</TRXD:ReclassFromAccruedInterestToShortTermConvertibleNotes>
    <TRXD:ReclassFromAccruedInterestToShortTermConvertibleNotes contextRef="From2018-01-01to2018-12-31" unitRef="USD" xsi:nil="true" />
    <TRXD:ArrangementToMoveRelatedPartyAccountsPayableToNotesPayable contextRef="From2017-01-01to2017-12-31" unitRef="USD" decimals="0">32552</TRXD:ArrangementToMoveRelatedPartyAccountsPayableToNotesPayable>
    <TRXD:ArrangementToMoveRelatedPartyAccountsPayableToNotesPayable contextRef="From2018-01-01to2018-12-31" unitRef="USD" xsi:nil="true" />
    <us-gaap:ProceedsFromRelatedPartyDebt contextRef="From2017-01-01to2017-12-31" unitRef="USD" decimals="0">180000</us-gaap:ProceedsFromRelatedPartyDebt>
    <us-gaap:ProceedsFromRelatedPartyDebt contextRef="From2018-01-01to2018-12-31" unitRef="USD" xsi:nil="true" />
    <us-gaap:SignificantAccountingPoliciesTextBlock contextRef="From2018-01-01to2018-12-31">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;NOTE&#13;2 &amp;#8211; SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The accompanying financial statements&#13;have been prepared in accordance with accounting principles generally accepted in the United States of America (&amp;#8220;GAAP&amp;#8221;).&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;The&#13;summary of significant accounting policies presented below is designed to assist in understanding the Company&amp;#8217;s financial&#13;statements. Such financial statements and accompanying notes are the representations of the Company&amp;#8217;s management, who are&#13;responsible for their integrity and objectivity. These accounting policies conform to accounting principles generally accepted&#13;in the United States of America (&amp;#8220;GAAP&amp;#8221;) in all material respects, and have been consistently applied in preparing&#13;the accompanying financial statements.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;Basis&#13;of Presentation &amp;#8211; Historically, operations have been funded primarily through the sale of equity or debt securities and&#13;operating activities. In 2018, the Company renewed outstanding debt (See Note 3 and 4), raised capital (See Note 5) and&#13;had positive operating cash flow from operations. The Company has the ability to maintain the current level of spending or reduce&#13;expenditures to maintain operations if funding is not available.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Use&#13;of Estimates &amp;#8211; In preparing these financial statements, management is required to make estimates and assumptions that effect&#13;the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities as of the date of the financial&#13;statements and the reported amount of revenues and expenses during the reporting periods. Actual results could differ from those&#13;estimates.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Reclassification&#13;&amp;#8211; Certain prior year amounts have been reclassified to conform to the current year presentation.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Principle&#13;of Consolidation &amp;#8211; The Company&amp;#8217;s consolidated financial statements include the accounts of Trxade Group, Inc., Trxade,&#13;Inc., Integra Pharma Solutions, Inc., Alliance Pharma Solutions, LLC and Community Specialty Pharmacy, LLC. All significant intercompany&#13;accounts and transactions have been eliminated.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Cash&#13;and Cash Equivalents &amp;#8211; Cash in bank accounts are at risk to the extent that they exceed U.S. Federal Deposit Insurance Corporation&#13;insured amounts. All investments purchased with a maturity of three months or less are cash equivalents. Cash and cash equivalents&#13;are available on demand and are generally within of FDIC insurance limits for 2018.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;Accounts&#13;Receivable &amp;#8211; The Company&amp;#8217;s receivables are from customers and are collected within 90 days. The Company determines&#13;the allowance based on known troubled accounts, historical experience, and other currently available evidence. During the years&#13;ended December 31, 2018 and 2017, $2,271 of bad debt expense and $0 of recovery of bad debt was recognized, respectively.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Inventory&#13;&amp;#8211; Inventories are stated at the lower of cost or net realizable value. Cost is determined on a weighted average basis. On&#13;a quarterly basis, we analyze our inventory levels and no reserve is maintained as obsolete or expired inventories are written&#13;off. There is no reserve for inventory obsolescence during the periods presented. &lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Beneficial&#13;Conversion Features &amp;#8211; The intrinsic value of a beneficial conversion feature inherent to a convertible note payable, which&#13;is not bifurcated and accounted for separately from the convertible note payable and may not be settled in cash upon conversion,&#13;is treated as a discount to the convertible note payable. This discount is amortized over the period from the date of issuance&#13;to the date the note is due using the effective interest method. If the note payable is retired prior to the end of its contractual&#13;term, the unamortized discount is expensed in the period of retirement to interest expense. In general, the beneficial conversion&#13;feature is measured by comparing the effective conversion price, after considering the relative value of detachable instruments&#13;included in the financing transaction, if any, to the fair value of the common shares at the commitment date to be received upon&#13;conversion.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Derivative&#13;financial instruments &amp;#8211; The Company evaluates its financial instruments to determine if such instruments are derivatives&#13;or contain features that qualify as embedded derivatives. For derivative financial instruments that are accounted for as liabilities,&#13;the derivative instrument is initially recorded at its fair value and is then re-valued at each reporting date, with changes in&#13;the fair value reported in the statements of operations. For stock-based derivative financial instruments, the Company uses a&#13;Black-Scholes option pricing model, assuming maximum value, in accordance with ASC 815-15 &amp;#8220;Derivative and Hedging&amp;#8221;&#13;to value the derivative instruments at inception and on subsequent valuation dates. The classification of derivative instruments,&#13;including whether such instruments should be recorded as liabilities or as equity, is evaluated at the end of each reporting period.&#13;Derivative instrument liabilities are classified in the balance sheet as current or non-current based on whether or not net-cash&#13;settlement of the derivative instrument could be required within 12 months of the balance sheet date.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Fair&#13;Value of Financial Instruments &amp;#8211; The Company measures its financial assets and liabilities in accordance with the requirements&#13;of FASB ASC 820, &amp;#8220;Fair Value Measurements and Disclosures&amp;#8221;. ASC 820 clarifies the definition of fair value, prescribes&#13;methods for measuring fair value, and establishes a fair value hierarchy to classify the inputs used in measuring fair value as&#13;follows:&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Level&#13;1 &amp;#8211; Quoted prices are available in active markets for identical assets or liabilities as of the reporting date. Active markets&#13;are those in which transactions for the asset or liability occur in sufficient frequency and volume to provide pricing information&#13;on an ongoing basis. Level 1 primarily consists of financial instruments such as exchange-traded derivatives, marketable securities&#13;and listed equities.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Level&#13;2 &amp;#8211; Pricing inputs are other than quoted prices in active markets included in level 1, which are either directly or indirectly&#13;observable as of the reported date and includes those financial instruments that are valued using models or other valuation methodologies.&#13;These models are primarily industry-standard models that consider various assumptions, including quoted forward prices for commodities,&#13;time value, volatility factors, and current market and contractual prices for the underlying instruments, as well as other relevant&#13;economic measures. Substantially all of these assumptions are observable in the marketplace throughout the full term of the instrument,&#13;can be derived from observable data or are supported by observable levels at which transactions are executed in the marketplace.&#13;Instruments in this category generally include non-exchange-traded derivatives such as commodity swaps, interest rate swaps, options&#13;and collars.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Level&#13;3 &amp;#8211; Pricing inputs include significant inputs that are generally less observable from objective sources. These inputs may&#13;be used with internally developed methodologies that result in management&amp;#8217;s best estimate of fair value.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;The&#13;Company does not have any assets or liabilities that are required to be measured and recorded at fair value on a recurring basis.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;The&#13;carrying amounts of cash, accounts receivable, accounts payable, accrued liabilities and short-term debt approximate fair value&#13;because of the short-term nature of these instruments. The carrying amount of long-term debt approximates fair value because the&#13;debt is based on current rates at which the Company could borrow funds with similar maturities.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Goodwill&#13;&amp;#8211; The Company accounts for goodwill and intangible assets in accordance with ASC 350 &amp;#8220;Intangibles Goodwill and Other&amp;#8221;.&#13;ASC 350 requires that goodwill and other intangibles with indefinite lives be tested for impairment annually or on an interim&#13;basis if events or circumstances indicate that the fair value of an asset has decreased below its carrying value. The Company&#13;performed impairment analysis using the qualitative analysis under ASC 350-20 and noted no impairment issues for 2018.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Revenue&#13;Recognition &amp;#8211; In May 2014, the Financial Accounting Standards Board (FASB) issued Accounting Standards Update No. 2014-09&#13;(Topic 606) &amp;#8220;Revenue from Contracts with Customers.&amp;#8221; Topic 606 supersedes the revenue recognition requirements in&#13;Accounting Standards Codification Topic 605, &amp;#8220;Revenue Recognition&amp;#8221;, and requires entities to recognize revenue when&#13;they transfer control of promised goods or services to customers in an amount that reflects the consideration to which the entity&#13;expects to be entitled to in exchange for those goods or services. The Company adopted ASU 2014-09 using the modified retrospective&#13;approach effective January 1, 2018, under which prior periods were not retrospectively adjusted. The adoption of Topic 606 does&#13;not have a material impact to our consolidated financial statements, including the presentation of revenues in our Consolidated&#13;Statements of Operations.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Trxade,&#13;Inc. provides an online website service, a buying and selling marketplace for licensed Pharmaceutical Wholesalers to sell products&#13;and services to licensed Pharmacies. The Company charges Suppliers a transaction fee, a percentage of the purchase price of the&#13;Prescription Drugs and other products sold through its website service. The fulfillment of confirmed orders, including delivery&#13;and shipment of Prescription Drugs and other products, is the responsibility of the Supplier and not of the Company. The Company&#13;holds no inventory and assumes no responsibility for the shipment or delivery of any products or services from our website. The&#13;Company considers itself an agent for this revenue stream and as such, reports revenue as net. Step One: Identify the contract&#13;with the customer &amp;#8211; Trxade, Inc.&amp;#8217;s Terms and Use Agreement is acknowledged between the Wholesaler and Trxade, Inc.&#13;which outlines the terms and conditions. The collection is probable based on the credit evaluation of the Wholesaler. Step Two:&#13;Identify the performance obligations in the contract &amp;#8211; The Company provides to the Supplier access to the online website,&#13;uploading of catalogs of products and Dashboard access to review status of inventory posted and processed orders. The Agreement&#13;requires the supplier to provide a catalog of pharmaceuticals for posting on the platform, deliver the pharmaceuticals and upon&#13;shipment remit the stated platform fee. Step Three: Determine the transaction price &amp;#8211; The Fee Agreement outlines the fee&#13;based on the type of product, generic, brand or non-drug. There are no discounts for volume of transactions or early payment of&#13;invoices. Step Four: Allocate the transaction price &amp;#8211; The Fee Agreement outlines the fee. There is no difference between&#13;contract price and &amp;#8220;stand-alone selling price&amp;#8221;. Step Five: Recognize revenue when or as the entity satisfies a performance&#13;obligation &amp;#8211; Revenue is recognized the day the order has been processed by the Supplier.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Integra&#13;Pharma Solutions, LLC is a licensed wholesaler and sells to licensed pharmacies brand, generic and non-drug products. The Company&#13;takes orders for product and creates invoices for each order and recognizes revenue at the time the Customer receives the product.&#13;Customer returns are not material. Step One: Identify the contract with the customer &amp;#8211; The Company requires that an application&#13;and a credit card for payment is completed by the Customer prior to the first order. Each transaction is evidenced by an order&#13;form sent by the customer and an invoice for the product is sent by the Company. The collection is probable based on the application&#13;and credit card information provided prior to the first order. Step Two: Identify the performance obligations in the contract&#13;&amp;#8211; Each order is distinct and evidenced by the shipping order and invoice. Step Three: Determine the transaction price &amp;#8211;&#13;The consideration is variable if product is returned. The variability is determined based on the return policy of the product&#13;manufacturer. There are no sales or volume discounts. The transaction price is determined at the time of the order evidenced by&#13;the invoice. Step Four: Allocate the transaction price &amp;#8211; There is no difference between contract price and &amp;#8220;stand-alone&#13;selling price&amp;#8221;. Step Five: Recognize revenue when or as the entity satisfies a performance obligation - The Revenue is recognized&#13;when the Customer receives the product.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;Community&#13;Specialty Pharmacy, LLC is in the retail pharmacy business. The Company fills prescriptions for drugs written by a doctor and&#13;recognizes revenue at the time the patient confirms delivery of the prescription. Customer returns are not material. Step One:&#13;Identify the contract with the customer &amp;#8211; The prescription is written by a doctor for a Customer and delivered to the Company.&#13;The prescription identifies the performance obligations in the contract. The Company fills the prescription and delivers to the&#13;Customer the prescription, fulfilling the contract. The collection is probable because there is confirmation that the customer&#13;has insurance for the reimbursement to the Company prior to filling of the prescription. Step Two: Identify the performance obligations&#13;in the contract &amp;#8211; Each prescription is distinct to the Customer. Step Three: Determine the transaction price &amp;#8211; The&#13;consideration is not variable. The transaction price is determined to be the price of the prescription at the time of delivery&#13;which considers the expected reimbursements from third party payors (e.g., pharmacy benefit managers, insurance companies and&#13;government agencies). Step Four: Allocate the transaction price &amp;#8211; The price of the prescription invoiced represents the&#13;expected amount of reimbursement from third party payors. There is no difference between contract price and &amp;#8220;stand-alone&#13;selling price&amp;#8221;. Step Five: Recognize revenue when or as the entity satisfies a performance obligation &amp;#8211; Revenue is&#13;recognized upon the delivery of the prescription.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="margin: 0; text-align: justify"&gt;Cost of Goods Sold &amp;#8211; The company recognized cost of goods sold in 2018 from activities in Integra&#13;Pharma Solutions, LLC and Community Specialty Pharmacy, LLC, which were not active in 2017.&lt;/p&gt;&#13;&#13;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Stock-Based&#13;Compensation &amp;#8211; The Company accounts for stock-based compensation to non-employees in accordance with the provision of ASC&#13;505, &amp;#8220;Equity Based Payments to Non-Employees&amp;#8221; (&amp;#8220;ASC 505&amp;#8221;), which requires that such equity instruments&#13;are recorded at their fair value on the measurement date. The measurement of stock-based compensation is subject to periodic adjustment&#13;as the underlying instruments vest.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;The&#13;Company accounts for stock-based compensation to employees in accordance with ASC 718, &amp;#8220;Compensation-Stock Compensation&amp;#8221;.&#13;ASC 718 requires companies to measure the cost of employee services received in exchange for an award of equity instruments, including&#13;stock options, based on the grant date fair value of the award and to recognize it as compensation expense over the period the&#13;employee is required to provide service in exchange for the award, usually the vesting period. Stock option forfeitures are recognized&#13;at the date of employee termination.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Income&#13;Taxes &amp;#8211; The Company accounts for income taxes utilizing ASC 740, &amp;#8220;Income Taxes&amp;#8221; (SFAS No. 109). ASC 740 requires&#13;the measurement of deferred tax assets for deductible temporary differences and operating loss carry forwards, and of deferred&#13;tax liabilities for taxable temporary differences. Measurement of current and deferred tax liabilities and assets is based on&#13;provisions of enacted tax law. The effects of future changes in tax rates are not included in the measurement. The Company recognizes&#13;the amount of taxes payable or refundable for the current year and recognizes deferred tax liabilities and assets for the expected&#13;future tax consequences of events and transactions that have been recognized in the Company&amp;#8217;s financial statements or tax&#13;returns. The Company currently has substantial net operating loss carry forwards. The Company has recorded a 100% valuation allowance&#13;against net deferred tax assets due to uncertainty of their ultimate realization. Valuation allowances are established when necessary&#13;to reduce deferred tax assets to the amount expected to be realized. Tax years from 2015 forward are open to examination&#13;by the Internal Revenue Service.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Income&#13;(loss) Per Share &amp;#8211; Basic net income (loss) per common share is computed by dividing net loss available to Common Stockholders&#13;by the weighted average number of common shares outstanding. Diluted net loss per common share is computed similar to basic net&#13;loss per common share except that the denominator is increased to include the number of additional common shares that would have&#13;been outstanding if the potential common shares had been issued and if the additional common shares were dilutive. The treasury&#13;stock method and as if converted methods are used to determine the dilutive shares for our options and warrants and convertible&#13;notes, respectively.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&amp;#160;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;The&#13;following table sets forth the computation of basic and diluted income per common share for the years ended December 31, 2018&#13;and 2017:&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;&#13;&#13;&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"&gt;&#13;&lt;tr style="vertical-align: bottom; font-family: Times New Roman, Times, Serif"&gt;&#13;    &lt;td style="padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;December&#13;    31, 2018&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;December&#13;    31, 2017&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255); font-family: Times New Roman, Times, Serif"&gt;&#13;    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Numerator:&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White; font-family: Times New Roman, Times, Serif"&gt;&#13;    &lt;td style="width: 60%; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Net&#13;    Income&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 2%; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 16%; text-align: right; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;9,038&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 2%; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 16%; text-align: right; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;288,983&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255); font-family: Times New Roman, Times, Serif"&gt;&#13;    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; font-family: Times New Roman, Times, Serif"&gt;&#13;    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Numerator&#13;    for basic and diluted income available to common shareholders&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;9,038&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;288,983&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255); font-family: Times New Roman, Times, Serif"&gt;&#13;    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; font-family: Times New Roman, Times, Serif"&gt;&#13;    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Denominator:&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255); font-family: Times New Roman, Times, Serif"&gt;&#13;    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Denominator&#13;    for basic income per common share &amp;#8211; Weighted average common shares outstanding&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;32,260,622&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;31,955,416&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; font-family: Times New Roman, Times, Serif"&gt;&#13;    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Dilutive&#13;    effect of Common Stock Equivalents&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;2,697,880&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;2,130,835&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255); font-family: Times New Roman, Times, Serif"&gt;&#13;    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Denominator&#13;    for diluted income per common share &amp;#8211; adjusted weighted average common shares outstanding&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;34,958,502&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;34,086,251&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; font-family: Times New Roman, Times, Serif"&gt;&#13;    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Basic&#13;    and Diluted income per common share&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;0.00&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;0.01&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;&#13;&#13;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;Concentration&#13;of Credit Risks and Major Customers - Financial instruments that potentially subject the company to credit risk consist principally&#13;of cash and cash equivalents and receivables. The Company places its cash and cash equivalents with financial institutions. Deposits&#13;are insured to Federal Deposit Insurance Corp limits. During the years ended December 31, 2018 and 2017, sales to&#13;two customers each represent greater than 10% of revenue.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Recent&#13;Accounting Pronouncements &amp;#8211; The Company has implemented all new relevant accounting pronouncements that are in effect through&#13;the date of these financial statements. The pronouncements did not have any material impact on the financial statements unless&#13;otherwise disclosed, and the Company does not believe that there are any other new accounting pronouncements that have been issued&#13;that might have a material impact on its consolidated financial position or results of operations.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;In&#13;February 2016, the FASB issued ASU 2016-02, Leases, which will amend current lease accounting to require lessees to recognize&#13;(i) a lease liability, which is a lessee&amp;#8217;s obligation to make lease payments arising from a lease, measured on a discounted&#13;basis, and (ii) a right-of-use asset, which is an asset that represents the lessee&amp;#8217;s right to use, or control the use of,&#13;a specified asset for the lease term. ASU 2016-02 does not significantly change lease accounting requirements applicable to lessors;&#13;however, certain changes were made to align, where necessary, lessor accounting with the lessee accounting model. This standard&#13;will be effective for fiscal years beginning after December 15, 2018, including interim periods within those fiscal years. The&#13;Company adopted the provisions of this ASU at January 1, 2019.&lt;/font&gt;&lt;/p&gt;</us-gaap:SignificantAccountingPoliciesTextBlock>
    <us-gaap:IncomeTaxDisclosureTextBlock contextRef="From2018-01-01to2018-12-31">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;NOTE&#13;8 &amp;#8211; INCOME TAXES&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&amp;#160;&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;On&#13;December 22, 2017 H.R. 1, originally known as the Tax Cuts and Jobs Act, (the &amp;#8220;Tax Act&amp;#8221;) was enacted. Among the significant&#13;changes to the U.S. Internal Revenue Code, the Tax Act lowers the U.S. federal corporate income tax rate (&amp;#8220;Federal Tax Rate&amp;#8221;)&#13;from 35% to 21% effective January 1, 2018.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&amp;#160;&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;The&#13;statutory tax rate is the percentage imposed by law; the effective tax rate is the percentage of income actually paid by a company&#13;after taking into account tax deductions, exemptions, credits and operating loss carry forwards.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&amp;#160;&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;At&#13;December 31, 2018 and 2017 deferred tax assets consist of the following:&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;table cellpadding="0" cellspacing="0" align="center" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"&gt;&#13;&lt;tr style="vertical-align: bottom; font-family: Times New Roman, Times, Serif"&gt;&#13;    &lt;td style="text-align: justify; padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;December&#13;    31, 2018&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;December&#13;    31, 2017&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255); font-family: Times New Roman, Times, Serif"&gt;&#13;    &lt;td style="width: 48%; text-align: left; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Federal&#13;    loss carry forwards&lt;/font&gt;&lt;/td&gt;&lt;td style="width: 2%; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%; text-align: left; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="width: 22%; text-align: right; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;922,850&lt;/font&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="width: 2%; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%; text-align: left; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="width: 22%; text-align: right; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;963,833&lt;/font&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White; font-family: Times New Roman, Times, Serif"&gt;&#13;    &lt;td style="text-align: justify; padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Less:&#13;    valuation allowance&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(922,850&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;(963,833&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255); font-family: Times New Roman, Times, Serif"&gt;&#13;    &lt;td style="text-align: justify; padding-bottom: 2.5pt; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; text-align: left; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; text-align: left; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;-&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;The&#13;Company has established a valuation allowance equal to the full amount of the deferred tax asset primarily due to uncertainty&#13;in the utilization of the net operating loss carry forwards.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;The&#13;estimated net operating loss carry forwards of approximately $4,400,000 will be available based on the new carryover rules in&#13;section 172(a) passed with the Tax Cuts and Jobs Acts.&lt;/font&gt;&lt;/p&gt;</us-gaap:IncomeTaxDisclosureTextBlock>
    <us-gaap:RelatedPartyTransactionsDisclosureTextBlock contextRef="From2018-01-01to2018-12-31">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;NOTE&#13;9 &amp;#8211; RELATED PARTIES&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&amp;#160;&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;In&#13;January 2017 Mr. Ajjarapu and Mr. Patel suspended their executive salaries of $165,000 and $125,000, for a period of five and&#13;six months, respectively. In January 2018, Mr. Ajjarapu and Mr. Patel&amp;#8217;s executive salaries were amended to $200,000 and&#13;$150,000, respectively. All of our executives are at-will employees or consultants. Each of Messrs. Ajjarapu and Patel are&#13;parties to an at-will executive employment agreement.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;The&#13;Company owed management wages to Mr. Prashant Patel at December 31, 2018 of $0 and December 31, 2017 of $62,500, respectively.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font-size: 10pt"&gt;In&#13;October 2018 in connection with the acquisition of Community Specialty Pharmacy, LLC a $300,000 promissory note was issued to&#13;Nikul Panchal, accruing interest a simple interest of 10%, interest payable annually, and principal payable at maturity on October&#13;15, 2021.&lt;/font&gt;&lt;/font&gt;&lt;font style="font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font-size: 10pt"&gt;&amp;#160;&lt;/font&gt;&lt;/font&gt;&lt;/p&gt;</us-gaap:RelatedPartyTransactionsDisclosureTextBlock>
    <us-gaap:CommitmentsAndContingenciesDisclosureTextBlock contextRef="From2018-01-01to2018-12-31">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;NOTE&#13;10 &amp;#8211; COMMITMENTS AND CONTINGENCIES&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;b&gt;&amp;#160;&lt;/b&gt;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;The&#13;Company leases two premises in Land O&amp;#8217; Lakes, Florida under an operating lease that expires in 2021 and in Tampa, Florida&#13;under an operating lease that expires in 2023. Future minimum rental payments under these non-cancelable operating leases as of&#13;December 31, 2018 are:&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;table cellpadding="0" cellspacing="0" align="center" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255); font-family: Times New Roman, Times, Serif"&gt;&#13;    &lt;td style="width: 60%; text-align: center; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;2019&lt;/font&gt;&lt;/td&gt;&lt;td style="width: 2%; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%; text-align: left; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="width: 36%; text-align: right; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;156,024&lt;/font&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White; font-family: Times New Roman, Times, Serif"&gt;&#13;    &lt;td style="text-align: center; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;2020&lt;/font&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;160,709&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: left; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255); font-family: Times New Roman, Times, Serif"&gt;&#13;    &lt;td style="text-align: center; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;2021&lt;/font&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;165,506&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: left; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White; font-family: Times New Roman, Times, Serif"&gt;&#13;    &lt;td style="text-align: center; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;2022&lt;/font&gt;&lt;/td&gt;&lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: left; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: right; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;49,080&lt;/font&gt;&lt;/td&gt;&lt;td style="text-align: left; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255); font-family: Times New Roman, Times, Serif"&gt;&#13;    &lt;td style="padding-bottom: 1.5pt; text-align: center; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;2023&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 1.5pt solid; text-align: left; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1.5pt solid; text-align: right; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;41,934&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1.5pt; text-align: left; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: White; font-family: Times New Roman, Times, Serif"&gt;&#13;    &lt;td style="padding-bottom: 2.5pt; text-align: center; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;Total&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: Black 2.5pt double; text-align: left; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;573,253&lt;/font&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left; font-family: Times New Roman, Times, Serif"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:CommitmentsAndContingenciesDisclosureTextBlock>
    <us-gaap:UseOfEstimates contextRef="From2018-01-01to2018-12-31">&lt;p style="margin: 0pt"&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Use of Estimates &amp;#8211; In preparing these&#13;financial statements, management is required to make estimates and assumptions that effect the reported amounts of assets and&#13;liabilities and disclosure of contingent assets and liabilities as of the date of the financial statements and the reported amount&#13;of revenues and expenses during the reporting periods. Actual results could differ from those estimates.&lt;/p&gt;</us-gaap:UseOfEstimates>
    <us-gaap:PriorPeriodReclassificationAdjustmentDescription contextRef="From2018-01-01to2018-12-31">&lt;p style="margin: 0pt"&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Reclassification &amp;#8211; Certain prior year&#13;amounts have been reclassified to conform to the current year presentation.&lt;/p&gt;</us-gaap:PriorPeriodReclassificationAdjustmentDescription>
    <us-gaap:ConsolidationPolicyTextBlock contextRef="From2018-01-01to2018-12-31">&lt;p style="margin: 0pt"&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Principle of Consolidation &amp;#8211; The Company&amp;#8217;s&#13;consolidated financial statements include the accounts of Trxade Group, Inc., Trxade, Inc., Integra Pharma Solutions, Inc., Alliance&#13;Pharma Solutions, LLC and Community Specialty Pharmacy, LLC. All significant intercompany accounts and transactions have been&#13;eliminated.&lt;/p&gt;</us-gaap:ConsolidationPolicyTextBlock>
    <us-gaap:CashAndCashEquivalentsPolicyTextBlock contextRef="From2018-01-01to2018-12-31">&lt;p style="margin: 0pt"&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Cash and Cash Equivalents &amp;#8211; Cash in&#13;bank accounts are at risk to the extent that they exceed U.S. Federal Deposit Insurance Corporation insured amounts. All investments&#13;purchased with a maturity of three months or less are cash equivalents. Cash and cash equivalents are available on demand and&#13;are generally within of FDIC insurance limits for 2018.&lt;/p&gt;</us-gaap:CashAndCashEquivalentsPolicyTextBlock>
    <us-gaap:TradeAndOtherAccountsReceivablePolicy contextRef="From2018-01-01to2018-12-31">&lt;p style="margin: 0pt"&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Accounts Receivable &amp;#8211; The Company&amp;#8217;s&#13;receivables are from customers and are collected within 90 days. The Company determines the allowance based on known troubled&#13;accounts, historical experience, and other currently available evidence. During the years ended December 31, 2018 and 2017, $2,271&#13;of bad debt expense and $0 of recovery of bad debt was recognized, respectively.&lt;/p&gt;</us-gaap:TradeAndOtherAccountsReceivablePolicy>
    <us-gaap:InventoryPolicyTextBlock contextRef="From2018-01-01to2018-12-31">&lt;p style="margin: 0pt"&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Inventory &amp;#8211; Inventories are stated at&#13;the lower of cost or net realizable value. Cost is determined on a weighted average basis. On a quarterly basis, we analyze our&#13;inventory levels and no reserve is maintained as obsolete or expired inventories are written off. There is no reserve for inventory&#13;obsolescence during the periods presented.&lt;/p&gt;</us-gaap:InventoryPolicyTextBlock>
    <us-gaap:DebtPolicyTextBlock contextRef="From2018-01-01to2018-12-31">&lt;p style="margin: 0pt"&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Beneficial Conversion Features &amp;#8211; The&#13;intrinsic value of a beneficial conversion feature inherent to a convertible note payable, which is not bifurcated and accounted&#13;for separately from the convertible note payable and may not be settled in cash upon conversion, is treated as a discount to the&#13;convertible note payable. This discount is amortized over the period from the date of issuance to the date the note is due using&#13;the effective interest method. If the note payable is retired prior to the end of its contractual term, the unamortized discount&#13;is expensed in the period of retirement to interest expense. In general, the beneficial conversion feature is measured by comparing&#13;the effective conversion price, after considering the relative value of detachable instruments included in the financing transaction,&#13;if any, to the fair value of the common shares at the commitment date to be received upon conversion.&lt;/p&gt;</us-gaap:DebtPolicyTextBlock>
    <us-gaap:DerivativesReportingOfDerivativeActivity contextRef="From2018-01-01to2018-12-31">&lt;p style="margin: 0pt"&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Derivative financial instruments &amp;#8211; The&#13;Company evaluates its financial instruments to determine if such instruments are derivatives or contain features that qualify&#13;as embedded derivatives. For derivative financial instruments that are accounted for as liabilities, the derivative instrument&#13;is initially recorded at its fair value and is then re-valued at each reporting date, with changes in the fair value reported&#13;in the statements of operations. For stock-based derivative financial instruments, the Company uses a Black-Scholes option pricing&#13;model, assuming maximum value, in accordance with ASC 815-15 &amp;#8220;Derivative and Hedging&amp;#8221; to value the derivative instruments&#13;at inception and on subsequent valuation dates. The classification of derivative instruments, including whether such instruments&#13;should be recorded as liabilities or as equity, is evaluated at the end of each reporting period. Derivative instrument liabilities&#13;are classified in the balance sheet as current or non-current based on whether or not net-cash settlement of the derivative instrument&#13;could be required within 12 months of the balance sheet date.&lt;/p&gt;</us-gaap:DerivativesReportingOfDerivativeActivity>
    <us-gaap:FairValueOfFinancialInstrumentsPolicy contextRef="From2018-01-01to2018-12-31">&lt;p style="margin: 0pt"&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Fair Value of Financial Instruments &amp;#8211;&#13;The Company measures its financial assets and liabilities in accordance with the requirements of FASB ASC 820, &amp;#8220;Fair Value&#13;Measurements and Disclosures&amp;#8221;. ASC 820 clarifies the definition of fair value, prescribes methods for measuring fair value,&#13;and establishes a fair value hierarchy to classify the inputs used in measuring fair value as follows:&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Level 1 &amp;#8211; Quoted prices are available&#13;in active markets for identical assets or liabilities as of the reporting date. Active markets are those in which transactions&#13;for the asset or liability occur in sufficient frequency and volume to provide pricing information on an ongoing basis. Level 1&#13;primarily consists of financial instruments such as exchange-traded derivatives, marketable securities and listed equities.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Level 2 &amp;#8211; Pricing inputs are other than&#13;quoted prices in active markets included in level 1, which are either directly or indirectly observable as of the reported date&#13;and includes those financial instruments that are valued using models or other valuation methodologies. These models are primarily&#13;industry-standard models that consider various assumptions, including quoted forward prices for commodities, time value, volatility&#13;factors, and current market and contractual prices for the underlying instruments, as well as other relevant economic measures.&#13;Substantially all of these assumptions are observable in the marketplace throughout the full term of the instrument, can be derived&#13;from observable data or are supported by observable levels at which transactions are executed in the marketplace. Instruments in&#13;this category generally include non-exchange-traded derivatives such as commodity swaps, interest rate swaps, options and collars.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Level 3 &amp;#8211; Pricing inputs include significant&#13;inputs that are generally less observable from objective sources. These inputs may be used with internally developed methodologies&#13;that result in management&amp;#8217;s best estimate of fair value.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The Company does not have any assets or liabilities&#13;that are required to be measured and recorded at fair value on a recurring basis.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The carrying amounts of cash, accounts receivable,&#13;accounts payable, accrued liabilities and short-term debt approximate fair value because of the short-term nature of these instruments.&#13;The carrying amount of long-term debt approximates fair value because the debt is based on current rates at which the Company&#13;could borrow funds with similar maturities.&lt;/p&gt;</us-gaap:FairValueOfFinancialInstrumentsPolicy>
    <us-gaap:GoodwillAndIntangibleAssetsGoodwillPolicy contextRef="From2018-01-01to2018-12-31">&lt;p style="margin: 0pt"&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Goodwill &amp;#8211; The Company accounts for&#13;goodwill and intangible assets in accordance with ASC 350 &amp;#8220;Intangibles Goodwill and Other&amp;#8221;. ASC 350 requires that&#13;goodwill and other intangibles with indefinite lives be tested for impairment annually or on an interim basis if events or circumstances&#13;indicate that the fair value of an asset has decreased below its carrying value. The Company performed impairment analysis using&#13;the qualitative analysis under ASC 350-20 and noted no impairment issues for 2018.&lt;/p&gt;</us-gaap:GoodwillAndIntangibleAssetsGoodwillPolicy>
    <us-gaap:RevenueRecognitionPolicyTextBlock contextRef="From2018-01-01to2018-12-31">&lt;p style="margin: 0pt"&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Revenue Recognition &amp;#8211; In May 2014, the&#13;Financial Accounting Standards Board (FASB) issued Accounting Standards Update No. 2014-09 (Topic 606) &amp;#8220;Revenue from Contracts&#13;with Customers.&amp;#8221; Topic 606 supersedes the revenue recognition requirements in Accounting Standards Codification Topic 605,&#13;&amp;#8220;Revenue Recognition&amp;#8221;, and requires entities to recognize revenue when they transfer control of promised goods or services&#13;to customers in an amount that reflects the consideration to which the entity expects to be entitled to in exchange for those goods&#13;or services. The Company adopted ASU 2014-09 using the modified retrospective approach effective January 1, 2018, under which prior&#13;periods were not retrospectively adjusted. The adoption of Topic 606 does not have a material impact to our consolidated financial&#13;statements, including the presentation of revenues in our Consolidated Statements of Operations.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Trxade, Inc. provides an online website service,&#13;a buying and selling marketplace for licensed Pharmaceutical Wholesalers to sell products and services to licensed Pharmacies.&#13;The Company charges Suppliers a transaction fee, a percentage of the purchase price of the Prescription Drugs and other products&#13;sold through its website service. The fulfillment of confirmed orders, including delivery and shipment of Prescription Drugs and&#13;other products, is the responsibility of the Supplier and not of the Company. The Company holds no inventory and assumes no responsibility&#13;for the shipment or delivery of any products or services from our website. The Company considers itself an agent for this revenue&#13;stream and as such, reports revenue as net. Step One: Identify the contract with the customer &amp;#8211; Trxade, Inc.&amp;#8217;s Terms&#13;and Use Agreement is acknowledged between the Wholesaler and Trxade, Inc. which outlines the terms and conditions. The collection&#13;is probable based on the credit evaluation of the Wholesaler. Step Two: Identify the performance obligations in the contract &amp;#8211;&#13;The Company provides to the Supplier access to the online website, uploading of catalogs of products and Dashboard access to review&#13;status of inventory posted and processed orders. The Agreement requires the supplier to provide a catalog of pharmaceuticals for&#13;posting on the platform, deliver the pharmaceuticals and upon shipment remit the stated platform fee. Step Three: Determine the&#13;transaction price &amp;#8211; The Fee Agreement outlines the fee based on the type of product, generic, brand or non-drug. There are&#13;no discounts for volume of transactions or early payment of invoices. Step Four: Allocate the transaction price &amp;#8211; The Fee&#13;Agreement outlines the fee. There is no difference between contract price and &amp;#8220;stand-alone selling price&amp;#8221;. Step Five:&#13;Recognize revenue when or as the entity satisfies a performance obligation &amp;#8211; Revenue is recognized the day the order has&#13;been processed by the Supplier.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Integra Pharma Solutions, LLC is a licensed&#13;wholesaler and sells to licensed pharmacies brand, generic and non-drug products. The Company takes orders for product and creates&#13;invoices for each order and recognizes revenue at the time the Customer receives the product. Customer returns are not material.&#13;Step One: Identify the contract with the customer &amp;#8211; The Company requires that an application and a credit card for payment&#13;is completed by the Customer prior to the first order. Each transaction is evidenced by an order form sent by the customer and&#13;an invoice for the product is sent by the Company. The collection is probable based on the application and credit card information&#13;provided prior to the first order. Step Two: Identify the performance obligations in the contract &amp;#8211; Each order is distinct&#13;and evidenced by the shipping order and invoice. Step Three: Determine the transaction price &amp;#8211; The consideration is variable&#13;if product is returned. The variability is determined based on the return policy of the product manufacturer. There are no sales&#13;or volume discounts. The transaction price is determined at the time of the order evidenced by the invoice. Step Four: Allocate&#13;the transaction price &amp;#8211; There is no difference between contract price and &amp;#8220;stand-alone selling price&amp;#8221;. Step Five:&#13;Recognize revenue when or as the entity satisfies a performance obligation - The Revenue is recognized when the Customer receives&#13;the product.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Community Specialty Pharmacy, LLC is in the&#13;retail pharmacy business. The Company fills prescriptions for drugs written by a doctor and recognizes revenue at the time the&#13;patient confirms delivery of the prescription. Customer returns are not material. Step One: Identify the contract with the customer&#13;&amp;#8211; The prescription is written by a doctor for a Customer and delivered to the Company. The prescription identifies the performance&#13;obligations in the contract. The Company fills the prescription and delivers to the Customer the prescription, fulfilling the&#13;contract. The collection is probable because there is confirmation that the customer has insurance for the reimbursement to the&#13;Company prior to filling of the prescription. Step Two: Identify the performance obligations in the contract &amp;#8211; Each prescription&#13;is distinct to the Customer. Step Three: Determine the transaction price &amp;#8211; The consideration is not variable. The transaction&#13;price is determined to be the price of the prescription at the time of delivery which considers the expected reimbursements from&#13;third party payors (e.g., pharmacy benefit managers, insurance companies and government agencies). Step Four: Allocate the transaction&#13;price &amp;#8211; The price of the prescription invoiced represents the expected amount of reimbursement from third party payors.&#13;There is no difference between contract price and &amp;#8220;stand-alone selling price&amp;#8221;. Step Five: Recognize revenue when or&#13;as the entity satisfies a performance obligation &amp;#8211; Revenue is recognized upon the delivery of the prescription.&lt;/p&gt;</us-gaap:RevenueRecognitionPolicyTextBlock>
    <TRXD:CostOfGoodsSoldPolicyTextBlock contextRef="From2018-01-01to2018-12-31">&lt;p style="margin: 0pt"&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Cost of Goods Sold &amp;#8211; The company recognized&#13;cost of goods sold in 2018 from activities in Integra Pharma Solutions, LLC and Community Specialty Pharmacy, LLC, which were&#13;not active in 2017.&lt;/p&gt;</TRXD:CostOfGoodsSoldPolicyTextBlock>
    <us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy contextRef="From2018-01-01to2018-12-31">&lt;p style="margin: 0pt"&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Stock-Based Compensation &amp;#8211; The Company&#13;accounts for stock-based compensation to non-employees in accordance with the provision of ASC 505, &amp;#8220;Equity Based Payments&#13;to Non-Employees&amp;#8221; (&amp;#8220;ASC 505&amp;#8221;), which requires that such equity instruments are recorded at their fair value on&#13;the measurement date. The measurement of stock-based compensation is subject to periodic adjustment as the underlying instruments&#13;vest.&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The Company accounts for stock-based compensation&#13;to employees in accordance with ASC 718, &amp;#8220;Compensation-Stock Compensation&amp;#8221;. ASC 718 requires companies to measure&#13;the cost of employee services received in exchange for an award of equity instruments, including stock options, based on the grant&#13;date fair value of the award and to recognize it as compensation expense over the period the employee is required to provide service&#13;in exchange for the award, usually the vesting period. Stock option forfeitures are recognized at the date of employee termination.&lt;/p&gt;</us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy>
    <us-gaap:IncomeTaxPolicyTextBlock contextRef="From2018-01-01to2018-12-31">&lt;p style="margin: 0pt"&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Income Taxes &amp;#8211; The Company accounts&#13;for income taxes utilizing ASC 740, &amp;#8220;Income Taxes&amp;#8221; (SFAS No. 109). ASC 740 requires the measurement of deferred tax&#13;assets for deductible temporary differences and operating loss carry forwards, and of deferred tax liabilities for taxable temporary&#13;differences. Measurement of current and deferred tax liabilities and assets is based on provisions of enacted tax law. The effects&#13;of future changes in tax rates are not included in the measurement. The Company recognizes the amount of taxes payable or refundable&#13;for the current year and recognizes deferred tax liabilities and assets for the expected future tax consequences of events and&#13;transactions that have been recognized in the Company&amp;#8217;s financial statements or tax returns. The Company currently has substantial&#13;net operating loss carry forwards. The Company has recorded a 100% valuation allowance against net deferred tax assets due to&#13;uncertainty of their ultimate realization. Valuation allowances are established when necessary to reduce deferred tax assets to&#13;the amount expected to be realized. Tax years from 2015 forward are open to examination by the Internal Revenue Service.&lt;/p&gt;</us-gaap:IncomeTaxPolicyTextBlock>
    <us-gaap:ConcentrationRiskCreditRisk contextRef="From2018-01-01to2018-12-31">&lt;p style="margin: 0pt"&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Concentration of Credit Risks and Major Customers&#13;- Financial instruments that potentially subject the company to credit risk consist principally of cash and cash equivalents and&#13;receivables. The Company places its cash and cash equivalents with financial institutions. Deposits are insured to Federal Deposit&#13;Insurance Corp limits. During the years ended December 31, 2018 and 2017, sales to two customers each represent greater than 10%&#13;of revenue.&lt;/p&gt;</us-gaap:ConcentrationRiskCreditRisk>
    <TRXD:RecoveryOfBadDebt contextRef="From2017-01-01to2017-12-31" unitRef="USD" decimals="0">0</TRXD:RecoveryOfBadDebt>
    <TRXD:RecoveryOfBadDebt contextRef="From2018-01-01to2018-12-31" unitRef="USD" decimals="0">0</TRXD:RecoveryOfBadDebt>
    <TRXD:ValuationAllowancePercentage contextRef="From2018-01-01to2018-12-31" unitRef="Percentage" decimals="INF">1.00</TRXD:ValuationAllowancePercentage>
    <us-gaap:ConcentrationRiskPercentage1 contextRef="From2018-01-01to2018-12-31_custom_TwoCustomersMember" unitRef="Percentage" decimals="INF">0.10</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1 contextRef="From2017-01-01to2017-12-31_custom_TwoCustomersMember" unitRef="Percentage" decimals="INF">0.10</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:DebtInstrumentTerm contextRef="From2016-09-01to2016-09-30_custom_PromissoryNoteMember">P494D</us-gaap:DebtInstrumentTerm>
    <us-gaap:DebtInstrumentTerm contextRef="From2016-08-01to2016-08-31_custom_RelatedPartyConvertiblePromissoryNoteMember_custom_MrShilpaPatelMember">P1Y</us-gaap:DebtInstrumentTerm>
    <us-gaap:DebtInstrumentTerm contextRef="From2016-09-01to2016-09-30_custom_RelatedPartyConvertiblePromissoryNoteMember_custom_MrNitilPatelMember">P1Y</us-gaap:DebtInstrumentTerm>
    <us-gaap:DebtInstrumentTerm contextRef="From2016-10-01to2016-10-31_custom_RelatedPartyConvertiblePromissoryNoteMember_custom_MrNitilPatelMember">P1Y</us-gaap:DebtInstrumentTerm>
    <us-gaap:DebtInstrumentTerm contextRef="From2017-04-01to2017-04-30_custom_RelatedPartyConvertiblePromissoryNoteMember">P1Y</us-gaap:DebtInstrumentTerm>
    <us-gaap:DebtInstrumentTerm contextRef="From2018-02-01to2018-02-28_custom_RelatedPartyConvertiblePromissoryNoteMember">P1Y</us-gaap:DebtInstrumentTerm>
    <us-gaap:DebtInstrumentTerm contextRef="From2017-04-01to2017-04-30_custom_ConvertiblePromissoryNoteMember">P2Y</us-gaap:DebtInstrumentTerm>
    <us-gaap:DebtInstrumentTerm contextRef="From2017-06-01to2017-06-30_custom_RelatedPartyPromissoryNoteMember_custom_SansurAssociatesLLCMember">P3Y</us-gaap:DebtInstrumentTerm>
    <us-gaap:DebtInstrumentTerm contextRef="From2015-04-01to2015-04-30_custom_ConvertiblePromissoryNoteMember">P1Y</us-gaap:DebtInstrumentTerm>
    <us-gaap:DebtInstrumentTerm contextRef="From2015-05-01to2015-05-31_custom_ConvertiblePromissoryNoteMember">P1Y</us-gaap:DebtInstrumentTerm>
    <us-gaap:DebtInstrumentTerm contextRef="From2016-01-01to2016-10-31_custom_PromissoryNoteMember">P1Y</us-gaap:DebtInstrumentTerm>
    <us-gaap:DebtInstrumentTerm contextRef="From2017-09-01to2017-09-30_custom_RelatedPartyConvertiblePromissoryNoteMember">P6M</us-gaap:DebtInstrumentTerm>
    <us-gaap:DebtInstrumentTerm contextRef="From2016-11-01to2016-11-30_custom_RelatedPartyConvertiblePromissoryNoteMember_custom_MrPrashantPatelMember">P90M</us-gaap:DebtInstrumentTerm>
    <us-gaap:DebtInstrumentTerm contextRef="From2017-02-01to2017-02-28_custom_RelatedPartyConvertiblePromissoryNoteMember_custom_MrPrashantPatelMember">P90M</us-gaap:DebtInstrumentTerm>
    <TRXD:GrantedWarrants contextRef="AsOf2015-04-30_custom_ConvertiblePromissoryNoteMember" unitRef="Shares" decimals="INF">1</TRXD:GrantedWarrants>
    <TRXD:GrantedWarrants contextRef="AsOf2015-05-31_custom_ConvertiblePromissoryNoteMember" unitRef="Shares" decimals="INF">1</TRXD:GrantedWarrants>
    <TRXD:GrantedWarrants contextRef="AsOf2016-04-30_custom_ConvertiblePromissoryNoteMember" unitRef="Shares" decimals="INF">1</TRXD:GrantedWarrants>
    <TRXD:GrantedWarrants contextRef="AsOf2016-05-31_custom_ConvertiblePromissoryNoteMember" unitRef="Shares" decimals="INF">1</TRXD:GrantedWarrants>
    <us-gaap:RepaymentsOfDebt contextRef="From2017-01-01to2017-12-31_custom_PromissoryNoteMember" unitRef="USD" decimals="0">250000</us-gaap:RepaymentsOfDebt>
    <us-gaap:RepaymentsOfDebt contextRef="From2018-02-01to2018-02-28_custom_RelatedPartyConvertiblePromissoryNoteMember" unitRef="USD" decimals="0">50000</us-gaap:RepaymentsOfDebt>
    <us-gaap:RepaymentsOfDebt contextRef="From2016-05-01to2016-05-31_custom_ConvertiblePromissoryNoteMember" unitRef="USD" decimals="0">50000</us-gaap:RepaymentsOfDebt>
    <us-gaap:RepaymentsOfDebt contextRef="From2016-04-01to2016-04-30_custom_ConvertiblePromissoryNoteMember" unitRef="USD" decimals="0">50000</us-gaap:RepaymentsOfDebt>
    <us-gaap:RepaymentsOfDebt contextRef="From2017-01-01to2017-12-31_custom_PromissoryNoteOneMember" unitRef="USD" decimals="0">43083</us-gaap:RepaymentsOfDebt>
    <us-gaap:RepaymentsOfDebt contextRef="From2018-01-01to2018-12-31_custom_PromissoryNotesMember" unitRef="USD" decimals="0">10739</us-gaap:RepaymentsOfDebt>
    <us-gaap:RepaymentsOfDebt contextRef="From2018-04-01to2018-04-30_custom_RelatedPartyConvertiblePromissoryNotesMember" unitRef="USD" decimals="0">61725</us-gaap:RepaymentsOfDebt>
    <us-gaap:RepaymentsOfDebt contextRef="From2017-01-01to2017-12-31_custom_ShortTermPromissoryNotesMember" unitRef="USD" decimals="0">139602</us-gaap:RepaymentsOfDebt>
    <us-gaap:InterestExpenseDebt contextRef="From2017-04-01to2017-04-30_custom_ConvertiblePromissoryNoteMember" unitRef="USD" decimals="0">5500</us-gaap:InterestExpenseDebt>
    <us-gaap:InterestExpenseDebt contextRef="From2016-05-01to2016-05-31_custom_ConvertiblePromissoryNoteMember" unitRef="USD" decimals="0">5000</us-gaap:InterestExpenseDebt>
    <us-gaap:InterestExpenseDebt contextRef="From2016-04-01to2016-04-30_custom_ConvertiblePromissoryNoteMember" unitRef="USD" decimals="0">5000</us-gaap:InterestExpenseDebt>
    <us-gaap:DebtInstrumentMaturityDateDescription contextRef="From2017-08-01to2017-08-31_custom_RelatedPartyConvertiblePromissoryNoteMember">A one-year extension was executed to August 2018. </us-gaap:DebtInstrumentMaturityDateDescription>
    <us-gaap:DebtInstrumentMaturityDateDescription contextRef="From2018-08-01to2018-08-31_custom_RelatedPartyConvertiblePromissoryNoteMember">A one-year extension was executed to August 2019. </us-gaap:DebtInstrumentMaturityDateDescription>
    <us-gaap:DebtInstrumentMaturityDateDescription contextRef="From2017-04-01to2017-04-30_custom_ConvertiblePromissoryNoteMember">A two-year extension was executed on the remaining notes </us-gaap:DebtInstrumentMaturityDateDescription>
    <us-gaap:DebtInstrumentMaturityDateDescription contextRef="From2016-05-01to2016-05-31_custom_ConvertiblePromissoryNoteMember">A one-year extension was executed on the remaining notes</us-gaap:DebtInstrumentMaturityDateDescription>
    <us-gaap:DebtInstrumentMaturityDateDescription contextRef="From2016-04-01to2016-04-30_custom_ConvertiblePromissoryNoteMember">A one-year extension was executed on the remaining notes</us-gaap:DebtInstrumentMaturityDateDescription>
    <us-gaap:InterestPayableCurrentAndNoncurrent contextRef="AsOf2017-04-30_custom_ConvertiblePromissoryNoteMember" unitRef="USD" decimals="0">16500</us-gaap:InterestPayableCurrentAndNoncurrent>
    <us-gaap:InterestPayableCurrentAndNoncurrent contextRef="AsOf2016-04-30_custom_ConvertiblePromissoryNoteMember" unitRef="USD" decimals="0">15000</us-gaap:InterestPayableCurrentAndNoncurrent>
    <us-gaap:InterestPayableCurrentAndNoncurrent contextRef="AsOf2016-05-31_custom_ConvertiblePromissoryNoteMember" unitRef="USD" decimals="0">15000</us-gaap:InterestPayableCurrentAndNoncurrent>
    <us-gaap:DebtInstrumentFaceAmount contextRef="AsOf2016-09-30_custom_PromissoryNoteMember" unitRef="USD" decimals="0">189000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentFaceAmount contextRef="AsOf2017-08-31_custom_RelatedPartyConvertiblePromissoryNoteMember" unitRef="USD" decimals="0">40000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentFaceAmount contextRef="AsOf2018-08-31_custom_RelatedPartyConvertiblePromissoryNoteMember" unitRef="USD" decimals="0">40000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentFaceAmount contextRef="AsOf2016-10-31_custom_RelatedPartyConvertiblePromissoryNoteMember_custom_MrNitilPatelMember" unitRef="USD" decimals="0">211725</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentFaceAmount contextRef="AsOf2016-09-30_custom_RelatedPartyConvertiblePromissoryNoteMember_custom_MrNitilPatelMember" unitRef="USD" decimals="0">211725</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentFaceAmount contextRef="AsOf2017-04-30_custom_ConvertiblePromissoryNoteMember" unitRef="USD" decimals="0">181500</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentFaceAmount contextRef="AsOf2017-06-30_custom_RelatedPartyPromissoryNoteMember_custom_NPRINVESTMENTGROUPLLCMember" unitRef="USD" decimals="0">250000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentFaceAmount contextRef="AsOf2018-12-31_custom_RelatedPartyPromissoryNoteMember_custom_NPRINVESTMENTGROUPLLCMember" unitRef="USD" decimals="0">80000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentFaceAmount contextRef="AsOf2018-12-31_custom_RelatedPartyPromissoryNoteMember_custom_PromissoryNoteMember" unitRef="USD" decimals="0">17280</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentFaceAmount contextRef="AsOf2016-04-30_custom_ConvertiblePromissoryNoteMember" unitRef="USD" decimals="0">165000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentFaceAmount contextRef="AsOf2016-05-31_custom_ConvertiblePromissoryNoteMember" unitRef="USD" decimals="0">165000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentFaceAmount contextRef="AsOf2016-05-31_custom_PromissoryNoteMember" unitRef="USD" decimals="0">250000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentFaceAmount contextRef="AsOf2016-12-31_custom_PromissoryNoteMember" unitRef="USD" decimals="0">250000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentFaceAmount contextRef="AsOf2016-10-31_custom_PromissoryNoteMember" unitRef="USD" decimals="0">47000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentFaceAmount contextRef="AsOf2016-12-31_custom_PromissoryNoteOneMember" unitRef="USD" decimals="0">43083</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentFaceAmount contextRef="AsOf2017-12-31_custom_PromissoryNoteOneMember" unitRef="USD" decimals="0">0</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentFaceAmount contextRef="AsOf2016-08-31_custom_RelatedPartyConvertiblePromissoryNoteMember_custom_MrShilpaPatelMember" unitRef="USD" decimals="0">40000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentFaceAmount contextRef="AsOf2019-02-28_us-gaap_SubsequentEventMember" unitRef="USD" decimals="0">150000</us-gaap:DebtInstrumentFaceAmount>
    <TRXD:DebtModificationsAmount contextRef="AsOf2015-12-31_us-gaap_WarrantMember" unitRef="USD" decimals="0">0</TRXD:DebtModificationsAmount>
    <us-gaap:DebtInstrumentPeriodicPaymentPrincipal contextRef="From2016-01-01to2016-10-31_custom_PromissoryNoteMember" unitRef="USD" decimals="0">3917</us-gaap:DebtInstrumentPeriodicPaymentPrincipal>
    <us-gaap:DebtInstrumentPeriodicPaymentPrincipal contextRef="From2016-01-01to2016-12-31_custom_PromissoryNoteTwoMember" unitRef="USD" decimals="0">537</us-gaap:DebtInstrumentPeriodicPaymentPrincipal>
    <us-gaap:DebtInstrumentUnamortizedDiscountCurrent contextRef="AsOf2018-12-31_custom_ShortTermNotesPayableMember" unitRef="USD" decimals="0">0</us-gaap:DebtInstrumentUnamortizedDiscountCurrent>
    <us-gaap:DebtInstrumentUnamortizedDiscountCurrent contextRef="AsOf2017-12-31_custom_ShortTermNotesPayableMember" unitRef="USD" decimals="0">152</us-gaap:DebtInstrumentUnamortizedDiscountCurrent>
    <us-gaap:DebtInstrumentUnamortizedDiscountCurrent contextRef="AsOf2016-12-31_custom_PromissoryNoteTwoMember" unitRef="USD" decimals="0">25306</us-gaap:DebtInstrumentUnamortizedDiscountCurrent>
    <us-gaap:LongTermDebt contextRef="AsOf2018-12-31" unitRef="USD" decimals="0">522052</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt contextRef="AsOf2016-12-31_custom_PromissoryNoteTwoMember" unitRef="USD" decimals="0">10739</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentUnamortizedDiscountNoncurrent contextRef="AsOf2016-12-31_custom_PromissoryNoteTwoMember" unitRef="USD" decimals="0">152</us-gaap:DebtInstrumentUnamortizedDiscountNoncurrent>
    <us-gaap:DebtInstrumentConvertibleBeneficialConversionFeature contextRef="From2018-01-01to2018-12-31_custom_RelatedPartyConvertiblePromissoryNoteMember" unitRef="USD" decimals="0">0</us-gaap:DebtInstrumentConvertibleBeneficialConversionFeature>
    <us-gaap:DueToRelatedPartiesCurrentAndNoncurrent contextRef="AsOf2017-04-30_custom_RelatedPartyConvertiblePromissoryNoteMember" unitRef="USD" decimals="0">61725</us-gaap:DueToRelatedPartiesCurrentAndNoncurrent>
    <us-gaap:DueToRelatedPartiesCurrentAndNoncurrent contextRef="AsOf2017-09-30_custom_RelatedPartyConvertiblePromissoryNoteMember" unitRef="USD" decimals="0">150000</us-gaap:DueToRelatedPartiesCurrentAndNoncurrent>
    <us-gaap:DueToRelatedPartiesCurrentAndNoncurrent contextRef="AsOf2018-02-28_custom_RelatedPartyConvertiblePromissoryNoteMember" unitRef="USD" decimals="0">100000</us-gaap:DueToRelatedPartiesCurrentAndNoncurrent>
    <us-gaap:DueToRelatedPartiesCurrentAndNoncurrent contextRef="AsOf2018-12-31_custom_MrPrashantPatelMember" unitRef="USD" decimals="0">0</us-gaap:DueToRelatedPartiesCurrentAndNoncurrent>
    <us-gaap:DueToRelatedPartiesCurrentAndNoncurrent contextRef="AsOf2017-12-31_custom_MrPrashantPatelMember" unitRef="USD" decimals="0">62500</us-gaap:DueToRelatedPartiesCurrentAndNoncurrent>
    <us-gaap:DueToRelatedPartiesCurrentAndNoncurrent contextRef="AsOf2018-12-31_custom_RelatedPartyPromissoryNoteMember_custom_MrPrashantPatelMember" unitRef="USD" decimals="0">122552</us-gaap:DueToRelatedPartiesCurrentAndNoncurrent>
    <us-gaap:LoansPayable contextRef="AsOf2016-11-30_custom_RelatedPartyConvertiblePromissoryNoteMember_custom_MrPrashantPatelMember" unitRef="USD" decimals="0">10000</us-gaap:LoansPayable>
    <us-gaap:LoansPayable contextRef="AsOf2016-12-31_custom_RelatedPartyConvertiblePromissoryNoteMember_custom_MrPrashantPatelMember" unitRef="USD" decimals="0">10000</us-gaap:LoansPayable>
    <us-gaap:AccountsPayableCurrentAndNoncurrent contextRef="AsOf2017-02-28_custom_RelatedPartyConvertiblePromissoryNoteMember_custom_MrPrashantPatelMember" unitRef="USD" decimals="0">7280</us-gaap:AccountsPayableCurrentAndNoncurrent>
    <us-gaap:AccountsPayableCurrentAndNoncurrent contextRef="AsOf2018-06-30_custom_RelatedPartyConvertiblePromissoryNoteMember_custom_MrPrashantPatelMember" unitRef="USD" decimals="0">25272</us-gaap:AccountsPayableCurrentAndNoncurrent>
    <us-gaap:DebtConversionConvertedInstrumentAmount1 contextRef="From2017-07-01to2017-07-31_custom_RelatedPartyConvertiblePromissoryNoteMember_custom_MrPrashantPatelMember" unitRef="USD" decimals="0">42552</us-gaap:DebtConversionConvertedInstrumentAmount1>
    <us-gaap:DebtConversionConvertedInstrumentAmount1 contextRef="From2019-09-29to2019-09-30_us-gaap_SubsequentEventMember_custom_SecuritiesPurchaseAgreementMember_custom_PromissoryNotesMember" unitRef="USD" decimals="0">175000</us-gaap:DebtConversionConvertedInstrumentAmount1>
    <us-gaap:ShortTermBorrowings contextRef="AsOf2017-06-30_custom_RelatedPartyPromissoryNoteMember_custom_SansurAssociatesLLCMember_custom_MrSurenAjjarapuMember" unitRef="USD" decimals="0">100000</us-gaap:ShortTermBorrowings>
    <us-gaap:ShortTermBorrowings contextRef="AsOf2017-06-30_custom_RelatedPartyPromissoryNoteMember_custom_SansurAssociatesLLCMember_custom_MrPrashantPatelMember" unitRef="USD" decimals="0">80000</us-gaap:ShortTermBorrowings>
    <TRXD:CreditCardObligationAmount contextRef="From2018-01-01to2018-12-31" unitRef="USD" decimals="0">25272</TRXD:CreditCardObligationAmount>
    <us-gaap:ConvertibleLongTermNotesPayable contextRef="AsOf2018-12-31" unitRef="USD" xsi:nil="true" />
    <us-gaap:ConvertibleLongTermNotesPayable contextRef="AsOf2017-12-31" unitRef="USD" decimals="0">181500</us-gaap:ConvertibleLongTermNotesPayable>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo contextRef="AsOf2018-12-31" unitRef="USD" decimals="0">222552</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree contextRef="AsOf2018-12-31" unitRef="USD" decimals="0">300000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour contextRef="AsOf2018-12-31" unitRef="USD" xsi:nil="true" />
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive contextRef="AsOf2018-12-31" unitRef="USD" xsi:nil="true" />
    <us-gaap:SaleOfStockPricePerShare contextRef="AsOf2018-07-31_custom_PrivateOfferMemorandumMember" unitRef="USDPShares" decimals="INF">1.00</us-gaap:SaleOfStockPricePerShare>
    <us-gaap:SaleOfStockPricePerShare contextRef="AsOf2017-01-31_custom_PrivateOfferMemorandumMember" unitRef="USDPShares" decimals="INF">1.00</us-gaap:SaleOfStockPricePerShare>
    <us-gaap:SaleOfStockPricePerShare contextRef="AsOf2018-11-30_custom_PrivateOfferMemorandumMember" unitRef="USDPShares" decimals="INF">0.50</us-gaap:SaleOfStockPricePerShare>
    <us-gaap:ProceedsFromIssuanceOfWarrants contextRef="From2017-02-01to2017-02-28" unitRef="USD" decimals="0">250</us-gaap:ProceedsFromIssuanceOfWarrants>
    <TRXD:WarrantIssuedForRenewalOfConvertibleDebt contextRef="AsOf2018-12-31" unitRef="Shares" decimals="INF">10000</TRXD:WarrantIssuedForRenewalOfConvertibleDebt>
    <TRXD:WarrantIssuedForRenewalOfConvertibleDebt contextRef="AsOf2017-12-31" unitRef="Shares" decimals="INF">28150</TRXD:WarrantIssuedForRenewalOfConvertibleDebt>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight contextRef="AsOf2018-12-31" unitRef="Shares" xsi:nil="true" />
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight contextRef="AsOf2017-12-31" unitRef="Shares" decimals="INF">25000</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight>
    <TRXD:FairValueAssumptionsMeasurementInputPercentages contextRef="AsOf2018-12-31_us-gaap_WarrantMember_us-gaap_MeasurementInputExpectedDividendRateMember" unitRef="Percentage" decimals="INF">0.00</TRXD:FairValueAssumptionsMeasurementInputPercentages>
    <TRXD:FairValueAssumptionsMeasurementInputPercentages contextRef="AsOf2017-12-31_us-gaap_WarrantMember_us-gaap_MeasurementInputExpectedDividendRateMember" unitRef="Percentage" decimals="INF">0.00</TRXD:FairValueAssumptionsMeasurementInputPercentages>
    <TRXD:FairValueAssumptionsMeasurementInputPercentages contextRef="AsOf2018-12-31_us-gaap_MeasurementInputPriceVolatilityMember_srt_MinimumMember_us-gaap_WarrantMember" unitRef="Percentage" decimals="INF">2.31</TRXD:FairValueAssumptionsMeasurementInputPercentages>
    <TRXD:FairValueAssumptionsMeasurementInputPercentages contextRef="AsOf2017-12-31_us-gaap_MeasurementInputPriceVolatilityMember_srt_MinimumMember_us-gaap_WarrantMember" unitRef="Percentage" decimals="INF">2.00</TRXD:FairValueAssumptionsMeasurementInputPercentages>
    <TRXD:FairValueAssumptionsMeasurementInputPercentages contextRef="AsOf2018-12-31_us-gaap_MeasurementInputPriceVolatilityMember_srt_MaximumMember_us-gaap_WarrantMember" unitRef="Percentage" decimals="INF">6.32</TRXD:FairValueAssumptionsMeasurementInputPercentages>
    <TRXD:FairValueAssumptionsMeasurementInputPercentages contextRef="AsOf2018-12-31_us-gaap_MeasurementInputRiskFreeInterestRateMember_srt_MinimumMember_us-gaap_WarrantMember" unitRef="Percentage" decimals="INF">0.0255</TRXD:FairValueAssumptionsMeasurementInputPercentages>
    <TRXD:FairValueAssumptionsMeasurementInputPercentages contextRef="AsOf2017-12-31_us-gaap_MeasurementInputRiskFreeInterestRateMember_srt_MinimumMember_us-gaap_WarrantMember" unitRef="Percentage" decimals="INF">0.0181</TRXD:FairValueAssumptionsMeasurementInputPercentages>
    <TRXD:FairValueAssumptionsMeasurementInputPercentages contextRef="AsOf2017-12-31_us-gaap_WarrantMember_us-gaap_MeasurementInputRiskFreeInterestRateMember_srt_MaximumMember" unitRef="Percentage" decimals="INF">0.0184</TRXD:FairValueAssumptionsMeasurementInputPercentages>
    <TRXD:FairValueAssumptionsMeasurementInputPercentages contextRef="AsOf2018-12-31_us-gaap_MeasurementInputRiskFreeInterestRateMember_srt_MaximumMember_us-gaap_WarrantMember" unitRef="Percentage" decimals="INF">0.0275</TRXD:FairValueAssumptionsMeasurementInputPercentages>
    <TRXD:FairValueAssumptionsMeasurementInputTerm contextRef="From2018-01-01to2018-12-31_us-gaap_MeasurementInputExpectedTermMember_srt_MinimumMember_us-gaap_WarrantMember">P5Y</TRXD:FairValueAssumptionsMeasurementInputTerm>
    <TRXD:FairValueAssumptionsMeasurementInputTerm contextRef="From2017-01-01to2017-12-31_us-gaap_MeasurementInputExpectedTermMember_srt_MinimumMember_us-gaap_WarrantMember">P5Y</TRXD:FairValueAssumptionsMeasurementInputTerm>
    <TRXD:FairValueAssumptionsMeasurementInputTerm contextRef="From2018-01-01to2018-12-31_us-gaap_MeasurementInputExpectedTermMember_srt_MaximumMember_us-gaap_WarrantMember">P8Y</TRXD:FairValueAssumptionsMeasurementInputTerm>
    <TRXD:WeightedAverageRemainingContractualLifeWarrantsOutstandingGranted contextRef="From2018-01-01to2018-12-31_us-gaap_WarrantMember">P7Y1M9D</TRXD:WeightedAverageRemainingContractualLifeWarrantsOutstandingGranted>
    <TRXD:WeightedAverageRemainingContractualLifeWarrantsOutstandingGranted contextRef="From2017-01-01to2017-12-31_us-gaap_WarrantMember">P5Y</TRXD:WeightedAverageRemainingContractualLifeWarrantsOutstandingGranted>
    <TRXD:WeightedAverageRemainingContractualLifeWarrantsOutstandingGranted contextRef="From2019-01-01to2019-06-30_us-gaap_WarrantMember">P0Y</TRXD:WeightedAverageRemainingContractualLifeWarrantsOutstandingGranted>
    <TRXD:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingIntrinsicValue contextRef="AsOf2018-12-31_us-gaap_WarrantMember" unitRef="USD" decimals="0">782385</TRXD:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingIntrinsicValue>
    <TRXD:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingIntrinsicValue contextRef="AsOf2017-12-31_us-gaap_WarrantMember" unitRef="USD" decimals="0">937567</TRXD:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingIntrinsicValue>
    <TRXD:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingIntrinsicValue contextRef="AsOf2016-12-31_us-gaap_WarrantMember" unitRef="USD" decimals="0">930751</TRXD:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingIntrinsicValue>
    <TRXD:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingIntrinsicValue contextRef="AsOf2019-06-30_us-gaap_WarrantMember" unitRef="USD" decimals="0">1448356</TRXD:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingIntrinsicValue>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit contextRef="From2018-01-01to2018-12-31_custom_EmployeeMember" unitRef="USDPShares" decimals="INF">0.41</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit contextRef="From2017-01-01to2017-12-31_custom_EmployeeMember" unitRef="USDPShares" decimals="INF">0.41</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit contextRef="From2018-01-01to2018-12-31_custom_EmployeeMember" unitRef="USDPShares" decimals="INF">1.02</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit contextRef="From2017-01-01to2017-12-31_custom_EmployeeMember" unitRef="USDPShares" decimals="INF">1.02</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit contextRef="From2017-04-01to2017-04-30" unitRef="USDPShares" decimals="INF">0.65</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit contextRef="From2018-04-01to2018-04-30" unitRef="USDPShares" decimals="INF">0.50</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod contextRef="From2018-01-01to2018-12-31_custom_EmployeeMember">P10Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod contextRef="From2017-01-01to2017-12-31_custom_EmployeeMember">P10Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod contextRef="From2017-04-01to2017-04-30">P10Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod contextRef="From2017-04-01to2017-04-30_custom_FourOptionGrantedMember">P10Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod contextRef="From2018-04-01to2018-04-30">P10Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate contextRef="From2018-01-01to2018-12-31_custom_EmployeeMember">2028-04-30</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate contextRef="From2017-01-01to2017-12-31_custom_EmployeeMember">2028-04-30</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate>
    <TRXD:FairValueOfOptionGranted contextRef="From2018-01-01to2018-12-31_us-gaap_ValuationTechniqueOptionPricingModelMember" unitRef="USD" decimals="0">278358</TRXD:FairValueOfOptionGranted>
    <TRXD:FairValueOfOptionGranted contextRef="From2017-01-01to2017-12-31_us-gaap_ValuationTechniqueOptionPricingModelMember" unitRef="USD" decimals="0">169100</TRXD:FairValueOfOptionGranted>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingRights contextRef="From2017-04-01to2017-04-30">The options vest over a period of one and four years.</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingRights>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingRights contextRef="From2018-04-01to2018-04-30">The options vest over a period of four to five years.</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingRights>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized contextRef="AsOf2018-12-31" unitRef="USD" decimals="0">192007</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized>
    <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate contextRef="From2018-01-01to2018-12-31" unitRef="Percentage" decimals="INF">0.21</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
    <us-gaap:IncomeTaxExaminationDescription contextRef="From2018-01-01to2018-12-31">On December 22, 2017 H.R. 1, originally known as the Tax Cuts and Jobs Act, (the "Tax Act") was enacted. Among the significant changes to the U.S. Internal Revenue Code, the Tax Act lowers the U.S. federal corporate income tax rate ("Federal Tax Rate") from 35% to 21% effective January 1, 2018.</us-gaap:IncomeTaxExaminationDescription>
    <us-gaap:OperatingLossCarryforwards contextRef="AsOf2018-12-31" unitRef="USD" decimals="0">4400000</us-gaap:OperatingLossCarryforwards>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwards contextRef="AsOf2018-12-31" unitRef="USD" decimals="0">922850</us-gaap:DeferredTaxAssetsOperatingLossCarryforwards>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwards contextRef="AsOf2017-12-31" unitRef="USD" decimals="0">963833</us-gaap:DeferredTaxAssetsOperatingLossCarryforwards>
    <us-gaap:DeferredTaxAssetsValuationAllowance contextRef="AsOf2018-12-31" unitRef="USD" decimals="0">922850</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:DeferredTaxAssetsValuationAllowance contextRef="AsOf2017-12-31" unitRef="USD" decimals="0">963833</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:DeferredTaxAssetsLiabilitiesNet contextRef="AsOf2018-12-31" unitRef="USD" xsi:nil="true" />
    <us-gaap:DeferredTaxAssetsLiabilitiesNet contextRef="AsOf2017-12-31" unitRef="USD" xsi:nil="true" />
    <us-gaap:OfficersCompensation contextRef="From2017-01-01to2017-01-31_custom_MrPrashantPatelMember" unitRef="USD" decimals="0">125000</us-gaap:OfficersCompensation>
    <us-gaap:OfficersCompensation contextRef="From2017-01-01to2017-01-31_custom_MrSurenAjjarapuMember" unitRef="USD" decimals="0">165000</us-gaap:OfficersCompensation>
    <us-gaap:OfficersCompensation contextRef="From2018-01-01to2018-01-31_custom_MrPrashantPatelMember_srt_MaximumMember" unitRef="USD" decimals="0">150000</us-gaap:OfficersCompensation>
    <us-gaap:OfficersCompensation contextRef="From2018-01-01to2018-01-31_custom_MrSurenAjjarapuMember_srt_MaximumMember" unitRef="USD" decimals="0">200000</us-gaap:OfficersCompensation>
    <us-gaap:LesseeOperatingLeaseDescription contextRef="From2018-01-01to2018-12-31">The Company leases two premises in Land O' Lakes, Florida under an operating lease that expires in 2021 and in Tampa, Florida under an operating lease that expires in 2023. </us-gaap:LesseeOperatingLeaseDescription>
    <us-gaap:OperatingLeasesFutureMinimumPaymentsDueCurrent contextRef="AsOf2018-12-31" unitRef="USD" decimals="0">156024</us-gaap:OperatingLeasesFutureMinimumPaymentsDueCurrent>
    <us-gaap:OperatingLeasesFutureMinimumPaymentsDueInTwoYears contextRef="AsOf2018-12-31" unitRef="USD" decimals="0">160709</us-gaap:OperatingLeasesFutureMinimumPaymentsDueInTwoYears>
    <us-gaap:OperatingLeasesFutureMinimumPaymentsDueInThreeYears contextRef="AsOf2018-12-31" unitRef="USD" decimals="0">165506</us-gaap:OperatingLeasesFutureMinimumPaymentsDueInThreeYears>
    <us-gaap:OperatingLeasesFutureMinimumPaymentsDueInFourYears contextRef="AsOf2018-12-31" unitRef="USD" decimals="0">49080</us-gaap:OperatingLeasesFutureMinimumPaymentsDueInFourYears>
    <us-gaap:OperatingLeasesFutureMinimumPaymentsDueInFiveYears contextRef="AsOf2018-12-31" unitRef="USD" decimals="0">41934</us-gaap:OperatingLeasesFutureMinimumPaymentsDueInFiveYears>
    <us-gaap:OperatingLeasesFutureMinimumPaymentsDue contextRef="AsOf2018-12-31" unitRef="USD" decimals="0">573253</us-gaap:OperatingLeasesFutureMinimumPaymentsDue>
    <us-gaap:AssetsFairValueDisclosure contextRef="AsOf2018-10-15_custom_CommunitySpecialtyPharmacyLLCMember_us-gaap_SubsequentEventMember" unitRef="USD" decimals="0">170291</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued contextRef="From2019-01-01to2019-01-31_custom_AlliancePharmaSolutionLLCMember_us-gaap_SubsequentEventMember" unitRef="Shares" decimals="INF">250000</us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued>
    <us-gaap:ConversionOfStockSharesConverted1 contextRef="From2019-02-01to2019-02-28_us-gaap_SubsequentEventMember" unitRef="Shares" decimals="INF">16666</us-gaap:ConversionOfStockSharesConverted1>
    <us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock contextRef="From2018-01-01to2018-12-31">&lt;p style="margin: 0pt"&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; background-color: white"&gt;Future maturities of long-term debt in&#13;the next five years are as follows:&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; background-color: white"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="width: 73%"&gt;&lt;font style="font-size: 10pt"&gt;Due in 2020&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 24%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;222,552&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Due in 2021&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;300,000&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Due in 2022&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;font style="font-size: 10pt"&gt;Due in 2023&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&lt;font style="font-size: 10pt"&gt;Total Debt&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;522,052&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&#13;&#13;&lt;p style="margin: 0pt"&gt;&lt;/p&gt;</us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock>
    <TRXD:SummaryOfEstimateFairValueOfWarrantsTableTextBlock contextRef="From2018-01-01to2018-12-31">&lt;p style="margin: 0pt"&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The following table summarizes the assumptions&#13;used to estimate the fair value of warrants granted during the years ended December 31, 2018 and 2017:&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;2018&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;2017&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="width: 62%"&gt;&lt;font style="font-size: 10pt"&gt;Expected dividend yield&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 16%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;0&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&lt;font style="font-size: 10pt"&gt;%&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 16%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;0&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&lt;font style="font-size: 10pt"&gt;%&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Weighted-average expected volatility&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;231-632&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;%&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;200&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;%&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Weighted-average risk-free interest rate&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;2.55-2.75&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;%&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;1.81-1.84&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;%&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;Expected life of warrants&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;5-8 years&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;5 years&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&#13;&#13;&lt;p style="margin: 0pt"&gt;&lt;/p&gt;</TRXD:SummaryOfEstimateFairValueOfWarrantsTableTextBlock>
    <us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock contextRef="From2018-01-01to2018-12-31">&lt;p style="margin: 0pt"&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;At December 31, 2018 and 2017 deferred tax&#13;assets consist of the following:&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;&#13;&lt;tr style="vertical-align: bottom"&gt;&#13;    &lt;td style="padding-bottom: 1.5pt; text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;December 31, 2018&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;December 31, 2017&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="width: 50%"&gt;&lt;font style="font-size: 10pt"&gt;Federal loss carry forwards&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 22%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;922,850&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 22%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;963,833&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td style="padding-bottom: 1.5pt; text-align: justify"&gt;&lt;font style="font-size: 10pt"&gt;Less: valuation allowance&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;(922,850&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;font style="font-size: 10pt"&gt;)&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;(963,833&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&lt;font style="font-size: 10pt"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="padding-bottom: 2.5pt; text-align: justify"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;-&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&#13;&#13;&lt;p style="margin: 0pt"&gt;&lt;/p&gt;</us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock>
    <us-gaap:ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock contextRef="From2018-01-01to2018-12-31">&lt;p style="margin: 0pt"&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Future minimum rental payments under these non-cancelable operating leases as of December 31, 2018 are:&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&amp;#160;&lt;/p&gt;&#13;&#13;&lt;table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="width: 61%; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;2019&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 36%; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;156,024&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="width: 1%"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td style="text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;2020&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;160,709&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;2021&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;165,506&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td style="text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;2022&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;49,080&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: #CCEEFF"&gt;&#13;    &lt;td style="padding-bottom: 1.5pt; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;2023&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 1.5pt solid; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;41,934&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 1.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;tr style="vertical-align: bottom; background-color: white"&gt;&#13;    &lt;td style="padding-bottom: 2.5pt; text-align: center"&gt;&lt;font style="font-size: 10pt"&gt;Total&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double"&gt;&lt;font style="font-size: 10pt"&gt;$&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="border-bottom: black 2.25pt double; text-align: right"&gt;&lt;font style="font-size: 10pt"&gt;573,253&lt;/font&gt;&lt;/td&gt;&#13;    &lt;td style="padding-bottom: 2.5pt"&gt;&amp;#160;&lt;/td&gt;&lt;/tr&gt;&#13;&lt;/table&gt;&#13;&#13;&#13;&lt;p style="margin: 0pt"&gt;&lt;/p&gt;</us-gaap:ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment contextRef="From2017-01-01to2017-12-31" unitRef="USD" xsi:nil="true" />
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment contextRef="From2018-01-01to2018-12-31" unitRef="USD" decimals="0">15006</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:EquityMethodInvestmentsPolicy contextRef="From2019-01-01to2019-06-30">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;i&gt;Equity&#13;Investments&lt;/i&gt; &amp;#8211; If the investments are less than 50% owned and more than 20% owned the entities use the equity method&#13;of accounting in accordance with ASC 323-10 &amp;#8211; Investments &amp;#8211; Equity Method and Joint Ventures.&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;&amp;#160;&lt;/font&gt;&lt;/p&gt;&#13;&#13;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;font style="font: 10pt Times New Roman, Times, Serif"&gt;The share of income (loss) of such entities is recorded as a single amount as share in equity income (loss)&#13;of investments. Dividends, if any, are recorded as a reduction of the investment.&amp;#160;&lt;/font&gt;&lt;/p&gt;</us-gaap:EquityMethodInvestmentsPolicy>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue contextRef="AsOf2018-12-31" unitRef="USD" xsi:nil="true" />
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue contextRef="AsOf2019-06-30" unitRef="USD" decimals="0">88350</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue contextRef="AsOf2016-12-31" unitRef="USD" xsi:nil="true" />
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue contextRef="AsOf2017-12-31" unitRef="USD" xsi:nil="true" />
    <us-gaap:IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities contextRef="From2019-01-01to2019-06-30" unitRef="USD" decimals="0">-6652</us-gaap:IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities>
    <us-gaap:IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities contextRef="From2017-01-01to2017-12-31" unitRef="USD" decimals="0">-293521</us-gaap:IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities>
    <us-gaap:IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities contextRef="From2018-01-01to2018-06-30" unitRef="USD" decimals="0">3485</us-gaap:IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities>
    <us-gaap:IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities contextRef="From2018-01-01to2018-12-31" unitRef="USD" decimals="0">-18791</us-gaap:IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities>
    <TRXD:ClassOfWarrantOrRightNumberOfSecuritiesExercisableByWarrantsOrRights contextRef="AsOf2020-04-01_srt_ScenarioForecastMember" unitRef="Shares" decimals="INF">150000</TRXD:ClassOfWarrantOrRightNumberOfSecuritiesExercisableByWarrantsOrRights>
    <TRXD:ClassOfWarrantOrRightNumberOfSecuritiesExercisableByWarrantsOrRights contextRef="AsOf2021-04-01_srt_ScenarioForecastMember" unitRef="Shares" decimals="INF">150000</TRXD:ClassOfWarrantOrRightNumberOfSecuritiesExercisableByWarrantsOrRights>
</xbrli:xbrl>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>18
<FILENAME>trxd-20190630.xsd
<DESCRIPTION>XBRL SCHEMA FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" ?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.1b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: http://www.novaworks.co -->
    <!-- Field: Doc-Info; Name: Source; Value: TRXD 20190630 S%2D1 DFN.xfr; Date: 2019%2D10%2D15T18:00:38Z -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
    <!-- Field: Doc-Info; Name: Misc; Value: 96Mps7xRiXgen8uDanwsWauNibP9z5Z8CekhvWB7bYmqDyYnKGQkHSMlAGQ24f0H -->
<schema xmlns="http://www.w3.org/2001/XMLSchema" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:dei="http://xbrl.sec.gov/dei/2019-01-31" xmlns:us-gaap="http://fasb.org/us-gaap/2019-01-31" xmlns:us-roles="http://fasb.org/us-roles/2019-01-31" xmlns:srt="http://fasb.org/srt/2019-01-31" xmlns:srt-types="http://fasb.org/srt-types/2019-01-31" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:num="http://www.xbrl.org/dtr/type/numeric" xmlns:us-types="http://fasb.org/us-types/2019-01-31" xmlns:TRXD="http://trxadegroup.com/20190630" elementFormDefault="qualified" targetNamespace="http://trxadegroup.com/20190630">
    <annotation>
      <appinfo>
	<link:roleType roleURI="http://trxadegroup.com/role/DocumentAndEntityInformation" id="DocumentAndEntityInformation">
	  <link:definition>00000001 - Document - Document and Entity Information</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://trxadegroup.com/role/BalanceSheets" id="BalanceSheets">
	  <link:definition>00000002 - Statement - Consolidated Balance Sheets</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://trxadegroup.com/role/BalanceSheetsParenthetical" id="BalanceSheetsParenthetical">
	  <link:definition>00000003 - Statement - Consolidated Balance Sheets (Parenthetical)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://trxadegroup.com/role/StatementsOfOperations" id="StatementsOfOperations">
	  <link:definition>00000004 - Statement - Consolidated Statements of Operations</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://trxadegroup.com/role/StatementsOfChangesInShareholdersEquity" id="StatementsOfChangesInShareholdersEquity">
	  <link:definition>00000005 - Statement - Consolidated Statements of Changes in Shareholders' Equity</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://trxadegroup.com/role/StatementsOfCashFlows" id="StatementsOfCashFlows">
	  <link:definition>00000006 - Statement - Consolidated Statements of Cash Flows</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://trxadegroup.com/role/OrganizationAndBasisOfPresentation" id="OrganizationAndBasisOfPresentation">
	  <link:definition>00000007 - Disclosure - Organization and Basis of Presentation</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://trxadegroup.com/role/SummaryOfSignificantAccountingPolicies" id="SummaryOfSignificantAccountingPolicies">
	  <link:definition>00000008 - Disclosure - Summary of Significant Accounting Policies</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://trxadegroup.com/role/Short-termDebtAndRelatedPartiesDebt" id="Short-termDebtAndRelatedPartiesDebt">
	  <link:definition>00000009 - Disclosure - Short-Term Debt and Related Parties Debt</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://trxadegroup.com/role/LongTermDebt-RelatedParties" id="LongTermDebt-RelatedParties">
	  <link:definition>00000010 - Disclosure - Long Term Debt - Related Parties</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://trxadegroup.com/role/ShareholdersEquity" id="ShareholdersEquity">
	  <link:definition>00000011 - Disclosure - Shareholders' Equity</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://trxadegroup.com/role/Warrants" id="Warrants">
	  <link:definition>00000012 - Disclosure - Warrants</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://trxadegroup.com/role/Options" id="Options">
	  <link:definition>00000013 - Disclosure - Options</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://trxadegroup.com/role/Leases" id="Leases">
	  <link:definition>00000014 - Disclosure - Leases</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://trxadegroup.com/role/IncomeTaxes" id="IncomeTaxes">
	  <link:definition>00000015 - Disclosure - Income Taxes</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://trxadegroup.com/role/RelatedParties" id="RelatedParties">
	  <link:definition>00000016 - Disclosure - Related Parties</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://trxadegroup.com/role/CommitmentsAndContingencies" id="CommitmentsAndContingencies">
	  <link:definition>00000017 - Disclosure - Commitments and Contingencies</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://trxadegroup.com/role/SegmentReporting" id="SegmentReporting">
	  <link:definition>00000018 - Disclosure - Segment Reporting</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://trxadegroup.com/role/BusinessCombination" id="BusinessCombination">
	  <link:definition>00000019 - Disclosure - Business Combination</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://trxadegroup.com/role/EquityMethodInvestment" id="EquityMethodInvestment">
	  <link:definition>00000020 - Disclosure - Equity Method Investment</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://trxadegroup.com/role/SubsequentEvents" id="SubsequentEvents">
	  <link:definition>00000021 - Disclosure - Subsequent Events</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://trxadegroup.com/role/SummaryOfSignificantAccountingPoliciesPolicies" id="SummaryOfSignificantAccountingPoliciesPolicies">
	  <link:definition>00000022 - Disclosure - Summary of Significant Accounting Policies (Policies)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://trxadegroup.com/role/OrganizationAndBasisOfPresentationTables" id="OrganizationAndBasisOfPresentationTables">
	  <link:definition>00000023 - Disclosure - Organization and Basis of Presentation (Tables)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://trxadegroup.com/role/SummaryOfSignificantAccountingPoliciesTables" id="SummaryOfSignificantAccountingPoliciesTables">
	  <link:definition>00000024 - Disclosure - Summary of Significant Accounting Policies (Tables)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://trxadegroup.com/role/LongTermDebt-RelatedPartiesTables" id="LongTermDebt-RelatedPartiesTables">
	  <link:definition>00000025 - Disclosure - Long Term Debt - Related Parties (Tables)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://trxadegroup.com/role/WarrantsTables" id="WarrantsTables">
	  <link:definition>00000026 - Disclosure - Warrants (Tables)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://trxadegroup.com/role/OptionsTables" id="OptionsTables">
	  <link:definition>00000027 - Disclosure - Options (Tables)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://trxadegroup.com/role/LeasesTables" id="LeasesTables">
	  <link:definition>00000028 - Disclosure - Leases (Tables)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://trxadegroup.com/role/IncomeTaxesTables" id="IncomeTaxesTables">
	  <link:definition>00000029 - Disclosure - Income Taxes (Tables)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://trxadegroup.com/role/CommitmentsAndContingenciesTables" id="CommitmentsAndContingenciesTables">
	  <link:definition>00000030 - Disclosure - Commitments and Contingencies (Tables)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://trxadegroup.com/role/SegmentReportingTables" id="SegmentReportingTables">
	  <link:definition>00000031 - Disclosure - Segment Reporting (Tables)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://trxadegroup.com/role/BusinessCombinationTables" id="BusinessCombinationTables">
	  <link:definition>00000032 - Disclosure - Business Combination (Tables)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://trxadegroup.com/role/OrganizationAndBasisOfPresentationDetailsNarrative" id="OrganizationAndBasisOfPresentationDetailsNarrative">
	  <link:definition>00000033 - Disclosure - Organization and Basis of Presentation (Details Narrative)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://trxadegroup.com/role/OrganizationDetailsNarrative10-k" id="OrganizationDetailsNarrative10-k">
	  <link:definition>00000034 - Disclosure - Organization (Details Narrative) (10-K)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://trxadegroup.com/role/OrganizationAndBasisOfPresentation-ScheduleOfEarningsPerShareBasicAndDilutedDetails" id="OrganizationAndBasisOfPresentation-ScheduleOfEarningsPerShareBasicAndDilutedDetails">
	  <link:definition>00000035 - Disclosure - Organization and Basis of Presentation - Schedule of Earnings Per Share, Basic and Diluted (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://trxadegroup.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative10-k" id="SummaryOfSignificantAccountingPoliciesDetailsNarrative10-k">
	  <link:definition>00000036 - Disclosure - Summary of Significant Accounting Policies (Details Narrative) (10-K)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://trxadegroup.com/role/SummaryOfSignificantAccountingPolicies-ScheduleOfEarningsPerShareBasicAndDilutedDetails10-k" id="SummaryOfSignificantAccountingPolicies-ScheduleOfEarningsPerShareBasicAndDilutedDetails10-k">
	  <link:definition>00000037 - Disclosure - Summary of Significant Accounting Policies - Schedule of Earnings Per Share, Basic and Diluted (Details) (10-K)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://trxadegroup.com/role/Short-termDebtAndRelatedPartiesDebtDetailsNarrative" id="Short-termDebtAndRelatedPartiesDebtDetailsNarrative">
	  <link:definition>00000038 - Disclosure - Short-term Debt and Related Parties Debt (Details Narrative)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://trxadegroup.com/role/Short-termDebtAndRelatedPartiesDebtDetailsNarrative10-k" id="Short-termDebtAndRelatedPartiesDebtDetailsNarrative10-k">
	  <link:definition>00000039 - Disclosure - Short-term Debt and Related Parties Debt (Details Narrative) (10-K)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://trxadegroup.com/role/LongTermDebt-RelatedPartiesDetailsNarrative" id="LongTermDebt-RelatedPartiesDetailsNarrative">
	  <link:definition>00000040 - Disclosure - Long Term Debt - Related Parties (Details Narrative)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://trxadegroup.com/role/LongTermDebtDetailsNarrative10-k" id="LongTermDebtDetailsNarrative10-k">
	  <link:definition>00000041 - Disclosure - Long Term Debt (Details Narrative) (10-K)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://trxadegroup.com/role/LongTermDebt-ScheduleOfFutureMaturitiesOfLong-termDebtDetails10-k" id="LongTermDebt-ScheduleOfFutureMaturitiesOfLong-termDebtDetails10-k">
	  <link:definition>00000042 - Disclosure - Long Term Debt - Schedule of Future Maturities of Long-term Debt (Details) (10-K)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://trxadegroup.com/role/ShareholdersEquityDetailsNarrative" id="ShareholdersEquityDetailsNarrative">
	  <link:definition>00000043 - Disclosure - Shareholders' Equity (Details Narrative)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://trxadegroup.com/role/StockholdersEquityDetailsNarrative10-k" id="StockholdersEquityDetailsNarrative10-k">
	  <link:definition>00000044 - Disclosure - Stockholders' Equity (Details Narrative) (10-K)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://trxadegroup.com/role/WarrantsDetailsNarrative" id="WarrantsDetailsNarrative">
	  <link:definition>00000045 - Disclosure - Warrants (Details Narrative)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://trxadegroup.com/role/WarrantsDetailsNarrative10-k" id="WarrantsDetailsNarrative10-k">
	  <link:definition>00000046 - Disclosure - Warrants (Details Narrative) (10-K)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://trxadegroup.com/role/Warrants-ScheduleOfOutstandingAndExercisableWarrantsDetails" id="Warrants-ScheduleOfOutstandingAndExercisableWarrantsDetails">
	  <link:definition>00000047 - Disclosure - Warrants - Schedule of Outstanding and Exercisable Warrants (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://trxadegroup.com/role/Warrants-SummaryOfEstimateFairValueOfWarrantsDetails10-k" id="Warrants-SummaryOfEstimateFairValueOfWarrantsDetails10-k">
	  <link:definition>00000048 - Disclosure - Warrants - Summary of Estimate the Fair Value of Warrants (Details) (10-K)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://trxadegroup.com/role/OptionsDetailsNarrative" id="OptionsDetailsNarrative">
	  <link:definition>00000049 - Disclosure - Options (Details Narrative)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://trxadegroup.com/role/OptionsDetailsNarrative10-k" id="OptionsDetailsNarrative10-k">
	  <link:definition>00000050 - Disclosure - Options (Details Narrative) (10-K)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://trxadegroup.com/role/Options-ScheduleOfEstimateFairValueOfStockOptionsDetails" id="Options-ScheduleOfEstimateFairValueOfStockOptionsDetails">
	  <link:definition>00000051 - Disclosure - Options - Schedule of Estimate the Fair Value of Stock Options (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://trxadegroup.com/role/Options-ScheduleOfStockOptionActivityDetails" id="Options-ScheduleOfStockOptionActivityDetails">
	  <link:definition>00000052 - Disclosure - Options - Schedule of Stock Option Activity (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://trxadegroup.com/role/LeasesDetailsNarrative" id="LeasesDetailsNarrative">
	  <link:definition>00000053 - Disclosure - Leases (Details Narrative)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://trxadegroup.com/role/Leases-ScheduleOfOperatingLeasesDetails" id="Leases-ScheduleOfOperatingLeasesDetails">
	  <link:definition>00000054 - Disclosure - Leases - Schedule of Operating Leases (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://trxadegroup.com/role/Leases-ScheduleOfFutureMinimumPaymentsForOperatingLeaseLiabilitiesDetails" id="Leases-ScheduleOfFutureMinimumPaymentsForOperatingLeaseLiabilitiesDetails">
	  <link:definition>00000055 - Disclosure - Leases - Schedule of Future Minimum Payments for Operating Lease Liabilities (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://trxadegroup.com/role/IncomeTaxesDetailsNarrative10-k" id="IncomeTaxesDetailsNarrative10-k">
	  <link:definition>00000056 - Disclosure - Income Taxes (Details Narrative) (10-K)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://trxadegroup.com/role/IncomeTaxes-ScheduleOfDeferredTaxAssetsDetails10-k" id="IncomeTaxes-ScheduleOfDeferredTaxAssetsDetails10-k">
	  <link:definition>00000057 - Disclosure - Income Taxes - Schedule of Deferred Tax Assets (Details) (10-K)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://trxadegroup.com/role/RelatedPartiesDetailsNarrative10-k" id="RelatedPartiesDetailsNarrative10-k">
	  <link:definition>00000058 - Disclosure - Related Parties (Details Narrative) (10-K)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://trxadegroup.com/role/CommitmentsAndContingenciesDetailsNarrative10-k" id="CommitmentsAndContingenciesDetailsNarrative10-k">
	  <link:definition>00000059 - Disclosure - Commitments and Contingencies (Details Narrative) (10-K)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://trxadegroup.com/role/CommitmentsAndContingencies-ScheduleOfFutureMinimumRentalPaymentsUnderNon-cancelableOperatingLeasesDetails10-k" id="CommitmentsAndContingencies-ScheduleOfFutureMinimumRentalPaymentsUnderNon-cancelableOperatingLeasesDetails10-k">
	  <link:definition>00000060 - Disclosure - Commitments and Contingencies - Schedule of Future Minimum Rental Payments Under Non-cancelable Operating Leases (Details) (10-K)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://trxadegroup.com/role/SegmentReporting-ScheduleOfBusinessInterestsIntoReportableSegmentsDetails" id="SegmentReporting-ScheduleOfBusinessInterestsIntoReportableSegmentsDetails">
	  <link:definition>00000061 - Disclosure - Segment Reporting - Schedule of Business Interests Into Reportable Segments (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://trxadegroup.com/role/BusinessCombinationDetailsNarrative" id="BusinessCombinationDetailsNarrative">
	  <link:definition>00000062 - Disclosure - Business Combination (Details Narrative)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://trxadegroup.com/role/BusinessCombinationDetailsNarrative10-k" id="BusinessCombinationDetailsNarrative10-k">
	  <link:definition>00000063 - Disclosure - Business Combination (Details Narrative) (10-K)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://trxadegroup.com/role/BusinessCombination-ScheduleOfAssetsAcquiredAndLiabilitiesAssumedDetails" id="BusinessCombination-ScheduleOfAssetsAcquiredAndLiabilitiesAssumedDetails">
	  <link:definition>00000064 - Disclosure - Business Combination - Schedule of Assets Acquired and Liabilities Assumed (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://trxadegroup.com/role/BusinessCombination-ScheduleOfUnauditedProFormaStatementsOfOperationsDetails" id="BusinessCombination-ScheduleOfUnauditedProFormaStatementsOfOperationsDetails">
	  <link:definition>00000065 - Disclosure - Business Combination - Schedule of Unaudited Pro Forma Statements of Operations (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://trxadegroup.com/role/EquityMethodInvestmentDetailsNarrative" id="EquityMethodInvestmentDetailsNarrative">
	  <link:definition>00000066 - Disclosure - Equity Method Investment (Details Narrative)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://trxadegroup.com/role/SubsequentEventsDetailsNarrative" id="SubsequentEventsDetailsNarrative">
	  <link:definition>00000067 - Disclosure - Subsequent Events (Details Narrative)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://trxadegroup.com/role/SubsequentEventsDetailsNarrative10-k" id="SubsequentEventsDetailsNarrative10-k">
	  <link:definition>00000068 - Disclosure - Subsequent Events (Details Narrative) (10-K)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:linkbaseRef xlink:type="simple" xlink:href="trxd-20190630_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Presentation Links" />
	<link:linkbaseRef xlink:type="simple" xlink:href="trxd-20190630_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Label Links" />
	<link:linkbaseRef xlink:type="simple" xlink:href="trxd-20190630_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Calculation Links" />
	<link:linkbaseRef xlink:type="simple" xlink:href="trxd-20190630_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Definition Links" />
      </appinfo>
    </annotation>
    <import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
    <import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" />
    <import namespace="http://xbrl.sec.gov/dei/2019-01-31" schemaLocation="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd" />
    <import namespace="http://fasb.org/us-gaap/2019-01-31" schemaLocation="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd" />
    <import namespace="http://fasb.org/us-types/2019-01-31" schemaLocation="http://xbrl.fasb.org/us-gaap/2019/elts/us-types-2019-01-31.xsd" />
    <import namespace="http://www.xbrl.org/dtr/type/non-numeric" schemaLocation="http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd" />
    <import namespace="http://www.xbrl.org/dtr/type/numeric" schemaLocation="http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd" />
    <import namespace="http://xbrl.sec.gov/country/2017-01-31" schemaLocation="https://xbrl.sec.gov/country/2017/country-2017-01-31.xsd" />
    <import namespace="http://fasb.org/srt/2019-01-31" schemaLocation="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd" />
    <import namespace="http://fasb.org/srt-types/2019-01-31" schemaLocation="http://xbrl.fasb.org/srt/2019/elts/srt-types-2019-01-31.xsd" />
    <element id="TRXD_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTermForfeitures" name="SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTermForfeitures" nillable="true" xbrli:periodType="duration" type="xbrli:durationItemType" substitutionGroup="xbrli:item" />
    <element id="TRXD_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTermExpired" name="SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTermExpired" nillable="true" xbrli:periodType="duration" type="xbrli:durationItemType" substitutionGroup="xbrli:item" />
    <element id="TRXD_WarrantsTextBlock" name="WarrantsTextBlock" nillable="true" xbrli:periodType="duration" type="nonnum:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="TRXD_ExerciseRestrictionsLapsePeriod" name="ExerciseRestrictionsLapsePeriod" nillable="true" xbrli:periodType="duration" type="xbrli:durationItemType" substitutionGroup="xbrli:item" />
    <element id="TRXD_ShortTermConvertibleNotesPayableRelatedParties" name="ShortTermConvertibleNotesPayableRelatedParties" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="TRXD_AmortizationOfRightToUseAsset" name="AmortizationOfRightToUseAsset" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="TRXD_RightUseOfAssetsAndOperatingLeaseObligationsRecognized" name="RightUseOfAssetsAndOperatingLeaseObligationsRecognized" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="TRXD_OperatingLeaseAmortizationOfLiabilities" name="OperatingLeaseAmortizationOfLiabilities" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="TRXD_OperatingLeasesUnits" name="OperatingLeasesUnits" nillable="true" xbrli:periodType="duration" type="xbrli:integerItemType" substitutionGroup="xbrli:item" />
    <element id="TRXD_OperatingLeaseInitialLeaseTerm" name="OperatingLeaseInitialLeaseTerm" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="TRXD_OperatingLeaseRenewalTerm" name="OperatingLeaseRenewalTerm" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="TRXD_IncreaseDecreaseInLeaseLiability" name="IncreaseDecreaseInLeaseLiability" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="TRXD_StockIssuedDuringPeriodValueStockWarrantExercised" name="StockIssuedDuringPeriodValueStockWarrantExercised" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="TRXD_StockIssuedDuringPeriodSharesStockWarrantExercised" name="StockIssuedDuringPeriodSharesStockWarrantExercised" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="TRXD_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTermGranted" name="SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTermGranted" nillable="true" xbrli:periodType="duration" type="xbrli:durationItemType" substitutionGroup="xbrli:item" />
    <element id="TRXD_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm" name="SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm" nillable="true" xbrli:periodType="duration" type="xbrli:durationItemType" substitutionGroup="xbrli:item" />
    <element id="TRXD_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm" name="SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm" nillable="true" xbrli:periodType="duration" type="xbrli:durationItemType" substitutionGroup="xbrli:item" />
    <element id="TRXD_NumeratorForBasicAndDilutedEpsIncomeLossAvailableToCommonShareholders" name="NumeratorForBasicAndDilutedEpsIncomeLossAvailableToCommonShareholders" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="TRXD_WarrantsIssued" name="WarrantsIssued" nillable="true" xbrli:periodType="instant" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="TRXD_StockIssuedDuringPeriodSharesWarrantsExercised" name="StockIssuedDuringPeriodSharesWarrantsExercised" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="TRXD_StockIssuedDuringPeriodValueWarrantsExercised" name="StockIssuedDuringPeriodValueWarrantsExercised" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="TRXD_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice" nillable="true" xbrli:periodType="instant" type="num:perShareItemType" substitutionGroup="xbrli:item" />
    <element id="TRXD_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGrantsInPeriodWeightedAverageExercisePrice" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGrantsInPeriodWeightedAverageExercisePrice" nillable="true" xbrli:periodType="duration" type="num:perShareItemType" substitutionGroup="xbrli:item" />
    <element id="TRXD_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitedInPeriodWeightedAverageExercisePrice" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitedInPeriodWeightedAverageExercisePrice" nillable="true" xbrli:periodType="duration" type="num:perShareItemType" substitutionGroup="xbrli:item" />
    <element id="TRXD_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisesInPeriodWeightedAverageExercisePrice" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisesInPeriodWeightedAverageExercisePrice" nillable="true" xbrli:periodType="duration" type="num:perShareItemType" substitutionGroup="xbrli:item" />
    <element id="TRXD_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageRemainingContractualTermBeginning" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageRemainingContractualTermBeginning" nillable="true" xbrli:periodType="duration" type="xbrli:durationItemType" substitutionGroup="xbrli:item" />
    <element id="TRXD_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageRemainingContractualTermEnding" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageRemainingContractualTermEnding" nillable="true" xbrli:periodType="duration" type="xbrli:durationItemType" substitutionGroup="xbrli:item" />
    <element id="TRXD_OperatingLeaseAmortizationOfAssets" name="OperatingLeaseAmortizationOfAssets" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="TRXD_EquityMethodInvestmentDescription" name="EquityMethodInvestmentDescription" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="TRXD_AdjustmentsToAdditionalPaidInCapitalWarrantsForAcquisition" name="AdjustmentsToAdditionalPaidInCapitalWarrantsForAcquisition" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="TRXD_RelatedPartyNotePayableAndWarrantsIssuedForAcquisition" name="RelatedPartyNotePayableAndWarrantsIssuedForAcquisition" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="TRXD_ReclassFromAccruedInterestToShortTermConvertibleNotes" name="ReclassFromAccruedInterestToShortTermConvertibleNotes" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="TRXD_ArrangementToMoveRelatedPartyAccountsPayableToNotesPayable" name="ArrangementToMoveRelatedPartyAccountsPayableToNotesPayable" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="TRXD_CostOfGoodsSoldPolicyTextBlock" name="CostOfGoodsSoldPolicyTextBlock" nillable="true" xbrli:periodType="duration" type="nonnum:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="TRXD_RecoveryOfBadDebt" name="RecoveryOfBadDebt" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="TRXD_ValuationAllowancePercentage" name="ValuationAllowancePercentage" nillable="true" xbrli:periodType="duration" type="num:percentItemType" substitutionGroup="xbrli:item" />
    <element id="TRXD_GrantedWarrants" name="GrantedWarrants" nillable="true" xbrli:periodType="instant" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="TRXD_DebtModificationsAmount" name="DebtModificationsAmount" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="TRXD_CreditCardObligationAmount" name="CreditCardObligationAmount" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="TRXD_WarrantIssuedForRenewalOfConvertibleDebt" name="WarrantIssuedForRenewalOfConvertibleDebt" nillable="true" xbrli:periodType="instant" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="TRXD_FairValueAssumptionsMeasurementInputPercentages" name="FairValueAssumptionsMeasurementInputPercentages" nillable="true" xbrli:periodType="instant" type="num:percentItemType" substitutionGroup="xbrli:item" />
    <element id="TRXD_FairValueAssumptionsMeasurementInputTerm" name="FairValueAssumptionsMeasurementInputTerm" nillable="true" xbrli:periodType="duration" type="xbrli:durationItemType" substitutionGroup="xbrli:item" />
    <element id="TRXD_WeightedAverageRemainingContractualLifeWarrantsOutstandingGranted" name="WeightedAverageRemainingContractualLifeWarrantsOutstandingGranted" nillable="true" xbrli:periodType="duration" type="xbrli:durationItemType" substitutionGroup="xbrli:item" />
    <element id="TRXD_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingIntrinsicValue" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingIntrinsicValue" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="TRXD_FairValueOfOptionGranted" name="FairValueOfOptionGranted" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="TRXD_SummaryOfEstimateFairValueOfWarrantsTableTextBlock" name="SummaryOfEstimateFairValueOfWarrantsTableTextBlock" nillable="true" xbrli:periodType="duration" type="nonnum:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="TRXD_ClassOfWarrantOrRightNumberOfSecuritiesExercisableByWarrantsOrRights" name="ClassOfWarrantOrRightNumberOfSecuritiesExercisableByWarrantsOrRights" nillable="true" xbrli:periodType="instant" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="TRXD_IntegraPharmaSolutionsLLCMember" name="IntegraPharmaSolutionsLLCMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="TRXD_PromissoryNoteMember" name="PromissoryNoteMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="TRXD_TwoThousandAndEighteenMember" name="TwoThousandAndEighteenMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="TRXD_RelatedPartyConvertiblePromissoryNoteMember" name="RelatedPartyConvertiblePromissoryNoteMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="TRXD_MrShilpaPatelMember" name="MrShilpaPatelMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="TRXD_MrNitilPatelMember" name="MrNitilPatelMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="TRXD_ShortTermRelatedPartyConvertibleNotesMember" name="ShortTermRelatedPartyConvertibleNotesMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="TRXD_CommunitySpecialtyPharmacyLLCMember" name="CommunitySpecialtyPharmacyLLCMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="TRXD_MrPrashantPatelMember" name="MrPrashantPatelMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="TRXD_MrSurenAjjarapuMember" name="MrSurenAjjarapuMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="TRXD_PrivateOfferMemorandumMember" name="PrivateOfferMemorandumMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="TRXD_ConvertiblePromissoryNoteMember" name="ConvertiblePromissoryNoteMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="TRXD_RelatedPartyPromissoryNotesMember" name="RelatedPartyPromissoryNotesMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="TRXD_NPRINVESTMENTGROUPLLCMember" name="NPRINVESTMENTGROUPLLCMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="TRXD_PromissoryNoteAgreementMember" name="PromissoryNoteAgreementMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="TRXD_SansurAssociatesLLCMember" name="SansurAssociatesLLCMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="TRXD_StockOptionPlanMember" name="StockOptionPlanMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="TRXD_EmployeeMember" name="EmployeeMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="TRXD_ShortTermNotesPayableMember" name="ShortTermNotesPayableMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="TRXD_ShortTermConvertibleNotesPayableMember" name="ShortTermConvertibleNotesPayableMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="TRXD_ShortTermConvertibleNotesPayableRelatedPartiesMember" name="ShortTermConvertibleNotesPayableRelatedPartiesMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="TRXD_NotesPayableMember" name="NotesPayableMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="TRXD_WestminsterPharmaceuticalsLLCMember" name="WestminsterPharmaceuticalsLLCMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="TRXD_SecuredConvertiblePromissoryNotesMember" name="SecuredConvertiblePromissoryNotesMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="TRXD_RelatedPartyPromissoryNoteMember" name="RelatedPartyPromissoryNoteMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="TRXD_PromissoryNoteOneMember" name="PromissoryNoteOneMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="TRXD_PromissoryNoteTwoMember" name="PromissoryNoteTwoMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="TRXD_ShortTermPromissoryNotesMember" name="ShortTermPromissoryNotesMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="TRXD_ConvertiblePromissoryNoteOneMember" name="ConvertiblePromissoryNoteOneMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="TRXD_PromissoryNotesMember" name="PromissoryNotesMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="TRXD_RelatedPartyConvertiblePromissoryNotesMember" name="RelatedPartyConvertiblePromissoryNotesMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="TRXD_FourOptionGrantedMember" name="FourOptionGrantedMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="TRXD_TrxadeIncMember" name="TrxadeIncMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="TRXD_OtherMember" name="OtherMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="TRXD_TrxadeMember" name="TrxadeMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="TRXD_AlliancePharmaSolutionLLCMember" name="AlliancePharmaSolutionLLCMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="TRXD_SyncHealthMSOLLCMember" name="SyncHealthMSOLLCMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="TRXD_JanuaryThortyOneTwoThousandTwentyMember" name="JanuaryThortyOneTwoThousandTwentyMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="TRXD_TwoCustomersMember" name="TwoCustomersMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="TRXD_NikulPanchalMember" name="NikulPanchalMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="TRXD_SpecialtyPharmacyLLCMember" name="SpecialtyPharmacyLLCMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="TRXD_LeaseOneMember" name="LeaseOneMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="TRXD_LeaseTwoMember" name="LeaseTwoMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="TRXD_PanOpticHealthLLCMember" name="PanOpticHealthLLCMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="TRXD_SecuritiesPurchaseAgreementMember" name="SecuritiesPurchaseAgreementMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="TRXD_AccreditedInvestorMember" name="AccreditedInvestorMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="TRXD_MayOneTwoThousandNineteenMember" name="MayOneTwoThousandNineteenMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="TRXD_AugustOneTwoThousandNineteenMember" name="AugustOneTwoThousandNineteenMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="TRXD_NovemberOneTwoThousandNineteenMember" name="NovemberOneTwoThousandNineteenMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="TRXD_MrPrashantPatelAndMrSurenAjjarapuMember" name="MrPrashantPatelAndMrSurenAjjarapuMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="TRXD_ConsultingAgreementMember" name="ConsultingAgreementMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="TRXD_DocumentAndEntityInformationAbstract" name="DocumentAndEntityInformationAbstract" abstract="true" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
</schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>19
<FILENAME>trxd-20190630_cal.xml
<DESCRIPTION>XBRL CALCULATION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.1b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: http://www.novaworks.co -->
    <!-- Field: Doc-Info; Name: Source; Value: TRXD 20190630 S%2D1 DFN.xfr; Date: 2019%2D10%2D15T18:00:38Z -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef roleURI="http://trxadegroup.com/role/DocumentAndEntityInformation" xlink:href="trxd-20190630.xsd#DocumentAndEntityInformation" xlink:type="simple" />
    <link:roleRef roleURI="http://trxadegroup.com/role/BalanceSheets" xlink:href="trxd-20190630.xsd#BalanceSheets" xlink:type="simple" />
    <link:roleRef roleURI="http://trxadegroup.com/role/BalanceSheetsParenthetical" xlink:href="trxd-20190630.xsd#BalanceSheetsParenthetical" xlink:type="simple" />
    <link:roleRef roleURI="http://trxadegroup.com/role/StatementsOfOperations" xlink:href="trxd-20190630.xsd#StatementsOfOperations" xlink:type="simple" />
    <link:roleRef roleURI="http://trxadegroup.com/role/StatementsOfChangesInShareholdersEquity" xlink:href="trxd-20190630.xsd#StatementsOfChangesInShareholdersEquity" xlink:type="simple" />
    <link:roleRef roleURI="http://trxadegroup.com/role/StatementsOfCashFlows" xlink:href="trxd-20190630.xsd#StatementsOfCashFlows" xlink:type="simple" />
    <link:roleRef roleURI="http://trxadegroup.com/role/OrganizationAndBasisOfPresentation" xlink:href="trxd-20190630.xsd#OrganizationAndBasisOfPresentation" xlink:type="simple" />
    <link:roleRef roleURI="http://trxadegroup.com/role/SummaryOfSignificantAccountingPolicies" xlink:href="trxd-20190630.xsd#SummaryOfSignificantAccountingPolicies" xlink:type="simple" />
    <link:roleRef roleURI="http://trxadegroup.com/role/Short-termDebtAndRelatedPartiesDebt" xlink:href="trxd-20190630.xsd#Short-termDebtAndRelatedPartiesDebt" xlink:type="simple" />
    <link:roleRef roleURI="http://trxadegroup.com/role/LongTermDebt-RelatedParties" xlink:href="trxd-20190630.xsd#LongTermDebt-RelatedParties" xlink:type="simple" />
    <link:roleRef roleURI="http://trxadegroup.com/role/ShareholdersEquity" xlink:href="trxd-20190630.xsd#ShareholdersEquity" xlink:type="simple" />
    <link:roleRef roleURI="http://trxadegroup.com/role/Warrants" xlink:href="trxd-20190630.xsd#Warrants" xlink:type="simple" />
    <link:roleRef roleURI="http://trxadegroup.com/role/Options" xlink:href="trxd-20190630.xsd#Options" xlink:type="simple" />
    <link:roleRef roleURI="http://trxadegroup.com/role/Leases" xlink:href="trxd-20190630.xsd#Leases" xlink:type="simple" />
    <link:roleRef roleURI="http://trxadegroup.com/role/IncomeTaxes" xlink:href="trxd-20190630.xsd#IncomeTaxes" xlink:type="simple" />
    <link:roleRef roleURI="http://trxadegroup.com/role/RelatedParties" xlink:href="trxd-20190630.xsd#RelatedParties" xlink:type="simple" />
    <link:roleRef roleURI="http://trxadegroup.com/role/CommitmentsAndContingencies" xlink:href="trxd-20190630.xsd#CommitmentsAndContingencies" xlink:type="simple" />
    <link:roleRef roleURI="http://trxadegroup.com/role/SegmentReporting" xlink:href="trxd-20190630.xsd#SegmentReporting" xlink:type="simple" />
    <link:roleRef roleURI="http://trxadegroup.com/role/BusinessCombination" xlink:href="trxd-20190630.xsd#BusinessCombination" xlink:type="simple" />
    <link:roleRef roleURI="http://trxadegroup.com/role/EquityMethodInvestment" xlink:href="trxd-20190630.xsd#EquityMethodInvestment" xlink:type="simple" />
    <link:roleRef roleURI="http://trxadegroup.com/role/SubsequentEvents" xlink:href="trxd-20190630.xsd#SubsequentEvents" xlink:type="simple" />
    <link:roleRef roleURI="http://trxadegroup.com/role/SummaryOfSignificantAccountingPoliciesPolicies" xlink:href="trxd-20190630.xsd#SummaryOfSignificantAccountingPoliciesPolicies" xlink:type="simple" />
    <link:roleRef roleURI="http://trxadegroup.com/role/OrganizationAndBasisOfPresentationTables" xlink:href="trxd-20190630.xsd#OrganizationAndBasisOfPresentationTables" xlink:type="simple" />
    <link:roleRef roleURI="http://trxadegroup.com/role/SummaryOfSignificantAccountingPoliciesTables" xlink:href="trxd-20190630.xsd#SummaryOfSignificantAccountingPoliciesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://trxadegroup.com/role/LongTermDebt-RelatedPartiesTables" xlink:href="trxd-20190630.xsd#LongTermDebt-RelatedPartiesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://trxadegroup.com/role/WarrantsTables" xlink:href="trxd-20190630.xsd#WarrantsTables" xlink:type="simple" />
    <link:roleRef roleURI="http://trxadegroup.com/role/OptionsTables" xlink:href="trxd-20190630.xsd#OptionsTables" xlink:type="simple" />
    <link:roleRef roleURI="http://trxadegroup.com/role/LeasesTables" xlink:href="trxd-20190630.xsd#LeasesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://trxadegroup.com/role/IncomeTaxesTables" xlink:href="trxd-20190630.xsd#IncomeTaxesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://trxadegroup.com/role/CommitmentsAndContingenciesTables" xlink:href="trxd-20190630.xsd#CommitmentsAndContingenciesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://trxadegroup.com/role/SegmentReportingTables" xlink:href="trxd-20190630.xsd#SegmentReportingTables" xlink:type="simple" />
    <link:roleRef roleURI="http://trxadegroup.com/role/BusinessCombinationTables" xlink:href="trxd-20190630.xsd#BusinessCombinationTables" xlink:type="simple" />
    <link:roleRef roleURI="http://trxadegroup.com/role/OrganizationAndBasisOfPresentationDetailsNarrative" xlink:href="trxd-20190630.xsd#OrganizationAndBasisOfPresentationDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://trxadegroup.com/role/OrganizationDetailsNarrative10-k" xlink:href="trxd-20190630.xsd#OrganizationDetailsNarrative10-k" xlink:type="simple" />
    <link:roleRef roleURI="http://trxadegroup.com/role/OrganizationAndBasisOfPresentation-ScheduleOfEarningsPerShareBasicAndDilutedDetails" xlink:href="trxd-20190630.xsd#OrganizationAndBasisOfPresentation-ScheduleOfEarningsPerShareBasicAndDilutedDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://trxadegroup.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative10-k" xlink:href="trxd-20190630.xsd#SummaryOfSignificantAccountingPoliciesDetailsNarrative10-k" xlink:type="simple" />
    <link:roleRef roleURI="http://trxadegroup.com/role/SummaryOfSignificantAccountingPolicies-ScheduleOfEarningsPerShareBasicAndDilutedDetails10-k" xlink:href="trxd-20190630.xsd#SummaryOfSignificantAccountingPolicies-ScheduleOfEarningsPerShareBasicAndDilutedDetails10-k" xlink:type="simple" />
    <link:roleRef roleURI="http://trxadegroup.com/role/Short-termDebtAndRelatedPartiesDebtDetailsNarrative" xlink:href="trxd-20190630.xsd#Short-termDebtAndRelatedPartiesDebtDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://trxadegroup.com/role/Short-termDebtAndRelatedPartiesDebtDetailsNarrative10-k" xlink:href="trxd-20190630.xsd#Short-termDebtAndRelatedPartiesDebtDetailsNarrative10-k" xlink:type="simple" />
    <link:roleRef roleURI="http://trxadegroup.com/role/LongTermDebt-RelatedPartiesDetailsNarrative" xlink:href="trxd-20190630.xsd#LongTermDebt-RelatedPartiesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://trxadegroup.com/role/LongTermDebtDetailsNarrative10-k" xlink:href="trxd-20190630.xsd#LongTermDebtDetailsNarrative10-k" xlink:type="simple" />
    <link:roleRef roleURI="http://trxadegroup.com/role/LongTermDebt-ScheduleOfFutureMaturitiesOfLong-termDebtDetails10-k" xlink:href="trxd-20190630.xsd#LongTermDebt-ScheduleOfFutureMaturitiesOfLong-termDebtDetails10-k" xlink:type="simple" />
    <link:roleRef roleURI="http://trxadegroup.com/role/ShareholdersEquityDetailsNarrative" xlink:href="trxd-20190630.xsd#ShareholdersEquityDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://trxadegroup.com/role/StockholdersEquityDetailsNarrative10-k" xlink:href="trxd-20190630.xsd#StockholdersEquityDetailsNarrative10-k" xlink:type="simple" />
    <link:roleRef roleURI="http://trxadegroup.com/role/WarrantsDetailsNarrative" xlink:href="trxd-20190630.xsd#WarrantsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://trxadegroup.com/role/WarrantsDetailsNarrative10-k" xlink:href="trxd-20190630.xsd#WarrantsDetailsNarrative10-k" xlink:type="simple" />
    <link:roleRef roleURI="http://trxadegroup.com/role/Warrants-ScheduleOfOutstandingAndExercisableWarrantsDetails" xlink:href="trxd-20190630.xsd#Warrants-ScheduleOfOutstandingAndExercisableWarrantsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://trxadegroup.com/role/Warrants-SummaryOfEstimateFairValueOfWarrantsDetails10-k" xlink:href="trxd-20190630.xsd#Warrants-SummaryOfEstimateFairValueOfWarrantsDetails10-k" xlink:type="simple" />
    <link:roleRef roleURI="http://trxadegroup.com/role/OptionsDetailsNarrative" xlink:href="trxd-20190630.xsd#OptionsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://trxadegroup.com/role/OptionsDetailsNarrative10-k" xlink:href="trxd-20190630.xsd#OptionsDetailsNarrative10-k" xlink:type="simple" />
    <link:roleRef roleURI="http://trxadegroup.com/role/Options-ScheduleOfEstimateFairValueOfStockOptionsDetails" xlink:href="trxd-20190630.xsd#Options-ScheduleOfEstimateFairValueOfStockOptionsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://trxadegroup.com/role/Options-ScheduleOfStockOptionActivityDetails" xlink:href="trxd-20190630.xsd#Options-ScheduleOfStockOptionActivityDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://trxadegroup.com/role/LeasesDetailsNarrative" xlink:href="trxd-20190630.xsd#LeasesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://trxadegroup.com/role/Leases-ScheduleOfOperatingLeasesDetails" xlink:href="trxd-20190630.xsd#Leases-ScheduleOfOperatingLeasesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://trxadegroup.com/role/Leases-ScheduleOfFutureMinimumPaymentsForOperatingLeaseLiabilitiesDetails" xlink:href="trxd-20190630.xsd#Leases-ScheduleOfFutureMinimumPaymentsForOperatingLeaseLiabilitiesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://trxadegroup.com/role/IncomeTaxesDetailsNarrative10-k" xlink:href="trxd-20190630.xsd#IncomeTaxesDetailsNarrative10-k" xlink:type="simple" />
    <link:roleRef roleURI="http://trxadegroup.com/role/IncomeTaxes-ScheduleOfDeferredTaxAssetsDetails10-k" xlink:href="trxd-20190630.xsd#IncomeTaxes-ScheduleOfDeferredTaxAssetsDetails10-k" xlink:type="simple" />
    <link:roleRef roleURI="http://trxadegroup.com/role/RelatedPartiesDetailsNarrative10-k" xlink:href="trxd-20190630.xsd#RelatedPartiesDetailsNarrative10-k" xlink:type="simple" />
    <link:roleRef roleURI="http://trxadegroup.com/role/CommitmentsAndContingenciesDetailsNarrative10-k" xlink:href="trxd-20190630.xsd#CommitmentsAndContingenciesDetailsNarrative10-k" xlink:type="simple" />
    <link:roleRef roleURI="http://trxadegroup.com/role/CommitmentsAndContingencies-ScheduleOfFutureMinimumRentalPaymentsUnderNon-cancelableOperatingLeasesDetails10-k" xlink:href="trxd-20190630.xsd#CommitmentsAndContingencies-ScheduleOfFutureMinimumRentalPaymentsUnderNon-cancelableOperatingLeasesDetails10-k" xlink:type="simple" />
    <link:roleRef roleURI="http://trxadegroup.com/role/SegmentReporting-ScheduleOfBusinessInterestsIntoReportableSegmentsDetails" xlink:href="trxd-20190630.xsd#SegmentReporting-ScheduleOfBusinessInterestsIntoReportableSegmentsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://trxadegroup.com/role/BusinessCombinationDetailsNarrative" xlink:href="trxd-20190630.xsd#BusinessCombinationDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://trxadegroup.com/role/BusinessCombinationDetailsNarrative10-k" xlink:href="trxd-20190630.xsd#BusinessCombinationDetailsNarrative10-k" xlink:type="simple" />
    <link:roleRef roleURI="http://trxadegroup.com/role/BusinessCombination-ScheduleOfAssetsAcquiredAndLiabilitiesAssumedDetails" xlink:href="trxd-20190630.xsd#BusinessCombination-ScheduleOfAssetsAcquiredAndLiabilitiesAssumedDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://trxadegroup.com/role/BusinessCombination-ScheduleOfUnauditedProFormaStatementsOfOperationsDetails" xlink:href="trxd-20190630.xsd#BusinessCombination-ScheduleOfUnauditedProFormaStatementsOfOperationsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://trxadegroup.com/role/EquityMethodInvestmentDetailsNarrative" xlink:href="trxd-20190630.xsd#EquityMethodInvestmentDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://trxadegroup.com/role/SubsequentEventsDetailsNarrative" xlink:href="trxd-20190630.xsd#SubsequentEventsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://trxadegroup.com/role/SubsequentEventsDetailsNarrative10-k" xlink:href="trxd-20190630.xsd#SubsequentEventsDetailsNarrative10-k" xlink:type="simple" />
    <link:calculationLink xlink:type="extended" xlink:role="http://trxadegroup.com/role/DocumentAndEntityInformation" xlink:title="00000001 - Document - Document and Entity Information" />
    <link:calculationLink xlink:type="extended" xlink:role="http://trxadegroup.com/role/BalanceSheets" xlink:title="00000002 - Statement - Consolidated Balance Sheets">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AssetsCurrent" xlink:label="loc_us-gaapAssetsCurrent" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="loc_us-gaapCashAndCashEquivalentsAtCarryingValue" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_us-gaapCashAndCashEquivalentsAtCarryingValue" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccountsReceivableNetCurrent" xlink:label="loc_us-gaapAccountsReceivableNetCurrent" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_us-gaapAccountsReceivableNetCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InventoryNet" xlink:label="loc_us-gaapInventoryNet" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_us-gaapInventoryNet" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PrepaidExpenseCurrent" xlink:label="loc_us-gaapPrepaidExpenseCurrent" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_us-gaapPrepaidExpenseCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherAssetsCurrent" xlink:label="loc_us-gaapOtherAssetsCurrent" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_us-gaapOtherAssetsCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_Assets" xlink:label="loc_us-gaapAssets" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssets" xlink:to="loc_us-gaapAssetsCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="loc_us-gaapPropertyPlantAndEquipmentNet" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssets" xlink:to="loc_us-gaapPropertyPlantAndEquipmentNet" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DepositsAssetsNoncurrent" xlink:label="loc_us-gaapDepositsAssetsNoncurrent" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssets" xlink:to="loc_us-gaapDepositsAssetsNoncurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset" xlink:label="loc_us-gaapOperatingLeaseRightOfUseAsset" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssets" xlink:to="loc_us-gaapOperatingLeaseRightOfUseAsset" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_Goodwill" xlink:label="loc_us-gaapGoodwill" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssets" xlink:to="loc_us-gaapGoodwill" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EquityMethodInvestments" xlink:label="loc_us-gaapEquityMethodInvestments" />
      <link:calculationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssets" xlink:to="loc_us-gaapEquityMethodInvestments" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LiabilitiesCurrent" xlink:label="loc_us-gaapLiabilitiesCurrent" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccountsPayableCurrent" xlink:label="loc_us-gaapAccountsPayableCurrent" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapAccountsPayableCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent" xlink:label="loc_us-gaapAccruedLiabilitiesCurrent" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapAccruedLiabilitiesCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent" xlink:label="loc_us-gaapOperatingLeaseLiabilityCurrent" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapOperatingLeaseLiabilityCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ConvertibleNotesPayableCurrent" xlink:label="loc_us-gaapConvertibleNotesPayableCurrent" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapConvertibleNotesPayableCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="trxd-20190630.xsd#TRXD_ShortTermConvertibleNotesPayableRelatedParties" xlink:label="loc_TRXDShortTermConvertibleNotesPayableRelatedParties" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_TRXDShortTermConvertibleNotesPayableRelatedParties" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NotesPayableCurrent" xlink:label="loc_us-gaapNotesPayableCurrent" />
      <link:calculationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapNotesPayableCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_Liabilities" xlink:label="loc_us-gaapLiabilities" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilities" xlink:to="loc_us-gaapLiabilitiesCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NotesPayableRelatedPartiesNoncurrent" xlink:label="loc_us-gaapNotesPayableRelatedPartiesNoncurrent" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilities" xlink:to="loc_us-gaapNotesPayableRelatedPartiesNoncurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:label="loc_us-gaapOperatingLeaseLiabilityNoncurrent" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilities" xlink:to="loc_us-gaapOperatingLeaseLiabilityNoncurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ConvertibleLongTermNotesPayable" xlink:label="loc_us-gaapConvertibleLongTermNotesPayable" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilities" xlink:to="loc_us-gaapConvertibleLongTermNotesPayable" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaapStockholdersEquity" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PreferredStockValue" xlink:label="loc_us-gaapPreferredStockValue" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquity" xlink:to="loc_us-gaapPreferredStockValue" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CommonStockValue" xlink:label="loc_us-gaapCommonStockValue" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquity" xlink:to="loc_us-gaapCommonStockValue" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AdditionalPaidInCapital" xlink:label="loc_us-gaapAdditionalPaidInCapital" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquity" xlink:to="loc_us-gaapAdditionalPaidInCapital" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="loc_us-gaapRetainedEarningsAccumulatedDeficit" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquity" xlink:to="loc_us-gaapRetainedEarningsAccumulatedDeficit" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="loc_us-gaapLiabilitiesAndStockholdersEquity" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquity" xlink:to="loc_us-gaapLiabilities" xlink:type="arc" weight="1" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquity" xlink:to="loc_us-gaapStockholdersEquity" xlink:type="arc" weight="1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://trxadegroup.com/role/BalanceSheetsParenthetical" xlink:title="00000003 - Statement - Consolidated Balance Sheets (Parenthetical)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://trxadegroup.com/role/StatementsOfOperations" xlink:title="00000004 - Statement - Consolidated Statements of Operations">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_GrossProfit" xlink:label="loc_us-gaapGrossProfit" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CostOfGoodsAndServicesSold" xlink:label="loc_us-gaapCostOfGoodsAndServicesSold" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapGrossProfit" xlink:to="loc_us-gaapCostOfGoodsAndServicesSold" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:label="loc_us-gaapRevenueFromContractWithCustomerExcludingAssessedTax" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapGrossProfit" xlink:to="loc_us-gaapRevenueFromContractWithCustomerExcludingAssessedTax" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingIncomeLoss" xlink:label="loc_us-gaapOperatingIncomeLoss" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingIncomeLoss" xlink:to="loc_us-gaapGrossProfit" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_GeneralAndAdministrativeExpense" xlink:label="loc_us-gaapGeneralAndAdministrativeExpense" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingIncomeLoss" xlink:to="loc_us-gaapGeneralAndAdministrativeExpense" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetIncomeLoss" xlink:to="loc_us-gaapOperatingIncomeLoss" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InterestExpense" xlink:label="loc_us-gaapInterestExpense" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetIncomeLoss" xlink:to="loc_us-gaapInterestExpense" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeLossFromEquityMethodInvestments" xlink:label="loc_us-gaapIncomeLossFromEquityMethodInvestments" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetIncomeLoss" xlink:to="loc_us-gaapIncomeLossFromEquityMethodInvestments" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherNonoperatingIncome" xlink:label="loc_us-gaapOtherNonoperatingIncome" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetIncomeLoss" xlink:to="loc_us-gaapOtherNonoperatingIncome" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:label="loc_us-gaapGainsLossesOnExtinguishmentOfDebt" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetIncomeLoss" xlink:to="loc_us-gaapGainsLossesOnExtinguishmentOfDebt" xlink:type="arc" weight="1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://trxadegroup.com/role/StatementsOfChangesInShareholdersEquity" xlink:title="00000005 - Statement - Consolidated Statements of Changes in Shareholders' Equity" />
    <link:calculationLink xlink:type="extended" xlink:role="http://trxadegroup.com/role/StatementsOfCashFlows" xlink:title="00000006 - Statement - Consolidated Statements of Cash Flows">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapNetIncomeLoss" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_Depreciation" xlink:label="loc_us-gaapDepreciation" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapDepreciation" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockOptionPlanExpense" xlink:label="loc_us-gaapStockOptionPlanExpense" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapStockOptionPlanExpense" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="trxd-20190630.xsd#TRXD_AmortizationOfRightToUseAsset" xlink:label="loc_TRXDAmortizationOfRightToUseAsset" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_TRXDAmortizationOfRightToUseAsset" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AmortizationOfDebtDiscountPremium" xlink:label="loc_us-gaapAmortizationOfDebtDiscountPremium" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapAmortizationOfDebtDiscountPremium" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:label="loc_us-gaapIncreaseDecreaseInAccountsReceivable" />
      <link:calculationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInAccountsReceivable" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:label="loc_us-gaapIncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" />
      <link:calculationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncreaseDecreaseInInventories" xlink:label="loc_us-gaapIncreaseDecreaseInInventories" />
      <link:calculationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInInventories" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="trxd-20190630.xsd#TRXD_IncreaseDecreaseInLeaseLiability" xlink:label="loc_TRXDIncreaseDecreaseInLeaseLiability" />
      <link:calculationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_TRXDIncreaseDecreaseInLeaseLiability" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayable" xlink:label="loc_us-gaapIncreaseDecreaseInAccountsPayable" />
      <link:calculationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInAccountsPayable" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeLossFromEquityMethodInvestments" xlink:label="loc_us-gaapIncomeLossFromEquityMethodInvestments" />
      <link:calculationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncomeLossFromEquityMethodInvestments" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims" xlink:label="loc_us-gaapIssuanceOfStockAndWarrantsForServicesOrClaims" />
      <link:calculationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIssuanceOfStockAndWarrantsForServicesOrClaims" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ProvisionForDoubtfulAccounts" xlink:label="loc_us-gaapProvisionForDoubtfulAccounts" />
      <link:calculationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapProvisionForDoubtfulAccounts" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:label="loc_us-gaapGainsLossesOnExtinguishmentOfDebt" />
      <link:calculationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapGainsLossesOnExtinguishmentOfDebt" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities" xlink:label="loc_us-gaapIncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities" />
      <link:calculationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PaymentsToAcquireEquityMethodInvestments" xlink:label="loc_us-gaapPaymentsToAcquireEquityMethodInvestments" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" xlink:to="loc_us-gaapPaymentsToAcquireEquityMethodInvestments" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PaymentsForProceedsFromInvestments" xlink:label="loc_us-gaapPaymentsForProceedsFromInvestments" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" xlink:to="loc_us-gaapPaymentsForProceedsFromInvestments" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:label="loc_us-gaapPaymentsToAcquirePropertyPlantAndEquipment" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" xlink:to="loc_us-gaapPaymentsToAcquirePropertyPlantAndEquipment" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RepaymentsOfShortTermDebt" xlink:label="loc_us-gaapRepaymentsOfShortTermDebt" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:to="loc_us-gaapRepaymentsOfShortTermDebt" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ProceedsFromWarrantExercises" xlink:label="loc_us-gaapProceedsFromWarrantExercises" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:to="loc_us-gaapProceedsFromWarrantExercises" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RepaymentsOfRelatedPartyDebt" xlink:label="loc_us-gaapRepaymentsOfRelatedPartyDebt" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:to="loc_us-gaapRepaymentsOfRelatedPartyDebt" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ProceedsFromRelatedPartyDebt" xlink:label="loc_us-gaapProceedsFromRelatedPartyDebt" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:to="loc_us-gaapProceedsFromRelatedPartyDebt" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:label="loc_us-gaapProceedsFromIssuanceOfCommonStock" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:to="loc_us-gaapProceedsFromIssuanceOfCommonStock" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:label="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" xlink:type="arc" weight="1" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:type="arc" weight="1" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:type="arc" weight="1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://trxadegroup.com/role/OrganizationAndBasisOfPresentation" xlink:title="00000007 - Disclosure - Organization and Basis of Presentation" />
    <link:calculationLink xlink:type="extended" xlink:role="http://trxadegroup.com/role/SummaryOfSignificantAccountingPolicies" xlink:title="00000008 - Disclosure - Summary of Significant Accounting Policies" />
    <link:calculationLink xlink:type="extended" xlink:role="http://trxadegroup.com/role/Short-termDebtAndRelatedPartiesDebt" xlink:title="00000009 - Disclosure - Short-Term Debt and Related Parties Debt" />
    <link:calculationLink xlink:type="extended" xlink:role="http://trxadegroup.com/role/LongTermDebt-RelatedParties" xlink:title="00000010 - Disclosure - Long Term Debt - Related Parties" />
    <link:calculationLink xlink:type="extended" xlink:role="http://trxadegroup.com/role/ShareholdersEquity" xlink:title="00000011 - Disclosure - Shareholders' Equity" />
    <link:calculationLink xlink:type="extended" xlink:role="http://trxadegroup.com/role/Warrants" xlink:title="00000012 - Disclosure - Warrants" />
    <link:calculationLink xlink:type="extended" xlink:role="http://trxadegroup.com/role/Options" xlink:title="00000013 - Disclosure - Options" />
    <link:calculationLink xlink:type="extended" xlink:role="http://trxadegroup.com/role/Leases" xlink:title="00000014 - Disclosure - Leases" />
    <link:calculationLink xlink:type="extended" xlink:role="http://trxadegroup.com/role/IncomeTaxes" xlink:title="00000015 - Disclosure - Income Taxes" />
    <link:calculationLink xlink:type="extended" xlink:role="http://trxadegroup.com/role/RelatedParties" xlink:title="00000016 - Disclosure - Related Parties" />
    <link:calculationLink xlink:type="extended" xlink:role="http://trxadegroup.com/role/CommitmentsAndContingencies" xlink:title="00000017 - Disclosure - Commitments and Contingencies" />
    <link:calculationLink xlink:type="extended" xlink:role="http://trxadegroup.com/role/SegmentReporting" xlink:title="00000018 - Disclosure - Segment Reporting" />
    <link:calculationLink xlink:type="extended" xlink:role="http://trxadegroup.com/role/BusinessCombination" xlink:title="00000019 - Disclosure - Business Combination" />
    <link:calculationLink xlink:type="extended" xlink:role="http://trxadegroup.com/role/EquityMethodInvestment" xlink:title="00000020 - Disclosure - Equity Method Investment" />
    <link:calculationLink xlink:type="extended" xlink:role="http://trxadegroup.com/role/SubsequentEvents" xlink:title="00000021 - Disclosure - Subsequent Events" />
    <link:calculationLink xlink:type="extended" xlink:role="http://trxadegroup.com/role/SummaryOfSignificantAccountingPoliciesPolicies" xlink:title="00000022 - Disclosure - Summary of Significant Accounting Policies (Policies)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://trxadegroup.com/role/OrganizationAndBasisOfPresentationTables" xlink:title="00000023 - Disclosure - Organization and Basis of Presentation (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://trxadegroup.com/role/SummaryOfSignificantAccountingPoliciesTables" xlink:title="00000024 - Disclosure - Summary of Significant Accounting Policies (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://trxadegroup.com/role/LongTermDebt-RelatedPartiesTables" xlink:title="00000025 - Disclosure - Long Term Debt - Related Parties (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://trxadegroup.com/role/WarrantsTables" xlink:title="00000026 - Disclosure - Warrants (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://trxadegroup.com/role/OptionsTables" xlink:title="00000027 - Disclosure - Options (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://trxadegroup.com/role/LeasesTables" xlink:title="00000028 - Disclosure - Leases (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://trxadegroup.com/role/IncomeTaxesTables" xlink:title="00000029 - Disclosure - Income Taxes (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://trxadegroup.com/role/CommitmentsAndContingenciesTables" xlink:title="00000030 - Disclosure - Commitments and Contingencies (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://trxadegroup.com/role/SegmentReportingTables" xlink:title="00000031 - Disclosure - Segment Reporting (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://trxadegroup.com/role/BusinessCombinationTables" xlink:title="00000032 - Disclosure - Business Combination (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://trxadegroup.com/role/OrganizationAndBasisOfPresentationDetailsNarrative" xlink:title="00000033 - Disclosure - Organization and Basis of Presentation (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://trxadegroup.com/role/OrganizationDetailsNarrative10-k" xlink:title="00000034 - Disclosure - Organization (Details Narrative) (10-K)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://trxadegroup.com/role/OrganizationAndBasisOfPresentation-ScheduleOfEarningsPerShareBasicAndDilutedDetails" xlink:title="00000035 - Disclosure - Organization and Basis of Presentation - Schedule of Earnings Per Share, Basic and Diluted (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://trxadegroup.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative10-k" xlink:title="00000036 - Disclosure - Summary of Significant Accounting Policies (Details Narrative) (10-K)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://trxadegroup.com/role/SummaryOfSignificantAccountingPolicies-ScheduleOfEarningsPerShareBasicAndDilutedDetails10-k" xlink:title="00000037 - Disclosure - Summary of Significant Accounting Policies - Schedule of Earnings Per Share, Basic and Diluted (Details) (10-K)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://trxadegroup.com/role/Short-termDebtAndRelatedPartiesDebtDetailsNarrative" xlink:title="00000038 - Disclosure - Short-term Debt and Related Parties Debt (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://trxadegroup.com/role/Short-termDebtAndRelatedPartiesDebtDetailsNarrative10-k" xlink:title="00000039 - Disclosure - Short-term Debt and Related Parties Debt (Details Narrative) (10-K)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://trxadegroup.com/role/LongTermDebt-RelatedPartiesDetailsNarrative" xlink:title="00000040 - Disclosure - Long Term Debt - Related Parties (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://trxadegroup.com/role/LongTermDebtDetailsNarrative10-k" xlink:title="00000041 - Disclosure - Long Term Debt (Details Narrative) (10-K)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://trxadegroup.com/role/LongTermDebt-ScheduleOfFutureMaturitiesOfLong-termDebtDetails10-k" xlink:title="00000042 - Disclosure - Long Term Debt - Schedule of Future Maturities of Long-term Debt (Details) (10-K)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LongTermDebt" xlink:label="loc_us-gaapLongTermDebt" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:label="loc_us-gaapLongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLongTermDebt" xlink:to="loc_us-gaapLongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:label="loc_us-gaapLongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLongTermDebt" xlink:to="loc_us-gaapLongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:label="loc_us-gaapLongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLongTermDebt" xlink:to="loc_us-gaapLongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive" xlink:label="loc_us-gaapLongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLongTermDebt" xlink:to="loc_us-gaapLongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive" xlink:type="arc" weight="1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://trxadegroup.com/role/ShareholdersEquityDetailsNarrative" xlink:title="00000043 - Disclosure - Shareholders' Equity (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://trxadegroup.com/role/StockholdersEquityDetailsNarrative10-k" xlink:title="00000044 - Disclosure - Stockholders' Equity (Details Narrative) (10-K)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://trxadegroup.com/role/WarrantsDetailsNarrative" xlink:title="00000045 - Disclosure - Warrants (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://trxadegroup.com/role/WarrantsDetailsNarrative10-k" xlink:title="00000046 - Disclosure - Warrants (Details Narrative) (10-K)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://trxadegroup.com/role/Warrants-ScheduleOfOutstandingAndExercisableWarrantsDetails" xlink:title="00000047 - Disclosure - Warrants - Schedule of Outstanding and Exercisable Warrants (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://trxadegroup.com/role/Warrants-SummaryOfEstimateFairValueOfWarrantsDetails10-k" xlink:title="00000048 - Disclosure - Warrants - Summary of Estimate the Fair Value of Warrants (Details) (10-K)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://trxadegroup.com/role/OptionsDetailsNarrative" xlink:title="00000049 - Disclosure - Options (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://trxadegroup.com/role/OptionsDetailsNarrative10-k" xlink:title="00000050 - Disclosure - Options (Details Narrative) (10-K)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://trxadegroup.com/role/Options-ScheduleOfEstimateFairValueOfStockOptionsDetails" xlink:title="00000051 - Disclosure - Options - Schedule of Estimate the Fair Value of Stock Options (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://trxadegroup.com/role/Options-ScheduleOfStockOptionActivityDetails" xlink:title="00000052 - Disclosure - Options - Schedule of Stock Option Activity (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://trxadegroup.com/role/LeasesDetailsNarrative" xlink:title="00000053 - Disclosure - Leases (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://trxadegroup.com/role/Leases-ScheduleOfOperatingLeasesDetails" xlink:title="00000054 - Disclosure - Leases - Schedule of Operating Leases (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://trxadegroup.com/role/Leases-ScheduleOfFutureMinimumPaymentsForOperatingLeaseLiabilitiesDetails" xlink:title="00000055 - Disclosure - Leases - Schedule of Future Minimum Payments for Operating Lease Liabilities (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:label="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDue" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:label="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:label="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueYearTwo" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:label="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueYearThree" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:label="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueYearFour" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:label="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueYearFive" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:label="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" />
      <link:calculationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:type="arc" weight="1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://trxadegroup.com/role/IncomeTaxesDetailsNarrative10-k" xlink:title="00000056 - Disclosure - Income Taxes (Details Narrative) (10-K)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://trxadegroup.com/role/IncomeTaxes-ScheduleOfDeferredTaxAssetsDetails10-k" xlink:title="00000057 - Disclosure - Income Taxes - Schedule of Deferred Tax Assets (Details) (10-K)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:label="loc_us-gaapDeferredTaxAssetsLiabilitiesNet" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:label="loc_us-gaapDeferredTaxAssetsOperatingLossCarryforwards" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapDeferredTaxAssetsLiabilitiesNet" xlink:to="loc_us-gaapDeferredTaxAssetsOperatingLossCarryforwards" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DeferredTaxAssetsValuationAllowance" xlink:label="loc_us-gaapDeferredTaxAssetsValuationAllowance" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapDeferredTaxAssetsLiabilitiesNet" xlink:to="loc_us-gaapDeferredTaxAssetsValuationAllowance" xlink:type="arc" weight="-1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://trxadegroup.com/role/RelatedPartiesDetailsNarrative10-k" xlink:title="00000058 - Disclosure - Related Parties (Details Narrative) (10-K)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://trxadegroup.com/role/CommitmentsAndContingenciesDetailsNarrative10-k" xlink:title="00000059 - Disclosure - Commitments and Contingencies (Details Narrative) (10-K)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://trxadegroup.com/role/CommitmentsAndContingencies-ScheduleOfFutureMinimumRentalPaymentsUnderNon-cancelableOperatingLeasesDetails10-k" xlink:title="00000060 - Disclosure - Commitments and Contingencies - Schedule of Future Minimum Rental Payments Under Non-cancelable Operating Leases (Details) (10-K)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDue" xlink:label="loc_us-gaapOperatingLeasesFutureMinimumPaymentsDue" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent" xlink:label="loc_us-gaapOperatingLeasesFutureMinimumPaymentsDueCurrent" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingLeasesFutureMinimumPaymentsDue" xlink:to="loc_us-gaapOperatingLeasesFutureMinimumPaymentsDueCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears" xlink:label="loc_us-gaapOperatingLeasesFutureMinimumPaymentsDueInTwoYears" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingLeasesFutureMinimumPaymentsDue" xlink:to="loc_us-gaapOperatingLeasesFutureMinimumPaymentsDueInTwoYears" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears" xlink:label="loc_us-gaapOperatingLeasesFutureMinimumPaymentsDueInThreeYears" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingLeasesFutureMinimumPaymentsDue" xlink:to="loc_us-gaapOperatingLeasesFutureMinimumPaymentsDueInThreeYears" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears" xlink:label="loc_us-gaapOperatingLeasesFutureMinimumPaymentsDueInFourYears" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingLeasesFutureMinimumPaymentsDue" xlink:to="loc_us-gaapOperatingLeasesFutureMinimumPaymentsDueInFourYears" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFiveYears" xlink:label="loc_us-gaapOperatingLeasesFutureMinimumPaymentsDueInFiveYears" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingLeasesFutureMinimumPaymentsDue" xlink:to="loc_us-gaapOperatingLeasesFutureMinimumPaymentsDueInFiveYears" xlink:type="arc" weight="1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://trxadegroup.com/role/SegmentReporting-ScheduleOfBusinessInterestsIntoReportableSegmentsDetails" xlink:title="00000061 - Disclosure - Segment Reporting - Schedule of Business Interests Into Reportable Segments (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://trxadegroup.com/role/BusinessCombinationDetailsNarrative" xlink:title="00000062 - Disclosure - Business Combination (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://trxadegroup.com/role/BusinessCombinationDetailsNarrative10-k" xlink:title="00000063 - Disclosure - Business Combination (Details Narrative) (10-K)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://trxadegroup.com/role/BusinessCombination-ScheduleOfAssetsAcquiredAndLiabilitiesAssumedDetails" xlink:title="00000064 - Disclosure - Business Combination - Schedule of Assets Acquired and Liabilities Assumed (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://trxadegroup.com/role/BusinessCombination-ScheduleOfUnauditedProFormaStatementsOfOperationsDetails" xlink:title="00000065 - Disclosure - Business Combination - Schedule of Unaudited Pro Forma Statements of Operations (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://trxadegroup.com/role/EquityMethodInvestmentDetailsNarrative" xlink:title="00000066 - Disclosure - Equity Method Investment (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://trxadegroup.com/role/SubsequentEventsDetailsNarrative" xlink:title="00000067 - Disclosure - Subsequent Events (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://trxadegroup.com/role/SubsequentEventsDetailsNarrative10-k" xlink:title="00000068 - Disclosure - Subsequent Events (Details Narrative) (10-K)" />
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>20
<FILENAME>trxd-20190630_def.xml
<DESCRIPTION>XBRL DEFINITION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.1b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: http://www.novaworks.co -->
    <!-- Field: Doc-Info; Name: Source; Value: TRXD 20190630 S%2D1 DFN.xfr; Date: 2019%2D10%2D15T18:00:38Z -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef roleURI="http://trxadegroup.com/role/DocumentAndEntityInformation" xlink:href="trxd-20190630.xsd#DocumentAndEntityInformation" xlink:type="simple" />
    <link:roleRef roleURI="http://trxadegroup.com/role/BalanceSheets" xlink:href="trxd-20190630.xsd#BalanceSheets" xlink:type="simple" />
    <link:roleRef roleURI="http://trxadegroup.com/role/BalanceSheetsParenthetical" xlink:href="trxd-20190630.xsd#BalanceSheetsParenthetical" xlink:type="simple" />
    <link:roleRef roleURI="http://trxadegroup.com/role/StatementsOfOperations" xlink:href="trxd-20190630.xsd#StatementsOfOperations" xlink:type="simple" />
    <link:roleRef roleURI="http://trxadegroup.com/role/StatementsOfChangesInShareholdersEquity" xlink:href="trxd-20190630.xsd#StatementsOfChangesInShareholdersEquity" xlink:type="simple" />
    <link:roleRef roleURI="http://trxadegroup.com/role/StatementsOfCashFlows" xlink:href="trxd-20190630.xsd#StatementsOfCashFlows" xlink:type="simple" />
    <link:roleRef roleURI="http://trxadegroup.com/role/OrganizationAndBasisOfPresentation" xlink:href="trxd-20190630.xsd#OrganizationAndBasisOfPresentation" xlink:type="simple" />
    <link:roleRef roleURI="http://trxadegroup.com/role/SummaryOfSignificantAccountingPolicies" xlink:href="trxd-20190630.xsd#SummaryOfSignificantAccountingPolicies" xlink:type="simple" />
    <link:roleRef roleURI="http://trxadegroup.com/role/Short-termDebtAndRelatedPartiesDebt" xlink:href="trxd-20190630.xsd#Short-termDebtAndRelatedPartiesDebt" xlink:type="simple" />
    <link:roleRef roleURI="http://trxadegroup.com/role/LongTermDebt-RelatedParties" xlink:href="trxd-20190630.xsd#LongTermDebt-RelatedParties" xlink:type="simple" />
    <link:roleRef roleURI="http://trxadegroup.com/role/ShareholdersEquity" xlink:href="trxd-20190630.xsd#ShareholdersEquity" xlink:type="simple" />
    <link:roleRef roleURI="http://trxadegroup.com/role/Warrants" xlink:href="trxd-20190630.xsd#Warrants" xlink:type="simple" />
    <link:roleRef roleURI="http://trxadegroup.com/role/Options" xlink:href="trxd-20190630.xsd#Options" xlink:type="simple" />
    <link:roleRef roleURI="http://trxadegroup.com/role/Leases" xlink:href="trxd-20190630.xsd#Leases" xlink:type="simple" />
    <link:roleRef roleURI="http://trxadegroup.com/role/IncomeTaxes" xlink:href="trxd-20190630.xsd#IncomeTaxes" xlink:type="simple" />
    <link:roleRef roleURI="http://trxadegroup.com/role/RelatedParties" xlink:href="trxd-20190630.xsd#RelatedParties" xlink:type="simple" />
    <link:roleRef roleURI="http://trxadegroup.com/role/CommitmentsAndContingencies" xlink:href="trxd-20190630.xsd#CommitmentsAndContingencies" xlink:type="simple" />
    <link:roleRef roleURI="http://trxadegroup.com/role/SegmentReporting" xlink:href="trxd-20190630.xsd#SegmentReporting" xlink:type="simple" />
    <link:roleRef roleURI="http://trxadegroup.com/role/BusinessCombination" xlink:href="trxd-20190630.xsd#BusinessCombination" xlink:type="simple" />
    <link:roleRef roleURI="http://trxadegroup.com/role/EquityMethodInvestment" xlink:href="trxd-20190630.xsd#EquityMethodInvestment" xlink:type="simple" />
    <link:roleRef roleURI="http://trxadegroup.com/role/SubsequentEvents" xlink:href="trxd-20190630.xsd#SubsequentEvents" xlink:type="simple" />
    <link:roleRef roleURI="http://trxadegroup.com/role/SummaryOfSignificantAccountingPoliciesPolicies" xlink:href="trxd-20190630.xsd#SummaryOfSignificantAccountingPoliciesPolicies" xlink:type="simple" />
    <link:roleRef roleURI="http://trxadegroup.com/role/OrganizationAndBasisOfPresentationTables" xlink:href="trxd-20190630.xsd#OrganizationAndBasisOfPresentationTables" xlink:type="simple" />
    <link:roleRef roleURI="http://trxadegroup.com/role/SummaryOfSignificantAccountingPoliciesTables" xlink:href="trxd-20190630.xsd#SummaryOfSignificantAccountingPoliciesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://trxadegroup.com/role/LongTermDebt-RelatedPartiesTables" xlink:href="trxd-20190630.xsd#LongTermDebt-RelatedPartiesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://trxadegroup.com/role/WarrantsTables" xlink:href="trxd-20190630.xsd#WarrantsTables" xlink:type="simple" />
    <link:roleRef roleURI="http://trxadegroup.com/role/OptionsTables" xlink:href="trxd-20190630.xsd#OptionsTables" xlink:type="simple" />
    <link:roleRef roleURI="http://trxadegroup.com/role/LeasesTables" xlink:href="trxd-20190630.xsd#LeasesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://trxadegroup.com/role/IncomeTaxesTables" xlink:href="trxd-20190630.xsd#IncomeTaxesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://trxadegroup.com/role/CommitmentsAndContingenciesTables" xlink:href="trxd-20190630.xsd#CommitmentsAndContingenciesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://trxadegroup.com/role/SegmentReportingTables" xlink:href="trxd-20190630.xsd#SegmentReportingTables" xlink:type="simple" />
    <link:roleRef roleURI="http://trxadegroup.com/role/BusinessCombinationTables" xlink:href="trxd-20190630.xsd#BusinessCombinationTables" xlink:type="simple" />
    <link:roleRef roleURI="http://trxadegroup.com/role/OrganizationAndBasisOfPresentationDetailsNarrative" xlink:href="trxd-20190630.xsd#OrganizationAndBasisOfPresentationDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://trxadegroup.com/role/OrganizationDetailsNarrative10-k" xlink:href="trxd-20190630.xsd#OrganizationDetailsNarrative10-k" xlink:type="simple" />
    <link:roleRef roleURI="http://trxadegroup.com/role/OrganizationAndBasisOfPresentation-ScheduleOfEarningsPerShareBasicAndDilutedDetails" xlink:href="trxd-20190630.xsd#OrganizationAndBasisOfPresentation-ScheduleOfEarningsPerShareBasicAndDilutedDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://trxadegroup.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative10-k" xlink:href="trxd-20190630.xsd#SummaryOfSignificantAccountingPoliciesDetailsNarrative10-k" xlink:type="simple" />
    <link:roleRef roleURI="http://trxadegroup.com/role/SummaryOfSignificantAccountingPolicies-ScheduleOfEarningsPerShareBasicAndDilutedDetails10-k" xlink:href="trxd-20190630.xsd#SummaryOfSignificantAccountingPolicies-ScheduleOfEarningsPerShareBasicAndDilutedDetails10-k" xlink:type="simple" />
    <link:roleRef roleURI="http://trxadegroup.com/role/Short-termDebtAndRelatedPartiesDebtDetailsNarrative" xlink:href="trxd-20190630.xsd#Short-termDebtAndRelatedPartiesDebtDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://trxadegroup.com/role/Short-termDebtAndRelatedPartiesDebtDetailsNarrative10-k" xlink:href="trxd-20190630.xsd#Short-termDebtAndRelatedPartiesDebtDetailsNarrative10-k" xlink:type="simple" />
    <link:roleRef roleURI="http://trxadegroup.com/role/LongTermDebt-RelatedPartiesDetailsNarrative" xlink:href="trxd-20190630.xsd#LongTermDebt-RelatedPartiesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://trxadegroup.com/role/LongTermDebtDetailsNarrative10-k" xlink:href="trxd-20190630.xsd#LongTermDebtDetailsNarrative10-k" xlink:type="simple" />
    <link:roleRef roleURI="http://trxadegroup.com/role/LongTermDebt-ScheduleOfFutureMaturitiesOfLong-termDebtDetails10-k" xlink:href="trxd-20190630.xsd#LongTermDebt-ScheduleOfFutureMaturitiesOfLong-termDebtDetails10-k" xlink:type="simple" />
    <link:roleRef roleURI="http://trxadegroup.com/role/ShareholdersEquityDetailsNarrative" xlink:href="trxd-20190630.xsd#ShareholdersEquityDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://trxadegroup.com/role/StockholdersEquityDetailsNarrative10-k" xlink:href="trxd-20190630.xsd#StockholdersEquityDetailsNarrative10-k" xlink:type="simple" />
    <link:roleRef roleURI="http://trxadegroup.com/role/WarrantsDetailsNarrative" xlink:href="trxd-20190630.xsd#WarrantsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://trxadegroup.com/role/WarrantsDetailsNarrative10-k" xlink:href="trxd-20190630.xsd#WarrantsDetailsNarrative10-k" xlink:type="simple" />
    <link:roleRef roleURI="http://trxadegroup.com/role/Warrants-ScheduleOfOutstandingAndExercisableWarrantsDetails" xlink:href="trxd-20190630.xsd#Warrants-ScheduleOfOutstandingAndExercisableWarrantsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://trxadegroup.com/role/Warrants-SummaryOfEstimateFairValueOfWarrantsDetails10-k" xlink:href="trxd-20190630.xsd#Warrants-SummaryOfEstimateFairValueOfWarrantsDetails10-k" xlink:type="simple" />
    <link:roleRef roleURI="http://trxadegroup.com/role/OptionsDetailsNarrative" xlink:href="trxd-20190630.xsd#OptionsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://trxadegroup.com/role/OptionsDetailsNarrative10-k" xlink:href="trxd-20190630.xsd#OptionsDetailsNarrative10-k" xlink:type="simple" />
    <link:roleRef roleURI="http://trxadegroup.com/role/Options-ScheduleOfEstimateFairValueOfStockOptionsDetails" xlink:href="trxd-20190630.xsd#Options-ScheduleOfEstimateFairValueOfStockOptionsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://trxadegroup.com/role/Options-ScheduleOfStockOptionActivityDetails" xlink:href="trxd-20190630.xsd#Options-ScheduleOfStockOptionActivityDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://trxadegroup.com/role/LeasesDetailsNarrative" xlink:href="trxd-20190630.xsd#LeasesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://trxadegroup.com/role/Leases-ScheduleOfOperatingLeasesDetails" xlink:href="trxd-20190630.xsd#Leases-ScheduleOfOperatingLeasesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://trxadegroup.com/role/Leases-ScheduleOfFutureMinimumPaymentsForOperatingLeaseLiabilitiesDetails" xlink:href="trxd-20190630.xsd#Leases-ScheduleOfFutureMinimumPaymentsForOperatingLeaseLiabilitiesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://trxadegroup.com/role/IncomeTaxesDetailsNarrative10-k" xlink:href="trxd-20190630.xsd#IncomeTaxesDetailsNarrative10-k" xlink:type="simple" />
    <link:roleRef roleURI="http://trxadegroup.com/role/IncomeTaxes-ScheduleOfDeferredTaxAssetsDetails10-k" xlink:href="trxd-20190630.xsd#IncomeTaxes-ScheduleOfDeferredTaxAssetsDetails10-k" xlink:type="simple" />
    <link:roleRef roleURI="http://trxadegroup.com/role/RelatedPartiesDetailsNarrative10-k" xlink:href="trxd-20190630.xsd#RelatedPartiesDetailsNarrative10-k" xlink:type="simple" />
    <link:roleRef roleURI="http://trxadegroup.com/role/CommitmentsAndContingenciesDetailsNarrative10-k" xlink:href="trxd-20190630.xsd#CommitmentsAndContingenciesDetailsNarrative10-k" xlink:type="simple" />
    <link:roleRef roleURI="http://trxadegroup.com/role/CommitmentsAndContingencies-ScheduleOfFutureMinimumRentalPaymentsUnderNon-cancelableOperatingLeasesDetails10-k" xlink:href="trxd-20190630.xsd#CommitmentsAndContingencies-ScheduleOfFutureMinimumRentalPaymentsUnderNon-cancelableOperatingLeasesDetails10-k" xlink:type="simple" />
    <link:roleRef roleURI="http://trxadegroup.com/role/SegmentReporting-ScheduleOfBusinessInterestsIntoReportableSegmentsDetails" xlink:href="trxd-20190630.xsd#SegmentReporting-ScheduleOfBusinessInterestsIntoReportableSegmentsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://trxadegroup.com/role/BusinessCombinationDetailsNarrative" xlink:href="trxd-20190630.xsd#BusinessCombinationDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://trxadegroup.com/role/BusinessCombinationDetailsNarrative10-k" xlink:href="trxd-20190630.xsd#BusinessCombinationDetailsNarrative10-k" xlink:type="simple" />
    <link:roleRef roleURI="http://trxadegroup.com/role/BusinessCombination-ScheduleOfAssetsAcquiredAndLiabilitiesAssumedDetails" xlink:href="trxd-20190630.xsd#BusinessCombination-ScheduleOfAssetsAcquiredAndLiabilitiesAssumedDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://trxadegroup.com/role/BusinessCombination-ScheduleOfUnauditedProFormaStatementsOfOperationsDetails" xlink:href="trxd-20190630.xsd#BusinessCombination-ScheduleOfUnauditedProFormaStatementsOfOperationsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://trxadegroup.com/role/EquityMethodInvestmentDetailsNarrative" xlink:href="trxd-20190630.xsd#EquityMethodInvestmentDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://trxadegroup.com/role/SubsequentEventsDetailsNarrative" xlink:href="trxd-20190630.xsd#SubsequentEventsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://trxadegroup.com/role/SubsequentEventsDetailsNarrative10-k" xlink:href="trxd-20190630.xsd#SubsequentEventsDetailsNarrative10-k" xlink:type="simple" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension" arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member" arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all" arcroleURI="http://xbrl.org/int/dim/arcrole/all" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#notAll" arcroleURI="http://xbrl.org/int/dim/arcrole/notAll" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" />
    <link:definitionLink xlink:type="extended" xlink:role="http://trxadegroup.com/role/DocumentAndEntityInformation" xlink:title="00000001 - Document - Document and Entity Information" />
    <link:definitionLink xlink:type="extended" xlink:role="http://trxadegroup.com/role/BalanceSheets" xlink:title="00000002 - Statement - Consolidated Balance Sheets" />
    <link:definitionLink xlink:type="extended" xlink:role="http://trxadegroup.com/role/BalanceSheetsParenthetical" xlink:title="00000003 - Statement - Consolidated Balance Sheets (Parenthetical)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentAxis" xlink:label="loc_us-gaapDebtInstrumentAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapDebtInstrumentAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="loc_us-gaapDebtInstrumentNameDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapDebtInstrumentAxis" xlink:to="loc_us-gaapDebtInstrumentNameDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="loc_us-gaapDebtInstrumentNameDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapDebtInstrumentAxis" xlink:to="loc_us-gaapDebtInstrumentNameDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="trxd-20190630.xsd#TRXD_ShortTermNotesPayableMember" xlink:label="loc_TRXDShortTermNotesPayableMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDebtInstrumentNameDomain" xlink:to="loc_TRXDShortTermNotesPayableMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentUnamortizedDiscountCurrent" xlink:label="loc_us-gaapDebtInstrumentUnamortizedDiscountCurrent_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDebtInstrumentUnamortizedDiscountCurrent_60" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare" xlink:label="loc_us-gaapPreferredStockParOrStatedValuePerShare_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapPreferredStockParOrStatedValuePerShare_60" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:label="loc_us-gaapPreferredStockSharesAuthorized_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapPreferredStockSharesAuthorized_60" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PreferredStockSharesIssued" xlink:label="loc_us-gaapPreferredStockSharesIssued_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapPreferredStockSharesIssued_60" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PreferredStockSharesOutstanding" xlink:label="loc_us-gaapPreferredStockSharesOutstanding_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapPreferredStockSharesOutstanding_60" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="loc_us-gaapCommonStockParOrStatedValuePerShare_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCommonStockParOrStatedValuePerShare_60" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="loc_us-gaapCommonStockSharesAuthorized_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCommonStockSharesAuthorized_60" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CommonStockSharesIssued" xlink:label="loc_us-gaapCommonStockSharesIssued_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCommonStockSharesIssued_60" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="loc_us-gaapCommonStockSharesOutstanding_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCommonStockSharesOutstanding_60" xlink:type="arc" order="8" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://trxadegroup.com/role/StatementsOfOperations" xlink:title="00000004 - Statement - Consolidated Statements of Operations" />
    <link:definitionLink xlink:type="extended" xlink:role="http://trxadegroup.com/role/StatementsOfChangesInShareholdersEquity" xlink:title="00000005 - Statement - Consolidated Statements of Changes in Shareholders' Equity">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaapStatementEquityComponentsAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementEquityComponentsAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PreferredStockMember" xlink:label="loc_us-gaapPreferredStockMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapPreferredStockMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaapCommonStockMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapCommonStockMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:label="loc_us-gaapAdditionalPaidInCapitalMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapAdditionalPaidInCapitalMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RetainedEarningsMember" xlink:label="loc_us-gaapRetainedEarningsMember_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapRetainedEarningsMember_30" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaapStockholdersEquity_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockholdersEquity_60" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SharesOutstanding" xlink:label="loc_us-gaapSharesOutstanding_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSharesOutstanding_60" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueNewIssues_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueNewIssues_60" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues_60" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueIssuedForServices" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueIssuedForServices_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueIssuedForServices_60" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesIssuedForServices_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesIssuedForServices_60" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" xlink:label="loc_us-gaapAdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapAdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition_60" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueConversionOfConvertibleSecurities_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueConversionOfConvertibleSecurities_60" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_60" xlink:type="arc" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued" xlink:label="loc_us-gaapAdjustmentsToAdditionalPaidInCapitalWarrantIssued_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapAdjustmentsToAdditionalPaidInCapitalWarrantIssued_60" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="trxd-20190630.xsd#TRXD_StockIssuedDuringPeriodValueStockWarrantExercised" xlink:label="loc_TRXDStockIssuedDuringPeriodValueStockWarrantExercised_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_TRXDStockIssuedDuringPeriodValueStockWarrantExercised_60" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="trxd-20190630.xsd#TRXD_StockIssuedDuringPeriodSharesStockWarrantExercised" xlink:label="loc_TRXDStockIssuedDuringPeriodSharesStockWarrantExercised_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_TRXDStockIssuedDuringPeriodSharesStockWarrantExercised_60" xlink:type="arc" order="13" />
      <link:loc xlink:type="locator" xlink:href="trxd-20190630.xsd#TRXD_AdjustmentsToAdditionalPaidInCapitalWarrantsForAcquisition" xlink:label="loc_TRXDAdjustmentsToAdditionalPaidInCapitalWarrantsForAcquisition_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_TRXDAdjustmentsToAdditionalPaidInCapitalWarrantsForAcquisition_60" xlink:type="arc" order="14" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapNetIncomeLoss_60" xlink:type="arc" order="15" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://trxadegroup.com/role/StatementsOfCashFlows" xlink:title="00000006 - Statement - Consolidated Statements of Cash Flows" />
    <link:definitionLink xlink:type="extended" xlink:role="http://trxadegroup.com/role/OrganizationAndBasisOfPresentation" xlink:title="00000007 - Disclosure - Organization and Basis of Presentation" />
    <link:definitionLink xlink:type="extended" xlink:role="http://trxadegroup.com/role/SummaryOfSignificantAccountingPolicies" xlink:title="00000008 - Disclosure - Summary of Significant Accounting Policies" />
    <link:definitionLink xlink:type="extended" xlink:role="http://trxadegroup.com/role/Short-termDebtAndRelatedPartiesDebt" xlink:title="00000009 - Disclosure - Short-Term Debt and Related Parties Debt" />
    <link:definitionLink xlink:type="extended" xlink:role="http://trxadegroup.com/role/LongTermDebt-RelatedParties" xlink:title="00000010 - Disclosure - Long Term Debt - Related Parties" />
    <link:definitionLink xlink:type="extended" xlink:role="http://trxadegroup.com/role/ShareholdersEquity" xlink:title="00000011 - Disclosure - Shareholders' Equity" />
    <link:definitionLink xlink:type="extended" xlink:role="http://trxadegroup.com/role/Warrants" xlink:title="00000012 - Disclosure - Warrants" />
    <link:definitionLink xlink:type="extended" xlink:role="http://trxadegroup.com/role/Options" xlink:title="00000013 - Disclosure - Options" />
    <link:definitionLink xlink:type="extended" xlink:role="http://trxadegroup.com/role/Leases" xlink:title="00000014 - Disclosure - Leases" />
    <link:definitionLink xlink:type="extended" xlink:role="http://trxadegroup.com/role/IncomeTaxes" xlink:title="00000015 - Disclosure - Income Taxes" />
    <link:definitionLink xlink:type="extended" xlink:role="http://trxadegroup.com/role/RelatedParties" xlink:title="00000016 - Disclosure - Related Parties" />
    <link:definitionLink xlink:type="extended" xlink:role="http://trxadegroup.com/role/CommitmentsAndContingencies" xlink:title="00000017 - Disclosure - Commitments and Contingencies" />
    <link:definitionLink xlink:type="extended" xlink:role="http://trxadegroup.com/role/SegmentReporting" xlink:title="00000018 - Disclosure - Segment Reporting" />
    <link:definitionLink xlink:type="extended" xlink:role="http://trxadegroup.com/role/BusinessCombination" xlink:title="00000019 - Disclosure - Business Combination" />
    <link:definitionLink xlink:type="extended" xlink:role="http://trxadegroup.com/role/EquityMethodInvestment" xlink:title="00000020 - Disclosure - Equity Method Investment" />
    <link:definitionLink xlink:type="extended" xlink:role="http://trxadegroup.com/role/SubsequentEvents" xlink:title="00000021 - Disclosure - Subsequent Events" />
    <link:definitionLink xlink:type="extended" xlink:role="http://trxadegroup.com/role/SummaryOfSignificantAccountingPoliciesPolicies" xlink:title="00000022 - Disclosure - Summary of Significant Accounting Policies (Policies)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://trxadegroup.com/role/OrganizationAndBasisOfPresentationTables" xlink:title="00000023 - Disclosure - Organization and Basis of Presentation (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://trxadegroup.com/role/SummaryOfSignificantAccountingPoliciesTables" xlink:title="00000024 - Disclosure - Summary of Significant Accounting Policies (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://trxadegroup.com/role/LongTermDebt-RelatedPartiesTables" xlink:title="00000025 - Disclosure - Long Term Debt - Related Parties (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://trxadegroup.com/role/WarrantsTables" xlink:title="00000026 - Disclosure - Warrants (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://trxadegroup.com/role/OptionsTables" xlink:title="00000027 - Disclosure - Options (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://trxadegroup.com/role/LeasesTables" xlink:title="00000028 - Disclosure - Leases (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://trxadegroup.com/role/IncomeTaxesTables" xlink:title="00000029 - Disclosure - Income Taxes (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://trxadegroup.com/role/CommitmentsAndContingenciesTables" xlink:title="00000030 - Disclosure - Commitments and Contingencies (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://trxadegroup.com/role/SegmentReportingTables" xlink:title="00000031 - Disclosure - Segment Reporting (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://trxadegroup.com/role/BusinessCombinationTables" xlink:title="00000032 - Disclosure - Business Combination (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://trxadegroup.com/role/OrganizationAndBasisOfPresentationDetailsNarrative" xlink:title="00000033 - Disclosure - Organization and Basis of Presentation (Details Narrative)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://trxadegroup.com/role/OrganizationDetailsNarrative10-k" xlink:title="00000034 - Disclosure - Organization (Details Narrative) (10-K)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://trxadegroup.com/role/OrganizationAndBasisOfPresentation-ScheduleOfEarningsPerShareBasicAndDilutedDetails" xlink:title="00000035 - Disclosure - Organization and Basis of Presentation - Schedule of Earnings Per Share, Basic and Diluted (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://trxadegroup.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative10-k" xlink:title="00000036 - Disclosure - Summary of Significant Accounting Policies (Details Narrative) (10-K)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_MajorCustomersAxis" xlink:label="loc_srtMajorCustomersAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_srtMajorCustomersAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_NameOfMajorCustomerDomain" xlink:label="loc_srtNameOfMajorCustomerDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtMajorCustomersAxis" xlink:to="loc_srtNameOfMajorCustomerDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_NameOfMajorCustomerDomain" xlink:label="loc_srtNameOfMajorCustomerDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtMajorCustomersAxis" xlink:to="loc_srtNameOfMajorCustomerDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="trxd-20190630.xsd#TRXD_TwoCustomersMember" xlink:label="loc_TRXDTwoCustomersMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtNameOfMajorCustomerDomain" xlink:to="loc_TRXDTwoCustomersMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ProvisionForDoubtfulAccounts" xlink:label="loc_us-gaapProvisionForDoubtfulAccounts_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapProvisionForDoubtfulAccounts_50" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="trxd-20190630.xsd#TRXD_RecoveryOfBadDebt" xlink:label="loc_TRXDRecoveryOfBadDebt_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_TRXDRecoveryOfBadDebt_50" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="trxd-20190630.xsd#TRXD_ValuationAllowancePercentage" xlink:label="loc_TRXDValuationAllowancePercentage_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_TRXDValuationAllowancePercentage_50" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ConcentrationRiskPercentage1" xlink:label="loc_us-gaapConcentrationRiskPercentage1_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapConcentrationRiskPercentage1_50" xlink:type="arc" order="3" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://trxadegroup.com/role/SummaryOfSignificantAccountingPolicies-ScheduleOfEarningsPerShareBasicAndDilutedDetails10-k" xlink:title="00000037 - Disclosure - Summary of Significant Accounting Policies - Schedule of Earnings Per Share, Basic and Diluted (Details) (10-K)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://trxadegroup.com/role/Short-termDebtAndRelatedPartiesDebtDetailsNarrative" xlink:title="00000038 - Disclosure - Short-term Debt and Related Parties Debt (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentAxis" xlink:label="loc_us-gaapDebtInstrumentAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapDebtInstrumentAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="loc_us-gaapDebtInstrumentNameDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapDebtInstrumentAxis" xlink:to="loc_us-gaapDebtInstrumentNameDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="loc_us-gaapDebtInstrumentNameDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapDebtInstrumentAxis" xlink:to="loc_us-gaapDebtInstrumentNameDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="trxd-20190630.xsd#TRXD_ConvertiblePromissoryNoteMember" xlink:label="loc_TRXDConvertiblePromissoryNoteMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDebtInstrumentNameDomain" xlink:to="loc_TRXDConvertiblePromissoryNoteMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="trxd-20190630.xsd#TRXD_RelatedPartyConvertiblePromissoryNoteMember" xlink:label="loc_TRXDRelatedPartyConvertiblePromissoryNoteMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDebtInstrumentNameDomain" xlink:to="loc_TRXDRelatedPartyConvertiblePromissoryNoteMember_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaapRelatedPartyDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:to="loc_us-gaapRelatedPartyDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaapRelatedPartyDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:to="loc_us-gaapRelatedPartyDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="trxd-20190630.xsd#TRXD_MrShilpaPatelMember" xlink:label="loc_TRXDMrShilpaPatelMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_TRXDMrShilpaPatelMember_40" xlink:type="arc" order="42" />
      <link:loc xlink:type="locator" xlink:href="trxd-20190630.xsd#TRXD_MrNitilPatelMember" xlink:label="loc_TRXDMrNitilPatelMember_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_TRXDMrNitilPatelMember_60" xlink:type="arc" order="62" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="loc_us-gaapSubsequentEventTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapSubsequentEventTypeAxis" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="loc_us-gaapSubsequentEventTypeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapSubsequentEventTypeAxis" xlink:to="loc_us-gaapSubsequentEventTypeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="loc_us-gaapSubsequentEventTypeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapSubsequentEventTypeAxis" xlink:to="loc_us-gaapSubsequentEventTypeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SubsequentEventMember" xlink:label="loc_us-gaapSubsequentEventMember_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsequentEventTypeDomain" xlink:to="loc_us-gaapSubsequentEventMember_80" xlink:type="arc" order="83" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LoanRestructuringModificationAxis" xlink:label="loc_us-gaapLoanRestructuringModificationAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapLoanRestructuringModificationAxis" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LoanRestructuringModificationDomain" xlink:label="loc_us-gaapLoanRestructuringModificationDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapLoanRestructuringModificationAxis" xlink:to="loc_us-gaapLoanRestructuringModificationDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LoanRestructuringModificationDomain" xlink:label="loc_us-gaapLoanRestructuringModificationDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapLoanRestructuringModificationAxis" xlink:to="loc_us-gaapLoanRestructuringModificationDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ExtendedMaturityMember" xlink:label="loc_us-gaapExtendedMaturityMember_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLoanRestructuringModificationDomain" xlink:to="loc_us-gaapExtendedMaturityMember_80" xlink:type="arc" order="84" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ConvertibleNotesPayable" xlink:label="loc_us-gaapConvertibleNotesPayable_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapConvertibleNotesPayable_100" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentConvertibleConversionPrice1" xlink:label="loc_us-gaapDebtInstrumentConvertibleConversionPrice1_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDebtInstrumentConvertibleConversionPrice1_100" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentPeriodicPayment" xlink:label="loc_us-gaapDebtInstrumentPeriodicPayment_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDebtInstrumentPeriodicPayment_100" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtConversionConvertedInstrumentSharesIssued1" xlink:label="loc_us-gaapDebtConversionConvertedInstrumentSharesIssued1_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDebtConversionConvertedInstrumentSharesIssued1_100" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ConvertibleNotesPayableCurrent" xlink:label="loc_us-gaapConvertibleNotesPayableCurrent_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapConvertibleNotesPayableCurrent_100" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentUnamortizedDiscount" xlink:label="loc_us-gaapDebtInstrumentUnamortizedDiscount_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDebtInstrumentUnamortizedDiscount_100" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="trxd-20190630.xsd#TRXD_ShortTermConvertibleNotesPayableRelatedParties" xlink:label="loc_TRXDShortTermConvertibleNotesPayableRelatedParties_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_TRXDShortTermConvertibleNotesPayableRelatedParties_100" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:label="loc_us-gaapDebtInstrumentInterestRateStatedPercentage_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDebtInstrumentInterestRateStatedPercentage_100" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentMaturityDate" xlink:label="loc_us-gaapDebtInstrumentMaturityDate_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDebtInstrumentMaturityDate_100" xlink:type="arc" order="8" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://trxadegroup.com/role/Short-termDebtAndRelatedPartiesDebtDetailsNarrative10-k" xlink:title="00000039 - Disclosure - Short-term Debt and Related Parties Debt (Details Narrative) (10-K)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentAxis" xlink:label="loc_us-gaapDebtInstrumentAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapDebtInstrumentAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="loc_us-gaapDebtInstrumentNameDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapDebtInstrumentAxis" xlink:to="loc_us-gaapDebtInstrumentNameDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="loc_us-gaapDebtInstrumentNameDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapDebtInstrumentAxis" xlink:to="loc_us-gaapDebtInstrumentNameDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="trxd-20190630.xsd#TRXD_ConvertiblePromissoryNoteMember" xlink:label="loc_TRXDConvertiblePromissoryNoteMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDebtInstrumentNameDomain" xlink:to="loc_TRXDConvertiblePromissoryNoteMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="trxd-20190630.xsd#TRXD_PromissoryNoteMember" xlink:label="loc_TRXDPromissoryNoteMember_140" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDebtInstrumentNameDomain" xlink:to="loc_TRXDPromissoryNoteMember_140" xlink:type="arc" order="141" />
      <link:loc xlink:type="locator" xlink:href="trxd-20190630.xsd#TRXD_PromissoryNoteOneMember" xlink:label="loc_TRXDPromissoryNoteOneMember_200" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDebtInstrumentNameDomain" xlink:to="loc_TRXDPromissoryNoteOneMember_200" xlink:type="arc" order="201" />
      <link:loc xlink:type="locator" xlink:href="trxd-20190630.xsd#TRXD_PromissoryNoteTwoMember" xlink:label="loc_TRXDPromissoryNoteTwoMember_250" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDebtInstrumentNameDomain" xlink:to="loc_TRXDPromissoryNoteTwoMember_250" xlink:type="arc" order="251" />
      <link:loc xlink:type="locator" xlink:href="trxd-20190630.xsd#TRXD_ShortTermPromissoryNotesMember" xlink:label="loc_TRXDShortTermPromissoryNotesMember_270" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDebtInstrumentNameDomain" xlink:to="loc_TRXDShortTermPromissoryNotesMember_270" xlink:type="arc" order="271" />
      <link:loc xlink:type="locator" xlink:href="trxd-20190630.xsd#TRXD_PromissoryNotesMember" xlink:label="loc_TRXDPromissoryNotesMember_290" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDebtInstrumentNameDomain" xlink:to="loc_TRXDPromissoryNotesMember_290" xlink:type="arc" order="291" />
      <link:loc xlink:type="locator" xlink:href="trxd-20190630.xsd#TRXD_RelatedPartyConvertiblePromissoryNoteMember" xlink:label="loc_TRXDRelatedPartyConvertiblePromissoryNoteMember_310" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDebtInstrumentNameDomain" xlink:to="loc_TRXDRelatedPartyConvertiblePromissoryNoteMember_310" xlink:type="arc" order="311" />
      <link:loc xlink:type="locator" xlink:href="trxd-20190630.xsd#TRXD_RelatedPartyConvertiblePromissoryNotesMember" xlink:label="loc_TRXDRelatedPartyConvertiblePromissoryNotesMember_450" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDebtInstrumentNameDomain" xlink:to="loc_TRXDRelatedPartyConvertiblePromissoryNotesMember_450" xlink:type="arc" order="451" />
      <link:loc xlink:type="locator" xlink:href="trxd-20190630.xsd#TRXD_ShortTermRelatedPartyConvertibleNotesMember" xlink:label="loc_TRXDShortTermRelatedPartyConvertibleNotesMember_520" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDebtInstrumentNameDomain" xlink:to="loc_TRXDShortTermRelatedPartyConvertibleNotesMember_520" xlink:type="arc" order="521" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaapStatementEquityComponentsAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementEquityComponentsAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_WarrantMember" xlink:label="loc_us-gaapWarrantMember_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapWarrantMember_100" xlink:type="arc" order="101" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaapRelatedPartyDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:to="loc_us-gaapRelatedPartyDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaapRelatedPartyDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:to="loc_us-gaapRelatedPartyDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="trxd-20190630.xsd#TRXD_MrShilpaPatelMember" xlink:label="loc_TRXDMrShilpaPatelMember_310" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_TRXDMrShilpaPatelMember_310" xlink:type="arc" order="312" />
      <link:loc xlink:type="locator" xlink:href="trxd-20190630.xsd#TRXD_MrNitilPatelMember" xlink:label="loc_TRXDMrNitilPatelMember_380" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_TRXDMrNitilPatelMember_380" xlink:type="arc" order="382" />
      <link:loc xlink:type="locator" xlink:href="trxd-20190630.xsd#TRXD_MrPrashantPatelMember" xlink:label="loc_TRXDMrPrashantPatelMember_530" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_TRXDMrPrashantPatelMember_530" xlink:type="arc" order="532" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ConvertibleNotesPayable" xlink:label="loc_us-gaapConvertibleNotesPayable_610" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapConvertibleNotesPayable_610" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentTerm" xlink:label="loc_us-gaapDebtInstrumentTerm_610" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDebtInstrumentTerm_610" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:label="loc_us-gaapDebtInstrumentInterestRateStatedPercentage_610" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDebtInstrumentInterestRateStatedPercentage_610" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentConvertibleConversionPrice1" xlink:label="loc_us-gaapDebtInstrumentConvertibleConversionPrice1_610" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDebtInstrumentConvertibleConversionPrice1_610" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="trxd-20190630.xsd#TRXD_GrantedWarrants" xlink:label="loc_TRXDGrantedWarrants_610" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_TRXDGrantedWarrants_610" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SharesIssuedPricePerShare" xlink:label="loc_us-gaapSharesIssuedPricePerShare_610" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSharesIssuedPricePerShare_610" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:label="loc_us-gaapClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_610" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_610" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:label="loc_us-gaapClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_610" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_610" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_WarrantsAndRightsOutstandingTerm" xlink:label="loc_us-gaapWarrantsAndRightsOutstandingTerm_610" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapWarrantsAndRightsOutstandingTerm_610" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentUnamortizedDiscount" xlink:label="loc_us-gaapDebtInstrumentUnamortizedDiscount_610" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDebtInstrumentUnamortizedDiscount_610" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RepaymentsOfDebt" xlink:label="loc_us-gaapRepaymentsOfDebt_610" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapRepaymentsOfDebt_610" xlink:type="arc" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InterestExpenseDebt" xlink:label="loc_us-gaapInterestExpenseDebt_610" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapInterestExpenseDebt_610" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentMaturityDateDescription" xlink:label="loc_us-gaapDebtInstrumentMaturityDateDescription_610" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDebtInstrumentMaturityDateDescription_610" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InterestPayableCurrentAndNoncurrent" xlink:label="loc_us-gaapInterestPayableCurrentAndNoncurrent_610" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapInterestPayableCurrentAndNoncurrent_610" xlink:type="arc" order="13" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentFaceAmount" xlink:label="loc_us-gaapDebtInstrumentFaceAmount_610" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDebtInstrumentFaceAmount_610" xlink:type="arc" order="14" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentMaturityDate" xlink:label="loc_us-gaapDebtInstrumentMaturityDate_610" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDebtInstrumentMaturityDate_610" xlink:type="arc" order="15" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:label="loc_us-gaapGainsLossesOnExtinguishmentOfDebt_610" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapGainsLossesOnExtinguishmentOfDebt_610" xlink:type="arc" order="16" />
      <link:loc xlink:type="locator" xlink:href="trxd-20190630.xsd#TRXD_DebtModificationsAmount" xlink:label="loc_TRXDDebtModificationsAmount_610" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_TRXDDebtModificationsAmount_610" xlink:type="arc" order="17" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AmortizationOfDebtDiscountPremium" xlink:label="loc_us-gaapAmortizationOfDebtDiscountPremium_610" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapAmortizationOfDebtDiscountPremium_610" xlink:type="arc" order="18" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ConvertibleNotesPayableCurrent" xlink:label="loc_us-gaapConvertibleNotesPayableCurrent_610" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapConvertibleNotesPayableCurrent_610" xlink:type="arc" order="19" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentPeriodicPaymentPrincipal" xlink:label="loc_us-gaapDebtInstrumentPeriodicPaymentPrincipal_610" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDebtInstrumentPeriodicPaymentPrincipal_610" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ProceedsFromIssuanceOfDebt" xlink:label="loc_us-gaapProceedsFromIssuanceOfDebt_610" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapProceedsFromIssuanceOfDebt_610" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentUnamortizedDiscountCurrent" xlink:label="loc_us-gaapDebtInstrumentUnamortizedDiscountCurrent_610" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDebtInstrumentUnamortizedDiscountCurrent_610" xlink:type="arc" order="22" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LongTermDebt" xlink:label="loc_us-gaapLongTermDebt_610" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapLongTermDebt_610" xlink:type="arc" order="23" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentUnamortizedDiscountNoncurrent" xlink:label="loc_us-gaapDebtInstrumentUnamortizedDiscountNoncurrent_610" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDebtInstrumentUnamortizedDiscountNoncurrent_610" xlink:type="arc" order="24" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentConvertibleBeneficialConversionFeature" xlink:label="loc_us-gaapDebtInstrumentConvertibleBeneficialConversionFeature_610" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDebtInstrumentConvertibleBeneficialConversionFeature_610" xlink:type="arc" order="25" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DueToRelatedPartiesCurrentAndNoncurrent" xlink:label="loc_us-gaapDueToRelatedPartiesCurrentAndNoncurrent_610" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDueToRelatedPartiesCurrentAndNoncurrent_610" xlink:type="arc" order="26" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LoansPayable" xlink:label="loc_us-gaapLoansPayable_610" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapLoansPayable_610" xlink:type="arc" order="27" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccountsPayableCurrentAndNoncurrent" xlink:label="loc_us-gaapAccountsPayableCurrentAndNoncurrent_610" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapAccountsPayableCurrentAndNoncurrent_610" xlink:type="arc" order="28" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtConversionConvertedInstrumentAmount1" xlink:label="loc_us-gaapDebtConversionConvertedInstrumentAmount1_610" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDebtConversionConvertedInstrumentAmount1_610" xlink:type="arc" order="29" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://trxadegroup.com/role/LongTermDebt-RelatedPartiesDetailsNarrative" xlink:title="00000040 - Disclosure - Long Term Debt - Related Parties (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentAxis" xlink:label="loc_us-gaapDebtInstrumentAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapDebtInstrumentAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="loc_us-gaapDebtInstrumentNameDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapDebtInstrumentAxis" xlink:to="loc_us-gaapDebtInstrumentNameDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="loc_us-gaapDebtInstrumentNameDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapDebtInstrumentAxis" xlink:to="loc_us-gaapDebtInstrumentNameDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="trxd-20190630.xsd#TRXD_RelatedPartyPromissoryNoteMember" xlink:label="loc_TRXDRelatedPartyPromissoryNoteMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDebtInstrumentNameDomain" xlink:to="loc_TRXDRelatedPartyPromissoryNoteMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_LegalEntityAxis" xlink:label="loc_deiLegalEntityAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_deiLegalEntityAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="trxd-20190630.xsd#TRXD_CommunitySpecialtyPharmacyLLCMember" xlink:label="loc_TRXDCommunitySpecialtyPharmacyLLCMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityDomain" xlink:to="loc_TRXDCommunitySpecialtyPharmacyLLCMember_0" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaapRelatedPartyDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:to="loc_us-gaapRelatedPartyDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaapRelatedPartyDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:to="loc_us-gaapRelatedPartyDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="trxd-20190630.xsd#TRXD_NikulPanchalMember" xlink:label="loc_TRXDNikulPanchalMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_TRXDNikulPanchalMember_0" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="trxd-20190630.xsd#TRXD_MrPrashantPatelMember" xlink:label="loc_TRXDMrPrashantPatelMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_TRXDMrPrashantPatelMember_20" xlink:type="arc" order="22" />
      <link:loc xlink:type="locator" xlink:href="trxd-20190630.xsd#TRXD_MrSurenAjjarapuMember" xlink:label="loc_TRXDMrSurenAjjarapuMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_TRXDMrSurenAjjarapuMember_40" xlink:type="arc" order="42" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ProceedsFromIssuanceOfDebt" xlink:label="loc_us-gaapProceedsFromIssuanceOfDebt_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapProceedsFromIssuanceOfDebt_70" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:label="loc_us-gaapDebtInstrumentInterestRateStatedPercentage_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDebtInstrumentInterestRateStatedPercentage_70" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentMaturityDate" xlink:label="loc_us-gaapDebtInstrumentMaturityDate_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDebtInstrumentMaturityDate_70" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NotesPayableRelatedPartiesNoncurrent" xlink:label="loc_us-gaapNotesPayableRelatedPartiesNoncurrent_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapNotesPayableRelatedPartiesNoncurrent_70" xlink:type="arc" order="3" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://trxadegroup.com/role/LongTermDebtDetailsNarrative10-k" xlink:title="00000041 - Disclosure - Long Term Debt (Details Narrative) (10-K)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentAxis" xlink:label="loc_us-gaapDebtInstrumentAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapDebtInstrumentAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="loc_us-gaapDebtInstrumentNameDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapDebtInstrumentAxis" xlink:to="loc_us-gaapDebtInstrumentNameDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="loc_us-gaapDebtInstrumentNameDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapDebtInstrumentAxis" xlink:to="loc_us-gaapDebtInstrumentNameDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="trxd-20190630.xsd#TRXD_RelatedPartyPromissoryNoteMember" xlink:label="loc_TRXDRelatedPartyPromissoryNoteMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDebtInstrumentNameDomain" xlink:to="loc_TRXDRelatedPartyPromissoryNoteMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="trxd-20190630.xsd#TRXD_PromissoryNoteMember" xlink:label="loc_TRXDPromissoryNoteMember_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDebtInstrumentNameDomain" xlink:to="loc_TRXDPromissoryNoteMember_90" xlink:type="arc" order="92" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_LegalEntityAxis" xlink:label="loc_deiLegalEntityAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_deiLegalEntityAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="trxd-20190630.xsd#TRXD_NPRINVESTMENTGROUPLLCMember" xlink:label="loc_TRXDNPRINVESTMENTGROUPLLCMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityDomain" xlink:to="loc_TRXDNPRINVESTMENTGROUPLLCMember_20" xlink:type="arc" order="22" />
      <link:loc xlink:type="locator" xlink:href="trxd-20190630.xsd#TRXD_SansurAssociatesLLCMember" xlink:label="loc_TRXDSansurAssociatesLLCMember_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityDomain" xlink:to="loc_TRXDSansurAssociatesLLCMember_30" xlink:type="arc" order="32" />
      <link:loc xlink:type="locator" xlink:href="trxd-20190630.xsd#TRXD_SpecialtyPharmacyLLCMember" xlink:label="loc_TRXDSpecialtyPharmacyLLCMember_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityDomain" xlink:to="loc_TRXDSpecialtyPharmacyLLCMember_110" xlink:type="arc" order="112" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaapRelatedPartyDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:to="loc_us-gaapRelatedPartyDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaapRelatedPartyDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:to="loc_us-gaapRelatedPartyDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="trxd-20190630.xsd#TRXD_MrSurenAjjarapuMember" xlink:label="loc_TRXDMrSurenAjjarapuMember_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_TRXDMrSurenAjjarapuMember_30" xlink:type="arc" order="33" />
      <link:loc xlink:type="locator" xlink:href="trxd-20190630.xsd#TRXD_MrPrashantPatelMember" xlink:label="loc_TRXDMrPrashantPatelMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_TRXDMrPrashantPatelMember_40" xlink:type="arc" order="43" />
      <link:loc xlink:type="locator" xlink:href="trxd-20190630.xsd#TRXD_RelatedPartyPromissoryNoteMember" xlink:label="loc_TRXDRelatedPartyPromissoryNoteMember_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_TRXDRelatedPartyPromissoryNoteMember_90" xlink:type="arc" order="91" />
      <link:loc xlink:type="locator" xlink:href="trxd-20190630.xsd#TRXD_NikulPanchalMember" xlink:label="loc_TRXDNikulPanchalMember_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_TRXDNikulPanchalMember_110" xlink:type="arc" order="113" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ConvertibleNotesPayable" xlink:label="loc_us-gaapConvertibleNotesPayable_150" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapConvertibleNotesPayable_150" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentMaturityDate" xlink:label="loc_us-gaapDebtInstrumentMaturityDate_150" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDebtInstrumentMaturityDate_150" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentFaceAmount" xlink:label="loc_us-gaapDebtInstrumentFaceAmount_150" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDebtInstrumentFaceAmount_150" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShortTermBorrowings" xlink:label="loc_us-gaapShortTermBorrowings_150" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShortTermBorrowings_150" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentTerm" xlink:label="loc_us-gaapDebtInstrumentTerm_150" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDebtInstrumentTerm_150" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:label="loc_us-gaapDebtInstrumentInterestRateStatedPercentage_150" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDebtInstrumentInterestRateStatedPercentage_150" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DueToRelatedPartiesCurrentAndNoncurrent" xlink:label="loc_us-gaapDueToRelatedPartiesCurrentAndNoncurrent_150" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDueToRelatedPartiesCurrentAndNoncurrent_150" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="trxd-20190630.xsd#TRXD_CreditCardObligationAmount" xlink:label="loc_TRXDCreditCardObligationAmount_150" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_TRXDCreditCardObligationAmount_150" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NotesPayableRelatedPartiesNoncurrent" xlink:label="loc_us-gaapNotesPayableRelatedPartiesNoncurrent_150" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapNotesPayableRelatedPartiesNoncurrent_150" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ProceedsFromIssuanceOfDebt" xlink:label="loc_us-gaapProceedsFromIssuanceOfDebt_150" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapProceedsFromIssuanceOfDebt_150" xlink:type="arc" order="9" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://trxadegroup.com/role/LongTermDebt-ScheduleOfFutureMaturitiesOfLong-termDebtDetails10-k" xlink:title="00000042 - Disclosure - Long Term Debt - Schedule of Future Maturities of Long-term Debt (Details) (10-K)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://trxadegroup.com/role/ShareholdersEquityDetailsNarrative" xlink:title="00000043 - Disclosure - Shareholders' Equity (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentAxis" xlink:label="loc_us-gaapDebtInstrumentAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapDebtInstrumentAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="loc_us-gaapDebtInstrumentNameDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapDebtInstrumentAxis" xlink:to="loc_us-gaapDebtInstrumentNameDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="loc_us-gaapDebtInstrumentNameDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapDebtInstrumentAxis" xlink:to="loc_us-gaapDebtInstrumentNameDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="trxd-20190630.xsd#TRXD_ConvertiblePromissoryNoteMember" xlink:label="loc_TRXDConvertiblePromissoryNoteMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDebtInstrumentNameDomain" xlink:to="loc_TRXDConvertiblePromissoryNoteMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaapStatementEquityComponentsAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementEquityComponentsAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_WarrantMember" xlink:label="loc_us-gaapWarrantMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapWarrantMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_RangeAxis" xlink:label="loc_srtRangeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_srtRangeAxis" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_RangeMember" xlink:label="loc_srtRangeMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtRangeAxis" xlink:to="loc_srtRangeMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_RangeMember" xlink:label="loc_srtRangeMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtRangeAxis" xlink:to="loc_srtRangeMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_MinimumMember" xlink:label="loc_srtMinimumMember_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMinimumMember_50" xlink:type="arc" order="51" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_MaximumMember" xlink:label="loc_srtMaximumMember_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMaximumMember_60" xlink:type="arc" order="61" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ConvertibleNotesPayable" xlink:label="loc_us-gaapConvertibleNotesPayable_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapConvertibleNotesPayable_110" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentConvertibleConversionPrice1" xlink:label="loc_us-gaapDebtInstrumentConvertibleConversionPrice1_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDebtInstrumentConvertibleConversionPrice1_110" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentPeriodicPayment" xlink:label="loc_us-gaapDebtInstrumentPeriodicPayment_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDebtInstrumentPeriodicPayment_110" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtConversionConvertedInstrumentSharesIssued1" xlink:label="loc_us-gaapDebtConversionConvertedInstrumentSharesIssued1_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDebtConversionConvertedInstrumentSharesIssued1_110" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="trxd-20190630.xsd#TRXD_WarrantsIssued" xlink:label="loc_TRXDWarrantsIssued_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_TRXDWarrantsIssued_110" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:label="loc_us-gaapClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_110" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="trxd-20190630.xsd#TRXD_StockIssuedDuringPeriodSharesWarrantsExercised" xlink:label="loc_TRXDStockIssuedDuringPeriodSharesWarrantsExercised_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_TRXDStockIssuedDuringPeriodSharesWarrantsExercised_110" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="trxd-20190630.xsd#TRXD_StockIssuedDuringPeriodValueWarrantsExercised" xlink:label="loc_TRXDStockIssuedDuringPeriodValueWarrantsExercised_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_TRXDStockIssuedDuringPeriodValueWarrantsExercised_110" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_110" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_110" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_110" xlink:type="arc" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_110" xlink:type="arc" order="11" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://trxadegroup.com/role/StockholdersEquityDetailsNarrative10-k" xlink:title="00000044 - Disclosure - Stockholders' Equity (Details Narrative) (10-K)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PlanNameAxis" xlink:label="loc_us-gaapPlanNameAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapPlanNameAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PlanNameDomain" xlink:label="loc_us-gaapPlanNameDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapPlanNameAxis" xlink:to="loc_us-gaapPlanNameDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PlanNameDomain" xlink:label="loc_us-gaapPlanNameDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapPlanNameAxis" xlink:to="loc_us-gaapPlanNameDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="trxd-20190630.xsd#TRXD_PrivateOfferMemorandumMember" xlink:label="loc_TRXDPrivateOfferMemorandumMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPlanNameDomain" xlink:to="loc_TRXDPrivateOfferMemorandumMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues_100" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueNewIssues_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueNewIssues_100" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SaleOfStockPricePerShare" xlink:label="loc_us-gaapSaleOfStockPricePerShare_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSaleOfStockPricePerShare_100" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:label="loc_us-gaapClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_100" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:label="loc_us-gaapClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_100" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_WarrantsAndRightsOutstandingTerm" xlink:label="loc_us-gaapWarrantsAndRightsOutstandingTerm_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapWarrantsAndRightsOutstandingTerm_100" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="trxd-20190630.xsd#TRXD_WarrantsIssued" xlink:label="loc_TRXDWarrantsIssued_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_TRXDWarrantsIssued_100" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ProceedsFromIssuanceOfWarrants" xlink:label="loc_us-gaapProceedsFromIssuanceOfWarrants_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapProceedsFromIssuanceOfWarrants_100" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesIssuedForServices_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesIssuedForServices_100" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueIssuedForServices" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueIssuedForServices_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueIssuedForServices_100" xlink:type="arc" order="9" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://trxadegroup.com/role/WarrantsDetailsNarrative" xlink:title="00000045 - Disclosure - Warrants (Details Narrative)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://trxadegroup.com/role/WarrantsDetailsNarrative10-k" xlink:title="00000046 - Disclosure - Warrants (Details Narrative) (10-K)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_LegalEntityAxis" xlink:label="loc_deiLegalEntityAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_deiLegalEntityAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="trxd-20190630.xsd#TRXD_CommunitySpecialtyPharmacyLLCMember" xlink:label="loc_TRXDCommunitySpecialtyPharmacyLLCMember_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityDomain" xlink:to="loc_TRXDCommunitySpecialtyPharmacyLLCMember_30" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:label="loc_us-gaapClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_60" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="trxd-20190630.xsd#TRXD_WarrantIssuedForRenewalOfConvertibleDebt" xlink:label="loc_TRXDWarrantIssuedForRenewalOfConvertibleDebt_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_TRXDWarrantIssuedForRenewalOfConvertibleDebt_60" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" xlink:label="loc_us-gaapClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight_60" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures_60" xlink:type="arc" order="3" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://trxadegroup.com/role/Warrants-ScheduleOfOutstandingAndExercisableWarrantsDetails" xlink:title="00000047 - Disclosure - Warrants - Schedule of Outstanding and Exercisable Warrants (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaapStatementEquityComponentsAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementEquityComponentsAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_WarrantMember" xlink:label="loc_us-gaapWarrantMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapWarrantMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_40" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted_40" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures_40" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised_40" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="trxd-20190630.xsd#TRXD_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice" xlink:label="loc_TRXDShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_TRXDShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice_40" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="trxd-20190630.xsd#TRXD_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGrantsInPeriodWeightedAverageExercisePrice" xlink:label="loc_TRXDShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGrantsInPeriodWeightedAverageExercisePrice_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_TRXDShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGrantsInPeriodWeightedAverageExercisePrice_40" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="trxd-20190630.xsd#TRXD_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitedInPeriodWeightedAverageExercisePrice" xlink:label="loc_TRXDShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitedInPeriodWeightedAverageExercisePrice_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_TRXDShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitedInPeriodWeightedAverageExercisePrice_40" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="trxd-20190630.xsd#TRXD_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisesInPeriodWeightedAverageExercisePrice" xlink:label="loc_TRXDShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisesInPeriodWeightedAverageExercisePrice_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_TRXDShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisesInPeriodWeightedAverageExercisePrice_40" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="trxd-20190630.xsd#TRXD_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageRemainingContractualTermBeginning" xlink:label="loc_TRXDShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageRemainingContractualTermBeginning_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_TRXDShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageRemainingContractualTermBeginning_40" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="trxd-20190630.xsd#TRXD_WeightedAverageRemainingContractualLifeWarrantsOutstandingGranted" xlink:label="loc_TRXDWeightedAverageRemainingContractualLifeWarrantsOutstandingGranted_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_TRXDWeightedAverageRemainingContractualLifeWarrantsOutstandingGranted_40" xlink:type="arc" order="13" />
      <link:loc xlink:type="locator" xlink:href="trxd-20190630.xsd#TRXD_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageRemainingContractualTermEnding" xlink:label="loc_TRXDShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageRemainingContractualTermEnding_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_TRXDShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageRemainingContractualTermEnding_40" xlink:type="arc" order="14" />
      <link:loc xlink:type="locator" xlink:href="trxd-20190630.xsd#TRXD_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingIntrinsicValue" xlink:label="loc_TRXDShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingIntrinsicValue_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_TRXDShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingIntrinsicValue_40" xlink:type="arc" order="16" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://trxadegroup.com/role/Warrants-SummaryOfEstimateFairValueOfWarrantsDetails10-k" xlink:title="00000048 - Disclosure - Warrants - Summary of Estimate the Fair Value of Warrants (Details) (10-K)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaapStatementEquityComponentsAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementEquityComponentsAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_WarrantMember" xlink:label="loc_us-gaapWarrantMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapWarrantMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_MeasurementInputTypeAxis" xlink:label="loc_us-gaapMeasurementInputTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapMeasurementInputTypeAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_MeasurementInputTypeDomain" xlink:label="loc_us-gaapMeasurementInputTypeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapMeasurementInputTypeAxis" xlink:to="loc_us-gaapMeasurementInputTypeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_MeasurementInputTypeDomain" xlink:label="loc_us-gaapMeasurementInputTypeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapMeasurementInputTypeAxis" xlink:to="loc_us-gaapMeasurementInputTypeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_MeasurementInputExpectedDividendRateMember" xlink:label="loc_us-gaapMeasurementInputExpectedDividendRateMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapMeasurementInputTypeDomain" xlink:to="loc_us-gaapMeasurementInputExpectedDividendRateMember_0" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_MeasurementInputPriceVolatilityMember" xlink:label="loc_us-gaapMeasurementInputPriceVolatilityMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapMeasurementInputTypeDomain" xlink:to="loc_us-gaapMeasurementInputPriceVolatilityMember_10" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_MeasurementInputRiskFreeInterestRateMember" xlink:label="loc_us-gaapMeasurementInputRiskFreeInterestRateMember_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapMeasurementInputTypeDomain" xlink:to="loc_us-gaapMeasurementInputRiskFreeInterestRateMember_30" xlink:type="arc" order="32" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_MeasurementInputExpectedTermMember" xlink:label="loc_us-gaapMeasurementInputExpectedTermMember_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapMeasurementInputTypeDomain" xlink:to="loc_us-gaapMeasurementInputExpectedTermMember_50" xlink:type="arc" order="52" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_RangeAxis" xlink:label="loc_srtRangeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_srtRangeAxis" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_RangeMember" xlink:label="loc_srtRangeMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtRangeAxis" xlink:to="loc_srtRangeMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_RangeMember" xlink:label="loc_srtRangeMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtRangeAxis" xlink:to="loc_srtRangeMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_MinimumMember" xlink:label="loc_srtMinimumMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMinimumMember_10" xlink:type="arc" order="13" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_MaximumMember" xlink:label="loc_srtMaximumMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMaximumMember_20" xlink:type="arc" order="23" />
      <link:loc xlink:type="locator" xlink:href="trxd-20190630.xsd#TRXD_FairValueAssumptionsMeasurementInputPercentages" xlink:label="loc_TRXDFairValueAssumptionsMeasurementInputPercentages_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_TRXDFairValueAssumptionsMeasurementInputPercentages_130" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="trxd-20190630.xsd#TRXD_FairValueAssumptionsMeasurementInputTerm" xlink:label="loc_TRXDFairValueAssumptionsMeasurementInputTerm_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_TRXDFairValueAssumptionsMeasurementInputTerm_130" xlink:type="arc" order="1" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://trxadegroup.com/role/OptionsDetailsNarrative" xlink:title="00000049 - Disclosure - Options (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PlanNameAxis" xlink:label="loc_us-gaapPlanNameAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapPlanNameAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PlanNameDomain" xlink:label="loc_us-gaapPlanNameDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapPlanNameAxis" xlink:to="loc_us-gaapPlanNameDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PlanNameDomain" xlink:label="loc_us-gaapPlanNameDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapPlanNameAxis" xlink:to="loc_us-gaapPlanNameDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="trxd-20190630.xsd#TRXD_StockOptionPlanMember" xlink:label="loc_TRXDStockOptionPlanMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPlanNameDomain" xlink:to="loc_TRXDStockOptionPlanMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_TitleOfIndividualAxis" xlink:label="loc_srtTitleOfIndividualAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_srtTitleOfIndividualAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtTitleOfIndividualAxis" xlink:to="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_srtTitleOfIndividualWithRelationshipToEntityDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtTitleOfIndividualAxis" xlink:to="loc_srtTitleOfIndividualWithRelationshipToEntityDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_RangeAxis" xlink:label="loc_srtRangeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_srtRangeAxis" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_RangeMember" xlink:label="loc_srtRangeMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtRangeAxis" xlink:to="loc_srtRangeMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_RangeMember" xlink:label="loc_srtRangeMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtRangeAxis" xlink:to="loc_srtRangeMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ValuationTechniqueAxis" xlink:label="loc_us-gaapValuationTechniqueAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapValuationTechniqueAxis" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ValuationTechniqueDomain" xlink:label="loc_us-gaapValuationTechniqueDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapValuationTechniqueAxis" xlink:to="loc_us-gaapValuationTechniqueDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ValuationTechniqueDomain" xlink:label="loc_us-gaapValuationTechniqueDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapValuationTechniqueAxis" xlink:to="loc_us-gaapValuationTechniqueDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OptionIndexedToIssuersEquityTypeAxis" xlink:label="loc_us-gaapOptionIndexedToIssuersEquityTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapOptionIndexedToIssuersEquityTypeAxis" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OptionIndexedToIssuersEquityTypeDomain" xlink:label="loc_us-gaapOptionIndexedToIssuersEquityTypeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapOptionIndexedToIssuersEquityTypeAxis" xlink:to="loc_us-gaapOptionIndexedToIssuersEquityTypeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OptionIndexedToIssuersEquityTypeDomain" xlink:label="loc_us-gaapOptionIndexedToIssuersEquityTypeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapOptionIndexedToIssuersEquityTypeAxis" xlink:to="loc_us-gaapOptionIndexedToIssuersEquityTypeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_40" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDescription" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardDescription_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardDescription_40" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_40" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_40" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockOptionPlanExpense" xlink:label="loc_us-gaapStockOptionPlanExpense_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockOptionPlanExpense_40" xlink:type="arc" order="4" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://trxadegroup.com/role/OptionsDetailsNarrative10-k" xlink:title="00000050 - Disclosure - Options (Details Narrative) (10-K)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PlanNameAxis" xlink:label="loc_us-gaapPlanNameAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapPlanNameAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PlanNameDomain" xlink:label="loc_us-gaapPlanNameDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapPlanNameAxis" xlink:to="loc_us-gaapPlanNameDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PlanNameDomain" xlink:label="loc_us-gaapPlanNameDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapPlanNameAxis" xlink:to="loc_us-gaapPlanNameDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="trxd-20190630.xsd#TRXD_StockOptionPlanMember" xlink:label="loc_TRXDStockOptionPlanMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapPlanNameDomain" xlink:to="loc_TRXDStockOptionPlanMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_TitleOfIndividualAxis" xlink:label="loc_srtTitleOfIndividualAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_srtTitleOfIndividualAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtTitleOfIndividualAxis" xlink:to="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_srtTitleOfIndividualWithRelationshipToEntityDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtTitleOfIndividualAxis" xlink:to="loc_srtTitleOfIndividualWithRelationshipToEntityDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="trxd-20190630.xsd#TRXD_EmployeeMember" xlink:label="loc_TRXDEmployeeMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_TRXDEmployeeMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_RangeAxis" xlink:label="loc_srtRangeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_srtRangeAxis" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_RangeMember" xlink:label="loc_srtRangeMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtRangeAxis" xlink:to="loc_srtRangeMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_RangeMember" xlink:label="loc_srtRangeMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtRangeAxis" xlink:to="loc_srtRangeMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_MinimumMember" xlink:label="loc_srtMinimumMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMinimumMember_10" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_MaximumMember" xlink:label="loc_srtMaximumMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMaximumMember_20" xlink:type="arc" order="22" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ValuationTechniqueAxis" xlink:label="loc_us-gaapValuationTechniqueAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapValuationTechniqueAxis" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ValuationTechniqueDomain" xlink:label="loc_us-gaapValuationTechniqueDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapValuationTechniqueAxis" xlink:to="loc_us-gaapValuationTechniqueDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ValuationTechniqueDomain" xlink:label="loc_us-gaapValuationTechniqueDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapValuationTechniqueAxis" xlink:to="loc_us-gaapValuationTechniqueDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ValuationTechniqueOptionPricingModelMember" xlink:label="loc_us-gaapValuationTechniqueOptionPricingModelMember_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapValuationTechniqueDomain" xlink:to="loc_us-gaapValuationTechniqueOptionPricingModelMember_70" xlink:type="arc" order="71" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OptionIndexedToIssuersEquityTypeAxis" xlink:label="loc_us-gaapOptionIndexedToIssuersEquityTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapOptionIndexedToIssuersEquityTypeAxis" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OptionIndexedToIssuersEquityTypeDomain" xlink:label="loc_us-gaapOptionIndexedToIssuersEquityTypeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapOptionIndexedToIssuersEquityTypeAxis" xlink:to="loc_us-gaapOptionIndexedToIssuersEquityTypeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OptionIndexedToIssuersEquityTypeDomain" xlink:label="loc_us-gaapOptionIndexedToIssuersEquityTypeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapOptionIndexedToIssuersEquityTypeAxis" xlink:to="loc_us-gaapOptionIndexedToIssuersEquityTypeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="trxd-20190630.xsd#TRXD_FourOptionGrantedMember" xlink:label="loc_TRXDFourOptionGrantedMember_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapOptionIndexedToIssuersEquityTypeDomain" xlink:to="loc_TRXDFourOptionGrantedMember_100" xlink:type="arc" order="101" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDescription" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardDescription_160" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardDescription_160" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_160" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_160" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_160" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_160" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit" xlink:label="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit_160" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit_160" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit" xlink:label="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit_160" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit_160" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_160" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_160" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate_160" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate_160" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="trxd-20190630.xsd#TRXD_FairValueOfOptionGranted" xlink:label="loc_TRXDFairValueOfOptionGranted_160" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_TRXDFairValueOfOptionGranted_160" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingRights" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingRights_160" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingRights_160" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockOptionPlanExpense" xlink:label="loc_us-gaapStockOptionPlanExpense_160" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockOptionPlanExpense_160" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:label="loc_us-gaapEmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_160" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapEmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_160" xlink:type="arc" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_160" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_160" xlink:type="arc" order="11" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://trxadegroup.com/role/Options-ScheduleOfEstimateFairValueOfStockOptionsDetails" xlink:title="00000051 - Disclosure - Options - Schedule of Estimate the Fair Value of Stock Options (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_RangeAxis" xlink:label="loc_srtRangeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_srtRangeAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_RangeMember" xlink:label="loc_srtRangeMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtRangeAxis" xlink:to="loc_srtRangeMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_RangeMember" xlink:label="loc_srtRangeMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtRangeAxis" xlink:to="loc_srtRangeMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_MinimumMember" xlink:label="loc_srtMinimumMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMinimumMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_MaximumMember" xlink:label="loc_srtMaximumMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMaximumMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_100" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum_100" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_100" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_100" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_100" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_100" xlink:type="arc" order="6" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://trxadegroup.com/role/Options-ScheduleOfStockOptionActivityDetails" xlink:title="00000052 - Disclosure - Options - Schedule of Stock Option Activity (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://trxadegroup.com/role/LeasesDetailsNarrative" xlink:title="00000053 - Disclosure - Leases (Details Narrative)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://trxadegroup.com/role/Leases-ScheduleOfOperatingLeasesDetails" xlink:title="00000054 - Disclosure - Leases - Schedule of Operating Leases (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LeaseArrangementTypeAxis" xlink:label="loc_us-gaapLeaseArrangementTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapLeaseArrangementTypeAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LeaseArrangementTypeDomain" xlink:label="loc_us-gaapLeaseArrangementTypeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapLeaseArrangementTypeAxis" xlink:to="loc_us-gaapLeaseArrangementTypeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LeaseArrangementTypeDomain" xlink:label="loc_us-gaapLeaseArrangementTypeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapLeaseArrangementTypeAxis" xlink:to="loc_us-gaapLeaseArrangementTypeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="trxd-20190630.xsd#TRXD_LeaseOneMember" xlink:label="loc_TRXDLeaseOneMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLeaseArrangementTypeDomain" xlink:to="loc_TRXDLeaseOneMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="trxd-20190630.xsd#TRXD_LeaseTwoMember" xlink:label="loc_TRXDLeaseTwoMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapLeaseArrangementTypeDomain" xlink:to="loc_TRXDLeaseTwoMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="trxd-20190630.xsd#TRXD_OperatingLeaseInitialLeaseTerm" xlink:label="loc_TRXDOperatingLeaseInitialLeaseTerm_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_TRXDOperatingLeaseInitialLeaseTerm_50" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="trxd-20190630.xsd#TRXD_OperatingLeaseRenewalTerm" xlink:label="loc_TRXDOperatingLeaseRenewalTerm_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_TRXDOperatingLeaseRenewalTerm_50" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset" xlink:label="loc_us-gaapOperatingLeaseRightOfUseAsset_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapOperatingLeaseRightOfUseAsset_50" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LesseeOperatingLeaseDiscountRate" xlink:label="loc_us-gaapLesseeOperatingLeaseDiscountRate_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapLesseeOperatingLeaseDiscountRate_50" xlink:type="arc" order="4" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://trxadegroup.com/role/Leases-ScheduleOfFutureMinimumPaymentsForOperatingLeaseLiabilitiesDetails" xlink:title="00000055 - Disclosure - Leases - Schedule of Future Minimum Payments for Operating Lease Liabilities (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://trxadegroup.com/role/IncomeTaxesDetailsNarrative10-k" xlink:title="00000056 - Disclosure - Income Taxes (Details Narrative) (10-K)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://trxadegroup.com/role/IncomeTaxes-ScheduleOfDeferredTaxAssetsDetails10-k" xlink:title="00000057 - Disclosure - Income Taxes - Schedule of Deferred Tax Assets (Details) (10-K)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://trxadegroup.com/role/RelatedPartiesDetailsNarrative10-k" xlink:title="00000058 - Disclosure - Related Parties (Details Narrative) (10-K)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaapRelatedPartyDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:to="loc_us-gaapRelatedPartyDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaapRelatedPartyDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:to="loc_us-gaapRelatedPartyDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="trxd-20190630.xsd#TRXD_MrSurenAjjarapuMember" xlink:label="loc_TRXDMrSurenAjjarapuMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_TRXDMrSurenAjjarapuMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="trxd-20190630.xsd#TRXD_MrPrashantPatelMember" xlink:label="loc_TRXDMrPrashantPatelMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_TRXDMrPrashantPatelMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_LegalEntityAxis" xlink:label="loc_deiLegalEntityAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_deiLegalEntityAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="trxd-20190630.xsd#TRXD_CommunitySpecialtyPharmacyLLCMember" xlink:label="loc_TRXDCommunitySpecialtyPharmacyLLCMember_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityDomain" xlink:to="loc_TRXDCommunitySpecialtyPharmacyLLCMember_60" xlink:type="arc" order="61" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OfficersCompensation" xlink:label="loc_us-gaapOfficersCompensation_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapOfficersCompensation_90" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DueToRelatedPartiesCurrentAndNoncurrent" xlink:label="loc_us-gaapDueToRelatedPartiesCurrentAndNoncurrent_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDueToRelatedPartiesCurrentAndNoncurrent_90" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ConvertibleNotesPayable" xlink:label="loc_us-gaapConvertibleNotesPayable_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapConvertibleNotesPayable_90" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentMaturityDate" xlink:label="loc_us-gaapDebtInstrumentMaturityDate_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDebtInstrumentMaturityDate_90" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:label="loc_us-gaapDebtInstrumentInterestRateStatedPercentage_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDebtInstrumentInterestRateStatedPercentage_90" xlink:type="arc" order="4" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://trxadegroup.com/role/CommitmentsAndContingenciesDetailsNarrative10-k" xlink:title="00000059 - Disclosure - Commitments and Contingencies (Details Narrative) (10-K)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://trxadegroup.com/role/CommitmentsAndContingencies-ScheduleOfFutureMinimumRentalPaymentsUnderNon-cancelableOperatingLeasesDetails10-k" xlink:title="00000060 - Disclosure - Commitments and Contingencies - Schedule of Future Minimum Rental Payments Under Non-cancelable Operating Leases (Details) (10-K)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://trxadegroup.com/role/SegmentReporting-ScheduleOfBusinessInterestsIntoReportableSegmentsDetails" xlink:title="00000061 - Disclosure - Segment Reporting - Schedule of Business Interests Into Reportable Segments (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis" xlink:label="loc_us-gaapStatementBusinessSegmentsAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementBusinessSegmentsAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SegmentDomain" xlink:label="loc_us-gaapSegmentDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementBusinessSegmentsAxis" xlink:to="loc_us-gaapSegmentDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SegmentDomain" xlink:label="loc_us-gaapSegmentDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementBusinessSegmentsAxis" xlink:to="loc_us-gaapSegmentDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="trxd-20190630.xsd#TRXD_TrxadeIncMember" xlink:label="loc_TRXDTrxadeIncMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSegmentDomain" xlink:to="loc_TRXDTrxadeIncMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="trxd-20190630.xsd#TRXD_CommunitySpecialtyPharmacyLLCMember" xlink:label="loc_TRXDCommunitySpecialtyPharmacyLLCMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSegmentDomain" xlink:to="loc_TRXDCommunitySpecialtyPharmacyLLCMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="trxd-20190630.xsd#TRXD_OtherMember" xlink:label="loc_TRXDOtherMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSegmentDomain" xlink:to="loc_TRXDOtherMember_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:label="loc_us-gaapRevenueFromContractWithCustomerExcludingAssessedTax_150" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapRevenueFromContractWithCustomerExcludingAssessedTax_150" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_GrossProfit" xlink:label="loc_us-gaapGrossProfit_150" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapGrossProfit_150" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_Assets" xlink:label="loc_us-gaapAssets_150" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapAssets_150" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ProfitLoss" xlink:label="loc_us-gaapProfitLoss_150" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapProfitLoss_150" xlink:type="arc" order="4" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://trxadegroup.com/role/BusinessCombinationDetailsNarrative" xlink:title="00000062 - Disclosure - Business Combination (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_LegalEntityAxis" xlink:label="loc_deiLegalEntityAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_deiLegalEntityAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="trxd-20190630.xsd#TRXD_CommunitySpecialtyPharmacyLLCMember" xlink:label="loc_TRXDCommunitySpecialtyPharmacyLLCMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityDomain" xlink:to="loc_TRXDCommunitySpecialtyPharmacyLLCMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:label="loc_us-gaapEquityMethodInvestmentOwnershipPercentage_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapEquityMethodInvestmentOwnershipPercentage_30" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesGross" xlink:label="loc_us-gaapPaymentsToAcquireBusinessesGross_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapPaymentsToAcquireBusinessesGross_30" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NotesPayable" xlink:label="loc_us-gaapNotesPayable_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapNotesPayable_30" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:label="loc_us-gaapClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_30" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_WarrantsAndRightsOutstandingTerm" xlink:label="loc_us-gaapWarrantsAndRightsOutstandingTerm_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapWarrantsAndRightsOutstandingTerm_30" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:label="loc_us-gaapClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_30" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="trxd-20190630.xsd#TRXD_ExerciseRestrictionsLapsePeriod" xlink:label="loc_TRXDExerciseRestrictionsLapsePeriod_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_TRXDExerciseRestrictionsLapsePeriod_30" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_Goodwill" xlink:label="loc_us-gaapGoodwill_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapGoodwill_30" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferred1" xlink:label="loc_us-gaapBusinessCombinationConsiderationTransferred1_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapBusinessCombinationConsiderationTransferred1_30" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_WarrantsNotSettleableInCashFairValueDisclosure" xlink:label="loc_us-gaapWarrantsNotSettleableInCashFairValueDisclosure_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapWarrantsNotSettleableInCashFairValueDisclosure_30" xlink:type="arc" order="9" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://trxadegroup.com/role/BusinessCombinationDetailsNarrative10-k" xlink:title="00000063 - Disclosure - Business Combination (Details Narrative) (10-K)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_LegalEntityAxis" xlink:label="loc_deiLegalEntityAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_deiLegalEntityAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="trxd-20190630.xsd#TRXD_CommunitySpecialtyPharmacyLLCMember" xlink:label="loc_TRXDCommunitySpecialtyPharmacyLLCMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityDomain" xlink:to="loc_TRXDCommunitySpecialtyPharmacyLLCMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:label="loc_us-gaapEquityMethodInvestmentOwnershipPercentage_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapEquityMethodInvestmentOwnershipPercentage_30" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesGross" xlink:label="loc_us-gaapPaymentsToAcquireBusinessesGross_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapPaymentsToAcquireBusinessesGross_30" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NotesPayable" xlink:label="loc_us-gaapNotesPayable_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapNotesPayable_30" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:label="loc_us-gaapClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_30" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_WarrantsAndRightsOutstandingTerm" xlink:label="loc_us-gaapWarrantsAndRightsOutstandingTerm_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapWarrantsAndRightsOutstandingTerm_30" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:label="loc_us-gaapClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_30" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="trxd-20190630.xsd#TRXD_ExerciseRestrictionsLapsePeriod" xlink:label="loc_TRXDExerciseRestrictionsLapsePeriod_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_TRXDExerciseRestrictionsLapsePeriod_30" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_Goodwill" xlink:label="loc_us-gaapGoodwill_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapGoodwill_30" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferred1" xlink:label="loc_us-gaapBusinessCombinationConsiderationTransferred1_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapBusinessCombinationConsiderationTransferred1_30" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AssetsFairValueDisclosure" xlink:label="loc_us-gaapAssetsFairValueDisclosure_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapAssetsFairValueDisclosure_30" xlink:type="arc" order="9" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://trxadegroup.com/role/BusinessCombination-ScheduleOfAssetsAcquiredAndLiabilitiesAssumedDetails" xlink:title="00000064 - Disclosure - Business Combination - Schedule of Assets Acquired and Liabilities Assumed (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_LegalEntityAxis" xlink:label="loc_deiLegalEntityAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_deiLegalEntityAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="trxd-20190630.xsd#TRXD_CommunitySpecialtyPharmacyLLCMember" xlink:label="loc_TRXDCommunitySpecialtyPharmacyLLCMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityDomain" xlink:to="loc_TRXDCommunitySpecialtyPharmacyLLCMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferred1" xlink:label="loc_us-gaapBusinessCombinationConsiderationTransferred1_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapBusinessCombinationConsiderationTransferred1_30" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" xlink:label="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_30" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" xlink:label="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_30" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" xlink:label="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_30" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets" xlink:label="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets_30" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" xlink:label="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_30" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther" xlink:label="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther_30" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_Goodwill" xlink:label="loc_us-gaapGoodwill_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapGoodwill_30" xlink:type="arc" order="7" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://trxadegroup.com/role/BusinessCombination-ScheduleOfUnauditedProFormaStatementsOfOperationsDetails" xlink:title="00000065 - Disclosure - Business Combination - Schedule of Unaudited Pro Forma Statements of Operations (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_LegalEntityAxis" xlink:label="loc_deiLegalEntityAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_deiLegalEntityAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="trxd-20190630.xsd#TRXD_TrxadeMember" xlink:label="loc_TRXDTrxadeMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityDomain" xlink:to="loc_TRXDTrxadeMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="trxd-20190630.xsd#TRXD_CommunitySpecialtyPharmacyLLCMember" xlink:label="loc_TRXDCommunitySpecialtyPharmacyLLCMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityDomain" xlink:to="loc_TRXDCommunitySpecialtyPharmacyLLCMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessAcquisitionsProFormaRevenue" xlink:label="loc_us-gaapBusinessAcquisitionsProFormaRevenue_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapBusinessAcquisitionsProFormaRevenue_130" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss" xlink:label="loc_us-gaapBusinessAcquisitionsProFormaNetIncomeLoss_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapBusinessAcquisitionsProFormaNetIncomeLoss_130" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessAcquisitionProFormaEarningsPerShareBasic" xlink:label="loc_us-gaapBusinessAcquisitionProFormaEarningsPerShareBasic_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapBusinessAcquisitionProFormaEarningsPerShareBasic_130" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessAcquisitionProFormaEarningsPerShareDiluted" xlink:label="loc_us-gaapBusinessAcquisitionProFormaEarningsPerShareDiluted_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapBusinessAcquisitionProFormaEarningsPerShareDiluted_130" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_WeightedAverageBasicSharesOutstandingProForma" xlink:label="loc_us-gaapWeightedAverageBasicSharesOutstandingProForma_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapWeightedAverageBasicSharesOutstandingProForma_130" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ProFormaWeightedAverageSharesOutstandingDiluted" xlink:label="loc_us-gaapProFormaWeightedAverageSharesOutstandingDiluted_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapProFormaWeightedAverageSharesOutstandingDiluted_130" xlink:type="arc" order="6" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://trxadegroup.com/role/EquityMethodInvestmentDetailsNarrative" xlink:title="00000066 - Disclosure - Equity Method Investment (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_LegalEntityAxis" xlink:label="loc_deiLegalEntityAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_deiLegalEntityAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="trxd-20190630.xsd#TRXD_AlliancePharmaSolutionLLCMember" xlink:label="loc_TRXDAlliancePharmaSolutionLLCMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityDomain" xlink:to="loc_TRXDAlliancePharmaSolutionLLCMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="trxd-20190630.xsd#TRXD_PanOpticHealthLLCMember" xlink:label="loc_TRXDPanOpticHealthLLCMember_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityDomain" xlink:to="loc_TRXDPanOpticHealthLLCMember_30" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_OwnershipAxis" xlink:label="loc_srtOwnershipAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_srtOwnershipAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_OwnershipDomain" xlink:label="loc_srtOwnershipDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtOwnershipAxis" xlink:to="loc_srtOwnershipDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_OwnershipDomain" xlink:label="loc_srtOwnershipDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtOwnershipAxis" xlink:to="loc_srtOwnershipDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="trxd-20190630.xsd#TRXD_SyncHealthMSOLLCMember" xlink:label="loc_TRXDSyncHealthMSOLLCMember_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtOwnershipDomain" xlink:to="loc_TRXDSyncHealthMSOLLCMember_30" xlink:type="arc" order="32" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_StatementScenarioAxis" xlink:label="loc_srtStatementScenarioAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_srtStatementScenarioAxis" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_ScenarioUnspecifiedDomain" xlink:label="loc_srtScenarioUnspecifiedDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtStatementScenarioAxis" xlink:to="loc_srtScenarioUnspecifiedDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_ScenarioUnspecifiedDomain" xlink:label="loc_srtScenarioUnspecifiedDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtStatementScenarioAxis" xlink:to="loc_srtScenarioUnspecifiedDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_ScenarioForecastMember" xlink:label="loc_srtScenarioForecastMember_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtScenarioUnspecifiedDomain" xlink:to="loc_srtScenarioForecastMember_60" xlink:type="arc" order="62" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AwardDateAxis" xlink:label="loc_us-gaapAwardDateAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapAwardDateAxis" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AwardDateDomain" xlink:label="loc_us-gaapAwardDateDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapAwardDateAxis" xlink:to="loc_us-gaapAwardDateDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AwardDateDomain" xlink:label="loc_us-gaapAwardDateDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapAwardDateAxis" xlink:to="loc_us-gaapAwardDateDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_RangeAxis" xlink:label="loc_srtRangeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_srtRangeAxis" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_RangeMember" xlink:label="loc_srtRangeMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtRangeAxis" xlink:to="loc_srtRangeMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_RangeMember" xlink:label="loc_srtRangeMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtRangeAxis" xlink:to="loc_srtRangeMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_MinimumMember" xlink:label="loc_srtMinimumMember_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMinimumMember_90" xlink:type="arc" order="91" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_MaximumMember" xlink:label="loc_srtMaximumMember_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMaximumMember_100" xlink:type="arc" order="101" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesAndInterestInAffiliates" xlink:label="loc_us-gaapPaymentsToAcquireBusinessesAndInterestInAffiliates_140" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapPaymentsToAcquireBusinessesAndInterestInAffiliates_140" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:label="loc_us-gaapEquityMethodInvestmentOwnershipPercentage_140" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapEquityMethodInvestmentOwnershipPercentage_140" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PaymentsForProceedsFromInvestments" xlink:label="loc_us-gaapPaymentsForProceedsFromInvestments_140" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapPaymentsForProceedsFromInvestments_140" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues_140" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues_140" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeLossFromEquityMethodInvestments" xlink:label="loc_us-gaapIncomeLossFromEquityMethodInvestments_140" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapIncomeLossFromEquityMethodInvestments_140" xlink:type="arc" order="5" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://trxadegroup.com/role/SubsequentEventsDetailsNarrative" xlink:title="00000067 - Disclosure - Subsequent Events (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="loc_us-gaapSubsequentEventTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapSubsequentEventTypeAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="loc_us-gaapSubsequentEventTypeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapSubsequentEventTypeAxis" xlink:to="loc_us-gaapSubsequentEventTypeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="loc_us-gaapSubsequentEventTypeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapSubsequentEventTypeAxis" xlink:to="loc_us-gaapSubsequentEventTypeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SubsequentEventMember" xlink:label="loc_us-gaapSubsequentEventMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsequentEventTypeDomain" xlink:to="loc_us-gaapSubsequentEventMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="loc_us-gaapTypeOfArrangementAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapTypeOfArrangementAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapTypeOfArrangementAxis" xlink:to="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="loc_us-gaapArrangementsAndNonarrangementTransactionsMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapTypeOfArrangementAxis" xlink:to="loc_us-gaapArrangementsAndNonarrangementTransactionsMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="trxd-20190630.xsd#TRXD_SecuritiesPurchaseAgreementMember" xlink:label="loc_TRXDSecuritiesPurchaseAgreementMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_TRXDSecuritiesPurchaseAgreementMember_0" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="trxd-20190630.xsd#TRXD_ConsultingAgreementMember" xlink:label="loc_TRXDConsultingAgreementMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_TRXDConsultingAgreementMember_20" xlink:type="arc" order="22" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaapRelatedPartyDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:to="loc_us-gaapRelatedPartyDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaapRelatedPartyDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:to="loc_us-gaapRelatedPartyDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="trxd-20190630.xsd#TRXD_AccreditedInvestorMember" xlink:label="loc_TRXDAccreditedInvestorMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_TRXDAccreditedInvestorMember_0" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="trxd-20190630.xsd#TRXD_MrPrashantPatelMember" xlink:label="loc_TRXDMrPrashantPatelMember_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_TRXDMrPrashantPatelMember_90" xlink:type="arc" order="93" />
      <link:loc xlink:type="locator" xlink:href="trxd-20190630.xsd#TRXD_MrSurenAjjarapuMember" xlink:label="loc_TRXDMrSurenAjjarapuMember_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_TRXDMrSurenAjjarapuMember_100" xlink:type="arc" order="103" />
      <link:loc xlink:type="locator" xlink:href="trxd-20190630.xsd#TRXD_MrPrashantPatelAndMrSurenAjjarapuMember" xlink:label="loc_TRXDMrPrashantPatelAndMrSurenAjjarapuMember_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_TRXDMrPrashantPatelAndMrSurenAjjarapuMember_110" xlink:type="arc" order="113" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_StatementScenarioAxis" xlink:label="loc_srtStatementScenarioAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_srtStatementScenarioAxis" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_ScenarioUnspecifiedDomain" xlink:label="loc_srtScenarioUnspecifiedDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtStatementScenarioAxis" xlink:to="loc_srtScenarioUnspecifiedDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_ScenarioUnspecifiedDomain" xlink:label="loc_srtScenarioUnspecifiedDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtStatementScenarioAxis" xlink:to="loc_srtScenarioUnspecifiedDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_ScenarioForecastMember" xlink:label="loc_srtScenarioForecastMember_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtScenarioUnspecifiedDomain" xlink:to="loc_srtScenarioForecastMember_30" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentAxis" xlink:label="loc_us-gaapDebtInstrumentAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapDebtInstrumentAxis" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="loc_us-gaapDebtInstrumentNameDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapDebtInstrumentAxis" xlink:to="loc_us-gaapDebtInstrumentNameDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="loc_us-gaapDebtInstrumentNameDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapDebtInstrumentAxis" xlink:to="loc_us-gaapDebtInstrumentNameDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="trxd-20190630.xsd#TRXD_PromissoryNotesMember" xlink:label="loc_TRXDPromissoryNotesMember_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDebtInstrumentNameDomain" xlink:to="loc_TRXDPromissoryNotesMember_70" xlink:type="arc" order="73" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues_130" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SharesIssuedPricePerShare" xlink:label="loc_us-gaapSharesIssuedPricePerShare_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSharesIssuedPricePerShare_130" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ProceedsFromIssuanceOfPrivatePlacement" xlink:label="loc_us-gaapProceedsFromIssuanceOfPrivatePlacement_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapProceedsFromIssuanceOfPrivatePlacement_130" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:label="loc_us-gaapClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_130" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:label="loc_us-gaapClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_130" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="trxd-20190630.xsd#TRXD_ClassOfWarrantOrRightNumberOfSecuritiesExercisableByWarrantsOrRights" xlink:label="loc_TRXDClassOfWarrantOrRightNumberOfSecuritiesExercisableByWarrantsOrRights_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_TRXDClassOfWarrantOrRightNumberOfSecuritiesExercisableByWarrantsOrRights_130" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtConversionConvertedInstrumentAmount1" xlink:label="loc_us-gaapDebtConversionConvertedInstrumentAmount1_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDebtConversionConvertedInstrumentAmount1_130" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtConversionConvertedInstrumentSharesIssued1" xlink:label="loc_us-gaapDebtConversionConvertedInstrumentSharesIssued1_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDebtConversionConvertedInstrumentSharesIssued1_130" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentConvertibleConversionPrice1" xlink:label="loc_us-gaapDebtInstrumentConvertibleConversionPrice1_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDebtInstrumentConvertibleConversionPrice1_130" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RepaymentsOfRelatedPartyDebt" xlink:label="loc_us-gaapRepaymentsOfRelatedPartyDebt_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapRepaymentsOfRelatedPartyDebt_130" xlink:type="arc" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentMaturityDate" xlink:label="loc_us-gaapDebtInstrumentMaturityDate_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDebtInstrumentMaturityDate_130" xlink:type="arc" order="11" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://trxadegroup.com/role/SubsequentEventsDetailsNarrative10-k" xlink:title="00000068 - Disclosure - Subsequent Events (Details Narrative) (10-K)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="loc_us-gaapSubsequentEventTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapSubsequentEventTypeAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="loc_us-gaapSubsequentEventTypeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapSubsequentEventTypeAxis" xlink:to="loc_us-gaapSubsequentEventTypeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="loc_us-gaapSubsequentEventTypeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapSubsequentEventTypeAxis" xlink:to="loc_us-gaapSubsequentEventTypeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SubsequentEventMember" xlink:label="loc_us-gaapSubsequentEventMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsequentEventTypeDomain" xlink:to="loc_us-gaapSubsequentEventMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_LegalEntityAxis" xlink:label="loc_deiLegalEntityAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_deiLegalEntityAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="trxd-20190630.xsd#TRXD_AlliancePharmaSolutionLLCMember" xlink:label="loc_TRXDAlliancePharmaSolutionLLCMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityDomain" xlink:to="loc_TRXDAlliancePharmaSolutionLLCMember_0" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="trxd-20190630.xsd#TRXD_PanOpticHealthLLCMember" xlink:label="loc_TRXDPanOpticHealthLLCMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityDomain" xlink:to="loc_TRXDPanOpticHealthLLCMember_20" xlink:type="arc" order="22" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_OwnershipAxis" xlink:label="loc_srtOwnershipAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_srtOwnershipAxis" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_OwnershipDomain" xlink:label="loc_srtOwnershipDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtOwnershipAxis" xlink:to="loc_srtOwnershipDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_OwnershipDomain" xlink:label="loc_srtOwnershipDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtOwnershipAxis" xlink:to="loc_srtOwnershipDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="trxd-20190630.xsd#TRXD_SyncHealthMSOLLCMember" xlink:label="loc_TRXDSyncHealthMSOLLCMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtOwnershipDomain" xlink:to="loc_TRXDSyncHealthMSOLLCMember_20" xlink:type="arc" order="23" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AwardDateAxis" xlink:label="loc_us-gaapAwardDateAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapAwardDateAxis" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AwardDateDomain" xlink:label="loc_us-gaapAwardDateDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapAwardDateAxis" xlink:to="loc_us-gaapAwardDateDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AwardDateDomain" xlink:label="loc_us-gaapAwardDateDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapAwardDateAxis" xlink:to="loc_us-gaapAwardDateDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="trxd-20190630.xsd#TRXD_MayOneTwoThousandNineteenMember" xlink:label="loc_TRXDMayOneTwoThousandNineteenMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAwardDateDomain" xlink:to="loc_TRXDMayOneTwoThousandNineteenMember_40" xlink:type="arc" order="43" />
      <link:loc xlink:type="locator" xlink:href="trxd-20190630.xsd#TRXD_AugustOneTwoThousandNineteenMember" xlink:label="loc_TRXDAugustOneTwoThousandNineteenMember_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAwardDateDomain" xlink:to="loc_TRXDAugustOneTwoThousandNineteenMember_50" xlink:type="arc" order="53" />
      <link:loc xlink:type="locator" xlink:href="trxd-20190630.xsd#TRXD_NovemberOneTwoThousandNineteenMember" xlink:label="loc_TRXDNovemberOneTwoThousandNineteenMember_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAwardDateDomain" xlink:to="loc_TRXDNovemberOneTwoThousandNineteenMember_60" xlink:type="arc" order="63" />
      <link:loc xlink:type="locator" xlink:href="trxd-20190630.xsd#TRXD_JanuaryThortyOneTwoThousandTwentyMember" xlink:label="loc_TRXDJanuaryThortyOneTwoThousandTwentyMember_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAwardDateDomain" xlink:to="loc_TRXDJanuaryThortyOneTwoThousandTwentyMember_70" xlink:type="arc" order="73" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_RangeAxis" xlink:label="loc_srtRangeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_srtRangeAxis" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_RangeMember" xlink:label="loc_srtRangeMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtRangeAxis" xlink:to="loc_srtRangeMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_RangeMember" xlink:label="loc_srtRangeMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtRangeAxis" xlink:to="loc_srtRangeMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_MaximumMember" xlink:label="loc_srtMaximumMember_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMaximumMember_110" xlink:type="arc" order="112" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_MinimumMember" xlink:label="loc_srtMinimumMember_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMinimumMember_120" xlink:type="arc" order="122" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" xlink:label="loc_us-gaapBusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_150" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapBusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_150" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:label="loc_us-gaapEquityMethodInvestmentOwnershipPercentage_150" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapEquityMethodInvestmentOwnershipPercentage_150" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferred1" xlink:label="loc_us-gaapBusinessCombinationConsiderationTransferred1_150" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapBusinessCombinationConsiderationTransferred1_150" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentFaceAmount" xlink:label="loc_us-gaapDebtInstrumentFaceAmount_150" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDebtInstrumentFaceAmount_150" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentConvertibleConversionPrice1" xlink:label="loc_us-gaapDebtInstrumentConvertibleConversionPrice1_150" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDebtInstrumentConvertibleConversionPrice1_150" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NotesPayable" xlink:label="loc_us-gaapNotesPayable_150" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapNotesPayable_150" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtConversionConvertedInstrumentSharesIssued1" xlink:label="loc_us-gaapDebtConversionConvertedInstrumentSharesIssued1_150" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDebtConversionConvertedInstrumentSharesIssued1_150" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="trxd-20190630.xsd#TRXD_WarrantsIssued" xlink:label="loc_TRXDWarrantsIssued_150" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_TRXDWarrantsIssued_150" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:label="loc_us-gaapClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_150" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_150" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ConversionOfStockSharesConverted1" xlink:label="loc_us-gaapConversionOfStockSharesConverted1_150" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapConversionOfStockSharesConverted1_150" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ConversionOfStockAmountConverted1" xlink:label="loc_us-gaapConversionOfStockAmountConverted1_150" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapConversionOfStockAmountConverted1_150" xlink:type="arc" order="10" />
    </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>21
<FILENAME>trxd-20190630_lab.xml
<DESCRIPTION>XBRL LABEL FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.1b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: http://www.novaworks.co -->
    <!-- Field: Doc-Info; Name: Source; Value: TRXD 20190630 S%2D1 DFN.xfr; Date: 2019%2D10%2D15T18:00:38Z -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" roleURI="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" roleURI="http://www.xbrl.org/2009/role/netLabel" />
    <link:labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentAxis" xlink:label="us-gaap_DebtInstrumentAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentAxis" xlink:to="us-gaap_DebtInstrumentAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentAxis_lbl" xml:lang="en-US">Debt Instrument [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="trxd-20190630.xsd#TRXD_PromissoryNoteMember" xlink:label="TRXD_PromissoryNoteMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="TRXD_PromissoryNoteMember" xlink:to="TRXD_PromissoryNoteMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="TRXD_PromissoryNoteMember_lbl" xml:lang="en-US">Promissory Note [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="trxd-20190630.xsd#TRXD_RelatedPartyConvertiblePromissoryNoteMember" xlink:label="TRXD_RelatedPartyConvertiblePromissoryNoteMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="TRXD_RelatedPartyConvertiblePromissoryNoteMember" xlink:to="TRXD_RelatedPartyConvertiblePromissoryNoteMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="TRXD_RelatedPartyConvertiblePromissoryNoteMember_lbl" xml:lang="en-US">Related Party Convertible Promissory Note [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_lbl" xml:lang="en-US">Related Party [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="trxd-20190630.xsd#TRXD_MrShilpaPatelMember" xlink:label="TRXD_MrShilpaPatelMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="TRXD_MrShilpaPatelMember" xlink:to="TRXD_MrShilpaPatelMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="TRXD_MrShilpaPatelMember_lbl" xml:lang="en-US">Mr. Shilpa Patel [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="trxd-20190630.xsd#TRXD_MrNitilPatelMember" xlink:label="TRXD_MrNitilPatelMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="TRXD_MrNitilPatelMember" xlink:to="TRXD_MrNitilPatelMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="TRXD_MrNitilPatelMember_lbl" xml:lang="en-US">Mr. Nitel Patel [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="trxd-20190630.xsd#TRXD_ShortTermRelatedPartyConvertibleNotesMember" xlink:label="TRXD_ShortTermRelatedPartyConvertibleNotesMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="TRXD_ShortTermRelatedPartyConvertibleNotesMember" xlink:to="TRXD_ShortTermRelatedPartyConvertibleNotesMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="TRXD_ShortTermRelatedPartyConvertibleNotesMember_lbl" xml:lang="en-US">Short-term Related Party Convertible Notes [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LegalEntityAxis" xlink:to="dei_LegalEntityAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_LegalEntityAxis_lbl" xml:lang="en-US">Legal Entity [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="trxd-20190630.xsd#TRXD_CommunitySpecialtyPharmacyLLCMember" xlink:label="TRXD_CommunitySpecialtyPharmacyLLCMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="TRXD_CommunitySpecialtyPharmacyLLCMember" xlink:to="TRXD_CommunitySpecialtyPharmacyLLCMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="TRXD_CommunitySpecialtyPharmacyLLCMember_lbl" xml:lang="en-US">Community Specialty Pharmacy, LLC [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="trxd-20190630.xsd#TRXD_MrPrashantPatelMember" xlink:label="TRXD_MrPrashantPatelMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="TRXD_MrPrashantPatelMember" xlink:to="TRXD_MrPrashantPatelMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="TRXD_MrPrashantPatelMember_lbl" xml:lang="en-US">Mr. Prashant Patel [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="trxd-20190630.xsd#TRXD_MrSurenAjjarapuMember" xlink:label="TRXD_MrSurenAjjarapuMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="TRXD_MrSurenAjjarapuMember" xlink:to="TRXD_MrSurenAjjarapuMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="TRXD_MrSurenAjjarapuMember_lbl" xml:lang="en-US">Mr. Suren Ajjarapu [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PlanNameAxis" xlink:label="us-gaap_PlanNameAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PlanNameAxis" xlink:to="us-gaap_PlanNameAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PlanNameAxis_lbl" xml:lang="en-US">Plan Name [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="trxd-20190630.xsd#TRXD_PrivateOfferMemorandumMember" xlink:label="TRXD_PrivateOfferMemorandumMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="TRXD_PrivateOfferMemorandumMember" xlink:to="TRXD_PrivateOfferMemorandumMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="TRXD_PrivateOfferMemorandumMember_lbl" xml:lang="en-US">Private Offer Memorandum [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="trxd-20190630.xsd#TRXD_ConvertiblePromissoryNoteMember" xlink:label="TRXD_ConvertiblePromissoryNoteMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="TRXD_ConvertiblePromissoryNoteMember" xlink:to="TRXD_ConvertiblePromissoryNoteMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="TRXD_ConvertiblePromissoryNoteMember_lbl" xml:lang="en-US">Convertible Promissory Note [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="us-gaap_StatementEquityComponentsAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_StatementEquityComponentsAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementEquityComponentsAxis_lbl" xml:lang="en-US">Equity Components [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_WarrantMember" xlink:label="us-gaap_WarrantMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WarrantMember" xlink:to="us-gaap_WarrantMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_WarrantMember_lbl" xml:lang="en-US">Warrant [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="trxd-20190630.xsd#TRXD_StockOptionPlanMember" xlink:label="TRXD_StockOptionPlanMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="TRXD_StockOptionPlanMember" xlink:to="TRXD_StockOptionPlanMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="TRXD_StockOptionPlanMember_lbl" xml:lang="en-US">Stock Option Plan [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_TitleOfIndividualAxis" xlink:label="srt_TitleOfIndividualAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_TitleOfIndividualAxis" xlink:to="srt_TitleOfIndividualAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_TitleOfIndividualAxis_lbl" xml:lang="en-US">Title of Individual [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="trxd-20190630.xsd#TRXD_EmployeeMember" xlink:label="TRXD_EmployeeMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="TRXD_EmployeeMember" xlink:to="TRXD_EmployeeMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="TRXD_EmployeeMember_lbl" xml:lang="en-US">Employee [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_RangeAxis" xlink:label="srt_RangeAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_RangeAxis" xlink:to="srt_RangeAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_RangeAxis_lbl" xml:lang="en-US">Range [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_MinimumMember" xlink:label="srt_MinimumMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_MinimumMember" xlink:to="srt_MinimumMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_MinimumMember_lbl" xml:lang="en-US">Minimum [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_MaximumMember" xlink:label="srt_MaximumMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_MaximumMember" xlink:to="srt_MaximumMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_MaximumMember_lbl" xml:lang="en-US">Maximum [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="trxd-20190630.xsd#TRXD_ShortTermNotesPayableMember" xlink:label="TRXD_ShortTermNotesPayableMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="TRXD_ShortTermNotesPayableMember" xlink:to="TRXD_ShortTermNotesPayableMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="TRXD_ShortTermNotesPayableMember_lbl" xml:lang="en-US">Short Term Notes Payable [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PreferredStockMember" xlink:label="us-gaap_PreferredStockMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockMember" xlink:to="us-gaap_PreferredStockMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockMember_lbl" xml:lang="en-US">Preferred Stock [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CommonStockMember" xlink:label="us-gaap_CommonStockMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockMember" xlink:to="us-gaap_CommonStockMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockMember_lbl" xml:lang="en-US">Common Stock [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:label="us-gaap_AdditionalPaidInCapitalMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdditionalPaidInCapitalMember" xlink:to="us-gaap_AdditionalPaidInCapitalMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdditionalPaidInCapitalMember_lbl" xml:lang="en-US">Additional Paid-in Capital [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RetainedEarningsMember" xlink:label="us-gaap_RetainedEarningsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RetainedEarningsMember" xlink:to="us-gaap_RetainedEarningsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RetainedEarningsMember_lbl" xml:lang="en-US">Accumulated Deficit [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="trxd-20190630.xsd#TRXD_RelatedPartyPromissoryNoteMember" xlink:label="TRXD_RelatedPartyPromissoryNoteMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="TRXD_RelatedPartyPromissoryNoteMember" xlink:to="TRXD_RelatedPartyPromissoryNoteMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="TRXD_RelatedPartyPromissoryNoteMember_lbl" xml:lang="en-US">Related Party Promissory Note [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="trxd-20190630.xsd#TRXD_NPRINVESTMENTGROUPLLCMember" xlink:label="TRXD_NPRINVESTMENTGROUPLLCMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="TRXD_NPRINVESTMENTGROUPLLCMember" xlink:to="TRXD_NPRINVESTMENTGROUPLLCMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="TRXD_NPRINVESTMENTGROUPLLCMember_lbl" xml:lang="en-US">NPR Investment Group, LLC [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="trxd-20190630.xsd#TRXD_SansurAssociatesLLCMember" xlink:label="TRXD_SansurAssociatesLLCMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="TRXD_SansurAssociatesLLCMember" xlink:to="TRXD_SansurAssociatesLLCMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="TRXD_SansurAssociatesLLCMember_lbl" xml:lang="en-US">Sansur Associates, LLC [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="trxd-20190630.xsd#TRXD_PromissoryNoteOneMember" xlink:label="TRXD_PromissoryNoteOneMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="TRXD_PromissoryNoteOneMember" xlink:to="TRXD_PromissoryNoteOneMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="TRXD_PromissoryNoteOneMember_lbl" xml:lang="en-US">Promissory Note One [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="trxd-20190630.xsd#TRXD_PromissoryNoteTwoMember" xlink:label="TRXD_PromissoryNoteTwoMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="TRXD_PromissoryNoteTwoMember" xlink:to="TRXD_PromissoryNoteTwoMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="TRXD_PromissoryNoteTwoMember_lbl" xml:lang="en-US">Promissory Note Two [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="trxd-20190630.xsd#TRXD_ShortTermPromissoryNotesMember" xlink:label="TRXD_ShortTermPromissoryNotesMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="TRXD_ShortTermPromissoryNotesMember" xlink:to="TRXD_ShortTermPromissoryNotesMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="TRXD_ShortTermPromissoryNotesMember_lbl" xml:lang="en-US">Short Term Promissory Notes [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="trxd-20190630.xsd#TRXD_PromissoryNotesMember" xlink:label="TRXD_PromissoryNotesMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="TRXD_PromissoryNotesMember" xlink:to="TRXD_PromissoryNotesMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="TRXD_PromissoryNotesMember_lbl" xml:lang="en-US">Promissory Notes [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="trxd-20190630.xsd#TRXD_RelatedPartyConvertiblePromissoryNotesMember" xlink:label="TRXD_RelatedPartyConvertiblePromissoryNotesMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="TRXD_RelatedPartyConvertiblePromissoryNotesMember" xlink:to="TRXD_RelatedPartyConvertiblePromissoryNotesMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="TRXD_RelatedPartyConvertiblePromissoryNotesMember_lbl" xml:lang="en-US">Related Party Convertible Promissory Note [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ValuationTechniqueAxis" xlink:label="us-gaap_ValuationTechniqueAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ValuationTechniqueAxis" xlink:to="us-gaap_ValuationTechniqueAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ValuationTechniqueAxis_lbl" xml:lang="en-US">Valuation Approach and Technique [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ValuationTechniqueOptionPricingModelMember" xlink:label="us-gaap_ValuationTechniqueOptionPricingModelMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ValuationTechniqueOptionPricingModelMember" xlink:to="us-gaap_ValuationTechniqueOptionPricingModelMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ValuationTechniqueOptionPricingModelMember_lbl" xml:lang="en-US">Black-Scholes Option Price Model [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OptionIndexedToIssuersEquityTypeAxis" xlink:label="us-gaap_OptionIndexedToIssuersEquityTypeAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OptionIndexedToIssuersEquityTypeAxis" xlink:to="us-gaap_OptionIndexedToIssuersEquityTypeAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OptionIndexedToIssuersEquityTypeAxis_lbl" xml:lang="en-US">Option Indexed to Issuer's Equity, Type [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="trxd-20190630.xsd#TRXD_FourOptionGrantedMember" xlink:label="TRXD_FourOptionGrantedMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="TRXD_FourOptionGrantedMember" xlink:to="TRXD_FourOptionGrantedMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="TRXD_FourOptionGrantedMember_lbl" xml:lang="en-US">Four Option Granted [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis" xlink:label="us-gaap_StatementBusinessSegmentsAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementBusinessSegmentsAxis" xlink:to="us-gaap_StatementBusinessSegmentsAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementBusinessSegmentsAxis_lbl" xml:lang="en-US">Segments [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="trxd-20190630.xsd#TRXD_TrxadeIncMember" xlink:label="TRXD_TrxadeIncMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="TRXD_TrxadeIncMember" xlink:to="TRXD_TrxadeIncMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="TRXD_TrxadeIncMember_lbl" xml:lang="en-US">Trxade, Inc.[Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="trxd-20190630.xsd#TRXD_OtherMember" xlink:label="TRXD_OtherMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="TRXD_OtherMember" xlink:to="TRXD_OtherMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="TRXD_OtherMember_lbl" xml:lang="en-US">Other [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="trxd-20190630.xsd#TRXD_TrxadeMember" xlink:label="TRXD_TrxadeMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="TRXD_TrxadeMember" xlink:to="TRXD_TrxadeMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="TRXD_TrxadeMember_lbl" xml:lang="en-US">Trxade [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="trxd-20190630.xsd#TRXD_AlliancePharmaSolutionLLCMember" xlink:label="TRXD_AlliancePharmaSolutionLLCMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="TRXD_AlliancePharmaSolutionLLCMember" xlink:to="TRXD_AlliancePharmaSolutionLLCMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="TRXD_AlliancePharmaSolutionLLCMember_lbl" xml:lang="en-US">Alliance Pharma Solution, LLC [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_OwnershipAxis" xlink:label="srt_OwnershipAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_OwnershipAxis" xlink:to="srt_OwnershipAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_OwnershipAxis_lbl" xml:lang="en-US">Ownership [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="trxd-20190630.xsd#TRXD_SyncHealthMSOLLCMember" xlink:label="TRXD_SyncHealthMSOLLCMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="TRXD_SyncHealthMSOLLCMember" xlink:to="TRXD_SyncHealthMSOLLCMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="TRXD_SyncHealthMSOLLCMember_lbl" xml:lang="en-US">SyncHealth MSO, LLC [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AwardDateAxis" xlink:label="us-gaap_AwardDateAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AwardDateAxis" xlink:to="us-gaap_AwardDateAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AwardDateAxis_lbl" xml:lang="en-US">Award Date [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="trxd-20190630.xsd#TRXD_JanuaryThortyOneTwoThousandTwentyMember" xlink:label="TRXD_JanuaryThortyOneTwoThousandTwentyMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="TRXD_JanuaryThortyOneTwoThousandTwentyMember" xlink:to="TRXD_JanuaryThortyOneTwoThousandTwentyMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="TRXD_JanuaryThortyOneTwoThousandTwentyMember_lbl" xml:lang="en-US">January 31, 2020 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_MeasurementInputTypeAxis" xlink:label="us-gaap_MeasurementInputTypeAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MeasurementInputTypeAxis" xlink:to="us-gaap_MeasurementInputTypeAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_MeasurementInputTypeAxis_lbl" xml:lang="en-US">Measurement Input Type [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_MeasurementInputExpectedDividendRateMember" xlink:label="us-gaap_MeasurementInputExpectedDividendRateMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MeasurementInputExpectedDividendRateMember" xlink:to="us-gaap_MeasurementInputExpectedDividendRateMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_MeasurementInputExpectedDividendRateMember_lbl" xml:lang="en-US">Dividend Yield [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_MeasurementInputPriceVolatilityMember" xlink:label="us-gaap_MeasurementInputPriceVolatilityMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MeasurementInputPriceVolatilityMember" xlink:to="us-gaap_MeasurementInputPriceVolatilityMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_MeasurementInputPriceVolatilityMember_lbl" xml:lang="en-US">Expected Volatility [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_MeasurementInputRiskFreeInterestRateMember" xlink:label="us-gaap_MeasurementInputRiskFreeInterestRateMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MeasurementInputRiskFreeInterestRateMember" xlink:to="us-gaap_MeasurementInputRiskFreeInterestRateMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_MeasurementInputRiskFreeInterestRateMember_lbl" xml:lang="en-US">Risk Free Interest Rate [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_MeasurementInputExpectedTermMember" xlink:label="us-gaap_MeasurementInputExpectedTermMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MeasurementInputExpectedTermMember" xlink:to="us-gaap_MeasurementInputExpectedTermMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_MeasurementInputExpectedTermMember_lbl" xml:lang="en-US">Expected Term of Options [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_MajorCustomersAxis" xlink:label="srt_MajorCustomersAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_MajorCustomersAxis" xlink:to="srt_MajorCustomersAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_MajorCustomersAxis_lbl" xml:lang="en-US">Customer [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="trxd-20190630.xsd#TRXD_TwoCustomersMember" xlink:label="TRXD_TwoCustomersMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="TRXD_TwoCustomersMember" xlink:to="TRXD_TwoCustomersMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="TRXD_TwoCustomersMember_lbl" xml:lang="en-US">Two Customers [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="trxd-20190630.xsd#TRXD_NikulPanchalMember" xlink:label="TRXD_NikulPanchalMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="TRXD_NikulPanchalMember" xlink:to="TRXD_NikulPanchalMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="TRXD_NikulPanchalMember_lbl" xml:lang="en-US">Nikul Panchal [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="trxd-20190630.xsd#TRXD_SpecialtyPharmacyLLCMember" xlink:label="TRXD_SpecialtyPharmacyLLCMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="TRXD_SpecialtyPharmacyLLCMember" xlink:to="TRXD_SpecialtyPharmacyLLCMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="TRXD_SpecialtyPharmacyLLCMember_lbl" xml:lang="en-US">Specialty Pharmacy, LLC [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LeaseArrangementTypeAxis" xlink:label="us-gaap_LeaseArrangementTypeAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LeaseArrangementTypeAxis" xlink:to="us-gaap_LeaseArrangementTypeAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LeaseArrangementTypeAxis_lbl" xml:lang="en-US">Lease Arrangement, Type [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="trxd-20190630.xsd#TRXD_LeaseOneMember" xlink:label="TRXD_LeaseOneMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="TRXD_LeaseOneMember" xlink:to="TRXD_LeaseOneMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="TRXD_LeaseOneMember_lbl" xml:lang="en-US">Lease 1 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="trxd-20190630.xsd#TRXD_LeaseTwoMember" xlink:label="TRXD_LeaseTwoMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="TRXD_LeaseTwoMember" xlink:to="TRXD_LeaseTwoMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="TRXD_LeaseTwoMember_lbl" xml:lang="en-US">Lease 2 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="trxd-20190630.xsd#TRXD_PanOpticHealthLLCMember" xlink:label="TRXD_PanOpticHealthLLCMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="TRXD_PanOpticHealthLLCMember" xlink:to="TRXD_PanOpticHealthLLCMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="TRXD_PanOpticHealthLLCMember_lbl" xml:lang="en-US">PanOptic Health, LLC [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_StatementScenarioAxis" xlink:label="srt_StatementScenarioAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_StatementScenarioAxis" xlink:to="srt_StatementScenarioAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_StatementScenarioAxis_lbl" xml:lang="en-US">Scenario [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_ScenarioForecastMember" xlink:label="srt_ScenarioForecastMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_ScenarioForecastMember" xlink:to="srt_ScenarioForecastMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_ScenarioForecastMember_lbl" xml:lang="en-US">Forecast [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="us-gaap_SubsequentEventTypeAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventTypeAxis" xlink:to="us-gaap_SubsequentEventTypeAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsequentEventTypeAxis_lbl" xml:lang="en-US">Subsequent Event Type [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SubsequentEventMember" xlink:label="us-gaap_SubsequentEventMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventMember" xlink:to="us-gaap_SubsequentEventMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsequentEventMember_lbl" xml:lang="en-US">Subsequent Event [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="us-gaap_TypeOfArrangementAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TypeOfArrangementAxis" xlink:to="us-gaap_TypeOfArrangementAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_TypeOfArrangementAxis_lbl" xml:lang="en-US">Type of Arrangement and Non-arrangement Transactions [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="trxd-20190630.xsd#TRXD_SecuritiesPurchaseAgreementMember" xlink:label="TRXD_SecuritiesPurchaseAgreementMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="TRXD_SecuritiesPurchaseAgreementMember" xlink:to="TRXD_SecuritiesPurchaseAgreementMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="TRXD_SecuritiesPurchaseAgreementMember_lbl" xml:lang="en-US">Securities Purchase Agreement [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="trxd-20190630.xsd#TRXD_AccreditedInvestorMember" xlink:label="TRXD_AccreditedInvestorMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="TRXD_AccreditedInvestorMember" xlink:to="TRXD_AccreditedInvestorMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="TRXD_AccreditedInvestorMember_lbl" xml:lang="en-US">Accredited Investor [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LoanRestructuringModificationAxis" xlink:label="us-gaap_LoanRestructuringModificationAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LoanRestructuringModificationAxis" xlink:to="us-gaap_LoanRestructuringModificationAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LoanRestructuringModificationAxis_lbl" xml:lang="en-US">Loan Restructuring Modification [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ExtendedMaturityMember" xlink:label="us-gaap_ExtendedMaturityMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ExtendedMaturityMember" xlink:to="us-gaap_ExtendedMaturityMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ExtendedMaturityMember_lbl" xml:lang="en-US">Extended Maturity [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="trxd-20190630.xsd#TRXD_MayOneTwoThousandNineteenMember" xlink:label="TRXD_MayOneTwoThousandNineteenMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="TRXD_MayOneTwoThousandNineteenMember" xlink:to="TRXD_MayOneTwoThousandNineteenMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="TRXD_MayOneTwoThousandNineteenMember_lbl" xml:lang="en-US">May 1, 2019 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="trxd-20190630.xsd#TRXD_AugustOneTwoThousandNineteenMember" xlink:label="TRXD_AugustOneTwoThousandNineteenMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="TRXD_AugustOneTwoThousandNineteenMember" xlink:to="TRXD_AugustOneTwoThousandNineteenMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="TRXD_AugustOneTwoThousandNineteenMember_lbl" xml:lang="en-US">August 1, 2019 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="trxd-20190630.xsd#TRXD_NovemberOneTwoThousandNineteenMember" xlink:label="TRXD_NovemberOneTwoThousandNineteenMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="TRXD_NovemberOneTwoThousandNineteenMember" xlink:to="TRXD_NovemberOneTwoThousandNineteenMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="TRXD_NovemberOneTwoThousandNineteenMember_lbl" xml:lang="en-US">November 1, 2019 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="trxd-20190630.xsd#TRXD_MrPrashantPatelAndMrSurenAjjarapuMember" xlink:label="TRXD_MrPrashantPatelAndMrSurenAjjarapuMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="TRXD_MrPrashantPatelAndMrSurenAjjarapuMember" xlink:to="TRXD_MrPrashantPatelAndMrSurenAjjarapuMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="TRXD_MrPrashantPatelAndMrSurenAjjarapuMember_lbl" xml:lang="en-US">Mr. Prashant Patel and Mr. Suren Ajjarapu [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="trxd-20190630.xsd#TRXD_ConsultingAgreementMember" xlink:label="TRXD_ConsultingAgreementMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="TRXD_ConsultingAgreementMember" xlink:to="TRXD_ConsultingAgreementMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="TRXD_ConsultingAgreementMember_lbl" xml:lang="en-US">Consulting Agreement [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="trxd-20190630.xsd#TRXD_DocumentAndEntityInformationAbstract" xlink:label="TRXD_DocumentAndEntityInformationAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="TRXD_DocumentAndEntityInformationAbstract" xlink:to="TRXD_DocumentAndEntityInformationAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="TRXD_DocumentAndEntityInformationAbstract_lbl" xml:lang="en-US">Document And Entity Information</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityRegistrantName_lbl" xml:lang="en-US">Entity Registrant Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCentralIndexKey_lbl" xml:lang="en-US">Entity Central Index Key</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentType" xlink:label="dei_DocumentType" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentType_lbl" xml:lang="en-US">Document Type</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodEndDate_lbl" xml:lang="en-US">Document Period End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentFlag_lbl" xml:lang="en-US">Amendment Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityFilerCategory" xlink:label="dei_EntityFilerCategory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFilerCategory" xlink:to="dei_EntityFilerCategory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFilerCategory_lbl" xml:lang="en-US">Entity Filer Category</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntitySmallBusiness" xlink:label="dei_EntitySmallBusiness" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntitySmallBusiness" xlink:to="dei_EntitySmallBusiness_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntitySmallBusiness_lbl" xml:lang="en-US">Entity Small Business Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xml:lang="en-US">Entity Emerging Growth Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityExTransitionPeriod" xlink:label="dei_EntityExTransitionPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityExTransitionPeriod" xlink:to="dei_EntityExTransitionPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityExTransitionPeriod_lbl" xml:lang="en-US">Entity Ex Transition Period</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="us-gaap_StatementOfFinancialPositionAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_StatementOfFinancialPositionAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementOfFinancialPositionAbstract_lbl" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AssetsAbstract" xlink:label="us-gaap_AssetsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_AssetsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetsAbstract_lbl" xml:lang="en-US">Assets</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AssetsCurrentAbstract" xlink:label="us-gaap_AssetsCurrentAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_AssetsCurrentAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetsCurrentAbstract_lbl" xml:lang="en-US">Current Assets</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl" xml:lang="en-US">Cash</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccountsReceivableNetCurrent" xlink:label="us-gaap_AccountsReceivableNetCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsReceivableNetCurrent" xlink:to="us-gaap_AccountsReceivableNetCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountsReceivableNetCurrent_lbl" xml:lang="en-US">Accounts Receivable, net</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InventoryNet" xlink:label="us-gaap_InventoryNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryNet" xlink:to="us-gaap_InventoryNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InventoryNet_lbl" xml:lang="en-US">Inventory</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PrepaidExpenseCurrent" xlink:label="us-gaap_PrepaidExpenseCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PrepaidExpenseCurrent" xlink:to="us-gaap_PrepaidExpenseCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PrepaidExpenseCurrent_lbl" xml:lang="en-US">Prepaid Assets</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherAssetsCurrent" xlink:label="us-gaap_OtherAssetsCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherAssetsCurrent" xlink:to="us-gaap_OtherAssetsCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherAssetsCurrent_lbl" xml:lang="en-US">Other Assets</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AssetsCurrent" xlink:label="us-gaap_AssetsCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_AssetsCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_AssetsCurrent_lbl" xml:lang="en-US">Total Current Assets</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="us-gaap_PropertyPlantAndEquipmentNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentNet" xlink:to="us-gaap_PropertyPlantAndEquipmentNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentNet_lbl" xml:lang="en-US">Property Plant and Equipment, Net</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AssetsNoncurrentAbstract" xlink:label="us-gaap_AssetsNoncurrentAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsNoncurrentAbstract" xlink:to="us-gaap_AssetsNoncurrentAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_AssetsNoncurrentAbstract_lbl" xml:lang="en-US">Other Assets</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DepositsAssetsNoncurrent" xlink:label="us-gaap_DepositsAssetsNoncurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DepositsAssetsNoncurrent" xlink:to="us-gaap_DepositsAssetsNoncurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DepositsAssetsNoncurrent_lbl" xml:lang="en-US">Deposits</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EquityMethodInvestments" xlink:label="us-gaap_EquityMethodInvestments" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EquityMethodInvestments" xlink:to="us-gaap_EquityMethodInvestments_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EquityMethodInvestments_lbl" xml:lang="en-US">Equity method investment</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset" xlink:label="us-gaap_OperatingLeaseRightOfUseAsset" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseRightOfUseAsset" xlink:to="us-gaap_OperatingLeaseRightOfUseAsset_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeaseRightOfUseAsset_lbl" xml:lang="en-US">Right of use leased assets</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_Goodwill" xlink:label="us-gaap_Goodwill" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Goodwill" xlink:to="us-gaap_Goodwill_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_Goodwill_lbl" xml:lang="en-US">Goodwill</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_Assets" xlink:label="us-gaap_Assets" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Assets" xlink:to="us-gaap_Assets_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_Assets_lbl" xml:lang="en-US">Total Assets</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:label="us-gaap_LiabilitiesAndStockholdersEquityAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_LiabilitiesAndStockholdersEquityAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesAndStockholdersEquityAbstract_lbl" xml:lang="en-US">Liabilities and Shareholders' Equity</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract" xlink:label="us-gaap_LiabilitiesCurrentAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_LiabilitiesCurrentAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesCurrentAbstract_lbl" xml:lang="en-US">Current Liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccountsPayableCurrent" xlink:label="us-gaap_AccountsPayableCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsPayableCurrent" xlink:to="us-gaap_AccountsPayableCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountsPayableCurrent_lbl" xml:lang="en-US">Accounts Payable</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent" xlink:label="us-gaap_AccruedLiabilitiesCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccruedLiabilitiesCurrent" xlink:to="us-gaap_AccruedLiabilitiesCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccruedLiabilitiesCurrent_lbl" xml:lang="en-US">Accrued Liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent" xlink:label="us-gaap_OperatingLeaseLiabilityCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseLiabilityCurrent" xlink:to="us-gaap_OperatingLeaseLiabilityCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeaseLiabilityCurrent_lbl" xml:lang="en-US">Current Portion Lease Liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NotesPayableCurrent" xlink:label="us-gaap_NotesPayableCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NotesPayableCurrent" xlink:to="us-gaap_NotesPayableCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NotesPayableCurrent_lbl" xml:lang="en-US">Short Term Notes Payable net of $0 and $152 discount</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ConvertibleNotesPayableCurrent" xlink:label="us-gaap_ConvertibleNotesPayableCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConvertibleNotesPayableCurrent" xlink:to="us-gaap_ConvertibleNotesPayableCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConvertibleNotesPayableCurrent_lbl" xml:lang="en-US">Short Term Convertible Notes Payable</link:label>
      <link:loc xlink:type="locator" xlink:href="trxd-20190630.xsd#TRXD_ShortTermConvertibleNotesPayableRelatedParties" xlink:label="TRXD_ShortTermConvertibleNotesPayableRelatedParties" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="TRXD_ShortTermConvertibleNotesPayableRelatedParties" xlink:to="TRXD_ShortTermConvertibleNotesPayableRelatedParties_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="TRXD_ShortTermConvertibleNotesPayableRelatedParties_lbl" xml:lang="en-US">Short Term Convertible Notes Payable - Related Parties</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LiabilitiesCurrent" xlink:label="us-gaap_LiabilitiesCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_LiabilitiesCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_LiabilitiesCurrent_lbl" xml:lang="en-US">Total Current Liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LiabilitiesNoncurrentAbstract" xlink:label="us-gaap_LiabilitiesNoncurrentAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesNoncurrentAbstract" xlink:to="us-gaap_LiabilitiesNoncurrentAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesNoncurrentAbstract_lbl" xml:lang="en-US">Long Term Liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ConvertibleLongTermNotesPayable" xlink:label="us-gaap_ConvertibleLongTermNotesPayable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConvertibleLongTermNotesPayable" xlink:to="us-gaap_ConvertibleLongTermNotesPayable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConvertibleLongTermNotesPayable_lbl" xml:lang="en-US">Convertible Notes Payable</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NotesPayableRelatedPartiesNoncurrent" xlink:label="us-gaap_NotesPayableRelatedPartiesNoncurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NotesPayableRelatedPartiesNoncurrent" xlink:to="us-gaap_NotesPayableRelatedPartiesNoncurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NotesPayableRelatedPartiesNoncurrent_lbl" xml:lang="en-US">Notes Payable - Related Parties</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:label="us-gaap_OperatingLeaseLiabilityNoncurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:to="us-gaap_OperatingLeaseLiabilityNoncurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeaseLiabilityNoncurrent_lbl" xml:lang="en-US">Other Long-term Liabilities - Leases</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_Liabilities" xlink:label="us-gaap_Liabilities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Liabilities" xlink:to="us-gaap_Liabilities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_Liabilities_lbl" xml:lang="en-US">Total Liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockholdersEquityAbstract" xlink:label="us-gaap_StockholdersEquityAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_StockholdersEquityAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockholdersEquityAbstract_lbl" xml:lang="en-US">Shareholders' Equity</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PreferredStockValue" xlink:label="us-gaap_PreferredStockValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockValue" xlink:to="us-gaap_PreferredStockValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockValue_lbl" xml:lang="en-US">Series A Preferred Stock, value</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CommonStockValue" xlink:label="us-gaap_CommonStockValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockValue" xlink:to="us-gaap_CommonStockValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockValue_lbl" xml:lang="en-US">Common Stock, value</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AdditionalPaidInCapital" xlink:label="us-gaap_AdditionalPaidInCapital" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdditionalPaidInCapital" xlink:to="us-gaap_AdditionalPaidInCapital_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdditionalPaidInCapital_lbl" xml:lang="en-US">Additional Paid-in Capital</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="us-gaap_RetainedEarningsAccumulatedDeficit_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit_lbl" xml:lang="en-US">Retained Deficit</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="us-gaap_StockholdersEquity" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_StockholdersEquity_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_StockholdersEquity_lbl" xml:lang="en-US">Total Shareholders' Equity</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_LiabilitiesAndStockholdersEquity_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity_lbl" xml:lang="en-US">Total Liabilities and Shareholders' Equity</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementTable_lbl" xml:lang="en-US">Statement [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementLineItems_lbl" xml:lang="en-US">Statement [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentUnamortizedDiscountCurrent" xlink:label="us-gaap_DebtInstrumentUnamortizedDiscountCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentUnamortizedDiscountCurrent" xlink:to="us-gaap_DebtInstrumentUnamortizedDiscountCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentUnamortizedDiscountCurrent_lbl" xml:lang="en-US">Short-term notes payable, discount</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockParOrStatedValuePerShare" xlink:to="us-gaap_PreferredStockParOrStatedValuePerShare_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare_lbl" xml:lang="en-US">Series A Preferred stock, par value</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:label="us-gaap_PreferredStockSharesAuthorized" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockSharesAuthorized" xlink:to="us-gaap_PreferredStockSharesAuthorized_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockSharesAuthorized_lbl" xml:lang="en-US">Series A Preferred stock, shares authorized</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PreferredStockSharesIssued" xlink:label="us-gaap_PreferredStockSharesIssued" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockSharesIssued" xlink:to="us-gaap_PreferredStockSharesIssued_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockSharesIssued_lbl" xml:lang="en-US">Series A Preferred stock, shares issued</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PreferredStockSharesOutstanding" xlink:label="us-gaap_PreferredStockSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockSharesOutstanding" xlink:to="us-gaap_PreferredStockSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockSharesOutstanding_lbl" xml:lang="en-US">Series A Preferred stock, shares outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockParOrStatedValuePerShare" xlink:to="us-gaap_CommonStockParOrStatedValuePerShare_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare_lbl" xml:lang="en-US">Common stock, par value</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="us-gaap_CommonStockSharesAuthorized" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesAuthorized" xlink:to="us-gaap_CommonStockSharesAuthorized_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockSharesAuthorized_lbl" xml:lang="en-US">Common stock, shares authorized</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CommonStockSharesIssued" xlink:label="us-gaap_CommonStockSharesIssued" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesIssued" xlink:to="us-gaap_CommonStockSharesIssued_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockSharesIssued_lbl" xml:lang="en-US">Common stock, shares issued</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="us-gaap_CommonStockSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesOutstanding" xlink:to="us-gaap_CommonStockSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockSharesOutstanding_lbl" xml:lang="en-US">Common stock, shares outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeStatementAbstract" xlink:label="us-gaap_IncomeStatementAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_IncomeStatementAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeStatementAbstract_lbl" xml:lang="en-US">Income Statement [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:label="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:to="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_lbl" xml:lang="en-US">Revenues</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CostOfGoodsAndServicesSold" xlink:label="us-gaap_CostOfGoodsAndServicesSold" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CostOfGoodsAndServicesSold" xlink:to="us-gaap_CostOfGoodsAndServicesSold_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CostOfGoodsAndServicesSold_lbl" xml:lang="en-US">Cost of Sales</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_GrossProfit" xlink:label="us-gaap_GrossProfit" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GrossProfit" xlink:to="us-gaap_GrossProfit_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_GrossProfit_lbl" xml:lang="en-US">Gross Profit</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingExpensesAbstract" xlink:label="us-gaap_OperatingExpensesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingExpensesAbstract" xlink:to="us-gaap_OperatingExpensesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingExpensesAbstract_lbl" xml:lang="en-US">Operating Expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_GeneralAndAdministrativeExpense" xlink:label="us-gaap_GeneralAndAdministrativeExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GeneralAndAdministrativeExpense" xlink:to="us-gaap_GeneralAndAdministrativeExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_GeneralAndAdministrativeExpense_lbl" xml:lang="en-US">General and Administrative</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingIncomeLoss" xlink:label="us-gaap_OperatingIncomeLoss" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingIncomeLoss" xlink:to="us-gaap_OperatingIncomeLoss_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_OperatingIncomeLoss_lbl" xml:lang="en-US">Operating Income</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeLossFromEquityMethodInvestments" xlink:label="us-gaap_IncomeLossFromEquityMethodInvestments" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeLossFromEquityMethodInvestments" xlink:to="us-gaap_IncomeLossFromEquityMethodInvestments_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeLossFromEquityMethodInvestments_lbl" xml:lang="en-US">Share in Equity Losses in Investment</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherNonoperatingIncome" xlink:label="us-gaap_OtherNonoperatingIncome" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherNonoperatingIncome" xlink:to="us-gaap_OtherNonoperatingIncome_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherNonoperatingIncome_lbl" xml:lang="en-US">Other Income</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:label="us-gaap_GainsLossesOnExtinguishmentOfDebt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:to="us-gaap_GainsLossesOnExtinguishmentOfDebt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_GainsLossesOnExtinguishmentOfDebt_lbl" xml:lang="en-US">Loss on Extinguishment of Debt</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InterestExpense" xlink:label="us-gaap_InterestExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestExpense" xlink:to="us-gaap_InterestExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_InterestExpense_lbl" xml:lang="en-US">Interest Expense</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="us-gaap_NetIncomeLoss" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_NetIncomeLoss_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NetIncomeLoss_lbl" xml:lang="en-US">Net Income</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EarningsPerShareBasic" xlink:label="us-gaap_EarningsPerShareBasic" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareBasic" xlink:to="us-gaap_EarningsPerShareBasic_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EarningsPerShareBasic_lbl" xml:lang="en-US">Net Income per Common Share - Basic:</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EarningsPerShareDiluted" xlink:label="us-gaap_EarningsPerShareDiluted" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareDiluted" xlink:to="us-gaap_EarningsPerShareDiluted_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EarningsPerShareDiluted_lbl" xml:lang="en-US">Net Income per Common Share - Diluted:</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:to="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_lbl" xml:lang="en-US">Weighted average Common Shares Outstanding Basic</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:label="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:to="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_lbl" xml:lang="en-US">Weighted average Common Shares Outstanding Diluted</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_StockholdersEquity_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_StockholdersEquity_2_lbl" xml:lang="en-US">Balance</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SharesOutstanding" xlink:label="us-gaap_SharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharesOutstanding" xlink:to="us-gaap_SharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_SharesOutstanding_lbl" xml:lang="en-US">Balance, shares</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:label="us-gaap_StockIssuedDuringPeriodValueNewIssues" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:to="us-gaap_StockIssuedDuringPeriodValueNewIssues_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodValueNewIssues_lbl" xml:lang="en-US">Common Stock Issued for Cash</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:to="us-gaap_StockIssuedDuringPeriodSharesNewIssues_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues_lbl" xml:lang="en-US">Common Stock Issued for Cash, shares</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueIssuedForServices" xlink:label="us-gaap_StockIssuedDuringPeriodValueIssuedForServices" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueIssuedForServices" xlink:to="us-gaap_StockIssuedDuringPeriodValueIssuedForServices_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodValueIssuedForServices_lbl" xml:lang="en-US">Common Stock Issued for Services</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" xlink:label="us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" xlink:to="us-gaap_StockIssuedDuringPeriodSharesIssuedForServices_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodSharesIssuedForServices_lbl" xml:lang="en-US">Common Stock Issued for Services, shares</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" xlink:to="us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition_lbl" xml:lang="en-US">Options Expense</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" xlink:label="us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" xlink:to="us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities_lbl" xml:lang="en-US">Common Stock issued for convertible debt and accrued interest</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:label="us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:to="us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_lbl" xml:lang="en-US">Common Stock issued for convertible debt and accrued interest, shares</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued" xlink:to="us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued_lbl" xml:lang="en-US">Warrants Issued for debt Amendment</link:label>
      <link:loc xlink:type="locator" xlink:href="trxd-20190630.xsd#TRXD_StockIssuedDuringPeriodValueStockWarrantExercised" xlink:label="TRXD_StockIssuedDuringPeriodValueStockWarrantExercised" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="TRXD_StockIssuedDuringPeriodValueStockWarrantExercised" xlink:to="TRXD_StockIssuedDuringPeriodValueStockWarrantExercised_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="TRXD_StockIssuedDuringPeriodValueStockWarrantExercised_lbl" xml:lang="en-US">Warrants Exercised</link:label>
      <link:loc xlink:type="locator" xlink:href="trxd-20190630.xsd#TRXD_StockIssuedDuringPeriodSharesStockWarrantExercised" xlink:label="TRXD_StockIssuedDuringPeriodSharesStockWarrantExercised" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="TRXD_StockIssuedDuringPeriodSharesStockWarrantExercised" xlink:to="TRXD_StockIssuedDuringPeriodSharesStockWarrantExercised_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="TRXD_StockIssuedDuringPeriodSharesStockWarrantExercised_lbl" xml:lang="en-US">Warrants Exercised, shares</link:label>
      <link:loc xlink:type="locator" xlink:href="trxd-20190630.xsd#TRXD_AdjustmentsToAdditionalPaidInCapitalWarrantsForAcquisition" xlink:label="TRXD_AdjustmentsToAdditionalPaidInCapitalWarrantsForAcquisition" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="TRXD_AdjustmentsToAdditionalPaidInCapitalWarrantsForAcquisition" xlink:to="TRXD_AdjustmentsToAdditionalPaidInCapitalWarrantsForAcquisition_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="TRXD_AdjustmentsToAdditionalPaidInCapitalWarrantsForAcquisition_lbl" xml:lang="en-US">Warrants for Acquisition of Community Specialty Pharmacy, LLC</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_NetIncomeLoss_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetIncomeLoss_2_lbl" xml:lang="en-US">Net Income</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_StockholdersEquity_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_StockholdersEquity_3_lbl" xml:lang="en-US">Balance</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharesOutstanding" xlink:to="us-gaap_SharesOutstanding_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_SharesOutstanding_2_lbl" xml:lang="en-US">Balance, shares</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract" xlink:label="us-gaap_StatementOfCashFlowsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_StatementOfCashFlowsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementOfCashFlowsAbstract_lbl" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xml:lang="en-US">Operating Activities:</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xml:lang="en-US">Adjustments to reconcile net income to net cash provided by (used in) operating activities:</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_Depreciation" xlink:label="us-gaap_Depreciation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Depreciation" xlink:to="us-gaap_Depreciation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_Depreciation_lbl" xml:lang="en-US">Depreciation Expense</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims" xlink:label="us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims" xlink:to="us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims_lbl" xml:lang="en-US">Stock Issued for Services</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockOptionPlanExpense" xlink:label="us-gaap_StockOptionPlanExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockOptionPlanExpense" xlink:to="us-gaap_StockOptionPlanExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockOptionPlanExpense_lbl" xml:lang="en-US">Options expense</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeLossFromEquityMethodInvestments" xlink:to="us-gaap_IncomeLossFromEquityMethodInvestments_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_IncomeLossFromEquityMethodInvestments_2_lbl" xml:lang="en-US">Share in Equity Losses in Investment</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ProvisionForDoubtfulAccounts" xlink:label="us-gaap_ProvisionForDoubtfulAccounts" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProvisionForDoubtfulAccounts" xlink:to="us-gaap_ProvisionForDoubtfulAccounts_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProvisionForDoubtfulAccounts_lbl" xml:lang="en-US">Bad Debt Expense</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:to="us-gaap_GainsLossesOnExtinguishmentOfDebt_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_GainsLossesOnExtinguishmentOfDebt_2_lbl" xml:lang="en-US">Loss on debt extinguishment</link:label>
      <link:loc xlink:type="locator" xlink:href="trxd-20190630.xsd#TRXD_AmortizationOfRightToUseAsset" xlink:label="TRXD_AmortizationOfRightToUseAsset" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="TRXD_AmortizationOfRightToUseAsset" xlink:to="TRXD_AmortizationOfRightToUseAsset_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="TRXD_AmortizationOfRightToUseAsset_lbl" xml:lang="en-US">Amortization of right to use asset</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AmortizationOfDebtDiscountPremium" xlink:label="us-gaap_AmortizationOfDebtDiscountPremium" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AmortizationOfDebtDiscountPremium" xlink:to="us-gaap_AmortizationOfDebtDiscountPremium_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AmortizationOfDebtDiscountPremium_lbl" xml:lang="en-US">Amortization of Debt Discount</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:label="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_lbl" xml:lang="en-US">Changes in operating assets and liabilities:</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:label="us-gaap_IncreaseDecreaseInAccountsReceivable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:to="us-gaap_IncreaseDecreaseInAccountsReceivable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_IncreaseDecreaseInAccountsReceivable_lbl" xml:lang="en-US">Accounts Receivable</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:label="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:to="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_lbl" xml:lang="en-US">Prepaid Assets and other Current Assets</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncreaseDecreaseInInventories" xlink:label="us-gaap_IncreaseDecreaseInInventories" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInInventories" xlink:to="us-gaap_IncreaseDecreaseInInventories_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_IncreaseDecreaseInInventories_lbl" xml:lang="en-US">Inventory</link:label>
      <link:loc xlink:type="locator" xlink:href="trxd-20190630.xsd#TRXD_IncreaseDecreaseInLeaseLiability" xlink:label="TRXD_IncreaseDecreaseInLeaseLiability" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="TRXD_IncreaseDecreaseInLeaseLiability" xlink:to="TRXD_IncreaseDecreaseInLeaseLiability_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="TRXD_IncreaseDecreaseInLeaseLiability_lbl" xml:lang="en-US">Lease Liability</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayable" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccountsPayable" xlink:to="us-gaap_IncreaseDecreaseInAccountsPayable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayable_lbl" xml:lang="en-US">Accounts Payable</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities" xlink:label="us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities" xlink:to="us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities_lbl" xml:lang="en-US">Accrued Liabilities and Other Liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl" xml:lang="en-US">Net Cash provided by (used in) operating activities</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_lbl" xml:lang="en-US">Investing Activities:</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PaymentsToAcquireEquityMethodInvestments" xlink:label="us-gaap_PaymentsToAcquireEquityMethodInvestments" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsToAcquireEquityMethodInvestments" xlink:to="us-gaap_PaymentsToAcquireEquityMethodInvestments_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_PaymentsToAcquireEquityMethodInvestments_lbl" xml:lang="en-US">Purchase of equity method investment</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:to="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_lbl" xml:lang="en-US">Purchase of Fixed Assets</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PaymentsForProceedsFromInvestments" xlink:label="us-gaap_PaymentsForProceedsFromInvestments" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsForProceedsFromInvestments" xlink:to="us-gaap_PaymentsForProceedsFromInvestments_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_PaymentsForProceedsFromInvestments_lbl" xml:lang="en-US">Cash paid for acquisition of Community Specialty Pharmacy, LLC, net of cash received</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities_lbl" xml:lang="en-US">Net cash Used in Investing activities</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_lbl" xml:lang="en-US">Financing Activities:</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RepaymentsOfRelatedPartyDebt" xlink:label="us-gaap_RepaymentsOfRelatedPartyDebt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RepaymentsOfRelatedPartyDebt" xlink:to="us-gaap_RepaymentsOfRelatedPartyDebt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_RepaymentsOfRelatedPartyDebt_lbl" xml:lang="en-US">Repayments of Short-Term Convertible Debt - Related Parties</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RepaymentsOfShortTermDebt" xlink:label="us-gaap_RepaymentsOfShortTermDebt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RepaymentsOfShortTermDebt" xlink:to="us-gaap_RepaymentsOfShortTermDebt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_RepaymentsOfShortTermDebt_lbl" xml:lang="en-US">Repayments of Short-Term Promissory Notes</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ProceedsFromRelatedPartyDebt" xlink:label="us-gaap_ProceedsFromRelatedPartyDebt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromRelatedPartyDebt" xlink:to="us-gaap_ProceedsFromRelatedPartyDebt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromRelatedPartyDebt_lbl" xml:lang="en-US">Proceeds from Convertible Note - Related Parties</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ProceedsFromWarrantExercises" xlink:label="us-gaap_ProceedsFromWarrantExercises" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromWarrantExercises" xlink:to="us-gaap_ProceedsFromWarrantExercises_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromWarrantExercises_lbl" xml:lang="en-US">Proceeds from exercise of Warrants</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:to="us-gaap_ProceedsFromIssuanceOfCommonStock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock_lbl" xml:lang="en-US">Proceeds from Issuance of Common Stock</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities_lbl" xml:lang="en-US">Net Cash provided by (used in) financing activities</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_lbl" xml:lang="en-US">Net increase (decrease) in Cash</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_lbl" xml:lang="en-US">Cash at Beginning of the Year</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_2_lbl" xml:lang="en-US">Cash at Ending of the year</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SupplementalCashFlowInformationAbstract" xlink:label="us-gaap_SupplementalCashFlowInformationAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SupplementalCashFlowInformationAbstract" xlink:to="us-gaap_SupplementalCashFlowInformationAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SupplementalCashFlowInformationAbstract_lbl" xml:lang="en-US">Supplemental Cash Flow Information</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InterestPaidNet" xlink:label="us-gaap_InterestPaidNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestPaidNet" xlink:to="us-gaap_InterestPaidNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InterestPaidNet_lbl" xml:lang="en-US">Cash Paid for Interest</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeTaxesPaidNet" xlink:label="us-gaap_IncomeTaxesPaidNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxesPaidNet" xlink:to="us-gaap_IncomeTaxesPaidNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxesPaidNet_lbl" xml:lang="en-US">Cash Paid for Income Taxes</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:label="us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:to="us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_lbl" xml:lang="en-US">Non-Cash Transactions</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ConversionOfStockAmountConverted1" xlink:label="us-gaap_ConversionOfStockAmountConverted1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConversionOfStockAmountConverted1" xlink:to="us-gaap_ConversionOfStockAmountConverted1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConversionOfStockAmountConverted1_lbl" xml:lang="en-US">Common Stock Issued for Conversion of Note and Accrued Interest</link:label>
      <link:loc xlink:type="locator" xlink:href="trxd-20190630.xsd#TRXD_RightUseOfAssetsAndOperatingLeaseObligationsRecognized" xlink:label="TRXD_RightUseOfAssetsAndOperatingLeaseObligationsRecognized" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="TRXD_RightUseOfAssetsAndOperatingLeaseObligationsRecognized" xlink:to="TRXD_RightUseOfAssetsAndOperatingLeaseObligationsRecognized_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="TRXD_RightUseOfAssetsAndOperatingLeaseObligationsRecognized_lbl" xml:lang="en-US">ROU assets and operating lease obligations recognized</link:label>
      <link:loc xlink:type="locator" xlink:href="trxd-20190630.xsd#TRXD_RelatedPartyNotePayableAndWarrantsIssuedForAcquisition" xlink:label="TRXD_RelatedPartyNotePayableAndWarrantsIssuedForAcquisition" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="TRXD_RelatedPartyNotePayableAndWarrantsIssuedForAcquisition" xlink:to="TRXD_RelatedPartyNotePayableAndWarrantsIssuedForAcquisition_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="TRXD_RelatedPartyNotePayableAndWarrantsIssuedForAcquisition_lbl" xml:lang="en-US">Related party note payable and warrants issued for acquisition of Community Specialty Pharmacy, LLC</link:label>
      <link:loc xlink:type="locator" xlink:href="trxd-20190630.xsd#TRXD_ReclassFromAccruedInterestToShortTermConvertibleNotes" xlink:label="TRXD_ReclassFromAccruedInterestToShortTermConvertibleNotes" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="TRXD_ReclassFromAccruedInterestToShortTermConvertibleNotes" xlink:to="TRXD_ReclassFromAccruedInterestToShortTermConvertibleNotes_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="TRXD_ReclassFromAccruedInterestToShortTermConvertibleNotes_lbl" xml:lang="en-US">Reclass from accrued interest to short term convertible notes</link:label>
      <link:loc xlink:type="locator" xlink:href="trxd-20190630.xsd#TRXD_ArrangementToMoveRelatedPartyAccountsPayableToNotesPayable" xlink:label="TRXD_ArrangementToMoveRelatedPartyAccountsPayableToNotesPayable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="TRXD_ArrangementToMoveRelatedPartyAccountsPayableToNotesPayable" xlink:to="TRXD_ArrangementToMoveRelatedPartyAccountsPayableToNotesPayable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="TRXD_ArrangementToMoveRelatedPartyAccountsPayableToNotesPayable_lbl" xml:lang="en-US">Arrangement to move related party Accounts Payable to Notes Payable</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_lbl" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock" xlink:label="us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock" xlink:to="us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock_lbl" xml:lang="en-US">Organization and Basis of Presentation</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="us-gaap_AccountingPoliciesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_AccountingPoliciesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountingPoliciesAbstract_lbl" xml:lang="en-US">Accounting Policies [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SignificantAccountingPoliciesTextBlock" xlink:label="us-gaap_SignificantAccountingPoliciesTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SignificantAccountingPoliciesTextBlock" xlink:to="us-gaap_SignificantAccountingPoliciesTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SignificantAccountingPoliciesTextBlock_lbl" xml:lang="en-US">Summary of Significant Accounting Policies</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="us-gaap_DebtDisclosureAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtDisclosureAbstract" xlink:to="us-gaap_DebtDisclosureAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtDisclosureAbstract_lbl" xml:lang="en-US">Debt Disclosure [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShortTermDebtTextBlock" xlink:label="us-gaap_ShortTermDebtTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShortTermDebtTextBlock" xlink:to="us-gaap_ShortTermDebtTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShortTermDebtTextBlock_lbl" xml:lang="en-US">Short-Term Debt and Related Parties Debt</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LongTermDebtTextBlock" xlink:label="us-gaap_LongTermDebtTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongTermDebtTextBlock" xlink:to="us-gaap_LongTermDebtTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LongTermDebtTextBlock_lbl" xml:lang="en-US">Long Term Debt - Related Parties</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EquityAbstract" xlink:label="us-gaap_EquityAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EquityAbstract" xlink:to="us-gaap_EquityAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EquityAbstract_lbl" xml:lang="en-US">Equity [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:label="us-gaap_StockholdersEquityNoteDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:to="us-gaap_StockholdersEquityNoteDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_StockholdersEquityNoteDisclosureTextBlock_lbl" xml:lang="en-US">Shareholders' Equity</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_WarrantsAndRightsNoteDisclosureAbstract" xlink:label="us-gaap_WarrantsAndRightsNoteDisclosureAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WarrantsAndRightsNoteDisclosureAbstract" xlink:to="us-gaap_WarrantsAndRightsNoteDisclosureAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_WarrantsAndRightsNoteDisclosureAbstract_lbl" xml:lang="en-US">Warrants and Rights Note Disclosure [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="trxd-20190630.xsd#TRXD_WarrantsTextBlock" xlink:label="TRXD_WarrantsTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="TRXD_WarrantsTextBlock" xlink:to="TRXD_WarrantsTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="TRXD_WarrantsTextBlock_lbl" xml:lang="en-US">Warrants</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_lbl" xml:lang="en-US">Share-based Payment Arrangement [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:to="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_lbl" xml:lang="en-US">Options</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LeasesAbstract" xlink:label="us-gaap_LeasesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LeasesAbstract" xlink:to="us-gaap_LeasesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LeasesAbstract_lbl" xml:lang="en-US">Leases [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LesseeOperatingLeasesTextBlock" xlink:label="us-gaap_LesseeOperatingLeasesTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeasesTextBlock" xlink:to="us-gaap_LesseeOperatingLeasesTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LesseeOperatingLeasesTextBlock_lbl" xml:lang="en-US">Leases</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="us-gaap_IncomeTaxDisclosureAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_IncomeTaxDisclosureAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxDisclosureAbstract_lbl" xml:lang="en-US">Income Tax Disclosure [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeTaxDisclosureTextBlock" xlink:label="us-gaap_IncomeTaxDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxDisclosureTextBlock" xlink:to="us-gaap_IncomeTaxDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxDisclosureTextBlock_lbl" xml:lang="en-US">Income Taxes</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RelatedPartyTransactionsAbstract" xlink:label="us-gaap_RelatedPartyTransactionsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyTransactionsAbstract" xlink:to="us-gaap_RelatedPartyTransactionsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RelatedPartyTransactionsAbstract_lbl" xml:lang="en-US">Related Party Transactions [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:label="us-gaap_RelatedPartyTransactionsDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:to="us-gaap_RelatedPartyTransactionsDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RelatedPartyTransactionsDisclosureTextBlock_lbl" xml:lang="en-US">Related Parties</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="us-gaap_CommitmentsAndContingenciesDisclosureAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureAbstract_lbl" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:to="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_lbl" xml:lang="en-US">Commitments and Contingencies</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SegmentReportingAbstract" xlink:label="us-gaap_SegmentReportingAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SegmentReportingAbstract" xlink:to="us-gaap_SegmentReportingAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SegmentReportingAbstract_lbl" xml:lang="en-US">Segment Reporting [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SegmentReportingDisclosureTextBlock" xlink:label="us-gaap_SegmentReportingDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SegmentReportingDisclosureTextBlock" xlink:to="us-gaap_SegmentReportingDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SegmentReportingDisclosureTextBlock_lbl" xml:lang="en-US">Segment Reporting</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessCombinationsAbstract" xlink:label="us-gaap_BusinessCombinationsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationsAbstract" xlink:to="us-gaap_BusinessCombinationsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessCombinationsAbstract_lbl" xml:lang="en-US">Business Combinations [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessCombinationDisclosureTextBlock" xlink:label="us-gaap_BusinessCombinationDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationDisclosureTextBlock" xlink:to="us-gaap_BusinessCombinationDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessCombinationDisclosureTextBlock_lbl" xml:lang="en-US">Business Combination</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract" xlink:label="us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract" xlink:to="us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract_lbl" xml:lang="en-US">Equity Method Investments and Joint Ventures [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EquityMethodInvestmentsDisclosureTextBlock" xlink:label="us-gaap_EquityMethodInvestmentsDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EquityMethodInvestmentsDisclosureTextBlock" xlink:to="us-gaap_EquityMethodInvestmentsDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EquityMethodInvestmentsDisclosureTextBlock_lbl" xml:lang="en-US">Equity Method Investment</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SubsequentEventsAbstract" xlink:label="us-gaap_SubsequentEventsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventsAbstract" xlink:to="us-gaap_SubsequentEventsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsequentEventsAbstract_lbl" xml:lang="en-US">Subsequent Events [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SubsequentEventsTextBlock" xlink:label="us-gaap_SubsequentEventsTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventsTextBlock" xlink:to="us-gaap_SubsequentEventsTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsequentEventsTextBlock_lbl" xml:lang="en-US">Subsequent Events</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:label="us-gaap_BasisOfAccountingPolicyPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:to="us-gaap_BasisOfAccountingPolicyPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BasisOfAccountingPolicyPolicyTextBlock_lbl" xml:lang="en-US">Basis of Presentation</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EquityMethodInvestmentsPolicy" xlink:label="us-gaap_EquityMethodInvestmentsPolicy" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EquityMethodInvestmentsPolicy" xlink:to="us-gaap_EquityMethodInvestmentsPolicy_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EquityMethodInvestmentsPolicy_lbl" xml:lang="en-US">Equity Investments</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_UseOfEstimates" xlink:label="us-gaap_UseOfEstimates" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_UseOfEstimates" xlink:to="us-gaap_UseOfEstimates_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_UseOfEstimates_lbl" xml:lang="en-US">Use of Estimates</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PriorPeriodReclassificationAdjustmentDescription" xlink:label="us-gaap_PriorPeriodReclassificationAdjustmentDescription" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PriorPeriodReclassificationAdjustmentDescription" xlink:to="us-gaap_PriorPeriodReclassificationAdjustmentDescription_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PriorPeriodReclassificationAdjustmentDescription_lbl" xml:lang="en-US">Reclassification</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ConsolidationPolicyTextBlock" xlink:label="us-gaap_ConsolidationPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConsolidationPolicyTextBlock" xlink:to="us-gaap_ConsolidationPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConsolidationPolicyTextBlock_lbl" xml:lang="en-US">Principle of Consolidation</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:label="us-gaap_CashAndCashEquivalentsPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:to="us-gaap_CashAndCashEquivalentsPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashAndCashEquivalentsPolicyTextBlock_lbl" xml:lang="en-US">Cash and Cash Equivalents</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_TradeAndOtherAccountsReceivablePolicy" xlink:label="us-gaap_TradeAndOtherAccountsReceivablePolicy" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TradeAndOtherAccountsReceivablePolicy" xlink:to="us-gaap_TradeAndOtherAccountsReceivablePolicy_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_TradeAndOtherAccountsReceivablePolicy_lbl" xml:lang="en-US">Accounts Receivable</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InventoryPolicyTextBlock" xlink:label="us-gaap_InventoryPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryPolicyTextBlock" xlink:to="us-gaap_InventoryPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_InventoryPolicyTextBlock_lbl" xml:lang="en-US">Inventory</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtPolicyTextBlock" xlink:label="us-gaap_DebtPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtPolicyTextBlock" xlink:to="us-gaap_DebtPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtPolicyTextBlock_lbl" xml:lang="en-US">Beneficial Conversion Features</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativesReportingOfDerivativeActivity" xlink:label="us-gaap_DerivativesReportingOfDerivativeActivity" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DerivativesReportingOfDerivativeActivity" xlink:to="us-gaap_DerivativesReportingOfDerivativeActivity_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DerivativesReportingOfDerivativeActivity_lbl" xml:lang="en-US">Derivative Financial Instruments</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:label="us-gaap_FairValueOfFinancialInstrumentsPolicy" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:to="us-gaap_FairValueOfFinancialInstrumentsPolicy_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueOfFinancialInstrumentsPolicy_lbl" xml:lang="en-US">Fair Value of Financial Instruments</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy" xlink:label="us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy" xlink:to="us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy_lbl" xml:lang="en-US">Goodwill</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RevenueRecognitionPolicyTextBlock" xlink:label="us-gaap_RevenueRecognitionPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RevenueRecognitionPolicyTextBlock" xlink:to="us-gaap_RevenueRecognitionPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RevenueRecognitionPolicyTextBlock_lbl" xml:lang="en-US">Revenue Recognition</link:label>
      <link:loc xlink:type="locator" xlink:href="trxd-20190630.xsd#TRXD_CostOfGoodsSoldPolicyTextBlock" xlink:label="TRXD_CostOfGoodsSoldPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="TRXD_CostOfGoodsSoldPolicyTextBlock" xlink:to="TRXD_CostOfGoodsSoldPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="TRXD_CostOfGoodsSoldPolicyTextBlock_lbl" xml:lang="en-US">Cost of Goods Sold</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:label="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:to="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_lbl" xml:lang="en-US">Stock-based Compensation</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeTaxPolicyTextBlock" xlink:label="us-gaap_IncomeTaxPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxPolicyTextBlock" xlink:to="us-gaap_IncomeTaxPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_IncomeTaxPolicyTextBlock_lbl" xml:lang="en-US">Income Taxes</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EarningsPerSharePolicyTextBlock" xlink:label="us-gaap_EarningsPerSharePolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerSharePolicyTextBlock" xlink:to="us-gaap_EarningsPerSharePolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EarningsPerSharePolicyTextBlock_lbl" xml:lang="en-US">Income (loss) Per Share</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ConcentrationRiskCreditRisk" xlink:label="us-gaap_ConcentrationRiskCreditRisk" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConcentrationRiskCreditRisk" xlink:to="us-gaap_ConcentrationRiskCreditRisk_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConcentrationRiskCreditRisk_lbl" xml:lang="en-US">Concentration of Credit Risks and Major Customers</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:label="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:to="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_lbl" xml:lang="en-US">Recent Accounting Pronouncements</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:label="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:to="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_lbl" xml:lang="en-US">Schedule of Earnings Per Share, Basic and Diluted</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:label="us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:to="us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_lbl" xml:lang="en-US">Schedule of Future Maturities of Long-term Debt</link:label>
      <link:loc xlink:type="locator" xlink:href="trxd-20190630.xsd#TRXD_SummaryOfEstimateFairValueOfWarrantsTableTextBlock" xlink:label="TRXD_SummaryOfEstimateFairValueOfWarrantsTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="TRXD_SummaryOfEstimateFairValueOfWarrantsTableTextBlock" xlink:to="TRXD_SummaryOfEstimateFairValueOfWarrantsTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="TRXD_SummaryOfEstimateFairValueOfWarrantsTableTextBlock_lbl" xml:lang="en-US">Summary of Estimate the Fair Value of Warrants</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock" xlink:label="us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock" xlink:to="us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock_lbl" xml:lang="en-US">Schedule of Outstanding and Exercisable Warrants</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:label="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:to="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_lbl" xml:lang="en-US">Schedule of Estimate Fair Value of Stock Options</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:label="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:to="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_lbl" xml:lang="en-US">Schedule of Stock Option Activity</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LeaseCostTableTextBlock" xlink:label="us-gaap_LeaseCostTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LeaseCostTableTextBlock" xlink:to="us-gaap_LeaseCostTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LeaseCostTableTextBlock_lbl" xml:lang="en-US">Schedule of Operating Leases</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_lbl" xml:lang="en-US">Schedule of Future Minimum Payments for Operating Lease Liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:label="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:to="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_lbl" xml:lang="en-US">Schedule of Deferred Tax Assets</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock" xlink:label="us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock" xlink:to="us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock_lbl" xml:lang="en-US">Schedule of Future Minimum Rental Payments Under Non-cancelable Operating Leases</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:label="us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:to="us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_lbl" xml:lang="en-US">Schedule of Business Interests Into Reportable Segments</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" xlink:label="us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" xlink:to="us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_lbl" xml:lang="en-US">Schedule of Assets Acquired and Liabilities Assumed</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessAcquisitionProFormaInformationTextBlock" xlink:label="us-gaap_BusinessAcquisitionProFormaInformationTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessAcquisitionProFormaInformationTextBlock" xlink:to="us-gaap_BusinessAcquisitionProFormaInformationTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessAcquisitionProFormaInformationTextBlock_lbl" xml:lang="en-US">Schedule of Unaudited Pro Forma Statements of Operations</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:label="us-gaap_EquityMethodInvestmentOwnershipPercentage" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:to="us-gaap_EquityMethodInvestmentOwnershipPercentage_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EquityMethodInvestmentOwnershipPercentage_lbl" xml:lang="en-US">Ownership percentage</link:label>
      <link:loc xlink:type="locator" xlink:href="trxd-20190630.xsd#TRXD_EquityMethodInvestmentDescription" xlink:label="TRXD_EquityMethodInvestmentDescription" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="TRXD_EquityMethodInvestmentDescription" xlink:to="TRXD_EquityMethodInvestmentDescription_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="TRXD_EquityMethodInvestmentDescription_lbl" xml:lang="en-US">Equity method investment, description</link:label>
      <link:loc xlink:type="locator" xlink:href="trxd-20190630.xsd#TRXD_NumeratorForBasicAndDilutedEpsIncomeLossAvailableToCommonShareholders" xlink:label="TRXD_NumeratorForBasicAndDilutedEpsIncomeLossAvailableToCommonShareholders" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="TRXD_NumeratorForBasicAndDilutedEpsIncomeLossAvailableToCommonShareholders" xlink:to="TRXD_NumeratorForBasicAndDilutedEpsIncomeLossAvailableToCommonShareholders_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="TRXD_NumeratorForBasicAndDilutedEpsIncomeLossAvailableToCommonShareholders_lbl" xml:lang="en-US">Numerator for basic and diluted EPS - income available to common Shareholders</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:to="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_2_lbl" xml:lang="en-US">Denominator for basic EPS - Weighted average shares</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment" xlink:label="us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment" xlink:to="us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_lbl" xml:lang="en-US">Dilutive Effect of Warrants, Options and Convertible Debt</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:to="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_2_lbl" xml:lang="en-US">Denominator for diluted EPS - adjusted Weighted average shares and assumed Conversions</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EarningsPerShareBasicAndDiluted" xlink:label="us-gaap_EarningsPerShareBasicAndDiluted" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareBasicAndDiluted" xlink:to="us-gaap_EarningsPerShareBasicAndDiluted_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EarningsPerShareBasicAndDiluted_lbl" xml:lang="en-US">Basic and Diluted income per common share</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProvisionForDoubtfulAccounts" xlink:to="us-gaap_ProvisionForDoubtfulAccounts_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ProvisionForDoubtfulAccounts_2_lbl" xml:lang="en-US">Bad debt expense</link:label>
      <link:loc xlink:type="locator" xlink:href="trxd-20190630.xsd#TRXD_RecoveryOfBadDebt" xlink:label="TRXD_RecoveryOfBadDebt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="TRXD_RecoveryOfBadDebt" xlink:to="TRXD_RecoveryOfBadDebt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="TRXD_RecoveryOfBadDebt_lbl" xml:lang="en-US">Recovery of bad debt</link:label>
      <link:loc xlink:type="locator" xlink:href="trxd-20190630.xsd#TRXD_ValuationAllowancePercentage" xlink:label="TRXD_ValuationAllowancePercentage" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="TRXD_ValuationAllowancePercentage" xlink:to="TRXD_ValuationAllowancePercentage_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="TRXD_ValuationAllowancePercentage_lbl" xml:lang="en-US">Valuation allowance percentage</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ConcentrationRiskPercentage1" xlink:label="us-gaap_ConcentrationRiskPercentage1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConcentrationRiskPercentage1" xlink:to="us-gaap_ConcentrationRiskPercentage1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConcentrationRiskPercentage1_lbl" xml:lang="en-US">Concentration risk, percentage</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="TRXD_NumeratorForBasicAndDilutedEpsIncomeLossAvailableToCommonShareholders" xlink:to="TRXD_NumeratorForBasicAndDilutedEpsIncomeLossAvailableToCommonShareholders_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="TRXD_NumeratorForBasicAndDilutedEpsIncomeLossAvailableToCommonShareholders_2_lbl" xml:lang="en-US">Numerator for basic and diluted income available to common shareholders</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:to="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_3_lbl" xml:lang="en-US">Denominator for basic income per common share - Weighted average common shares outstanding</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment" xlink:to="us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_2_lbl" xml:lang="en-US">Dilutive effect of Common Stock Equivalents</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:to="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_3_lbl" xml:lang="en-US">Denominator for diluted income per common share - adjusted weighted average common shares outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ConvertibleNotesPayable" xlink:label="us-gaap_ConvertibleNotesPayable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConvertibleNotesPayable" xlink:to="us-gaap_ConvertibleNotesPayable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConvertibleNotesPayable_lbl" xml:lang="en-US">Convertible promissory notes</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentConvertibleConversionPrice1" xlink:label="us-gaap_DebtInstrumentConvertibleConversionPrice1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentConvertibleConversionPrice1" xlink:to="us-gaap_DebtInstrumentConvertibleConversionPrice1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentConvertibleConversionPrice1_lbl" xml:lang="en-US">Conversion price per share</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentPeriodicPayment" xlink:label="us-gaap_DebtInstrumentPeriodicPayment" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentPeriodicPayment" xlink:to="us-gaap_DebtInstrumentPeriodicPayment_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentPeriodicPayment_lbl" xml:lang="en-US">Principal and accrued interest</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtConversionConvertedInstrumentSharesIssued1" xlink:label="us-gaap_DebtConversionConvertedInstrumentSharesIssued1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtConversionConvertedInstrumentSharesIssued1" xlink:to="us-gaap_DebtConversionConvertedInstrumentSharesIssued1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtConversionConvertedInstrumentSharesIssued1_lbl" xml:lang="en-US">Debt instrument conversion shares</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConvertibleNotesPayableCurrent" xlink:to="us-gaap_ConvertibleNotesPayableCurrent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ConvertibleNotesPayableCurrent_2_lbl" xml:lang="en-US">Short term convertible notes payable</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentUnamortizedDiscount" xlink:label="us-gaap_DebtInstrumentUnamortizedDiscount" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentUnamortizedDiscount" xlink:to="us-gaap_DebtInstrumentUnamortizedDiscount_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentUnamortizedDiscount_lbl" xml:lang="en-US">Debt discount unamortized</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="TRXD_ShortTermConvertibleNotesPayableRelatedParties" xlink:to="TRXD_ShortTermConvertibleNotesPayableRelatedParties_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="TRXD_ShortTermConvertibleNotesPayableRelatedParties_2_lbl" xml:lang="en-US">Short term convertible payable - related parties</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:label="us-gaap_DebtInstrumentInterestRateStatedPercentage" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:to="us-gaap_DebtInstrumentInterestRateStatedPercentage_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentInterestRateStatedPercentage_lbl" xml:lang="en-US">Interest rate</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentMaturityDate" xlink:label="us-gaap_DebtInstrumentMaturityDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentMaturityDate" xlink:to="us-gaap_DebtInstrumentMaturityDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentMaturityDate_lbl" xml:lang="en-US">Debt instrument maturity date</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentTerm" xlink:label="us-gaap_DebtInstrumentTerm" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentTerm" xlink:to="us-gaap_DebtInstrumentTerm_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentTerm_lbl" xml:lang="en-US">Debt notes term</link:label>
      <link:loc xlink:type="locator" xlink:href="trxd-20190630.xsd#TRXD_GrantedWarrants" xlink:label="TRXD_GrantedWarrants" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="TRXD_GrantedWarrants" xlink:to="TRXD_GrantedWarrants_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="TRXD_GrantedWarrants_lbl" xml:lang="en-US">Granted warrants</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SharesIssuedPricePerShare" xlink:label="us-gaap_SharesIssuedPricePerShare" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharesIssuedPricePerShare" xlink:to="us-gaap_SharesIssuedPricePerShare_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharesIssuedPricePerShare_lbl" xml:lang="en-US">Shares issued price per shares</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:label="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:to="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_lbl" xml:lang="en-US">Warrant purchased from common stock</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:label="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:to="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_lbl" xml:lang="en-US">Warrant strike price</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_WarrantsAndRightsOutstandingTerm" xlink:label="us-gaap_WarrantsAndRightsOutstandingTerm" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WarrantsAndRightsOutstandingTerm" xlink:to="us-gaap_WarrantsAndRightsOutstandingTerm_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_WarrantsAndRightsOutstandingTerm_lbl" xml:lang="en-US">Warrants term</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentUnamortizedDiscount" xlink:to="us-gaap_DebtInstrumentUnamortizedDiscount_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_DebtInstrumentUnamortizedDiscount_2_lbl" xml:lang="en-US">Debt discount</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RepaymentsOfDebt" xlink:label="us-gaap_RepaymentsOfDebt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RepaymentsOfDebt" xlink:to="us-gaap_RepaymentsOfDebt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RepaymentsOfDebt_lbl" xml:lang="en-US">Payment for promissory note</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InterestExpenseDebt" xlink:label="us-gaap_InterestExpenseDebt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestExpenseDebt" xlink:to="us-gaap_InterestExpenseDebt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InterestExpenseDebt_lbl" xml:lang="en-US">Interest expenses debt</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentMaturityDateDescription" xlink:label="us-gaap_DebtInstrumentMaturityDateDescription" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentMaturityDateDescription" xlink:to="us-gaap_DebtInstrumentMaturityDateDescription_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentMaturityDateDescription_lbl" xml:lang="en-US">Debt instrument maturity, description</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InterestPayableCurrentAndNoncurrent" xlink:label="us-gaap_InterestPayableCurrentAndNoncurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestPayableCurrentAndNoncurrent" xlink:to="us-gaap_InterestPayableCurrentAndNoncurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InterestPayableCurrentAndNoncurrent_lbl" xml:lang="en-US">Interest owed part of adjusted principal amount</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentFaceAmount" xlink:label="us-gaap_DebtInstrumentFaceAmount" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentFaceAmount" xlink:to="us-gaap_DebtInstrumentFaceAmount_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentFaceAmount_lbl" xml:lang="en-US">Debt instrument face amount</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:to="us-gaap_GainsLossesOnExtinguishmentOfDebt_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_GainsLossesOnExtinguishmentOfDebt_3_lbl" xml:lang="en-US">Loss on extinguishment of debt</link:label>
      <link:loc xlink:type="locator" xlink:href="trxd-20190630.xsd#TRXD_DebtModificationsAmount" xlink:label="TRXD_DebtModificationsAmount" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="TRXD_DebtModificationsAmount" xlink:to="TRXD_DebtModificationsAmount_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="TRXD_DebtModificationsAmount_lbl" xml:lang="en-US">Debt modification amount</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AmortizationOfDebtDiscountPremium" xlink:to="us-gaap_AmortizationOfDebtDiscountPremium_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_AmortizationOfDebtDiscountPremium_2_lbl" xml:lang="en-US">Amortized debt</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentPeriodicPaymentPrincipal" xlink:label="us-gaap_DebtInstrumentPeriodicPaymentPrincipal" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentPeriodicPaymentPrincipal" xlink:to="us-gaap_DebtInstrumentPeriodicPaymentPrincipal_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentPeriodicPaymentPrincipal_lbl" xml:lang="en-US">Principal payments</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ProceedsFromIssuanceOfDebt" xlink:label="us-gaap_ProceedsFromIssuanceOfDebt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromIssuanceOfDebt" xlink:to="us-gaap_ProceedsFromIssuanceOfDebt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromIssuanceOfDebt_lbl" xml:lang="en-US">Proceeds from promissory note</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentUnamortizedDiscountCurrent" xlink:to="us-gaap_DebtInstrumentUnamortizedDiscountCurrent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_DebtInstrumentUnamortizedDiscountCurrent_2_lbl" xml:lang="en-US">Debt discount, current</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LongTermDebt" xlink:label="us-gaap_LongTermDebt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongTermDebt" xlink:to="us-gaap_LongTermDebt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LongTermDebt_lbl" xml:lang="en-US">Long term promissory debt</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentUnamortizedDiscountNoncurrent" xlink:label="us-gaap_DebtInstrumentUnamortizedDiscountNoncurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentUnamortizedDiscountNoncurrent" xlink:to="us-gaap_DebtInstrumentUnamortizedDiscountNoncurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentUnamortizedDiscountNoncurrent_lbl" xml:lang="en-US">Debt discount non current</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentConvertibleBeneficialConversionFeature" xlink:label="us-gaap_DebtInstrumentConvertibleBeneficialConversionFeature" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentConvertibleBeneficialConversionFeature" xlink:to="us-gaap_DebtInstrumentConvertibleBeneficialConversionFeature_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentConvertibleBeneficialConversionFeature_lbl" xml:lang="en-US">Debt instrument beneficial conversion features</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DueToRelatedPartiesCurrentAndNoncurrent" xlink:label="us-gaap_DueToRelatedPartiesCurrentAndNoncurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DueToRelatedPartiesCurrentAndNoncurrent" xlink:to="us-gaap_DueToRelatedPartiesCurrentAndNoncurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DueToRelatedPartiesCurrentAndNoncurrent_lbl" xml:lang="en-US">Due to related parties</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LoansPayable" xlink:label="us-gaap_LoansPayable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LoansPayable" xlink:to="us-gaap_LoansPayable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LoansPayable_lbl" xml:lang="en-US">Loan payable</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccountsPayableCurrentAndNoncurrent" xlink:label="us-gaap_AccountsPayableCurrentAndNoncurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsPayableCurrentAndNoncurrent" xlink:to="us-gaap_AccountsPayableCurrentAndNoncurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountsPayableCurrentAndNoncurrent_lbl" xml:lang="en-US">Accounts payable</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtConversionConvertedInstrumentAmount1" xlink:label="us-gaap_DebtConversionConvertedInstrumentAmount1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtConversionConvertedInstrumentAmount1" xlink:to="us-gaap_DebtConversionConvertedInstrumentAmount1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtConversionConvertedInstrumentAmount1_lbl" xml:lang="en-US">Debt instrument conversion amount</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromIssuanceOfDebt" xlink:to="us-gaap_ProceedsFromIssuanceOfDebt_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ProceedsFromIssuanceOfDebt_2_lbl" xml:lang="en-US">Proceeds from issuance of promissory note</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NotesPayableRelatedPartiesNoncurrent" xlink:to="us-gaap_NotesPayableRelatedPartiesNoncurrent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_NotesPayableRelatedPartiesNoncurrent_2_lbl" xml:lang="en-US">Long term debt related party</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShortTermBorrowings" xlink:label="us-gaap_ShortTermBorrowings" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShortTermBorrowings" xlink:to="us-gaap_ShortTermBorrowings_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShortTermBorrowings_lbl" xml:lang="en-US">Short term promissory note</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentTerm" xlink:to="us-gaap_DebtInstrumentTerm_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_DebtInstrumentTerm_2_lbl" xml:lang="en-US">Debt instrument term</link:label>
      <link:loc xlink:type="locator" xlink:href="trxd-20190630.xsd#TRXD_CreditCardObligationAmount" xlink:label="TRXD_CreditCardObligationAmount" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="TRXD_CreditCardObligationAmount" xlink:to="TRXD_CreditCardObligationAmount_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="TRXD_CreditCardObligationAmount_lbl" xml:lang="en-US">Credit card obligation</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:label="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:to="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_lbl" xml:lang="en-US">Due in 2020</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:label="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:to="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_lbl" xml:lang="en-US">Due in 2021</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:label="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:to="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_lbl" xml:lang="en-US">Due in 2022</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive" xlink:label="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive" xlink:to="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive_lbl" xml:lang="en-US">Due in 2023</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongTermDebt" xlink:to="us-gaap_LongTermDebt_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_LongTermDebt_2_lbl" xml:lang="en-US">Total Debt</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_RangeAxis" xlink:to="srt_RangeAxis_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="srt_RangeAxis_2_lbl" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="trxd-20190630.xsd#TRXD_WarrantsIssued" xlink:label="TRXD_WarrantsIssued" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="TRXD_WarrantsIssued" xlink:to="TRXD_WarrantsIssued_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="TRXD_WarrantsIssued_lbl" xml:lang="en-US">Warrants issued</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:to="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_2_lbl" xml:lang="en-US">Warrant exercise price</link:label>
      <link:loc xlink:type="locator" xlink:href="trxd-20190630.xsd#TRXD_StockIssuedDuringPeriodSharesWarrantsExercised" xlink:label="TRXD_StockIssuedDuringPeriodSharesWarrantsExercised" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="TRXD_StockIssuedDuringPeriodSharesWarrantsExercised" xlink:to="TRXD_StockIssuedDuringPeriodSharesWarrantsExercised_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="TRXD_StockIssuedDuringPeriodSharesWarrantsExercised_lbl" xml:lang="en-US">Number of warrants exercised</link:label>
      <link:loc xlink:type="locator" xlink:href="trxd-20190630.xsd#TRXD_StockIssuedDuringPeriodValueWarrantsExercised" xlink:label="TRXD_StockIssuedDuringPeriodValueWarrantsExercised" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="TRXD_StockIssuedDuringPeriodValueWarrantsExercised" xlink:to="TRXD_StockIssuedDuringPeriodValueWarrantsExercised_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="TRXD_StockIssuedDuringPeriodValueWarrantsExercised_lbl" xml:lang="en-US">Number of warrants exercised, value</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_lbl" xml:lang="en-US">Number of options, granted</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_lbl" xml:lang="en-US">Exercise price of options granted</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_lbl" xml:lang="en-US">Option term</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_lbl" xml:lang="en-US">Option vested period</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:to="us-gaap_StockIssuedDuringPeriodSharesNewIssues_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues_2_lbl" xml:lang="en-US">Number of common stock issued</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:to="us-gaap_StockIssuedDuringPeriodValueNewIssues_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_StockIssuedDuringPeriodValueNewIssues_2_lbl" xml:lang="en-US">Number of common stock issued, value</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SaleOfStockPricePerShare" xlink:label="us-gaap_SaleOfStockPricePerShare" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SaleOfStockPricePerShare" xlink:to="us-gaap_SaleOfStockPricePerShare_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SaleOfStockPricePerShare_lbl" xml:lang="en-US">Sale of stock price per shares</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ProceedsFromIssuanceOfWarrants" xlink:label="us-gaap_ProceedsFromIssuanceOfWarrants" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromIssuanceOfWarrants" xlink:to="us-gaap_ProceedsFromIssuanceOfWarrants_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromIssuanceOfWarrants_lbl" xml:lang="en-US">Warrant grant price</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" xlink:to="us-gaap_StockIssuedDuringPeriodSharesIssuedForServices_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_StockIssuedDuringPeriodSharesIssuedForServices_2_lbl" xml:lang="en-US">Number of shares issued for services</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueIssuedForServices" xlink:to="us-gaap_StockIssuedDuringPeriodValueIssuedForServices_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_StockIssuedDuringPeriodValueIssuedForServices_2_lbl" xml:lang="en-US">Number of shares issued for services, value</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="TRXD_StockIssuedDuringPeriodSharesStockWarrantExercised" xlink:to="TRXD_StockIssuedDuringPeriodSharesStockWarrantExercised_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="TRXD_StockIssuedDuringPeriodSharesStockWarrantExercised_2_lbl" xml:lang="en-US">Warrants exercised, shares</link:label>
      <link:loc xlink:type="locator" xlink:href="trxd-20190630.xsd#TRXD_WarrantIssuedForRenewalOfConvertibleDebt" xlink:label="TRXD_WarrantIssuedForRenewalOfConvertibleDebt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="TRXD_WarrantIssuedForRenewalOfConvertibleDebt" xlink:to="TRXD_WarrantIssuedForRenewalOfConvertibleDebt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="TRXD_WarrantIssuedForRenewalOfConvertibleDebt_lbl" xml:lang="en-US">Warrant issued for renewal of convertible debt</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" xlink:label="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" xlink:to="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight_lbl" xml:lang="en-US">Warrants exercised</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures_lbl" xml:lang="en-US">Warrant forfeited of shares</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_lbl" xml:lang="en-US">Number of Outstanding Shares, Warrants Outstanding Beginning</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted_lbl" xml:lang="en-US">Number of Outstanding Shares, Warrants granted</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures_2_lbl" xml:lang="en-US">Number of Outstanding Shares, Warrants forfeited</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised_lbl" xml:lang="en-US">Number of Outstanding Shares, Warrants exercised</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_2_lbl" xml:lang="en-US">Number of Outstanding Shares, Warrants Outstanding Ending</link:label>
      <link:loc xlink:type="locator" xlink:href="trxd-20190630.xsd#TRXD_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice" xlink:label="TRXD_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="TRXD_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice" xlink:to="TRXD_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="TRXD_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice_lbl" xml:lang="en-US">Weighted Average Exercise Price, Outstanding Beginning</link:label>
      <link:loc xlink:type="locator" xlink:href="trxd-20190630.xsd#TRXD_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGrantsInPeriodWeightedAverageExercisePrice" xlink:label="TRXD_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGrantsInPeriodWeightedAverageExercisePrice" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="TRXD_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGrantsInPeriodWeightedAverageExercisePrice" xlink:to="TRXD_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGrantsInPeriodWeightedAverageExercisePrice_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="TRXD_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGrantsInPeriodWeightedAverageExercisePrice_lbl" xml:lang="en-US">Weighted Average Exercise Price, Warrants granted</link:label>
      <link:loc xlink:type="locator" xlink:href="trxd-20190630.xsd#TRXD_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitedInPeriodWeightedAverageExercisePrice" xlink:label="TRXD_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitedInPeriodWeightedAverageExercisePrice" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="TRXD_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitedInPeriodWeightedAverageExercisePrice" xlink:to="TRXD_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitedInPeriodWeightedAverageExercisePrice_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="TRXD_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitedInPeriodWeightedAverageExercisePrice_lbl" xml:lang="en-US">Weighted Average Exercise Price, Warrants forfeited</link:label>
      <link:loc xlink:type="locator" xlink:href="trxd-20190630.xsd#TRXD_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisesInPeriodWeightedAverageExercisePrice" xlink:label="TRXD_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisesInPeriodWeightedAverageExercisePrice" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="TRXD_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisesInPeriodWeightedAverageExercisePrice" xlink:to="TRXD_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisesInPeriodWeightedAverageExercisePrice_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="TRXD_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisesInPeriodWeightedAverageExercisePrice_lbl" xml:lang="en-US">Weighted Average Exercise Price, Warrants exercised</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="TRXD_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice" xlink:to="TRXD_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="TRXD_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice_2_lbl" xml:lang="en-US">Weighted Average Exercise Price, Outstanding Ending</link:label>
      <link:loc xlink:type="locator" xlink:href="trxd-20190630.xsd#TRXD_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageRemainingContractualTermBeginning" xlink:label="TRXD_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageRemainingContractualTermBeginning" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="TRXD_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageRemainingContractualTermBeginning" xlink:to="TRXD_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageRemainingContractualTermBeginning_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="TRXD_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageRemainingContractualTermBeginning_lbl" xml:lang="en-US">Weighted Average Remaining Contractual Life Warrants Outstanding, Beginning</link:label>
      <link:loc xlink:type="locator" xlink:href="trxd-20190630.xsd#TRXD_WeightedAverageRemainingContractualLifeWarrantsOutstandingGranted" xlink:label="TRXD_WeightedAverageRemainingContractualLifeWarrantsOutstandingGranted" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="TRXD_WeightedAverageRemainingContractualLifeWarrantsOutstandingGranted" xlink:to="TRXD_WeightedAverageRemainingContractualLifeWarrantsOutstandingGranted_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="TRXD_WeightedAverageRemainingContractualLifeWarrantsOutstandingGranted_lbl" xml:lang="en-US">Weighted Average Remaining Contractual Life Warrants Outstanding, granted</link:label>
      <link:loc xlink:type="locator" xlink:href="trxd-20190630.xsd#TRXD_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageRemainingContractualTermEnding" xlink:label="TRXD_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageRemainingContractualTermEnding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="TRXD_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageRemainingContractualTermEnding" xlink:to="TRXD_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageRemainingContractualTermEnding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="TRXD_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageRemainingContractualTermEnding_lbl" xml:lang="en-US">Weighted Average Remaining Contractual Life Warrants Outstanding Ending</link:label>
      <link:loc xlink:type="locator" xlink:href="trxd-20190630.xsd#TRXD_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingIntrinsicValue" xlink:label="TRXD_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingIntrinsicValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="TRXD_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingIntrinsicValue" xlink:to="TRXD_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingIntrinsicValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="TRXD_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingIntrinsicValue_lbl" xml:lang="en-US">Aggregate Intrinsic Value Outstanding Beginning</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="TRXD_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingIntrinsicValue" xlink:to="TRXD_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingIntrinsicValue_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="TRXD_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingIntrinsicValue_2_lbl" xml:lang="en-US">Aggregate Intrinsic Value Outstanding Ending</link:label>
      <link:loc xlink:type="locator" xlink:href="trxd-20190630.xsd#TRXD_FairValueAssumptionsMeasurementInputPercentages" xlink:label="TRXD_FairValueAssumptionsMeasurementInputPercentages" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="TRXD_FairValueAssumptionsMeasurementInputPercentages" xlink:to="TRXD_FairValueAssumptionsMeasurementInputPercentages_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="TRXD_FairValueAssumptionsMeasurementInputPercentages_lbl" xml:lang="en-US">Fair value assumptions, measurement input, percentages</link:label>
      <link:loc xlink:type="locator" xlink:href="trxd-20190630.xsd#TRXD_FairValueAssumptionsMeasurementInputTerm" xlink:label="TRXD_FairValueAssumptionsMeasurementInputTerm" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="TRXD_FairValueAssumptionsMeasurementInputTerm" xlink:to="TRXD_FairValueAssumptionsMeasurementInputTerm_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="TRXD_FairValueAssumptionsMeasurementInputTerm_lbl" xml:lang="en-US">Fair value assumptions, measurement input, term</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_2_lbl" xml:lang="en-US">Stock option granted</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDescription" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDescription" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDescription" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDescription_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDescription_lbl" xml:lang="en-US">Stock option, description</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_2_lbl" xml:lang="en-US">Stock option vested period</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_lbl" xml:lang="en-US">Stock option issued, forfeited or expired</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockOptionPlanExpense" xlink:to="us-gaap_StockOptionPlanExpense_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_StockOptionPlanExpense_2_lbl" xml:lang="en-US">Option expense</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit" xlink:label="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit" xlink:to="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit_lbl" xml:lang="en-US">Stock option exercise price, lower range limit</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit" xlink:label="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit" xlink:to="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit_lbl" xml:lang="en-US">Stock option exercise price, upper range limit</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_lbl" xml:lang="en-US">Stock option term</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate_lbl" xml:lang="en-US">Options expire date</link:label>
      <link:loc xlink:type="locator" xlink:href="trxd-20190630.xsd#TRXD_FairValueOfOptionGranted" xlink:label="TRXD_FairValueOfOptionGranted" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="TRXD_FairValueOfOptionGranted" xlink:to="TRXD_FairValueOfOptionGranted_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="TRXD_FairValueOfOptionGranted_lbl" xml:lang="en-US">Fair value of options granted</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingRights" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingRights" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingRights" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingRights_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingRights_lbl" xml:lang="en-US">Stock option vested, description</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_lbl" xml:lang="en-US">Unrecognized compensation costs</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_lbl" xml:lang="en-US">Weighted average period term</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_lbl" xml:lang="en-US">Expected dividend yield</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum_lbl" xml:lang="en-US">Weighted-average expected volatility, minimum</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_lbl" xml:lang="en-US">Weighted-average expected volatility, maximum</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_lbl" xml:lang="en-US">Weighted-average risk-free interest rate, minimum</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_lbl" xml:lang="en-US">Weighted-average risk-free interest rate, maximum</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_2_lbl" xml:lang="en-US">Expected life of warrants</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_lbl" xml:lang="en-US">Number of Options Outstanding, Beginning Balance</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_lbl" xml:lang="en-US">Number of Options Exercisable, Beginning Balance</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_3_lbl" xml:lang="en-US">Number of Options, Granted</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_lbl" xml:lang="en-US">Number of Options, Forfeited</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_lbl" xml:lang="en-US">Number of Options, Expired</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_2_lbl" xml:lang="en-US">Number of Options Outstanding, Ending Balance</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_2_lbl" xml:lang="en-US">Number of Options Exercisable, Ending Balance</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_lbl" xml:lang="en-US">Weighted Average Exercise Price Outstanding, Beginning Balance</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_lbl" xml:lang="en-US">Weighted Average Exercise Price Exercisable, Beginning Balance</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_2_lbl" xml:lang="en-US">Weighted Average Exercise Price, Granted</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_lbl" xml:lang="en-US">Weighted Average Exercise Price, Forfeited</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_lbl" xml:lang="en-US">Weighted Average Exercise Price, Expired</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_2_lbl" xml:lang="en-US">Weighted Average Exercise Price Outstanding, Ending Balance</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_2_lbl" xml:lang="en-US">Weighted Average Exercise Price Exercisable, Ending Balance</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_2_lbl" xml:lang="en-US">Contractual Life in Years Outstanding, Beinning Balance</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_lbl" xml:lang="en-US">Contractual Life in Years Exercisable, Beinning Balance</link:label>
      <link:loc xlink:type="locator" xlink:href="trxd-20190630.xsd#TRXD_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTermGranted" xlink:label="TRXD_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTermGranted" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="TRXD_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTermGranted" xlink:to="TRXD_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTermGranted_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="TRXD_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTermGranted_lbl" xml:lang="en-US">Contractual Life in Years, Granted</link:label>
      <link:loc xlink:type="locator" xlink:href="trxd-20190630.xsd#TRXD_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTermForfeitures" xlink:label="TRXD_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTermForfeitures" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="TRXD_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTermForfeitures" xlink:to="TRXD_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTermForfeitures_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="TRXD_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTermForfeitures_lbl" xml:lang="en-US">Contractual Life in Years, Forfeited</link:label>
      <link:loc xlink:type="locator" xlink:href="trxd-20190630.xsd#TRXD_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTermExpired" xlink:label="TRXD_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTermExpired" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="TRXD_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTermExpired" xlink:to="TRXD_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTermExpired_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="TRXD_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTermExpired_lbl" xml:lang="en-US">Contractual Life in Years, Expired</link:label>
      <link:loc xlink:type="locator" xlink:href="trxd-20190630.xsd#TRXD_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm" xlink:label="TRXD_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="TRXD_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm" xlink:to="TRXD_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="TRXD_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm_lbl" xml:lang="en-US">Contractual Life in Years Outstanding, Ending Balance</link:label>
      <link:loc xlink:type="locator" xlink:href="trxd-20190630.xsd#TRXD_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm" xlink:label="TRXD_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="TRXD_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm" xlink:to="TRXD_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="TRXD_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm_lbl" xml:lang="en-US">Contractual Life in Years Exercisable, Ending Balance</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_lbl" xml:lang="en-US">Intrinsic Value Outstanding, Beginning Balance</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_lbl" xml:lang="en-US">Intrinsic Value Exercisable, Beginning Balance</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_2_lbl" xml:lang="en-US">Intrinsic Value Outstanding, Ending Balance</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_2_lbl" xml:lang="en-US">Intrinsic Value Exercisable, Ending Balance</link:label>
      <link:loc xlink:type="locator" xlink:href="trxd-20190630.xsd#TRXD_OperatingLeasesUnits" xlink:label="TRXD_OperatingLeasesUnits" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="TRXD_OperatingLeasesUnits" xlink:to="TRXD_OperatingLeasesUnits_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="TRXD_OperatingLeasesUnits_lbl" xml:lang="en-US">Operating leases units</link:label>
      <link:loc xlink:type="locator" xlink:href="trxd-20190630.xsd#TRXD_OperatingLeaseAmortizationOfAssets" xlink:label="TRXD_OperatingLeaseAmortizationOfAssets" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="TRXD_OperatingLeaseAmortizationOfAssets" xlink:to="TRXD_OperatingLeaseAmortizationOfAssets_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="TRXD_OperatingLeaseAmortizationOfAssets_lbl" xml:lang="en-US">Operating lease amortization of assets</link:label>
      <link:loc xlink:type="locator" xlink:href="trxd-20190630.xsd#TRXD_OperatingLeaseAmortizationOfLiabilities" xlink:label="TRXD_OperatingLeaseAmortizationOfLiabilities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="TRXD_OperatingLeaseAmortizationOfLiabilities" xlink:to="TRXD_OperatingLeaseAmortizationOfLiabilities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="TRXD_OperatingLeaseAmortizationOfLiabilities_lbl" xml:lang="en-US">Operating lease amortization of liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="trxd-20190630.xsd#TRXD_OperatingLeaseInitialLeaseTerm" xlink:label="TRXD_OperatingLeaseInitialLeaseTerm" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="TRXD_OperatingLeaseInitialLeaseTerm" xlink:to="TRXD_OperatingLeaseInitialLeaseTerm_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="TRXD_OperatingLeaseInitialLeaseTerm_lbl" xml:lang="en-US">Initial Lease Term</link:label>
      <link:loc xlink:type="locator" xlink:href="trxd-20190630.xsd#TRXD_OperatingLeaseRenewalTerm" xlink:label="TRXD_OperatingLeaseRenewalTerm" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="TRXD_OperatingLeaseRenewalTerm" xlink:to="TRXD_OperatingLeaseRenewalTerm_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="TRXD_OperatingLeaseRenewalTerm_lbl" xml:lang="en-US">Renewal Term</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseRightOfUseAsset" xlink:to="us-gaap_OperatingLeaseRightOfUseAsset_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_OperatingLeaseRightOfUseAsset_2_lbl" xml:lang="en-US">Initial Recognition of Right to use assets at January 1, 2019</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LesseeOperatingLeaseDiscountRate" xlink:label="us-gaap_LesseeOperatingLeaseDiscountRate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseDiscountRate" xlink:to="us-gaap_LesseeOperatingLeaseDiscountRate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LesseeOperatingLeaseDiscountRate_lbl" xml:lang="en-US">Incremental Borrowing Rate</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_lbl" xml:lang="en-US">2019</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_lbl" xml:lang="en-US">2020</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_lbl" xml:lang="en-US">2021</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_lbl" xml:lang="en-US">2022</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_lbl" xml:lang="en-US">2023</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_lbl" xml:lang="en-US">Thereafter</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_lbl" xml:lang="en-US">Total minimum lease payments</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_lbl" xml:lang="en-US">Less: effect of discounting</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingLeaseLiability" xlink:label="us-gaap_OperatingLeaseLiability" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseLiability" xlink:to="us-gaap_OperatingLeaseLiability_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeaseLiability_lbl" xml:lang="en-US">Present value of future minimum lease payments</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseLiabilityCurrent" xlink:to="us-gaap_OperatingLeaseLiabilityCurrent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_OperatingLeaseLiabilityCurrent_2_lbl" xml:lang="en-US">Less: current obligations under leases</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:to="us-gaap_OperatingLeaseLiabilityNoncurrent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_OperatingLeaseLiabilityNoncurrent_2_lbl" xml:lang="en-US">Long-term lease obligations</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_lbl" xml:lang="en-US">Federal corporate income tax rate</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeTaxExaminationDescription" xlink:label="us-gaap_IncomeTaxExaminationDescription" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxExaminationDescription" xlink:to="us-gaap_IncomeTaxExaminationDescription_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxExaminationDescription_lbl" xml:lang="en-US">Income tax, description</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingLossCarryforwards" xlink:label="us-gaap_OperatingLossCarryforwards" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLossCarryforwards" xlink:to="us-gaap_OperatingLossCarryforwards_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLossCarryforwards_lbl" xml:lang="en-US">Net operating loss carry forwards</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:to="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_lbl" xml:lang="en-US">Federal loss carry forwards</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DeferredTaxAssetsValuationAllowance" xlink:label="us-gaap_DeferredTaxAssetsValuationAllowance" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsValuationAllowance" xlink:to="us-gaap_DeferredTaxAssetsValuationAllowance_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_DeferredTaxAssetsValuationAllowance_lbl" xml:lang="en-US">Less: valuation allowance</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:label="us-gaap_DeferredTaxAssetsLiabilitiesNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:to="us-gaap_DeferredTaxAssetsLiabilitiesNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_DeferredTaxAssetsLiabilitiesNet_lbl" xml:lang="en-US">Deferred tax assets</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OfficersCompensation" xlink:label="us-gaap_OfficersCompensation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OfficersCompensation" xlink:to="us-gaap_OfficersCompensation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OfficersCompensation_lbl" xml:lang="en-US">Executive salaries</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LesseeOperatingLeaseDescription" xlink:label="us-gaap_LesseeOperatingLeaseDescription" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseDescription" xlink:to="us-gaap_LesseeOperatingLeaseDescription_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LesseeOperatingLeaseDescription_lbl" xml:lang="en-US">Operating lease description</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent" xlink:to="us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent_lbl" xml:lang="en-US">2019</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears" xlink:to="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears_lbl" xml:lang="en-US">2020</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears" xlink:to="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears_lbl" xml:lang="en-US">2021</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears" xlink:to="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears_lbl" xml:lang="en-US">2022</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFiveYears" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFiveYears" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFiveYears" xlink:to="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFiveYears_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFiveYears_lbl" xml:lang="en-US">2023</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDue" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeasesFutureMinimumPaymentsDue" xlink:to="us-gaap_OperatingLeasesFutureMinimumPaymentsDue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDue_lbl" xml:lang="en-US">Total</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:to="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_2_lbl" xml:lang="en-US">Revenue</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GrossProfit" xlink:to="us-gaap_GrossProfit_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_GrossProfit_2_lbl" xml:lang="en-US">Gross Profit</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Assets" xlink:to="us-gaap_Assets_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_Assets_2_lbl" xml:lang="en-US">Segment Assets</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ProfitLoss" xlink:label="us-gaap_ProfitLoss" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProfitLoss" xlink:to="us-gaap_ProfitLoss_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProfitLoss_lbl" xml:lang="en-US">Segment Profit/Loss</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:to="us-gaap_EquityMethodInvestmentOwnershipPercentage_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_EquityMethodInvestmentOwnershipPercentage_2_lbl" xml:lang="en-US">Equity method investment ownership percentage</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesGross" xlink:label="us-gaap_PaymentsToAcquireBusinessesGross" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsToAcquireBusinessesGross" xlink:to="us-gaap_PaymentsToAcquireBusinessesGross_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PaymentsToAcquireBusinessesGross_lbl" xml:lang="en-US">Purchase price, cash</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NotesPayable" xlink:label="us-gaap_NotesPayable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NotesPayable" xlink:to="us-gaap_NotesPayable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NotesPayable_lbl" xml:lang="en-US">Promissory note issued</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:to="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_2_lbl" xml:lang="en-US">Number of shares entitled for warrants issued</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WarrantsAndRightsOutstandingTerm" xlink:to="us-gaap_WarrantsAndRightsOutstandingTerm_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_WarrantsAndRightsOutstandingTerm_2_lbl" xml:lang="en-US">Warrant term</link:label>
      <link:loc xlink:type="locator" xlink:href="trxd-20190630.xsd#TRXD_ExerciseRestrictionsLapsePeriod" xlink:label="TRXD_ExerciseRestrictionsLapsePeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="TRXD_ExerciseRestrictionsLapsePeriod" xlink:to="TRXD_ExerciseRestrictionsLapsePeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="TRXD_ExerciseRestrictionsLapsePeriod_lbl" xml:lang="en-US">Exercise restrictions lapse period</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferred1" xlink:label="us-gaap_BusinessCombinationConsiderationTransferred1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationConsiderationTransferred1" xlink:to="us-gaap_BusinessCombinationConsiderationTransferred1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessCombinationConsiderationTransferred1_lbl" xml:lang="en-US">Total purchase price</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_WarrantsNotSettleableInCashFairValueDisclosure" xlink:label="us-gaap_WarrantsNotSettleableInCashFairValueDisclosure" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WarrantsNotSettleableInCashFairValueDisclosure" xlink:to="us-gaap_WarrantsNotSettleableInCashFairValueDisclosure_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_WarrantsNotSettleableInCashFairValueDisclosure_lbl" xml:lang="en-US">Fair value of the warrants issued</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AssetsFairValueDisclosure" xlink:label="us-gaap_AssetsFairValueDisclosure" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsFairValueDisclosure" xlink:to="us-gaap_AssetsFairValueDisclosure_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetsFairValueDisclosure_lbl" xml:lang="en-US">Fair value of warrants</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationConsiderationTransferred1" xlink:to="us-gaap_BusinessCombinationConsiderationTransferred1_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_BusinessCombinationConsiderationTransferred1_2_lbl" xml:lang="en-US">Purchase Price</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_lbl" xml:lang="en-US">Cash</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_lbl" xml:lang="en-US">Accounts Receivable</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_lbl" xml:lang="en-US">Inventory</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets_lbl" xml:lang="en-US">Prepaid</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_lbl" xml:lang="en-US">Accounts Payable</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther_lbl" xml:lang="en-US">Accrued Expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessAcquisitionsProFormaRevenue" xlink:label="us-gaap_BusinessAcquisitionsProFormaRevenue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessAcquisitionsProFormaRevenue" xlink:to="us-gaap_BusinessAcquisitionsProFormaRevenue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessAcquisitionsProFormaRevenue_lbl" xml:lang="en-US">Revenue</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss" xlink:label="us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss" xlink:to="us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss_lbl" xml:lang="en-US">Net Income (Loss)</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessAcquisitionProFormaEarningsPerShareBasic" xlink:label="us-gaap_BusinessAcquisitionProFormaEarningsPerShareBasic" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessAcquisitionProFormaEarningsPerShareBasic" xlink:to="us-gaap_BusinessAcquisitionProFormaEarningsPerShareBasic_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessAcquisitionProFormaEarningsPerShareBasic_lbl" xml:lang="en-US">Net Income per common share - basic</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessAcquisitionProFormaEarningsPerShareDiluted" xlink:label="us-gaap_BusinessAcquisitionProFormaEarningsPerShareDiluted" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessAcquisitionProFormaEarningsPerShareDiluted" xlink:to="us-gaap_BusinessAcquisitionProFormaEarningsPerShareDiluted_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessAcquisitionProFormaEarningsPerShareDiluted_lbl" xml:lang="en-US">Net Income per common share - diluted</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_WeightedAverageBasicSharesOutstandingProForma" xlink:label="us-gaap_WeightedAverageBasicSharesOutstandingProForma" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WeightedAverageBasicSharesOutstandingProForma" xlink:to="us-gaap_WeightedAverageBasicSharesOutstandingProForma_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_WeightedAverageBasicSharesOutstandingProForma_lbl" xml:lang="en-US">Weighted average common shares - basic</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ProFormaWeightedAverageSharesOutstandingDiluted" xlink:label="us-gaap_ProFormaWeightedAverageSharesOutstandingDiluted" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProFormaWeightedAverageSharesOutstandingDiluted" xlink:to="us-gaap_ProFormaWeightedAverageSharesOutstandingDiluted_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProFormaWeightedAverageSharesOutstandingDiluted_lbl" xml:lang="en-US">Weighted average common shares - diluted</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesAndInterestInAffiliates" xlink:label="us-gaap_PaymentsToAcquireBusinessesAndInterestInAffiliates" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsToAcquireBusinessesAndInterestInAffiliates" xlink:to="us-gaap_PaymentsToAcquireBusinessesAndInterestInAffiliates_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PaymentsToAcquireBusinessesAndInterestInAffiliates_lbl" xml:lang="en-US">Payments contributed for equity interest</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsForProceedsFromInvestments" xlink:to="us-gaap_PaymentsForProceedsFromInvestments_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:label="us-gaap_PaymentsForProceedsFromInvestments_2_lbl" xml:lang="en-US">Payment of investment</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeLossFromEquityMethodInvestments" xlink:to="us-gaap_IncomeLossFromEquityMethodInvestments_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:label="us-gaap_IncomeLossFromEquityMethodInvestments_3_lbl" xml:lang="en-US">Equity method investment loss</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TypeOfArrangementAxis" xlink:to="us-gaap_TypeOfArrangementAxis_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_TypeOfArrangementAxis_2_lbl" xml:lang="en-US">Collaborative Arrangement and Arrangement Other than Collaborative [Axis]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:to="us-gaap_StockIssuedDuringPeriodSharesNewIssues_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues_3_lbl" xml:lang="en-US">Number of common stock issued under private placement, shares</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharesIssuedPricePerShare" xlink:to="us-gaap_SharesIssuedPricePerShare_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_SharesIssuedPricePerShare_2_lbl" xml:lang="en-US">Common stock purchase price per share</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ProceedsFromIssuanceOfPrivatePlacement" xlink:label="us-gaap_ProceedsFromIssuanceOfPrivatePlacement" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromIssuanceOfPrivatePlacement" xlink:to="us-gaap_ProceedsFromIssuanceOfPrivatePlacement_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromIssuanceOfPrivatePlacement_lbl" xml:lang="en-US">Gross proceeds from shares issued under private placement</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:to="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_3_lbl" xml:lang="en-US">Number of warrants to purchase shares of common stock</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:to="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_3_lbl" xml:lang="en-US">Warrant exercise price per share</link:label>
      <link:loc xlink:type="locator" xlink:href="trxd-20190630.xsd#TRXD_ClassOfWarrantOrRightNumberOfSecuritiesExercisableByWarrantsOrRights" xlink:label="TRXD_ClassOfWarrantOrRightNumberOfSecuritiesExercisableByWarrantsOrRights" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="TRXD_ClassOfWarrantOrRightNumberOfSecuritiesExercisableByWarrantsOrRights" xlink:to="TRXD_ClassOfWarrantOrRightNumberOfSecuritiesExercisableByWarrantsOrRights_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="TRXD_ClassOfWarrantOrRightNumberOfSecuritiesExercisableByWarrantsOrRights_lbl" xml:lang="en-US">Number of warrants exercisable</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtConversionConvertedInstrumentAmount1" xlink:to="us-gaap_DebtConversionConvertedInstrumentAmount1_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_DebtConversionConvertedInstrumentAmount1_2_lbl" xml:lang="en-US">Debt instrument converted conversion, value</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtConversionConvertedInstrumentSharesIssued1" xlink:to="us-gaap_DebtConversionConvertedInstrumentSharesIssued1_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_DebtConversionConvertedInstrumentSharesIssued1_2_lbl" xml:lang="en-US">Debt instrument converted conversion, shares</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentConvertibleConversionPrice1" xlink:to="us-gaap_DebtInstrumentConvertibleConversionPrice1_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_DebtInstrumentConvertibleConversionPrice1_2_lbl" xml:lang="en-US">Debt instrument conversion price per shares</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RepaymentsOfRelatedPartyDebt" xlink:to="us-gaap_RepaymentsOfRelatedPartyDebt_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RepaymentsOfRelatedPartyDebt_2_lbl" xml:lang="en-US">Repayment of related party debt</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" xlink:label="us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" xlink:to="us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_lbl" xml:lang="en-US">Shares transferred</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationConsiderationTransferred1" xlink:to="us-gaap_BusinessCombinationConsiderationTransferred1_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_BusinessCombinationConsiderationTransferred1_3_lbl" xml:lang="en-US">Business combination consideration transferred</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentFaceAmount" xlink:to="us-gaap_DebtInstrumentFaceAmount_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_DebtInstrumentFaceAmount_2_lbl" xml:lang="en-US">Promissory note issued amount</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentConvertibleConversionPrice1" xlink:to="us-gaap_DebtInstrumentConvertibleConversionPrice1_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DebtInstrumentConvertibleConversionPrice1_3_lbl" xml:lang="en-US">Conversion price of promissory note</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NotesPayable" xlink:to="us-gaap_NotesPayable_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_NotesPayable_2_lbl" xml:lang="en-US">Principal and accrued interest</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtConversionConvertedInstrumentSharesIssued1" xlink:to="us-gaap_DebtConversionConvertedInstrumentSharesIssued1_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DebtConversionConvertedInstrumentSharesIssued1_3_lbl" xml:lang="en-US">Conversion of convertible debt, converted number of shares</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ConversionOfStockSharesConverted1" xlink:label="us-gaap_ConversionOfStockSharesConverted1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConversionOfStockSharesConverted1" xlink:to="us-gaap_ConversionOfStockSharesConverted1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConversionOfStockSharesConverted1_lbl" xml:lang="en-US">Number of common stock shares converted</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConversionOfStockAmountConverted1" xlink:to="us-gaap_ConversionOfStockAmountConverted1_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ConversionOfStockAmountConverted1_2_lbl" xml:lang="en-US">Value of common stock shares converted</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="TRXD_AlliancePharmaSolutionLLCMember" xlink:to="TRXD_AlliancePharmaSolutionLLCMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="TRXD_AlliancePharmaSolutionLLCMember_doc" xml:lang="en-US">Alliance Pharma Solution, LLC [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="TRXD_CommunitySpecialtyPharmacyLLCMember" xlink:to="TRXD_CommunitySpecialtyPharmacyLLCMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="TRXD_CommunitySpecialtyPharmacyLLCMember_doc" xml:lang="en-US">Community Specialty Pharmacy, LLC [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="TRXD_ConvertiblePromissoryNoteMember" xlink:to="TRXD_ConvertiblePromissoryNoteMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="TRXD_ConvertiblePromissoryNoteMember_doc" xml:lang="en-US">Convertible Promissory Note [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="trxd-20190630.xsd#TRXD_ConvertiblePromissoryNoteOneMember" xlink:label="TRXD_ConvertiblePromissoryNoteOneMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="TRXD_ConvertiblePromissoryNoteOneMember" xlink:to="TRXD_ConvertiblePromissoryNoteOneMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="TRXD_ConvertiblePromissoryNoteOneMember_doc" xml:lang="en-US">Convertible Promissory Note One [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="TRXD_EmployeeMember" xlink:to="TRXD_EmployeeMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="TRXD_EmployeeMember_doc" xml:lang="en-US">Employee [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="TRXD_ExerciseRestrictionsLapsePeriod" xlink:to="TRXD_ExerciseRestrictionsLapsePeriod_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="TRXD_ExerciseRestrictionsLapsePeriod_doc" xml:lang="en-US">Exercise restrictions lapse period.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="TRXD_FourOptionGrantedMember" xlink:to="TRXD_FourOptionGrantedMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="TRXD_FourOptionGrantedMember_doc" xml:lang="en-US">Four Option Granted [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="trxd-20190630.xsd#TRXD_IntegraPharmaSolutionsLLCMember" xlink:label="TRXD_IntegraPharmaSolutionsLLCMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="TRXD_IntegraPharmaSolutionsLLCMember" xlink:to="TRXD_IntegraPharmaSolutionsLLCMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="TRXD_IntegraPharmaSolutionsLLCMember_doc" xml:lang="en-US">Integra Pharma Solutions, LLC [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="TRXD_JanuaryThortyOneTwoThousandTwentyMember" xlink:to="TRXD_JanuaryThortyOneTwoThousandTwentyMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="TRXD_JanuaryThortyOneTwoThousandTwentyMember_doc" xml:lang="en-US">January 31, 2020 [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="TRXD_MrNitilPatelMember" xlink:to="TRXD_MrNitilPatelMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="TRXD_MrNitilPatelMember_doc" xml:lang="en-US">Mr. Nitil Patel [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="TRXD_MrPrashantPatelMember" xlink:to="TRXD_MrPrashantPatelMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="TRXD_MrPrashantPatelMember_doc" xml:lang="en-US">Mr. Prashant Patel [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="TRXD_MrShilpaPatelMember" xlink:to="TRXD_MrShilpaPatelMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="TRXD_MrShilpaPatelMember_doc" xml:lang="en-US">Mr. Shilpa Patel [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="TRXD_MrSurenAjjarapuMember" xlink:to="TRXD_MrSurenAjjarapuMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="TRXD_MrSurenAjjarapuMember_doc" xml:lang="en-US">Mr. Suren Ajjarapu [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="TRXD_NPRINVESTMENTGROUPLLCMember" xlink:to="TRXD_NPRINVESTMENTGROUPLLCMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="TRXD_NPRINVESTMENTGROUPLLCMember_doc" xml:lang="en-US">NPR INVESTMENT GROUP, LLC [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="TRXD_NikulPanchalMember" xlink:to="TRXD_NikulPanchalMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="TRXD_NikulPanchalMember_doc" xml:lang="en-US">Nikul Panchal [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="trxd-20190630.xsd#TRXD_NotesPayableMember" xlink:label="TRXD_NotesPayableMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="TRXD_NotesPayableMember" xlink:to="TRXD_NotesPayableMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="TRXD_NotesPayableMember_doc" xml:lang="en-US">Notes Payable [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="TRXD_OtherMember" xlink:to="TRXD_OtherMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="TRXD_OtherMember_doc" xml:lang="en-US">Other [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="TRXD_PanOpticHealthLLCMember" xlink:to="TRXD_PanOpticHealthLLCMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="TRXD_PanOpticHealthLLCMember_doc" xml:lang="en-US">PanOptic Health, LLC [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="TRXD_PrivateOfferMemorandumMember" xlink:to="TRXD_PrivateOfferMemorandumMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="TRXD_PrivateOfferMemorandumMember_doc" xml:lang="en-US">Private Offer Memorandum [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="trxd-20190630.xsd#TRXD_PromissoryNoteAgreementMember" xlink:label="TRXD_PromissoryNoteAgreementMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="TRXD_PromissoryNoteAgreementMember" xlink:to="TRXD_PromissoryNoteAgreementMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="TRXD_PromissoryNoteAgreementMember_doc" xml:lang="en-US">Promissory Note Agreement [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="TRXD_PromissoryNoteMember" xlink:to="TRXD_PromissoryNoteMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="TRXD_PromissoryNoteMember_doc" xml:lang="en-US">Promissory Note [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="TRXD_PromissoryNoteOneMember" xlink:to="TRXD_PromissoryNoteOneMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="TRXD_PromissoryNoteOneMember_doc" xml:lang="en-US">Promissory Note One [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="TRXD_PromissoryNoteTwoMember" xlink:to="TRXD_PromissoryNoteTwoMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="TRXD_PromissoryNoteTwoMember_doc" xml:lang="en-US">Promissory Note Two [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="TRXD_PromissoryNotesMember" xlink:to="TRXD_PromissoryNotesMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="TRXD_PromissoryNotesMember_doc" xml:lang="en-US">Promissory Notes [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="TRXD_RelatedPartyConvertiblePromissoryNoteMember" xlink:to="TRXD_RelatedPartyConvertiblePromissoryNoteMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="TRXD_RelatedPartyConvertiblePromissoryNoteMember_doc" xml:lang="en-US">Related Party Convertible Promissory Note [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="TRXD_RelatedPartyConvertiblePromissoryNotesMember" xlink:to="TRXD_RelatedPartyConvertiblePromissoryNotesMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="TRXD_RelatedPartyConvertiblePromissoryNotesMember_doc" xml:lang="en-US">Related Party Convertible Promissory Note [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="TRXD_RelatedPartyPromissoryNoteMember" xlink:to="TRXD_RelatedPartyPromissoryNoteMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="TRXD_RelatedPartyPromissoryNoteMember_doc" xml:lang="en-US">Related Party Promissory Note [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="trxd-20190630.xsd#TRXD_RelatedPartyPromissoryNotesMember" xlink:label="TRXD_RelatedPartyPromissoryNotesMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="TRXD_RelatedPartyPromissoryNotesMember" xlink:to="TRXD_RelatedPartyPromissoryNotesMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="TRXD_RelatedPartyPromissoryNotesMember_doc" xml:lang="en-US">Related Party Promissory Notes [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="TRXD_SansurAssociatesLLCMember" xlink:to="TRXD_SansurAssociatesLLCMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="TRXD_SansurAssociatesLLCMember_doc" xml:lang="en-US">Sansur Associates, LLC [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="trxd-20190630.xsd#TRXD_SecuredConvertiblePromissoryNotesMember" xlink:label="TRXD_SecuredConvertiblePromissoryNotesMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="TRXD_SecuredConvertiblePromissoryNotesMember" xlink:to="TRXD_SecuredConvertiblePromissoryNotesMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="TRXD_SecuredConvertiblePromissoryNotesMember_doc" xml:lang="en-US">Secured Convertible Promissory Notes [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="TRXD_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm" xlink:to="TRXD_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="TRXD_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm_doc" xml:lang="en-US">Contractual Life in Years Exercisable, Ending Balance.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="TRXD_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTermExpired" xlink:to="TRXD_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTermExpired_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="TRXD_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTermExpired_doc" xml:lang="en-US">Contractual Life in Years, Expired.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="TRXD_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTermForfeitures" xlink:to="TRXD_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTermForfeitures_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="TRXD_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTermForfeitures_doc" xml:lang="en-US">Contractual Life in Years, Forfeited.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="TRXD_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTermGranted" xlink:to="TRXD_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTermGranted_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="TRXD_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTermGranted_doc" xml:lang="en-US">Contractual Life in Years, Granted.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="TRXD_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm" xlink:to="TRXD_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="TRXD_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm_doc" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term Granted.</link:label>
      <link:loc xlink:type="locator" xlink:href="trxd-20190630.xsd#TRXD_ShortTermConvertibleNotesPayableMember" xlink:label="TRXD_ShortTermConvertibleNotesPayableMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="TRXD_ShortTermConvertibleNotesPayableMember" xlink:to="TRXD_ShortTermConvertibleNotesPayableMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="TRXD_ShortTermConvertibleNotesPayableMember_doc" xml:lang="en-US">Short Term Convertible Notes Payable [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="TRXD_ShortTermConvertibleNotesPayableRelatedParties" xlink:to="TRXD_ShortTermConvertibleNotesPayableRelatedParties_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="TRXD_ShortTermConvertibleNotesPayableRelatedParties_doc" xml:lang="en-US">Short term convertible notes payable - related parties.</link:label>
      <link:loc xlink:type="locator" xlink:href="trxd-20190630.xsd#TRXD_ShortTermConvertibleNotesPayableRelatedPartiesMember" xlink:label="TRXD_ShortTermConvertibleNotesPayableRelatedPartiesMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="TRXD_ShortTermConvertibleNotesPayableRelatedPartiesMember" xlink:to="TRXD_ShortTermConvertibleNotesPayableRelatedPartiesMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="TRXD_ShortTermConvertibleNotesPayableRelatedPartiesMember_doc" xml:lang="en-US">Short Term Convertible Notes Payable - Related Parties [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="TRXD_ShortTermNotesPayableMember" xlink:to="TRXD_ShortTermNotesPayableMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="TRXD_ShortTermNotesPayableMember_doc" xml:lang="en-US">Short Term Notes Payable [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="TRXD_ShortTermPromissoryNotesMember" xlink:to="TRXD_ShortTermPromissoryNotesMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="TRXD_ShortTermPromissoryNotesMember_doc" xml:lang="en-US">Short Term Promissory Notes [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="TRXD_ShortTermRelatedPartyConvertibleNotesMember" xlink:to="TRXD_ShortTermRelatedPartyConvertibleNotesMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="TRXD_ShortTermRelatedPartyConvertibleNotesMember_doc" xml:lang="en-US">Short-term Related Party Convertible Notes [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="TRXD_SpecialtyPharmacyLLCMember" xlink:to="TRXD_SpecialtyPharmacyLLCMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="TRXD_SpecialtyPharmacyLLCMember_doc" xml:lang="en-US">Specialty Pharmacy, LLC [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="TRXD_StockOptionPlanMember" xlink:to="TRXD_StockOptionPlanMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="TRXD_StockOptionPlanMember_doc" xml:lang="en-US">Stock Option Plan [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="TRXD_SyncHealthMSOLLCMember" xlink:to="TRXD_SyncHealthMSOLLCMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="TRXD_SyncHealthMSOLLCMember_doc" xml:lang="en-US">SyncHealth MSO, LLC [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="TRXD_TrxadeIncMember" xlink:to="TRXD_TrxadeIncMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="TRXD_TrxadeIncMember_doc" xml:lang="en-US">Trxade, Inc.[Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="TRXD_TrxadeMember" xlink:to="TRXD_TrxadeMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="TRXD_TrxadeMember_doc" xml:lang="en-US">Trxade [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="TRXD_TwoCustomersMember" xlink:to="TRXD_TwoCustomersMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="TRXD_TwoCustomersMember_doc" xml:lang="en-US">Two Customers [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="trxd-20190630.xsd#TRXD_TwoThousandAndEighteenMember" xlink:label="TRXD_TwoThousandAndEighteenMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="TRXD_TwoThousandAndEighteenMember" xlink:to="TRXD_TwoThousandAndEighteenMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="TRXD_TwoThousandAndEighteenMember_doc" xml:lang="en-US">2018 [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="TRXD_WarrantsTextBlock" xlink:to="TRXD_WarrantsTextBlock_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="TRXD_WarrantsTextBlock_doc" xml:lang="en-US">Warrants [Text Block]</link:label>
      <link:loc xlink:type="locator" xlink:href="trxd-20190630.xsd#TRXD_WestminsterPharmaceuticalsLLCMember" xlink:label="TRXD_WestminsterPharmaceuticalsLLCMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="TRXD_WestminsterPharmaceuticalsLLCMember" xlink:to="TRXD_WestminsterPharmaceuticalsLLCMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="TRXD_WestminsterPharmaceuticalsLLCMember_doc" xml:lang="en-US">Westminster Pharmaceuticals, LLC [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="TRXD_IncreaseDecreaseInLeaseLiability" xlink:to="TRXD_IncreaseDecreaseInLeaseLiability_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="TRXD_IncreaseDecreaseInLeaseLiability_doc" xml:lang="en-US">Increase decrease in lease liability.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="TRXD_AmortizationOfRightToUseAsset" xlink:to="TRXD_AmortizationOfRightToUseAsset_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="TRXD_AmortizationOfRightToUseAsset_doc" xml:lang="en-US">Amortization of right to use asset.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="TRXD_RightUseOfAssetsAndOperatingLeaseObligationsRecognized" xlink:to="TRXD_RightUseOfAssetsAndOperatingLeaseObligationsRecognized_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="TRXD_RightUseOfAssetsAndOperatingLeaseObligationsRecognized_doc" xml:lang="en-US">Right-use-of assets and operating lease obligations recognized.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="TRXD_OperatingLeaseAmortizationOfLiabilities" xlink:to="TRXD_OperatingLeaseAmortizationOfLiabilities_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="TRXD_OperatingLeaseAmortizationOfLiabilities_doc" xml:lang="en-US">Operating lease amortization of liabilities.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="TRXD_OperatingLeasesUnits" xlink:to="TRXD_OperatingLeasesUnits_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="TRXD_OperatingLeasesUnits_doc" xml:lang="en-US">Operating leases units.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="TRXD_OperatingLeaseInitialLeaseTerm" xlink:to="TRXD_OperatingLeaseInitialLeaseTerm_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="TRXD_OperatingLeaseInitialLeaseTerm_doc" xml:lang="en-US">Operating lease initial lease term.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="TRXD_OperatingLeaseRenewalTerm" xlink:to="TRXD_OperatingLeaseRenewalTerm_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="TRXD_OperatingLeaseRenewalTerm_doc" xml:lang="en-US">Operating lease renewal term.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="TRXD_LeaseOneMember" xlink:to="TRXD_LeaseOneMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="TRXD_LeaseOneMember_doc" xml:lang="en-US">Lease 1 [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="TRXD_LeaseTwoMember" xlink:to="TRXD_LeaseTwoMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="TRXD_LeaseTwoMember_doc" xml:lang="en-US">Lease 2 [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="TRXD_StockIssuedDuringPeriodValueStockWarrantExercised" xlink:to="TRXD_StockIssuedDuringPeriodValueStockWarrantExercised_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="TRXD_StockIssuedDuringPeriodValueStockWarrantExercised_doc" xml:lang="en-US">Stock issued during period value stock warrant exercised.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="TRXD_StockIssuedDuringPeriodSharesStockWarrantExercised" xlink:to="TRXD_StockIssuedDuringPeriodSharesStockWarrantExercised_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="TRXD_StockIssuedDuringPeriodSharesStockWarrantExercised_doc" xml:lang="en-US">Stock issued during period shares stock warrant exercised.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="TRXD_SecuritiesPurchaseAgreementMember" xlink:to="TRXD_SecuritiesPurchaseAgreementMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="TRXD_SecuritiesPurchaseAgreementMember_doc" xml:lang="en-US">Securities Purchase Agreement [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="TRXD_AccreditedInvestorMember" xlink:to="TRXD_AccreditedInvestorMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="TRXD_AccreditedInvestorMember_doc" xml:lang="en-US">Accredited Investor [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="TRXD_NumeratorForBasicAndDilutedEpsIncomeLossAvailableToCommonShareholders" xlink:to="TRXD_NumeratorForBasicAndDilutedEpsIncomeLossAvailableToCommonShareholders_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="TRXD_NumeratorForBasicAndDilutedEpsIncomeLossAvailableToCommonShareholders_doc" xml:lang="en-US">Represents the monetary amount of Numerator for basic and diluted EPS - income (loss) Available to common shareholders, during the indicated time period.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="TRXD_WarrantsIssued" xlink:to="TRXD_WarrantsIssued_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="TRXD_WarrantsIssued_doc" xml:lang="en-US">Warrants issued.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="TRXD_StockIssuedDuringPeriodSharesWarrantsExercised" xlink:to="TRXD_StockIssuedDuringPeriodSharesWarrantsExercised_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="TRXD_StockIssuedDuringPeriodSharesWarrantsExercised_doc" xml:lang="en-US">Stock issued during period shares warrants exercised.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="TRXD_StockIssuedDuringPeriodValueWarrantsExercised" xlink:to="TRXD_StockIssuedDuringPeriodValueWarrantsExercised_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="TRXD_StockIssuedDuringPeriodValueWarrantsExercised_doc" xml:lang="en-US">Stock issued during period value warrants exercised.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="TRXD_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice" xlink:to="TRXD_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="TRXD_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice_doc" xml:lang="en-US">Weighted average price at which grantees can acquire the shares reserved for issuance under the stock non-option equity plan.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="TRXD_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGrantsInPeriodWeightedAverageExercisePrice" xlink:to="TRXD_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGrantsInPeriodWeightedAverageExercisePrice_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="TRXD_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGrantsInPeriodWeightedAverageExercisePrice_doc" xml:lang="en-US">Weighted average per share amount at which grantees can acquire shares of common stock by exercise of non-option equity.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="TRXD_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitedInPeriodWeightedAverageExercisePrice" xlink:to="TRXD_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitedInPeriodWeightedAverageExercisePrice_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="TRXD_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitedInPeriodWeightedAverageExercisePrice_doc" xml:lang="en-US">Exercise Price Per Share Warrants forfeited.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="TRXD_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisesInPeriodWeightedAverageExercisePrice" xlink:to="TRXD_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisesInPeriodWeightedAverageExercisePrice_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="TRXD_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisesInPeriodWeightedAverageExercisePrice_doc" xml:lang="en-US">Weighted average price at which non-option equity holders acquired shares when converting their non-option equity into shares.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="TRXD_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageRemainingContractualTermBeginning" xlink:to="TRXD_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageRemainingContractualTermBeginning_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="TRXD_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageRemainingContractualTermBeginning_doc" xml:lang="en-US">Weighted average remaining contractual term for non-option equity awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="TRXD_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageRemainingContractualTermEnding" xlink:to="TRXD_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageRemainingContractualTermEnding_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="TRXD_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageRemainingContractualTermEnding_doc" xml:lang="en-US">Weighted average remaining contractual term for non-option equity awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="TRXD_OperatingLeaseAmortizationOfAssets" xlink:to="TRXD_OperatingLeaseAmortizationOfAssets_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="TRXD_OperatingLeaseAmortizationOfAssets_doc" xml:lang="en-US">Operating lease amortization of assets.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="TRXD_EquityMethodInvestmentDescription" xlink:to="TRXD_EquityMethodInvestmentDescription_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="TRXD_EquityMethodInvestmentDescription_doc" xml:lang="en-US">Equity method investment, description.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="TRXD_AdjustmentsToAdditionalPaidInCapitalWarrantsForAcquisition" xlink:to="TRXD_AdjustmentsToAdditionalPaidInCapitalWarrantsForAcquisition_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="TRXD_AdjustmentsToAdditionalPaidInCapitalWarrantsForAcquisition_doc" xml:lang="en-US">Adjustments to additional paid in capital warrants for acquisition.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="TRXD_RelatedPartyNotePayableAndWarrantsIssuedForAcquisition" xlink:to="TRXD_RelatedPartyNotePayableAndWarrantsIssuedForAcquisition_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="TRXD_RelatedPartyNotePayableAndWarrantsIssuedForAcquisition_doc" xml:lang="en-US">Related party note payable and warrants issued for acquisition.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="TRXD_ReclassFromAccruedInterestToShortTermConvertibleNotes" xlink:to="TRXD_ReclassFromAccruedInterestToShortTermConvertibleNotes_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="TRXD_ReclassFromAccruedInterestToShortTermConvertibleNotes_doc" xml:lang="en-US">Reclass from accrued interest to short term convertible notes.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="TRXD_ArrangementToMoveRelatedPartyAccountsPayableToNotesPayable" xlink:to="TRXD_ArrangementToMoveRelatedPartyAccountsPayableToNotesPayable_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="TRXD_ArrangementToMoveRelatedPartyAccountsPayableToNotesPayable_doc" xml:lang="en-US">Arrangement to move related party Accounts Payable to Notes Payable.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="TRXD_CostOfGoodsSoldPolicyTextBlock" xlink:to="TRXD_CostOfGoodsSoldPolicyTextBlock_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="TRXD_CostOfGoodsSoldPolicyTextBlock_doc" xml:lang="en-US">Cost of Goods Sold [Policy Text Block]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="TRXD_RecoveryOfBadDebt" xlink:to="TRXD_RecoveryOfBadDebt_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="TRXD_RecoveryOfBadDebt_doc" xml:lang="en-US">Represents the monetary amount of Recovery of bad debt, during the indicated time period.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="TRXD_ValuationAllowancePercentage" xlink:to="TRXD_ValuationAllowancePercentage_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="TRXD_ValuationAllowancePercentage_doc" xml:lang="en-US">Valuation allowance percentage.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="TRXD_GrantedWarrants" xlink:to="TRXD_GrantedWarrants_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="TRXD_GrantedWarrants_doc" xml:lang="en-US">Granted warrants.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="TRXD_DebtModificationsAmount" xlink:to="TRXD_DebtModificationsAmount_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="TRXD_DebtModificationsAmount_doc" xml:lang="en-US">Debt modification amount.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="TRXD_CreditCardObligationAmount" xlink:to="TRXD_CreditCardObligationAmount_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="TRXD_CreditCardObligationAmount_doc" xml:lang="en-US">Credit card obligation.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="TRXD_WarrantIssuedForRenewalOfConvertibleDebt" xlink:to="TRXD_WarrantIssuedForRenewalOfConvertibleDebt_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="TRXD_WarrantIssuedForRenewalOfConvertibleDebt_doc" xml:lang="en-US">Warrant issued for renewal of convertible debt.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="TRXD_FairValueAssumptionsMeasurementInputPercentages" xlink:to="TRXD_FairValueAssumptionsMeasurementInputPercentages_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="TRXD_FairValueAssumptionsMeasurementInputPercentages_doc" xml:lang="en-US">Fair value assumptions, measurement input, percentages.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="TRXD_FairValueAssumptionsMeasurementInputTerm" xlink:to="TRXD_FairValueAssumptionsMeasurementInputTerm_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="TRXD_FairValueAssumptionsMeasurementInputTerm_doc" xml:lang="en-US">Fair value assumptions, measurement input, term.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="TRXD_WeightedAverageRemainingContractualLifeWarrantsOutstandingGranted" xlink:to="TRXD_WeightedAverageRemainingContractualLifeWarrantsOutstandingGranted_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="TRXD_WeightedAverageRemainingContractualLifeWarrantsOutstandingGranted_doc" xml:lang="en-US">Weighted average remaining contractual term for vested portions of non-option equity outstanding and currently exercisable or convertible, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="TRXD_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingIntrinsicValue" xlink:to="TRXD_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingIntrinsicValue_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="TRXD_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingIntrinsicValue_doc" xml:lang="en-US">Sharebased compensation arrangement by sharebased payment award non options outstanding intrinsic value.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="TRXD_FairValueOfOptionGranted" xlink:to="TRXD_FairValueOfOptionGranted_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="TRXD_FairValueOfOptionGranted_doc" xml:lang="en-US">Fair value of option granted.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="TRXD_MayOneTwoThousandNineteenMember" xlink:to="TRXD_MayOneTwoThousandNineteenMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="TRXD_MayOneTwoThousandNineteenMember_doc" xml:lang="en-US">May 1, 2019 [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="TRXD_AugustOneTwoThousandNineteenMember" xlink:to="TRXD_AugustOneTwoThousandNineteenMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="TRXD_AugustOneTwoThousandNineteenMember_doc" xml:lang="en-US">August 1, 2019 [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="TRXD_NovemberOneTwoThousandNineteenMember" xlink:to="TRXD_NovemberOneTwoThousandNineteenMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="TRXD_NovemberOneTwoThousandNineteenMember_doc" xml:lang="en-US">November 1, 2019 [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="TRXD_SummaryOfEstimateFairValueOfWarrantsTableTextBlock" xlink:to="TRXD_SummaryOfEstimateFairValueOfWarrantsTableTextBlock_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="TRXD_SummaryOfEstimateFairValueOfWarrantsTableTextBlock_doc" xml:lang="en-US">Summary of estimate the fair value of warrants [Table Text Block]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="TRXD_MrPrashantPatelAndMrSurenAjjarapuMember" xlink:to="TRXD_MrPrashantPatelAndMrSurenAjjarapuMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="TRXD_MrPrashantPatelAndMrSurenAjjarapuMember_doc" xml:lang="en-US">Mr. Prashant Patel and Mr. Suren Ajjarapu [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="TRXD_ConsultingAgreementMember" xlink:to="TRXD_ConsultingAgreementMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="TRXD_ConsultingAgreementMember_doc" xml:lang="en-US">Consulting Agreement [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="TRXD_ClassOfWarrantOrRightNumberOfSecuritiesExercisableByWarrantsOrRights" xlink:to="TRXD_ClassOfWarrantOrRightNumberOfSecuritiesExercisableByWarrantsOrRights_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="TRXD_ClassOfWarrantOrRightNumberOfSecuritiesExercisableByWarrantsOrRights_doc" xml:lang="en-US">Number of warrant exercisable.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="TRXD_RelatedPartyConvertiblePromissoryNotesMember" xlink:to="TRXD_RelatedPartyConvertiblePromissoryNotesMember_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="TRXD_RelatedPartyConvertiblePromissoryNotesMember_3_lbl" xml:lang="en-US">RelatedPartyConvertiblePromissoryNotesMember</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_AssetsCurrent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetsCurrent_2_lbl" xml:lang="en-US">Assets, Current</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_LiabilitiesCurrent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesCurrent_2_lbl" xml:lang="en-US">Liabilities, Current</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Liabilities" xlink:to="us-gaap_Liabilities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_Liabilities_2_lbl" xml:lang="en-US">Liabilities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_StockholdersEquity_4_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockholdersEquity_4_lbl" xml:lang="en-US">Stockholders' Equity Attributable to Parent</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_LiabilitiesAndStockholdersEquity_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity_2_lbl" xml:lang="en-US">Liabilities and Equity</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingIncomeLoss" xlink:to="us-gaap_OperatingIncomeLoss_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingIncomeLoss_2_lbl" xml:lang="en-US">Operating Income (Loss)</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestExpense" xlink:to="us-gaap_InterestExpense_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InterestExpense_2_lbl" xml:lang="en-US">Interest Expense</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharesOutstanding" xlink:to="us-gaap_SharesOutstanding_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharesOutstanding_3_lbl" xml:lang="en-US">Shares, Outstanding</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:to="us-gaap_IncreaseDecreaseInAccountsReceivable_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInAccountsReceivable_2_lbl" xml:lang="en-US">Increase (Decrease) in Accounts Receivable</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:to="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_2_lbl" xml:lang="en-US">Increase (Decrease) in Prepaid Expense and Other Assets</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInInventories" xlink:to="us-gaap_IncreaseDecreaseInInventories_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInInventories_2_lbl" xml:lang="en-US">Increase (Decrease) in Inventories</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="TRXD_IncreaseDecreaseInLeaseLiability" xlink:to="TRXD_IncreaseDecreaseInLeaseLiability_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="TRXD_IncreaseDecreaseInLeaseLiability_3_lbl" xml:lang="en-US">IncreaseDecreaseInLeaseLiability</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccountsPayable" xlink:to="us-gaap_IncreaseDecreaseInAccountsPayable_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayable_2_lbl" xml:lang="en-US">Increase (Decrease) in Accounts Payable</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities_2_lbl" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsToAcquireEquityMethodInvestments" xlink:to="us-gaap_PaymentsToAcquireEquityMethodInvestments_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PaymentsToAcquireEquityMethodInvestments_2_lbl" xml:lang="en-US">Payments to Acquire Equity Method Investments</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:to="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_2_lbl" xml:lang="en-US">Payments to Acquire Property, Plant, and Equipment</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsForProceedsFromInvestments" xlink:to="us-gaap_PaymentsForProceedsFromInvestments_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PaymentsForProceedsFromInvestments_3_lbl" xml:lang="en-US">Payments for (Proceeds from) Investments</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities_2_lbl" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RepaymentsOfShortTermDebt" xlink:to="us-gaap_RepaymentsOfShortTermDebt_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RepaymentsOfShortTermDebt_2_lbl" xml:lang="en-US">Repayments of Short-term Debt</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities_2_lbl" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_2_lbl" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_3_lbl" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:to="us-gaap_StockholdersEquityNoteDisclosureTextBlock_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockholdersEquityNoteDisclosureTextBlock_2_lbl" xml:lang="en-US">Stockholders' Equity Note Disclosure [Text Block]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryPolicyTextBlock" xlink:to="us-gaap_InventoryPolicyTextBlock_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InventoryPolicyTextBlock_2_lbl" xml:lang="en-US">Inventory, Policy [Policy Text Block]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy" xlink:to="us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy_2_lbl" xml:lang="en-US">Goodwill and Intangible Assets, Goodwill, Policy [Policy Text Block]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxPolicyTextBlock" xlink:to="us-gaap_IncomeTaxPolicyTextBlock_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxPolicyTextBlock_2_lbl" xml:lang="en-US">Income Tax, Policy [Policy Text Block]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_3_lbl" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Outstanding, Number</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised_2_lbl" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Exercised</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="TRXD_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice" xlink:to="TRXD_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice_4_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="TRXD_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice_4_lbl" xml:lang="en-US">ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="TRXD_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingIntrinsicValue" xlink:to="TRXD_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingIntrinsicValue_4_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="TRXD_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingIntrinsicValue_4_lbl" xml:lang="en-US">ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingIntrinsicValue</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_3_lbl" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_3_lbl" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_2_lbl" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_2_lbl" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_3_lbl" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_3_lbl" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_3_lbl" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_3_lbl" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_2_lbl" xml:lang="en-US">Lessee, Operating Lease, Liability, Payments, Due</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_2_lbl" xml:lang="en-US">Lessee, Operating Lease, Liability, Undiscounted Excess Amount</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsValuationAllowance" xlink:to="us-gaap_DeferredTaxAssetsValuationAllowance_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsValuationAllowance_2_lbl" xml:lang="en-US">Deferred Tax Assets, Valuation Allowance</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:to="us-gaap_DeferredTaxAssetsLiabilitiesNet_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsLiabilitiesNet_2_lbl" xml:lang="en-US">Deferred Tax Assets, Net</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent" xlink:to="us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent_2_lbl" xml:lang="en-US">Operating Leases, Future Minimum Payments Due, Next Twelve Months</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears" xlink:to="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears_2_lbl" xml:lang="en-US">Operating Leases, Future Minimum Payments, Due in Two Years</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears" xlink:to="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears_2_lbl" xml:lang="en-US">Operating Leases, Future Minimum Payments, Due in Three Years</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears" xlink:to="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears_2_lbl" xml:lang="en-US">Operating Leases, Future Minimum Payments, Due in Four Years</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFiveYears" xlink:to="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFiveYears_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFiveYears_2_lbl" xml:lang="en-US">Operating Leases, Future Minimum Payments, Due in Five Years</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeasesFutureMinimumPaymentsDue" xlink:to="us-gaap_OperatingLeasesFutureMinimumPaymentsDue_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDue_2_lbl" xml:lang="en-US">Operating Leases, Future Minimum Payments Due</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_2_lbl" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Cash and Equivalents</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_2_lbl" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Receivables</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_2_lbl" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Inventory</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets_2_lbl" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Prepaid Expense and Other Assets</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_2_lbl" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Accounts Payable</link:label>
    </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>22
<FILENAME>trxd-20190630_pre.xml
<DESCRIPTION>XBRL PRESENTATION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.1b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: http://www.novaworks.co -->
    <!-- Field: Doc-Info; Name: Source; Value: TRXD 20190630 S%2D1 DFN.xfr; Date: 2019%2D10%2D15T18:00:38Z -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef roleURI="http://trxadegroup.com/role/DocumentAndEntityInformation" xlink:href="trxd-20190630.xsd#DocumentAndEntityInformation" xlink:type="simple" />
    <link:roleRef roleURI="http://trxadegroup.com/role/BalanceSheets" xlink:href="trxd-20190630.xsd#BalanceSheets" xlink:type="simple" />
    <link:roleRef roleURI="http://trxadegroup.com/role/BalanceSheetsParenthetical" xlink:href="trxd-20190630.xsd#BalanceSheetsParenthetical" xlink:type="simple" />
    <link:roleRef roleURI="http://trxadegroup.com/role/StatementsOfOperations" xlink:href="trxd-20190630.xsd#StatementsOfOperations" xlink:type="simple" />
    <link:roleRef roleURI="http://trxadegroup.com/role/StatementsOfChangesInShareholdersEquity" xlink:href="trxd-20190630.xsd#StatementsOfChangesInShareholdersEquity" xlink:type="simple" />
    <link:roleRef roleURI="http://trxadegroup.com/role/StatementsOfCashFlows" xlink:href="trxd-20190630.xsd#StatementsOfCashFlows" xlink:type="simple" />
    <link:roleRef roleURI="http://trxadegroup.com/role/OrganizationAndBasisOfPresentation" xlink:href="trxd-20190630.xsd#OrganizationAndBasisOfPresentation" xlink:type="simple" />
    <link:roleRef roleURI="http://trxadegroup.com/role/SummaryOfSignificantAccountingPolicies" xlink:href="trxd-20190630.xsd#SummaryOfSignificantAccountingPolicies" xlink:type="simple" />
    <link:roleRef roleURI="http://trxadegroup.com/role/Short-termDebtAndRelatedPartiesDebt" xlink:href="trxd-20190630.xsd#Short-termDebtAndRelatedPartiesDebt" xlink:type="simple" />
    <link:roleRef roleURI="http://trxadegroup.com/role/LongTermDebt-RelatedParties" xlink:href="trxd-20190630.xsd#LongTermDebt-RelatedParties" xlink:type="simple" />
    <link:roleRef roleURI="http://trxadegroup.com/role/ShareholdersEquity" xlink:href="trxd-20190630.xsd#ShareholdersEquity" xlink:type="simple" />
    <link:roleRef roleURI="http://trxadegroup.com/role/Warrants" xlink:href="trxd-20190630.xsd#Warrants" xlink:type="simple" />
    <link:roleRef roleURI="http://trxadegroup.com/role/Options" xlink:href="trxd-20190630.xsd#Options" xlink:type="simple" />
    <link:roleRef roleURI="http://trxadegroup.com/role/Leases" xlink:href="trxd-20190630.xsd#Leases" xlink:type="simple" />
    <link:roleRef roleURI="http://trxadegroup.com/role/IncomeTaxes" xlink:href="trxd-20190630.xsd#IncomeTaxes" xlink:type="simple" />
    <link:roleRef roleURI="http://trxadegroup.com/role/RelatedParties" xlink:href="trxd-20190630.xsd#RelatedParties" xlink:type="simple" />
    <link:roleRef roleURI="http://trxadegroup.com/role/CommitmentsAndContingencies" xlink:href="trxd-20190630.xsd#CommitmentsAndContingencies" xlink:type="simple" />
    <link:roleRef roleURI="http://trxadegroup.com/role/SegmentReporting" xlink:href="trxd-20190630.xsd#SegmentReporting" xlink:type="simple" />
    <link:roleRef roleURI="http://trxadegroup.com/role/BusinessCombination" xlink:href="trxd-20190630.xsd#BusinessCombination" xlink:type="simple" />
    <link:roleRef roleURI="http://trxadegroup.com/role/EquityMethodInvestment" xlink:href="trxd-20190630.xsd#EquityMethodInvestment" xlink:type="simple" />
    <link:roleRef roleURI="http://trxadegroup.com/role/SubsequentEvents" xlink:href="trxd-20190630.xsd#SubsequentEvents" xlink:type="simple" />
    <link:roleRef roleURI="http://trxadegroup.com/role/SummaryOfSignificantAccountingPoliciesPolicies" xlink:href="trxd-20190630.xsd#SummaryOfSignificantAccountingPoliciesPolicies" xlink:type="simple" />
    <link:roleRef roleURI="http://trxadegroup.com/role/OrganizationAndBasisOfPresentationTables" xlink:href="trxd-20190630.xsd#OrganizationAndBasisOfPresentationTables" xlink:type="simple" />
    <link:roleRef roleURI="http://trxadegroup.com/role/SummaryOfSignificantAccountingPoliciesTables" xlink:href="trxd-20190630.xsd#SummaryOfSignificantAccountingPoliciesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://trxadegroup.com/role/LongTermDebt-RelatedPartiesTables" xlink:href="trxd-20190630.xsd#LongTermDebt-RelatedPartiesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://trxadegroup.com/role/WarrantsTables" xlink:href="trxd-20190630.xsd#WarrantsTables" xlink:type="simple" />
    <link:roleRef roleURI="http://trxadegroup.com/role/OptionsTables" xlink:href="trxd-20190630.xsd#OptionsTables" xlink:type="simple" />
    <link:roleRef roleURI="http://trxadegroup.com/role/LeasesTables" xlink:href="trxd-20190630.xsd#LeasesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://trxadegroup.com/role/IncomeTaxesTables" xlink:href="trxd-20190630.xsd#IncomeTaxesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://trxadegroup.com/role/CommitmentsAndContingenciesTables" xlink:href="trxd-20190630.xsd#CommitmentsAndContingenciesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://trxadegroup.com/role/SegmentReportingTables" xlink:href="trxd-20190630.xsd#SegmentReportingTables" xlink:type="simple" />
    <link:roleRef roleURI="http://trxadegroup.com/role/BusinessCombinationTables" xlink:href="trxd-20190630.xsd#BusinessCombinationTables" xlink:type="simple" />
    <link:roleRef roleURI="http://trxadegroup.com/role/OrganizationAndBasisOfPresentationDetailsNarrative" xlink:href="trxd-20190630.xsd#OrganizationAndBasisOfPresentationDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://trxadegroup.com/role/OrganizationDetailsNarrative10-k" xlink:href="trxd-20190630.xsd#OrganizationDetailsNarrative10-k" xlink:type="simple" />
    <link:roleRef roleURI="http://trxadegroup.com/role/OrganizationAndBasisOfPresentation-ScheduleOfEarningsPerShareBasicAndDilutedDetails" xlink:href="trxd-20190630.xsd#OrganizationAndBasisOfPresentation-ScheduleOfEarningsPerShareBasicAndDilutedDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://trxadegroup.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative10-k" xlink:href="trxd-20190630.xsd#SummaryOfSignificantAccountingPoliciesDetailsNarrative10-k" xlink:type="simple" />
    <link:roleRef roleURI="http://trxadegroup.com/role/SummaryOfSignificantAccountingPolicies-ScheduleOfEarningsPerShareBasicAndDilutedDetails10-k" xlink:href="trxd-20190630.xsd#SummaryOfSignificantAccountingPolicies-ScheduleOfEarningsPerShareBasicAndDilutedDetails10-k" xlink:type="simple" />
    <link:roleRef roleURI="http://trxadegroup.com/role/Short-termDebtAndRelatedPartiesDebtDetailsNarrative" xlink:href="trxd-20190630.xsd#Short-termDebtAndRelatedPartiesDebtDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://trxadegroup.com/role/Short-termDebtAndRelatedPartiesDebtDetailsNarrative10-k" xlink:href="trxd-20190630.xsd#Short-termDebtAndRelatedPartiesDebtDetailsNarrative10-k" xlink:type="simple" />
    <link:roleRef roleURI="http://trxadegroup.com/role/LongTermDebt-RelatedPartiesDetailsNarrative" xlink:href="trxd-20190630.xsd#LongTermDebt-RelatedPartiesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://trxadegroup.com/role/LongTermDebtDetailsNarrative10-k" xlink:href="trxd-20190630.xsd#LongTermDebtDetailsNarrative10-k" xlink:type="simple" />
    <link:roleRef roleURI="http://trxadegroup.com/role/LongTermDebt-ScheduleOfFutureMaturitiesOfLong-termDebtDetails10-k" xlink:href="trxd-20190630.xsd#LongTermDebt-ScheduleOfFutureMaturitiesOfLong-termDebtDetails10-k" xlink:type="simple" />
    <link:roleRef roleURI="http://trxadegroup.com/role/ShareholdersEquityDetailsNarrative" xlink:href="trxd-20190630.xsd#ShareholdersEquityDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://trxadegroup.com/role/StockholdersEquityDetailsNarrative10-k" xlink:href="trxd-20190630.xsd#StockholdersEquityDetailsNarrative10-k" xlink:type="simple" />
    <link:roleRef roleURI="http://trxadegroup.com/role/WarrantsDetailsNarrative" xlink:href="trxd-20190630.xsd#WarrantsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://trxadegroup.com/role/WarrantsDetailsNarrative10-k" xlink:href="trxd-20190630.xsd#WarrantsDetailsNarrative10-k" xlink:type="simple" />
    <link:roleRef roleURI="http://trxadegroup.com/role/Warrants-ScheduleOfOutstandingAndExercisableWarrantsDetails" xlink:href="trxd-20190630.xsd#Warrants-ScheduleOfOutstandingAndExercisableWarrantsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://trxadegroup.com/role/Warrants-SummaryOfEstimateFairValueOfWarrantsDetails10-k" xlink:href="trxd-20190630.xsd#Warrants-SummaryOfEstimateFairValueOfWarrantsDetails10-k" xlink:type="simple" />
    <link:roleRef roleURI="http://trxadegroup.com/role/OptionsDetailsNarrative" xlink:href="trxd-20190630.xsd#OptionsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://trxadegroup.com/role/OptionsDetailsNarrative10-k" xlink:href="trxd-20190630.xsd#OptionsDetailsNarrative10-k" xlink:type="simple" />
    <link:roleRef roleURI="http://trxadegroup.com/role/Options-ScheduleOfEstimateFairValueOfStockOptionsDetails" xlink:href="trxd-20190630.xsd#Options-ScheduleOfEstimateFairValueOfStockOptionsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://trxadegroup.com/role/Options-ScheduleOfStockOptionActivityDetails" xlink:href="trxd-20190630.xsd#Options-ScheduleOfStockOptionActivityDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://trxadegroup.com/role/LeasesDetailsNarrative" xlink:href="trxd-20190630.xsd#LeasesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://trxadegroup.com/role/Leases-ScheduleOfOperatingLeasesDetails" xlink:href="trxd-20190630.xsd#Leases-ScheduleOfOperatingLeasesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://trxadegroup.com/role/Leases-ScheduleOfFutureMinimumPaymentsForOperatingLeaseLiabilitiesDetails" xlink:href="trxd-20190630.xsd#Leases-ScheduleOfFutureMinimumPaymentsForOperatingLeaseLiabilitiesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://trxadegroup.com/role/IncomeTaxesDetailsNarrative10-k" xlink:href="trxd-20190630.xsd#IncomeTaxesDetailsNarrative10-k" xlink:type="simple" />
    <link:roleRef roleURI="http://trxadegroup.com/role/IncomeTaxes-ScheduleOfDeferredTaxAssetsDetails10-k" xlink:href="trxd-20190630.xsd#IncomeTaxes-ScheduleOfDeferredTaxAssetsDetails10-k" xlink:type="simple" />
    <link:roleRef roleURI="http://trxadegroup.com/role/RelatedPartiesDetailsNarrative10-k" xlink:href="trxd-20190630.xsd#RelatedPartiesDetailsNarrative10-k" xlink:type="simple" />
    <link:roleRef roleURI="http://trxadegroup.com/role/CommitmentsAndContingenciesDetailsNarrative10-k" xlink:href="trxd-20190630.xsd#CommitmentsAndContingenciesDetailsNarrative10-k" xlink:type="simple" />
    <link:roleRef roleURI="http://trxadegroup.com/role/CommitmentsAndContingencies-ScheduleOfFutureMinimumRentalPaymentsUnderNon-cancelableOperatingLeasesDetails10-k" xlink:href="trxd-20190630.xsd#CommitmentsAndContingencies-ScheduleOfFutureMinimumRentalPaymentsUnderNon-cancelableOperatingLeasesDetails10-k" xlink:type="simple" />
    <link:roleRef roleURI="http://trxadegroup.com/role/SegmentReporting-ScheduleOfBusinessInterestsIntoReportableSegmentsDetails" xlink:href="trxd-20190630.xsd#SegmentReporting-ScheduleOfBusinessInterestsIntoReportableSegmentsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://trxadegroup.com/role/BusinessCombinationDetailsNarrative" xlink:href="trxd-20190630.xsd#BusinessCombinationDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://trxadegroup.com/role/BusinessCombinationDetailsNarrative10-k" xlink:href="trxd-20190630.xsd#BusinessCombinationDetailsNarrative10-k" xlink:type="simple" />
    <link:roleRef roleURI="http://trxadegroup.com/role/BusinessCombination-ScheduleOfAssetsAcquiredAndLiabilitiesAssumedDetails" xlink:href="trxd-20190630.xsd#BusinessCombination-ScheduleOfAssetsAcquiredAndLiabilitiesAssumedDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://trxadegroup.com/role/BusinessCombination-ScheduleOfUnauditedProFormaStatementsOfOperationsDetails" xlink:href="trxd-20190630.xsd#BusinessCombination-ScheduleOfUnauditedProFormaStatementsOfOperationsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://trxadegroup.com/role/EquityMethodInvestmentDetailsNarrative" xlink:href="trxd-20190630.xsd#EquityMethodInvestmentDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://trxadegroup.com/role/SubsequentEventsDetailsNarrative" xlink:href="trxd-20190630.xsd#SubsequentEventsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://trxadegroup.com/role/SubsequentEventsDetailsNarrative10-k" xlink:href="trxd-20190630.xsd#SubsequentEventsDetailsNarrative10-k" xlink:type="simple" />
    <link:presentationLink xlink:type="extended" xlink:role="http://trxadegroup.com/role/DocumentAndEntityInformation" xlink:title="00000001 - Document - Document and Entity Information">
      <link:loc xlink:type="locator" xlink:href="trxd-20190630.xsd#TRXD_DocumentAndEntityInformationAbstract" xlink:label="loc_TRXDDocumentAndEntityInformationAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityRegistrantName" xlink:label="loc_deiEntityRegistrantName" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_TRXDDocumentAndEntityInformationAbstract" xlink:to="loc_deiEntityRegistrantName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityCentralIndexKey" xlink:label="loc_deiEntityCentralIndexKey" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_TRXDDocumentAndEntityInformationAbstract" xlink:to="loc_deiEntityCentralIndexKey" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentType" xlink:label="loc_deiDocumentType" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_TRXDDocumentAndEntityInformationAbstract" xlink:to="loc_deiDocumentType" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_deiDocumentPeriodEndDate" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_TRXDDocumentAndEntityInformationAbstract" xlink:to="loc_deiDocumentPeriodEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_AmendmentFlag" xlink:label="loc_deiAmendmentFlag" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_TRXDDocumentAndEntityInformationAbstract" xlink:to="loc_deiAmendmentFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityFilerCategory" xlink:label="loc_deiEntityFilerCategory" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_TRXDDocumentAndEntityInformationAbstract" xlink:to="loc_deiEntityFilerCategory" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntitySmallBusiness" xlink:label="loc_deiEntitySmallBusiness" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_TRXDDocumentAndEntityInformationAbstract" xlink:to="loc_deiEntitySmallBusiness" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_deiEntityEmergingGrowthCompany" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_TRXDDocumentAndEntityInformationAbstract" xlink:to="loc_deiEntityEmergingGrowthCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityExTransitionPeriod" xlink:label="loc_deiEntityExTransitionPeriod" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_TRXDDocumentAndEntityInformationAbstract" xlink:to="loc_deiEntityExTransitionPeriod" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://trxadegroup.com/role/BalanceSheets" xlink:title="00000002 - Statement - Consolidated Balance Sheets">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="loc_us-gaapStatementOfFinancialPositionAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AssetsAbstract" xlink:label="loc_us-gaapAssetsAbstract" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapAssetsAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AssetsCurrentAbstract" xlink:label="loc_us-gaapAssetsCurrentAbstract" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsAbstract" xlink:to="loc_us-gaapAssetsCurrentAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="loc_us-gaapCashAndCashEquivalentsAtCarryingValue" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_us-gaapCashAndCashEquivalentsAtCarryingValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccountsReceivableNetCurrent" xlink:label="loc_us-gaapAccountsReceivableNetCurrent" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_us-gaapAccountsReceivableNetCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InventoryNet" xlink:label="loc_us-gaapInventoryNet" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_us-gaapInventoryNet" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PrepaidExpenseCurrent" xlink:label="loc_us-gaapPrepaidExpenseCurrent" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_us-gaapPrepaidExpenseCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherAssetsCurrent" xlink:label="loc_us-gaapOtherAssetsCurrent" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_us-gaapOtherAssetsCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AssetsCurrent" xlink:label="loc_us-gaapAssetsCurrent" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_us-gaapAssetsCurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="loc_us-gaapPropertyPlantAndEquipmentNet" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsAbstract" xlink:to="loc_us-gaapPropertyPlantAndEquipmentNet" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AssetsNoncurrentAbstract" xlink:label="loc_us-gaapAssetsNoncurrentAbstract" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsAbstract" xlink:to="loc_us-gaapAssetsNoncurrentAbstract" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DepositsAssetsNoncurrent" xlink:label="loc_us-gaapDepositsAssetsNoncurrent" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsNoncurrentAbstract" xlink:to="loc_us-gaapDepositsAssetsNoncurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EquityMethodInvestments" xlink:label="loc_us-gaapEquityMethodInvestments" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsNoncurrentAbstract" xlink:to="loc_us-gaapEquityMethodInvestments" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset" xlink:label="loc_us-gaapOperatingLeaseRightOfUseAsset" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsNoncurrentAbstract" xlink:to="loc_us-gaapOperatingLeaseRightOfUseAsset" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_Goodwill" xlink:label="loc_us-gaapGoodwill" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsNoncurrentAbstract" xlink:to="loc_us-gaapGoodwill" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_Assets" xlink:label="loc_us-gaapAssets" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsAbstract" xlink:to="loc_us-gaapAssets" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:label="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract" xlink:label="loc_us-gaapLiabilitiesCurrentAbstract" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" xlink:to="loc_us-gaapLiabilitiesCurrentAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccountsPayableCurrent" xlink:label="loc_us-gaapAccountsPayableCurrent" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract" xlink:to="loc_us-gaapAccountsPayableCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent" xlink:label="loc_us-gaapAccruedLiabilitiesCurrent" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract" xlink:to="loc_us-gaapAccruedLiabilitiesCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent" xlink:label="loc_us-gaapOperatingLeaseLiabilityCurrent" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract" xlink:to="loc_us-gaapOperatingLeaseLiabilityCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NotesPayableCurrent" xlink:label="loc_us-gaapNotesPayableCurrent" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract" xlink:to="loc_us-gaapNotesPayableCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ConvertibleNotesPayableCurrent" xlink:label="loc_us-gaapConvertibleNotesPayableCurrent" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract" xlink:to="loc_us-gaapConvertibleNotesPayableCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="trxd-20190630.xsd#TRXD_ShortTermConvertibleNotesPayableRelatedParties" xlink:label="loc_TRXDShortTermConvertibleNotesPayableRelatedParties" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract" xlink:to="loc_TRXDShortTermConvertibleNotesPayableRelatedParties" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LiabilitiesCurrent" xlink:label="loc_us-gaapLiabilitiesCurrent" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract" xlink:to="loc_us-gaapLiabilitiesCurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LiabilitiesNoncurrentAbstract" xlink:label="loc_us-gaapLiabilitiesNoncurrentAbstract" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" xlink:to="loc_us-gaapLiabilitiesNoncurrentAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ConvertibleLongTermNotesPayable" xlink:label="loc_us-gaapConvertibleLongTermNotesPayable" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesNoncurrentAbstract" xlink:to="loc_us-gaapConvertibleLongTermNotesPayable" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NotesPayableRelatedPartiesNoncurrent" xlink:label="loc_us-gaapNotesPayableRelatedPartiesNoncurrent" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesNoncurrentAbstract" xlink:to="loc_us-gaapNotesPayableRelatedPartiesNoncurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:label="loc_us-gaapOperatingLeaseLiabilityNoncurrent" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesNoncurrentAbstract" xlink:to="loc_us-gaapOperatingLeaseLiabilityNoncurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_Liabilities" xlink:label="loc_us-gaapLiabilities" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" xlink:to="loc_us-gaapLiabilities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockholdersEquityAbstract" xlink:label="loc_us-gaapStockholdersEquityAbstract" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" xlink:to="loc_us-gaapStockholdersEquityAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PreferredStockValue" xlink:label="loc_us-gaapPreferredStockValue" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityAbstract" xlink:to="loc_us-gaapPreferredStockValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CommonStockValue" xlink:label="loc_us-gaapCommonStockValue" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityAbstract" xlink:to="loc_us-gaapCommonStockValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AdditionalPaidInCapital" xlink:label="loc_us-gaapAdditionalPaidInCapital" />
      <link:presentationArc order="320" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityAbstract" xlink:to="loc_us-gaapAdditionalPaidInCapital" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="loc_us-gaapRetainedEarningsAccumulatedDeficit" />
      <link:presentationArc order="330" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityAbstract" xlink:to="loc_us-gaapRetainedEarningsAccumulatedDeficit" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaapStockholdersEquity" />
      <link:presentationArc order="340" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStockholdersEquityAbstract" xlink:to="loc_us-gaapStockholdersEquity" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="loc_us-gaapLiabilitiesAndStockholdersEquity" />
      <link:presentationArc order="350" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquityAbstract" xlink:to="loc_us-gaapLiabilitiesAndStockholdersEquity" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://trxadegroup.com/role/BalanceSheetsParenthetical" xlink:title="00000003 - Statement - Consolidated Balance Sheets (Parenthetical)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="loc_us-gaapStatementOfFinancialPositionAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentAxis" xlink:label="loc_us-gaapDebtInstrumentAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapDebtInstrumentAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="loc_us-gaapDebtInstrumentNameDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentAxis" xlink:to="loc_us-gaapDebtInstrumentNameDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="trxd-20190630.xsd#TRXD_ShortTermNotesPayableMember" xlink:label="loc_TRXDShortTermNotesPayableMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentNameDomain" xlink:to="loc_TRXDShortTermNotesPayableMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentUnamortizedDiscountCurrent" xlink:label="loc_us-gaapDebtInstrumentUnamortizedDiscountCurrent" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDebtInstrumentUnamortizedDiscountCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare" xlink:label="loc_us-gaapPreferredStockParOrStatedValuePerShare" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapPreferredStockParOrStatedValuePerShare" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:label="loc_us-gaapPreferredStockSharesAuthorized" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapPreferredStockSharesAuthorized" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PreferredStockSharesIssued" xlink:label="loc_us-gaapPreferredStockSharesIssued" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapPreferredStockSharesIssued" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PreferredStockSharesOutstanding" xlink:label="loc_us-gaapPreferredStockSharesOutstanding" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapPreferredStockSharesOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="loc_us-gaapCommonStockParOrStatedValuePerShare" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCommonStockParOrStatedValuePerShare" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="loc_us-gaapCommonStockSharesAuthorized" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCommonStockSharesAuthorized" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CommonStockSharesIssued" xlink:label="loc_us-gaapCommonStockSharesIssued" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCommonStockSharesIssued" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="loc_us-gaapCommonStockSharesOutstanding" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCommonStockSharesOutstanding" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://trxadegroup.com/role/StatementsOfOperations" xlink:title="00000004 - Statement - Consolidated Statements of Operations">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeStatementAbstract" xlink:label="loc_us-gaapIncomeStatementAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:label="loc_us-gaapRevenueFromContractWithCustomerExcludingAssessedTax" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapRevenueFromContractWithCustomerExcludingAssessedTax" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CostOfGoodsAndServicesSold" xlink:label="loc_us-gaapCostOfGoodsAndServicesSold" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapCostOfGoodsAndServicesSold" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_GrossProfit" xlink:label="loc_us-gaapGrossProfit" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapGrossProfit" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingExpensesAbstract" xlink:label="loc_us-gaapOperatingExpensesAbstract" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapOperatingExpensesAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_GeneralAndAdministrativeExpense" xlink:label="loc_us-gaapGeneralAndAdministrativeExpense" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOperatingExpensesAbstract" xlink:to="loc_us-gaapGeneralAndAdministrativeExpense" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingIncomeLoss" xlink:label="loc_us-gaapOperatingIncomeLoss" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapOperatingIncomeLoss" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeLossFromEquityMethodInvestments" xlink:label="loc_us-gaapIncomeLossFromEquityMethodInvestments" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapIncomeLossFromEquityMethodInvestments" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherNonoperatingIncome" xlink:label="loc_us-gaapOtherNonoperatingIncome" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapOtherNonoperatingIncome" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:label="loc_us-gaapGainsLossesOnExtinguishmentOfDebt" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapGainsLossesOnExtinguishmentOfDebt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InterestExpense" xlink:label="loc_us-gaapInterestExpense" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapInterestExpense" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapNetIncomeLoss" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EarningsPerShareBasic" xlink:label="loc_us-gaapEarningsPerShareBasic" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapEarningsPerShareBasic" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EarningsPerShareDiluted" xlink:label="loc_us-gaapEarningsPerShareDiluted" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapEarningsPerShareDiluted" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:label="loc_us-gaapWeightedAverageNumberOfSharesOutstandingBasic" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapWeightedAverageNumberOfSharesOutstandingBasic" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:label="loc_us-gaapWeightedAverageNumberOfDilutedSharesOutstanding" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapWeightedAverageNumberOfDilutedSharesOutstanding" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://trxadegroup.com/role/StatementsOfChangesInShareholdersEquity" xlink:title="00000005 - Statement - Consolidated Statements of Changes in Shareholders' Equity">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementOfStockholdersEquityAbstract" xlink:label="loc_us-gaapStatementOfStockholdersEquityAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfStockholdersEquityAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaapStatementEquityComponentsAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementEquityComponentsAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain" order="50" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PreferredStockMember" xlink:label="loc_us-gaapPreferredStockMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapPreferredStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaapCommonStockMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapCommonStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:label="loc_us-gaapAdditionalPaidInCapitalMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapAdditionalPaidInCapitalMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RetainedEarningsMember" xlink:label="loc_us-gaapRetainedEarningsMember" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapRetainedEarningsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaapStockholdersEquity" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockholdersEquity" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SharesOutstanding" xlink:label="loc_us-gaapSharesOutstanding" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSharesOutstanding" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueNewIssues" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueNewIssues" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueIssuedForServices" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueIssuedForServices" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueIssuedForServices" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesIssuedForServices" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesIssuedForServices" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" xlink:label="loc_us-gaapAdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapAdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueConversionOfConvertibleSecurities" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueConversionOfConvertibleSecurities" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued" xlink:label="loc_us-gaapAdjustmentsToAdditionalPaidInCapitalWarrantIssued" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapAdjustmentsToAdditionalPaidInCapitalWarrantIssued" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="trxd-20190630.xsd#TRXD_StockIssuedDuringPeriodValueStockWarrantExercised" xlink:label="loc_TRXDStockIssuedDuringPeriodValueStockWarrantExercised" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_TRXDStockIssuedDuringPeriodValueStockWarrantExercised" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="trxd-20190630.xsd#TRXD_StockIssuedDuringPeriodSharesStockWarrantExercised" xlink:label="loc_TRXDStockIssuedDuringPeriodSharesStockWarrantExercised" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_TRXDStockIssuedDuringPeriodSharesStockWarrantExercised" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="trxd-20190630.xsd#TRXD_AdjustmentsToAdditionalPaidInCapitalWarrantsForAcquisition" xlink:label="loc_TRXDAdjustmentsToAdditionalPaidInCapitalWarrantsForAcquisition" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_TRXDAdjustmentsToAdditionalPaidInCapitalWarrantsForAcquisition" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapNetIncomeLoss" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaapStockholdersEquity_2" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockholdersEquity_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SharesOutstanding" xlink:label="loc_us-gaapSharesOutstanding_2" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSharesOutstanding_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://trxadegroup.com/role/StatementsOfCashFlows" xlink:title="00000006 - Statement - Consolidated Statements of Cash Flows">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract" xlink:label="loc_us-gaapStatementOfCashFlowsAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapNetIncomeLoss" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_Depreciation" xlink:label="loc_us-gaapDepreciation" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapDepreciation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims" xlink:label="loc_us-gaapIssuanceOfStockAndWarrantsForServicesOrClaims" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapIssuanceOfStockAndWarrantsForServicesOrClaims" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockOptionPlanExpense" xlink:label="loc_us-gaapStockOptionPlanExpense" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapStockOptionPlanExpense" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeLossFromEquityMethodInvestments" xlink:label="loc_us-gaapIncomeLossFromEquityMethodInvestments" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapIncomeLossFromEquityMethodInvestments" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ProvisionForDoubtfulAccounts" xlink:label="loc_us-gaapProvisionForDoubtfulAccounts" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapProvisionForDoubtfulAccounts" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:label="loc_us-gaapGainsLossesOnExtinguishmentOfDebt" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapGainsLossesOnExtinguishmentOfDebt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="trxd-20190630.xsd#TRXD_AmortizationOfRightToUseAsset" xlink:label="loc_TRXDAmortizationOfRightToUseAsset" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_TRXDAmortizationOfRightToUseAsset" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AmortizationOfDebtDiscountPremium" xlink:label="loc_us-gaapAmortizationOfDebtDiscountPremium" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapAmortizationOfDebtDiscountPremium" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:label="loc_us-gaapIncreaseDecreaseInOperatingCapitalAbstract" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInOperatingCapitalAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:label="loc_us-gaapIncreaseDecreaseInAccountsReceivable" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingCapitalAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInAccountsReceivable" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:label="loc_us-gaapIncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingCapitalAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncreaseDecreaseInInventories" xlink:label="loc_us-gaapIncreaseDecreaseInInventories" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingCapitalAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInInventories" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="trxd-20190630.xsd#TRXD_IncreaseDecreaseInLeaseLiability" xlink:label="loc_TRXDIncreaseDecreaseInLeaseLiability" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingCapitalAbstract" xlink:to="loc_TRXDIncreaseDecreaseInLeaseLiability" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayable" xlink:label="loc_us-gaapIncreaseDecreaseInAccountsPayable" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingCapitalAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInAccountsPayable" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities" xlink:label="loc_us-gaapIncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingCapitalAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:label="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesAbstract" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PaymentsToAcquireEquityMethodInvestments" xlink:label="loc_us-gaapPaymentsToAcquireEquityMethodInvestments" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="loc_us-gaapPaymentsToAcquireEquityMethodInvestments" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:label="loc_us-gaapPaymentsToAcquirePropertyPlantAndEquipment" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="loc_us-gaapPaymentsToAcquirePropertyPlantAndEquipment" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PaymentsForProceedsFromInvestments" xlink:label="loc_us-gaapPaymentsForProceedsFromInvestments" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="loc_us-gaapPaymentsForProceedsFromInvestments" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:label="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RepaymentsOfRelatedPartyDebt" xlink:label="loc_us-gaapRepaymentsOfRelatedPartyDebt" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="loc_us-gaapRepaymentsOfRelatedPartyDebt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RepaymentsOfShortTermDebt" xlink:label="loc_us-gaapRepaymentsOfShortTermDebt" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="loc_us-gaapRepaymentsOfShortTermDebt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ProceedsFromRelatedPartyDebt" xlink:label="loc_us-gaapProceedsFromRelatedPartyDebt" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="loc_us-gaapProceedsFromRelatedPartyDebt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ProceedsFromWarrantExercises" xlink:label="loc_us-gaapProceedsFromWarrantExercises" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="loc_us-gaapProceedsFromWarrantExercises" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:label="loc_us-gaapProceedsFromIssuanceOfCommonStock" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="loc_us-gaapProceedsFromIssuanceOfCommonStock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:label="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:label="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" />
      <link:presentationArc order="320" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:label="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_2" />
      <link:presentationArc order="330" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SupplementalCashFlowInformationAbstract" xlink:label="loc_us-gaapSupplementalCashFlowInformationAbstract" />
      <link:presentationArc order="340" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapSupplementalCashFlowInformationAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InterestPaidNet" xlink:label="loc_us-gaapInterestPaidNet" />
      <link:presentationArc order="350" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSupplementalCashFlowInformationAbstract" xlink:to="loc_us-gaapInterestPaidNet" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeTaxesPaidNet" xlink:label="loc_us-gaapIncomeTaxesPaidNet" />
      <link:presentationArc order="360" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSupplementalCashFlowInformationAbstract" xlink:to="loc_us-gaapIncomeTaxesPaidNet" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:label="loc_us-gaapCashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" />
      <link:presentationArc order="370" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapCashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ConversionOfStockAmountConverted1" xlink:label="loc_us-gaapConversionOfStockAmountConverted1" />
      <link:presentationArc order="380" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:to="loc_us-gaapConversionOfStockAmountConverted1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="trxd-20190630.xsd#TRXD_RightUseOfAssetsAndOperatingLeaseObligationsRecognized" xlink:label="loc_TRXDRightUseOfAssetsAndOperatingLeaseObligationsRecognized" />
      <link:presentationArc order="390" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:to="loc_TRXDRightUseOfAssetsAndOperatingLeaseObligationsRecognized" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="trxd-20190630.xsd#TRXD_RelatedPartyNotePayableAndWarrantsIssuedForAcquisition" xlink:label="loc_TRXDRelatedPartyNotePayableAndWarrantsIssuedForAcquisition" />
      <link:presentationArc order="400" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:to="loc_TRXDRelatedPartyNotePayableAndWarrantsIssuedForAcquisition" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="trxd-20190630.xsd#TRXD_ReclassFromAccruedInterestToShortTermConvertibleNotes" xlink:label="loc_TRXDReclassFromAccruedInterestToShortTermConvertibleNotes" />
      <link:presentationArc order="410" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:to="loc_TRXDReclassFromAccruedInterestToShortTermConvertibleNotes" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="trxd-20190630.xsd#TRXD_ArrangementToMoveRelatedPartyAccountsPayableToNotesPayable" xlink:label="loc_TRXDArrangementToMoveRelatedPartyAccountsPayableToNotesPayable" />
      <link:presentationArc order="420" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:to="loc_TRXDArrangementToMoveRelatedPartyAccountsPayableToNotesPayable" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://trxadegroup.com/role/OrganizationAndBasisOfPresentation" xlink:title="00000007 - Disclosure - Organization and Basis of Presentation">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:label="loc_us-gaapOrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock" xlink:label="loc_us-gaapOrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="loc_us-gaapOrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://trxadegroup.com/role/SummaryOfSignificantAccountingPolicies" xlink:title="00000008 - Disclosure - Summary of Significant Accounting Policies">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaapAccountingPoliciesAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SignificantAccountingPoliciesTextBlock" xlink:label="loc_us-gaapSignificantAccountingPoliciesTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapSignificantAccountingPoliciesTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://trxadegroup.com/role/Short-termDebtAndRelatedPartiesDebt" xlink:title="00000009 - Disclosure - Short-Term Debt and Related Parties Debt">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="loc_us-gaapDebtDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShortTermDebtTextBlock" xlink:label="loc_us-gaapShortTermDebtTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtDisclosureAbstract" xlink:to="loc_us-gaapShortTermDebtTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://trxadegroup.com/role/LongTermDebt-RelatedParties" xlink:title="00000010 - Disclosure - Long Term Debt - Related Parties">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="loc_us-gaapDebtDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LongTermDebtTextBlock" xlink:label="loc_us-gaapLongTermDebtTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtDisclosureAbstract" xlink:to="loc_us-gaapLongTermDebtTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://trxadegroup.com/role/ShareholdersEquity" xlink:title="00000011 - Disclosure - Shareholders' Equity">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EquityAbstract" xlink:label="loc_us-gaapEquityAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:label="loc_us-gaapStockholdersEquityNoteDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_us-gaapStockholdersEquityNoteDisclosureTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://trxadegroup.com/role/Warrants" xlink:title="00000012 - Disclosure - Warrants">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_WarrantsAndRightsNoteDisclosureAbstract" xlink:label="loc_us-gaapWarrantsAndRightsNoteDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="trxd-20190630.xsd#TRXD_WarrantsTextBlock" xlink:label="loc_TRXDWarrantsTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapWarrantsAndRightsNoteDisclosureAbstract" xlink:to="loc_TRXDWarrantsTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://trxadegroup.com/role/Options" xlink:title="00000013 - Disclosure - Options">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="loc_us-gaapDisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:label="loc_us-gaapDisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="loc_us-gaapDisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://trxadegroup.com/role/Leases" xlink:title="00000014 - Disclosure - Leases">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LeasesAbstract" xlink:label="loc_us-gaapLeasesAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LesseeOperatingLeasesTextBlock" xlink:label="loc_us-gaapLesseeOperatingLeasesTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLeasesAbstract" xlink:to="loc_us-gaapLesseeOperatingLeasesTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://trxadegroup.com/role/IncomeTaxes" xlink:title="00000015 - Disclosure - Income Taxes">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="loc_us-gaapIncomeTaxDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeTaxDisclosureTextBlock" xlink:label="loc_us-gaapIncomeTaxDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapIncomeTaxDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://trxadegroup.com/role/RelatedParties" xlink:title="00000016 - Disclosure - Related Parties">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RelatedPartyTransactionsAbstract" xlink:label="loc_us-gaapRelatedPartyTransactionsAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:label="loc_us-gaapRelatedPartyTransactionsDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionsAbstract" xlink:to="loc_us-gaapRelatedPartyTransactionsDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://trxadegroup.com/role/CommitmentsAndContingencies" xlink:title="00000017 - Disclosure - Commitments and Contingencies">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:label="loc_us-gaapCommitmentsAndContingenciesDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" xlink:to="loc_us-gaapCommitmentsAndContingenciesDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://trxadegroup.com/role/SegmentReporting" xlink:title="00000018 - Disclosure - Segment Reporting">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SegmentReportingAbstract" xlink:label="loc_us-gaapSegmentReportingAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SegmentReportingDisclosureTextBlock" xlink:label="loc_us-gaapSegmentReportingDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSegmentReportingAbstract" xlink:to="loc_us-gaapSegmentReportingDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://trxadegroup.com/role/BusinessCombination" xlink:title="00000019 - Disclosure - Business Combination">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessCombinationsAbstract" xlink:label="loc_us-gaapBusinessCombinationsAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessCombinationDisclosureTextBlock" xlink:label="loc_us-gaapBusinessCombinationDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessCombinationsAbstract" xlink:to="loc_us-gaapBusinessCombinationDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://trxadegroup.com/role/EquityMethodInvestment" xlink:title="00000020 - Disclosure - Equity Method Investment">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract" xlink:label="loc_us-gaapEquityMethodInvestmentsAndJointVenturesAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EquityMethodInvestmentsDisclosureTextBlock" xlink:label="loc_us-gaapEquityMethodInvestmentsDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityMethodInvestmentsAndJointVenturesAbstract" xlink:to="loc_us-gaapEquityMethodInvestmentsDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://trxadegroup.com/role/SubsequentEvents" xlink:title="00000021 - Disclosure - Subsequent Events">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SubsequentEventsAbstract" xlink:label="loc_us-gaapSubsequentEventsAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SubsequentEventsTextBlock" xlink:label="loc_us-gaapSubsequentEventsTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventsAbstract" xlink:to="loc_us-gaapSubsequentEventsTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://trxadegroup.com/role/SummaryOfSignificantAccountingPoliciesPolicies" xlink:title="00000022 - Disclosure - Summary of Significant Accounting Policies (Policies)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaapAccountingPoliciesAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:label="loc_us-gaapBasisOfAccountingPolicyPolicyTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapBasisOfAccountingPolicyPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EquityMethodInvestmentsPolicy" xlink:label="loc_us-gaapEquityMethodInvestmentsPolicy" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapEquityMethodInvestmentsPolicy" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_UseOfEstimates" xlink:label="loc_us-gaapUseOfEstimates" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapUseOfEstimates" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PriorPeriodReclassificationAdjustmentDescription" xlink:label="loc_us-gaapPriorPeriodReclassificationAdjustmentDescription" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapPriorPeriodReclassificationAdjustmentDescription" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ConsolidationPolicyTextBlock" xlink:label="loc_us-gaapConsolidationPolicyTextBlock" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapConsolidationPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:label="loc_us-gaapCashAndCashEquivalentsPolicyTextBlock" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapCashAndCashEquivalentsPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_TradeAndOtherAccountsReceivablePolicy" xlink:label="loc_us-gaapTradeAndOtherAccountsReceivablePolicy" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapTradeAndOtherAccountsReceivablePolicy" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InventoryPolicyTextBlock" xlink:label="loc_us-gaapInventoryPolicyTextBlock" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapInventoryPolicyTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtPolicyTextBlock" xlink:label="loc_us-gaapDebtPolicyTextBlock" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapDebtPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativesReportingOfDerivativeActivity" xlink:label="loc_us-gaapDerivativesReportingOfDerivativeActivity" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapDerivativesReportingOfDerivativeActivity" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:label="loc_us-gaapFairValueOfFinancialInstrumentsPolicy" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapFairValueOfFinancialInstrumentsPolicy" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy" xlink:label="loc_us-gaapGoodwillAndIntangibleAssetsGoodwillPolicy" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapGoodwillAndIntangibleAssetsGoodwillPolicy" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RevenueRecognitionPolicyTextBlock" xlink:label="loc_us-gaapRevenueRecognitionPolicyTextBlock" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapRevenueRecognitionPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="trxd-20190630.xsd#TRXD_CostOfGoodsSoldPolicyTextBlock" xlink:label="loc_TRXDCostOfGoodsSoldPolicyTextBlock" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_TRXDCostOfGoodsSoldPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:label="loc_us-gaapShareBasedCompensationOptionAndIncentivePlansPolicy" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeTaxPolicyTextBlock" xlink:label="loc_us-gaapIncomeTaxPolicyTextBlock" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapIncomeTaxPolicyTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EarningsPerSharePolicyTextBlock" xlink:label="loc_us-gaapEarningsPerSharePolicyTextBlock" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapEarningsPerSharePolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ConcentrationRiskCreditRisk" xlink:label="loc_us-gaapConcentrationRiskCreditRisk" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapConcentrationRiskCreditRisk" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:label="loc_us-gaapNewAccountingPronouncementsPolicyPolicyTextBlock" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapNewAccountingPronouncementsPolicyPolicyTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://trxadegroup.com/role/OrganizationAndBasisOfPresentationTables" xlink:title="00000023 - Disclosure - Organization and Basis of Presentation (Tables)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:label="loc_us-gaapOrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:label="loc_us-gaapScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="loc_us-gaapScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://trxadegroup.com/role/SummaryOfSignificantAccountingPoliciesTables" xlink:title="00000024 - Disclosure - Summary of Significant Accounting Policies (Tables)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaapAccountingPoliciesAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:label="loc_us-gaapScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://trxadegroup.com/role/LongTermDebt-RelatedPartiesTables" xlink:title="00000025 - Disclosure - Long Term Debt - Related Parties (Tables)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="loc_us-gaapDebtDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:label="loc_us-gaapScheduleOfMaturitiesOfLongTermDebtTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtDisclosureAbstract" xlink:to="loc_us-gaapScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://trxadegroup.com/role/WarrantsTables" xlink:title="00000026 - Disclosure - Warrants (Tables)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_WarrantsAndRightsNoteDisclosureAbstract" xlink:label="loc_us-gaapWarrantsAndRightsNoteDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="trxd-20190630.xsd#TRXD_SummaryOfEstimateFairValueOfWarrantsTableTextBlock" xlink:label="loc_TRXDSummaryOfEstimateFairValueOfWarrantsTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapWarrantsAndRightsNoteDisclosureAbstract" xlink:to="loc_TRXDSummaryOfEstimateFairValueOfWarrantsTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock" xlink:label="loc_us-gaapScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapWarrantsAndRightsNoteDisclosureAbstract" xlink:to="loc_us-gaapScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://trxadegroup.com/role/OptionsTables" xlink:title="00000027 - Disclosure - Options (Tables)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="loc_us-gaapDisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:label="loc_us-gaapScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="loc_us-gaapScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:label="loc_us-gaapScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="loc_us-gaapScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://trxadegroup.com/role/LeasesTables" xlink:title="00000028 - Disclosure - Leases (Tables)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LeasesAbstract" xlink:label="loc_us-gaapLeasesAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LeaseCostTableTextBlock" xlink:label="loc_us-gaapLeaseCostTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLeasesAbstract" xlink:to="loc_us-gaapLeaseCostTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:label="loc_us-gaapLesseeOperatingLeaseLiabilityMaturityTableTextBlock" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLeasesAbstract" xlink:to="loc_us-gaapLesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://trxadegroup.com/role/IncomeTaxesTables" xlink:title="00000029 - Disclosure - Income Taxes (Tables)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="loc_us-gaapIncomeTaxDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:label="loc_us-gaapScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://trxadegroup.com/role/CommitmentsAndContingenciesTables" xlink:title="00000030 - Disclosure - Commitments and Contingencies (Tables)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock" xlink:label="loc_us-gaapScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" xlink:to="loc_us-gaapScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://trxadegroup.com/role/SegmentReportingTables" xlink:title="00000031 - Disclosure - Segment Reporting (Tables)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SegmentReportingAbstract" xlink:label="loc_us-gaapSegmentReportingAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:label="loc_us-gaapScheduleOfSegmentReportingInformationBySegmentTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSegmentReportingAbstract" xlink:to="loc_us-gaapScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://trxadegroup.com/role/BusinessCombinationTables" xlink:title="00000032 - Disclosure - Business Combination (Tables)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessCombinationsAbstract" xlink:label="loc_us-gaapBusinessCombinationsAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" xlink:label="loc_us-gaapScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessCombinationsAbstract" xlink:to="loc_us-gaapScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessAcquisitionProFormaInformationTextBlock" xlink:label="loc_us-gaapBusinessAcquisitionProFormaInformationTextBlock" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessCombinationsAbstract" xlink:to="loc_us-gaapBusinessAcquisitionProFormaInformationTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://trxadegroup.com/role/OrganizationAndBasisOfPresentationDetailsNarrative" xlink:title="00000033 - Disclosure - Organization and Basis of Presentation (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:label="loc_us-gaapOrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:label="loc_us-gaapEquityMethodInvestmentOwnershipPercentage" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="loc_us-gaapEquityMethodInvestmentOwnershipPercentage" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="trxd-20190630.xsd#TRXD_EquityMethodInvestmentDescription" xlink:label="loc_TRXDEquityMethodInvestmentDescription" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="loc_TRXDEquityMethodInvestmentDescription" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://trxadegroup.com/role/OrganizationDetailsNarrative10-k" xlink:title="00000034 - Disclosure - Organization (Details Narrative) (10-K)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:label="loc_us-gaapOrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:label="loc_us-gaapEquityMethodInvestmentOwnershipPercentage" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="loc_us-gaapEquityMethodInvestmentOwnershipPercentage" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://trxadegroup.com/role/OrganizationAndBasisOfPresentation-ScheduleOfEarningsPerShareBasicAndDilutedDetails" xlink:title="00000035 - Disclosure - Organization and Basis of Presentation - Schedule of Earnings Per Share, Basic and Diluted (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:label="loc_us-gaapOrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="loc_us-gaapNetIncomeLoss" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="trxd-20190630.xsd#TRXD_NumeratorForBasicAndDilutedEpsIncomeLossAvailableToCommonShareholders" xlink:label="loc_TRXDNumeratorForBasicAndDilutedEpsIncomeLossAvailableToCommonShareholders" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="loc_TRXDNumeratorForBasicAndDilutedEpsIncomeLossAvailableToCommonShareholders" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:label="loc_us-gaapWeightedAverageNumberOfSharesOutstandingBasic" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="loc_us-gaapWeightedAverageNumberOfSharesOutstandingBasic" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment" xlink:label="loc_us-gaapWeightedAverageNumberDilutedSharesOutstandingAdjustment" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="loc_us-gaapWeightedAverageNumberDilutedSharesOutstandingAdjustment" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:label="loc_us-gaapWeightedAverageNumberOfDilutedSharesOutstanding" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="loc_us-gaapWeightedAverageNumberOfDilutedSharesOutstanding" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EarningsPerShareBasicAndDiluted" xlink:label="loc_us-gaapEarningsPerShareBasicAndDiluted" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="loc_us-gaapEarningsPerShareBasicAndDiluted" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://trxadegroup.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative10-k" xlink:title="00000036 - Disclosure - Summary of Significant Accounting Policies (Details Narrative) (10-K)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaapAccountingPoliciesAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_MajorCustomersAxis" xlink:label="loc_srtMajorCustomersAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_srtMajorCustomersAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_NameOfMajorCustomerDomain" xlink:label="loc_srtNameOfMajorCustomerDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtMajorCustomersAxis" xlink:to="loc_srtNameOfMajorCustomerDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="trxd-20190630.xsd#TRXD_TwoCustomersMember" xlink:label="loc_TRXDTwoCustomersMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtNameOfMajorCustomerDomain" xlink:to="loc_TRXDTwoCustomersMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ProvisionForDoubtfulAccounts" xlink:label="loc_us-gaapProvisionForDoubtfulAccounts" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapProvisionForDoubtfulAccounts" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="trxd-20190630.xsd#TRXD_RecoveryOfBadDebt" xlink:label="loc_TRXDRecoveryOfBadDebt" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_TRXDRecoveryOfBadDebt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="trxd-20190630.xsd#TRXD_ValuationAllowancePercentage" xlink:label="loc_TRXDValuationAllowancePercentage" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_TRXDValuationAllowancePercentage" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ConcentrationRiskPercentage1" xlink:label="loc_us-gaapConcentrationRiskPercentage1" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapConcentrationRiskPercentage1" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://trxadegroup.com/role/SummaryOfSignificantAccountingPolicies-ScheduleOfEarningsPerShareBasicAndDilutedDetails10-k" xlink:title="00000037 - Disclosure - Summary of Significant Accounting Policies - Schedule of Earnings Per Share, Basic and Diluted (Details) (10-K)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaapAccountingPoliciesAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapNetIncomeLoss" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="trxd-20190630.xsd#TRXD_NumeratorForBasicAndDilutedEpsIncomeLossAvailableToCommonShareholders" xlink:label="loc_TRXDNumeratorForBasicAndDilutedEpsIncomeLossAvailableToCommonShareholders" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_TRXDNumeratorForBasicAndDilutedEpsIncomeLossAvailableToCommonShareholders" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:label="loc_us-gaapWeightedAverageNumberOfSharesOutstandingBasic" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapWeightedAverageNumberOfSharesOutstandingBasic" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment" xlink:label="loc_us-gaapWeightedAverageNumberDilutedSharesOutstandingAdjustment" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapWeightedAverageNumberDilutedSharesOutstandingAdjustment" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:label="loc_us-gaapWeightedAverageNumberOfDilutedSharesOutstanding" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapWeightedAverageNumberOfDilutedSharesOutstanding" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EarningsPerShareBasicAndDiluted" xlink:label="loc_us-gaapEarningsPerShareBasicAndDiluted" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapEarningsPerShareBasicAndDiluted" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://trxadegroup.com/role/Short-termDebtAndRelatedPartiesDebtDetailsNarrative" xlink:title="00000038 - Disclosure - Short-term Debt and Related Parties Debt (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="loc_us-gaapDebtDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtDisclosureAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentAxis" xlink:label="loc_us-gaapDebtInstrumentAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapDebtInstrumentAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="loc_us-gaapDebtInstrumentNameDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentAxis" xlink:to="loc_us-gaapDebtInstrumentNameDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="trxd-20190630.xsd#TRXD_ConvertiblePromissoryNoteMember" xlink:label="loc_TRXDConvertiblePromissoryNoteMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentNameDomain" xlink:to="loc_TRXDConvertiblePromissoryNoteMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="trxd-20190630.xsd#TRXD_RelatedPartyConvertiblePromissoryNoteMember" xlink:label="loc_TRXDRelatedPartyConvertiblePromissoryNoteMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentNameDomain" xlink:to="loc_TRXDRelatedPartyConvertiblePromissoryNoteMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaapRelatedPartyDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:to="loc_us-gaapRelatedPartyDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="trxd-20190630.xsd#TRXD_MrShilpaPatelMember" xlink:label="loc_TRXDMrShilpaPatelMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_TRXDMrShilpaPatelMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="trxd-20190630.xsd#TRXD_MrNitilPatelMember" xlink:label="loc_TRXDMrNitilPatelMember" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_TRXDMrNitilPatelMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="loc_us-gaapSubsequentEventTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapSubsequentEventTypeAxis" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="loc_us-gaapSubsequentEventTypeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventTypeAxis" xlink:to="loc_us-gaapSubsequentEventTypeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SubsequentEventMember" xlink:label="loc_us-gaapSubsequentEventMember" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventTypeDomain" xlink:to="loc_us-gaapSubsequentEventMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LoanRestructuringModificationAxis" xlink:label="loc_us-gaapLoanRestructuringModificationAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapLoanRestructuringModificationAxis" order="40" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LoanRestructuringModificationDomain" xlink:label="loc_us-gaapLoanRestructuringModificationDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLoanRestructuringModificationAxis" xlink:to="loc_us-gaapLoanRestructuringModificationDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ExtendedMaturityMember" xlink:label="loc_us-gaapExtendedMaturityMember" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLoanRestructuringModificationDomain" xlink:to="loc_us-gaapExtendedMaturityMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ConvertibleNotesPayable" xlink:label="loc_us-gaapConvertibleNotesPayable" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapConvertibleNotesPayable" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentConvertibleConversionPrice1" xlink:label="loc_us-gaapDebtInstrumentConvertibleConversionPrice1" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDebtInstrumentConvertibleConversionPrice1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentPeriodicPayment" xlink:label="loc_us-gaapDebtInstrumentPeriodicPayment" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDebtInstrumentPeriodicPayment" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtConversionConvertedInstrumentSharesIssued1" xlink:label="loc_us-gaapDebtConversionConvertedInstrumentSharesIssued1" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDebtConversionConvertedInstrumentSharesIssued1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ConvertibleNotesPayableCurrent" xlink:label="loc_us-gaapConvertibleNotesPayableCurrent" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapConvertibleNotesPayableCurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentUnamortizedDiscount" xlink:label="loc_us-gaapDebtInstrumentUnamortizedDiscount" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDebtInstrumentUnamortizedDiscount" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="trxd-20190630.xsd#TRXD_ShortTermConvertibleNotesPayableRelatedParties" xlink:label="loc_TRXDShortTermConvertibleNotesPayableRelatedParties" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_TRXDShortTermConvertibleNotesPayableRelatedParties" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:label="loc_us-gaapDebtInstrumentInterestRateStatedPercentage" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDebtInstrumentInterestRateStatedPercentage" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentMaturityDate" xlink:label="loc_us-gaapDebtInstrumentMaturityDate" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDebtInstrumentMaturityDate" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://trxadegroup.com/role/Short-termDebtAndRelatedPartiesDebtDetailsNarrative10-k" xlink:title="00000039 - Disclosure - Short-term Debt and Related Parties Debt (Details Narrative) (10-K)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="loc_us-gaapDebtDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtDisclosureAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentAxis" xlink:label="loc_us-gaapDebtInstrumentAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapDebtInstrumentAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="loc_us-gaapDebtInstrumentNameDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentAxis" xlink:to="loc_us-gaapDebtInstrumentNameDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="trxd-20190630.xsd#TRXD_ConvertiblePromissoryNoteMember" xlink:label="loc_TRXDConvertiblePromissoryNoteMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentNameDomain" xlink:to="loc_TRXDConvertiblePromissoryNoteMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="trxd-20190630.xsd#TRXD_PromissoryNoteMember" xlink:label="loc_TRXDPromissoryNoteMember" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentNameDomain" xlink:to="loc_TRXDPromissoryNoteMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="trxd-20190630.xsd#TRXD_PromissoryNoteOneMember" xlink:label="loc_TRXDPromissoryNoteOneMember" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentNameDomain" xlink:to="loc_TRXDPromissoryNoteOneMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="trxd-20190630.xsd#TRXD_PromissoryNoteTwoMember" xlink:label="loc_TRXDPromissoryNoteTwoMember" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentNameDomain" xlink:to="loc_TRXDPromissoryNoteTwoMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="trxd-20190630.xsd#TRXD_ShortTermPromissoryNotesMember" xlink:label="loc_TRXDShortTermPromissoryNotesMember" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentNameDomain" xlink:to="loc_TRXDShortTermPromissoryNotesMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="trxd-20190630.xsd#TRXD_PromissoryNotesMember" xlink:label="loc_TRXDPromissoryNotesMember" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentNameDomain" xlink:to="loc_TRXDPromissoryNotesMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="trxd-20190630.xsd#TRXD_RelatedPartyConvertiblePromissoryNoteMember" xlink:label="loc_TRXDRelatedPartyConvertiblePromissoryNoteMember" />
      <link:presentationArc order="320" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentNameDomain" xlink:to="loc_TRXDRelatedPartyConvertiblePromissoryNoteMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="trxd-20190630.xsd#TRXD_RelatedPartyConvertiblePromissoryNotesMember" xlink:label="loc_TRXDRelatedPartyConvertiblePromissoryNotesMember" />
      <link:presentationArc order="460" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentNameDomain" xlink:to="loc_TRXDRelatedPartyConvertiblePromissoryNotesMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="trxd-20190630.xsd#TRXD_ShortTermRelatedPartyConvertibleNotesMember" xlink:label="loc_TRXDShortTermRelatedPartyConvertibleNotesMember" />
      <link:presentationArc order="530" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentNameDomain" xlink:to="loc_TRXDShortTermRelatedPartyConvertibleNotesMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaapStatementEquityComponentsAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementEquityComponentsAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_WarrantMember" xlink:label="loc_us-gaapWarrantMember" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapWarrantMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaapRelatedPartyDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:to="loc_us-gaapRelatedPartyDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="trxd-20190630.xsd#TRXD_MrShilpaPatelMember" xlink:label="loc_TRXDMrShilpaPatelMember" />
      <link:presentationArc order="320" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_TRXDMrShilpaPatelMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="trxd-20190630.xsd#TRXD_MrNitilPatelMember" xlink:label="loc_TRXDMrNitilPatelMember" />
      <link:presentationArc order="390" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_TRXDMrNitilPatelMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="trxd-20190630.xsd#TRXD_MrPrashantPatelMember" xlink:label="loc_TRXDMrPrashantPatelMember" />
      <link:presentationArc order="540" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_TRXDMrPrashantPatelMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ConvertibleNotesPayable" xlink:label="loc_us-gaapConvertibleNotesPayable" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapConvertibleNotesPayable" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentTerm" xlink:label="loc_us-gaapDebtInstrumentTerm" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDebtInstrumentTerm" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:label="loc_us-gaapDebtInstrumentInterestRateStatedPercentage" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDebtInstrumentInterestRateStatedPercentage" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentConvertibleConversionPrice1" xlink:label="loc_us-gaapDebtInstrumentConvertibleConversionPrice1" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDebtInstrumentConvertibleConversionPrice1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="trxd-20190630.xsd#TRXD_GrantedWarrants" xlink:label="loc_TRXDGrantedWarrants" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_TRXDGrantedWarrants" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SharesIssuedPricePerShare" xlink:label="loc_us-gaapSharesIssuedPricePerShare" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSharesIssuedPricePerShare" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:label="loc_us-gaapClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:label="loc_us-gaapClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_WarrantsAndRightsOutstandingTerm" xlink:label="loc_us-gaapWarrantsAndRightsOutstandingTerm" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapWarrantsAndRightsOutstandingTerm" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentUnamortizedDiscount" xlink:label="loc_us-gaapDebtInstrumentUnamortizedDiscount" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDebtInstrumentUnamortizedDiscount" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RepaymentsOfDebt" xlink:label="loc_us-gaapRepaymentsOfDebt" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapRepaymentsOfDebt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InterestExpenseDebt" xlink:label="loc_us-gaapInterestExpenseDebt" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapInterestExpenseDebt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentMaturityDateDescription" xlink:label="loc_us-gaapDebtInstrumentMaturityDateDescription" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDebtInstrumentMaturityDateDescription" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InterestPayableCurrentAndNoncurrent" xlink:label="loc_us-gaapInterestPayableCurrentAndNoncurrent" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapInterestPayableCurrentAndNoncurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentFaceAmount" xlink:label="loc_us-gaapDebtInstrumentFaceAmount" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDebtInstrumentFaceAmount" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentMaturityDate" xlink:label="loc_us-gaapDebtInstrumentMaturityDate" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDebtInstrumentMaturityDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:label="loc_us-gaapGainsLossesOnExtinguishmentOfDebt" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapGainsLossesOnExtinguishmentOfDebt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="trxd-20190630.xsd#TRXD_DebtModificationsAmount" xlink:label="loc_TRXDDebtModificationsAmount" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_TRXDDebtModificationsAmount" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AmortizationOfDebtDiscountPremium" xlink:label="loc_us-gaapAmortizationOfDebtDiscountPremium" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapAmortizationOfDebtDiscountPremium" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ConvertibleNotesPayableCurrent" xlink:label="loc_us-gaapConvertibleNotesPayableCurrent" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapConvertibleNotesPayableCurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentPeriodicPaymentPrincipal" xlink:label="loc_us-gaapDebtInstrumentPeriodicPaymentPrincipal" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDebtInstrumentPeriodicPaymentPrincipal" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ProceedsFromIssuanceOfDebt" xlink:label="loc_us-gaapProceedsFromIssuanceOfDebt" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapProceedsFromIssuanceOfDebt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentUnamortizedDiscountCurrent" xlink:label="loc_us-gaapDebtInstrumentUnamortizedDiscountCurrent" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDebtInstrumentUnamortizedDiscountCurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LongTermDebt" xlink:label="loc_us-gaapLongTermDebt" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapLongTermDebt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentUnamortizedDiscountNoncurrent" xlink:label="loc_us-gaapDebtInstrumentUnamortizedDiscountNoncurrent" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDebtInstrumentUnamortizedDiscountNoncurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentConvertibleBeneficialConversionFeature" xlink:label="loc_us-gaapDebtInstrumentConvertibleBeneficialConversionFeature" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDebtInstrumentConvertibleBeneficialConversionFeature" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DueToRelatedPartiesCurrentAndNoncurrent" xlink:label="loc_us-gaapDueToRelatedPartiesCurrentAndNoncurrent" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDueToRelatedPartiesCurrentAndNoncurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LoansPayable" xlink:label="loc_us-gaapLoansPayable" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapLoansPayable" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccountsPayableCurrentAndNoncurrent" xlink:label="loc_us-gaapAccountsPayableCurrentAndNoncurrent" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapAccountsPayableCurrentAndNoncurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtConversionConvertedInstrumentAmount1" xlink:label="loc_us-gaapDebtConversionConvertedInstrumentAmount1" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDebtConversionConvertedInstrumentAmount1" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://trxadegroup.com/role/LongTermDebt-RelatedPartiesDetailsNarrative" xlink:title="00000040 - Disclosure - Long Term Debt - Related Parties (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="loc_us-gaapDebtDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtDisclosureAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentAxis" xlink:label="loc_us-gaapDebtInstrumentAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapDebtInstrumentAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="loc_us-gaapDebtInstrumentNameDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentAxis" xlink:to="loc_us-gaapDebtInstrumentNameDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="trxd-20190630.xsd#TRXD_RelatedPartyPromissoryNoteMember" xlink:label="loc_TRXDRelatedPartyPromissoryNoteMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentNameDomain" xlink:to="loc_TRXDRelatedPartyPromissoryNoteMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_LegalEntityAxis" xlink:label="loc_deiLegalEntityAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_deiLegalEntityAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="trxd-20190630.xsd#TRXD_CommunitySpecialtyPharmacyLLCMember" xlink:label="loc_TRXDCommunitySpecialtyPharmacyLLCMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityDomain" xlink:to="loc_TRXDCommunitySpecialtyPharmacyLLCMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaapRelatedPartyDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:to="loc_us-gaapRelatedPartyDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="trxd-20190630.xsd#TRXD_NikulPanchalMember" xlink:label="loc_TRXDNikulPanchalMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_TRXDNikulPanchalMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="trxd-20190630.xsd#TRXD_MrPrashantPatelMember" xlink:label="loc_TRXDMrPrashantPatelMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_TRXDMrPrashantPatelMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="trxd-20190630.xsd#TRXD_MrSurenAjjarapuMember" xlink:label="loc_TRXDMrSurenAjjarapuMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_TRXDMrSurenAjjarapuMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ProceedsFromIssuanceOfDebt" xlink:label="loc_us-gaapProceedsFromIssuanceOfDebt" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapProceedsFromIssuanceOfDebt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:label="loc_us-gaapDebtInstrumentInterestRateStatedPercentage" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDebtInstrumentInterestRateStatedPercentage" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentMaturityDate" xlink:label="loc_us-gaapDebtInstrumentMaturityDate" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDebtInstrumentMaturityDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NotesPayableRelatedPartiesNoncurrent" xlink:label="loc_us-gaapNotesPayableRelatedPartiesNoncurrent" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapNotesPayableRelatedPartiesNoncurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://trxadegroup.com/role/LongTermDebtDetailsNarrative10-k" xlink:title="00000041 - Disclosure - Long Term Debt (Details Narrative) (10-K)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="loc_us-gaapDebtDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtDisclosureAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentAxis" xlink:label="loc_us-gaapDebtInstrumentAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapDebtInstrumentAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="loc_us-gaapDebtInstrumentNameDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentAxis" xlink:to="loc_us-gaapDebtInstrumentNameDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="trxd-20190630.xsd#TRXD_RelatedPartyPromissoryNoteMember" xlink:label="loc_TRXDRelatedPartyPromissoryNoteMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentNameDomain" xlink:to="loc_TRXDRelatedPartyPromissoryNoteMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="trxd-20190630.xsd#TRXD_PromissoryNoteMember" xlink:label="loc_TRXDPromissoryNoteMember" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentNameDomain" xlink:to="loc_TRXDPromissoryNoteMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_LegalEntityAxis" xlink:label="loc_deiLegalEntityAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_deiLegalEntityAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="trxd-20190630.xsd#TRXD_NPRINVESTMENTGROUPLLCMember" xlink:label="loc_TRXDNPRINVESTMENTGROUPLLCMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityDomain" xlink:to="loc_TRXDNPRINVESTMENTGROUPLLCMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="trxd-20190630.xsd#TRXD_SansurAssociatesLLCMember" xlink:label="loc_TRXDSansurAssociatesLLCMember" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityDomain" xlink:to="loc_TRXDSansurAssociatesLLCMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="trxd-20190630.xsd#TRXD_SpecialtyPharmacyLLCMember" xlink:label="loc_TRXDSpecialtyPharmacyLLCMember" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityDomain" xlink:to="loc_TRXDSpecialtyPharmacyLLCMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaapRelatedPartyDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:to="loc_us-gaapRelatedPartyDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="trxd-20190630.xsd#TRXD_MrSurenAjjarapuMember" xlink:label="loc_TRXDMrSurenAjjarapuMember" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_TRXDMrSurenAjjarapuMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="trxd-20190630.xsd#TRXD_MrPrashantPatelMember" xlink:label="loc_TRXDMrPrashantPatelMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_TRXDMrPrashantPatelMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="trxd-20190630.xsd#TRXD_RelatedPartyPromissoryNoteMember" xlink:label="loc_TRXDRelatedPartyPromissoryNoteMember_2" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_TRXDRelatedPartyPromissoryNoteMember_2" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="trxd-20190630.xsd#TRXD_NikulPanchalMember" xlink:label="loc_TRXDNikulPanchalMember" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_TRXDNikulPanchalMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ConvertibleNotesPayable" xlink:label="loc_us-gaapConvertibleNotesPayable" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapConvertibleNotesPayable" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentMaturityDate" xlink:label="loc_us-gaapDebtInstrumentMaturityDate" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDebtInstrumentMaturityDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentFaceAmount" xlink:label="loc_us-gaapDebtInstrumentFaceAmount" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDebtInstrumentFaceAmount" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShortTermBorrowings" xlink:label="loc_us-gaapShortTermBorrowings" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShortTermBorrowings" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentTerm" xlink:label="loc_us-gaapDebtInstrumentTerm" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDebtInstrumentTerm" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:label="loc_us-gaapDebtInstrumentInterestRateStatedPercentage" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDebtInstrumentInterestRateStatedPercentage" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DueToRelatedPartiesCurrentAndNoncurrent" xlink:label="loc_us-gaapDueToRelatedPartiesCurrentAndNoncurrent" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDueToRelatedPartiesCurrentAndNoncurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="trxd-20190630.xsd#TRXD_CreditCardObligationAmount" xlink:label="loc_TRXDCreditCardObligationAmount" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_TRXDCreditCardObligationAmount" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NotesPayableRelatedPartiesNoncurrent" xlink:label="loc_us-gaapNotesPayableRelatedPartiesNoncurrent" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapNotesPayableRelatedPartiesNoncurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ProceedsFromIssuanceOfDebt" xlink:label="loc_us-gaapProceedsFromIssuanceOfDebt" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapProceedsFromIssuanceOfDebt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://trxadegroup.com/role/LongTermDebt-ScheduleOfFutureMaturitiesOfLong-termDebtDetails10-k" xlink:title="00000042 - Disclosure - Long Term Debt - Schedule of Future Maturities of Long-term Debt (Details) (10-K)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="loc_us-gaapDebtDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:label="loc_us-gaapLongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtDisclosureAbstract" xlink:to="loc_us-gaapLongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:label="loc_us-gaapLongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtDisclosureAbstract" xlink:to="loc_us-gaapLongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:label="loc_us-gaapLongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtDisclosureAbstract" xlink:to="loc_us-gaapLongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive" xlink:label="loc_us-gaapLongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtDisclosureAbstract" xlink:to="loc_us-gaapLongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LongTermDebt" xlink:label="loc_us-gaapLongTermDebt" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtDisclosureAbstract" xlink:to="loc_us-gaapLongTermDebt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://trxadegroup.com/role/ShareholdersEquityDetailsNarrative" xlink:title="00000043 - Disclosure - Shareholders' Equity (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EquityAbstract" xlink:label="loc_us-gaapEquityAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentAxis" xlink:label="loc_us-gaapDebtInstrumentAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapDebtInstrumentAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="loc_us-gaapDebtInstrumentNameDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentAxis" xlink:to="loc_us-gaapDebtInstrumentNameDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="trxd-20190630.xsd#TRXD_ConvertiblePromissoryNoteMember" xlink:label="loc_TRXDConvertiblePromissoryNoteMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentNameDomain" xlink:to="loc_TRXDConvertiblePromissoryNoteMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaapStatementEquityComponentsAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementEquityComponentsAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_WarrantMember" xlink:label="loc_us-gaapWarrantMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapWarrantMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_RangeAxis" xlink:label="loc_srtRangeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_srtRangeAxis" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_RangeMember" xlink:label="loc_srtRangeMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRangeAxis" xlink:to="loc_srtRangeMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_MinimumMember" xlink:label="loc_srtMinimumMember" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMinimumMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_MaximumMember" xlink:label="loc_srtMaximumMember" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMaximumMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ConvertibleNotesPayable" xlink:label="loc_us-gaapConvertibleNotesPayable" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapConvertibleNotesPayable" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentConvertibleConversionPrice1" xlink:label="loc_us-gaapDebtInstrumentConvertibleConversionPrice1" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDebtInstrumentConvertibleConversionPrice1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentPeriodicPayment" xlink:label="loc_us-gaapDebtInstrumentPeriodicPayment" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDebtInstrumentPeriodicPayment" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtConversionConvertedInstrumentSharesIssued1" xlink:label="loc_us-gaapDebtConversionConvertedInstrumentSharesIssued1" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDebtConversionConvertedInstrumentSharesIssued1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="trxd-20190630.xsd#TRXD_WarrantsIssued" xlink:label="loc_TRXDWarrantsIssued" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_TRXDWarrantsIssued" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:label="loc_us-gaapClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="trxd-20190630.xsd#TRXD_StockIssuedDuringPeriodSharesWarrantsExercised" xlink:label="loc_TRXDStockIssuedDuringPeriodSharesWarrantsExercised" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_TRXDStockIssuedDuringPeriodSharesWarrantsExercised" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="trxd-20190630.xsd#TRXD_StockIssuedDuringPeriodValueWarrantsExercised" xlink:label="loc_TRXDStockIssuedDuringPeriodValueWarrantsExercised" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_TRXDStockIssuedDuringPeriodValueWarrantsExercised" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://trxadegroup.com/role/StockholdersEquityDetailsNarrative10-k" xlink:title="00000044 - Disclosure - Stockholders' Equity (Details Narrative) (10-K)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EquityAbstract" xlink:label="loc_us-gaapEquityAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PlanNameAxis" xlink:label="loc_us-gaapPlanNameAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapPlanNameAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PlanNameDomain" xlink:label="loc_us-gaapPlanNameDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPlanNameAxis" xlink:to="loc_us-gaapPlanNameDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="trxd-20190630.xsd#TRXD_PrivateOfferMemorandumMember" xlink:label="loc_TRXDPrivateOfferMemorandumMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPlanNameDomain" xlink:to="loc_TRXDPrivateOfferMemorandumMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueNewIssues" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueNewIssues" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SaleOfStockPricePerShare" xlink:label="loc_us-gaapSaleOfStockPricePerShare" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSaleOfStockPricePerShare" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:label="loc_us-gaapClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:label="loc_us-gaapClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_WarrantsAndRightsOutstandingTerm" xlink:label="loc_us-gaapWarrantsAndRightsOutstandingTerm" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapWarrantsAndRightsOutstandingTerm" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="trxd-20190630.xsd#TRXD_WarrantsIssued" xlink:label="loc_TRXDWarrantsIssued" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_TRXDWarrantsIssued" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ProceedsFromIssuanceOfWarrants" xlink:label="loc_us-gaapProceedsFromIssuanceOfWarrants" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapProceedsFromIssuanceOfWarrants" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesIssuedForServices" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesIssuedForServices" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueIssuedForServices" xlink:label="loc_us-gaapStockIssuedDuringPeriodValueIssuedForServices" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodValueIssuedForServices" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://trxadegroup.com/role/WarrantsDetailsNarrative" xlink:title="00000045 - Disclosure - Warrants (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_WarrantsAndRightsNoteDisclosureAbstract" xlink:label="loc_us-gaapWarrantsAndRightsNoteDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="trxd-20190630.xsd#TRXD_StockIssuedDuringPeriodSharesStockWarrantExercised" xlink:label="loc_TRXDStockIssuedDuringPeriodSharesStockWarrantExercised" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapWarrantsAndRightsNoteDisclosureAbstract" xlink:to="loc_TRXDStockIssuedDuringPeriodSharesStockWarrantExercised" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://trxadegroup.com/role/WarrantsDetailsNarrative10-k" xlink:title="00000046 - Disclosure - Warrants (Details Narrative) (10-K)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_WarrantsAndRightsNoteDisclosureAbstract" xlink:label="loc_us-gaapWarrantsAndRightsNoteDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapWarrantsAndRightsNoteDisclosureAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_LegalEntityAxis" xlink:label="loc_deiLegalEntityAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_deiLegalEntityAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="trxd-20190630.xsd#TRXD_CommunitySpecialtyPharmacyLLCMember" xlink:label="loc_TRXDCommunitySpecialtyPharmacyLLCMember" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityDomain" xlink:to="loc_TRXDCommunitySpecialtyPharmacyLLCMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:label="loc_us-gaapClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="trxd-20190630.xsd#TRXD_WarrantIssuedForRenewalOfConvertibleDebt" xlink:label="loc_TRXDWarrantIssuedForRenewalOfConvertibleDebt" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_TRXDWarrantIssuedForRenewalOfConvertibleDebt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" xlink:label="loc_us-gaapClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://trxadegroup.com/role/Warrants-ScheduleOfOutstandingAndExercisableWarrantsDetails" xlink:title="00000047 - Disclosure - Warrants - Schedule of Outstanding and Exercisable Warrants (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_WarrantsAndRightsNoteDisclosureAbstract" xlink:label="loc_us-gaapWarrantsAndRightsNoteDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapWarrantsAndRightsNoteDisclosureAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaapStatementEquityComponentsAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementEquityComponentsAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_WarrantMember" xlink:label="loc_us-gaapWarrantMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapWarrantMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_2" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
      <link:loc xlink:type="locator" xlink:href="trxd-20190630.xsd#TRXD_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice" xlink:label="loc_TRXDShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_TRXDShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="trxd-20190630.xsd#TRXD_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGrantsInPeriodWeightedAverageExercisePrice" xlink:label="loc_TRXDShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGrantsInPeriodWeightedAverageExercisePrice" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_TRXDShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGrantsInPeriodWeightedAverageExercisePrice" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="trxd-20190630.xsd#TRXD_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitedInPeriodWeightedAverageExercisePrice" xlink:label="loc_TRXDShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitedInPeriodWeightedAverageExercisePrice" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_TRXDShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitedInPeriodWeightedAverageExercisePrice" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="trxd-20190630.xsd#TRXD_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisesInPeriodWeightedAverageExercisePrice" xlink:label="loc_TRXDShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisesInPeriodWeightedAverageExercisePrice" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_TRXDShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisesInPeriodWeightedAverageExercisePrice" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="trxd-20190630.xsd#TRXD_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice" xlink:label="loc_TRXDShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice_2" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_TRXDShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
      <link:loc xlink:type="locator" xlink:href="trxd-20190630.xsd#TRXD_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageRemainingContractualTermBeginning" xlink:label="loc_TRXDShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageRemainingContractualTermBeginning" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_TRXDShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageRemainingContractualTermBeginning" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="trxd-20190630.xsd#TRXD_WeightedAverageRemainingContractualLifeWarrantsOutstandingGranted" xlink:label="loc_TRXDWeightedAverageRemainingContractualLifeWarrantsOutstandingGranted" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_TRXDWeightedAverageRemainingContractualLifeWarrantsOutstandingGranted" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="trxd-20190630.xsd#TRXD_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageRemainingContractualTermEnding" xlink:label="loc_TRXDShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageRemainingContractualTermEnding" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_TRXDShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageRemainingContractualTermEnding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="trxd-20190630.xsd#TRXD_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingIntrinsicValue" xlink:label="loc_TRXDShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingIntrinsicValue" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_TRXDShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingIntrinsicValue" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="trxd-20190630.xsd#TRXD_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingIntrinsicValue" xlink:label="loc_TRXDShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingIntrinsicValue_2" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_TRXDShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingIntrinsicValue_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://trxadegroup.com/role/Warrants-SummaryOfEstimateFairValueOfWarrantsDetails10-k" xlink:title="00000048 - Disclosure - Warrants - Summary of Estimate the Fair Value of Warrants (Details) (10-K)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_WarrantsAndRightsNoteDisclosureAbstract" xlink:label="loc_us-gaapWarrantsAndRightsNoteDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapWarrantsAndRightsNoteDisclosureAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaapStatementEquityComponentsAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementEquityComponentsAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_WarrantMember" xlink:label="loc_us-gaapWarrantMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapWarrantMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_MeasurementInputTypeAxis" xlink:label="loc_us-gaapMeasurementInputTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapMeasurementInputTypeAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_MeasurementInputTypeDomain" xlink:label="loc_us-gaapMeasurementInputTypeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapMeasurementInputTypeAxis" xlink:to="loc_us-gaapMeasurementInputTypeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_MeasurementInputExpectedDividendRateMember" xlink:label="loc_us-gaapMeasurementInputExpectedDividendRateMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapMeasurementInputTypeDomain" xlink:to="loc_us-gaapMeasurementInputExpectedDividendRateMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_MeasurementInputPriceVolatilityMember" xlink:label="loc_us-gaapMeasurementInputPriceVolatilityMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapMeasurementInputTypeDomain" xlink:to="loc_us-gaapMeasurementInputPriceVolatilityMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_MeasurementInputRiskFreeInterestRateMember" xlink:label="loc_us-gaapMeasurementInputRiskFreeInterestRateMember" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapMeasurementInputTypeDomain" xlink:to="loc_us-gaapMeasurementInputRiskFreeInterestRateMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_MeasurementInputExpectedTermMember" xlink:label="loc_us-gaapMeasurementInputExpectedTermMember" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapMeasurementInputTypeDomain" xlink:to="loc_us-gaapMeasurementInputExpectedTermMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_RangeAxis" xlink:label="loc_srtRangeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_srtRangeAxis" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_RangeMember" xlink:label="loc_srtRangeMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRangeAxis" xlink:to="loc_srtRangeMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_MinimumMember" xlink:label="loc_srtMinimumMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMinimumMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_MaximumMember" xlink:label="loc_srtMaximumMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMaximumMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="trxd-20190630.xsd#TRXD_FairValueAssumptionsMeasurementInputPercentages" xlink:label="loc_TRXDFairValueAssumptionsMeasurementInputPercentages" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_TRXDFairValueAssumptionsMeasurementInputPercentages" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="trxd-20190630.xsd#TRXD_FairValueAssumptionsMeasurementInputTerm" xlink:label="loc_TRXDFairValueAssumptionsMeasurementInputTerm" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_TRXDFairValueAssumptionsMeasurementInputTerm" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://trxadegroup.com/role/OptionsDetailsNarrative" xlink:title="00000049 - Disclosure - Options (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="loc_us-gaapDisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PlanNameAxis" xlink:label="loc_us-gaapPlanNameAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapPlanNameAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PlanNameDomain" xlink:label="loc_us-gaapPlanNameDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPlanNameAxis" xlink:to="loc_us-gaapPlanNameDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="trxd-20190630.xsd#TRXD_StockOptionPlanMember" xlink:label="loc_TRXDStockOptionPlanMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPlanNameDomain" xlink:to="loc_TRXDStockOptionPlanMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_TitleOfIndividualAxis" xlink:label="loc_srtTitleOfIndividualAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_srtTitleOfIndividualAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtTitleOfIndividualAxis" xlink:to="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_RangeAxis" xlink:label="loc_srtRangeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_srtRangeAxis" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_RangeMember" xlink:label="loc_srtRangeMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRangeAxis" xlink:to="loc_srtRangeMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ValuationTechniqueAxis" xlink:label="loc_us-gaapValuationTechniqueAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapValuationTechniqueAxis" order="40" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ValuationTechniqueDomain" xlink:label="loc_us-gaapValuationTechniqueDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapValuationTechniqueAxis" xlink:to="loc_us-gaapValuationTechniqueDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OptionIndexedToIssuersEquityTypeAxis" xlink:label="loc_us-gaapOptionIndexedToIssuersEquityTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapOptionIndexedToIssuersEquityTypeAxis" order="50" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OptionIndexedToIssuersEquityTypeDomain" xlink:label="loc_us-gaapOptionIndexedToIssuersEquityTypeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOptionIndexedToIssuersEquityTypeAxis" xlink:to="loc_us-gaapOptionIndexedToIssuersEquityTypeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDescription" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardDescription" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardDescription" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockOptionPlanExpense" xlink:label="loc_us-gaapStockOptionPlanExpense" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockOptionPlanExpense" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://trxadegroup.com/role/OptionsDetailsNarrative10-k" xlink:title="00000050 - Disclosure - Options (Details Narrative) (10-K)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="loc_us-gaapDisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PlanNameAxis" xlink:label="loc_us-gaapPlanNameAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapPlanNameAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PlanNameDomain" xlink:label="loc_us-gaapPlanNameDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPlanNameAxis" xlink:to="loc_us-gaapPlanNameDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="trxd-20190630.xsd#TRXD_StockOptionPlanMember" xlink:label="loc_TRXDStockOptionPlanMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPlanNameDomain" xlink:to="loc_TRXDStockOptionPlanMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_TitleOfIndividualAxis" xlink:label="loc_srtTitleOfIndividualAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_srtTitleOfIndividualAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtTitleOfIndividualAxis" xlink:to="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="trxd-20190630.xsd#TRXD_EmployeeMember" xlink:label="loc_TRXDEmployeeMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtTitleOfIndividualWithRelationshipToEntityDomain" xlink:to="loc_TRXDEmployeeMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_RangeAxis" xlink:label="loc_srtRangeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_srtRangeAxis" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_RangeMember" xlink:label="loc_srtRangeMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRangeAxis" xlink:to="loc_srtRangeMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_MinimumMember" xlink:label="loc_srtMinimumMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMinimumMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_MaximumMember" xlink:label="loc_srtMaximumMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMaximumMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ValuationTechniqueAxis" xlink:label="loc_us-gaapValuationTechniqueAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapValuationTechniqueAxis" order="40" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ValuationTechniqueDomain" xlink:label="loc_us-gaapValuationTechniqueDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapValuationTechniqueAxis" xlink:to="loc_us-gaapValuationTechniqueDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ValuationTechniqueOptionPricingModelMember" xlink:label="loc_us-gaapValuationTechniqueOptionPricingModelMember" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapValuationTechniqueDomain" xlink:to="loc_us-gaapValuationTechniqueOptionPricingModelMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OptionIndexedToIssuersEquityTypeAxis" xlink:label="loc_us-gaapOptionIndexedToIssuersEquityTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapOptionIndexedToIssuersEquityTypeAxis" order="50" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OptionIndexedToIssuersEquityTypeDomain" xlink:label="loc_us-gaapOptionIndexedToIssuersEquityTypeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOptionIndexedToIssuersEquityTypeAxis" xlink:to="loc_us-gaapOptionIndexedToIssuersEquityTypeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="trxd-20190630.xsd#TRXD_FourOptionGrantedMember" xlink:label="loc_TRXDFourOptionGrantedMember" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapOptionIndexedToIssuersEquityTypeDomain" xlink:to="loc_TRXDFourOptionGrantedMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDescription" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardDescription" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardDescription" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit" xlink:label="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit" xlink:label="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="trxd-20190630.xsd#TRXD_FairValueOfOptionGranted" xlink:label="loc_TRXDFairValueOfOptionGranted" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_TRXDFairValueOfOptionGranted" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingRights" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingRights" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingRights" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockOptionPlanExpense" xlink:label="loc_us-gaapStockOptionPlanExpense" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockOptionPlanExpense" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:label="loc_us-gaapEmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapEmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://trxadegroup.com/role/Options-ScheduleOfEstimateFairValueOfStockOptionsDetails" xlink:title="00000051 - Disclosure - Options - Schedule of Estimate the Fair Value of Stock Options (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="loc_us-gaapDisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_RangeAxis" xlink:label="loc_srtRangeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_srtRangeAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_RangeMember" xlink:label="loc_srtRangeMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRangeAxis" xlink:to="loc_srtRangeMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_MinimumMember" xlink:label="loc_srtMinimumMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMinimumMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_MaximumMember" xlink:label="loc_srtMaximumMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMaximumMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://trxadegroup.com/role/Options-ScheduleOfStockOptionActivityDetails" xlink:title="00000052 - Disclosure - Options - Schedule of Stock Option Activity (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="loc_us-gaapDisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_2" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_2" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_2" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_2" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="trxd-20190630.xsd#TRXD_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTermGranted" xlink:label="loc_TRXDSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTermGranted" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="loc_TRXDSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTermGranted" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="trxd-20190630.xsd#TRXD_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTermForfeitures" xlink:label="loc_TRXDSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTermForfeitures" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="loc_TRXDSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTermForfeitures" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="trxd-20190630.xsd#TRXD_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTermExpired" xlink:label="loc_TRXDSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTermExpired" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="loc_TRXDSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTermExpired" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="trxd-20190630.xsd#TRXD_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm" xlink:label="loc_TRXDSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="loc_TRXDSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="trxd-20190630.xsd#TRXD_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm" xlink:label="loc_TRXDSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="loc_TRXDSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_2" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:label="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_2" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="loc_us-gaapSharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://trxadegroup.com/role/LeasesDetailsNarrative" xlink:title="00000053 - Disclosure - Leases (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LeasesAbstract" xlink:label="loc_us-gaapLeasesAbstract" />
      <link:loc xlink:type="locator" xlink:href="trxd-20190630.xsd#TRXD_OperatingLeasesUnits" xlink:label="loc_TRXDOperatingLeasesUnits" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLeasesAbstract" xlink:to="loc_TRXDOperatingLeasesUnits" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="trxd-20190630.xsd#TRXD_OperatingLeaseAmortizationOfAssets" xlink:label="loc_TRXDOperatingLeaseAmortizationOfAssets" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLeasesAbstract" xlink:to="loc_TRXDOperatingLeaseAmortizationOfAssets" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="trxd-20190630.xsd#TRXD_OperatingLeaseAmortizationOfLiabilities" xlink:label="loc_TRXDOperatingLeaseAmortizationOfLiabilities" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLeasesAbstract" xlink:to="loc_TRXDOperatingLeaseAmortizationOfLiabilities" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://trxadegroup.com/role/Leases-ScheduleOfOperatingLeasesDetails" xlink:title="00000054 - Disclosure - Leases - Schedule of Operating Leases (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LeasesAbstract" xlink:label="loc_us-gaapLeasesAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLeasesAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LeaseArrangementTypeAxis" xlink:label="loc_us-gaapLeaseArrangementTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapLeaseArrangementTypeAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LeaseArrangementTypeDomain" xlink:label="loc_us-gaapLeaseArrangementTypeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLeaseArrangementTypeAxis" xlink:to="loc_us-gaapLeaseArrangementTypeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="trxd-20190630.xsd#TRXD_LeaseOneMember" xlink:label="loc_TRXDLeaseOneMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLeaseArrangementTypeDomain" xlink:to="loc_TRXDLeaseOneMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="trxd-20190630.xsd#TRXD_LeaseTwoMember" xlink:label="loc_TRXDLeaseTwoMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLeaseArrangementTypeDomain" xlink:to="loc_TRXDLeaseTwoMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="trxd-20190630.xsd#TRXD_OperatingLeaseInitialLeaseTerm" xlink:label="loc_TRXDOperatingLeaseInitialLeaseTerm" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_TRXDOperatingLeaseInitialLeaseTerm" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="trxd-20190630.xsd#TRXD_OperatingLeaseRenewalTerm" xlink:label="loc_TRXDOperatingLeaseRenewalTerm" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_TRXDOperatingLeaseRenewalTerm" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset" xlink:label="loc_us-gaapOperatingLeaseRightOfUseAsset" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapOperatingLeaseRightOfUseAsset" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LesseeOperatingLeaseDiscountRate" xlink:label="loc_us-gaapLesseeOperatingLeaseDiscountRate" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapLesseeOperatingLeaseDiscountRate" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://trxadegroup.com/role/Leases-ScheduleOfFutureMinimumPaymentsForOperatingLeaseLiabilitiesDetails" xlink:title="00000055 - Disclosure - Leases - Schedule of Future Minimum Payments for Operating Lease Liabilities (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LeasesAbstract" xlink:label="loc_us-gaapLeasesAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:label="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLeasesAbstract" xlink:to="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:label="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueYearTwo" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLeasesAbstract" xlink:to="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:label="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueYearThree" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLeasesAbstract" xlink:to="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:label="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueYearFour" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLeasesAbstract" xlink:to="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:label="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueYearFive" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLeasesAbstract" xlink:to="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:label="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLeasesAbstract" xlink:to="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:label="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDue" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLeasesAbstract" xlink:to="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDue" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:label="loc_us-gaapLesseeOperatingLeaseLiabilityUndiscountedExcessAmount" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLeasesAbstract" xlink:to="loc_us-gaapLesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingLeaseLiability" xlink:label="loc_us-gaapOperatingLeaseLiability" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLeasesAbstract" xlink:to="loc_us-gaapOperatingLeaseLiability" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent" xlink:label="loc_us-gaapOperatingLeaseLiabilityCurrent" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLeasesAbstract" xlink:to="loc_us-gaapOperatingLeaseLiabilityCurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:label="loc_us-gaapOperatingLeaseLiabilityNoncurrent" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLeasesAbstract" xlink:to="loc_us-gaapOperatingLeaseLiabilityNoncurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://trxadegroup.com/role/IncomeTaxesDetailsNarrative10-k" xlink:title="00000056 - Disclosure - Income Taxes (Details Narrative) (10-K)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="loc_us-gaapIncomeTaxDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:label="loc_us-gaapEffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapEffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeTaxExaminationDescription" xlink:label="loc_us-gaapIncomeTaxExaminationDescription" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapIncomeTaxExaminationDescription" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingLossCarryforwards" xlink:label="loc_us-gaapOperatingLossCarryforwards" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapOperatingLossCarryforwards" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://trxadegroup.com/role/IncomeTaxes-ScheduleOfDeferredTaxAssetsDetails10-k" xlink:title="00000057 - Disclosure - Income Taxes - Schedule of Deferred Tax Assets (Details) (10-K)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="loc_us-gaapIncomeTaxDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:label="loc_us-gaapDeferredTaxAssetsOperatingLossCarryforwards" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapDeferredTaxAssetsOperatingLossCarryforwards" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DeferredTaxAssetsValuationAllowance" xlink:label="loc_us-gaapDeferredTaxAssetsValuationAllowance" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapDeferredTaxAssetsValuationAllowance" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:label="loc_us-gaapDeferredTaxAssetsLiabilitiesNet" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapDeferredTaxAssetsLiabilitiesNet" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://trxadegroup.com/role/RelatedPartiesDetailsNarrative10-k" xlink:title="00000058 - Disclosure - Related Parties (Details Narrative) (10-K)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RelatedPartyTransactionsAbstract" xlink:label="loc_us-gaapRelatedPartyTransactionsAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionsAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaapRelatedPartyDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:to="loc_us-gaapRelatedPartyDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="trxd-20190630.xsd#TRXD_MrSurenAjjarapuMember" xlink:label="loc_TRXDMrSurenAjjarapuMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_TRXDMrSurenAjjarapuMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="trxd-20190630.xsd#TRXD_MrPrashantPatelMember" xlink:label="loc_TRXDMrPrashantPatelMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_TRXDMrPrashantPatelMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_LegalEntityAxis" xlink:label="loc_deiLegalEntityAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_deiLegalEntityAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="trxd-20190630.xsd#TRXD_CommunitySpecialtyPharmacyLLCMember" xlink:label="loc_TRXDCommunitySpecialtyPharmacyLLCMember" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityDomain" xlink:to="loc_TRXDCommunitySpecialtyPharmacyLLCMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OfficersCompensation" xlink:label="loc_us-gaapOfficersCompensation" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapOfficersCompensation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DueToRelatedPartiesCurrentAndNoncurrent" xlink:label="loc_us-gaapDueToRelatedPartiesCurrentAndNoncurrent" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDueToRelatedPartiesCurrentAndNoncurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ConvertibleNotesPayable" xlink:label="loc_us-gaapConvertibleNotesPayable" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapConvertibleNotesPayable" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentMaturityDate" xlink:label="loc_us-gaapDebtInstrumentMaturityDate" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDebtInstrumentMaturityDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:label="loc_us-gaapDebtInstrumentInterestRateStatedPercentage" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDebtInstrumentInterestRateStatedPercentage" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://trxadegroup.com/role/CommitmentsAndContingenciesDetailsNarrative10-k" xlink:title="00000059 - Disclosure - Commitments and Contingencies (Details Narrative) (10-K)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LesseeOperatingLeaseDescription" xlink:label="loc_us-gaapLesseeOperatingLeaseDescription" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" xlink:to="loc_us-gaapLesseeOperatingLeaseDescription" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://trxadegroup.com/role/CommitmentsAndContingencies-ScheduleOfFutureMinimumRentalPaymentsUnderNon-cancelableOperatingLeasesDetails10-k" xlink:title="00000060 - Disclosure - Commitments and Contingencies - Schedule of Future Minimum Rental Payments Under Non-cancelable Operating Leases (Details) (10-K)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent" xlink:label="loc_us-gaapOperatingLeasesFutureMinimumPaymentsDueCurrent" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" xlink:to="loc_us-gaapOperatingLeasesFutureMinimumPaymentsDueCurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears" xlink:label="loc_us-gaapOperatingLeasesFutureMinimumPaymentsDueInTwoYears" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" xlink:to="loc_us-gaapOperatingLeasesFutureMinimumPaymentsDueInTwoYears" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears" xlink:label="loc_us-gaapOperatingLeasesFutureMinimumPaymentsDueInThreeYears" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" xlink:to="loc_us-gaapOperatingLeasesFutureMinimumPaymentsDueInThreeYears" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears" xlink:label="loc_us-gaapOperatingLeasesFutureMinimumPaymentsDueInFourYears" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" xlink:to="loc_us-gaapOperatingLeasesFutureMinimumPaymentsDueInFourYears" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFiveYears" xlink:label="loc_us-gaapOperatingLeasesFutureMinimumPaymentsDueInFiveYears" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" xlink:to="loc_us-gaapOperatingLeasesFutureMinimumPaymentsDueInFiveYears" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDue" xlink:label="loc_us-gaapOperatingLeasesFutureMinimumPaymentsDue" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" xlink:to="loc_us-gaapOperatingLeasesFutureMinimumPaymentsDue" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://trxadegroup.com/role/SegmentReporting-ScheduleOfBusinessInterestsIntoReportableSegmentsDetails" xlink:title="00000061 - Disclosure - Segment Reporting - Schedule of Business Interests Into Reportable Segments (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SegmentReportingAbstract" xlink:label="loc_us-gaapSegmentReportingAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSegmentReportingAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis" xlink:label="loc_us-gaapStatementBusinessSegmentsAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementBusinessSegmentsAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SegmentDomain" xlink:label="loc_us-gaapSegmentDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementBusinessSegmentsAxis" xlink:to="loc_us-gaapSegmentDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="trxd-20190630.xsd#TRXD_TrxadeIncMember" xlink:label="loc_TRXDTrxadeIncMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSegmentDomain" xlink:to="loc_TRXDTrxadeIncMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="trxd-20190630.xsd#TRXD_CommunitySpecialtyPharmacyLLCMember" xlink:label="loc_TRXDCommunitySpecialtyPharmacyLLCMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSegmentDomain" xlink:to="loc_TRXDCommunitySpecialtyPharmacyLLCMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="trxd-20190630.xsd#TRXD_OtherMember" xlink:label="loc_TRXDOtherMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSegmentDomain" xlink:to="loc_TRXDOtherMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:label="loc_us-gaapRevenueFromContractWithCustomerExcludingAssessedTax" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapRevenueFromContractWithCustomerExcludingAssessedTax" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_GrossProfit" xlink:label="loc_us-gaapGrossProfit" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapGrossProfit" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_Assets" xlink:label="loc_us-gaapAssets" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapAssets" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ProfitLoss" xlink:label="loc_us-gaapProfitLoss" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapProfitLoss" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://trxadegroup.com/role/BusinessCombinationDetailsNarrative" xlink:title="00000062 - Disclosure - Business Combination (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessCombinationsAbstract" xlink:label="loc_us-gaapBusinessCombinationsAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessCombinationsAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_LegalEntityAxis" xlink:label="loc_deiLegalEntityAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_deiLegalEntityAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="trxd-20190630.xsd#TRXD_CommunitySpecialtyPharmacyLLCMember" xlink:label="loc_TRXDCommunitySpecialtyPharmacyLLCMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityDomain" xlink:to="loc_TRXDCommunitySpecialtyPharmacyLLCMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:label="loc_us-gaapEquityMethodInvestmentOwnershipPercentage" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapEquityMethodInvestmentOwnershipPercentage" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesGross" xlink:label="loc_us-gaapPaymentsToAcquireBusinessesGross" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapPaymentsToAcquireBusinessesGross" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NotesPayable" xlink:label="loc_us-gaapNotesPayable" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapNotesPayable" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:label="loc_us-gaapClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_WarrantsAndRightsOutstandingTerm" xlink:label="loc_us-gaapWarrantsAndRightsOutstandingTerm" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapWarrantsAndRightsOutstandingTerm" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:label="loc_us-gaapClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="trxd-20190630.xsd#TRXD_ExerciseRestrictionsLapsePeriod" xlink:label="loc_TRXDExerciseRestrictionsLapsePeriod" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_TRXDExerciseRestrictionsLapsePeriod" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_Goodwill" xlink:label="loc_us-gaapGoodwill" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapGoodwill" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferred1" xlink:label="loc_us-gaapBusinessCombinationConsiderationTransferred1" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapBusinessCombinationConsiderationTransferred1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_WarrantsNotSettleableInCashFairValueDisclosure" xlink:label="loc_us-gaapWarrantsNotSettleableInCashFairValueDisclosure" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapWarrantsNotSettleableInCashFairValueDisclosure" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://trxadegroup.com/role/BusinessCombinationDetailsNarrative10-k" xlink:title="00000063 - Disclosure - Business Combination (Details Narrative) (10-K)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessCombinationsAbstract" xlink:label="loc_us-gaapBusinessCombinationsAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessCombinationsAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_LegalEntityAxis" xlink:label="loc_deiLegalEntityAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_deiLegalEntityAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="trxd-20190630.xsd#TRXD_CommunitySpecialtyPharmacyLLCMember" xlink:label="loc_TRXDCommunitySpecialtyPharmacyLLCMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityDomain" xlink:to="loc_TRXDCommunitySpecialtyPharmacyLLCMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:label="loc_us-gaapEquityMethodInvestmentOwnershipPercentage" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapEquityMethodInvestmentOwnershipPercentage" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesGross" xlink:label="loc_us-gaapPaymentsToAcquireBusinessesGross" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapPaymentsToAcquireBusinessesGross" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NotesPayable" xlink:label="loc_us-gaapNotesPayable" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapNotesPayable" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:label="loc_us-gaapClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_WarrantsAndRightsOutstandingTerm" xlink:label="loc_us-gaapWarrantsAndRightsOutstandingTerm" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapWarrantsAndRightsOutstandingTerm" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:label="loc_us-gaapClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="trxd-20190630.xsd#TRXD_ExerciseRestrictionsLapsePeriod" xlink:label="loc_TRXDExerciseRestrictionsLapsePeriod" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_TRXDExerciseRestrictionsLapsePeriod" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_Goodwill" xlink:label="loc_us-gaapGoodwill" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapGoodwill" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferred1" xlink:label="loc_us-gaapBusinessCombinationConsiderationTransferred1" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapBusinessCombinationConsiderationTransferred1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AssetsFairValueDisclosure" xlink:label="loc_us-gaapAssetsFairValueDisclosure" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapAssetsFairValueDisclosure" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://trxadegroup.com/role/BusinessCombination-ScheduleOfAssetsAcquiredAndLiabilitiesAssumedDetails" xlink:title="00000064 - Disclosure - Business Combination - Schedule of Assets Acquired and Liabilities Assumed (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessCombinationsAbstract" xlink:label="loc_us-gaapBusinessCombinationsAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessCombinationsAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_LegalEntityAxis" xlink:label="loc_deiLegalEntityAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_deiLegalEntityAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="trxd-20190630.xsd#TRXD_CommunitySpecialtyPharmacyLLCMember" xlink:label="loc_TRXDCommunitySpecialtyPharmacyLLCMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityDomain" xlink:to="loc_TRXDCommunitySpecialtyPharmacyLLCMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferred1" xlink:label="loc_us-gaapBusinessCombinationConsiderationTransferred1" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapBusinessCombinationConsiderationTransferred1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" xlink:label="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" xlink:label="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" xlink:label="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets" xlink:label="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" xlink:label="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther" xlink:label="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapBusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_Goodwill" xlink:label="loc_us-gaapGoodwill" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapGoodwill" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://trxadegroup.com/role/BusinessCombination-ScheduleOfUnauditedProFormaStatementsOfOperationsDetails" xlink:title="00000065 - Disclosure - Business Combination - Schedule of Unaudited Pro Forma Statements of Operations (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessCombinationsAbstract" xlink:label="loc_us-gaapBusinessCombinationsAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapBusinessCombinationsAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_LegalEntityAxis" xlink:label="loc_deiLegalEntityAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_deiLegalEntityAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="trxd-20190630.xsd#TRXD_TrxadeMember" xlink:label="loc_TRXDTrxadeMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityDomain" xlink:to="loc_TRXDTrxadeMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="trxd-20190630.xsd#TRXD_CommunitySpecialtyPharmacyLLCMember" xlink:label="loc_TRXDCommunitySpecialtyPharmacyLLCMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityDomain" xlink:to="loc_TRXDCommunitySpecialtyPharmacyLLCMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessAcquisitionsProFormaRevenue" xlink:label="loc_us-gaapBusinessAcquisitionsProFormaRevenue" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapBusinessAcquisitionsProFormaRevenue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss" xlink:label="loc_us-gaapBusinessAcquisitionsProFormaNetIncomeLoss" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapBusinessAcquisitionsProFormaNetIncomeLoss" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessAcquisitionProFormaEarningsPerShareBasic" xlink:label="loc_us-gaapBusinessAcquisitionProFormaEarningsPerShareBasic" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapBusinessAcquisitionProFormaEarningsPerShareBasic" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessAcquisitionProFormaEarningsPerShareDiluted" xlink:label="loc_us-gaapBusinessAcquisitionProFormaEarningsPerShareDiluted" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapBusinessAcquisitionProFormaEarningsPerShareDiluted" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_WeightedAverageBasicSharesOutstandingProForma" xlink:label="loc_us-gaapWeightedAverageBasicSharesOutstandingProForma" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapWeightedAverageBasicSharesOutstandingProForma" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ProFormaWeightedAverageSharesOutstandingDiluted" xlink:label="loc_us-gaapProFormaWeightedAverageSharesOutstandingDiluted" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapProFormaWeightedAverageSharesOutstandingDiluted" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://trxadegroup.com/role/EquityMethodInvestmentDetailsNarrative" xlink:title="00000066 - Disclosure - Equity Method Investment (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract" xlink:label="loc_us-gaapEquityMethodInvestmentsAndJointVenturesAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityMethodInvestmentsAndJointVenturesAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_LegalEntityAxis" xlink:label="loc_deiLegalEntityAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_deiLegalEntityAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="trxd-20190630.xsd#TRXD_AlliancePharmaSolutionLLCMember" xlink:label="loc_TRXDAlliancePharmaSolutionLLCMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityDomain" xlink:to="loc_TRXDAlliancePharmaSolutionLLCMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="trxd-20190630.xsd#TRXD_PanOpticHealthLLCMember" xlink:label="loc_TRXDPanOpticHealthLLCMember" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityDomain" xlink:to="loc_TRXDPanOpticHealthLLCMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_OwnershipAxis" xlink:label="loc_srtOwnershipAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_srtOwnershipAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_OwnershipDomain" xlink:label="loc_srtOwnershipDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtOwnershipAxis" xlink:to="loc_srtOwnershipDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="trxd-20190630.xsd#TRXD_SyncHealthMSOLLCMember" xlink:label="loc_TRXDSyncHealthMSOLLCMember" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtOwnershipDomain" xlink:to="loc_TRXDSyncHealthMSOLLCMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_StatementScenarioAxis" xlink:label="loc_srtStatementScenarioAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_srtStatementScenarioAxis" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_ScenarioUnspecifiedDomain" xlink:label="loc_srtScenarioUnspecifiedDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtStatementScenarioAxis" xlink:to="loc_srtScenarioUnspecifiedDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_ScenarioForecastMember" xlink:label="loc_srtScenarioForecastMember" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtScenarioUnspecifiedDomain" xlink:to="loc_srtScenarioForecastMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AwardDateAxis" xlink:label="loc_us-gaapAwardDateAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapAwardDateAxis" order="40" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AwardDateDomain" xlink:label="loc_us-gaapAwardDateDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAwardDateAxis" xlink:to="loc_us-gaapAwardDateDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_RangeAxis" xlink:label="loc_srtRangeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_srtRangeAxis" order="50" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_RangeMember" xlink:label="loc_srtRangeMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRangeAxis" xlink:to="loc_srtRangeMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_MinimumMember" xlink:label="loc_srtMinimumMember" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMinimumMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_MaximumMember" xlink:label="loc_srtMaximumMember" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMaximumMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesAndInterestInAffiliates" xlink:label="loc_us-gaapPaymentsToAcquireBusinessesAndInterestInAffiliates" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapPaymentsToAcquireBusinessesAndInterestInAffiliates" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:label="loc_us-gaapEquityMethodInvestmentOwnershipPercentage" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapEquityMethodInvestmentOwnershipPercentage" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PaymentsForProceedsFromInvestments" xlink:label="loc_us-gaapPaymentsForProceedsFromInvestments" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapPaymentsForProceedsFromInvestments" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeLossFromEquityMethodInvestments" xlink:label="loc_us-gaapIncomeLossFromEquityMethodInvestments" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapIncomeLossFromEquityMethodInvestments" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://trxadegroup.com/role/SubsequentEventsDetailsNarrative" xlink:title="00000067 - Disclosure - Subsequent Events (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SubsequentEventsAbstract" xlink:label="loc_us-gaapSubsequentEventsAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventsAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="loc_us-gaapSubsequentEventTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapSubsequentEventTypeAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="loc_us-gaapSubsequentEventTypeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventTypeAxis" xlink:to="loc_us-gaapSubsequentEventTypeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SubsequentEventMember" xlink:label="loc_us-gaapSubsequentEventMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventTypeDomain" xlink:to="loc_us-gaapSubsequentEventMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="loc_us-gaapTypeOfArrangementAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapTypeOfArrangementAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapTypeOfArrangementAxis" xlink:to="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="trxd-20190630.xsd#TRXD_SecuritiesPurchaseAgreementMember" xlink:label="loc_TRXDSecuritiesPurchaseAgreementMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_TRXDSecuritiesPurchaseAgreementMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="trxd-20190630.xsd#TRXD_ConsultingAgreementMember" xlink:label="loc_TRXDConsultingAgreementMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapArrangementsAndNonarrangementTransactionsMember" xlink:to="loc_TRXDConsultingAgreementMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:label="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RelatedPartyDomain" xlink:label="loc_us-gaapRelatedPartyDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyTransactionsByRelatedPartyAxis" xlink:to="loc_us-gaapRelatedPartyDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="trxd-20190630.xsd#TRXD_AccreditedInvestorMember" xlink:label="loc_TRXDAccreditedInvestorMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_TRXDAccreditedInvestorMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="trxd-20190630.xsd#TRXD_MrPrashantPatelMember" xlink:label="loc_TRXDMrPrashantPatelMember" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_TRXDMrPrashantPatelMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="trxd-20190630.xsd#TRXD_MrSurenAjjarapuMember" xlink:label="loc_TRXDMrSurenAjjarapuMember" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_TRXDMrSurenAjjarapuMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="trxd-20190630.xsd#TRXD_MrPrashantPatelAndMrSurenAjjarapuMember" xlink:label="loc_TRXDMrPrashantPatelAndMrSurenAjjarapuMember" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRelatedPartyDomain" xlink:to="loc_TRXDMrPrashantPatelAndMrSurenAjjarapuMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_StatementScenarioAxis" xlink:label="loc_srtStatementScenarioAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_srtStatementScenarioAxis" order="40" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_ScenarioUnspecifiedDomain" xlink:label="loc_srtScenarioUnspecifiedDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtStatementScenarioAxis" xlink:to="loc_srtScenarioUnspecifiedDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_ScenarioForecastMember" xlink:label="loc_srtScenarioForecastMember" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtScenarioUnspecifiedDomain" xlink:to="loc_srtScenarioForecastMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentAxis" xlink:label="loc_us-gaapDebtInstrumentAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapDebtInstrumentAxis" order="50" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="loc_us-gaapDebtInstrumentNameDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentAxis" xlink:to="loc_us-gaapDebtInstrumentNameDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="trxd-20190630.xsd#TRXD_PromissoryNotesMember" xlink:label="loc_TRXDPromissoryNotesMember" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDebtInstrumentNameDomain" xlink:to="loc_TRXDPromissoryNotesMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockIssuedDuringPeriodSharesNewIssues" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SharesIssuedPricePerShare" xlink:label="loc_us-gaapSharesIssuedPricePerShare" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapSharesIssuedPricePerShare" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ProceedsFromIssuanceOfPrivatePlacement" xlink:label="loc_us-gaapProceedsFromIssuanceOfPrivatePlacement" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapProceedsFromIssuanceOfPrivatePlacement" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:label="loc_us-gaapClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:label="loc_us-gaapClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
      <link:loc xlink:type="locator" xlink:href="trxd-20190630.xsd#TRXD_ClassOfWarrantOrRightNumberOfSecuritiesExercisableByWarrantsOrRights" xlink:label="loc_TRXDClassOfWarrantOrRightNumberOfSecuritiesExercisableByWarrantsOrRights" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_TRXDClassOfWarrantOrRightNumberOfSecuritiesExercisableByWarrantsOrRights" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtConversionConvertedInstrumentAmount1" xlink:label="loc_us-gaapDebtConversionConvertedInstrumentAmount1" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDebtConversionConvertedInstrumentAmount1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtConversionConvertedInstrumentSharesIssued1" xlink:label="loc_us-gaapDebtConversionConvertedInstrumentSharesIssued1" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDebtConversionConvertedInstrumentSharesIssued1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentConvertibleConversionPrice1" xlink:label="loc_us-gaapDebtInstrumentConvertibleConversionPrice1" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDebtInstrumentConvertibleConversionPrice1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RepaymentsOfRelatedPartyDebt" xlink:label="loc_us-gaapRepaymentsOfRelatedPartyDebt" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapRepaymentsOfRelatedPartyDebt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentMaturityDate" xlink:label="loc_us-gaapDebtInstrumentMaturityDate" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDebtInstrumentMaturityDate" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://trxadegroup.com/role/SubsequentEventsDetailsNarrative10-k" xlink:title="00000068 - Disclosure - Subsequent Events (Details Narrative) (10-K)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SubsequentEventsAbstract" xlink:label="loc_us-gaapSubsequentEventsAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventsAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="loc_us-gaapSubsequentEventTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapSubsequentEventTypeAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="loc_us-gaapSubsequentEventTypeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventTypeAxis" xlink:to="loc_us-gaapSubsequentEventTypeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SubsequentEventMember" xlink:label="loc_us-gaapSubsequentEventMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventTypeDomain" xlink:to="loc_us-gaapSubsequentEventMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_LegalEntityAxis" xlink:label="loc_deiLegalEntityAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_deiLegalEntityAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="trxd-20190630.xsd#TRXD_AlliancePharmaSolutionLLCMember" xlink:label="loc_TRXDAlliancePharmaSolutionLLCMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityDomain" xlink:to="loc_TRXDAlliancePharmaSolutionLLCMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="trxd-20190630.xsd#TRXD_PanOpticHealthLLCMember" xlink:label="loc_TRXDPanOpticHealthLLCMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityDomain" xlink:to="loc_TRXDPanOpticHealthLLCMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_OwnershipAxis" xlink:label="loc_srtOwnershipAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_srtOwnershipAxis" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_OwnershipDomain" xlink:label="loc_srtOwnershipDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtOwnershipAxis" xlink:to="loc_srtOwnershipDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="trxd-20190630.xsd#TRXD_SyncHealthMSOLLCMember" xlink:label="loc_TRXDSyncHealthMSOLLCMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtOwnershipDomain" xlink:to="loc_TRXDSyncHealthMSOLLCMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AwardDateAxis" xlink:label="loc_us-gaapAwardDateAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapAwardDateAxis" order="40" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AwardDateDomain" xlink:label="loc_us-gaapAwardDateDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAwardDateAxis" xlink:to="loc_us-gaapAwardDateDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="trxd-20190630.xsd#TRXD_MayOneTwoThousandNineteenMember" xlink:label="loc_TRXDMayOneTwoThousandNineteenMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAwardDateDomain" xlink:to="loc_TRXDMayOneTwoThousandNineteenMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="trxd-20190630.xsd#TRXD_AugustOneTwoThousandNineteenMember" xlink:label="loc_TRXDAugustOneTwoThousandNineteenMember" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAwardDateDomain" xlink:to="loc_TRXDAugustOneTwoThousandNineteenMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="trxd-20190630.xsd#TRXD_NovemberOneTwoThousandNineteenMember" xlink:label="loc_TRXDNovemberOneTwoThousandNineteenMember" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAwardDateDomain" xlink:to="loc_TRXDNovemberOneTwoThousandNineteenMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="trxd-20190630.xsd#TRXD_JanuaryThortyOneTwoThousandTwentyMember" xlink:label="loc_TRXDJanuaryThortyOneTwoThousandTwentyMember" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAwardDateDomain" xlink:to="loc_TRXDJanuaryThortyOneTwoThousandTwentyMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_RangeAxis" xlink:label="loc_srtRangeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_srtRangeAxis" order="50" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_RangeMember" xlink:label="loc_srtRangeMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRangeAxis" xlink:to="loc_srtRangeMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_MaximumMember" xlink:label="loc_srtMaximumMember" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMaximumMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_MinimumMember" xlink:label="loc_srtMinimumMember" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtRangeMember" xlink:to="loc_srtMinimumMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" xlink:label="loc_us-gaapBusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapBusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:label="loc_us-gaapEquityMethodInvestmentOwnershipPercentage" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapEquityMethodInvestmentOwnershipPercentage" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferred1" xlink:label="loc_us-gaapBusinessCombinationConsiderationTransferred1" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapBusinessCombinationConsiderationTransferred1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentFaceAmount" xlink:label="loc_us-gaapDebtInstrumentFaceAmount" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDebtInstrumentFaceAmount" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentConvertibleConversionPrice1" xlink:label="loc_us-gaapDebtInstrumentConvertibleConversionPrice1" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDebtInstrumentConvertibleConversionPrice1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NotesPayable" xlink:label="loc_us-gaapNotesPayable" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapNotesPayable" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtConversionConvertedInstrumentSharesIssued1" xlink:label="loc_us-gaapDebtConversionConvertedInstrumentSharesIssued1" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDebtConversionConvertedInstrumentSharesIssued1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
      <link:loc xlink:type="locator" xlink:href="trxd-20190630.xsd#TRXD_WarrantsIssued" xlink:label="loc_TRXDWarrantsIssued" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_TRXDWarrantsIssued" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:label="loc_us-gaapClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ConversionOfStockSharesConverted1" xlink:label="loc_us-gaapConversionOfStockSharesConverted1" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapConversionOfStockSharesConverted1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ConversionOfStockAmountConverted1" xlink:label="loc_us-gaapConversionOfStockAmountConverted1" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapConversionOfStockAmountConverted1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>23
<FILENAME>R62.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3</span><table class="report" border="0" cellspacing="2" id="idp6780417568">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Business Combination (Details Narrative) - USD ($)<br></strong></div></th>
<th class="th"><div>Oct. 15, 2018</div></th>
<th class="th"><div>Jun. 30, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
<th class="th"><div>Dec. 31, 2017</div></th>
<th class="th"><div>Feb. 28, 2017</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentOwnershipPercentage', window );">Equity method investment ownership percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Number of shares entitled for warrants issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">161,538<span></span>
</td>
<td class="nump">87,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Warrant exercise price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 725,973<span></span>
</td>
<td class="nump">$ 725,973<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LegalEntityAxis=TRXD_CommunitySpecialtyPharmacyLLCMember', window );">Community Specialty Pharmacy, LLC [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentOwnershipPercentage', window );">Equity method investment ownership percentage</a></td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesGross', window );">Purchase price, cash</a></td>
<td class="nump">$ 300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NotesPayable', window );">Promissory note issued</a></td>
<td class="nump">$ 300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Number of shares entitled for warrants issued</a></td>
<td class="nump">405,507<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">405,507<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingTerm', window );">Warrant term</a></td>
<td class="text">8 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Warrant exercise price</a></td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_TRXD_ExerciseRestrictionsLapsePeriod', window );">Exercise restrictions lapse period</a></td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">$ 725,973<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferred1', window );">Total purchase price</a></td>
<td class="nump">770,291<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WarrantsNotSettleableInCashFairValueDisclosure', window );">Fair value of the warrants issued</a></td>
<td class="nump">$ 170,291<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_TRXD_ExerciseRestrictionsLapsePeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Exercise restrictions lapse period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">TRXD_ExerciseRestrictionsLapsePeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>TRXD_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationConsiderationTransferred1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 30<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=116859721&amp;loc=d3e6613-128477<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=35744584&amp;loc=d3e6927-128479<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 30<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=116859721&amp;loc=d3e6578-128477<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationConsiderationTransferred1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Exercise price per share or per unit of warrants or rights outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(i)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(i)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentOwnershipPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentOwnershipPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=77989000&amp;loc=SL49117168-202975<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NotesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Including the current and noncurrent portions, aggregate carrying amount of all types of notes payable, as of the balance sheet date, with initial maturities beyond one year or beyond the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=119400593&amp;loc=d3e572229-122910<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=6876686&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NotesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireBusinessesGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of business during the period. The cash portion only of the acquisition price.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=35744584&amp;loc=d3e6927-128479<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireBusinessesGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WarrantsAndRightsOutstandingTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Period between issuance and expiration of outstanding warrant and right embodying unconditional obligation requiring redemption by transferring asset at specified or determinable date or upon event certain to occur, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WarrantsAndRightsOutstandingTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WarrantsNotSettleableInCashFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of warrants not settleable in cash classified as equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WarrantsNotSettleableInCashFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=TRXD_CommunitySpecialtyPharmacyLLCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=TRXD_CommunitySpecialtyPharmacyLLCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>24
<FILENAME>R66.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3</span><table class="report" border="0" cellspacing="2" id="idp6764034784">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Equity Method Investment (Details Narrative) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">1 Months Ended</th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Apr. 30, 2019</div></th>
<th class="th"><div>Jan. 31, 2019</div></th>
<th class="th"><div>Jun. 30, 2019</div></th>
<th class="th"><div>Jun. 30, 2018</div></th>
<th class="th"><div>Jun. 30, 2019</div></th>
<th class="th"><div>Jun. 30, 2018</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
<th class="th"><div>Dec. 31, 2017</div></th>
<th class="th"><div>Jan. 31, 2020</div></th>
<th class="th"><div>Nov. 01, 2019</div></th>
<th class="th"><div>Aug. 01, 2019</div></th>
<th class="th"><div>May 01, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentOwnershipPercentage', window );">Equity method investment ownership percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForProceedsFromInvestments', window );">Payment of investment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (250,273)<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromEquityMethodInvestments', window );">Equity method investment loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 58,850<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 87,822<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Number of common stock issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,273,329<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Number of common stock issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">14,776,638<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_OwnershipAxis=TRXD_SyncHealthMSOLLCMember', window );">SyncHealth MSO, LLC [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentOwnershipPercentage', window );">Equity method investment ownership percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_OwnershipAxis=TRXD_SyncHealthMSOLLCMember', window );">SyncHealth MSO, LLC [Member] | Forecast [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentOwnershipPercentage', window );">Equity method investment ownership percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">51.00%<span></span>
</td>
<td class="nump">7.00%<span></span>
</td>
<td class="nump">6.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LegalEntityAxis=TRXD_AlliancePharmaSolutionLLCMember', window );">Alliance Pharma Solution, LLC [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesAndInterestInAffiliates', window );">Payments contributed for equity interest</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 250,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentOwnershipPercentage', window );">Equity method investment ownership percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">49.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForProceedsFromInvestments', window );">Payment of investment</a></td>
<td class="nump">$ 40,000<span></span>
</td>
<td class="nump">$ 210,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LegalEntityAxis=TRXD_AlliancePharmaSolutionLLCMember', window );">Alliance Pharma Solution, LLC [Member] | SyncHealth MSO, LLC [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentOwnershipPercentage', window );">Equity method investment ownership percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">30.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LegalEntityAxis=TRXD_PanOpticHealthLLCMember', window );">PanOptic Health, LLC [Member] | SyncHealth MSO, LLC [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentOwnershipPercentage', window );">Equity method investment ownership percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">70.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentOwnershipPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentOwnershipPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromEquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) for proportionate share of equity method investee's income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=116634182&amp;loc=SL114868664-224227<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(10))<br> -URI http://asc.fasb.org/extlink&amp;oid=116637232&amp;loc=SL114874131-224263<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3602-108585<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(13)(f))<br> -URI http://asc.fasb.org/extlink&amp;oid=116637391&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=115929826&amp;loc=d3e8736-108599<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=109237563&amp;loc=d3e33749-111570<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromEquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForProceedsFromInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net cash paid (received) associated with the acquisition or disposal of all investments, including securities and other assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e24072-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForProceedsFromInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireBusinessesAndInterestInAffiliates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of a controlling interest in another entity or an entity that is related to it but not strictly controlled (for example, an unconsolidated subsidiary, affiliate, joint venture or equity method investment).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireBusinessesAndInterestInAffiliates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of new stock issued during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_OwnershipAxis=TRXD_SyncHealthMSOLLCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_OwnershipAxis=TRXD_SyncHealthMSOLLCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementScenarioAxis=srt_ScenarioForecastMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementScenarioAxis=srt_ScenarioForecastMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=TRXD_AlliancePharmaSolutionLLCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=TRXD_AlliancePharmaSolutionLLCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=TRXD_PanOpticHealthLLCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=TRXD_PanOpticHealthLLCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>25
<FILENAME>R49.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3</span><table class="report" border="0" cellspacing="2" id="idp6779162640">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Options (Details Narrative) - USD ($)<br></strong></div></th>
<th class="th" colspan="4">1 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>May 31, 2019</div></th>
<th class="th"><div>Apr. 30, 2019</div></th>
<th class="th"><div>Apr. 30, 2018</div></th>
<th class="th"><div>Apr. 30, 2017</div></th>
<th class="th"><div>Jun. 30, 2019</div></th>
<th class="th"><div>Jun. 30, 2018</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
<th class="th"><div>Dec. 31, 2017</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Stock option granted</a></td>
<td class="nump">505,000<span></span>
</td>
<td class="nump">505,000<span></span>
</td>
<td class="nump">560,400<span></span>
</td>
<td class="nump">253,846<span></span>
</td>
<td class="nump">505,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">560,400<span></span>
</td>
<td class="nump">263,846<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod', window );">Stock option issued, forfeited or expired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockOptionPlanExpense', window );">Option expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 99,990<span></span>
</td>
<td class="nump">$ 88,072<span></span>
</td>
<td class="nump">$ 169,828<span></span>
</td>
<td class="nump">$ 267,835<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=TRXD_StockOptionPlanMember', window );">Stock Option Plan [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Stock option granted</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDescription', window );">Stock option, description</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">All options may be exercised for a period up to four 1/2 years following the grant date, after which they expire. <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">All options may be exercised for a period up to four 1/2 years following the grant date, after which they expire. <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Stock option vested period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDescription">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Description of terms of share-based payment arrangement. Includes, but is not limited to, type of award or grantee and reason for issuance.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5047-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDescription</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For presentations that combine terminations, the number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan or that expired.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(3)-(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Gross number of share options (or share units) granted during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockOptionPlanExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for option under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockOptionPlanExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=TRXD_StockOptionPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=TRXD_StockOptionPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>26
<FILENAME>R45.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3</span><table class="report" border="0" cellspacing="2" id="idp6941168832">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Warrants (Details Narrative)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th">
<div>Jun. 30, 2019 </div>
<div>shares</div>
</th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsNoteDisclosureAbstract', window );"><strong>Warrants and Rights Note Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_TRXD_StockIssuedDuringPeriodSharesStockWarrantExercised', window );">Warrants exercised, shares</a></td>
<td class="nump">16,666<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_TRXD_StockIssuedDuringPeriodSharesStockWarrantExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Stock issued during period shares stock warrant exercised.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">TRXD_StockIssuedDuringPeriodSharesStockWarrantExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>TRXD_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WarrantsAndRightsNoteDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WarrantsAndRightsNoteDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>27
<FILENAME>R41.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3</span><table class="report" border="0" cellspacing="2" id="idp6862893600">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Long Term Debt (Details Narrative) (10-K) - USD ($)<br></strong></div></th>
<th class="th" colspan="3">1 Months Ended</th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="1">10 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Oct. 31, 2018</div></th>
<th class="th"><div>Jun. 30, 2017</div></th>
<th class="th"><div>Sep. 30, 2016</div></th>
<th class="th"><div>Jun. 30, 2019</div></th>
<th class="th"><div>Oct. 31, 2016</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
<th class="th"><div>Dec. 31, 2017</div></th>
<th class="th"><div>Oct. 30, 2018</div></th>
<th class="th"><div>Dec. 31, 2016</div></th>
<th class="th"><div>May 31, 2016</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConvertibleNotesPayable', window );">Convertible promissory notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 181,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentMaturityDate', window );">Debt instrument maturity date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">May 31,  2019<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_TRXD_CreditCardObligationAmount', window );">Credit card obligation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 25,272<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NotesPayableRelatedPartiesNoncurrent', window );">Long term debt related party</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 522,552<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">522,552<span></span>
</td>
<td class="nump">$ 222,552<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=TRXD_MrPrashantPatelMember', window );">Mr. Prashant Patel [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DueToRelatedPartiesCurrentAndNoncurrent', window );">Due to related parties</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">$ 62,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=TRXD_RelatedPartyPromissoryNoteMember', window );">Related Party Promissory Note [Member] | Mr. Suren Ajjarapu [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentMaturityDate', window );">Debt instrument maturity date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Jul.  01,  2020<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NotesPayableRelatedPartiesNoncurrent', window );">Long term debt related party</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=TRXD_RelatedPartyPromissoryNoteMember', window );">Related Party Promissory Note [Member] | Mr. Prashant Patel [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentMaturityDate', window );">Debt instrument maturity date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Jul.  01,  2020<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DueToRelatedPartiesCurrentAndNoncurrent', window );">Due to related parties</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">122,552<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NotesPayableRelatedPartiesNoncurrent', window );">Long term debt related party</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 122,552<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=TRXD_RelatedPartyPromissoryNoteMember', window );">Related Party Promissory Note [Member] | NPR Investment Group, LLC [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Debt instrument face amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 250,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">80,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=TRXD_RelatedPartyPromissoryNoteMember', window );">Related Party Promissory Note [Member] | Sansur Associates, LLC [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentTerm', window );">Debt instrument term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=TRXD_RelatedPartyPromissoryNoteMember', window );">Related Party Promissory Note [Member] | Sansur Associates, LLC [Member] | Mr. Suren Ajjarapu [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortTermBorrowings', window );">Short term promissory note</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=TRXD_RelatedPartyPromissoryNoteMember', window );">Related Party Promissory Note [Member] | Sansur Associates, LLC [Member] | Mr. Prashant Patel [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortTermBorrowings', window );">Short term promissory note</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 80,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=TRXD_RelatedPartyPromissoryNoteMember', window );">Related Party Promissory Note [Member] | Specialty Pharmacy, LLC [Member] | Nikul Panchal [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentMaturityDate', window );">Debt instrument maturity date</a></td>
<td class="text">Oct. 15,  2021<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfDebt', window );">Proceeds from issuance of promissory note</a></td>
<td class="nump">$ 300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=TRXD_PromissoryNoteMember', window );">Promissory Note [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Debt instrument face amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 189,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 47,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 250,000<span></span>
</td>
<td class="nump">$ 250,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentTerm', window );">Debt instrument term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">494 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">1 year<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfDebt', window );">Proceeds from issuance of promissory note</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 150,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=TRXD_PromissoryNoteMember', window );">Promissory Note [Member] | Related Party Promissory Note [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Debt instrument face amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 17,280<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_TRXD_CreditCardObligationAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Credit card obligation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">TRXD_CreditCardObligationAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>TRXD_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConvertibleNotesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Including the current and noncurrent portions, carrying value as of the balance sheet date of a written promise to pay a note, initially due after one year or beyond the operating cycle if longer, which can be exchanged for a specified amount of one or more securities (typically common stock), at the option of the issuer or the holder.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=6876686&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=6488278&amp;loc=d3e603758-122996<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16)(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=119400593&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConvertibleNotesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFaceAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face (par) amount of debt instrument at time of issuance.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=114775744&amp;loc=d3e28551-108399<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFaceAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateStatedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Contractual interest rate for funds borrowed, under the debt agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateStatedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentMaturityDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Date when the debt instrument is scheduled to be fully repaid, in CCYY-MM-DD format.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentMaturityDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Period of time between issuance and maturity of debt instrument, in PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DueToRelatedPartiesCurrentAndNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount as of the balance sheet date of obligations due all related parties.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(k)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=119400593&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.15(3),(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=6876686&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DueToRelatedPartiesCurrentAndNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NotesPayableRelatedPartiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount for notes payable (written promise to pay), payable to related parties, which are due after one year (or one business cycle).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(k)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.23)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NotesPayableRelatedPartiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow during the period from additional borrowings in aggregate debt. Includes proceeds from short-term and long-term debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermBorrowings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Reflects the total carrying amount as of the balance sheet date of debt having initial terms less than one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19)(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16)(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=119400593&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=6876686&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermBorrowings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=TRXD_MrPrashantPatelMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=TRXD_MrPrashantPatelMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=TRXD_RelatedPartyPromissoryNoteMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=TRXD_RelatedPartyPromissoryNoteMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=TRXD_MrSurenAjjarapuMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=TRXD_MrSurenAjjarapuMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=TRXD_NPRINVESTMENTGROUPLLCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=TRXD_NPRINVESTMENTGROUPLLCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=TRXD_SansurAssociatesLLCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=TRXD_SansurAssociatesLLCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=TRXD_SpecialtyPharmacyLLCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=TRXD_SpecialtyPharmacyLLCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=TRXD_NikulPanchalMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=TRXD_NikulPanchalMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=TRXD_PromissoryNoteMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=TRXD_PromissoryNoteMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=TRXD_RelatedPartyPromissoryNoteMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=TRXD_RelatedPartyPromissoryNoteMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>28
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3</span><table class="report" border="0" cellspacing="2" id="idp6700203696">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Equity Method Investment<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2019</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract', window );"><strong>Equity Method Investments and Joint Ventures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentsDisclosureTextBlock', window );">Equity Method Investment</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif"><b>NOTE
10 &#8211; EQUITY METHOD INVESTMENT</b></font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">In
January 2019, Trxade Group, Inc. through its wholly-owned subsidiary Alliance Pharma Solution, LLC (Alliance) entered into a transaction
to form SyncHealth MSO, LLC (&#8220;SyncHealth&#8221;). SyncHealth is owned by PanOptic Health, LLC (PanOptic) and Alliance. Alliance
contributed $250,000 for the acquisition of a 49% equity interest in SyncHealth and the option to acquire the remaining ownership
from PanOptic shareholders. Prior to March 31, 2019, $210,000 was paid with the remaining $40,000 paid in April 2019. Pursuant
to the operating agreement, PanOptic owns 70% of SyncHealth and Alliance owns 30%; however, pursuant to the Letter Agreement,
PanOptic will transfer to Alliance an additional 6% of SyncHealth&#8217;s membership units on May 1, 2019, an additional 6% on
August 1, 2019 and an additional 7% on November 1, 2019 and at Alliance&#8217;s option, the 51% balance on January 31, 2020, upon
transfer of Trxade Group, Inc. stock between 2,273,329 and 14,776,638 based on 2019 Gross Revenue Quotas.</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">For
the three-months and six-months ended June 30, 2019, the Company recorded its equity share in the losses of SyncHealth amounting
to $58,850 and $87,822, respectively.</font></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for equity method investments and joint ventures. Equity method investments are investments that give the investor the ability to exercise significant influence over the operating and financial policies of an investee. Joint ventures are entities owned and operated by a small group of businesses as a separate and specific business or project for the mutual benefit of the members of the group.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section S99<br> -Paragraph 4<br> -Subparagraph (SX 210.3A-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=116822174&amp;loc=d3e355119-122828<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -URI http://asc.fasb.org/topic&amp;trid=2196965<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>29
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3</span><table class="report" border="0" cellspacing="2" id="idp6699927200">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock', window );">Schedule of Earnings Per Share, Basic and Diluted</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">The
following table sets forth the computation of basic and diluted Income per Share:</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="padding-bottom: 1.5pt; text-align: center">&#160;</td>
    <td colspan="6" style="text-align: center; border-bottom: Black 1.5pt solid">For three months ended June 30,</td><td style="padding-bottom: 1.5pt; text-align: center">&#160;</td><td style="padding-bottom: 1.5pt; text-align: center">&#160;</td>
    <td colspan="6" style="text-align: center; border-bottom: Black 1.5pt solid">For six months ended June 30,</td><td style="padding-bottom: 1.5pt; text-align: center">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="padding-bottom: 1.5pt; text-align: center">&#160;</td>
    <td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid">2019</td><td style="padding-bottom: 1.5pt; text-align: center">&#160;</td><td style="padding-bottom: 1.5pt; text-align: center">&#160;</td>
    <td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid">2018</td><td style="padding-bottom: 1.5pt; text-align: center">&#160;</td><td style="padding-bottom: 1.5pt; text-align: center">&#160;</td>
    <td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid">2019</td><td style="padding-bottom: 1.5pt; text-align: center">&#160;</td><td style="padding-bottom: 1.5pt; text-align: center">&#160;</td>
    <td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid">2018</td><td style="padding-bottom: 1.5pt; text-align: center">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify">Numerator:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="width: 40%; text-align: justify">Net Income</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 11%; text-align: right">57,981</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 11%; text-align: right">20,513</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 11%; text-align: right">183,210</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 11%; text-align: right">102,782</td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Numerator for basic and diluted EPS - income available to common Shareholders</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">57,981</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">20,513</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">183,210</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">102,782</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify">Denominator:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Denominator for basic EPS &#8211; Weighted average shares</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">33,726,489</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">31,985,827</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">33,546,329</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">31,985,827</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Dilutive Effect of Warrants, Options and Convertible Debt</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,627,262</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,493,579</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,807,422</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,486,984</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Denominator for diluted EPS &#8211; adjusted Weighted average shares and assumed Conversions</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">36,353,751</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">34,479,406</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">36,353,751</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">34,472,811</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Basic and Diluted income per common share</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">0.00</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">0.00</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">0.01</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">0.00</td><td style="text-align: left">&#160;</td></tr></table><span></span>
</td>
<td class="text"><p style="margin: 0pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The following table sets forth the computation
of basic and diluted income per common share for the years ended December 31, 2018 and 2017:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: bottom">
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt">December 31, 2018</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt">December 31, 2017</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td><font style="font-size: 10pt">Numerator:</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td style="width: 62%"><font style="font-size: 10pt">Net Income</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%"><font style="font-size: 10pt">$</font></td>
    <td style="width: 16%; text-align: right"><font style="font-size: 10pt">9,038</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%"><font style="font-size: 10pt">$</font></td>
    <td style="width: 16%; text-align: right"><font style="font-size: 10pt">288,983</font></td>
    <td style="width: 1%">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td><font style="font-size: 10pt">Numerator for basic and diluted income available to common shareholders</font></td>
    <td>&#160;</td>
    <td><font style="font-size: 10pt">$</font></td>
    <td style="text-align: right"><font style="font-size: 10pt">9,038</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td><font style="font-size: 10pt">$</font></td>
    <td style="text-align: right"><font style="font-size: 10pt">288,983</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td><font style="font-size: 10pt">Denominator:</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td><font style="font-size: 10pt">Denominator for basic income per common share &#8211; Weighted average common shares outstanding</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">32,260,622</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">31,955,416</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td><font style="font-size: 10pt">Dilutive effect of Common Stock Equivalents</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">2,697,880</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">2,130,835</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td><font style="font-size: 10pt">Denominator for diluted income per common share &#8211; adjusted weighted average common shares outstanding</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">34,958,502</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">34,086,251</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td><font style="font-size: 10pt">Basic and Diluted income per common share</font></td>
    <td>&#160;</td>
    <td><font style="font-size: 10pt">$</font></td>
    <td style="text-align: right"><font style="font-size: 10pt">0.00</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td><font style="font-size: 10pt">$</font></td>
    <td style="text-align: right"><font style="font-size: 10pt">0.01</font></td>
    <td></td></tr>
</table>


<p style="margin: 0pt"></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>30
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.19.3</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>280</ContextCount>
  <ElementCount>392</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>58</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>5</UnitCount>
  <MyReports>
    <Report instance="trxd-20190630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>00000001 - Document - Document and Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://trxadegroup.com/role/DocumentAndEntityInformation</Role>
      <ShortName>Document and Entity Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="trxd-20190630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>00000002 - Statement - Consolidated Balance Sheets</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://trxadegroup.com/role/BalanceSheets</Role>
      <ShortName>Consolidated Balance Sheets</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="trxd-20190630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>00000003 - Statement - Consolidated Balance Sheets (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://trxadegroup.com/role/BalanceSheetsParenthetical</Role>
      <ShortName>Consolidated Balance Sheets (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="trxd-20190630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>00000004 - Statement - Consolidated Statements of Operations</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://trxadegroup.com/role/StatementsOfOperations</Role>
      <ShortName>Consolidated Statements of Operations</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report instance="trxd-20190630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>00000005 - Statement - Consolidated Statements of Changes in Shareholders' Equity</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://trxadegroup.com/role/StatementsOfChangesInShareholdersEquity</Role>
      <ShortName>Consolidated Statements of Changes in Shareholders' Equity</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>5</Position>
    </Report>
    <Report instance="trxd-20190630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>00000006 - Statement - Consolidated Statements of Cash Flows</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://trxadegroup.com/role/StatementsOfCashFlows</Role>
      <ShortName>Consolidated Statements of Cash Flows</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>6</Position>
    </Report>
    <Report instance="trxd-20190630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>00000007 - Disclosure - Organization and Basis of Presentation</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://trxadegroup.com/role/OrganizationAndBasisOfPresentation</Role>
      <ShortName>Organization and Basis of Presentation</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>7</Position>
    </Report>
    <Report instance="trxd-20190630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>00000008 - Disclosure - Summary of Significant Accounting Policies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://trxadegroup.com/role/SummaryOfSignificantAccountingPolicies</Role>
      <ShortName>Summary of Significant Accounting Policies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>8</Position>
    </Report>
    <Report instance="trxd-20190630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>00000009 - Disclosure - Short-Term Debt and Related Parties Debt</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://trxadegroup.com/role/Short-termDebtAndRelatedPartiesDebt</Role>
      <ShortName>Short-Term Debt and Related Parties Debt</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>9</Position>
    </Report>
    <Report instance="trxd-20190630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>00000010 - Disclosure - Long Term Debt - Related Parties</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://trxadegroup.com/role/LongTermDebt-RelatedParties</Role>
      <ShortName>Long Term Debt - Related Parties</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>10</Position>
    </Report>
    <Report instance="trxd-20190630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>00000011 - Disclosure - Shareholders' Equity</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://trxadegroup.com/role/ShareholdersEquity</Role>
      <ShortName>Shareholders' Equity</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>11</Position>
    </Report>
    <Report instance="trxd-20190630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>00000012 - Disclosure - Warrants</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://trxadegroup.com/role/Warrants</Role>
      <ShortName>Warrants</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>12</Position>
    </Report>
    <Report instance="trxd-20190630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>00000013 - Disclosure - Options</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://trxadegroup.com/role/Options</Role>
      <ShortName>Options</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>13</Position>
    </Report>
    <Report instance="trxd-20190630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>00000014 - Disclosure - Leases</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://trxadegroup.com/role/Leases</Role>
      <ShortName>Leases</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>14</Position>
    </Report>
    <Report instance="trxd-20190630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>00000015 - Disclosure - Income Taxes</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://trxadegroup.com/role/IncomeTaxes</Role>
      <ShortName>Income Taxes</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>15</Position>
    </Report>
    <Report instance="trxd-20190630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>00000016 - Disclosure - Related Parties</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://trxadegroup.com/role/RelatedParties</Role>
      <ShortName>Related Parties</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>16</Position>
    </Report>
    <Report instance="trxd-20190630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>00000017 - Disclosure - Commitments and Contingencies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://trxadegroup.com/role/CommitmentsAndContingencies</Role>
      <ShortName>Commitments and Contingencies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>17</Position>
    </Report>
    <Report instance="trxd-20190630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>00000018 - Disclosure - Segment Reporting</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://trxadegroup.com/role/SegmentReporting</Role>
      <ShortName>Segment Reporting</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>18</Position>
    </Report>
    <Report instance="trxd-20190630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>00000019 - Disclosure - Business Combination</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://trxadegroup.com/role/BusinessCombination</Role>
      <ShortName>Business Combination</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>19</Position>
    </Report>
    <Report instance="trxd-20190630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>00000020 - Disclosure - Equity Method Investment</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://trxadegroup.com/role/EquityMethodInvestment</Role>
      <ShortName>Equity Method Investment</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>20</Position>
    </Report>
    <Report instance="trxd-20190630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>00000021 - Disclosure - Subsequent Events</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://trxadegroup.com/role/SubsequentEvents</Role>
      <ShortName>Subsequent Events</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>21</Position>
    </Report>
    <Report instance="trxd-20190630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>00000022 - Disclosure - Summary of Significant Accounting Policies (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://trxadegroup.com/role/SummaryOfSignificantAccountingPoliciesPolicies</Role>
      <ShortName>Summary of Significant Accounting Policies (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <ParentRole>http://trxadegroup.com/role/SummaryOfSignificantAccountingPolicies</ParentRole>
      <Position>22</Position>
    </Report>
    <Report instance="trxd-20190630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>00000023 - Disclosure - Organization and Basis of Presentation (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://trxadegroup.com/role/OrganizationAndBasisOfPresentationTables</Role>
      <ShortName>Organization and Basis of Presentation (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://trxadegroup.com/role/OrganizationAndBasisOfPresentation</ParentRole>
      <Position>23</Position>
    </Report>
    <Report instance="trxd-20190630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
      <LongName>00000024 - Disclosure - Summary of Significant Accounting Policies (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://trxadegroup.com/role/SummaryOfSignificantAccountingPoliciesTables</Role>
      <ShortName>Summary of Significant Accounting Policies (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://trxadegroup.com/role/SummaryOfSignificantAccountingPolicies</ParentRole>
      <Position>24</Position>
    </Report>
    <Report instance="trxd-20190630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R25.htm</HtmlFileName>
      <LongName>00000025 - Disclosure - Long Term Debt - Related Parties (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://trxadegroup.com/role/LongTermDebt-RelatedPartiesTables</Role>
      <ShortName>Long Term Debt - Related Parties (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://trxadegroup.com/role/LongTermDebt-RelatedParties</ParentRole>
      <Position>25</Position>
    </Report>
    <Report instance="trxd-20190630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R26.htm</HtmlFileName>
      <LongName>00000026 - Disclosure - Warrants (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://trxadegroup.com/role/WarrantsTables</Role>
      <ShortName>Warrants (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://trxadegroup.com/role/Warrants</ParentRole>
      <Position>26</Position>
    </Report>
    <Report instance="trxd-20190630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R27.htm</HtmlFileName>
      <LongName>00000027 - Disclosure - Options (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://trxadegroup.com/role/OptionsTables</Role>
      <ShortName>Options (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://trxadegroup.com/role/Options</ParentRole>
      <Position>27</Position>
    </Report>
    <Report instance="trxd-20190630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R28.htm</HtmlFileName>
      <LongName>00000028 - Disclosure - Leases (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://trxadegroup.com/role/LeasesTables</Role>
      <ShortName>Leases (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://trxadegroup.com/role/Leases</ParentRole>
      <Position>28</Position>
    </Report>
    <Report instance="trxd-20190630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R29.htm</HtmlFileName>
      <LongName>00000029 - Disclosure - Income Taxes (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://trxadegroup.com/role/IncomeTaxesTables</Role>
      <ShortName>Income Taxes (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://trxadegroup.com/role/IncomeTaxes</ParentRole>
      <Position>29</Position>
    </Report>
    <Report instance="trxd-20190630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R30.htm</HtmlFileName>
      <LongName>00000030 - Disclosure - Commitments and Contingencies (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://trxadegroup.com/role/CommitmentsAndContingenciesTables</Role>
      <ShortName>Commitments and Contingencies (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://trxadegroup.com/role/CommitmentsAndContingencies</ParentRole>
      <Position>30</Position>
    </Report>
    <Report instance="trxd-20190630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R31.htm</HtmlFileName>
      <LongName>00000031 - Disclosure - Segment Reporting (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://trxadegroup.com/role/SegmentReportingTables</Role>
      <ShortName>Segment Reporting (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://trxadegroup.com/role/SegmentReporting</ParentRole>
      <Position>31</Position>
    </Report>
    <Report instance="trxd-20190630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R32.htm</HtmlFileName>
      <LongName>00000032 - Disclosure - Business Combination (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://trxadegroup.com/role/BusinessCombinationTables</Role>
      <ShortName>Business Combination (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://trxadegroup.com/role/BusinessCombination</ParentRole>
      <Position>32</Position>
    </Report>
    <Report instance="trxd-20190630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R33.htm</HtmlFileName>
      <LongName>00000033 - Disclosure - Organization and Basis of Presentation (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://trxadegroup.com/role/OrganizationAndBasisOfPresentationDetailsNarrative</Role>
      <ShortName>Organization and Basis of Presentation (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://trxadegroup.com/role/OrganizationAndBasisOfPresentationTables</ParentRole>
      <Position>33</Position>
    </Report>
    <Report instance="trxd-20190630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R34.htm</HtmlFileName>
      <LongName>00000034 - Disclosure - Organization (Details Narrative) (10-K)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://trxadegroup.com/role/OrganizationDetailsNarrative10-k</Role>
      <ShortName>Organization (Details Narrative) (10-K)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://trxadegroup.com/role/OrganizationAndBasisOfPresentationTables</ParentRole>
      <Position>34</Position>
    </Report>
    <Report instance="trxd-20190630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R35.htm</HtmlFileName>
      <LongName>00000035 - Disclosure - Organization and Basis of Presentation - Schedule of Earnings Per Share, Basic and Diluted (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://trxadegroup.com/role/OrganizationAndBasisOfPresentation-ScheduleOfEarningsPerShareBasicAndDilutedDetails</Role>
      <ShortName>Organization and Basis of Presentation - Schedule of Earnings Per Share, Basic and Diluted (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>35</Position>
    </Report>
    <Report instance="trxd-20190630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R36.htm</HtmlFileName>
      <LongName>00000036 - Disclosure - Summary of Significant Accounting Policies (Details Narrative) (10-K)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://trxadegroup.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative10-k</Role>
      <ShortName>Summary of Significant Accounting Policies (Details Narrative) (10-K)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://trxadegroup.com/role/SummaryOfSignificantAccountingPoliciesTables</ParentRole>
      <Position>36</Position>
    </Report>
    <Report instance="trxd-20190630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R37.htm</HtmlFileName>
      <LongName>00000037 - Disclosure - Summary of Significant Accounting Policies - Schedule of Earnings Per Share, Basic and Diluted (Details) (10-K)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://trxadegroup.com/role/SummaryOfSignificantAccountingPolicies-ScheduleOfEarningsPerShareBasicAndDilutedDetails10-k</Role>
      <ShortName>Summary of Significant Accounting Policies - Schedule of Earnings Per Share, Basic and Diluted (Details) (10-K)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>37</Position>
    </Report>
    <Report instance="trxd-20190630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R38.htm</HtmlFileName>
      <LongName>00000038 - Disclosure - Short-term Debt and Related Parties Debt (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://trxadegroup.com/role/Short-termDebtAndRelatedPartiesDebtDetailsNarrative</Role>
      <ShortName>Short-term Debt and Related Parties Debt (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>38</Position>
    </Report>
    <Report instance="trxd-20190630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R39.htm</HtmlFileName>
      <LongName>00000039 - Disclosure - Short-term Debt and Related Parties Debt (Details Narrative) (10-K)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://trxadegroup.com/role/Short-termDebtAndRelatedPartiesDebtDetailsNarrative10-k</Role>
      <ShortName>Short-term Debt and Related Parties Debt (Details Narrative) (10-K)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>39</Position>
    </Report>
    <Report instance="trxd-20190630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R40.htm</HtmlFileName>
      <LongName>00000040 - Disclosure - Long Term Debt - Related Parties (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://trxadegroup.com/role/LongTermDebt-RelatedPartiesDetailsNarrative</Role>
      <ShortName>Long Term Debt - Related Parties (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://trxadegroup.com/role/LongTermDebt-RelatedPartiesTables</ParentRole>
      <Position>40</Position>
    </Report>
    <Report instance="trxd-20190630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R41.htm</HtmlFileName>
      <LongName>00000041 - Disclosure - Long Term Debt (Details Narrative) (10-K)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://trxadegroup.com/role/LongTermDebtDetailsNarrative10-k</Role>
      <ShortName>Long Term Debt (Details Narrative) (10-K)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://trxadegroup.com/role/LongTermDebt-RelatedPartiesTables</ParentRole>
      <Position>41</Position>
    </Report>
    <Report instance="trxd-20190630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R42.htm</HtmlFileName>
      <LongName>00000042 - Disclosure - Long Term Debt - Schedule of Future Maturities of Long-term Debt (Details) (10-K)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://trxadegroup.com/role/LongTermDebt-ScheduleOfFutureMaturitiesOfLong-termDebtDetails10-k</Role>
      <ShortName>Long Term Debt - Schedule of Future Maturities of Long-term Debt (Details) (10-K)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>42</Position>
    </Report>
    <Report instance="trxd-20190630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R43.htm</HtmlFileName>
      <LongName>00000043 - Disclosure - Shareholders' Equity (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://trxadegroup.com/role/ShareholdersEquityDetailsNarrative</Role>
      <ShortName>Shareholders' Equity (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://trxadegroup.com/role/ShareholdersEquity</ParentRole>
      <Position>43</Position>
    </Report>
    <Report instance="trxd-20190630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R44.htm</HtmlFileName>
      <LongName>00000044 - Disclosure - Stockholders' Equity (Details Narrative) (10-K)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://trxadegroup.com/role/StockholdersEquityDetailsNarrative10-k</Role>
      <ShortName>Stockholders' Equity (Details Narrative) (10-K)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>44</Position>
    </Report>
    <Report instance="trxd-20190630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R45.htm</HtmlFileName>
      <LongName>00000045 - Disclosure - Warrants (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://trxadegroup.com/role/WarrantsDetailsNarrative</Role>
      <ShortName>Warrants (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://trxadegroup.com/role/WarrantsTables</ParentRole>
      <Position>45</Position>
    </Report>
    <Report instance="trxd-20190630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R46.htm</HtmlFileName>
      <LongName>00000046 - Disclosure - Warrants (Details Narrative) (10-K)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://trxadegroup.com/role/WarrantsDetailsNarrative10-k</Role>
      <ShortName>Warrants (Details Narrative) (10-K)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://trxadegroup.com/role/WarrantsTables</ParentRole>
      <Position>46</Position>
    </Report>
    <Report instance="trxd-20190630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R47.htm</HtmlFileName>
      <LongName>00000047 - Disclosure - Warrants - Schedule of Outstanding and Exercisable Warrants (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://trxadegroup.com/role/Warrants-ScheduleOfOutstandingAndExercisableWarrantsDetails</Role>
      <ShortName>Warrants - Schedule of Outstanding and Exercisable Warrants (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>47</Position>
    </Report>
    <Report instance="trxd-20190630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R48.htm</HtmlFileName>
      <LongName>00000048 - Disclosure - Warrants - Summary of Estimate the Fair Value of Warrants (Details) (10-K)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://trxadegroup.com/role/Warrants-SummaryOfEstimateFairValueOfWarrantsDetails10-k</Role>
      <ShortName>Warrants - Summary of Estimate the Fair Value of Warrants (Details) (10-K)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>48</Position>
    </Report>
    <Report instance="trxd-20190630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R49.htm</HtmlFileName>
      <LongName>00000049 - Disclosure - Options (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://trxadegroup.com/role/OptionsDetailsNarrative</Role>
      <ShortName>Options (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://trxadegroup.com/role/OptionsTables</ParentRole>
      <Position>49</Position>
    </Report>
    <Report instance="trxd-20190630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R50.htm</HtmlFileName>
      <LongName>00000050 - Disclosure - Options (Details Narrative) (10-K)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://trxadegroup.com/role/OptionsDetailsNarrative10-k</Role>
      <ShortName>Options (Details Narrative) (10-K)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://trxadegroup.com/role/OptionsTables</ParentRole>
      <Position>50</Position>
    </Report>
    <Report instance="trxd-20190630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R51.htm</HtmlFileName>
      <LongName>00000051 - Disclosure - Options - Schedule of Estimate the Fair Value of Stock Options (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://trxadegroup.com/role/Options-ScheduleOfEstimateFairValueOfStockOptionsDetails</Role>
      <ShortName>Options - Schedule of Estimate the Fair Value of Stock Options (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>51</Position>
    </Report>
    <Report instance="trxd-20190630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R52.htm</HtmlFileName>
      <LongName>00000052 - Disclosure - Options - Schedule of Stock Option Activity (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://trxadegroup.com/role/Options-ScheduleOfStockOptionActivityDetails</Role>
      <ShortName>Options - Schedule of Stock Option Activity (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>52</Position>
    </Report>
    <Report instance="trxd-20190630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R53.htm</HtmlFileName>
      <LongName>00000053 - Disclosure - Leases (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://trxadegroup.com/role/LeasesDetailsNarrative</Role>
      <ShortName>Leases (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://trxadegroup.com/role/LeasesTables</ParentRole>
      <Position>53</Position>
    </Report>
    <Report instance="trxd-20190630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R54.htm</HtmlFileName>
      <LongName>00000054 - Disclosure - Leases - Schedule of Operating Leases (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://trxadegroup.com/role/Leases-ScheduleOfOperatingLeasesDetails</Role>
      <ShortName>Leases - Schedule of Operating Leases (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>54</Position>
    </Report>
    <Report instance="trxd-20190630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R55.htm</HtmlFileName>
      <LongName>00000055 - Disclosure - Leases - Schedule of Future Minimum Payments for Operating Lease Liabilities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://trxadegroup.com/role/Leases-ScheduleOfFutureMinimumPaymentsForOperatingLeaseLiabilitiesDetails</Role>
      <ShortName>Leases - Schedule of Future Minimum Payments for Operating Lease Liabilities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>55</Position>
    </Report>
    <Report instance="trxd-20190630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R56.htm</HtmlFileName>
      <LongName>00000056 - Disclosure - Income Taxes (Details Narrative) (10-K)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://trxadegroup.com/role/IncomeTaxesDetailsNarrative10-k</Role>
      <ShortName>Income Taxes (Details Narrative) (10-K)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://trxadegroup.com/role/IncomeTaxesTables</ParentRole>
      <Position>56</Position>
    </Report>
    <Report instance="trxd-20190630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R57.htm</HtmlFileName>
      <LongName>00000057 - Disclosure - Income Taxes - Schedule of Deferred Tax Assets (Details) (10-K)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://trxadegroup.com/role/IncomeTaxes-ScheduleOfDeferredTaxAssetsDetails10-k</Role>
      <ShortName>Income Taxes - Schedule of Deferred Tax Assets (Details) (10-K)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>57</Position>
    </Report>
    <Report instance="trxd-20190630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R58.htm</HtmlFileName>
      <LongName>00000058 - Disclosure - Related Parties (Details Narrative) (10-K)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://trxadegroup.com/role/RelatedPartiesDetailsNarrative10-k</Role>
      <ShortName>Related Parties (Details Narrative) (10-K)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://trxadegroup.com/role/RelatedParties</ParentRole>
      <Position>58</Position>
    </Report>
    <Report instance="trxd-20190630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R59.htm</HtmlFileName>
      <LongName>00000059 - Disclosure - Commitments and Contingencies (Details Narrative) (10-K)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://trxadegroup.com/role/CommitmentsAndContingenciesDetailsNarrative10-k</Role>
      <ShortName>Commitments and Contingencies (Details Narrative) (10-K)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://trxadegroup.com/role/CommitmentsAndContingenciesTables</ParentRole>
      <Position>59</Position>
    </Report>
    <Report instance="trxd-20190630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R60.htm</HtmlFileName>
      <LongName>00000060 - Disclosure - Commitments and Contingencies - Schedule of Future Minimum Rental Payments Under Non-cancelable Operating Leases (Details) (10-K)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://trxadegroup.com/role/CommitmentsAndContingencies-ScheduleOfFutureMinimumRentalPaymentsUnderNon-cancelableOperatingLeasesDetails10-k</Role>
      <ShortName>Commitments and Contingencies - Schedule of Future Minimum Rental Payments Under Non-cancelable Operating Leases (Details) (10-K)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>60</Position>
    </Report>
    <Report instance="trxd-20190630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R61.htm</HtmlFileName>
      <LongName>00000061 - Disclosure - Segment Reporting - Schedule of Business Interests Into Reportable Segments (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://trxadegroup.com/role/SegmentReporting-ScheduleOfBusinessInterestsIntoReportableSegmentsDetails</Role>
      <ShortName>Segment Reporting - Schedule of Business Interests Into Reportable Segments (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>61</Position>
    </Report>
    <Report instance="trxd-20190630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R62.htm</HtmlFileName>
      <LongName>00000062 - Disclosure - Business Combination (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://trxadegroup.com/role/BusinessCombinationDetailsNarrative</Role>
      <ShortName>Business Combination (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://trxadegroup.com/role/BusinessCombinationTables</ParentRole>
      <Position>62</Position>
    </Report>
    <Report instance="trxd-20190630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R63.htm</HtmlFileName>
      <LongName>00000063 - Disclosure - Business Combination (Details Narrative) (10-K)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://trxadegroup.com/role/BusinessCombinationDetailsNarrative10-k</Role>
      <ShortName>Business Combination (Details Narrative) (10-K)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://trxadegroup.com/role/BusinessCombinationTables</ParentRole>
      <Position>63</Position>
    </Report>
    <Report instance="trxd-20190630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R64.htm</HtmlFileName>
      <LongName>00000064 - Disclosure - Business Combination - Schedule of Assets Acquired and Liabilities Assumed (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://trxadegroup.com/role/BusinessCombination-ScheduleOfAssetsAcquiredAndLiabilitiesAssumedDetails</Role>
      <ShortName>Business Combination - Schedule of Assets Acquired and Liabilities Assumed (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>64</Position>
    </Report>
    <Report instance="trxd-20190630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R65.htm</HtmlFileName>
      <LongName>00000065 - Disclosure - Business Combination - Schedule of Unaudited Pro Forma Statements of Operations (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://trxadegroup.com/role/BusinessCombination-ScheduleOfUnauditedProFormaStatementsOfOperationsDetails</Role>
      <ShortName>Business Combination - Schedule of Unaudited Pro Forma Statements of Operations (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>65</Position>
    </Report>
    <Report instance="trxd-20190630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R66.htm</HtmlFileName>
      <LongName>00000066 - Disclosure - Equity Method Investment (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://trxadegroup.com/role/EquityMethodInvestmentDetailsNarrative</Role>
      <ShortName>Equity Method Investment (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://trxadegroup.com/role/EquityMethodInvestment</ParentRole>
      <Position>66</Position>
    </Report>
    <Report instance="trxd-20190630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R67.htm</HtmlFileName>
      <LongName>00000067 - Disclosure - Subsequent Events (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://trxadegroup.com/role/SubsequentEventsDetailsNarrative</Role>
      <ShortName>Subsequent Events (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://trxadegroup.com/role/SubsequentEvents</ParentRole>
      <Position>67</Position>
    </Report>
    <Report instance="trxd-20190630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R68.htm</HtmlFileName>
      <LongName>00000068 - Disclosure - Subsequent Events (Details Narrative) (10-K)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://trxadegroup.com/role/SubsequentEventsDetailsNarrative10-k</Role>
      <ShortName>Subsequent Events (Details Narrative) (10-K)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://trxadegroup.com/role/SubsequentEvents</ParentRole>
      <Position>68</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File>trxd-20190630.xml</File>
    <File>trxd-20190630.xsd</File>
    <File>trxd-20190630_cal.xml</File>
    <File>trxd-20190630_def.xml</File>
    <File>trxd-20190630_lab.xml</File>
    <File>trxd-20190630_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy>http://fasb.org/us-gaap/2019-01-31</BaseTaxonomy>
    <BaseTaxonomy>http://fasb.org/srt/2019-01-31</BaseTaxonomy>
    <BaseTaxonomy>http://xbrl.sec.gov/dei/2019-01-31</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>31
<FILENAME>R28.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3</span><table class="report" border="0" cellspacing="2" id="idp6935151200">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2019</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeaseCostTableTextBlock', window );">Schedule of Operating Leases</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">The
following table outlines the details:</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid">Lease 1</td><td style="padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid">Lease 2</td><td style="padding-bottom: 1.5pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Initial Lease Term</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">December 2017 to December 2021</font></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">November 2018 to November 2023</font></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Renewal Term</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">January 2021 to December 2024</font></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">November 2023 to November 2028</font></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 36%; text-align: left">Initial Recognition of Right to use assets at January 1, 2019</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 28%; text-align: right">534,140</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 28%; text-align: right">313,301</td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Incremental Borrowing Rate</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">10</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">10</td><td style="text-align: left">%</td></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock', window );">Schedule of Future Minimum Payments for Operating Lease Liabilities</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">The
table below reconciles the fixed component of the undiscounted cash flows for each of the first five years and the total remaining
years to the operating lease liabilities recorded in the Consolidated Balance Sheet as of June 30, 2019</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<table cellpadding="0" cellspacing="0" align="center" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<tr style="vertical-align: bottom">
    <td style="font-weight: bold; text-align: justify; border-bottom: Black 1.5pt solid">Amounts due within twelve months of June 30</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 78%; text-align: justify">2019</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 18%; text-align: right">158,366</td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify">2020</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">163,102</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify">2021</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">167,984</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify">2022</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">173,038</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify">2023</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">178,237</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify; padding-bottom: 1.5pt">Thereafter</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">305,012</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify">Total minimum lease payments</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,145,739</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify; padding-bottom: 1.5pt">Less: effect of discounting</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(334,574</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify">Present value of future minimum lease payments</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">811,165</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify; padding-bottom: 1.5pt">Less: current obligations under leases</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">80,832</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify; padding-bottom: 2.5pt">Long-term lease obligations</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">730,333</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseCostTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of lessee's lease cost. Includes, but is not limited to, interest expense for finance lease, amortization of right-of-use asset for finance lease, operating lease cost, short-term lease cost, variable lease cost and sublease income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=77888426&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseCostTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=77888426&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>32
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3</span><table class="report" border="0" cellspacing="2" id="idp6777632496">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Consolidated Statements of Operations - USD ($)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2019</div></th>
<th class="th"><div>Jun. 30, 2018</div></th>
<th class="th"><div>Jun. 30, 2019</div></th>
<th class="th"><div>Jun. 30, 2018</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
<th class="th"><div>Dec. 31, 2017</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementAbstract', window );"><strong>Income Statement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues</a></td>
<td class="nump">$ 1,916,414<span></span>
</td>
<td class="nump">$ 837,688<span></span>
</td>
<td class="nump">$ 3,428,935<span></span>
</td>
<td class="nump">$ 1,690,611<span></span>
</td>
<td class="nump">$ 3,831,778<span></span>
</td>
<td class="nump">$ 2,931,280<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostOfGoodsAndServicesSold', window );">Cost of Sales</a></td>
<td class="nump">753,138<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">1,118,977<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">449,049<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GrossProfit', window );">Gross Profit</a></td>
<td class="nump">1,163,276<span></span>
</td>
<td class="nump">837,688<span></span>
</td>
<td class="nump">2,309,958<span></span>
</td>
<td class="nump">1,690,611<span></span>
</td>
<td class="nump">3,382,729<span></span>
</td>
<td class="nump">2,931,280<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingExpensesAbstract', window );"><strong>Operating Expenses</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GeneralAndAdministrativeExpense', window );">General and Administrative</a></td>
<td class="nump">1,030,571<span></span>
</td>
<td class="nump">806,242<span></span>
</td>
<td class="nump">2,005,494<span></span>
</td>
<td class="nump">1,560,437<span></span>
</td>
<td class="nump">3,470,345<span></span>
</td>
<td class="nump">2,536,185<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Operating Income</a></td>
<td class="nump">132,705<span></span>
</td>
<td class="nump">31,446<span></span>
</td>
<td class="nump">304,464<span></span>
</td>
<td class="nump">130,174<span></span>
</td>
<td class="num">(87,616)<span></span>
</td>
<td class="nump">395,095<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromEquityMethodInvestments', window );">Share in Equity Losses in Investment</a></td>
<td class="num">(58,850)<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(87,822)<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncome', window );">Other Income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">161,639<span></span>
</td>
<td class="nump">67,500<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainsLossesOnExtinguishmentOfDebt', window );">Loss on Extinguishment of Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(7,444)<span></span>
</td>
<td class="num">(16,556)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestExpense', window );">Interest Expense</a></td>
<td class="num">(15,874)<span></span>
</td>
<td class="num">(10,933)<span></span>
</td>
<td class="num">(33,432)<span></span>
</td>
<td class="num">(27,392)<span></span>
</td>
<td class="num">(57,541)<span></span>
</td>
<td class="num">(157,056)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net Income</a></td>
<td class="nump">$ 57,981<span></span>
</td>
<td class="nump">$ 20,513<span></span>
</td>
<td class="nump">$ 183,210<span></span>
</td>
<td class="nump">$ 102,782<span></span>
</td>
<td class="nump">$ 9,038<span></span>
</td>
<td class="nump">$ 288,983<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Net Income per Common Share - Basic:</a></td>
<td class="nump">$ 0.00<span></span>
</td>
<td class="nump">$ 0.00<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="nump">$ 0.00<span></span>
</td>
<td class="nump">$ 0.00<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Net Income per Common Share - Diluted:</a></td>
<td class="nump">$ 0.00<span></span>
</td>
<td class="nump">$ 0.00<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="nump">$ 0.00<span></span>
</td>
<td class="nump">$ 0.00<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Weighted average Common Shares Outstanding Basic</a></td>
<td class="nump">33,726,489<span></span>
</td>
<td class="nump">31,985,827<span></span>
</td>
<td class="nump">33,546,329<span></span>
</td>
<td class="nump">31,985,827<span></span>
</td>
<td class="nump">32,260,622<span></span>
</td>
<td class="nump">31,955,416<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Weighted average Common Shares Outstanding Diluted</a></td>
<td class="nump">36,353,751<span></span>
</td>
<td class="nump">34,479,406<span></span>
</td>
<td class="nump">36,353,751<span></span>
</td>
<td class="nump">34,472,811<span></span>
</td>
<td class="nump">34,958,502<span></span>
</td>
<td class="nump">34,086,251<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfGoodsAndServicesSold">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.2(a),(d))<br> -URI http://asc.fasb.org/extlink&amp;oid=116634182&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfGoodsAndServicesSold</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI http://asc.fasb.org/extlink&amp;oid=116637232&amp;loc=SL114874131-224263<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=117326831&amp;loc=d3e1337-109256<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=117327953&amp;loc=d3e4984-109258<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI http://asc.fasb.org/extlink&amp;oid=116634182&amp;loc=SL114868664-224227<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=117326831&amp;loc=d3e1252-109256<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=116637391&amp;loc=SL114874048-224260<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=117326831&amp;loc=SL5780133-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=117327953&amp;loc=d3e4984-109258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=117326831&amp;loc=d3e1252-109256<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=116637391&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=117326831&amp;loc=d3e1337-109256<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI http://asc.fasb.org/extlink&amp;oid=116634182&amp;loc=SL114868664-224227<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=117326831&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI http://asc.fasb.org/extlink&amp;oid=116637232&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainsLossesOnExtinguishmentOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=117329964&amp;loc=d3e12355-112629<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=117329964&amp;loc=d3e12317-112629<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainsLossesOnExtinguishmentOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=116634182&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GrossProfit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.1,2)<br> -URI http://asc.fasb.org/extlink&amp;oid=116634182&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GrossProfit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromEquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) for proportionate share of equity method investee's income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=116634182&amp;loc=SL114868664-224227<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(10))<br> -URI http://asc.fasb.org/extlink&amp;oid=116637232&amp;loc=SL114874131-224263<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3602-108585<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(13)(f))<br> -URI http://asc.fasb.org/extlink&amp;oid=116637391&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=115929826&amp;loc=d3e8736-108599<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=109237563&amp;loc=d3e33749-111570<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromEquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the cost of borrowed funds accounted for as interest expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6450988&amp;loc=d3e26243-108391<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=114775744&amp;loc=d3e28555-108399<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=115929826&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (210.5-03(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=116634182&amp;loc=SL114868664-224227<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=116637391&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=SL7669619-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=116637391&amp;loc=SL114874048-224260<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=SL7669625-108580<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=116637232&amp;loc=SL114874131-224263<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=116634182&amp;loc=SL114868664-224227<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3602-108585<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income related to nonoperating activities, classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=116634182&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118956577&amp;loc=SL49130543-203045<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=118956577&amp;loc=SL49130545-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=117326831&amp;loc=d3e1505-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=117326831&amp;loc=d3e1448-109256<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>33
<FILENAME>R39.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3</span><table class="report" border="0" cellspacing="2" id="idp6865511840">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Short-term Debt and Related Parties Debt (Details Narrative) (10-K) - USD ($)<br></strong></div></th>
<th class="th" colspan="16">1 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
<th class="th" colspan="1">10 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Aug. 31, 2018</div></th>
<th class="th"><div>Apr. 30, 2018</div></th>
<th class="th"><div>Feb. 28, 2018</div></th>
<th class="th"><div>Sep. 30, 2017</div></th>
<th class="th"><div>Aug. 31, 2017</div></th>
<th class="th"><div>Jul. 31, 2017</div></th>
<th class="th"><div>Apr. 30, 2017</div></th>
<th class="th"><div>Feb. 28, 2017</div></th>
<th class="th"><div>Nov. 30, 2016</div></th>
<th class="th"><div>Oct. 31, 2016</div></th>
<th class="th"><div>Sep. 30, 2016</div></th>
<th class="th"><div>Aug. 31, 2016</div></th>
<th class="th"><div>May 31, 2016</div></th>
<th class="th"><div>Apr. 30, 2016</div></th>
<th class="th"><div>May 31, 2015</div></th>
<th class="th"><div>Apr. 30, 2015</div></th>
<th class="th"><div>Jun. 30, 2019</div></th>
<th class="th"><div>Jun. 30, 2018</div></th>
<th class="th"><div>Oct. 31, 2016</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
<th class="th"><div>Dec. 31, 2017</div></th>
<th class="th"><div>Dec. 31, 2016</div></th>
<th class="th"><div>Feb. 28, 2019</div></th>
<th class="th"><div>Dec. 31, 2015</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConvertibleNotesPayable', window );">Convertible promissory notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 181,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Warrant purchased from common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">161,538<span></span>
</td>
<td class="nump">87,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Warrant strike price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentMaturityDate', window );">Debt instrument maturity date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">May 31,  2019<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainsLossesOnExtinguishmentOfDebt', window );">Loss on extinguishment of debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (7,444)<span></span>
</td>
<td class="num">$ (16,556)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfDebtDiscountPremium', window );">Amortized debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 152<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">152<span></span>
</td>
<td class="nump">88,647<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConvertibleNotesPayableCurrent', window );">Short term convertible notes payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">181,500<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long term promissory debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">522,052<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=TRXD_MrPrashantPatelMember', window );">Mr. Prashant Patel [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DueToRelatedPartiesCurrentAndNoncurrent', window );">Due to related parties</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">62,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_WarrantMember', window );">Warrant [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Warrant strike price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentUnamortizedDiscount', window );">Debt discount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 53,546<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_TRXD_DebtModificationsAmount', window );">Debt modification amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=TRXD_ConvertiblePromissoryNoteMember', window );">Convertible Promissory Note [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConvertibleNotesPayable', window );">Convertible promissory notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 165,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 200,000<span></span>
</td>
<td class="nump">$ 200,000<span></span>
</td>
<td class="nump">$ 200,000<span></span>
</td>
<td class="nump">$ 200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 181,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentTerm', window );">Debt notes term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">2 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">1 year<span></span>
</td>
<td class="text">1 year<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10.00%<span></span>
</td>
<td class="nump">10.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleConversionPrice1', window );">Conversion price per share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.85<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1.50<span></span>
</td>
<td class="nump">$ 1.50<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.50<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_TRXD_GrantedWarrants', window );">Granted warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesIssuedPricePerShare', window );">Shares issued price per shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4.00<span></span>
</td>
<td class="nump">$ 4.00<span></span>
</td>
<td class="nump">$ 4.00<span></span>
</td>
<td class="nump">$ 4.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Warrant purchased from common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">18,150<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">41,250<span></span>
</td>
<td class="nump">41,250<span></span>
</td>
<td class="nump">50,000<span></span>
</td>
<td class="nump">50,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Warrant strike price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.65<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1.50<span></span>
</td>
<td class="nump">$ 1.50<span></span>
</td>
<td class="nump">$ 1.50<span></span>
</td>
<td class="nump">$ 1.50<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingTerm', window );">Warrants term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentUnamortizedDiscount', window );">Debt discount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 53,546<span></span>
</td>
<td class="nump">$ 53,546<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfDebt', window );">Payment for promissory note</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 50,000<span></span>
</td>
<td class="nump">$ 50,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestExpenseDebt', window );">Interest expenses debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,000<span></span>
</td>
<td class="nump">$ 5,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentMaturityDateDescription', window );">Debt instrument maturity, description</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">A two-year extension was executed on the remaining notes <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">A one-year extension was executed on the remaining notes<span></span>
</td>
<td class="text">A one-year extension was executed on the remaining notes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestPayableCurrentAndNoncurrent', window );">Interest owed part of adjusted principal amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 16,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 15,000<span></span>
</td>
<td class="nump">$ 15,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Debt instrument face amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 181,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 165,000<span></span>
</td>
<td class="nump">$ 165,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentMaturityDate', window );">Debt instrument maturity date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">May 31,  2019<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">May 31,  2017<span></span>
</td>
<td class="text">May 31,  2017<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainsLossesOnExtinguishmentOfDebt', window );">Loss on extinguishment of debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 11,512<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 37,579<span></span>
</td>
<td class="nump">$ 37,579<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfDebtDiscountPremium', window );">Amortized debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConvertibleNotesPayableCurrent', window );">Short term convertible notes payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">181,500<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=TRXD_PromissoryNoteMember', window );">Promissory Note [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentTerm', window );">Debt notes term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">494 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">1 year<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentUnamortizedDiscount', window );">Debt discount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 39,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">45,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 15,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfDebt', window );">Payment for promissory note</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">250,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Debt instrument face amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 47,000<span></span>
</td>
<td class="nump">189,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 250,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 47,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">250,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfDebtDiscountPremium', window );">Amortized debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15,000<span></span>
</td>
<td class="nump">45,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentPeriodicPaymentPrincipal', window );">Principal payments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,917<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfDebt', window );">Proceeds from promissory note</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 150,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=TRXD_PromissoryNoteOneMember', window );">Promissory Note One [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfDebt', window );">Payment for promissory note</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">43,083<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Debt instrument face amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">43,083<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=TRXD_PromissoryNoteTwoMember', window );">Promissory Note Two [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConvertibleNotesPayableCurrent', window );">Short term convertible notes payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">139,602<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentPeriodicPaymentPrincipal', window );">Principal payments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">537<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentUnamortizedDiscountCurrent', window );">Debt discount, current</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">25,306<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long term promissory debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,739<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentUnamortizedDiscountNoncurrent', window );">Debt discount non current</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">152<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=TRXD_ShortTermPromissoryNotesMember', window );">Short Term Promissory Notes [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentUnamortizedDiscount', window );">Debt discount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">152<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfDebt', window );">Payment for promissory note</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">139,602<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfDebtDiscountPremium', window );">Amortized debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">25,306<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConvertibleNotesPayableCurrent', window );">Short term convertible notes payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">10,739<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=TRXD_PromissoryNotesMember', window );">Promissory Notes [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfDebt', window );">Payment for promissory note</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,739<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfDebtDiscountPremium', window );">Amortized debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">152<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=TRXD_RelatedPartyConvertiblePromissoryNoteMember', window );">Related Party Convertible Promissory Note [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentTerm', window );">Debt notes term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">1 year<span></span>
</td>
<td class="text">6 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">1 year<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10.00%<span></span>
</td>
<td class="nump">10.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Warrant purchased from common stock</a></td>
<td class="nump">10,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Warrant strike price</a></td>
<td class="nump">$ 0.50<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.80<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingTerm', window );">Warrants term</a></td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentUnamortizedDiscount', window );">Debt discount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">65,390<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfDebt', window );">Payment for promissory note</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 50,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentMaturityDateDescription', window );">Debt instrument maturity, description</a></td>
<td class="text">A one-year extension was executed to August 2019. <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">A one-year extension was executed to August 2018. <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Debt instrument face amount</a></td>
<td class="nump">$ 40,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 40,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentMaturityDate', window );">Debt instrument maturity date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Jul. 31,  2019<span></span>
</td>
<td class="text">Feb. 28,  2018<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Apr. 30,  2018<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainsLossesOnExtinguishmentOfDebt', window );">Loss on extinguishment of debt</a></td>
<td class="nump">$ 7,444<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,044<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfDebtDiscountPremium', window );">Amortized debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">48,341<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConvertibleNotesPayableCurrent', window );">Short term convertible notes payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 251,725<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleBeneficialConversionFeature', window );">Debt instrument beneficial conversion features</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DueToRelatedPartiesCurrentAndNoncurrent', window );">Due to related parties</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 100,000<span></span>
</td>
<td class="nump">$ 150,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 61,725<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=TRXD_RelatedPartyConvertiblePromissoryNoteMember', window );">Related Party Convertible Promissory Note [Member] | Mr. Shilpa Patel [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentTerm', window );">Debt notes term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">1 year<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleConversionPrice1', window );">Conversion price per share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1.50<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1.50<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Debt instrument face amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 40,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentMaturityDate', window );">Debt instrument maturity date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Aug.  08,  2019<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=TRXD_RelatedPartyConvertiblePromissoryNoteMember', window );">Related Party Convertible Promissory Note [Member] | Mr. Nitel Patel [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentTerm', window );">Debt notes term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">1 year<span></span>
</td>
<td class="text">1 year<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10.00%<span></span>
</td>
<td class="nump">10.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleConversionPrice1', window );">Conversion price per share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.62<span></span>
</td>
<td class="nump">$ 0.62<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.62<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.62<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Warrant purchased from common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">52,861<span></span>
</td>
<td class="nump">52,861<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">52,861<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Warrant strike price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.62<span></span>
</td>
<td class="nump">$ 0.62<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.62<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingTerm', window );">Warrants term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Debt instrument face amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 211,725<span></span>
</td>
<td class="nump">$ 211,725<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 211,725<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentMaturityDate', window );">Debt instrument maturity date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Jul.  07,  2019<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=TRXD_RelatedPartyConvertiblePromissoryNoteMember', window );">Related Party Convertible Promissory Note [Member] | Mr. Prashant Patel [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentTerm', window );">Debt notes term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">90 months<span></span>
</td>
<td class="text">90 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentMaturityDate', window );">Debt instrument maturity date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Jul. 31,  2020<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LoansPayable', window );">Loan payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableCurrentAndNoncurrent', window );">Accounts payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7,280<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 25,272<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtConversionConvertedInstrumentAmount1', window );">Debt instrument conversion amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 42,552<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=TRXD_RelatedPartyConvertiblePromissoryNotesMember', window );">Related Party Convertible Promissory Note [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfDebt', window );">Payment for promissory note</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 61,725<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=TRXD_ShortTermRelatedPartyConvertibleNotesMember', window );">Short-term Related Party Convertible Notes [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentUnamortizedDiscount', window );">Debt discount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConvertibleNotesPayableCurrent', window );">Short term convertible notes payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 140,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_TRXD_DebtModificationsAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Debt modification amount.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">TRXD_DebtModificationsAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>TRXD_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_TRXD_GrantedWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Granted warrants.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">TRXD_GrantedWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>TRXD_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableCurrentAndNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.15(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=119400593&amp;loc=d3e572229-122910<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.15(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=6876686&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableCurrentAndNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfDebtDiscountPremium">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense included in interest expense to amortize debt discount and premium associated with the related debt instruments. Excludes amortization of financing costs. Alternate captions include noncash interest expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1A<br> -URI http://asc.fasb.org/extlink&amp;oid=114775744&amp;loc=d3e28541-108399<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3602-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.8)<br> -URI http://asc.fasb.org/extlink&amp;oid=116634182&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfDebtDiscountPremium</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Exercise price per share or per unit of warrants or rights outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(i)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(i)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConvertibleNotesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Including the current and noncurrent portions, carrying value as of the balance sheet date of a written promise to pay a note, initially due after one year or beyond the operating cycle if longer, which can be exchanged for a specified amount of one or more securities (typically common stock), at the option of the issuer or the holder.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=6876686&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=6488278&amp;loc=d3e603758-122996<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16)(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=119400593&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConvertibleNotesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConvertibleNotesPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of the portion of long-term debt due within one year or the operating cycle if longer identified as Convertible Notes Payable. Convertible Notes Payable is a written promise to pay a note which can be exchanged for a specified amount of another, related security, at the option of the issuer and the holder.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConvertibleNotesPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtConversionConvertedInstrumentAmount1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The value of the financial instrument(s) that the original debt is being converted into in a noncash (or part noncash) transaction. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=98513485&amp;loc=d3e4304-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=98513485&amp;loc=d3e4332-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtConversionConvertedInstrumentAmount1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentConvertibleBeneficialConversionFeature">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of a favorable spread to a debt holder between the amount of debt being converted and the value of the securities received upon conversion. This is an embedded conversion feature of convertible debt issued that is in-the-money at the commitment date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21538-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentConvertibleBeneficialConversionFeature</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentConvertibleConversionPrice1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The price per share of the conversion feature embedded in the debt instrument.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109500613&amp;loc=SL6031898-161870<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentConvertibleConversionPrice1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFaceAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face (par) amount of debt instrument at time of issuance.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=114775744&amp;loc=d3e28551-108399<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFaceAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateStatedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Contractual interest rate for funds borrowed, under the debt agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateStatedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentMaturityDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Date when the debt instrument is scheduled to be fully repaid, in CCYY-MM-DD format.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentMaturityDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentMaturityDateDescription">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Description of the maturity date of the debt instrument including whether the debt matures serially and, if so, a brief description of the serial maturities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentMaturityDateDescription</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentPeriodicPaymentPrincipal">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the required periodic payments applied to principal.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentPeriodicPaymentPrincipal</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Period of time between issuance and maturity of debt instrument, in PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentUnamortizedDiscount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated amortization, of debt discount.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1A<br> -URI http://asc.fasb.org/extlink&amp;oid=114775744&amp;loc=d3e28541-108399<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentUnamortizedDiscount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentUnamortizedDiscountCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of debt discount to be amortized within one year or within the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1A<br> -URI http://asc.fasb.org/extlink&amp;oid=114775744&amp;loc=d3e28541-108399<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentUnamortizedDiscountCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentUnamortizedDiscountNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of debt discount to be amortized after one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1A<br> -URI http://asc.fasb.org/extlink&amp;oid=114775744&amp;loc=d3e28541-108399<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentUnamortizedDiscountNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DueToRelatedPartiesCurrentAndNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount as of the balance sheet date of obligations due all related parties.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(k)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=119400593&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.15(3),(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=6876686&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DueToRelatedPartiesCurrentAndNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainsLossesOnExtinguishmentOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=117329964&amp;loc=d3e12355-112629<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=117329964&amp;loc=d3e12317-112629<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainsLossesOnExtinguishmentOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpenseDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the cost of borrowed funds accounted for as interest expense for debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109500613&amp;loc=SL6036836-161870<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.8)<br> -URI http://asc.fasb.org/extlink&amp;oid=116634182&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpenseDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestPayableCurrentAndNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of interest payable on debt, including, but not limited to, trade payables.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.15(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=6876686&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.15(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=119400593&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestPayableCurrentAndNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LoansPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Including the current and noncurrent portions, aggregate carrying value as of the balance sheet date of loans payable (with maturities initially due after one year or beyond the operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=6876686&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(16)(a)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=119400593&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LoansPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=109500613&amp;loc=SL6031897-161870<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=119400593&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=6876686&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow during the period from additional borrowings in aggregate debt. Includes proceeds from short-term and long-term debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow during the period from the repayment of aggregate short-term and long-term debt. Excludes payment of capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesIssuedPricePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Per share or per unit amount of equity securities issued.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesIssuedPricePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WarrantsAndRightsOutstandingTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Period between issuance and expiration of outstanding warrant and right embodying unconditional obligation requiring redemption by transferring asset at specified or determinable date or upon event certain to occur, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WarrantsAndRightsOutstandingTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=TRXD_MrPrashantPatelMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=TRXD_MrPrashantPatelMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_WarrantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_WarrantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=TRXD_ConvertiblePromissoryNoteMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=TRXD_ConvertiblePromissoryNoteMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=TRXD_PromissoryNoteMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=TRXD_PromissoryNoteMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=TRXD_PromissoryNoteOneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=TRXD_PromissoryNoteOneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=TRXD_PromissoryNoteTwoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=TRXD_PromissoryNoteTwoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=TRXD_ShortTermPromissoryNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=TRXD_ShortTermPromissoryNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=TRXD_PromissoryNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=TRXD_PromissoryNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=TRXD_RelatedPartyConvertiblePromissoryNoteMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=TRXD_RelatedPartyConvertiblePromissoryNoteMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=TRXD_MrShilpaPatelMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=TRXD_MrShilpaPatelMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=TRXD_MrNitilPatelMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=TRXD_MrNitilPatelMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=TRXD_RelatedPartyConvertiblePromissoryNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=TRXD_RelatedPartyConvertiblePromissoryNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=TRXD_ShortTermRelatedPartyConvertibleNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=TRXD_ShortTermRelatedPartyConvertibleNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>34
<FILENAME>R35.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3</span><table class="report" border="0" cellspacing="2" id="idp6778813184">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Organization and Basis of Presentation - Schedule of Earnings Per Share, Basic and Diluted (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="4">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2019</div></th>
<th class="th"><div>Mar. 31, 2019</div></th>
<th class="th"><div>Jun. 30, 2018</div></th>
<th class="th"><div>Mar. 31, 2018</div></th>
<th class="th"><div>Jun. 30, 2019</div></th>
<th class="th"><div>Jun. 30, 2018</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
<th class="th"><div>Dec. 31, 2017</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net Income</a></td>
<td class="nump">$ 57,981<span></span>
</td>
<td class="nump">$ 125,229<span></span>
</td>
<td class="nump">$ 20,513<span></span>
</td>
<td class="nump">$ 82,269<span></span>
</td>
<td class="nump">$ 183,210<span></span>
</td>
<td class="nump">$ 102,782<span></span>
</td>
<td class="nump">$ 9,038<span></span>
</td>
<td class="nump">$ 288,983<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_TRXD_NumeratorForBasicAndDilutedEpsIncomeLossAvailableToCommonShareholders', window );">Numerator for basic and diluted EPS - income available to common Shareholders</a></td>
<td class="nump">$ 57,981<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 20,513<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 183,210<span></span>
</td>
<td class="nump">$ 102,782<span></span>
</td>
<td class="nump">$ 9,038<span></span>
</td>
<td class="nump">$ 288,983<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Denominator for basic EPS - Weighted average shares</a></td>
<td class="nump">33,726,489<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">31,985,827<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">33,546,329<span></span>
</td>
<td class="nump">31,985,827<span></span>
</td>
<td class="nump">32,260,622<span></span>
</td>
<td class="nump">31,955,416<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment', window );">Dilutive Effect of Warrants, Options and Convertible Debt</a></td>
<td class="nump">2,627,262<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,493,579<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,807,422<span></span>
</td>
<td class="nump">2,486,984<span></span>
</td>
<td class="nump">2,697,880<span></span>
</td>
<td class="nump">2,130,835<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Denominator for diluted EPS - adjusted Weighted average shares and assumed Conversions</a></td>
<td class="nump">36,353,751<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">34,479,406<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">36,353,751<span></span>
</td>
<td class="nump">34,472,811<span></span>
</td>
<td class="nump">34,958,502<span></span>
</td>
<td class="nump">34,086,251<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasicAndDiluted', window );">Basic and Diluted income per common share</a></td>
<td class="nump">$ 0.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="nump">$ 0.00<span></span>
</td>
<td class="nump">$ 0.00<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_TRXD_NumeratorForBasicAndDilutedEpsIncomeLossAvailableToCommonShareholders">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the monetary amount of Numerator for basic and diluted EPS - income (loss) Available to common shareholders, during the indicated time period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">TRXD_NumeratorForBasicAndDilutedEpsIncomeLossAvailableToCommonShareholders</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>TRXD_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasicAndDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income or loss for the period per each share in instances when basic and diluted earnings per share are the same amount and reported as a single line item on the face of the financial statements.  Basic earnings per share is the amount of net income or loss for the period per each share of common stock or unit outstanding during the reporting period.  Diluted earnings per share includes the amount of net income or loss for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=117326831&amp;loc=d3e1337-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasicAndDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=SL7669619-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=116637391&amp;loc=SL114874048-224260<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=SL7669625-108580<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=116637232&amp;loc=SL114874131-224263<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=116634182&amp;loc=SL114868664-224227<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3602-108585<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The sum of dilutive potential common shares or units used in the calculation of the diluted per-share or per-unit computation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=117326831&amp;loc=d3e1505-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=117326831&amp;loc=d3e1448-109256<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>35
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3</span><table class="report" border="0" cellspacing="2" id="idp6941189600">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2018</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SignificantAccountingPoliciesTextBlock', window );">Summary of Significant Accounting Policies</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif"><b>NOTE
2 &#8211; SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</b></font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The accompanying financial statements
have been prepared in accordance with accounting principles generally accepted in the United States of America (&#8220;GAAP&#8221;).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">The
summary of significant accounting policies presented below is designed to assist in understanding the Company&#8217;s financial
statements. Such financial statements and accompanying notes are the representations of the Company&#8217;s management, who are
responsible for their integrity and objectivity. These accounting policies conform to accounting principles generally accepted
in the United States of America (&#8220;GAAP&#8221;) in all material respects, and have been consistently applied in preparing
the accompanying financial statements.</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><font style="font-family: Times New Roman, Times, Serif">Basis
of Presentation &#8211; Historically, operations have been funded primarily through the sale of equity or debt securities and
operating activities. In 2018, the Company renewed outstanding debt (See Note 3 and 4), raised capital (See Note 5) and
had positive operating cash flow from operations. The Company has the ability to maintain the current level of spending or reduce
expenditures to maintain operations if funding is not available.</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">Use
of Estimates &#8211; In preparing these financial statements, management is required to make estimates and assumptions that effect
the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities as of the date of the financial
statements and the reported amount of revenues and expenses during the reporting periods. Actual results could differ from those
estimates.</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">Reclassification
&#8211; Certain prior year amounts have been reclassified to conform to the current year presentation.</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">Principle
of Consolidation &#8211; The Company&#8217;s consolidated financial statements include the accounts of Trxade Group, Inc., Trxade,
Inc., Integra Pharma Solutions, Inc., Alliance Pharma Solutions, LLC and Community Specialty Pharmacy, LLC. All significant intercompany
accounts and transactions have been eliminated.</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">Cash
and Cash Equivalents &#8211; Cash in bank accounts are at risk to the extent that they exceed U.S. Federal Deposit Insurance Corporation
insured amounts. All investments purchased with a maturity of three months or less are cash equivalents. Cash and cash equivalents
are available on demand and are generally within of FDIC insurance limits for 2018.</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif"></font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;Accounts
Receivable &#8211; The Company&#8217;s receivables are from customers and are collected within 90 days. The Company determines
the allowance based on known troubled accounts, historical experience, and other currently available evidence. During the years
ended December 31, 2018 and 2017, $2,271 of bad debt expense and $0 of recovery of bad debt was recognized, respectively.</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">Inventory
&#8211; Inventories are stated at the lower of cost or net realizable value. Cost is determined on a weighted average basis. On
a quarterly basis, we analyze our inventory levels and no reserve is maintained as obsolete or expired inventories are written
off. There is no reserve for inventory obsolescence during the periods presented. </font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">Beneficial
Conversion Features &#8211; The intrinsic value of a beneficial conversion feature inherent to a convertible note payable, which
is not bifurcated and accounted for separately from the convertible note payable and may not be settled in cash upon conversion,
is treated as a discount to the convertible note payable. This discount is amortized over the period from the date of issuance
to the date the note is due using the effective interest method. If the note payable is retired prior to the end of its contractual
term, the unamortized discount is expensed in the period of retirement to interest expense. In general, the beneficial conversion
feature is measured by comparing the effective conversion price, after considering the relative value of detachable instruments
included in the financing transaction, if any, to the fair value of the common shares at the commitment date to be received upon
conversion.</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">Derivative
financial instruments &#8211; The Company evaluates its financial instruments to determine if such instruments are derivatives
or contain features that qualify as embedded derivatives. For derivative financial instruments that are accounted for as liabilities,
the derivative instrument is initially recorded at its fair value and is then re-valued at each reporting date, with changes in
the fair value reported in the statements of operations. For stock-based derivative financial instruments, the Company uses a
Black-Scholes option pricing model, assuming maximum value, in accordance with ASC 815-15 &#8220;Derivative and Hedging&#8221;
to value the derivative instruments at inception and on subsequent valuation dates. The classification of derivative instruments,
including whether such instruments should be recorded as liabilities or as equity, is evaluated at the end of each reporting period.
Derivative instrument liabilities are classified in the balance sheet as current or non-current based on whether or not net-cash
settlement of the derivative instrument could be required within 12 months of the balance sheet date.</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">Fair
Value of Financial Instruments &#8211; The Company measures its financial assets and liabilities in accordance with the requirements
of FASB ASC 820, &#8220;Fair Value Measurements and Disclosures&#8221;. ASC 820 clarifies the definition of fair value, prescribes
methods for measuring fair value, and establishes a fair value hierarchy to classify the inputs used in measuring fair value as
follows:</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">Level
1 &#8211; Quoted prices are available in active markets for identical assets or liabilities as of the reporting date. Active markets
are those in which transactions for the asset or liability occur in sufficient frequency and volume to provide pricing information
on an ongoing basis. Level 1 primarily consists of financial instruments such as exchange-traded derivatives, marketable securities
and listed equities.</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">Level
2 &#8211; Pricing inputs are other than quoted prices in active markets included in level 1, which are either directly or indirectly
observable as of the reported date and includes those financial instruments that are valued using models or other valuation methodologies.
These models are primarily industry-standard models that consider various assumptions, including quoted forward prices for commodities,
time value, volatility factors, and current market and contractual prices for the underlying instruments, as well as other relevant
economic measures. Substantially all of these assumptions are observable in the marketplace throughout the full term of the instrument,
can be derived from observable data or are supported by observable levels at which transactions are executed in the marketplace.
Instruments in this category generally include non-exchange-traded derivatives such as commodity swaps, interest rate swaps, options
and collars.</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">Level
3 &#8211; Pricing inputs include significant inputs that are generally less observable from objective sources. These inputs may
be used with internally developed methodologies that result in management&#8217;s best estimate of fair value.</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">The
Company does not have any assets or liabilities that are required to be measured and recorded at fair value on a recurring basis.</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">The
carrying amounts of cash, accounts receivable, accounts payable, accrued liabilities and short-term debt approximate fair value
because of the short-term nature of these instruments. The carrying amount of long-term debt approximates fair value because the
debt is based on current rates at which the Company could borrow funds with similar maturities.</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">Goodwill
&#8211; The Company accounts for goodwill and intangible assets in accordance with ASC 350 &#8220;Intangibles Goodwill and Other&#8221;.
ASC 350 requires that goodwill and other intangibles with indefinite lives be tested for impairment annually or on an interim
basis if events or circumstances indicate that the fair value of an asset has decreased below its carrying value. The Company
performed impairment analysis using the qualitative analysis under ASC 350-20 and noted no impairment issues for 2018.</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">Revenue
Recognition &#8211; In May 2014, the Financial Accounting Standards Board (FASB) issued Accounting Standards Update No. 2014-09
(Topic 606) &#8220;Revenue from Contracts with Customers.&#8221; Topic 606 supersedes the revenue recognition requirements in
Accounting Standards Codification Topic 605, &#8220;Revenue Recognition&#8221;, and requires entities to recognize revenue when
they transfer control of promised goods or services to customers in an amount that reflects the consideration to which the entity
expects to be entitled to in exchange for those goods or services. The Company adopted ASU 2014-09 using the modified retrospective
approach effective January 1, 2018, under which prior periods were not retrospectively adjusted. The adoption of Topic 606 does
not have a material impact to our consolidated financial statements, including the presentation of revenues in our Consolidated
Statements of Operations.</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">Trxade,
Inc. provides an online website service, a buying and selling marketplace for licensed Pharmaceutical Wholesalers to sell products
and services to licensed Pharmacies. The Company charges Suppliers a transaction fee, a percentage of the purchase price of the
Prescription Drugs and other products sold through its website service. The fulfillment of confirmed orders, including delivery
and shipment of Prescription Drugs and other products, is the responsibility of the Supplier and not of the Company. The Company
holds no inventory and assumes no responsibility for the shipment or delivery of any products or services from our website. The
Company considers itself an agent for this revenue stream and as such, reports revenue as net. Step One: Identify the contract
with the customer &#8211; Trxade, Inc.&#8217;s Terms and Use Agreement is acknowledged between the Wholesaler and Trxade, Inc.
which outlines the terms and conditions. The collection is probable based on the credit evaluation of the Wholesaler. Step Two:
Identify the performance obligations in the contract &#8211; The Company provides to the Supplier access to the online website,
uploading of catalogs of products and Dashboard access to review status of inventory posted and processed orders. The Agreement
requires the supplier to provide a catalog of pharmaceuticals for posting on the platform, deliver the pharmaceuticals and upon
shipment remit the stated platform fee. Step Three: Determine the transaction price &#8211; The Fee Agreement outlines the fee
based on the type of product, generic, brand or non-drug. There are no discounts for volume of transactions or early payment of
invoices. Step Four: Allocate the transaction price &#8211; The Fee Agreement outlines the fee. There is no difference between
contract price and &#8220;stand-alone selling price&#8221;. Step Five: Recognize revenue when or as the entity satisfies a performance
obligation &#8211; Revenue is recognized the day the order has been processed by the Supplier.</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">Integra
Pharma Solutions, LLC is a licensed wholesaler and sells to licensed pharmacies brand, generic and non-drug products. The Company
takes orders for product and creates invoices for each order and recognizes revenue at the time the Customer receives the product.
Customer returns are not material. Step One: Identify the contract with the customer &#8211; The Company requires that an application
and a credit card for payment is completed by the Customer prior to the first order. Each transaction is evidenced by an order
form sent by the customer and an invoice for the product is sent by the Company. The collection is probable based on the application
and credit card information provided prior to the first order. Step Two: Identify the performance obligations in the contract
&#8211; Each order is distinct and evidenced by the shipping order and invoice. Step Three: Determine the transaction price &#8211;
The consideration is variable if product is returned. The variability is determined based on the return policy of the product
manufacturer. There are no sales or volume discounts. The transaction price is determined at the time of the order evidenced by
the invoice. Step Four: Allocate the transaction price &#8211; There is no difference between contract price and &#8220;stand-alone
selling price&#8221;. Step Five: Recognize revenue when or as the entity satisfies a performance obligation - The Revenue is recognized
when the Customer receives the product.</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><font style="font-family: Times New Roman, Times, Serif">Community
Specialty Pharmacy, LLC is in the retail pharmacy business. The Company fills prescriptions for drugs written by a doctor and
recognizes revenue at the time the patient confirms delivery of the prescription. Customer returns are not material. Step One:
Identify the contract with the customer &#8211; The prescription is written by a doctor for a Customer and delivered to the Company.
The prescription identifies the performance obligations in the contract. The Company fills the prescription and delivers to the
Customer the prescription, fulfilling the contract. The collection is probable because there is confirmation that the customer
has insurance for the reimbursement to the Company prior to filling of the prescription. Step Two: Identify the performance obligations
in the contract &#8211; Each prescription is distinct to the Customer. Step Three: Determine the transaction price &#8211; The
consideration is not variable. The transaction price is determined to be the price of the prescription at the time of delivery
which considers the expected reimbursements from third party payors (e.g., pharmacy benefit managers, insurance companies and
government agencies). Step Four: Allocate the transaction price &#8211; The price of the prescription invoiced represents the
expected amount of reimbursement from third party payors. There is no difference between contract price and &#8220;stand-alone
selling price&#8221;. Step Five: Recognize revenue when or as the entity satisfies a performance obligation &#8211; Revenue is
recognized upon the delivery of the prescription.</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif"></font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif"></font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="margin: 0; text-align: justify">Cost of Goods Sold &#8211; The company recognized cost of goods sold in 2018 from activities in Integra
Pharma Solutions, LLC and Community Specialty Pharmacy, LLC, which were not active in 2017.</p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif"></font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">Stock-Based
Compensation &#8211; The Company accounts for stock-based compensation to non-employees in accordance with the provision of ASC
505, &#8220;Equity Based Payments to Non-Employees&#8221; (&#8220;ASC 505&#8221;), which requires that such equity instruments
are recorded at their fair value on the measurement date. The measurement of stock-based compensation is subject to periodic adjustment
as the underlying instruments vest.</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">The
Company accounts for stock-based compensation to employees in accordance with ASC 718, &#8220;Compensation-Stock Compensation&#8221;.
ASC 718 requires companies to measure the cost of employee services received in exchange for an award of equity instruments, including
stock options, based on the grant date fair value of the award and to recognize it as compensation expense over the period the
employee is required to provide service in exchange for the award, usually the vesting period. Stock option forfeitures are recognized
at the date of employee termination.</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">Income
Taxes &#8211; The Company accounts for income taxes utilizing ASC 740, &#8220;Income Taxes&#8221; (SFAS No. 109). ASC 740 requires
the measurement of deferred tax assets for deductible temporary differences and operating loss carry forwards, and of deferred
tax liabilities for taxable temporary differences. Measurement of current and deferred tax liabilities and assets is based on
provisions of enacted tax law. The effects of future changes in tax rates are not included in the measurement. The Company recognizes
the amount of taxes payable or refundable for the current year and recognizes deferred tax liabilities and assets for the expected
future tax consequences of events and transactions that have been recognized in the Company&#8217;s financial statements or tax
returns. The Company currently has substantial net operating loss carry forwards. The Company has recorded a 100% valuation allowance
against net deferred tax assets due to uncertainty of their ultimate realization. Valuation allowances are established when necessary
to reduce deferred tax assets to the amount expected to be realized. Tax years from 2015 forward are open to examination
by the Internal Revenue Service.</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">Income
(loss) Per Share &#8211; Basic net income (loss) per common share is computed by dividing net loss available to Common Stockholders
by the weighted average number of common shares outstanding. Diluted net loss per common share is computed similar to basic net
loss per common share except that the denominator is increased to include the number of additional common shares that would have
been outstanding if the potential common shares had been issued and if the additional common shares were dilutive. The treasury
stock method and as if converted methods are used to determine the dilutive shares for our options and warrants and convertible
notes, respectively.</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;<font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><font style="font-family: Times New Roman, Times, Serif">The
following table sets forth the computation of basic and diluted income per common share for the years ended December 31, 2018
and 2017:</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<tr style="vertical-align: bottom; font-family: Times New Roman, Times, Serif">
    <td style="padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">December
    31, 2018</font></td>
    <td style="padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">December
    31, 2017</font></td>
    <td style="padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255); font-family: Times New Roman, Times, Serif">
    <td style="font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">Numerator:</font></td>
    <td style="font-family: Times New Roman, Times, Serif"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font-family: Times New Roman, Times, Serif"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: right; font-family: Times New Roman, Times, Serif"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font-family: Times New Roman, Times, Serif"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font-family: Times New Roman, Times, Serif"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font-family: Times New Roman, Times, Serif"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: right; font-family: Times New Roman, Times, Serif"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font-family: Times New Roman, Times, Serif"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: White; font-family: Times New Roman, Times, Serif">
    <td style="width: 60%; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">Net
    Income</font></td>
    <td style="width: 2%; font-family: Times New Roman, Times, Serif"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="width: 1%; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td style="width: 16%; text-align: right; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">9,038</font></td>
    <td style="width: 1%; font-family: Times New Roman, Times, Serif"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="width: 2%; font-family: Times New Roman, Times, Serif"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="width: 1%; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td style="width: 16%; text-align: right; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">288,983</font></td>
    <td style="width: 1%; font-family: Times New Roman, Times, Serif"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255); font-family: Times New Roman, Times, Serif">
    <td style="font-family: Times New Roman, Times, Serif"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font-family: Times New Roman, Times, Serif"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font-family: Times New Roman, Times, Serif"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: right; font-family: Times New Roman, Times, Serif"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font-family: Times New Roman, Times, Serif"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font-family: Times New Roman, Times, Serif"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font-family: Times New Roman, Times, Serif"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: right; font-family: Times New Roman, Times, Serif"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font-family: Times New Roman, Times, Serif"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom; font-family: Times New Roman, Times, Serif">
    <td style="font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">Numerator
    for basic and diluted income available to common shareholders</font></td>
    <td style="font-family: Times New Roman, Times, Serif"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td style="text-align: right; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">9,038</font></td>
    <td style="font-family: Times New Roman, Times, Serif"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font-family: Times New Roman, Times, Serif"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td style="text-align: right; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">288,983</font></td>
    <td style="font-family: Times New Roman, Times, Serif"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255); font-family: Times New Roman, Times, Serif">
    <td style="font-family: Times New Roman, Times, Serif"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font-family: Times New Roman, Times, Serif"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font-family: Times New Roman, Times, Serif"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: right; font-family: Times New Roman, Times, Serif"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font-family: Times New Roman, Times, Serif"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font-family: Times New Roman, Times, Serif"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font-family: Times New Roman, Times, Serif"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: right; font-family: Times New Roman, Times, Serif"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font-family: Times New Roman, Times, Serif"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom; font-family: Times New Roman, Times, Serif">
    <td style="font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">Denominator:</font></td>
    <td style="font-family: Times New Roman, Times, Serif"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font-family: Times New Roman, Times, Serif"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: right; font-family: Times New Roman, Times, Serif"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font-family: Times New Roman, Times, Serif"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font-family: Times New Roman, Times, Serif"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font-family: Times New Roman, Times, Serif"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: right; font-family: Times New Roman, Times, Serif"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font-family: Times New Roman, Times, Serif"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255); font-family: Times New Roman, Times, Serif">
    <td style="font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">Denominator
    for basic income per common share &#8211; Weighted average common shares outstanding</font></td>
    <td style="font-family: Times New Roman, Times, Serif"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font-family: Times New Roman, Times, Serif"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: right; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">32,260,622</font></td>
    <td style="font-family: Times New Roman, Times, Serif"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font-family: Times New Roman, Times, Serif"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font-family: Times New Roman, Times, Serif"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: right; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">31,955,416</font></td>
    <td style="font-family: Times New Roman, Times, Serif"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom; font-family: Times New Roman, Times, Serif">
    <td style="font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">Dilutive
    effect of Common Stock Equivalents</font></td>
    <td style="font-family: Times New Roman, Times, Serif"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font-family: Times New Roman, Times, Serif"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: right; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">2,697,880</font></td>
    <td style="font-family: Times New Roman, Times, Serif"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font-family: Times New Roman, Times, Serif"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font-family: Times New Roman, Times, Serif"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: right; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">2,130,835</font></td>
    <td style="font-family: Times New Roman, Times, Serif"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255); font-family: Times New Roman, Times, Serif">
    <td style="font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">Denominator
    for diluted income per common share &#8211; adjusted weighted average common shares outstanding</font></td>
    <td style="font-family: Times New Roman, Times, Serif"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font-family: Times New Roman, Times, Serif"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: right; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">34,958,502</font></td>
    <td style="font-family: Times New Roman, Times, Serif"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font-family: Times New Roman, Times, Serif"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font-family: Times New Roman, Times, Serif"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: right; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">34,086,251</font></td>
    <td style="font-family: Times New Roman, Times, Serif"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom; font-family: Times New Roman, Times, Serif">
    <td style="font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">Basic
    and Diluted income per common share</font></td>
    <td style="font-family: Times New Roman, Times, Serif"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td style="text-align: right; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">0.00</font></td>
    <td style="font-family: Times New Roman, Times, Serif"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font-family: Times New Roman, Times, Serif"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td>
    <td style="text-align: right; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">0.01</font></td>
    <td style="font-family: Times New Roman, Times, Serif"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td></tr>
</table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><font style="font-family: Times New Roman, Times, Serif">Concentration
of Credit Risks and Major Customers - Financial instruments that potentially subject the company to credit risk consist principally
of cash and cash equivalents and receivables. The Company places its cash and cash equivalents with financial institutions. Deposits
are insured to Federal Deposit Insurance Corp limits. During the years ended December 31, 2018 and 2017, sales to
two customers each represent greater than 10% of revenue.</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">Recent
Accounting Pronouncements &#8211; The Company has implemented all new relevant accounting pronouncements that are in effect through
the date of these financial statements. The pronouncements did not have any material impact on the financial statements unless
otherwise disclosed, and the Company does not believe that there are any other new accounting pronouncements that have been issued
that might have a material impact on its consolidated financial position or results of operations.</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">In
February 2016, the FASB issued ASU 2016-02, Leases, which will amend current lease accounting to require lessees to recognize
(i) a lease liability, which is a lessee&#8217;s obligation to make lease payments arising from a lease, measured on a discounted
basis, and (ii) a right-of-use asset, which is an asset that represents the lessee&#8217;s right to use, or control the use of,
a specified asset for the lease term. ASU 2016-02 does not significantly change lease accounting requirements applicable to lessors;
however, certain changes were made to align, where necessary, lessor accounting with the lessee accounting model. This standard
will be effective for fiscal years beginning after December 15, 2018, including interim periods within those fiscal years. The
Company adopted the provisions of this ASU at January 1, 2019.</font></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SignificantAccountingPoliciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for all significant accounting policies of the reporting entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -URI http://asc.fasb.org/topic&amp;trid=2122369<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SignificantAccountingPoliciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>36
<FILENAME>R31.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3</span><table class="report" border="0" cellspacing="2" id="idp6762829920">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment Reporting (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock', window );">Schedule of Business Interests Into Reportable Segments</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">The
Company classifies its business interests into reportable segments which are Trxade, Community and Other.</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<table cellpadding="0" cellspacing="0" align="center" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<tr style="vertical-align: bottom">
    <td style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Six Months Ended June 30, 2019</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Trxade, Inc.</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Community Specialty Pharmacy, LLC</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Other</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Total</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 36%">Revenue</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">2,182,668</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">892,357</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">353,910</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">3,428,935</td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Segment Assets</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">1,401,724</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">224,863</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">2,051,478</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">3,678,065</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Segment Profit/Loss</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">1,166,543</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">(61,628</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">(921,705</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">183,210</td><td style="text-align: left">&#160;</td></tr></table><span></span>
</td>
<td class="text"><p style="margin: 0pt"></p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: bottom">
    <td style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>Year Ended December 31, 2018</b></font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>Trxade, Inc.</b></font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>Community Specialty Pharmacy,&#160;LLC</b></font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>Other</b></font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="width: 46%"><font style="font-size: 10pt">Revenue</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%"><font style="font-size: 10pt">$</font></td>
    <td style="width: 14%; text-align: right"><font style="font-size: 10pt">3,407,822</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%"><font style="font-size: 10pt">$</font></td>
    <td style="width: 16%; text-align: right"><font style="font-size: 10pt">395,418</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%"><font style="font-size: 10pt">$</font></td>
    <td style="width: 15%; text-align: right"><font style="font-size: 10pt">28,538</font></td>
    <td style="width: 1%">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td><font style="font-size: 10pt">Gross Profit</font></td>
    <td>&#160;</td>
    <td><font style="font-size: 10pt">$</font></td>
    <td style="text-align: right"><font style="font-size: 10pt">3,407,822</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td><font style="font-size: 10pt">$</font></td>
    <td style="text-align: right"><font style="font-size: 10pt">(34,971</font></td>
    <td><font style="font-size: 10pt">)</font></td>
    <td>&#160;</td>
    <td><font style="font-size: 10pt">$</font></td>
    <td style="text-align: right"><font style="font-size: 10pt">9,878</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td><font style="font-size: 10pt">Segment Assets</font></td>
    <td>&#160;</td>
    <td><font style="font-size: 10pt">$</font></td>
    <td style="text-align: right"><font style="font-size: 10pt">822,412</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td><font style="font-size: 10pt">$</font></td>
    <td style="text-align: right"><font style="font-size: 10pt">112,123</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td><font style="font-size: 10pt">$</font></td>
    <td style="text-align: right"><font style="font-size: 10pt">1,293,052</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td><font style="font-size: 10pt">Segment Profit/Loss</font></td>
    <td>&#160;</td>
    <td><font style="font-size: 10pt">$</font></td>
    <td style="text-align: right"><font style="font-size: 10pt">1,371,615</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td><font style="font-size: 10pt">$</font></td>
    <td style="text-align: right"><font style="font-size: 10pt">(116,588</font></td>
    <td><font style="font-size: 10pt">)</font></td>
    <td>&#160;</td>
    <td><font style="font-size: 10pt">$</font></td>
    <td style="text-align: right"><font style="font-size: 10pt">(1,245,989</font></td>
    <td><font style="font-size: 10pt">)</font></td></tr>
</table>


<p style="margin: 0pt"></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=115929826&amp;loc=d3e8736-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 25<br> -URI http://asc.fasb.org/extlink&amp;oid=115929826&amp;loc=d3e8813-108599<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=108376223&amp;loc=d3e13816-109267<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=115929826&amp;loc=d3e8721-108599<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -URI http://asc.fasb.org/extlink&amp;oid=115929826&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>37
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3</span><table class="report" border="0" cellspacing="2" id="idp6941163648">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Warrants<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsNoteDisclosureAbstract', window );"><strong>Warrants and Rights Note Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_TRXD_WarrantsTextBlock', window );">Warrants</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif"><b>NOTE
5 - WARRANTS</b></font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">For
the six-month period ended June 30, 2019, 16,666 warrants were exercised, See NOTE 4 &#8211; SHAREHOLDERS&#8217; EQUITY, none
were granted or forfeited.</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">The
Company&#8217;s outstanding and exercisable warrants as of June 30, 2019 are presented below:</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>Number</b></font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>Outstanding</b></font></p></td><td style="padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>Weighted</b></font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>Average</b></font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>Exercise Price</b></font></p></td><td style="padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>Contractual Life</b></font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>in Years</b></font></p></td><td style="padding-bottom: 1.5pt">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Intrinsic Value</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 44%; text-align: justify">Warrants Outstanding as of December 31, 2018</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 10%; text-align: right">2,880,141</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right">0.08</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 10%; text-align: right">3.74</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right">782,385</td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify">Warrants granted</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify">Warrants forfeited</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify">Warrants exercised</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(16,666</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">0.01</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify">Warrants Outstanding as of June 30, 2019</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,863,475</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">0.08</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">3.08</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">1,448,356</td><td style="text-align: left">&#160;</td></tr></table><span></span>
</td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif"><b>NOTE
6 - WARRANTS</b></font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><font style="font-family: Times New Roman, Times, Serif">In
2017, 87,500 warrants were issued related to common shares sold for cash (See Note 5). Likewise, 28,150 were issued
for renewal of convertible debt (see Note 3) and 25,000 warrants were exercised. No warrants were forfeited in 2017.</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><font style="font-family: Times New Roman, Times, Serif">In
2018, 161,538 warrants were issued related to common shares sold for cash (see Note 5), 10,000 were issued for renewal
of convertible debt (see Note 3), 405,507 were issued related to the acquisition of Community Specialty Pharmacy, LLC,
none were exercised and 435,000 were forfeited.</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">The
following table summarizes the assumptions used to estimate the fair value of warrants granted during the years ended December
31, 2018 and 2017:</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<table cellpadding="0" cellspacing="0" align="center" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<tr style="vertical-align: bottom; font-family: Times New Roman, Times, Serif">
    <td style="font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">2018</font></td><td style="padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">2017</font></td><td style="padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255); font-family: Times New Roman, Times, Serif">
    <td style="width: 60%; text-align: left; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">Expected
    dividend yield</font></td><td style="width: 2%; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="width: 1%; text-align: left; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="width: 16%; text-align: right; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">0</font></td><td style="width: 1%; text-align: left; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">%</font></td><td style="width: 2%; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="width: 1%; text-align: left; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="width: 16%; text-align: right; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">0</font></td><td style="width: 1%; text-align: left; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">%</font></td></tr>
<tr style="vertical-align: bottom; background-color: White; font-family: Times New Roman, Times, Serif">
    <td style="text-align: left; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">Weighted-average
    expected volatility</font></td><td style="font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: left; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="text-align: right; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">231-632</font></td><td style="text-align: left; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">%</font></td><td style="font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: left; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="text-align: right; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">200</font></td><td style="text-align: left; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">%</font></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255); font-family: Times New Roman, Times, Serif">
    <td style="text-align: left; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">Weighted-average
    risk-free interest rate</font></td><td style="font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: left; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="text-align: right; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">2.55-2.75</font></td><td style="text-align: left; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">%</font></td><td style="font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: left; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="text-align: right; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">1.81-1.84</font></td><td style="text-align: left; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">%</font></td></tr>
<tr style="vertical-align: bottom; background-color: White; font-family: Times New Roman, Times, Serif">
    <td style="text-align: left; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">Expected
    life of warrants</font></td><td style="font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: left; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="text-align: right; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">5-8
                                         years</font></td><td style="text-align: left; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: left; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="text-align: right; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">5
                                         years</font></td><td style="text-align: left; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr>
</table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">The
Company&#8217;s outstanding and exercisable warrants as of December 31, 2018 and 2017 are presented below:</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<tr style="vertical-align: bottom; font-family: Times New Roman, Times, Serif">
    <td style="text-align: center; padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="font-weight: bold; text-align: center; padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">Number
    Outstanding</font></td><td style="font-weight: bold; text-align: center; padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="font-weight: bold; text-align: center; padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">Weighted
    Average Exercise Price</font></td><td style="font-weight: bold; text-align: center; padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="font-weight: bold; text-align: center; padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">Contractual
    Life in Years</font></td><td style="font-weight: bold; text-align: center; padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="font-weight: bold; text-align: center; padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">Intrinsic
    Value</font></td><td style="font-weight: bold; text-align: center; padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255); font-family: Times New Roman, Times, Serif">
    <td style="width: 40%; text-align: left; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">Warrants
    Outstanding as of December 31, 2016</font></td><td style="width: 2%; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="width: 1%; text-align: left; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="width: 11%; text-align: right; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">2,647,446</font></td><td style="width: 1%; text-align: left; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="width: 2%; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="width: 1%; text-align: left; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td><td style="width: 11%; text-align: right; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">0.24</font></td><td style="width: 1%; text-align: left; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="width: 2%; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="width: 1%; text-align: left; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="width: 11%; text-align: right; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">4.24</font></td><td style="width: 1%; text-align: left; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="width: 2%; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="width: 1%; text-align: left; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td><td style="width: 11%; text-align: right; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">930,751</font></td><td style="width: 1%; text-align: left; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: White; font-family: Times New Roman, Times, Serif">
    <td style="text-align: left; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">Warrants
    granted</font></td><td style="font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: left; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="text-align: right; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">115,650</font></td><td style="text-align: left; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: left; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td><td style="text-align: right; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">0.18</font></td><td style="text-align: left; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: left; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="text-align: right; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">5.0</font></td><td style="text-align: left; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: left; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="text-align: right; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td><td style="text-align: left; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255); font-family: Times New Roman, Times, Serif">
    <td style="text-align: left; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">Warrants
    forfeited</font></td><td style="font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: left; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="text-align: right; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td><td style="text-align: left; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: left; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="text-align: right; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td><td style="text-align: left; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: left; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="text-align: right; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td><td style="text-align: left; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: left; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="text-align: right; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td><td style="text-align: left; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: White; font-family: Times New Roman, Times, Serif">
    <td style="text-align: left; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">Warrants
    exercised</font></td><td style="font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: left; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="text-align: right; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">(25,000</font></td><td style="text-align: left; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td><td style="font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: left; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td><td style="text-align: right; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">0.01</font></td><td style="text-align: left; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: left; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="text-align: right; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td><td style="text-align: left; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: left; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="text-align: right; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td><td style="text-align: left; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255); font-family: Times New Roman, Times, Serif">
    <td style="text-align: left; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: left; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="text-align: right; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="text-align: left; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: left; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="text-align: right; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="text-align: left; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: left; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="text-align: right; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="text-align: left; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: left; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="text-align: right; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="text-align: left; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: White; font-family: Times New Roman, Times, Serif">
    <td style="text-align: left; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">Warrants
    Outstanding as of December 31, 2017</font></td><td style="font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: left; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="text-align: right; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">2,738,096</font></td><td style="text-align: left; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: left; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td><td style="text-align: right; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">0.24</font></td><td style="text-align: left; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: left; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="text-align: right; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">3.28</font></td><td style="text-align: left; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: left; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td><td style="text-align: right; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">937,567</font></td><td style="text-align: left; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255); font-family: Times New Roman, Times, Serif">
    <td style="text-align: left; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">Warrants
    granted</font></td><td style="font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: left; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="text-align: right; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">577,045</font></td><td style="text-align: left; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: left; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td><td style="text-align: right; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">0.02</font></td><td style="text-align: left; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: left; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="text-align: right; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">7.11</font></td><td style="text-align: left; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: left; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="text-align: right; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="text-align: left; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: White; font-family: Times New Roman, Times, Serif">
    <td style="text-align: left; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">Warrants
    forfeited</font></td><td style="font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: left; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="text-align: right; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">(435,000</font></td><td style="text-align: left; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td><td style="font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: left; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="text-align: right; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td><td style="text-align: left; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: left; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="text-align: right; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td><td style="text-align: left; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: left; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="text-align: right; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td><td style="text-align: left; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255); font-family: Times New Roman, Times, Serif">
    <td style="text-align: left; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">Warrants
    exercised</font></td><td style="font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: left; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="text-align: right; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td><td style="text-align: left; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: left; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="text-align: right; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td><td style="text-align: left; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: left; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="text-align: right; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td><td style="text-align: left; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: left; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="text-align: right; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td><td style="text-align: left; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: White; font-family: Times New Roman, Times, Serif">
    <td style="text-align: left; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: left; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="text-align: right; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="text-align: left; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: left; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="text-align: right; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="text-align: left; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: left; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="text-align: right; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="text-align: left; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: left; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="text-align: right; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="text-align: left; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255); font-family: Times New Roman, Times, Serif">
    <td style="text-align: left; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">Warrants
    Outstanding as of December 31, 2018</font></td><td style="font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: left; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="text-align: right; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">2,880,141</font></td><td style="text-align: left; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: left; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td><td style="text-align: right; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">0.08</font></td><td style="text-align: left; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: left; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="text-align: right; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">3.74</font></td><td style="text-align: left; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: left; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td><td style="text-align: right; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">782,385</font></td><td style="text-align: left; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_TRXD_WarrantsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Warrants [Text Block]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">TRXD_WarrantsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>TRXD_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WarrantsAndRightsNoteDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WarrantsAndRightsNoteDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>38
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3</span><table class="report" border="0" cellspacing="2" id="idp6767419584">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Related Parties<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2018</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsAbstract', window );"><strong>Related Party Transactions [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsDisclosureTextBlock', window );">Related Parties</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif"><b>NOTE
9 &#8211; RELATED PARTIES</b></font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><font style="font-family: Times New Roman, Times, Serif">In
January 2017 Mr. Ajjarapu and Mr. Patel suspended their executive salaries of $165,000 and $125,000, for a period of five and
six months, respectively. In January 2018, Mr. Ajjarapu and Mr. Patel&#8217;s executive salaries were amended to $200,000 and
$150,000, respectively. All of our executives are at-will employees or consultants. Each of Messrs. Ajjarapu and Patel are
parties to an at-will executive employment agreement.</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">The
Company owed management wages to Mr. Prashant Patel at December 31, 2018 of $0 and December 31, 2017 of $62,500, respectively.</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><font style="font-family: Times New Roman, Times, Serif"><font style="font-size: 10pt">In
October 2018 in connection with the acquisition of Community Specialty Pharmacy, LLC a $300,000 promissory note was issued to
Nikul Panchal, accruing interest a simple interest of 10%, interest payable annually, and principal payable at maturity on October
15, 2021.</font></font><font style="font-family: Times New Roman, Times, Serif"><font style="font-size: 10pt">&#160;</font></font></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -URI http://asc.fasb.org/topic&amp;trid=2122745<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>39
<FILENAME>R50.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3</span><table class="report" border="0" cellspacing="2" id="idp6762567520">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Options (Details Narrative) (10-K) - USD ($)<br></strong></div></th>
<th class="th" colspan="4">1 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>May 31, 2019</div></th>
<th class="th"><div>Apr. 30, 2019</div></th>
<th class="th"><div>Apr. 30, 2018</div></th>
<th class="th"><div>Apr. 30, 2017</div></th>
<th class="th"><div>Jun. 30, 2019</div></th>
<th class="th"><div>Jun. 30, 2018</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
<th class="th"><div>Dec. 31, 2017</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Stock option granted</a></td>
<td class="nump">505,000<span></span>
</td>
<td class="nump">505,000<span></span>
</td>
<td class="nump">560,400<span></span>
</td>
<td class="nump">253,846<span></span>
</td>
<td class="nump">505,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">560,400<span></span>
</td>
<td class="nump">263,846<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit', window );">Stock option exercise price, upper range limit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.50<span></span>
</td>
<td class="nump">$ 0.65<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod', window );">Stock option term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">10 years<span></span>
</td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingRights', window );">Stock option vested, description</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">The options vest over a period of four to five years.<span></span>
</td>
<td class="text">The options vest over a period of one and four years.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockOptionPlanExpense', window );">Option expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 99,990<span></span>
</td>
<td class="nump">$ 88,072<span></span>
</td>
<td class="nump">$ 169,828<span></span>
</td>
<td class="nump">$ 267,835<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized', window );">Unrecognized compensation costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 192,007<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Weighted average period term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">6 years 11 months 23 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OptionIndexedToIssuersEquityTypeAxis=TRXD_FourOptionGrantedMember', window );">Four Option Granted [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Stock option granted</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">650,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod', window );">Stock option term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockOptionPlanExpense', window );">Option expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 69,611<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ValuationTechniqueAxis=us-gaap_ValuationTechniqueOptionPricingModelMember', window );">Black-Scholes Option Price Model [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_TRXD_FairValueOfOptionGranted', window );">Fair value of options granted</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 278,358<span></span>
</td>
<td class="nump">$ 169,100<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Stock option vested period</a></td>
<td class="text">4 years<span></span>
</td>
<td class="text">4 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Weighted average period term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">4 years<span></span>
</td>
<td class="text">4 years 8 months 26 days<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Stock option vested period</a></td>
<td class="text">5 years<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Weighted average period term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">7 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">7 years 6 months<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_TitleOfIndividualAxis=TRXD_EmployeeMember', window );">Employee [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Stock option granted</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">560,400<span></span>
</td>
<td class="nump">263,846<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit', window );">Stock option exercise price, lower range limit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.41<span></span>
</td>
<td class="nump">$ 0.41<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit', window );">Stock option exercise price, upper range limit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1.02<span></span>
</td>
<td class="nump">$ 1.02<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod', window );">Stock option term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">10 years<span></span>
</td>
<td class="text">10 years<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate', window );">Options expire date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Apr. 30,  2028<span></span>
</td>
<td class="text">Apr. 30,  2028<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_TitleOfIndividualAxis=TRXD_EmployeeMember', window );">Employee [Member] | Minimum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Stock option vested period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">4 years<span></span>
</td>
<td class="text">4 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_TitleOfIndividualAxis=TRXD_EmployeeMember', window );">Employee [Member] | Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Stock option vested period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">5 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=TRXD_StockOptionPlanMember', window );">Stock Option Plan [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDescription', window );">Stock option, description</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">All options may be exercised for a period up to four 1/2 years following the grant date, after which they expire. <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">All options may be exercised for a period up to four 1/2 years following the grant date, after which they expire. <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Stock option vested period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Stock option granted</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_TRXD_FairValueOfOptionGranted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of option granted.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">TRXD_FairValueOfOptionGranted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>TRXD_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cost not yet recognized for nonvested award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingRights">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Description of service or performance condition required to be met for earning right to award under share-based payment arrangement. Includes, but is not limited to, combination of market, performance or service condition.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingRights</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDescription">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Description of terms of share-based payment arrangement. Includes, but is not limited to, type of award or grantee and reason for issuance.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5047-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDescription</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Date the equity-based award expires, in CCYY-MM-DD format.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Gross number of share options (or share units) granted during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The floor of a customized range of exercise prices for purposes of disclosing shares potentially issuable under outstanding stock option awards on all stock option plans and other required information pertaining to awards in the customized range.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The ceiling of a customized range of exercise prices for purposes of disclosing shares potentially issuable under outstanding stock option awards on all stock option plans and other required information pertaining to awards in the customized range.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Period from grant date that an equity-based award expires, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.D.2)<br> -URI http://asc.fasb.org/extlink&amp;oid=115993241&amp;loc=d3e301413-122809<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockOptionPlanExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for option under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockOptionPlanExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OptionIndexedToIssuersEquityTypeAxis=TRXD_FourOptionGrantedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OptionIndexedToIssuersEquityTypeAxis=TRXD_FourOptionGrantedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationTechniqueAxis=us-gaap_ValuationTechniqueOptionPricingModelMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValuationTechniqueAxis=us-gaap_ValuationTechniqueOptionPricingModelMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=TRXD_EmployeeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=TRXD_EmployeeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=TRXD_StockOptionPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=TRXD_StockOptionPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>40
<FILENAME>R54.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3</span><table class="report" border="0" cellspacing="2" id="idp6766723088">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases - Schedule of Operating Leases (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Initial Recognition of Right to use assets at January 1, 2019</a></td>
<td class="nump">$ 803,502<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeaseArrangementTypeAxis=TRXD_LeaseOneMember', window );">Lease 1 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_TRXD_OperatingLeaseInitialLeaseTerm', window );">Initial Lease Term</a></td>
<td class="text">December 2017 to December 2021<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_TRXD_OperatingLeaseRenewalTerm', window );">Renewal Term</a></td>
<td class="text">January 2021 to December 2024<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Initial Recognition of Right to use assets at January 1, 2019</a></td>
<td class="nump">$ 534,140<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseDiscountRate', window );">Incremental Borrowing Rate</a></td>
<td class="nump">10.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeaseArrangementTypeAxis=TRXD_LeaseTwoMember', window );">Lease 2 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_TRXD_OperatingLeaseInitialLeaseTerm', window );">Initial Lease Term</a></td>
<td class="text">November 2018 to November 2023<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_TRXD_OperatingLeaseRenewalTerm', window );">Renewal Term</a></td>
<td class="text">November 2023 to November 2028<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Initial Recognition of Right to use assets at January 1, 2019</a></td>
<td class="nump">$ 313,301<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseDiscountRate', window );">Incremental Borrowing Rate</a></td>
<td class="nump">10.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_TRXD_OperatingLeaseInitialLeaseTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Operating lease initial lease term.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">TRXD_OperatingLeaseInitialLeaseTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>TRXD_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_TRXD_OperatingLeaseRenewalTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Operating lease renewal term.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">TRXD_OperatingLeaseRenewalTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>TRXD_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseDiscountRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Discount rate used by lessee to determine present value of operating lease payments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=77888426&amp;loc=SL77918673-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseDiscountRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=77888419&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseArrangementTypeAxis=TRXD_LeaseOneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseArrangementTypeAxis=TRXD_LeaseOneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseArrangementTypeAxis=TRXD_LeaseTwoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseArrangementTypeAxis=TRXD_LeaseTwoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>41
<FILENAME>R58.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3</span><table class="report" border="0" cellspacing="2" id="idp6779162832">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Related Parties (Details Narrative) (10-K) - USD ($)<br></strong></div></th>
<th class="th" colspan="3">1 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Oct. 31, 2018</div></th>
<th class="th"><div>Jan. 31, 2018</div></th>
<th class="th"><div>Jan. 31, 2017</div></th>
<th class="th"><div>Dec. 31, 2017</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConvertibleNotesPayable', window );">Convertible promissory notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 181,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentMaturityDate', window );">Debt instrument maturity date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">May 31,  2019<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LegalEntityAxis=TRXD_CommunitySpecialtyPharmacyLLCMember', window );">Community Specialty Pharmacy, LLC [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConvertibleNotesPayable', window );">Convertible promissory notes</a></td>
<td class="nump">$ 300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentMaturityDate', window );">Debt instrument maturity date</a></td>
<td class="text">Oct. 15,  2021<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate</a></td>
<td class="nump">10.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=TRXD_MrSurenAjjarapuMember', window );">Mr. Suren Ajjarapu [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OfficersCompensation', window );">Executive salaries</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 200,000<span></span>
</td>
<td class="nump">$ 165,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=TRXD_MrPrashantPatelMember', window );">Mr. Prashant Patel [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OfficersCompensation', window );">Executive salaries</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 150,000<span></span>
</td>
<td class="nump">$ 125,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DueToRelatedPartiesCurrentAndNoncurrent', window );">Due to related parties</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 62,500<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConvertibleNotesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Including the current and noncurrent portions, carrying value as of the balance sheet date of a written promise to pay a note, initially due after one year or beyond the operating cycle if longer, which can be exchanged for a specified amount of one or more securities (typically common stock), at the option of the issuer or the holder.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=6876686&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=6488278&amp;loc=d3e603758-122996<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16)(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=119400593&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConvertibleNotesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateStatedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Contractual interest rate for funds borrowed, under the debt agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateStatedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentMaturityDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Date when the debt instrument is scheduled to be fully repaid, in CCYY-MM-DD format.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentMaturityDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DueToRelatedPartiesCurrentAndNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount as of the balance sheet date of obligations due all related parties.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(k)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=119400593&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.15(3),(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=6876686&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DueToRelatedPartiesCurrentAndNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OfficersCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for salary and wage arising from service rendered by officer. Excludes allocated cost, labor-related nonsalary expense, and direct and overhead labor cost included in cost of good and service sold.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=116634182&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OfficersCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=TRXD_CommunitySpecialtyPharmacyLLCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=TRXD_CommunitySpecialtyPharmacyLLCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=TRXD_MrSurenAjjarapuMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=TRXD_MrSurenAjjarapuMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=TRXD_MrPrashantPatelMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=TRXD_MrPrashantPatelMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>42
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3</span><table class="report" border="0" cellspacing="2" id="idp6757654176">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Short-Term Debt and Related Parties Debt<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortTermDebtTextBlock', window );">Short-Term Debt and Related Parties Debt</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif"><b>NOTE
2 &#8211; SHORT-TERM DEBT AND RELATED PARTIES DEBT</b></font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif"><b>Convertible
Promissory Note</b></font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">In
February 2019, convertible promissory notes issued in 2015 for $181,500 were amended to a conversion price of $0.50 and the principal
and accrued interest total of $211,983 were then converted to 423,966 common shares.</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">As
of June 30, 2019 and December 31, 2018, short-tern convertible notes payable has a balance of $0 and $181,500 respectively, net
of $0 unamortized debt discount.</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif"><b>Related
Party Convertible Promissory Notes</b></font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">As
of June 30, 2019, $40,000 in convertible promissory notes were due to Mr. Shilpa Patel, a relative of Mr. Prashant Patel. Simple
interest of 10% is payable at the maturity date of the note, which is August 8, 2019. Prior to maturity the note may be converted
for common stock at a conversion price of $1.50.</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">As
of June 30, 2019, $100,000 in convertible promissory notes were due to Mr. Nitil Patel, the brother of Mr. Prashant Patel. Simple
interest of 10% is payable at the maturity date of the notes, which is July 7, 2019. Prior to maturity the notes may be converted
for common stock at a conversion price of $0.62. In July 2019, the note was extended to October 15, 2019.</font></p><span></span>
</td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif"><b>NOTE
3 &#8211; SHORT-TERM DEBT AND RELATED PARTIES DEBT</b></font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif"><b>Convertible
Promissory Note</b></font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">Convertible
promissory notes were issued in the aggregate amount of $200,000 in April and May 2015. The term of the notes was one year. Simple
interest of 10% was payable at the maturity date of the note. Prior to maturity the notes may be converted for Common Stock at
a conversion price of $1.50. The holders of the notes were granted warrants at one share of Common Stock for every $4.00 of the
note principal amount, which totaled a warrant to purchase 50,000 shares of Common Stock. These warrants were issued at a strike
price of $1.50 and an expiration date of five years from date of issuance. The Company used the Black-Scholes pricing model to
estimate the fair value of the warrants issued along with convertible notes on the date of grant. The Company accounted for the
relative fair value of the warrants issued and a total debt discount $53,546 was recorded.</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">In
April and May 2016, $50,000 of the $200,000 in convertible promissory notes (plus $5,000 in interest) was repaid. A one-year extension
was executed on the remaining notes and the interest owed, totaling $15,000 became part of the adjusted principal of notes and
the balance of $165,000 is due May 2017. In connection with the one-year extension of the maturity date of the outstanding notes,
the holders of the notes were granted warrants at one Common Stock for $4.00 of the note amount and warrants to purchase 41,250
shares of Common Stock were issued at a strike price of $1.50 and an expiration date of five years from date of issuance. The
amendment of the note was considered a debt extinguishment and a loss on extinguishment of debt was booked in the amount of $37,579.</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">In
April 2017, $165,000 in convertible promissory notes (plus $5,500 in interest) was amended. A two-year extension was executed
on the remaining notes and the interest owed, totaling $16,500 became part of the adjusted principal of the notes and the balance
of $181,500 is due May 2019. The conversion price was adjusted to $0.85 per share. In connection with the two-year extension of
the maturity date of the outstanding notes, the holders of the notes were granted warrants to purchase 18,150 shares of Common
Stock that was issued at a strike price of $0.65 and an expiration date of five years from date of issuance. The amendment of
the note was considered a debt extinguishment and a loss on extinguishment of debt was booked in the amount of $11,512.</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">The
Company evaluated the embedded conversion feature within the above convertible notes under ASC 815-15 and ASC 815-40 and determined
that the embedded conversion feature does not meet the definition of a derivative liability. Then the Company evaluated the conversion
feature for a beneficial conversion feature at inception. The Company accounted for the intrinsic value of a Beneficial Conversion
Feature inherent to the convertible note payable the conversion was not beneficial and a total debt discount from the issued warrants
of $53,546 was recorded in 2015 and $0 as of the date of the debt modification.</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<p style="margin: 0; text-align: justify; font: 10pt Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">During
2017, debt discount of $0 was amortized. As of December 31, 2018 and 2017, short-tern convertible note has a balance of $181,500
and $0 respectively, net of $0 unamortized debt discount.</font></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif"><b>Promissory
Note</b></font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">In
May 2016, a promissory note that was issued in May 2015 was renewed in the face amount of $250,000 and the term was extended an
additional year. The note has an original issuance discount of $45,000 and this amount was paid in cash at the renewal. During
2016, a debt discount of $45,000 was amortized. As of December 31, 2016, the promissory note has a balance of $250,000 with an
unamortized debt discount of $15,000.</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">During
2017 the debt discount of $15,000 was fully amortized and the balance of $250,000 was paid.</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">In
October 2016, a promissory note was issued in the face amount of $47,000. The term of the note was one year. Payments are made
daily and $3,917 of principal was paid in 2016. At December 31, 2016 the balance was $43,083.</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">In
2017 $43,083 of principal was paid and at December 31, 2017 the balance was $0.</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">In
September 2016, a promissory note was issued for $189,000. The term of the note is 494 days. The debt discount was $39,000 thus
the initial net proceeds were $150,000. At December 31, 2016, $139,602 was classified as short term with a discount of $25,306
and $10,739 was classified as long term with a discount of $152. Payments are made each weekday in the amount of $537. In 2017,
$139,602 was paid off by cash and debt discount of $25,306 was amortized.</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">As
of December 31, 2017, short term promissory notes have a balance of $10,739, net of $152 unamortized debt discount.</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><font style="font-family: Times New Roman, Times, Serif">In
2018, $10,739 was paid off by cash and the debt discount of $152 was amortized.</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;<font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">As
of December 31, 2018, short term promissory notes have a balance of $0, net of $0 unamortized debt discount.</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif"><b>Related
Party Convertible Promissory Notes</b></font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">In
August 2016, $40,000 in promissory notes were issued to Mr. Shilpa Patel, a relative of Mr. Prashant Patel. The term of the note
was one year. Simple interest of 10% is payable at the maturity date of the note. Prior to maturity the note may be converted
for Common Stock at a conversion price of $1.50.</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">In
August 2017, $40,000 in convertible promissory notes was amended. A one-year extension was executed to August 2018. In connection
with the one-year extension of the maturity date of the outstanding notes, the holder of the notes was granted warrants to purchase
10,000 shares of Common Stock that was issued at a strike price of $0.80 and an expiration date of five years from date of issuance.
The amendment of the note was considered a debt extinguishment and a loss on extinguishment of debt was booked in the amount of
$5,044.</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">In
August 2018, $40,000 in convertible promissory notes was amended. A one-year extension was executed to August 2019. In connection
with the one-year extension of the maturity date of the outstanding notes, the holder of the notes was granted warrants to purchase
10,000 shares of Common Stock that was issued at a strike price of $0.50 and an expiration date of five years from date of issuance.
The amendment of the note was considered a debt extinguishment and a loss on extinguishment of debt was booked in the amount of
$7,444.</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">The
Company evaluated the embedded conversion feature within the above convertible notes under ASC 815-15 and ASC 815-40 and determined
that the embedded conversion feature does not meet the definition of a derivative liability. Then the Company evaluated the conversion
feature for a beneficial conversion feature at inception. The Company accounted for the intrinsic value of a Beneficial Conversion
Feature inherent to the convertible note payable and $0 was recorded as of the grant date.</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">In
September and October 2016, convertible promissory notes were issued in the aggregate amount of $211,725 to a related party, Mr.
Nitil Patel, the brother of Mr. Prashant Patel. The term of the notes was one year. Simple interest of 10% is payable at the maturity
date of the notes. Prior to maturity the notes may be converted for Common Stock at a conversion price of $0.62. In connection
with the notes, the holders of the notes were granted warrants to purchase 52,861 shares of Common Stock. These warrants were
issued at a strike price of $0.62 and an expiration date of five years from date of issuance.</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">The
Company evaluated the embedded conversion feature within the above convertible notes under ASC 815-15 and ASC 815-40 and determined
that the embedded conversion feature does not meet the definition of a derivative liability. Then the Company evaluated the conversion
feature for a beneficial conversion feature at inception. The Company accounted for the intrinsic value of a Beneficial Conversion
Feature inherent to the convertible note payable and the beneficial feature was not beneficial and a total debt discount of $65,390
due to the warrants was recorded as of the grant date.</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">In
April 2017, a $61,725 related party note was renewed for a one-year extension at the same interest rate of 10%, due April 2018.
In April 2018, $61,725 was paid in cash for full payment.</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">In
September 2017, a $150,000 related party note was renewed for a six-month extension at the same interest rate of 10%, due in February
2018. In February 2018, $100,000 of the related party note was extended to July 2018 and then renewed for a year extension at
the same interest rate of 10%, due July 2019. The remaining $50,000 was paid in cash in February 2018.</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">During
2017, the remaining debt discount of $48,341 was fully amortized. As of December 31, 2017, the short-term related party convertible
notes had a principal balance of $251,725, net of an unamortized debt discount of $0.</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">As
of December 31, 2018, the short-term related party convertible notes had a principal balance of $140,000, net of an unamortized
debt discount of $0.</font></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif"><b>Related
Party Promissory Note</b></font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">In
November 2016, Mr. Prashant Patel loaned the Company $10,000. The term of the loan is 90 days and is at zero percent interest.
The balance at December 31, 2016 was $10,000.</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><font style="font-family: Times New Roman, Times, Serif">In
February 2017, $7,280 of accounts payable to Mr. Patel was added to the loan. The term of the loan was extended for 90 days and
is at zero interest rate. An additional $25,272 of accounts payable was added to the loan in the second quarter and the balance
of $42,552 was converted to long-term debt in July 2017 and will mature in July 2020. (See Note 4).</font></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermDebtTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for short-term debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -URI http://asc.fasb.org/topic&amp;trid=2208564<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermDebtTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>43
<FILENAME>R34.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3</span><table class="report" border="0" cellspacing="2" id="idp6941148832">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Organization (Details Narrative) (10-K)<br></strong></div></th>
<th class="th"><div>Jun. 30, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentOwnershipPercentage', window );">Ownership percentage</a></td>
<td class="nump">100.00%<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentOwnershipPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentOwnershipPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>44
<FILENAME>R30.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3</span><table class="report" border="0" cellspacing="2" id="idp6941148832">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments and Contingencies (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2018</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock', window );">Schedule of Future Minimum Rental Payments Under Non-cancelable Operating Leases</a></td>
<td class="text"><p style="margin: 0pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Future minimum rental payments under these non-cancelable operating leases as of December 31, 2018 are:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="width: 61%; text-align: center"><font style="font-size: 10pt">2019</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%"><font style="font-size: 10pt">$</font></td>
    <td style="width: 36%; text-align: right"><font style="font-size: 10pt">156,024</font></td>
    <td style="width: 1%">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td style="text-align: center"><font style="font-size: 10pt">2020</font></td>
    <td>&#160;</td>
    <td><font style="font-size: 10pt">$</font></td>
    <td style="text-align: right"><font style="font-size: 10pt">160,709</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="text-align: center"><font style="font-size: 10pt">2021</font></td>
    <td>&#160;</td>
    <td><font style="font-size: 10pt">$</font></td>
    <td style="text-align: right"><font style="font-size: 10pt">165,506</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td style="text-align: center"><font style="font-size: 10pt">2022</font></td>
    <td>&#160;</td>
    <td><font style="font-size: 10pt">$</font></td>
    <td style="text-align: right"><font style="font-size: 10pt">49,080</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-bottom: 1.5pt; text-align: center"><font style="font-size: 10pt">2023</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1.5pt solid"><font style="font-size: 10pt">$</font></td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">41,934</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td style="padding-bottom: 2.5pt; text-align: center"><font style="font-size: 10pt">Total</font></td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td>
    <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">573,253</font></td>
    <td style="padding-bottom: 2.5pt">&#160;</td></tr>
</table>


<p style="margin: 0pt"></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of future minimum payments required in the aggregate and for each of the five succeeding fiscal years for operating leases having initial or remaining noncancelable lease terms in excess of one year and the total minimum rentals to be received in the future under noncancelable subleases as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=77902758&amp;loc=d3e41502-112717<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>45
<FILENAME>R38.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3</span><table class="report" border="0" cellspacing="2" id="idp6780218912">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Short-term Debt and Related Parties Debt (Details Narrative) - USD ($)<br></strong></div></th>
<th class="th" colspan="7">1 Months Ended</th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Jul. 31, 2019</div></th>
<th class="th"><div>Feb. 28, 2019</div></th>
<th class="th"><div>Feb. 28, 2018</div></th>
<th class="th"><div>Sep. 30, 2017</div></th>
<th class="th"><div>Apr. 30, 2017</div></th>
<th class="th"><div>May 31, 2016</div></th>
<th class="th"><div>Apr. 30, 2016</div></th>
<th class="th"><div>Jun. 30, 2019</div></th>
<th class="th"><div>Dec. 31, 2017</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
<th class="th"><div>Oct. 31, 2016</div></th>
<th class="th"><div>Sep. 30, 2016</div></th>
<th class="th"><div>Aug. 31, 2016</div></th>
<th class="th"><div>May 31, 2015</div></th>
<th class="th"><div>Apr. 30, 2015</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConvertibleNotesPayable', window );">Convertible promissory notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 181,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConvertibleNotesPayableCurrent', window );">Short term convertible notes payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 181,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_TRXD_ShortTermConvertibleNotesPayableRelatedParties', window );">Short term convertible payable - related parties</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">140,000<span></span>
</td>
<td class="nump">$ 251,725<span></span>
</td>
<td class="nump">140,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentMaturityDate', window );">Debt instrument maturity date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">May 31,  2019<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtConversionConvertedInstrumentSharesIssued1', window );">Debt instrument conversion shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">423,966<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=TRXD_ConvertiblePromissoryNoteMember', window );">Convertible Promissory Note [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConvertibleNotesPayable', window );">Convertible promissory notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 181,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 165,000<span></span>
</td>
<td class="nump">$ 200,000<span></span>
</td>
<td class="nump">$ 200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 200,000<span></span>
</td>
<td class="nump">$ 200,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleConversionPrice1', window );">Conversion price per share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.50<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.85<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1.50<span></span>
</td>
<td class="nump">$ 1.50<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentPeriodicPayment', window );">Principal and accrued interest</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 211,983<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtConversionConvertedInstrumentSharesIssued1', window );">Debt instrument conversion shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">423,966<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConvertibleNotesPayableCurrent', window );">Short term convertible notes payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">181,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentUnamortizedDiscount', window );">Debt discount unamortized</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 53,546<span></span>
</td>
<td class="nump">$ 53,546<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10.00%<span></span>
</td>
<td class="nump">10.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentMaturityDate', window );">Debt instrument maturity date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">May 31,  2019<span></span>
</td>
<td class="text">May 31,  2017<span></span>
</td>
<td class="text">May 31,  2017<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=TRXD_RelatedPartyConvertiblePromissoryNoteMember', window );">Related Party Convertible Promissory Note [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConvertibleNotesPayableCurrent', window );">Short term convertible notes payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">251,725<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentUnamortizedDiscount', window );">Debt discount unamortized</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 65,390<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10.00%<span></span>
</td>
<td class="nump">10.00%<span></span>
</td>
<td class="nump">10.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentMaturityDate', window );">Debt instrument maturity date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Jul. 31,  2019<span></span>
</td>
<td class="text">Feb. 28,  2018<span></span>
</td>
<td class="text">Apr. 30,  2018<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=TRXD_RelatedPartyConvertiblePromissoryNoteMember', window );">Related Party Convertible Promissory Note [Member] | Mr. Shilpa Patel [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleConversionPrice1', window );">Conversion price per share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1.50<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1.50<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_TRXD_ShortTermConvertibleNotesPayableRelatedParties', window );">Short term convertible payable - related parties</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 40,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentMaturityDate', window );">Debt instrument maturity date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Aug.  08,  2019<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=TRXD_RelatedPartyConvertiblePromissoryNoteMember', window );">Related Party Convertible Promissory Note [Member] | Mr. Nitel Patel [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleConversionPrice1', window );">Conversion price per share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.62<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.62<span></span>
</td>
<td class="nump">$ 0.62<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_TRXD_ShortTermConvertibleNotesPayableRelatedParties', window );">Short term convertible payable - related parties</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10.00%<span></span>
</td>
<td class="nump">10.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentMaturityDate', window );">Debt instrument maturity date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Jul.  07,  2019<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=TRXD_RelatedPartyConvertiblePromissoryNoteMember', window );">Related Party Convertible Promissory Note [Member] | Mr. Nitel Patel [Member] | Subsequent Event [Member] | Extended Maturity [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentMaturityDate', window );">Debt instrument maturity date</a></td>
<td class="text">Oct. 15,  2019<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_TRXD_ShortTermConvertibleNotesPayableRelatedParties">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Short term convertible notes payable - related parties.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">TRXD_ShortTermConvertibleNotesPayableRelatedParties</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>TRXD_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConvertibleNotesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Including the current and noncurrent portions, carrying value as of the balance sheet date of a written promise to pay a note, initially due after one year or beyond the operating cycle if longer, which can be exchanged for a specified amount of one or more securities (typically common stock), at the option of the issuer or the holder.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=6876686&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=6488278&amp;loc=d3e603758-122996<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16)(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=119400593&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConvertibleNotesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConvertibleNotesPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of the portion of long-term debt due within one year or the operating cycle if longer identified as Convertible Notes Payable. Convertible Notes Payable is a written promise to pay a note which can be exchanged for a specified amount of another, related security, at the option of the issuer and the holder.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConvertibleNotesPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtConversionConvertedInstrumentSharesIssued1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of shares issued in exchange for the original debt being converted in a noncash (or part noncash) transaction. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or payments in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=98513485&amp;loc=d3e4332-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=98513485&amp;loc=d3e4304-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtConversionConvertedInstrumentSharesIssued1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentConvertibleConversionPrice1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The price per share of the conversion feature embedded in the debt instrument.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109500613&amp;loc=SL6031898-161870<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentConvertibleConversionPrice1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateStatedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Contractual interest rate for funds borrowed, under the debt agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateStatedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentMaturityDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Date when the debt instrument is scheduled to be fully repaid, in CCYY-MM-DD format.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentMaturityDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentPeriodicPayment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the required periodic payments including both interest and principal payments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 470<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=75038535&amp;loc=d3e64711-112823<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentPeriodicPayment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentUnamortizedDiscount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated amortization, of debt discount.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1A<br> -URI http://asc.fasb.org/extlink&amp;oid=114775744&amp;loc=d3e28541-108399<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentUnamortizedDiscount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=TRXD_ConvertiblePromissoryNoteMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=TRXD_ConvertiblePromissoryNoteMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=TRXD_RelatedPartyConvertiblePromissoryNoteMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=TRXD_RelatedPartyConvertiblePromissoryNoteMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=TRXD_MrShilpaPatelMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=TRXD_MrShilpaPatelMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=TRXD_MrNitilPatelMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=TRXD_MrNitilPatelMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LoanRestructuringModificationAxis=us-gaap_ExtendedMaturityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LoanRestructuringModificationAxis=us-gaap_ExtendedMaturityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>46
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3</span><table class="report" border="0" cellspacing="2" id="idp6777922400">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Consolidated Statements of Changes in Shareholders' Equity - USD ($)<br></strong></div></th>
<th class="th"><div>Preferred Stock [Member]</div></th>
<th class="th"><div>Common Stock [Member]</div></th>
<th class="th"><div>Additional Paid-in Capital [Member]</div></th>
<th class="th"><div>Accumulated Deficit [Member]</div></th>
<th class="th"><div>Total</div></th>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at Dec. 31, 2016</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 316<span></span>
</td>
<td class="nump">$ 7,260,723<span></span>
</td>
<td class="num">$ (8,409,096)<span></span>
</td>
<td class="num">$ (1,148,057)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Balance, shares at Dec. 31, 2016</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">31,660,827<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Common Stock Issued for Cash</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 3<span></span>
</td>
<td class="nump">249,997<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">250,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Common Stock Issued for Cash, shares</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">250,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueIssuedForServices', window );">Common Stock Issued for Services</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
<td class="nump">12,499<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">12,500<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices', window );">Common Stock Issued for Services, shares</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">50,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition', window );">Options Expense</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">267,835<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">267,835<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued', window );">Warrants Issued for debt Amendment</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">16,556<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">16,556<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_TRXD_StockIssuedDuringPeriodValueStockWarrantExercised', window );">Warrants Exercised</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">250<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">250<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_TRXD_StockIssuedDuringPeriodSharesStockWarrantExercised', window );">Warrants Exercised, shares</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">25,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net Income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">288,983<span></span>
</td>
<td class="nump">288,983<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at Dec. 31, 2017</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 320<span></span>
</td>
<td class="nump">7,807,860<span></span>
</td>
<td class="num">(8,120,113)<span></span>
</td>
<td class="num">(311,933)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Balance, shares at Dec. 31, 2017</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">31,985,827<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition', window );">Options Expense</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">37,456<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">37,456<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net Income</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">82,269<span></span>
</td>
<td class="nump">82,269<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at Mar. 31, 2018</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 320<span></span>
</td>
<td class="nump">7,845,316<span></span>
</td>
<td class="num">(8,037,844)<span></span>
</td>
<td class="num">(192,208)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Balance, shares at Mar. 31, 2018</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">31,985,827<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at Dec. 31, 2017</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 320<span></span>
</td>
<td class="nump">7,807,860<span></span>
</td>
<td class="num">(8,120,113)<span></span>
</td>
<td class="num">(311,933)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Balance, shares at Dec. 31, 2017</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">31,985,827<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net Income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">102,782<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at Jun. 30, 2018</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 320<span></span>
</td>
<td class="nump">7,895,932<span></span>
</td>
<td class="num">(8,017,331)<span></span>
</td>
<td class="num">(121,079)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Balance, shares at Jun. 30, 2018</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">31,985,827<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at Dec. 31, 2017</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 320<span></span>
</td>
<td class="nump">7,807,860<span></span>
</td>
<td class="num">(8,120,113)<span></span>
</td>
<td class="num">(311,933)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Balance, shares at Dec. 31, 2017</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">31,985,827<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Common Stock Issued for Cash</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 12<span></span>
</td>
<td class="nump">799,988<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">800,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Common Stock Issued for Cash, shares</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">1,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition', window );">Options Expense</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">169,828<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">169,828<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued', window );">Warrants Issued for debt Amendment</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">7,444<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">7,444<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_TRXD_StockIssuedDuringPeriodValueStockWarrantExercised', window );">Warrants Exercised</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_TRXD_AdjustmentsToAdditionalPaidInCapitalWarrantsForAcquisition', window );">Warrants for Acquisition of Community Specialty Pharmacy, LLC</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">170,291<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">170,291<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net Income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,038<span></span>
</td>
<td class="nump">9,038<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at Dec. 31, 2018</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 332<span></span>
</td>
<td class="nump">8,955,411<span></span>
</td>
<td class="num">(8,111,075)<span></span>
</td>
<td class="nump">844,668<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Balance, shares at Dec. 31, 2018</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">33,285,827<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at Mar. 31, 2018</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 320<span></span>
</td>
<td class="nump">7,845,316<span></span>
</td>
<td class="num">(8,037,844)<span></span>
</td>
<td class="num">(192,208)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Balance, shares at Mar. 31, 2018</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">31,985,827<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition', window );">Options Expense</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">50,616<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">50,616<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net Income</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">20,513<span></span>
</td>
<td class="nump">20,513<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at Jun. 30, 2018</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 320<span></span>
</td>
<td class="nump">7,895,932<span></span>
</td>
<td class="num">(8,017,331)<span></span>
</td>
<td class="num">(121,079)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Balance, shares at Jun. 30, 2018</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">31,985,827<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at Dec. 31, 2018</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 332<span></span>
</td>
<td class="nump">8,955,411<span></span>
</td>
<td class="num">(8,111,075)<span></span>
</td>
<td class="nump">844,668<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Balance, shares at Dec. 31, 2018</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">33,285,827<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition', window );">Options Expense</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">35,979<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">35,979<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities', window );">Common Stock issued for convertible debt and accrued interest</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 4<span></span>
</td>
<td class="nump">211,979<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">211,983<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities', window );">Common Stock issued for convertible debt and accrued interest, shares</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">423,996<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_TRXD_StockIssuedDuringPeriodValueStockWarrantExercised', window );">Warrants Exercised</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
<td class="nump">165<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">166<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_TRXD_StockIssuedDuringPeriodSharesStockWarrantExercised', window );">Warrants Exercised, shares</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">16,666<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net Income</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">125,229<span></span>
</td>
<td class="nump">125,229<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at Mar. 31, 2019</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 337<span></span>
</td>
<td class="nump">9,203,534<span></span>
</td>
<td class="num">(7,985,846)<span></span>
</td>
<td class="nump">1,218,025<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Balance, shares at Mar. 31, 2019</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">33,726,489<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at Dec. 31, 2018</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 332<span></span>
</td>
<td class="nump">8,955,411<span></span>
</td>
<td class="num">(8,111,075)<span></span>
</td>
<td class="nump">$ 844,668<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Balance, shares at Dec. 31, 2018</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">33,285,827<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_TRXD_StockIssuedDuringPeriodSharesStockWarrantExercised', window );">Warrants Exercised, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">16,666<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net Income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 183,210<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at Jun. 30, 2019</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 337<span></span>
</td>
<td class="nump">9,267,545<span></span>
</td>
<td class="num">(7,927,865)<span></span>
</td>
<td class="nump">1,340,017<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Balance, shares at Jun. 30, 2019</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">33,726,489<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at Mar. 31, 2019</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 337<span></span>
</td>
<td class="nump">9,203,534<span></span>
</td>
<td class="num">(7,985,846)<span></span>
</td>
<td class="nump">1,218,025<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Balance, shares at Mar. 31, 2019</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">33,726,489<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition', window );">Options Expense</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">64,011<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">64,011<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net Income</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">57,981<span></span>
</td>
<td class="nump">57,981<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at Jun. 30, 2019</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 337<span></span>
</td>
<td class="nump">$ 9,267,545<span></span>
</td>
<td class="num">$ (7,927,865)<span></span>
</td>
<td class="nump">$ 1,340,017<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Balance, shares at Jun. 30, 2019</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">33,726,489<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_TRXD_AdjustmentsToAdditionalPaidInCapitalWarrantsForAcquisition">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Adjustments to additional paid in capital warrants for acquisition.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">TRXD_AdjustmentsToAdditionalPaidInCapitalWarrantsForAcquisition</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>TRXD_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_TRXD_StockIssuedDuringPeriodSharesStockWarrantExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Stock issued during period shares stock warrant exercised.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">TRXD_StockIssuedDuringPeriodSharesStockWarrantExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>TRXD_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_TRXD_StockIssuedDuringPeriodValueStockWarrantExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Stock issued during period value stock warrant exercised.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">TRXD_StockIssuedDuringPeriodValueStockWarrantExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>TRXD_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase to additional paid-in capital (APIC) for recognition of cost for option under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in additional paid in capital (APIC) resulting from the issuance of warrants. Includes allocation of proceeds of debt securities issued with detachable stock purchase warrants.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 25<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109126253&amp;loc=d3e4724-112606<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=SL7669619-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=116637391&amp;loc=SL114874048-224260<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=SL7669625-108580<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=116637232&amp;loc=SL114874131-224263<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=116634182&amp;loc=SL114868664-224227<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3602-108585<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued which are neither cancelled nor held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued during the period as a result of the conversion of convertible securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29-30)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21475-112644<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued in lieu of cash for services contributed to the entity. Number of shares includes, but is not limited to, shares issued for services contributed by vendors and founders.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesIssuedForServices</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of new stock issued during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The gross value of stock issued during the period upon the conversion of convertible securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29-31)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueIssuedForServices">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of stock issued in lieu of cash for services contributed to the entity. Value of the stock issued includes, but is not limited to, services contributed by vendors and founders.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueIssuedForServices</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI http://asc.fasb.org/extlink&amp;oid=27010918&amp;loc=d3e74512-122707<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>47
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3</span><table class="report" border="0" cellspacing="2" id="idp6774381696">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Document and Entity Information<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2019</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_TRXD_DocumentAndEntityInformationAbstract', window );"><strong>Document And Entity Information</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">TRXADE GROUP, INC.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001382574<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">S-1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Jun. 30,  2019<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
<td class="text">Non-accelerated Filer<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntitySmallBusiness', window );">Entity Small Business Flag</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityExTransitionPeriod', window );">Entity Ex Transition Period</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_TRXD_DocumentAndEntityInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">TRXD_DocumentAndEntityInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>TRXD_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented.  If there is no historical data in the report, use the filing date. The format of the date is CCYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityExTransitionPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 7A<br> -Section B<br> -Subsection 2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityExTransitionPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFilerCategory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:filerCategoryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntitySmallBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicates that the company is a Smaller Reporting Company (SRC).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntitySmallBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>48
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3</span><table class="report" border="0" cellspacing="2" id="idp6700203696">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Options<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Share-based Payment Arrangement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock', window );">Options</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif"><b>NOTE
6 &#8211; OPTIONS</b></font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">The
Company maintains a stock option plan under which certain employees are awarded option grants based on a combination of performance
and tenure. The stock option plan provides for the grant of up to 2,000,000 shares. All options may be exercised for a period
up to four 1/2 years following the grant date, after which they expire. Options are vested up to 5 years from the grant date.</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">For
the six-month period ended June 30, 2019, 505,000 options were issued, none were forfeited or expired due to employee resignation.</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">The
Company uses the Black-Sholes option pricing model to estimate the fair value of stock-based awards on the date of the grant.
The following table summarizes the assumptions used to estimate the fair value of the stock options granted during the quarter
ended June 30, 2019.</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<table cellpadding="0" cellspacing="0" align="center" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid">2019</td><td style="padding-bottom: 1.5pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 78%; text-align: justify">Expected dividend yield</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: center">&#160;</td><td style="width: 18%; text-align: center">0%</td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify">Weighted-average expected volatility</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td style="text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">209-250%</font></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify">Weighted-average risk-free interest rate</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td style="text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">2.08-2.55%</font></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify">Expected life of options</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td style="text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">5-7 years</font></td><td style="text-align: left">&#160;</td></tr>
</table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">Total
compensation cost related to stock options was $99,990 and $88,072 for the six-months ended June 30, 2019 and 2018 respectively.</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">The
following table represents stock option activity for the six-month period ended June 30, 2019:</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>Number</b></font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>Outstanding</b></font></p></td><td style="padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>Weighted</b></font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>Average</b></font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>Exercise Price</b></font></p></td><td style="padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>Contractual Life</b></font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>in Years</b></font></p></td><td style="padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>Intrinsic</b></font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>Value</b></font></p></td><td style="padding-bottom: 1.5pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 44%">Options Outstanding as of December 31, 2018</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 10%; text-align: right">1,732,846</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right">1.19</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 10%; text-align: right">6.98</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right">-</td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td>Options Exercisable as of December 31, 2018</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,107,259</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">0.96</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">5.91</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Options granted</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">505,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">0.43</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">9.86</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Options forfeited</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Options expired</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Options Outstanding as of June 30, 2019</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,237,846</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">0.73</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">7.27</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">88,350</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td>Options Exercisable as of June 30, 2019</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,239,384</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">0.91</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">5.77</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">8,809</td><td style="text-align: left">&#160;</td></tr></table><span></span>
</td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif"><b>NOTE
7 - OPTIONS</b></font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">The
Company maintains a stock option plan under which certain employees and management are awarded option grants based on a combination
of performance and tenure. All options may be exercised for a period up to four &#189; years following the grant date, after
which they expire. Options are vested up to 5 years from the grant date. The Board has authorized the use of 2,000,000 shares
for option grants.</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><font style="font-family: Times New Roman, Times, Serif">Stock
options were granted during 2018 and 2017 to employees totaling, 560,400 and 263,846 respectively. These options vest over a period
of 4 to 5 years, are granted with an exercise price of between $0.41 and $1.02 per share and have a term of 10 years. The
last options expire April 2028.</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">Under
the Black-Scholes option price model, fair value of the options granted in 2018 and 2017 were $278,358 and $169,100, respectfully.</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">In
April 2017, 253,846 options were granted with an exercise price of $0.65 and a term of 10 years from the grant date. The options
vest over a period of one and four years.</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">In
April 2017, four option grants, totaling 650,000 options, were amended to extend the exercise terms to 10 years from the date
of grant. Incremental option expense recognized as a result of the amendment amounted to $69,611.</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">In
April 2018, 560,400 options were granted with an exercise price of $0.50 and a term of 10 years from the grant date. The options
vest over a period of four to five years.</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">The
Company uses the Black-Scholes option pricing model to estimate the fair value of stock-based awards on the date of grant. The
following table summarizes the assumptions used to estimate the fair value of stock options granted during the years ended December
31, 2018 and 2017:</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<table cellpadding="0" cellspacing="0" align="center" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<tr style="vertical-align: bottom; font-family: Times New Roman, Times, Serif">
    <td style="font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">2018</font></td><td style="padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">2017</font></td><td style="padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255); font-family: Times New Roman, Times, Serif">
    <td style="width: 56%; text-align: left; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">Expected
    dividend yield</font></td><td style="width: 2%; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="width: 1%; text-align: left; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="width: 18%; text-align: right; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">0</font></td><td style="width: 1%; text-align: left; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">%</font></td><td style="width: 2%; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="width: 1%; text-align: left; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="width: 18%; text-align: right; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">0</font></td><td style="width: 1%; text-align: left; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">%</font></td></tr>
<tr style="vertical-align: bottom; background-color: White; font-family: Times New Roman, Times, Serif">
    <td style="text-align: left; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">Weighted-average
    expected volatility</font></td><td style="font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: left; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="text-align: right; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">192-265</font></td><td style="text-align: left; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">%</font></td><td style="font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: left; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="text-align: right; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">200</font></td><td style="text-align: left; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">%</font></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255); font-family: Times New Roman, Times, Serif">
    <td style="text-align: left; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">Weighted-average
    risk-free interest rate</font></td><td style="font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: left; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="text-align: right; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">2.08-2.73</font></td><td style="text-align: left; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">%</font></td><td style="font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: left; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="text-align: right; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">1.92</font></td><td style="text-align: left; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">%</font></td></tr>
<tr style="vertical-align: bottom; background-color: White; font-family: Times New Roman, Times, Serif">
    <td style="text-align: left; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">Expected
    life of warrants</font></td><td style="font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: left; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="text-align: right; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">4-5
                                         years</font></td><td style="text-align: left; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: left; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="text-align: right; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">4.74
                                         -7.50 years</font></td><td style="text-align: left; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr>
</table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">Total
compensation cost related to stock options was $169,828 and $267,835 for the years ended December 31, 2018 and 2017, respectively.
As of December 31, 2018, there was $192,007 of unrecognized compensation costs related to stock options, which is expected to
be recognized over a weighted average period of 6.98 years. The following table represents stock option activity for the two years
ended December 31, 2018:</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<tr style="vertical-align: bottom; font-family: Times New Roman, Times, Serif">
    <td style="text-align: center; padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="font-weight: bold; text-align: center; padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">Number
    Outstanding</font></td><td style="font-weight: bold; text-align: center; padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="font-weight: bold; text-align: center; padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">Weighted
    Average Exercise Price</font></td><td style="font-weight: bold; text-align: center; padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="font-weight: bold; text-align: center; padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">Contractual
    Life in Years</font></td><td style="font-weight: bold; text-align: center; padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="font-weight: bold; text-align: center; padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">Intrinsic
    Value</font></td><td style="font-weight: bold; text-align: center; padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255); font-family: Times New Roman, Times, Serif">
    <td style="width: 42%; text-align: left; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">Options
    Outstanding as of December 31, 2016</font></td><td style="width: 2%; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="width: 1%; text-align: left; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="width: 11%; text-align: right; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">1,044,500</font></td><td style="width: 1%; text-align: left; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="width: 2%; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="width: 1%; text-align: left; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td><td style="width: 11%; text-align: right; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">0.92</font></td><td style="width: 1%; text-align: left; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="width: 2%; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="width: 1%; text-align: left; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="width: 10%; text-align: right; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">3.38</font></td><td style="width: 1%; text-align: left; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="width: 2%; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="width: 1%; text-align: left; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td><td style="width: 10%; text-align: right; font-family: Times New Roman, Times, Serif">&#160;&#160;&#160;&#160;&#160;&#160;<font style="font: 10pt Times New Roman, Times, Serif">-</font></td><td style="width: 1%; text-align: left; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: White; font-family: Times New Roman, Times, Serif">
    <td style="text-align: left; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">Options
    Exercisable as of December 31, 2016</font></td><td style="font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: left; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="text-align: right; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">584,000</font></td><td style="text-align: left; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: left; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td><td style="text-align: right; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">1.05</font></td><td style="text-align: left; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: left; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="text-align: right; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">3.02</font></td><td style="text-align: left; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: left; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="text-align: right; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="text-align: left; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255); font-family: Times New Roman, Times, Serif">
    <td style="text-align: left; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">Options
    granted</font></td><td style="font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: left; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="text-align: right; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">263,846</font></td><td style="text-align: left; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: left; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="text-align: right; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">0.64</font></td><td style="text-align: left; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: left; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="text-align: right; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">9.05</font></td><td style="text-align: left; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: left; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="text-align: right; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td><td style="text-align: left; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: White; font-family: Times New Roman, Times, Serif">
    <td style="text-align: left; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">Options
    forfeited</font></td><td style="font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: left; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="text-align: right; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">(35,000</font></td><td style="text-align: left; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td><td style="font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: left; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="text-align: right; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">1.02</font></td><td style="text-align: left; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: left; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="text-align: right; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">8.25</font></td><td style="text-align: left; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: left; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="text-align: right; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td><td style="text-align: left; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255); font-family: Times New Roman, Times, Serif">
    <td style="text-align: left; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">Options
    expired</font></td><td style="font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: left; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="text-align: right; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">(75,000</font></td><td style="text-align: left; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td><td style="font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: left; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="text-align: right; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">1.13</font></td><td style="text-align: left; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: left; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="text-align: right; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">4.54</font></td><td style="text-align: left; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: left; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="text-align: right; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td><td style="text-align: left; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: White; font-family: Times New Roman, Times, Serif">
    <td style="text-align: left; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: left; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="text-align: right; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="text-align: left; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: left; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="text-align: right; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="text-align: left; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: left; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="text-align: right; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="text-align: left; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: left; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="text-align: right; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="text-align: left; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255); font-family: Times New Roman, Times, Serif">
    <td style="text-align: left; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">Options
    Outstanding as of December 31, 2017</font></td><td style="font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: left; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="text-align: right; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">1,197,846</font></td><td style="text-align: left; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: left; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td><td style="text-align: right; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">0.97</font></td><td style="text-align: left; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: left; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="text-align: right; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">6.96</font></td><td style="text-align: left; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: left; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td><td style="text-align: right; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td><td style="text-align: left; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: White; font-family: Times New Roman, Times, Serif">
    <td style="text-align: left; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">Options
    Exercisable as of December 31, 2017</font></td><td style="font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: left; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="text-align: right; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">781,300</font></td><td style="text-align: left; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: left; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td><td style="text-align: right; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">1.02</font></td><td style="text-align: left; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: left; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="text-align: right; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">6.30</font></td><td style="text-align: left; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: left; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td><td style="text-align: right; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td><td style="text-align: left; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255); font-family: Times New Roman, Times, Serif">
    <td style="text-align: left; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">Options
    granted</font></td><td style="font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: left; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="text-align: right; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">560,400</font></td><td style="text-align: left; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: left; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="text-align: right; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">0.50</font></td><td style="text-align: left; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: left; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="text-align: right; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">9.26</font></td><td style="text-align: left; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: left; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="text-align: right; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="text-align: left; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: White; font-family: Times New Roman, Times, Serif">
    <td style="text-align: left; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">Options
    forfeited</font></td><td style="font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: left; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="text-align: right; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">(25,400</font></td><td style="text-align: left; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td><td style="font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: left; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="text-align: right; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">0.46</font></td><td style="text-align: left; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: left; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="text-align: right; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">9.06</font></td><td style="text-align: left; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: left; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="text-align: right; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="text-align: left; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255); font-family: Times New Roman, Times, Serif">
    <td style="text-align: left; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">Options
    expired</font></td><td style="font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: left; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="text-align: right; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td><td style="text-align: left; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: left; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="text-align: right; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td><td style="text-align: left; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: left; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="text-align: right; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td><td style="text-align: left; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: left; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="text-align: right; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td><td style="text-align: left; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: White; font-family: Times New Roman, Times, Serif">
    <td style="text-align: left; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: left; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="text-align: right; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="text-align: left; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: left; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="text-align: right; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="text-align: left; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: left; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="text-align: right; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="text-align: left; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: left; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="text-align: right; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="text-align: left; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255); font-family: Times New Roman, Times, Serif">
    <td style="text-align: left; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">Options
    Outstanding as of December 31, 2018</font></td><td style="font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: left; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="text-align: right; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">1,732,846</font></td><td style="text-align: left; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: left; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td><td style="text-align: right; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">1.19</font></td><td style="text-align: left; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: left; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="text-align: right; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">6.98</font></td><td style="text-align: left; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: left; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td><td style="text-align: right; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td><td style="text-align: left; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: White; font-family: Times New Roman, Times, Serif">
    <td style="text-align: left; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">Options
    Exercisable as of December 31, 2018</font></td><td style="font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: left; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="text-align: right; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">1,107,259</font></td><td style="text-align: left; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: left; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td><td style="text-align: right; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">0.96</font></td><td style="text-align: left; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: left; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="text-align: right; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">5.91</font></td><td style="text-align: left; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: left; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td><td style="text-align: right; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td><td style="text-align: left; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -URI http://asc.fasb.org/topic&amp;trid=2228938<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>49
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3</span><table class="report" border="0" cellspacing="2" id="idp6642403408">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments and Contingencies<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2018</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock', window );">Commitments and Contingencies</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif"><b>NOTE
10 &#8211; COMMITMENTS AND CONTINGENCIES</b></font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">The
Company leases two premises in Land O&#8217; Lakes, Florida under an operating lease that expires in 2021 and in Tampa, Florida
under an operating lease that expires in 2023. Future minimum rental payments under these non-cancelable operating leases as of
December 31, 2018 are:</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<table cellpadding="0" cellspacing="0" align="center" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<tr style="vertical-align: bottom; background-color: rgb(204,238,255); font-family: Times New Roman, Times, Serif">
    <td style="width: 60%; text-align: center; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">2019</font></td><td style="width: 2%; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="width: 1%; text-align: left; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td><td style="width: 36%; text-align: right; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">156,024</font></td><td style="width: 1%; text-align: left; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: White; font-family: Times New Roman, Times, Serif">
    <td style="text-align: center; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">2020</font></td><td style="font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: left; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td><td style="text-align: right; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">160,709</font></td><td style="text-align: left; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255); font-family: Times New Roman, Times, Serif">
    <td style="text-align: center; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">2021</font></td><td style="font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: left; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td><td style="text-align: right; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">165,506</font></td><td style="text-align: left; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: White; font-family: Times New Roman, Times, Serif">
    <td style="text-align: center; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">2022</font></td><td style="font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: left; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td><td style="text-align: right; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">49,080</font></td><td style="text-align: left; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255); font-family: Times New Roman, Times, Serif">
    <td style="padding-bottom: 1.5pt; text-align: center; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">2023</font></td><td style="padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td><td style="border-bottom: Black 1.5pt solid; text-align: right; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">41,934</font></td><td style="padding-bottom: 1.5pt; text-align: left; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: White; font-family: Times New Roman, Times, Serif">
    <td style="padding-bottom: 2.5pt; text-align: center; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">Total</font></td><td style="padding-bottom: 2.5pt; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td><td style="border-bottom: Black 2.5pt double; text-align: right; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">573,253</font></td><td style="padding-bottom: 2.5pt; text-align: left; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for commitments and contingencies.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -URI http://asc.fasb.org/topic&amp;trid=2127136<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -URI http://asc.fasb.org/topic&amp;trid=2144648<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>50
<FILENAME>R59.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3</span><table class="report" border="0" cellspacing="2" id="idp6635516016">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments and Contingencies (Details Narrative) (10-K)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2018</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseDescription', window );">Operating lease description</a></td>
<td class="text">The Company leases two premises in Land O' Lakes, Florida under an operating lease that expires in 2021 and in Tampa, Florida under an operating lease that expires in 2023. <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseDescription">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Description of lessee's operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=77888426&amp;loc=SL77918673-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseDescription</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>51
<FILENAME>R51.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3</span><table class="report" border="0" cellspacing="2" id="idp6765527616">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Options - Schedule of Estimate the Fair Value of Stock Options (Details)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
<th class="th"><div>Dec. 31, 2017</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate', window );">Expected dividend yield</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum', window );">Weighted-average expected volatility, minimum</a></td>
<td class="nump">209.00%<span></span>
</td>
<td class="nump">192.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum', window );">Weighted-average expected volatility, maximum</a></td>
<td class="nump">250.00%<span></span>
</td>
<td class="nump">265.00%<span></span>
</td>
<td class="nump">200.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum', window );">Weighted-average risk-free interest rate, minimum</a></td>
<td class="nump">2.08%<span></span>
</td>
<td class="nump">2.08%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum', window );">Weighted-average risk-free interest rate, maximum</a></td>
<td class="nump">2.55%<span></span>
</td>
<td class="nump">2.73%<span></span>
</td>
<td class="nump">1.92%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Expected life of warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">6 years 11 months 23 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Expected life of warrants</a></td>
<td class="text">5 years<span></span>
</td>
<td class="text">4 years<span></span>
</td>
<td class="text">4 years 8 months 26 days<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Expected life of warrants</a></td>
<td class="text">7 years<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">7 years 6 months<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The estimated measure of the maximum percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The estimated measure of the minimum percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum risk-free interest rate assumption that is used in valuing an option on its own shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The minimum risk-free interest rate assumption that is used in valuing an option on its own shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.D.2)<br> -URI http://asc.fasb.org/extlink&amp;oid=115993241&amp;loc=d3e301413-122809<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>52
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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MMWF\81AU8\K(XK%T-8943OTJDH\ Q:X831F:3LTXXFBD(3^ G/,6+V2?$9/
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M]8??5=@-QN[L/S:^",H6?MV%_ )02P,$%     @ W8M/3YE<G",0!@  G"<
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M.AQG0GS/]O:1I24RS^_Y"NM./&<?5I:P7<_/Y)Z,<B.[W?98??9/1VXCUZG
MLR+7E$8D19_(+;KD$3BU20TR$S\(G8:8:E < J0),9:AAOBTQJP1X!-]M[X(
MR-^-B/>K;YH]5Z%82=J$^!!&&N*<<^9ST6S[!Z5&T?95O-RCEU@5 9<8WS2J
M-2S%UGB5P/&MG#P=$Q+-E L&08:7)"82J3E^34@3_BNEVOZ<TT#PE"\D^DJ1
MCVFS(Z=T)LWH,QK!1J\;=8=HTCQZ_@7YG#4*')$;'0)G&[-&(81IN_ >KR2.
MFJW"$2M"/F(9-AIRM1:!MG&IA&!:$L;1>$[2M!'\6:PUDSY@R.S-D77.UI$.
M$9)>-T(^8LZ+D!&_'H8X2IKMHG%8!/V>7L-)P>B"RV;]N'Z&U3-L+([W1]07
M2N0/)J<_Z3(T!Z.:60F]A%9JGZJ'-#ZH'C(*!?&Y'C[E>G@*-Y;&O%"N@GL!
M_]':-\*K^(+ .7\N?<^E[[GT/:'2MS<C?6?!TXM;WD9N6\3[KC':US0N*&-7
M<LW(QU2ODRG8.9_ [/UH/I[Q[?K9)(2OFEDM(Q:02X&S022X_(O*\"K$">AD
M6R4)RU3393>*$IY"&V[I4_5*E=?EK[DHN#Q;Y.FOH70^+,_Y/%_GM,T+,T.W
M<DOJMI2^M28X2O2QS'!.'LL,.V<\DAVV=Z =-?OV77;D(Z4P4Y=#N!I"O@-M
MNIW<.CB>F)&Y"M-2D&_#^>G%>!KB.=D$N7V85VWGV-'1^^?!4;"C[SR6'<>(
M\J(A[J&&F,_#0X=Y>U^89Y7&4#04;6RL)"Q&MV"XU_$L%.!D8"V@!X.O40+R
M4E5@,5O& RN0HGQ,C$7H<.>77%_CT9+CVZ9EM6ZO*7<9;2)2.<)IF!-GJ\K>
M9;'!51W/55ORL+YJ/;053L_^6:W(GPP13A8+$DACE!>F2J+S&5.^YRM)Q%4X
MOT4SMA*7&+SCYL=Q3E.X$G:V#P(RN;LYJ7IE,6>F\M\M# DL6XA9$N)-7>W5
MYYN<KGHB=OJ7=\%@\OUPR4</Y3OG7_1=0ZY^]MWC^FZ3.TA,G'G%$0%T10(C
ME1P&%A<RY%#NDI &$P'-E,E$\ *"9*8<@)CZ"[WR#+DI%<ZM/CE_12R#ADY>
MTB42%(JP# 4A%W+C[^^3:G>,U_HL@6V$5#)DU1?*0XG!/3-R0]A4)?.NVB8+
MA=OB5,V[&KXF8$O#>FZ=+2?_VU[4/;07/4;SHYG@'K.'<YMZN,)%K/]8UA[Y
M,M\Y<-LZW@->YA,L0Z1^P7V*BH 1JV*^NJ]/^26<.[1[\8$@F_S6VZ3VW> ,
M?-2K6J5D*Q$_2P=\'Y(&8XQ;]#1?CQ1BK::QK<;:,0QY@%CS#*%F.-^'19H:
M,]6+K#F-"F]!U4#E/]O4#6CV#30<D05>,9FV-J/D3@H\W/[O#;#"Q([A[8N_
M 5!+ P04    " #=BT]/UISV2AX"  #H!@  &    'AL+W=O<FMS:&5E=',O
M<VAE970Q+GAM;'55VXZ;,!#]%<0'K,&YKPA2LE752JT4;=7VV2&3@-;&U';"
M]N]K&Y8B/+Q@>WS.G!D/'F>M5&^Z!##1N^"UWL>E,<TS(;HH03#])!NH[<Y5
M*L&,7:H;T8T"=O$DP0E-DC41K*KC//.VD\HS>3>\JN&D(GT7@JF_1^"RW<=I
M_&%XK6ZE<0:29PV[P0\P/YN3LBLR>+E4 FI=R3I2<-W'A_3YF%)'\(A?%;1Z
M-(]<*F<IW]SBZV4?)RXBX% 8YX+9X0$OP+GS9./XTSN-!TU'',\_O'_VR=MD
MSDS#B^2_JXLI]_$VCBYP97=N7F7[!?J$5G'49_\-'L MW$5B-0K)M?]&Q5T;
M*7HO-A3!WKNQJOW8=CL+VM-P NT)="!03R"=D(_\$S,LSY1L(]4=?L-<C=-G
M:L^F<$9_%'[/!J^M]9$G&7DX-SWBV"'H")$."&)]#P(4$SC2@$YQ^@*-;^'I
MBQ%]@=.7*'WIZ<L1?3E)+T2L<($5*K *Z.N)0(C8X )K5& =T+<3@1"QPP4V
MJ, FH*?37P"!S/P#6U1B&_+I1 *!S!1ZATKL0OZTT@ADIM1I@M^5)/0PK3:&
MF:EW.G,CT]##M.089DX%O9:'E(8>=E,5!#,M"ADU&@'JYENLC@IYKWU_'UF'
M-G[H&M5_>/<&?&?J5M4Z.DMCVYUO2E<I#=A0DB=[BTK[[ P+#E?CIAL[5UWO
M[19&-OV[0H;'+?\'4$L#!!0    ( -V+3T^=*VUAYP0  #X8   8    >&PO
M=V]R:W-H965T<R]S:&5E=#(N>&ULC5E=;^,V$/PKAM_OQ%U^B P< [6-H@5:
MX'!%VV<E9F+C;,N5E.3Z[TO).M?:709YB2UY=CFD5C-+9O%6-]_:78S=[/OQ
M<&KOY[NN.]\51?NXB\>J_5R?XRG]\E0WQZI+E\UST9Z;6&V'H..A0*5<<:SV
MI_ER,=S[TBP7]4MWV)_BEV;6OAR/5?/O*A[JM_LYS'_<^+I_WG7]C6*Y.%?/
M\8_8_7G^TJ2KXIIENS_&4[NO3[,F/MW/?X*[C;9]P(#X:Q_?VIOOLWXJ#W7]
MK;_X=7L_5SVC>(B/79^B2A^O<1T/ASY3XO'/F'1^';,/O/W^(_O/P^339!ZJ
M-J[KP]_[;;>[G_OY;!N?JI=#][5^^R6.$[+SV3C[W^)K/"1XSR2-\5@?VN'O
M[/&E[>KCF"51.5;?+Y_[T_#Y=OG%VC%,#L Q *\!8-X-T&. _FB &0,,"2@N
M4QG69E-UU7+1U&^SYO)XSU5?17!GTNH_]C>'Q1Y^2\O3IKNO2U2+XK7/,T)6
M%PC>0J:(M8" *60C0/[/4B2*5YXH\L0A7M_&:SE>B_%ZB#>W\8;,\P*Q ^0T
M0*Q12A/8FL.\"]:69,(<!EX',#)I(Y(VG+0EI"\0=S-,"=J4@9#F,*.U0TJ:
MPS0$XTJ9M!5)6T[:$=*6#6.-\T!@:PXK0W $M1'&R_!U(E_'XSWAZQ@1L&E=
M2(VO.<QC8&LL)%.H@I4YER+GDG.F3UR 4"8E8Y+\0LD\O,C#LT$T50_/IQLL
M8DEP:P%GG%,E)<UQ"61*)],.(NW :9-GN0J<#EI%*U1 6451&SY<KD)!R2*M
MN/J%3(:,S .?,E'QU8B9U ,X3><LP92E"[@18*"RY06RZ@-RVIK21CZ00R@]
MY<US91^#["' 382ZPVK$3$1 ::N890J&E&,CFP-P=]#4'4"P![2AU)3-QW ;
M8<PL:]D=@,LUK; 5<.'7KO3*64J; S%)B_54- 2@@[QJ@.P4X-AKJ'.SEW4;
MN"IK:C; 9;ET&@Q[9AR7VA5K#)T[QX%RRF<Z$9"5'@2I#Y2YH.$*P+,W4<!I
MKY%5FX"S+CC(,)?%'KC\&M;B<B'WRE.%7 NI<N6/LI*CXF1H&R%@F'6/F.E2
MW];]E(QL"LA-P5!3$#"4S!H%J?>]$5+2[^::,L[L KB&T_=BA8(?F(GSC*P_
MAML(.+108J9A0]D[D.L]?5-7R+T#E+?)@REUP62<THY5"<=9M-KF%ETV&C1,
M]DQN\K+H(Q=]0]L* <.KGLLX*;0I&UG&D7?\IJ2/@G?IJ6FUEBK"!W$; 8=3
MW)2Y;!_([<-0^T#!/K32M&U:"[FR+Z-L"<@MP5!+0"[AJ+57E/9: "9/P "!
MKB0'!@Q&9?IAE$T! ZMIFZDB+2NYYBIMZ29"P##Q_ !F\SYFRE:6>LVEE];H
M2G,9UYK1E4"TVB40YI975GK-E=Y2I==<F0.ZTAK:)PI 'ZPU0#<M C#UG642
MUPSYS&$3%WO+3INX-G\J Z:Q&'L!Z0% E9;2%Y&8>K#<69FL^)JW^99N+33?
M,H!._@FL8CC0F[2U]Y0\QWW2 $'GN,M>H[F/6+K!&#&WAW/R!D, RAL, 2AN
M,(J;<]G^9/WWJGG>G]K90]UU]7$XB'VJZRZFG.ISRK:+U?9Z<8A/7?^U3-^;
MRXGVY:*KS^-I?7']E\'R/U!+ P04    " #=BT]/I%=!4W4"  #+"0  &
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MBD?4S#@V&L>ZL:\8QS>+3:W?Q62QA)S9)T;[1+</%/M$F\GW8R\*$N4KW9I
M+PD3K4@,H+N:@S/UE5%]I:LKKS=?+54W@49U WA7W77,NXFCRT<W,MS8CUP]
M@_J]#DPXL57+R("XH;KA@,DF*8XY/R Y52VU=ICQ_5;NBD>,&>()G2>>JN0G
MJ[%3HR,3S9BW27^\Z#L,=\/1"8SGM^P?4$L#!!0    ( -V+3T_DN"Z=C00
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MVCG-@%8$%]KI*"YGG8#?W/M<US.[86(X8G"@XF6'N=XLXB8%]P "9ZQF-[8
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M=#6EJX_M[=OV5M!%B,X%W1/$'2&[(\0H+_@B)M<^R[41I!'WKK!9F94B8$6
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MSQ#K^8!1+/XK7($[N'?B]J@4-^&+JM%8):**LR+8RSSV,HS3O))ED;9-H)%
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M'%(<XD_'4U/5QCE(EG2L@F<P?[JCLA:958I&0*L;V2(%98KOPMTA=G@/^-O
MH!=[Y"HY2?GJC%]%B@.7$'#(C5-@=CG# 3AW0C:-?Y,FGD,ZXG+_J7[O:[>U
MG)B&@^0O36'J%-]B5$#)>FZ>Y/  4ST;C*;B?\,9N(6[3&R,7'+MORCOM9%B
M4K&I"/8VKDWKUV$\H>%$6R?0B4!GPFWP+2&:"-$%@8R9^5)_,L.R1,D!J?&Q
M.N9Z(MQ%]C)SY_1WY\]LM=IZS]DF2,C9Z4R0_0BA"TCX/^)PC=A^B1 ;?TZ"
MKB6QIU=\>A%A!1&N1XA6RXP\/UK6L(W6!>)5@=@+Q-_=TS4DW,87=:QA-A=Y
MD,7;"5"5;W.-<MFW?L06WGF2[JA_^R_X.(:/3%5-J]%)&MM!_IU+*0W85((;
MV]NUG?S9X% :M]W:O1K[?S2,[*;1)O/_)?L 4$L#!!0    ( -V+3T^>NI7P
MS0$  &T$   9    >&PO=V]R:W-H965T<R]S:&5E=#$R+GAM;'U4VV[<(!#]
M%<0'!-\:;U>VI>Q652HUTBI5VV?6'E\4, [@=?+W!>RXS@;EQ3##.8<SP#B;
MA'Q2+8!&+YSU*L>MUL.>$%6VP*FZ$0/T9J46DE-M0MD0-4B@E2-Q1J(@N"6<
M=CTN,I<[R2(3HV9=#R>)U,@YE:\'8&+*<8C?$H]=TVJ;($4VT 9^@?X]G*2)
MR*I2=1QZU8D>2:AS?!?NCXG%.\"?#B:UF2-;R5F()QO\J'(<6$/ H-16@9KA
M D=@S H9&\^+)EZWM,3M_$W]NZO=U'*F"HZ"_>TJW>9XAU$%-1V9?A33/2SU
M?,%H*?XG7( 9N'5B]B@%4^Z+RE%IP1<58X73EWGL>C=.\TJ2+C0_(5H(T4K8
M!9\2XH407Q'([,R5^HUJ6F123$C.ES50^R;"?6P.L[1)=W9NS52K3/92A.EM
M1BY6:,$<9DRTQ;Q''#\BTF"%$&-@=1'Y7!RB#_SH:@</(O3O$'OKC!T_?E=G
MZA=(O *)$T@^/2@?9G=5B _S]<H(V=P>!]FXAZY0*<;>-=DFN_;27>1N_S]\
M;L0'*INN5^@LM'E#[J9K(308*\&->=VMZ?TU8%!K.TW-7,X=, =:#$MSD_4/
M4_P#4$L#!!0    ( -V+3T_P(@QDR@$  &T$   9    >&PO=V]R:W-H965T
M<R]S:&5E=#$S+GAM;'U4VV[<(!#]%<0'!-_2K%:VI>Q&52NUTBI5VV?6'E\4
M+B[@=?KW!4P<9^/FQ3##.8<SP#B?I'K2'8!!SYP)7>#.F&%/B*XZX%3?R &$
M76FDXM384+5$#PIH[4F<D22*/A%.>X'+W.=.JLSE:%@OX*20'CFGZN\!F)P*
M'..7Q&/?=L8E2)D/M(4?8'X.)V4CLJC4/0>A>RF0@J; ]_'^F#F\!_SJ8=*K
M.7*5G*5\<L'7NL"1,P0,*N,4J!TN< 3&G)"U\2=HXF5+1US/7]0_^]IM+6>J
MX2C9[[XV78%W&-70T)&91SE]@5#/+4:A^&]P 6;ASHG=HY),^R^J1FTD#RK6
M"J?/\]@+/T[S2I8&VC8A"81D(>RB#PEI(*17!#([\Z4^4$/+7,D)J?FR!NK>
M1+Q/[6%6+NG/SJ_9:K7-7LIX%^7DXH0"YC!CDC7F+>+X'G'W*D*L@<5%LN7B
MD+SC)U<[;"#B[1W2S3I3ST_?U/D?@6Q3(/,"V8<'M86Y+F0+DUX9(:O;XZ!:
M_] UJN0H?).MLDLOW2?^]E_A<R-^IZKMA49G:>P;\C?=2&G 6HEN[.ON;.\O
M 8/&N.F=G:NY ^; R"$T-UG^,.4_4$L#!!0    ( -V+3T^%Y3\DM $  -(#
M   9    >&PO=V]R:W-H965T<R]S:&5E=#$T+GAM;'U3VV[<(!#]%<0'A%W6
M25<KVU(V4=5(K;1*U>:9M<<V"A<'\#K]^P(FCI-:?0%FF'/FS##DHS;/M@-P
MZ%4*90O<.=<?"+%5!Y+9*]V#\C>--I(Y;YJ6V-X JR-("D(WFQLB&5>XS*/O
M9,I<#TYP!2>#[" E,W^.(/18X"U^<SSRMG/!0<J\9RW\!/>K/QEOD9FEYA*4
MY5HA TV!;[>'8Q;B8\!O#J-=G%&HY*SU<S >Z@)O@B 04+G P/QV@3L0(A!Y
M&2^)$\\I W!Y?F/_&FOWM9R9A3LMGGCMN@+O,:JA88-PCWK\!JF>:XQ2\=_A
M L*'!R4^1Z6%C2NJ!NNT3"Q>BF2OT\Y5W,=TLT^P=0!- #H#]C$/F1)%Y??,
ML3(W>D1FZGW/PA-O#]3WI@K.V(IXY\5;[[V4VWV6DTL@2C''*88N8^8(XMGG
M%'0MQ9'^ Z?K\-VJPEV$[SXHO%XGR%8)LDB0_;?$M9B;3TG(HJ<23!NGR:)*
M#RI.\L([#^PMC6_R'CY-^P]F6JXL.FOG7S;VO]':@9>RN?(CU/D/-AL"&A>.
M7_S93&,V&4[WZ0>1^1N7?P%02P,$%     @ W8M/3[^ZR:VW 0  U ,  !D
M  !X;"]W;W)K<VAE971S+W-H965T,34N>&UL?5/M;IPP$'P5RP\0@[GVKB=
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M^[V9!FT*G.[G-T26AUS^!E!+ P04    " #=BT]/U9#!%;4!  #4 P  &0
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M+QYA A=/4ERKZ82"L-0OQ2F(TCR@$^@)9$I1^#( 0P,I1F#1/Q$**/PD@Z!
MEA%<^H0!"C_/$(@%$HW@#D% :;-)IT2@0*X1W #(M+I9[LN #L!80 :W  +J
MFV6^#@*%L@UW 0)*G$W2#8%F 1W<" BH<C;W=1!H$=#!O8!,"YW,)VD-ND$6
M^F3B;D!!H6?^IQN")M]6! HD"\4M@X)VD/G) D&!9*&X9U#0#K+"#QJ!_!N
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M;&U3ZXZ<(!1^%<(#+,HXETS49&>;IDW:9+)-V]^,'I4L%PLX;M^^@*ZU6_\
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MMO$%&JT=^%22!S]$G?]BBR&@<>%X]&<S#=ID.-W/?X@L'[G\ U!+ P04
M" #=BT]/ J:[2N !  #2!   &0   'AL+W=O<FMS:&5E=',O<VAE970R-BYX
M;6Q]5-MNG# 0_17D#XBY+&&S J3L5E$KM=(J5=-G+PP7Q<;$-DOZ][4-H82U
M^H(]XW/.G#&VTY&+5]D *.^=T4YFJ%&J/V LBP88D7>\ATZO5%PPHG0H:BQ[
M :2T)$9QZ/OWF)&V0WEJ<V>1IWQ0M.W@+#PY,$;$GR-0/F8H0!^)Y[9NE$G@
M/.U)#3]!_>K/0D=X42E;!IUL>><)J#+T&!Q.L<%;P$L+HUS-/=/)A?-7$WPK
M,^0;0T"A4$:!Z.$*)Z#4"&D;;[,F6DH:XGK^H?YD>]>]7(B$$Z>_VU(U&=HC
MKX2*#%0]\_$KS/W$R)N;_PY7H!ING.@:!:?2?KUBD(JS645;8>1]&MO.CN.T
MLGN8:6Y".!/"A;#W_TN(9D*T(>#)F6WU"U$D3P4?/3']K)Z8,Q$<(KV9A4G:
MO;-KNENIL]<\C),47XW0C#E.F'"%"3XC3K>(Q%\@6!M87(0N%\?PAA]N*C@0
M@;M"Y.PSLOQHW4.2N 5V3H&=%=A]VJC]QJ0+\^ N$CN+Q+<"]_[F;[@PV__A
MPH0;(WAU1!B(VMXFZ15\Z.Q-7F67"_L8VB/V#S[=]A]$U&TGO0M7^J#:XU1Q
MKD!;\>^TET8_,$M H5)FFNBYF*[9%"C>SR\(7IZQ_"]02P,$%     @ W8M/
M3]\W36?C 0  ]@0  !D   !X;"]W;W)K<VAE971S+W-H965T,C<N>&UL?53;
M;MP@$/T5BP\(ONYN5K:E[$95*[72*E7;9]8>7Q0P+N!U^O<%[+B.0_-BF.&<
MPQD\D(Y</,L&0'DOC'8R0XU2_1%C633 B+SC/71ZI>*"$:5#46/9"R"E)3&*
M0]_?84;:#N6IS5U$GO)!T;:#B_#DP!@1?TY ^9BA +TFGMJZ42:!\[0G-7P'
M]:._"!WA1:5L&72RY9TGH,K00W \)P9O 3];&.5J[IE*KIP_F^!+F2'?& (*
MA3(*1 \W. .E1DC;^#UKHF5+0US/7]4_V=IU+5<BX<SIK[94388.R"NA(@-5
M3WS\#',]"?+FXK_"#:B&&R=ZCX)3:;]>,4C%V:RBK3#R,HUM9\=Q6HGO9YJ;
M$,Z$<"$<_ \)T4R(-@0\.;.E/A)%\E3PT1/3S^J)Z8G@&.G#+$S2GIU=T]5*
MG;WEX2Y*\<T(S9C3A E7F. MXOP>L?<7"-8&%A>AR\4I?,</-SLX$(%[A\A9
M9V3YT;J&PW\$8J= ; 7B-P<5;P[*A4DVA;@P.[>1Q&DD<0CL-T9<F,/&B MS
MOS&"5VW$0-3VQDFOX$-G;_LJNUSJA]"VX3_X]")\(Z)N.^E=N=+-;%NNXER!
MMN+?:2^-?H26@$*ES'2OYV*ZBE.@>#^_,GAYZO*_4$L#!!0    ( -V+3T]V
M-4ZDQ0$  #<$   9    >&PO=V]R:W-H965T<R]S:&5E=#(X+GAM;'54T8Z<
M(!3]%<('+,J,NY.)FNQLT[1)FTRV:?O,Z%7)@EC <?OW!71=.Z4O I=SSSD7
MN.:3TB^F [#H58K>%+BS=C@28JH.)#-W:H#>[31*2V;=4K?$#!I8'9*D(#1)
M[HEDO,=E'F)G7>9JM(+W<-;(C%(R_?L$0DT%3O%;X)FWG?4!4N8#:^$;V._#
M6;L565EJ+J$W7/5(0U/@Q_1XRCP^ 'YPF,QFCGPE%Z5>_.)S7>#$&P(!E?4,
MS U7> (A/)&S\6OAQ*ND3]S.W]@_AMI=+1=FX$F)G[RV78$/&-70L%'89S5]
M@J6>#*.E^"]P!>'@WHG3J)0PX8NJT5@E%Q9G1;+7>>1]&*=YY_ZPI,43Z))
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MZ+6D^T-.KD%HQIPF#%UA]LD"(5Y^R4&W<ISH?WR:;O-WFS7N(G^WXJ>/V;9
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MUMG-RK:4W:IJI59:I6K[S-KCBP+&!;Q._[Z '==Q:%\,,YQS.#,&TE'(9]4
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MTW:B)CO3-&W2)I-MNOW-Z/4C"V(!Q^W;%]"QKJ6;_2/<R[GGGH- .@KYI!H
MC9XYZU2&&ZW[ R&J:(!3=2=ZZ,Q*)22GVH2R)JJ70$M7Q!D)@V!/.&T[G*<N
M=Y9Y*@;-V@[.$JF!<RI_'X&),<,[?$L\M'6C;8+D:4]K^ [Z1W^6)B(+2]ER
MZ%0K.B2ARO#][G!*+-X!'EL8U6J.K).+$$\V^%)F.+""@$&A+0,UPQ5.P)@E
M,C)^S9QX:6D+U_,;^R?GW7BY4 4GP7ZVI6XR_!ZC$BHZ,/T@QL\P^TDPFLU_
MA2LP [=*3(]",.6^J!B4%GQF,5(X?9[&MG/C.//?ROP%X5P0OK4@F@NBI6 7
M._.3,F?U(]4T3Z48D9Q^5D_MF=@=(K.9A4VZO7-KQJTRV6L>?@A3<K5$,^8X
M8<(59K<@B&%?6H2^%L?PG_)-@Y,'\9\.D==$Y.JCM<!]X">(O02Q(XA?[$*T
MV04?)MX8>1WS0DCB%9)X")*-$!]FOVE"5O^?@ZS=55&H$$/GKNDJN]S&^]"=
MG[_PZ2I_H[)N.X4N0IM3Z,Y*)80&(R6X,UH:\WHL 8-*V^D[,Y?3'9H"+?KY
M>2#+&Y7_ 5!+ P04    " #=BT]/FT(+.J@!  #0 P  &0   'AL+W=O<FMS
M:&5E=',O<VAE970S-"YX;6Q]4^UNVR 4?17$ Q1_9&T7V9;63-4F;5+4:=UO
M8E_'J&!<(''[]KM@8KF1U3^&>SGG< Z&8M3FQ78 CKPIV=N2=LX-6\9LW8'B
M]D8/T.-*JXWB#DMS9'8PP)M 4I)E27++%!<]K8K0VYNJT"<G10][0^Q)*6[>
M'T#JL:0IO32>Q+%SOL&J8N!'^ /N[[ W6+%9I1$*>BMT3PRT)?V6;G>YQP?
MLX#1+N;$)SEH_>*+GTU)$V\()-3.*W <SK #*;T0VGB-FG3>TA.7\XOZ8\B.
M60[<PD[+?Z)Q74GO*6F@Y2?IGO3X V*>+Y3$\+_@#!+AW@GN46MIPY?4)^NT
MBBIH1?&W:11]&,>H?Z&M$[)(R&9"NOF4D$="?D5@D[,0]3MWO"J,'HF9?M;
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MD<FMKF]C<U^V!X5VH=6A.P,%EX/8^#]02P,$%     @ W8M/3V.0M .I!
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M%X-[SH;H9(1$ R')'*[#, )A(G*=D0D%HL%<PTB$ 1)!QVED0 [#!9]A!,(
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MK6&$T$4\G7'M(AZI&+9 OC6,"+J(&Y!K%]Y8-.BM8\3+15Q8#!&DN88857)
ME30C-XZ1&X>VI<382PC1A]U;(-\:1I <R.]H!%\BB$;P50PTC('N6R#?+T8!
M'5! .A<N*X@\*1$X%D,-HZC[-LKWC7O^&#V '$10F%!JZ>B+%U=QV'TKYAO.
MZ+(#DDLW$Y<5U#8H,=1]&^4_&LV(?(:R71I*$**='0/=MT"^R<Q*D,7<HF3@
MVD-X"W9E=1QWW\[YMC/K1A:1/ \1Q!V+9,RJD84+@DJ8\^^,61 RL"!0,;\
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M1\3; R?8R!$VZFJVXLBS-HH--7M"<%YHP+XC,$P<7[[&C4NDO@X0'="5;86
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MO*L6&C'%@ EGF,2?()Z2GW*$:SF*T.*'P?L4NQ5(^!ZRMR$H2=9M1*NE1D8
MS02B&"]*'3"QP;0&$\0!CM*%71N6)MB_T12TZ@99;E"R2%,@VXWOS](,9FQ4
MF ;XAAF\:@:OF/FT,&-CPF3A!-M.L'^K+?&JD]AVDBX*+F(K#8JPW1=;*KQQ
M7I)5*XEM)4#K NFJ0/H?!RZU:_$Q]A>=W?\3-MCQ9I]] _QL1JIP2G9II?YV
M9M%I:M^'>FPLXD6PV0W#]TUFN J^$WZN6^$<F%1#R8R.$V,2E$O_3AV 2MT^
MTX;"2>IEHM9\F,'#1K)NO%Z\Z8[+_P)02P,$%     @ W8M/3QT<+>MY P
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MA3@*1U&X9>^',[$(U(% 8O'!8Q56+"R*".7PX2*ZT(]('("@$5W 0\X#'#Q
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M)IDC! N<8($2+!XX;PRSQ),LT23+>P*8N+G@X_;P']")@0 F\DS8$!"*"0<
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M"=5-9)_UE4 _$+0=JAQG++6R?U!+ P04    " #=BT]/ORBTR:$$  !.&
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M;S@'=Y(8<&0G&0D7+O8V%T@GF_1Z@$:YI!<ULY#Z%P#1;A(#D&PG8_$3QBR
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MK-V[[;XD81\&!X1]0#@$$/S? -('D"$ 1\Y\EYFS^HEJFJVE:#W95:NA]J?
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MT^I=0SX+H;GQ0T^&6)HS>IK4_*SM,#%C.1Q4PT2+;CR$@^F?0/$74$L#!!0
M   ( -V+3T\)__OLW $  *,$   9    >&PO=V]R:W-H965T<R]S:&5E=#4V
M+GAM;&U4VXZ;,!#]%8L/6'-/% '29JNJE5HIVJKMLP/#16MC:INP_?OZ0BA-
MG0?L&9\Y9\:9<;%P\29[ (7>&1UE&?1*32>,9=T#(_*)3S#JDY8+1I0V18?E
M)( T-HA1'(=ACAD9QJ JK.\BJH+/B@XC7 22,V-$_#X#Y4L91,'=\3ITO3(.
M7!43Z> ;J._316@+;RS-P&"4 Q^1@+8,GJ/3.3=X"_@QP")W>V0JN7+^9HS/
M31F$)B&@4"O#0/1R@Q>@U!#I-'ZMG,$F:0+W^SO[1UN[KN5*)+QP^G-H5%\&
MQP UT)*9JE>^?(*UGBQ :_%?X 94PTTF6J/F5-HOJF>I.%M9="J,O+MU&.VZ
MN)/T'N8/B-> > LXV@#LA&SF'X@B52'X@H2[^XF8OS@ZQ?IN:N.T5V'/=/)2
M>V]5GD0%OAFB%7-VF'B'.80;!&OZ32/V:9SC_^+3Y. G2+Q))I8@V1%$QZ.?
M(/42I)8@_:?*^*%*'R;QBV1>D<Q#D#Z(^#"97R3WBN0>@OQ!Q&$RBQG=?:>A
M^3T(X5V3,!"='0^):CZ/=C1WWFT"GV/;9'_A;GR_$M$-HT17KG2KVH9J.5>@
MTPF?=":]?C$V@T*KS/:@]\+-C3,4G]8G 6_O4O4'4$L#!!0    ( -V+3T_8
M5Y 9W@$  .\$   9    >&PO=V]R:W-H965T<R]S:&5E=#4W+GAM;'U476^;
M,!3]*XCWU6 @H1$@+4S3)FU2U*G;LP.7@&HPLYW0_?OY@R)*K;Q@W^MSCL\!
MXVQB_$6T -)[[>D@<K^5<CP@)*H6>B(>V B#6FD8[XE4);\@,7(@M2'U%.$@
MV*&>=(-?9*9WXD7&KI)V YRX)ZY]3_B_(U VY7[HOS6>NDLK=0,5V4@N\ OD
M\WCBJD*+2MWU,(B.#1Z')O<_AX<RT7@#^-W!)%9S3R<Y,_:BB^]U[@?:$%"H
MI%8@:KA!"91J(67C[ZSI+UMJXGK^IO[59%=9SD1 R>B?KI9M[J>^5T-#KE0^
ML>D;S'D2WYO#_X ;4 773M0>%:/"/+WJ*B3K9Q5EI2>O=NP&,TYV91_/-#<!
MSP2\$,+[A&@F1!L"LLY,U"]$DB+C;/*X_5@CT6<B/$3J95:Z:=Z=65-IA>K>
MBEVTS]!-"\V8H\7@%0:'[R&E X(7"%(.%AO8:0,;?K3BAVGJ%HB< I$1B-_E
M2#<Y+"8QF,%@'C%.DV"3Q0%36E'DMA,[[<0..X\;.Q:S6^WSR>G'A;MC*'$:
M2CX:BC<;'3]B\.8HE'<AU@9:'3U]%?PD_-(-PCLSJ4ZQ.6L-8Q*47/"@]%IU
M^RP%A4;JZ5[-N?T';2'9.%\O:+GCBO]02P,$%     @ W8M/3^Q7$E>9 @
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M&U0C2]T/]AF!/J.OJ[$<8@BBL,D8-!D/34C6,P$PG:_YS.06-+D="+".R9D
M2N&%G0(2I+>B JA;=7Q>]695 3C$Z,7901?V&C0LRZ5= H';Q +A:[+"PV@I
ME!6 PY]D!2]U!*SU$>IOC\/%SC#M1[0"8/U@DL[.7@JU\^>RCM;R4!FW8W5&
MV[-_@=W)T!M?HLE]<X)_R#07BI]<[?)*1R_2V'/'GPY;*8VP$:8W-K:]O<.T
MG4)LC6N.;%LU!WG3,;(.EY2DO2G-_P-02P,$%     @ W8M/3V(=0%^Z 0
MU ,  !D   !X;"]W;W)K<VAE971S+W-H965T-3DN>&UL;5/;;MP@$/T5Q <$
MF_7NIBO;4C95U4JMM$K5])FUQS8*%Q?P.OW[ G9<-_4+,,,Y9RX,^:C-B^T
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M5T\+C--9=%*&#*8<,/$(DV;9%//@8N(I8NE!P"GDT0.QK*Q<2(+_F8EDK)>
M8V_ L3:0C@-&V K&Q<2%E93E^YB)(XG7D<3CB)75Y8#!&M-J#,00);F5-Q>6
M9P@ OS>IUYO4\29-+6]6 R8?R8 [<"7YR*N"')4$6;D?(&@DDL6HR!(K,[?!
M'EW!./,[C+T.8S<M\,HN9UX#V<?E5KJ8JZ64>T5RCXA5(V7N)"P!ZN?7*;PZ
MA4>GL'2*_]*!P-^5P,>'HS2@<=FG "%@'Z*/<5.7KC1*Z+J$@>V2"T*C%C;5
M\?<GZ#86YR26!G3;483^_@,]#0A#6\@%I<FUO?1W%NBV%OO0EP;SSG&>*OF[
M"W1/.\:Q+86<:L@R$!?7DN?O"]!M#!@[46$G*NB3BD8?:W6A^T;XOFK[8,V$
M_.[KK_..,4&E37 GK1WD'?(RJ>E.J&$FQWRX2 T3P3IS28PN-]7%7U!+ P04
M    " #=BT]/KJ$&/E@"  #A!P  &0   'AL+W=O<FMS:&5E=',O<VAE970V
M-"YX;6R-56NOFR 8_BO&[SN(XJVQ)FM/ERW9DN8LVS[3EE9S5!S0>O;O!VB=
M%7K6+PKX7-Y';EE'V2LO"!'.6UTU?.D60K0+ /B^(#7F3[0EC?QRI*S&0G;9
M"?"6$7S0I+H"ON=%H,9EX^:9'MNR/*-G494-V3*'G^L:LS\K4M%NZ4+W.O!2
MG@JA!D">M?A$OA/QH]TRV0.CRJ&L2<-+VCB,')?N1[C80$W0B)\EZ?BD[:@H
M.TI?5>?+8>EZJB)2D;U0$EB^+F1-JDHIR3I^#Z+NZ*F(T_95_9,.+\/L,"=K
M6OTJ#Z)8NHGK',@1GROQ0KO/9 @4NLZ0_BNYD$K"52728T\KKI_._LP%K0<5
M64J-W_IWV>AW-^A?:7:"/Q#\D0#1NX1@( 2/$M! 0(\2PH$0S@B@SZY_YC,6
M.,\8[1S6KX<6JV4'%Z&<KKT:U+.CO\G_R>7H)8^B* ,7)31@5CW&GV!0'-]B
MUB;&OT4\6Q#P%K*Q0/ZI )EC#.-;P_B:CR;\()S5V4-"#6DT)/;#- YFQ3X&
MVYB&?FPO.+ 6'!A\!)%= %D%D"$01;.I62$S2^SY*;3[A%:?T R*9C8]))K8
M?$!I["=VF\AJ$QDV,/!F/I'I R%*TM1N%%N-8C//?-7'ID\<P3"RVR16F\0R
M/<G,)S%] L_S[#:IU28UU_W<)35<8)H&\,[V@I[]L/ L>=+Y:>&95F%PQ^?.
MH03_NY%7 ^:=+=H[@<E)J"Z_;YB=RH8[.RKDH:J/OB.E@DA-[TFJ%?*^'3L5
M.0K5C&6;]9=.WQ&T'2Y4,-[J^5]02P,$%     @ W8M/3T 0OGK) P  -A$
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M#RG9LNHVX/=%?8ZL'Q@]-&=DJSVHC_\#4$L#!!0    ( -V+3T^K#,3'G ,
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M7<,YESEB@\"N^NJ;]:I<+_,%+?QUNDQ7\RRZ0G0OHT[T^>IM=/+B9>T\LCG
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MN1BYJ6QE85,&X7JS/UU4;#7[D%-V35>*<I]:OK%WGX1V^;O1\.0,;\&**(A
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M(\M0?(G1(),6]O(.VBZOKB2TXM$C>S_<NLF,Y0%+ /QG45_*->BZ(@B5EAV
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M'3P7<P!1ID/!B:3;&Z&<V*_A31]D23S%7G<\!*R!UYJPYL1*#@E*&--N?]2
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M@[Z9K;<+XNW)R"SKJ';\4P2<1IG&B@<JN^NC(>1$Q<5K1,@ME:R/F.*)"&L
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MK.:(LD['LK?M\%V2!^<V[_/9]!?!J_]02P$"% ,4    " #=BT]/'R// \
M   3 @  "P              @ $     7W)E;',O+G)E;'-02P$"% ,4
M" #=BT]/)^B'#H(   "Q    $               @ 'I    9&]C4')O<',O
M87!P+GAM;%!+ 0(4 Q0    ( -V+3T^X]E^Y[P   "L"   1
M  "  9D!  !D;V-0<F]P<R]C;W)E+GAM;%!+ 0(4 Q0    ( -V+3T^97)PC
M$ 8  )PG   3              "  ;<"  !X;"]T:&5M92]T:&5M93$N>&UL
M4$L! A0#%     @ W8M/3]:<]DH> @  Z 8  !@              ( !^ @
M 'AL+W=O<FMS:&5E=',O<VAE970Q+GAM;%!+ 0(4 Q0    ( -V+3T^=*VUA
MYP0  #X8   8              "  4P+  !X;"]W;W)K<VAE971S+W-H965T
M,BYX;6Q02P$"% ,4    " #=BT]/I%=!4W4"  #+"0  &
M@ %I$   >&PO=V]R:W-H965T<R]S:&5E=#,N>&UL4$L! A0#%     @ W8M/
M3^2X+IV-!   OQ0  !@              ( !%!,  'AL+W=O<FMS:&5E=',O
M<VAE970T+GAM;%!+ 0(4 Q0    ( -V+3T\U87JX\ <  ,4T   8
M      "  =<7  !X;"]W;W)K<VAE971S+W-H965T-2YX;6Q02P$"% ,4
M" #=BT]/VB:],QL&   T(   &               @ ']'P  >&PO=V]R:W-H
M965T<R]S:&5E=#8N>&UL4$L! A0#%     @ W8M/3ZEW21C* 0  ;00  !@
M             ( !3B8  'AL+W=O<FMS:&5E=',O<VAE970W+GAM;%!+ 0(4
M Q0    ( -V+3T\4^][LM@$  -0#   8              "  4XH  !X;"]W
M;W)K<VAE971S+W-H965T."YX;6Q02P$"% ,4    " #=BT]/%]9[G,T!  !M
M!   &               @ $Z*@  >&PO=V]R:W-H965T<R]S:&5E=#DN>&UL
M4$L! A0#%     @ W8M/3T7@51G+ 0  ;00  !D              ( !/2P
M 'AL+W=O<FMS:&5E=',O<VAE970Q,"YX;6Q02P$"% ,4    " #=BT]/PA-Z
MH<\!  !K!   &0              @ $_+@  >&PO=V]R:W-H965T<R]S:&5E
M=#$Q+GAM;%!+ 0(4 Q0    ( -V+3T^>NI7PS0$  &T$   9
M  "  44P  !X;"]W;W)K<VAE971S+W-H965T,3(N>&UL4$L! A0#%     @
MW8M/3_ B#&3* 0  ;00  !D              ( !23(  'AL+W=O<FMS:&5E
M=',O<VAE970Q,RYX;6Q02P$"% ,4    " #=BT]/A>4_)+0!  #2 P  &0
M            @ %*-   >&PO=V]R:W-H965T<R]S:&5E=#$T+GAM;%!+ 0(4
M Q0    ( -V+3T^_NLFMMP$  -0#   9              "  34V  !X;"]W
M;W)K<VAE971S+W-H965T,34N>&UL4$L! A0#%     @ W8M/3]60P16U 0
MU ,  !D              ( !(S@  'AL+W=O<FMS:&5E=',O<VAE970Q-BYX
M;6Q02P$"% ,4    " #=BT]/2#*)6K<!  #4 P  &0              @ $/
M.@  >&PO=V]R:W-H965T<R]S:&5E=#$W+GAM;%!+ 0(4 Q0    ( -V+3T_H
M6T*)S0$  &T$   9              "  ?T[  !X;"]W;W)K<VAE971S+W-H
M965T,3@N>&UL4$L! A0#%     @ W8M/3U;J.BG+ 0  ;00  !D
M     ( ! 3X  'AL+W=O<FMS:&5E=',O<VAE970Q.2YX;6Q02P$"% ,4
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M+GAM;%!+ 0(4 Q0    ( -V+3T^N*%QWT $  &T$   9              "
M ?](  !X;"]W;W)K<VAE971S+W-H965T,C0N>&UL4$L! A0#%     @ W8M/
M3XK;;<BY 0  U ,  !D              ( !!DL  'AL+W=O<FMS:&5E=',O
M<VAE970R-2YX;6Q02P$"% ,4    " #=BT]/ J:[2N !  #2!   &0
M        @ 'V3   >&PO=V]R:W-H965T<R]S:&5E=#(V+GAM;%!+ 0(4 Q0
M   ( -V+3T_?-TUGXP$  /8$   9              "  0U/  !X;"]W;W)K
M<VAE971S+W-H965T,C<N>&UL4$L! A0#%     @ W8M/3W8U3J3% 0  -P0
M !D              ( !)U$  'AL+W=O<FMS:&5E=',O<VAE970R."YX;6Q0
M2P$"% ,4    " #=BT]/T$.M1;H!  #4 P  &0              @ $C4P
M>&PO=V]R:W-H965T<R]S:&5E=#(Y+GAM;%!+ 0(4 Q0    ( -V+3T^=:?R,
MM@$  -0#   9              "  115  !X;"]W;W)K<VAE971S+W-H965T
M,S N>&UL4$L! A0#%     @ W8M/3_49CS[0 0  ;00  !D
M ( ! 5<  'AL+W=O<FMS:&5E=',O<VAE970S,2YX;6Q02P$"% ,4    " #=
MBT]/J?J1#N0!  #V!   &0              @ $(60  >&PO=V]R:W-H965T
M<R]S:&5E=#,R+GAM;%!+ 0(4 Q0    ( -V+3T]T%02UUP$  *\$   9
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M970S-RYX;6Q02P$"% ,4    " #=BT]/8Y"T ZD$   \&0  &0
M    @ &!:   >&PO=V]R:W-H965T<R]S:&5E=#,X+GAM;%!+ 0(4 Q0    (
M -V+3T]SFF5_* H  .="   9              "  6%M  !X;"]W;W)K<VAE
M971S+W-H965T,SDN>&UL4$L! A0#%     @ W8M/3U)*/7O" @  # L  !D
M             ( !P'<  'AL+W=O<FMS:&5E=',O<VAE970T,"YX;6Q02P$"
M% ,4    " #=BT]//#+@9B\$  "/%   &0              @ &Y>@  >&PO
M=V]R:W-H965T<R]S:&5E=#0Q+GAM;%!+ 0(4 Q0    ( -V+3T^5-LBMWP$
M /4$   9              "  1]_  !X;"]W;W)K<VAE971S+W-H965T-#(N
M>&UL4$L! A0#%     @ W8M/3R&W":@X!   M!0  !D              ( !
M-8$  'AL+W=O<FMS:&5E=',O<VAE970T,RYX;6Q02P$"% ,4    " #=BT]/
MLN*>2!<#  #9#   &0              @ &DA0  >&PO=V]R:W-H965T<R]S
M:&5E=#0T+GAM;%!+ 0(4 Q0    ( -V+3T^DL\?4P $  -8#   9
M      "  ?*(  !X;"]W;W)K<VAE971S+W-H965T-#4N>&UL4$L! A0#%
M  @ W8M/3TIN <=+ @  [P8  !D              ( !Z8H  'AL+W=O<FMS
M:&5E=',O<VAE970T-BYX;6Q02P$"% ,4    " #=BT]/'1PMZWD#  !M#P
M&0              @ %KC0  >&PO=V]R:W-H965T<R]S:&5E=#0W+GAM;%!+
M 0(4 Q0    ( -V+3T]"QA;ZB (  /L)   9              "  1N1  !X
M;"]W;W)K<VAE971S+W-H965T-#@N>&UL4$L! A0#%     @ W8M/3UOR5]/-
M @  @ H  !D              ( !VI,  'AL+W=O<FMS:&5E=',O<VAE970T
M.2YX;6Q02P$"% ,4    " #=BT]/O/*DFG,$  "<%@  &0
M@ '>E@  >&PO=V]R:W-H965T<R]S:&5E=#4P+GAM;%!+ 0(4 Q0    ( -V+
M3T\,KK';B (  '8)   9              "  8B;  !X;"]W;W)K<VAE971S
M+W-H965T-3$N>&UL4$L! A0#%     @ W8M/3[\HM,FA!   3A@  !D
M         ( !1YX  'AL+W=O<FMS:&5E=',O<VAE970U,BYX;6Q02P$"% ,4
M    " #=BT]/%RI5 @8"  !D!0  &0              @ $?HP  >&PO=V]R
M:W-H965T<R]S:&5E=#4S+GAM;%!+ 0(4 Q0    ( -V+3T\_*52]30(  ,@'
M   9              "  5RE  !X;"]W;W)K<VAE971S+W-H965T-30N>&UL
M4$L! A0#%     @ W8M/3X;UL2ME @  %0@  !D              ( !X*<
M 'AL+W=O<FMS:&5E=',O<VAE970U-2YX;6Q02P$"% ,4    " #=BT]/"?_[
M[-P!  "C!   &0              @ %\J@  >&PO=V]R:W-H965T<R]S:&5E
M=#4V+GAM;%!+ 0(4 Q0    ( -V+3T_85Y 9W@$  .\$   9
M  "  8^L  !X;"]W;W)K<VAE971S+W-H965T-3<N>&UL4$L! A0#%     @
MW8M/3^Q7$E>9 @  -0D  !D              ( !I*X  'AL+W=O<FMS:&5E
M=',O<VAE970U."YX;6Q02P$"% ,4    " #=BT]/8AU 7[H!  #4 P  &0
M            @ %TL0  >&PO=V]R:W-H965T<R]S:&5E=#4Y+GAM;%!+ 0(4
M Q0    ( -V+3T\[PX8"]@$  &(%   9              "  66S  !X;"]W
M;W)K<VAE971S+W-H965T-C N>&UL4$L! A0#%     @ W8M/3SQ.G178 P
ML1   !D              ( !DK4  'AL+W=O<FMS:&5E=',O<VAE970V,2YX
M;6Q02P$"% ,4    " #=BT]/$AXB L,"  "U"@  &0              @ &A
MN0  >&PO=V]R:W-H965T<R]S:&5E=#8R+GAM;%!+ 0(4 Q0    ( -V+3T\7
MJR&[PP(  +4*   9              "  9N\  !X;"]W;W)K<VAE971S+W-H
M965T-C,N>&UL4$L! A0#%     @ W8M/3ZZA!CY8 @  X0<  !D
M     ( !E;\  'AL+W=O<FMS:&5E=',O<VAE970V-"YX;6Q02P$"% ,4
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M+GAM;%!+ 0(4 Q0    ( -V+3T_!I3H>B7@  *KS 0 4              "
M 0#2  !X;"]S:&%R9613=')I;F=S+GAM;%!+ 0(4 Q0    ( -V+3T\JLH1P
M/P(  (0*   -              "  ;M* 0!X;"]S='EL97,N>&UL4$L! A0#
M%     @ W8M/3Q+\X<(1!0  [2P   \              ( !)4T! 'AL+W=O
M<FMB;V]K+GAM;%!+ 0(4 Q0    ( -V+3T_R&/*P0 (  /$H   :
M      "  6-2 0!X;"]?<F5L<R]W;W)K8F]O:RYX;6PN<F5L<U!+ 0(4 Q0
M   ( -V+3T\"4&KX_@$  "HH   3              "  =M4 0!;0V]N=&5N
B=%]4>7!E<UTN>&UL4$L%!@    !- $T #14   I7 0    $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>53
<FILENAME>R55.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3</span><table class="report" border="0" cellspacing="2" id="idp6777501872">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Leases - Schedule of Future Minimum Payments for Operating Lease Liabilities (Details) - USD ($)<br></strong></div></th>
<th class="th"><div>Jun. 30, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths', window );">2019</a></td>
<td class="nump">$ 158,366<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo', window );">2020</a></td>
<td class="nump">163,102<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree', window );">2021</a></td>
<td class="nump">167,984<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour', window );">2022</a></td>
<td class="nump">173,038<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive', window );">2023</a></td>
<td class="nump">178,237<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive', window );">Thereafter</a></td>
<td class="nump">305,012<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue', window );">Total minimum lease payments</a></td>
<td class="nump">1,145,739<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount', window );">Less: effect of discounting</a></td>
<td class="num">(334,574)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiability', window );">Present value of future minimum lease payments</a></td>
<td class="nump">811,165<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Less: current obligations under leases</a></td>
<td class="nump">80,832<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Long-term lease obligations</a></td>
<td class="nump">$ 730,333<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payments for operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=77888426&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payments for operating lease, due after fifth fiscal year following latest fiscal year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=77888426&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payments for operating lease, due in next fiscal year following latest fiscal year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=77888426&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payments for operating lease, due in fifth fiscal year following latest fiscal year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=77888426&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payments for operating lease, due in fourth fiscal year following latest fiscal year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=77888426&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payments for operating lease, due in third fiscal year following latest fiscal year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=77888426&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payments for operating lease, due in second fiscal year following latest fiscal year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=77888426&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=77888426&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=77888419&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=77888419&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=77888419&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>54
<FILENAME>0001493152-19-015539-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001493152-19-015539-xbrl.zip
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M%0QECE$2 SME<&)^@.&!7CQTX1]N80 L!YH7P',LYZGG>>B*0"AF_L0\ D,
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M[IADDS;)/[]!'^<P(IL0Z\'NC?*O&E@N(*]MUDO/RTCMYW?+L>9I^O/GF\E
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M1#@_G",!6/^):0((<_,8A"%N>#<)P9I;]9/C-Q JO<3%_14"#SDV0D(!^H<
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M2LY$B.3)=ER8N=X"\T^JX+EW^@_<$@+/7_& & OQ)E1" GX?MPN0R7G6GXD
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M=9G-Q)-FW]U!2(R!DTF[DQ]XS@.6CYXUP,+"0?3J$>6'>+Z(:">NXCD[S3>
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M"H'(\??D,T_5ED=;Q^7_M#]E^K:GMR;QT9)(N,.P_1@VT&%I?XZU8[P.P]>
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MP(-3SC5L3A=Z #3V<,@P"PVFA>#@SP=/#GR]>\[I=&H!!D)%$8BY"D9RD$O
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M4W8RQXJ>W9Y+NJ:?J$H6PA1HZ>\YFM(7FH& ^Y</ B[]&YY$H>E8\7 9*6
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MLR'>O#&U@[A]F#U"VN%E0K$R@U_B8>-#+>GLF-H7R/!^38)$)OGG0 H/4V4
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M*O>[^ZQF6+$+HL3PG ,-OL:-G<5IGCOA3LF=TJ)\33*=3'?8_Y$:W)=K-T]
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M_QYY'P:>_[<W0,CN&^LO*UBI3-EW-N Z8YEI#H$O>G"?F2"K_6%7@]]=.WS
MHOG%'!6-C/*UR-K+PX\=/!?=0;.6U5(667WI/5S*9*854>;\ZV.KP-6M?V_[
M[DV?NE#AE%LLT:=BF +%YB3E\\'APO!TWPV!8078O7_TG,>Z;HOJ:ZHI%E8
MRC(@4T[[;H'<2=LORX-<J[86 /D6!UVX3H02X2J*1MB_X::?6WU57/<W*S";
M@#5]N90HDP^O:"S@91#>N0/WQ?9O^@;[+>_3+3IG9C9S+;@R*"=E3P&4#11
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M]56&\;_:BD6B+CZ<#I?"1X,&([,O*3-C\,*$0<K18E,KY;G7_G!Z/D=TAOF
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M/C!K\F5>DV%52]9MJSZ+5OU:"_VKO%;WZ[I4[#E;+(@O@VCP92&\%M$ IFE
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M0Z45*7)W9.R[+I'GK3*[4)H/MYZL\9Z,5]3^#B/7G]^,AWJ@7U;:N-S_131
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M*&- $T3T8&Y$>%4@@;#LG*)^(F3VC,-0K9--"S?"N4+\=4:<DW1S05 3SI4
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M ]2"2 PN<YY<=#*OT C><&;E!<4'OG\NEBQ5H1A"H=L+YX/"@/*B^=90#9I
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M+J <E/2745\#?-_]?M/H/<#WPBUFUT\I*E$F'BPZ34P_C&#1T&<(=*KUMI(
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MV]EHK3>-%_Q..<3I_&L=9GM!@RR:.PLT75_VC=@(F1.?YX#NXX:14K_H56H
M]A7\BH8,/:7,Y"47RT$PRSUG_+BU85QIMJ=\ NTIU8SDI5X<]A^GU$_=!&,M
M+M;B@M3B8I.J#IA4U>R&S295Q1QQ;9.J*B+XPR55'5M.5;0GTAYVP*5M7G8Z
M&_3X4>O=U*/A)@\AS4+HVEB%5@/3"_B-X5K]B3SO\S5J6YGU5S/+83"OO$)=
MVV3_U9CS1-FB^A/W.B?3*]2U*O,*AKQ.,H?UNAO03 ^4INXR1A!>G4,@%T@=
MNTYDU]-VH6W"JIXDKY&RZ;4II:9H(+UL&YD^G%[F6PN>,1>3:FJ1]>JT4U\Z
MD(*V#:P?3D$+7I#-G5IDO3H%U9<.I*!MTP%BV&A"">6^DCL_X-]CV'Q*B7QU
MRKNMK$!K4-OC.10?)R?NS)^OHAE*;,&FPC3D;-MV<6M,-^R!((_Y9 SI]W%:
M&/-LE5&(6_&P"0I4X;9I 'I3X3*?IXP=/XA\+[UHV)M.PEW^Z$HFX1S4FI(-
MQEAL7[)<NN'+9'X<Q?Z2B>O$]<.4]/55\CS2#KXH^5D4V)=UP./ZBBZ<^)XX
MO!\G[8C_5 _KL_<I;72?BCG?1O?9Z+XQQ(_9Z#[,Z-CH/AO=]XJC^\Z)RW=N
M7,E.@X<DOF$=BA<AN ;N]4?&*;8(D29Z93.<J(Z914@J=3E(R!>A;G'"O!QU
MAB7FY6B3ZN/G!^+%9';D/_HS=M:^8E.-;*U2;\/00J8PS,18BCD:QX2:^M-^
MIPLW]A=L6=<%M;%Z#\-W&$!A;CKWT/2#YI4??3\)"3EE<UI(HKC-.(7;&#PK
M25>X2E@")V%<X!;3#3?*MYU\UW6G^R,%$V % G&_4Q"C,"X!R/[:!(]]-;WB
MEG/@_,!^+_V,]+!0)1(<'F8$"ZI^07518."]?J/0:#-IP^SB.Y<IRGVYNMP'
MW'$KB?Z<R6TI>(J'E:D4&7Q?!:@M%9 ';I2&GRW.W6>I>,M%IDVCSZQX:^2!
M$T?'020K-^A!%"7+S,M;VRVSU89]=N\:KW;Q9C1;F>X9VF"J.<I;<0,!UG'F
M,Q7:@!<15%G+'A48/4)K-A1LT0.')>3A%&JII;]L1AWDM1LS2R/P\M:0LV$$
M-HS OI[:@(9]/=6^GFI?3Q4ST_DQ#@I%Y6]69"LKIT*8V+FQ+-KW4D%J!YEP
ME$YP-WS#,YF?!C/N84G<!6Q4 XHBG>AA@@?Q&K43_A]^?']%%FEX<'3O/]S0
M8W&2^28N98T,;[03 R$ 3$T>*(Q\)K!$N>;TAS<VXZ)U0B PF%LGA'5"F'-"
M:!\NN.TLG=YNB'<?^'\EDD,U5![IC"*A&@+%[!NW=6IE1S^XAIG#MT3>,G"0
M'\B[PP?EQ-8EAIBGONP@S#9[Y)G,;FCZ>DH89;'N\G!PM=JXIT4="32$V:!&
M3S8D5>N;F4"UD-$#%?GD.@RNF"?>WK''/"FWOIJ>NT*K.=E^"VG41Q):N#.\
M%_][YAG2IY&JTQ&)O-!/6>Y!?TJM_[@*L\DD3J]F:_;2?WXG4;QZU7RO!TUI
MZ.7'U1B(V4$\)(,O5:6$W>G38@]^F!F:B\FUOX5+VO6/JV-:$AC$!-TB2*GB
MQN6W(X)(&*S45!X_Q##9"G8[''%\8 :A_5V-6#Z;&<B&]-F0/AO2UYO4;4C?
M&.2.V6AE0_KZV"O9D#[,$[T-Z;,A?3\ZEBC7G+&%] &KTO'R84%?"!P%Q4M5
M"YFX#]QVR% A$^#Z-/P"9>,F$<3XV;A)&S=IDS?@2=XP_%;U525O,.NZLE&_
M-NK71OW:J-]7&/5;ISFWGH6^YP=WYW1&%K)4>^IM3#^9,1Q*1Y<,2"%#$+2?
MS'HS;$"W#>BV =W8UDT;T#W2@&XH[QA-PHRL_*E#H?D2*,TH-K,P:@XFJL@)
M>(S>'6ETZW#QSWL?L<>A=<8EI"4CC9$W%P']X^H,R"TXPXQ3=[!<U_EQ-4G&
M-+A=1*A0Z;?101+?T]#_F\R^L?4[W A]B2KOQ:>&VC/Z1,+LD[_T8UW-ZJ;7
ML:I8E]P/XI(TJVO?'AX,Z-I&KZ],UQJYQVG=3SF\E4_CMYO3^/IJBM*EH"ZZ
M&(D6=<<J3H-8ZY5_S>01DV</^ZEJ!R-1EZX8A93E8\=FEO6KY!6K V1G 8HC
M!D=.-NAG&.>X+)_MKOR[^[B/LTZ]$\0JT!>SD.)\_A'N;>*'4T WA,P7H\@4
M\:G7)'QDF\MF?;R@P2-3-9)I771#8W=1_OV01O$%C?\?B:^(1^\"OI&%P>VM
M2_SZT3/KL"W>_++19L_:],1)^44\F=&UES[Q:UG?O(-J9OPQF9UK[Y[,$AZT
M?\R6QB436&F?59J=B^OJ*V8J-]3WH!OJ.T[1@4/G3M&%$]\3A_?CI!WQG]*N
M:A?;[3UV>X]]+/?8[?T1DS='[?T1>W]D"[G;^R,&[X\,/UN\JOLC(W7[B_;6
M1_QZ*=OQ7O5CM%;MVEAH6O_F,CT1_& 1)R+F?Z?\-O/"CU\X^_DL-[ .-M+P
M2I51((LQA:UT*X5L<3"KE1D-5BLW93&F )>64KCRH^\G(2&G;)\>DB@>?J84
M4/#*-%(J"<1!,+W*8- Y4D"!U4>U^1%!A,T/Y)(9A<[UR+M":(YQCTS)_7+@
MQ>S0%;\(O3#OU+PP95>+4S1<<KFL!= ]DV>$X55+?=S,SOM-=K+*35F/!Z"Y
MA,OD@?!^@[L*-\U,? "8J$*R:G&31^L LPZPL3C M%%*=;TTI<LOWL,UD+K+
MI'3CM)PUT2N[?"VJ8^8BO53J<I"07YCO%B>4/KRNL1ST GQ*QB00I^VL%C*4
M/EI!^:F(Y*[G,9% ;YZH7*"K0H.[1MM+M$ISY_Y20*;5[>PI%XN[R.AAYR5
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MB&Z<_L,C<AN?!E$<)IR_<S=.0C[-"YU1<!WT $E(Q^DVK!)=OI&0\CV[9*<
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M,N2W:]9G*B1S(&==O^;@H=-^J<I;E79PYNDZCCV^)Z%0VJ42TP](I;I)(WC
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M+G%)2%>449YL5KK3 IV\QU,#,^S!Z8%:.#@E;!&*IPE,!3$=U"OM>PR9<90
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MN#-YU"MXX<>XT[O.K>^P#T0#76,7P"INLG=R,'BA!V>ZST[D_5+B[KFPI<1
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MFDSH+_-E4:[XTO*>+!VCN);Y9J?GC3,N;G3TL5&"P20'I,+=T$85$5W$E=%
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MO#^J'D%SDK>SF:04E &P4N&0!2TGFM!Y*8?K0LS#Z33YGR^*L@U&G-&$)38
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MJ9NNL[*1$3"M8"YRX1".RU3#]1 C^@FQG>PB:%WUOKIFW&._-<C.7W 9IY5
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M!*Y(F]OIPJ#O*"^<W>Q-K^+YH0@C^,D;$4IY,'2S "F^#)[F<;K.FL? !_I
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MMO$_-BD9+<>#+MOZ<@Z V-%7PC2<G1:1O$'MY!, &]HN_=(U0&X3M4;9:<;
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M-:N!H9@]5F'_M=&$Q3YC$@U^"# [,4JG#BHERL0IIV0HC2X81CH"=DB $O1
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M%Z1P=U52W!9H5@_=W8K4U-#A<GJ 7DWI#X=*Z?1I9STUMP6;T@-WMZ,T,73
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MJ' %AF!X9+=<RC3&1RB.JD<8E+LJ:EP1KVC6;(7/8Q&?5)*!&])F^#L8BDA
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ML2ISJ(Q_!EC&IHPIO(P_A#_JX\\6GFU*TL#XXP[L*3'V6[-ITS[K( FI=[4
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M):<R-&"*: "LG/V^)<#O/R@#AO;\74 S/*_N2L.:CGF&@N'GT<DXD<%0KL&
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M3Y_)O\B?VS^1_T7C,LA?_G]02P,$%     @ W8M/3R=H"4S&20  ^Z<% !4
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MJLG/'"_*0D'FR\8D=+#J.N[0=@[M*Y.\F^GI@:Y$ZJY#3[-Z[FS#F>F\^JR
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M+2)PLW9\O[Q:R1!H- 0B\!,^!+@46T3@=$VBE1>L/D7A4W+/*@@X@70M"#H
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M/5+^T:O,QMLX7VY_6U2ND>A/^ A ](S57NN GAYS<$!ZYGC1KXZ?DDK5C_.
M$IJ"KNS [N"K.QHTM?B" \I/8;AX\GR?;N/GE+?!BI7XRHO\E7]2P:DQ!!12
M/.88;?Z,?Q.])O28D)*BCJ/671/0%2H">*P_8'X8*H;',HWF2R9M\4WH+]1@
ML%ZJ3E 8$-AN(.1@4JG;I+!JVMB\K%EU'KB4.W1O9Z]:*_?*3H-!P<5CU>G!
M,QR@;Y(Y-"Z6HAY0^/#8=%34CW]3/'6B@/*#/?^4R2H89F5'*-IX[#Y 7N!8
MF,=AICORQURNO?CW8RI[7L)^DMK,Q9V@@.$Q_ !X@ .L2_)4(2X* _JC2RJ7
M)_"RTQ\)"BL>TT]7;N&(Q5%7[KUE5F1!%$Z[8@6H?N_LK_F@-N-OID*^J@.T
M>T\6J<]\[HV=AF'J9B]U^6E"%AF6D#"[K@/N<?'=GDS&H4-@\7PR/=(J?J$3
MS6=?E^Q1+-^TZCM?GO=A*4L*BLK6;ZM<AZJL*(95NP?U1;<R=^$D:92]/#%?
MUFIP:B]3Z$BVJTUIU?+MR"<<BW)3TTZR EN%/\I.&%;:..LG;HXU9<QIQ;%8
M@T3E!>@RT'@K,'9G&P[KQU97\&NSEC3,HYPS6LI5>TC;D?,=!:$_X9@4<%&'
M4Z9_VR\9Y7TPJ-^IB*=LD3>+1QX].=$B$]<"0J:[\O46Q^FZ(@IZ*W^0[]@^
M=)DH\6D&"W2;"=>W6J6MC#+K(UNZ8]O>7G8F4-V8CF/[*4IY2G:?5NVBO N&
MS6>4563I5)CH05>BL,,XZL9*J<6A1WG%;3][SIWGLS3-_$X/5IR=!K.M*3O7
M  :R"8>JJQ0&ENF[5G6I:GE@#%IOK^H$;_?3DR)JB,YQ\P1Y*5^EB5CKY*(Y
MX.BJ"_=D'8Y%*:G]*%FD[UN5J:1U4#&LVE=7$'4KGF<I*\]TX07>.EU?,^'Q
MR]/V61@UJ\IKK_->P^]!^=1!&8U#*S1K5\I40;OP5;.V*H;EOR]%5K?7W\;T
MSH-E&*TS ?CX4OQ1S]"@-Z#MZEF:Q5C[\0W'JN24NY0MS%89+5Z95@QK<\_J
MM6YEK4AH^I,LSA<LNV+ID45Q0'3_2#UZ8JP?%#/#9Y?PFX$^-+X*L(9XC<,P
M4O(C(R#.\^*B\(RIJXK6TJ@ #![(MD&D1RU@36;AT.SJ2.T3DCB>'U\RIRI+
MT^*K_,XQV\7PL\WX4_@VXO!M?@6[^5- HOC>>[@B$4M&<59$S 2-(?8X1%N;
MD882D/GSD->48QT!_6RK<B/P 6G'JN*;ROSP[<'O?(7>"IZO*72.VI[]E0[V
MSTE[3]I[TMX0[8WRL'< SC<H% !?>;0B]X&GP8-9^7WVIW(&,SJ%63:'_Y/U
M<[,1BGEL5-&D>1!KGDN2Y&ZNSV$LJ2;<:+;'&H3+$$-GO,MTS>S_843OI(U5
M?/H0;Z=Q]$C746:5")EW(@RR-5>$UPK.@0.-O;=GQ4%YC\,X])6PJ&JR.'JD
ME*T(I?".1$547#Q/DSBAZIGJ[8Q<\5K7',9V87&3RJ 31\=?=X5+=K$X6K1O
M:WAKBA1D0-O%SG<N7' NH]8Y(C*TM8YX(-M%U"WH'157QZ]Y%'<;R?57U=%V
MR7:CMUX8UW#<=6'E(^#VL%8JK$XQ"8S6LGTJ+U%*<.93E;BM&^U4B[4EST:6
MK'Y-B 89U6+)&%"@JY><TQ\E%WU>6QQH\&5)A$!E^IL+R* HQ%%208#^5Y/[
M]%??+IS?PNB8'MSH93**CYX]'N=I0UZ[,7!=,/6*46#'#+]TUEG5A\J<3L*U
MX_&\9;2]I+EE]@LXVV*_A(*M$6Y(F]7M4[B9TP5AYU*! 8K7T-IU3LZIMG5(
M3"6.:]=5%#YZ,>7:64BI2.^29>J7C\&(E;N\E^WP3>$NU7I/3$V[S9N08.&P
M:#0Z.CWX?G06K :-8-UPVMDVPJJA$4S<J/5\FQSN^^$3O3(1J9^4]9%WL6W)
MA+$90C8.)=6J@+N=Z*%82<E[V38(@K44A/@Q7<BU'=#B&WNK>(K&C;V7(WJZ
MV[]VSW&'<L^3.QB1.UCO 1-3/MZ1&M=?IW]8>\GOUNF;4!'#*ANOTN4[C+QT
M\N/NEUYY!3[@H72+,<<N$NVROV[=WN_XX/;5WH=1<I 419-94=!:C?"L*#,H
M"ZU5L6P[<EXRG-W7FD7#LS_@RD/;AR+BH_;)ZM4!G_RQK\8?VVDI;]\)%OAF
M*U+7;#LB%'C3-^*C[0D"<]$)W;5<6JH]<  B%BLI*%5"S#ANC\. 'CH3]I3R
M%9VT%\=AE%7EEGIQE;UL6X14$E1_T!;$ D/FO<K9Z:4;&%HCV#X9ZP#3@34X
M7%S5B=]&3A#3PPBK3/'QI?H7^>:B,P8.'0?:='3(JM@ D8"IVH9X;7& HR^2
M$N#,;DD7] KL^0_.%?V>+]5\W):V-9Q87JJZ34*DH8WF(KKT$L^'<+7=$,A4
M8^_L0IDJ(A''OG"3WL7DCY22>_K(]"3]GGP3$'; H51@EST1#163/2Y,5%I>
MT@4)+G(Y4P,TD((W@I!0=_')T=1@'XR%"*GD3(X*1G7V.72":\+.\BXK*A^L
M+L)%%J63\52JV !=D2PEB(H#4%/Q.6%%3*7V0)UQH :63!T@42G%T\)K4[[G
MH-**HO:VU:*&1#9=9E(.X-"0%:L%LU7$5\Z+W+TB[#"6,'P%Q3A@J1NA*E/.
M?V19!%>1Y\KBD36&L&T+!6.GS1:,:%Z1R*,JQ"WJZ4,1;'6S':#6$34!^7B0
MVLI2(6!DL9U]'NIR'L<I62@6G\XXMH/'M+#49Q .< 6:_SB-(NDZ5/6S'<W5
M=^MK,&#\@7UUA?,E<-;L@80_R8)%8+"P)ZC.Y7:U;;[MJ'<E;#!DS\UBI=C+
M]0*YJP=E"6R]NH, T?G);C)<-];LV\H\#Q)"X4FN*:T9WQ:0BK$Z8]CV"G1<
MJQ#&X-A3Z_,N;[HG=,I0 .M]@(#]C PP'N&C#8459T"V'K3L$PYK/ZMQBHJU
M; 6=HF*Q(#%%Q8X&A2DJ=HJ*G:)B;4?%:G"]'ZM1!+I:9_ \T.%QI3742HY"
MI!4T[X33MT^A!J<KK:&<-F9ZZ<[I%LVF+6+US\L+TJDZ0?EN[,ZLPW<8!W8B
MZ'*N]V/V^[<8F&V#QSBS1=X;\X(B3Q?I@Y)\@>@- ?61H=@<NG '8>7&C:X5
MT*.Q]4!&@/K%C#FQ.^U#<-[@,+AO3 3YDW''X?HA# BKM2^/TY=WPW';UC-"
M\2G!D9+5F)O*#")HC@P5F<1QWS-L$80B,/4K\T"HH_0;S:#7=6/W2*E(-<OU
M\$C$H;^FS-,A,T\MIR9-F:="TL:<>6KNMO2:4T_?&TM1L)U[*F3J5>3$]W0C
M@O"5VQ9ZIS 66PEEK812'/ONE.@Q@D0/=B&%.DOSMK8==AWCI:J$8@0"360B
MMNR-L48F(DFAPI' L=,4*L'AX!.[H))%<5,517^W6N'/M>!.&]/"J&;H9%"7
M)5TEUD-QE]%D0RC)QH'.L>_$\7Q9B,X\NF:%ES>UW(G+PHP]$A\[OD\6'U]*
M$2L:2HPFO0?&GUDQ%*7HY>'TF6ZZ7DPR.=[\<4.![)6B;L.-)H^B%[MP(%Y.
MC\7J9_.K%%:77Q#4/4>37@%E @[(4"0<FBL,9#+A<*2);-?D(<]?I\I&\"CB
MQH+4; F^LUL'5$0ECE57WD5/GQ]($!,Y#-S&UIUZ8"0DM.( 0YP/=T)B-_(>
M&$^A:E#8'0H8-K.)@A\X("QEK%X6@.[ EV'@JHHD@#I#X;-O)M'@!0[PZO)V
MYKCD:*US\JCV@,)DOZ*%BFJ,V.PL2=I<ZHC9+&D+"'URO"!F3RJ2>!Z</K-W
MD5(OOF>35IWO %VA>-DWG8#Y@##<E4VO6ILO%BI UES8&@J615N'=/Z8EM51
M?@',)IC+3WD3O(K(VDLEM@Q 5RA2]JT98#Z,_V)LN<C6H7TKR.NLLM4HZW<5
M>8'K/3@^](0C[@_VE%M'7H\C.%3T512ZA"SB,THU<XXY 3.1RX\\LC[6\VW!
M:*DIQX&0TJJJU*WP$:#H8;.OJ+DR?GW[.<Q='_*U66\%Q=.^P85'W4C6'\0\
MIC4(%#5L]A<0;S""6CFR?20!H7<JS_&W 5%GA!DNP,8:Z&A0F+&9<?2XA03O
ME-R&]=)W>O9M\ #6RV# 4=7C"0X@V7,,ZN#U>BLH)/;#5WC4X>![\6!\W,DY
M!.ILO8X)W)P#YP4.\)15VW/C89^"]IL1H##:-]3H<@5'0=?J0?F@6<RU7LAU
M,_%J$=<?WC:+N+(19[>;&JX'K0JNG.*M4]76J6KK5+75-A)3U=;1H#!5;=VM
M@D)9M;6:3=RQ(MKXZ[9"F3#$T3DNET=,W.]7X>.;!?'RE4%_:"X(^JMOG\G*
M\4\#>F(2U2"AK5J-<(B]7 _QYCU$L21M%N<3$.H8VJ3>PC)S>7QK<;8^8U,E
MG]?K-*"?N7D@S.)&5\^]$ZT=]^7SYV-%V6= 3VLJI,6^MLK0(!W'A7NJ<C15
M.<*BP#KP70F<64UWZ?V>^E=.X-X[\JHQO(:VCT*PBC%B$D=?C,>8+QE!+1YQ
M6:Z4$G#TVV].Y#RDJL)<O+:V\^C!E;G$A.+8>BT%-%FW9FN%,XTT! 9ID1[[
ML6S[4:1G9YDQV,+7\";&B!\EA?A]8;UMGRO H.DP8V!E:]G1"'XB\H=#A7=Q
M>@AR<BE.+L7)I3BY%">7XN12'+]+$<5K+KMR*=I^"Q+AJV*3SW;RV4X^6Z$G
MX^KZ_/+7TYO;B]/+VT_7\R]7*E^MM(<UG0SPT0)(-:1^;YR WAJ.J$IR/;J:
M8A6+)>VME1<&,%A)IBGVZH8;#!%E,+R%#L+A*;I@BBZP">847;";-Y1VY*RU
M_BJ-06>M]3 #ZY[PW8<9&+KK?WN'X 8*XSJ$%*,0["0TR?+S:^9BDZ:GK+HY
M'D?XE-7NJEQ:1V<LOGP+)6*Q!5I@K1"[>8[\8QA%X9,7K&3.0UYCV^9ZC7=X
MA*3BP&)'3_)A*]XC>%5CBA0<,E(06RF?$44*8BO@\^KJ]XC2TJAN\))C)UK,
M[WQOE;-)5GE9U@'(>\NUE]4DXU@SB((W[1?ML1B\^7JR(.P7]=EY&H3M$D W
M[CU9I#XE\BQE=?>*^R>5Z_F2-3Q(ZC&\XM#==\K"0.6W9N%REG]MMOT<^^7F
M@_5@WRG$=^@"L%NV5]_HVM28/@_^FSC1[5,H)K#;:)8M9EIQPGWXA6,#UZ>
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M=*&M5[X3L$@X>:18O=6(.%^?.(Y UG).J@"P9CL<;.<)C(#I9H-4Z=WFD4K
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M%<I\.4NH8!OF;)UI?(:64S5QR -Q],(+O+7DX4/:IM'$VE[>Y%F+HUQ:[*F
M"^=9R=IZ$VLI;6K6\F@QY*#>^%N.XCA=YTZHUGF,1"[CS(J;)LN&T1X%?1V
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MBK>8XBVZ^I"G> L,J@=QO(5 .9VN'_SPA8@]_ZQ5LY'-%)^.<E7557R:IUS
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MZHIKPJK?T]\?AT$&6^KX+%3UG6()['HRT,4P0DN['5SWY(K:@WEB32)BGHG
M^3Z3@2X*8U4:42Z*'K@:JLJY>XKD93\MS@<JLB/Q*5GFYIY);<7"A$9R:W."
M2N](O$,(.+IG$IS9E!#IW<U\P$'7D^2"T44JM?J7 D/BVF4B4#D=B>_%%AM1
M"ZC^PD.C3^$".A)GBBTV[JDOY9R2Z06QYV9IX#OQGC0_"170UV4V5F*T1S%+
MPRSE.IMV8_IJ?1,JS"-,"C"*TAY)\YXH9@V/WKL1.C%,L6SRX>%4S3KB_&K=
M#QR>&9)G"Q6 /A/*@/*1ATLG8J%4C]OC5*W6S_MFK9^\\Z:,SVS3WV9!GWQ2
MZ@(]S79#WJWG%&&'/4J5?^1+X'$?_6)M^4TM%['A\[!ZVY11:,A@4?_DT3J,
M$N_/C"/SY5$<$R"+^1UM%V'1Y;B,? O\_^PY=ZPZJ2?T^8![VRXLT@\)#B-P
M//R3DU6I]-98P=(J;S\(-'^]R-MFQ.;&\&JV@^FY'=7Z$4Q]>CYG?Y_/Z;9D
M*T?U6_I!P<LZ59GC]A@1(F(BC+R_,P@L)R%S#>@!4_;! 8U*V  @E03U?--'
M<.S*OC@/Q*\@L5;-1BB.LU)9J1ZH^"0:.L9F'[M]"M7\K#1"<2C5XV>+Q)U<
M"\[I1=!S_'P&8I^OJI-M^84]7 XC?2=\OR8!>9*ZV27M;4MW%VYS",;AAVY,
MDWG2Y\LO,<GNZ.*=4M'-=O%"<-EU$/GC3UOX3"@]I$XLNR&':9#(WQ!3][1=
M] ^,-90)2"T@9RD+7RT>,"G]"F=A5">H8M&1VDA^!-E(\F_.BH_.RJ_.EF'4
MM)_,*E^>3"G#+=.2K2\E\T]2<DG%Z?:)^(_D(@R2>^E5L^N(J&WZO:G#M 5#
MJ?AOXD3TF-P?[,U ML^M@X+<8,\(L:4?UMR)%4/9/BD/CV^51>-#^"Q,)<5"
M]4>R?<P>'-\J@T8(;R46H2>\V4BV3];#PUL-UA@5O$?+A$3#8=P8SG85ZD&!
MYK)J7&CW!]A^E>9!,>UM"4G"Q/%QVD$V]'X)%H4U@"Q.GUW:]&C-_JNC-(B'
M XJ&L1#&_J*A8M7X'S80$ ZUB%8ZV"YH#4);02X.]2V8Y'$:,39H0[/I9[O\
M<A^$&L2/WU0MH/,R#-R..%>[6J\VW ?K-@_&_Z;K>4!_)+?.<SNL^_#MP>]\
MX_5/3>-U/LHL&X87X#W[*QWLGS:MT1LZM_-6FZ:EG2RNT=/EDK!7<<EF@LQ_
M<DU<*J!44O/5E)P1NI8<G_EG4CJ1EUIC,=&##&[9>@U N['D!V0ICLUZ,[73
M9V?M!1D!)R1V(R]+60$(O:BC;:NU/KA 7N  ;KOYA'%\3%7HRS*,6*Z1Q,TD
MZV/;"*T/EYH#.%S$E;VSXB<^*<X!]/=YHD6Q'8JWT[])M].Z1[@<G?UQEH^_
M]?9.V^RPC[TWD>RR-+4&&=VVV8%%.+1L:^(L73/GL^^'3TX@*P@-ZCR^;5*#
M)^,W,+6(K<3/7,I"[Y0=Q[?A GDQJ/79PGY=I(A?.5$E/ MPW?VYN3\7 \V*
MD7#>>"O4OMQ&3A!3_%FNNGH_5O?$D'0URG0W*"A3 ARR="O$"7 BF?KX4OV+
M/"5.9XP1H:9#%HZTN>J\5.ERO+8XP-$720EP9A/F+J(;NJD'1[_]YD3.0RK-
M\Q*TM7W2%\M,-2%&2JBAK*.+Z"IRXGLG2*[H#'T%<[EM;9^FH<R5$#K$C3<N
M54M,W.]7X>.;!?%RK4)_:"H3^JMOG^E%RS\-Z$E6I/IIJU8C'.I#KMMY\ZY(
MP>Y8G$] J*5IDWH+R\SE\:W%V?J,S:C<XW"]3@/ZF9L'XGJ.G[Q<W3O1VG%?
M/G\^ENH(4$]KX3TM]K7UA ;I..QD\^72<TD45^NB2?P0W-:6K9KP9$0)K3C0
M.$G);5@W8Q0!*$?! A*B 1[ ]ID&#)HF2W#@>!P&CX3.E>YNEV%"XBOG16[-
M$':P?3P"XZ0@&0<N)^0N.0_B)$H921=.DD9,G4OC)61];">(P%>1DG", )T'
M":$<S;*',U(75R1R&8-78,#D8]A. >D(((0Q.'SH[$#D)7F-UF#!G@SP@A4)
M7"T#_8>F@;XRZLP)%K/:N#C-]3)&:/C2-8=!E@L "E!2=K1\WNR$)*16 BAB
M"=<:%M5/N&:?]\L,ER_T>Q$]JQVXS,?LLW,!O]ZD4 7\]%9/!4C++.23VU9;
MR*8WJ\]/4KYRTB66@]9C;JD.>E'0S%10C[,'FJ8;Z_8MST%(]WEP^Q2R;$I0
M]"5X*-O7ZQU*3IN#KTEX6,&$P<2G,ICM>_]N!:C%Q5<D0JPFPU 25!G+MFEB
MIP+4XN%KDA]ZOQU,?K9CV;:,[%9^FCQ\-?+36VCL5]?8H:3T%@\DD;(W9,5(
MNB8/[+6*8%6YQG],8R\@<5R:&-D/8=Z0W8N+GM+BAS\=-B_K1:_9YH.-"WKY
MT=GFJ^RG<+;];CD$CMJ'3?ZI[]KB'ACB.T<9:ZL"88JQQ1+1@S_&=C.U4A.5
MZD8>5JOH-D9L^)3@")XMYJ2*FVTT0X:"3,*:H-0),1.M=9L=$,X#5QJ9U6IE
MV\+%E85J*): +D.1L#ABWLP%&JBXO</ -]$+",D]B:2<KK6P?6M1<I1##XX8
MC6OR2(*4G%&*V&6+';F^>LG]<1HGX9I$I\^NG[*'?UFJ(?T?RSH4Z^I.@UG7
M/="HC1ZL&K\%XE,4QO%5%"X]R;VHULBVT1N,*X<T'&M3^/)IT4#S@5/[@6O#
MOF4Z#)-SX%D!!#&CJVULFU+!S&X3AB, I3PRTT/&W::\#^"-ZI_>-0U1&T-3
M92AD+U9SB 7D=,M[8;A9C]+&! %CLC-AM64,;6>:DO0@27J]C$13DMZK2M(;
M_HJVCTEZIW^D=+87)+D/%^?!(XDS;^?\*2!1?.\]0)(B-(882SJ?-E?&?Z4N
M7=&WX9%+J8](>3XA<78EE=Q'E#U'8U2!,@''VH7E_XTTZ0]OIM^Q[\3Q?/F5
MW>BH4HBRIT<O4Z;;Y\L;XK+\-Y9*ZO@^67Q\*=K%14/)0NH]\&A,+P.Q</Q:
MMZ3L*%CDI,W3)$Z<@%EN!4\L%UW5/4=C&X(R8?QP<^7^])D>)[R87$6>2S9_
MW C[H:;"4 ]GW3_52TU V6536@07HW+JU_1 26>?F7P^.P^4%A)YX8(#-.NF
M[&7[O2K8J^I XG'L\9_"</'D^;[$N[1I8?M-*+AKJ4$4#E9S[*#'5#2\118V
M&P99$;A\^4I4H=XHMA]V D/6A3DX8"WU,CW'WY D\0D[R)\'QTY\?^9X$:L/
M3;;^$_4Y!SJ.[1>AM$\]>@P:C==,G&_]OJOGS'YV].1 FQQHDP-M<J#A9O7D
M0)L<:),#;7*@63S<3@ZTR8$V.="L0C$YT"8'VN1 FQQHDP-M<J!-#K3)@;;;
MA3HYT"8'VN1 ZY]OI^4KDW09C5M,239:#UBETE%.1'$%7M!C6>555/JW=$T6
MTBI'/X!<9/5"1\6+WN5'L\K%E<_.BN^B*'(T^=$F/]KD1YO\:+A9/?G1)C_:
MY$>;;C'6S\0]+S$CM?5QJ+XF;K@*O#_)XGQ!^>8M/::W :=M%E5'_\#<DH^.
MSSQ46C(TZ'='X\S;#0#Z@OHA%]2 [C%)T79_!+5X@#!K24<AE%VTYZ[$5?CU
MT;@]=PG&)+I5;K$XCX#.\V4WLEKYW&C<MD;9/4FC<.U>1>3!\1:GS^QQ7D+;
M9Q40517-+$UG-&YGJW!-TLYA7_4/KANF])BE#&_:\31&XSNW L]T:Y.S+5,$
MMF2Y^#C^:(%=<@.3#>FU!AV@\W]^"9QTX;&WHZ/P+(S6SH;:>+XL'L0) _E+
M+S]V\(%NOCNC'YYE7YYM/\U:;#\^.4(G1^CD")T<H9,C='*$[KLC-'^P!/ *
MRQA<FSQB]OKIE>&-ZOOL0,ZN,;&7[=[E\;-X+$-]HI)V'IWC#L *_-A=DN0\
MH/<.(G\506.(T?FRP&Q!BV8YZU,G"KQ@%5^1Z(:J$_+1B3U7"U3%2*-S!>DR
M:700GWA^FA!>;HX^)S9CC<Y'HL\H'$!_)2PIC"R.'DGDK')1S&9;S3$L*1)C
MK#G,:)P$G=B# ]ER5@T26K-7KE_M@49C0._((AP66GX)#MCC1C\U;:_Y8+-\
MM-EV.&0/'/%I9GG1_QEZ0?(K_0]*#\#"JCT0!F/?*(VN'2&;[+!8C(.3'7:R
MPTYV6)@]\<CW/2=P26Y*NPGIL8%M]@I;HK(79FLMD&1#!MPK)Y@_))[['\3Q
MDWL5HX6MK5TW 0Q6D&CDLA%'2643I/_55!+T5]\VU=X$6IBV:309@PYNS[IB
M+K3%8:$FKLX6B3)N,U#,8+/:^.8E*%;-Q<U<I1M$C:VI!AZ?VMI!3J,]Y;!9
M9#<N"9S("\5*0M!T),I",/N*'7K7G"_F\26(F6=OZ9&%3'U(FMM7)%(IJH(@
M)J*G:NF/PUD8$=>)$Z'VJ<R_V=9:$*.<IT+^\VG%80\]>G*BQ0F5)X$F*MHU
MFHU!"_%G7MF8,'!=J(.:LT>B??A,E3/>NLZY=H*52+[IWRM_QL%=Y>Y:F7'%
M)V2#JS+U76M@?]=L24&3H>54K<GIA1=XZW0MXVFC"=@$8F(KY A A:5<8NR=
MO"^<9R5OZTV@O!W>OJ3F+8\8'.<)22GTHV!Q'B2$LC$Y#XZ62\_WJ)[K5B%>
M.-9HHM6Z,PH'T"A?@+ ?O/:*GX"@UYRK*'0)6<1GE'\5MZ9ZB<OZCB:X#<Z(
MOFG<MU2:$"!_DX3N[^=QG-)+<!JQF)^L)G,>*7))GK(_29V_L/ZCB7O38\CX
ME_XV%I<)NB"H08P_L/MHXN*TV&%"!U@(N+I)[V+R1TI'/&6566)8J-7?FJ%6
MVV%F^3C(8JR:9*J#J<0],(3FC#)J2@7"%!Z%Q4AE.CQJ\ 5]2[\G-X$+.XP)
M#Q$-0\13&<%$92"7=$&"BUS.U "9-)_W14AH3N.38SUR2\UE""H8[6Z,AOGR
MB#UJM,K4@%R9"9HC63(052:@P$A8DKY_;SLM9LV[# -G^YNL;K&3OV2D6D#:
M ^% 4"J-33^A+HF&PJ(VSP=>I9%[[\3D:!61;!+R""EU/]OJKJ,TU@*JH-PQ
M5I(@B%,_\8(5#!5)>]OFQ '04'(#QYYT37QFJ+ARHN2E2MC'E^I?Y!N5SA@X
M=!]H]](ARTC07"\P58=R7EL<X.B+I 0XPUD3KAN1K*Q;;CP,(WFZA+"Y[>U'
M+#FUC D%N88VEHOH*G+B>R=(KN@D?2F+!6WM!6%H,5A*J3'NWJ24@*/??G,B
MYR%5<)?;UEX8AB9W)93N1G;I84*/W\#>4 2,.=\[R;>*&U,2@.4D@&%#<*<D
M@"D)8&<92/N6!'!"[I+S($ZB5&TYY+4=@SZ23-](#'5/$"Z=M=+W(>Z! Q"Q
M6$E!J1)BYFIU16?JQ7$8O5R&"1$;8;-$8WY;H/HQ]A2X2EIJN=(R<G%H(&21
M9/;#@W<4298@"23,R,K)O8H\EY35X22(B[N,)EA82?;X(P1K@;"44%848[ZD
MQ#Y2'EWYCILQ2@PSM+]MJ[Y.=34-AN#0SL>^$\?SY=?,49',HVM6&.XR9=O(
M?+EU#1T[OD\6'U^*=G'14**V>P\\FLC@@5@X=D7/9</I,XE<+R:9"MS\<4.[
MY.'CCL.-)J"X%[OLR8K(B0M; P5][!('TB691W20H?&7Z!R.5DS["[O,'(<!
M/;3$^2/?]*?,$;2Y.Z[9LW$210 ?P5KQ"-VUK\N4\9\5E117S\M]A*$QCNV[
M_' BP670?@C&ELB";H\JMBTSLLU0(1/ (8#B\ &%.&BQ9?R2<$T>BB3+^;+F
M%J2LD,6CR'I9]]^# 8=0CV='WXKFA9.P0\D+JP8#7:+U/M:C #HN2A[E. JE
MJ_+V#M\>_+Z9<2UW[^=.N7NSO](1_SFE\$TI?%,*'Q8LIA2^*87//"93"M^4
MPK?_*7S3@PV0!QMZY>5-#S9,#S9,#S;T?[!A>"?X]& #-ATL?+#!0NWUZ<&&
MT3S8,+QJ0/M@@_;!>2J5;I7K4ZGTOHKDPGF9!^3V*;R]#]/8"1:77D 20@)Y
MGIBJE^UH&H&$U'+#8)0;.MT=I:LT3CJP'M+1=LP*@/MP^@T!<!D^9I_I  &L
MJ^V@$@ (.CPP!,-_.D'J1"_TVU'26(^W3Y3(%RD2X-ZVPSD 8&ARPM[E:'HZ
MPQA7IZ<S1O&\P_!9(HB>=[#\+(F1VR:69TFT;SKE Q#9>Q"QQYB5EY N'X,H
M OOF498W0O7;)NBW$O8GOB --3X07>N1.,/R$X>,H'QUPW[0U2M\=:.4[N-P
M?><%&22L+)Q'$<G^(ZMNE1,F"8O5&V4TB95=F#/VU*IZX.&9XY(\04 ,OKC'
M:+(I542/?YVCC'VWGT^YN]AW),L[*]UPY;S(@S[KK6Q;9L%H\HC;CZ6+.)_)
M8AJCG7PF4WFM97*E\ +&6C4;V389PW)-^:3AN N-*I?<?O*@G5QR-,IXJV?H
M_9X5U\EURT;IR"1#W74T.8-@-B!9X\WIYL?[3JBUNXXG\P_,AX$7JC@QK?@+
M^\>=$Q/ZF_\/4$L! A0#%     @ W8M/3RLK4UQ%%0$ W^$/ !$
M     ( !     '1R>&0M,C Q.3 V,S N>&UL4$L! A0#%     @ W8M/3WVP
MPC3$$@  *M<  !$              ( !=!4! '1R>&0M,C Q.3 V,S N>'-D
M4$L! A0#%     @ W8M/3^F(M_4I%   T0(! !4              ( !9R@!
M '1R>&0M,C Q.3 V,S!?8V%L+GAM;%!+ 0(4 Q0    ( -V+3T][DV&#/#,
M  KP P 5              "  <,\ 0!T<GAD+3(P,3DP-C,P7V1E9BYX;6Q0
M2P$"% ,4    " #=BT]/,.F'(VUC  "O!@8 %0              @ $R< $
M=')X9"TR,#$Y,#8S,%]L86(N>&UL4$L! A0#%     @ W8M/3R=H"4S&20
M^Z<% !4              ( !TM,! '1R>&0M,C Q.3 V,S!?<')E+GAM;%!+
4!08     !@ & (H!  #+'0(    !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>55
<FILENAME>R63.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3</span><table class="report" border="0" cellspacing="2" id="idp6765105072">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Business Combination (Details Narrative) (10-K) - USD ($)<br></strong></div></th>
<th class="th"><div>Oct. 15, 2018</div></th>
<th class="th"><div>Jun. 30, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
<th class="th"><div>Dec. 31, 2017</div></th>
<th class="th"><div>Feb. 28, 2017</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentOwnershipPercentage', window );">Equity method investment ownership percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Number of shares entitled for warrants issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">161,538<span></span>
</td>
<td class="nump">87,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Warrant exercise price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 725,973<span></span>
</td>
<td class="nump">$ 725,973<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LegalEntityAxis=TRXD_CommunitySpecialtyPharmacyLLCMember', window );">Community Specialty Pharmacy, LLC [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentOwnershipPercentage', window );">Equity method investment ownership percentage</a></td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesGross', window );">Purchase price, cash</a></td>
<td class="nump">$ 300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NotesPayable', window );">Promissory note issued</a></td>
<td class="nump">$ 300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Number of shares entitled for warrants issued</a></td>
<td class="nump">405,507<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">405,507<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingTerm', window );">Warrant term</a></td>
<td class="text">8 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Warrant exercise price</a></td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_TRXD_ExerciseRestrictionsLapsePeriod', window );">Exercise restrictions lapse period</a></td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">$ 725,973<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferred1', window );">Total purchase price</a></td>
<td class="nump">770,291<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Fair value of warrants</a></td>
<td class="nump">$ 170,291<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_TRXD_ExerciseRestrictionsLapsePeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Exercise restrictions lapse period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">TRXD_ExerciseRestrictionsLapsePeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>TRXD_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationConsiderationTransferred1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 30<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=116859721&amp;loc=d3e6613-128477<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=35744584&amp;loc=d3e6927-128479<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 30<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=116859721&amp;loc=d3e6578-128477<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationConsiderationTransferred1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Exercise price per share or per unit of warrants or rights outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(i)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(i)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentOwnershipPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentOwnershipPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=77989000&amp;loc=SL49117168-202975<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NotesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Including the current and noncurrent portions, aggregate carrying amount of all types of notes payable, as of the balance sheet date, with initial maturities beyond one year or beyond the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=119400593&amp;loc=d3e572229-122910<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=6876686&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NotesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireBusinessesGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of business during the period. The cash portion only of the acquisition price.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=35744584&amp;loc=d3e6927-128479<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireBusinessesGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WarrantsAndRightsOutstandingTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Period between issuance and expiration of outstanding warrant and right embodying unconditional obligation requiring redemption by transferring asset at specified or determinable date or upon event certain to occur, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WarrantsAndRightsOutstandingTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=TRXD_CommunitySpecialtyPharmacyLLCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=TRXD_CommunitySpecialtyPharmacyLLCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>56
<FILENAME>R67.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3</span><table class="report" border="0" cellspacing="2" id="idp6763948000">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Subsequent Events (Details Narrative) - USD ($)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Oct. 08, 2019</div></th>
<th class="th"><div>Sep. 30, 2019</div></th>
<th class="th"><div>Jul. 10, 2019</div></th>
<th class="th"><div>Feb. 28, 2019</div></th>
<th class="th"><div>Jun. 30, 2019</div></th>
<th class="th"><div>Jun. 30, 2018</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
<th class="th"><div>Dec. 31, 2017</div></th>
<th class="th"><div>Apr. 01, 2021</div></th>
<th class="th"><div>Apr. 01, 2020</div></th>
<th class="th"><div>Aug. 28, 2019</div></th>
<th class="th"><div>Feb. 28, 2017</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Number of warrants to purchase shares of common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">161,538<span></span>
</td>
<td class="nump">87,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Warrant exercise price per share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfRelatedPartyDebt', window );">Repayment of related party debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 111,725<span></span>
</td>
<td class="nump">$ 111,725<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentMaturityDate', window );">Debt instrument maturity date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">May 31,  2019<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementScenarioAxis=srt_ScenarioForecastMember', window );">Forecast [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_TRXD_ClassOfWarrantOrRightNumberOfSecuritiesExercisableByWarrantsOrRights', window );">Number of warrants exercisable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">150,000<span></span>
</td>
<td class="nump">150,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Warrant exercise price per share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtConversionConvertedInstrumentSharesIssued1', window );">Debt instrument converted conversion, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">423,966<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event [Member] | Securities Purchase Agreement [Member] | Promissory Notes [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtConversionConvertedInstrumentAmount1', window );">Debt instrument converted conversion, value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 175,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtConversionConvertedInstrumentSharesIssued1', window );">Debt instrument converted conversion, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">350,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleConversionPrice1', window );">Debt instrument conversion price per shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.50<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event [Member] | Securities Purchase Agreement [Member] | Accredited Investor [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Number of common stock issued under private placement, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,910,000<span></span>
</td>
<td class="nump">2,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesIssuedPricePerShare', window );">Common stock purchase price per share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.50<span></span>
</td>
<td class="nump">$ 0.50<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfPrivatePlacement', window );">Gross proceeds from shares issued under private placement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,455,000<span></span>
</td>
<td class="nump">$ 1,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event [Member] | Securities Purchase Agreement [Member] | Mr. Prashant Patel [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfRelatedPartyDebt', window );">Repayment of related party debt</a></td>
<td class="nump">$ 122,552<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event [Member] | Securities Purchase Agreement [Member] | Mr. Suren Ajjarapu [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfRelatedPartyDebt', window );">Repayment of related party debt</a></td>
<td class="nump">$ 100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event [Member] | Securities Purchase Agreement [Member] | Mr. Prashant Patel and Mr. Suren Ajjarapu [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentMaturityDate', window );">Debt instrument maturity date</a></td>
<td class="text">Jul.  01,  2020<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event [Member] | Consulting Agreement [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Number of warrants to purchase shares of common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Warrant exercise price per share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_TRXD_ClassOfWarrantOrRightNumberOfSecuritiesExercisableByWarrantsOrRights">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of warrant exercisable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">TRXD_ClassOfWarrantOrRightNumberOfSecuritiesExercisableByWarrantsOrRights</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>TRXD_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Exercise price per share or per unit of warrants or rights outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(i)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(i)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtConversionConvertedInstrumentAmount1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The value of the financial instrument(s) that the original debt is being converted into in a noncash (or part noncash) transaction. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=98513485&amp;loc=d3e4304-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=98513485&amp;loc=d3e4332-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtConversionConvertedInstrumentAmount1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtConversionConvertedInstrumentSharesIssued1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of shares issued in exchange for the original debt being converted in a noncash (or part noncash) transaction. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or payments in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=98513485&amp;loc=d3e4332-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=98513485&amp;loc=d3e4304-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtConversionConvertedInstrumentSharesIssued1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentConvertibleConversionPrice1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The price per share of the conversion feature embedded in the debt instrument.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109500613&amp;loc=SL6031898-161870<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentConvertibleConversionPrice1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentMaturityDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Date when the debt instrument is scheduled to be fully repaid, in CCYY-MM-DD format.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentMaturityDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfPrivatePlacement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the amount received from entity's raising of capital via private rather than public placement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfPrivatePlacement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfRelatedPartyDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for the payment of a long-term borrowing made from a related party where one party can exercise control or significant influence over another party; including affiliates, owners or officers and their immediate families, pension trusts, and so forth. Alternate caption: Payments for Advances from Affiliates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfRelatedPartyDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesIssuedPricePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Per share or per unit amount of equity securities issued.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesIssuedPricePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of new stock issued during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementScenarioAxis=srt_ScenarioForecastMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementScenarioAxis=srt_ScenarioForecastMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=TRXD_SecuritiesPurchaseAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=TRXD_SecuritiesPurchaseAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=TRXD_PromissoryNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=TRXD_PromissoryNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=TRXD_AccreditedInvestorMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=TRXD_AccreditedInvestorMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=TRXD_MrPrashantPatelMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=TRXD_MrPrashantPatelMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=TRXD_MrSurenAjjarapuMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=TRXD_MrSurenAjjarapuMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=TRXD_MrPrashantPatelAndMrSurenAjjarapuMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=TRXD_MrPrashantPatelAndMrSurenAjjarapuMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=TRXD_ConsultingAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=TRXD_ConsultingAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>57
<FILENAME>R44.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3</span><table class="report" border="0" cellspacing="2" id="idp6763638208">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholders' Equity (Details Narrative) (10-K) - USD ($)<br></strong></div></th>
<th class="th" colspan="5">1 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Nov. 30, 2018</div></th>
<th class="th"><div>Jul. 31, 2018</div></th>
<th class="th"><div>Mar. 31, 2017</div></th>
<th class="th"><div>Feb. 28, 2017</div></th>
<th class="th"><div>Jan. 31, 2017</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
<th class="th"><div>Dec. 31, 2017</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Number of common stock issued, value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 800,000<span></span>
</td>
<td class="nump">$ 250,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Warrant purchased from common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">161,538<span></span>
</td>
<td class="nump">87,500<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Warrant exercise price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_TRXD_WarrantsIssued', window );">Warrants issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">25,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfWarrants', window );">Warrant grant price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 250<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices', window );">Number of shares issued for services</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueIssuedForServices', window );">Number of shares issued for services, value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 12,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 12,500<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=TRXD_PrivateOfferMemorandumMember', window );">Private Offer Memorandum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Number of common stock issued</a></td>
<td class="nump">1,000,000<span></span>
</td>
<td class="nump">300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">250,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Number of common stock issued, value</a></td>
<td class="nump">$ 500,000<span></span>
</td>
<td class="nump">$ 300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 250,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SaleOfStockPricePerShare', window );">Sale of stock price per shares</a></td>
<td class="nump">$ 0.50<span></span>
</td>
<td class="nump">$ 1.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Warrant purchased from common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">161,538<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">87,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Warrant exercise price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingTerm', window );">Warrants term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_TRXD_WarrantsIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Warrants issued.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">TRXD_WarrantsIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>TRXD_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Exercise price per share or per unit of warrants or rights outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(i)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(i)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from issuance of rights to purchase common shares at predetermined price (usually issued together with corporate debt).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockPricePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Per share amount received by subsidiary or equity investee for each share of common stock issued or sold in the stock transaction.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockPricePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued in lieu of cash for services contributed to the entity. Number of shares includes, but is not limited to, shares issued for services contributed by vendors and founders.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesIssuedForServices</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of new stock issued during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueIssuedForServices">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of stock issued in lieu of cash for services contributed to the entity. Value of the stock issued includes, but is not limited to, services contributed by vendors and founders.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueIssuedForServices</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WarrantsAndRightsOutstandingTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Period between issuance and expiration of outstanding warrant and right embodying unconditional obligation requiring redemption by transferring asset at specified or determinable date or upon event certain to occur, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WarrantsAndRightsOutstandingTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=TRXD_PrivateOfferMemorandumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=TRXD_PrivateOfferMemorandumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>58
<FILENAME>R40.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3</span><table class="report" border="0" cellspacing="2" id="idp6778875984">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Long Term Debt - Related Parties (Details Narrative) - USD ($)<br></strong></div></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Oct. 31, 2018</div></th>
<th class="th"><div>Jun. 30, 2019</div></th>
<th class="th"><div>Dec. 31, 2017</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentMaturityDate', window );">Debt instrument maturity date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">May 31,  2019<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NotesPayableRelatedPartiesNoncurrent', window );">Long term debt related party</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 522,552<span></span>
</td>
<td class="nump">$ 222,552<span></span>
</td>
<td class="nump">$ 522,552<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LegalEntityAxis=TRXD_CommunitySpecialtyPharmacyLLCMember', window );">Community Specialty Pharmacy, LLC [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate</a></td>
<td class="nump">10.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentMaturityDate', window );">Debt instrument maturity date</a></td>
<td class="text">Oct. 15,  2021<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=TRXD_RelatedPartyPromissoryNoteMember', window );">Related Party Promissory Note [Member] | Mr. Prashant Patel [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentMaturityDate', window );">Debt instrument maturity date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Jul.  01,  2020<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NotesPayableRelatedPartiesNoncurrent', window );">Long term debt related party</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 122,552<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=TRXD_RelatedPartyPromissoryNoteMember', window );">Related Party Promissory Note [Member] | Mr. Suren Ajjarapu [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentMaturityDate', window );">Debt instrument maturity date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Jul.  01,  2020<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NotesPayableRelatedPartiesNoncurrent', window );">Long term debt related party</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=TRXD_RelatedPartyPromissoryNoteMember', window );">Related Party Promissory Note [Member] | Community Specialty Pharmacy, LLC [Member] | Nikul Panchal [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfDebt', window );">Proceeds from issuance of promissory note</a></td>
<td class="nump">$ 300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate</a></td>
<td class="nump">10.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentMaturityDate', window );">Debt instrument maturity date</a></td>
<td class="text">Oct. 31,  2021<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateStatedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Contractual interest rate for funds borrowed, under the debt agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateStatedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentMaturityDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Date when the debt instrument is scheduled to be fully repaid, in CCYY-MM-DD format.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentMaturityDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NotesPayableRelatedPartiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount for notes payable (written promise to pay), payable to related parties, which are due after one year (or one business cycle).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(k)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.23)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NotesPayableRelatedPartiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow during the period from additional borrowings in aggregate debt. Includes proceeds from short-term and long-term debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=TRXD_CommunitySpecialtyPharmacyLLCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=TRXD_CommunitySpecialtyPharmacyLLCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=TRXD_RelatedPartyPromissoryNoteMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=TRXD_RelatedPartyPromissoryNoteMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=TRXD_MrPrashantPatelMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=TRXD_MrPrashantPatelMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=TRXD_MrSurenAjjarapuMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=TRXD_MrSurenAjjarapuMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=TRXD_NikulPanchalMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=TRXD_NikulPanchalMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>59
<FILENAME>R48.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3</span><table class="report" border="0" cellspacing="2" id="idp6935223104">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Warrants - Summary of Estimate the Fair Value of Warrants (Details) (10-K) - Warrant [Member]<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2018</div></th>
<th class="th"><div>Dec. 31, 2017</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_WarrantMember', window );">Dividend Yield [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_TRXD_FairValueAssumptionsMeasurementInputPercentages', window );">Fair value assumptions, measurement input, percentages</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_WarrantMember', window );">Expected Volatility [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_TRXD_FairValueAssumptionsMeasurementInputPercentages', window );">Fair value assumptions, measurement input, percentages</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">200.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_WarrantMember', window );">Expected Volatility [Member] | Minimum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_TRXD_FairValueAssumptionsMeasurementInputPercentages', window );">Fair value assumptions, measurement input, percentages</a></td>
<td class="nump">231.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_WarrantMember', window );">Expected Volatility [Member] | Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_TRXD_FairValueAssumptionsMeasurementInputPercentages', window );">Fair value assumptions, measurement input, percentages</a></td>
<td class="nump">632.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_WarrantMember', window );">Risk Free Interest Rate [Member] | Minimum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_TRXD_FairValueAssumptionsMeasurementInputPercentages', window );">Fair value assumptions, measurement input, percentages</a></td>
<td class="nump">2.55%<span></span>
</td>
<td class="nump">1.81%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_WarrantMember', window );">Risk Free Interest Rate [Member] | Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_TRXD_FairValueAssumptionsMeasurementInputPercentages', window );">Fair value assumptions, measurement input, percentages</a></td>
<td class="nump">2.75%<span></span>
</td>
<td class="nump">1.84%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_WarrantMember', window );">Expected Term of Options [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_TRXD_FairValueAssumptionsMeasurementInputTerm', window );">Fair value assumptions, measurement input, term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_WarrantMember', window );">Expected Term of Options [Member] | Minimum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_TRXD_FairValueAssumptionsMeasurementInputTerm', window );">Fair value assumptions, measurement input, term</a></td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_WarrantMember', window );">Expected Term of Options [Member] | Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_TRXD_FairValueAssumptionsMeasurementInputTerm', window );">Fair value assumptions, measurement input, term</a></td>
<td class="text">8 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_TRXD_FairValueAssumptionsMeasurementInputPercentages">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value assumptions, measurement input, percentages.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">TRXD_FairValueAssumptionsMeasurementInputPercentages</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>TRXD_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_TRXD_FairValueAssumptionsMeasurementInputTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value assumptions, measurement input, term.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">TRXD_FairValueAssumptionsMeasurementInputTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>TRXD_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_WarrantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_WarrantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputExpectedDividendRateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputExpectedDividendRateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputPriceVolatilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputPriceVolatilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputRiskFreeInterestRateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputRiskFreeInterestRateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputExpectedTermMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputExpectedTermMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>60
<FILENAME>R29.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3</span><table class="report" border="0" cellspacing="2" id="idp6779183216">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2018</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock', window );">Schedule of Deferred Tax Assets</a></td>
<td class="text"><p style="margin: 0pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">At December 31, 2018 and 2017 deferred tax
assets consist of the following:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: bottom">
    <td style="padding-bottom: 1.5pt; text-align: justify">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt">December 31, 2018</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt">December 31, 2017</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="width: 50%"><font style="font-size: 10pt">Federal loss carry forwards</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%"><font style="font-size: 10pt">$</font></td>
    <td style="width: 22%; text-align: right"><font style="font-size: 10pt">922,850</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%"><font style="font-size: 10pt">$</font></td>
    <td style="width: 22%; text-align: right"><font style="font-size: 10pt">963,833</font></td>
    <td style="width: 1%">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td style="padding-bottom: 1.5pt; text-align: justify"><font style="font-size: 10pt">Less: valuation allowance</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">(922,850</font></td>
    <td style="padding-bottom: 1.5pt"><font style="font-size: 10pt">)</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">(963,833</font></td>
    <td style="padding-bottom: 1.5pt"><font style="font-size: 10pt">)</font></td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-bottom: 2.5pt; text-align: justify">&#160;</td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td>
    <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">-</font></td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td>
    <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">-</font></td>
    <td style="padding-bottom: 2.5pt"></td></tr>
</table>


<p style="margin: 0pt"></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>61
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3</span><table class="report" border="0" cellspacing="2" id="idp6650900816">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Subsequent Events<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventsAbstract', window );"><strong>Subsequent Events [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventsTextBlock', window );">Subsequent Events</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif"><b>NOTE
11 &#8211; SUBSEQUENT EVENTS</b></font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">On
July 10, 2019, the Company entered into a Securities Purchase Agreement with a certain accredited investor with respect to the
private placement of 2,000,000 share of its common stock at a purchase price of $0.50 per share, for gross proceeds of $1,000,000.</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On August 28, 2019, the Company entered into
a Consulting Agreement which included the grant of warrants to purchase 300,000 shares of Company stock at an exercise price of
$0.01 per share. 150,000 of the warrants are exercisable on April 1, 2020 and 150,000 are exercisable on April 1, 2021. The warrants
have a term of 5 years.</p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">On
September 30, 2019, the Company entered into a Securities Purchase Agreement with certain accredited investors with respect to
the private placement of 2,910,000 shares of its common stock at a purchase price of $0.50 per share, for gross proceeds of $1,455,000.</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">On
September 30, 2019, the Company converted $175,000 of principal under various outstanding promissory notes (&#8220;Promissory
Notes&#8221;) into 350,000 shares common stock of the Company at $0.50 per share under the terms of the Securities Purchase Agreement
referenced above.</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<p style="margin: 0; text-align: justify; font: 10pt Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">On
October 8, 2019, $122,552 and $100,000 in promissory notes due to Mr. Prashant Patel and Mr. Suren Ajjarapu, respectively, were
paid in full. The notes were due July 1, 2020.</font></p><span></span>
</td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif"><b>NOTE
13 &#8211; SUBSEQUENT EVENTS</b></font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><font style="font-family: Times New Roman, Times, Serif">In
January 2019, Trxade Group, Inc. through its wholly owned subsidiary Alliance Pharma Solution, LLC (&#8220;Alliance&#8221;)
entered into a transaction to form SyncHealth MSO, LLC (&#8220;SyncHealth&#8221;). It will be owned by PanOptic Health,
LLC (&#8220;PanOptic&#8221;) and Alliance. Alliance will transfer $250,000 for the acquisition of the remaining
49% and the option to acquire the remaining ownership from PanOptic shareholders. Pursuant to the operating agreement PanOptic
initially owns 70% of SyncHealth and Alliance owns 30%; however, pursuant to the Letter Agreement, PanOptic will transfer
to Alliance an additional 6% of the SyncHealth units on May 1, 2019, an additional 6% on August 1, 2019, an additional
7% on November 1, 2019 and at Alliance&#8217;s option, the balance of 51% on January 31, 2020. The Company has transferred
$250,000 and has a 30% equity interest.</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><font style="font-family: Times New Roman, Times, Serif">In
February 2019, convertible promissory notes issued in 2015 for $150,000 were amended to reduce the conversion price from
$0.85 to $0.50 and the remaining principal and accrued interest total of $211,983 were converted to 423,966 common
shares.</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">In
February 2019, 16,666 of warrants issued in 2014 at $0.01 were converted for $166 to 16,666 of common shares.</font></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 855<br> -URI http://asc.fasb.org/topic&amp;trid=2122774<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>62
<FILENAME>R25.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3</span><table class="report" border="0" cellspacing="2" id="idp6767363536">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Long Term Debt - Related Parties (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2018</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock', window );">Schedule of Future Maturities of Long-term Debt</a></td>
<td class="text"><p style="margin: 0pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; background-color: white">Future maturities of long-term debt in
the next five years are as follows:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; background-color: white">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="width: 73%"><font style="font-size: 10pt">Due in 2020</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%"><font style="font-size: 10pt">$</font></td>
    <td style="width: 24%; text-align: right"><font style="font-size: 10pt">222,552</font></td>
    <td style="width: 1%">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td><font style="font-size: 10pt">Due in 2021</font></td>
    <td>&#160;</td>
    <td><font style="font-size: 10pt">$</font></td>
    <td style="text-align: right"><font style="font-size: 10pt">300,000</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td><font style="font-size: 10pt">Due in 2022</font></td>
    <td>&#160;</td>
    <td><font style="font-size: 10pt">$</font></td>
    <td style="text-align: right"><font style="font-size: 10pt">-</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td style="padding-bottom: 1.5pt"><font style="font-size: 10pt">Due in 2023</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1.5pt solid"><font style="font-size: 10pt">$</font></td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">-</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-bottom: 2.5pt"><font style="font-size: 10pt">Total Debt</font></td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td>
    <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">522,052</font></td>
    <td style="padding-bottom: 2.5pt"></td></tr>
</table>


<p style="margin: 0pt"></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the combined aggregate amount of maturities and sinking fund requirements for all long-term borrowings for each of the five years following the date of the latest balance sheet date presented.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6802200&amp;loc=d3e1835-112601<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>63
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3</span><table class="report" border="0" cellspacing="2" id="idp6777465200">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Shareholders' Equity<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock', window );">Shareholders' Equity</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif"><b>NOTE
4 &#8211; SHAREHOLDERS&#8217; EQUITY</b></font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">In
February 2019, convertible promissory notes issued in 2015 for $181,500 were amended to a conversion price of $0.50 and the principal
and accrued interest total of $211,983 were then converted to 423,966 common shares.</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">In
February 2019, 16,666 of warrants issued in 2014 at $0.01 per share were exercised for 16,666 of common shares. $166 was received
in cash.</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">In
April and May 2019, 505,000 options were granted with exercise prices ranging from $0.41 to $0.44 and a term of 10 years from
the grant date. The options vest over a period ranging from four to five years.</font></p><span></span>
</td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>NOTE 5 &#8211; STOCKHOLDERS&#8217; EQUITY</b></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><font style="font: 10pt Times New Roman, Times, Serif"><b>2017</b></font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><font style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">In
January 2017, under a Private Offer Memorandum, 250,000 shares of Common Stock were issued for $250,000 cash. The Common Stock
was sold at $1.00 per share. In connection with this Common Stock offering, warrants to purchase 87,500 shares of Common Stock
were issued with a strike price of $0.01 and an expiration date of five years.</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;<font style="font: normal 10pt Times New Roman, Times, Serif">&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font-family: Times New Roman, Times, Serif">In
February 2017, 25,000 shares were issued when warrants were exercised at $0.01 grant price for $250.</font></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">In
March 2017, 50,000 shares were issued for services performed for the Company and valued at fair value of $12,500.</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif"><b>2018</b></font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">In
July 2018, under a Private Offer Memorandum, 300,000 shares of Common Stock were issued for $300,000 cash. The Common Stock was
sold at $1.00 per share. In connection with this Common Stock offering, warrants to purchase 161,538 shares of Common Stock were
issued with a strike price of $0.01 and an expiration date of five years.</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<p style="margin: 0; text-align: justify; font: 10pt Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">In
November 2018, under a Private Offer Memorandum, 1,000,000 shares of Common Stock were issued for $500,000 cash. The Common Stock
was sold at $0.50 per share.</font></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -URI http://asc.fasb.org/topic&amp;trid=2208762<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>64
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3</span><table class="report" border="0" cellspacing="2" id="idp6700203696">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2018</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureTextBlock', window );">Income Taxes</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif"><b>NOTE
8 &#8211; INCOME TAXES</b></font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">On
December 22, 2017 H.R. 1, originally known as the Tax Cuts and Jobs Act, (the &#8220;Tax Act&#8221;) was enacted. Among the significant
changes to the U.S. Internal Revenue Code, the Tax Act lowers the U.S. federal corporate income tax rate (&#8220;Federal Tax Rate&#8221;)
from 35% to 21% effective January 1, 2018.</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">The
statutory tax rate is the percentage imposed by law; the effective tax rate is the percentage of income actually paid by a company
after taking into account tax deductions, exemptions, credits and operating loss carry forwards.</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">At
December 31, 2018 and 2017 deferred tax assets consist of the following:</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<table cellpadding="0" cellspacing="0" align="center" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<tr style="vertical-align: bottom; font-family: Times New Roman, Times, Serif">
    <td style="text-align: justify; padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">December
    31, 2018</font></td><td style="padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">December
    31, 2017</font></td><td style="padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255); font-family: Times New Roman, Times, Serif">
    <td style="width: 48%; text-align: left; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">Federal
    loss carry forwards</font></td><td style="width: 2%; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="width: 1%; text-align: left; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td><td style="width: 22%; text-align: right; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">922,850</font></td><td style="width: 1%; text-align: left; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="width: 2%; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="width: 1%; text-align: left; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td><td style="width: 22%; text-align: right; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">963,833</font></td><td style="width: 1%; text-align: left; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: White; font-family: Times New Roman, Times, Serif">
    <td style="text-align: justify; padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">Less:
    valuation allowance</font></td><td style="padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="border-bottom: Black 1.5pt solid; text-align: right; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">(922,850</font></td><td style="padding-bottom: 1.5pt; text-align: left; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td><td style="padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="border-bottom: Black 1.5pt solid; text-align: right; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">(963,833</font></td><td style="padding-bottom: 1.5pt; text-align: left; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255); font-family: Times New Roman, Times, Serif">
    <td style="text-align: justify; padding-bottom: 2.5pt; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="padding-bottom: 2.5pt; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td><td style="border-bottom: Black 2.5pt double; text-align: right; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td><td style="padding-bottom: 2.5pt; text-align: left; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="padding-bottom: 2.5pt; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td><td style="border-bottom: Black 2.5pt double; text-align: right; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td><td style="padding-bottom: 2.5pt; text-align: left; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr>
</table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">The
Company has established a valuation allowance equal to the full amount of the deferred tax asset primarily due to uncertainty
in the utilization of the net operating loss carry forwards.</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">The
estimated net operating loss carry forwards of approximately $4,400,000 will be available based on the new carryover rules in
section 172(a) passed with the Tax Cuts and Jobs Acts.</font></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -URI http://asc.fasb.org/topic&amp;trid=2144680<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>65
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3</span><table class="report" border="0" cellspacing="2" id="idp6767415712">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Business Combination<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationsAbstract', window );"><strong>Business Combinations [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationDisclosureTextBlock', window );">Business Combination</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif"><b>NOTE
9 &#8211; BUSINESS COMBINATION</b></font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">On
October 15, 2018, Trxade Group, Inc. (&#8220;Company&#8221;) entered into and consummated the purchase of 100% of the equity
interests of Community Specialty Pharmacy, LLC, a Florida limited liability company, (&#8220;CSP&#8221;), pursuant to the terms
and conditions of the Membership Interest Purchase Agreement, entered into by and among the Company as the buyer, and CSP, and
Nikul Panchal, the equity owner of CSP (collectively, the &#8220;Seller&#8221;). The purchase price for the 100% equity interest
in CSP was $300,000 in cash, a promissory note from the Company of $300,000 (see Note 3), and warrants to purchase 405,507 shares
of the Common Stock of the Company which vested at the acquisition date, are exercisable for eight (8) years from the issuance
date at a strike price of $0.01 per share, and subject to exercise restrictions which lapse over three (3) years.</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">The
Company recorded the acquisition under ASC 805 &#8220;Business Combination. All of the assets acquired and liabilities
assumed are recorded at their corresponding fair values. The excess of the purchase price over the net assets acquired
resulted in goodwill of $725,973. The following table is a summary of the allocation of the purchase price of $770,291
consisting of $300,000 in cash, a promissory note from the Company of $300,000, and the fair value of the warrants issued
calculated under the Black-Scholes calculation at $170,291.</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<table cellpadding="0" cellspacing="0" align="center" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Purchase Price Allocation</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 78%">Purchase Price</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 18%; text-align: right">770,291</td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td>Cash</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(49,728</td><td style="text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Accounts Receivable</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(114,899</td><td style="text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td>Inventory</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(76,156</td><td style="text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Prepaid</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(3,000</td><td style="text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Accounts Payable</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">199,312</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">Accrued Expenses</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">153</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 2.5pt">Goodwill</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">725,973</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
</table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;<font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">The
accompanying unaudited pro forma statements of operations presents the accounts of Trxade and CSP for the six- months ended June
30, 2018, assuming the acquisition occurred on January 1, 2018.</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<table cellpadding="0" cellspacing="0" align="center" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<tr style="vertical-align: bottom">
    <td style="font-weight: bold; border-bottom: Black 1.5pt solid">2018 Summary Statement of Operations</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Trxade</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">CSP</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Combined</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 55%; font-weight: bold">Revenue</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 11%; text-align: right">1,690,611</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 11%; text-align: right">1,323,117</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 11%; text-align: right">3,013,723</td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left">Net Income</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">102,782</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">64,800</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">167,582</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left">Net Income per common share &#8211; basic</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">0.00</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">0.01</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left">Net Income per common share - diluted</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">0.00</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">0.00</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold">Weighted average common shares - basic</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">31,985,827</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">31,985,827</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold">Weighted average common shares - diluted</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">34,472,811</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">34,472,811</td><td style="text-align: left">&#160;</td></tr>
</table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">The
accompanying unaudited pro forma statements of operations presents the accounts of Trxade and CSP for the three- months ended
June 30, 2018, assuming the acquisition occurred on January 1, 2018.</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<table cellpadding="0" cellspacing="0" align="center" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<tr style="vertical-align: bottom">
    <td style="font-weight: bold; border-bottom: Black 1.5pt solid">2018 Summary Statement of Operations</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Trxade</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">CSP</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Combined</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 55%; font-weight: bold">Revenue</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 11%; text-align: right">837,688</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 11%; text-align: right">677,900</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 11%; text-align: right">1,515,588</td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left">Net Income (Loss)</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">20,513</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">(12,185</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">8,328</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left">Net Income per common share &#8211; basic</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">0.00</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">0.00</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left">Net Income per common share - diluted</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">0.00</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">0.00</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold">Weighted average common shares - basic</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">31,985,827</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">31,985,827</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold">Weighted average common shares - diluted</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">34,479,406</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">34,479,406</td><td style="text-align: left">&#160;</td></tr></table><span></span>
</td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif"><b>NOTE
12 &#8211; BUSINESS COMBINATION</b></font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><font style="font-family: Times New Roman, Times, Serif">On
October 15, 2018, the Company entered into and consummated the purchase of 100% of the equity interests of Community Specialty
Pharmacy, LLC, a Florida limited liability company, (&#8220;CSP&#8221;), pursuant to the terms and conditions of the Membership
Interest Purchase Agreement, entered into by and among the Company as the buyer, and CSP, and Nikul Panchal, the equity owner
of CSP (collectively, the &#8220;Seller&#8221;). The purchase price for the 100% equity interest in CSP was
$300,000 in cash, a promissory note issued by the Company of $300,000 (see Note 4), and warrants to purchase 405,507
shares of the Common Stock of the Company which vested at the acquisition date, are exercisable for eight (8) years
from the issuance date at a strike price of $0.01 per share, and subject to exercise restrictions which lapse over a period
of three (3) years.</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><font style="font-family: Times New Roman, Times, Serif">The
Company recorded the acquisition under the guidance of ASC 805 &#8220;Business Combinations&#8221;. All the assets
acquired and liabilities assumed are recorded at their corresponding fair values. The excess of the purchase
price over the net assets acquired resulted in goodwill of $725,973. The following table is a summary of the allocation of
the purchase price of $770,291 consisting of $300,000 in cash, a promissory note from the Company of $300,000, and <font style="background-color: white">the
fair value for the warrants issued calculated under the Black-Scholes calculation at $170,291.</font></font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<table cellpadding="0" cellspacing="0" align="center" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<tr style="vertical-align: bottom; font-family: Times New Roman, Times, Serif">
    <td style="font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="font-weight: bold; padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">Purchase
    Price Allocation</font></td><td style="padding-bottom: 1.5pt; font-weight: bold; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255); font-family: Times New Roman, Times, Serif">
    <td style="width: 64%; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">Purchase
    Price</font></td><td style="width: 2%; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="width: 1%; text-align: left; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td><td style="width: 32%; text-align: right; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">770,291</font></td><td style="width: 1%; text-align: left; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: White; font-family: Times New Roman, Times, Serif">
    <td style="font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">Cash</font></td><td style="font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: left; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="text-align: right; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">(49,728</font></td><td style="text-align: left; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255); font-family: Times New Roman, Times, Serif">
    <td style="text-align: left; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">Accounts
    Receivable</font></td><td style="font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: left; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="text-align: right; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">(114,899</font></td><td style="text-align: left; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td></tr>
<tr style="vertical-align: bottom; background-color: White; font-family: Times New Roman, Times, Serif">
    <td style="font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">Inventory</font></td><td style="font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: left; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="text-align: right; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">(76,156</font></td><td style="text-align: left; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255); font-family: Times New Roman, Times, Serif">
    <td style="font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">Prepaid</font></td><td style="font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: left; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="text-align: right; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">(3,000</font></td><td style="text-align: left; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td></tr>
<tr style="vertical-align: bottom; background-color: White; font-family: Times New Roman, Times, Serif">
    <td style="text-align: left; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">Accounts
    Payable</font></td><td style="font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: left; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="text-align: right; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">199,312</font></td><td style="text-align: left; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255); font-family: Times New Roman, Times, Serif">
    <td style="text-align: left; padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">Accrued
    Expenses</font></td><td style="padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="border-bottom: Black 1.5pt solid; text-align: right; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">153</font></td><td style="padding-bottom: 1.5pt; text-align: left; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: White; font-family: Times New Roman, Times, Serif">
    <td style="padding-bottom: 2.5pt; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">Goodwill</font></td><td style="padding-bottom: 2.5pt; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td><td style="border-bottom: Black 2.5pt double; text-align: right; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">725,973</font></td><td style="padding-bottom: 2.5pt; text-align: left; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr>
</table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><font style="font-family: Times New Roman, Times, Serif">The
accompanying unaudited pro forma combined statements of operations presents the accounts of Trxade and CSP for the years
ended December 31, 2018 and 2017, respectively, assuming the acquisition occurred on January 1, 2017.</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<table cellpadding="0" cellspacing="0" align="center" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<tr style="vertical-align: bottom; font-family: Times New Roman, Times, Serif">
    <td style="font-weight: bold; border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif"><font style="font-family: Times New Roman, Times, Serif">2018
    Summary Statement of Operations</font></td><td style="font-weight: bold; padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif"><font style="font-family: Times New Roman, Times, Serif">Trxade</font></td><td style="padding-bottom: 1.5pt; font-weight: bold; font-family: Times New Roman, Times, Serif"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-weight: bold; padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif"><font style="font-family: Times New Roman, Times, Serif">CSP</font></td><td style="padding-bottom: 1.5pt; font-weight: bold; font-family: Times New Roman, Times, Serif"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-weight: bold; padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif"><font style="font-family: Times New Roman, Times, Serif">Combined</font></td><td style="padding-bottom: 1.5pt; font-weight: bold; font-family: Times New Roman, Times, Serif"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255); font-family: Times New Roman, Times, Serif">
    <td style="width: 49%; font-weight: bold; font-family: Times New Roman, Times, Serif"><font style="font-family: Times New Roman, Times, Serif">Revenue</font></td><td style="width: 2%; font-family: Times New Roman, Times, Serif"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="width: 1%; text-align: left; font-family: Times New Roman, Times, Serif"><font style="font-family: Times New Roman, Times, Serif">$</font></td><td style="width: 13%; text-align: right; font-family: Times New Roman, Times, Serif"><font style="font-family: Times New Roman, Times, Serif">3,436,360</font></td><td style="width: 1%; text-align: left; font-family: Times New Roman, Times, Serif"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="width: 2%; font-family: Times New Roman, Times, Serif"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="width: 1%; text-align: left; font-family: Times New Roman, Times, Serif"><font style="font-family: Times New Roman, Times, Serif">$</font></td><td style="width: 13%; text-align: right; font-family: Times New Roman, Times, Serif"><font style="font-family: Times New Roman, Times, Serif">2,387,636</font></td><td style="width: 1%; text-align: left; font-family: Times New Roman, Times, Serif"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="width: 2%; font-family: Times New Roman, Times, Serif"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="width: 1%; text-align: left; font-family: Times New Roman, Times, Serif"><font style="font-family: Times New Roman, Times, Serif">$</font></td><td style="width: 13%; text-align: right; font-family: Times New Roman, Times, Serif"><font style="font-family: Times New Roman, Times, Serif">5,823,996</font></td><td style="width: 1%; text-align: left; font-family: Times New Roman, Times, Serif"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: White; font-family: Times New Roman, Times, Serif">
    <td style="font-family: Times New Roman, Times, Serif"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-family: Times New Roman, Times, Serif"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: left; font-family: Times New Roman, Times, Serif"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="text-align: right; font-family: Times New Roman, Times, Serif"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="text-align: left; font-family: Times New Roman, Times, Serif"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-family: Times New Roman, Times, Serif"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: left; font-family: Times New Roman, Times, Serif"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="text-align: right; font-family: Times New Roman, Times, Serif"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="text-align: left; font-family: Times New Roman, Times, Serif"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-family: Times New Roman, Times, Serif"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: left; font-family: Times New Roman, Times, Serif"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="text-align: right; font-family: Times New Roman, Times, Serif"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="text-align: left; font-family: Times New Roman, Times, Serif"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255); font-family: Times New Roman, Times, Serif">
    <td style="font-weight: bold; text-align: left; padding-bottom: 2.5pt; font-family: Times New Roman, Times, Serif"><font style="font-family: Times New Roman, Times, Serif">Net
    Income (Loss)</font></td><td style="padding-bottom: 2.5pt; font-family: Times New Roman, Times, Serif"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: left; border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif"><font style="font-family: Times New Roman, Times, Serif">$</font></td><td style="text-align: right; border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif"><font style="font-family: Times New Roman, Times, Serif">125,626</font></td><td style="text-align: left; padding-bottom: 2.5pt; font-family: Times New Roman, Times, Serif"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="padding-bottom: 2.5pt; font-family: Times New Roman, Times, Serif"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: left; border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif"><font style="font-family: Times New Roman, Times, Serif">$</font></td><td style="text-align: right; border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif"><font style="font-family: Times New Roman, Times, Serif">(6,723</font></td><td style="text-align: left; padding-bottom: 2.5pt; font-family: Times New Roman, Times, Serif"><font style="font-family: Times New Roman, Times, Serif">)</font></td><td style="padding-bottom: 2.5pt; font-family: Times New Roman, Times, Serif"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: left; border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif"><font style="font-family: Times New Roman, Times, Serif">$</font></td><td style="text-align: right; border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif"><font style="font-family: Times New Roman, Times, Serif">118,903</font></td><td style="text-align: left; padding-bottom: 2.5pt; font-family: Times New Roman, Times, Serif"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: White; font-family: Times New Roman, Times, Serif">
    <td style="font-family: Times New Roman, Times, Serif"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-family: Times New Roman, Times, Serif"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: left; font-family: Times New Roman, Times, Serif"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="text-align: right; font-family: Times New Roman, Times, Serif"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="text-align: left; font-family: Times New Roman, Times, Serif"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-family: Times New Roman, Times, Serif"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: left; font-family: Times New Roman, Times, Serif"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="text-align: right; font-family: Times New Roman, Times, Serif"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="text-align: left; font-family: Times New Roman, Times, Serif"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-family: Times New Roman, Times, Serif"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: left; font-family: Times New Roman, Times, Serif"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="text-align: right; font-family: Times New Roman, Times, Serif"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="text-align: left; font-family: Times New Roman, Times, Serif"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255); font-family: Times New Roman, Times, Serif">
    <td style="font-weight: bold; text-align: left; padding-bottom: 2.5pt; font-family: Times New Roman, Times, Serif"><font style="font-family: Times New Roman, Times, Serif">Net
    Income per common share &#8211; basic</font></td><td style="padding-bottom: 2.5pt; font-family: Times New Roman, Times, Serif"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: left; border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif"><font style="font-family: Times New Roman, Times, Serif">$</font></td><td style="text-align: right; border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif"><font style="font-family: Times New Roman, Times, Serif">0.00</font></td><td style="text-align: left; padding-bottom: 2.5pt; font-family: Times New Roman, Times, Serif"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="padding-bottom: 2.5pt; font-family: Times New Roman, Times, Serif"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: left; padding-bottom: 2.5pt; font-family: Times New Roman, Times, Serif"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="text-align: right; padding-bottom: 2.5pt; font-family: Times New Roman, Times, Serif"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="text-align: left; padding-bottom: 2.5pt; font-family: Times New Roman, Times, Serif"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="padding-bottom: 2.5pt; font-family: Times New Roman, Times, Serif"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: left; border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif"><font style="font-family: Times New Roman, Times, Serif">$</font></td><td style="text-align: right; border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif"><font style="font-family: Times New Roman, Times, Serif">0.00</font></td><td style="text-align: left; padding-bottom: 2.5pt; font-family: Times New Roman, Times, Serif"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: White; font-family: Times New Roman, Times, Serif">
    <td style="font-family: Times New Roman, Times, Serif"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-family: Times New Roman, Times, Serif"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: left; font-family: Times New Roman, Times, Serif"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="text-align: right; font-family: Times New Roman, Times, Serif"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="text-align: left; font-family: Times New Roman, Times, Serif"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-family: Times New Roman, Times, Serif"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: left; font-family: Times New Roman, Times, Serif"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="text-align: right; font-family: Times New Roman, Times, Serif"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="text-align: left; font-family: Times New Roman, Times, Serif"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-family: Times New Roman, Times, Serif"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: left; font-family: Times New Roman, Times, Serif"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="text-align: right; font-family: Times New Roman, Times, Serif"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="text-align: left; font-family: Times New Roman, Times, Serif"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255); font-family: Times New Roman, Times, Serif">
    <td style="font-weight: bold; text-align: left; padding-bottom: 2.5pt; font-family: Times New Roman, Times, Serif"><font style="font-family: Times New Roman, Times, Serif">Net
    Income per common share - diluted</font></td><td style="padding-bottom: 2.5pt; font-family: Times New Roman, Times, Serif"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: left; border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif"><font style="font-family: Times New Roman, Times, Serif">$</font></td><td style="text-align: right; border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif"><font style="font-family: Times New Roman, Times, Serif">0.00</font></td><td style="text-align: left; padding-bottom: 2.5pt; font-family: Times New Roman, Times, Serif"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="padding-bottom: 2.5pt; font-family: Times New Roman, Times, Serif"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: left; padding-bottom: 2.5pt; font-family: Times New Roman, Times, Serif"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="text-align: right; padding-bottom: 2.5pt; font-family: Times New Roman, Times, Serif"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="text-align: left; padding-bottom: 2.5pt; font-family: Times New Roman, Times, Serif"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="padding-bottom: 2.5pt; font-family: Times New Roman, Times, Serif"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: left; border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif"><font style="font-family: Times New Roman, Times, Serif">$</font></td><td style="text-align: right; border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif"><font style="font-family: Times New Roman, Times, Serif">0.00</font></td><td style="text-align: left; padding-bottom: 2.5pt; font-family: Times New Roman, Times, Serif"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: White; font-family: Times New Roman, Times, Serif">
    <td style="font-family: Times New Roman, Times, Serif"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-family: Times New Roman, Times, Serif"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: left; font-family: Times New Roman, Times, Serif"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="text-align: right; font-family: Times New Roman, Times, Serif"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="text-align: left; font-family: Times New Roman, Times, Serif"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-family: Times New Roman, Times, Serif"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: left; font-family: Times New Roman, Times, Serif"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="text-align: right; font-family: Times New Roman, Times, Serif"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="text-align: left; font-family: Times New Roman, Times, Serif"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-family: Times New Roman, Times, Serif"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: left; font-family: Times New Roman, Times, Serif"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="text-align: right; font-family: Times New Roman, Times, Serif"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="text-align: left; font-family: Times New Roman, Times, Serif"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255); font-family: Times New Roman, Times, Serif">
    <td style="font-weight: bold; font-family: Times New Roman, Times, Serif"><font style="font-family: Times New Roman, Times, Serif">Weighted
    average common shares - basic</font></td><td style="font-family: Times New Roman, Times, Serif"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: left; font-family: Times New Roman, Times, Serif"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="text-align: right; font-family: Times New Roman, Times, Serif"><font style="font-family: Times New Roman, Times, Serif">32,260,622</font></td><td style="text-align: left; font-family: Times New Roman, Times, Serif"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-family: Times New Roman, Times, Serif"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: left; font-family: Times New Roman, Times, Serif"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="text-align: right; font-family: Times New Roman, Times, Serif"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="text-align: left; font-family: Times New Roman, Times, Serif"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-family: Times New Roman, Times, Serif"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: left; font-family: Times New Roman, Times, Serif"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="text-align: right; font-family: Times New Roman, Times, Serif"><font style="font-family: Times New Roman, Times, Serif">32,260,622</font></td><td style="text-align: left; font-family: Times New Roman, Times, Serif"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: White; font-family: Times New Roman, Times, Serif">
    <td style="font-family: Times New Roman, Times, Serif"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-family: Times New Roman, Times, Serif"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: left; font-family: Times New Roman, Times, Serif"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="text-align: right; font-family: Times New Roman, Times, Serif"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="text-align: left; font-family: Times New Roman, Times, Serif"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-family: Times New Roman, Times, Serif"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: left; font-family: Times New Roman, Times, Serif"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="text-align: right; font-family: Times New Roman, Times, Serif"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="text-align: left; font-family: Times New Roman, Times, Serif"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-family: Times New Roman, Times, Serif"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: left; font-family: Times New Roman, Times, Serif"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="text-align: right; font-family: Times New Roman, Times, Serif"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="text-align: left; font-family: Times New Roman, Times, Serif"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255); font-family: Times New Roman, Times, Serif">
    <td style="font-weight: bold; font-family: Times New Roman, Times, Serif"><font style="font-family: Times New Roman, Times, Serif">Weighted
    average common shares - diluted</font></td><td style="font-family: Times New Roman, Times, Serif"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: left; font-family: Times New Roman, Times, Serif"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="text-align: right; font-family: Times New Roman, Times, Serif"><font style="font-family: Times New Roman, Times, Serif">34,958,502</font></td><td style="text-align: left; font-family: Times New Roman, Times, Serif"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-family: Times New Roman, Times, Serif"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: left; font-family: Times New Roman, Times, Serif"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="text-align: right; font-family: Times New Roman, Times, Serif"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="text-align: left; font-family: Times New Roman, Times, Serif"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-family: Times New Roman, Times, Serif"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: left; font-family: Times New Roman, Times, Serif"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="text-align: right; font-family: Times New Roman, Times, Serif"><font style="font-family: Times New Roman, Times, Serif">34,958,502</font></td><td style="text-align: left; font-family: Times New Roman, Times, Serif"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td></tr>
</table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<table cellpadding="0" cellspacing="0" align="center" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<tr style="vertical-align: bottom; font-family: Times New Roman, Times, Serif">
    <td style="font-weight: bold; border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">2017
    Summary Statement of Operations</font></td><td style="font-weight: bold; padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">Trxade</font></td><td style="padding-bottom: 1.5pt; font-weight: bold; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="font-weight: bold; padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">CSP</font></td><td style="padding-bottom: 1.5pt; font-weight: bold; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="font-weight: bold; padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">Combined</font></td><td style="padding-bottom: 1.5pt; font-weight: bold; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255); font-family: Times New Roman, Times, Serif">
    <td style="width: 49%; font-weight: bold; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">Revenue</font></td><td style="width: 2%; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="width: 1%; text-align: left; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td><td style="width: 13%; text-align: right; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">2,931,280</font></td><td style="width: 1%; text-align: left; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="width: 2%; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="width: 1%; text-align: left; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td><td style="width: 13%; text-align: right; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">2,633,914</font></td><td style="width: 1%; text-align: left; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="width: 2%; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="width: 1%; text-align: left; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td><td style="width: 13%; text-align: right; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">5,565,194</font></td><td style="width: 1%; text-align: left; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: White; font-family: Times New Roman, Times, Serif">
    <td style="font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: left; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="text-align: right; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="text-align: left; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: left; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="text-align: right; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="text-align: left; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: left; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="text-align: right; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="text-align: left; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255); font-family: Times New Roman, Times, Serif">
    <td style="font-weight: bold; text-align: left; padding-bottom: 2.5pt; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">Net
    Income (Loss)</font></td><td style="padding-bottom: 2.5pt; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td><td style="border-bottom: Black 2.5pt double; text-align: right; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">288,983</font></td><td style="padding-bottom: 2.5pt; text-align: left; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="padding-bottom: 2.5pt; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td><td style="border-bottom: Black 2.5pt double; text-align: right; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">(63,132</font></td><td style="padding-bottom: 2.5pt; text-align: left; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td><td style="padding-bottom: 2.5pt; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td><td style="border-bottom: Black 2.5pt double; text-align: right; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">225,851</font></td><td style="padding-bottom: 2.5pt; text-align: left; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: White; font-family: Times New Roman, Times, Serif">
    <td style="font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: left; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="text-align: right; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="text-align: left; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: left; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="text-align: right; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="text-align: left; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: left; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="text-align: right; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="text-align: left; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255); font-family: Times New Roman, Times, Serif">
    <td style="font-weight: bold; text-align: left; padding-bottom: 2.5pt; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">Net
    Income per common share &#8211; basic</font></td><td style="padding-bottom: 2.5pt; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td><td style="border-bottom: Black 2.5pt double; text-align: right; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">0.01</font></td><td style="padding-bottom: 2.5pt; text-align: left; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="padding-bottom: 2.5pt; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="padding-bottom: 2.5pt; text-align: left; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="padding-bottom: 2.5pt; text-align: right; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="padding-bottom: 2.5pt; text-align: left; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="padding-bottom: 2.5pt; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td><td style="border-bottom: Black 2.5pt double; text-align: right; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">0.01</font></td><td style="padding-bottom: 2.5pt; text-align: left; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: White; font-family: Times New Roman, Times, Serif">
    <td style="font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: left; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="text-align: right; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="text-align: left; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: left; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="text-align: right; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="text-align: left; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: left; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="text-align: right; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="text-align: left; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255); font-family: Times New Roman, Times, Serif">
    <td style="font-weight: bold; text-align: left; padding-bottom: 2.5pt; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">Net
    Income per common share - diluted</font></td><td style="padding-bottom: 2.5pt; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td><td style="border-bottom: Black 2.5pt double; text-align: right; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">0.01</font></td><td style="padding-bottom: 2.5pt; text-align: left; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="padding-bottom: 2.5pt; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="padding-bottom: 2.5pt; text-align: left; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="padding-bottom: 2.5pt; text-align: right; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="padding-bottom: 2.5pt; text-align: left; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="padding-bottom: 2.5pt; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td><td style="border-bottom: Black 2.5pt double; text-align: right; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">0.01</font></td><td style="padding-bottom: 2.5pt; text-align: left; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: White; font-family: Times New Roman, Times, Serif">
    <td style="font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: left; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="text-align: right; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="text-align: left; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: left; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="text-align: right; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="text-align: left; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: left; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="text-align: right; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="text-align: left; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255); font-family: Times New Roman, Times, Serif">
    <td style="font-weight: bold; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">Weighted
    average common shares - basic</font></td><td style="font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: left; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="text-align: right; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">31,955,416</font></td><td style="text-align: left; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: left; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="text-align: right; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="text-align: left; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: left; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="text-align: right; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">31,955,416</font></td><td style="text-align: left; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: White; font-family: Times New Roman, Times, Serif">
    <td style="font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: left; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="text-align: right; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="text-align: left; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: left; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="text-align: right; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="text-align: left; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: left; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="text-align: right; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="text-align: left; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255); font-family: Times New Roman, Times, Serif">
    <td style="font-weight: bold; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">Weighted
    average common shares - diluted</font></td><td style="font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: left; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="text-align: right; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">34,086,251</font></td><td style="text-align: left; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: left; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="text-align: right; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="text-align: left; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: left; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="text-align: right; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">34,086,251</font></td><td style="text-align: left; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for a business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities. The disclosure may include leverage buyout transactions (as applicable).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -URI http://asc.fasb.org/topic&amp;trid=2303972<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>66
<FILENAME>R36.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3</span><table class="report" border="0" cellspacing="2" id="idp6763579744">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies (Details Narrative) (10-K) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2018</div></th>
<th class="th"><div>Dec. 31, 2017</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProvisionForDoubtfulAccounts', window );">Bad debt expense</a></td>
<td class="nump">$ 2,271<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_TRXD_RecoveryOfBadDebt', window );">Recovery of bad debt</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_TRXD_ValuationAllowancePercentage', window );">Valuation allowance percentage</a></td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MajorCustomersAxis=TRXD_TwoCustomersMember', window );">Two Customers [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration risk, percentage</a></td>
<td class="nump">10.00%<span></span>
</td>
<td class="nump">10.00%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_TRXD_RecoveryOfBadDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the monetary amount of Recovery of bad debt, during the indicated time period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">TRXD_RecoveryOfBadDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>TRXD_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_TRXD_ValuationAllowancePercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Valuation allowance percentage.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">TRXD_ValuationAllowancePercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>TRXD_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskPercentage1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the "benchmark" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6351-108592<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=118260190&amp;loc=d3e13531-108611<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118260190&amp;loc=d3e13537-108611<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6404-108592<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskPercentage1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProvisionForDoubtfulAccounts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expense (reversal of expense) for expected credit loss on accounts receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=119407570&amp;loc=SL82919249-210447<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=116634182&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProvisionForDoubtfulAccounts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=TRXD_TwoCustomersMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=TRXD_TwoCustomersMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>67
<FILENAME>R32.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3</span><table class="report" border="0" cellspacing="2" id="idp6935209808">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Business Combination (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationsAbstract', window );"><strong>Business Combinations [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock', window );">Schedule of Assets Acquired and Liabilities Assumed</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><font style="font: 10pt Times New Roman, Times, Serif"></font></p>

<table cellpadding="0" cellspacing="0" align="center" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Purchase Price Allocation</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 78%">Purchase Price</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 18%; text-align: right">770,291</td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td>Cash</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(49,728</td><td style="text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Accounts Receivable</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(114,899</td><td style="text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td>Inventory</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(76,156</td><td style="text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Prepaid</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(3,000</td><td style="text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Accounts Payable</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">199,312</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 1.5pt">Accrued Expenses</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">153</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="padding-bottom: 2.5pt">Goodwill</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">725,973</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr></table><span></span>
</td>
<td class="text"><p style="margin: 0pt"></p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>Purchase Price Allocation</b></font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="width: 65%"><font style="font-size: 10pt">Purchase Price</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%"><font style="font-size: 10pt">$</font></td>
    <td style="width: 32%; text-align: right"><font style="font-size: 10pt">770,291</font></td>
    <td style="width: 1%">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td><font style="font-size: 10pt">Cash</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">(49,728</font></td>
    <td><font style="font-size: 10pt">)</font></td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td><font style="font-size: 10pt">Accounts Receivable</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">(114,899</font></td>
    <td><font style="font-size: 10pt">)</font></td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td><font style="font-size: 10pt">Inventory</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">(76,156</font></td>
    <td><font style="font-size: 10pt">)</font></td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td><font style="font-size: 10pt">Prepaid</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">(3,000</font></td>
    <td><font style="font-size: 10pt">)</font></td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td><font style="font-size: 10pt">Accounts Payable</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">199,312</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-bottom: 1.5pt"><font style="font-size: 10pt">Accrued Expenses</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: black 1.5pt solid">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">153</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td style="padding-bottom: 2.5pt"><font style="font-size: 10pt">Goodwill</font></td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td>
    <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">725,973</font></td>
    <td style="padding-bottom: 2.5pt"></td></tr>
</table>


<p style="margin: 0pt"></p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionProFormaInformationTextBlock', window );">Schedule of Unaudited Pro Forma Statements of Operations</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">The
accompanying unaudited pro forma statements of operations presents the accounts of Trxade and CSP for the six- months ended June
30, 2018, assuming the acquisition occurred on January 1, 2018.</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<table cellpadding="0" cellspacing="0" align="center" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<tr style="vertical-align: bottom">
    <td style="font-weight: bold; border-bottom: Black 1.5pt solid">2018 Summary Statement of Operations</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Trxade</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">CSP</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Combined</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 55%; font-weight: bold">Revenue</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 11%; text-align: right">1,690,611</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 11%; text-align: right">1,323,117</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 11%; text-align: right">3,013,723</td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left">Net Income</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">102,782</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">64,800</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">167,582</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left">Net Income per common share &#8211; basic</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">0.00</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">0.01</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left">Net Income per common share - diluted</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">0.00</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">0.00</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold">Weighted average common shares - basic</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">31,985,827</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">31,985,827</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold">Weighted average common shares - diluted</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">34,472,811</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">34,472,811</td><td style="text-align: left">&#160;</td></tr>
</table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">The
accompanying unaudited pro forma statements of operations presents the accounts of Trxade and CSP for the three- months ended
June 30, 2018, assuming the acquisition occurred on January 1, 2018.</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<table cellpadding="0" cellspacing="0" align="center" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<tr style="vertical-align: bottom">
    <td style="font-weight: bold; border-bottom: Black 1.5pt solid">2018 Summary Statement of Operations</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Trxade</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">CSP</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Combined</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 55%; font-weight: bold">Revenue</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 11%; text-align: right">837,688</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 11%; text-align: right">677,900</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 11%; text-align: right">1,515,588</td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left">Net Income (Loss)</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">20,513</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">(12,185</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">8,328</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left">Net Income per common share &#8211; basic</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">0.00</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">0.00</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left">Net Income per common share - diluted</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">0.00</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">0.00</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold">Weighted average common shares - basic</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">31,985,827</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">31,985,827</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold">Weighted average common shares - diluted</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">34,479,406</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">34,479,406</td><td style="text-align: left">&#160;</td></tr></table><span></span>
</td>
<td class="text"><p style="margin: 0pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The accompanying unaudited pro forma combined
statements of operations presents the accounts of Trxade and CSP for the years ended December 31, 2018 and 2017, respectively,
assuming the acquisition occurred on January 1, 2017.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: bottom">
    <td style="border-bottom: black 1.5pt solid"><font style="font-size: 10pt"><b>2018 Summary Statement of Operations</b></font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>Trxade</b></font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>CSP</b></font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>Combined</b></font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="width: 52%"><font style="font-size: 10pt"><b>Revenue</b></font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%"><font style="font-size: 10pt">$</font></td>
    <td style="width: 13%; text-align: right"><font style="font-size: 10pt">3,436,360</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%"><font style="font-size: 10pt">$</font></td>
    <td style="width: 13%; text-align: right"><font style="font-size: 10pt">2,387,636</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%"><font style="font-size: 10pt">$</font></td>
    <td style="width: 13%; text-align: right"><font style="font-size: 10pt">5,823,996</font></td>
    <td style="width: 1%">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-bottom: 2.5pt"><font style="font-size: 10pt"><b>Net Income (Loss)</b></font></td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td>
    <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">125,626</font></td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td>
    <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">(6,723</font></td>
    <td style="padding-bottom: 2.5pt"><font style="font-size: 10pt">)</font></td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td>
    <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">118,903</font></td>
    <td style="padding-bottom: 2.5pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-bottom: 2.5pt"><font style="font-size: 10pt"><b>Net Income per common share &#8211; basic</b></font></td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td>
    <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">0.00</font></td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt; text-align: right">&#160;</td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td>
    <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">0.00</font></td>
    <td style="padding-bottom: 2.5pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-bottom: 2.5pt"><font style="font-size: 10pt"><b>Net Income per common share - diluted</b></font></td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td>
    <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">0.00</font></td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt; text-align: right">&#160;</td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td>
    <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">0.00</font></td>
    <td style="padding-bottom: 2.5pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td><font style="font-size: 10pt"><b>Weighted average common shares - basic</b></font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">32,260,622</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">32,260,622</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td><font style="font-size: 10pt"><b>Weighted average common shares - diluted</b></font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">34,958,502</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">34,958,502</font></td>
    <td>&#160;</td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>&#160;</b></p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: bottom">
    <td style="padding-bottom: 1.5pt"><font style="font-size: 10pt"><b>2017 Summary Statement of Operations</b></font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>Trxade</b></font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>CSP</b></font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>Combined</b></font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="width: 52%"><font style="font-size: 10pt"><b>Revenue</b></font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%"><font style="font-size: 10pt">$</font></td>
    <td style="width: 13%; text-align: right"><font style="font-size: 10pt">2,931,280</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%"><font style="font-size: 10pt">$</font></td>
    <td style="width: 13%; text-align: right"><font style="font-size: 10pt">2,633,914</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%"><font style="font-size: 10pt">$</font></td>
    <td style="width: 13%; text-align: right"><font style="font-size: 10pt">5,565,194</font></td>
    <td style="width: 1%">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-bottom: 2.5pt"><font style="font-size: 10pt"><b>Net Income (Loss)</b></font></td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td>
    <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">288,983</font></td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td>
    <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">(63,132</font></td>
    <td style="padding-bottom: 2.5pt"><font style="font-size: 10pt">)</font></td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td>
    <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">225,851</font></td>
    <td style="padding-bottom: 2.5pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-bottom: 2.5pt"><font style="font-size: 10pt"><b>Net Income per common share &#8211; basic</b></font></td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td>
    <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">0.01</font></td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt; text-align: right">&#160;</td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td>
    <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">0.01</font></td>
    <td style="padding-bottom: 2.5pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="padding-bottom: 2.5pt"><font style="font-size: 10pt"><b>Net Income per common share - diluted</b></font></td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td>
    <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">0.01</font></td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt; text-align: right">&#160;</td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td>
    <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">0.01</font></td>
    <td style="padding-bottom: 2.5pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td><font style="font-size: 10pt"><b>Weighted average common shares - basic</b></font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">31,955,416</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">31,955,416</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td><font style="font-size: 10pt"><b>Weighted average common shares - diluted</b></font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">34,086,251</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">34,086,251</font></td>
    <td></td></tr>
</table>


<p style="margin: 0pt"></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionProFormaInformationTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of pro forma results of operations for a material business acquisition or series of individually immaterial business acquisitions that are material in the aggregate.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionProFormaInformationTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the amounts recognized as of the acquisition date for each major class of assets acquired and liabilities assumed. May include but not limited to the following: (a) acquired receivables; (b) contingencies recognized at the acquisition date; and (c) the fair value of noncontrolling interests in the acquiree.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=116869197&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>68
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3</span><table class="report" border="0" cellspacing="2" id="idp6654006560">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Organization and Basis of Presentation<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock', window );">Organization and Basis of Presentation</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif"><b>NOTE
1 &#8211; ORGANIZATION AND BASIS OF PRESENTATION</b></font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">Trxade
Group, Inc. (&#8220;we&#8221;, &#8220;our&#8221;, &#8220;Trxade&#8221;, and the &#8220;Company&#8221;) owns 100% of
Trxade, Inc., Integra Pharma Solutions, LLC, Community Specialty Pharmacy, LLC and Alliance Pharma Solutions, LLC. The merger
of Trxade, Inc. and Trxade Group, Inc. occurred in May 2013. Community Specialty Pharmacy was acquired in October
2018.</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.5in"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">Trxade,
Inc. operates a web-based market platform that enables commerce among healthcare buyers and sellers of pharmaceuticals, accessories
and services.</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">Integra
Pharma Solutions, LLC is a licensed pharmaceutical wholesaler and sells brand, generic and non-drug products.</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">Community
Specialty Pharmacy, LLC is an accredited independent retail pharmacy with a focus on specialty medications. The company operates
with innovative pharmacy model which offers home delivery services to any patient thereby providing convenience.</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">Alliance
Pharma Solutions, LLC has developed same day Pharma delivery software &#8211; Delivmeds.com and invested in SyncHealth MSO, LLC
a managed services organization during January 2019.</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif"><i>Basis
of Presentation</i> - The accompanying unaudited interim consolidated financial statements of Trxade Group, Inc. have been prepared
in accordance with accounting principles generally accepted in the United States of America and the rules of the Securities and
Exchange Commission and should be read in conjunction with the audited financial statements and notes thereto contained in the
Company&#8217;s Form 10K.</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">In
the opinion of management, all adjustments, consisting of normal recurring adjustments, necessary for a fair presentation of financial
position and the results of operations for the interim periods presented have been reflected herein. The results of operations
for the interim periods are not necessarily indicative of the results to be expected for the full year. Notes to the financial
statements that would substantially duplicate the disclosures contained in the audited financial statements for the year ended
December 31, 2018 as reported in the Company&#8217;s Annual Report on Form 10K have been omitted.</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif"><i>Equity
Investments</i> &#8211; If the investments are less than 50% owned and more than 20% owned the entities use the equity method
of accounting in accordance with ASC 323-10 &#8211; Investments &#8211; Equity Method and Joint Ventures.</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">The share of income (loss) of such entities is recorded as a single amount as share in equity income (loss)
of investments. Dividends, if any, are recorded as a reduction of the investment.&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif"><i>Income
Per Common Share</i> &#8211; Basic net income per common share is computed by dividing net income available to common stockholders
by the weighted average number of common shares outstanding. Diluted net income per common share is computed similar to basic
net income per common share except that the denominator is increased to include the number of additional common shares that would
have been outstanding if the potential common shares had been issued and if the additional common shares were dilutive. The dilutive
effect of the Company&#8217;s options and warrants is computed using the treasury stock method while the dilutive effect of our
convertible notes is computed using the if-converted method.</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;<font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">The
following table sets forth the computation of basic and diluted Income per Share:</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="padding-bottom: 1.5pt; text-align: center">&#160;</td>
    <td colspan="6" style="text-align: center; border-bottom: Black 1.5pt solid">For three months ended June 30,</td><td style="padding-bottom: 1.5pt; text-align: center">&#160;</td><td style="padding-bottom: 1.5pt; text-align: center">&#160;</td>
    <td colspan="6" style="text-align: center; border-bottom: Black 1.5pt solid">For six months ended June 30,</td><td style="padding-bottom: 1.5pt; text-align: center">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="padding-bottom: 1.5pt; text-align: center">&#160;</td>
    <td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid">2019</td><td style="padding-bottom: 1.5pt; text-align: center">&#160;</td><td style="padding-bottom: 1.5pt; text-align: center">&#160;</td>
    <td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid">2018</td><td style="padding-bottom: 1.5pt; text-align: center">&#160;</td><td style="padding-bottom: 1.5pt; text-align: center">&#160;</td>
    <td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid">2019</td><td style="padding-bottom: 1.5pt; text-align: center">&#160;</td><td style="padding-bottom: 1.5pt; text-align: center">&#160;</td>
    <td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid">2018</td><td style="padding-bottom: 1.5pt; text-align: center">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify">Numerator:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="width: 40%; text-align: justify">Net Income</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 11%; text-align: right">57,981</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 11%; text-align: right">20,513</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 11%; text-align: right">183,210</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 11%; text-align: right">102,782</td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Numerator for basic and diluted EPS - income available to common Shareholders</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">57,981</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">20,513</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">183,210</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">102,782</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify">Denominator:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Denominator for basic EPS &#8211; Weighted average shares</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">33,726,489</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">31,985,827</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">33,546,329</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">31,985,827</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Dilutive Effect of Warrants, Options and Convertible Debt</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,627,262</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,493,579</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,807,422</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,486,984</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Denominator for diluted EPS &#8211; adjusted Weighted average shares and assumed Conversions</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">36,353,751</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">34,479,406</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">36,353,751</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">34,472,811</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Basic and Diluted income per common share</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">0.00</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">0.00</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">0.01</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">0.00</td><td style="text-align: left">&#160;</td></tr>
</table>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif"><i>Recent
Accounting Pronouncements </i>&#8211; The Company has implemented all new relevant accounting pronouncements that are in effect
through the date of these financial statements. The pronouncements did not have any material impact on the financial statements
unless otherwise disclosed, and the Company does not believe that there are any other new accounting pronouncements that have
been issued that might have a material impact on its consolidated financial position or results of operations.</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">Effective
January 1, 2019, the Company adopted ASU No. 2016-02, <i>Leases (Topic 842</i>) (&#8220;ASU 2016-02&#8221;) using the required
modified retrospective approach. The most significant changes under the new guidance include clarification of the definition of
a lease, and the requirements for lessees to recognize a Right of Use (&#8220;ROU&#8221;) asset and a lease liability for all
qualifying leases with terms longer than twelve months in the consolidated balance sheet. In addition, under Topic 842, additional
disclosures are required to meet the objective of enabling users of financial statements to assess the amount, timing and uncertainty
of cash flows arising from leases. See Footnote #7 below for more detail on the Company&#8217;s accounting with respect to leases.</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">Effective
January 1, 2019, the Company adopted ASU No. 2018-07, Compensation &#8211; Stock Based Compensation (Topic 718): Improvements
to Nonemployee Share-Based Payment Accounting (&#8220;ASU 2018-7&#8221;), which aligns accounting for share-based payments issued
to nonemployees to that of employees under the existing guidance of Topic 718, with certain exceptions. This update supersedes
previous guidance for equity-based payments to nonemployees under Subtopic 505-50, Equity &#8211; Equity-Based Payments to Non-Employees.
The adoption of ASU 2018-07 did not have a material impact on the Company&#8217;s consolidated financial statements.</font></p><span></span>
</td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif"><b>NOTE
1 &#8211; ORGANIZATION</b></font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">Trxade
Group, Inc. (&#8220;we&#8221;, &#8220;our&#8221;, &#8220;Trxade&#8221;, and the &#8220;Company&#8221;) owns 100% of
Trxade, Inc., Integra Pharma Solutions, LLC, Community Specialty Pharmacy, LLC and Alliance Pharma Solutions, LLC. The merger
of Trxade, Inc. and Trxade Group, Inc. occurred in May 2013. Community Specialty Pharmacy was acquired October
2018.</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">Trxade,
Inc. operates a web-based market platform that enables commerce among healthcare buyers and sellers of pharmaceuticals, accessories
and services.</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">Integra
Pharma Solutions, LLC is a licensed pharmaceutical wholesaler and sells brand, generic and non-drug products.</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><font style="font: 10pt Times New Roman, Times, Serif">Community
Specialty Pharmacy, LLC is an accredited independent retail pharmacy with a focus on specialty medications. The company operates
with innovative pharmacy model which offers home delivery services to any patient thereby providing convenience.</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><font style="font-family: Times New Roman, Times, Serif">Alliance
Pharma Solutions, LLC has developed same day Pharma delivery software &#8211; Delivmeds.com and invested in SyncHealth MSO, LLC
a managed services organization in January 2019. (See Note 13).</font></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the general note to the financial statements for the reporting entity which may include, descriptions of the basis of presentation, business description, significant accounting policies, consolidations, reclassifications, new pronouncements not yet adopted and changes in accounting principles.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -URI http://asc.fasb.org/topic&amp;trid=2197479<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -URI http://asc.fasb.org/topic&amp;trid=2134479<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -URI http://asc.fasb.org/topic&amp;trid=2122394<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -URI http://asc.fasb.org/topic&amp;trid=2122369<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>69
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3</span><table class="report" border="0" cellspacing="2" id="idp6935151200">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Consolidated Balance Sheets (Parenthetical) - USD ($)<br></strong></div></th>
<th class="th"><div>Jun. 30, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
<th class="th"><div>Dec. 31, 2017</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Series A Preferred stock, par value</a></td>
<td class="nump">$ 0.00001<span></span>
</td>
<td class="nump">$ 0.00001<span></span>
</td>
<td class="nump">$ 0.00001<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Series A Preferred stock, shares authorized</a></td>
<td class="nump">10,000,000<span></span>
</td>
<td class="nump">10,000,000<span></span>
</td>
<td class="nump">10,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesIssued', window );">Series A Preferred stock, shares issued</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Series A Preferred stock, shares outstanding</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value</a></td>
<td class="nump">$ 0.00001<span></span>
</td>
<td class="nump">$ 0.00001<span></span>
</td>
<td class="nump">$ 0.00001<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock, shares authorized</a></td>
<td class="nump">100,000,000<span></span>
</td>
<td class="nump">100,000,000<span></span>
</td>
<td class="nump">100,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, shares issued</a></td>
<td class="nump">33,726,489<span></span>
</td>
<td class="nump">33,285,827<span></span>
</td>
<td class="nump">31,985,827<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, shares outstanding</a></td>
<td class="nump">33,726,489<span></span>
</td>
<td class="nump">33,285,827<span></span>
</td>
<td class="nump">31,985,827<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=TRXD_ShortTermNotesPayableMember', window );">Short Term Notes Payable [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentUnamortizedDiscountCurrent', window );">Short-term notes payable, discount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 152<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentUnamortizedDiscountCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of debt discount to be amortized within one year or within the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1A<br> -URI http://asc.fasb.org/extlink&amp;oid=114775744&amp;loc=d3e28541-108399<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentUnamortizedDiscountCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=TRXD_ShortTermNotesPayableMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=TRXD_ShortTermNotesPayableMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>70
<FILENAME>R53.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3</span><table class="report" border="0" cellspacing="2" id="idp6610456752">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases (Details Narrative)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Jun. 30, 2019 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jun. 30, 2019 </div>
<div>USD ($) </div>
<div>Integer</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_TRXD_OperatingLeasesUnits', window );">Operating leases units | Integer</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_TRXD_OperatingLeaseAmortizationOfAssets', window );">Operating lease amortization of assets</a></td>
<td class="nump">$ 22,195<span></span>
</td>
<td class="nump">$ 43,939<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_TRXD_OperatingLeaseAmortizationOfLiabilities', window );">Operating lease amortization of liabilities</a></td>
<td class="nump">$ 18,363<span></span>
</td>
<td class="nump">$ 36,276<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_TRXD_OperatingLeaseAmortizationOfAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Operating lease amortization of assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">TRXD_OperatingLeaseAmortizationOfAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>TRXD_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_TRXD_OperatingLeaseAmortizationOfLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Operating lease amortization of liabilities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">TRXD_OperatingLeaseAmortizationOfLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>TRXD_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_TRXD_OperatingLeasesUnits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Operating leases units.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">TRXD_OperatingLeasesUnits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>TRXD_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>71
<FILENAME>R57.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3</span><table class="report" border="0" cellspacing="2" id="idp6941323680">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Income Taxes - Schedule of Deferred Tax Assets (Details) (10-K) - USD ($)<br></strong></div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
<th class="th"><div>Dec. 31, 2017</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards', window );">Federal loss carry forwards</a></td>
<td class="nump">$ 922,850<span></span>
</td>
<td class="nump">$ 963,833<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsValuationAllowance', window );">Less: valuation allowance</a></td>
<td class="num">(922,850)<span></span>
</td>
<td class="num">(963,833)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsLiabilitiesNet', window );">Deferred tax assets</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsLiabilitiesNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, without jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsLiabilitiesNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32621-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32632-109319<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 25<br> -Paragraph 20<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=117330534&amp;loc=d3e28680-109314<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsOperatingLossCarryforwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>72
<FILENAME>R46.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3</span><table class="report" border="0" cellspacing="2" id="idp6777487440">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Warrants (Details Narrative) (10-K) - shares<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2018</div></th>
<th class="th"><div>Dec. 31, 2017</div></th>
<th class="th"><div>Oct. 15, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Warrant purchased from common stock</a></td>
<td class="nump">161,538<span></span>
</td>
<td class="nump">87,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_TRXD_WarrantIssuedForRenewalOfConvertibleDebt', window );">Warrant issued for renewal of convertible debt</a></td>
<td class="nump">10,000<span></span>
</td>
<td class="nump">28,150<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight', window );">Warrants exercised</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">25,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures', window );">Warrant forfeited of shares</a></td>
<td class="nump">435,000<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LegalEntityAxis=TRXD_CommunitySpecialtyPharmacyLLCMember', window );">Community Specialty Pharmacy, LLC [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Warrant purchased from common stock</a></td>
<td class="nump">405,507<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">405,507<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_TRXD_WarrantIssuedForRenewalOfConvertibleDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Warrant issued for renewal of convertible debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">TRXD_WarrantIssuedForRenewalOfConvertibleDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>TRXD_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of securities into which each warrant or right may be converted. For example, but not limited to, each warrant may be converted into two shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(i)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares under non-option equity instrument agreements that were cancelled as a result of occurrence of a terminating event.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=TRXD_CommunitySpecialtyPharmacyLLCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=TRXD_CommunitySpecialtyPharmacyLLCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>73
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>74
<FILENAME>R42.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3</span><table class="report" border="0" cellspacing="2" id="idp6941153824">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Long Term Debt - Schedule of Future Maturities of Long-term Debt (Details) (10-K)<br></strong></div></th>
<th class="th">
<div>Dec. 31, 2018 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo', window );">Due in 2020</a></td>
<td class="nump">$ 222,552<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree', window );">Due in 2021</a></td>
<td class="nump">300,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour', window );">Due in 2022</a></td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive', window );">Due in 2023</a></td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Total Debt</a></td>
<td class="nump">$ 522,052<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=109500613&amp;loc=SL6031897-161870<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=119400593&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=6876686&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirements, and other securities issued that are redeemable by holder at fixed or determinable prices and dates maturing in the fifth fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04.(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e24072-122690<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6802200&amp;loc=d3e1835-112601<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirements, and other securities issued that are redeemable by holder at fixed or determinable prices and dates maturing in the fourth fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04.(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e24072-122690<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6802200&amp;loc=d3e1835-112601<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirements, and other securities issued that are redeemable by holder at fixed or determinable prices and dates maturing in the third fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04.(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e24072-122690<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6802200&amp;loc=d3e1835-112601<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirements, and other securities issued that are redeemable by holder at fixed or determinable prices and dates maturing in the second fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04.(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e24072-122690<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6802200&amp;loc=d3e1835-112601<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>75
<FILENAME>R61.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3</span><table class="report" border="0" cellspacing="2" id="idp6781244640">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment Reporting - Schedule of Business Interests Into Reportable Segments (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2019</div></th>
<th class="th"><div>Jun. 30, 2018</div></th>
<th class="th"><div>Jun. 30, 2019</div></th>
<th class="th"><div>Jun. 30, 2018</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
<th class="th"><div>Dec. 31, 2017</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue</a></td>
<td class="nump">$ 1,916,414<span></span>
</td>
<td class="nump">$ 837,688<span></span>
</td>
<td class="nump">$ 3,428,935<span></span>
</td>
<td class="nump">$ 1,690,611<span></span>
</td>
<td class="nump">$ 3,831,778<span></span>
</td>
<td class="nump">$ 2,931,280<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GrossProfit', window );">Gross Profit</a></td>
<td class="nump">1,163,276<span></span>
</td>
<td class="nump">$ 837,688<span></span>
</td>
<td class="nump">2,309,958<span></span>
</td>
<td class="nump">$ 1,690,611<span></span>
</td>
<td class="nump">3,382,729<span></span>
</td>
<td class="nump">2,931,280<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">Segment Assets</a></td>
<td class="nump">3,678,065<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,678,065<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,227,587<span></span>
</td>
<td class="nump">$ 617,476<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Segment Profit/Loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">183,210<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=TRXD_TrxadeIncMember', window );">Trxade, Inc.[Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,182,668<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,407,822<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GrossProfit', window );">Gross Profit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,407,822<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">Segment Assets</a></td>
<td class="nump">1,401,724<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,401,724<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">822,412<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Segment Profit/Loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,166,543<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,371,615<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=TRXD_CommunitySpecialtyPharmacyLLCMember', window );">Community Specialty Pharmacy, LLC [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">892,357<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">395,418<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GrossProfit', window );">Gross Profit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(34,971)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">Segment Assets</a></td>
<td class="nump">224,863<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">224,863<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">112,123<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Segment Profit/Loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(61,628)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(116,588)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=TRXD_OtherMember', window );">Other [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">353,910<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">28,538<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GrossProfit', window );">Gross Profit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,878<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">Segment Assets</a></td>
<td class="nump">$ 2,051,478<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,051,478<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,293,052<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Segment Profit/Loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (921,705)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (1,245,989)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=6876686&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=115929826&amp;loc=d3e8736-108599<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=119400593&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GrossProfit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.1,2)<br> -URI http://asc.fasb.org/extlink&amp;oid=116634182&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GrossProfit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=SL7669619-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=SL7669625-108580<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=115929826&amp;loc=d3e8736-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=116874947&amp;loc=SL4591551-111686<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3000-108585<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569616-111683<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=115929826&amp;loc=d3e8933-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI http://asc.fasb.org/extlink&amp;oid=116874947&amp;loc=SL4591552-111686<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118956577&amp;loc=SL49130543-203045<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=118956577&amp;loc=SL49130545-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=TRXD_TrxadeIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=TRXD_TrxadeIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=TRXD_CommunitySpecialtyPharmacyLLCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=TRXD_CommunitySpecialtyPharmacyLLCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=TRXD_OtherMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=TRXD_OtherMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>76
<FILENAME>R65.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3</span><table class="report" border="0" cellspacing="2" id="idp6774469872">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Business Combination - Schedule of Unaudited Pro Forma Statements of Operations (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2018</div></th>
<th class="th"><div>Jun. 30, 2018</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
<th class="th"><div>Dec. 31, 2017</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionsProFormaRevenue', window );">Revenue</a></td>
<td class="nump">$ 1,515,588<span></span>
</td>
<td class="nump">$ 3,013,723<span></span>
</td>
<td class="nump">$ 5,823,996<span></span>
</td>
<td class="nump">$ 5,565,194<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss', window );">Net Income (Loss)</a></td>
<td class="nump">$ 8,328<span></span>
</td>
<td class="nump">$ 167,582<span></span>
</td>
<td class="nump">$ 118,903<span></span>
</td>
<td class="nump">$ 225,851<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionProFormaEarningsPerShareBasic', window );">Net Income per common share - basic</a></td>
<td class="nump">$ 0.00<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="nump">$ 0.00<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionProFormaEarningsPerShareDiluted', window );">Net Income per common share - diluted</a></td>
<td class="nump">$ 0.00<span></span>
</td>
<td class="nump">$ 0.00<span></span>
</td>
<td class="nump">$ 0.00<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageBasicSharesOutstandingProForma', window );">Weighted average common shares - basic</a></td>
<td class="nump">31,985,827<span></span>
</td>
<td class="nump">31,985,827<span></span>
</td>
<td class="nump">32,260,622<span></span>
</td>
<td class="nump">31,955,416<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProFormaWeightedAverageSharesOutstandingDiluted', window );">Weighted average common shares - diluted</a></td>
<td class="nump">34,479,406<span></span>
</td>
<td class="nump">34,472,811<span></span>
</td>
<td class="nump">34,958,502<span></span>
</td>
<td class="nump">34,086,251<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LegalEntityAxis=TRXD_TrxadeMember', window );">Trxade [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionsProFormaRevenue', window );">Revenue</a></td>
<td class="nump">$ 837,688<span></span>
</td>
<td class="nump">$ 1,690,611<span></span>
</td>
<td class="nump">$ 3,436,360<span></span>
</td>
<td class="nump">$ 2,931,280<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss', window );">Net Income (Loss)</a></td>
<td class="nump">$ 20,513<span></span>
</td>
<td class="nump">$ 102,782<span></span>
</td>
<td class="nump">$ 125,626<span></span>
</td>
<td class="nump">$ 288,983<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionProFormaEarningsPerShareBasic', window );">Net Income per common share - basic</a></td>
<td class="nump">$ 0.00<span></span>
</td>
<td class="nump">$ 0.00<span></span>
</td>
<td class="nump">$ 0.00<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionProFormaEarningsPerShareDiluted', window );">Net Income per common share - diluted</a></td>
<td class="nump">$ 0.00<span></span>
</td>
<td class="nump">$ 0.00<span></span>
</td>
<td class="nump">$ 0.00<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageBasicSharesOutstandingProForma', window );">Weighted average common shares - basic</a></td>
<td class="nump">31,985,827<span></span>
</td>
<td class="nump">31,985,827<span></span>
</td>
<td class="nump">32,260,622<span></span>
</td>
<td class="nump">31,955,416<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProFormaWeightedAverageSharesOutstandingDiluted', window );">Weighted average common shares - diluted</a></td>
<td class="nump">34,479,406<span></span>
</td>
<td class="nump">34,472,811<span></span>
</td>
<td class="nump">34,958,502<span></span>
</td>
<td class="nump">34,086,251<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LegalEntityAxis=TRXD_CommunitySpecialtyPharmacyLLCMember', window );">Community Specialty Pharmacy, LLC [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionsProFormaRevenue', window );">Revenue</a></td>
<td class="nump">$ 677,900<span></span>
</td>
<td class="nump">$ 1,323,117<span></span>
</td>
<td class="nump">$ 2,387,636<span></span>
</td>
<td class="nump">$ 2,633,914<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss', window );">Net Income (Loss)</a></td>
<td class="num">$ (12,185)<span></span>
</td>
<td class="nump">$ 64,800<span></span>
</td>
<td class="num">$ (6,723)<span></span>
</td>
<td class="num">$ (63,132)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionProFormaEarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The pro forma basic net income per share for a period as if the business combination or combinations had been completed at the beginning of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionProFormaEarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionProFormaEarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The pro forma diluted net income per share for a period as if the business combination or combinations had been completed at the beginning of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionProFormaEarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The pro forma net Income or Loss for the period as if the business combination or combinations had been completed at the beginning of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionsProFormaRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The pro forma revenue for a period as if the business combination or combinations had been completed at the beginning of the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionsProFormaRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProFormaWeightedAverageSharesOutstandingDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average number of shares or units and dilutive common stock or unit equivalents outstanding in the calculation of proforma diluted earnings per share (earnings per unit), which is commonly presented in initial public offerings based on the terms of the offering.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProFormaWeightedAverageSharesOutstandingDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageBasicSharesOutstandingProForma">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average number of shares (units) outstanding in the calculation of pro forma basic earnings per share (earnings per unit), which is commonly presented in initial public offerings based on the terms of the offering.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageBasicSharesOutstandingProForma</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=TRXD_TrxadeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=TRXD_TrxadeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=TRXD_CommunitySpecialtyPharmacyLLCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=TRXD_CommunitySpecialtyPharmacyLLCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>77
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3</span><table class="report" border="0" cellspacing="2" id="idp6645911328">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Organization and Basis of Presentation (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock', window );">Schedule of Earnings Per Share, Basic and Diluted</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">The
following table sets forth the computation of basic and diluted Income per Share:</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="padding-bottom: 1.5pt; text-align: center">&#160;</td>
    <td colspan="6" style="text-align: center; border-bottom: Black 1.5pt solid">For three months ended June 30,</td><td style="padding-bottom: 1.5pt; text-align: center">&#160;</td><td style="padding-bottom: 1.5pt; text-align: center">&#160;</td>
    <td colspan="6" style="text-align: center; border-bottom: Black 1.5pt solid">For six months ended June 30,</td><td style="padding-bottom: 1.5pt; text-align: center">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="padding-bottom: 1.5pt; text-align: center">&#160;</td>
    <td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid">2019</td><td style="padding-bottom: 1.5pt; text-align: center">&#160;</td><td style="padding-bottom: 1.5pt; text-align: center">&#160;</td>
    <td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid">2018</td><td style="padding-bottom: 1.5pt; text-align: center">&#160;</td><td style="padding-bottom: 1.5pt; text-align: center">&#160;</td>
    <td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid">2019</td><td style="padding-bottom: 1.5pt; text-align: center">&#160;</td><td style="padding-bottom: 1.5pt; text-align: center">&#160;</td>
    <td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid">2018</td><td style="padding-bottom: 1.5pt; text-align: center">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify">Numerator:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="width: 40%; text-align: justify">Net Income</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 11%; text-align: right">57,981</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 11%; text-align: right">20,513</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 11%; text-align: right">183,210</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 11%; text-align: right">102,782</td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Numerator for basic and diluted EPS - income available to common Shareholders</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">57,981</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">20,513</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">183,210</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">102,782</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify">Denominator:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Denominator for basic EPS &#8211; Weighted average shares</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">33,726,489</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">31,985,827</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">33,546,329</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">31,985,827</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Dilutive Effect of Warrants, Options and Convertible Debt</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,627,262</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,493,579</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,807,422</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,486,984</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Denominator for diluted EPS &#8211; adjusted Weighted average shares and assumed Conversions</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">36,353,751</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">34,479,406</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">36,353,751</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">34,472,811</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Basic and Diluted income per common share</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">0.00</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">0.00</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">0.01</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">0.00</td><td style="text-align: left">&#160;</td></tr></table><span></span>
</td>
<td class="text"><p style="margin: 0pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The following table sets forth the computation
of basic and diluted income per common share for the years ended December 31, 2018 and 2017:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: bottom">
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt">December 31, 2018</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt">December 31, 2017</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td><font style="font-size: 10pt">Numerator:</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td style="width: 62%"><font style="font-size: 10pt">Net Income</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%"><font style="font-size: 10pt">$</font></td>
    <td style="width: 16%; text-align: right"><font style="font-size: 10pt">9,038</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%"><font style="font-size: 10pt">$</font></td>
    <td style="width: 16%; text-align: right"><font style="font-size: 10pt">288,983</font></td>
    <td style="width: 1%">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td><font style="font-size: 10pt">Numerator for basic and diluted income available to common shareholders</font></td>
    <td>&#160;</td>
    <td><font style="font-size: 10pt">$</font></td>
    <td style="text-align: right"><font style="font-size: 10pt">9,038</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td><font style="font-size: 10pt">$</font></td>
    <td style="text-align: right"><font style="font-size: 10pt">288,983</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td><font style="font-size: 10pt">Denominator:</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td><font style="font-size: 10pt">Denominator for basic income per common share &#8211; Weighted average common shares outstanding</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">32,260,622</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">31,955,416</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td><font style="font-size: 10pt">Dilutive effect of Common Stock Equivalents</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">2,697,880</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">2,130,835</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td><font style="font-size: 10pt">Denominator for diluted income per common share &#8211; adjusted weighted average common shares outstanding</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">34,958,502</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">34,086,251</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td><font style="font-size: 10pt">Basic and Diluted income per common share</font></td>
    <td>&#160;</td>
    <td><font style="font-size: 10pt">$</font></td>
    <td style="text-align: right"><font style="font-size: 10pt">0.00</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td><font style="font-size: 10pt">$</font></td>
    <td style="text-align: right"><font style="font-size: 10pt">0.01</font></td>
    <td></td></tr>
</table>


<p style="margin: 0pt"></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>78
<FILENAME>R27.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3</span><table class="report" border="0" cellspacing="2" id="idp6651351264">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Options (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Share-based Payment Arrangement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock', window );">Schedule of Estimate Fair Value of Stock Options</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">The following table summarizes the assumptions used to estimate the fair value of the stock options granted during the quarter
ended June 30, 2019.</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<table cellpadding="0" cellspacing="0" align="center" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid">2019</td><td style="padding-bottom: 1.5pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 78%; text-align: justify">Expected dividend yield</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: center">&#160;</td><td style="width: 18%; text-align: center">0%</td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify">Weighted-average expected volatility</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td style="text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">209-250%</font></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify">Weighted-average risk-free interest rate</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td style="text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">2.08-2.55%</font></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify">Expected life of options</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td style="text-align: center"><font style="font: 10pt Times New Roman, Times, Serif">5-7 years</font></td><td style="text-align: left">&#160;</td></tr></table><span></span>
</td>
<td class="text"><p style="margin: 0pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company uses the Black-Scholes option pricing
model to estimate the fair value of stock-based awards on the date of grant. The following table summarizes the assumptions used
to estimate the fair value of stock options granted during the years ended December 31, 2018 and 2017:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt">2018</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt">2017</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="width: 58%"><font style="font-size: 10pt">Expected dividend yield</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 18%; text-align: right"><font style="font-size: 10pt">0</font></td>
    <td style="width: 1%"><font style="font-size: 10pt">%</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 18%; text-align: right"><font style="font-size: 10pt">0</font></td>
    <td style="width: 1%"><font style="font-size: 10pt">%</font></td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td><font style="font-size: 10pt">Weighted-average expected volatility</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">192-265</font></td>
    <td><font style="font-size: 10pt">%</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">200</font></td>
    <td><font style="font-size: 10pt">%</font></td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td><font style="font-size: 10pt">Weighted-average risk-free interest rate</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">2.08-2.73</font></td>
    <td><font style="font-size: 10pt">%</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">1.92</font></td>
    <td><font style="font-size: 10pt">%</font></td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td><font style="font-size: 10pt">Expected life of warrants</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">4-5 years</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">4.74 -7.50 years</font></td>
    <td></td></tr>
</table>


<p style="margin: 0pt"></p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock', window );">Schedule of Stock Option Activity</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">The
following table represents stock option activity for the six-month period ended June 30, 2019:</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>Number</b></font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>Outstanding</b></font></p></td><td style="padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>Weighted</b></font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>Average</b></font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>Exercise Price</b></font></p></td><td style="padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>Contractual Life</b></font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>in Years</b></font></p></td><td style="padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>Intrinsic</b></font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>Value</b></font></p></td><td style="padding-bottom: 1.5pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 44%">Options Outstanding as of December 31, 2018</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 10%; text-align: right">1,732,846</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right">1.19</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 10%; text-align: right">6.98</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right">-</td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td>Options Exercisable as of December 31, 2018</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,107,259</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">0.96</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">5.91</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Options granted</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">505,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">0.43</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">9.86</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Options forfeited</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Options expired</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Options Outstanding as of June 30, 2019</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,237,846</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">0.73</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">7.27</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">88,350</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td>Options Exercisable as of June 30, 2019</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,239,384</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">0.91</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">5.77</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">8,809</td><td style="text-align: left">&#160;</td></tr></table><span></span>
</td>
<td class="text"><p style="margin: 0pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The following table represents stock option
activity for the two years ended December 31, 2018:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: bottom">
    <td style="padding-bottom: 1.5pt; text-align: center">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: center">&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>Number Outstanding</b></font></td>
    <td style="padding-bottom: 1.5pt; text-align: center">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: center">&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>Weighted Average Exercise Price</b></font></td>
    <td style="padding-bottom: 1.5pt; text-align: center">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: center">&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>Contractual Life in Years</b></font></td>
    <td style="padding-bottom: 1.5pt; text-align: center">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: center">&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>Intrinsic Value</b></font></td>
    <td style="padding-bottom: 1.5pt; text-align: center">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="width: 46%"><font style="font-size: 10pt">Options Outstanding as of December 31, 2016</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 11%; text-align: right"><font style="font-size: 10pt">1,044,500</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%"><font style="font-size: 10pt">$</font></td>
    <td style="width: 11%; text-align: right"><font style="font-size: 10pt">0.92</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 10%; text-align: right"><font style="font-size: 10pt">3.38</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%"><font style="font-size: 10pt">$</font></td>
    <td style="width: 10%; text-align: right"><font style="font-size: 10pt">-</font></td>
    <td style="width: 1%">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td><font style="font-size: 10pt">Options Exercisable as of December 31, 2016</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">584,000</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td><font style="font-size: 10pt">$</font></td>
    <td style="text-align: right"><font style="font-size: 10pt">1.05</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">3.02</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td><font style="font-size: 10pt">Options granted</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">263,846</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">0.64</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">9.05</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">-</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td><font style="font-size: 10pt">Options forfeited</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">(35,000</font></td>
    <td><font style="font-size: 10pt">)</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">1.02</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">8.25</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">-</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td><font style="font-size: 10pt">Options expired</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">(75,000</font></td>
    <td><font style="font-size: 10pt">)</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">1.13</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">4.54</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">-</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td><font style="font-size: 10pt">Options Outstanding as of December 31, 2017</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">1,197,846</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td><font style="font-size: 10pt">$</font></td>
    <td style="text-align: right"><font style="font-size: 10pt">0.97</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">6.96</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td><font style="font-size: 10pt">$</font></td>
    <td style="text-align: right"><font style="font-size: 10pt">-</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td><font style="font-size: 10pt">Options Exercisable as of December 31, 2017</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">781,300</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td><font style="font-size: 10pt">$</font></td>
    <td style="text-align: right"><font style="font-size: 10pt">1.02</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">6.30</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td><font style="font-size: 10pt">$</font></td>
    <td style="text-align: right"><font style="font-size: 10pt">-</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td><font style="font-size: 10pt">Options granted</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">560,400</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">0.50</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">9.26</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td><font style="font-size: 10pt">Options forfeited</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">(25,400</font></td>
    <td><font style="font-size: 10pt">)</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">0.46</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">9.06</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td><font style="font-size: 10pt">Options expired</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">-</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">-</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">-</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">-</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td><font style="font-size: 10pt">Options Outstanding as of December 31, 2018</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">1,732,846</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td><font style="font-size: 10pt">$</font></td>
    <td style="text-align: right"><font style="font-size: 10pt">1.19</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">6.98</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td><font style="font-size: 10pt">$</font></td>
    <td style="text-align: right"><font style="font-size: 10pt">-</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td><font style="font-size: 10pt">Options Exercisable as of December 31, 2018</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">1,107,259</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td><font style="font-size: 10pt">$</font></td>
    <td style="text-align: right"><font style="font-size: 10pt">0.96</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">5.91</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td><font style="font-size: 10pt">$</font></td>
    <td style="text-align: right"><font style="font-size: 10pt">-</font></td>
    <td></td></tr>
</table>


<p style="margin: 0pt"></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>79
<FILENAME>R47.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3</span><table class="report" border="0" cellspacing="2" id="idp6777477200">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Warrants - Schedule of Outstanding and Exercisable Warrants (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
<th class="th"><div>Dec. 31, 2017</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures', window );">Number of Outstanding Shares, Warrants forfeited</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">435,000<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_WarrantMember', window );">Warrant [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber', window );">Number of Outstanding Shares, Warrants Outstanding Beginning</a></td>
<td class="nump">2,880,141<span></span>
</td>
<td class="nump">2,738,096<span></span>
</td>
<td class="nump">2,647,446<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted', window );">Number of Outstanding Shares, Warrants granted</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">577,045<span></span>
</td>
<td class="nump">115,650<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures', window );">Number of Outstanding Shares, Warrants forfeited</a></td>
<td class="text"> <span></span>
</td>
<td class="num">(435,000)<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised', window );">Number of Outstanding Shares, Warrants exercised</a></td>
<td class="num">(16,666)<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(25,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber', window );">Number of Outstanding Shares, Warrants Outstanding Ending</a></td>
<td class="nump">2,863,475<span></span>
</td>
<td class="nump">2,880,141<span></span>
</td>
<td class="nump">2,738,096<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_TRXD_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice', window );">Weighted Average Exercise Price, Outstanding Beginning</a></td>
<td class="nump">$ 0.08<span></span>
</td>
<td class="nump">$ 0.24<span></span>
</td>
<td class="nump">$ 0.24<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_TRXD_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGrantsInPeriodWeightedAverageExercisePrice', window );">Weighted Average Exercise Price, Warrants granted</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">0.02<span></span>
</td>
<td class="nump">0.18<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_TRXD_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitedInPeriodWeightedAverageExercisePrice', window );">Weighted Average Exercise Price, Warrants forfeited</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_TRXD_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisesInPeriodWeightedAverageExercisePrice', window );">Weighted Average Exercise Price, Warrants exercised</a></td>
<td class="nump">0.01<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">0.01<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_TRXD_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice', window );">Weighted Average Exercise Price, Outstanding Ending</a></td>
<td class="nump">$ 0.08<span></span>
</td>
<td class="nump">$ 0.08<span></span>
</td>
<td class="nump">$ 0.24<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_TRXD_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageRemainingContractualTermBeginning', window );">Weighted Average Remaining Contractual Life Warrants Outstanding, Beginning</a></td>
<td class="text">3 years 8 months 26 days<span></span>
</td>
<td class="text">3 years 3 months 11 days<span></span>
</td>
<td class="text">4 years 2 months 27 days<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_TRXD_WeightedAverageRemainingContractualLifeWarrantsOutstandingGranted', window );">Weighted Average Remaining Contractual Life Warrants Outstanding, granted</a></td>
<td class="text">0 years<span></span>
</td>
<td class="text">7 years 1 month 9 days<span></span>
</td>
<td class="text">5 years<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_TRXD_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageRemainingContractualTermEnding', window );">Weighted Average Remaining Contractual Life Warrants Outstanding Ending</a></td>
<td class="text">3 years 29 days<span></span>
</td>
<td class="text">3 years 8 months 26 days<span></span>
</td>
<td class="text">3 years 3 months 11 days<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_TRXD_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingIntrinsicValue', window );">Aggregate Intrinsic Value Outstanding Beginning</a></td>
<td class="nump">$ 782,385<span></span>
</td>
<td class="nump">$ 937,567<span></span>
</td>
<td class="nump">$ 930,751<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_TRXD_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingIntrinsicValue', window );">Aggregate Intrinsic Value Outstanding Ending</a></td>
<td class="nump">$ 1,448,356<span></span>
</td>
<td class="nump">$ 782,385<span></span>
</td>
<td class="nump">$ 937,567<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_TRXD_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisesInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which non-option equity holders acquired shares when converting their non-option equity into shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">TRXD_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisesInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>TRXD_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_TRXD_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitedInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Exercise Price Per Share Warrants forfeited.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">TRXD_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitedInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>TRXD_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_TRXD_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGrantsInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average per share amount at which grantees can acquire shares of common stock by exercise of non-option equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">TRXD_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGrantsInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>TRXD_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_TRXD_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees can acquire the shares reserved for issuance under the stock non-option equity plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">TRXD_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>TRXD_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_TRXD_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageRemainingContractualTermBeginning">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for non-option equity awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">TRXD_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageRemainingContractualTermBeginning</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>TRXD_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_TRXD_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageRemainingContractualTermEnding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for non-option equity awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">TRXD_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageRemainingContractualTermEnding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>TRXD_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_TRXD_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sharebased compensation arrangement by sharebased payment award non options outstanding intrinsic value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">TRXD_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>TRXD_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_TRXD_WeightedAverageRemainingContractualLifeWarrantsOutstandingGranted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for vested portions of non-option equity outstanding and currently exercisable or convertible, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">TRXD_WeightedAverageRemainingContractualLifeWarrantsOutstandingGranted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>TRXD_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of non-option equity instruments exercised by participants.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares under non-option equity instrument agreements that were cancelled as a result of occurrence of a terminating event.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Net number of non-option equity instruments granted to participants.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of equity instruments other than options outstanding, including both vested and non-vested instruments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_WarrantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_WarrantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>80
<FILENAME>R43.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3</span><table class="report" border="0" cellspacing="2" id="idp6782827104">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Shareholders' Equity (Details Narrative) - USD ($)<br></strong></div></th>
<th class="th" colspan="5">1 Months Ended</th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>May 31, 2019</div></th>
<th class="th"><div>Apr. 30, 2019</div></th>
<th class="th"><div>Feb. 28, 2019</div></th>
<th class="th"><div>Apr. 30, 2018</div></th>
<th class="th"><div>Apr. 30, 2017</div></th>
<th class="th"><div>Jun. 30, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
<th class="th"><div>Dec. 31, 2017</div></th>
<th class="th"><div>Feb. 28, 2017</div></th>
<th class="th"><div>May 31, 2016</div></th>
<th class="th"><div>Apr. 30, 2016</div></th>
<th class="th"><div>May 31, 2015</div></th>
<th class="th"><div>Apr. 30, 2015</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConvertibleNotesPayable', window );">Convertible promissory notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 181,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_TRXD_WarrantsIssued', window );">Warrants issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">25,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Warrant exercise price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_TRXD_StockIssuedDuringPeriodSharesWarrantsExercised', window );">Number of warrants exercised</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">16,666<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_TRXD_StockIssuedDuringPeriodValueWarrantsExercised', window );">Number of warrants exercised, value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 166<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Number of options, granted</a></td>
<td class="nump">505,000<span></span>
</td>
<td class="nump">505,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">560,400<span></span>
</td>
<td class="nump">253,846<span></span>
</td>
<td class="nump">505,000<span></span>
</td>
<td class="nump">560,400<span></span>
</td>
<td class="nump">263,846<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice', window );">Exercise price of options granted</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.43<span></span>
</td>
<td class="nump">$ 0.50<span></span>
</td>
<td class="nump">$ 0.64<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2', window );">Option term</a></td>
<td class="text">10 years<span></span>
</td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">6 years 11 months 23 days<span></span>
</td>
<td class="text">6 years 11 months 15 days<span></span>
</td>
<td class="text">3 years 4 months 17 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice', window );">Exercise price of options granted</a></td>
<td class="nump">$ 0.41<span></span>
</td>
<td class="nump">$ 0.41<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Option vested period</a></td>
<td class="text">4 years<span></span>
</td>
<td class="text">4 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice', window );">Exercise price of options granted</a></td>
<td class="nump">$ 0.44<span></span>
</td>
<td class="nump">$ 0.44<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Option vested period</a></td>
<td class="text">5 years<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_WarrantMember', window );">Warrant [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_TRXD_WarrantsIssued', window );">Warrants issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">16,666<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Warrant exercise price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=TRXD_ConvertiblePromissoryNoteMember', window );">Convertible Promissory Note [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConvertibleNotesPayable', window );">Convertible promissory notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 181,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 165,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 200,000<span></span>
</td>
<td class="nump">$ 200,000<span></span>
</td>
<td class="nump">$ 200,000<span></span>
</td>
<td class="nump">$ 200,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleConversionPrice1', window );">Conversion price per share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.50<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.85<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1.50<span></span>
</td>
<td class="nump">$ 1.50<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentPeriodicPayment', window );">Principal and accrued interest</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 211,983<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtConversionConvertedInstrumentSharesIssued1', window );">Debt instrument conversion shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">423,966<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Warrant exercise price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.65<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1.50<span></span>
</td>
<td class="nump">$ 1.50<span></span>
</td>
<td class="nump">$ 1.50<span></span>
</td>
<td class="nump">$ 1.50<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_TRXD_StockIssuedDuringPeriodSharesWarrantsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Stock issued during period shares warrants exercised.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">TRXD_StockIssuedDuringPeriodSharesWarrantsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>TRXD_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_TRXD_StockIssuedDuringPeriodValueWarrantsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Stock issued during period value warrants exercised.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">TRXD_StockIssuedDuringPeriodValueWarrantsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>TRXD_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_TRXD_WarrantsIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Warrants issued.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">TRXD_WarrantsIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>TRXD_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Exercise price per share or per unit of warrants or rights outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(i)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConvertibleNotesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Including the current and noncurrent portions, carrying value as of the balance sheet date of a written promise to pay a note, initially due after one year or beyond the operating cycle if longer, which can be exchanged for a specified amount of one or more securities (typically common stock), at the option of the issuer or the holder.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=6876686&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=6488278&amp;loc=d3e603758-122996<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16)(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=119400593&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConvertibleNotesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtConversionConvertedInstrumentSharesIssued1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of shares issued in exchange for the original debt being converted in a noncash (or part noncash) transaction. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or payments in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=98513485&amp;loc=d3e4332-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=98513485&amp;loc=d3e4304-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtConversionConvertedInstrumentSharesIssued1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentConvertibleConversionPrice1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The price per share of the conversion feature embedded in the debt instrument.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109500613&amp;loc=SL6031898-161870<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentConvertibleConversionPrice1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentPeriodicPayment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the required periodic payments including both interest and principal payments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 470<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=75038535&amp;loc=d3e64711-112823<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentPeriodicPayment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Gross number of share options (or share units) granted during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_WarrantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_WarrantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=TRXD_ConvertiblePromissoryNoteMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=TRXD_ConvertiblePromissoryNoteMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>81
<FILENAME>R68.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3</span><table class="report" border="0" cellspacing="2" id="idp6778145344">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Subsequent Events (Details Narrative) (10-K) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">1 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Feb. 28, 2019</div></th>
<th class="th"><div>Jan. 31, 2019</div></th>
<th class="th"><div>Jun. 30, 2019</div></th>
<th class="th"><div>Jun. 30, 2018</div></th>
<th class="th"><div>May 01, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
<th class="th"><div>Feb. 28, 2017</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentOwnershipPercentage', window );">Equity method investment ownership percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_TRXD_WarrantsIssued', window );">Warrants issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">25,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Warrant exercise price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConversionOfStockAmountConverted1', window );">Value of common stock shares converted</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 211,983<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_OwnershipAxis=TRXD_SyncHealthMSOLLCMember', window );">SyncHealth MSO, LLC [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentOwnershipPercentage', window );">Equity method investment ownership percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LegalEntityAxis=TRXD_AlliancePharmaSolutionLLCMember', window );">Alliance Pharma Solution, LLC [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentOwnershipPercentage', window );">Equity method investment ownership percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">49.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LegalEntityAxis=TRXD_AlliancePharmaSolutionLLCMember', window );">Alliance Pharma Solution, LLC [Member] | SyncHealth MSO, LLC [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentOwnershipPercentage', window );">Equity method investment ownership percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">30.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LegalEntityAxis=TRXD_AlliancePharmaSolutionLLCMember', window );">Alliance Pharma Solution, LLC [Member] | SyncHealth MSO, LLC [Member] | May 1, 2019 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentOwnershipPercentage', window );">Equity method investment ownership percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LegalEntityAxis=TRXD_AlliancePharmaSolutionLLCMember', window );">Alliance Pharma Solution, LLC [Member] | SyncHealth MSO, LLC [Member] | August 1, 2019 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentOwnershipPercentage', window );">Equity method investment ownership percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LegalEntityAxis=TRXD_AlliancePharmaSolutionLLCMember', window );">Alliance Pharma Solution, LLC [Member] | SyncHealth MSO, LLC [Member] | November 1, 2019 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentOwnershipPercentage', window );">Equity method investment ownership percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LegalEntityAxis=TRXD_AlliancePharmaSolutionLLCMember', window );">Alliance Pharma Solution, LLC [Member] | SyncHealth MSO, LLC [Member] | January 31, 2020 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentOwnershipPercentage', window );">Equity method investment ownership percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">51.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LegalEntityAxis=TRXD_PanOpticHealthLLCMember', window );">PanOptic Health, LLC [Member] | SyncHealth MSO, LLC [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentOwnershipPercentage', window );">Equity method investment ownership percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">70.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentOwnershipPercentage', window );">Equity method investment ownership percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">30.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferred1', window );">Business combination consideration transferred</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 250,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Promissory note issued amount</a></td>
<td class="nump">$ 150,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NotesPayable', window );">Principal and accrued interest</a></td>
<td class="nump">$ 211,983<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtConversionConvertedInstrumentSharesIssued1', window );">Conversion of convertible debt, converted number of shares</a></td>
<td class="nump">423,966<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_TRXD_WarrantsIssued', window );">Warrants issued</a></td>
<td class="nump">16,666<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Warrant exercise price</a></td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConversionOfStockSharesConverted1', window );">Number of common stock shares converted</a></td>
<td class="nump">16,666<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConversionOfStockAmountConverted1', window );">Value of common stock shares converted</a></td>
<td class="nump">$ 166<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event [Member] | Maximum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleConversionPrice1', window );">Conversion price of promissory note</a></td>
<td class="nump">$ 0.85<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event [Member] | Minimum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleConversionPrice1', window );">Conversion price of promissory note</a></td>
<td class="nump">$ 0.50<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event [Member] | Alliance Pharma Solution, LLC [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued', window );">Shares transferred</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">250,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentOwnershipPercentage', window );">Equity method investment ownership percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">49.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event [Member] | Alliance Pharma Solution, LLC [Member] | SyncHealth MSO, LLC [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentOwnershipPercentage', window );">Equity method investment ownership percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">30.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event [Member] | PanOptic Health, LLC [Member] | SyncHealth MSO, LLC [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentOwnershipPercentage', window );">Equity method investment ownership percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">70.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_TRXD_WarrantsIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Warrants issued.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">TRXD_WarrantsIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>TRXD_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of equity interests issued or issuable to acquire entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=35744584&amp;loc=d3e6927-128479<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationConsiderationTransferred1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 30<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=116859721&amp;loc=d3e6613-128477<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=35744584&amp;loc=d3e6927-128479<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 30<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=116859721&amp;loc=d3e6578-128477<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationConsiderationTransferred1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Exercise price per share or per unit of warrants or rights outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(i)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConversionOfStockAmountConverted1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The value of the stock converted in a noncash (or part noncash) transaction. Noncash is defined as transactions during a period that do not result in cash receipts or cash payments in the period. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=98513485&amp;loc=d3e4313-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=98513485&amp;loc=d3e4332-108586<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=98513485&amp;loc=d3e4304-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConversionOfStockAmountConverted1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConversionOfStockSharesConverted1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of shares converted in a noncash (or part noncash) transaction. Noncash is defined as transactions during a period that do not result in cash receipts or cash payments in the period. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=98513485&amp;loc=d3e4313-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=98513485&amp;loc=d3e4304-108586<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=98513485&amp;loc=d3e4332-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConversionOfStockSharesConverted1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtConversionConvertedInstrumentSharesIssued1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of shares issued in exchange for the original debt being converted in a noncash (or part noncash) transaction. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or payments in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=98513485&amp;loc=d3e4332-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=98513485&amp;loc=d3e4304-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtConversionConvertedInstrumentSharesIssued1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentConvertibleConversionPrice1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The price per share of the conversion feature embedded in the debt instrument.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109500613&amp;loc=SL6031898-161870<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentConvertibleConversionPrice1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFaceAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face (par) amount of debt instrument at time of issuance.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=114775744&amp;loc=d3e28551-108399<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFaceAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentOwnershipPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentOwnershipPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NotesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Including the current and noncurrent portions, aggregate carrying amount of all types of notes payable, as of the balance sheet date, with initial maturities beyond one year or beyond the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=119400593&amp;loc=d3e572229-122910<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=6876686&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NotesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_OwnershipAxis=TRXD_SyncHealthMSOLLCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_OwnershipAxis=TRXD_SyncHealthMSOLLCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=TRXD_AlliancePharmaSolutionLLCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=TRXD_AlliancePharmaSolutionLLCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardDateAxis=TRXD_MayOneTwoThousandNineteenMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardDateAxis=TRXD_MayOneTwoThousandNineteenMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardDateAxis=TRXD_AugustOneTwoThousandNineteenMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardDateAxis=TRXD_AugustOneTwoThousandNineteenMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardDateAxis=TRXD_NovemberOneTwoThousandNineteenMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardDateAxis=TRXD_NovemberOneTwoThousandNineteenMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardDateAxis=TRXD_JanuaryThortyOneTwoThousandTwentyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardDateAxis=TRXD_JanuaryThortyOneTwoThousandTwentyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=TRXD_PanOpticHealthLLCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=TRXD_PanOpticHealthLLCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>83
<FILENAME>R60.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3</span><table class="report" border="0" cellspacing="2" id="idp6609082992">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Commitments and Contingencies - Schedule of Future Minimum Rental Payments Under Non-cancelable Operating Leases (Details) (10-K)<br></strong></div></th>
<th class="th">
<div>Dec. 31, 2018 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent', window );">2019</a></td>
<td class="nump">$ 156,024<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears', window );">2020</a></td>
<td class="nump">160,709<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears', window );">2021</a></td>
<td class="nump">165,506<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears', window );">2022</a></td>
<td class="nump">49,080<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFiveYears', window );">2023</a></td>
<td class="nump">41,934<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDue', window );">Total</a></td>
<td class="nump">$ 573,253<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of required minimum rental payments for leases having an initial or remaining non-cancelable letter-terms in excess of one year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=77902758&amp;loc=d3e41502-112717<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 10<br> -Section 55<br> -Paragraph 40<br> -Subparagraph (Note 3)<br> -URI http://asc.fasb.org/extlink&amp;oid=82846649&amp;loc=d3e38371-112697<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasesFutureMinimumPaymentsDue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due in the next fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=77902758&amp;loc=d3e41502-112717<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 10<br> -Section 55<br> -Paragraph 40<br> -Subparagraph (Note 3)<br> -URI http://asc.fasb.org/extlink&amp;oid=82846649&amp;loc=d3e38371-112697<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFiveYears">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due in the fifth fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=77902758&amp;loc=d3e41502-112717<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 10<br> -Section 55<br> -Paragraph 40<br> -Subparagraph (Note 3)<br> -URI http://asc.fasb.org/extlink&amp;oid=82846649&amp;loc=d3e38371-112697<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFiveYears</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due in the fourth fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=77902758&amp;loc=d3e41502-112717<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 10<br> -Section 55<br> -Paragraph 40<br> -Subparagraph (Note 3)<br> -URI http://asc.fasb.org/extlink&amp;oid=82846649&amp;loc=d3e38371-112697<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due in the third fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 10<br> -Section 55<br> -Paragraph 40<br> -Subparagraph (Note 3)<br> -URI http://asc.fasb.org/extlink&amp;oid=82846649&amp;loc=d3e38371-112697<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=77902758&amp;loc=d3e41502-112717<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due in the second fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=77902758&amp;loc=d3e41502-112717<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 10<br> -Section 55<br> -Paragraph 40<br> -Subparagraph (Note 3)<br> -URI http://asc.fasb.org/extlink&amp;oid=82846649&amp;loc=d3e38371-112697<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>84
<FILENAME>R64.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3</span><table class="report" border="0" cellspacing="2" id="idp6765520848">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Business Combination - Schedule of Assets Acquired and Liabilities Assumed (Details) - USD ($)<br></strong></div></th>
<th class="th"><div>Oct. 15, 2018</div></th>
<th class="th"><div>Jun. 30, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
<th class="th"><div>Dec. 31, 2017</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 725,973<span></span>
</td>
<td class="nump">$ 725,973<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LegalEntityAxis=TRXD_CommunitySpecialtyPharmacyLLCMember', window );">Community Specialty Pharmacy, LLC [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferred1', window );">Purchase Price</a></td>
<td class="nump">$ 770,291<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents', window );">Cash</a></td>
<td class="num">(49,728)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables', window );">Accounts Receivable</a></td>
<td class="num">(114,899)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory', window );">Inventory</a></td>
<td class="num">(76,156)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets', window );">Prepaid</a></td>
<td class="num">(3,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable', window );">Accounts Payable</a></td>
<td class="nump">199,312<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther', window );">Accrued Expenses</a></td>
<td class="nump">153<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">$ 725,973<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationConsiderationTransferred1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 30<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=116859721&amp;loc=d3e6613-128477<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=35744584&amp;loc=d3e6927-128479<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 30<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=116859721&amp;loc=d3e6578-128477<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationConsiderationTransferred1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions, acquired at the acquisition date. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=116869197&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer, acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=116869197&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount due from customers or clients for goods or services, including trade receivables, that have been delivered or sold in the normal course of business, and amounts due from others, including related parties expected to be converted to cash, sold or exchanged within one year or the normal operating cycle, if longer, acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=116869197&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities incurred for goods and services received that are used in an entity's business and related party payables, assumed at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=116869197&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of other liabilities due within one year or within the normal operating cycle, if longer, assumed at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=116869197&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of inventory recognized as of the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=116869197&amp;loc=d3e4845-128472<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 55<br> -Paragraph 37<br> -URI http://asc.fasb.org/extlink&amp;oid=116868840&amp;loc=d3e2207-128464<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=77989000&amp;loc=SL49117168-202975<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=TRXD_CommunitySpecialtyPharmacyLLCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=TRXD_CommunitySpecialtyPharmacyLLCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>85
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3</span><table class="report" border="0" cellspacing="2" id="idp6935177472">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies (Policies)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock', window );">Basis of Presentation</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif"><i>Basis
of Presentation</i> - The accompanying unaudited interim consolidated financial statements of Trxade Group, Inc. have been prepared
in accordance with accounting principles generally accepted in the United States of America and the rules of the Securities and
Exchange Commission and should be read in conjunction with the audited financial statements and notes thereto contained in the
Company&#8217;s Form 10K.</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">In
the opinion of management, all adjustments, consisting of normal recurring adjustments, necessary for a fair presentation of financial
position and the results of operations for the interim periods presented have been reflected herein. The results of operations
for the interim periods are not necessarily indicative of the results to be expected for the full year. Notes to the financial
statements that would substantially duplicate the disclosures contained in the audited financial statements for the year ended
December 31, 2018 as reported in the Company&#8217;s Annual Report on Form 10K have been omitted.</font></p><span></span>
</td>
<td class="text"><p style="margin: 0pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Basis of Presentation &#8211; Historically,
operations have been funded primarily through the sale of equity or debt securities and operating activities. In 2018, the Company
renewed outstanding debt (See Note 3 and 4), raised capital (See Note 5) and had positive operating cash flow from operations.
The Company has the ability to maintain the current level of spending or reduce expenditures to maintain operations if funding
is not available.</p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentsPolicy', window );">Equity Investments</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif"><i>Equity
Investments</i> &#8211; If the investments are less than 50% owned and more than 20% owned the entities use the equity method
of accounting in accordance with ASC 323-10 &#8211; Investments &#8211; Equity Method and Joint Ventures.</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">The share of income (loss) of such entities is recorded as a single amount as share in equity income (loss)
of investments. Dividends, if any, are recorded as a reduction of the investment.&#160;</font></p><span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UseOfEstimates', window );">Use of Estimates</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"><p style="margin: 0pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Use of Estimates &#8211; In preparing these
financial statements, management is required to make estimates and assumptions that effect the reported amounts of assets and
liabilities and disclosure of contingent assets and liabilities as of the date of the financial statements and the reported amount
of revenues and expenses during the reporting periods. Actual results could differ from those estimates.</p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PriorPeriodReclassificationAdjustmentDescription', window );">Reclassification</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"><p style="margin: 0pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Reclassification &#8211; Certain prior year
amounts have been reclassified to conform to the current year presentation.</p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConsolidationPolicyTextBlock', window );">Principle of Consolidation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"><p style="margin: 0pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Principle of Consolidation &#8211; The Company&#8217;s
consolidated financial statements include the accounts of Trxade Group, Inc., Trxade, Inc., Integra Pharma Solutions, Inc., Alliance
Pharma Solutions, LLC and Community Specialty Pharmacy, LLC. All significant intercompany accounts and transactions have been
eliminated.</p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsPolicyTextBlock', window );">Cash and Cash Equivalents</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"><p style="margin: 0pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Cash and Cash Equivalents &#8211; Cash in
bank accounts are at risk to the extent that they exceed U.S. Federal Deposit Insurance Corporation insured amounts. All investments
purchased with a maturity of three months or less are cash equivalents. Cash and cash equivalents are available on demand and
are generally within of FDIC insurance limits for 2018.</p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TradeAndOtherAccountsReceivablePolicy', window );">Accounts Receivable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"><p style="margin: 0pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Accounts Receivable &#8211; The Company&#8217;s
receivables are from customers and are collected within 90 days. The Company determines the allowance based on known troubled
accounts, historical experience, and other currently available evidence. During the years ended December 31, 2018 and 2017, $2,271
of bad debt expense and $0 of recovery of bad debt was recognized, respectively.</p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryPolicyTextBlock', window );">Inventory</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"><p style="margin: 0pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Inventory &#8211; Inventories are stated at
the lower of cost or net realizable value. Cost is determined on a weighted average basis. On a quarterly basis, we analyze our
inventory levels and no reserve is maintained as obsolete or expired inventories are written off. There is no reserve for inventory
obsolescence during the periods presented.</p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtPolicyTextBlock', window );">Beneficial Conversion Features</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"><p style="margin: 0pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Beneficial Conversion Features &#8211; The
intrinsic value of a beneficial conversion feature inherent to a convertible note payable, which is not bifurcated and accounted
for separately from the convertible note payable and may not be settled in cash upon conversion, is treated as a discount to the
convertible note payable. This discount is amortized over the period from the date of issuance to the date the note is due using
the effective interest method. If the note payable is retired prior to the end of its contractual term, the unamortized discount
is expensed in the period of retirement to interest expense. In general, the beneficial conversion feature is measured by comparing
the effective conversion price, after considering the relative value of detachable instruments included in the financing transaction,
if any, to the fair value of the common shares at the commitment date to be received upon conversion.</p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativesReportingOfDerivativeActivity', window );">Derivative Financial Instruments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"><p style="margin: 0pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Derivative financial instruments &#8211; The
Company evaluates its financial instruments to determine if such instruments are derivatives or contain features that qualify
as embedded derivatives. For derivative financial instruments that are accounted for as liabilities, the derivative instrument
is initially recorded at its fair value and is then re-valued at each reporting date, with changes in the fair value reported
in the statements of operations. For stock-based derivative financial instruments, the Company uses a Black-Scholes option pricing
model, assuming maximum value, in accordance with ASC 815-15 &#8220;Derivative and Hedging&#8221; to value the derivative instruments
at inception and on subsequent valuation dates. The classification of derivative instruments, including whether such instruments
should be recorded as liabilities or as equity, is evaluated at the end of each reporting period. Derivative instrument liabilities
are classified in the balance sheet as current or non-current based on whether or not net-cash settlement of the derivative instrument
could be required within 12 months of the balance sheet date.</p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueOfFinancialInstrumentsPolicy', window );">Fair Value of Financial Instruments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"><p style="margin: 0pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Fair Value of Financial Instruments &#8211;
The Company measures its financial assets and liabilities in accordance with the requirements of FASB ASC 820, &#8220;Fair Value
Measurements and Disclosures&#8221;. ASC 820 clarifies the definition of fair value, prescribes methods for measuring fair value,
and establishes a fair value hierarchy to classify the inputs used in measuring fair value as follows:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Level 1 &#8211; Quoted prices are available
in active markets for identical assets or liabilities as of the reporting date. Active markets are those in which transactions
for the asset or liability occur in sufficient frequency and volume to provide pricing information on an ongoing basis. Level 1
primarily consists of financial instruments such as exchange-traded derivatives, marketable securities and listed equities.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Level 2 &#8211; Pricing inputs are other than
quoted prices in active markets included in level 1, which are either directly or indirectly observable as of the reported date
and includes those financial instruments that are valued using models or other valuation methodologies. These models are primarily
industry-standard models that consider various assumptions, including quoted forward prices for commodities, time value, volatility
factors, and current market and contractual prices for the underlying instruments, as well as other relevant economic measures.
Substantially all of these assumptions are observable in the marketplace throughout the full term of the instrument, can be derived
from observable data or are supported by observable levels at which transactions are executed in the marketplace. Instruments in
this category generally include non-exchange-traded derivatives such as commodity swaps, interest rate swaps, options and collars.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Level 3 &#8211; Pricing inputs include significant
inputs that are generally less observable from objective sources. These inputs may be used with internally developed methodologies
that result in management&#8217;s best estimate of fair value.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company does not have any assets or liabilities
that are required to be measured and recorded at fair value on a recurring basis.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The carrying amounts of cash, accounts receivable,
accounts payable, accrued liabilities and short-term debt approximate fair value because of the short-term nature of these instruments.
The carrying amount of long-term debt approximates fair value because the debt is based on current rates at which the Company
could borrow funds with similar maturities.</p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"><p style="margin: 0pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Goodwill &#8211; The Company accounts for
goodwill and intangible assets in accordance with ASC 350 &#8220;Intangibles Goodwill and Other&#8221;. ASC 350 requires that
goodwill and other intangibles with indefinite lives be tested for impairment annually or on an interim basis if events or circumstances
indicate that the fair value of an asset has decreased below its carrying value. The Company performed impairment analysis using
the qualitative analysis under ASC 350-20 and noted no impairment issues for 2018.</p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRecognitionPolicyTextBlock', window );">Revenue Recognition</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"><p style="margin: 0pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Revenue Recognition &#8211; In May 2014, the
Financial Accounting Standards Board (FASB) issued Accounting Standards Update No. 2014-09 (Topic 606) &#8220;Revenue from Contracts
with Customers.&#8221; Topic 606 supersedes the revenue recognition requirements in Accounting Standards Codification Topic 605,
&#8220;Revenue Recognition&#8221;, and requires entities to recognize revenue when they transfer control of promised goods or services
to customers in an amount that reflects the consideration to which the entity expects to be entitled to in exchange for those goods
or services. The Company adopted ASU 2014-09 using the modified retrospective approach effective January 1, 2018, under which prior
periods were not retrospectively adjusted. The adoption of Topic 606 does not have a material impact to our consolidated financial
statements, including the presentation of revenues in our Consolidated Statements of Operations.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Trxade, Inc. provides an online website service,
a buying and selling marketplace for licensed Pharmaceutical Wholesalers to sell products and services to licensed Pharmacies.
The Company charges Suppliers a transaction fee, a percentage of the purchase price of the Prescription Drugs and other products
sold through its website service. The fulfillment of confirmed orders, including delivery and shipment of Prescription Drugs and
other products, is the responsibility of the Supplier and not of the Company. The Company holds no inventory and assumes no responsibility
for the shipment or delivery of any products or services from our website. The Company considers itself an agent for this revenue
stream and as such, reports revenue as net. Step One: Identify the contract with the customer &#8211; Trxade, Inc.&#8217;s Terms
and Use Agreement is acknowledged between the Wholesaler and Trxade, Inc. which outlines the terms and conditions. The collection
is probable based on the credit evaluation of the Wholesaler. Step Two: Identify the performance obligations in the contract &#8211;
The Company provides to the Supplier access to the online website, uploading of catalogs of products and Dashboard access to review
status of inventory posted and processed orders. The Agreement requires the supplier to provide a catalog of pharmaceuticals for
posting on the platform, deliver the pharmaceuticals and upon shipment remit the stated platform fee. Step Three: Determine the
transaction price &#8211; The Fee Agreement outlines the fee based on the type of product, generic, brand or non-drug. There are
no discounts for volume of transactions or early payment of invoices. Step Four: Allocate the transaction price &#8211; The Fee
Agreement outlines the fee. There is no difference between contract price and &#8220;stand-alone selling price&#8221;. Step Five:
Recognize revenue when or as the entity satisfies a performance obligation &#8211; Revenue is recognized the day the order has
been processed by the Supplier.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Integra Pharma Solutions, LLC is a licensed
wholesaler and sells to licensed pharmacies brand, generic and non-drug products. The Company takes orders for product and creates
invoices for each order and recognizes revenue at the time the Customer receives the product. Customer returns are not material.
Step One: Identify the contract with the customer &#8211; The Company requires that an application and a credit card for payment
is completed by the Customer prior to the first order. Each transaction is evidenced by an order form sent by the customer and
an invoice for the product is sent by the Company. The collection is probable based on the application and credit card information
provided prior to the first order. Step Two: Identify the performance obligations in the contract &#8211; Each order is distinct
and evidenced by the shipping order and invoice. Step Three: Determine the transaction price &#8211; The consideration is variable
if product is returned. The variability is determined based on the return policy of the product manufacturer. There are no sales
or volume discounts. The transaction price is determined at the time of the order evidenced by the invoice. Step Four: Allocate
the transaction price &#8211; There is no difference between contract price and &#8220;stand-alone selling price&#8221;. Step Five:
Recognize revenue when or as the entity satisfies a performance obligation - The Revenue is recognized when the Customer receives
the product.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Community Specialty Pharmacy, LLC is in the
retail pharmacy business. The Company fills prescriptions for drugs written by a doctor and recognizes revenue at the time the
patient confirms delivery of the prescription. Customer returns are not material. Step One: Identify the contract with the customer
&#8211; The prescription is written by a doctor for a Customer and delivered to the Company. The prescription identifies the performance
obligations in the contract. The Company fills the prescription and delivers to the Customer the prescription, fulfilling the
contract. The collection is probable because there is confirmation that the customer has insurance for the reimbursement to the
Company prior to filling of the prescription. Step Two: Identify the performance obligations in the contract &#8211; Each prescription
is distinct to the Customer. Step Three: Determine the transaction price &#8211; The consideration is not variable. The transaction
price is determined to be the price of the prescription at the time of delivery which considers the expected reimbursements from
third party payors (e.g., pharmacy benefit managers, insurance companies and government agencies). Step Four: Allocate the transaction
price &#8211; The price of the prescription invoiced represents the expected amount of reimbursement from third party payors.
There is no difference between contract price and &#8220;stand-alone selling price&#8221;. Step Five: Recognize revenue when or
as the entity satisfies a performance obligation &#8211; Revenue is recognized upon the delivery of the prescription.</p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_TRXD_CostOfGoodsSoldPolicyTextBlock', window );">Cost of Goods Sold</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"><p style="margin: 0pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Cost of Goods Sold &#8211; The company recognized
cost of goods sold in 2018 from activities in Integra Pharma Solutions, LLC and Community Specialty Pharmacy, LLC, which were
not active in 2017.</p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy', window );">Stock-based Compensation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"><p style="margin: 0pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Stock-Based Compensation &#8211; The Company
accounts for stock-based compensation to non-employees in accordance with the provision of ASC 505, &#8220;Equity Based Payments
to Non-Employees&#8221; (&#8220;ASC 505&#8221;), which requires that such equity instruments are recorded at their fair value on
the measurement date. The measurement of stock-based compensation is subject to periodic adjustment as the underlying instruments
vest.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company accounts for stock-based compensation
to employees in accordance with ASC 718, &#8220;Compensation-Stock Compensation&#8221;. ASC 718 requires companies to measure
the cost of employee services received in exchange for an award of equity instruments, including stock options, based on the grant
date fair value of the award and to recognize it as compensation expense over the period the employee is required to provide service
in exchange for the award, usually the vesting period. Stock option forfeitures are recognized at the date of employee termination.</p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxPolicyTextBlock', window );">Income Taxes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"><p style="margin: 0pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Income Taxes &#8211; The Company accounts
for income taxes utilizing ASC 740, &#8220;Income Taxes&#8221; (SFAS No. 109). ASC 740 requires the measurement of deferred tax
assets for deductible temporary differences and operating loss carry forwards, and of deferred tax liabilities for taxable temporary
differences. Measurement of current and deferred tax liabilities and assets is based on provisions of enacted tax law. The effects
of future changes in tax rates are not included in the measurement. The Company recognizes the amount of taxes payable or refundable
for the current year and recognizes deferred tax liabilities and assets for the expected future tax consequences of events and
transactions that have been recognized in the Company&#8217;s financial statements or tax returns. The Company currently has substantial
net operating loss carry forwards. The Company has recorded a 100% valuation allowance against net deferred tax assets due to
uncertainty of their ultimate realization. Valuation allowances are established when necessary to reduce deferred tax assets to
the amount expected to be realized. Tax years from 2015 forward are open to examination by the Internal Revenue Service.</p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerSharePolicyTextBlock', window );">Income (loss) Per Share</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif"><i>ncome
Per Common Share</i> &#8211; Basic net income per common share is computed by dividing net income available to common stockholders
by the weighted average number of common shares outstanding. Diluted net income per common share is computed similar to basic
net income per common share except that the denominator is increased to include the number of additional common shares that would
have been outstanding if the potential common shares had been issued and if the additional common shares were dilutive. The dilutive
effect of the Company&#8217;s options and warrants is computed using the treasury stock method while the dilutive effect of our
convertible notes is computed using the if-converted method.</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;<font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">The
following table sets forth the computation of basic and diluted Income per Share:</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="padding-bottom: 1.5pt; text-align: center">&#160;</td>
    <td colspan="6" style="text-align: center; border-bottom: Black 1.5pt solid">For three months ended June 30,</td><td style="padding-bottom: 1.5pt; text-align: center">&#160;</td><td style="padding-bottom: 1.5pt; text-align: center">&#160;</td>
    <td colspan="6" style="text-align: center; border-bottom: Black 1.5pt solid">For six months ended June 30,</td><td style="padding-bottom: 1.5pt; text-align: center">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="padding-bottom: 1.5pt; text-align: center">&#160;</td>
    <td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid">2019</td><td style="padding-bottom: 1.5pt; text-align: center">&#160;</td><td style="padding-bottom: 1.5pt; text-align: center">&#160;</td>
    <td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid">2018</td><td style="padding-bottom: 1.5pt; text-align: center">&#160;</td><td style="padding-bottom: 1.5pt; text-align: center">&#160;</td>
    <td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid">2019</td><td style="padding-bottom: 1.5pt; text-align: center">&#160;</td><td style="padding-bottom: 1.5pt; text-align: center">&#160;</td>
    <td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid">2018</td><td style="padding-bottom: 1.5pt; text-align: center">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify">Numerator:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="width: 40%; text-align: justify">Net Income</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 11%; text-align: right">57,981</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 11%; text-align: right">20,513</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 11%; text-align: right">183,210</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 11%; text-align: right">102,782</td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Numerator for basic and diluted EPS - income available to common Shareholders</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">57,981</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">20,513</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">183,210</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">102,782</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify">Denominator:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Denominator for basic EPS &#8211; Weighted average shares</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">33,726,489</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">31,985,827</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">33,546,329</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">31,985,827</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Dilutive Effect of Warrants, Options and Convertible Debt</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,627,262</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,493,579</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,807,422</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,486,984</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Denominator for diluted EPS &#8211; adjusted Weighted average shares and assumed Conversions</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">36,353,751</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">34,479,406</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">36,353,751</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">34,472,811</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Basic and Diluted income per common share</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">0.00</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">0.00</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">0.01</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">0.00</td><td style="text-align: left">&#160;</td></tr></table><span></span>
</td>
<td class="text"><p style="margin: 0pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Income (loss) Per Share &#8211; Basic net income
(loss) per common share is computed by dividing net loss available to common stockholders by the weighted average number of common
shares outstanding. Diluted net loss per common share is computed similar to basic net loss per common share except that the denominator
is increased to include the number of additional common shares that would have been outstanding if the potential common shares
had been issued and if the additional common shares were dilutive. The treasury stock method and as if converted methods are used
to determine the dilutive shares for our options and warrants and convertible notes, respectively.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The following table sets forth the computation
of basic and diluted income per common share for the years ended December 31, 2018 and 2017:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: bottom">
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt">December 31, 2018</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt">December 31, 2017</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td><font style="font-size: 10pt">Numerator:</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td style="width: 62%"><font style="font-size: 10pt">Net Income</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%"><font style="font-size: 10pt">$</font></td>
    <td style="width: 16%; text-align: right"><font style="font-size: 10pt">9,038</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%"><font style="font-size: 10pt">$</font></td>
    <td style="width: 16%; text-align: right"><font style="font-size: 10pt">288,983</font></td>
    <td style="width: 1%">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td><font style="font-size: 10pt">Numerator for basic and diluted income available to common shareholders</font></td>
    <td>&#160;</td>
    <td><font style="font-size: 10pt">$</font></td>
    <td style="text-align: right"><font style="font-size: 10pt">9,038</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td><font style="font-size: 10pt">$</font></td>
    <td style="text-align: right"><font style="font-size: 10pt">288,983</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td><font style="font-size: 10pt">Denominator:</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td><font style="font-size: 10pt">Denominator for basic income per common share &#8211; Weighted average common shares outstanding</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">32,260,622</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">31,955,416</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td><font style="font-size: 10pt">Dilutive effect of Common Stock Equivalents</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">2,697,880</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">2,130,835</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td><font style="font-size: 10pt">Denominator for diluted income per common share &#8211; adjusted weighted average common shares outstanding</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">34,958,502</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">34,086,251</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td><font style="font-size: 10pt">Basic and Diluted income per common share</font></td>
    <td>&#160;</td>
    <td><font style="font-size: 10pt">$</font></td>
    <td style="text-align: right"><font style="font-size: 10pt">0.00</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td><font style="font-size: 10pt">$</font></td>
    <td style="text-align: right"><font style="font-size: 10pt">0.01</font></td>
    <td></td></tr>
</table>


<p style="margin: 0pt"></p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskCreditRisk', window );">Concentration of Credit Risks and Major Customers</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"><p style="margin: 0pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Concentration of Credit Risks and Major Customers
- Financial instruments that potentially subject the company to credit risk consist principally of cash and cash equivalents and
receivables. The Company places its cash and cash equivalents with financial institutions. Deposits are insured to Federal Deposit
Insurance Corp limits. During the years ended December 31, 2018 and 2017, sales to two customers each represent greater than 10%
of revenue.</p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock', window );">Recent Accounting Pronouncements</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif"><i>Recent
Accounting Pronouncements </i>&#8211; The Company has implemented all new relevant accounting pronouncements that are in effect
through the date of these financial statements. The pronouncements did not have any material impact on the financial statements
unless otherwise disclosed, and the Company does not believe that there are any other new accounting pronouncements that have
been issued that might have a material impact on its consolidated financial position or results of operations.</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">Effective
January 1, 2019, the Company adopted ASU No. 2016-02, <i>Leases (Topic 842</i>) (&#8220;ASU 2016-02&#8221;) using the required
modified retrospective approach. The most significant changes under the new guidance include clarification of the definition of
a lease, and the requirements for lessees to recognize a Right of Use (&#8220;ROU&#8221;) asset and a lease liability for all
qualifying leases with terms longer than twelve months in the consolidated balance sheet. In addition, under Topic 842, additional
disclosures are required to meet the objective of enabling users of financial statements to assess the amount, timing and uncertainty
of cash flows arising from leases. See Footnote #7 below for more detail on the Company&#8217;s accounting with respect to leases.</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">Effective
January 1, 2019, the Company adopted ASU No. 2018-07, Compensation &#8211; Stock Based Compensation (Topic 718): Improvements
to Nonemployee Share-Based Payment Accounting (&#8220;ASU 2018-7&#8221;), which aligns accounting for share-based payments issued
to nonemployees to that of employees under the existing guidance of Topic 718, with certain exceptions. This update supersedes
previous guidance for equity-based payments to nonemployees under Subtopic 505-50, Equity &#8211; Equity-Based Payments to Non-Employees.
The adoption of ASU 2018-07 did not have a material impact on the Company&#8217;s consolidated financial statements.</font></p><span></span>
</td>
<td class="text"><p style="margin: 0pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Recent Accounting Pronouncements &#8211; The
Company has implemented all new relevant accounting pronouncements that are in effect through the date of these financial statements.
The pronouncements did not have any material impact on the financial statements unless otherwise disclosed, and the Company does
not believe that there are any other new accounting pronouncements that have been issued that might have a material impact on its
consolidated financial position or results of operations.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">In February 2016, the FASB issued ASU 2016-02,
Leases, which will amend current lease accounting to require lessees to recognize (i) a lease liability, which is a lessee&#8217;s
obligation to make lease payments arising from a lease, measured on a discounted basis, and (ii) a right-of-use asset, which is
an asset that represents the lessee&#8217;s right to use, or control the use of, a specified asset for the lease term. ASU 2016-02
does not significantly change lease accounting requirements applicable to lessors; however, certain changes were made to align,
where necessary, lessor accounting with the lessee accounting model. This standard will be effective for fiscal years beginning
after December 15, 2018, including interim periods within those fiscal years. The Company adopted the provisions of this ASU at
January 1, 2019.</p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_TRXD_CostOfGoodsSoldPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cost of Goods Sold [Policy Text Block]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">TRXD_CostOfGoodsSoldPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>TRXD_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BasisOfAccountingPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=98513485&amp;loc=d3e4273-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskCreditRisk">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for credit risk.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 825<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=108315417&amp;loc=d3e61044-112788<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskCreditRisk</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConsolidationPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting.  The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.3A-02)<br> -URI http://asc.fasb.org/extlink&amp;oid=116822174&amp;loc=d3e355033-122828<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.3A-03)<br> -URI http://asc.fasb.org/extlink&amp;oid=116822174&amp;loc=d3e355100-122828<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=d3e5614-111684<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConsolidationPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy related to debt. Includes, but is not limited to, debt issuance costs, the effects of refinancings, method of amortizing debt issuance costs and original issue discount, and classifications of debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6802200&amp;loc=d3e1835-112601<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativesReportingOfDerivativeActivity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for derivatives entered into for trading purposes and those entered into for purposes other than trading including where and when derivative financial instruments and derivative commodity instruments and their related gains or losses are reported in the entity's statements of financial position, cash flows, and results of operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=109980867&amp;loc=SL5579240-113959<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(n)(7))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativesReportingOfDerivativeActivity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerSharePolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3630-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerSharePolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentsPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for equity method of accounting for investments and other interests. Investment includes, but is not limited to, unconsolidated subsidiary, corporate joint venture, noncontrolling interest in real estate venture, limited partnership, and limited liability company. Information includes, but is not limited to, ownership percentage, reason equity method is or is not considered appropriate, and accounting policy election for distribution received.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.12)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 21D<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=SL94080555-108585<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentsPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueOfFinancialInstrumentsPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for determining the fair value of financial instruments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 60<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=7493716&amp;loc=d3e21868-110260<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=118260190&amp;loc=d3e13279-108611<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueOfFinancialInstrumentsPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for goodwill. This accounting policy also may address how an entity assesses and measures impairment of goodwill, how reporting units are determined, how goodwill is allocated to such units, and how the fair values of the reporting units are determined.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=108376223&amp;loc=d3e13816-109267<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32847-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 740<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6491622&amp;loc=d3e9504-115650<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32809-109319<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=116657188&amp;loc=SL116659661-227067<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32840-109319<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI http://asc.fasb.org/extlink&amp;oid=116821951&amp;loc=d3e32247-109318<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=116821951&amp;loc=d3e32280-109318<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 30<br> -Section 05<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=65884525&amp;loc=d3e40913-109327<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of inventory accounting policy for inventory classes, including, but not limited to, basis for determining inventory amounts, methods by which amounts are added and removed from inventory classes, loss recognition on impairment of inventories, and situations in which inventories are stated above cost.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=116847112&amp;loc=d3e4556-108314<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6361739&amp;loc=d3e7789-107766<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 270<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116846552&amp;loc=d3e543-108305<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=116847112&amp;loc=d3e4492-108314<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PriorPeriodReclassificationAdjustmentDescription">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for reclassifications that affects the comparability of the financial statements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6359566&amp;loc=d3e326-107755<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PriorPeriodReclassificationAdjustmentDescription</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRecognitionPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for revenue. Includes revenue from contract with customer and from other sources.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18823-107790<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18823-107790<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRecognitionPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for award under share-based payment arrangement. Includes, but is not limited to, methodology and assumption used in measuring cost.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b),(f)<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5047-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TradeAndOtherAccountsReceivablePolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for accounts receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118936363&amp;loc=d3e4975-111524<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118936363&amp;loc=SL6953423-111524<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=118936363&amp;loc=d3e5033-111524<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=118936363&amp;loc=d3e5212-111524<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=118936363&amp;loc=d3e5093-111524<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=84159169&amp;loc=d3e10133-111534<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TradeAndOtherAccountsReceivablePolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UseOfEstimates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6191-108592<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6161-108592<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6143-108592<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6061-108592<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6132-108592<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UseOfEstimates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>86
<FILENAME>R26.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3</span><table class="report" border="0" cellspacing="2" id="idp6651865328">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Warrants (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsNoteDisclosureAbstract', window );"><strong>Warrants and Rights Note Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_TRXD_SummaryOfEstimateFairValueOfWarrantsTableTextBlock', window );">Summary of Estimate the Fair Value of Warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"><p style="margin: 0pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The following table summarizes the assumptions
used to estimate the fair value of warrants granted during the years ended December 31, 2018 and 2017:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt">2018</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt">2017</font></td>
    <td style="padding-bottom: 1.5pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="width: 62%"><font style="font-size: 10pt">Expected dividend yield</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 16%; text-align: right"><font style="font-size: 10pt">0</font></td>
    <td style="width: 1%"><font style="font-size: 10pt">%</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 16%; text-align: right"><font style="font-size: 10pt">0</font></td>
    <td style="width: 1%"><font style="font-size: 10pt">%</font></td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td><font style="font-size: 10pt">Weighted-average expected volatility</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">231-632</font></td>
    <td><font style="font-size: 10pt">%</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">200</font></td>
    <td><font style="font-size: 10pt">%</font></td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td><font style="font-size: 10pt">Weighted-average risk-free interest rate</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">2.55-2.75</font></td>
    <td><font style="font-size: 10pt">%</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">1.81-1.84</font></td>
    <td><font style="font-size: 10pt">%</font></td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td><font style="font-size: 10pt">Expected life of warrants</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">5-8 years</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">5 years</font></td>
    <td></td></tr>
</table>


<p style="margin: 0pt"></p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock', window );">Schedule of Outstanding and Exercisable Warrants</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">The
Company&#8217;s outstanding and exercisable warrants as of June 30, 2019 are presented below:</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>Number</b></font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>Outstanding</b></font></p></td><td style="padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>Weighted</b></font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>Average</b></font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>Exercise Price</b></font></p></td><td style="padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>Contractual Life</b></font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><font style="font: 10pt Times New Roman, Times, Serif"><b>in Years</b></font></p></td><td style="padding-bottom: 1.5pt">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Intrinsic Value</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 44%; text-align: justify">Warrants Outstanding as of December 31, 2018</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 10%; text-align: right">2,880,141</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right">0.08</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 10%; text-align: right">3.74</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right">782,385</td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify">Warrants granted</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify">Warrants forfeited</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify">Warrants exercised</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">(16,666</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">0.01</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">-</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify">Warrants Outstanding as of June 30, 2019</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,863,475</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">0.08</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">3.08</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">1,448,356</td><td style="text-align: left">&#160;</td></tr></table><span></span>
</td>
<td class="text"><p style="margin: 0pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company&#8217;s outstanding and exercisable
warrants as of December 31, 2018 and 2017 are presented below:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: bottom">
    <td style="padding-bottom: 1.5pt; text-align: center">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: center">&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>Number Outstanding</b></font></td>
    <td style="padding-bottom: 1.5pt; text-align: center">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: center">&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>Weighted Average Exercise Price</b></font></td>
    <td style="padding-bottom: 1.5pt; text-align: center">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: center">&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>Contractual Life in Years</b></font></td>
    <td style="padding-bottom: 1.5pt; text-align: center">&#160;</td>
    <td style="padding-bottom: 1.5pt; text-align: center">&#160;</td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>Intrinsic Value</b></font></td>
    <td style="padding-bottom: 1.5pt; text-align: center">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="width: 44%"><font style="font-size: 10pt">Warrants Outstanding as of December 31, 2016</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 11%; text-align: right"><font style="font-size: 10pt">2,647,446</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%"><font style="font-size: 10pt">$</font></td>
    <td style="width: 11%; text-align: right"><font style="font-size: 10pt">0.24</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 11%; text-align: right"><font style="font-size: 10pt">4.24</font></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 1%"><font style="font-size: 10pt">$</font></td>
    <td style="width: 11%; text-align: right"><font style="font-size: 10pt">930,751</font></td>
    <td style="width: 1%">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td><font style="font-size: 10pt">Warrants granted</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">115,650</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td><font style="font-size: 10pt">$</font></td>
    <td style="text-align: right"><font style="font-size: 10pt">0.18</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">5.0</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">-</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td><font style="font-size: 10pt">Warrants forfeited</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">-</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">-</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">-</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">-</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td><font style="font-size: 10pt">Warrants exercised</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">(25,000</font></td>
    <td><font style="font-size: 10pt">)</font></td>
    <td>&#160;</td>
    <td><font style="font-size: 10pt">$</font></td>
    <td style="text-align: right"><font style="font-size: 10pt">0.01</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">-</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">-</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td><font style="font-size: 10pt">Warrants Outstanding as of December 31, 2017</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">2,738,096</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td><font style="font-size: 10pt">$</font></td>
    <td style="text-align: right"><font style="font-size: 10pt">0.24</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">3.28</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td><font style="font-size: 10pt">$</font></td>
    <td style="text-align: right"><font style="font-size: 10pt">937,567</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td><font style="font-size: 10pt">Warrants granted</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">577,045</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td><font style="font-size: 10pt">$</font></td>
    <td style="text-align: right"><font style="font-size: 10pt">0.02</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">7.11</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td><font style="font-size: 10pt">Warrants forfeited</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">(435,000</font></td>
    <td><font style="font-size: 10pt">)</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">-</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">-</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">-</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td><font style="font-size: 10pt">Warrants exercised</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">-</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">-</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">-</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">-</font></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: white">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td><font style="font-size: 10pt">Warrants Outstanding as of December 31, 2018</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">2,880,141</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td><font style="font-size: 10pt">$</font></td>
    <td style="text-align: right"><font style="font-size: 10pt">0.08</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><font style="font-size: 10pt">3.74</font></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td><font style="font-size: 10pt">$</font></td>
    <td style="text-align: right"><font style="font-size: 10pt">782,385</font></td>
    <td></td></tr>
</table>


<p style="margin: 0pt"></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_TRXD_SummaryOfEstimateFairValueOfWarrantsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Summary of estimate the fair value of warrants [Table Text Block]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">TRXD_SummaryOfEstimateFairValueOfWarrantsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>TRXD_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of warrants or rights issued. Warrants and rights outstanding are derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months. Disclose the title of issue of securities called for by warrants and rights outstanding, the aggregate amount of securities called for by warrants and rights outstanding, the date from which the warrants or rights are exercisable, and the price at which the warrant or right is exercisable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5047-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 50<br> -Section S99<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6784392&amp;loc=d3e188667-122775<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WarrantsAndRightsNoteDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WarrantsAndRightsNoteDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>87
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>88
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3</span><table class="report" border="0" cellspacing="2" id="idp6649024960">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment Reporting<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingDisclosureTextBlock', window );">Segment Reporting</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif"><b>NOTE
8 &#8211; SEGMENT REPORTING</b></font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">The
Company classifies its business interests into reportable segments which are Trxade, Community and Other.</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<table cellpadding="0" cellspacing="0" align="center" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<tr style="vertical-align: bottom">
    <td style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Six Months Ended June 30, 2019</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Trxade, Inc.</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Community Specialty Pharmacy, LLC</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Other</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Total</td><td style="padding-bottom: 1.5pt; font-weight: bold">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 36%">Revenue</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">2,182,668</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">892,357</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">353,910</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 12%; text-align: right">3,428,935</td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Segment Assets</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">1,401,724</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">224,863</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">2,051,478</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">3,678,065</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Segment Profit/Loss</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">1,166,543</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">(61,628</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">(921,705</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">183,210</td><td style="text-align: left">&#160;</td></tr>
</table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">The
Company had no reportable segments for the six months ended June 30, 2018. See NOTE 9 &#8211; BUSINESS COMBINATION</font></p><span></span>
</td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0"><font style="font: 10pt Times New Roman, Times, Serif"><b>NOTE
11 &#8211; SEGMENT REPORTING</b></font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0"><font style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0"><font style="font: 10pt Times New Roman, Times, Serif">The
Company classifies its business interests into reportable segments which are Trxade, Inc., Community Specialty Pharmacy, LLC,
and Other. Operating segments are defined as the components of an enterprise about which separate financial information is available
that is evaluated regularly by the chief operating decision maker in deciding how to allocate resources and in assessi</font><font style="font-family: Times New Roman, Times, Serif">ng
performance. Our chief operating decision makers direct the allocation of resources to operating segments based on the profitability,
cash flows, and growth opportunities of each respective segment.</font></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0in"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<table cellpadding="0" cellspacing="0" align="center" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<tr style="vertical-align: bottom; font-family: Times New Roman, Times, Serif">
    <td style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">Year
    Ended December 31, 2018</font></td><td style="font-weight: bold; padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">Trxade,
    Inc.</font></td><td style="padding-bottom: 1.5pt; font-weight: bold; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="font-weight: bold; padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">Community
    Specialty Pharmacy,&#160;LLC</font></td><td style="padding-bottom: 1.5pt; font-weight: bold; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="font-weight: bold; padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">Other</font></td><td style="padding-bottom: 1.5pt; font-weight: bold; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255); font-family: Times New Roman, Times, Serif">
    <td style="width: 43%; text-align: left; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">Revenue</font></td><td style="width: 2%; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="width: 1%; text-align: left; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td><td style="width: 14%; text-align: right; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">3,407,822</font></td><td style="width: 1%; text-align: left; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="width: 2%; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="width: 1%; text-align: left; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td><td style="width: 16%; text-align: right; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">395,418</font></td><td style="width: 1%; text-align: left; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="width: 2%; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="width: 1%; text-align: left; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td><td style="width: 15%; text-align: right; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">28,538</font></td><td style="width: 1%; text-align: left; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: White; font-family: Times New Roman, Times, Serif">
    <td style="text-align: left; font-family: Times New Roman, Times, Serif"><font style="font-family: Times New Roman, Times, Serif">Gross
    Profit</font></td><td style="font-family: Times New Roman, Times, Serif"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: left; font-family: Times New Roman, Times, Serif"><font style="font-family: Times New Roman, Times, Serif">$</font></td><td style="text-align: right; font-family: Times New Roman, Times, Serif"><p style="margin: 0; font-family: Times New Roman, Times, Serif"><font style="font-family: Times New Roman, Times, Serif">3,407,822</font></p>


</td><td style="text-align: left; font-family: Times New Roman, Times, Serif"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td><td style="font-family: Times New Roman, Times, Serif"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: left; font-family: Times New Roman, Times, Serif"><font style="font-family: Times New Roman, Times, Serif">$</font></td><td style="text-align: right; font-family: Times New Roman, Times, Serif"><p style="margin: 0; font-family: Times New Roman, Times, Serif"><font style="font-family: Times New Roman, Times, Serif">(34,971</font></p>


</td><td style="text-align: left; font-family: Times New Roman, Times, Serif"><font style="font-family: Times New Roman, Times, Serif">)</font></td><td style="font-family: Times New Roman, Times, Serif"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: left; font-family: Times New Roman, Times, Serif"><font style="font-family: Times New Roman, Times, Serif">$</font></td><td style="text-align: right; font-family: Times New Roman, Times, Serif"><p style="margin: 0; font-family: Times New Roman, Times, Serif"><font style="font-family: Times New Roman, Times, Serif">9,878</font></p>


</td><td style="text-align: left; font-family: Times New Roman, Times, Serif"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255); font-family: Times New Roman, Times, Serif">
    <td style="text-align: left; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">Segment
    Assets</font></td><td style="font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: left; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td><td style="text-align: right; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">822,412</font></td><td style="text-align: left; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: left; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td><td style="text-align: right; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">112,123</font></td><td style="text-align: left; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: left; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td><td style="text-align: right; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">1,293,052</font></td><td style="text-align: left; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: White; font-family: Times New Roman, Times, Serif">
    <td style="text-align: left; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">Segment
    Profit/Loss</font></td><td style="font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: left; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td><td style="text-align: right; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">1,371,615</font></td><td style="text-align: left; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td><td style="font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: left; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td><td style="text-align: right; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">(116,588</font></td><td style="text-align: left; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td><td style="font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: left; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td><td style="text-align: right; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">(1,245,989</font></td><td style="text-align: left; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">)</font></td></tr>
</table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font-family: Times New Roman, Times, Serif">The
Company had no reportable segments in 2017. See Note 12.</font></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -URI http://asc.fasb.org/topic&amp;trid=2134510<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>89
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3</span><table class="report" border="0" cellspacing="2" id="idp6774411984">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Long Term Debt - Related Parties<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtTextBlock', window );">Long Term Debt - Related Parties</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif"><b>NOTE
3 &#8211; LONG TERM DEBT &#8211; RELATED PARTIES</b></font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">In
October 2018 in connection with the acquisition of Community Specialty Pharmacy, LLC a $300,000 promissory note was issued to
Nikul Panchal, accruing interest at simple interest of 10%, interest payable annually, and principal payable at maturity in October
2021.</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">As
of June 30, 2019, $122,552 and $100,000 in promissory notes was due to Mr. Prashant Patel and Mr. Suren Ajjarapu, respectively.
The notes are due July 1, 2020 and each bear an interest rate of 6%.</font></p><span></span>
</td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif"><b>NOTE
4 &#8211; LONG TERM DEBT</b></font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><font style="font-family: Times New Roman, Times, Serif">In
2017, there are $181,500 in convertible promissory notes due in May 2019 as described in Note 3.</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif"><b>Related
Party Promissory Notes</b></font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif"><b>&#160;</b></font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">In
June 2017, the Company satisfied an outstanding promissory note, dated May 8, 2016, as amended, in the principal amount of $250,000
(the &#8220;NPR Note&#8221;), made by between the Company and NPR INVESTMENT GROUP, LLC (the &#8220;Lender&#8221;). The NPR Note
included a personal guarantee from Suren Ajjarapu and Prashant Patel, who both serve on the Board of Directors of the Company
and are controlling stockholders of the Company. Further, Mr. Ajjarapu is the CEO and President of the Company and Mr. Patel is
Vice Chairman and Executive Director of Strategy.</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">In
connection with the foregoing satisfaction of the NPR Note above, the Company received funds in June 2017 and entered into a promissory
note agreement on July 1, 2017, whereby the Company borrowed $100,000 and $80,000 from Sansur Associates, LLC, a limited liability
company controlled by Mr. Ajjarapu, and Mr. Patel, respectively (the &#8220;Promissory Notes&#8221;). The term of each of these
N<font style="background-color: white">otes is three years and they each bear interest at 6%, which is payable annually.</font></font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><font style="font: 10pt Times New Roman, Times, Serif; background-color: white">The
note due to Mr. Patel is $</font><font style="font: 10pt Times New Roman, Times, Serif">122,552. It comprises
$80,000 for the NPR note, $17,280 for an existing promissory note and $25,272 assumption of credit card obligation related to
business expenses of the Company.</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><font style="font: 10pt Times New Roman, Times, Serif">In
October 2018 in connection with the acquisition of Community Specialty Pharmacy, LLC a $300,000 promissory note was issued to
Nikul Panchal, accruing interest a simple interest of 10%, interest payable annually, and principal payable at maturity on October
15, 2021.&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<p style="margin: 0; font: 10pt Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">At
December 31, 2018 and 2017, total related party long term debt was $522,552 and $222,552, respectively.</font></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><font style="font-family: Times New Roman, Times, Serif"></font></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><font style="font: 10pt Times New Roman, Times, Serif">Future
maturities of long-term debt in the next five years are as follows:</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<table cellpadding="0" cellspacing="0" align="center" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<tr style="vertical-align: bottom; background-color: rgb(204,238,255); font-family: Times New Roman, Times, Serif">
    <td style="text-align: left; width: 72%; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">Due
    in 2020</font></td><td style="width: 2%; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: left; width: 1%; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td><td style="text-align: right; width: 24%; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">222,552</font></td><td style="text-align: left; width: 1%; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: White; font-family: Times New Roman, Times, Serif">
    <td style="text-align: left; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">Due
    in 2021</font></td><td style="font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: left; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td><td style="text-align: right; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">300,000</font></td><td style="text-align: left; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255); font-family: Times New Roman, Times, Serif">
    <td style="text-align: left; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">Due
    in 2022</font></td><td style="font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="text-align: left; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td><td style="text-align: right; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td><td style="text-align: left; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: White; font-family: Times New Roman, Times, Serif">
    <td style="text-align: left; padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">Due
    in 2023</font></td><td style="padding-bottom: 1.5pt; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td><td style="border-bottom: Black 1.5pt solid; text-align: right; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">-</font></td><td style="padding-bottom: 1.5pt; text-align: left; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255); font-family: Times New Roman, Times, Serif">
    <td style="text-align: left; padding-bottom: 2.5pt; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">Total
    Debt</font></td><td style="padding-bottom: 2.5pt; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">$</font></td><td style="border-bottom: Black 2.5pt double; text-align: right; font-family: Times New Roman, Times, Serif"><font style="font-family: Times New Roman, Times, Serif"><font style="font-size: 10pt">522</font></font><font style="font-family: Times New Roman, Times, Serif"><font style="font-size: 10pt">,052</font></font></td><td style="padding-bottom: 2.5pt; text-align: left; font-family: Times New Roman, Times, Serif"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></td></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for long-term debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -URI http://asc.fasb.org/topic&amp;trid=2208564<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>90
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3</span><table class="report" border="0" cellspacing="2" id="idp6757663152">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2019</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeasesTextBlock', window );">Leases</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif"><b>NOTE
7 &#8211; LEASES</b></font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">The
Company elected the practical expedient under ASU 2018-11 &#8220;Leases: Targeted Improvements&#8221; which allows the Company
to apply the transition provision for Topic 842 at the Company&#8217;s adoption date instead of at the earliest comparative
period presented in the financial statements. Therefore, the Company recognized and measured leases existing at January 1, 2019
but without retrospective application. In addition, the Company elected the optional practical expedient permitted under the transition
guidance which allows the Company to carry forward the historical accounting treatment for existing leases upon adoption. No impact
was recorded to the beginning retained earnings for Topic 842. The Company has two operating leases for corporate offices. The
following table outlines the details:</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<tr style="vertical-align: bottom">
    <td>&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid">Lease 1</td><td style="padding-bottom: 1.5pt">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid">Lease 2</td><td style="padding-bottom: 1.5pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Initial Lease Term</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">December 2017 to December 2021</font></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">November 2018 to November 2023</font></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Renewal Term</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">January 2021 to December 2024</font></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><font style="font: 10pt Times New Roman, Times, Serif">November 2023 to November 2028</font></td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 36%; text-align: left">Initial Recognition of Right to use assets at January 1, 2019</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 28%; text-align: right">534,140</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 28%; text-align: right">313,301</td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Incremental Borrowing Rate</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">10</td><td style="text-align: left">%</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">10</td><td style="text-align: left">%</td></tr>
</table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;<font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">The
table below reconciles the fixed component of the undiscounted cash flows for each of the first five years and the total remaining
years to the operating lease liabilities recorded in the Consolidated Balance Sheet as of June 30, 2019</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<table cellpadding="0" cellspacing="0" align="center" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<tr style="vertical-align: bottom">
    <td style="font-weight: bold; text-align: justify; border-bottom: Black 1.5pt solid">Amounts due within twelve months of June 30</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td colspan="2" style="text-align: right">&#160;</td><td style="padding-bottom: 1.5pt">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 78%; text-align: justify">2019</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 18%; text-align: right">158,366</td><td style="width: 1%; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify">2020</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">163,102</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify">2021</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">167,984</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify">2022</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">173,038</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify">2023</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">178,237</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify; padding-bottom: 1.5pt">Thereafter</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">305,012</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify">Total minimum lease payments</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,145,739</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify; padding-bottom: 1.5pt">Less: effect of discounting</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">(334,574</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify">Present value of future minimum lease payments</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">811,165</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify; padding-bottom: 1.5pt">Less: current obligations under leases</td><td style="padding-bottom: 1.5pt">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1.5pt solid; text-align: right">80,832</td><td style="padding-bottom: 1.5pt; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify; padding-bottom: 2.5pt">Long-term lease obligations</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">730,333</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
</table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">For
the three-months and six-months ended June 30, 2019 amortization of assets were $22,195 and $43,939, respectively.</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">&#160;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><font style="font: 10pt Times New Roman, Times, Serif">For
the three-months and six-months ended June 30, 2019, amortization of liabilities were $18,363 and 36,276, respectively.</font></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeasesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -URI http://asc.fasb.org/subtopic&amp;trid=77888251<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeasesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>91
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3</span><table class="report" border="0" cellspacing="2" id="idp6778897808">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Consolidated Statements of Cash Flows - USD ($)<br></strong></div></th>
<th class="th" colspan="2">6 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2019</div></th>
<th class="th"><div>Jun. 30, 2018</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
<th class="th"><div>Dec. 31, 2017</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Operating Activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net Income</a></td>
<td class="nump">$ 183,210<span></span>
</td>
<td class="nump">$ 102,782<span></span>
</td>
<td class="nump">$ 9,038<span></span>
</td>
<td class="nump">$ 288,983<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Adjustments to reconcile net income to net cash provided by (used in) operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Depreciation', window );">Depreciation Expense</a></td>
<td class="nump">2,500<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims', window );">Stock Issued for Services</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">12,500<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockOptionPlanExpense', window );">Options expense</a></td>
<td class="nump">99,990<span></span>
</td>
<td class="nump">88,072<span></span>
</td>
<td class="nump">169,828<span></span>
</td>
<td class="nump">267,835<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromEquityMethodInvestments', window );">Share in Equity Losses in Investment</a></td>
<td class="nump">87,822<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProvisionForDoubtfulAccounts', window );">Bad Debt Expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,271<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainsLossesOnExtinguishmentOfDebt', window );">Loss on debt extinguishment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,444<span></span>
</td>
<td class="nump">16,556<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_TRXD_AmortizationOfRightToUseAsset', window );">Amortization of right to use asset</a></td>
<td class="nump">43,939<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfDebtDiscountPremium', window );">Amortization of Debt Discount</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">152<span></span>
</td>
<td class="nump">152<span></span>
</td>
<td class="nump">88,647<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract', window );"><strong>Changes in operating assets and liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsReceivable', window );">Accounts Receivable</a></td>
<td class="num">(279,852)<span></span>
</td>
<td class="num">(5,875)<span></span>
</td>
<td class="num">(1,532)<span></span>
</td>
<td class="num">(20,354)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets', window );">Prepaid Assets and other Current Assets</a></td>
<td class="num">(70,119)<span></span>
</td>
<td class="num">(64,831)<span></span>
</td>
<td class="nump">13,637<span></span>
</td>
<td class="num">(90,763)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInInventories', window );">Inventory</a></td>
<td class="num">(466,850)<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(3,810)<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_TRXD_IncreaseDecreaseInLeaseLiability', window );">Lease Liability</a></td>
<td class="num">(36,276)<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsPayable', window );">Accounts Payable</a></td>
<td class="nump">362,599<span></span>
</td>
<td class="nump">22,671<span></span>
</td>
<td class="nump">95,149<span></span>
</td>
<td class="num">(98,213)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities', window );">Accrued Liabilities and Other Liabilities</a></td>
<td class="num">(6,652)<span></span>
</td>
<td class="nump">3,485<span></span>
</td>
<td class="num">(18,791)<span></span>
</td>
<td class="num">(293,521)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net Cash provided by (used in) operating activities</a></td>
<td class="num">(79,689)<span></span>
</td>
<td class="nump">146,456<span></span>
</td>
<td class="nump">273,386<span></span>
</td>
<td class="nump">171,670<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract', window );"><strong>Investing Activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireEquityMethodInvestments', window );">Purchase of equity method investment</a></td>
<td class="num">(250,000)<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Purchase of Fixed Assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(15,006)<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForProceedsFromInvestments', window );">Cash paid for acquisition of Community Specialty Pharmacy, LLC, net of cash received</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(250,273)<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivities', window );">Net cash Used in Investing activities</a></td>
<td class="num">(250,000)<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(265,279)<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>Financing Activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfRelatedPartyDebt', window );">Repayments of Short-Term Convertible Debt - Related Parties</a></td>
<td class="text"> <span></span>
</td>
<td class="num">(111,725)<span></span>
</td>
<td class="num">(111,725)<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfShortTermDebt', window );">Repayments of Short-Term Promissory Notes</a></td>
<td class="text"> <span></span>
</td>
<td class="num">(10,739)<span></span>
</td>
<td class="num">(10,739)<span></span>
</td>
<td class="num">(432,685)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromRelatedPartyDebt', window );">Proceeds from Convertible Note - Related Parties</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">180,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromWarrantExercises', window );">Proceeds from exercise of Warrants</a></td>
<td class="nump">166<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">250<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfCommonStock', window );">Proceeds from Issuance of Common Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">800,000<span></span>
</td>
<td class="nump">250,000<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">Net Cash provided by (used in) financing activities</a></td>
<td class="nump">166<span></span>
</td>
<td class="num">(122,464)<span></span>
</td>
<td class="nump">677,536<span></span>
</td>
<td class="num">(2,435)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect', window );">Net increase (decrease) in Cash</a></td>
<td class="num">(329,523)<span></span>
</td>
<td class="nump">23,992<span></span>
</td>
<td class="nump">685,643<span></span>
</td>
<td class="nump">169,235<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations', window );">Cash at Beginning of the Year</a></td>
<td class="nump">869,557<span></span>
</td>
<td class="nump">183,914<span></span>
</td>
<td class="nump">183,914<span></span>
</td>
<td class="nump">14,679<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations', window );">Cash at Ending of the year</a></td>
<td class="nump">540,034<span></span>
</td>
<td class="nump">207,906<span></span>
</td>
<td class="nump">869,557<span></span>
</td>
<td class="nump">183,914<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SupplementalCashFlowInformationAbstract', window );"><strong>Supplemental Cash Flow Information</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestPaidNet', window );">Cash Paid for Interest</a></td>
<td class="nump">2,997<span></span>
</td>
<td class="nump">27,392<span></span>
</td>
<td class="nump">36,970<span></span>
</td>
<td class="nump">71,210<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxesPaidNet', window );">Cash Paid for Income Taxes</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract', window );"><strong>Non-Cash Transactions</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConversionOfStockAmountConverted1', window );">Common Stock Issued for Conversion of Note and Accrued Interest</a></td>
<td class="nump">211,983<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_TRXD_RightUseOfAssetsAndOperatingLeaseObligationsRecognized', window );">ROU assets and operating lease obligations recognized</a></td>
<td class="nump">$ 847,441<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_TRXD_RelatedPartyNotePayableAndWarrantsIssuedForAcquisition', window );">Related party note payable and warrants issued for acquisition of Community Specialty Pharmacy, LLC</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">470,921<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_TRXD_ReclassFromAccruedInterestToShortTermConvertibleNotes', window );">Reclass from accrued interest to short term convertible notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">16,500<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_TRXD_ArrangementToMoveRelatedPartyAccountsPayableToNotesPayable', window );">Arrangement to move related party Accounts Payable to Notes Payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 32,552<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_TRXD_AmortizationOfRightToUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amortization of right to use asset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">TRXD_AmortizationOfRightToUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>TRXD_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_TRXD_ArrangementToMoveRelatedPartyAccountsPayableToNotesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Arrangement to move related party Accounts Payable to Notes Payable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">TRXD_ArrangementToMoveRelatedPartyAccountsPayableToNotesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>TRXD_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_TRXD_IncreaseDecreaseInLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Increase decrease in lease liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">TRXD_IncreaseDecreaseInLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>TRXD_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_TRXD_ReclassFromAccruedInterestToShortTermConvertibleNotes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Reclass from accrued interest to short term convertible notes.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">TRXD_ReclassFromAccruedInterestToShortTermConvertibleNotes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>TRXD_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_TRXD_RelatedPartyNotePayableAndWarrantsIssuedForAcquisition">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Related party note payable and warrants issued for acquisition.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">TRXD_RelatedPartyNotePayableAndWarrantsIssuedForAcquisition</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>TRXD_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_TRXD_RightUseOfAssetsAndOperatingLeaseObligationsRecognized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Right-use-of assets and operating lease obligations recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">TRXD_RightUseOfAssetsAndOperatingLeaseObligationsRecognized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>TRXD_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfDebtDiscountPremium">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense included in interest expense to amortize debt discount and premium associated with the related debt instruments. Excludes amortization of financing costs. Alternate captions include noncash interest expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1A<br> -URI http://asc.fasb.org/extlink&amp;oid=114775744&amp;loc=d3e28541-108399<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3602-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.8)<br> -URI http://asc.fasb.org/extlink&amp;oid=116634182&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfDebtDiscountPremium</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including, but not limited to, disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=98513485&amp;loc=SL98516268-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3521-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3044-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=98513438&amp;loc=d3e33268-110906<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConversionOfStockAmountConverted1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The value of the stock converted in a noncash (or part noncash) transaction. Noncash is defined as transactions during a period that do not result in cash receipts or cash payments in the period. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=98513485&amp;loc=d3e4313-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=98513485&amp;loc=d3e4332-108586<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=98513485&amp;loc=d3e4304-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConversionOfStockAmountConverted1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Depreciation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Depreciation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainsLossesOnExtinguishmentOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=117329964&amp;loc=d3e12355-112629<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=117329964&amp;loc=d3e12317-112629<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainsLossesOnExtinguishmentOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromEquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) for proportionate share of equity method investee's income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=116634182&amp;loc=SL114868664-224227<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(10))<br> -URI http://asc.fasb.org/extlink&amp;oid=116637232&amp;loc=SL114874131-224263<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3602-108585<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(13)(f))<br> -URI http://asc.fasb.org/extlink&amp;oid=116637391&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=115929826&amp;loc=d3e8736-108599<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=109237563&amp;loc=d3e33749-111570<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromEquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxesPaidNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income, net of any cash received during the current period as refunds for the overpayment of taxes.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=98513485&amp;loc=d3e4297-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxesPaidNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in accrued expenses, and obligations classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInInventories">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInInventories</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingCapitalAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in prepaid expenses, and assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestPaidNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=98513485&amp;loc=d3e4297-108586<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3367-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3536-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestPaidNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of share-based compensation granted to nonemployees as payment for services rendered or acknowledged claims.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3536-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3521-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=SL7669619-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=116637391&amp;loc=SL114874048-224260<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=SL7669625-108580<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=116637232&amp;loc=SL114874131-224263<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=116634182&amp;loc=SL114868664-224227<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3602-108585<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForProceedsFromInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net cash paid (received) associated with the acquisition or disposal of all investments, including securities and other assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e24072-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForProceedsFromInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireEquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the purchase of or advances to an equity method investments, which are investments in joint ventures and entities in which the entity has an equity ownership interest normally of 20 to 50 percent and exercises significant influence.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireEquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquirePropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the additional capital contribution to the entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromRelatedPartyDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from a long-term borrowing made from related parties where one party can exercise control or significant influence over another party; including affiliates, owners or officers and their immediate families, pension trusts, and so forth. Alternate caption: Proceeds from Advances from Affiliates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromRelatedPartyDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromWarrantExercises">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the amount received from holders exercising their stock warrants.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromWarrantExercises</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProvisionForDoubtfulAccounts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expense (reversal of expense) for expected credit loss on accounts receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=119407570&amp;loc=SL82919249-210447<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=116634182&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProvisionForDoubtfulAccounts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfRelatedPartyDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for the payment of a long-term borrowing made from a related party where one party can exercise control or significant influence over another party; including affiliates, owners or officers and their immediate families, pension trusts, and so forth. Alternate caption: Payments for Advances from Affiliates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfRelatedPartyDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfShortTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for a borrowing having initial term of repayment within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfShortTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockOptionPlanExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for option under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockOptionPlanExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplementalCashFlowInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SupplementalCashFlowInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>92
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3</span><table class="report" border="0" cellspacing="2" id="idp6777263840">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Consolidated Balance Sheets - USD ($)<br></strong></div></th>
<th class="th"><div>Jun. 30, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
<th class="th"><div>Dec. 31, 2017</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Current Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash</a></td>
<td class="nump">$ 540,034<span></span>
</td>
<td class="nump">$ 869,557<span></span>
</td>
<td class="nump">$ 183,914<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsReceivableNetCurrent', window );">Accounts Receivable, net</a></td>
<td class="nump">713,479<span></span>
</td>
<td class="nump">433,627<span></span>
</td>
<td class="nump">319,467<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryNet', window );">Inventory</a></td>
<td class="nump">546,816<span></span>
</td>
<td class="nump">79,966<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PrepaidExpenseCurrent', window );">Prepaid Assets</a></td>
<td class="nump">151,941<span></span>
</td>
<td class="nump">82,927<span></span>
</td>
<td class="nump">102,095<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAssetsCurrent', window );">Other Assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">2,000<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total Current Assets</a></td>
<td class="nump">1,952,270<span></span>
</td>
<td class="nump">1,466,077<span></span>
</td>
<td class="nump">607,476<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property Plant and Equipment, Net</a></td>
<td class="nump">12,506<span></span>
</td>
<td class="nump">15,006<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsNoncurrentAbstract', window );"><strong>Other Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepositsAssetsNoncurrent', window );">Deposits</a></td>
<td class="nump">21,636<span></span>
</td>
<td class="nump">20,531<span></span>
</td>
<td class="nump">10,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestments', window );">Equity method investment</a></td>
<td class="nump">162,178<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Right of use leased assets</a></td>
<td class="nump">803,502<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">725,973<span></span>
</td>
<td class="nump">725,973<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">Total Assets</a></td>
<td class="nump">3,678,065<span></span>
</td>
<td class="nump">2,227,587<span></span>
</td>
<td class="nump">617,476<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>Current Liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableCurrent', window );">Accounts Payable</a></td>
<td class="nump">763,143<span></span>
</td>
<td class="nump">400,544<span></span>
</td>
<td class="nump">106,084<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrent', window );">Accrued Liabilities</a></td>
<td class="nump">101,188<span></span>
</td>
<td class="nump">138,323<span></span>
</td>
<td class="nump">156,961<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Current Portion Lease Liabilities</a></td>
<td class="nump">80,832<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NotesPayableCurrent', window );">Short Term Notes Payable net of $0 and $152 discount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">10,587<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConvertibleNotesPayableCurrent', window );">Short Term Convertible Notes Payable</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">181,500<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_TRXD_ShortTermConvertibleNotesPayableRelatedParties', window );">Short Term Convertible Notes Payable - Related Parties</a></td>
<td class="nump">140,000<span></span>
</td>
<td class="nump">140,000<span></span>
</td>
<td class="nump">251,725<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total Current Liabilities</a></td>
<td class="nump">1,085,163<span></span>
</td>
<td class="nump">860,367<span></span>
</td>
<td class="nump">525,357<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesNoncurrentAbstract', window );"><strong>Long Term Liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConvertibleLongTermNotesPayable', window );">Convertible Notes Payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">181,500<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NotesPayableRelatedPartiesNoncurrent', window );">Notes Payable - Related Parties</a></td>
<td class="nump">522,552<span></span>
</td>
<td class="nump">522,552<span></span>
</td>
<td class="nump">222,552<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Other Long-term Liabilities - Leases</a></td>
<td class="nump">730,333<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Total Liabilities</a></td>
<td class="nump">2,338,048<span></span>
</td>
<td class="nump">1,382,919<span></span>
</td>
<td class="nump">929,409<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>Shareholders' Equity</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockValue', window );">Series A Preferred Stock, value</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common Stock, value</a></td>
<td class="nump">337<span></span>
</td>
<td class="nump">332<span></span>
</td>
<td class="nump">320<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapital', window );">Additional Paid-in Capital</a></td>
<td class="nump">9,267,545<span></span>
</td>
<td class="nump">8,955,411<span></span>
</td>
<td class="nump">7,807,860<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Retained Deficit</a></td>
<td class="num">(7,927,865)<span></span>
</td>
<td class="num">(8,111,075)<span></span>
</td>
<td class="num">(8,120,113)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total Shareholders' Equity</a></td>
<td class="nump">1,340,017<span></span>
</td>
<td class="nump">844,668<span></span>
</td>
<td class="num">(311,933)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">Total Liabilities and Shareholders' Equity</a></td>
<td class="nump">$ 3,678,065<span></span>
</td>
<td class="nump">$ 2,227,587<span></span>
</td>
<td class="nump">$ 617,476<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_TRXD_ShortTermConvertibleNotesPayableRelatedParties">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Short term convertible notes payable - related parties.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">TRXD_ShortTermConvertibleNotesPayableRelatedParties</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>TRXD_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118956577&amp;loc=SL49130549-203045<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=118952595&amp;loc=d3e4428-111522<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=118951113&amp;loc=d3e6676-107765<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=118952595&amp;loc=d3e4531-111522<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalPaidInCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders. Includes adjustments to additional paid in capital. Some examples of such adjustments include recording the issuance of debt with a beneficial conversion feature and certain tax consequences of equity instruments awarded to employees. Use this element for the aggregate amount of additional paid-in capital associated with common and preferred stock. For additional paid-in capital associated with only common stock, use the element additional paid in capital, common stock. For additional paid-in capital associated with only preferred stock, use the element additional paid in capital, preferred stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalPaidInCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=6876686&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=115929826&amp;loc=d3e8736-108599<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=119400593&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=118951113&amp;loc=d3e6801-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=118951113&amp;loc=d3e6676-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsNoncurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsNoncurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3044-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118951113&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConvertibleLongTermNotesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of long-term debt (with maturities initially due after one year or beyond the operating cycle if longer) identified as Convertible Notes Payable, excluding current portion. Convertible Notes Payable is a written promise to pay a note which can be exchanged for a specified amount of another, related security, at the option of the issuer and the holder.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConvertibleLongTermNotesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConvertibleNotesPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of the portion of long-term debt due within one year or the operating cycle if longer identified as Convertible Notes Payable. Convertible Notes Payable is a written promise to pay a note which can be exchanged for a specified amount of another, related security, at the option of the issuer and the holder.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConvertibleNotesPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepositsAssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value of amounts transferred to third parties for security purposes that are expected to be returned or applied towards payment after one year or beyond the operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepositsAssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This item represents the carrying amount on the entity's balance sheet of its investment in common stock of an equity method investee. This is not an indicator of the fair value of the investment, rather it is the initial cost adjusted for the entity's share of earnings and losses of the investee, adjusted for any distributions (dividends) and other than temporary impairment (OTTI) losses recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=109237563&amp;loc=d3e33749-111570<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=115929826&amp;loc=d3e8813-108599<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.12)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=77989000&amp;loc=SL49117168-202975<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118951113&amp;loc=d3e6676-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section 35<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=116846819&amp;loc=d3e3927-108312<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Liabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19-26)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Liabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=6876686&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=119400593&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(32))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.21)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesNoncurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesNoncurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NotesPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying values as of the balance sheet date of the portions of long-term notes payable due within one year or the operating cycle if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19,20)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NotesPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NotesPayableRelatedPartiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount for notes payable (written promise to pay), payable to related parties, which are due after one year (or one business cycle).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(k)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.23)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NotesPayableRelatedPartiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=77888419&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=77888419&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=77888419&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.8)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits within a future period of one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=118951113&amp;loc=d3e6787-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=118951113&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 340<br> -SubTopic 10<br> -Section 05<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=68074540&amp;loc=d3e5879-108316<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=119400593&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cumulative amount of the reporting entity's undistributed earnings or deficit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=119400593&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI http://asc.fasb.org/extlink&amp;oid=27010918&amp;loc=d3e74512-122707<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>93
<FILENAME>R37.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3</span><table class="report" border="0" cellspacing="2" id="idp6762665568">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies - Schedule of Earnings Per Share, Basic and Diluted (Details) (10-K) - USD ($)<br></strong></div></th>
<th class="th" colspan="4">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2019</div></th>
<th class="th"><div>Mar. 31, 2019</div></th>
<th class="th"><div>Jun. 30, 2018</div></th>
<th class="th"><div>Mar. 31, 2018</div></th>
<th class="th"><div>Jun. 30, 2019</div></th>
<th class="th"><div>Jun. 30, 2018</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
<th class="th"><div>Dec. 31, 2017</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net Income</a></td>
<td class="nump">$ 57,981<span></span>
</td>
<td class="nump">$ 125,229<span></span>
</td>
<td class="nump">$ 20,513<span></span>
</td>
<td class="nump">$ 82,269<span></span>
</td>
<td class="nump">$ 183,210<span></span>
</td>
<td class="nump">$ 102,782<span></span>
</td>
<td class="nump">$ 9,038<span></span>
</td>
<td class="nump">$ 288,983<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_TRXD_NumeratorForBasicAndDilutedEpsIncomeLossAvailableToCommonShareholders', window );">Numerator for basic and diluted income available to common shareholders</a></td>
<td class="nump">$ 57,981<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 20,513<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 183,210<span></span>
</td>
<td class="nump">$ 102,782<span></span>
</td>
<td class="nump">$ 9,038<span></span>
</td>
<td class="nump">$ 288,983<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Denominator for basic income per common share - Weighted average common shares outstanding</a></td>
<td class="nump">33,726,489<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">31,985,827<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">33,546,329<span></span>
</td>
<td class="nump">31,985,827<span></span>
</td>
<td class="nump">32,260,622<span></span>
</td>
<td class="nump">31,955,416<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment', window );">Dilutive effect of Common Stock Equivalents</a></td>
<td class="nump">2,627,262<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,493,579<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,807,422<span></span>
</td>
<td class="nump">2,486,984<span></span>
</td>
<td class="nump">2,697,880<span></span>
</td>
<td class="nump">2,130,835<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Denominator for diluted income per common share - adjusted weighted average common shares outstanding</a></td>
<td class="nump">36,353,751<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">34,479,406<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">36,353,751<span></span>
</td>
<td class="nump">34,472,811<span></span>
</td>
<td class="nump">34,958,502<span></span>
</td>
<td class="nump">34,086,251<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasicAndDiluted', window );">Basic and Diluted income per common share</a></td>
<td class="nump">$ 0.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="nump">$ 0.00<span></span>
</td>
<td class="nump">$ 0.00<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_TRXD_NumeratorForBasicAndDilutedEpsIncomeLossAvailableToCommonShareholders">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the monetary amount of Numerator for basic and diluted EPS - income (loss) Available to common shareholders, during the indicated time period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">TRXD_NumeratorForBasicAndDilutedEpsIncomeLossAvailableToCommonShareholders</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>TRXD_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasicAndDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income or loss for the period per each share in instances when basic and diluted earnings per share are the same amount and reported as a single line item on the face of the financial statements.  Basic earnings per share is the amount of net income or loss for the period per each share of common stock or unit outstanding during the reporting period.  Diluted earnings per share includes the amount of net income or loss for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=117326831&amp;loc=d3e1337-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasicAndDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=SL7669619-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=116637391&amp;loc=SL114874048-224260<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=SL7669625-108580<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=116637232&amp;loc=SL114874131-224263<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=116634182&amp;loc=SL114868664-224227<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3602-108585<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The sum of dilutive potential common shares or units used in the calculation of the diluted per-share or per-unit computation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=117326831&amp;loc=d3e1505-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=117326831&amp;loc=d3e1448-109256<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>94
<FILENAME>R33.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3</span><table class="report" border="0" cellspacing="2" id="idp6935279232">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Organization and Basis of Presentation (Details Narrative)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentOwnershipPercentage', window );">Ownership percentage</a></td>
<td class="nump">100.00%<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_TRXD_EquityMethodInvestmentDescription', window );">Equity method investment, description</a></td>
<td class="text">If the investments are less than 50% owned and more than 20% owned the entities use the equity method of accounting in accordance with ASC 323-10<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_TRXD_EquityMethodInvestmentDescription">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity method investment, description.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">TRXD_EquityMethodInvestmentDescription</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>TRXD_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentOwnershipPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentOwnershipPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>95
<FILENAME>R52.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3</span><table class="report" border="0" cellspacing="2" id="idp6774641952">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Options - Schedule of Stock Option Activity (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="4">1 Months Ended</th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>May 31, 2019</div></th>
<th class="th"><div>Apr. 30, 2019</div></th>
<th class="th"><div>Apr. 30, 2018</div></th>
<th class="th"><div>Apr. 30, 2017</div></th>
<th class="th"><div>Jun. 30, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
<th class="th"><div>Dec. 31, 2017</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Share-based Payment Arrangement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Number of Options Outstanding, Beginning Balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,732,846<span></span>
</td>
<td class="nump">1,197,846<span></span>
</td>
<td class="nump">1,044,500<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber', window );">Number of Options Exercisable, Beginning Balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,107,259<span></span>
</td>
<td class="nump">781,300<span></span>
</td>
<td class="nump">584,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Number of Options, Granted</a></td>
<td class="nump">505,000<span></span>
</td>
<td class="nump">505,000<span></span>
</td>
<td class="nump">560,400<span></span>
</td>
<td class="nump">253,846<span></span>
</td>
<td class="nump">505,000<span></span>
</td>
<td class="nump">560,400<span></span>
</td>
<td class="nump">263,846<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod', window );">Number of Options, Forfeited</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(25,400)<span></span>
</td>
<td class="num">(35,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod', window );">Number of Options, Expired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(75,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Number of Options Outstanding, Ending Balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,237,846<span></span>
</td>
<td class="nump">1,732,846<span></span>
</td>
<td class="nump">1,197,846<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber', window );">Number of Options Exercisable, Ending Balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,239,384<span></span>
</td>
<td class="nump">1,107,259<span></span>
</td>
<td class="nump">781,300<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Weighted Average Exercise Price Outstanding, Beginning Balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1.19<span></span>
</td>
<td class="nump">$ 0.97<span></span>
</td>
<td class="nump">$ 0.92<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice', window );">Weighted Average Exercise Price Exercisable, Beginning Balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.96<span></span>
</td>
<td class="nump">1.02<span></span>
</td>
<td class="nump">1.05<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice', window );">Weighted Average Exercise Price, Granted</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.43<span></span>
</td>
<td class="nump">0.50<span></span>
</td>
<td class="nump">0.64<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice', window );">Weighted Average Exercise Price, Forfeited</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">0.46<span></span>
</td>
<td class="nump">1.02<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice', window );">Weighted Average Exercise Price, Expired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">1.13<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Weighted Average Exercise Price Outstanding, Ending Balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.73<span></span>
</td>
<td class="nump">1.19<span></span>
</td>
<td class="nump">0.97<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice', window );">Weighted Average Exercise Price Exercisable, Ending Balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.91<span></span>
</td>
<td class="nump">$ 0.96<span></span>
</td>
<td class="nump">$ 1.02<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2', window );">Contractual Life in Years Outstanding, Beinning Balance</a></td>
<td class="text">10 years<span></span>
</td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">6 years 11 months 23 days<span></span>
</td>
<td class="text">6 years 11 months 15 days<span></span>
</td>
<td class="text">3 years 4 months 17 days<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1', window );">Contractual Life in Years Exercisable, Beinning Balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years 10 months 28 days<span></span>
</td>
<td class="text">6 years 3 months 19 days<span></span>
</td>
<td class="text">3 years 7 days<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_TRXD_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTermGranted', window );">Contractual Life in Years, Granted</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">9 years 10 months 10 days<span></span>
</td>
<td class="text">9 years 3 months 4 days<span></span>
</td>
<td class="text">9 years 18 days<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_TRXD_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTermForfeitures', window );">Contractual Life in Years, Forfeited</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">0 years<span></span>
</td>
<td class="text">9 years 22 days<span></span>
</td>
<td class="text">8 years 2 months 30 days<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_TRXD_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTermExpired', window );">Contractual Life in Years, Expired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">0 years<span></span>
</td>
<td class="text">0 years<span></span>
</td>
<td class="text">4 years 6 months 14 days<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_TRXD_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm', window );">Contractual Life in Years Outstanding, Ending Balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">7 years 3 months 8 days<span></span>
</td>
<td class="text">6 years 11 months 23 days<span></span>
</td>
<td class="text">6 years 11 months 15 days<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_TRXD_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm', window );">Contractual Life in Years Exercisable, Ending Balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years 9 months 7 days<span></span>
</td>
<td class="text">5 years 10 months 28 days<span></span>
</td>
<td class="text">6 years 3 months 19 days<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue', window );">Intrinsic Value Outstanding, Beginning Balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1', window );">Intrinsic Value Exercisable, Beginning Balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue', window );">Intrinsic Value Outstanding, Ending Balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">88,350<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1', window );">Intrinsic Value Exercisable, Ending Balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 8,809<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_TRXD_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Contractual Life in Years Exercisable, Ending Balance.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">TRXD_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>TRXD_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_TRXD_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTermExpired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Contractual Life in Years, Expired.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">TRXD_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTermExpired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>TRXD_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_TRXD_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTermForfeitures">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Contractual Life in Years, Forfeited.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">TRXD_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTermForfeitures</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>TRXD_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_TRXD_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTermGranted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Contractual Life in Years, Granted.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">TRXD_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTermGranted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>TRXD_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_TRXD_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term Granted.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">TRXD_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>TRXD_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of options or other stock instruments for which the right to exercise has lapsed under the terms of the plan agreements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Gross number of share options (or share units) granted during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of options outstanding, including both vested and non-vested options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees could have acquired the underlying shares with respect to stock options of the plan that expired.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees could have acquired the underlying shares with respect to stock options that were terminated.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of difference between fair value of the underlying shares reserved for issuance and exercise price of vested portions of options outstanding and currently exercisable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for vested portions of options outstanding and currently exercisable or convertible, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=116856206&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>96
<FILENAME>R56.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.19.3</span><table class="report" border="0" cellspacing="2" id="idp6767436624">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes (Details Narrative) (10-K)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Dec. 31, 2018 </div>
<div>USD ($)</div>
</th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate', window );">Federal corporate income tax rate</a></td>
<td class="nump">21.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExaminationDescription', window );">Income tax, description</a></td>
<td class="text">On December 22, 2017 H.R. 1, originally known as the Tax Cuts and Jobs Act, (the "Tax Act") was enacted. Among the significant changes to the U.S. Internal Revenue Code, the Tax Act lowers the U.S. federal corporate income tax rate ("Federal Tax Rate") from 35% to 21% effective January 1, 2018.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwards', window );">Net operating loss carry forwards</a></td>
<td class="nump">$ 4,400,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of domestic federal statutory tax rate applicable to pretax income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32698-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExaminationDescription">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A brief description of status of the tax examination, significant findings to date, and the entity's position with respect to the findings.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -Subparagraph (d)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32718-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExaminationDescription</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLossCarryforwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of operating loss carryforward, before tax effects, available to reduce future taxable income under enacted tax laws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32559-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLossCarryforwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
